ID   A0A024R497_HUMAN        Unreviewed;       720 AA.
AC   A0A024R497;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 29.
DE   SubName: Full=Acyl-CoA synthetase long-chain family member 3, isoform CRA_a {ECO:0000313|EMBL:EAW70809.1};
GN   Name=ACSL3 {ECO:0000313|EMBL:EAW70809.1};
GN   ORFNames=hCG_21017 {ECO:0000313|EMBL:EAW70809.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW70809.1};
RN   [1] {ECO:0000313|EMBL:EAW70809.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW70809.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471063; EAW70807.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70808.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70809.1; -; Genomic_DNA.
DR   RefSeq; NP_004448.2; NM_004457.3.
DR   RefSeq; NP_976251.1; NM_203372.1.
DR   RefSeq; XP_016859073.1; XM_017003584.1.
DR   UniGene; Hs.655772; -.
DR   SMR; A0A024R497; -.
DR   GeneID; 2181; -.
DR   KEGG; hsa:2181; -.
DR   CTD; 2181; -.
DR   EuPathDB; HostDB:ENSG00000123983.13; -.
DR   eggNOG; KOG1256; Eukaryota.
DR   eggNOG; COG1022; LUCA.
DR   KO; K01897; -.
DR   OMA; HDINRMY; -.
DR   OrthoDB; EOG091G02F4; -.
DR   ChiTaRS; ACSL3; human.
DR   GenomeRNAi; 2181; -.
DR   Bgee; ENSG00000123983; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   Pfam; PF00501; AMP-binding; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     21     44       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      129    587       AMP-binding. {ECO:0000259|Pfam:PF00501}.
SQ   SEQUENCE   720 AA;  80420 MW;  AAC4B0B4543EC8DD CRC64;
     MNNHVSSKPS TMKLKHTINP ILLYFIHFLI SLYTILTYIP FYFFSESRQE KSNRIKAKPV
     NSKPDSAYRS VNSLDGLASV LYPGCDTLDK VFTYAKNKFK NKRLLGTREV LNEEDEVQPN
     GKIFKKVILG QYNWLSYEDV FVRAFNFGNG LQMLGQKPKT NIAIFCETRA EWMIAAQACF
     MYNFQLVTLY ATLGGPAIVH ALNETEVTNI ITSKELLQTK LKDIVSLVPR LRHIITVDGK
     PPTWSEFPKG IIVHTMAAVE ALGAKASMEN QPHSKPLPSD IAVIMYTSGS TGLPKGVMIS
     HSNIIAGITG MAERIPELGE EDVYIGYLPL AHVLELSAEL VCLSHGCRIG YSSPQTLADQ
     SSKIKKGSKG DTSMLKPTLM AAVPEIMDRI YKNVMNKVSE MSSFQRNLFI LAYNYKMEQI
     SKGRNTPLCD SFVFRKVRSL LGGNIRLLLC GGAPLSATTQ RFMNICFCCP VGQGYGLTES
     AGAGTISEVW DYNTGRVGAP LVCCEIKLKN WEEGGYFNTD KPHPRGEILI GGQSVTMGYY
     KNEAKTKADF FEDENGQRWL CTGDIGEFEP DGCLKIIDRK KDLVKLQAGE YVSLGKVEAA
     LKNLPLVDNI CAYANSYHSY VIGFVVPNQK ELTELARKKG LKGTWEELCN SCEMENEVLK
     VLSEAAISAS LEKFEIPVKI RLSPEPWTPE TGLVTDAFKL KRKELKTHYQ ADIERMYGRK
//
ID   ACSL3_HUMAN             Reviewed;         720 AA.
AC   O95573; Q60I92; Q8IUM9;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 3.
DT   28-FEB-2018, entry version 162.
DE   RecName: Full=Long-chain-fatty-acid--CoA ligase 3;
DE            EC=6.2.1.3;
DE   AltName: Full=Long-chain acyl-CoA synthetase 3;
DE            Short=LACS 3;
GN   Name=ACSL3; Synonyms=ACS3, FACL3, LACS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-551.
RC   TISSUE=Placenta;
RX   PubMed=9177793; DOI=10.1006/geno.1997.4710;
RA   Minekura H., Fujino T., Kang M.-J., Fujita T., Endo Y., Yamamoto T.T.;
RT   "Human acyl-coenzyme A synthetase 3 cDNA and localization of its gene
RT   (ACS3) to chromosome band 2q34-q35.";
RL   Genomics 42:180-181(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT SER-551.
RX   PubMed=11707336; DOI=10.1016/S0378-1119(01)00714-4;
RA   Minekura H., Kang M.-J., Inagaki Y., Suzuki H., Sato H., Fujino T.,
RA   Yamamoto T.T.;
RT   "Genomic organization and transcription units of the human acyl-CoA
RT   synthetase 3 gene.";
RL   Gene 278:185-192(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION.
RX   PubMed=18003621; DOI=10.1074/jbc.M706160200;
RA   Yao H., Ye J.;
RT   "Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine
RT   synthesis is required for assembly of very low density lipoproteins in
RT   human hepatoma Huh7 cells.";
RL   J. Biol. Chem. 283:849-854(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-683, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-683, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Acyl-CoA synthetases (ACSL) activates long-chain fatty
CC       acids for both synthesis of cellular lipids, and degradation via
CC       beta-oxidation. ACSL3 mediates hepatic lipogenesis (By
CC       similarity). Preferentially uses myristate, laurate, arachidonate
CC       and eicosapentaenoate as substrates (By similarity). Has mainly an
CC       anabolic role in energy metabolism. Required for the incorporation
CC       of fatty acids into phosphatidylcholine, the major phospholipid
CC       located on the surface of VLDL (very low density lipoproteins).
CC       {ECO:0000250, ECO:0000269|PubMed:18003621}.
CC   -!- CATALYTIC ACTIVITY: ATP + a long-chain fatty acid + CoA = AMP +
CC       diphosphate + an acyl-CoA.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250};
CC       Single-pass type III membrane protein {ECO:0000250}. Peroxisome
CC       membrane {ECO:0000250}; Single-pass type III membrane protein
CC       {ECO:0000250}. Microsome membrane {ECO:0000250}; Single-pass type
CC       III membrane protein {ECO:0000250}. Endoplasmic reticulum membrane
CC       {ECO:0000250}; Single-pass type III membrane protein
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D89053; BAA37142.1; -; mRNA.
DR   EMBL; AB061712; BAB72074.1; -; mRNA.
DR   EMBL; AB061436; BAB72139.1; -; Genomic_DNA.
DR   EMBL; BC041692; AAH41692.1; -; mRNA.
DR   CCDS; CCDS2455.1; -.
DR   RefSeq; NP_004448.2; NM_004457.3.
DR   RefSeq; NP_976251.1; NM_203372.1.
DR   RefSeq; XP_016859073.1; XM_017003584.1.
DR   UniGene; Hs.655772; -.
DR   ProteinModelPortal; O95573; -.
DR   SMR; O95573; -.
DR   BioGrid; 108477; 40.
DR   IntAct; O95573; 37.
DR   MINT; O95573; -.
DR   STRING; 9606.ENSP00000350012; -.
DR   DrugBank; DB00159; Icosapent.
DR   SwissLipids; SLP:000000200; -.
DR   iPTMnet; O95573; -.
DR   PhosphoSitePlus; O95573; -.
DR   SwissPalm; O95573; -.
DR   BioMuta; ACSL3; -.
DR   EPD; O95573; -.
DR   MaxQB; O95573; -.
DR   PaxDb; O95573; -.
DR   PeptideAtlas; O95573; -.
DR   PRIDE; O95573; -.
DR   Ensembl; ENST00000357430; ENSP00000350012; ENSG00000123983.
DR   Ensembl; ENST00000392066; ENSP00000375918; ENSG00000123983.
DR   GeneID; 2181; -.
DR   KEGG; hsa:2181; -.
DR   UCSC; uc002vni.4; human.
DR   CTD; 2181; -.
DR   DisGeNET; 2181; -.
DR   EuPathDB; HostDB:ENSG00000123983.13; -.
DR   GeneCards; ACSL3; -.
DR   HGNC; HGNC:3570; ACSL3.
DR   HPA; HPA011315; -.
DR   HPA; HPA071021; -.
DR   MIM; 602371; gene.
DR   neXtProt; NX_O95573; -.
DR   OpenTargets; ENSG00000123983; -.
DR   PharmGKB; PA27967; -.
DR   eggNOG; KOG1256; Eukaryota.
DR   eggNOG; COG1022; LUCA.
DR   GeneTree; ENSGT00870000136474; -.
DR   HOGENOM; HOG000159459; -.
DR   HOVERGEN; HBG106947; -.
DR   InParanoid; O95573; -.
DR   KO; K01897; -.
DR   OMA; HDINRMY; -.
DR   OrthoDB; EOG091G02F4; -.
DR   PhylomeDB; O95573; -.
DR   TreeFam; TF314012; -.
DR   BioCyc; MetaCyc:HS04703-MONOMER; -.
DR   BRENDA; 6.2.1.3; 2681.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   ChiTaRS; ACSL3; human.
DR   GeneWiki; ACSL3; -.
DR   GenomeRNAi; 2181; -.
DR   PRO; PR:O95573; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000123983; -.
DR   CleanEx; HS_ACSL3; -.
DR   ExpressionAtlas; O95573; baseline and differential.
DR   Genevisible; O95573; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005811; C:lipid droplet; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0102391; F:decanoate--CoA ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IMP:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0044539; P:long-chain fatty acid import; IDA:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0042998; P:positive regulation of Golgi to plasma membrane protein transport; IMP:UniProtKB.
DR   GO; GO:2001247; P:positive regulation of phosphatidylcholine biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0051047; P:positive regulation of secretion; IMP:UniProtKB.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0034379; P:very-low-density lipoprotein particle assembly; IMP:UniProtKB.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   Pfam; PF00501; AMP-binding; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Endoplasmic reticulum;
KW   Fatty acid metabolism; Ligase; Lipid metabolism; Magnesium; Membrane;
KW   Microsome; Mitochondrion; Mitochondrion outer membrane;
KW   Nucleotide-binding; Peroxisome; Phosphoprotein; Polymorphism;
KW   Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1    720       Long-chain-fatty-acid--CoA ligase 3.
FT                                /FTId=PRO_0000193107.
FT   TRANSMEM     21     41       Helical; Signal-anchor for type III
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     42    720       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     683    683       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT     551    551       F -> S (in dbSNP:rs1046032).
FT                                {ECO:0000269|PubMed:11707336,
FT                                ECO:0000269|PubMed:9177793}.
FT                                /FTId=VAR_026716.
FT   CONFLICT    246    246       E -> D (in Ref. 1; BAA37142 and 2;
FT                                BAB72074/BAB72139). {ECO:0000305}.
SQ   SEQUENCE   720 AA;  80420 MW;  AAC4B0B4543EC8DD CRC64;
     MNNHVSSKPS TMKLKHTINP ILLYFIHFLI SLYTILTYIP FYFFSESRQE KSNRIKAKPV
     NSKPDSAYRS VNSLDGLASV LYPGCDTLDK VFTYAKNKFK NKRLLGTREV LNEEDEVQPN
     GKIFKKVILG QYNWLSYEDV FVRAFNFGNG LQMLGQKPKT NIAIFCETRA EWMIAAQACF
     MYNFQLVTLY ATLGGPAIVH ALNETEVTNI ITSKELLQTK LKDIVSLVPR LRHIITVDGK
     PPTWSEFPKG IIVHTMAAVE ALGAKASMEN QPHSKPLPSD IAVIMYTSGS TGLPKGVMIS
     HSNIIAGITG MAERIPELGE EDVYIGYLPL AHVLELSAEL VCLSHGCRIG YSSPQTLADQ
     SSKIKKGSKG DTSMLKPTLM AAVPEIMDRI YKNVMNKVSE MSSFQRNLFI LAYNYKMEQI
     SKGRNTPLCD SFVFRKVRSL LGGNIRLLLC GGAPLSATTQ RFMNICFCCP VGQGYGLTES
     AGAGTISEVW DYNTGRVGAP LVCCEIKLKN WEEGGYFNTD KPHPRGEILI GGQSVTMGYY
     KNEAKTKADF FEDENGQRWL CTGDIGEFEP DGCLKIIDRK KDLVKLQAGE YVSLGKVEAA
     LKNLPLVDNI CAYANSYHSY VIGFVVPNQK ELTELARKKG LKGTWEELCN SCEMENEVLK
     VLSEAAISAS LEKFEIPVKI RLSPEPWTPE TGLVTDAFKL KRKELKTHYQ ADIERMYGRK
//
ID   B4DJU9_HUMAN            Unreviewed;       849 AA.
AC   B4DJU9;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 32.
DE   SubName: Full=cDNA FLJ55278, highly similar to AF4/FMR2 family member 1 {ECO:0000313|EMBL:BAG58961.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58961.1};
RN   [1] {ECO:0000313|EMBL:BAG58961.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thalamus {ECO:0000313|EMBL:BAG58961.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK296243; BAG58961.1; -; mRNA.
DR   RefSeq; NP_001300889.1; NM_001313960.1.
DR   UniGene; Hs.480190; -.
DR   PeptideAtlas; B4DJU9; -.
DR   GeneID; 4299; -.
DR   CTD; 4299; -.
DR   eggNOG; ENOG410IGJB; Eukaryota.
DR   eggNOG; ENOG410XRXU; LUCA.
DR   HOVERGEN; HBG004189; -.
DR   InterPro; IPR007797; TF_AF4/FMR2.
DR   PANTHER; PTHR10528; PTHR10528; 1.
DR   Pfam; PF05110; AF-4; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   849 AA;  91610 MW;  9812BA3843CC0608 CRC64;
     MTHSWPPPLT AIHTPSTAEP SKFPFPTKDS QHVSSVTQNQ KQYDTSSKTH SNSQQGTSSM
     LEDDLQLSDS EDSDSEQTPE KPPSSSAPPS APQSLPEPVA SAHSSSAESE STSDSDSSSD
     SESESSSSDS EENEPLETPA PEPEPPTTNK WQLDNWLTKV SQPAAPPEGP RSTEPPRRHP
     ESKGSSDSAT SQEHSESKDP PPKSSSKAPR APPEAPHPGK RSCQKSPAQQ EPPQRQTVGT
     KQPKKPVKAS ARAGSRTSLQ GEREPGLLPY GSRDQTSKDK PKVKTKGRPR AAASNEPKPA
     VPPSSEKKKH KSSLPAPSKA LSGPEPAKDN VEDRTPEHFA LVPLTESQGP PHSGSGSRTS
     GCRQAVVVQE DSRKDRLPLP LRDTKLLSPL RDTPPPQSLM VKITLDLLSR IPQPPGKGSR
     QRKAEDKQPP AGKKHSSEKR SSDSSSKLAK KRKGEAERDC DNKKIRLEKE IKSQSSSSSS
     SHKESSKTKP SRPSSQSSKK EMLPPPPVSS SSQKPAKPAL KRSRREADTC GQDPPKSASS
     TKSNHKDSSI PKQRRVEGKG SRSSSEHKGS SGDTANPFPV PSLPNGNSKP GKPQVKFDKQ
     QADLHMREAK KMKQKAELMT DRVGKAFKYL EAVLSFIECG IATESESQSS KSAYSVYSET
     VDLIKFIMSL KSFSDATAPT QEKIFAVLCM RCQSILNMAM FRCKKDIAIK YSRTLNKHFE
     SSSKVAQAPS PCIARSTGTP SPLSPMPSPA SSVGSQSSAG SVGSSGVAAT ISTPVTIQNM
     TSSYVTTTSH VLTAFDLWEQ AEALTRKNKE FFARLSTNVC TLALNSSLVD LVHYTRQGFQ
     QLQELTKTP
//
ID   AFF1_HUMAN              Reviewed;        1210 AA.
AC   P51825; B4DTU1; E9PBM3;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   28-FEB-2018, entry version 152.
DE   RecName: Full=AF4/FMR2 family member 1;
DE   AltName: Full=ALL1-fused gene from chromosome 4 protein;
DE            Short=Protein AF-4;
DE   AltName: Full=Protein FEL;
DE   AltName: Full=Proto-oncogene AF4;
GN   Name=AFF1; Synonyms=AF4, FEL, MLLT2, PBM1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8506309; DOI=10.1073/pnas.90.10.4631;
RA   Nakamura T., Alder H., Gu Y., Prasad R., Canaani O., Kamada N.,
RA   Gale R.P., Lange B., Crist W.M., Nowell P.C., Croce C.M., Canaani E.;
RT   "Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in
RT   acute leukemia share sequence homology and/or common motifs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:4631-4635(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND CHROMOSOMAL TRANSLOCATION
RP   WITH KMT2A.
RX   PubMed=8443374;
RA   Morrissey J., Tkachuk D.C., Milatovich A., Francke U., Link M.,
RA   Cleary M.L.;
RT   "A serine/proline-rich protein is fused to HRX in t(4;11) acute
RT   leukemias.";
RL   Blood 81:1124-1131(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   CHROMOSOMAL TRANSLOCATION WITH KMT2A.
RX   PubMed=1423625; DOI=10.1016/0092-8674(92)90603-A;
RA   Gu Y., Nakamura T., Alder H., Prasad R., Canaani O., Cimino G.,
RA   Croce C.M., Canaani E.;
RT   "The t(4;11) chromosome translocation of human acute leukemias fuses
RT   the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene.";
RL   Cell 71:701-708(1992).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206; SER-212 AND
RP   THR-697, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206; SER-212; THR-220;
RP   SER-750 AND THR-755, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206; SER-212; SER-588
RP   AND SER-750, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206 AND SER-750, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-681, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=22195968; DOI=10.1016/j.molcel.2011.12.008;
RA   Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D.,
RA   Jackson J., Saraf A., Swanson S.K., Seidel C., Florens L.,
RA   Washburn M.P., Eissenberg J.C., Shilatifard A.;
RT   "The little elongation complex regulates small nuclear RNA
RT   transcription.";
RL   Mol. Cell 44:954-965(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-697, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   REVIEW ON THE SUPER ELONGATION COMPLEX.
RX   PubMed=22895430; DOI=10.1038/nrm3417;
RA   Luo Z., Lin C., Shilatifard A.;
RT   "The super elongation complex (SEC) family in transcriptional
RT   control.";
RL   Nat. Rev. Mol. Cell Biol. 13:543-547(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-588 AND SER-750, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   STRUCTURE BY NMR OF 738-779 IN COMPLEX WITH MLLT3.
RX   PubMed=23260655; DOI=10.1016/j.str.2012.11.011;
RA   Leach B.I., Kuntimaddi A., Schmidt C.R., Cierpicki T., Johnson S.A.,
RA   Bushweller J.H.;
RT   "Leukemia fusion target AF9 is an intrinsically disordered
RT   transcriptional regulator that recruits multiple partners via coupled
RT   folding and binding.";
RL   Structure 21:176-183(2013).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-1204.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- SUBUNIT: Component of the super elongation complex (SEC), at least
CC       composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the
CC       P-TEFb complex and ELL (ELL, ELL2 or ELL3).
CC       {ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:23260655}.
CC   -!- INTERACTION:
CC       P42568:MLLT3; NbExp=7; IntAct=EBI-2610180, EBI-716132;
CC       P04608:tat (xeno); NbExp=3; IntAct=EBI-2610180, EBI-6164389;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P51825-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51825-2; Sequence=VSP_046095, VSP_046096;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P51825-3; Sequence=VSP_046096;
CC   -!- DISEASE: Note=A chromosomal aberration involving AFF1 is
CC       associated with acute leukemias. Translocation t(4;11)(q21;q23)
CC       with KMT2A/MLL1. The result is a rogue activator protein.
CC   -!- SIMILARITY: Belongs to the AF4 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36642.1; Type=Frameshift; Positions=897, 905, 1178; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF4ID3.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L13773; AAA58360.1; -; mRNA.
DR   EMBL; L25050; AAA36642.1; ALT_FRAME; mRNA.
DR   EMBL; AK300364; BAG62103.1; -; mRNA.
DR   EMBL; AC092658; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093779; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093827; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS3616.1; -. [P51825-1]
DR   CCDS; CCDS54775.1; -. [P51825-2]
DR   PIR; A58198; A58198.
DR   PIR; I39410; I39410.
DR   RefSeq; NP_001160165.1; NM_001166693.2. [P51825-2]
DR   RefSeq; NP_001300888.1; NM_001313959.1. [P51825-3]
DR   RefSeq; NP_001300889.1; NM_001313960.1.
DR   RefSeq; NP_005926.1; NM_005935.3. [P51825-1]
DR   RefSeq; XP_005263064.1; XM_005263007.3. [P51825-2]
DR   RefSeq; XP_011530275.1; XM_011531973.2. [P51825-2]
DR   UniGene; Hs.480190; -.
DR   PDB; 2LM0; NMR; -; A=738-779.
DR   PDBsum; 2LM0; -.
DR   ProteinModelPortal; P51825; -.
DR   SMR; P51825; -.
DR   BioGrid; 110445; 41.
DR   CORUM; P51825; -.
DR   DIP; DIP-56407N; -.
DR   IntAct; P51825; 24.
DR   MINT; P51825; -.
DR   STRING; 9606.ENSP00000378578; -.
DR   iPTMnet; P51825; -.
DR   PhosphoSitePlus; P51825; -.
DR   BioMuta; AFF1; -.
DR   DMDM; 1703194; -.
DR   EPD; P51825; -.
DR   MaxQB; P51825; -.
DR   PaxDb; P51825; -.
DR   PeptideAtlas; P51825; -.
DR   PRIDE; P51825; -.
DR   Ensembl; ENST00000307808; ENSP00000305689; ENSG00000172493. [P51825-1]
DR   Ensembl; ENST00000395146; ENSP00000378578; ENSG00000172493. [P51825-2]
DR   GeneID; 4299; -.
DR   KEGG; hsa:4299; -.
DR   UCSC; uc003hqj.5; human. [P51825-1]
DR   CTD; 4299; -.
DR   DisGeNET; 4299; -.
DR   EuPathDB; HostDB:ENSG00000172493.20; -.
DR   GeneCards; AFF1; -.
DR   HGNC; HGNC:7135; AFF1.
DR   HPA; HPA069947; -.
DR   MalaCards; AFF1; -.
DR   MIM; 159557; gene.
DR   neXtProt; NX_P51825; -.
DR   OpenTargets; ENSG00000172493; -.
DR   Orphanet; 99860; Precursor B-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA30851; -.
DR   eggNOG; ENOG410IGJB; Eukaryota.
DR   eggNOG; ENOG410XRXU; LUCA.
DR   GeneTree; ENSGT00530000063217; -.
DR   HOGENOM; HOG000246991; -.
DR   HOVERGEN; HBG004189; -.
DR   InParanoid; P51825; -.
DR   KO; K15184; -.
DR   OMA; QGTSMLE; -.
DR   OrthoDB; EOG091G0KKW; -.
DR   PhylomeDB; P51825; -.
DR   TreeFam; TF326216; -.
DR   SIGNOR; P51825; -.
DR   ChiTaRS; AFF1; human.
DR   GeneWiki; AFF1; -.
DR   GenomeRNAi; 4299; -.
DR   PRO; PR:P51825; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000172493; -.
DR   CleanEx; HS_AFF1; -.
DR   ExpressionAtlas; P51825; baseline and differential.
DR   Genevisible; P51825; HS.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; TAS:ProtInc.
DR   InterPro; IPR007797; TF_AF4/FMR2.
DR   PANTHER; PTHR10528; PTHR10528; 1.
DR   Pfam; PF05110; AF-4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome; Nucleus; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome.
FT   CHAIN         1   1210       AF4/FMR2 family member 1.
FT                                /FTId=PRO_0000215910.
FT   COMPBIAS    483    492       Poly-Ser.
FT   COMPBIAS    835    843       Poly-Ser.
FT   COMPBIAS    866    869       Poly-Pro.
FT   COMPBIAS    871    874       Poly-Ser.
FT   MOD_RES     199    199       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88573}.
FT   MOD_RES     206    206       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     212    212       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES     220    220       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     588    588       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     681    681       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     697    697       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     750    750       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     755    755       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ       1      5       MAAQS -> MAFTERVNSSGN (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046095.
FT   VAR_SEQ    1096   1096       A -> AR (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:8443374}.
FT                                /FTId=VSP_046096.
FT   VARIANT     209    209       P -> A (in dbSNP:rs3733378).
FT                                /FTId=VAR_020370.
FT   VARIANT    1204   1204       Q -> K (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036130.
FT   CONFLICT     46     46       K -> R (in Ref. 2; AAA36642).
FT                                {ECO:0000305}.
FT   CONFLICT    624    624       E -> G (in Ref. 2; AAA36642).
FT                                {ECO:0000305}.
FT   CONFLICT    762    762       M -> V (in Ref. 3; BAG62103).
FT                                {ECO:0000305}.
FT   CONFLICT    820    820       R -> G (in Ref. 3; BAG62103).
FT                                {ECO:0000305}.
FT   CONFLICT    899    905       SASSTKS -> VPAVPRV (in Ref. 2; AAA36642).
FT                                {ECO:0000305}.
FT   CONFLICT    928    929       EH -> AD (in Ref. 2; AAA36642).
FT                                {ECO:0000305}.
FT   CONFLICT    999    999       I -> N (in Ref. 2; AAA36642).
FT                                {ECO:0000305}.
FT   CONFLICT   1140   1140       N -> I (in Ref. 2; AAA36642).
FT                                {ECO:0000305}.
FT   TURN        768    770       {ECO:0000244|PDB:2LM0}.
SQ   SEQUENCE   1210 AA;  131422 MW;  F0E334DF8FC2FF04 CRC64;
     MAAQSSLYND DRNLLRIREK ERRNQEAHQE KEAFPEKIPL FGEPYKTAKG DELSSRIQNM
     LGNYEEVKEF LSTKSHTHRL DASENRLGKP KYPLIPDKGS SIPSSSFHTS VHHQSIHTPA
     SGPLSVGNIS HNPKMAQPRT EPMPSLHAKS CGPPDSQHLT QDRLGQEGFG SSHHKKGDRR
     ADGDHCASVT DSAPERELSP LISLPSPVPP LSPIHSNQQT LPRTQGSSKV HGSSNNSKGY
     CPAKSPKDLA VKVHDKETPQ DSLVAPAQPP SQTFPPPSLP SKSVAMQQKP TAYVRPMDGQ
     DQAPSESPEL KPLPEDYRQQ TFEKTDLKVP AKAKLTKLKM PSQSVEQTYS NEVHCVEEIL
     KEMTHSWPPP LTAIHTPSTA EPSKFPFPTK DSQHVSSVTQ NQKQYDTSSK THSNSQQGTS
     SMLEDDLQLS DSEDSDSEQT PEKPPSSSAP PSAPQSLPEP VASAHSSSAE SESTSDSDSS
     SDSESESSSS DSEENEPLET PAPEPEPPTT NKWQLDNWLT KVSQPAAPPE GPRSTEPPRR
     HPESKGSSDS ATSQEHSESK DPPPKSSSKA PRAPPEAPHP GKRSCQKSPA QQEPPQRQTV
     GTKQPKKPVK ASARAGSRTS LQGEREPGLL PYGSRDQTSK DKPKVKTKGR PRAAASNEPK
     PAVPPSSEKK KHKSSLPAPS KALSGPEPAK DNVEDRTPEH FALVPLTESQ GPPHSGSGSR
     TSGCRQAVVV QEDSRKDRLP LPLRDTKLLS PLRDTPPPQS LMVKITLDLL SRIPQPPGKG
     SRQRKAEDKQ PPAGKKHSSE KRSSDSSSKL AKKRKGEAER DCDNKKIRLE KEIKSQSSSS
     SSSHKESSKT KPSRPSSQSS KKEMLPPPPV SSSSQKPAKP ALKRSRREAD TCGQDPPKSA
     SSTKSNHKDS SIPKQRRVEG KGSRSSSEHK GSSGDTANPF PVPSLPNGNS KPGKPQVKFD
     KQQADLHMRE AKKMKQKAEL MTDRVGKAFK YLEAVLSFIE CGIATESESQ SSKSAYSVYS
     ETVDLIKFIM SLKSFSDATA PTQEKIFAVL CMRCQSILNM AMFRCKKDIA IKYSRTLNKH
     FESSSKVAQA PSPCIASTGT PSPLSPMPSP ASSVGSQSSA GSVGSSGVAA TISTPVTIQN
     MTSSYVTITS HVLTAFDLWE QAEALTRKNK EFFARLSTNV CTLALNSSLV DLVHYTRQGF
     QQLQELTKTP
//
ID   Q14C88_HUMAN            Unreviewed;      1211 AA.
AC   Q14C88;
DT   22-AUG-2006, integrated into UniProtKB/TrEMBL.
DT   22-AUG-2006, sequence version 1.
DT   28-FEB-2018, entry version 83.
DE   SubName: Full=AF4/FMR2 family, member 1 {ECO:0000313|EMBL:AAI14931.1};
DE   SubName: Full=AF4/FMR2 family, member 1, isoform CRA_b {ECO:0000313|EMBL:EAX05979.1};
GN   Name=AFF1 {ECO:0000313|EMBL:AAI14931.1};
GN   ORFNames=hCG_1816301 {ECO:0000313|EMBL:EAX05979.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI14931.1};
RN   [1] {ECO:0000313|EMBL:EAX05979.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAI14931.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000313|EMBL:EAX05979.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC114930; AAI14931.1; -; mRNA.
DR   EMBL; CH471057; EAX05979.1; -; Genomic_DNA.
DR   RefSeq; NP_001160165.1; NM_001166693.2.
DR   RefSeq; NP_001300888.1; NM_001313959.1.
DR   RefSeq; NP_001300889.1; NM_001313960.1.
DR   RefSeq; NP_005926.1; NM_005935.3.
DR   UniGene; Hs.480190; -.
DR   SMR; Q14C88; -.
DR   GeneID; 4299; -.
DR   KEGG; hsa:4299; -.
DR   CTD; 4299; -.
DR   PharmGKB; PA30851; -.
DR   eggNOG; ENOG410IGJB; Eukaryota.
DR   eggNOG; ENOG410XRXU; LUCA.
DR   HOGENOM; HOG000246991; -.
DR   HOVERGEN; HBG004189; -.
DR   KO; K15184; -.
DR   ChiTaRS; AFF1; human.
DR   InterPro; IPR007797; TF_AF4/FMR2.
DR   PANTHER; PTHR10528; PTHR10528; 1.
DR   Pfam; PF05110; AF-4; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   1211 AA;  131578 MW;  FD08BE7A2BE38BFC CRC64;
     MAAQSSLYND DRNLLRIREK ERRNQEAHQE KEAFPEKIPL FGEPYKTAKG DELSSRIQNM
     LGNYEEVKEF LSTKSHTHRL DASENRLGKP KYPLIPDKGS SIPSSSFHTS VHHQSIHTPA
     SGPLSVGNIS HNPKMAQPRT EPMPSLHAKS CGPPDSQHLT QDRLGQEGFG SSHHKKGDRR
     ADGDHCASVT DSAPERELSP LISLPSPVPP LSPIHSNQQT LPRTQGSSKV HGSSNNSKGY
     CPAKSPKDLA VKVHDKETPQ DSLVAPAQPP SQTFPPPSLP SKSVAMQQKP TAYVRPMDGQ
     DQAPSESPEL KPLPEDYRQQ TFEKTDLKVP AKAKLTKLKM PSQSVEQTYS NEVHCVEEIL
     KEMTHSWPPP LTAIHTPSTA EPSKFPFPTK DSQHVSSVTQ NQKQYDTSSK THSNSQQGTS
     SMLEDDLQLS DSEDSDSEQT PEKPPSSSAP PSAPQSLPEP VASAHSSSAE SESTSDSDSS
     SDSESESSSS DSEENEPLET PAPEPEPPTT NKWQLDNWLT KVSQPAAPPE GPRSTEPPRR
     HPESKGSSDS ATSQEHSESK DPPPKSSSKA PRAPPEAPHP GKRSCQKSPA QQEPPQRQTV
     GTKQPKKPVK ASARAGSRTS LQGEREPGLL PYGSRDQTSK DKPKVKTKGR PRAAASNEPK
     PAVPPSSEKK KHKSSLPAPS KALSGPEPAK DNVEDRTPEH FALVPLTESQ GPPHSGSGSR
     TSGCRQAVVV QEDSRKDRLP LPLRDTKLLS PLRDTPPPQS LMVKITLDLL SRIPQPPGKG
     SRQRKAEDKQ PPAGKKHSSE KRSSDSSSKL AKKRKGEAER DCDNKKIRLE KEIKSQSSSS
     SSSHKESSKT KPSRPSSQSS KKEMLPPPPV SSSSQKPAKP ALKRSRREAD TCGQDPPKSA
     SSTKSNHKDS SIPKQRRVEG KGSRSSSEHK GSSGDTANPF PVPSLPNGNS KPGKPQVKFD
     KQQADLHMRE AKKMKQKAEL MTDRVGKAFK YLEAVLSFIE CGIATESESQ SSKSAYSVYS
     ETVDLIKFIM SLKSFSDATA PTQEKIFAVL CMRCQSILNM AMFRCKKDIA IKYSRTLNKH
     FESSSKVAQA PSPCIARSTG TPSPLSPMPS PASSVGSQSS AGSVGSSGVA ATISTPVTIQ
     NMTSSYVTIT SHVLTAFDLW EQAEALTRKN KEFFARLSTN VCTLALNSSL VDLVHYTRQG
     FQQLQELTKT P
//
ID   ASPC1_HUMAN             Reviewed;         553 AA.
AC   Q9BZE9; A8K3K9; Q7Z6N7; Q8WV59; Q96LS5; Q96M40;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   28-FEB-2018, entry version 128.
DE   RecName: Full=Tether containing UBX domain for GLUT4;
DE   AltName: Full=Alveolar soft part sarcoma chromosomal region candidate gene 1 protein;
DE   AltName: Full=Alveolar soft part sarcoma locus;
DE   AltName: Full=Renal papillary cell carcinoma protein 17;
DE   AltName: Full=UBX domain-containing protein 9;
GN   Name=ASPSCR1; Synonyms=ASPL, RCC17, TUG, UBXD9, UBXN9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION WITH
RP   TFE3, TISSUE SPECIFICITY, AND INVOLVEMENT IN ASPS.
RX   PubMed=11244503; DOI=10.1038/sj.onc.1204074;
RA   Ladanyi M., Lui M.Y., Antonescu C.R., Krause-Boehm A., Meindl A.,
RA   Argani P., Healey J.H., Ueda T., Yoshikawa H., Meloni-Ehrig A.,
RA   Sorensen P.H.B., Mertens F., Mandahl N., van den Berghe H., Sciot R.,
RA   Dal Cin P., Bridge J.;
RT   "The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses
RT   the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.";
RL   Oncogene 20:48-57(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND
RP   VARIANT GLN-252.
RC   TISSUE=Brain, Heart, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), AND VARIANT
RP   GLN-252.
RC   TISSUE=Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   CHROMOSOMAL TRANSLOCATION WITH TFE3, AND TISSUE SPECIFICITY.
RX   PubMed=11358836;
RA   Heimann P., El Housni H., Ogur G., Weterman M.A.J., Petty E.M.,
RA   Vassart G.;
RT   "Fusion of a novel gene, RCC17, to the TFE3 gene in
RT   t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas.";
RL   Cancer Res. 61:4130-4135(2001).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-500, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH VCP.
RX   PubMed=22207755; DOI=10.1074/jbc.M111.284232;
RA   Orme C.M., Bogan J.S.;
RT   "The ubiquitin regulatory X (UBX) domain-containing protein TUG
RT   regulates the p97 ATPase and resides at the endoplasmic reticulum-
RT   golgi intermediate compartment.";
RL   J. Biol. Chem. 287:6679-6692(2012).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275; SER-500 AND
RP   SER-502, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   FUNCTION IN VCP METHYLATION, INTERACTION WITH VCPKMT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine
RT   methyltransferases preferentially interact with molecular chaperones
RT   to regulate their activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275; SER-500 AND
RP   SER-502, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Tethering protein that sequesters GLUT4-containing
CC       vesicles in the cytoplasm in the absence of insulin. Modulates the
CC       amount of GLUT4 that is available at the cell surface (By
CC       similarity). Enhances VCP methylation catalyzed by VCPKMT.
CC       {ECO:0000250, ECO:0000269|PubMed:23349634}.
CC   -!- SUBUNIT: Interacts with GLUT4 (By similarity). Interacts with
CC       VCPKMT. Interacts with VCP. {ECO:0000250,
CC       ECO:0000269|PubMed:22207755, ECO:0000269|PubMed:23349634}.
CC   -!- INTERACTION:
CC       Q6UY14-3:ADAMTSL4; NbExp=3; IntAct=EBI-1993677, EBI-10173507;
CC       V9HW80:HEL-S-70; NbExp=3; IntAct=EBI-1993677, EBI-10175326;
CC       Q15323:KRT31; NbExp=3; IntAct=EBI-1993677, EBI-948001;
CC       P60410:KRTAP10-8; NbExp=3; IntAct=EBI-1993677, EBI-10171774;
CC       Q7Z3S9:NOTCH2NL; NbExp=3; IntAct=EBI-1993677, EBI-945833;
CC       Q9Y6A5:TACC3; NbExp=3; IntAct=EBI-1993677, EBI-2554984;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-1993677, EBI-533224;
CC       P55072:VCP; NbExp=6; IntAct=EBI-1993677, EBI-355164;
CC   -!- SUBCELLULAR LOCATION: Endomembrane system {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}. Endoplasmic reticulum-
CC       Golgi intermediate compartment membrane
CC       {ECO:0000269|PubMed:22207755}; Peripheral membrane protein.
CC       Cytoplasm {ECO:0000269|PubMed:23349634}. Nucleus
CC       {ECO:0000269|PubMed:23349634}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9BZE9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BZE9-2; Sequence=VSP_020578;
CC       Name=3;
CC         IsoId=Q9BZE9-3; Sequence=VSP_020574, VSP_020577;
CC       Name=4;
CC         IsoId=Q9BZE9-4; Sequence=VSP_020574, VSP_020575, VSP_020576;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in testis, heart,
CC       skeletal muscle and pancreas. {ECO:0000269|PubMed:11244503,
CC       ECO:0000269|PubMed:11358836}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ASPSCR1 is found
CC       in patients with alveolar soft part sarcoma. Translocation
CC       t(X;17)(p11;q25) with TFE3 forms a ASPSCR1-TFE3 fusion protein.
CC       {ECO:0000269|PubMed:11244503}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ASPSCR1 has been
CC       found in two patients with of papillary renal cell carcinoma.
CC       Translocation t(X;17)(p11.2;q25). {ECO:0000269|PubMed:11358836}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ASPSCR1ID358.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF324219; AAK08959.2; -; mRNA.
DR   EMBL; AK057403; BAB71472.1; -; mRNA.
DR   EMBL; AK057851; BAB71595.1; -; mRNA.
DR   EMBL; AK290624; BAF83313.1; -; mRNA.
DR   EMBL; BC006152; AAH06152.1; -; mRNA.
DR   EMBL; BC018722; AAH18722.1; -; mRNA.
DR   CCDS; CCDS11796.1; -. [Q9BZE9-1]
DR   CCDS; CCDS58611.1; -. [Q9BZE9-2]
DR   CCDS; CCDS82222.1; -. [Q9BZE9-3]
DR   RefSeq; NP_001238817.1; NM_001251888.1. [Q9BZE9-2]
DR   RefSeq; NP_001317457.1; NM_001330528.1. [Q9BZE9-3]
DR   RefSeq; NP_076988.1; NM_024083.3. [Q9BZE9-1]
DR   UniGene; Hs.298351; -.
DR   PDB; 5IFS; X-ray; 2.46 A; A/C=317-553.
DR   PDB; 5IFW; X-ray; 3.40 A; A=317-504.
DR   PDBsum; 5IFS; -.
DR   PDBsum; 5IFW; -.
DR   ProteinModelPortal; Q9BZE9; -.
DR   SMR; Q9BZE9; -.
DR   BioGrid; 122516; 51.
DR   IntAct; Q9BZE9; 15.
DR   MINT; Q9BZE9; -.
DR   STRING; 9606.ENSP00000302176; -.
DR   iPTMnet; Q9BZE9; -.
DR   PhosphoSitePlus; Q9BZE9; -.
DR   BioMuta; ASPSCR1; -.
DR   DMDM; 74717746; -.
DR   EPD; Q9BZE9; -.
DR   MaxQB; Q9BZE9; -.
DR   PaxDb; Q9BZE9; -.
DR   PeptideAtlas; Q9BZE9; -.
DR   PRIDE; Q9BZE9; -.
DR   DNASU; 79058; -.
DR   Ensembl; ENST00000306729; ENSP00000306625; ENSG00000169696. [Q9BZE9-2]
DR   Ensembl; ENST00000306739; ENSP00000302176; ENSG00000169696. [Q9BZE9-1]
DR   Ensembl; ENST00000580534; ENSP00000462329; ENSG00000169696. [Q9BZE9-3]
DR   GeneID; 79058; -.
DR   KEGG; hsa:79058; -.
DR   UCSC; uc002kcx.3; human. [Q9BZE9-1]
DR   CTD; 79058; -.
DR   DisGeNET; 79058; -.
DR   EuPathDB; HostDB:ENSG00000169696.15; -.
DR   GeneCards; ASPSCR1; -.
DR   H-InvDB; HIX0022398; -.
DR   HGNC; HGNC:13825; ASPSCR1.
DR   HPA; HPA026749; -.
DR   MalaCards; ASPSCR1; -.
DR   MIM; 606236; gene.
DR   neXtProt; NX_Q9BZE9; -.
DR   OpenTargets; ENSG00000169696; -.
DR   Orphanet; 163699; Alveolar soft-tissue sarcoma.
DR   Orphanet; 319308; Translocation renal cell carcinoma.
DR   PharmGKB; PA25058; -.
DR   eggNOG; KOG2699; Eukaryota.
DR   eggNOG; ENOG410XQQK; LUCA.
DR   GeneTree; ENSGT00910000144171; -.
DR   HOGENOM; HOG000231241; -.
DR   HOVERGEN; HBG066860; -.
DR   InParanoid; Q9BZE9; -.
DR   KO; K15627; -.
DR   OMA; AEEHCLK; -.
DR   OrthoDB; EOG091G0EB3; -.
DR   PhylomeDB; Q9BZE9; -.
DR   TreeFam; TF320363; -.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   SIGNOR; Q9BZE9; -.
DR   ChiTaRS; ASPSCR1; human.
DR   GeneWiki; ASPSCR1; -.
DR   GenomeRNAi; 79058; -.
DR   PRO; PR:Q9BZE9; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000169696; -.
DR   CleanEx; HS_ASPSCR1; -.
DR   ExpressionAtlas; Q9BZE9; baseline and differential.
DR   Genevisible; Q9BZE9; HS.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0019898; C:extrinsic component of membrane; IEA:Ensembl.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0012506; C:vesicle membrane; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:Ensembl.
DR   GO; GO:0031401; P:positive regulation of protein modification process; IMP:UniProtKB.
DR   GO; GO:0046324; P:regulation of glucose import; IEA:Ensembl.
DR   InterPro; IPR021569; TUG-UBL1.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR001012; UBX_dom.
DR   Pfam; PF11470; TUG-UBL1; 1.
DR   Pfam; PF00789; UBX; 1.
DR   SUPFAM; SSF54236; SSF54236; 2.
DR   PROSITE; PS50033; UBX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm; Membrane;
KW   Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    553       Tether containing UBX domain for GLUT4.
FT                                /FTId=PRO_0000249885.
FT   DOMAIN      386    462       UBX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00215}.
FT   REGION      317    380       Interaction with GLUT4. {ECO:0000250}.
FT   SITE        311    312       Breakpoint for translocation to form
FT                                ASPSCR1-TFE3.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     184    184       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VBT9}.
FT   MOD_RES     275    275       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     500    500       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     502    502       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1     77       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020574.
FT   VAR_SEQ     390    425       KVALRVLFPDRYVLQGFFRPSETVGDLRDFVRSHLG -> R
FT                                RSLSLSPRLESVVPSQLTASSASRVQVVLLPQPPK (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020575.
FT   VAR_SEQ     426    553       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020576.
FT   VAR_SEQ     434    434       F -> CLSSFGRMDGRGPRCFLTRRCLLSSV (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020577.
FT   VAR_SEQ     451    451       Q -> QPQLGDRVAPFTLGPSLKRCLGPEQRTRLPVVGDGG
FT                                DVDSGRLLFWGPSRGRASPSTGQPPCHPVCRPSSPPSPRPS
FT                                SGDPSRVKAGHKHVGTGR (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020578.
FT   VARIANT     252    252       L -> Q (in dbSNP:rs8074498).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027503.
FT   VARIANT     318    318       V -> M (in dbSNP:rs34085048).
FT                                /FTId=VAR_034745.
FT   VARIANT     487    487       D -> E (in dbSNP:rs13087).
FT                                /FTId=VAR_027504.
FT   CONFLICT    257    257       G -> E (in Ref. 2; BAB71595).
FT                                {ECO:0000305}.
FT   CONFLICT    444    444       D -> G (in Ref. 2; BAB71595).
FT                                {ECO:0000305}.
FT   STRAND      323    325       {ECO:0000244|PDB:5IFS}.
FT   HELIX       327    329       {ECO:0000244|PDB:5IFS}.
FT   HELIX       342    345       {ECO:0000244|PDB:5IFS}.
FT   HELIX       349    368       {ECO:0000244|PDB:5IFS}.
FT   HELIX       374    387       {ECO:0000244|PDB:5IFS}.
FT   STRAND      391    396       {ECO:0000244|PDB:5IFS}.
FT   STRAND      402    407       {ECO:0000244|PDB:5IFS}.
FT   HELIX       413    422       {ECO:0000244|PDB:5IFS}.
FT   STRAND      424    426       {ECO:0000244|PDB:5IFS}.
FT   STRAND      432    435       {ECO:0000244|PDB:5IFS}.
FT   TURN        436    439       {ECO:0000244|PDB:5IFS}.
FT   STRAND      445    448       {ECO:0000244|PDB:5IFW}.
FT   TURN        449    453       {ECO:0000244|PDB:5IFS}.
FT   STRAND      456    463       {ECO:0000244|PDB:5IFS}.
FT   HELIX       467    469       {ECO:0000244|PDB:5IFW}.
FT   HELIX       474    477       {ECO:0000244|PDB:5IFS}.
FT   HELIX       483    494       {ECO:0000244|PDB:5IFS}.
SQ   SEQUENCE   553 AA;  60183 MW;  B013FDF9A48D2E5E CRC64;
     MAAPAGGGGS AVSVLAPNGR RHTVKVTPST VLLQVLEDTC RRQDFNPCEY DLKFQRSVLD
     LSLQWRFANL PNNAKLEMVP ASRSREGPEN MVRIALQLDD GSRLQDSFCS GQTLWELLSH
     FPQIRECLQH PGGATPVCVY TRDEVTGEAA LRGTTLQSLG LTGGSATIRF VMKCYDPVGK
     TPGSLGSSAS AGQAAASAPL PLESGELSRG DLSRPEDADT SGPCCEHTQE KQSTRAPAAA
     PFVPFSGGGQ RLGGPPGPTR PLTSSSAKLP KSLSSPGGPS KPKKSKSGQD PQQEQEQERE
     RDPQQEQERE RPVDREPVDR EPVVCHPDLE ERLQAWPAEL PDEFFELTVD DVRRRLAQLK
     SERKRLEEAP LVTKAFREAQ IKEKLERYPK VALRVLFPDR YVLQGFFRPS ETVGDLRDFV
     RSHLGNPELS FYLFITPPKT VLDDHTQTLF QANLFPAALV HLGAEEPAGV YLEPGLLEHA
     ISPSAADVLV ARYMSRAAGS PSPLPAPDPA PKSEPAAEEG ALVPPEPIPG TAQPVKRSLG
     KVPKWLKLPA SKR
//
ID   PUR9_HUMAN              Reviewed;         592 AA.
AC   P31939; A8K202; E9PBU3; Q13856; Q53S28;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2002, sequence version 3.
DT   28-FEB-2018, entry version 185.
DE   RecName: Full=Bifunctional purine biosynthesis protein PURH;
DE   Includes:
DE     RecName: Full=Phosphoribosylaminoimidazolecarboxamide formyltransferase;
DE              EC=2.1.2.3;
DE     AltName: Full=5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase;
DE     AltName: Full=AICAR transformylase;
DE   Includes:
DE     RecName: Full=IMP cyclohydrolase;
DE              EC=3.5.4.10;
DE     AltName: Full=ATIC;
DE     AltName: Full=IMP synthase;
DE     AltName: Full=Inosinicase;
DE   Contains:
DE     RecName: Full=Bifunctional purine biosynthesis protein PURH, N-terminally processed;
GN   Name=ATIC; Synonyms=PURH; ORFNames=OK/SW-cl.86;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Hepatoma;
RX   PubMed=8567683; DOI=10.1074/jbc.271.4.2225;
RA   Rayl E.A., Moroson B.A., Beardsley G.P.;
RT   "The human purH gene product, 5-aminoimidazole-4-carboxamide
RT   ribonucleotide formyltransferase/IMP cyclohydrolase. Cloning,
RT   sequencing, expression, purification, kinetic analysis, and domain
RT   mapping.";
RL   J. Biol. Chem. 271:2225-2233(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=8867801; DOI=10.1093/dnares/2.6.269;
RA   Yamauchi M., Seki N., Mita K., Saito T., Tsuji S., Hongo E.,
RA   Morimyo M., Shiomi T., Koyama H.;
RT   "Isolation of human purH gene expressed in the rodent transformant
RT   cells by subtractive enrichment of 3'-untranslated region of human
RT   transcript.";
RL   DNA Res. 2:269-275(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=9378707; DOI=10.1093/oxfordjournals.jbchem.a021754;
RA   Sugita T., Aya H., Ueno M., Ishizuka T., Kawashima K.;
RT   "Characterization of molecularly cloned human 5-aminoimidazole-4-
RT   carboxamide ribonucleotide transformylase.";
RL   J. Biochem. 122:309-313(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-
RT   reactive CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   SER-116.
RC   TISSUE=Substantia nigra;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-116.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 15-39; 91-97; 178-194; 208-225; 267-285 AND
RP   417-426, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 178-189 AND 267-281.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=25687571; DOI=10.1074/mcp.M114.047159;
RA   Boutchueng-Djidjou M., Collard-Simard G., Fortier S., Hebert S.S.,
RA   Kelly I., Landry C.R., Faure R.L.;
RT   "The last enzyme of the de novo purine synthesis pathway 5-
RT   aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP
RT   cyclohydrolase (ATIC) plays a central role in insulin signaling and
RT   the Golgi/endosomes protein network.";
RL   Mol. Cell. Proteomics 14:1079-1092(2015).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH XMP, AND
RP   SUBUNIT.
RX   PubMed=14756553; DOI=10.1021/bi030162i;
RA   Wolan D.W., Cheong C.-G., Greasley S.E., Wilson I.A.;
RT   "Structural insights into the human and avian IMP cyclohydrolase
RT   mechanism via crystal structures with the bound XMP inhibitor.";
RL   Biochemistry 43:1171-1183(2004).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) IN COMPLEX WITH AICAR; XMP AND
RP   THE INHIBITORS BW1540 AND BW2315, FUNCTION, AND SUBUNIT.
RX   PubMed=14966129; DOI=10.1074/jbc.M313691200;
RA   Cheong C.-G., Wolan D.W., Greasley S.E., Horton P.A., Beardsley G.P.,
RA   Wilson I.A.;
RT   "Crystal structures of human bifunctional enzyme aminoimidazole-4-
RT   carboxamide ribonucleotide transformylase/IMP cyclohydrolase in
RT   complex with potent sulfonyl-containing antifolates.";
RL   J. Biol. Chem. 279:18034-18045(2004).
RN   [20]
RP   VARIANT AICAR ARG-426, AND CHARACTERIZATION OF VARIANT AICAR ARG-426.
RX   PubMed=15114530; DOI=10.1086/421475;
RA   Marie S., Heron B., Bitoun P., Timmerman T., Van Den Berghe G.,
RA   Vincent M.-F.;
RT   "AICA-ribosiduria: a novel, neurologically devastating inborn error of
RT   purine biosynthesis caused by mutation of ATIC.";
RL   Am. J. Hum. Genet. 74:1276-1281(2004).
CC   -!- FUNCTION: Bifunctional enzyme that catalyzes 2 steps in purine
CC       biosynthesis. {ECO:0000269|PubMed:14966129}.
CC   -!- FUNCTION: Promotes insulin receptor/INSR autophosphorylation and
CC       is involved in INSR internalization (PubMed:25687571).
CC       {ECO:0000269|PubMed:25687571}.
CC   -!- CATALYTIC ACTIVITY: 10-formyltetrahydrofolate + 5-amino-1-(5-
CC       phospho-D-ribosyl)imidazole-4-carboxamide = tetrahydrofolate + 5-
CC       formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide.
CC   -!- CATALYTIC ACTIVITY: IMP + H(2)O = 5-formamido-1-(5-phospho-D-
CC       ribosyl)imidazole-4-carboxamide.
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway;
CC       5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-
CC       amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl
CC       THF route): step 1/1.
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway;
CC       IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-
CC       carboxamide: step 1/1.
CC   -!- SUBUNIT: Homodimer (PubMed:14756553, PubMed:14966129). Associates
CC       with internalized INSR complexes on Golgi/endosomal membranes.
CC       Interacts with INSR; ATIC together with PRKAA2/AMPK2 and
CC       HACD3/PTPLAD1 is proposed to be part of a signaling network
CC       regulating INSR autophosphorylation and endocytosis
CC       (PubMed:25687571). {ECO:0000269|PubMed:14756553,
CC       ECO:0000269|PubMed:14966129, ECO:0000269|PubMed:25687571}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P31939-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P31939-2; Sequence=VSP_053495;
CC   -!- DOMAIN: The IMP cyclohydrolase activity resides in the N-terminal
CC       region.
CC   -!- DISEASE: AICAR transformylase/IMP cyclohydrolase deficiency
CC       (AICAR) [MIM:608688]: A neurologically devastating inborn error of
CC       purine biosynthesis. Patients excrete massive amounts of AICA-
CC       riboside in the urine and accumulate AICA-ribotide and its
CC       derivatives in erythrocytes and fibroblasts. AICAR causes profound
CC       mental retardation, epilepsy, dysmorphic features and congenital
CC       blindness. {ECO:0000269|PubMed:15114530}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PurH family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ATICID227.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U37436; AAA97405.1; -; mRNA.
DR   EMBL; D82348; BAA11559.1; -; mRNA.
DR   EMBL; D89976; BAA21762.1; -; mRNA.
DR   EMBL; AB062403; BAB93490.1; -; mRNA.
DR   EMBL; AK290067; BAF82756.1; -; mRNA.
DR   EMBL; AC073284; AAY24062.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70529.1; -; Genomic_DNA.
DR   EMBL; BC008879; AAH08879.1; -; mRNA.
DR   CCDS; CCDS2398.1; -. [P31939-1]
DR   PIR; JC4642; JC4642.
DR   RefSeq; NP_004035.2; NM_004044.6. [P31939-1]
DR   UniGene; Hs.90280; -.
DR   PDB; 1P4R; X-ray; 2.55 A; A/B=1-592.
DR   PDB; 1PKX; X-ray; 1.90 A; A/B/C/D=1-592.
DR   PDB; 1PL0; X-ray; 2.60 A; A/B/C/D=1-592.
DR   PDB; 5UY8; X-ray; 2.39 A; A/B/C/D=2-592.
DR   PDB; 5UZ0; X-ray; 1.79 A; A/B/C/D=2-592.
DR   PDBsum; 1P4R; -.
DR   PDBsum; 1PKX; -.
DR   PDBsum; 1PL0; -.
DR   PDBsum; 5UY8; -.
DR   PDBsum; 5UZ0; -.
DR   ProteinModelPortal; P31939; -.
DR   SMR; P31939; -.
DR   BioGrid; 106961; 72.
DR   IntAct; P31939; 9.
DR   STRING; 9606.ENSP00000236959; -.
DR   BindingDB; P31939; -.
DR   ChEMBL; CHEMBL2518; -.
DR   DrugBank; DB03442; 2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid.
DR   DrugBank; DB02309; 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine.
DR   DrugBank; DB01700; Aicar.
DR   DrugBank; DB01972; Guanosine-5'-Monophosphate.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB00642; Pemetrexed.
DR   DrugBank; DB00116; Tetrahydrofolic acid.
DR   iPTMnet; P31939; -.
DR   PhosphoSitePlus; P31939; -.
DR   SwissPalm; P31939; -.
DR   BioMuta; ATIC; -.
DR   DMDM; 23831360; -.
DR   REPRODUCTION-2DPAGE; IPI00289499; -.
DR   UCD-2DPAGE; P31939; -.
DR   EPD; P31939; -.
DR   PaxDb; P31939; -.
DR   PeptideAtlas; P31939; -.
DR   PRIDE; P31939; -.
DR   DNASU; 471; -.
DR   Ensembl; ENST00000236959; ENSP00000236959; ENSG00000138363. [P31939-1]
DR   Ensembl; ENST00000435675; ENSP00000415935; ENSG00000138363. [P31939-2]
DR   GeneID; 471; -.
DR   KEGG; hsa:471; -.
DR   UCSC; uc002vey.5; human. [P31939-1]
DR   CTD; 471; -.
DR   DisGeNET; 471; -.
DR   EuPathDB; HostDB:ENSG00000138363.14; -.
DR   GeneCards; ATIC; -.
DR   HGNC; HGNC:794; ATIC.
DR   HPA; CAB013462; -.
DR   HPA; HPA021012; -.
DR   MalaCards; ATIC; -.
DR   MIM; 601731; gene.
DR   MIM; 608688; phenotype.
DR   neXtProt; NX_P31939; -.
DR   OpenTargets; ENSG00000138363; -.
DR   Orphanet; 250977; AICA-ribosiduria.
DR   PharmGKB; PA25094; -.
DR   eggNOG; KOG2555; Eukaryota.
DR   eggNOG; COG0138; LUCA.
DR   GeneTree; ENSGT00390000004553; -.
DR   HOGENOM; HOG000230372; -.
DR   HOVERGEN; HBG006912; -.
DR   InParanoid; P31939; -.
DR   KO; K00602; -.
DR   OMA; DLLFAWK; -.
DR   OrthoDB; EOG091G03H4; -.
DR   PhylomeDB; P31939; -.
DR   TreeFam; TF105642; -.
DR   BioCyc; MetaCyc:HS06490-MONOMER; -.
DR   BRENDA; 2.1.2.3; 2681.
DR   BRENDA; 3.5.4.10; 2681.
DR   Reactome; R-HSA-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   SABIO-RK; P31939; -.
DR   UniPathway; UPA00074; UER00133.
DR   UniPathway; UPA00074; UER00135.
DR   ChiTaRS; ATIC; human.
DR   EvolutionaryTrace; P31939; -.
DR   GeneWiki; Inosine_monophosphate_synthase; -.
DR   GenomeRNAi; 471; -.
DR   PRO; PR:P31939; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000138363; -.
DR   CleanEx; HS_ATIC; -.
DR   ExpressionAtlas; P31939; baseline and differential.
DR   Genevisible; P31939; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0003937; F:IMP cyclohydrolase activity; TAS:Reactome.
DR   GO; GO:0004643; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity; TAS:Reactome.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0003360; P:brainstem development; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0046452; P:dihydrofolate metabolic process; IEA:Ensembl.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0009116; P:nucleoside metabolic process; IEA:Ensembl.
DR   GO; GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome.
DR   GO; GO:0010035; P:response to inorganic substance; IEA:Ensembl.
DR   GO; GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:Ensembl.
DR   Gene3D; 3.40.140.20; -; 3.
DR   Gene3D; 3.40.50.1380; -; 1.
DR   HAMAP; MF_00139; PurH; 1.
DR   InterPro; IPR024051; AICAR_Tfase_dup_dom_sf.
DR   InterPro; IPR016193; Cytidine_deaminase-like.
DR   InterPro; IPR011607; MGS-like_dom.
DR   InterPro; IPR036914; MGS-like_dom_sf.
DR   InterPro; IPR002695; PurH-like.
DR   PANTHER; PTHR11692; PTHR11692; 1.
DR   Pfam; PF01808; AICARFT_IMPCHas; 1.
DR   Pfam; PF02142; MGS; 1.
DR   PIRSF; PIRSF000414; AICARFT_IMPCHas; 1.
DR   SMART; SM00798; AICARFT_IMPCHas; 1.
DR   SMART; SM00851; MGS; 1.
DR   SUPFAM; SSF52335; SSF52335; 1.
DR   SUPFAM; SSF53927; SSF53927; 1.
DR   TIGRFAMs; TIGR00355; purH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Epilepsy; Hydrolase;
KW   Multifunctional enzyme; Polymorphism; Purine biosynthesis;
KW   Reference proteome; Transferase.
FT   CHAIN         1    592       Bifunctional purine biosynthesis protein
FT                                PURH.
FT                                /FTId=PRO_0000192156.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    592       Bifunctional purine biosynthesis protein
FT                                PURH, N-terminally processed.
FT                                /FTId=PRO_0000434376.
FT   NP_BIND      12     14       IMP.
FT   NP_BIND      34     37       IMP.
FT   NP_BIND      64     67       IMP.
FT   NP_BIND     101    104       IMP.
FT   NP_BIND     125    127       IMP.
FT   REGION      207    208       AICAR binding.
FT   ACT_SITE    137    137       Proton acceptor. {ECO:0000255}.
FT   ACT_SITE    267    267       Proton acceptor. {ECO:0000305}.
FT   BINDING     316    316       AICAR; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:14966129}.
FT   BINDING     339    339       AICAR. {ECO:0000269|PubMed:14966129}.
FT   BINDING     431    431       AICAR; shared with dimeric partner.
FT                                {ECO:0000269|PubMed:14966129}.
FT   BINDING     451    451       AICAR; shared with dimeric partner.
FT                                {ECO:0000269|PubMed:14966129}.
FT   BINDING     541    541       AICAR; via carbonyl oxygen; shared with
FT                                dimeric partner.
FT                                {ECO:0000269|PubMed:14966129}.
FT   BINDING     588    588       AICAR; shared with dimeric partner.
FT                                {ECO:0000269|PubMed:14966129}.
FT   SITE        266    266       Transition state stabilizer.
FT                                {ECO:0000255}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     199    199       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1      6       MAPGQL -> MSSLS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:8567683}.
FT                                /FTId=VSP_053495.
FT   VARIANT     116    116       T -> S (in dbSNP:rs2372536).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_019306.
FT   VARIANT     426    426       K -> R (in AICAR; loss of transformylase
FT                                activity; dbSNP:rs121434478).
FT                                {ECO:0000269|PubMed:15114530}.
FT                                /FTId=VAR_019307.
FT   CONFLICT    165    165       D -> G (in Ref. 1; AAA97405).
FT                                {ECO:0000305}.
FT   STRAND        6     10       {ECO:0000244|PDB:1PKX}.
FT   HELIX        17     25       {ECO:0000244|PDB:1PKX}.
FT   TURN         26     28       {ECO:0000244|PDB:1PKX}.
FT   STRAND       30     33       {ECO:0000244|PDB:1PKX}.
FT   HELIX        35     42       {ECO:0000244|PDB:1PKX}.
FT   TURN         43     45       {ECO:0000244|PDB:1PKX}.
FT   HELIX        51     55       {ECO:0000244|PDB:1PKX}.
FT   TURN         61     64       {ECO:0000244|PDB:1PKX}.
FT   STRAND       65     67       {ECO:0000244|PDB:1PKX}.
FT   HELIX        70     77       {ECO:0000244|PDB:1PKX}.
FT   HELIX        82     91       {ECO:0000244|PDB:1PKX}.
FT   STRAND       96    101       {ECO:0000244|PDB:1PKX}.
FT   HELIX       106    111       {ECO:0000244|PDB:1PKX}.
FT   HELIX       117    122       {ECO:0000244|PDB:1PKX}.
FT   HELIX       127    137       {ECO:0000244|PDB:1PKX}.
FT   TURN        138    141       {ECO:0000244|PDB:1PKX}.
FT   STRAND      143    145       {ECO:0000244|PDB:1PKX}.
FT   HELIX       148    150       {ECO:0000244|PDB:1PKX}.
FT   HELIX       151    160       {ECO:0000244|PDB:1PKX}.
FT   STRAND      161    165       {ECO:0000244|PDB:1P4R}.
FT   HELIX       168    197       {ECO:0000244|PDB:1PKX}.
FT   TURN        200    202       {ECO:0000244|PDB:1PKX}.
FT   STRAND      203    207       {ECO:0000244|PDB:1PKX}.
FT   STRAND      209    211       {ECO:0000244|PDB:1PKX}.
FT   STRAND      217    220       {ECO:0000244|PDB:1PKX}.
FT   STRAND      222    225       {ECO:0000244|PDB:1PKX}.
FT   STRAND      227    233       {ECO:0000244|PDB:1PKX}.
FT   HELIX       237    257       {ECO:0000244|PDB:1PKX}.
FT   STRAND      261    266       {ECO:0000244|PDB:1PKX}.
FT   STRAND      269    275       {ECO:0000244|PDB:1PKX}.
FT   HELIX       281    286       {ECO:0000244|PDB:1PKX}.
FT   HELIX       290    295       {ECO:0000244|PDB:1PKX}.
FT   HELIX       298    308       {ECO:0000244|PDB:1PKX}.
FT   TURN        311    316       {ECO:0000244|PDB:1PKX}.
FT   STRAND      317    323       {ECO:0000244|PDB:1PKX}.
FT   HELIX       327    334       {ECO:0000244|PDB:1PKX}.
FT   STRAND      338    344       {ECO:0000244|PDB:1PKX}.
FT   HELIX       348    360       {ECO:0000244|PDB:1PKX}.
FT   STRAND      363    367       {ECO:0000244|PDB:1PKX}.
FT   STRAND      375    381       {ECO:0000244|PDB:1PKX}.
FT   STRAND      384    389       {ECO:0000244|PDB:1PKX}.
FT   HELIX       397    400       {ECO:0000244|PDB:1PKX}.
FT   HELIX       412    426       {ECO:0000244|PDB:1PKX}.
FT   STRAND      433    437       {ECO:0000244|PDB:1PKX}.
FT   STRAND      440    445       {ECO:0000244|PDB:1PKX}.
FT   HELIX       451    467       {ECO:0000244|PDB:1PKX}.
FT   HELIX       471    474       {ECO:0000244|PDB:1PKX}.
FT   HELIX       486    496       {ECO:0000244|PDB:1PKX}.
FT   HELIX       503    509       {ECO:0000244|PDB:1PKX}.
FT   STRAND      512    514       {ECO:0000244|PDB:1PKX}.
FT   HELIX       521    528       {ECO:0000244|PDB:1PKX}.
FT   STRAND      534    540       {ECO:0000244|PDB:1PKX}.
FT   STRAND      543    545       {ECO:0000244|PDB:1PL0}.
FT   HELIX       546    552       {ECO:0000244|PDB:1PKX}.
FT   TURN        553    555       {ECO:0000244|PDB:1PKX}.
FT   STRAND      556    562       {ECO:0000244|PDB:1PKX}.
FT   HELIX       568    578       {ECO:0000244|PDB:1PKX}.
FT   STRAND      581    586       {ECO:0000244|PDB:1PKX}.
SQ   SEQUENCE   592 AA;  64616 MW;  AD778892021F0888 CRC64;
     MAPGQLALFS VSDKTGLVEF ARNLTALGLN LVASGGTAKA LRDAGLAVRD VSELTGFPEM
     LGGRVKTLHP AVHAGILARN IPEDNADMAR LDFNLIRVVA CNLYPFVKTV ASPGVTVEEA
     VEQIDIGGVT LLRAAAKNHA RVTVVCEPED YVVVSTEMQS SESKDTSLET RRQLALKAFT
     HTAQYDEAIS DYFRKQYSKG VSQMPLRYGM NPHQTPAQLY TLQPKLPITV LNGAPGFINL
     CDALNAWQLV KELKEALGIP AAASFKHVSP AGAAVGIPLS EDEAKVCMVY DLYKTLTPIS
     AAYARARGAD RMSSFGDFVA LSDVCDVPTA KIISREVSDG IIAPGYEEEA LTILSKKKNG
     NYCVLQMDQS YKPDENEVRT LFGLHLSQKR NNGVVDKSLF SNVVTKNKDL PESALRDLIV
     ATIAVKYTQS NSVCYAKNGQ VIGIGAGQQS RIHCTRLAGD KANYWWLRHH PQVLSMKFKT
     GVKRAEISNA IDQYVTGTIG EDEDLIKWKA LFEEVPELLT EAEKKEWVEK LTEVSISSDA
     FFPFRDNVDR AKRSGVAYIA APSGSAADKV VIEACDELGI ILAHTNLRLF HH
//
ID   V9HWH7_HUMAN            Unreviewed;       592 AA.
AC   V9HWH7;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   28-FEB-2018, entry version 30.
DE   SubName: Full=Epididymis secretory sperm binding protein Li 70p {ECO:0000313|EMBL:ACJ13708.1};
GN   Name=HEL-S-70p {ECO:0000313|EMBL:ACJ13708.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ13708.1};
RN   [1] {ECO:0000313|EMBL:ACJ13708.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU794654; ACJ13708.1; -; mRNA.
DR   RefSeq; NP_004035.2; NM_004044.6.
DR   UniGene; Hs.90280; -.
DR   ProteinModelPortal; V9HWH7; -.
DR   SMR; V9HWH7; -.
DR   MaxQB; V9HWH7; -.
DR   GeneID; 471; -.
DR   KEGG; hsa:471; -.
DR   UCSC; uc002vex.5; human.
DR   CTD; 471; -.
DR   EuPathDB; HostDB:ENSG00000138363.14; -.
DR   eggNOG; KOG2555; Eukaryota.
DR   eggNOG; COG0138; LUCA.
DR   KO; K00602; -.
DR   OMA; DLLFAWK; -.
DR   OrthoDB; EOG091G03H4; -.
DR   PhylomeDB; V9HWH7; -.
DR   ChiTaRS; ATIC; human.
DR   GenomeRNAi; 471; -.
DR   Bgee; ENSG00000138363; -.
DR   ExpressionAtlas; V9HWH7; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0003937; F:IMP cyclohydrolase activity; IEA:Ensembl.
DR   GO; GO:0004643; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity; IEA:Ensembl.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:Ensembl.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0003360; P:brainstem development; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0046452; P:dihydrofolate metabolic process; IEA:Ensembl.
DR   GO; GO:0009116; P:nucleoside metabolic process; IEA:Ensembl.
DR   GO; GO:0010035; P:response to inorganic substance; IEA:Ensembl.
DR   GO; GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:Ensembl.
DR   Gene3D; 3.40.140.20; -; 3.
DR   Gene3D; 3.40.50.1380; -; 1.
DR   HAMAP; MF_00139; PurH; 1.
DR   InterPro; IPR024051; AICAR_Tfase_dup_dom_sf.
DR   InterPro; IPR016193; Cytidine_deaminase-like.
DR   InterPro; IPR011607; MGS-like_dom.
DR   InterPro; IPR036914; MGS-like_dom_sf.
DR   InterPro; IPR002695; PurH-like.
DR   PANTHER; PTHR11692; PTHR11692; 1.
DR   Pfam; PF01808; AICARFT_IMPCHas; 1.
DR   Pfam; PF02142; MGS; 1.
DR   PIRSF; PIRSF000414; AICARFT_IMPCHas; 1.
DR   SMART; SM00798; AICARFT_IMPCHas; 1.
DR   SMART; SM00851; MGS; 1.
DR   SUPFAM; SSF52335; SSF52335; 1.
DR   SUPFAM; SSF53927; SSF53927; 1.
DR   TIGRFAMs; TIGR00355; purH; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       16    130       MGS. {ECO:0000259|SMART:SM00851}.
SQ   SEQUENCE   592 AA;  64616 MW;  AD778892021F0888 CRC64;
     MAPGQLALFS VSDKTGLVEF ARNLTALGLN LVASGGTAKA LRDAGLAVRD VSELTGFPEM
     LGGRVKTLHP AVHAGILARN IPEDNADMAR LDFNLIRVVA CNLYPFVKTV ASPGVTVEEA
     VEQIDIGGVT LLRAAAKNHA RVTVVCEPED YVVVSTEMQS SESKDTSLET RRQLALKAFT
     HTAQYDEAIS DYFRKQYSKG VSQMPLRYGM NPHQTPAQLY TLQPKLPITV LNGAPGFINL
     CDALNAWQLV KELKEALGIP AAASFKHVSP AGAAVGIPLS EDEAKVCMVY DLYKTLTPIS
     AAYARARGAD RMSSFGDFVA LSDVCDVPTA KIISREVSDG IIAPGYEEEA LTILSKKKNG
     NYCVLQMDQS YKPDENEVRT LFGLHLSQKR NNGVVDKSLF SNVVTKNKDL PESALRDLIV
     ATIAVKYTQS NSVCYAKNGQ VIGIGAGQQS RIHCTRLAGD KANYWWLRHH PQVLSMKFKT
     GVKRAEISNA IDQYVTGTIG EDEDLIKWKA LFEEVPELLT EAEKKEWVEK LTEVSISSDA
     FFPFRDNVDR AKRSGVAYIA APSGSAADKV VIEACDELGI ILAHTNLRLF HH
//
ID   BCL7A_HUMAN             Reviewed;         210 AA.
AC   Q4VC05; B4DJN6; B7ZB21; Q13843; Q14CT7;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 1.
DT   28-FEB-2018, entry version 102.
DE   RecName: Full=B-cell CLL/lymphoma 7 protein family member A;
GN   Name=BCL7A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND CHROMOSOMAL TRANSLOCATION.
RC   TISSUE=Brain;
RX   PubMed=8605326;
RA   Zani V.J., Asou N., Jadayel D., Heward J.M., Shipley J., Nacheva E.,
RA   Takasuki K., Catovsky D., Dyer M.J.S.;
RT   "Molecular cloning of complex chromosomal translocation
RT   t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines
RT   a new gene (BCL7A) with homology to caldesmon.";
RL   Blood 87:3124-3134(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND SER-207, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-199, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
CC   -!- INTERACTION:
CC       P13196:ALAS1; NbExp=3; IntAct=EBI-359917, EBI-3905054;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Isoform b;
CC         IsoId=Q4VC05-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q4VC05-2; Sequence=VSP_019271;
CC   -!- DISEASE: Note=Chromosomal aberrations involving BCL7A may be a
CC       cause of B-cell non-Hodgkin lymphoma. Three-way translocation
CC       t(8;14;12)(q24.1;q32.3;q24.1) with MYC and with immunoglobulin
CC       gene regions. {ECO:0000269|PubMed:8605326}.
CC   -!- SIMILARITY: Belongs to the BCL7 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X89984; CAA62011.1; -; mRNA.
DR   EMBL; AK296159; BAG58898.1; -; mRNA.
DR   EMBL; AK316486; BAH14857.1; -; mRNA.
DR   EMBL; CH471054; EAW98302.1; -; Genomic_DNA.
DR   EMBL; BC094723; AAH94723.1; -; mRNA.
DR   EMBL; BC113627; AAI13628.1; -; mRNA.
DR   CCDS; CCDS53841.1; -. [Q4VC05-1]
DR   CCDS; CCDS9226.1; -. [Q4VC05-2]
DR   PIR; S58237; S58245.
DR   RefSeq; NP_001019979.1; NM_001024808.2. [Q4VC05-1]
DR   RefSeq; NP_066273.1; NM_020993.4. [Q4VC05-2]
DR   UniGene; Hs.530970; -.
DR   ProteinModelPortal; Q4VC05; -.
DR   BioGrid; 107077; 56.
DR   DIP; DIP-27608N; -.
DR   IntAct; Q4VC05; 9.
DR   iPTMnet; Q4VC05; -.
DR   PhosphoSitePlus; Q4VC05; -.
DR   BioMuta; BCL7A; -.
DR   DMDM; 74754614; -.
DR   EPD; Q4VC05; -.
DR   MaxQB; Q4VC05; -.
DR   PeptideAtlas; Q4VC05; -.
DR   PRIDE; Q4VC05; -.
DR   DNASU; 605; -.
DR   Ensembl; ENST00000261822; ENSP00000261822; ENSG00000110987. [Q4VC05-1]
DR   Ensembl; ENST00000538010; ENSP00000445868; ENSG00000110987. [Q4VC05-2]
DR   Ensembl; ENST00000635191; ENSP00000489010; ENSG00000282873. [Q4VC05-2]
DR   Ensembl; ENST00000635403; ENSP00000489305; ENSG00000282873. [Q4VC05-1]
DR   GeneID; 605; -.
DR   KEGG; hsa:605; -.
DR   UCSC; uc001ubo.4; human. [Q4VC05-1]
DR   CTD; 605; -.
DR   DisGeNET; 605; -.
DR   EuPathDB; HostDB:ENSG00000110987.8; -.
DR   GeneCards; BCL7A; -.
DR   HGNC; HGNC:1004; BCL7A.
DR   HPA; HPA019762; -.
DR   MIM; 601406; gene.
DR   neXtProt; NX_Q4VC05; -.
DR   OpenTargets; ENSG00000110987; -.
DR   PharmGKB; PA25314; -.
DR   GeneTree; ENSGT00390000002172; -.
DR   HOGENOM; HOG000232196; -.
DR   HOVERGEN; HBG008481; -.
DR   InParanoid; Q4VC05; -.
DR   OMA; KLETSQQ; -.
DR   OrthoDB; EOG091G0T7O; -.
DR   PhylomeDB; Q4VC05; -.
DR   TreeFam; TF317441; -.
DR   ChiTaRS; BCL7A; human.
DR   GenomeRNAi; 605; -.
DR   PRO; PR:Q4VC05; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000110987; -.
DR   CleanEx; HS_BCL7A; -.
DR   Genevisible; Q4VC05; HS.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   InterPro; IPR006804; BCL7.
DR   PANTHER; PTHR12767; PTHR12767; 1.
DR   Pfam; PF04714; BCL_N; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Complete proteome;
KW   Isopeptide bond; Phosphoprotein; Polymorphism; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN         1    210       B-cell CLL/lymphoma 7 protein family
FT                                member A.
FT                                /FTId=PRO_0000239823.
FT   MOD_RES     203    203       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     207    207       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   CROSSLNK    199    199       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   VAR_SEQ     187    187       Q -> QVPRSRSQRGSQIGREPIGLSG (in isoform
FT                                2). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8605326}.
FT                                /FTId=VSP_019271.
FT   VARIANT     120    120       N -> T (in dbSNP:rs34821485).
FT                                /FTId=VAR_033539.
SQ   SEQUENCE   210 AA;  22810 MW;  4AB4AC3B309ADDB8 CRC64;
     MSGRSVRAET RSRAKDDIKR VMAAIEKVRK WEKKWVTVGD TSLRIYKWVP VTEPKVDDKN
     KNKKKGKDEK CGSEVTTPEN SSSPGMMDMH DDNSNQSSIA DASPIKQENS SNSSPAPEPN
     SAVPSDGTEA KVDEAQADGK EHPGAEDASD EQNSQSSMEH SMNSSEKVDR QPSGDSGLAA
     ETSAISQDLE GVPPSKKMKL EASQQNSEEM
//
ID   BCR_HUMAN               Reviewed;        1271 AA.
AC   P11274; P78501; Q12842; Q4LE80; Q6NZI3;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   28-FEB-2018, entry version 212.
DE   RecName: Full=Breakpoint cluster region protein;
DE            EC=2.7.11.1;
DE   AltName: Full=Renal carcinoma antigen NY-REN-26;
GN   Name=BCR; Synonyms=BCR1, D22S11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT SER-796.
RX   PubMed=3285291;
RA   Lifshitz B., Fainstein E., Marcelle C., Shtivelman E., Amson R.,
RA   Gale R.P., Canaani E.;
RT   "bcr genes and transcripts.";
RL   Oncogene 2:113-117(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHROMOSOMAL TRANSLOCATION.
RX   PubMed=7665185; DOI=10.1006/geno.1995.1008;
RA   Chissoe S.L., Bodenteich A., Wang Y.-F., Wang Y.-P., Burian D.,
RA   Clifton S.W., Crabtree J., Freeman A., Iyer K., Jian L., Ma Y.,
RA   McLaury H.-J., Pan H.-Q., Sarhan O.H., Toth S., Wang Z., Zhang G.,
RA   Heisterkamp N., Groffen J., Roe B.A.;
RT   "Sequence and analysis of the human ABL gene, the BCR gene, and
RT   regions involved in the Philadelphia chromosomal translocation.";
RL   Genomics 27:67-82(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   SER-796.
RC   TISSUE=Brain;
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M.,
RA   Ohara R., Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long
RT   cDNAs encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-872, CHROMOSOMAL TRANSLOCATION,
RP   INVOLVEMENT IN CML, AND VARIANT SER-796.
RX   PubMed=3107980;
RA   Hariharan I.K., Adams J.M.;
RT   "cDNA sequence for human bcr, the gene that translocates to the abl
RT   oncogene in chronic myeloid leukaemia.";
RL   EMBO J. 6:115-119(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-693, AND INVOLVEMENT IN CML.
RX   PubMed=3540951; DOI=10.1073/pnas.83.24.9768;
RA   Mes-Masson A.-M., McLaughlin J., Daley G.Q., Paskind M., Witte O.N.;
RT   "Overlapping cDNA clones define the complete coding region for the
RT   P210c-abl gene product associated with chronic myelogenous leukemia
RT   cells containing the Philadelphia chromosome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:9768-9772(1986).
RN   [6]
RP   ERRATUM, AND SEQUENCE REVISION.
RA   Mes-Masson A.M., McLaughlin J., Daley G.Q., Paskind M., Witte O.N.;
RL   Proc. Natl. Acad. Sci. U.S.A. 84:2507-2507(1987).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 683-1271 (ISOFORM 1).
RX   PubMed=2989703; DOI=10.1038/315758a0;
RA   Heisterkamp N., Stam K., Groffen J., de Klein A., Grosveld G.;
RT   "Structural organization of the bcr gene and its role in the Ph'
RT   translocation.";
RL   Nature 315:758-761(1985).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-46 AND 275-426.
RX   PubMed=2263470; DOI=10.1093/nar/18.23.7119;
RA   Zhu Q.S., Heisterkamp N., Groffen J.;
RT   "Unique organization of the human BCR gene promoter.";
RL   Nucleic Acids Res. 18:7119-7125(1990).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 56-426.
RX   PubMed=2825022; DOI=10.1038/330386a0;
RA   Fainstein E., Marcelle C., Rosner A., Canaani E., Gale R.P.,
RA   Dreazen O., Smith S.D., Croce C.M.;
RT   "A new fused transcript in Philadelphia chromosome positive acute
RT   lymphocytic leukaemia.";
RL   Nature 330:386-388(1987).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 362-438, AND ALTERNATIVE SPLICING.
RX   PubMed=2915904;
RA   Romero P., Beran M., Shtalrid M., Andersson B., Talpaz M., Blick M.;
RT   "Alternative 5' end of the bcr-abl transcript in chronic myelogenous
RT   leukemia.";
RL   Oncogene 4:93-98(1989).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 670-842, INVOLVEMENT IN CML, AND
RP   VARIANT SER-796.
RX   PubMed=2407300;
RA   Selleri L., von Lindern M., Hermans A., Meijer D., Torelli G.,
RA   Grosveld G.;
RT   "Chronic myeloid leukemia may be associated with several bcr-abl
RT   transcripts including the acute lymphoid leukemia-type 7 kb
RT   transcript.";
RL   Blood 75:1146-1153(1990).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-4.
RX   PubMed=1900918; DOI=10.1128/MCB.11.4.1854;
RA   Shah N.P., Witte O.N., Denny C.T.;
RT   "Characterization of the BCR promoter in Philadelphia chromosome-
RT   positive and -negative cell lines.";
RL   Mol. Cell. Biol. 11:1854-1860(1991).
RN   [13]
RP   FUNCTION.
RX   PubMed=1903516; DOI=10.1038/351400a0;
RA   Diekmann D., Brill S., Garrett M.D., Totty N., Hsuan J., Monfries C.,
RA   Hall C., Lim L., Hall A.;
RT   "Bcr encodes a GTPase-activating protein for p21rac.";
RL   Nature 351:400-402(1991).
RN   [14]
RP   INTERACTION WITH ABL1 SH2-DOMAIN.
RX   PubMed=1712671; DOI=10.1016/0092-8674(91)90148-R;
RA   Pendergast A.M., Muller A.J., Havlik M.H., Maru Y., Witte O.N.;
RT   "BCR sequences essential for transformation by the BCR-ABL oncogene
RT   bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-
RT   dependent manner.";
RL   Cell 66:161-171(1991).
RN   [15]
RP   FUNCTION AS PROTEIN KINASE.
RX   PubMed=1657398; DOI=10.1016/0092-8674(91)90521-Y;
RA   Maru Y., Witte O.N.;
RT   "The BCR gene encodes a novel serine/threonine kinase activity within
RT   a single exon.";
RL   Cell 67:459-468(1991).
RN   [16]
RP   PHOSPHORYLATION AT TYR-177 BY HCK, MUTAGENESIS OF TYR-177, AND
RP   INTERACTION WITH HCK AND GRB2.
RX   PubMed=9407116; DOI=10.1074/jbc.272.52.33260;
RA   Warmuth M., Bergmann M., Priess A., Hauslmann K., Emmerich B.,
RA   Hallek M.;
RT   "The Src family kinase Hck interacts with Bcr-Abl by a kinase-
RT   independent mechanism and phosphorylates the Grb2-binding site of
RT   Bcr.";
RL   J. Biol. Chem. 272:33260-33270(1997).
RN   [17]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1264, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [19]
RP   INTERACTION WITH FES/FPS; ABL1; PIK3R1 AND GRB2, MUTAGENESIS OF
RP   TYR-177, AND PHOSPHORYLATION AT TYR-246.
RX   PubMed=15302586; DOI=10.1016/j.yexcr.2004.05.010;
RA   Laurent C.E., Smithgall T.E.;
RT   "The c-Fes tyrosine kinase cooperates with the breakpoint cluster
RT   region protein (Bcr) to induce neurite extension in a Rac- and Cdc42-
RT   dependent manner.";
RL   Exp. Cell Res. 299:188-198(2004).
RN   [20]
RP   INTERACTION WITH PDZK1, AND MUTAGENESIS OF 1269-THR--GLU-1271 AND
RP   VAL-1271.
RX   PubMed=15494376; DOI=10.1242/jcs.01472;
RA   Malmberg E.K., Andersson C.X., Gentzsch M., Chen J.H., Mengos A.,
RA   Cui L., Hansson G.C., Riordan J.R.;
RT   "Bcr (breakpoint cluster region) protein binds to PDZ-domains of
RT   scaffold protein PDZK1 and vesicle coat protein Mint3.";
RL   J. Cell Sci. 117:5535-5541(2004).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-459, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-177; SER-459 AND
RP   SER-1264, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122; SER-215 AND
RP   SER-459, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122; SER-139; SER-202;
RP   SER-215; SER-222; SER-356; SER-377; SER-459; SER-463; SER-473;
RP   SER-488; TYR-554; THR-641; TYR-644; THR-693 AND SER-894, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-459, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 3-72, AND
RP   HOMOTETRAMERIZATION.
RX   PubMed=11780146; DOI=10.1038/nsb747;
RA   Zhao X., Ghaffari S., Lodish H., Malashkevich V.N., Kim P.S.;
RT   "Structure of the Bcr-Abl oncoprotein oligomerization domain.";
RL   Nat. Struct. Biol. 9:117-120(2002).
RN   [31]
RP   INTERACTION WITH SH2D5.
RX   PubMed=25331951; DOI=10.1074/jbc.M114.615112;
RA   Gray E.J., Petsalaki E., James D.A., Bagshaw R.D., Stacey M.M.,
RA   Rocks O., Gingras A.C., Pawson T.;
RT   "src homology 2 domain containing protein 5 (sh2d5) binds the
RT   breakpoint cluster region protein, BCR, and regulates levels of Rac1-
RT   GTP.";
RL   J. Biol. Chem. 289:35397-35408(2014).
RN   [32]
RP   VARIANTS [LARGE SCALE ANALYSIS] PRO-400; MET-413; GLU-752; SER-796;
RP   CYS-910; ILE-949; LYS-1037; MET-1091; ALA-1096; GLY-1104; ASN-1106;
RP   THR-1149; LYS-1161; GLU-1187; MET-1189; GLY-1204 AND ARG-1235.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: GTPase-activating protein for RAC1 and CDC42. Promotes
CC       the exchange of RAC or CDC42-bound GDP by GTP, thereby activating
CC       them. Displays serine/threonine kinase activity.
CC       {ECO:0000269|PubMed:1657398, ECO:0000269|PubMed:1903516}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Homotetramer. Interacts with PDZK1. May interact with
CC       CCPG1 (By similarity). Interacts with FES/FPS, ABL1, PIK3R1 and
CC       GRB2. Interacts with HCK. Interacts with SH2D5 (PubMed:25331951).
CC       {ECO:0000250|UniProtKB:Q6PAJ1, ECO:0000269|PubMed:15302586,
CC       ECO:0000269|PubMed:15494376, ECO:0000269|PubMed:1712671,
CC       ECO:0000269|PubMed:25331951, ECO:0000269|PubMed:9407116}.
CC   -!- INTERACTION:
CC       P62993:GRB2; NbExp=8; IntAct=EBI-712838, EBI-401755;
CC       P18031:PTPN1; NbExp=3; IntAct=EBI-8658094, EBI-968788;
CC       Q6ZV89-1:SH2D5; NbExp=2; IntAct=EBI-712838, EBI-15101685;
CC       A2AM67:Sh2d5 (xeno); NbExp=7; IntAct=EBI-712838, EBI-15101945;
CC       Q8JZW5:Sh2d5 (xeno); NbExp=2; IntAct=EBI-712838, EBI-15101675;
CC       Q9H2K2:TNKS2; NbExp=3; IntAct=EBI-712838, EBI-4398527;
CC       P04637:TP53; NbExp=2; IntAct=EBI-712838, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane, postsynaptic density {ECO:0000250|UniProtKB:Q6PAJ1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11274-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11274-2; Sequence=VSP_024352;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The region involved in binding to ABL1 SH2-domain is rich
CC       in serine residues and needs to be Ser/Thr phosphorylated prior to
CC       SH2 binding. This region is essential for the activation of the
CC       ABL1 tyrosine kinase and transforming potential of the chimeric
CC       BCR-ABL oncogene.
CC   -!- DOMAIN: The DH domain is involved in interaction with CCPG1.
CC       {ECO:0000250}.
CC   -!- PTM: Autophosphorylated. Phosphorylated by FES/FPS on tyrosine
CC       residues, leading to down-regulation of the BCR kinase activity.
CC       Phosphorylation at Tyr-177 by HCK is important for interaction
CC       with GRB2. {ECO:0000269|PubMed:15302586,
CC       ECO:0000269|PubMed:9407116}.
CC   -!- DISEASE: Leukemia, chronic myeloid (CML) [MIM:608232]: A clonal
CC       myeloproliferative disorder of a pluripotent stem cell with a
CC       specific cytogenetic abnormality, the Philadelphia chromosome
CC       (Ph), involving myeloid, erythroid, megakaryocytic, B-lymphoid,
CC       and sometimes T-lymphoid cells, but not marrow fibroblasts.
CC       {ECO:0000269|PubMed:2407300, ECO:0000269|PubMed:3107980,
CC       ECO:0000269|PubMed:3540951}. Note=The gene represented in this
CC       entry is involved in disease pathogenesis.
CC   -!- DISEASE: Note=A chromosomal aberration involving BCR has been
CC       found in patients with chronic myeloid leukemia. Translocation
CC       t(9;22)(q34;q11) with ABL1. The translocation produces a BCR-ABL
CC       found also in acute myeloid leukemia (AML) and acute lymphoblastic
CC       leukemia (ALL). {ECO:0000269|PubMed:3107980,
CC       ECO:0000269|PubMed:7665185}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE06073.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BCRID55.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00661; CAA68676.1; -; mRNA.
DR   EMBL; U07000; AAB60388.1; -; Genomic_DNA.
DR   EMBL; AB209991; BAE06073.1; ALT_INIT; mRNA.
DR   EMBL; X02596; CAA26441.1; -; mRNA.
DR   EMBL; M15025; AAA35594.1; -; Genomic_DNA.
DR   EMBL; X52828; CAA37010.1; -; Genomic_DNA.
DR   EMBL; X52829; CAA37011.1; -; Genomic_DNA.
DR   EMBL; X14676; CAA32806.1; -; mRNA.
DR   EMBL; M64437; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS13806.1; -. [P11274-1]
DR   CCDS; CCDS13807.1; -. [P11274-2]
DR   PIR; A26664; TVHUA2.
DR   PIR; A91064; TVHUBR.
DR   RefSeq; NP_004318.3; NM_004327.3. [P11274-1]
DR   RefSeq; NP_067585.2; NM_021574.2. [P11274-2]
DR   UniGene; Hs.517461; -.
DR   UniGene; Hs.715409; -.
DR   PDB; 1K1F; X-ray; 2.20 A; A/B/C/D/E/F/G/H=1-72.
DR   PDB; 2AIN; NMR; -; B=1266-1271.
DR   PDB; 5N6R; NMR; -; A=487-702.
DR   PDB; 5N7E; X-ray; 1.65 A; B=487-702.
DR   PDB; 5OC7; X-ray; 1.65 A; A/D=704-893.
DR   PDBsum; 1K1F; -.
DR   PDBsum; 2AIN; -.
DR   PDBsum; 5N6R; -.
DR   PDBsum; 5N7E; -.
DR   PDBsum; 5OC7; -.
DR   ProteinModelPortal; P11274; -.
DR   SMR; P11274; -.
DR   BioGrid; 107083; 77.
DR   ELM; P11274; -.
DR   IntAct; P11274; 33.
DR   MINT; P11274; -.
DR   STRING; 9606.ENSP00000303507; -.
DR   BindingDB; P11274; -.
DR   ChEMBL; CHEMBL5146; -.
DR   DrugBank; DB06616; Bosutinib.
DR   DrugBank; DB08901; Ponatinib.
DR   iPTMnet; P11274; -.
DR   PhosphoSitePlus; P11274; -.
DR   BioMuta; BCR; -.
DR   DMDM; 143811366; -.
DR   EPD; P11274; -.
DR   MaxQB; P11274; -.
DR   PaxDb; P11274; -.
DR   PeptideAtlas; P11274; -.
DR   PRIDE; P11274; -.
DR   Ensembl; ENST00000305877; ENSP00000303507; ENSG00000186716. [P11274-1]
DR   Ensembl; ENST00000359540; ENSP00000352535; ENSG00000186716. [P11274-2]
DR   GeneID; 613; -.
DR   KEGG; hsa:613; -.
DR   UCSC; uc002zww.4; human. [P11274-1]
DR   CTD; 613; -.
DR   DisGeNET; 613; -.
DR   EuPathDB; HostDB:ENSG00000186716.19; -.
DR   GeneCards; BCR; -.
DR   H-InvDB; HIX0016226; -.
DR   H-InvDB; HIX0016271; -.
DR   H-InvDB; HIX0027936; -.
DR   H-InvDB; HIX0041406; -.
DR   HGNC; HGNC:1014; BCR.
DR   HPA; CAB010421; -.
DR   HPA; CAB018545; -.
DR   HPA; HPA038337; -.
DR   MalaCards; BCR; -.
DR   MIM; 151410; gene.
DR   MIM; 608232; phenotype.
DR   neXtProt; NX_P11274; -.
DR   OpenTargets; ENSG00000186716; -.
DR   Orphanet; 521; Chronic myeloid leukemia.
DR   Orphanet; 261330; Distal 22q11.2 microdeletion syndrome.
DR   Orphanet; 99860; Precursor B-cell acute lymphoblastic leukemia.
DR   Orphanet; 99861; Precursor T-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA25321; -.
DR   eggNOG; KOG4269; Eukaryota.
DR   eggNOG; ENOG410XPGZ; LUCA.
DR   GeneTree; ENSGT00910000143995; -.
DR   HOGENOM; HOG000006779; -.
DR   HOVERGEN; HBG004165; -.
DR   InParanoid; P11274; -.
DR   KO; K08878; -.
DR   OMA; DRIMGKG; -.
DR   OrthoDB; EOG091G03M3; -.
DR   PhylomeDB; P11274; -.
DR   TreeFam; TF105082; -.
DR   Reactome; R-HSA-1839117; Signaling by cytosolic FGFR1 fusion mutants.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-5655302; Signaling by FGFR1 in disease.
DR   SignaLink; P11274; -.
DR   SIGNOR; P11274; -.
DR   ChiTaRS; BCR; human.
DR   EvolutionaryTrace; P11274; -.
DR   GeneWiki; BCR_(gene); -.
DR   GenomeRNAi; 613; -.
DR   PRO; PR:P11274; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000186716; -.
DR   CleanEx; HS_BCR; -.
DR   ExpressionAtlas; P11274; baseline and differential.
DR   Genevisible; P11274; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005096; F:GTPase activator activity; IBA:GO_Central.
DR   GO; GO:0016301; F:kinase activity; TAS:Reactome.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0060216; P:definitive hemopoiesis; IEA:Ensembl.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0065002; P:intracellular protein transmembrane transport; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0060313; P:negative regulation of blood vessel remodeling; IEA:Ensembl.
DR   GO; GO:0002692; P:negative regulation of cellular extravasation; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0043314; P:negative regulation of neutrophil degranulation; IEA:Ensembl.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:0060268; P:negative regulation of respiratory burst; IEA:Ensembl.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IBA:GO_Central.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:0051171; P:regulation of nitrogen compound metabolic process; IEA:Ensembl.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0043114; P:regulation of vascular permeability; IEA:Ensembl.
DR   GO; GO:0003014; P:renal system process; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR037769; Abr/Bcr.
DR   InterPro; IPR015123; Bcr-Abl_oncoprot_oligo.
DR   InterPro; IPR036481; Bcr-Abl_oncoprot_oligo_sf.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   PANTHER; PTHR23182; PTHR23182; 1.
DR   Pfam; PF09036; Bcr-Abl_Oligo; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50729; SSF50729; 2.
DR   SUPFAM; SSF69036; SSF69036; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell junction; Cell membrane; Chromosomal rearrangement;
KW   Complete proteome; GTPase activation;
KW   Guanine-nucleotide releasing factor; Kinase; Membrane; Methylation;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Postsynaptic cell membrane; Proto-oncogene; Reference proteome;
KW   Serine/threonine-protein kinase; Synapse; Transferase.
FT   CHAIN         1   1271       Breakpoint cluster region protein.
FT                                /FTId=PRO_0000080933.
FT   DOMAIN      498    691       DH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00062}.
FT   DOMAIN      708    866       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      870   1002       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN     1054   1248       Rho-GAP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00172}.
FT   REGION        1    426       Kinase.
FT   REGION      197    385       Binding to ABL SH2-domain.
FT   COMPBIAS    824    827       Poly-Leu.
FT   SITE        426    427       Breakpoint for translocation to form BCR-
FT                                ABL oncogene.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   MOD_RES     122    122       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     139    139       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     177    177       Phosphotyrosine; by HCK.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000269|PubMed:9407116}.
FT   MOD_RES     202    202       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     215    215       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     222    222       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     236    236       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PAJ1}.
FT   MOD_RES     246    246       Phosphotyrosine; by FES.
FT                                {ECO:0000269|PubMed:15302586}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     377    377       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     382    382       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PAJ1}.
FT   MOD_RES     385    385       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q6PAJ1}.
FT   MOD_RES     459    459       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     463    463       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     471    471       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q6PAJ1}.
FT   MOD_RES     473    473       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     488    488       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     554    554       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     641    641       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     644    644       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     693    693       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     894    894       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1264   1264       Phosphoserine.
FT                                {ECO:0000244|PubMed:15144186,
FT                                ECO:0000244|PubMed:19690332}.
FT   VAR_SEQ     961   1004       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:3285291}.
FT                                /FTId=VSP_024352.
FT   VARIANT     400    400       S -> P (in a bladder transitional cell
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041883.
FT   VARIANT     413    413       I -> M (in dbSNP:rs56321828).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041884.
FT   VARIANT     558    558       K -> T (in dbSNP:rs4437065).
FT                                /FTId=VAR_051983.
FT   VARIANT     752    752       D -> E (in dbSNP:rs12484731).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041885.
FT   VARIANT     796    796       N -> S (in dbSNP:rs140504).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:2407300,
FT                                ECO:0000269|PubMed:3107980,
FT                                ECO:0000269|PubMed:3285291,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_031552.
FT   VARIANT     910    910       Y -> C (in dbSNP:rs35537221).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041886.
FT   VARIANT     949    949       V -> I (in dbSNP:rs2229038).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041887.
FT   VARIANT    1037   1037       E -> K (in dbSNP:rs776552570).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_031553.
FT   VARIANT    1091   1091       V -> M (in dbSNP:rs778229520).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041888.
FT   VARIANT    1096   1096       T -> A (in dbSNP:rs745459086).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041889.
FT   VARIANT    1104   1104       A -> G (in dbSNP:rs11558696).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041890.
FT   VARIANT    1106   1106       D -> N (in dbSNP:rs879255379).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041891.
FT   VARIANT    1127   1127       T -> M (in dbSNP:rs35812689).
FT                                /FTId=VAR_031554.
FT   VARIANT    1149   1149       A -> T (in dbSNP:rs200099830).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041892.
FT   VARIANT    1161   1161       E -> K. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041893.
FT   VARIANT    1187   1187       K -> E. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041894.
FT   VARIANT    1189   1189       V -> M (in dbSNP:rs55816482).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041895.
FT   VARIANT    1204   1204       A -> G (in dbSNP:rs56265970).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041896.
FT   VARIANT    1235   1235       W -> R (in dbSNP:rs55719322).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041897.
FT   MUTAGEN     177    177       Y->F: Abolishes interaction with FES and
FT                                GRB2. {ECO:0000269|PubMed:15302586,
FT                                ECO:0000269|PubMed:9407116}.
FT   MUTAGEN    1269   1271       Missing: Abolishes interaction with
FT                                PDZK1. {ECO:0000269|PubMed:15494376}.
FT   MUTAGEN    1271   1271       V->A: Reduces interaction with PDZK1.
FT                                {ECO:0000269|PubMed:15494376}.
FT   CONFLICT    287    287       M -> I (in Ref. 1; CAA68676).
FT                                {ECO:0000305}.
FT   CONFLICT    418    418       G -> D (in Ref. 1; CAA68676).
FT                                {ECO:0000305}.
FT   CONFLICT    483    483       E -> K (in Ref. 1; CAA68676).
FT                                {ECO:0000305}.
FT   CONFLICT    560    560       F -> S (in Ref. 1; CAA68676).
FT                                {ECO:0000305}.
FT   CONFLICT    690    690       E -> D (in Ref. 11). {ECO:0000305}.
FT   CONFLICT    733    733       D -> E (in Ref. 4; CAA26441).
FT                                {ECO:0000305}.
FT   HELIX         4     14       {ECO:0000244|PDB:1K1F}.
FT   HELIX        28     64       {ECO:0000244|PDB:1K1F}.
FT   STRAND     1268   1271       {ECO:0000244|PDB:2AIN}.
SQ   SEQUENCE   1271 AA;  142819 MW;  4BF66FA1E9D205FE CRC64;
     MVDPVGFAEA WKAQFPDSEP PRMELRSVGD IEQELERCKA SIRRLEQEVN QERFRMIYLQ
     TLLAKEKKSY DRQRWGFRRA AQAPDGASEP RASASRPQPA PADGADPPPA EEPEARPDGE
     GSPGKARPGT ARRPGAAASG ERDDRGPPAS VAALRSNFER IRKGHGQPGA DAEKPFYVNV
     EFHHERGLVK VNDKEVSDRI SSLGSQAMQM ERKKSQHGAG SSVGDASRPP YRGRSSESSC
     GVDGDYEDAE LNPRFLKDNL IDANGGSRPP WPPLEYQPYQ SIYVGGMMEG EGKGPLLRSQ
     STSEQEKRLT WPRRSYSPRS FEDCGGGYTP DCSSNENLTS SEEDFSSGQS SRVSPSPTTY
     RMFRDKSRSP SQNSQQSFDS SSPPTPQCHK RHRHCPVVVS EATIVGVRKT GQIWPNDGEG
     AFHGDADGSF GTPPGYGCAA DRAEEQRRHQ DGLPYIDDSP SSSPHLSSKG RGSRDALVSG
     ALESTKASEL DLEKGLEMRK WVLSGILASE ETYLSHLEAL LLPMKPLKAA ATTSQPVLTS
     QQIETIFFKV PELYEIHKEF YDGLFPRVQQ WSHQQRVGDL FQKLASQLGV YRAFVDNYGV
     AMEMAEKCCQ ANAQFAEISE NLRARSNKDA KDPTTKNSLE TLLYKPVDRV TRSTLVLHDL
     LKHTPASHPD HPLLQDALRI SQNFLSSINE EITPRRQSMT VKKGEHRQLL KDSFMVELVE
     GARKLRHVFL FTDLLLCTKL KKQSGGKTQQ YDCKWYIPLT DLSFQMVDEL EAVPNIPLVP
     DEELDALKIK ISQIKNDIQR EKRANKGSKA TERLKKKLSE QESLLLLMSP SMAFRVHSRN
     GKSYTFLISS DYERAEWREN IREQQKKCFR SFSLTSVELQ MLTNSCVKLQ TVHSIPLTIN
     KEDDESPGLY GFLNVIVHSA TGFKQSSNLY CTLEVDSFGY FVNKAKTRVY RDTAEPNWNE
     EFEIELEGSQ TLRILCYEKC YNKTKIPKED GESTDRLMGK GQVQLDPQAL QDRDWQRTVI
     AMNGIEVKLS VKFNSREFSL KRMPSRKQTG VFGVKIAVVT KRERSKVPYI VRQCVEEIER
     RGMEEVGIYR VSGVATDIQA LKAAFDVNNK DVSVMMSEMD VNAIAGTLKL YFRELPEPLF
     TDEFYPNFAE GIALSDPVAK ESCMLNLLLS LPEANLLTFL FLLDHLKRVA EKEAVNKMSL
     HNLATVFGPT LLRPSEKESK LPANPSQPIT MTDSWSLEVM SQVQVLLYFL QLEAIPAPDS
     KRQSILFSTE V
//
ID   WDCP_HUMAN              Reviewed;         721 AA.
AC   Q9H6R7; D6W532; Q8IYK0; Q9HBP5;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-FEB-2018, entry version 120.
DE   RecName: Full=WD repeat and coiled-coil-containing protein {ECO:0000305};
GN   Name=WDCP {ECO:0000312|HGNC:HGNC:26157}; Synonyms=C2orf44;
GN   ORFNames=PP384;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH HCK, AND MUTAGENESIS OF
RP   PRO-540 AND PRO-543.
RX   PubMed=25469238; DOI=10.3892/br.2014.374;
RA   Yokoyama N., Miller W.T.;
RT   "Molecular characterization of WDCP, a novel fusion partner for the
RT   anaplastic lymphoma tyrosine kinase ALK.";
RL   Biomed. Rep. 3:9-13(2015).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hepatoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH HCK, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12029088; DOI=10.1074/jbc.M202783200;
RA   Scott M.P., Zappacosta F., Kim E.Y., Annan R.S., Miller W.T.;
RT   "Identification of novel SH3 domain ligands for the Src family kinase
RT   Hck. Wiskott-Aldrich syndrome protein (WASP), WASP-interacting protein
RT   (WIP), and ELMO1.";
RL   J. Biol. Chem. 277:28238-28246(2002).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299; SER-501 AND
RP   SER-523, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-690, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-690, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   CHROMOSOMAL TRANSLOCATION WITH ALK.
RX   PubMed=22327622; DOI=10.1038/nm.2673;
RA   Lipson D., Capelletti M., Yelensky R., Otto G., Parker A., Jarosz M.,
RA   Curran J.A., Balasubramanian S., Bloom T., Brennan K.W., Donahue A.,
RA   Downing S.R., Frampton G.M., Garcia L., Juhn F., Mitchell K.C.,
RA   White E., White J., Zwirko Z., Peretz T., Nechushtan H.,
RA   Soussan-Gutman L., Kim J., Sasaki H., Kim H.R., Park S.I., Ercan D.,
RA   Sheehan C.E., Ross J.S., Cronin M.T., Jaenne P.A., Stephens P.J.;
RT   "Identification of new ALK and RET gene fusions from colorectal and
RT   lung cancer biopsies.";
RL   Nat. Med. 18:382-384(2012).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299; SER-468; THR-530;
RP   SER-686 AND SER-690, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-454.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- SUBUNIT: Oligomer. Interacts with HCK (via SH3 domain).
CC       {ECO:0000269|PubMed:12029088, ECO:0000269|PubMed:25469238}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9H6R7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H6R7-2; Sequence=VSP_027713, VSP_027714;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9H6R7-3; Sequence=VSP_027712, VSP_027715;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylated on Tyr when associated with HCK.
CC       {ECO:0000269|PubMed:25469238}.
CC   -!- DISEASE: Note=A chromosomal aberration involving WDCP is found in
CC       one subject with colorectal cancer. Translocation
CC       t(2;2)(p23.3;p23.1). A 5 million base pair tandem duplication
CC       generates an in-frame WDCP-ALK gene fusion.
CC       {ECO:0000269|PubMed:22327622}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF218013; AAG17255.1; -; mRNA.
DR   EMBL; AK025598; BAB15186.1; -; mRNA.
DR   EMBL; AC104665; AAY24115.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00771.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00772.1; -; Genomic_DNA.
DR   EMBL; BC035698; AAH35698.1; -; mRNA.
DR   CCDS; CCDS1705.1; -. [Q9H6R7-1]
DR   CCDS; CCDS46229.1; -. [Q9H6R7-2]
DR   RefSeq; NP_001135791.1; NM_001142319.1. [Q9H6R7-2]
DR   RefSeq; NP_079479.1; NM_025203.2. [Q9H6R7-1]
DR   UniGene; Hs.24624; -.
DR   ProteinModelPortal; Q9H6R7; -.
DR   BioGrid; 123217; 52.
DR   IntAct; Q9H6R7; 33.
DR   MINT; Q9H6R7; -.
DR   STRING; 9606.ENSP00000295148; -.
DR   iPTMnet; Q9H6R7; -.
DR   PhosphoSitePlus; Q9H6R7; -.
DR   BioMuta; C2orf44; -.
DR   DMDM; 74752699; -.
DR   EPD; Q9H6R7; -.
DR   MaxQB; Q9H6R7; -.
DR   PaxDb; Q9H6R7; -.
DR   PeptideAtlas; Q9H6R7; -.
DR   PRIDE; Q9H6R7; -.
DR   Ensembl; ENST00000295148; ENSP00000295148; ENSG00000163026. [Q9H6R7-1]
DR   Ensembl; ENST00000406895; ENSP00000385816; ENSG00000163026. [Q9H6R7-2]
DR   GeneID; 80304; -.
DR   KEGG; hsa:80304; -.
DR   UCSC; uc002rep.3; human. [Q9H6R7-1]
DR   CTD; 80304; -.
DR   DisGeNET; 80304; -.
DR   EuPathDB; HostDB:ENSG00000163026.11; -.
DR   GeneCards; WDCP; -.
DR   H-InvDB; HIX0001870; -.
DR   HGNC; HGNC:26157; WDCP.
DR   HPA; HPA041054; -.
DR   MIM; 616234; gene.
DR   neXtProt; NX_Q9H6R7; -.
DR   OpenTargets; ENSG00000163026; -.
DR   PharmGKB; PA147358716; -.
DR   eggNOG; ENOG410IJSA; Eukaryota.
DR   eggNOG; ENOG410YM0Q; LUCA.
DR   GeneTree; ENSGT00390000001660; -.
DR   HOGENOM; HOG000111320; -.
DR   HOVERGEN; HBG055062; -.
DR   InParanoid; Q9H6R7; -.
DR   OMA; SYIWDSA; -.
DR   OrthoDB; EOG091G0Q4H; -.
DR   PhylomeDB; Q9H6R7; -.
DR   TreeFam; TF333528; -.
DR   GenomeRNAi; 80304; -.
DR   PRO; PR:Q9H6R7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000163026; -.
DR   CleanEx; HS_C2orf44; -.
DR   ExpressionAtlas; Q9H6R7; baseline and differential.
DR   Genevisible; Q9H6R7; HS.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0051259; P:protein oligomerization; IDA:UniProtKB.
DR   InterPro; IPR028041; WDCP.
DR   PANTHER; PTHR14897; PTHR14897; 1.
DR   Pfam; PF15390; WDCP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Coiled coil; Complete proteome; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; WD repeat.
FT   CHAIN         1    721       WD repeat and coiled-coil-containing
FT                                protein.
FT                                /FTId=PRO_0000299501.
FT   REPEAT       55     98       WD 1.
FT   REPEAT      154    194       WD 2.
FT   REGION      539    545       Interaction with HCK.
FT                                {ECO:0000269|PubMed:25469238}.
FT   COILED      556    584       {ECO:0000255}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     299    299       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     468    468       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     501    501       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     523    523       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     530    530       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     686    686       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     690    690       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    487       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15498874}.
FT                                /FTId=VSP_027712.
FT   VAR_SEQ     488    488       N -> M (in isoform 3).
FT                                {ECO:0000303|PubMed:15498874}.
FT                                /FTId=VSP_027715.
FT   VAR_SEQ     607    622       KPYYLGPVVEKRAVLL -> IPTGFFSLLTVRALSR (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027713.
FT   VAR_SEQ     623    721       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027714.
FT   VARIANT     102    102       T -> M (in dbSNP:rs3731620).
FT                                /FTId=VAR_034834.
FT   VARIANT     454    454       P -> S (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035876.
FT   MUTAGEN     540    540       P->A: Loss of interaction with HCK; when
FT                                associated with P-543.
FT                                {ECO:0000269|PubMed:25469238}.
FT   MUTAGEN     543    543       P->A: Loss of interaction with HCK; when
FT                                associated with P-543.
FT                                {ECO:0000269|PubMed:25469238}.
SQ   SEQUENCE   721 AA;  79136 MW;  4A4164C81A693DAE CRC64;
     MELGKGKLLR TGLNALHQAV HPIHGLAWTD GNQVVLTDLR LHSGEVKFGD SKVIGQFECV
     CGLSWAPPVA DDTPVLLAVQ HEKHVTVWQL CPSPMESSKW LTSQTCEIRG SLPILPQGCV
     WHPKCAILTV LTAQDVSIFP NVHSDDSQVK ADINTQGRIH CACWTQDGLR LVVAVGSSLH
     SYIWDSAQKT LHRCSSCLVF DVDSHVCSIT ATVDSQVAIA TELPLDKICG LNASETFNIP
     PNSKDMTPYA LPVIGEVRSM DKEATDSETN SEVSVSSSYL EPLDLTHIHF NQHKSEGNSL
     ICLRKKDYLT GTGQDSSHLV LVTFKKAVTM TRKVTIPGIL VPDLIAFNLK AHVVAVASNT
     CNIILIYSVI PSSVPNIQQI RLENTERPKG ICFLTDQLLL ILVGKQKLTD TTFLPSSKSD
     QYAISLIVRE IMLEEEPSIT SGESQTTYST FSAPLNKANR KKLIESLSPD FCHQNKGLLL
     TVNTSSQNGR PGRTLIKEIQ SPLSSICDGS IALDAEPVTQ PASLPRHSST PDHTSTLEPP
     RLPQRKNLQS EKETYQLSKE VEILSRNLVE MQRCLSELTN RLHNGKKSSS VYPLSQDLPY
     VHIIYQKPYY LGPVVEKRAV LLCDGKLRLS TVQQTFGLSL IEMLHDSHWI LLSADSEGFI
     PLTFTATQEI IIRDGSLSRS DVFRDSFSHS PGAVSSLKVF TGLAAPSLDT TGCCNHVDGM
     A
//
ID   A0A024R8U8_HUMAN        Unreviewed;       401 AA.
AC   A0A024R8U8;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 31.
DE   SubName: Full=Calcium activated nucleotidase 1, isoform CRA_b {ECO:0000313|EMBL:EAW89554.1};
GN   Name=CANT1 {ECO:0000313|EMBL:EAW89554.1};
GN   ORFNames=hCG_2039938 {ECO:0000313|EMBL:EAW89554.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW89554.1};
RN   [1] {ECO:0000313|EMBL:EAW89554.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW89554.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471099; EAW89549.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89550.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89551.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89553.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89554.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89555.1; -; Genomic_DNA.
DR   RefSeq; NP_001153244.1; NM_001159772.1.
DR   RefSeq; NP_001153245.1; NM_001159773.1.
DR   RefSeq; NP_620148.1; NM_138793.3.
DR   RefSeq; XP_005257078.1; XM_005257021.1.
DR   RefSeq; XP_005257079.1; XM_005257022.1.
DR   RefSeq; XP_006721746.1; XM_006721683.1.
DR   RefSeq; XP_011522593.1; XM_011524291.1.
DR   RefSeq; XP_011522595.1; XM_011524293.1.
DR   RefSeq; XP_011522596.1; XM_011524294.1.
DR   RefSeq; XP_011522597.1; XM_011524295.2.
DR   UniGene; Hs.8859; -.
DR   SMR; A0A024R8U8; -.
DR   GeneID; 124583; -.
DR   KEGG; hsa:124583; -.
DR   CTD; 124583; -.
DR   EuPathDB; HostDB:ENSG00000171302.16; -.
DR   eggNOG; KOG4494; Eukaryota.
DR   eggNOG; ENOG410XS4T; LUCA.
DR   KO; K12304; -.
DR   OMA; GSMGKEW; -.
DR   OrthoDB; EOG091G0DL5; -.
DR   ChiTaRS; CANT1; human.
DR   GenomeRNAi; 124583; -.
DR   Bgee; ENSG00000171302; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0017110; F:nucleoside-diphosphatase activity; IEA:InterPro.
DR   InterPro; IPR009283; Apyrase.
DR   InterPro; IPR036258; Apyrase-like_sf.
DR   PANTHER; PTHR13023; PTHR13023; 1.
DR   Pfam; PF06079; Apyrase; 1.
DR   SUPFAM; SSF101887; SSF101887; 1.
PE   4: Predicted;
SQ   SEQUENCE   401 AA;  44840 MW;  5B78EB24C0B2C4CA CRC64;
     MPVQLSEHPE WNESMHSLRI SVGGLPVLAS MTKAADPRFR PRWKVILTFF VGAAILWLLC
     SHRPAPGRPP THNAHNWRLG QAPANWYNDT YPLSPPQRTP AGIRYRIAVI ADLDTESRAQ
     EENTWFSYLK KGYLTLSDSG DKVAVEWDKD HGVLESHLAE KGRGMELSDL IVFNGKLYSV
     DDRTGVVYQI EGSKAVPWVI LSDGDGTVEK GFKAEWLAVK DERLYVGGLG KEWTTTTGDV
     VNENPEWVKV VGYKGSVDHE NWVSNYNALR AAAGIQPPGY LIHESACWSD TLQRWFFLPR
     RASQERYSEK DDERKGANLL LSASPDFGDI AVSHVGAVVP THGFSSFKFI PNTDDQIIVA
     LKSEEDSGRV ASYIMAFTLD GRFLLPETKI GSVKYEGIEF I
//
ID   CANT1_HUMAN             Reviewed;         401 AA.
AC   Q8WVQ1; B4DJ54; Q7Z2J7; Q8NG05; Q8NHP0; Q9BSD5;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   28-FEB-2018, entry version 139.
DE   RecName: Full=Soluble calcium-activated nucleotidase 1;
DE            Short=SCAN-1;
DE            EC=3.6.1.6 {ECO:0000269|PubMed:12234496, ECO:0000269|PubMed:15006348, ECO:0000269|PubMed:15248776, ECO:0000269|PubMed:16835225};
DE   AltName: Full=Apyrase homolog;
DE   AltName: Full=Putative MAPK-activating protein PM09;
DE   AltName: Full=Putative NF-kappa-B-activating protein 107;
GN   Name=CANT1; Synonyms=SHAPY;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, SUBUNIT, SUBCELLULAR LOCATION, GLYCOSYLATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Mammary tumor;
RX   PubMed=12234496; DOI=10.1016/S0003-9861(02)00420-4;
RA   Smith T., Hicks-Berger C., Kim S., Kirley T.;
RT   "Cloning, expression, and characterization of a soluble calcium-
RT   activated nucleotidase, a human enzyme belonging to a new family of
RT   extracellular nucleotidases.";
RL   Arch. Biochem. Biophys. 406:105-115(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung fibroblast;
RX   PubMed=12761501; DOI=10.1038/sj.onc.1206406;
RA   Matsuda A., Suzuki Y., Honda G., Muramatsu S., Matsuzaki O.,
RA   Nagano Y., Doi T., Shimotohno K., Harada T., Nishida E., Hayashi H.,
RA   Sugano S.;
RT   "Large-scale identification and characterization of human genes that
RT   activate NF-kappaB and MAPK signaling pathways.";
RL   Oncogene 22:3307-3318(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Mammary gland, and Substantia nigra;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary, Pancreas, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 141-401 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=12167635; DOI=10.1074/jbc.M201656200;
RA   Failer B.U., Braun N., Zimmermann H.;
RT   "Cloning, expression, and functional characterization of a Ca2+-
RT   dependent endoplasmic reticulum nucleoside diphosphatase.";
RL   J. Biol. Chem. 277:36978-36986(2002).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND MUTAGENESIS OF ASP-114;
RP   GLY-152; GLU-160; ARG-163; ASP-181; ASP-205 AND ARG-301.
RX   PubMed=15248776; DOI=10.1021/bi049565o;
RA   Yang M., Kirley T.L.;
RT   "Site-directed mutagenesis of human soluble calcium-activated
RT   nucleotidase 1 (hSCAN-1): identification of residues essential for
RT   enzyme activity and the Ca(2+)-induced conformational change.";
RL   Biochemistry 43:9185-9194(2004).
RN   [7]
RP   INVOLVEMENT IN DBQD1.
RX   PubMed=20425819; DOI=10.1002/ajmg.a.33404;
RA   Faden M., Al-Zahrani F., Arafah D., Alkuraya F.S.;
RT   "Mutation of CANT1 causes Desbuquois dysplasia.";
RL   Am. J. Med. Genet. A 152:1157-1160(2010).
RN   [8]
RP   FUNCTION IN PROTEOGLYCAN SYNTHESIS, AND VARIANTS DBQD1 HIS-300;
RP   ARG-303 AND ASN-374.
RX   PubMed=22539336; DOI=10.1002/humu.22104;
RA   Nizon M., Huber C., De Leonardis F., Merrina R., Forlino A.,
RA   Fradin M., Tuysuz B., Abu-Libdeh B.Y., Alanay Y., Albrecht B.,
RA   Al-Gazali L., Basaran S.Y., Clayton-Smith J., Desir J., Gill H.,
RA   Greally M.T., Koparir E., van Maarle M.C., Mackay S., Mortier G.,
RA   Morton J., Sillence D., Vilain C., Young I., Zerres K., Le Merrer M.,
RA   Munnich A., Le Goff C., Rossi A., Cormier-Daire V.;
RT   "Further delineation of CANT1 phenotypic spectrum and demonstration of
RT   its role in proteoglycan synthesis.";
RL   Hum. Mutat. 33:1261-1266(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 71-401 IN COMPLEX WITH
RP   SUBSTRATE ANALOG AND CALCIUM IONS, CATALYTIC ACTIVITY, COFACTOR,
RP   SUBUNIT, AND MUTAGENESIS OF ASP-112; ASP-114; GLU-166; SER-168;
RP   ASP-169; ASP-182; GLU-215; GLU-246 AND ARG-301.
RX   PubMed=15006348; DOI=10.1016/S0092-8674(04)00172-2;
RA   Dai J., Liu J., Deng Y., Smith T.M., Lu M.;
RT   "Structure and protein design of a human platelet function
RT   inhibitor.";
RL   Cell 116:649-659(2004).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 69-401 IN COMPLEX WITH
RP   CALCIUM, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, DIMERIZATION,
RP   SUBCELLULAR LOCATION, DISULFIDE BOND, AND MUTAGENESIS OF CYS-60;
RP   SER-139; GLU-160; ILE-200; SER-202; SER-256; CYS-287; SER-308 AND
RP   ALA-317.
RX   PubMed=16835225; DOI=10.1074/jbc.M604413200;
RA   Yang M., Horii K., Herr A.B., Kirley T.L.;
RT   "Calcium-dependent dimerization of human soluble calcium activated
RT   nucleotidase: characterization of the dimer interface.";
RL   J. Biol. Chem. 281:28307-28317(2006).
RN   [11]
RP   VARIANTS DBQD1 LEU-299; CYS-300 AND HIS-300.
RX   PubMed=19853239; DOI=10.1016/j.ajhg.2009.10.001;
RA   Huber C., Oules B., Bertoli M., Chami M., Fradin M., Alanay Y.,
RA   Al-Gazali L.I., Ausems M.G., Bitoun P., Cavalcanti D.P., Krebs A.,
RA   Le Merrer M., Mortier G., Shafeghati Y., Superti-Furga A.,
RA   Robertson S.P., Le Goff C., Muda A.O., Paterlini-Brechot P.,
RA   Munnich A., Cormier-Daire V.;
RT   "Identification of CANT1 mutations in Desbuquois dysplasia.";
RL   Am. J. Hum. Genet. 85:706-710(2009).
RN   [12]
RP   VARIANT DBQD1 GLU-112.
RX   PubMed=21654728; DOI=10.1038/ejhg.2011.101;
RA   Laccone F., Schoner K., Krabichler B., Kluge B., Schwerdtfeger R.,
RA   Schulze B., Zschocke J., Rehder H.;
RT   "Desbuquois dysplasia type I and fetal hydrops due to novel mutations
RT   in the CANT1 gene.";
RL   Eur. J. Hum. Genet. 19:1133-1137(2011).
RN   [13]
RP   VARIANT DBQD1 MET-226.
RX   PubMed=21412251; DOI=10.1038/jhg.2011.28;
RA   Dai J., Kim O.H., Cho T.J., Miyake N., Song H.R., Karasugi T.,
RA   Sakazume S., Ikema M., Matsui Y., Nagai T., Matsumoto N., Ohashi H.,
RA   Kamatani N., Nishimura G., Furuichi T., Takahashi A., Ikegawa S.;
RT   "A founder mutation of CANT1 common in Korean and Japanese Desbuquois
RT   dysplasia.";
RL   J. Hum. Genet. 56:398-400(2011).
RN   [14]
RP   VARIANTS DBQD1 CYS-125; THR-165; PRO-224; MET-226 AND ASP-360,
RP   CHARACTERIZATION OF VARIANTS DBQD1 CYS-125; THR-165; PRO-224; MET-226;
RP   CYS-300 AND ASP-360, AND CHARACTERIZATION OF VARIANTS THR-323 AND
RP   GLU-391.
RX   PubMed=21037275; DOI=10.1136/jmg.2010.080226;
RA   Furuichi T., Dai J., Cho T.J., Sakazume S., Ikema M., Matsui Y.,
RA   Baynam G., Nagai T., Miyake N., Matsumoto N., Ohashi H., Unger S.,
RA   Superti-Furga A., Kim O.H., Nishimura G., Ikegawa S.;
RT   "CANT1 mutation is also responsible for Desbuquois dysplasia, type 2
RT   and Kim variant.";
RL   J. Med. Genet. 48:32-37(2011).
CC   -!- FUNCTION: Calcium-dependent nucleotidase with a preference for
CC       UDP. The order of activity with different substrates is UDP > GDP
CC       > UTP > GTP. Has very low activity towards ADP and even lower
CC       activity towards ATP. Does not hydrolyze AMP and GMP
CC       (PubMed:12234496, PubMed:15248776, PubMed:15006348,
CC       PubMed:16835225). Involved in proteoglycan synthesis
CC       (PubMed:22539336). {ECO:0000269|PubMed:12234496,
CC       ECO:0000269|PubMed:15006348, ECO:0000269|PubMed:15248776,
CC       ECO:0000269|PubMed:16835225, ECO:0000269|PubMed:22539336}.
CC   -!- CATALYTIC ACTIVITY: A nucleoside diphosphate + H(2)O = a
CC       nucleoside phosphate + phosphate. {ECO:0000269|PubMed:12234496,
CC       ECO:0000269|PubMed:15248776, ECO:0000269|PubMed:16835225}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:12234496,
CC         ECO:0000269|PubMed:15006348, ECO:0000269|PubMed:15248776,
CC         ECO:0000269|PubMed:16835225};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.8.;
CC   -!- SUBUNIT: Monomer (PubMed:12234496, PubMed:15006348). Homodimer;
CC       dimerization is Ca(2+)-dependent (PubMed:16835225). Homodimer;
CC       disulfide-linked (membrane form) (PubMed:16835225).
CC       {ECO:0000269|PubMed:12234496, ECO:0000269|PubMed:15006348,
CC       ECO:0000269|PubMed:16835225}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12234496}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:12234496}. Golgi apparatus, Golgi
CC       stack membrane {ECO:0000269|PubMed:12234496}; Single-pass type II
CC       membrane protein {ECO:0000269|PubMed:12234496}. Cell membrane
CC       {ECO:0000269|PubMed:16835225}. Note=Processed form: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8WVQ1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WVQ1-2; Sequence=VSP_013760, VSP_013761;
CC       Name=3;
CC         IsoId=Q8WVQ1-3; Sequence=VSP_054260;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:12234496}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:12234496}.
CC   -!- DISEASE: Desbuquois dysplasia 1 (DBQD1) [MIM:251450]: A
CC       chondrodysplasia characterized by severe prenatal and postnatal
CC       growth retardation (less than -5 SD), joint laxity, short
CC       extremities, progressive scoliosis, round face, midface
CC       hypoplasia, prominent bulging eyes. The main radiologic features
CC       are short long bones with metaphyseal splay, a 'Swedish key'
CC       appearance of the proximal femur (exaggerated trochanter), and
CC       advance carpal and tarsal bone age. Two forms of Desbuquois
CC       dysplasia are distinguished on the basis of the presence or
CC       absence of characteristic hand anomalies: an extra ossification
CC       center distal to the second metacarpal, delta phalanx, bifid
CC       distal thumb phalanx, and phalangeal dislocations.
CC       {ECO:0000269|PubMed:19853239, ECO:0000269|PubMed:20425819,
CC       ECO:0000269|PubMed:21037275, ECO:0000269|PubMed:21412251,
CC       ECO:0000269|PubMed:21654728, ECO:0000269|PubMed:22539336}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: Not inhibited by azide.
CC   -!- SIMILARITY: Belongs to the apyrase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAM94564.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF328554; AAM94564.1; ALT_INIT; mRNA.
DR   EMBL; AB097006; BAC77359.1; -; mRNA.
DR   EMBL; AB097033; BAC77386.1; -; mRNA.
DR   EMBL; AK074687; BAC11139.1; -; mRNA.
DR   EMBL; AK295930; BAG58716.1; -; mRNA.
DR   EMBL; BC005104; AAH05104.1; -; mRNA.
DR   EMBL; BC017655; AAH17655.1; -; mRNA.
DR   EMBL; BC065038; AAH65038.1; -; mRNA.
DR   EMBL; AJ312208; CAC85468.1; -; mRNA.
DR   CCDS; CCDS11760.1; -. [Q8WVQ1-1]
DR   RefSeq; NP_001153244.1; NM_001159772.1. [Q8WVQ1-1]
DR   RefSeq; NP_001153245.1; NM_001159773.1. [Q8WVQ1-1]
DR   RefSeq; NP_620148.1; NM_138793.3. [Q8WVQ1-1]
DR   RefSeq; XP_005257078.1; XM_005257021.1. [Q8WVQ1-1]
DR   RefSeq; XP_005257079.1; XM_005257022.1. [Q8WVQ1-1]
DR   RefSeq; XP_006721746.1; XM_006721683.1. [Q8WVQ1-1]
DR   RefSeq; XP_011522593.1; XM_011524291.1. [Q8WVQ1-1]
DR   RefSeq; XP_011522595.1; XM_011524293.1. [Q8WVQ1-1]
DR   RefSeq; XP_011522596.1; XM_011524294.1. [Q8WVQ1-1]
DR   RefSeq; XP_011522597.1; XM_011524295.2. [Q8WVQ1-1]
DR   UniGene; Hs.8859; -.
DR   PDB; 1S18; X-ray; 1.70 A; A/B=71-401.
DR   PDB; 1S1D; X-ray; 1.60 A; A/B=71-401.
DR   PDB; 2H2N; X-ray; 2.30 A; A/B=69-401.
DR   PDB; 2H2U; X-ray; 2.40 A; A/B=69-401.
DR   PDBsum; 1S18; -.
DR   PDBsum; 1S1D; -.
DR   PDBsum; 2H2N; -.
DR   PDBsum; 2H2U; -.
DR   ProteinModelPortal; Q8WVQ1; -.
DR   SMR; Q8WVQ1; -.
DR   BioGrid; 125875; 22.
DR   STRING; 9606.ENSP00000307674; -.
DR   DrugBank; DB03486; Phosphomethylphosphonic Acid Guanosyl Ester.
DR   DrugBank; DB03754; Tris.
DR   iPTMnet; Q8WVQ1; -.
DR   PhosphoSitePlus; Q8WVQ1; -.
DR   BioMuta; CANT1; -.
DR   DMDM; 66774052; -.
DR   EPD; Q8WVQ1; -.
DR   MaxQB; Q8WVQ1; -.
DR   PaxDb; Q8WVQ1; -.
DR   PeptideAtlas; Q8WVQ1; -.
DR   PRIDE; Q8WVQ1; -.
DR   Ensembl; ENST00000302345; ENSP00000307674; ENSG00000171302. [Q8WVQ1-1]
DR   Ensembl; ENST00000392446; ENSP00000376241; ENSG00000171302. [Q8WVQ1-1]
DR   Ensembl; ENST00000591773; ENSP00000467437; ENSG00000171302. [Q8WVQ1-1]
DR   Ensembl; ENST00000620915; ENSP00000477798; ENSG00000171302. [Q8WVQ1-1]
DR   GeneID; 124583; -.
DR   KEGG; hsa:124583; -.
DR   UCSC; uc002jwj.4; human. [Q8WVQ1-1]
DR   CTD; 124583; -.
DR   DisGeNET; 124583; -.
DR   EuPathDB; HostDB:ENSG00000171302.16; -.
DR   GeneCards; CANT1; -.
DR   HGNC; HGNC:19721; CANT1.
DR   HPA; HPA019627; -.
DR   HPA; HPA019639; -.
DR   HPA; HPA022818; -.
DR   MalaCards; CANT1; -.
DR   MIM; 251450; phenotype.
DR   MIM; 613165; gene.
DR   neXtProt; NX_Q8WVQ1; -.
DR   OpenTargets; ENSG00000171302; -.
DR   Orphanet; 1425; Desbuquois syndrome.
DR   PharmGKB; PA134984439; -.
DR   eggNOG; KOG4494; Eukaryota.
DR   eggNOG; ENOG410XS4T; LUCA.
DR   GeneTree; ENSGT00390000012872; -.
DR   HOGENOM; HOG000008129; -.
DR   HOVERGEN; HBG059824; -.
DR   InParanoid; Q8WVQ1; -.
DR   KO; K12304; -.
DR   OMA; GSMGKEW; -.
DR   OrthoDB; EOG091G0DL5; -.
DR   PhylomeDB; Q8WVQ1; -.
DR   TreeFam; TF315248; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; CANT1; human.
DR   EvolutionaryTrace; Q8WVQ1; -.
DR   GeneWiki; CANT1; -.
DR   GenomeRNAi; 124583; -.
DR   PRO; PR:Q8WVQ1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000171302; -.
DR   CleanEx; HS_CANT1; -.
DR   ExpressionAtlas; Q8WVQ1; baseline and differential.
DR   Genevisible; Q8WVQ1; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0043262; F:adenosine-diphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0004382; F:guanosine-diphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004871; F:signal transducer activity; HMP:UniProtKB.
DR   GO; GO:0045134; F:uridine-diphosphatase activity; IBA:GO_Central.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; HMP:UniProtKB.
DR   GO; GO:0030166; P:proteoglycan biosynthetic process; IMP:UniProtKB.
DR   InterPro; IPR009283; Apyrase.
DR   InterPro; IPR036258; Apyrase-like_sf.
DR   PANTHER; PTHR13023; PTHR13023; 1.
DR   Pfam; PF06079; Apyrase; 1.
DR   SUPFAM; SSF101887; SSF101887; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane;
KW   Complete proteome; Disease mutation; Disulfide bond; Dwarfism;
KW   Endoplasmic reticulum; Glycoprotein; Golgi apparatus; Hydrolase;
KW   Membrane; Metal-binding; Polymorphism; Reference proteome;
KW   Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1    401       Soluble calcium-activated nucleotidase 1.
FT                                /FTId=PRO_0000209925.
FT   TOPO_DOM      1     44       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     45     62       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     63    401       Lumenal. {ECO:0000255}.
FT   METAL       168    168       Calcium; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:1S18,
FT                                ECO:0000244|PDB:1S1D,
FT                                ECO:0000244|PDB:2H2N,
FT                                ECO:0000244|PDB:2H2U,
FT                                ECO:0000269|PubMed:15006348,
FT                                ECO:0000269|PubMed:16835225}.
FT   METAL       169    169       Calcium. {ECO:0000244|PDB:1S18,
FT                                ECO:0000244|PDB:2H2N,
FT                                ECO:0000244|PDB:2H2U,
FT                                ECO:0000269|PubMed:15006348,
FT                                ECO:0000269|PubMed:16835225}.
FT   METAL       215    215       Calcium; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:1S18,
FT                                ECO:0000244|PDB:1S1D,
FT                                ECO:0000244|PDB:2H2N,
FT                                ECO:0000244|PDB:2H2U,
FT                                ECO:0000269|PubMed:15006348,
FT                                ECO:0000269|PubMed:16835225}.
FT   METAL       284    284       Calcium; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:1S18,
FT                                ECO:0000244|PDB:1S1D,
FT                                ECO:0000244|PDB:2H2N,
FT                                ECO:0000244|PDB:2H2U,
FT                                ECO:0000269|PubMed:15006348,
FT                                ECO:0000269|PubMed:16835225}.
FT   METAL       345    345       Calcium; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:1S18,
FT                                ECO:0000244|PDB:1S1D,
FT                                ECO:0000244|PDB:2H2N,
FT                                ECO:0000244|PDB:2H2U,
FT                                ECO:0000269|PubMed:15006348,
FT                                ECO:0000269|PubMed:16835225}.
FT   METAL       396    396       Calcium; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:1S18,
FT                                ECO:0000244|PDB:1S1D,
FT                                ECO:0000244|PDB:2H2N,
FT                                ECO:0000244|PDB:2H2U,
FT                                ECO:0000269|PubMed:15006348,
FT                                ECO:0000269|PubMed:16835225}.
FT   SITE        160    160       Important for dimer formation.
FT                                {ECO:0000269|PubMed:16835225}.
FT   SITE        200    200       Important for dimer formation.
FT                                {ECO:0000269|PubMed:16835225}.
FT   SITE        202    202       Important for dimer formation.
FT                                {ECO:0000269|PubMed:16835225}.
FT   SITE        256    256       Important for dimer formation.
FT                                {ECO:0000269|PubMed:16835225}.
FT   CARBOHYD     88     88       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     60     60       Interchain.
FT                                {ECO:0000269|PubMed:16835225}.
FT   VAR_SEQ      41     91       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054260.
FT   VAR_SEQ     220    245       KDERLYVGGLGKEWTTTTGDVVNENP -> REIVRKRWRLV
FT                                KQVSHVGVLGQWIQR (in isoform 2).
FT                                {ECO:0000303|PubMed:12761501}.
FT                                /FTId=VSP_013760.
FT   VAR_SEQ     246    401       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12761501}.
FT                                /FTId=VSP_013761.
FT   VARIANT     112    112       D -> E (in DBQD1; dbSNP:rs749246739).
FT                                {ECO:0000269|PubMed:21654728}.
FT                                /FTId=VAR_068655.
FT   VARIANT     125    125       W -> C (in DBQD1; severely affects
FT                                activity; dbSNP:rs587776898).
FT                                {ECO:0000269|PubMed:21037275}.
FT                                /FTId=VAR_068656.
FT   VARIANT     165    165       M -> T (in DBQD1; severely affects
FT                                activity). {ECO:0000269|PubMed:21037275}.
FT                                /FTId=VAR_068657.
FT   VARIANT     224    224       L -> P (in DBQD1; affects protein
FT                                stability and secretion;
FT                                dbSNP:rs150181226).
FT                                {ECO:0000269|PubMed:21037275}.
FT                                /FTId=VAR_068658.
FT   VARIANT     226    226       V -> M (in DBQD1; severely affects
FT                                activity; dbSNP:rs377546036).
FT                                {ECO:0000269|PubMed:21037275,
FT                                ECO:0000269|PubMed:21412251}.
FT                                /FTId=VAR_068659.
FT   VARIANT     299    299       P -> L (in DBQD1; dbSNP:rs267606700).
FT                                {ECO:0000269|PubMed:19853239}.
FT                                /FTId=VAR_062980.
FT   VARIANT     300    300       R -> C (in DBQD1; severely affects
FT                                activity; dbSNP:rs267606701).
FT                                {ECO:0000269|PubMed:19853239,
FT                                ECO:0000269|PubMed:21037275}.
FT                                /FTId=VAR_062981.
FT   VARIANT     300    300       R -> H (in DBQD1; dbSNP:rs267606699).
FT                                {ECO:0000269|PubMed:19853239,
FT                                ECO:0000269|PubMed:22539336}.
FT                                /FTId=VAR_062982.
FT   VARIANT     303    303       S -> R (in DBQD1).
FT                                {ECO:0000269|PubMed:22539336}.
FT                                /FTId=VAR_068660.
FT   VARIANT     323    323       A -> T (polymorphism; does not affect
FT                                activity; dbSNP:rs9903215).
FT                                {ECO:0000269|PubMed:21037275}.
FT                                /FTId=VAR_068661.
FT   VARIANT     360    360       A -> D (in DBQD1; affects protein
FT                                secretion; dbSNP:rs387907081).
FT                                {ECO:0000269|PubMed:21037275}.
FT                                /FTId=VAR_068662.
FT   VARIANT     374    374       I -> N (in DBQD1).
FT                                {ECO:0000269|PubMed:22539336}.
FT                                /FTId=VAR_068663.
FT   VARIANT     391    391       G -> E (polymorphism; does not affect
FT                                activity; dbSNP:rs34082669).
FT                                {ECO:0000269|PubMed:21037275}.
FT                                /FTId=VAR_068664.
FT   MUTAGEN      60     60       C->S: Loss of dimer formation.
FT                                {ECO:0000269|PubMed:16835225}.
FT   MUTAGEN     112    112       D->A: Reduces activity by 99%.
FT                                {ECO:0000269|PubMed:15006348}.
FT   MUTAGEN     114    114       D->A: Reduces activity by 99%.
FT                                {ECO:0000269|PubMed:15006348,
FT                                ECO:0000269|PubMed:15248776}.
FT   MUTAGEN     139    139       S->C: Reduces GDPase and ADPase
FT                                activities 1.7-fold. Severe loss of dimer
FT                                formation; when associated with S-287.
FT                                {ECO:0000269|PubMed:16835225}.
FT   MUTAGEN     152    152       G->E: Slightly reduced activity.
FT                                {ECO:0000269|PubMed:15248776}.
FT   MUTAGEN     160    160       E->Y: Increases GDPase activity 2-fold
FT                                and ADPase activity 5-fold. Forms dimer
FT                                even at suboptimal Ca(2+) concentrations.
FT                                {ECO:0000269|PubMed:15248776,
FT                                ECO:0000269|PubMed:16835225}.
FT   MUTAGEN     163    163       R->A: Reduces activity by 98%.
FT                                {ECO:0000269|PubMed:15248776}.
FT   MUTAGEN     166    166       E->Q: Reduces activity by 95%.
FT                                {ECO:0000269|PubMed:15006348}.
FT   MUTAGEN     168    168       S->A: Reduces activity by over 99.9%.
FT                                {ECO:0000269|PubMed:15006348}.
FT   MUTAGEN     169    169       D->N: Reduces activity by 96%.
FT                                {ECO:0000269|PubMed:15006348}.
FT   MUTAGEN     181    181       D->A: Loss of activity.
FT                                {ECO:0000269|PubMed:15248776}.
FT   MUTAGEN     182    182       D->N: Reduces activity by over 99.9%.
FT                                {ECO:0000269|PubMed:15006348}.
FT   MUTAGEN     200    200       I->C: Reduces GDPase activity 2-fold and
FT                                ADPase activity 2.5-fold. No effect on
FT                                dimer formation; when associated with S-
FT                                287. {ECO:0000269|PubMed:16835225}.
FT   MUTAGEN     202    202       S->C: Reduces GDPase activity 1.7-fold
FT                                and ADPase activity 1.5-fold. No effect
FT                                on dimer formation; when associated with
FT                                S-287. {ECO:0000269|PubMed:16835225}.
FT   MUTAGEN     205    205       D->A: Slightly reduced activity.
FT                                {ECO:0000269|PubMed:15248776}.
FT   MUTAGEN     215    215       E->Q: Reduces activity by 99%.
FT                                {ECO:0000269|PubMed:15006348}.
FT   MUTAGEN     246    246       E->M: Increases activity 5-fold.
FT                                {ECO:0000269|PubMed:15006348}.
FT   MUTAGEN     256    256       S->C: No effect on GDPase and ADPase
FT                                activities. No effect on dimer formation;
FT                                when associated with S-287.
FT                                {ECO:0000269|PubMed:16835225}.
FT   MUTAGEN     287    287       C->S: Reduces GDPase and ADPase
FT                                activities 1.3-fold.
FT                                {ECO:0000269|PubMed:16835225}.
FT   MUTAGEN     301    301       R->A: Reduces activity by 99%.
FT                                {ECO:0000269|PubMed:15006348,
FT                                ECO:0000269|PubMed:15248776}.
FT   MUTAGEN     308    308       S->C: Reduces GDPase activity 1.3-fold
FT                                and ADPase activity 2-fold. Severe loss
FT                                of dimer formation; when associated with
FT                                S-287. {ECO:0000269|PubMed:16835225}.
FT   MUTAGEN     317    317       A->C: Reduces GDPase activity 1.7-fold
FT                                and ADPase activity 1.5-fold. Severe loss
FT                                of dimer formation; when associated with
FT                                S-287. {ECO:0000269|PubMed:16835225}.
FT   STRAND       92     94       {ECO:0000244|PDB:1S1D}.
FT   STRAND       97     99       {ECO:0000244|PDB:1S1D}.
FT   STRAND      102    112       {ECO:0000244|PDB:1S1D}.
FT   HELIX       114    117       {ECO:0000244|PDB:1S1D}.
FT   STRAND      125    137       {ECO:0000244|PDB:1S1D}.
FT   STRAND      143    147       {ECO:0000244|PDB:1S1D}.
FT   STRAND      152    157       {ECO:0000244|PDB:1S1D}.
FT   STRAND      158    160       {ECO:0000244|PDB:2H2U}.
FT   STRAND      167    173       {ECO:0000244|PDB:1S1D}.
FT   STRAND      176    181       {ECO:0000244|PDB:1S1D}.
FT   TURN        182    184       {ECO:0000244|PDB:1S1D}.
FT   STRAND      186    191       {ECO:0000244|PDB:1S1D}.
FT   STRAND      194    200       {ECO:0000244|PDB:1S1D}.
FT   TURN        204    207       {ECO:0000244|PDB:1S1D}.
FT   STRAND      208    211       {ECO:0000244|PDB:1S1D}.
FT   STRAND      216    220       {ECO:0000244|PDB:1S1D}.
FT   STRAND      223    227       {ECO:0000244|PDB:1S1D}.
FT   STRAND      240    242       {ECO:0000244|PDB:1S1D}.
FT   HELIX       244    246       {ECO:0000244|PDB:1S1D}.
FT   STRAND      247    251       {ECO:0000244|PDB:1S1D}.
FT   STRAND      257    261       {ECO:0000244|PDB:1S1D}.
FT   HELIX       263    272       {ECO:0000244|PDB:1S1D}.
FT   STRAND      280    282       {ECO:0000244|PDB:1S1D}.
FT   STRAND      286    289       {ECO:0000244|PDB:1S1D}.
FT   TURN        290    293       {ECO:0000244|PDB:1S1D}.
FT   STRAND      294    297       {ECO:0000244|PDB:1S1D}.
FT   STRAND      300    305       {ECO:0000244|PDB:1S1D}.
FT   HELIX       309    312       {ECO:0000244|PDB:1S1D}.
FT   STRAND      319    323       {ECO:0000244|PDB:1S1D}.
FT   STRAND      330    334       {ECO:0000244|PDB:1S1D}.
FT   STRAND      342    349       {ECO:0000244|PDB:1S1D}.
FT   STRAND      357    366       {ECO:0000244|PDB:1S1D}.
FT   STRAND      369    378       {ECO:0000244|PDB:1S1D}.
FT   STRAND      383    400       {ECO:0000244|PDB:1S1D}.
SQ   SEQUENCE   401 AA;  44840 MW;  5B78EB24C0B2C4CA CRC64;
     MPVQLSEHPE WNESMHSLRI SVGGLPVLAS MTKAADPRFR PRWKVILTFF VGAAILWLLC
     SHRPAPGRPP THNAHNWRLG QAPANWYNDT YPLSPPQRTP AGIRYRIAVI ADLDTESRAQ
     EENTWFSYLK KGYLTLSDSG DKVAVEWDKD HGVLESHLAE KGRGMELSDL IVFNGKLYSV
     DDRTGVVYQI EGSKAVPWVI LSDGDGTVEK GFKAEWLAVK DERLYVGGLG KEWTTTTGDV
     VNENPEWVKV VGYKGSVDHE NWVSNYNALR AAAGIQPPGY LIHESACWSD TLQRWFFLPR
     RASQERYSEK DDERKGANLL LSASPDFGDI AVSHVGAVVP THGFSSFKFI PNTDDQIIVA
     LKSEEDSGRV ASYIMAFTLD GRFLLPETKI GSVKYEGIEF I
//
ID   E5RHM5_HUMAN            Unreviewed;        46 AA.
AC   E5RHM5;
DT   08-FEB-2011, integrated into UniProtKB/TrEMBL.
DT   08-FEB-2011, sequence version 1.
DT   31-JAN-2018, entry version 44.
DE   SubName: Full=Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 {ECO:0000313|Ensembl:ENSP00000430882};
GN   Name=CHCHD7 {ECO:0000313|Ensembl:ENSP00000430882};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000430882, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000430882}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Glockner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3] {ECO:0000313|Ensembl:ENSP00000430882}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000430882}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC107952; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001304788.1; NM_001317859.1.
DR   UniGene; Hs.436913; -.
DR   ProteinModelPortal; E5RHM5; -.
DR   MaxQB; E5RHM5; -.
DR   PeptideAtlas; E5RHM5; -.
DR   PRIDE; E5RHM5; -.
DR   Ensembl; ENST00000523061; ENSP00000430882; ENSG00000170791.
DR   GeneID; 79145; -.
DR   UCSC; uc064mza.1; human.
DR   CTD; 79145; -.
DR   EuPathDB; HostDB:ENSG00000170791.17; -.
DR   HGNC; HGNC:28314; CHCHD7.
DR   OpenTargets; ENSG00000170791; -.
DR   eggNOG; KOG4618; Eukaryota.
DR   eggNOG; ENOG4112B0H; LUCA.
DR   GeneTree; ENSGT00390000001029; -.
DR   ChiTaRS; CHCHD7; human.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000170791; -.
DR   ExpressionAtlas; E5RHM5; baseline and differential.
DR   InterPro; IPR009069; Cys_alpha_HP_mot_SF.
DR   SUPFAM; SSF47072; SSF47072; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00756830};
KW   Proteomics identification {ECO:0000213|MaxQB:E5RHM5,
KW   ECO:0000213|PeptideAtlas:E5RHM5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   46 AA;  5382 MW;  639642393A62729D CRC64;
     MPSVTQRLRD PDINPCLSES DASTRCLDEN NYDRERCSTY FLRILS
//
ID   CHCH7_HUMAN             Reviewed;          85 AA.
AC   Q9BUK0; A8K223; E9PBH3; J3KNE9; Q7Z588;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   27-SEP-2017, entry version 121.
DE   RecName: Full=Coiled-coil-helix-coiled-coil-helix domain-containing protein 7;
GN   Name=CHCHD7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Guo J.H., Zan Q., Yu L.;
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Heart, and Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHROMOSOMAL REARRANGEMENT WITH PLAG1.
RX   PubMed=16736500; DOI=10.1002/gcc.20346;
RA   Asp J., Persson F., Kost-Alimova M., Stenman G.;
RT   "CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic,
RT   intrachromosomal 8q rearrangements in pleomorphic salivary gland
RT   adenomas.";
RL   Genes Chromosomes Cancer 45:820-828(2006).
RN   [7]
RP   STRUCTURE BY NMR, SUBUNIT, PUTATIVE SUBCELLULAR LOCATION,
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND DISULFIDE BONDS.
RX   PubMed=22842048; DOI=10.1016/j.jsb.2012.07.007;
RA   Banci L., Bertini I., Ciofi-Baffoni S., Jaiswal D., Neri S.,
RA   Peruzzini R., Winkelmann J.;
RT   "Structural characterization of CHCHD5 and CHCHD7: two atypical human
RT   twin CX9C proteins.";
RL   J. Struct. Biol. 180:190-200(2012).
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:22842048}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion intermembrane space
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9BUK0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BUK0-2; Sequence=VSP_038076;
CC       Name=3;
CC         IsoId=Q9BUK0-3; Sequence=VSP_038076, VSP_038077;
CC       Name=4;
CC         IsoId=Q9BUK0-4; Sequence=VSP_046698;
CC         Note=Gene prediction based on EST data.;
CC       Name=5;
CC         IsoId=Q9BUK0-5; Sequence=VSP_038077;
CC   -!- DISEASE: Note=A chromosomal aberration involving CHCHD7 is found
CC       in salivary gland pleiomorphic adenomas, the most common benign
CC       epithelial tumors of the salivary gland. Translocation
CC       t(6;8)(p21.3-22;q13) with PLAG1. {ECO:0000269|PubMed:16736500}.
CC   -!- SIMILARITY: Belongs to the CHCHD7 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=EAW86776.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY070434; AAL65261.1; -; mRNA.
DR   EMBL; AK095922; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK290088; BAF82777.1; -; mRNA.
DR   EMBL; AC107952; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471068; EAW86776.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471068; EAW86778.1; -; Genomic_DNA.
DR   EMBL; BC002546; AAH02546.2; -; mRNA.
DR   CCDS; CCDS34895.1; -. [Q9BUK0-4]
DR   CCDS; CCDS34896.1; -. [Q9BUK0-1]
DR   CCDS; CCDS55232.1; -. [Q9BUK0-3]
DR   CCDS; CCDS55233.1; -. [Q9BUK0-5]
DR   CCDS; CCDS6166.2; -. [Q9BUK0-2]
DR   RefSeq; NP_001011667.1; NM_001011667.2.
DR   RefSeq; NP_001011668.1; NM_001011668.2. [Q9BUK0-4]
DR   RefSeq; NP_001011669.1; NM_001011669.2. [Q9BUK0-3]
DR   RefSeq; NP_001011670.1; NM_001011670.2. [Q9BUK0-5]
DR   RefSeq; NP_001011671.1; NM_001011671.2. [Q9BUK0-1]
DR   RefSeq; NP_001304787.1; NM_001317858.1. [Q9BUK0-3]
DR   RefSeq; NP_001304788.1; NM_001317859.1.
DR   RefSeq; NP_077276.2; NM_024300.4. [Q9BUK0-2]
DR   UniGene; Hs.436913; -.
DR   PDB; 2LQT; NMR; -; A=1-85.
DR   PDBsum; 2LQT; -.
DR   ProteinModelPortal; Q9BUK0; -.
DR   SMR; Q9BUK0; -.
DR   BioGrid; 122564; 1.
DR   IntAct; Q9BUK0; 1.
DR   STRING; 9606.ENSP00000306425; -.
DR   iPTMnet; Q9BUK0; -.
DR   PhosphoSitePlus; Q9BUK0; -.
DR   BioMuta; CHCHD7; -.
DR   DMDM; 62510507; -.
DR   MaxQB; Q9BUK0; -.
DR   PaxDb; Q9BUK0; -.
DR   PeptideAtlas; Q9BUK0; -.
DR   PRIDE; Q9BUK0; -.
DR   DNASU; 79145; -.
DR   Ensembl; ENST00000303759; ENSP00000306425; ENSG00000170791. [Q9BUK0-4]
DR   Ensembl; ENST00000355315; ENSP00000347469; ENSG00000170791. [Q9BUK0-1]
DR   Ensembl; ENST00000518801; ENSP00000428274; ENSG00000170791. [Q9BUK0-3]
DR   Ensembl; ENST00000519367; ENSP00000428095; ENSG00000170791. [Q9BUK0-5]
DR   Ensembl; ENST00000521524; ENSP00000430458; ENSG00000170791. [Q9BUK0-3]
DR   Ensembl; ENST00000521831; ENSP00000429635; ENSG00000170791. [Q9BUK0-5]
DR   Ensembl; ENST00000523975; ENSP00000428917; ENSG00000170791. [Q9BUK0-2]
DR   GeneID; 79145; -.
DR   KEGG; hsa:79145; -.
DR   UCSC; uc003xss.4; human. [Q9BUK0-1]
DR   CTD; 79145; -.
DR   DisGeNET; 79145; -.
DR   EuPathDB; HostDB:ENSG00000170791.17; -.
DR   GeneCards; CHCHD7; -.
DR   HGNC; HGNC:28314; CHCHD7.
DR   HPA; HPA050783; -.
DR   MIM; 611238; gene.
DR   neXtProt; NX_Q9BUK0; -.
DR   OpenTargets; ENSG00000170791; -.
DR   PharmGKB; PA134883538; -.
DR   eggNOG; KOG4618; Eukaryota.
DR   eggNOG; ENOG4112B0H; LUCA.
DR   GeneTree; ENSGT00390000001029; -.
DR   HOGENOM; HOG000008048; -.
DR   HOVERGEN; HBG050939; -.
DR   InParanoid; Q9BUK0; -.
DR   OMA; KAEYMKG; -.
DR   OrthoDB; EOG091G13QO; -.
DR   PhylomeDB; Q9BUK0; -.
DR   TreeFam; TF300284; -.
DR   Reactome; R-HSA-1268020; Mitochondrial protein import.
DR   ChiTaRS; CHCHD7; human.
DR   GenomeRNAi; 79145; -.
DR   PRO; PR:Q9BUK0; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000170791; -.
DR   CleanEx; HS_CHCHD7; -.
DR   ExpressionAtlas; Q9BUK0; baseline and differential.
DR   Genevisible; Q9BUK0; HS.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IEA:UniProtKB-SubCell.
DR   InterPro; IPR009069; Cys_alpha_HP_mot_SF.
DR   SUPFAM; SSF47072; SSF47072; 1.
DR   PROSITE; PS51808; CHCH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement;
KW   Complete proteome; Disulfide bond; Mitochondrion; Reference proteome.
FT   CHAIN         1     85       Coiled-coil-helix-coiled-coil-helix
FT                                domain-containing protein 7.
FT                                /FTId=PRO_0000129171.
FT   DOMAIN       13     55       CHCH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01150}.
FT   MOTIF        16     26       Cx9C motif 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01150}.
FT   MOTIF        37     47       Cx9C motif 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01150}.
FT   DISULFID     16     47       {ECO:0000255|PROSITE-ProRule:PRU01150,
FT                                ECO:0000269|PubMed:22842048}.
FT   DISULFID     26     37       {ECO:0000255|PROSITE-ProRule:PRU01150,
FT                                ECO:0000269|PubMed:22842048}.
FT   VAR_SEQ       1      1       M -> MHQTRTGKKTVRM (in isoform 2 and
FT                                isoform 3). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_038076.
FT   VAR_SEQ       1      1       M -> MKCEETHAPNSNWVYVMLPSKKTVRM (in
FT                                isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_046698.
FT   VAR_SEQ      19     85       ESDASTRCLDENNYDRERCSTYFLRYKNCRRFWNSIVMQRR
FT                                KNGVKPFMPTAAERDEILRAVGNMPY -> ILFYLLNDASL
FT                                ISVRNLMLPPDVWMKITMTGKGVPLTS (in isoform 3
FT                                and isoform 5). {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_038077.
FT   HELIX        17     29       {ECO:0000244|PDB:2LQT}.
FT   TURN         30     32       {ECO:0000244|PDB:2LQT}.
FT   TURN         34     37       {ECO:0000244|PDB:2LQT}.
FT   HELIX        38     59       {ECO:0000244|PDB:2LQT}.
FT   HELIX        70     80       {ECO:0000244|PDB:2LQT}.
SQ   SEQUENCE   85 AA;  10095 MW;  957C3727AB9B3C8C CRC64;
     MPSVTQRLRD PDINPCLSES DASTRCLDEN NYDRERCSTY FLRYKNCRRF WNSIVMQRRK
     NGVKPFMPTA AERDEILRAV GNMPY
//
ID   A0A024RBR1_HUMAN        Unreviewed;      1427 AA.
AC   A0A024RBR1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 33.
DE   SubName: Full=Restin (Reed-Steinberg cell-expressed intermediate filament-associated protein), isoform CRA_b {ECO:0000313|EMBL:EAW98322.1};
GN   Name=RSN {ECO:0000313|EMBL:EAW98322.1};
GN   ORFNames=hCG_2016686 {ECO:0000313|EMBL:EAW98322.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW98322.1};
RN   [1] {ECO:0000313|EMBL:EAW98322.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW98322.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471054; EAW98321.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW98322.1; -; Genomic_DNA.
DR   RefSeq; NP_002947.1; NM_002956.2.
DR   RefSeq; XP_016875275.1; XM_017019786.1.
DR   UniGene; Hs.524809; -.
DR   SMR; A0A024RBR1; -.
DR   GeneID; 6249; -.
DR   CTD; 6249; -.
DR   EuPathDB; HostDB:ENSG00000130779.19; -.
DR   eggNOG; KOG4568; Eukaryota.
DR   eggNOG; COG5244; LUCA.
DR   ChiTaRS; CLIP1; human.
DR   GenomeRNAi; 6249; -.
DR   Bgee; ENSG00000130779; -.
DR   Gene3D; 2.30.30.190; -; 2.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR032108; CLIP1_ZNF.
DR   Pfam; PF01302; CAP_GLY; 2.
DR   Pfam; PF16641; CLIP1_ZNF; 2.
DR   SMART; SM01052; CAP_GLY; 2.
DR   SUPFAM; SSF74924; SSF74924; 2.
DR   PROSITE; PS00845; CAP_GLY_1; 2.
DR   PROSITE; PS50245; CAP_GLY_2; 2.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       78    120       CAP-Gly. {ECO:0000259|PROSITE:PS50245}.
FT   DOMAIN      232    274       CAP-Gly. {ECO:0000259|PROSITE:PS50245}.
FT   COILED      350    377       {ECO:0000256|SAM:Coils}.
FT   COILED      403    451       {ECO:0000256|SAM:Coils}.
FT   COILED      466    486       {ECO:0000256|SAM:Coils}.
FT   COILED      501    521       {ECO:0000256|SAM:Coils}.
FT   COILED      577    604       {ECO:0000256|SAM:Coils}.
FT   COILED      613    633       {ECO:0000256|SAM:Coils}.
FT   COILED      649    806       {ECO:0000256|SAM:Coils}.
FT   COILED      821    862       {ECO:0000256|SAM:Coils}.
FT   COILED      870    925       {ECO:0000256|SAM:Coils}.
FT   COILED      933   1181       {ECO:0000256|SAM:Coils}.
FT   COILED     1185   1205       {ECO:0000256|SAM:Coils}.
FT   COILED     1231   1258       {ECO:0000256|SAM:Coils}.
FT   COILED     1262   1296       {ECO:0000256|SAM:Coils}.
FT   COILED     1312   1339       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1427 AA;  160990 MW;  0A4F166DD94254E8 CRC64;
     MSMLKPSGLK APTKILKPGS TALKTPTAVV APVEKTISSE KASSTPSSET QEEFVDDFRV
     GERVWVNGNK PGFIQFLGET QFAPGQWAGI VLDEPIGKND GSVAGVRYFQ CEPLKGIFTR
     PSKLTRKVQA EDEANGLQTT PASRATSPLC TSTASMVSSS PSTPSNIPQK PSQPAAKEPS
     ATPPISNLTK TASESISNLS EAGSIKKGER ELKIGDRVLV GGTKAGVVRF LGETDFAKGE
     WCGVELDEPL GKNDGAVAGT RYFQCQPKYG LFAPVHKVTK IGFPSTTPAK AKANAVRRVM
     ATTSASLKRS PSASSLSSMS SVASSVSSRP SRTGLLTETS SRYARKISGT TALQEALKEK
     QQHIEQLLAE RDLERAEVAK ATSHVGEIEQ ELALARDGHD QHVLELEAKM DQLRTMVEAA
     DREKVELLNQ LEEEKRKVED LQFRVEEESI TKGDLETQTK LEHARIKELE QSLLFEKTKA
     DKLQRELEDT RVATVSEKSR IMELEKDLAL RVQEVAELRR RLESNKPAGD VDMSLSLLQE
     ISSLQEKLEV TRTDHQREIT SLKEHFGARE ETHQKEIKAL YTATEKLSKE NESLKSKLEH
     ANKENSDVIA LWKSKLETAI ASHQQAMEEL KVSFSKGLGT ETAEFAELKT QIEKMRLDYQ
     HEIENLQNQQ DSERAAHAKE MEALRAKLMK VIKEKENSLE AIRSKLDKAE DQHLVEMEDT
     LNKLQEAEIK VKELEVLQAK CNEQTKVIDN FTSQLKATEE KLLDLDALRK ASSEGKSEMK
     KLRQQLEAAE KQIKHLEIEK NAESSKASSI TRELQGRELK LTNLQENLSE VSQVKETLEK
     ELQILKEKFA EASEEAVSVQ RSMQETVNKL HQKEEQFNML SSDLEKLREN LADMEAKFRE
     KDEREEQLIK AKEKLENDIA EIMKMSGDNS SQLTKMNDEL RLKERDVEEL QLKLTKANEN
     ASFLQKSIED MTVKAEQSQQ EAAKKHEEEK KELERKLSDL EKKMETSHNQ CQELKARYER
     ATSETKTKHE EILQNLQKTL LDTEDKLKGA REENSGLLQE LEELRKQADK AKAAQTAEDA
     MQIMEQMTKE KTETLASLED TKQTNAKLQN ELDTLKENNL KNVEELNKSK ELLTVENQKM
     EEFRKEIETL KQAAAQKSQQ LSALQEENVK LAEELGRSRD EVTSHQKLEE ERSVLNNQLL
     EMKKRESKFI KDADEEKASL QKSISITSAL LTEKDAELEK LRNEVTVLRG ENASAKSLHS
     VVQTLESDKV KLELKVKNLE LQLKENKRQL SSSSGNTDTQ ADEDERAQES QIDFLNSVIV
     DLQRKNQDLK MKVEMMSEAA LNGNGDDLNN YDSDDQEKQS KKKPRLFCDI CDCFDLHDTE
     DCPTQAQMSE DPPHSTHHGS RGEERPYCEI CEMFGHWATN CNDDETF
//
ID   B3KXA5_HUMAN            Unreviewed;       472 AA.
AC   B3KXA5;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 47.
DE   SubName: Full=cDNA FLJ45045 fis, clone BRAWH3021580, highly similar to Restin (Cytoplasmic linker protein 170 alpha-2) {ECO:0000313|EMBL:BAG54417.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54417.1};
RN   [1] {ECO:0000313|EMBL:BAG54417.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG54417.1};
RA   Kawakami B., Sugiyama A., Takemoto M., Sugiyama T., Irie R.,
RA   Otsuki T., Sato H., Ota T., Wakamatsu A., Ishii S., Yamamoto J.,
RA   Isono Y., Kawai-Hio Y., Saito K., Nishikawa T., Kimura K.,
RA   Yamashita H., Matsuo K., Nakamura Y., Sekine M., Kikuchi H., Kanda K.,
RA   Wagatsuma M., Murakawa K., Kanehori K., Takahashi-Fujii A., Oshima A.,
RA   Suzuki Y., Sugano S., Nagahari K., Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK126990; BAG54417.1; -; mRNA.
DR   RefSeq; NP_002947.1; NM_002956.2.
DR   RefSeq; NP_937883.1; NM_198240.1.
DR   UniGene; Hs.524809; -.
DR   PeptideAtlas; B3KXA5; -.
DR   PRIDE; B3KXA5; -.
DR   GeneID; 6249; -.
DR   CTD; 6249; -.
DR   PharmGKB; PA162382349; -.
DR   eggNOG; KOG4568; Eukaryota.
DR   eggNOG; COG5244; LUCA.
DR   HOGENOM; HOG000169618; -.
DR   HOVERGEN; HBG078781; -.
DR   GenomeRNAi; 6249; -.
DR   Genevisible; B3KXA5; HS.
DR   InterPro; IPR032108; CLIP1_ZNF.
DR   Pfam; PF16641; CLIP1_ZNF; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN      410    427       CLIP1_ZNF. {ECO:0000259|Pfam:PF16641}.
FT   DOMAIN      450    466       CLIP1_ZNF. {ECO:0000259|Pfam:PF16641}.
FT   COILED       11    224       {ECO:0000256|SAM:Coils}.
FT   COILED      228    248       {ECO:0000256|SAM:Coils}.
FT   COILED      274    301       {ECO:0000256|SAM:Coils}.
FT   COILED      305    339       {ECO:0000256|SAM:Coils}.
FT   COILED      350    384       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   472 AA;  54323 MW;  4311F3A5ED51D25A CRC64;
     MKMQVFCKKS IEDMTVKAEQ SQQEAAKKHE EEKKELERKL SDLEKKMETS HNQCQELKAR
     YERATSETKT KHEEILQNLQ KTLLDTEDKL KGAREENSGL LQELEELRKQ ADKAKAAQTA
     EDAMQIMEQM TKEKTETLAS LEDTKQTNAK LQNELDTLKE NNLKNVEELN KSKELLTVEN
     QKMEEFRKEI ETLKQAAAQK SQQLSALQEE NVKLAEELGR SRDEVTSHQK LEEERSVLNN
     QLLEMKKRES KFIKDADEEK ASLQKSISIT SALLTEKDAE LEKLRNEVTV LRGENASAKS
     LHSVVQTLES DKVKLELKVK NLELQLKENK RQLSSSSGNT DTQADEDERA QESQQMIDFL
     NSVIVDLQRK NQDLKMKVEM MSEAALNGNG DDLNNYDSDD QEKQSKKKPR LFCDICDCFD
     LHDTEDCPTQ AQMSEDPPHS THHGSRGEER PYCEICEMFG HWATNCNDDE TF
//
ID   CLIP1_HUMAN             Reviewed;        1438 AA.
AC   P30622; A0AVD3; Q17RS4; Q29RG0;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   13-OCT-2009, sequence version 2.
DT   28-FEB-2018, entry version 183.
DE   RecName: Full=CAP-Gly domain-containing linker protein 1;
DE   AltName: Full=Cytoplasmic linker protein 1;
DE   AltName: Full=Cytoplasmic linker protein 170 alpha-2;
DE            Short=CLIP-170;
DE   AltName: Full=Reed-Sternberg intermediate filament-associated protein;
DE   AltName: Full=Restin;
GN   Name=CLIP1; Synonyms=CYLN1, RSN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Peripheral blood monocyte;
RX   PubMed=1600942;
RA   Bilbe G., Delabie J., Brueggen J., Richener H., Asselbergs F.A.M.,
RA   Cerletti N., Sorg C., Odink K., Tarcsay L., Wiesendanger W.,
RA   de Wolf-Peeters C., Shipman R.;
RT   "Restin: a novel intermediate filament-associated protein highly
RT   expressed in the Reed-Sternberg cells of Hodgkin's disease.";
RL   EMBO J. 11:2103-2113(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND VARIANT GLU-1080.
RX   PubMed=1356075; DOI=10.1016/0092-8674(92)90240-D;
RA   Pierre P., Scheel J., Rickard J.E., Kreis T.E.;
RT   "CLIP-170 links endocytic vesicles to microtubules.";
RL   Cell 70:887-900(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND
RP   VARIANTS PRO-941 AND GLU-1080.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12433698; DOI=10.1182/blood.V100.12.4139;
RA   Sahin U., Neumann F., Tureci O., Schmits R., Perez F.,
RA   Pfreundschuh M.;
RT   "Hodgkin and Reed-Sternberg cell-associated autoantigen CLIP-
RT   170/restin is a marker for dendritic cells and is involved in the
RT   trafficking of macropinosomes to the cytoskeleton, supporting a
RT   function-based concept of Hodgkin and Reed-Sternberg cells.";
RL   Blood 100:4139-4145(2002).
RN   [5]
RP   INTERACTION WITH MTOR, AND PHOSPHORYLATION BY MTOR.
RX   PubMed=12231510; DOI=10.1093/embo-reports/kvf197;
RA   Choi J.H., Bertram P.G., Drenan R., Carvalho J., Zhou H.H.,
RA   Zheng X.F.;
RT   "The FKBP12-rapamycin-associated protein (FRAP) is a CLIP-170
RT   kinase.";
RL   EMBO Rep. 3:988-994(2002).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200 AND SER-204, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-195, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; THR-140; SER-143;
RP   SER-147; THR-182; SER-197; SER-200 AND SER-204, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-195; SER-200 AND
RP   SER-204, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   INTERACTION WITH DCTN1.
RX   PubMed=20679239; DOI=10.1073/pnas.1006615107;
RA   Li H., Liu X.S., Yang X., Song B., Wang Y., Liu X.;
RT   "Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear
RT   envelope breakdown during prophase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:14633-14638(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; THR-140; SER-143;
RP   SER-200; SER-204 AND SER-1364, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-50; THR-140; SER-143;
RP   THR-182; SER-195; SER-200 AND SER-204, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200 AND THR-1310, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   STRUCTURE BY NMR OF 1-340.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the 1st and 2nd CAP-Gly domain in human CLIP-
RT   170/Restin.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 57-128, FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF 98-LYS-ASN-99, AND INTERACTION
RP   WITH TUBULIN.
RX   PubMed=17889670; DOI=10.1016/j.molcel.2007.07.023;
RA   Slep K.C., Vale R.D.;
RT   "Structural basis of microtubule plus end tracking by XMAP215, CLIP-
RT   170, and EB1.";
RL   Mol. Cell 27:976-991(2007).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1388-1427 IN COMPLEX WITH
RP   DCTN1.
RX   PubMed=17828277; DOI=10.1038/nsmb1291;
RA   Weisbrich A., Honnappa S., Jaussi R., Okhrimenko O., Frey D.,
RA   Jelesarov I., Akhmanova A., Steinmetz M.O.;
RT   "Structure-function relationship of CAP-Gly domains.";
RL   Nat. Struct. Mol. Biol. 14:959-967(2007).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 1416-1438 IN COMPLEX WITH
RP   DCTN1 AND ZINC, INTERACTION WITH DCTN1, AND ZINC-FINGER.
RX   PubMed=17828275; DOI=10.1038/nsmb1299;
RA   Hayashi I., Plevin M.J., Ikura M.;
RT   "CLIP170 autoinhibition mimics intermolecular interactions with
RT   p150Glued or EB1.";
RL   Nat. Struct. Mol. Biol. 14:980-981(2007).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 211-300, STRUCTURE BY NMR OF
RP   203-300 IN COMPLEX WITH TUBA1B, INTERACTION WITH TUBULIN; TUBA1B;
RP   MAPRE1 AND MAPRE3, FUNCTION, AND ZINC-FINGER DOMAIN.
RX   PubMed=17563362; DOI=10.1073/pnas.0703876104;
RA   Mishima M., Maesaki R., Kasa M., Watanabe T., Fukata M., Kaibuchi K.,
RA   Hakoshima T.;
RT   "Structural basis for tubulin recognition by cytoplasmic linker
RT   protein 170 and its autoinhibition.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:10346-10351(2007).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 56-127 IN COMPLEX WITH
RP   SLAIN2, SUBCELLULAR LOCATION, AND INTERACTION WITH SLAIN2.
RX   PubMed=21646404; DOI=10.1083/jcb.201012179;
RA   van der Vaart B., Manatschal C., Grigoriev I., Olieric V.,
RA   Gouveia S.M., Bjelic S., Demmers J., Vorobjev I., Hoogenraad C.C.,
RA   Steinmetz M.O., Akhmanova A.;
RT   "SLAIN2 links microtubule plus end-tracking proteins and controls
RT   microtubule growth in interphase.";
RL   J. Cell Biol. 193:1083-1099(2011).
RN   [22]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-1213.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Binds to the plus end of microtubules and regulates the
CC       dynamics of the microtubule cytoskeleton. Promotes microtubule
CC       growth and microtubule bundling. Links cytoplasmic vesicles to
CC       microtubules and thereby plays an important role in intracellular
CC       vesicle trafficking. Plays a role macropinocytosis and endosome
CC       trafficking. {ECO:0000269|PubMed:12433698,
CC       ECO:0000269|PubMed:17563362, ECO:0000269|PubMed:17889670}.
CC   -!- SUBUNIT: Interacts with MTOR; phosphorylates and regulates CLIP1
CC       (PubMed:12231510). Interacts (via CAP-Gly domains) with tubulin
CC       (PubMed:17563362, PubMed:17889670). Interacts with SLAIN2
CC       (PubMed:21646404). Interacts (via zinc finger) with DCTN1
CC       (PubMed:17828275, PubMed:20679239). Interacts with TUBA1B, MAPRE1
CC       and MAPRE3 (PubMed:17563362). Binds preferentially to tyrosinated
CC       microtubules, and only marginally to detyrosinated microtubules
CC       (By similarity). {ECO:0000250|UniProtKB:Q922J3,
CC       ECO:0000269|PubMed:12231510, ECO:0000269|PubMed:17563362,
CC       ECO:0000269|PubMed:17828275, ECO:0000269|PubMed:17828277,
CC       ECO:0000269|PubMed:17889670, ECO:0000269|PubMed:20679239,
CC       ECO:0000269|PubMed:21646404}.
CC   -!- INTERACTION:
CC       Q14203:DCTN1; NbExp=7; IntAct=EBI-9640673, EBI-724352;
CC       Q15691:MAPRE1; NbExp=4; IntAct=EBI-6479976, EBI-1004115;
CC       Q71U36:TUBA1A; NbExp=3; IntAct=EBI-6479976, EBI-302552;
CC       P68366:TUBA4A; NbExp=3; IntAct=EBI-2683569, EBI-351772;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Cytoplasm,
CC       cytoskeleton {ECO:0000269|PubMed:17889670,
CC       ECO:0000269|PubMed:21646404}. Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:12433698}; Peripheral membrane protein;
CC       Cytoplasmic side. Cell projection, ruffle
CC       {ECO:0000269|PubMed:12433698}. Note=Localizes to microtubule plus
CC       ends (PubMed:21646404, PubMed:17889670). Localizes preferentially
CC       to the ends of tyrosinated microtubules (By similarity).
CC       Accumulates in plasma membrane regions with ruffling and
CC       protrusions. Associates with the membranes of intermediate
CC       macropinocytic vesicles (PubMed:12433698).
CC       {ECO:0000250|UniProtKB:Q922J3, ECO:0000269|PubMed:12433698,
CC       ECO:0000269|PubMed:17889670, ECO:0000269|PubMed:21646404}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P30622-3; Sequence=Displayed;
CC       Name=2; Synonyms=Long;
CC         IsoId=P30622-1; Sequence=VSP_038201;
CC       Name=3; Synonyms=Short;
CC         IsoId=P30622-2; Sequence=VSP_000765;
CC   -!- TISSUE SPECIFICITY: Detected in dendritic cells (at protein
CC       level). Highly expressed in the Reed-Sternberg cells of Hodgkin
CC       disease. {ECO:0000269|PubMed:12433698,
CC       ECO:0000269|PubMed:1600942}.
CC   -!- DOMAIN: Intramolecular interaction between the zinc finger domain
CC       and the CAP-Gly domains may inhibit interaction with tubulin.
CC       {ECO:0000269|PubMed:17563362}.
CC   -!- PTM: Phosphorylated. Phosphorylation induces conformational
CC       changes by increasing the affinity of the N-terminus for C-
CC       terminus, resulting in inhibition of its function thus decreasing
CC       its binding to microtubules and DCTN1. Exhibits a folded,
CC       autoinhibited conformation when phosphorylated and an open
CC       conformation when dephosphorylated with increased binding affinity
CC       to microtubules and DCTN1. Phosphorylation regulates its
CC       recruitment to tyrosinated microtubules and the recruitment of
CC       vesicular cargo to microtubules in neurons (By similarity).
CC       Phosphorylation by MTOR may positively regulate CLIP1 association
CC       with microtubules (PubMed:12231510).
CC       {ECO:0000250|UniProtKB:Q9JK25, ECO:0000269|PubMed:12231510}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X64838; CAA46050.1; -; mRNA.
DR   EMBL; M97501; AAA35693.1; -; mRNA.
DR   EMBL; BC114213; AAI14214.1; -; mRNA.
DR   EMBL; BC117209; AAI17210.1; -; mRNA.
DR   EMBL; BC126305; AAI26306.1; -; mRNA.
DR   CCDS; CCDS58285.1; -. [P30622-3]
DR   CCDS; CCDS9232.1; -. [P30622-1]
DR   CCDS; CCDS9233.1; -. [P30622-2]
DR   PIR; A43336; A43336.
DR   PIR; S22695; S22695.
DR   RefSeq; NP_001234926.1; NM_001247997.1. [P30622-3]
DR   RefSeq; NP_002947.1; NM_002956.2. [P30622-1]
DR   RefSeq; NP_937883.1; NM_198240.1. [P30622-2]
DR   RefSeq; XP_016875275.1; XM_017019786.1. [P30622-1]
DR   RefSeq; XP_016875279.1; XM_017019790.1. [P30622-2]
DR   UniGene; Hs.524809; -.
DR   PDB; 2CP5; NMR; -; A=1-128.
DR   PDB; 2CP6; NMR; -; A=181-339.
DR   PDB; 2E3H; X-ray; 1.45 A; A=211-300.
DR   PDB; 2E3I; X-ray; 2.00 A; A=56-141.
DR   PDB; 2E4H; NMR; -; A=203-300.
DR   PDB; 2HQH; X-ray; 1.80 A; E/F/G/H=1416-1438.
DR   PDB; 2QK0; X-ray; 2.00 A; A=57-128.
DR   PDB; 3E2U; X-ray; 2.60 A; E/F/G/H=1399-1438.
DR   PDB; 3RDV; X-ray; 1.75 A; A/B/C/D=56-127.
DR   PDBsum; 2CP5; -.
DR   PDBsum; 2CP6; -.
DR   PDBsum; 2E3H; -.
DR   PDBsum; 2E3I; -.
DR   PDBsum; 2E4H; -.
DR   PDBsum; 2HQH; -.
DR   PDBsum; 2QK0; -.
DR   PDBsum; 3E2U; -.
DR   PDBsum; 3RDV; -.
DR   ProteinModelPortal; P30622; -.
DR   SMR; P30622; -.
DR   BioGrid; 112163; 34.
DR   CORUM; P30622; -.
DR   DIP; DIP-42826N; -.
DR   ELM; P30622; -.
DR   IntAct; P30622; 25.
DR   MINT; P30622; -.
DR   STRING; 9606.ENSP00000303585; -.
DR   iPTMnet; P30622; -.
DR   PhosphoSitePlus; P30622; -.
DR   UniCarbKB; P30622; -.
DR   BioMuta; CLIP1; -.
DR   DMDM; 261260059; -.
DR   EPD; P30622; -.
DR   PaxDb; P30622; -.
DR   PeptideAtlas; P30622; -.
DR   PRIDE; P30622; -.
DR   Ensembl; ENST00000302528; ENSP00000303585; ENSG00000130779. [P30622-1]
DR   Ensembl; ENST00000358808; ENSP00000351665; ENSG00000130779. [P30622-1]
DR   Ensembl; ENST00000537178; ENSP00000445531; ENSG00000130779. [P30622-2]
DR   Ensembl; ENST00000540338; ENSP00000439093; ENSG00000130779. [P30622-3]
DR   Ensembl; ENST00000620786; ENSP00000479322; ENSG00000130779. [P30622-3]
DR   GeneID; 6249; -.
DR   KEGG; hsa:6249; -.
DR   UCSC; uc001ucg.2; human. [P30622-3]
DR   CTD; 6249; -.
DR   DisGeNET; 6249; -.
DR   EuPathDB; HostDB:ENSG00000130779.19; -.
DR   GeneCards; CLIP1; -.
DR   HGNC; HGNC:10461; CLIP1.
DR   HPA; CAB004399; -.
DR   HPA; HPA026678; -.
DR   MalaCards; CLIP1; -.
DR   MIM; 179838; gene.
DR   neXtProt; NX_P30622; -.
DR   OpenTargets; ENSG00000130779; -.
DR   Orphanet; 88616; Autosomal recessive non-syndromic intellectual disability.
DR   PharmGKB; PA162382349; -.
DR   eggNOG; KOG4568; Eukaryota.
DR   eggNOG; COG5244; LUCA.
DR   GeneTree; ENSGT00760000119173; -.
DR   HOGENOM; HOG000092755; -.
DR   HOVERGEN; HBG007123; -.
DR   InParanoid; P30622; -.
DR   KO; K10421; -.
DR   OMA; EAKFRER; -.
DR   OrthoDB; EOG091G0J1Y; -.
DR   PhylomeDB; P30622; -.
DR   TreeFam; TF326096; -.
DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   SIGNOR; P30622; -.
DR   ChiTaRS; CLIP1; human.
DR   EvolutionaryTrace; P30622; -.
DR   GeneWiki; CLIP1; -.
DR   GenomeRNAi; 6249; -.
DR   PRO; PR:P30622; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000130779; -.
DR   CleanEx; HS_CLIP1; -.
DR   ExpressionAtlas; P30622; baseline and differential.
DR   Genevisible; P30622; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IEA:Ensembl.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; TAS:ProtInc.
DR   GO; GO:0005882; C:intermediate filament; TAS:ProtInc.
DR   GO; GO:0000776; C:kinetochore; TAS:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IMP:UniProtKB.
DR   GO; GO:0035371; C:microtubule plus-end; IEA:Ensembl.
DR   GO; GO:0005635; C:nuclear envelope; IEA:Ensembl.
DR   GO; GO:0001726; C:ruffle; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; NAS:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; TAS:UniProtKB.
DR   GO; GO:0015631; F:tubulin binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0001578; P:microtubule bundle formation; IMP:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; TAS:UniProtKB.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IMP:UniProtKB.
DR   GO; GO:0044861; P:protein transport into plasma membrane raft; IEA:Ensembl.
DR   GO; GO:0007062; P:sister chromatid cohesion; TAS:Reactome.
DR   Gene3D; 2.30.30.190; -; 2.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR032108; CLIP1_ZNF.
DR   Pfam; PF01302; CAP_GLY; 2.
DR   Pfam; PF16641; CLIP1_ZNF; 2.
DR   SMART; SM01052; CAP_GLY; 2.
DR   SUPFAM; SSF74924; SSF74924; 2.
DR   PROSITE; PS00845; CAP_GLY_1; 2.
DR   PROSITE; PS50245; CAP_GLY_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell projection; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoplasmic vesicle; Cytoskeleton;
KW   Membrane; Metal-binding; Microtubule; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transport; Zinc; Zinc-finger.
FT   CHAIN         1   1438       CAP-Gly domain-containing linker protein
FT                                1.
FT                                /FTId=PRO_0000083527.
FT   DOMAIN       78    120       CAP-Gly 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00045}.
FT   DOMAIN      232    274       CAP-Gly 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00045}.
FT   ZN_FING    1417   1434       CCHC-type. {ECO:0000269|PubMed:17563362,
FT                                ECO:0000269|PubMed:17828275}.
FT   REGION       97    101       Important for tubulin binding.
FT                                {ECO:0000269|PubMed:17889670}.
FT   COILED      350   1353       {ECO:0000255}.
FT   COMPBIAS    143    204       Ser-rich.
FT   COMPBIAS    304    331       Ser-rich.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES      50     50       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     140    140       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     143    143       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     147    147       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     182    182       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     195    195       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     197    197       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     200    200       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     204    204       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     310    310       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JK25}.
FT   MOD_RES     312    312       Phosphoserine; by PKA.
FT                                {ECO:0000250|UniProtKB:Q9JK25}.
FT   MOD_RES     315    315       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q922J3}.
FT   MOD_RES     348    348       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JK25}.
FT   MOD_RES    1236   1236       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JK25}.
FT   MOD_RES    1310   1310       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1364   1364       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ     457    502       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:1356075,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000765.
FT   VAR_SEQ     457    467       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1600942}.
FT                                /FTId=VSP_038201.
FT   VARIANT     162    162       S -> P (in dbSNP:rs7963597).
FT                                /FTId=VAR_059206.
FT   VARIANT     780    780       R -> W (in dbSNP:rs3741447).
FT                                /FTId=VAR_048672.
FT   VARIANT     941    941       S -> P (in dbSNP:rs17883517).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_048673.
FT   VARIANT    1080   1080       D -> E (in dbSNP:rs1129167).
FT                                {ECO:0000269|PubMed:1356075,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_020398.
FT   VARIANT    1213   1213       M -> I (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036446.
FT   VARIANT    1224   1224       A -> S (in dbSNP:rs17881033).
FT                                /FTId=VAR_048674.
FT   MUTAGEN      98     99       KN->EE: Abolishes interaction with
FT                                tubulin. Abolishes localization at the
FT                                microtubule plus end.
FT                                {ECO:0000269|PubMed:17889670}.
FT   CONFLICT    193    193       S -> G (in Ref. 3; AAI14214).
FT                                {ECO:0000305}.
FT   CONFLICT    324    324       S -> P (in Ref. 3; AAI14214).
FT                                {ECO:0000305}.
FT   CONFLICT    651    651       T -> A (in Ref. 3; AAI14214).
FT                                {ECO:0000305}.
FT   CONFLICT    682    682       D -> N (in Ref. 3; AAI14214).
FT                                {ECO:0000305}.
FT   CONFLICT    766    766       L -> P (in Ref. 3; AAI14214).
FT                                {ECO:0000305}.
FT   CONFLICT   1432   1432       C -> R (in Ref. 3; AAI14214).
FT                                {ECO:0000305}.
FT   STRAND       37     39       {ECO:0000244|PDB:2CP5}.
FT   STRAND       63     66       {ECO:0000244|PDB:3RDV}.
FT   TURN         67     69       {ECO:0000244|PDB:3RDV}.
FT   STRAND       70     78       {ECO:0000244|PDB:3RDV}.
FT   STRAND       81     85       {ECO:0000244|PDB:3RDV}.
FT   STRAND       87     95       {ECO:0000244|PDB:3RDV}.
FT   STRAND       97    103       {ECO:0000244|PDB:3RDV}.
FT   STRAND      106    108       {ECO:0000244|PDB:3RDV}.
FT   TURN        113    115       {ECO:0000244|PDB:2QK0}.
FT   STRAND      116    119       {ECO:0000244|PDB:3RDV}.
FT   HELIX       121    123       {ECO:0000244|PDB:3RDV}.
FT   STRAND      124    127       {ECO:0000244|PDB:2E3I}.
FT   STRAND      193    196       {ECO:0000244|PDB:2CP6}.
FT   STRAND      217    220       {ECO:0000244|PDB:2E3H}.
FT   TURN        221    223       {ECO:0000244|PDB:2E3H}.
FT   STRAND      224    233       {ECO:0000244|PDB:2E3H}.
FT   STRAND      235    249       {ECO:0000244|PDB:2E3H}.
FT   STRAND      252    257       {ECO:0000244|PDB:2E3H}.
FT   STRAND      260    262       {ECO:0000244|PDB:2E3H}.
FT   TURN        267    269       {ECO:0000244|PDB:2CP6}.
FT   STRAND      270    274       {ECO:0000244|PDB:2E3H}.
FT   HELIX       275    277       {ECO:0000244|PDB:2E3H}.
FT   STRAND      278    280       {ECO:0000244|PDB:2E3H}.
FT   STRAND      295    298       {ECO:0000244|PDB:2CP6}.
FT   TURN       1420   1423       {ECO:0000244|PDB:2HQH}.
FT   STRAND     1424   1427       {ECO:0000244|PDB:2HQH}.
FT   HELIX      1429   1431       {ECO:0000244|PDB:2HQH}.
SQ   SEQUENCE   1438 AA;  162246 MW;  A7F125F7A96DBDDB CRC64;
     MSMLKPSGLK APTKILKPGS TALKTPTAVV APVEKTISSE KASSTPSSET QEEFVDDFRV
     GERVWVNGNK PGFIQFLGET QFAPGQWAGI VLDEPIGKND GSVAGVRYFQ CEPLKGIFTR
     PSKLTRKVQA EDEANGLQTT PASRATSPLC TSTASMVSSS PSTPSNIPQK PSQPAAKEPS
     ATPPISNLTK TASESISNLS EAGSIKKGER ELKIGDRVLV GGTKAGVVRF LGETDFAKGE
     WCGVELDEPL GKNDGAVAGT RYFQCQPKYG LFAPVHKVTK IGFPSTTPAK AKANAVRRVM
     ATTSASLKRS PSASSLSSMS SVASSVSSRP SRTGLLTETS SRYARKISGT TALQEALKEK
     QQHIEQLLAE RDLERAEVAK ATSHVGEIEQ ELALARDGHD QHVLELEAKM DQLRTMVEAA
     DREKVELLNQ LEEEKRKVED LQFRVEEESI TKGDLEQKSQ ISEDPENTQT KLEHARIKEL
     EQSLLFEKTK ADKLQRELED TRVATVSEKS RIMELEKDLA LRVQEVAELR RRLESNKPAG
     DVDMSLSLLQ EISSLQEKLE VTRTDHQREI TSLKEHFGAR EETHQKEIKA LYTATEKLSK
     ENESLKSKLE HANKENSDVI ALWKSKLETA IASHQQAMEE LKVSFSKGLG TETAEFAELK
     TQIEKMRLDY QHEIENLQNQ QDSERAAHAK EMEALRAKLM KVIKEKENSL EAIRSKLDKA
     EDQHLVEMED TLNKLQEAEI KVKELEVLQA KCNEQTKVID NFTSQLKATE EKLLDLDALR
     KASSEGKSEM KKLRQQLEAA EKQIKHLEIE KNAESSKASS ITRELQGREL KLTNLQENLS
     EVSQVKETLE KELQILKEKF AEASEEAVSV QRSMQETVNK LHQKEEQFNM LSSDLEKLRE
     NLADMEAKFR EKDEREEQLI KAKEKLENDI AEIMKMSGDN SSQLTKMNDE LRLKERDVEE
     LQLKLTKANE NASFLQKSIE DMTVKAEQSQ QEAAKKHEEE KKELERKLSD LEKKMETSHN
     QCQELKARYE RATSETKTKH EEILQNLQKT LLDTEDKLKG AREENSGLLQ ELEELRKQAD
     KAKAAQTAED AMQIMEQMTK EKTETLASLE DTKQTNAKLQ NELDTLKENN LKNVEELNKS
     KELLTVENQK MEEFRKEIET LKQAAAQKSQ QLSALQEENV KLAEELGRSR DEVTSHQKLE
     EERSVLNNQL LEMKKRESKF IKDADEEKAS LQKSISITSA LLTEKDAELE KLRNEVTVLR
     GENASAKSLH SVVQTLESDK VKLELKVKNL ELQLKENKRQ LSSSSGNTDT QADEDERAQE
     SQIDFLNSVI VDLQRKNQDL KMKVEMMSEA ALNGNGDDLN NYDSDDQEKQ SKKKPRLFCD
     ICDCFDLHDT EDCPTQAQMS EDPPHSTHHG SRGEERPYCE ICEMFGHWAT NCNDDETF
//
ID   B2RP65_HUMAN            Unreviewed;      2325 AA.
AC   B2RP65;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   28-FEB-2018, entry version 50.
DE   SubName: Full=Centrosomal protein 110kDa {ECO:0000313|EMBL:AAI37285.1};
GN   Name=CEP110 {ECO:0000313|EMBL:AAI37285.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI37285.1};
RN   [1] {ECO:0000313|EMBL:AAI37285.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC137284; AAI37285.1; -; mRNA.
DR   RefSeq; NP_001317691.1; NM_001330762.1.
DR   UniGene; Hs.653263; -.
DR   ProteinModelPortal; B2RP65; -.
DR   PRIDE; B2RP65; -.
DR   GeneID; 11064; -.
DR   CTD; 11064; -.
DR   eggNOG; ENOG410IJGD; Eukaryota.
DR   eggNOG; ENOG410ZX4Y; LUCA.
DR   HOGENOM; HOG000111909; -.
DR   HOVERGEN; HBG101203; -.
DR   GO; GO:0051301; P:cell division; IEA:InterPro.
DR   GO; GO:0000278; P:mitotic cell cycle; IEA:InterPro.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR028640; CEP110.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   PANTHER; PTHR44555; PTHR44555; 1.
DR   SMART; SM00369; LRR_TYP; 3.
DR   PROSITE; PS51450; LRR; 5.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED      269    292       {ECO:0000256|SAM:Coils}.
FT   COILED      307    341       {ECO:0000256|SAM:Coils}.
FT   COILED      439    480       {ECO:0000256|SAM:Coils}.
FT   COILED      505    546       {ECO:0000256|SAM:Coils}.
FT   COILED      557    612       {ECO:0000256|SAM:Coils}.
FT   COILED      625    697       {ECO:0000256|SAM:Coils}.
FT   COILED      705    795       {ECO:0000256|SAM:Coils}.
FT   COILED      851    885       {ECO:0000256|SAM:Coils}.
FT   COILED      895    929       {ECO:0000256|SAM:Coils}.
FT   COILED      937    964       {ECO:0000256|SAM:Coils}.
FT   COILED     1008   1056       {ECO:0000256|SAM:Coils}.
FT   COILED     1070   1097       {ECO:0000256|SAM:Coils}.
FT   COILED     1318   1341       {ECO:0000256|SAM:Coils}.
FT   COILED     1349   1390       {ECO:0000256|SAM:Coils}.
FT   COILED     1428   1518       {ECO:0000256|SAM:Coils}.
FT   COILED     1533   1602       {ECO:0000256|SAM:Coils}.
FT   COILED     1663   1715       {ECO:0000256|SAM:Coils}.
FT   COILED     1726   1746       {ECO:0000256|SAM:Coils}.
FT   COILED     1754   1886       {ECO:0000256|SAM:Coils}.
FT   COILED     1915   2104       {ECO:0000256|SAM:Coils}.
FT   COILED     2119   2146       {ECO:0000256|SAM:Coils}.
FT   COILED     2186   2213       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   2325 AA;  268916 MW;  0CB58A9ACE5C037E CRC64;
     MKKGSQQKIF SKAKIPSSSH SPIPSSMSNM RSRSLSPLIG SETLPFHSGG QWCEQIEIAD
     ENNMLLDYQD HKGADSHAGV RYITEALIKK LTKQDNLALI KSLNLSLSKD GGKKFKYIEN
     LEKCVKLEVL NLSYNLIGKI EKLDKLLKLR ELNLSYNKIS KIEGIENMCN LQKLNLAGNE
     IEHIPVWLGK KLKSLRVLNL KGNKISSLQD ISKLKLLQDL ISLILVENPV VTLPHYLQFT
     IFHLRSLESL EGQPVTTQDR QEAFERFSLE EVERLERDLE KKMIETEELK SKQTRFLEEI
     KNQDKLNKSL KEEAMLQKQS CEELKSDLNT KNELLKQKTI ELTRACQKQY ELEQELAFYK
     IDAKFEPLNY YPSEYAEIDK APDESPYIGK SRYKRNMFAT ESYIIDSAQA VQIKKMEPDE
     QLRNDHMNLR GHTPLDTQLE DKEKKISAAQ TRLSELHDEI EKAEQQILRA TEEFKQLEEA
     IQLKKISEAG KDLLYKQLSG RLQLVNKLRQ EALDLELQME KQKQEIAGKQ KEIKDLQIAI
     DSLDSKDPKH SHMKAQKSGK EQQLDIMNKQ YQQLESRLDE ILSRIAKETE EIKDLEEQLT
     EGQIAANEAL KKDLEGVISG LQEYLGTIKG QATQAQNECR KLRDEKETLL QRLTEVEQER
     DQLEIVAMDA ENMRKELAEL ESALQEQHEV NASLQQTQGD LSAYEAELEA RLNLRDAEAN
     QLKEELEKVT RLTQLEQSAL QAELEKERQA LKNALGKAQF SEEKEQENSE LHAKLKHLQD
     DNNLLKQQLK DFQNHLNHVV DGLVRPEEVA ARVDELRRKL KLGTGEMNIH SPSDVLGKSL
     ADLQKQFSEI LARSKWERDE AQVRERKLQE EMALQQEKLA TGQEEFRQAC ERALEARMNF
     DKRQHEARIQ QMENEIHYLQ ENLKSMEEIQ GLTDLQLQEA DEEKERILAQ LRELEKKKKL
     EDAKSQEQVF GLDKELKKLK KAVATSDKLA TAELTIAKDQ LKSLHGTVMK INQERAEELQ
     EAERFSRKAA QAARDLTRAE AEIELLQNLL RQKGEQFRLE MEKTGVGTGA NSQVLEIEKL
     NETMERQRTE IARLQNVLDL TGSDNKGGFE NVLEEIAELR REVSYQNDYI SSMADPFKRR
     GYWYFMPPPP SSKVSSHSSQ ATKDSGVGLK YSASTPVRKP RPGQQDGKEG SQPPPASGYW
     VYSPIRSGLH KLFPSRDADS GGDSQEESEL DDQEEPPFVP PPGYMMYTVL PDGSPVPQGM
     ALYAPPPPLP NNSRPLTPGT VVYGPPPAGA PMVYGPPPPN FSIPFIPMGV LHCNVPEHHN
     LENEVSRLED IMQHLKSKKR EERWMRASKR QSEKEMEELH HNIDDLLQEK KSLECEVEEL
     HRTVQKRQQQ KDFIDGNVES LMTELEIEKS LKHHEDIVDE IECIEKTLLK RRSELREADR
     LLAEAESELS CTKEKTKNAV EKFTDAKRSL LQTESDAEEL ERRAQETAVN LVKADQQLRS
     LQADAKDLEQ HKIKQEEILK EINKIVAAKD SDFQCLSKKK EKLTEELQKL QKDIEMAERN
     EDHHLQVLKE SEVLLQAKRA ELEKLKSQVT SQQQEMAVLD RQLGHKKEEL HLLQGSMVQA
     KADLQEALRL GETEVTEKCN HIREVKSLLE ELSFQKGELN VQISERKTQL TLIKQEIEKE
     EENLQVVLRQ MSKHKTELKN ILDMLQLENH ELQGLKLQHD QRVSELEKTQ VAVLEEKLEL
     ENLQQISQQQ KGEIEWQKQL LERDKREIER MTAESRALQS CVECLSKEKE DLQEKCDIWE
     KKLAQTKRVL AAAEENSKME QSNLEKLELN VRKLQQELDQ LNRDKLSLHN DISAMQQQLQ
     EKREAVNSLQ EELANVQDHL NLAKQDLLHT TKHQDVLLSE QTRLQKDISE WANRFEDCQK
     EEETKQQQLQ VLQNEIEENK LKLVQQEMMF QRLQKERESE ESKLETSKVT LKEQQHQLEK
     ELTDQKSKLD QVLSKVLAAE ERVRTLQEEE RWCESLEKTL SQTKRQLSER EQQLVEKSGE
     LLALQKEADS MRADFSLLRN QFLTERKKAE KQVASLKEAL KIQRSQLEKN LLEQKQENSC
     IQKEMATIEL VAQDNHERAR RLMKELNQMQ YEYTELKKQM ANQKDLERRQ MEISDAMRTL
     KSEVKDEIRT SLKNLNQFLP ELPADLEAIL ERNENLEGEL ESLKENLPFT MNEGPFEEKL
     NFSQVHIMDE HWRGEALREK LRHREDRLKA QLRHCMSKQA EVLIKGKRQT EGTLHSLRRQ
     VDALGELVTS TSADSASSPS LSQLESSLTE DSQLGQNQEK NASAR
//
ID   CNTRL_HUMAN             Reviewed;        2325 AA.
AC   Q7Z7A1; A2A2Y1; B2RP67; Q3MN79; Q5FWF8; Q5JVD0; Q6MZR3; Q6PKC1;
AC   Q8TEP3; Q9Y489;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAR-2008, sequence version 2.
DT   28-FEB-2018, entry version 133.
DE   RecName: Full=Centriolin;
DE   AltName: Full=Centrosomal protein 1;
DE   AltName: Full=Centrosomal protein of 110 kDa;
DE            Short=Cep110;
GN   Name=CNTRL; Synonyms=CEP1, CEP110;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY,
RP   CHROMOSOMAL TRANSLOCATION WITH FGFR1, AND SUBCELLULAR LOCATION.
RX   PubMed=10688839;
RA   Guasch G., Mack G.J., Popovici C., Dastugue N., Birnbaum D.,
RA   Rattner J.B., Pebusque M.-J.;
RT   "FGFR1 is fused to the centrosome-associated protein CEP110 in the
RT   8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33).";
RL   Blood 95:1788-1796(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ILE-56, SUBCELLULAR
RP   LOCATION, AND FUNCTION.
RX   PubMed=12732615; DOI=10.1083/jcb.200301105;
RA   Gromley A., Jurczyk A., Sillibourne J., Halilovic E., Mogensen M.,
RA   Groisman I., Blomberg M., Doxsey S.J.;
RT   "A novel human protein of the maternal centriole is required for the
RT   final stages of cytokinesis and entry into S phase.";
RL   J. Cell Biol. 161:535-545(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1513 (ISOFORM 2).
RC   TISSUE=Lymph, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 434-1677 (ISOFORM 1).
RX   PubMed=16112646; DOI=10.1016/j.bbrc.2005.08.024;
RA   Guinn B.-A., Bland E.A., Lodi U., Liggins A.P., Tobal K., Petters S.,
RA   Wells J.W., Banham A.H., Mufti G.J.;
RT   "Humoral detection of leukaemia-associated antigens in presentation
RT   acute myeloid leukaemia.";
RL   Biochem. Biophys. Res. Commun. 335:1293-1304(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 527-2325 (ISOFORM 5).
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11956314;
RA   Ou Y.Y., Mack G.J., Zhang M., Rattner J.B.;
RT   "CEP110 and ninein are located in a specific domain of the centrosome
RT   associated with centrosome maturation.";
RL   J. Cell Sci. 115:1825-1835(2002).
RN   [9]
RP   FUNCTION, INTERACTION WITH EXOC6 AND SNAPIN, AND SUBCELLULAR LOCATION.
RX   PubMed=16213214; DOI=10.1016/j.cell.2005.07.027;
RA   Gromley A., Yeaman C., Rosa J., Redick S., Chen C.-T., Mirabelle S.,
RA   Guha M., Sillibourne J., Doxsey S.J.;
RT   "Centriolin anchoring of exocyst and SNARE complexes at the midbody is
RT   required for secretory-vesicle-mediated abscission.";
RL   Cell 123:75-87(2005).
RN   [10]
RP   INTERACTION WITH HOOK2.
RX   PubMed=17140400; DOI=10.1111/j.1600-0854.2006.00511.x;
RA   Szebenyi G., Hall B., Yu R., Hashim A.I., Kraemer H.;
RT   "Hook2 localizes to the centrosome, binds directly to
RT   centriolin/CEP110 and contributes to centrosomal function.";
RL   Traffic 8:32-46(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-831 AND SER-1475, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Involved in cell cycle progression and cytokinesis.
CC       During the late steps of cytokinesis, anchors exocyst and SNARE
CC       complexes at the midbody, thereby allowing secretory vesicle-
CC       mediated abscission. {ECO:0000269|PubMed:12732615,
CC       ECO:0000269|PubMed:16213214}.
CC   -!- SUBUNIT: Interacts with HOOK2. Interacts with EXOC6 and SNAPIN.
CC       Associates with the exocyst complex. {ECO:0000269|PubMed:16213214,
CC       ECO:0000269|PubMed:17140400}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:10688839,
CC       ECO:0000269|PubMed:11956314, ECO:0000269|PubMed:12732615}.
CC       Midbody, Midbody ring {ECO:0000269|PubMed:12732615,
CC       ECO:0000269|PubMed:16213214}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q7Z7A1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z7A1-2; Sequence=VSP_032048;
CC       Name=3;
CC         IsoId=Q7Z7A1-3; Sequence=VSP_032047;
CC       Name=4;
CC         IsoId=Q7Z7A1-4; Sequence=VSP_032046, VSP_032050;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q7Z7A1-5; Sequence=VSP_032049;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in testis
CC       and trachea. {ECO:0000269|PubMed:10688839}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CEP110 may be a
CC       cause of stem cell myeloproliferative disorder (MPD).
CC       Translocation t(8;9)(p12;q33) with FGFR1. MPD is characterized by
CC       myeloid hyperplasia, eosinophilia and T-cell or B-cell
CC       lymphoblastic lymphoma. In general it progresses to acute myeloid
CC       leukemia. The fusion protein CEP110-FGFR1 is found in the
CC       cytoplasm, exhibits constitutive kinase activity and may be
CC       responsible for the transforming activity.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH02932.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH02932.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH89415.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF083322; AAC32373.1; -; mRNA.
DR   EMBL; AF513978; AAP43846.1; -; mRNA.
DR   EMBL; BX640927; CAE45965.1; -; mRNA.
DR   EMBL; AL137068; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002932; AAH02932.1; ALT_SEQ; mRNA.
DR   EMBL; BC089415; AAH89415.1; ALT_SEQ; mRNA.
DR   EMBL; BC137286; AAI37287.1; -; mRNA.
DR   EMBL; AY651261; AAX35689.1; -; mRNA.
DR   EMBL; AK074079; BAB84905.1; -; mRNA.
DR   CCDS; CCDS35118.1; -. [Q7Z7A1-1]
DR   CCDS; CCDS83409.1; -. [Q7Z7A1-2]
DR   RefSeq; NP_001317691.1; NM_001330762.1. [Q7Z7A1-2]
DR   RefSeq; NP_008949.4; NM_007018.4. [Q7Z7A1-1]
DR   RefSeq; XP_005251736.1; XM_005251679.3. [Q7Z7A1-1]
DR   UniGene; Hs.653263; -.
DR   ProteinModelPortal; Q7Z7A1; -.
DR   SMR; Q7Z7A1; -.
DR   BioGrid; 116248; 160.
DR   DIP; DIP-47280N; -.
DR   IntAct; Q7Z7A1; 173.
DR   MINT; Q7Z7A1; -.
DR   STRING; 9606.ENSP00000238341; -.
DR   CarbonylDB; Q7Z7A1; -.
DR   iPTMnet; Q7Z7A1; -.
DR   PhosphoSitePlus; Q7Z7A1; -.
DR   BioMuta; CNTRL; -.
DR   DMDM; 172045911; -.
DR   EPD; Q7Z7A1; -.
DR   MaxQB; Q7Z7A1; -.
DR   PaxDb; Q7Z7A1; -.
DR   PeptideAtlas; Q7Z7A1; -.
DR   PRIDE; Q7Z7A1; -.
DR   Ensembl; ENST00000238341; ENSP00000238341; ENSG00000119397. [Q7Z7A1-1]
DR   Ensembl; ENST00000373850; ENSP00000362956; ENSG00000119397. [Q7Z7A1-2]
DR   Ensembl; ENST00000373855; ENSP00000362962; ENSG00000119397. [Q7Z7A1-1]
DR   Ensembl; ENST00000613863; ENSP00000481072; ENSG00000119397. [Q7Z7A1-4]
DR   GeneID; 11064; -.
DR   KEGG; hsa:11064; -.
DR   UCSC; uc004bkx.1; human. [Q7Z7A1-1]
DR   CTD; 11064; -.
DR   DisGeNET; 11064; -.
DR   EuPathDB; HostDB:ENSG00000119397.16; -.
DR   GeneCards; CNTRL; -.
DR   H-InvDB; HIX0008344; -.
DR   HGNC; HGNC:1858; CNTRL.
DR   HPA; HPA020468; -.
DR   HPA; HPA020480; -.
DR   HPA; HPA051583; -.
DR   MIM; 605496; gene.
DR   neXtProt; NX_Q7Z7A1; -.
DR   OpenTargets; ENSG00000119397; -.
DR   PharmGKB; PA26414; -.
DR   eggNOG; ENOG410IJGD; Eukaryota.
DR   eggNOG; ENOG410ZX4Y; LUCA.
DR   GeneTree; ENSGT00900000140836; -.
DR   HOVERGEN; HBG101203; -.
DR   InParanoid; Q7Z7A1; -.
DR   KO; K16770; -.
DR   OMA; DESPYIG; -.
DR   OrthoDB; EOG091G0066; -.
DR   PhylomeDB; Q7Z7A1; -.
DR   TreeFam; TF101135; -.
DR   Reactome; R-HSA-1839117; Signaling by cytosolic FGFR1 fusion mutants.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5655302; Signaling by FGFR1 in disease.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; Q7Z7A1; -.
DR   ChiTaRS; CNTRL; human.
DR   GeneWiki; CNTRL; -.
DR   GenomeRNAi; 11064; -.
DR   PRO; PR:Q7Z7A1; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000119397; -.
DR   CleanEx; HS_CEP110; -.
DR   ExpressionAtlas; Q7Z7A1; baseline and differential.
DR   Genevisible; Q7Z7A1; HS.
DR   GO; GO:0120103; C:centriolar subdistal appendage; IDA:GO_Central.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0090543; C:Flemming body; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR028640; CEP110.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   PANTHER; PTHR44555; PTHR44555; 1.
DR   SMART; SM00369; LRR_TYP; 3.
DR   PROSITE; PS51450; LRR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division;
KW   Chromosomal rearrangement; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Leucine-rich repeat; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat.
FT   CHAIN         1   2325       Centriolin.
FT                                /FTId=PRO_0000323675.
FT   REPEAT      126    147       LRR 1.
FT   REPEAT      148    169       LRR 2.
FT   REPEAT      170    191       LRR 3.
FT   REPEAT      194    215       LRR 4.
FT   DOMAIN      228    266       LRRCT.
FT   REGION     1948   2118       Required for centrosome localization.
FT   REGION     1985   2325       Sufficient for interaction with HOOK2.
FT                                {ECO:0000269|PubMed:17140400}.
FT   COILED      267    343       {ECO:0000255}.
FT   COILED      435    799       {ECO:0000255}.
FT   COILED      851   1101       {ECO:0000255}.
FT   COILED     1317   2255       {ECO:0000255}.
FT   COMPBIAS    956    959       Poly-Lys.
FT   COMPBIAS   1147   1150       Poly-Pro.
FT   COMPBIAS   1236   1307       Pro-rich.
FT   SITE       2139   2140       Breakpoint for translocation to form
FT                                CEP110-FGFR1.
FT   MOD_RES     831    831       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1475   1475       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1   1818       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_032046.
FT   VAR_SEQ       1   1331       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10688839}.
FT                                /FTId=VSP_032047.
FT   VAR_SEQ       1    552       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_032048.
FT   VAR_SEQ    1291   1296       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:12693554}.
FT                                /FTId=VSP_032049.
FT   VAR_SEQ    1962   1986       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_032050.
FT   VARIANT      56     56       V -> I (in dbSNP:rs10818503).
FT                                {ECO:0000269|PubMed:12732615}.
FT                                /FTId=VAR_039559.
FT   VARIANT     216    216       P -> L (in dbSNP:rs10818504).
FT                                /FTId=VAR_039560.
FT   VARIANT     889    889       A -> T (in dbSNP:rs17292952).
FT                                /FTId=VAR_039561.
FT   VARIANT    1146   1146       M -> V (in dbSNP:rs35342437).
FT                                /FTId=VAR_061622.
FT   CONFLICT   1389   1389       Q -> R (in Ref. 1; AAC32373).
FT                                {ECO:0000305}.
FT   CONFLICT   1699   1699       K -> Q (in Ref. 1; AAC32373).
FT                                {ECO:0000305}.
FT   CONFLICT   1828   1828       E -> D (in Ref. 1; AAC32373).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2325 AA;  268886 MW;  93DD4CA08B5BD4AF CRC64;
     MKKGSQQKIF SKAKIPSSSH SPIPSSMSNM RSRSLSPLIG SETLPFHSGG QWCEQVEIAD
     ENNMLLDYQD HKGADSHAGV RYITEALIKK LTKQDNLALI KSLNLSLSKD GGKKFKYIEN
     LEKCVKLEVL NLSYNLIGKI EKLDKLLKLR ELNLSYNKIS KIEGIENMCN LQKLNLAGNE
     IEHIPVWLGK KLKSLRVLNL KGNKISSLQD ISKLKPLQDL ISLILVENPV VTLPHYLQFT
     IFHLRSLESL EGQPVTTQDR QEAFERFSLE EVERLERDLE KKMIETEELK SKQTRFLEEI
     KNQDKLNKSL KEEAMLQKQS CEELKSDLNT KNELLKQKTI ELTRACQKQY ELEQELAFYK
     IDAKFEPLNY YPSEYAEIDK APDESPYIGK SRYKRNMFAT ESYIIDSAQA VQIKKMEPDE
     QLRNDHMNLR GHTPLDTQLE DKEKKISAAQ TRLSELHDEI EKAEQQILRA TEEFKQLEEA
     IQLKKISEAG KDLLYKQLSG RLQLVNKLRQ EALDLELQME KQKQEIAGKQ KEIKDLQIAI
     DSLDSKDPKH SHMKAQKSGK EQQLDIMNKQ YQQLESRLDE ILSRIAKETE EIKDLEEQLT
     EGQIAANEAL KKDLEGVISG LQEYLGTIKG QATQAQNECR KLRDEKETLL QRLTEVEQER
     DQLEIVAMDA ENMRKELAEL ESALQEQHEV NASLQQTQGD LSAYEAELEA RLNLRDAEAN
     QLKEELEKVT RLTQLEQSAL QAELEKERQA LKNALGKAQF SEEKEQENSE LHAKLKHLQD
     DNNLLKQQLK DFQNHLNHVV DGLVRPEEVA ARVDELRRKL KLGTGEMNIH SPSDVLGKSL
     ADLQKQFSEI LARSKWERDE AQVRERKLQE EMALQQEKLA TGQEEFRQAC ERALEARMNF
     DKRQHEARIQ QMENEIHYLQ ENLKSMEEIQ GLTDLQLQEA DEEKERILAQ LRELEKKKKL
     EDAKSQEQVF GLDKELKKLK KAVATSDKLA TAELTIAKDQ LKSLHGTVMK INQERAEELQ
     EAERFSRKAA QAARDLTRAE AEIELLQNLL RQKGEQFRLE MEKTGVGTGA NSQVLEIEKL
     NETMERQRTE IARLQNVLDL TGSDNKGGFE NVLEEIAELR REVSYQNDYI SSMADPFKRR
     GYWYFMPPPP SSKVSSHSSQ ATKDSGVGLK YSASTPVRKP RPGQQDGKEG SQPPPASGYW
     VYSPIRSGLH KLFPSRDADS GGDSQEESEL DDQEEPPFVP PPGYMMYTVL PDGSPVPQGM
     ALYAPPPPLP NNSRPLTPGT VVYGPPPAGA PMVYGPPPPN FSIPFIPMGV LHCNVPEHHN
     LENEVSRLED IMQHLKSKKR EERWMRASKR QSEKEMEELH HNIDDLLQEK KSLECEVEEL
     HRTVQKRQQQ KDFIDGNVES LMTELEIEKS LKHHEDIVDE IECIEKTLLK RRSELREADR
     LLAEAESELS CTKEKTKNAV EKFTDAKRSL LQTESDAEEL ERRAQETAVN LVKADQQLRS
     LQADAKDLEQ HKIKQEEILK EINKIVAAKD SDFQCLSKKK EKLTEELQKL QKDIEMAERN
     EDHHLQVLKE SEVLLQAKRA ELEKLKSQVT SQQQEMAVLD RQLGHKKEEL HLLQGSMVQA
     KADLQEALRL GETEVTEKCN HIREVKSLLE ELSFQKGELN VQISERKTQL TLIKQEIEKE
     EENLQVVLRQ MSKHKTELKN ILDMLQLENH ELQGLKLQHD QRVSELEKTQ VAVLEEKLEL
     ENLQQISQQQ KGEIEWQKQL LERDKREIER MTAESRALQS CVECLSKEKE DLQEKCDIWE
     KKLAQTKRVL AAAEENSKME QSNLEKLELN VRKLQQELDQ LNRDKLSLHN DISAMQQQLQ
     EKREAVNSLQ EELANVQDHL NLAKQDLLHT TKHQDVLLSE QTRLQKDISE WANRFEDCQK
     EEETKQQQLQ VLQNEIEENK LKLVQQEMMF QRLQKERESE ESKLETSKVT LKEQQHQLEK
     ELTDQKSKLD QVLSKVLAAE ERVRTLQEEE RWCESLEKTL SQTKRQLSER EQQLVEKSGE
     LLALQKEADS MRADFSLLRN QFLTERKKAE KQVASLKEAL KIQRSQLEKN LLEQKQENSC
     IQKEMATIEL VAQDNHERAR RLMKELNQMQ YEYTELKKQM ANQKDLERRQ MEISDAMRTL
     KSEVKDEIRT SLKNLNQFLP ELPADLEAIL ERNENLEGEL ESLKENLPFT MNEGPFEEKL
     NFSQVHIMDE HWRGEALREK LRHREDRLKA QLRHCMSKQA EVLIKGKRQT EGTLHSLRRQ
     VDALGELVTS TSADSASSPS LSQLESSLTE DSQLGQNQEK NASAR
//
ID   CO1A1_HUMAN             Reviewed;        1464 AA.
AC   P02452; O76045; P78441; Q13896; Q13902; Q13903; Q14037; Q14992;
AC   Q15176; Q15201; Q16050; Q59F64; Q7KZ30; Q7KZ34; Q8IVI5; Q8N473;
AC   Q9UML6; Q9UMM7;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 5.
DT   28-FEB-2018, entry version 223.
DE   RecName: Full=Collagen alpha-1(I) chain;
DE   AltName: Full=Alpha-1 type I collagen;
DE   Flags: Precursor;
GN   Name=COL1A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ALA-1019; ALA-1075; LYS-1391
RP   AND SER-1434.
RA   Dalgleish R.;
RL   Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ALA-1075 AND LYS-1391.
RX   PubMed=9443882; DOI=10.1086/301689;
RA   Korkko J.M., Ala-Kokko L., De Paepe A., Nuytinck L., Earley J.J.,
RA   Prockop D.J.;
RT   "Analysis of the COL1A1 and COL1A2 genes by PCR amplification and
RT   scanning by conformation-sensitive gel electrophoresis identifies only
RT   COL1A1 mutations in 15 patients with osteogenesis imperfecta type I:
RT   identification of common sequences of null-allele mutations.";
RL   Am. J. Hum. Genet. 62:98-110(1998).
RN   [3]
RP   SEQUENCE REVISION TO 1049.
RA   Korkko J.M., Earley J.J., Nuytinck L., DePaepe A., Prockop D.J.,
RA   Ala-Kokko L.;
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-1075.
RC   TISSUE=Spleen;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ALA-1075;
RP   ARG-1438 AND HIS-1460.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-589.
RX   PubMed=2843432; DOI=10.1016/0378-1119(88)90013-3;
RA   D'Alessio M., Bernard M.P., Pretorius P.J., de Wet W., Ramirez F.,
RA   Pretorious P.J.;
RT   "Complete nucleotide sequence of the region encompassing the first
RT   twenty-five exons of the human pro alpha 1(I) collagen gene
RT   (COL1A1).";
RL   Gene 67:105-115(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-472.
RX   PubMed=3178743; DOI=10.1042/bj2530919;
RA   Tromp G., Kuivaniemi H., Stacey A., Shikata H., Baldwin C.T.,
RA   Jaenisch R., Prockup D.J.;
RT   "Structure of a full-length cDNA clone for the prepro alpha 1(I) chain
RT   of human type I procollagen.";
RL   Biochem. J. 253:919-922(1988).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-181.
RX   PubMed=6462220; DOI=10.1038/310337a0;
RA   Chu M.-L., de Wet W.J., Bernard M.P., Ding J.-F., Morabito M.,
RA   Myers J., Williams C., Ramirez F.;
RT   "Human pro alpha 1(I) collagen gene structure reveals evolutionary
RT   conservation of a pattern of introns and exons.";
RL   Nature 310:337-340(1984).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-44.
RX   PubMed=2822714;
RA   Rossouw C.M.S., Vergeer W.P., du Plooy S.J., Bernard M.P., Ramirez F.,
RA   de Wet W.;
RT   "DNA sequences in the first intron of the human pro-alpha 1(I)
RT   collagen gene enhance transcription.";
RL   J. Biol. Chem. 262:15151-15157(1987).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-34.
RX   PubMed=2857713;
RA   Chu M.-L., de Wet W., Bernard M.P., Ramirez F.;
RT   "Fine structural analysis of the human pro-alpha 1 (I) collagen gene.
RT   Promoter structure, AluI repeats, and polymorphic transcripts.";
RL   J. Biol. Chem. 260:2315-2320(1985).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-34.
RX   PubMed=3480516; DOI=10.1073/pnas.84.24.8869;
RA   Bornstein P., McKay J., Morishima J.K., Devarayalu S., Gelinas R.E.;
RT   "Regulatory elements in the first intron contribute to transcriptional
RT   control of the human alpha 1(I) collagen gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:8869-8873(1987).
RN   [12]
RP   PROTEIN SEQUENCE OF 33-52.
RX   PubMed=2318855;
RA   Wirtz M.K., Keene D.R., Hori H., Glanville R.W., Steinmann B.,
RA   Rao V.H., Hollister D.W.;
RT   "In vivo and in vitro noncovalent association of excised alpha 1 (I)
RT   amino-terminal propeptides with mutant pN alpha 2(I) collagen chains
RT   in native mutant collagen in a case of Ehlers-Danlos syndrome, type
RT   VII.";
RL   J. Biol. Chem. 265:6312-6317(1990).
RN   [13]
RP   NUCLEOTIDE SEQUENCE OF 156-183.
RX   PubMed=2767050;
RA   Weil D., D'Alessio M., Ramirez F., de Wet W., Cole W.G., Chan D.,
RA   Bateman J.F.;
RT   "A base substitution in the exon of a collagen gene causes alternative
RT   splicing and generates a structurally abnormal polypeptide in a
RT   patient with Ehlers-Danlos syndrome type VII.";
RL   EMBO J. 8:1705-1710(1989).
RN   [14]
RP   PROTEIN SEQUENCE OF 162-301, ALLYSINE AT LYS-170, AND PYROGLUTAMATE
RP   FORMATION AT GLN-162.
RC   TISSUE=Skin;
RX   PubMed=5529814; DOI=10.1021/bi00826a012;
RA   Click E.M., Bornstein P.;
RT   "Isolation and characterization of the cyanogen bromide peptides from
RT   the alpha 1 and alpha 2 chains of human skin collagen.";
RL   Biochemistry 9:4699-4706(1970).
RN   [15]
RP   PROTEIN SEQUENCE OF 175-187 AND 274-289.
RX   PubMed=2169412; DOI=10.1111/j.1432-1033.1990.tb19208.x;
RA   Baetge B., Notbohm H., Diebold J., Lehmann H., Bodo M., Deutzmann R.,
RA   Muller P.K.;
RT   "A critical crosslink region in human-bone-derived collagen type I.
RT   Specific cleavage site at residue Leu95.";
RL   Eur. J. Biochem. 192:153-159(1990).
RN   [16]
RP   PROTEIN SEQUENCE OF 263-268, HYDROXYLATION AT LYS-265, AND
RP   GLYCOSYLATION AT LYS-265.
RC   TISSUE=Skin;
RX   PubMed=4319110;
RA   Morgan P.H., Jacobs H.G., Segrest J.P., Cunningham L.W.;
RT   "A comparative study of glycopeptides derived from selected vertebrate
RT   collagens. A possible role of the carbohydrate in fibril formation.";
RL   J. Biol. Chem. 245:5042-5048(1970).
RN   [17]
RP   NUCLEOTIDE SEQUENCE OF 281-302; 402-420; 823-842; 924-944; 1026-1045
RP   AND 1143-1162.
RX   PubMed=2374517;
RA   Labhard M.E., Hollister D.W.;
RT   "Segmental amplification of the entire helical and telopeptide regions
RT   of the cDNA for human alpha 1 (I) collagen.";
RL   Matrix 10:124-130(1990).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 425-1464, AND VARIANTS ALA-1019 AND
RP   ALA-1075.
RX   PubMed=6689127; DOI=10.1021/bi00291a023;
RA   Bernard M.P., Chu M.-L., Myers J.C., Ramirez F., Eikenberry E.F.,
RA   Prockop D.J.;
RT   "Nucleotide sequences of complementary deoxyribonucleic acids for the
RT   pro alpha 1 chain of human type I procollagen. Statistical evaluation
RT   of structures that are conserved during evolution.";
RL   Biochemistry 22:5213-5223(1983).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 425-490; 965-1024; 999-1039 AND
RP   1453-1464.
RX   PubMed=6183642; DOI=10.1093/nar/10.19.5925;
RA   Chu M.-L., Myers J.C., Bernard M.P., Ding J.-F., Ramirez F.;
RT   "Cloning and characterization of five overlapping cDNAs specific for
RT   the human pro alpha 1(I) collagen chain.";
RL   Nucleic Acids Res. 10:5925-5934(1982).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 472-607.
RX   PubMed=2981843;
RA   Chu M.-L., Gargiulo V., Williams C.J., Ramirez F.;
RT   "Multiexon deletion in an osteogenesis imperfecta variant with
RT   increased type III collagen mRNA.";
RL   J. Biol. Chem. 260:691-694(1985).
RN   [21]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 488-625.
RX   PubMed=3857621; DOI=10.1073/pnas.82.9.2870;
RA   Barsh G.S., Roush C.L., Bonadio J., Byers P.H., Gelinas R.E.;
RT   "Intron-mediated recombination may cause a deletion in an alpha 1 type
RT   I collagen chain in a lethal form of osteogenesis imperfecta.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:2870-2874(1985).
RN   [22]
RP   NUCLEOTIDE SEQUENCE OF 710-745, AND VARIANT OI2 ARG-728.
RX   PubMed=2339700;
RA   Wallis G.A., Starman B.J., Zinn A.B., Byers P.H.;
RT   "Variable expression of osteogenesis imperfecta in a nuclear family is
RT   explained by somatic mosaicism for a lethal point mutation in the
RT   alpha 1(I) gene (COL1A1) of type I collagen in a parent.";
RL   Am. J. Hum. Genet. 46:1034-1040(1990).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 746-781, AND VARIANT OI3 SER-767.
RX   PubMed=7881420; DOI=10.1093/hmg/3.12.2201;
RA   Forlino A., Zolezzi F., Valli M., Pignatti P.F., Cetta G.,
RA   Brunelli P.C., Mottes M.;
RT   "Severe (type III) osteogenesis imperfecta due to glycine
RT   substitutions in the central domain of the collagen triple helix.";
RL   Hum. Mol. Genet. 3:2201-2206(1994).
RN   [24]
RP   PROTEIN SEQUENCE OF 1063-1084, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND VARIANT ALA-1075.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [25]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1179-1464, VARIANTS OI2 HIS-1277;
RP   ARG-1388 AND 1337-GLU-TYR-1338 DEL, AND VARIANTS THR-1251 AND
RP   SER-1434.
RX   PubMed=8349697;
RA   Chessler S.D., Wallis G.A., Byers P.H.;
RT   "Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I)
RT   chain of type I collagen result in defective chain association and
RT   produce lethal osteogenesis imperfecta.";
RL   J. Biol. Chem. 268:18218-18225(1993).
RN   [26]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1187-1220, AND VARIANT CYS-1195.
RX   PubMed=3170557;
RA   Cohn D.H., Apone S., Eyre D.R., Starman B.J., Andreassen P.,
RA   Charbonneau H., Nicholls A.C., Pope F.M., Byers P.H.;
RT   "Substitution of cysteine for glycine within the carboxyl-terminal
RT   telopeptide of the alpha 1 chain of type I collagen produces mild
RT   osteogenesis imperfecta.";
RL   J. Biol. Chem. 263:14605-14607(1988).
RN   [27]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1229-1454, AND VARIANT LYS-1391.
RC   TISSUE=Bone;
RX   PubMed=3340531; DOI=10.1093/nar/16.1.349;
RA   Maekelae J.K., Raassina M., Virta A., Vuorio E.;
RT   "Human pro alpha 1(I) collagen: cDNA sequence for the C-propeptide
RT   domain.";
RL   Nucleic Acids Res. 16:349-349(1988).
RN   [28]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1440-1464.
RX   PubMed=2295701; DOI=10.1172/JCI114424;
RA   Willing M.C., Cohn D.H., Byers P.H.;
RT   "Frameshift mutation near the 3' end of the COL1A1 gene of type I
RT   collagen predicts an elongated Pro alpha 1(I) chain and results in
RT   osteogenesis imperfecta type I.";
RL   J. Clin. Invest. 85:282-290(1990).
RN   [29]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1454-1464, AND VARIANT ALA-1075.
RX   PubMed=1995349; DOI=10.1016/0014-5793(91)80237-W;
RA   Maatta A., Bornstein P., Penttinen R.P.;
RT   "Highly conserved sequences in the 3'-untranslated region of the
RT   COL1A1 gene bind cell-specific nuclear proteins.";
RL   FEBS Lett. 279:9-13(1991).
RN   [30]
RP   REVIEW ON VARIANTS.
RX   PubMed=2010058;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in collagen genes: causes of rare and some common diseases
RT   in humans.";
RL   FASEB J. 5:2052-2060(1991).
RN   [31]
RP   REVIEW ON VARIANTS.
RX   PubMed=9101290;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in fibrillar collagens (types I, II, III, and XI), fibril-
RT   associated collagen (type IX), and network-forming collagen (type X)
RT   cause a spectrum of diseases of bone, cartilage, and blood vessels.";
RL   Hum. Mutat. 9:300-315(1997).
RN   [32]
RP   REVIEW ON VARIANTS.
RX   PubMed=1895312; DOI=10.1136/jmg.28.7.433;
RA   Byers P.H., Wallis G.A., Willing M.C.;
RT   "Osteogenesis imperfecta: translation of mutation to phenotype.";
RL   J. Med. Genet. 28:433-442(1991).
RN   [33]
RP   INTERACTION WITH TRAM2.
RX   PubMed=14749390; DOI=10.1128/MCB.24.4.1758-1768.2004;
RA   Stefanovic B., Stefanovic L., Schnabl B., Bataller R., Brenner D.A.;
RT   "TRAM2 protein interacts with endoplasmic reticulum Ca2+ pump Serca2b
RT   and is necessary for collagen type I synthesis.";
RL   Mol. Cell. Biol. 24:1758-1768(2004).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [36]
RP   VARIANT OI2 CYS-1166.
RX   PubMed=3016737; DOI=10.1073/pnas.83.16.6045;
RA   Cohn D.H., Byers P.H., Steinmann B., Gelinas R.E.;
RT   "Lethal osteogenesis imperfecta resulting from a single nucleotide
RT   change in one human pro alpha 1(I) collagen allele.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:6045-6047(1986).
RN   [37]
RP   VARIANT OI2 ARG-569.
RX   PubMed=3108247;
RA   Bateman J.F., Chan D., Walkers I.D., Rogers J.G., Cole W.G.;
RT   "Lethal perinatal osteogenesis imperfecta due to the substitution of
RT   arginine for glycine at residue 391 of the alpha 1(I) chain of type I
RT   collagen.";
RL   J. Biol. Chem. 262:7021-7027(1987).
RN   [38]
RP   VARIANT OI2 CYS-926.
RX   PubMed=3667599;
RA   Vogel B.E., Minor R.R., Freund M., Prockop D.J.;
RT   "A point mutation in a type I procollagen gene converts glycine 748 of
RT   the alpha 1 chain to cysteine and destabilizes the triple helix in a
RT   lethal variant of osteogenesis imperfecta.";
RL   J. Biol. Chem. 262:14737-14744(1987).
RN   [39]
RP   VARIANT OI2 ARG-842.
RX   PubMed=3403550;
RA   Bateman J.F., Lamande S.R., Dahl H.-H.M., Chan D., Cole W.G.;
RT   "Substitution of arginine for glycine 664 in the collagen alpha 1(I)
RT   chain in lethal perinatal osteogenesis imperfecta. Demonstration of
RT   the peptide defect by in vitro expression of the mutant cDNA.";
RL   J. Biol. Chem. 263:11627-11630(1988).
RN   [40]
RP   VARIANT OI1 CYS-1195.
RX   PubMed=3244312;
RA   Labhard M.E., Wirtz M.K., Pope F.M., Nicholls A.C., Hollister D.W.;
RT   "A cysteine for glycine substitution at position 1017 in an alpha 1(I)
RT   chain of type I collagen in a patient with mild dominantly inherited
RT   osteogenesis imperfecta.";
RL   Mol. Biol. Med. 5:197-207(1988).
RN   [41]
RP   VARIANT OI2 VAL-434.
RX   PubMed=2470760;
RA   Patterson E., Smiley E., Bonadio J.;
RT   "RNA sequence analysis of a perinatal lethal osteogenesis imperfecta
RT   mutation.";
RL   J. Biol. Chem. 264:10083-10087(1989).
RN   [42]
RP   VARIANT OI4 SER-1010.
RX   PubMed=2745420;
RA   Marini J.C., Grange D.K., Gottesman G.S., Lewis M.B., Koeplin D.A.;
RT   "Osteogenesis imperfecta type IV. Detection of a point mutation in one
RT   alpha 1(I) collagen allele (COL1A1) by RNA/RNA hybrid analysis.";
RL   J. Biol. Chem. 264:11893-11900(1989).
RN   [43]
RP   VARIANTS OI2 ALA-1106; VAL-1151; ARG-1154 AND VAL-1184.
RX   PubMed=2777764;
RA   Lamande S.R., Dahl H.-H.M., Cole W.G., Bateman J.F.;
RT   "Characterization of point mutations in the collagen COL1A1 and COL1A2
RT   genes causing lethal perinatal osteogenesis imperfecta.";
RL   J. Biol. Chem. 264:15809-15812(1989).
RN   [44]
RP   VARIANT OI3 SER-1022.
RX   PubMed=2511192;
RA   Pack M., Constantinou C.D., Kalia K., Nielsen K.B., Prockop D.J.;
RT   "Substitution of serine for alpha 1(I)-glycine 844 in a severe variant
RT   of osteogenesis imperfecta minimally destabilizes the triple helix of
RT   type I procollagen. The effects of glycine substitutions on thermal
RT   stability are either position of amino acid specific.";
RL   J. Biol. Chem. 264:19694-19699(1989).
RN   [45]
RP   VARIANT OI2 CYS-1082.
RX   PubMed=2913053; DOI=10.1172/JCI113920;
RA   Constantinou C.D., Nielsen K.B., Prockop D.J.;
RT   "A lethal variant of osteogenesis imperfecta has a single base
RT   mutation that substitutes cysteine for glycine 904 of the alpha 1(I)
RT   chain of type I procollagen. The asymptomatic mother has an
RT   unidentified mutation producing an overmodified and unstable type I
RT   procollagen.";
RL   J. Clin. Invest. 83:574-584(1989).
RN   [46]
RP   VARIANT OI1 CYS-272, VARIANT OI3 CYS-704, AND VARIANT OI2 CYS-896.
RX   PubMed=2794057; DOI=10.1172/JCI114286;
RA   Starman B.J., Eyre D.R., Charbonneau H., Harrylock M., Weis M.A.,
RA   Weiss L., Graham J.M. Jr., Byers P.H.;
RT   "Osteogenesis imperfecta. The position of substitution for glycine by
RT   cysteine in the triple helical domain of the pro alpha 1(I) chains of
RT   type I collagen determines the clinical phenotype.";
RL   J. Clin. Invest. 84:1206-1214(1989).
RN   [47]
RP   VARIANT OI2 CYS-422.
RA   Fertala A., Westerhausen A., Morris G.M., Rooney J.E., Prockop D.J.;
RT   "Two cysteine substitutions in the type I procollagen genes (COL1A1
RT   and COL1A2) that cause lethal osteogenesis imperfecta. The location of
RT   glycine substitutions does not in any simple way predict their effects
RT   on protein function or phenotype.";
RL   Am. J. Hum. Genet. 47:A216-A216(1990).
RN   [48]
RP   VARIANTS OI2 SER-776 AND SER-809.
RX   PubMed=2116413;
RA   Westerhausen A., Kishi J., Prockop D.J.;
RT   "Mutations that substitute serine for glycine alpha 1-598 and glycine
RT   alpha 1-631 in type I procollagen. The effects on thermal unfolding of
RT   the triple helix are position-specific and demonstrate that the
RT   protein unfolds through a series of cooperative blocks.";
RL   J. Biol. Chem. 265:13995-14000(1990).
RN   [49]
RP   VARIANT OI2 ARG-1025.
RX   PubMed=2211725;
RA   Wallis G.A., Starman B.J., Schwartz M.F., Byers P.H.;
RT   "Substitution of arginine for glycine at position 847 in the triple-
RT   helical domain of the alpha 1 (I) chain of type I collagen produces
RT   lethal osteogenesis imperfecta. Molecules that contain one or two
RT   abnormal chains differ in stability and secretion.";
RL   J. Biol. Chem. 265:18628-18633(1990).
RN   [50]
RP   VARIANTS OI2 SER-1091; SER-1181; SER-1187 AND VAL-1187.
RA   Cohn D.H., Wallis G.A., Zhang X., Byers P.H.;
RT   "Serine for glycine substitutions in the alpha1(I) chain of type I
RT   collagen: biological plasticity in the Gly-Pro-Hyp clamp at the
RT   carboxyl-terminal end of triple helicalH domain.";
RL   Matrix 10:236-236(1990).
RN   [51]
RP   VARIANT OI2 ASP-719.
RX   PubMed=2035536;
RA   Zhuang J., Constantinou C.D., Ganguly A., Prockop D.J.;
RT   "A single base mutation in type I procollagen (COL1A1) that converts
RT   glycine alpha 1-541 to aspartate in a lethal variant of osteogenesis
RT   imperfecta: detection of the mutation with a carbodiimide reaction of
RT   DNA heteroduplexes and direct sequencing of products of the PCR.";
RL   Am. J. Hum. Genet. 48:1186-1191(1991).
RN   [52]
RP   VARIANT OI2 CYS-869.
RX   PubMed=1953667; DOI=10.1042/bj2790747;
RA   Steinmann B., Westerhausen A., Constantinou C.D., Superti-Furga A.,
RA   Prockop D.J.;
RT   "Substitution of cysteine for glycine-alpha 1-691 in the pro alpha
RT   1(I) chain of type I procollagen in a proband with lethal osteogenesis
RT   imperfecta destabilizes the triple helix at a site C-terminal to the
RT   substitution.";
RL   Biochem. J. 279:747-752(1991).
RN   [53]
RP   VARIANT OI2 CYS-926.
RX   PubMed=2036375; DOI=10.1021/bi00234a035;
RA   Kadler K.E., Torre-Blanco A., Adachi E., Vogel B.E., Hojima Y.,
RA   Prockop D.J.;
RT   "A type I collagen with substitution of a cysteine for glycine-748 in
RT   the alpha 1(I) chain copolymerizes with normal type I collagen and can
RT   generate fractallike structures.";
RL   Biochemistry 30:5081-5088(1991).
RN   [54]
RP   VARIANT OI3 ARG-332, AND VARIANT OI2 SER-1181.
RX   PubMed=2037280; DOI=10.1007/BF01213088;
RA   Pruchno C.J., Cohn D.H., Wallis G.A., Willing M.C., Starman B.J.,
RA   Zhang X., Byers P.H.;
RT   "Osteogenesis imperfecta due to recurrent point mutations at CpG
RT   dinucleotides in the COL1A1 gene of type I collagen.";
RL   Hum. Genet. 87:33-40(1991).
RN   [55]
RP   VARIANT OI4 CYS-356.
RX   PubMed=1988452;
RA   Valli M., Mottes M., Tenni R., Sangalli A., Gomez Lira M., Rossi A.,
RA   Antoniazzi F., Cetta G., Pignatti P.F.;
RT   "A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for
RT   a moderate case of osteogenesis imperfecta. Substitution of cysteine
RT   for glycine 178 in the triple helical domain.";
RL   J. Biol. Chem. 266:1872-1878(1991).
RN   [56]
RP   VARIANT OI2 VAL-815.
RX   PubMed=1874719;
RA   Tsuneyoshi T., Westerhausen A., Constantinou C.D., Prockop D.J.;
RT   "Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type
RT   I procollagen in lethal osteogenesis imperfecta. The conformational
RT   strain on the triple helix introduced by a glycine substitution can be
RT   transmitted along the helix.";
RL   J. Biol. Chem. 266:15608-15613(1991).
RN   [57]
RP   VARIANT OI1 ARG-263.
RX   PubMed=1718984;
RA   Deak S.B., Scholz P.M., Amenta P.S., Constantinou C.D.,
RA   Levi-Minzi S.A., Gonzalez-Lavin L., MacKenzie J.W.;
RT   "The substitution of arginine for glycine 85 of the alpha 1(I)
RT   procollagen chain results in mild osteogenesis imperfecta. The
RT   mutation provides direct evidence for three discrete domains of
RT   cooperative melting of intact type I collagen.";
RL   J. Biol. Chem. 266:21827-21832(1991).
RN   [58]
RP   VARIANT OI2 1046-GLY--PRO-1048 DEL.
RX   PubMed=1939261;
RA   Hawkins J.R., Superti-Furga A., Steinmann B., Dalgleish R.;
RT   "A 9-base pair deletion in COL1A1 in a lethal variant of osteogenesis
RT   imperfecta.";
RL   J. Biol. Chem. 266:22370-22374(1991).
RN   [59]
RP   VARIANT OI3 CYS-593, AND VARIANT OI4 CYS-593.
RX   PubMed=1770532; DOI=10.1136/jmg.28.11.757;
RA   Nicholls A.C., Oliver J.E., Renouf D.V., Keston M., Pope F.M.;
RT   "Substitution of cysteine for glycine at residue 415 of one allele of
RT   the alpha 1(I) chain of type I procollagen in type III/IV osteogenesis
RT   imperfecta.";
RL   J. Med. Genet. 28:757-764(1991).
RN   [60]
RP   VARIANT ALA-1075.
RX   PubMed=1870989; DOI=10.1093/nar/19.15.4302;
RA   Sokolov B.P., Constantinou C.D., Tsuneyoshi T., Zhuang J.,
RA   Prockop D.J.;
RT   "G to A polymorphism in exon 45 of the COL1A1 gene.";
RL   Nucleic Acids Res. 19:4302-4302(1991).
RN   [61]
RP   VARIANT OI1 SER-1079.
RX   PubMed=1634225; DOI=10.1007/BF00219169;
RA   Mottes M., Sangalli A., Valli M., Gomez Lira M., Tenni R.,
RA   Buttitta P., Pignatti P.F., Cetta G.;
RT   "Mild dominant osteogenesis imperfecta with intrafamilial variability:
RT   the cause is a serine for glycine alpha 1(I) 901 substitution in a
RT   type-I collagen gene.";
RL   Hum. Genet. 89:480-484(1992).
RN   [62]
RP   VARIANT OI2 VAL-980.
RX   PubMed=1511982; DOI=10.1007/BF00221955;
RA   Bonaventure J., Cohen-Solal L., Lasselin C., Maroteaux P.;
RT   "A dominant mutation in the COL1A1 gene that substitutes glycine for
RT   valine causes recurrent lethal osteogenesis imperfecta.";
RL   Hum. Genet. 89:640-646(1992).
RN   [63]
RP   VARIANT OI2 1046-GLY--PRO-1048 DEL.
RX   PubMed=1460047;
RA   Wallis G.A., Kadler K.E., Starman B.J., Byers P.H.;
RT   "A tripeptide deletion in the triple-helical domain of the pro alpha
RT   1(I) chain of type I procollagen in a patient with lethal osteogenesis
RT   imperfecta does not alter cleavage of the molecule by N-proteinase.";
RL   J. Biol. Chem. 267:25529-25534(1992).
RN   [64]
RP   VARIANT OI1 CYS-221.
RX   PubMed=1737847; DOI=10.1172/JCI115622;
RA   Shapiro J.R., Stover M.L., Burn V.E., McKinstry M.B., Burshell A.L.,
RA   Chipman S.D., Rowe D.W.;
RT   "An osteopenic nonfracture syndrome with features of mild osteogenesis
RT   imperfecta associated with the substitution of a cysteine for glycine
RT   at triple helix position 43 in the pro alpha 1(I) chain of type I
RT   collagen.";
RL   J. Clin. Invest. 89:567-573(1992).
RN   [65]
RP   VARIANTS OI2 VAL-434; VAL-1151 AND VAL-1184.
RX   PubMed=1613761; DOI=10.1136/jmg.29.2.112;
RA   Cole W.G., Patterson E., Bonadio J., Campbell P.E., Fortune D.W.;
RT   "The clinicopathological features of three babies with osteogenesis
RT   imperfecta resulting from the substitution of glycine by valine in the
RT   pro alpha 1 (I) chain of type I procollagen.";
RL   J. Med. Genet. 29:112-118(1992).
RN   [66]
RP   VARIANT OI2 CYS-1312.
RX   PubMed=8456808; DOI=10.1002/ajmg.1320450216;
RA   Bateman J.F., Lamande S.R., Hannagan M., Moeller I., Dahl H.-H.M.,
RA   Cole W.G.;
RT   "Chemical cleavage method for the detection of RNA base changes:
RT   experience in the application to collagen mutations in osteogenesis
RT   imperfecta.";
RL   Am. J. Med. Genet. 45:233-240(1993).
RN   [67]
RP   VARIANT OI3 SER-530.
RX   PubMed=8456809; DOI=10.1002/ajmg.1320450217;
RA   Marini J.C., Lewis M.B., Chen K.J.;
RT   "Moderately severe osteogenesis imperfecta associated with
RT   substitutions of serine for glycine in the alpha 1(I) chain of type I
RT   collagen.";
RL   Am. J. Med. Genet. 45:241-245(1993).
RN   [68]
RP   VARIANT OI4 CYS-353.
RX   PubMed=8339541; DOI=10.3109/03008209309061961;
RA   Wirtz M.K., Rao V.H., Glanville R.W., Labhard M.E., Pretorius P.J.,
RA   de Vries W.N., de Wet W., Hollister D.W.;
RT   "A cysteine for glycine substitution at position 175 in an alpha 1 (I)
RT   chain of type I collagen produces a clinically heterogeneous form of
RT   osteogenesis imperfecta.";
RL   Connect. Tissue Res. 29:1-11(1993).
RN   [69]
RP   VARIANT OI2 ALA-1088.
RX   PubMed=7679635; DOI=10.1111/j.1432-1033.1993.tb17565.x;
RA   Valli M., Sangalli A., Rossi A., Mottes M., Forlino A., Tenni R.,
RA   Pignatti P.F., Cetta G.;
RT   "Osteogenesis imperfecta and type-I collagen mutations. A lethal
RT   variant caused by a Gly910-->Ala substitution in the alpha 1 (I)
RT   chain.";
RL   Eur. J. Biochem. 211:415-419(1993).
RN   [70]
RP   VARIANT OI1 VAL-263.
RX   PubMed=8223589; DOI=10.1111/j.1432-1033.1993.tb18220.x;
RA   Valli M., Zolezzi F., Mottes M., Antoniazzi F., Stanzial F., Tenni R.,
RA   Pignatti P.F., Cetta G.;
RT   "Gly85 to Val substitution in pro alpha 1(I) chain causes mild
RT   osteogenesis imperfecta and introduces a susceptibility to protease
RT   digestion.";
RL   Eur. J. Biochem. 217:77-82(1993).
RN   [71]
RP   VARIANT OI2 VAL-743.
RX   PubMed=8100209; DOI=10.1007/BF00217768;
RA   Mackay K., Lund A.M., Raghunath M., Steinmann B., Dalgleish R.;
RT   "SSCP detection of a Gly565Val substitution in the pro alpha 1(I)
RT   collagen chain resulting in osteogenesis imperfecta type II.";
RL   Hum. Genet. 91:439-444(1993).
RN   [72]
RP   VARIANTS OI2 SER-425 AND SER-530, VARIANT OI4 SER-560, VARIANT OI3
RP   SER-719, AND VARIANT ALA-823.
RX   PubMed=7691343; DOI=10.1093/hmg/2.8.1155;
RA   Mackay K., Byers P.H., Dalgleish R.;
RT   "An RT-PCR-SSCP screening strategy for detection of mutations in the
RT   gene encoding the alpha 1 chain of type I collagen: application to
RT   four patients with osteogenesis imperfecta.";
RL   Hum. Mol. Genet. 2:1155-1160(1993).
RN   [73]
RP   VARIANT OI2 SER-593, AND VARIANT OI3 SER-593.
RX   PubMed=8364588; DOI=10.1002/humu.1380020308;
RA   Mottes M., Gomez Lira M., Valli M., Scarano G., Lonardo F.,
RA   Forlino A., Cetta G., Pignatti P.F.;
RT   "Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415)
RT   causes recurrent osteogenesis imperfecta.";
RL   Hum. Mutat. 2:196-204(1993).
RN   [74]
RP   VARIANT OI4 SER-530.
RX   PubMed=8094076;
RA   Marini J.C., Lewis M.B., Wang Q., Chen K.J., Orrison B.M.;
RT   "Serine for glycine substitutions in type I collagen in two cases of
RT   type IV osteogenesis imperfecta (OI). Additional evidence for a
RT   regional model of OI pathophysiology.";
RL   J. Biol. Chem. 268:2667-2673(1993).
RN   [75]
RP   VARIANTS OI2.
RX   PubMed=8349698;
RA   Chessler S.D., Byers P.H.;
RT   "BiP binds type I procollagen pro alpha chains with mutations in the
RT   carboxyl-terminal propeptide synthesized by cells from patients with
RT   osteogenesis imperfecta.";
RL   J. Biol. Chem. 268:18226-18233(1993).
RN   [76]
RP   VARIANT OI2 ARG-389.
RX   PubMed=7520724; DOI=10.1016/8756-3282(94)90295-X;
RA   Sztrolovics R., Glorieux F.H., Travers R., van der Rest M.,
RA   Roughley P.J.;
RT   "Osteogenesis imperfecta: comparison of molecular defects with bone
RT   histological changes.";
RL   Bone 15:321-328(1994).
RN   [77]
RP   VARIANT OI3 ARG-350.
RX   PubMed=8019571; DOI=10.1002/humu.1380030327;
RA   Mackay K., de Paepe A., Nuytinck L., Dalgleish R.;
RT   "Substitution of glycine-172 by arginine in the alpha 1 chain of type
RT   I collagen in a patient with osteogenesis imperfecta, type III.";
RL   Hum. Mutat. 3:324-326(1994).
RN   [78]
RP   VARIANT OI2 CYS-1124.
RX   PubMed=7961597; DOI=10.1093/oxfordjournals.jbchem.a124429;
RA   Kurosaka D., Hattori S., Hori H., Yamaguchi N., Hasegawa T.,
RA   Akimoto H., Nagai Y.;
RT   "Substitution of cysteine for glycine-946 in the alpha 1(I) chain of
RT   type I procollagen causes lethal osteogenesis imperfecta.";
RL   J. Biochem. 115:853-857(1994).
RN   [79]
RP   VARIANT OI4 SER-1061.
RX   PubMed=7982948;
RA   Lightfoot S.J., Atkinson M.S., Murphy G., Byers P.H., Kadler K.E.;
RT   "Substitution of serine for glycine 883 in the triple helix of the pro
RT   alpha 1 (I) chain of type I procollagen produces osteogenesis
RT   imperfecta type IV and introduces a structural change in the triple
RT   helix that does not alter cleavage of the molecule by procollagen N-
RT   proteinase.";
RL   J. Biol. Chem. 269:30352-30357(1994).
RN   [80]
RP   VARIANT OI3 ARG-332.
RX   PubMed=8669434;
RX   DOI=10.1002/(SICI)1096-8628(19960111)61:2<111::AID-AJMG1>3.0.CO;2-#;
RA   Zhuang J., Tromp G., Kuivaniemi H., Castells S., Prockop D.J.;
RT   "Substitution of arginine for glycine at position 154 of the alpha 1
RT   chain of type I collagen in a variant of osteogenesis imperfecta:
RT   comparison to previous cases with the same mutation.";
RL   Am. J. Med. Genet. 61:111-116(1996).
RN   [81]
RP   VARIANT OI2 SER-839.
RX   PubMed=8786074; DOI=10.1007/BF02185764;
RA   Nuytinck L., Dalgleish R., Spotila L., Renard J.-P.,
RA   van Regemorter N., de Paepe A.;
RT   "Substitution of glycine-661 by serine in the alpha1(I) and alpha2(I)
RT   chains of type I collagen results in different clinical and
RT   biochemical phenotypes.";
RL   Hum. Genet. 97:324-329(1996).
RN   [82]
RP   VARIANT OI3 PRO-1464.
RX   PubMed=8723681;
RX   DOI=10.1002/(SICI)1098-1004(1996)7:4<318::AID-HUMU5>3.0.CO;2-4;
RA   Oliver J.E., Thompson E.M., Pope F.M., Nicholls A.C.;
RT   "Mutation in the carboxy-terminal propeptide of the Pro alpha 1(I)
RT   chain of type I collagen in a child with severe osteogenesis
RT   imperfecta (OI type III): possible implications for protein folding.";
RL   Hum. Mutat. 7:318-326(1996).
RN   [83]
RP   INVOLVEMENT IN OSTEOPOROSIS.
RX   PubMed=8841196; DOI=10.1038/ng1096-203;
RA   Grant S.F.A., Reid D.M., Blake G., Herd R., Fogelman I., Ralston S.H.;
RT   "Reduced bone density and osteoporosis associated with a polymorphic
RT   Sp1 binding site in the collagen type I alpha 1 gene.";
RL   Nat. Genet. 14:203-205(1996).
RN   [84]
RP   VARIANTS OI3 SER-821; SER-1040; SER-1049; SER-1058 AND SER-1076.
RX   PubMed=9101304;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:4<378::AID-HUMU16>3.3.CO;2-5;
RA   Lund A.M., Skovby F., Schwartz M.;
RT   "Serine for glycine substitutions in the C-terminal third of the alpha
RT   1(I) chain of collagen I in five patients with nonlethal osteogenesis
RT   imperfecta.";
RL   Hum. Mutat. 9:378-382(1997).
RN   [85]
RP   VARIANT OI2 VAL-764.
RX   PubMed=9143923;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:5<431::AID-HUMU9>3.0.CO;2-6;
RA   Lund A.M., Skovby F., Schwartz M.;
RT   "(G586V) substitutions in the alpha 1 and alpha 2 chains of collagen
RT   I: effect of alpha-chain stoichiometry on the phenotype of
RT   osteogenesis imperfecta?";
RL   Hum. Mutat. 9:431-436(1997).
RN   [86]
RP   VARIANTS OI4 ALA-398; CYS-527 AND CYS-701.
RX   PubMed=9600458;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:5<395::AID-HUMU7>3.0.CO;2-4;
RA   Sarafova A.P., Choi H., Forlino A., Gajko A., Cabral W.A., Tosi L.,
RA   Reing C.M., Marini J.C.;
RT   "Three novel type I collagen mutations in osteogenesis imperfecta type
RT   IV probands are associated with discrepancies between electrophoretic
RT   migration of osteoblast and fibroblast collagen.";
RL   Hum. Mutat. 11:395-403(1998).
RN   [87]
RP   VARIANTS OI2 SER-656 AND ASP-1172.
RX   PubMed=10627137;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:1<71::AID-HUMU16>3.0.CO;2-4;
RA   Mottes M., Gomez Lira M., Zolezzi F., Valli M., Lisi V., Freising P.;
RT   "Four new cases of lethal osteogenesis imperfecta due to glycine
RT   substitutions in COL1A1 and genes.";
RL   Hum. Mutat. 12:71-72(1998).
RN   [88]
RP   INVOLVEMENT IN INVOLUTIONAL OSTEOPOROSIS.
RX   PubMed=9535665; DOI=10.1056/NEJM199804093381502;
RA   Uitterlinden A.G., Burger H., Huang Q., Yue F., McGuigan F.E.A.,
RA   Grant S.F.A., Hofman A., van Leeuwen J.P.T.M., Pols H.A.P.,
RA   Ralston S.H.;
RT   "Relation of alleles of the collagen type Ialpha1 gene to bone density
RT   and the risk of osteoporotic fractures in postmenopausal women.";
RL   N. Engl. J. Med. 338:1016-1021(1998).
RN   [89]
RP   VARIANT OI3 SER-866.
RX   PubMed=10408781;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:6<503::AID-HUMU11>3.0.CO;2-L;
RA   Lund A.M., Astroem E., Soederhaell S., Schwartz M., Skovby F.;
RT   "Osteogenesis imperfecta: mosaicism and refinement of the genotype-
RT   phenotype map in OI type III.";
RL   Hum. Mutat. 13:503-503(1999).
RN   [90]
RP   VARIANT EDS CYS-312.
RX   PubMed=10739762; DOI=10.1086/302859;
RA   Nuytinck L., Freund M., Lagae L., Pierard G.E., Hermanns-Le T.,
RA   De Paepe A.;
RT   "Classical Ehlers-Danlos syndrome caused by a mutation in type I
RT   collagen.";
RL   Am. J. Hum. Genet. 66:1398-1402(2000).
RN   [91]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH PDGFB.
RX   PubMed=8988177; DOI=10.1038/ng0197-95;
RA   Simon M.-P., Pedeutour F., Sirvent N., Grosgeorge J., Minoletti F.,
RA   Coindre J.-M., Terrier-Lacombe M.-J., Mandahl N., Craver R.D.,
RA   Blin N., Sozzi G., Turc-Carel C., O'Brien K.P., Kedra D., Fransson I.,
RA   Guilbaud C., Dumanski J.P.;
RT   "Deregulation of the platelet-derived growth factor B-chain gene via
RT   fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans
RT   and giant-cell fibroblastoma.";
RL   Nat. Genet. 15:95-98(1997).
RN   [92]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH PDGFB.
RX   PubMed=12660034; DOI=10.1016/S0165-4608(02)00844-0;
RA   Sandberg A.A., Anderson W.D., Fredenberg C., Hashimoto H.;
RT   "Dermatofibrosarcoma protuberans of breast.";
RL   Cancer Genet. Cytogenet. 142:56-59(2003).
RN   [93]
RP   VARIANT CAFFD CYS-1014.
RX   PubMed=15864348; DOI=10.1172/JCI22760;
RA   Gensure R.C., Maekitie O., Barclay C., Chan C., Depalma S.R.,
RA   Bastepe M., Abuzahra H., Couper R., Mundlos S., Sillence D.,
RA   Ala-Kokko L., Seidman J.G., Cole W.G., Jueppner H.;
RT   "A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey
RT   disease) expands the spectrum of collagen-related disorders.";
RL   J. Clin. Invest. 115:1250-1257(2005).
RN   [94]
RP   VARIANTS OI3 VAL-203 AND SER-821, AND VARIANTS OI4 ARG-257 AND
RP   SER-683.
RX   PubMed=16879195; DOI=10.1111/j.1399-0004.2006.00646.x;
RA   Venturi G., Tedeschi E., Mottes M., Valli M., Camilot M., Viglio S.,
RA   Antoniazzi F., Tato L.;
RT   "Osteogenesis imperfecta: clinical, biochemical and molecular
RT   findings.";
RL   Clin. Genet. 70:131-139(2006).
RN   [95]
RP   VARIANTS OI1/OI3/OI4 ARG-194; ASP-242; ARG-257; SER-722; SER-767;
RP   SER-821 AND SER-1058.
RX   PubMed=16705691; DOI=10.1002/humu.9423;
RA   Lee K.S., Song H.R., Cho T.J., Kim H.J., Lee T.M., Jin H.S.,
RA   Park H.Y., Kang S., Jung S.C., Koo S.K.;
RT   "Mutational spectrum of type I collagen genes in Korean patients with
RT   osteogenesis imperfecta.";
RL   Hum. Mutat. 27:599-599(2006).
RN   [96]
RP   VARIANTS OI2 ARG-22; ARG-581; VAL-734 AND ASN-1413, VARIANTS OI4
RP   ARG-197 AND CYS-338, VARIANTS OI1 VAL-320; ARG-555; SER-647 AND
RP   GLU-1219, AND VARIANTS ALA-205; LYS-288; SER-906 AND HIS-1356.
RX   PubMed=16786509; DOI=10.1002/humu.9430;
RA   Pollitt R., McMahon R., Nunn J., Bamford R., Afifi A., Bishop N.,
RA   Dalton A.;
RT   "Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with
RT   osteogenesis imperfecta type I-IV.";
RL   Hum. Mutat. 27:716-716(2006).
RN   [97]
RP   VARIANT OI2 ASP-833.
RX   PubMed=16566045; DOI=10.1002/pd.1428;
RA   Aerts M., Van Holsbeke C., de Ravel T., Devlieger R.;
RT   "Prenatal diagnosis of type II osteogenesis imperfecta, describing a
RT   new mutation in the COL1A1 gene.";
RL   Prenat. Diagn. 26:394-394(2006).
RN   [98]
RP   VARIANT OI1 ASP-1157.
RX   PubMed=16638323;
RA   Wang Z., Xu D.L., Chen Z., Hu J.Y., Yang Z., Wang L.T.;
RT   "A new mutation in COL1A1 gene in a family with osteogenesis
RT   imperfecta.";
RL   Zhonghua Yi Xue Za Zhi 86:170-173(2006).
RN   [99]
RP   VARIANT EDS CYS-312, AND VARIANTS CYS-574 AND CYS-1093.
RX   PubMed=17211858; DOI=10.1002/humu.20455;
RA   Malfait F., Symoens S., De Backer J., Hermanns-Le T., Sakalihasan N.,
RA   Lapiere C.M., Coucke P., De Paepe A.;
RT   "Three arginine to cysteine substitutions in the pro-alpha (I)-
RT   collagen chain cause Ehlers-Danlos syndrome with a propensity to
RT   arterial rupture in early adulthood.";
RL   Hum. Mutat. 28:387-395(2007).
RN   [100]
RP   VARIANT CYS-1066.
RX   PubMed=17206620; DOI=10.1002/humu.20456;
RA   Cabral W.A., Makareeva E., Letocha A.D., Scribanu N., Fertala A.,
RA   Steplewski A., Keene D.R., Persikov A.V., Leikin S., Marini J.C.;
RT   "Y-position cysteine substitution in type I collagen (alpha1(I)
RT   R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-
RT   Danlos syndrome phenotype.";
RL   Hum. Mutat. 28:396-405(2007).
RN   [101]
RP   VARIANTS OI1 GLU-266 AND SER-287, AND VARIANT OI4 SER-353.
RX   PubMed=17875077; DOI=10.1111/j.1442-200X.2007.02422.x;
RA   Kataoka K., Ogura E., Hasegawa K., Inoue M., Seino Y., Morishima T.,
RA   Tanaka H.;
RT   "Mutations in type I collagen genes in Japanese osteogenesis
RT   imperfecta patients.";
RL   Pediatr. Int. 49:564-569(2007).
RN   [102]
RP   VARIANTS ALA-1075; GLN-1141 AND ILE-1177.
RX   PubMed=18272325; DOI=10.1016/j.ygeno.2007.12.008;
RA   Chan T.F., Poon A., Basu A., Addleman N.R., Chen J., Phong A.,
RA   Byers P.H., Klein T.E., Kwok P.Y.;
RT   "Natural variation in four human collagen genes across an ethnically
RT   diverse population.";
RL   Genomics 91:307-314(2008).
RN   [103]
RP   VARIANTS OI1 VAL-200 AND PHE-349, VARIANT OI2 SER-866, AND VARIANT OI3
RP   SER-1040.
RX   PubMed=18670065; DOI=10.1007/BF03195625;
RA   Witecka J., Augusciak-Duma A.M., Kruczek A., Szydlo A., Lesiak M.,
RA   Krzak M., Pietrzyk J.J., Mannikko M., Sieron A.L.;
RT   "Two novel COL1A1 mutations in patients with osteogenesis imperfecta
RT   (OI) affect the stability of the collagen type I triple-helix.";
RL   J. Appl. Genet. 49:283-295(2008).
RN   [104]
RP   VARIANTS OI2 THR-146; VAL-288; ASP-353; VAL-368; THR-390; SER-425;
RP   ASP-455; VAL-470; VAL-509; ALA-548; ARG-602; ASP-605; ARG-614;
RP   ARG-740; SER-809; ARG-824; ARG-845; ARG-848; HIS-855; SER-866;
RP   SER-875; SER-884; ASP-896; CYS-947; ASP-977; CYS-1001; VAL-1022;
RP   ALA-PRO-GLY-1052 INS; ASP-1055; SER-1094; ASP-1100 AND ASN-1413, AND
RP   VARIANT ALA-1075.
RX   PubMed=18996919; DOI=10.1093/hmg/ddn374;
RA   Bodian D.L., Chan T.F., Poon A., Schwarze U., Yang K., Byers P.H.,
RA   Kwok P.Y., Klein T.E.;
RT   "Mutation and polymorphism spectrum in osteogenesis imperfecta type
RT   II: implications for genotype-phenotype relationships.";
RL   Hum. Mol. Genet. 18:463-471(2009).
RN   [105]
RP   VARIANT ASN-1219, AND CHARACTERIZATION OF VARIANT ASN-1219.
RX   PubMed=21344539; DOI=10.1002/humu.21475;
RA   Lindahl K., Barnes A.M., Fratzl-Zelman N., Whyte M.P., Hefferan T.E.,
RA   Makareeva E., Brusel M., Yaszemski M.J., Rubin C.J., Kindmark A.,
RA   Roschger P., Klaushofer K., McAlister W.H., Mumm S., Leikin S.,
RA   Kessler E., Boskey A.L., Ljunggren O., Marini J.C.;
RT   "COL1 C-propeptide cleavage site mutations cause high bone mass
RT   osteogenesis imperfecta.";
RL   Hum. Mutat. 32:598-609(2011).
RN   [106]
RP   VARIANT OI1 GLU-1088.
RX   PubMed=24682174; DOI=10.3892/mmr.2014.2084;
RA   Xia X.Y., Li W.W., Li N., Wu Q.Y., Cui Y.X., Li X.J.;
RT   "A novel mild variant of osteogenesis imperfecta type I caused by a
RT   Gly1088Glu mutation in COL1A1.";
RL   Mol. Med. Report. 9:2187-2190(2014).
RN   [107]
RP   VARIANT OI2 CYS-773.
RX   PubMed=25958000; DOI=10.1186/s40246-015-0028-0;
RA   Maasalu K., Nikopensius T., Koks S., Noukas M., Kals M., Prans E.,
RA   Zhytnik L., Metspalu A., Maertson A.;
RT   "Whole-exome sequencing identifies de novo mutation in the COL1A1 gene
RT   to underlie the severe osteogenesis imperfecta.";
RL   Hum. Genomics 9:6-6(2015).
CC   -!- FUNCTION: Type I collagen is a member of group I collagen
CC       (fibrillar forming collagen).
CC   -!- SUBUNIT: Trimers of one alpha 2(I) and two alpha 1(I) chains.
CC       Interacts with MRC2 (By similarity). Interacts with TRAM2
CC       (PubMed:14749390). Interacts with MFAP4 in a Ca (2+)-dependent
CC       manner (By similarity). {ECO:0000250|UniProtKB:P02453,
CC       ECO:0000250|UniProtKB:P02454, ECO:0000269|PubMed:14749390}.
CC   -!- INTERACTION:
CC       O01949:AAEL010235 (xeno); NbExp=5; IntAct=EBI-982999, EBI-7685554;
CC       P02751:FN1; NbExp=2; IntAct=EBI-982999, EBI-1220319;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- TISSUE SPECIFICITY: Forms the fibrils of tendon, ligaments and
CC       bones. In bones the fibrils are mineralized with calcium
CC       hydroxyapatite.
CC   -!- DOMAIN: The C-terminal propeptide, also known as COLFI domain,
CC       have crucial roles in tissue growth and repair by controlling both
CC       the intracellular assembly of procollagen molecules and the
CC       extracellular assembly of collagen fibrils. It binds a calcium ion
CC       which is essential for its function (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Contains mostly 4-hydroxyproline. Proline residues at the
CC       third position of the tripeptide repeating unit (G-X-Y) are
CC       hydroxylated in some or all of the chains.
CC       {ECO:0000269|PubMed:4319110}.
CC   -!- PTM: Contains 3-hydroxyproline at a few sites. This modification
CC       occurs on the first proline residue in the sequence motif Gly-Pro-
CC       Hyp, where Hyp is 4-hydroxyproline.
CC       {ECO:0000250|UniProtKB:P11087}.
CC   -!- PTM: Lysine residues at the third position of the tripeptide
CC       repeating unit (G-X-Y) are 5-hydroxylated in some or all of the
CC       chains. {ECO:0000269|PubMed:4319110}.
CC   -!- PTM: O-glycosylated on hydroxylated lysine residues. The O-linked
CC       glycan consists of a Glc-Gal disaccharide.
CC       {ECO:0000269|PubMed:4319110}.
CC   -!- DISEASE: Caffey disease (CAFFD) [MIM:114000]: Characterized by an
CC       infantile episode of massive subperiosteal new bone formation that
CC       typically involves the diaphyses of the long bones, mandible, and
CC       clavicles. The involved bones may also appear inflamed, with
CC       painful swelling and systemic fever often accompanying the
CC       illness. The bone changes usually begin before 5 months of age and
CC       resolve before 2 years of age. {ECO:0000269|PubMed:15864348}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Ehlers-Danlos syndrome, classic type (EDS) [MIM:130000]:
CC       A connective tissue disorder characterized by hyperextensible
CC       skin, atrophic cutaneous scars due to tissue fragility and joint
CC       hyperlaxity. {ECO:0000269|PubMed:10739762,
CC       ECO:0000269|PubMed:17211858}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Ehlers-Danlos syndrome 7A (EDS7A) [MIM:130060]: A
CC       connective tissue disorder characterized by hyperextensible skin,
CC       atrophic cutaneous scars due to tissue fragility and joint
CC       hyperlaxity. Marked by bilateral congenital hip dislocation,
CC       hyperlaxity of the joints, and recurrent partial dislocations.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An
CC       autosomal dominant form of osteogenesis imperfecta, a connective
CC       tissue disorder characterized by low bone mass, bone fragility and
CC       susceptibility to fractures after minimal trauma. Disease severity
CC       ranges from very mild forms without fractures to intrauterine
CC       fractures and perinatal lethality. Extraskeletal manifestations,
CC       which affect a variable number of patients, are dentinogenesis
CC       imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming
CC       form with normal height or mild short stature, and no
CC       dentinogenesis imperfecta. {ECO:0000269|PubMed:1634225,
CC       ECO:0000269|PubMed:16638323, ECO:0000269|PubMed:16705691,
CC       ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1718984,
CC       ECO:0000269|PubMed:1737847, ECO:0000269|PubMed:17875077,
CC       ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:24682174,
CC       ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:3244312,
CC       ECO:0000269|PubMed:8223589}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An
CC       autosomal dominant form of osteogenesis imperfecta, a connective
CC       tissue disorder characterized by low bone mass, bone fragility and
CC       susceptibility to fractures after minimal trauma. Disease severity
CC       ranges from very mild forms without fractures to intrauterine
CC       fractures and perinatal lethality. Extraskeletal manifestations,
CC       which affect a variable number of patients, are dentinogenesis
CC       imperfecta, hearing loss, and blue sclerae. OI2 is characterized
CC       by bone fragility, with many perinatal fractures, severe bowing of
CC       long bones, undermineralization, and death in the perinatal period
CC       due to respiratory insufficiency. {ECO:0000269|PubMed:10627137,
CC       ECO:0000269|PubMed:1460047, ECO:0000269|PubMed:1511982,
CC       ECO:0000269|PubMed:1613761, ECO:0000269|PubMed:16566045,
CC       ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:18670065,
CC       ECO:0000269|PubMed:1874719, ECO:0000269|PubMed:18996919,
CC       ECO:0000269|PubMed:1939261, ECO:0000269|PubMed:1953667,
CC       ECO:0000269|PubMed:2035536, ECO:0000269|PubMed:2036375,
CC       ECO:0000269|PubMed:2037280, ECO:0000269|PubMed:2116413,
CC       ECO:0000269|PubMed:2211725, ECO:0000269|PubMed:2339700,
CC       ECO:0000269|PubMed:2470760, ECO:0000269|PubMed:25958000,
CC       ECO:0000269|PubMed:2777764, ECO:0000269|PubMed:2794057,
CC       ECO:0000269|PubMed:2913053, ECO:0000269|PubMed:3016737,
CC       ECO:0000269|PubMed:3108247, ECO:0000269|PubMed:3403550,
CC       ECO:0000269|PubMed:3667599, ECO:0000269|PubMed:7520724,
CC       ECO:0000269|PubMed:7679635, ECO:0000269|PubMed:7691343,
CC       ECO:0000269|PubMed:7961597, ECO:0000269|PubMed:8100209,
CC       ECO:0000269|PubMed:8349697, ECO:0000269|PubMed:8349698,
CC       ECO:0000269|PubMed:8364588, ECO:0000269|PubMed:8456808,
CC       ECO:0000269|PubMed:8786074, ECO:0000269|PubMed:9143923,
CC       ECO:0000269|Ref.47, ECO:0000269|Ref.50}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An
CC       autosomal dominant form of osteogenesis imperfecta, a connective
CC       tissue disorder characterized by low bone mass, bone fragility and
CC       susceptibility to fractures after minimal trauma. Disease severity
CC       ranges from very mild forms without fractures to intrauterine
CC       fractures and perinatal lethality. Extraskeletal manifestations,
CC       which affect a variable number of patients, are dentinogenesis
CC       imperfecta, hearing loss, and blue sclerae. OI3 is characterized
CC       by progressively deforming bones, very short stature, a triangular
CC       face, severe scoliosis, grayish sclera and dentinogenesis
CC       imperfecta. {ECO:0000269|PubMed:10408781,
CC       ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1770532,
CC       ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:2037280,
CC       ECO:0000269|PubMed:2511192, ECO:0000269|PubMed:2794057,
CC       ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7881420,
CC       ECO:0000269|PubMed:8019571, ECO:0000269|PubMed:8364588,
CC       ECO:0000269|PubMed:8456809, ECO:0000269|PubMed:8669434,
CC       ECO:0000269|PubMed:8723681, ECO:0000269|PubMed:9101304}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An
CC       autosomal dominant form of osteogenesis imperfecta, a connective
CC       tissue disorder characterized by low bone mass, bone fragility and
CC       susceptibility to fractures after minimal trauma. Disease severity
CC       ranges from very mild forms without fractures to intrauterine
CC       fractures and perinatal lethality. Extraskeletal manifestations,
CC       which affect a variable number of patients, are dentinogenesis
CC       imperfecta, hearing loss, and blue sclerae. OI4 is characterized
CC       by moderately short stature, mild to moderate scoliosis, grayish
CC       or white sclera and dentinogenesis imperfecta.
CC       {ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195,
CC       ECO:0000269|PubMed:1770532, ECO:0000269|PubMed:17875077,
CC       ECO:0000269|PubMed:1988452, ECO:0000269|PubMed:2745420,
CC       ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7982948,
CC       ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8339541,
CC       ECO:0000269|PubMed:9600458}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Osteoporosis (OSTEOP) [MIM:166710]: A systemic skeletal
CC       disorder characterized by decreased bone mass and deterioration of
CC       bone microarchitecture without alteration in the composition of
CC       bone. The result is fragile bones and an increased risk of
CC       fractures, even after minimal trauma. Osteoporosis is a chronic
CC       condition of multifactorial etiology and is usually clinically
CC       silent until a fracture occurs. {ECO:0000269|PubMed:8841196,
CC       ECO:0000269|PubMed:9535665}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving COL1A1 is found
CC       in dermatofibrosarcoma protuberans. Translocation
CC       t(17;22)(q22;q13) with PDGF.
CC   -!- SIMILARITY: Belongs to the fibrillar collagen family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92834.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Osteogenesis imperfecta variant database;
CC       Note=Collagen type I alpha 1 (COL1A1);
CC       URL="http://oi.gene.le.ac.uk/home.php?select_db=COL1A1";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/COL1A1ID186.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Type-I collagen entry;
CC       URL="https://en.wikipedia.org/wiki/Type-I_collagen";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z74615; CAA98968.1; -; mRNA.
DR   EMBL; AF017178; AAB94054.3; -; Genomic_DNA.
DR   EMBL; AB209597; BAD92834.1; ALT_INIT; mRNA.
DR   EMBL; BC036531; AAH36531.1; -; mRNA.
DR   EMBL; M20789; AAB59373.1; -; Genomic_DNA.
DR   EMBL; M36546; AAA60150.1; -; mRNA.
DR   EMBL; X07884; CAA30731.1; -; mRNA.
DR   EMBL; X00820; CAA25394.1; -; Genomic_DNA.
DR   EMBL; J02829; AAA51993.1; -; Genomic_DNA.
DR   EMBL; M10627; AAA51992.1; -; Genomic_DNA.
DR   EMBL; J03559; AAA52052.1; -; Genomic_DNA.
DR   EMBL; K01228; AAA51995.1; -; mRNA.
DR   EMBL; J00110; AAA52289.1; -; mRNA.
DR   EMBL; J00111; AAA52290.1; -; mRNA.
DR   EMBL; J00112; AAA52291.1; -; mRNA.
DR   EMBL; J00113; AAN86574.1; -; mRNA.
DR   EMBL; K03179; AAA51847.1; -; Genomic_DNA.
DR   EMBL; M11162; AAA75386.1; -; Genomic_DNA.
DR   EMBL; L47667; AAB59576.1; -; Genomic_DNA.
DR   EMBL; S64596; AAB27856.1; -; mRNA.
DR   EMBL; M23213; AAB59363.1; -; Genomic_DNA.
DR   EMBL; X06269; CAA29605.1; -; mRNA.
DR   EMBL; M32798; AAA52049.1; -; mRNA.
DR   EMBL; M55998; AAA52036.1; -; Genomic_DNA.
DR   CCDS; CCDS11561.1; -.
DR   PIR; I60114; CGHU1S.
DR   RefSeq; NP_000079.2; NM_000088.3.
DR   UniGene; Hs.172928; -.
DR   UniGene; Hs.681002; -.
DR   PDB; 1Q7D; X-ray; 1.80 A; A/B/C=677-685.
DR   PDB; 2LLP; NMR; -; A/B/C=949-965.
DR   PDB; 3EJH; X-ray; 2.10 A; E/F=956-977.
DR   PDB; 3GXE; X-ray; 2.60 A; E/F=254-275.
DR   PDB; 5CTD; X-ray; 1.60 A; A=572-583, C=554-583.
DR   PDB; 5CTI; X-ray; 1.90 A; A=572-583, C=554-583, C=611-665.
DR   PDB; 5CVA; X-ray; 2.10 A; B/C/E/F=554-583, B/E=593-629.
DR   PDB; 5CVB; X-ray; 2.25 A; A/D=572-583, B/C/E/F=554-583, B/E=593-606.
DR   PDB; 5K31; X-ray; 2.20 A; A/B/C/D/E/F=1219-1464.
DR   PDBsum; 1Q7D; -.
DR   PDBsum; 2LLP; -.
DR   PDBsum; 3EJH; -.
DR   PDBsum; 3GXE; -.
DR   PDBsum; 5CTD; -.
DR   PDBsum; 5CTI; -.
DR   PDBsum; 5CVA; -.
DR   PDBsum; 5CVB; -.
DR   PDBsum; 5K31; -.
DR   ProteinModelPortal; P02452; -.
DR   SMR; P02452; -.
DR   BioGrid; 107674; 54.
DR   CORUM; P02452; -.
DR   DIP; DIP-36077N; -.
DR   IntAct; P02452; 21.
DR   MINT; P02452; -.
DR   STRING; 9606.ENSP00000225964; -.
DR   ChEMBL; CHEMBL2364188; -.
DR   DrugBank; DB00048; Collagenase clostridium histolyticum.
DR   DrugBank; DB04866; Halofuginone.
DR   iPTMnet; P02452; -.
DR   PhosphoSitePlus; P02452; -.
DR   BioMuta; COL1A1; -.
DR   DMDM; 296439504; -.
DR   DOSAC-COBS-2DPAGE; P02452; -.
DR   EPD; P02452; -.
DR   MaxQB; P02452; -.
DR   PaxDb; P02452; -.
DR   PeptideAtlas; P02452; -.
DR   PRIDE; P02452; -.
DR   DNASU; 1277; -.
DR   Ensembl; ENST00000225964; ENSP00000225964; ENSG00000108821.
DR   GeneID; 1277; -.
DR   KEGG; hsa:1277; -.
DR   UCSC; uc002iqm.4; human.
DR   CTD; 1277; -.
DR   DisGeNET; 1277; -.
DR   EuPathDB; HostDB:ENSG00000108821.13; -.
DR   GeneCards; COL1A1; -.
DR   GeneReviews; COL1A1; -.
DR   HGNC; HGNC:2197; COL1A1.
DR   HPA; HPA008405; -.
DR   HPA; HPA011795; -.
DR   MalaCards; COL1A1; -.
DR   MIM; 114000; phenotype.
DR   MIM; 120150; gene.
DR   MIM; 130000; phenotype.
DR   MIM; 130060; phenotype.
DR   MIM; 166200; phenotype.
DR   MIM; 166210; phenotype.
DR   MIM; 166220; phenotype.
DR   MIM; 166710; phenotype.
DR   MIM; 259420; phenotype.
DR   MIM; 607907; phenotype.
DR   neXtProt; NX_P02452; -.
DR   Orphanet; 1310; Caffey disease.
DR   Orphanet; 31112; Dermatofibrosarcoma protuberans.
DR   Orphanet; 90309; Ehlers-Danlos syndrome type 1.
DR   Orphanet; 99875; Ehlers-Danlos syndrome type 7A.
DR   Orphanet; 230845; Ehlers-Danlos syndrome, vascular-like type.
DR   Orphanet; 230857; Ehlers-Danlos/osteogenesis imperfecta syndrome.
DR   Orphanet; 314029; High bone mass osteogenesis imperfecta.
DR   Orphanet; 216796; Osteogenesis imperfecta type 1.
DR   Orphanet; 216804; Osteogenesis imperfecta type 2.
DR   Orphanet; 216812; Osteogenesis imperfecta type 3.
DR   Orphanet; 216820; Osteogenesis imperfecta type 4.
DR   PharmGKB; PA35041; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   eggNOG; ENOG410XNMM; LUCA.
DR   HOVERGEN; HBG004933; -.
DR   InParanoid; P02452; -.
DR   KO; K06236; -.
DR   OrthoDB; EOG091G03LV; -.
DR   PhylomeDB; P02452; -.
DR   TreeFam; TF344135; -.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1474244; Extracellular matrix organization.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-2214320; Anchoring fibril formation.
DR   Reactome; R-HSA-2243919; Crosslinking of collagen fibrils.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000171; Non-integrin membrane-ECM interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-3000480; Scavenging by Class A Receptors.
DR   Reactome; R-HSA-430116; GP1b-IX-V activation signalling.
DR   Reactome; R-HSA-75892; Platelet Adhesion to exposed collagen.
DR   Reactome; R-HSA-76009; Platelet Aggregation (Plug Formation).
DR   Reactome; R-HSA-8874081; MET activates PTK2 signaling.
DR   Reactome; R-HSA-8940973; RUNX2 regulates osteoblast differentiation.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   SIGNOR; P02452; -.
DR   ChiTaRS; COL1A1; human.
DR   EvolutionaryTrace; P02452; -.
DR   GeneWiki; Collagen,_type_I,_alpha_1; -.
DR   GenomeRNAi; 1277; -.
DR   PMAP-CutDB; P02452; -.
DR   PRO; PR:P02452; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108821; -.
DR   ExpressionAtlas; P02452; baseline and differential.
DR   Genevisible; P02452; HS.
DR   GO; GO:0005584; C:collagen type I trimer; IDA:CAFA.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0005576; C:extracellular region; IDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0030141; C:secretory granule; IEA:Ensembl.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0048407; F:platelet-derived growth factor binding; IDA:MGI.
DR   GO; GO:0002020; F:protease binding; IPI:CAFA.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0001568; P:blood vessel development; IMP:UniProtKB.
DR   GO; GO:0060346; P:bone trabecula formation; IEA:Ensembl.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEA:Ensembl.
DR   GO; GO:1902618; P:cellular response to fluoride; IEA:Ensembl.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0071306; P:cellular response to vitamin E; IEA:Ensembl.
DR   GO; GO:0032964; P:collagen biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0030574; P:collagen catabolic process; TAS:Reactome.
DR   GO; GO:0030199; P:collagen fibril organization; IMP:UniProtKB.
DR   GO; GO:0038063; P:collagen-activated tyrosine kinase receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IMP:UniProtKB.
DR   GO; GO:0001958; P:endochondral ossification; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0060325; P:face morphogenesis; IEA:Ensembl.
DR   GO; GO:0001957; P:intramembranous ossification; IEA:Ensembl.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0010812; P:negative regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0070208; P:protein heterotrimerization; IEA:Ensembl.
DR   GO; GO:0034504; P:protein localization to nucleus; IDA:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:Ensembl.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0031960; P:response to corticosteroid; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; IMP:UniProtKB.
DR   GO; GO:0043589; P:skin morphogenesis; IMP:UniProtKB.
DR   GO; GO:0044691; P:tooth eruption; IEA:Ensembl.
DR   GO; GO:0034505; P:tooth mineralization; IMP:UniProtKB.
DR   GO; GO:0007601; P:visual perception; IMP:UniProtKB.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR000885; Fib_collagen_C.
DR   InterPro; IPR001007; VWF_dom.
DR   Pfam; PF01410; COLFI; 1.
DR   Pfam; PF01391; Collagen; 11.
DR   Pfam; PF00093; VWC; 1.
DR   ProDom; PD002078; Fib_collagen_C; 1.
DR   SMART; SM00038; COLFI; 1.
DR   SMART; SM00214; VWC; 1.
DR   PROSITE; PS51461; NC1_FIB; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Chromosomal rearrangement; Collagen;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Disulfide bond; Dwarfism; Ehlers-Danlos syndrome;
KW   Extracellular matrix; Glycoprotein; Hydroxylation; Metal-binding;
KW   Osteogenesis imperfecta; Phosphoprotein; Polymorphism;
KW   Pyrrolidone carboxylic acid; Reference proteome; Repeat; Secreted;
KW   Signal.
FT   SIGNAL        1     22
FT   PROPEP       23    161       N-terminal propeptide.
FT                                {ECO:0000269|PubMed:5529814}.
FT                                /FTId=PRO_0000005719.
FT   CHAIN       162   1218       Collagen alpha-1(I) chain.
FT                                /FTId=PRO_0000005720.
FT   PROPEP     1219   1464       C-terminal propeptide.
FT                                /FTId=PRO_0000005721.
FT   DOMAIN       38     96       VWFC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00220}.
FT   DOMAIN     1229   1464       Fibrillar collagen NC1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   REGION      162    178       Nonhelical region (N-terminal).
FT   REGION      179   1192       Triple-helical region.
FT   REGION     1193   1218       Nonhelical region (C-terminal).
FT   MOTIF       745    747       Cell attachment site. {ECO:0000255}.
FT   MOTIF      1093   1095       Cell attachment site. {ECO:0000255}.
FT   METAL      1277   1277       Calcium. {ECO:0000250}.
FT   METAL      1279   1279       Calcium. {ECO:0000250}.
FT   METAL      1280   1280       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL      1282   1282       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL      1285   1285       Calcium. {ECO:0000250}.
FT   SITE        161    162       Cleavage; by procollagen N-endopeptidase.
FT   SITE        953    954       Cleavage; by collagenase. {ECO:0000250}.
FT   SITE       1218   1219       Cleavage; by procollagen C-endopeptidase.
FT   MOD_RES     162    162       Pyrrolidone carboxylic acid.
FT                                {ECO:0000269|PubMed:5529814}.
FT   MOD_RES     170    170       Allysine.
FT   MOD_RES     171    171       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P02454}.
FT   MOD_RES     190    190       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     193    193       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     196    196       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     205    205       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     208    208       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     211    211       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     226    226       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     241    241       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     247    247       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     256    256       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     262    262       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     265    265       5-hydroxylysine; alternate.
FT                                {ECO:0000269|PubMed:4319110}.
FT   MOD_RES     271    271       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P02454}.
FT   MOD_RES     289    289       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     292    292       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     298    298       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     307    307       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     313    313       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     334    334       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     343    343       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     346    346       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     373    373       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     376    376       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     388    388       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     394    394       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     403    403       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     409    409       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     412    412       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     427    427       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     430    430       5-hydroxylysine.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     436    436       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     439    439       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     451    451       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     460    460       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     475    475       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     481    481       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     490    490       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     496    496       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     505    505       5-hydroxylysine.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     514    514       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     523    523       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     529    529       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     535    535       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     544    544       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     547    547       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     556    556       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     565    565       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     571    571       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     583    583       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     592    592       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     601    601       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     604    604       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     622    622       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     640    640       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     646    646       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     652    652       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     658    658       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     664    664       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     670    670       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     682    682       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     691    691       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     703    703       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     715    715       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     718    718       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     724    724       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     730    730       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     739    739       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     751    751       5-hydroxylysine.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     757    757       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     772    772       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     778    778       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     787    787       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P02454}.
FT   MOD_RES     799    799       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     805    805       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     808    808       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     817    817       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     823    823       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     841    841       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     850    850       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     859    859       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     862    862       5-hydroxylysine.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     871    871       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     877    877       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     885    885       3-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES     886    886       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES     895    895       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES     898    898       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES     919    919       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     928    928       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     937    937       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     946    946       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     964    964       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     973    973       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     976    976       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     982    982       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES     997    997       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1003   1003       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1009   1009       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1018   1018       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1024   1024       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1033   1033       5-hydroxylysine.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1045   1045       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1048   1048       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1051   1051       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1096   1096       5-hydroxylysine.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1108   1108       5-hydroxylysine; alternate.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1120   1120       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1123   1123       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1126   1126       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1144   1144       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   MOD_RES    1159   1159       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES    1164   1164       3-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES    1165   1165       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES    1179   1179       3-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES    1180   1180       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES    1182   1182       3-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES    1183   1183       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES    1185   1185       3-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES    1186   1186       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES    1189   1189       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES    1192   1192       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P11087}.
FT   MOD_RES    1208   1208       Allysine. {ECO:0000250}.
FT   CARBOHYD    265    265       O-linked (Gal...) hydroxylysine;
FT                                alternate. {ECO:0000269|PubMed:4319110}.
FT   CARBOHYD   1108   1108       O-linked (Gal...) hydroxylysine;
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P02457}.
FT   CARBOHYD   1365   1365       N-linked (GlcNAc...) asparagine.
FT   DISULFID   1259   1291       {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   DISULFID   1265   1265       Interchain. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00793}.
FT   DISULFID   1282   1282       Interchain. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00793}.
FT   DISULFID   1299   1462       {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   DISULFID   1370   1415       {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   VARIANT      22     22       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063290.
FT   VARIANT     146    146       P -> T (in OI2; rare variant; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063291.
FT   VARIANT     194    194       G -> R (in OI1).
FT                                {ECO:0000269|PubMed:16705691}.
FT                                /FTId=VAR_063292.
FT   VARIANT     197    197       G -> C (in dbSNP:rs8179178).
FT                                /FTId=VAR_001642.
FT   VARIANT     197    197       G -> R (in OI4).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063293.
FT   VARIANT     200    200       G -> V (in OI1; patient diagnosed with
FT                                OI1/OI4). {ECO:0000269|PubMed:18670065}.
FT                                /FTId=VAR_063294.
FT   VARIANT     203    203       G -> V (in OI3).
FT                                {ECO:0000269|PubMed:16879195}.
FT                                /FTId=VAR_063295.
FT   VARIANT     205    205       P -> A (in dbSNP:rs72667032).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_001643.
FT   VARIANT     221    221       G -> C (in OI1; mild form).
FT                                {ECO:0000269|PubMed:1737847}.
FT                                /FTId=VAR_001644.
FT   VARIANT     224    224       G -> C (in OI1; mild phenotype).
FT                                /FTId=VAR_001645.
FT   VARIANT     242    242       G -> D (in OI).
FT                                {ECO:0000269|PubMed:16705691}.
FT                                /FTId=VAR_063296.
FT   VARIANT     257    257       G -> R (in OI4).
FT                                {ECO:0000269|PubMed:16705691,
FT                                ECO:0000269|PubMed:16879195}.
FT                                /FTId=VAR_063297.
FT   VARIANT     263    263       G -> R (in OI1; mild form).
FT                                {ECO:0000269|PubMed:1718984}.
FT                                /FTId=VAR_001646.
FT   VARIANT     263    263       G -> V (in OI1; mild form).
FT                                {ECO:0000269|PubMed:8223589}.
FT                                /FTId=VAR_001647.
FT   VARIANT     266    266       G -> E (in OI1).
FT                                {ECO:0000269|PubMed:17875077}.
FT                                /FTId=VAR_063298.
FT   VARIANT     272    272       G -> C (in OI1).
FT                                {ECO:0000269|PubMed:2794057}.
FT                                /FTId=VAR_001648.
FT   VARIANT     275    275       G -> D (in OI2).
FT                                /FTId=VAR_001649.
FT   VARIANT     287    287       G -> S (in OI1).
FT                                {ECO:0000269|PubMed:17875077}.
FT                                /FTId=VAR_063299.
FT   VARIANT     288    288       E -> K (in OI1; the patient also has
FT                                mutation Glu-1219; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063300.
FT   VARIANT     288    288       E -> V (in OI2; rare variant; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063301.
FT   VARIANT     312    312       R -> C (in EDS).
FT                                {ECO:0000269|PubMed:10739762,
FT                                ECO:0000269|PubMed:17211858}.
FT                                /FTId=VAR_013579.
FT   VARIANT     320    320       G -> V (in OI1).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063302.
FT   VARIANT     332    332       G -> R (in OI3; mild to moderate form).
FT                                {ECO:0000269|PubMed:2037280,
FT                                ECO:0000269|PubMed:8669434}.
FT                                /FTId=VAR_001650.
FT   VARIANT     338    338       G -> C (in OI4).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063303.
FT   VARIANT     349    349       V -> F (in OI1).
FT                                {ECO:0000269|PubMed:18670065}.
FT                                /FTId=VAR_063304.
FT   VARIANT     350    350       G -> R (in OI3).
FT                                {ECO:0000269|PubMed:8019571}.
FT                                /FTId=VAR_001651.
FT   VARIANT     353    353       G -> C (in OI4).
FT                                {ECO:0000269|PubMed:8339541}.
FT                                /FTId=VAR_001652.
FT   VARIANT     353    353       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063305.
FT   VARIANT     353    353       G -> S (in OI4).
FT                                {ECO:0000269|PubMed:17875077}.
FT                                /FTId=VAR_063306.
FT   VARIANT     356    356       G -> C (in OI4; mild form).
FT                                {ECO:0000269|PubMed:1988452}.
FT                                /FTId=VAR_001653.
FT   VARIANT     368    368       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063307.
FT   VARIANT     383    383       G -> C (in OI4).
FT                                /FTId=VAR_001654.
FT   VARIANT     389    389       G -> C (in OI; moderate form).
FT                                /FTId=VAR_001655.
FT   VARIANT     389    389       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:7520724}.
FT                                /FTId=VAR_001656.
FT   VARIANT     390    390       A -> T (in OI2; rare variant; unknown
FT                                pathological significance;
FT                                dbSNP:rs116794104).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063308.
FT   VARIANT     398    398       G -> A (in OI4).
FT                                {ECO:0000269|PubMed:9600458}.
FT                                /FTId=VAR_001657.
FT   VARIANT     398    398       G -> D (in OI2).
FT                                /FTId=VAR_001658.
FT   VARIANT     401    401       G -> C (in OI4).
FT                                /FTId=VAR_001659.
FT   VARIANT     404    404       G -> C (in OI; moderate form).
FT                                /FTId=VAR_001660.
FT   VARIANT     422    422       G -> C (in OI2). {ECO:0000269|Ref.47}.
FT                                /FTId=VAR_001661.
FT   VARIANT     425    425       G -> S (in OI2; lethal form).
FT                                {ECO:0000269|PubMed:18996919,
FT                                ECO:0000269|PubMed:7691343}.
FT                                /FTId=VAR_001662.
FT   VARIANT     434    434       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:1613761,
FT                                ECO:0000269|PubMed:2470760}.
FT                                /FTId=VAR_001663.
FT   VARIANT     455    455       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063309.
FT   VARIANT     470    470       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063310.
FT   VARIANT     476    476       G -> R (in OI2; dbSNP:rs57377812).
FT                                /FTId=VAR_001664.
FT   VARIANT     509    509       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063311.
FT   VARIANT     527    527       G -> C (in OI4).
FT                                {ECO:0000269|PubMed:9600458}.
FT                                /FTId=VAR_001665.
FT   VARIANT     530    530       G -> S (in OI2, OI3 and OI4; mild to
FT                                lethal form).
FT                                {ECO:0000269|PubMed:7691343,
FT                                ECO:0000269|PubMed:8094076,
FT                                ECO:0000269|PubMed:8456809}.
FT                                /FTId=VAR_001666.
FT   VARIANT     533    533       G -> D (in OI2).
FT                                /FTId=VAR_001667.
FT   VARIANT     548    548       G -> A (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063312.
FT   VARIANT     555    555       P -> R (in OI1).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063313.
FT   VARIANT     560    560       G -> C (in OI4).
FT                                /FTId=VAR_001669.
FT   VARIANT     560    560       G -> R (in OI2).
FT                                /FTId=VAR_001670.
FT   VARIANT     560    560       G -> S (in OI4).
FT                                {ECO:0000269|PubMed:7691343}.
FT                                /FTId=VAR_001668.
FT   VARIANT     564    564       R -> H (in dbSNP:rs1800211).
FT                                /FTId=VAR_001671.
FT   VARIANT     569    569       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:3108247}.
FT                                /FTId=VAR_001672.
FT   VARIANT     574    574       R -> C (found in a patient with isolated
FT                                osteopenia and vascular rupture; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:17211858}.
FT                                /FTId=VAR_063314.
FT   VARIANT     581    581       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063315.
FT   VARIANT     593    593       G -> C (in OI3 and OI4).
FT                                {ECO:0000269|PubMed:1770532}.
FT                                /FTId=VAR_001673.
FT   VARIANT     593    593       G -> S (in OI2 and OI3; moderate to
FT                                lethal form).
FT                                {ECO:0000269|PubMed:8364588}.
FT                                /FTId=VAR_001674.
FT   VARIANT     602    602       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063316.
FT   VARIANT     605    605       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063317.
FT   VARIANT     614    614       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063318.
FT   VARIANT     647    647       G -> S (in OI1).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063319.
FT   VARIANT     656    656       G -> S (in OI2).
FT                                {ECO:0000269|PubMed:10627137}.
FT                                /FTId=VAR_001676.
FT   VARIANT     683    683       G -> S (in OI4).
FT                                {ECO:0000269|PubMed:16879195}.
FT                                /FTId=VAR_063320.
FT   VARIANT     701    701       G -> C (in OI4).
FT                                {ECO:0000269|PubMed:9600458}.
FT                                /FTId=VAR_001677.
FT   VARIANT     704    704       G -> C (in OI3).
FT                                {ECO:0000269|PubMed:2794057}.
FT                                /FTId=VAR_001678.
FT   VARIANT     719    719       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:2035536}.
FT                                /FTId=VAR_001679.
FT   VARIANT     719    719       G -> S (in OI3).
FT                                {ECO:0000269|PubMed:7691343}.
FT                                /FTId=VAR_001680.
FT   VARIANT     722    722       G -> S (in OI1).
FT                                {ECO:0000269|PubMed:16705691}.
FT                                /FTId=VAR_063321.
FT   VARIANT     728    728       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:2339700}.
FT                                /FTId=VAR_001681.
FT   VARIANT     734    734       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063322.
FT   VARIANT     737    737       G -> D (in OI2).
FT                                /FTId=VAR_001682.
FT   VARIANT     740    740       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063323.
FT   VARIANT     743    743       G -> S (in OI2).
FT                                /FTId=VAR_001683.
FT   VARIANT     743    743       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:8100209}.
FT                                /FTId=VAR_001684.
FT   VARIANT     764    764       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:9143923}.
FT                                /FTId=VAR_001685.
FT   VARIANT     767    767       G -> S (in OI3; severe).
FT                                {ECO:0000269|PubMed:16705691,
FT                                ECO:0000269|PubMed:7881420}.
FT                                /FTId=VAR_001686.
FT   VARIANT     773    773       G -> C (in OI2; de novo mutation).
FT                                {ECO:0000269|PubMed:25958000}.
FT                                /FTId=VAR_074158.
FT   VARIANT     776    776       G -> S (in OI2).
FT                                {ECO:0000269|PubMed:2116413}.
FT                                /FTId=VAR_001687.
FT   VARIANT     809    809       G -> S (in OI2).
FT                                {ECO:0000269|PubMed:18996919,
FT                                ECO:0000269|PubMed:2116413}.
FT                                /FTId=VAR_001688.
FT   VARIANT     815    815       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:1874719}.
FT                                /FTId=VAR_001689.
FT   VARIANT     821    821       G -> S (in OI3).
FT                                {ECO:0000269|PubMed:16705691,
FT                                ECO:0000269|PubMed:16879195,
FT                                ECO:0000269|PubMed:9101304}.
FT                                /FTId=VAR_001690.
FT   VARIANT     823    823       P -> A (in dbSNP:rs1800214).
FT                                {ECO:0000269|PubMed:7691343}.
FT                                /FTId=VAR_001691.
FT   VARIANT     824    824       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063324.
FT   VARIANT     833    833       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:16566045}.
FT                                /FTId=VAR_063325.
FT   VARIANT     839    839       G -> S (in OI2; mild to moderate form).
FT                                {ECO:0000269|PubMed:8786074}.
FT                                /FTId=VAR_001692.
FT   VARIANT     842    842       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:3403550}.
FT                                /FTId=VAR_001693.
FT   VARIANT     845    845       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_001694.
FT   VARIANT     848    848       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063342.
FT   VARIANT     851    851       G -> D (in OI2).
FT                                /FTId=VAR_001695.
FT   VARIANT     855    855       N -> H (in OI2; rare variant; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063326.
FT   VARIANT     866    866       G -> S (in OI3 and OI2).
FT                                {ECO:0000269|PubMed:10408781,
FT                                ECO:0000269|PubMed:18670065,
FT                                ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_008118.
FT   VARIANT     869    869       G -> C (in OI2).
FT                                {ECO:0000269|PubMed:1953667}.
FT                                /FTId=VAR_001696.
FT   VARIANT     875    875       G -> S (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063327.
FT   VARIANT     884    884       G -> S (in OI2 and OI3; extremely severe
FT                                form). {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_001697.
FT   VARIANT     896    896       G -> C (in OI2).
FT                                {ECO:0000269|PubMed:2794057}.
FT                                /FTId=VAR_001698.
FT   VARIANT     896    896       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063328.
FT   VARIANT     906    906       G -> S (found in a patient with mild
FT                                osteogenesis imperfecta; uncertain
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063329.
FT   VARIANT     926    926       G -> C (in OI2).
FT                                {ECO:0000269|PubMed:2036375,
FT                                ECO:0000269|PubMed:3667599}.
FT                                /FTId=VAR_001699.
FT   VARIANT     947    947       G -> C (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063330.
FT   VARIANT     977    977       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063331.
FT   VARIANT     980    980       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:1511982}.
FT                                /FTId=VAR_001700.
FT   VARIANT    1001   1001       G -> C (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063332.
FT   VARIANT    1010   1010       G -> S (in OI4).
FT                                {ECO:0000269|PubMed:2745420}.
FT                                /FTId=VAR_001701.
FT   VARIANT    1014   1014       R -> C (in CAFFD).
FT                                {ECO:0000269|PubMed:15864348}.
FT                                /FTId=VAR_033097.
FT   VARIANT    1019   1019       G -> A (in dbSNP:rs1135348).
FT                                {ECO:0000269|PubMed:6689127,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_030013.
FT   VARIANT    1022   1022       G -> S (in OI3; severe form).
FT                                {ECO:0000269|PubMed:2511192}.
FT                                /FTId=VAR_001702.
FT   VARIANT    1022   1022       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_001703.
FT   VARIANT    1025   1025       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:2211725}.
FT                                /FTId=VAR_001704.
FT   VARIANT    1040   1040       G -> S (in OI2 and OI3; moderate to
FT                                lethal form).
FT                                {ECO:0000269|PubMed:18670065,
FT                                ECO:0000269|PubMed:9101304}.
FT                                /FTId=VAR_001705.
FT   VARIANT    1043   1043       G -> S (in OI2).
FT                                /FTId=VAR_001706.
FT   VARIANT    1046   1048       Missing (in OI2).
FT                                {ECO:0000269|PubMed:1460047,
FT                                ECO:0000269|PubMed:1939261}.
FT                                /FTId=VAR_001707.
FT   VARIANT    1049   1049       G -> S (in OI3).
FT                                {ECO:0000269|PubMed:9101304}.
FT                                /FTId=VAR_001708.
FT   VARIANT    1052   1052       G -> GAPG (in OI2).
FT                                /FTId=VAR_063333.
FT   VARIANT    1055   1055       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063334.
FT   VARIANT    1058   1058       G -> S (in OI3 and OI4; mild form).
FT                                {ECO:0000269|PubMed:16705691,
FT                                ECO:0000269|PubMed:9101304}.
FT                                /FTId=VAR_001709.
FT   VARIANT    1061   1061       G -> D (in OI2).
FT                                /FTId=VAR_001710.
FT   VARIANT    1061   1061       G -> S (in OI4).
FT                                {ECO:0000269|PubMed:7982948}.
FT                                /FTId=VAR_001711.
FT   VARIANT    1066   1066       R -> C (probable disease-associated
FT                                mutation found in a patient with
FT                                overlapping features of osteogenesis
FT                                imperfecta and Ehlers-Danlos syndrome;
FT                                affects dimer formation, helix stability
FT                                and organization of collagen fibrils).
FT                                {ECO:0000269|PubMed:17206620}.
FT                                /FTId=VAR_063335.
FT   VARIANT    1075   1075       T -> A (in dbSNP:rs1800215).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18272325,
FT                                ECO:0000269|PubMed:1870989,
FT                                ECO:0000269|PubMed:18996919,
FT                                ECO:0000269|PubMed:1995349,
FT                                ECO:0000269|PubMed:6689127,
FT                                ECO:0000269|PubMed:9443882,
FT                                ECO:0000269|Ref.1, ECO:0000269|Ref.24,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_001712.
FT   VARIANT    1076   1076       G -> S (in OI3; severe form).
FT                                {ECO:0000269|PubMed:9101304}.
FT                                /FTId=VAR_001713.
FT   VARIANT    1079   1079       G -> S (in OI1 and OI2; mild to moderate
FT                                form). {ECO:0000269|PubMed:1634225}.
FT                                /FTId=VAR_001714.
FT   VARIANT    1082   1082       G -> C (in OI2).
FT                                {ECO:0000269|PubMed:2913053}.
FT                                /FTId=VAR_001715.
FT   VARIANT    1088   1088       G -> A (in OI2).
FT                                {ECO:0000269|PubMed:7679635}.
FT                                /FTId=VAR_001716.
FT   VARIANT    1088   1088       G -> E (in OI1; de novo mutation; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:24682174}.
FT                                /FTId=VAR_074159.
FT   VARIANT    1091   1091       G -> S (in OI2). {ECO:0000269|Ref.50}.
FT                                /FTId=VAR_001717.
FT   VARIANT    1093   1093       R -> C (found in a patient with isolated
FT                                osteopenia and vascular rupture; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:17211858}.
FT                                /FTId=VAR_063336.
FT   VARIANT    1094   1094       G -> S (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063337.
FT   VARIANT    1100   1100       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_001718.
FT   VARIANT    1106   1106       G -> A (in OI2).
FT                                {ECO:0000269|PubMed:2777764}.
FT                                /FTId=VAR_001719.
FT   VARIANT    1124   1124       G -> C (in OI2).
FT                                {ECO:0000269|PubMed:7961597}.
FT                                /FTId=VAR_001720.
FT   VARIANT    1141   1141       R -> Q (in dbSNP:rs41316713).
FT                                {ECO:0000269|PubMed:18272325}.
FT                                /FTId=VAR_033778.
FT   VARIANT    1142   1142       G -> S (in OI2).
FT                                /FTId=VAR_001721.
FT   VARIANT    1151   1151       G -> S (in OI3).
FT                                /FTId=VAR_001722.
FT   VARIANT    1151   1151       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:1613761,
FT                                ECO:0000269|PubMed:2777764}.
FT                                /FTId=VAR_001723.
FT   VARIANT    1154   1154       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:2777764}.
FT                                /FTId=VAR_001724.
FT   VARIANT    1157   1157       G -> D (in OI1).
FT                                {ECO:0000269|PubMed:16638323}.
FT                                /FTId=VAR_063338.
FT   VARIANT    1166   1166       G -> C (in OI2).
FT                                {ECO:0000269|PubMed:3016737}.
FT                                /FTId=VAR_001725.
FT   VARIANT    1172   1172       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:10627137}.
FT                                /FTId=VAR_001726.
FT   VARIANT    1177   1177       V -> I (in dbSNP:rs41316719).
FT                                {ECO:0000269|PubMed:18272325}.
FT                                /FTId=VAR_033779.
FT   VARIANT    1181   1181       G -> S (in OI2).
FT                                {ECO:0000269|PubMed:2037280,
FT                                ECO:0000269|Ref.50}.
FT                                /FTId=VAR_001727.
FT   VARIANT    1184   1184       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:1613761,
FT                                ECO:0000269|PubMed:2777764}.
FT                                /FTId=VAR_001728.
FT   VARIANT    1187   1187       G -> S (in OI2 and OI3; extremely severe
FT                                form). {ECO:0000269|Ref.50}.
FT                                /FTId=VAR_001729.
FT   VARIANT    1187   1187       G -> V (in OI2). {ECO:0000269|Ref.50}.
FT                                /FTId=VAR_001730.
FT   VARIANT    1195   1195       G -> C (in OI1; mild form).
FT                                {ECO:0000269|PubMed:3170557,
FT                                ECO:0000269|PubMed:3244312}.
FT                                /FTId=VAR_001731.
FT   VARIANT    1219   1219       D -> E (in OI1).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063339.
FT   VARIANT    1219   1219       D -> N (found in a patient with mild
FT                                osteogenesis imperfecta associated with
FT                                increased bone mineral density; results
FT                                in defective type I procollagen
FT                                processing; incorporation of the immature
FT                                procollagen into the matrix leads to
FT                                increased bone matrix mineralization and
FT                                altered collagen fibril structure).
FT                                {ECO:0000269|PubMed:21344539}.
FT                                /FTId=VAR_066385.
FT   VARIANT    1251   1251       S -> T (in dbSNP:rs3205325).
FT                                {ECO:0000269|PubMed:8349697}.
FT                                /FTId=VAR_030014.
FT   VARIANT    1277   1277       D -> H (in OI2; impaired pro-alpha chain
FT                                association).
FT                                {ECO:0000269|PubMed:8349697}.
FT                                /FTId=VAR_001732.
FT   VARIANT    1312   1312       W -> C (in OI2).
FT                                {ECO:0000269|PubMed:8456808}.
FT                                /FTId=VAR_001733.
FT   VARIANT    1337   1338       Missing (in OI2; impaired pro-alpha chain
FT                                association).
FT                                {ECO:0000269|PubMed:8349697}.
FT                                /FTId=VAR_001734.
FT   VARIANT    1356   1356       R -> H. {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063340.
FT   VARIANT    1388   1388       L -> R (in OI2; impaired pro-alpha chain
FT                                association).
FT                                {ECO:0000269|PubMed:8349697}.
FT                                /FTId=VAR_001735.
FT   VARIANT    1391   1391       Q -> K (in dbSNP:rs2586486).
FT                                {ECO:0000269|PubMed:3340531,
FT                                ECO:0000269|PubMed:9443882,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_030015.
FT   VARIANT    1413   1413       D -> N (in OI2).
FT                                {ECO:0000269|PubMed:16786509,
FT                                ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063341.
FT   VARIANT    1430   1430       K -> N (in dbSNP:rs1059454).
FT                                /FTId=VAR_033780.
FT   VARIANT    1431   1431       T -> P (in dbSNP:rs1059454).
FT                                /FTId=VAR_033781.
FT   VARIANT    1434   1434       T -> S (in dbSNP:rs1800220).
FT                                {ECO:0000269|PubMed:8349697,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_001736.
FT   VARIANT    1438   1438       P -> R (in dbSNP:rs17857117).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030016.
FT   VARIANT    1460   1460       P -> H (in dbSNP:rs17853657).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030017.
FT   VARIANT    1464   1464       L -> P (in OI3).
FT                                {ECO:0000269|PubMed:8723681}.
FT                                /FTId=VAR_001737.
FT   CONFLICT     59     59       R -> Q (in Ref. 8; CAA25394).
FT                                {ECO:0000305}.
FT   CONFLICT    112    114       Missing (in Ref. 2; AAB94054).
FT                                {ECO:0000305}.
FT   CONFLICT    288    288       E -> P (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    370    370       R -> L (in Ref. 6; AAB59373).
FT                                {ECO:0000305}.
FT   CONFLICT    484    484       P -> L (in Ref. 19; AAA52289).
FT                                {ECO:0000305}.
FT   CONFLICT    595    595       A -> R (in Ref. 20; AAA51847).
FT                                {ECO:0000305}.
FT   CONFLICT    721    721       Q -> E (in Ref. 22; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    738    738       L -> E (in Ref. 22; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    975    976       LP -> PL (in Ref. 19; AAA52291).
FT                                {ECO:0000305}.
FT   CONFLICT   1081   1081       V -> A (in Ref. 18; AAA51995).
FT                                {ECO:0000305}.
FT   CONFLICT   1329   1329       S -> T (in Ref. 25; AAB27856).
FT                                {ECO:0000305}.
FT   STRAND      264    266       {ECO:0000244|PDB:3GXE}.
FT   STRAND      966    968       {ECO:0000244|PDB:3EJH}.
FT   HELIX      1227   1246       {ECO:0000244|PDB:5K31}.
FT   STRAND     1251   1254       {ECO:0000244|PDB:5K31}.
FT   HELIX      1259   1265       {ECO:0000244|PDB:5K31}.
FT   STRAND     1271   1276       {ECO:0000244|PDB:5K31}.
FT   HELIX      1283   1285       {ECO:0000244|PDB:5K31}.
FT   STRAND     1287   1292       {ECO:0000244|PDB:5K31}.
FT   TURN       1293   1296       {ECO:0000244|PDB:5K31}.
FT   STRAND     1297   1300       {ECO:0000244|PDB:5K31}.
FT   STRAND     1306   1310       {ECO:0000244|PDB:5K31}.
FT   HELIX      1326   1329       {ECO:0000244|PDB:5K31}.
FT   HELIX      1345   1357       {ECO:0000244|PDB:5K31}.
FT   STRAND     1362   1372       {ECO:0000244|PDB:5K31}.
FT   TURN       1379   1382       {ECO:0000244|PDB:5K31}.
FT   STRAND     1389   1391       {ECO:0000244|PDB:5K31}.
FT   STRAND     1397   1403       {ECO:0000244|PDB:5K31}.
FT   STRAND     1409   1413       {ECO:0000244|PDB:5K31}.
FT   STRAND     1420   1432       {ECO:0000244|PDB:5K31}.
FT   HELIX      1434   1436       {ECO:0000244|PDB:5K31}.
FT   STRAND     1441   1443       {ECO:0000244|PDB:5K31}.
FT   STRAND     1453   1463       {ECO:0000244|PDB:5K31}.
SQ   SEQUENCE   1464 AA;  138941 MW;  F0EC4DE778FFFC11 CRC64;
     MFSFVDLRLL LLLAATALLT HGQEEGQVEG QDEDIPPITC VQNGLRYHDR DVWKPEPCRI
     CVCDNGKVLC DDVICDETKN CPGAEVPEGE CCPVCPDGSE SPTDQETTGV EGPKGDTGPR
     GPRGPAGPPG RDGIPGQPGL PGPPGPPGPP GPPGLGGNFA PQLSYGYDEK STGGISVPGP
     MGPSGPRGLP GPPGAPGPQG FQGPPGEPGE PGASGPMGPR GPPGPPGKNG DDGEAGKPGR
     PGERGPPGPQ GARGLPGTAG LPGMKGHRGF SGLDGAKGDA GPAGPKGEPG SPGENGAPGQ
     MGPRGLPGER GRPGAPGPAG ARGNDGATGA AGPPGPTGPA GPPGFPGAVG AKGEAGPQGP
     RGSEGPQGVR GEPGPPGPAG AAGPAGNPGA DGQPGAKGAN GAPGIAGAPG FPGARGPSGP
     QGPGGPPGPK GNSGEPGAPG SKGDTGAKGE PGPVGVQGPP GPAGEEGKRG ARGEPGPTGL
     PGPPGERGGP GSRGFPGADG VAGPKGPAGE RGSPGPAGPK GSPGEAGRPG EAGLPGAKGL
     TGSPGSPGPD GKTGPPGPAG QDGRPGPPGP PGARGQAGVM GFPGPKGAAG EPGKAGERGV
     PGPPGAVGPA GKDGEAGAQG PPGPAGPAGE RGEQGPAGSP GFQGLPGPAG PPGEAGKPGE
     QGVPGDLGAP GPSGARGERG FPGERGVQGP PGPAGPRGAN GAPGNDGAKG DAGAPGAPGS
     QGAPGLQGMP GERGAAGLPG PKGDRGDAGP KGADGSPGKD GVRGLTGPIG PPGPAGAPGD
     KGESGPSGPA GPTGARGAPG DRGEPGPPGP AGFAGPPGAD GQPGAKGEPG DAGAKGDAGP
     PGPAGPAGPP GPIGNVGAPG AKGARGSAGP PGATGFPGAA GRVGPPGPSG NAGPPGPPGP
     AGKEGGKGPR GETGPAGRPG EVGPPGPPGP AGEKGSPGAD GPAGAPGTPG PQGIAGQRGV
     VGLPGQRGER GFPGLPGPSG EPGKQGPSGA SGERGPPGPM GPPGLAGPPG ESGREGAPGA
     EGSPGRDGSP GAKGDRGETG PAGPPGAPGA PGAPGPVGPA GKSGDRGETG PAGPTGPVGP
     VGARGPAGPQ GPRGDKGETG EQGDRGIKGH RGFSGLQGPP GPPGSPGEQG PSGASGPAGP
     RGPPGSAGAP GKDGLNGLPG PIGPPGPRGR TGDAGPVGPP GPPGPPGPPG PPSAGFDFSF
     LPQPPQEKAH DGGRYYRADD ANVVRDRDLE VDTTLKSLSQ QIENIRSPEG SRKNPARTCR
     DLKMCHSDWK SGEYWIDPNQ GCNLDAIKVF CNMETGETCV YPTQPSVAQK NWYISKNPKD
     KRHVWFGESM TDGFQFEYGG QGSDPADVAI QLTFLRLMST EASQNITYHC KNSVAYMDQQ
     TGNLKKALLL QGSNEIEIRA EGNSRFTYSV TVDGCTSHTG AWGKTVIEYK TTKTSRLPII
     DVAPLDVGAP DQEFGFDVGP VCFL
//
ID   CO2A1_HUMAN             Reviewed;        1487 AA.
AC   P02458; A6NGA0; Q12985; Q14009; Q14044; Q14045; Q14046; Q14047;
AC   Q14056; Q14058; Q16672; Q1JQ82; Q2V4X7; Q6LBY1; Q6LBY2; Q6LBY3;
AC   Q96IT5; Q99227; Q9UE38; Q9UE39; Q9UE40; Q9UE41; Q9UE42; Q9UE43;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-FEB-2018, entry version 218.
DE   RecName: Full=Collagen alpha-1(II) chain {ECO:0000305};
DE   AltName: Full=Alpha-1 type II collagen {ECO:0000305};
DE   Contains:
DE     RecName: Full=Collagen alpha-1(II) chain {ECO:0000305};
DE   Contains:
DE     RecName: Full=Chondrocalcin {ECO:0000303|PubMed:3800925};
DE   Flags: Precursor;
GN   Name=COL2A1 {ECO:0000312|HGNC:HGNC:2200};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS SER-9 AND
RP   LEU-158.
RX   PubMed=2587267; DOI=10.1093/nar/17.22.9473;
RA   Su M.W., Lee B., Ramirez F., Machado M.A., Horton W.A.;
RT   "Nucleotide sequence of the full length cDNA encoding for human type
RT   II procollagen.";
RL   Nucleic Acids Res. 17:9473-9473(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2), AND VARIANT SER-9.
RC   TISSUE=Blood;
RX   PubMed=8948452; DOI=10.1042/bj3080923;
RA   Ala-Kokko L., Kvist A.-P., Metsaranta M., Kivirikko K.I.,
RA   de Crombrugghe B., Prockop D.J., Vuorio E.;
RT   "Conservation of the sizes of 53 introns and over 100 intronic
RT   sequences for the binding of common transcription factors in the human
RT   and mouse genes for type II procollagen (COL2A1).";
RL   Biochem. J. 308:923-929(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1109-1487 (ISOFORMS 1/2).
RC   TISSUE=Embryonic stem cell, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-1229 (ISOFORM 1), AND VARIANT SER-9.
RX   PubMed=2803268; DOI=10.1042/bj2620521;
RA   Baldwin C.T., Reginato A.M., Smith C., Jimenez S.A., Prockop D.J.;
RT   "Structure of cDNA clones coding for human type II procollagen. The
RT   alpha 1(II) chain is more similar to the alpha 1(I) chain than two
RT   other alpha chains of fibrillar collagens.";
RL   Biochem. J. 262:521-528(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-236 (ISOFORM 1), AND VARIANT
RP   SER-9.
RX   PubMed=2714801; DOI=10.1016/0888-7543(89)90353-4;
RA   Su M.W., Benson-Chanda V., Vissing H., Ramirez F.;
RT   "Organization of the exons coding for pro alpha 1(II) collagen N-
RT   propeptide confirms a distinct evolutionary history of this domain of
RT   the fibrillar collagen genes.";
RL   Genomics 4:438-441(1989).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-103 (ISOFORM 2), AND VARIANT
RP   SER-9.
RX   PubMed=2081599; DOI=10.1016/0888-7543(90)90224-I;
RA   Ryan M.C., Sieraski M., Sandell L.J.;
RT   "The human type II procollagen gene: identification of an additional
RT   protein-coding domain and location of potential regulatory sequences
RT   in the promoter and first intron.";
RL   Genomics 8:41-48(1990).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-28 (ISOFORMS 1/2).
RX   PubMed=3021582; DOI=10.1016/0378-1119(86)90037-5;
RA   Nunez A.M., Kohno K., Martin G.R., Yamada Y.;
RT   "Promoter region of the human pro-alpha 1(II)-collagen gene.";
RL   Gene 44:11-16(1986).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-28 (ISOFORMS 1/2).
RX   PubMed=1637314; DOI=10.1042/bj2850287;
RA   Vikkula M., Metsaranta M., Syvaenen A.-C., Ala-Kokko L., Vuorio E.,
RA   Peltonen L.;
RT   "Structural analysis of the regulatory elements of the type-II
RT   procollagen gene. Conservation of promoter and first intron sequences
RT   between human and mouse.";
RL   Biochem. J. 285:287-294(1992).
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 27-103 (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=2355003;
RA   Ryan M.C., Sandell L.J.;
RT   "Differential expression of a cysteine-rich domain in the amino-
RT   terminal propeptide of type II (cartilage) procollagen by alternative
RT   splicing of mRNA.";
RL   J. Biol. Chem. 265:10334-10339(1990).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 99-341 (ISOFORMS 1/2).
RC   TISSUE=Fetal sternum;
RX   PubMed=1999183; DOI=10.1111/j.1432-1033.1991.tb15742.x;
RA   Huang M.C., Seyer J.M., Thompson J.P., Spinella D.G., Cheah K.S.,
RA   Kang A.H.;
RT   "Genomic organization of the human procollagen alpha 1(II) collagen
RT   gene.";
RL   Eur. J. Biochem. 195:593-600(1991).
RN   [13]
RP   PROTEIN SEQUENCE OF 188-195 AND 1224-1236.
RX   PubMed=8660302; DOI=10.1042/bj3140327;
RA   Diab M., Wu J.J., Eyre D.R.;
RT   "Collagen type IX from human cartilage: a structural profile of
RT   intermolecular cross-linking sites.";
RL   Biochem. J. 314:327-332(1996).
RN   [14]
RP   PROTEIN SEQUENCE OF 243-261; 575-590 AND 756-779.
RX   PubMed=8529631; DOI=10.1111/j.1432-1033.1995.125_c.x;
RA   Franc S., Marzin E., Boutillon M.-M., Lafont R.,
RA   Lechene de la Porte P., Herbage D.;
RT   "Immunohistochemical and biochemical analyses of 20,000-25,000-year-
RT   old fossil cartilage.";
RL   Eur. J. Biochem. 234:125-131(1995).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 440-509 (ISOFORMS 1/2).
RX   PubMed=7847372;
RA   Tiller G.E., Weis M.A., Polumbo P.A., Gruber H.E., Rimoin D.L.,
RA   Cohn D.H., Eyre D.R.;
RT   "An RNA-splicing mutation (G+5IVS20) in the type II collagen gene
RT   (COL2A1) in a family with spondyloepiphyseal dysplasia congenita.";
RL   Am. J. Hum. Genet. 56:388-395(1995).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 501-1214 (ISOFORMS 1/2).
RA   Ramirez F.;
RL   Submitted (DEC-1988) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 541-578; 784-803; 1056-1109 AND
RP   1200-1487 (ISOFORMS 1/2).
RX   PubMed=2987845; DOI=10.1093/nar/13.7.2207;
RA   Sangiorgi F.O., Benson-Chanda V., de Wet W.J., Sobel M.E.,
RA   Tsipouras P., Ramirez F.;
RT   "Isolation and partial characterization of the entire human pro alpha
RT   1(II) collagen gene.";
RL   Nucleic Acids Res. 13:2207-2225(1985).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 630-785 (ISOFORMS 1/2).
RX   PubMed=2753125; DOI=10.1016/0014-5793(89)80713-6;
RA   Vikkula M., Peltonen L.;
RT   "Structural analyses of the polymorphic area in type II collagen
RT   gene.";
RL   FEBS Lett. 250:171-174(1989).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1032-1487 (ISOFORMS 1/2).
RX   PubMed=3857598; DOI=10.1073/pnas.82.9.2555;
RA   Cheah K.S.E., Stoker N.G., Griffin J.R., Grosveld F.G., Solomon E.;
RT   "Identification and characterization of the human type II collagen
RT   gene (COL2A1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:2555-2559(1985).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1038-1055 (ISOFORMS 1/2), AND
RP   VARIANT HYPOCHONDROGENESIS GLU-1053.
RX   PubMed=1429602;
RA   Bogaert R., Tiller G.E., Wies M.A., Gruber H.E., Rimoin D.L.,
RA   Cohn D.H., Eyre D.R.;
RT   "An amino acid substitution (Gly853-->Glu) in the collagen alpha 1(II)
RT   chain produces hypochondrogenesis.";
RL   J. Biol. Chem. 267:22522-22526(1992).
RN   [21]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1082-1288 (ISOFORMS 1/2).
RX   PubMed=1905723;
RA   Chan D., Cole W.G.;
RT   "Low basal transcription of genes for tissue-specific collagens by
RT   fibroblasts and lymphoblastoid cells. Application to the
RT   characterization of a glycine 997 to serine substitution in alpha
RT   1(II) collagen chains of a patient with spondyloepiphyseal
RT   dysplasia.";
RL   J. Biol. Chem. 266:12487-12494(1991).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1146-1199 (ISOFORMS 1/2), AND
RP   VARIANT SEDC 1164-GLY--TYR-1399 DEL.
RX   PubMed=2543071; DOI=10.1126/science.2543071;
RA   Lee B., Vissing H., Ramirez F., Rogers D., Rimoin D.L.;
RT   "Identification of the molecular defect in a family with
RT   spondyloepiphyseal dysplasia.";
RL   Science 244:978-980(1989).
RN   [23]
RP   NUCLEOTIDE SEQUENCE OF 1164-1199 (ISOFORMS 1/2), AND VARIANT SEDC
RP   GLY-PRO-SER-GLY-LYS-ASP-GLY-ALA-ASN-GLY-ILE-PRO-GLY-PRO-ILE-1184 INS.
RX   PubMed=2339128; DOI=10.1073/pnas.87.10.3889;
RA   Tiller G.E., Rimoin D.L., Murray L.W., Cohn D.H.;
RT   "Tandem duplication within a type II collagen gene (COL2A1) exon in an
RT   individual with spondyloepiphyseal dysplasia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:3889-3893(1990).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1175-1487 (ISOFORMS 1/2).
RX   PubMed=2825137; DOI=10.1093/nar/15.22.9499;
RA   Elima K., Vuorio T., Vuorio E.;
RT   "Determination of the single polyadenylation site of the human pro
RT   alpha 1(II) collagen gene.";
RL   Nucleic Acids Res. 15:9499-9504(1987).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1189-1467 (ISOFORMS 1/2).
RX   PubMed=3840017; DOI=10.1042/bj2290183;
RA   Elima K., Maekelae J.K., Vuorio T., Kauppinen S., Knowles J.,
RA   Vuorio E.;
RT   "Construction and identification of a cDNA clone for human type II
RT   procollagen mRNA.";
RL   Biochem. J. 229:183-188(1985).
RN   [26]
RP   PROTEIN SEQUENCE OF 1242-1265; 1295-1305 AND 1395-1408.
RX   PubMed=3800925;
RA   Van der Rest M., Rosenberg L.C., Olsen B.R., Poole A.R.;
RT   "Chondrocalcin is identical with the C-propeptide of type II
RT   procollagen.";
RL   Biochem. J. 237:923-925(1986).
RN   [27]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1245-1295 (ISOFORMS 1/2/3).
RX   PubMed=6320112; DOI=10.1093/nar/12.2.1025;
RA   Strom C.M., Upholt W.B.;
RT   "Isolation and characterization of genomic clones corresponding to the
RT   human type II procollagen gene.";
RL   Nucleic Acids Res. 12:1025-1038(1984).
RN   [28]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1296-1358 (ISOFORMS 1/2/3).
RX   PubMed=3002437; DOI=10.1021/bi00344a004;
RA   Nunez A.M., Francomano C., Young M.F., Martin G.R., Yamada Y.;
RT   "Isolation and partial characterization of genomic clones coding for a
RT   human pro-alpha 1 (II) collagen chain and demonstration of restriction
RT   fragment length polymorphism at the 3' end of the gene.";
RL   Biochemistry 24:6343-6348(1985).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1238-1247.
RX   PubMed=9354468; DOI=10.1016/S1074-7613(00)80369-6;
RA   Dessen A., Lawrence C.M., Cupo S., Zaller D.M., Wiley D.C.;
RT   "X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed
RT   with a peptide from human collagen II.";
RL   Immunity 7:473-481(1997).
RN   [30]
RP   STRUCTURE BY NMR OF 25-162 (ISOFORM 2), AND DISULFIDE BONDS.
RX   PubMed=15466413; DOI=10.1074/jbc.M409225200;
RA   O'Leary J.M., Hamilton J.M., Deane C.M., Valeyev N.V., Sandell L.J.,
RA   Downing A.K.;
RT   "Solution structure and dynamics of a prototypical chordin-like
RT   cysteine-rich repeat (von Willebrand Factor type C module) from
RT   collagen IIA.";
RL   J. Biol. Chem. 279:53857-53866(2004).
RN   [31]
RP   INVOLVEMENT IN SEDSTN, AND VARIANT SEDSTN ARG-207.
RX   PubMed=26183434; DOI=10.1002/humu.22839;
RA   Jurgens J., Sobreira N., Modaff P., Reiser C.A., Seo S.H., Seong M.W.,
RA   Park S.S., Kim O.H., Cho T.J., Pauli R.M.;
RT   "Novel COL2A1 variant (c.619G>A, p.Gly207Arg) manifesting as a
RT   phenotype similar to progressive pseudorheumatoid dysplasia and
RT   spondyloepiphyseal dysplasia, Stanescu type.";
RL   Hum. Mutat. 36:1004-1008(2015).
RN   [32]
RP   REVIEW ON VARIANTS.
RX   PubMed=2010058;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in collagen genes: causes of rare and some common diseases
RT   in humans.";
RL   FASEB J. 5:2052-2060(1991).
RN   [33]
RP   REVIEW ON VARIANTS.
RX   PubMed=9101290;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in fibrillar collagens (types I, II, III, and XI), fibril-
RT   associated collagen (type IX), and network-forming collagen (type X)
RT   cause a spectrum of diseases of bone, cartilage, and blood vessels.";
RL   Hum. Mutat. 9:300-315(1997).
RN   [34]
RP   VARIANT ACG2 SER-1143.
RX   PubMed=2572591;
RA   Vissing H., D'Alessio M., Lee B., Ramirez F., Godfrey M.,
RA   Hollister D.W.;
RT   "Glycine to serine substitution in the triple helical domain of pro-
RT   alpha 1 (II) collagen results in a lethal perinatal form of short-
RT   limbed dwarfism.";
RL   J. Biol. Chem. 264:18265-18267(1989).
RN   [35]
RP   VARIANT OSCDP CYS-719.
RX   PubMed=1975693; DOI=10.1073/pnas.87.17.6565;
RA   Ala-Kokko L., Baldwin C.T., Moskowitz R.W., Prockop D.J.;
RT   "Single base mutation in the type II procollagen gene (COL2A1) as a
RT   cause of primary osteoarthritis associated with a mild
RT   chondrodysplasia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:6565-6568(1990).
RN   [36]
RP   VARIANT OSCDP CYS-719.
RX   PubMed=1985108; DOI=10.1172/JCI114994;
RA   Eyre D.R., Weis M.A., Moskowitz R.W.;
RT   "Cartilage expression of a type II collagen mutation in an inherited
RT   form of osteoarthritis associated with a mild chondrodysplasia.";
RL   J. Clin. Invest. 87:357-361(1991).
RN   [37]
RP   VARIANT HYPOCHONDROGENESIS SER-774.
RX   PubMed=1374906; DOI=10.1073/pnas.89.10.4583;
RA   Horton W.A., Machado M.A., Ellard J., Campbell D., Bartley J.,
RA   Ramirez F., Vitale E., Lee B.;
RT   "Characterization of a type II collagen gene (COL2A1) mutation
RT   identified in cultured chondrocytes from human hypochondrogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:4583-4587(1992).
RN   [38]
RP   VARIANT STL1O ASP-267.
RX   PubMed=8317498;
RA   Koerkkoe J., Ritvaniemi P., Haataja L., Kaeaeriaeinen H.,
RA   Kivirikko K.I., Prockop D.J., Ala-Kokko L.;
RT   "Mutation in type II procollagen (COL2A1) that substitutes aspartate
RT   for glycine alpha 1-67 and that causes cataracts and retinal
RT   detachment: evidence for molecular heterogeneity in the Wagner
RT   syndrome and the Stickler syndrome (arthro-ophthalmopathy).";
RL   Am. J. Hum. Genet. 53:55-61(1993).
RN   [39]
RP   VARIANTS SEMDSTWK VAL-897 AND CYS-909.
RA   Tiller G.E., Weis M.A., Lachman R.S., Cohn D.H., Rimoin D.L.,
RA   Eyre D.R.;
RT   "A dominant mutation in the type II collagen gene (COL2A1) produces
RT   spondyloepimetaphyseal dysplasia (SEMD), Strudwick type.";
RL   Am. J. Hum. Genet. 53:A209-A209(1993).
RN   [40]
RP   VARIANT OSCDP CYS-719.
RX   PubMed=8507190; DOI=10.1006/bbrc.1993.1539;
RA   Holderbaum D., Malemud C.J., Moskowitz R.W., Haqqi T.M.;
RT   "Human cartilage from late stage familial osteoarthritis transcribes
RT   type II collagen mRNA encoding a cysteine in position 519.";
RL   Biochem. Biophys. Res. Commun. 192:1169-1174(1993).
RN   [41]
RP   VARIANT SPONDYLOMETAPHYSEAL DYSPLASIA ARG-354.
RX   PubMed=8486375; DOI=10.1006/geno.1993.1179;
RA   Vikkula M., Ritvaniemi P., Vuorio A.F., Kaitila I., Ala-Kokko L.,
RA   Peltonen L.;
RT   "A mutation in the amino-terminal end of the triple helix of type II
RT   collagen causing severe osteochondrodysplasia.";
RL   Genomics 16:282-285(1993).
RN   [42]
RP   VARIANT CZECHD CYS-275.
RX   PubMed=8244341; DOI=10.1007/BF00216458;
RA   Williams C.J., Considine E.L., Knowlton R.G., Reginato A., Neumann G.,
RA   Harrison D., Buxton P., Jimenez S.A., Prockop D.J.;
RT   "Spondyloepiphyseal dysplasia and precocious osteoarthritis in a
RT   family with an Arg75-->Cys mutation in the procollagen type II gene
RT   (COL2A1).";
RL   Hum. Genet. 92:499-505(1993).
RN   [43]
RP   VARIANT SEDC CYS-989.
RX   PubMed=8325895;
RA   Chan D., Taylor T.K.F., Cole W.G.;
RT   "Characterization of an arginine 789 to cysteine substitution in alpha
RT   1 (II) collagen chains of a patient with spondyloepiphyseal
RT   dysplasia.";
RL   J. Biol. Chem. 268:15238-15245(1993).
RN   [44]
RP   VARIANT SEDC SER-1197.
RX   PubMed=8423604; DOI=10.1136/jmg.30.1.27;
RA   Cole W.G., Hall R.K., Rogers J.G.;
RT   "The clinical features of spondyloepiphyseal dysplasia congenita
RT   resulting from the substitution of glycine 997 by serine in the alpha
RT   1(II) chain of type II collagen.";
RL   J. Med. Genet. 30:27-35(1993).
RN   [45]
RP   VARIANT STL1 302-ALA--LYS-308 DEL.
RX   PubMed=7977371;
RA   Bogaert R., Wilkin D.J., Wilcox W.R., Lachman R.S., Rimoin D.L.,
RA   Cohn D.H., Eyre D.R.;
RT   "Expression, in cartilage, of a 7-amino-acid deletion in type II
RT   collagen from two unrelated individuals with Kniest dysplasia.";
RL   Am. J. Hum. Genet. 55:1128-1136(1994).
RN   [46]
RP   VARIANT KD ASP-303.
RX   PubMed=7874117; DOI=10.1093/hmg/3.11.1999;
RA   Wilkin D.J., Bogaert R., Lachman R.S., Rimoin D.L., Eyres D.R.,
RA   Cohn D.H.;
RT   "A single amino acid substitution (G103D) in the type II collagen
RT   triple helix produces Kniest dysplasia.";
RL   Hum. Mol. Genet. 3:1999-2003(1994).
RN   [47]
RP   VARIANT SEDC SER-447.
RX   PubMed=8019561; DOI=10.1002/humu.1380030314;
RA   Ritvaniemi P., Sokolov B.P., Williams C.J., Considine W., Yurgenev L.,
RA   Meerson E.M., Ala-Kokko L., Prockop D.J.;
RT   "A single base mutation in the type II procollagen gene (COL2A1) that
RT   converts glycine alpha 1-247 to serine in a family with late-onset
RT   spondyloepiphyseal dysplasia.";
RL   Hum. Mutat. 3:261-267(1994).
RN   [48]
RP   VARIANT ACG2 ARG-891.
RX   PubMed=7757081; DOI=10.1093/hmg/4.2.285;
RA   Mortier G.R., Wilkin D.J., Wilcox W.R., Rimoin D.L., Lachman R.S.,
RA   Eyre D.R., Cohn D.H.;
RT   "A radiographic, morphologic, biochemical and molecular analysis of a
RT   case of achondrogenesis type II resulting from substitution for a
RT   glycine residue (Gly691-->Arg) in the type II collagen trimer.";
RL   Hum. Mol. Genet. 4:285-288(1995).
RN   [49]
RP   VARIANT CZECHD CYS-275, VARIANT SEDC SER-1176, VARIANT OSCDP CYS-719,
RP   VARIANT HYPOCHONDROGENESIS ARG-891, AND VARIANT ACG2 ARG-1188.
RX   PubMed=7757086; DOI=10.1093/hmg/4.2.309;
RA   Williams C.J., Rock M., Considine E.L., McCarron S., Gow P., Ladda R.,
RA   McLain D., Michels V.M., Murphy W., Prockop D.J., Ganguly A.;
RT   "Three new point mutations in type II procollagen (COL2A1) and
RT   identification of a fourth family with the COL2A1 Arg519-->Cys base
RT   substitution using conformation sensitive gel electrophoresis.";
RL   Hum. Mol. Genet. 4:309-312(1995).
RN   [50]
RP   VARIANT ACG2 SER-969.
RX   PubMed=7829510; DOI=10.1074/jbc.270.44.26292;
RA   Chan D., Cole W.G., Chow C.W., Mundlos S., Bateman J.F.;
RT   "A COL2A1 mutation in achondrogenesis type II results in the
RT   replacement of type II collagen by type I and III collagens in
RT   cartilage.";
RL   J. Biol. Chem. 270:1747-1753(1995).
RN   [51]
RP   VARIANTS SEMDSTWK VAL-492; CYS-504 AND CYS-909.
RX   PubMed=7550321; DOI=10.1038/ng0995-87;
RA   Tiller G.E., Polumbo P.A., Weis M.A., Bogaert R., Lachman R.S.,
RA   Cohn D.H., Rimoin D.L., Eyre D.R.;
RT   "Dominant mutations in the type II collagen gene, COL2A1, produce
RT   spondyloepimetaphyseal dysplasia, Strudwick type.";
RL   Nat. Genet. 11:87-89(1995).
RN   [52]
RP   VARIANT HYPOCHONDROGENESIS CYS-1113.
RX   PubMed=8723098;
RX   DOI=10.1002/(SICI)1096-8628(19960503)63:1<129::AID-AJMG23>3.0.CO;2-P;
RA   Mundlos S., Chan D., McGill J., Bateman J.F.;
RT   "An alpha 1(II) Gly913 to Cys substitution prevents the matrix
RT   incorporation of type II collagen which is replaced with type I and
RT   III collagens in cartilage from a patient with hypochondrogenesis.";
RL   Am. J. Med. Genet. 63:129-136(1996).
RN   [53]
RP   VARIANT KD 1207-PRO--GLY-1212 DEL.
RX   PubMed=8863156; DOI=10.1136/jmg.33.8.649;
RA   Winterpacht A., Superti-Furga A., Schwarze U., Stoess H.,
RA   Steinmann B., Spranger J., Zabel B.;
RT   "The deletion of six amino acids at the C-terminus of the alpha 1 (II)
RT   chain causes overmodification of type II and type XI collagen: further
RT   evidence for the association between small deletions in COL2A1 and
RT   Kniest dysplasia.";
RL   J. Med. Genet. 33:649-654(1996).
RN   [54]
RP   VARIANT EDMMD CYS-904.
RX   PubMed=9800905;
RX   DOI=10.1002/(SICI)1096-8628(19981102)80:1<6::AID-AJMG2>3.0.CO;2-0;
RA   Ballo R., Beighton P.H., Ramesar R.S.;
RT   "Stickler-like syndrome due to a dominant negative mutation in the
RT   COL2A1 gene.";
RL   Am. J. Med. Genet. 80:6-11(1998).
RN   [55]
RP   VARIANT SPONDYLOEPIPHYSEAL DYSPLASIA CYS-719.
RX   PubMed=9711874;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:3<172::AID-HUMU4>3.0.CO;2-J;
RA   Bleasel J.F., Holderbaum D., Brancolini V., Moskowitz R.W.,
RA   Considine E.L., Prockop D.J., Devoto M., Williams C.J.;
RT   "Five families with arginine 519-cysteine mutation in COL2A1: evidence
RT   for three distinct founders.";
RL   Hum. Mutat. 12:172-176(1998).
RN   [56]
RP   VARIANT STL1 CYS-565, AND VARIANT DRRD PHE-667.
RX   PubMed=11007540; DOI=10.1086/321189;
RA   Richards A.J., Baguley D.M., Yates J.R.W., Lane C., Nicol M.,
RA   Harper P.S., Scott J.D., Snead M.P.;
RT   "Variation in the vitreous phenotype of Stickler syndrome can be
RT   caused by different amino acid substitutions in the X position of the
RT   type II collagen Gly-X-Y triple helix.";
RL   Am. J. Hum. Genet. 67:1083-1094(2000).
RN   [57]
RP   VARIANT SEDC ARG-1173.
RX   PubMed=10678662;
RX   DOI=10.1002/(SICI)1096-8628(20000131)90:3<239::AID-AJMG10>3.3.CO;2-F;
RA   Sobetzko D., Eich G., Kalff-Suske M., Grzeschik K.-H.,
RA   Superti-Furga A.;
RT   "Boy with syndactylies, macrocephaly, and severe skeletal dysplasia:
RT   not a new syndrome, but two dominant mutations (GLI3 E543X and COL2A1
RT   G973R) in the same individual.";
RL   Am. J. Med. Genet. 90:239-242(2000).
RN   [58]
RP   VARIANTS ACG2 VAL-453; ASP-453; ASP-771; ARG-780; ARG-795; GLU-894;
RP   ASP-948; SER-981; VAL-1065 AND ARG-1119, VARIANT HYPOCHONDROGENESIS
RP   1017-GLY--VAL-1022 DEL, AND VARIANT ILE-1331.
RX   PubMed=10797431;
RX   DOI=10.1002/(SICI)1096-8628(20000515)92:2<95::AID-AJMG3>3.0.CO;2-9;
RA   Koerkkoe J., Cohn D.H., Ala-Kokko L., Krakow D., Prockop D.J.;
RT   "Widely distributed mutations in the COL2A1 gene produce
RT   achondrogenesis type II/hypochondrogenesis.";
RL   Am. J. Med. Genet. 92:95-100(2000).
RN   [59]
RP   VARIANTS ACG2 SER-513; VAL-717; ALA-771; CYS-1110 AND SER-1143, AND
RP   VARIANT PLSD-T ASN-1390.
RX   PubMed=10745044; DOI=10.1136/jmg.37.4.263;
RA   Mortier G.R., Weis M., Nuytinck L., King L.M., Wilkin D.J.,
RA   De Paepe A., Lachman R.S., Rimoin D.L., Eyre D.R., Cohn D.H.;
RT   "Report of five novel and one recurrent COL2A1 mutations with analysis
RT   of genotype-phenotype correlation in patients with a lethal type II
RT   collagen disorder.";
RL   J. Med. Genet. 37:263-271(2000).
RN   [60]
RP   VARIANT SEDC MET-1439.
RX   PubMed=11746045; DOI=10.1002/ajmg.10062;
RA   Unger S., Koerkkoe J., Krakow D., Lachman R.S., Rimoin D.L.,
RA   Cohn D.H.;
RT   "Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal
RT   dysplasia congenita.";
RL   Am. J. Med. Genet. 104:140-146(2001).
RN   [61]
RP   VARIANT VITREORETINOPATHY ASP-1305.
RX   PubMed=12205109; DOI=10.1136/jmg.39.9.661;
RA   Richards A.J., Morgan J., Bearcroft P.W.P., Pickering E., Owen M.J.,
RA   Holmans P., Williams N., Tysoe C., Pope F.M., Snead M.P., Hughes H.;
RT   "Vitreoretinopathy with phalangeal epiphyseal dysplasia, a type II
RT   collagenopathy resulting from a novel mutation in the C-propeptide
RT   region of the molecule.";
RL   J. Med. Genet. 39:661-665(2002).
RN   [62]
RP   VARIANT ACG2 ASP-516.
RX   PubMed=15054848; DOI=10.1002/ajmg.a.20597;
RA   Faivre L., Le Merrer M., Douvier S., Laurent N., Thauvin-Robinet C.,
RA   Rousseau T., Vereecke I., Sagot P., Delezoide A.-L., Coucke P.,
RA   Mortier G.;
RT   "Recurrence of achondrogenesis type II within the same family:
RT   evidence for germline mosaicism.";
RL   Am. J. Med. Genet. A 126:308-312(2004).
RN   [63]
RP   INVOLVEMENT IN SPONDYLOPERIPHERAL DYSPLASIA.
RX   PubMed=15316962; DOI=10.1002/ajmg.a.30222;
RA   Zankl A., Zabel B., Hilbert K., Wildhardt G., Cuenot S., Xavier B.,
RA   Ha-Vinh R., Bonafe L., Spranger J., Superti-Furga A.;
RT   "Spondyloperipheral dysplasia is caused by truncating mutations in the
RT   C-propeptide of COL2A1.";
RL   Am. J. Med. Genet. A 129:144-148(2004).
RN   [64]
RP   VARIANT PLSD-T CYS-1391.
RX   PubMed=14729840; DOI=10.1136/jmg.2003.013722;
RA   Nishimura G., Nakashima E., Mabuchi A., Shimamoto K., Shimamoto T.,
RA   Shimao Y., Nagai T., Yamaguchi T., Kosaki R., Ohashi H., Makita Y.,
RA   Ikegawa S.;
RT   "Identification of COL2A1 mutations in platyspondylic skeletal
RT   dysplasia, Torrance type.";
RL   J. Med. Genet. 41:75-79(2004).
RN   [65]
RP   VARIANTS PLSD-T PRO-1448; HIS-1469; VAL-1484 DEL AND GLY-1485, AND
RP   DISCUSSION OF VARIANT ASN-1390.
RX   PubMed=15643621; DOI=10.1002/ajmg.a.30531;
RA   Zankl A., Neumann L., Ignatius J., Nikkels P., Schrander-Stumpel C.,
RA   Mortier G., Omran H., Wright M., Hilbert K., Bonafe L., Spranger J.,
RA   Zabel B., Superti-Furga A.;
RT   "Dominant negative mutations in the C-propeptide of COL2A1 cause
RT   platyspondylic lethal skeletal dysplasia, torrance type, and define a
RT   novel subfamily within the type 2 collagenopathies.";
RL   Am. J. Med. Genet. A 133:61-67(2005).
RN   [66]
RP   VARIANT SEMDSTWK GLY-992.
RX   PubMed=16088915; DOI=10.1002/ajmg.a.30881;
RA   Sulko J., Czarny-Ratajczak M., Wozniak A., Latos-Bielenska A.,
RA   Kozlowski K.;
RT   "Novel amino acid substitution in the Y-position of collagen type II
RT   causes spondyloepimetaphyseal dysplasia congenita.";
RL   Am. J. Med. Genet. A 137:292-297(2005).
RN   [67]
RP   VARIANTS DRRD ARG-318 AND PHE-667.
RX   PubMed=15671297; DOI=10.1167/iovs.04-1017;
RA   Richards A.J., Meredith S., Poulson A., Bearcroft P., Crossland G.,
RA   Baguley D.M., Scott J.D., Snead M.P.;
RT   "A novel mutation of COL2A1 resulting in dominantly inherited
RT   rhegmatogenous retinal detachment.";
RL   Invest. Ophthalmol. Vis. Sci. 46:663-668(2005).
RN   [68]
RP   VARIANTS ANFH1 SER-717 AND SER-1170.
RX   PubMed=15930420; DOI=10.1056/NEJMoa042480;
RA   Liu Y.-F., Chen W.-M., Lin Y.-F., Yang R.-C., Lin M.-W., Li L.-H.,
RA   Chang Y.-H., Jou Y.-S., Lin P.-Y., Su J.-S., Huang S.-F., Hsiao K.-J.,
RA   Fann C.S.J., Hwang H.-W., Chen Y.-T., Tsai S.-F.;
RT   "Type II collagen gene variants and inherited osteonecrosis of the
RT   femoral head.";
RL   N. Engl. J. Med. 352:2294-2301(2005).
RN   [69]
RP   INVOLVEMENT IN STL1O.
RX   PubMed=16752401; DOI=10.1002/humu.20347;
RA   Richards A.J., Laidlaw M., Whittaker J., Treacy B., Rai H.,
RA   Bearcroft P., Baguley D.M., Poulson A., Ang A., Scott J.D.,
RA   Snead M.P.;
RT   "High efficiency of mutation detection in type 1 stickler syndrome
RT   using a two-stage approach: vitreoretinal assessment coupled with exon
RT   sequencing for screening COL2A1.";
RL   Hum. Mutat. 27:696-704(2006).
RN   [70]
RP   VARIANT ACG2 VAL-547.
RX   PubMed=17994563; DOI=10.1002/ajmg.a.32047;
RA   Forzano F., Lituania M., Viassolo A., Superti-Furga V., Wildhardt G.,
RA   Zabel B., Faravelli F.;
RT   "A familial case of achondrogenesis type II caused by a dominant
RT   COL2A1 mutation and 'patchy' expression in the mosaic father.";
RL   Am. J. Med. Genet. A 143:2815-2820(2007).
RN   [71]
RP   VARIANT LCPD SER-1170.
RX   PubMed=17394019; DOI=10.1007/s00439-007-0354-y;
RA   Miyamoto Y., Matsuda T., Kitoh H., Haga N., Ohashi H., Nishimura G.,
RA   Ikegawa S.;
RT   "A recurrent mutation in type II collagen gene causes Legg-Calve-
RT   Perthes disease in a Japanese family.";
RL   Hum. Genet. 121:625-629(2007).
RN   [72]
RP   VARIANT CZECHD CYS-275.
RX   PubMed=18553548; DOI=10.1002/ajmg.a.32389;
RA   Tzschach A., Tinschert S., Kaminsky E., Lusga E., Mundlos S.,
RA   Graul-Neumann L.M.;
RT   "Czech dysplasia: report of a large family and further delineation of
RT   the phenotype.";
RL   Am. J. Med. Genet. A 146:1859-1864(2008).
RN   [73]
RP   VARIANTS SER-9; ASP-142; ILE-638; THR-1051; ILE-1331 AND SER-1405.
RX   PubMed=18272325; DOI=10.1016/j.ygeno.2007.12.008;
RA   Chan T.F., Poon A., Basu A., Addleman N.R., Chen J., Phong A.,
RA   Byers P.H., Klein T.E., Kwok P.Y.;
RT   "Natural variation in four human collagen genes across an ethnically
RT   diverse population.";
RL   Genomics 91:307-314(2008).
RN   [74]
RP   VARIANT STL1O TYR-57.
RX   PubMed=17721977; DOI=10.1002/humu.20603;
RA   McAlinden A., Majava M., Bishop P.N., Perveen R., Black G.C.M.,
RA   Pierpont M.E., Ala-Kokko L., Maennikkoe M.;
RT   "Missense and nonsense mutations in the alternatively-spliced exon 2
RT   of COL2A1 cause the ocular variant of Stickler syndrome.";
RL   Hum. Mutat. 29:83-90(2008).
RN   [75]
RP   VARIANT CZECHD CYS-275.
RX   PubMed=19764028; DOI=10.1002/ajmg.a.33010;
RA   Matsui Y., Michigami T., Tachikawa K., Yamazaki M., Kawabata H.,
RA   Nishimura G.;
RT   "Czech dysplasia occurring in a Japanese family.";
RL   Am. J. Med. Genet. A 149:2285-2289(2009).
RN   [76]
RP   VARIANTS STL1 ASP-240; ARG-270; ASP-282; ALA-453; ARG-501; CYS-904 AND
RP   ALA-1158.
RX   PubMed=20513134; DOI=10.1002/humu.21257;
RA   Richards A.J., McNinch A., Martin H., Oakhill K., Rai H., Waller S.,
RA   Treacy B., Whittaker J., Meredith S., Poulson A., Snead M.P.;
RT   "Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and
RT   COL11A1.";
RL   Hum. Mutat. 31:E1461-E1471(2010).
RN   [77]
RP   VARIANT ANFH1 MET-1383.
RX   PubMed=21671384; DOI=10.1002/ajmg.a.34056;
RA   Kannu P., O'Rielly D.D., Hyland J.C., Kokko L.A.;
RT   "Avascular necrosis of the femoral head due to a novel C propeptide
RT   mutation in COL2A1.";
RL   Am. J. Med. Genet. A 155A:1759-1762(2011).
RN   [78]
RP   VARIANTS VAL-1176 AND ARG-1179.
RX   PubMed=21922596; DOI=10.1002/humu.21611;
RA   Jackson G.C., Mittaz-Crettol L., Taylor J.A., Mortier G.R.,
RA   Spranger J., Zabel B., Le Merrer M., Cormier-Daire V., Hall C.M.,
RA   Offiah A., Wright M.J., Savarirayan R., Nishimura G., Ramsden S.C.,
RA   Elles R., Bonafe L., Superti-Furga A., Unger S., Zankl A.,
RA   Briggs M.D.;
RT   "Pseudoachondroplasia and multiple epiphyseal dysplasia: A 7-year
RT   comprehensive analysis of the known disease genes identify novel and
RT   recurrent mutations and provides an accurate assessment of their
RT   relative contribution.";
RL   Hum. Mutat. 33:144-157(2012).
RN   [79]
RP   VARIANT CYS-1459.
RX   PubMed=28887846; DOI=10.1002/humu.23335;
RA   Zhou X.L., He L.X., Yu L.J., Wang Y., Wang X.J., Wang E.D., Yang T.;
RT   "Mutations in KARS cause early-onset hearing loss and
RT   leukoencephalopathy: Potential pathogenic mechanism.";
RL   Hum. Mutat. 38:1740-1750(2017).
CC   -!- FUNCTION: Type II collagen is specific for cartilaginous tissues.
CC       It is essential for the normal embryonic development of the
CC       skeleton, for linear growth and for the ability of cartilage to
CC       resist compressive forces.
CC   -!- SUBUNIT: Homotrimers of alpha 1(II) chains.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=2;
CC         IsoId=P02458-2; Sequence=Displayed;
CC       Name=1;
CC         IsoId=P02458-1; Sequence=VSP_022366;
CC       Name=3;
CC         IsoId=P02458-3; Sequence=VSP_022365;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is highly expressed in juvenile
CC       chondrocyte and low in fetal chondrocyte.
CC       {ECO:0000269|PubMed:2355003}.
CC   -!- DOMAIN: The C-terminal propeptide, also known as COLFI domain,
CC       have crucial roles in tissue growth and repair by controlling both
CC       the intracellular assembly of procollagen molecules and the
CC       extracellular assembly of collagen fibrils. It binds a calcium ion
CC       which is essential for its function (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: The N-telopeptide is covalently linked to the helical COL2
CC       region of alpha 1(IX), alpha 2(IX) and alpha 3(IX) chain. The C-
CC       telopeptide is covalently linked to an another site in the helical
CC       region of alpha 3(IX) COL2.
CC   -!- PTM: Contains mostly 4-hydroxyproline. Prolines at the third
CC       position of the tripeptide repeating unit (G-X-P) are 4-
CC       hydroxylated in some or all of the chains.
CC       {ECO:0000250|UniProtKB:P05539}.
CC   -!- PTM: Contains 3-hydroxyproline at a few sites. This modification
CC       occurs on the first proline residue in the sequence motif Gly-Pro-
CC       Hyp, where Hyp is 4-hydroxyproline.
CC       {ECO:0000250|UniProtKB:P05539}.
CC   -!- PTM: Lysine residues at the third position of the tripeptide
CC       repeating unit (G-X-Y) are 5-hydroxylated in some or all of the
CC       chains. {ECO:0000250|UniProtKB:P05539}.
CC   -!- PTM: O-glycosylated on hydroxylated lysine residues. The O-linked
CC       glycan consists of a Glc-Gal disaccharide.
CC       {ECO:0000250|UniProtKB:P05539}.
CC   -!- DISEASE: Spondyloepiphyseal dysplasia congenital type (SEDC)
CC       [MIM:183900]: Disorder characterized by disproportionate short
CC       stature and pleiotropic involvement of the skeletal and ocular
CC       systems. {ECO:0000269|PubMed:10678662,
CC       ECO:0000269|PubMed:11746045, ECO:0000269|PubMed:2339128,
CC       ECO:0000269|PubMed:2543071, ECO:0000269|PubMed:7757086,
CC       ECO:0000269|PubMed:8019561, ECO:0000269|PubMed:8325895,
CC       ECO:0000269|PubMed:8423604}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Spondyloepiphyseal dysplasia, Stanescu type (SEDSTN)
CC       [MIM:616583]: An autosomal dominant spondyloepiphyseal dysplasia
CC       characterized by glycoproteins accumulation in chondrocytes.
CC       Clinical features include progressive joint contractures,
CC       premature degenerative joint disease particularly in the knee, hip
CC       and finger joints, and osseous distention of the metaphyseal ends
CC       of the phalanges causing swolling of interphalangeal joints of the
CC       hands. Radiological features include generalized platyspondyly,
CC       hypoplastic pelvis, epiphyseal flattening with metaphyseal
CC       splaying of the long bones, and enlarged phalangeal epimetaphyses
CC       of the hands. {ECO:0000269|PubMed:26183434}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Spondyloepimetaphyseal dysplasia, Strudwick type
CC       (SEMDSTWK) [MIM:184250]: A bone disease characterized by
CC       disproportionate short stature from birth, with a very short trunk
CC       and shortened limbs, and skeletal abnormalities including
CC       lordosis, scoliosis, flattened vertebrae, pectus carinatum, coxa
CC       vara, clubfoot, and abnormal epiphyses or metaphyses. A
CC       distinctive radiographic feature is irregular sclerotic changes,
CC       described as dappled in the metaphyses of the long bones.
CC       {ECO:0000269|PubMed:16088915, ECO:0000269|PubMed:7550321,
CC       ECO:0000269|Ref.39}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Achondrogenesis 2 (ACG2) [MIM:200610]: A disease
CC       characterized by the absence of ossification in the vertebral
CC       column, sacrum and pubic bones. {ECO:0000269|PubMed:10745044,
CC       ECO:0000269|PubMed:10797431, ECO:0000269|PubMed:15054848,
CC       ECO:0000269|PubMed:17994563, ECO:0000269|PubMed:2572591,
CC       ECO:0000269|PubMed:7757081, ECO:0000269|PubMed:7757086,
CC       ECO:0000269|PubMed:7829510}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Legg-Calve-Perthes disease (LCPD) [MIM:150600]:
CC       Characterized by loss of circulation to the femoral head,
CC       resulting in avascular necrosis in a growing child. Clinical
CC       pictures of the disease vary, depending on the phase of disease
CC       progression through ischemia, revascularization, fracture and
CC       collapse, and repair and remodeling of the bone.
CC       {ECO:0000269|PubMed:17394019}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Kniest dysplasia (KD) [MIM:156550]: Moderately severe
CC       chondrodysplasia phenotype that results from mutations in the
CC       COL2A1 gene. Characteristics of the disorder include a short trunk
CC       and extremities, mid-face hypoplasia, cleft palate, myopia,
CC       retinal detachment, and hearing loss. {ECO:0000269|PubMed:7874117,
CC       ECO:0000269|PubMed:8863156}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Avascular necrosis of femoral head, primary, 1 (ANFH1)
CC       [MIM:608805]: A disease characterized by mechanical failure of the
CC       subchondral bone, and degeneration of the hip joint. It usually
CC       leads to destruction of the hip joint in the third to fifth decade
CC       of life. The clinical manifestations, such as pain on exertion, a
CC       limping gait, and a discrepancy in leg length, cause considerable
CC       disability. ANFH1 inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:15930420, ECO:0000269|PubMed:21671384}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Osteoarthritis with mild chondrodysplasia (OSCDP)
CC       [MIM:604864]: Osteoarthritis is a common disease that produces
CC       joint pain and stiffness together with radiologic evidence of
CC       progressive degeneration of joint cartilage.
CC       {ECO:0000269|PubMed:1975693, ECO:0000269|PubMed:1985108,
CC       ECO:0000269|PubMed:7757086, ECO:0000269|PubMed:8507190}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Platyspondylic lethal skeletal dysplasia Torrance type
CC       (PLSD-T) [MIM:151210]: Platyspondylic lethal skeletal dysplasias
CC       (PLSDs) are a heterogeneous group of chondrodysplasias
CC       characterized by severe platyspondyly and limb shortening. PLSD-T
CC       is characterized by varying platyspondyly, short ribs with
CC       anterior cupping, hypoplasia of the lower ilia with broad ischial
CC       and pubic bones, and shortening of the tubular bones with splayed
CC       and cupped metaphyses. Histology of the growth plate typically
CC       shows focal hypercellularity with slightly enlarged chondrocytes
CC       in the resting cartilage and relatively well-preserved columnar
CC       formation and ossification at the chondro-osseous junction. PLSD-T
CC       is generally a perinatally lethal disease, but a few long-term
CC       survivors have been reported. {ECO:0000269|PubMed:10745044,
CC       ECO:0000269|PubMed:14729840, ECO:0000269|PubMed:15643621}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Multiple epiphyseal dysplasia with myopia and conductive
CC       deafness (EDMMD) [MIM:132450]: A generalized skeletal dysplasia
CC       associated with significant morbidity. Joint pain, joint
CC       deformity, waddling gait, and short stature are the main clinical
CC       signs and symptoms. EDMMD is an autosomal dominant disorder
CC       characterized by epiphyseal dysplasia associated with progressive
CC       myopia, retinal thinning, crenated cataracts, conductive deafness.
CC       {ECO:0000269|PubMed:9800905}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Spondyloperipheral dysplasia (SPD) [MIM:271700]: SPD
CC       patients manifest short stature, midface hypoplasia, sensorineural
CC       hearing loss, spondyloepiphyseal dysplasia, platyspondyly and
CC       brachydactyly. {ECO:0000269|PubMed:15316962}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Stickler syndrome 1 (STL1) [MIM:108300]: An autosomal
CC       dominant form of Stickler syndrome, an inherited disorder that
CC       associates ocular signs with more or less complete forms of Pierre
CC       Robin sequence, bone disorders and sensorineural deafness. Ocular
CC       disorders may include juvenile cataract, myopia, strabismus,
CC       vitreoretinal or chorioretinal degeneration, retinal detachment,
CC       and chronic uveitis. Pierre Robin sequence includes an opening in
CC       the roof of the mouth (a cleft palate), a large tongue
CC       (macroglossia), and a small lower jaw (micrognathia). Bones are
CC       affected by slight platyspondylisis and large, often defective
CC       epiphyses. Juvenile joint laxity is followed by early signs of
CC       arthrosis. The degree of hearing loss varies among affected
CC       individuals and may become more severe over time. Syndrome
CC       expressivity is variable. {ECO:0000269|PubMed:11007540,
CC       ECO:0000269|PubMed:20513134, ECO:0000269|PubMed:7977371}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Stickler syndrome 1 non-syndromic ocular (STL1O)
CC       [MIM:609508]: An autosomal dominant form of Stickler syndrome
CC       characterized by the ocular signs typically seen in Stickler
CC       syndrome type 1 such as cataract, myopia, retinal detachment.
CC       Systemic features of premature osteoarthritis, cleft palate,
CC       hearing impairment, and craniofacial abnormalities are either
CC       absent or very mild. {ECO:0000269|PubMed:16752401,
CC       ECO:0000269|PubMed:17721977, ECO:0000269|PubMed:8317498}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Rhegmatogenous retinal detachment autosomal dominant
CC       (DRRD) [MIM:609508]: A eye disease that most frequently results
CC       from a break or tear in the retina that allows fluid from the
CC       vitreous humor to enter the potential space beneath the retina. It
CC       is often associated with pathologic myopia and in most cases leads
CC       to visual impairment or blindness if untreated.
CC       {ECO:0000269|PubMed:11007540, ECO:0000269|PubMed:15671297}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Czech dysplasia (CZECHD) [MIM:609162]: A skeletal
CC       dysplasia characterized by early-onset, progressive
CC       pseudorheumatoid arthritis, platyspondyly, and short third and
CC       fourth toes. {ECO:0000269|PubMed:18553548,
CC       ECO:0000269|PubMed:19764028, ECO:0000269|PubMed:7757086,
CC       ECO:0000269|PubMed:8244341}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the fibrillar collagen family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH07252.1; Type=Frameshift; Positions=1198; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16468; CAA34488.1; -; mRNA.
DR   EMBL; L10347; AAC41772.1; -; Genomic_DNA.
DR   EMBL; BT007205; AAP35869.1; -; mRNA.
DR   EMBL; AC004801; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007252; AAH07252.1; ALT_FRAME; mRNA.
DR   EMBL; BC116449; AAI16450.1; -; mRNA.
DR   EMBL; X16711; CAA34683.1; -; mRNA.
DR   EMBL; M25730; AAA58428.2; -; Genomic_DNA.
DR   EMBL; M32168; AAA58428.2; JOINED; Genomic_DNA.
DR   EMBL; M25655; AAA58428.2; JOINED; Genomic_DNA.
DR   EMBL; M25656; AAA58428.2; JOINED; Genomic_DNA.
DR   EMBL; M64345; AAA58428.2; JOINED; Genomic_DNA.
DR   EMBL; M60299; AAA73873.1; -; Genomic_DNA.
DR   EMBL; M25698; AAA52051.1; -; Genomic_DNA.
DR   EMBL; X58709; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X57010; CAA40330.1; -; Genomic_DNA.
DR   EMBL; U15195; AAB60370.1; -; Genomic_DNA.
DR   EMBL; X13783; CAA32030.1; -; mRNA.
DR   EMBL; M25728; AAD15287.1; -; Genomic_DNA.
DR   EMBL; X02371; CAA26223.1; -; Genomic_DNA.
DR   EMBL; X02372; CAA26223.1; JOINED; Genomic_DNA.
DR   EMBL; X02373; CAA26223.1; JOINED; Genomic_DNA.
DR   EMBL; X02374; CAA26223.1; JOINED; Genomic_DNA.
DR   EMBL; X02375; CAA26224.1; -; Genomic_DNA.
DR   EMBL; X02376; CAA26225.1; -; Genomic_DNA.
DR   EMBL; X02377; CAA26226.1; -; Genomic_DNA.
DR   EMBL; X02378; CAA26227.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34278.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34279.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34280.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34281.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34282.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34283.1; -; Genomic_DNA.
DR   EMBL; X16158; CAA34284.1; -; Genomic_DNA.
DR   EMBL; J00116; AAA51997.1; -; Genomic_DNA.
DR   EMBL; L00977; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M63281; AAA52038.1; -; mRNA.
DR   EMBL; M27468; AAA52039.1; -; Genomic_DNA.
DR   EMBL; X06268; CAA29604.1; -; mRNA.
DR   EMBL; X00339; CAA25092.1; -; Genomic_DNA.
DR   EMBL; M12048; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS41778.1; -. [P02458-2]
DR   CCDS; CCDS8759.1; -. [P02458-1]
DR   PIR; A38513; CGHU6C.
DR   RefSeq; NP_001835.3; NM_001844.4. [P02458-2]
DR   RefSeq; NP_149162.2; NM_033150.2. [P02458-1]
DR   UniGene; Hs.408182; -.
DR   PDB; 1U5M; NMR; -; A=29-97.
DR   PDB; 2FSE; X-ray; 3.10 A; E/F=461-474.
DR   PDB; 2SEB; X-ray; 2.50 A; E=1238-1247.
DR   PDB; 5NIR; X-ray; 1.74 A; A/B=29-98.
DR   PDBsum; 1U5M; -.
DR   PDBsum; 2FSE; -.
DR   PDBsum; 2SEB; -.
DR   PDBsum; 5NIR; -.
DR   DisProt; DP00274; -.
DR   ProteinModelPortal; P02458; -.
DR   SMR; P02458; -.
DR   BioGrid; 107677; 27.
DR   IntAct; P02458; 4.
DR   MINT; P02458; -.
DR   STRING; 9606.ENSP00000369889; -.
DR   ChEMBL; CHEMBL2364188; -.
DR   DrugBank; DB00048; Collagenase clostridium histolyticum.
DR   iPTMnet; P02458; -.
DR   PhosphoSitePlus; P02458; -.
DR   BioMuta; COL2A1; -.
DR   DMDM; 124056489; -.
DR   PaxDb; P02458; -.
DR   PeptideAtlas; P02458; -.
DR   PRIDE; P02458; -.
DR   DNASU; 1280; -.
DR   Ensembl; ENST00000337299; ENSP00000338213; ENSG00000139219. [P02458-1]
DR   Ensembl; ENST00000380518; ENSP00000369889; ENSG00000139219. [P02458-2]
DR   GeneID; 1280; -.
DR   KEGG; hsa:1280; -.
DR   UCSC; uc001rqu.4; human. [P02458-2]
DR   CTD; 1280; -.
DR   DisGeNET; 1280; -.
DR   EuPathDB; HostDB:ENSG00000139219.17; -.
DR   GeneCards; COL2A1; -.
DR   GeneReviews; COL2A1; -.
DR   HGNC; HGNC:2200; COL2A1.
DR   HPA; CAB002214; -.
DR   HPA; HPA055753; -.
DR   MalaCards; COL2A1; -.
DR   MIM; 108300; phenotype.
DR   MIM; 120140; gene+phenotype.
DR   MIM; 132450; phenotype.
DR   MIM; 150600; phenotype.
DR   MIM; 151210; phenotype.
DR   MIM; 156550; phenotype.
DR   MIM; 183900; phenotype.
DR   MIM; 184250; phenotype.
DR   MIM; 200610; phenotype.
DR   MIM; 271700; phenotype.
DR   MIM; 604864; phenotype.
DR   MIM; 608805; phenotype.
DR   MIM; 609162; phenotype.
DR   MIM; 609508; phenotype.
DR   MIM; 616583; phenotype.
DR   neXtProt; NX_P02458; -.
DR   OpenTargets; ENSG00000139219; -.
DR   Orphanet; 93296; Achondrogenesis type 2.
DR   Orphanet; 209867; Autosomal dominant rhegmatogenous retinal detachment.
DR   Orphanet; 137678; Czech dysplasia, metatarsal type.
DR   Orphanet; 85198; Dysspondyloenchondromatosis.
DR   Orphanet; 86820; Familial avascular necrosis of femoral head.
DR   Orphanet; 93297; Hypochondrogenesis.
DR   Orphanet; 485; Kniest dysplasia.
DR   Orphanet; 2380; Legg-Calve-Perthes disease.
DR   Orphanet; 93279; Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis.
DR   Orphanet; 166011; Multiple epiphyseal dysplasia, Beighton type.
DR   Orphanet; 85166; Platyspondylic dysplasia, Torrance type.
DR   Orphanet; 93346; Spondyloepimetaphyseal dysplasia congenita, Strudwick type.
DR   Orphanet; 94068; Spondyloepiphyseal dysplasia congenita.
DR   Orphanet; 93315; Spondylometaphyseal dysplasia, 'corner fracture' type.
DR   Orphanet; 93316; Spondylometaphyseal dysplasia, Schmidt type.
DR   Orphanet; 1856; Spondyloperipheral dysplasia - short ulna.
DR   Orphanet; 90653; Stickler syndrome type 1.
DR   Orphanet; 3450; Weissenbacher- Zweymuller syndrome.
DR   PharmGKB; PA26715; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   eggNOG; ENOG410XNMM; LUCA.
DR   GeneTree; ENSGT00900000140789; -.
DR   HOVERGEN; HBG004933; -.
DR   InParanoid; P02458; -.
DR   KO; K19719; -.
DR   OMA; PLQYMRA; -.
DR   OrthoDB; EOG091G03LV; -.
DR   PhylomeDB; P02458; -.
DR   TreeFam; TF344135; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1474244; Extracellular matrix organization.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-186797; Signaling by PDGF.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000171; Non-integrin membrane-ECM interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   Reactome; R-HSA-8874081; MET activates PTK2 signaling.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   SIGNOR; P02458; -.
DR   ChiTaRS; COL2A1; human.
DR   EvolutionaryTrace; P02458; -.
DR   GeneWiki; Collagen,_type_II,_alpha_1; -.
DR   GenomeRNAi; 1280; -.
DR   PMAP-CutDB; P02458; -.
DR   PRO; PR:P02458; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139219; -.
DR   Genevisible; P02458; HS.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0005585; C:collagen type II trimer; IDA:BHF-UCL.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0005576; C:extracellular region; IDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IMP:UniProtKB.
DR   GO; GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; IC:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; NAS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042289; F:MHC class II protein binding; IPI:CAFA.
DR   GO; GO:0048407; F:platelet-derived growth factor binding; IDA:MGI.
DR   GO; GO:0001502; P:cartilage condensation; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; TAS:BHF-UCL.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0030574; P:collagen catabolic process; TAS:Reactome.
DR   GO; GO:0030199; P:collagen fibril organization; IMP:BHF-UCL.
DR   GO; GO:0060272; P:embryonic skeletal joint morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0001958; P:endochondral ossification; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0003007; P:heart morphogenesis; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0060174; P:limb bud formation; IEA:Ensembl.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR   GO; GO:0030903; P:notochord development; IEA:Ensembl.
DR   GO; GO:0071599; P:otic vesicle development; IEA:Ensembl.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0006029; P:proteoglycan metabolic process; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:BHF-UCL.
DR   GO; GO:0001501; P:skeletal system development; IMP:BHF-UCL.
DR   GO; GO:0001894; P:tissue homeostasis; IEA:Ensembl.
DR   GO; GO:0007601; P:visual perception; IMP:UniProtKB.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR000885; Fib_collagen_C.
DR   InterPro; IPR001007; VWF_dom.
DR   Pfam; PF01410; COLFI; 1.
DR   Pfam; PF01391; Collagen; 6.
DR   Pfam; PF00093; VWC; 1.
DR   ProDom; PD002078; Fib_collagen_C; 1.
DR   SMART; SM00038; COLFI; 1.
DR   SMART; SM00214; VWC; 1.
DR   PROSITE; PS51461; NC1_FIB; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cataract; Collagen;
KW   Complete proteome; Deafness; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Dwarfism; Extracellular matrix;
KW   Glycoprotein; Hydroxylation; Metal-binding; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal; Stickler syndrome.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   PROPEP       26    181       N-terminal propeptide.
FT                                /FTId=PRO_0000005729.
FT   CHAIN       182   1241       Collagen alpha-1(II) chain.
FT                                /FTId=PRO_0000005730.
FT   CHAIN      1242   1487       Chondrocalcin.
FT                                /FTId=PRO_0000005731.
FT   DOMAIN       32     90       VWFC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00220}.
FT   DOMAIN     1253   1487       Fibrillar collagen NC1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   REGION      201   1214       Triple-helical region.
FT   REGION     1215   1241       Nonhelical region (C-terminal).
FT   METAL      1301   1301       Calcium. {ECO:0000250}.
FT   METAL      1303   1303       Calcium. {ECO:0000250}.
FT   METAL      1304   1304       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL      1306   1306       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL      1309   1309       Calcium. {ECO:0000250}.
FT   SITE        181    182       Cleavage; by procollagen N-endopeptidase.
FT                                {ECO:0000250}.
FT   SITE       1241   1242       Cleavage; by procollagen C-endopeptidase.
FT                                {ECO:0000250}.
FT   MOD_RES     190    190       5-hydroxylysine. {ECO:0000250}.
FT   MOD_RES     287    287       5-hydroxylysine. {ECO:0000250}.
FT   MOD_RES     299    299       5-hydroxylysine. {ECO:0000250}.
FT   MOD_RES     308    308       5-hydroxylysine. {ECO:0000250}.
FT   MOD_RES     374    374       5-hydroxylysine. {ECO:0000250}.
FT   MOD_RES     608    608       5-hydroxylysine. {ECO:0000250}.
FT   MOD_RES     620    620       5-hydroxylysine. {ECO:0000250}.
FT   MOD_RES     659    659       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES     668    668       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES     670    670       3-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES     671    671       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES     674    674       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES     907    907       3-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES     908    908       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES     914    914       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES     920    920       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES    1130   1130       5-hydroxylysine. {ECO:0000250}.
FT   MOD_RES    1144   1144       3-hydroxyproline. {ECO:0000250}.
FT   MOD_RES    1181   1181       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES    1186   1186       3-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES    1187   1187       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES    1201   1201       3-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES    1202   1202       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES    1205   1205       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES    1207   1207       3-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES    1208   1208       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES    1211   1211       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES    1213   1213       3-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   MOD_RES    1214   1214       4-hydroxyproline.
FT                                {ECO:0000250|UniProtKB:P05539}.
FT   CARBOHYD    190    190       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000250}.
FT   CARBOHYD    287    287       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000250}.
FT   CARBOHYD    299    299       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000250}.
FT   CARBOHYD    308    308       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000250}.
FT   CARBOHYD    374    374       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000250}.
FT   CARBOHYD    608    608       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000250}.
FT   CARBOHYD    620    620       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000250}.
FT   CARBOHYD   1130   1130       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000250}.
FT   CARBOHYD   1388   1388       N-linked (GlcNAc...) asparagine.
FT   DISULFID   1283   1315       {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   DISULFID   1289   1289       Interchain (with C-1306).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   DISULFID   1306   1306       Interchain (with C-1289).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   DISULFID   1323   1485       {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   DISULFID   1393   1438       {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   VAR_SEQ       1   1219       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_022365.
FT   VAR_SEQ      29     98       QEAGSCVQDGQRYNDKDVWKPEPCRICVCDTGTVLCDDIIC
FT                                EDVKDCLSPEIPFGECCPICPTDLATASG -> R (in
FT                                isoform 1). {ECO:0000303|PubMed:2587267,
FT                                ECO:0000303|PubMed:2803268}.
FT                                /FTId=VSP_022366.
FT   VARIANT       9      9       T -> S (in dbSNP:rs3803183).
FT                                {ECO:0000269|PubMed:18272325,
FT                                ECO:0000269|PubMed:2081599,
FT                                ECO:0000269|PubMed:2587267,
FT                                ECO:0000269|PubMed:2714801,
FT                                ECO:0000269|PubMed:2803268,
FT                                ECO:0000269|PubMed:8948452}.
FT                                /FTId=VAR_017638.
FT   VARIANT      57     57       C -> Y (in STL1O; dbSNP:rs121912898).
FT                                {ECO:0000269|PubMed:17721977}.
FT                                /FTId=VAR_063891.
FT   VARIANT     142    142       E -> D (in dbSNP:rs34392760).
FT                                {ECO:0000269|PubMed:18272325}.
FT                                /FTId=VAR_033782.
FT   VARIANT     158    158       P -> L (in dbSNP:rs1050861).
FT                                {ECO:0000269|PubMed:2587267}.
FT                                /FTId=VAR_019836.
FT   VARIANT     207    207       G -> R (in SEDSTN; dbSNP:rs869312907).
FT                                {ECO:0000269|PubMed:26183434}.
FT                                /FTId=VAR_075729.
FT   VARIANT     240    240       G -> D (in STL1).
FT                                {ECO:0000269|PubMed:20513134}.
FT                                /FTId=VAR_063892.
FT   VARIANT     267    267       G -> D (in STL1O; dbSNP:rs121912872).
FT                                {ECO:0000269|PubMed:8317498}.
FT                                /FTId=VAR_001738.
FT   VARIANT     270    270       G -> R (in STL1).
FT                                {ECO:0000269|PubMed:20513134}.
FT                                /FTId=VAR_063893.
FT   VARIANT     275    275       R -> C (in CZECHD; dbSNP:rs121912876).
FT                                {ECO:0000269|PubMed:18553548,
FT                                ECO:0000269|PubMed:19764028,
FT                                ECO:0000269|PubMed:7757086,
FT                                ECO:0000269|PubMed:8244341}.
FT                                /FTId=VAR_001739.
FT   VARIANT     282    282       G -> D (in STL1).
FT                                {ECO:0000269|PubMed:20513134}.
FT                                /FTId=VAR_063894.
FT   VARIANT     302    308       Missing (in STL1).
FT                                {ECO:0000269|PubMed:7977371}.
FT                                /FTId=VAR_001740.
FT   VARIANT     303    303       G -> D (in KD; abnormal allele expressed
FT                                in the cartilage; dbSNP:rs121912877).
FT                                {ECO:0000269|PubMed:7874117}.
FT                                /FTId=VAR_001741.
FT   VARIANT     318    318       G -> R (in DRRD; dbSNP:rs121912894).
FT                                {ECO:0000269|PubMed:15671297}.
FT                                /FTId=VAR_023925.
FT   VARIANT     354    354       G -> R (in spondylometaphyseal dysplasia;
FT                                congenital type; dbSNP:rs121912871).
FT                                {ECO:0000269|PubMed:8486375}.
FT                                /FTId=VAR_001742.
FT   VARIANT     375    375       G -> R (in SEDC).
FT                                /FTId=VAR_001743.
FT   VARIANT     447    447       G -> S (in SEDC).
FT                                {ECO:0000269|PubMed:8019561}.
FT                                /FTId=VAR_001744.
FT   VARIANT     453    453       G -> A (in STL1; dbSNP:rs794727339).
FT                                {ECO:0000269|PubMed:20513134}.
FT                                /FTId=VAR_063895.
FT   VARIANT     453    453       G -> D (in ACG2).
FT                                {ECO:0000269|PubMed:10797431}.
FT                                /FTId=VAR_017639.
FT   VARIANT     453    453       G -> V (in ACG2).
FT                                {ECO:0000269|PubMed:10797431}.
FT                                /FTId=VAR_017640.
FT   VARIANT     492    492       G -> V (in SEMDSTWK; dbSNP:rs121912881).
FT                                {ECO:0000269|PubMed:7550321}.
FT                                /FTId=VAR_001745.
FT   VARIANT     501    501       G -> R (in STL1).
FT                                {ECO:0000269|PubMed:20513134}.
FT                                /FTId=VAR_063896.
FT   VARIANT     504    504       G -> C (in SEMDSTWK; dbSNP:rs121912880).
FT                                {ECO:0000269|PubMed:7550321}.
FT                                /FTId=VAR_001746.
FT   VARIANT     510    510       G -> D (in ACG2).
FT                                /FTId=VAR_001747.
FT   VARIANT     513    513       G -> S (in ACG2).
FT                                {ECO:0000269|PubMed:10745044}.
FT                                /FTId=VAR_024819.
FT   VARIANT     516    516       G -> D (in ACG2; dbSNP:rs121912888).
FT                                {ECO:0000269|PubMed:15054848}.
FT                                /FTId=VAR_023926.
FT   VARIANT     547    547       D -> V (in ACG2).
FT                                {ECO:0000269|PubMed:17994563}.
FT                                /FTId=VAR_063897.
FT   VARIANT     565    565       R -> C (in STL1; dbSNP:rs121912884).
FT                                {ECO:0000269|PubMed:11007540}.
FT                                /FTId=VAR_023927.
FT   VARIANT     638    638       T -> I (in dbSNP:rs41263847).
FT                                {ECO:0000269|PubMed:18272325}.
FT                                /FTId=VAR_033783.
FT   VARIANT     667    667       L -> F (in DRRD; dbSNP:rs121912885).
FT                                {ECO:0000269|PubMed:11007540,
FT                                ECO:0000269|PubMed:15671297}.
FT                                /FTId=VAR_023928.
FT   VARIANT     717    717       G -> S (in ANFH1; dbSNP:rs387906558).
FT                                {ECO:0000269|PubMed:15930420}.
FT                                /FTId=VAR_023929.
FT   VARIANT     717    717       G -> V (in ACG2).
FT                                {ECO:0000269|PubMed:10745044}.
FT                                /FTId=VAR_024820.
FT   VARIANT     719    719       R -> C (in OSCDP; also in mild
FT                                spondyloepiphyseal dysplasia and
FT                                precocious osteoarthritis;
FT                                dbSNP:rs121912865).
FT                                {ECO:0000269|PubMed:1975693,
FT                                ECO:0000269|PubMed:1985108,
FT                                ECO:0000269|PubMed:7757086,
FT                                ECO:0000269|PubMed:8507190,
FT                                ECO:0000269|PubMed:9711874}.
FT                                /FTId=VAR_001748.
FT   VARIANT     771    771       G -> A (in ACG2).
FT                                {ECO:0000269|PubMed:10745044}.
FT                                /FTId=VAR_024821.
FT   VARIANT     771    771       G -> D (in ACG2).
FT                                {ECO:0000269|PubMed:10797431}.
FT                                /FTId=VAR_017641.
FT   VARIANT     774    774       G -> S (in SEDC and hypochondrogenesis;
FT                                lethal; dbSNP:rs121912867).
FT                                {ECO:0000269|PubMed:1374906}.
FT                                /FTId=VAR_001749.
FT   VARIANT     780    780       G -> R (in ACG2).
FT                                {ECO:0000269|PubMed:10797431}.
FT                                /FTId=VAR_017642.
FT   VARIANT     795    795       G -> R (in ACG2).
FT                                {ECO:0000269|PubMed:10797431}.
FT                                /FTId=VAR_017643.
FT   VARIANT     804    804       G -> A (in hypochondrogenesis).
FT                                /FTId=VAR_001751.
FT   VARIANT     855    855       G -> S (in SEDC).
FT                                /FTId=VAR_023930.
FT   VARIANT     891    891       G -> R (in ACG2 and SEDC;
FT                                dbSNP:rs121912879).
FT                                {ECO:0000269|PubMed:7757081,
FT                                ECO:0000269|PubMed:7757086}.
FT                                /FTId=VAR_001752.
FT   VARIANT     894    894       G -> E (in ACG2).
FT                                {ECO:0000269|PubMed:10797431}.
FT                                /FTId=VAR_017644.
FT   VARIANT     897    897       G -> V (in SEMDSTWK).
FT                                {ECO:0000269|Ref.39}.
FT                                /FTId=VAR_023931.
FT   VARIANT     904    904       R -> C (in EDMMD and STL1;
FT                                dbSNP:rs121912882).
FT                                {ECO:0000269|PubMed:20513134,
FT                                ECO:0000269|PubMed:9800905}.
FT                                /FTId=VAR_017645.
FT   VARIANT     909    909       G -> C (in SEMDSTWK; dbSNP:rs121912875).
FT                                {ECO:0000269|PubMed:7550321,
FT                                ECO:0000269|Ref.39}.
FT                                /FTId=VAR_001753.
FT   VARIANT     948    948       G -> D (in ACG2).
FT                                {ECO:0000269|PubMed:10797431}.
FT                                /FTId=VAR_017646.
FT   VARIANT     969    969       G -> S (in ACG2; dbSNP:rs121912878).
FT                                {ECO:0000269|PubMed:7829510}.
FT                                /FTId=VAR_001754.
FT   VARIANT     981    981       G -> S (in ACG2).
FT                                {ECO:0000269|PubMed:10797431}.
FT                                /FTId=VAR_017647.
FT   VARIANT     989    989       R -> C (in SEDC; dbSNP:rs121912874).
FT                                {ECO:0000269|PubMed:8325895}.
FT                                /FTId=VAR_001755.
FT   VARIANT     992    992       R -> G (in SEMDSTWK; dbSNP:rs121912895).
FT                                {ECO:0000269|PubMed:16088915}.
FT                                /FTId=VAR_023932.
FT   VARIANT    1005   1005       G -> S (in hypochondrogenesis;
FT                                dbSNP:rs753342774).
FT                                /FTId=VAR_001756.
FT   VARIANT    1017   1022       Missing (in hypochondrogenesis).
FT                                {ECO:0000269|PubMed:10797431}.
FT                                /FTId=VAR_017648.
FT   VARIANT    1017   1017       G -> V (in ACG2).
FT                                /FTId=VAR_001757.
FT   VARIANT    1051   1051       A -> T (in dbSNP:rs41272041).
FT                                {ECO:0000269|PubMed:18272325}.
FT                                /FTId=VAR_033784.
FT   VARIANT    1053   1053       G -> E (in hypochondrogenesis; lethal;
FT                                dbSNP:rs121912868).
FT                                {ECO:0000269|PubMed:1429602}.
FT                                /FTId=VAR_001758.
FT   VARIANT    1065   1065       G -> V (in ACG2).
FT                                {ECO:0000269|PubMed:10797431}.
FT                                /FTId=VAR_017649.
FT   VARIANT    1110   1110       G -> C (in ACG2).
FT                                {ECO:0000269|PubMed:10745044}.
FT                                /FTId=VAR_001759.
FT   VARIANT    1113   1113       G -> C (in hypochondrogenesis).
FT                                {ECO:0000269|PubMed:8723098}.
FT                                /FTId=VAR_001760.
FT   VARIANT    1119   1119       G -> R (in ACG2).
FT                                {ECO:0000269|PubMed:10797431}.
FT                                /FTId=VAR_017650.
FT   VARIANT    1143   1143       G -> S (in ACG2).
FT                                {ECO:0000269|PubMed:10745044,
FT                                ECO:0000269|PubMed:2572591}.
FT                                /FTId=VAR_001761.
FT   VARIANT    1158   1158       G -> A (in STL1).
FT                                {ECO:0000269|PubMed:20513134}.
FT                                /FTId=VAR_063898.
FT   VARIANT    1164   1199       Missing (in SEDC).
FT                                /FTId=VAR_001762.
FT   VARIANT    1170   1170       G -> S (in ANFH1 and LCPD;
FT                                dbSNP:rs121912891).
FT                                {ECO:0000269|PubMed:15930420,
FT                                ECO:0000269|PubMed:17394019}.
FT                                /FTId=VAR_023933.
FT   VARIANT    1173   1173       G -> R (in SEDC; dbSNP:rs121912883).
FT                                {ECO:0000269|PubMed:10678662}.
FT                                /FTId=VAR_017651.
FT   VARIANT    1176   1176       G -> S (in SEDC).
FT                                {ECO:0000269|PubMed:7757086}.
FT                                /FTId=VAR_001763.
FT   VARIANT    1176   1176       G -> V (mutation found in a patient with
FT                                features of multiple epiphyseal
FT                                dysplasia; features overlap with SEDC).
FT                                {ECO:0000269|PubMed:21922596}.
FT                                /FTId=VAR_066836.
FT   VARIANT    1179   1179       G -> R (mutation found in a patient with
FT                                features of multiple epiphyseal
FT                                dysplasia; features overlap with SEDC).
FT                                {ECO:0000269|PubMed:21922596}.
FT                                /FTId=VAR_066837.
FT   VARIANT    1184   1184       I -> IGPSGKDGANGIPGPI (in SEDC).
FT                                {ECO:0000269|PubMed:2339128}.
FT                                /FTId=VAR_019837.
FT   VARIANT    1188   1188       G -> R (in ACG2).
FT                                {ECO:0000269|PubMed:7757086}.
FT                                /FTId=VAR_001764.
FT   VARIANT    1197   1197       G -> S (in SEDC; dbSNP:rs121912870).
FT                                {ECO:0000269|PubMed:8423604}.
FT                                /FTId=VAR_001765.
FT   VARIANT    1207   1212       Missing (in KD).
FT                                {ECO:0000269|PubMed:8863156}.
FT                                /FTId=VAR_001766.
FT   VARIANT    1305   1305       G -> D (in vitreoretinopathy; with
FT                                phalangeal epiphyseal dysplasia;
FT                                dbSNP:rs121912887).
FT                                {ECO:0000269|PubMed:12205109}.
FT                                /FTId=VAR_023934.
FT   VARIANT    1331   1331       V -> I (in dbSNP:rs12721427).
FT                                {ECO:0000269|PubMed:10797431,
FT                                ECO:0000269|PubMed:18272325}.
FT                                /FTId=VAR_017652.
FT   VARIANT    1383   1383       T -> M (in ANFH1; dbSNP:rs138498898).
FT                                {ECO:0000269|PubMed:21671384}.
FT                                /FTId=VAR_075730.
FT   VARIANT    1390   1390       T -> N (in PLSD-T; phenotype previously
FT                                considered as achondrogenesis-
FT                                hypochondrogenesis type 2).
FT                                {ECO:0000269|PubMed:10745044,
FT                                ECO:0000269|PubMed:15643621}.
FT                                /FTId=VAR_024822.
FT   VARIANT    1391   1391       Y -> C (in PLSD-T; dbSNP:rs121912889).
FT                                {ECO:0000269|PubMed:14729840}.
FT                                /FTId=VAR_023935.
FT   VARIANT    1405   1405       G -> S (in dbSNP:rs2070739).
FT                                {ECO:0000269|PubMed:18272325}.
FT                                /FTId=VAR_033785.
FT   VARIANT    1439   1439       T -> M (in SEDC; dbSNP:rs121912886).
FT                                {ECO:0000269|PubMed:11746045}.
FT                                /FTId=VAR_017105.
FT   VARIANT    1448   1448       T -> P (in PLSD-T).
FT                                {ECO:0000269|PubMed:15643621}.
FT                                /FTId=VAR_024823.
FT   VARIANT    1459   1459       R -> C (in dbSNP:rs148838496).
FT                                {ECO:0000269|PubMed:28887846}.
FT                                /FTId=VAR_079748.
FT   VARIANT    1469   1469       D -> H (in PLSD-T).
FT                                {ECO:0000269|PubMed:15643621}.
FT                                /FTId=VAR_024824.
FT   VARIANT    1484   1484       Missing (in PLSD-T).
FT                                {ECO:0000269|PubMed:15643621}.
FT                                /FTId=VAR_024825.
FT   VARIANT    1485   1485       C -> G (in PLSD-T).
FT                                {ECO:0000269|PubMed:15643621}.
FT                                /FTId=VAR_024826.
FT   CONFLICT    441    441       G -> D (in Ref. 1; CAA34488).
FT                                {ECO:0000305}.
FT   CONFLICT    457    457       E -> K (in Ref. 1; CAA34488).
FT                                {ECO:0000305}.
FT   CONFLICT    481    481       A -> P (in Ref. 15; AAB60370).
FT                                {ECO:0000305}.
FT   CONFLICT    641    641       A -> E (in Ref. 1; CAA34488 and 16;
FT                                CAA32030). {ECO:0000305}.
FT   CONFLICT    677    677       G -> A (in Ref. 16; CAA32030).
FT                                {ECO:0000305}.
FT   CONFLICT    784    784       G -> A (in Ref. 16; CAA32030).
FT                                {ECO:0000305}.
FT   CONFLICT    832    835       PAGF -> TSGI (in Ref. 1; CAA34488).
FT                                {ECO:0000305}.
FT   CONFLICT   1006   1006       K -> Q (in Ref. 1; CAA34488 and 16;
FT                                CAA32030). {ECO:0000305}.
FT   CONFLICT   1037   1037       E -> Q (in Ref. 6; CAA34683).
FT                                {ECO:0000305}.
FT   CONFLICT   1057   1057       D -> N (in Ref. 17; AAD15287/CAA26223 and
FT                                19; AAA51997). {ECO:0000305}.
FT   CONFLICT   1069   1069       A -> T (in Ref. 6; CAA34683, 17;
FT                                AAD15287/CAA26223 and 19; AAA51997).
FT                                {ECO:0000305}.
FT   CONFLICT   1243   1243       Q -> E (in Ref. 24; CAA29604).
FT                                {ECO:0000305}.
FT   CONFLICT   1247   1247       G -> N (in Ref. 24; CAA29604).
FT                                {ECO:0000305}.
FT   CONFLICT   1271   1271       S -> T (in Ref. 21; AAA52038).
FT                                {ECO:0000305}.
FT   CONFLICT   1274   1274       G -> A (in Ref. 21; AAA52038).
FT                                {ECO:0000305}.
FT   CONFLICT   1333   1333       K -> R (in Ref. 28; M12048).
FT                                {ECO:0000305}.
FT   CONFLICT   1350   1350       G -> A (in Ref. 28; M12048).
FT                                {ECO:0000305}.
FT   CONFLICT   1372   1372       N -> D (in Ref. 17; CAA26223).
FT                                {ECO:0000305}.
FT   CONFLICT   1383   1383       T -> A (in Ref. 17; CAA26223).
FT                                {ECO:0000305}.
FT   CONFLICT   1400   1400       L -> M (in Ref. 17; CAA26223).
FT                                {ECO:0000305}.
FT   STRAND       34     36       {ECO:0000244|PDB:5NIR}.
FT   STRAND       39     41       {ECO:0000244|PDB:5NIR}.
FT   STRAND       46     50       {ECO:0000244|PDB:5NIR}.
FT   STRAND       53     58       {ECO:0000244|PDB:5NIR}.
FT   STRAND       61     70       {ECO:0000244|PDB:5NIR}.
FT   TURN         93     95       {ECO:0000244|PDB:5NIR}.
SQ   SEQUENCE   1487 AA;  141785 MW;  A8312503825BF0BB CRC64;
     MIRLGAPQTL VLLTLLVAAV LRCQGQDVQE AGSCVQDGQR YNDKDVWKPE PCRICVCDTG
     TVLCDDIICE DVKDCLSPEI PFGECCPICP TDLATASGQP GPKGQKGEPG DIKDIVGPKG
     PPGPQGPAGE QGPRGDRGDK GEKGAPGPRG RDGEPGTPGN PGPPGPPGPP GPPGLGGNFA
     AQMAGGFDEK AGGAQLGVMQ GPMGPMGPRG PPGPAGAPGP QGFQGNPGEP GEPGVSGPMG
     PRGPPGPPGK PGDDGEAGKP GKAGERGPPG PQGARGFPGT PGLPGVKGHR GYPGLDGAKG
     EAGAPGVKGE SGSPGENGSP GPMGPRGLPG ERGRTGPAGA AGARGNDGQP GPAGPPGPVG
     PAGGPGFPGA PGAKGEAGPT GARGPEGAQG PRGEPGTPGS PGPAGASGNP GTDGIPGAKG
     SAGAPGIAGA PGFPGPRGPP GPQGATGPLG PKGQTGEPGI AGFKGEQGPK GEPGPAGPQG
     APGPAGEEGK RGARGEPGGV GPIGPPGERG APGNRGFPGQ DGLAGPKGAP GERGPSGLAG
     PKGANGDPGR PGEPGLPGAR GLTGRPGDAG PQGKVGPSGA PGEDGRPGPP GPQGARGQPG
     VMGFPGPKGA NGEPGKAGEK GLPGAPGLRG LPGKDGETGA AGPPGPAGPA GERGEQGAPG
     PSGFQGLPGP PGPPGEGGKP GDQGVPGEAG APGLVGPRGE RGFPGERGSP GAQGLQGPRG
     LPGTPGTDGP KGASGPAGPP GAQGPPGLQG MPGERGAAGI AGPKGDRGDV GEKGPEGAPG
     KDGGRGLTGP IGPPGPAGAN GEKGEVGPPG PAGSAGARGA PGERGETGPP GPAGFAGPPG
     ADGQPGAKGE QGEAGQKGDA GAPGPQGPSG APGPQGPTGV TGPKGARGAQ GPPGATGFPG
     AAGRVGPPGS NGNPGPPGPP GPSGKDGPKG ARGDSGPPGR AGEPGLQGPA GPPGEKGEPG
     DDGPSGAEGP PGPQGLAGQR GIVGLPGQRG ERGFPGLPGP SGEPGKQGAP GASGDRGPPG
     PVGPPGLTGP AGEPGREGSP GADGPPGRDG AAGVKGDRGE TGAVGAPGAP GPPGSPGPAG
     PTGKQGDRGE AGAQGPMGPS GPAGARGIQG PQGPRGDKGE AGEPGERGLK GHRGFTGLQG
     LPGPPGPSGD QGASGPAGPS GPRGPPGPVG PSGKDGANGI PGPIGPPGPR GRSGETGPAG
     PPGNPGPPGP PGPPGPGIDM SAFAGLGPRE KGPDPLQYMR ADQAAGGLRQ HDAEVDATLK
     SLNNQIESIR SPEGSRKNPA RTCRDLKLCH PEWKSGDYWI DPNQGCTLDA MKVFCNMETG
     ETCVYPNPAN VPKKNWWSSK SKEKKHIWFG ETINGGFHFS YGDDNLAPNT ANVQMTFLRL
     LSTEGSQNIT YHCKNSIAYL DEAAGNLKKA LLIQGSNDVE IRAEGNSRFT YTALKDGCTK
     HTGKWGKTVI EYRSQKTSRL PIIDIAPMDI GGPEQEFGVD IGPVCFL
//
ID   CRTC3_HUMAN             Reviewed;         619 AA.
AC   Q6UUV7; Q6DK61; Q6DK62; Q8NF38; Q9H6U2;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 2.
DT   28-FEB-2018, entry version 105.
DE   RecName: Full=CREB-regulated transcription coactivator 3;
DE   AltName: Full=Transducer of regulated cAMP response element-binding protein 3;
DE            Short=TORC-3;
DE            Short=Transducer of CREB protein 3;
GN   Name=CRTC3; Synonyms=TORC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, INTERACTION WITH CREB1, AND VARIANT ASN-72.
RX   PubMed=14506290; DOI=10.1073/pnas.1932773100;
RA   Iourgenko V., Zhang W., Mickanin C., Daly I., Jiang C., Hexham J.M.,
RA   Orth A.P., Miraglia L., Meltzer J., Garza D., Chirn G.-W.,
RA   McWhinnie E., Cohen D., Skelton J., Terry R., Yu Y., Bodian D.,
RA   Buxton F.P., Zhu J., Song C., Labow M.A.;
RT   "Identification of a family of cAMP response element-binding protein
RT   coactivators by genome-scale functional analysis in mammalian cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12147-12152(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   ASN-72.
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 217-619 (ISOFORM 1).
RC   TISSUE=Hepatoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 292-619 (ISOFORM 1), AND
RP   VARIANT SER-346.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=14536081; DOI=10.1016/j.molcel.2003.08.013;
RA   Conkright M.D., Canettieri G., Screaton R., Guzman E., Miraglia L.,
RA   Hogenesch J.B., Montminy M.;
RT   "TORCs: transducers of regulated CREB activity.";
RL   Mol. Cell 12:413-423(2003).
RN   [7]
RP   SUBCELLULAR LOCATION, FUNCTION, AND MUTAGENESIS OF TYR-282.
RX   PubMed=15454081; DOI=10.1016/j.cell.2004.09.015;
RA   Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G.,
RA   Jeffries S., Guzman E., Niessen S., Yates J.R. III, Takemori H.,
RA   Okamoto M., Montminy M.;
RT   "The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive
RT   coincidence detector.";
RL   Cell 119:61-74(2004).
RN   [8]
RP   INTERACTION WITH HTLV-1 TAX, AND FUNCTION.
RX   PubMed=15466468; DOI=10.1074/jbc.M409021200;
RA   Koga H., Ohshima T., Shimotohno K.;
RT   "Enhanced activation of tax-dependent transcription of human T-cell
RT   leukemia virus type I (HTLV-I) long terminal repeat by TORC3.";
RL   J. Biol. Chem. 279:52978-52983(2004).
RN   [9]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=15589160; DOI=10.1016/j.cub.2004.11.002;
RA   Bittinger M.A., McWhinnie E., Meltzer J., Iourgenko V., Latario B.,
RA   Liu X., Chen C.H., Song C., Garza D., Labow M.;
RT   "Activation of cAMP response element-mediated gene expression by
RT   regulated nuclear transport of TORC proteins.";
RL   Curr. Biol. 14:2156-2161(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=16817901; DOI=10.1111/j.1742-4658.2006.05291.x;
RA   Katoh Y., Takemori H., Lin X.-Z., Tamura M., Muraoka M., Satoh T.,
RA   Tsuchiya Y., Min L., Doi J., Miyauchi A., Witters L.A., Nakamura H.,
RA   Okamoto M.;
RT   "Silencing the constitutive active transcription factor CREB by the
RT   LKB1-SIK signaling cascade.";
RL   FEBS J. 273:2730-2748(2006).
RN   [12]
RP   INTERACTION WITH HTLV-1 TAX.
RX   PubMed=16809310; DOI=10.1128/JVI.00103-06;
RA   Siu Y.-T., Chin K.-T., Siu K.-L., Yee Wai Choy E., Jeang K.-T.,
RA   Jin D.-Y.;
RT   "TORC1 and TORC2 coactivators are required for tax activation of the
RT   human T-cell leukemia virus type 1 long terminal repeats.";
RL   J. Virol. 80:7052-7059(2006).
RN   [13]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16980408; DOI=10.1073/pnas.0606714103;
RA   Wu Z., Huang X., Feng Y., Handschin C., Feng Y., Gullicksen P.S.,
RA   Bare O., Labow M., Spiegelman B., Stevenson S.C.;
RT   "Transducer of regulated CREB-binding proteins (TORCs) induce PGC-
RT   1alpha transcription and mitochondrial biogenesis in muscle cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:14379-14384(2006).
RN   [14]
RP   INTERACTION WITH BCL3 IN BCL3/TORC3/CREB1 COMPLEX, AND FUNCTION.
RX   PubMed=17644518; DOI=10.1074/jbc.M702656200;
RA   Hishiki T., Ohshima T., Ego T., Shimotohno K.;
RT   "BCL3 acts as a negative regulator of transcription from the human T-
RT   cell leukemia virus type 1 long terminal repeat through interactions
RT   with TORC3.";
RL   J. Biol. Chem. 282:28335-28343(2007).
RN   [15]
RP   FUNCTION.
RX   PubMed=17210223; DOI=10.1016/j.mce.2006.12.020;
RA   Takemori H., Kanematsu M., Kajimura J., Hatano O., Katoh Y.,
RA   Lin X.-Z., Min L., Yamazaki T., Doi J., Okamoto M.;
RT   "Dephosphorylation of TORC initiates expression of the StAR gene.";
RL   Mol. Cell. Endocrinol. 265:196-204(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-443, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391 AND SER-443, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329; SER-370 AND
RP   SER-443, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-62; SER-329;
RP   SER-332; SER-370; SER-391; SER-396 AND SER-410, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-232, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Transcriptional coactivator for CREB1 which activates
CC       transcription through both consensus and variant cAMP response
CC       element (CRE) sites. Acts as a coactivator, in the SIK/TORC
CC       signaling pathway, being active when dephosphorylated and acts
CC       independently of CREB1 'Ser-133' phosphorylation. Enhances the
CC       interaction of CREB1 with TAF4. Regulates the expression of
CC       specific CREB-activated genes such as the steroidogenic gene,
CC       StAR. Potent coactivator of PPARGC1A and inducer of mitochondrial
CC       biogenesis in muscle cells. Also coactivator for TAX activation of
CC       the human T-cell leukemia virus type 1 (HTLV-1) long terminal
CC       repeats (LTR). {ECO:0000269|PubMed:14506290,
CC       ECO:0000269|PubMed:15454081, ECO:0000269|PubMed:15466468,
CC       ECO:0000269|PubMed:16817901, ECO:0000269|PubMed:16980408,
CC       ECO:0000269|PubMed:17210223, ECO:0000269|PubMed:17644518}.
CC   -!- SUBUNIT: Binding, as a tetramer, through its N-terminal region,
CC       with the bZIP domain of CREB1 enhances recruitment of TAF4 to the
CC       promoter (PubMed:14506290). 'Arg-314' in the bZIP domain of CREB1
CC       is essential for this interaction (By similarity). Interaction
CC       with HTLV-1 TAX enhances its transcriptional activity
CC       (PubMed:15466468, PubMed:16809310). Interacts, via the N-terminal
CC       with the ankyrin repeats of BCL3, to form a complex with CREB1 on
CC       CRE and TxRE responsive elements and represses HTLV-1 LTR-mediated
CC       transcription (PubMed:17644518). {ECO:0000250|UniProtKB:Q91X84,
CC       ECO:0000269|PubMed:14506290, ECO:0000269|PubMed:15466468,
CC       ECO:0000269|PubMed:16809310, ECO:0000269|PubMed:17644518}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15454081,
CC       ECO:0000269|PubMed:15589160, ECO:0000269|PubMed:16817901}.
CC       Cytoplasm {ECO:0000269|PubMed:15589160,
CC       ECO:0000269|PubMed:16817901}. Note=Appears to be mainly nuclear.
CC       {ECO:0000269|PubMed:15454081}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6UUV7-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=Q6UUV7-3; Sequence=VSP_031220;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in B and T
CC       lymphocytes. Highest levels in lung. Also expressed in brain,
CC       colon, heart, kidney, ovary, and prostate. Weak expression in
CC       liver, pancreas, muscle, small intestine, spleen and stomach.
CC       {ECO:0000269|PubMed:14536081, ECO:0000269|PubMed:16980408}.
CC   -!- SIMILARITY: Belongs to the TORC family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC03424.1; Type=Frameshift; Positions=82; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY360173; AAQ98858.1; -; mRNA.
DR   EMBL; AK090443; BAC03424.1; ALT_FRAME; mRNA.
DR   EMBL; AC021422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103739; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK025521; BAB15160.1; -; mRNA.
DR   EMBL; BC074730; AAH74730.2; -; mRNA.
DR   EMBL; BC074731; AAH74731.3; -; mRNA.
DR   CCDS; CCDS32331.1; -. [Q6UUV7-1]
DR   CCDS; CCDS45348.1; -. [Q6UUV7-3]
DR   RefSeq; NP_001036039.1; NM_001042574.2. [Q6UUV7-3]
DR   RefSeq; NP_073606.3; NM_022769.4. [Q6UUV7-1]
DR   UniGene; Hs.567572; -.
DR   ProteinModelPortal; Q6UUV7; -.
DR   SMR; Q6UUV7; -.
DR   BioGrid; 122294; 31.
DR   DIP; DIP-59211N; -.
DR   IntAct; Q6UUV7; 21.
DR   STRING; 9606.ENSP00000268184; -.
DR   iPTMnet; Q6UUV7; -.
DR   PhosphoSitePlus; Q6UUV7; -.
DR   BioMuta; CRTC3; -.
DR   DMDM; 167009130; -.
DR   EPD; Q6UUV7; -.
DR   MaxQB; Q6UUV7; -.
DR   PaxDb; Q6UUV7; -.
DR   PeptideAtlas; Q6UUV7; -.
DR   PRIDE; Q6UUV7; -.
DR   Ensembl; ENST00000268184; ENSP00000268184; ENSG00000140577. [Q6UUV7-1]
DR   Ensembl; ENST00000420329; ENSP00000416573; ENSG00000140577. [Q6UUV7-3]
DR   GeneID; 64784; -.
DR   KEGG; hsa:64784; -.
DR   UCSC; uc002bpo.5; human. [Q6UUV7-1]
DR   CTD; 64784; -.
DR   DisGeNET; 64784; -.
DR   EuPathDB; HostDB:ENSG00000140577.15; -.
DR   GeneCards; CRTC3; -.
DR   HGNC; HGNC:26148; CRTC3.
DR   HPA; HPA043735; -.
DR   HPA; HPA063691; -.
DR   MIM; 608986; gene.
DR   neXtProt; NX_Q6UUV7; -.
DR   OpenTargets; ENSG00000140577; -.
DR   PharmGKB; PA142672074; -.
DR   eggNOG; ENOG410IGNT; Eukaryota.
DR   eggNOG; ENOG410XPDQ; LUCA.
DR   GeneTree; ENSGT00390000010652; -.
DR   HOGENOM; HOG000111980; -.
DR   HOVERGEN; HBG058314; -.
DR   InParanoid; Q6UUV7; -.
DR   KO; K16334; -.
DR   OMA; GFCDGEN; -.
DR   OrthoDB; EOG091G03YN; -.
DR   PhylomeDB; Q6UUV7; -.
DR   TreeFam; TF321571; -.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   SIGNOR; Q6UUV7; -.
DR   ChiTaRS; CRTC3; human.
DR   GeneWiki; CRTC3; -.
DR   GenomeRNAi; 64784; -.
DR   PRO; PR:Q6UUV7; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140577; -.
DR   CleanEx; HS_CRTC3; -.
DR   ExpressionAtlas; Q6UUV7; baseline and differential.
DR   Genevisible; Q6UUV7; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0008140; F:cAMP response element binding protein binding; IBA:GO_Central.
DR   GO; GO:0097009; P:energy homeostasis; IEA:Ensembl.
DR   GO; GO:0042116; P:macrophage activation; IMP:CACAO.
DR   GO; GO:0043951; P:negative regulation of cAMP-mediated signaling; IEA:Ensembl.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; IEA:Ensembl.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0051289; P:protein homotetramerization; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   InterPro; IPR024786; TORC.
DR   InterPro; IPR024785; TORC_C.
DR   InterPro; IPR024784; TORC_M.
DR   InterPro; IPR024783; TORC_N.
DR   PANTHER; PTHR13589; PTHR13589; 1.
DR   Pfam; PF12886; TORC_C; 1.
DR   Pfam; PF12885; TORC_M; 1.
DR   Pfam; PF12884; TORC_N; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Complete proteome; Cytoplasm;
KW   Host-virus interaction; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1    619       CREB-regulated transcription coactivator
FT                                3.
FT                                /FTId=PRO_0000318531.
FT   REGION        1    103       Required for interaction with HTLV-1 TAX.
FT   COMPBIAS    180    183       Poly-Gly.
FT   COMPBIAS    444    451       Poly-Pro.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      62     62       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     160    160       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q91X84}.
FT   MOD_RES     162    162       Phosphoserine; by SIK2.
FT                                {ECO:0000250|UniProtKB:Q91X84}.
FT   MOD_RES     273    273       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91X84}.
FT   MOD_RES     329    329       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     332    332       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     370    370       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     391    391       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     396    396       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     410    410       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     443    443       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   CROSSLNK    232    232       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     551    551       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12693554}.
FT                                /FTId=VSP_031220.
FT   VARIANT      72     72       S -> N (in dbSNP:rs8033595).
FT                                {ECO:0000269|PubMed:12693554,
FT                                ECO:0000269|PubMed:14506290}.
FT                                /FTId=VAR_038758.
FT   VARIANT     346    346       L -> S. {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_038759.
FT   MUTAGEN     282    282       Y->F: Translocates to the cytoplasm.
FT                                Represses basal TORC3 activity towards
FT                                CREB. {ECO:0000269|PubMed:15454081}.
FT   CONFLICT    545    545       P -> S (in Ref. 4; BAB15160).
FT                                {ECO:0000305}.
FT   CONFLICT    616    616       A -> T (in Ref. 2; BAC03424).
FT                                {ECO:0000305}.
SQ   SEQUENCE   619 AA;  66959 MW;  A274B96DD1C2678E CRC64;
     MAASPGSGSA NPRKFSEKIA LHTQRQAEET RAFEQLMTDL TLSRVQFQKL QQLRLTQYHG
     GSLPNVSQLR SSASEFQPSF HQADNVRGTR HHGLVERPSR NRFHPLHRRS GDKPGRQFDG
     SAFGANYSSQ PLDESWPRQQ PPWKDEKHPG FRLTSALNRT NSDSALHTSA LSTKPQDPYG
     GGGQSAWPAP YMGFCDGENN GHGEVASFPG PLKEENLLNV PKPLPKQLWE TKEIQSLSGR
     PRSCDVGGGN AFPHNGQNLG LSPFLGTLNT GGSLPDLTNL HYSTPLPASL DTTDHHFGSM
     SVGNSVNNIP AAMTHLGIRS SSGLQSSRSN PSIQATLNKT VLSSSLNNHP QTSVPNASAL
     HPSLRLFSLS NPSLSTTNLS GPSRRRQPPV SPLTLSPGPE AHQGFSRQLS STSPLAPYPT
     SQMVSSDRSQ LSFLPTEAQA QVSPPPPYPA PQELTQPLLQ QPRAPEAPAQ QPQAASSLPQ
     SDFQLLPAQG SSLTNFFPDV GFDQQSMRPG PAFPQQVPLV QQGSRELQDS FHLRPSPYSN
     CGSLPNTILP EDSSTSLFKD LNSALAGLPE VSLNVDTPFP LEEELQIEPL SLDGLNMLSD
     SSMGLLDPSV EETFRADRL
//
ID   Q8TEF4_HUMAN            Unreviewed;       503 AA.
AC   Q8TEF4;
DT   01-JUN-2002, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2002, sequence version 1.
DT   31-JAN-2018, entry version 71.
DE   SubName: Full=FLJ00243 protein {ECO:0000313|EMBL:BAB84996.1};
DE   Flags: Fragment;
GN   Name=FLJ00243 {ECO:0000313|EMBL:BAB84996.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAB84996.1};
RN   [1] {ECO:0000313|EMBL:BAB84996.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Spleen {ECO:0000313|EMBL:BAB84996.1};
RA   Jikuya H., Takano J., Nomura N., Kikuno R., Nagase T., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human
RT   spleen.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK074170; BAB84996.1; -; mRNA.
DR   RefSeq; NP_001036039.1; NM_001042574.2.
DR   RefSeq; NP_073606.3; NM_022769.4.
DR   UniGene; Hs.567572; -.
DR   PeptideAtlas; Q8TEF4; -.
DR   GeneID; 64784; -.
DR   KEGG; hsa:64784; -.
DR   CTD; 64784; -.
DR   PharmGKB; PA142672074; -.
DR   eggNOG; ENOG410IGNT; Eukaryota.
DR   eggNOG; ENOG410XPDQ; LUCA.
DR   HOGENOM; HOG000111980; -.
DR   HOVERGEN; HBG058314; -.
DR   KO; K16334; -.
DR   GenomeRNAi; 64784; -.
DR   Genevisible; Q8TEF4; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; IEA:InterPro.
DR   InterPro; IPR024786; TORC.
DR   InterPro; IPR024785; TORC_C.
DR   InterPro; IPR024784; TORC_M.
DR   PANTHER; PTHR13589; PTHR13589; 1.
DR   Pfam; PF12886; TORC_C; 1.
DR   Pfam; PF12885; TORC_M; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       44    206       TORC_M. {ECO:0000259|Pfam:PF12885}.
FT   DOMAIN      430    503       TORC_C. {ECO:0000259|Pfam:PF12886}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAB84996.1}.
SQ   SEQUENCE   503 AA;  53812 MW;  F5620C45284942FE CRC64;
     RQFDGSAFGA NYSSQPLDES WPRQQPPWKD EKHPGFRLTS ALNRTNSDSA LHTSALSTKP
     QDPYGGGGQS AWPAPYMGFC DGENNGHGEV ASFPGPLKEE NLLNVPKPLP KQLWETKEIQ
     SLSGRPRSCD VGGGNAFPHN GQNLGLSPFL GTLNTGGSLP DLTNLHYSTP LPASLDTTDH
     HFGSMSVGNS VNNIPAAMTH LGIRSSSGLQ SSRSNPSIQA TLNKTVLSSS LNNHPQTSVP
     NASALHPSLR LFSLSNPSLS TTNLSGPSRR RQPPVSPLTL SPGPEANQGF SRQLSSTSPL
     APYPTSQMVS SDRSQLSFLP TEAQAQVSPP PPYPAPQELT QPLLQQPRAP EAPAQQPQAA
     SSLPQSDFQL LPAQGSSLTN FFPDVGFDQQ SMRPGPAFPQ QVPLVQQGSR ELQDSFHLRP
     SPYSNCGSLP NTILPDSSTS LFKDLNSALA GLPEVSLNVD TPFPLEEELQ IEPLSLDGLN
     MLSDSSMGLL DPSVEETFRA DRL
//
ID   DCTN1_HUMAN             Reviewed;        1278 AA.
AC   Q14203; A8MY36; B4DM45; E9PFS5; E9PGE1; G5E9H4; O95296; Q6IQ37;
AC   Q9BRM9; Q9UIU1; Q9UIU2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 3.
DT   28-FEB-2018, entry version 183.
DE   RecName: Full=Dynactin subunit 1;
DE   AltName: Full=150 kDa dynein-associated polypeptide;
DE   AltName: Full=DAP-150;
DE            Short=DP-150;
DE   AltName: Full=p135;
DE   AltName: Full=p150-glued;
GN   Name=DCTN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=9799602; DOI=10.1006/geno.1998.5542;
RA   Collin G.B., Nishina P.M., Marshall J.D., Naggert J.K.;
RT   "Human DCTN1: genomic structure and evaluation as a candidate for
RT   Alstrom syndrome.";
RL   Genomics 53:359-364(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Brain, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 9-1278.
RC   TISSUE=Brain;
RX   PubMed=8838327; DOI=10.1006/geno.1996.0068;
RA   Holzbaur E.L.F., Tokito M.K.;
RT   "Localization of the DCTN1 gene encoding p150Glued to human chromosome
RT   2p13 by fluorescence in situ hybridization.";
RL   Genomics 31:398-399(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-1278 (ISOFORM 6), AND ALTERNATIVE
RP   SPLICING.
RC   TISSUE=Brain;
RX   PubMed=8856662; DOI=10.1091/mbc.7.8.1167;
RA   Tokito M.K., Howland D.S., Lee V.M.-Y., Holzbaur E.L.F.;
RT   "Functionally distinct isoforms of dynactin are expressed in human
RT   neurons.";
RL   Mol. Biol. Cell 7:1167-1180(1996).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 18-1278.
RX   PubMed=9805007; DOI=10.1016/S0167-4781(98)00195-X;
RA   Tokito M.K., Holzbaur E.L.F.;
RT   "The genomic structure of DCTN1, a candidate gene for limb-girdle
RT   muscular dystrophy.";
RL   Biochim. Biophys. Acta 1442:432-436(1998).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1081-1278.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   INTERACTION WITH MAPRE1; MAPRE2 AND MAPRE3.
RX   PubMed=14514668; DOI=10.1074/jbc.M306194200;
RA   Bu W., Su L.-K.;
RT   "Characterization of functional domains of human EB1 family
RT   proteins.";
RL   J. Biol. Chem. 278:49721-49731(2003).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   UBIQUITINATION, AND INTERACTION WITH FBXL5.
RX   PubMed=17532294; DOI=10.1016/j.bbrc.2007.05.068;
RA   Zhang N., Liu J., Ding X., Aikhionbare F., Jin C., Yao X.;
RT   "FBXL5 interacts with p150Glued and regulates its ubiquitination.";
RL   Biochem. Biophys. Res. Commun. 359:34-39(2007).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   INTERACTION WITH SNX6.
RX   PubMed=19935774; DOI=10.1038/cr.2009.130;
RA   Hong Z., Yang Y., Zhang C., Niu Y., Li K., Zhao X., Liu J.J.;
RT   "The retromer component SNX6 interacts with dynactin p150(Glued) and
RT   mediates endosome-to-TGN transport.";
RL   Cell Res. 19:1334-1349(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-108, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   INTERACTION WITH ECM29.
RX   PubMed=20682791; DOI=10.1074/jbc.M110.154120;
RA   Gorbea C., Pratt G., Ustrell V., Bell R., Sahasrabudhe S.,
RA   Hughes R.E., Rechsteiner M.;
RT   "A protein interaction network for Ecm29 links the 26 S proteasome to
RT   molecular motors and endosomal components.";
RL   J. Biol. Chem. 285:31616-31633(2010).
RN   [17]
RP   INTERACTION WITH PARD6A, AND SUBCELLULAR LOCATION.
RX   PubMed=20719959; DOI=10.1091/mbc.E10-05-0430;
RA   Kodani A., Tonthat V., Wu B., Suetterlin C.;
RT   "Par6 alpha interacts with the dynactin subunit p150 Glued and is a
RT   critical regulator of centrosomal protein recruitment.";
RL   Mol. Biol. Cell 21:3376-3385(2010).
RN   [18]
RP   INTERACTION WITH DYNAP.
RX   PubMed=20978158; DOI=10.1158/1535-7163.MCT-10-0730;
RA   Kunoh T., Noda T., Koseki K., Sekigawa M., Takagi M., Shin-ya K.,
RA   Goshima N., Iemura S., Natsume T., Wada S., Mukai Y., Ohta S.,
RA   Sasaki R., Mizukami T.;
RT   "A novel human dynactin-associated protein, dynAP, promotes activation
RT   of Akt, and ergosterol-related compounds induce dynAP-dependent
RT   apoptosis of human cancer cells.";
RL   Mol. Cancer Ther. 9:2934-2942(2010).
RN   [19]
RP   PHOSPHORYLATION AT SER-179 AND SER-212, MUTAGENESIS OF SER-179 AND
RP   SER-212, INTERACTION WITH PLK1 AND CLIP1, AND SUBCELLULAR LOCATION.
RX   PubMed=20679239; DOI=10.1073/pnas.1006615107;
RA   Li H., Liu X.S., Yang X., Song B., Wang Y., Liu X.;
RT   "Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear
RT   envelope breakdown during prophase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:14633-14638(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   INTERACTION WITH CLN3.
RX   PubMed=22261744; DOI=10.1007/s00018-011-0913-1;
RA   Uusi-Rauva K., Kyttala A., van der Kant R., Vesa J., Tanhuanpaa K.,
RA   Neefjes J., Olkkonen V.M., Jalanko A.;
RT   "Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor
RT   proteins and modifies location of late endosomal compartments.";
RL   Cell. Mol. Life Sci. 69:2075-2089(2012).
RN   [22]
RP   INTERACTION WITH CEP131.
RX   PubMed=22797915; DOI=10.1242/jcs.104059;
RA   Staples C.J., Myers K.N., Beveridge R.D., Patil A.A., Lee A.J.,
RA   Swanton C., Howell M., Boulton S.J., Collis S.J.;
RT   "The centriolar satellite protein Cep131 is important for genome
RT   stability.";
RL   J. Cell Sci. 125:4770-4779(2012).
RN   [23]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22327364; DOI=10.1038/ncb2440;
RA   Kiyomitsu T., Cheeseman I.M.;
RT   "Chromosome- and spindle-pole-derived signals generate an intrinsic
RT   code for spindle position and orientation.";
RL   Nat. Cell Biol. 14:311-317(2012).
RN   [24]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23386061; DOI=10.1038/emboj.2013.3;
RA   Kodani A., Salome Sirerol-Piquer M., Seol A., Garcia-Verdugo J.M.,
RA   Reiter J.F.;
RT   "Kif3a interacts with Dynactin subunit p150 Glued to organize
RT   centriole subdistal appendages.";
RL   EMBO J. 32:597-607(2013).
RN   [25]
RP   INTERACTION WITH MISP.
RX   PubMed=23509069; DOI=10.1083/jcb.201207050;
RA   Zhu M., Settele F., Kotak S., Sanchez-Pulido L., Ehret L.,
RA   Ponting C.P., Goenczy P., Hoffmann I.;
RT   "MISP is a novel Plk1 substrate required for proper spindle
RT   orientation and mitotic progression.";
RL   J. Cell Biol. 200:773-787(2013).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   PHOSPHORYLATION AT THR-145; THR-146 AND THR-147, SUBCELLULAR LOCATION,
RP   AND MUTAGENESIS OF THR-145; THR-146 AND THR-147.
RX   PubMed=23985322; DOI=10.1091/mbc.E13-03-0137;
RA   Zhapparova O.N., Fokin A.I., Vorobyeva N.E., Bryantseva S.A.,
RA   Nadezhdina E.S.;
RT   "Ste20-like protein kinase SLK (LOSK) regulates microtubule
RT   organization by targeting dynactin to the centrosome.";
RL   Mol. Biol. Cell 24:3205-3214(2013).
RN   [28]
RP   INTERACTION WITH CEP126.
RX   PubMed=24867236; DOI=10.1111/boc.201300087;
RA   Bonavita R., Walas D., Brown A.K., Luini A., Stephens D.J.,
RA   Colanzi A.;
RT   "Cep126 is required for pericentriolar satellite localisation to the
RT   centrosome and for primary cilium formation.";
RL   Biol. Cell 106:254-267(2014).
RN   [29]
RP   INTERACTION WITH HPS6.
RX   PubMed=25189619; DOI=10.1242/jcs.141978;
RA   Li K., Yang L., Zhang C., Niu Y., Li W., Liu J.J.;
RT   "HPS6 interacts with dynactin p150Glued to mediate retrograde
RT   trafficking and maturation of lysosomes.";
RL   J. Cell Sci. 127:4574-4588(2014).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25774020; DOI=10.1002/jcb.25160;
RA   Chen T.Y., Syu J.S., Han T.Y., Cheng H.L., Lu F.I., Wang C.Y.;
RT   "Cell cycle-dependent localization of dynactin subunit p150 glued at
RT   centrosome.";
RL   J. Cell. Biochem. 116:2049-2060(2015).
RN   [32]
RP   ASSOCIATION WITH MICROTUBULES, AND DOMAIN CAP-GLY.
RX   PubMed=26968983; DOI=10.15252/embj.201593071;
RA   McKenney R.J., Huynh W., Vale R.D., Sirajuddin M.;
RT   "Tyrosination of alpha-tubulin controls the initiation of processive
RT   dynein-dynactin motility.";
RL   EMBO J. 35:1175-1185(2016).
RN   [33]
RP   INTERACTION WITH BCCIP.
RX   PubMed=28394342; DOI=10.1038/onc.2017.92;
RA   Huhn S.C., Liu J., Ye C., Lu H., Jiang X., Feng X., Ganesan S.,
RA   White E., Shen Z.;
RT   "Regulation of spindle integrity and mitotic fidelity by BCCIP.";
RL   Oncogene 36:4750-4766(2017).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 15-107 IN COMPLEX WITH
RP   MAPRE1, AND INTERACTION WITH MAPRE1.
RX   PubMed=16109370; DOI=10.1016/j.molcel.2005.06.034;
RA   Hayashi I., Wilde A., Mal T.K., Ikura M.;
RT   "Structural basis for the activation of microtubule assembly by the
RT   EB1 and p150Glued complex.";
RL   Mol. Cell 19:449-460(2005).
RN   [35]
RP   STRUCTURE BY NMR OF 1-99.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the CAP-Gly domain in human dynactin 1.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS) OF 18-111 IN COMPLEX WITH
RP   MAPRE1, AND INTERACTION WITH MAPRE1.
RX   PubMed=16949363; DOI=10.1016/j.molcel.2006.07.013;
RA   Honnappa S., Okhrimenko O., Jaussi R., Jawhari H., Jelesarov I.,
RA   Winkler F.K., Steinmetz M.O.;
RT   "Key interaction modes of dynamic +TIP networks.";
RL   Mol. Cell 23:663-671(2006).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 15-111 IN COMPLEX WITH
RP   CLIP1, SUBCELLULAR LOCATION, AND INTERACTION WITH CLIP1.
RX   PubMed=17828277; DOI=10.1038/nsmb1291;
RA   Weisbrich A., Honnappa S., Jaussi R., Okhrimenko O., Frey D.,
RA   Jelesarov I., Akhmanova A., Steinmetz M.O.;
RT   "Structure-function relationship of CAP-Gly domains.";
RL   Nat. Struct. Mol. Biol. 14:959-967(2007).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 15-107 IN COMPLEX WITH
RP   CLIP1, INTERACTION WITH CLIP1, AND MUTAGENESIS OF LYS-68 AND ARG-90.
RX   PubMed=17828275; DOI=10.1038/nsmb1299;
RA   Hayashi I., Plevin M.J., Ikura M.;
RT   "CLIP170 autoinhibition mimics intermolecular interactions with
RT   p150Glued or EB1.";
RL   Nat. Struct. Mol. Biol. 14:980-981(2007).
RN   [39]
RP   VARIANT HMN7B SER-59.
RX   PubMed=12627231; DOI=10.1038/ng1123;
RA   Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M.,
RA   Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., Brown R.H. Jr.,
RA   Ludlow C.L., Fischbeck K.H.;
RT   "Mutant dynactin in motor neuron disease.";
RL   Nat. Genet. 33:455-456(2003).
RN   [40]
RP   INVOLVEMENT IN ALS, AND VARIANTS ALS THR-571; TRP-785 AND ILE-1249.
RX   PubMed=15326253; DOI=10.1212/01.WNL.0000134608.83927.B1;
RA   Muench C., Sedlmeier R., Meyer T., Homberg V., Sperfeld A.D., Kurt A.,
RA   Prudlo J., Peraus G., Hanemann C.O., Stumm G., Ludolph A.C.;
RT   "Point mutations of the p150 subunit of dynactin (DCTN1) gene in
RT   ALS.";
RL   Neurology 63:724-726(2004).
RN   [41]
RP   VARIANT ALS LYS-1101.
RX   PubMed=16240349; DOI=10.1002/ana.20631;
RA   Muench C., Rosenbohm A., Sperfeld A.-D., Uttner I., Reske S.,
RA   Krause B.J., Sedlmeier R., Meyer T., Hanemann C.O., Stumm G.,
RA   Ludolph A.C.;
RT   "Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS
RT   and FTD.";
RL   Ann. Neurol. 58:777-780(2005).
RN   [42]
RP   CHARACTERIZATION OF VARIANT HMN7B SER-59, AND INTERACTION WITH MAPRE1.
RX   PubMed=16505168; DOI=10.1083/jcb.200511068;
RA   Levy J.R., Sumner C.J., Caviston J.P., Tokito M.K., Ranganathan S.,
RA   Ligon L.A., Wallace K.E., LaMonte B.H., Harmison G.G., Puls I.,
RA   Fischbeck K.H., Holzbaur E.L.F.;
RT   "A motor neuron disease-associated mutation in p150Glued perturbs
RT   dynactin function and induces protein aggregation.";
RL   J. Cell Biol. 172:733-745(2006).
RN   [43]
RP   VARIANTS VAL-196; GLN-495 AND ILE-1249.
RX   PubMed=17824900; DOI=10.1111/j.1600-0404.2007.00884.x;
RA   Muench C., Meyer R., Linke P., Meyer T., Ludolph A.C., Haas J.,
RA   Hemmer B.;
RT   "The p150 subunit of dynactin (DCTN1) gene in multiple sclerosis.";
RL   Acta Neurol. Scand. 116:231-234(2007).
RN   [44]
RP   VARIANTS PERRYS ARG-71; GLU-71; ALA-71; PRO-72 AND PRO-74,
RP   CHARACTERIZATION OF VARIANTS PERRYS ARG-71 AND PRO-74, AND
RP   CHARACTERIZATION OF VARIANT HMN7B SER-59.
RX   PubMed=19136952; DOI=10.1038/ng.293;
RA   Farrer M.J., Hulihan M.M., Kachergus J.M., Daechsel J.C.,
RA   Stoessl A.J., Grantier L.L., Calne S., Calne D.B., Lechevalier B.,
RA   Chapon F., Tsuboi Y., Yamada T., Gutmann L., Elibol B., Bhatia K.P.,
RA   Wider C., Vilarino-Gueell C., Ross O.A., Brown L.A.,
RA   Castanedes-Casey M., Dickson D.W., Wszolek Z.K.;
RT   "DCTN1 mutations in Perry syndrome.";
RL   Nat. Genet. 41:163-165(2009).
RN   [45]
RP   VARIANT ILE-1249.
RX   PubMed=19506225; DOI=10.1212/WNL.0b013e3181a92c4c;
RA   Vilarino-Gueell C., Wider C., Soto-Ortolaza A.I., Cobb S.A.,
RA   Kachergus J.M., Keeling B.H., Dachsel J.C., Hulihan M.M.,
RA   Dickson D.W., Wszolek Z.K., Uitti R.J., Graff-Radford N.R.,
RA   Boeve B.F., Josephs K.A., Miller B., Boylan K.B., Gwinn K.,
RA   Adler C.H., Aasly J.O., Hentati F., Destee A., Krygowska-Wajs A.,
RA   Chartier-Harlin M.-C., Ross O.A., Rademakers R., Farrer M.J.;
RT   "Characterization of DCTN1 genetic variability in neurodegeneration.";
RL   Neurology 72:2024-2028(2009).
RN   [46]
RP   CHARACTERIZATION OF VARIANT HMN7B SER-59.
RX   PubMed=19279216; DOI=10.1073/pnas.0810828106;
RA   Moore J.K., Sept D., Cooper J.A.;
RT   "Neurodegeneration mutations in dynactin impair dynein-dependent
RT   nuclear migration.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:5147-5152(2009).
RN   [47]
RP   CHARACTERIZATION OF VARIANT HMN7B SER-59, CHARACTERIZATION OF VARIANT
RP   196-ILE, INTERACTION WITH TBCB, AND SUBCELLULAR LOCATION.
RX   PubMed=22777741; DOI=10.1007/s00441-012-1463-z;
RA   Kuh G.F., Stockmann M., Meyer-Ohlendorf M., Linta L., Proepper C.,
RA   Ludolph A.C., Bockmann J., Boeckers T.M., Liebau S.;
RT   "Tubulin-binding cofactor B is a direct interaction partner of the
RT   dynactin subunit p150(Glued).";
RL   Cell Tissue Res. 350:13-26(2012).
RN   [48]
RP   CHARACTERIZATION OF VARIANT PERRYS PRO-74, FUNCTION, SUBUNIT, AND
RP   INTERACTION WITH MAPRE1.
RX   PubMed=23874158; DOI=10.1371/journal.pbio.1001611;
RA   Lazarus J.E., Moughamian A.J., Tokito M.K., Holzbaur E.L.;
RT   "Dynactin subunit p150(Glued) is a neuron-specific anti-catastrophe
RT   factor.";
RL   PLoS Biol. 11:E1001611-E1001611(2013).
RN   [49]
RP   VARIANT PHE-670.
RX   PubMed=24627108; DOI=10.1007/s00415-014-7289-8;
RA   Schabhuettl M., Wieland T., Senderek J., Baets J., Timmerman V.,
RA   De Jonghe P., Reilly M.M., Stieglbauer K., Laich E., Windhager R.,
RA   Erwa W., Trajanoski S., Strom T.M., Auer-Grumbach M.;
RT   "Whole-exome sequencing in patients with inherited neuropathies:
RT   outcome and challenges.";
RL   J. Neurol. 261:970-982(2014).
RN   [50]
RP   VARIANT PERRYS LEU-52.
RX   PubMed=24676999; DOI=10.1002/mds.25833;
RA   Araki E., Tsuboi Y., Daechsel J., Milnerwood A., Vilarino-Guell C.,
RA   Fujii N., Mishima T., Oka T., Hara H., Fukae J., Farrer M.J.;
RT   "A Novel DCTN1 mutation with late-onset parkinsonism and
RT   frontotemporal atrophy.";
RL   Mov. Disord. 29:1201-1204(2014).
RN   [51]
RP   CHARACTERIZATION OF VARIANTS PERRYS ARG-71 AND PRO-74, FUNCTION,
RP   INTERACTION WITH DYNEIN INTERMEDIATE CHAIN AND DYNEIN HEAVY CHAIN, AND
RP   DOMAIN CAP-GLY.
RX   PubMed=25185702; DOI=10.1038/ncomms5807;
RA   Ayloo S., Lazarus J.E., Dodda A., Tokito M., Ostap E.M.,
RA   Holzbaur E.L.;
RT   "Dynactin functions as both a dynamic tether and brake during dynein-
RT   driven motility.";
RL   Nat. Commun. 5:4807-4807(2014).
RN   [52]
RP   VARIANTS PERRYS ARG-71 AND CYS-78, AND CHARACTERIZATION OF VARIANTS
RP   PERRYS ARG-71 AND CYS-78.
RX   PubMed=24881494; DOI=10.1016/j.parkreldis.2014.05.004;
RA   Tacik P., Fiesel F.C., Fujioka S., Ross O.A., Pretelt F.,
RA   Castaneda Cardona C., Kidd A., Hlavac M., Raizis A., Okun M.S.,
RA   Traynor S., Strongosky A.J., Springer W., Wszolek Z.K.;
RT   "Three families with Perry syndrome from distinct parts of the
RT   world.";
RL   Parkinsonism Relat. Disord. 20:884-888(2014).
RN   [53]
RP   CHARACTERIZATION OF VARIANT PERRYS ARG-71, SUBCELLULAR LOCATION,
RP   DOMAIN CAP-GLY, INTERACTION WITH CLIP1, AND ASSOCIATION WITH
RP   MICROTUBULES.
RX   PubMed=26972003; DOI=10.1016/j.celrep.2016.02.046;
RA   Nirschl J.J., Magiera M.M., Lazarus J.E., Janke C., Holzbaur E.L.;
RT   "Alpha-tubulin tyrosination and CLIP-170 phosphorylation regulate the
RT   initiation of dynein-driven transport in neurons.";
RL   Cell Rep. 14:2637-2652(2016).
CC   -!- FUNCTION: Plays a key role in dynein-mediated retrograde transport
CC       of vesicles and organelles along microtubules by recruiting and
CC       tethering dynein to microtubules. Binds to both dynein and
CC       microtubules providing a link between specific cargos,
CC       microtubules and dynein. Essential for targeting dynein to
CC       microtubule plus ends, recruiting dynein to membranous cargos and
CC       enhancing dynein processivity (the ability to move along a
CC       microtubule for a long distance without falling off the track).
CC       Can also act as a brake to slow the dynein motor during motility
CC       along the microtubule (PubMed:25185702). Can regulate microtubule
CC       stability by promoting microtubule formation, nucleation and
CC       polymerization and by inhibiting microtubule catastrophe in
CC       neurons. Inhibits microtubule catastrophe by binding both to
CC       microtubules and to tubulin, leading to enhanced microtubule
CC       stability along the axon (PubMed:23874158). Plays a role in
CC       metaphase spindle orientation (PubMed:22327364). Plays a role in
CC       centriole cohesion and subdistal appendage organization and
CC       function. Its recruitement to the centriole in a KIF3A-dependent
CC       manner is essential for the maintenance of centriole cohesion and
CC       the formation of subdistal appendage. Also required for
CC       microtubule anchoring at the mother centriole (PubMed:23386061).
CC       Plays a role in primary cilia formation (PubMed:25774020).
CC       {ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23386061,
CC       ECO:0000269|PubMed:23874158, ECO:0000269|PubMed:25185702,
CC       ECO:0000269|PubMed:25774020}.
CC   -!- SUBUNIT: Monomer and homodimer (PubMed:23874158). Dynactin is a
CC       large macromolecular complex of at least 10 components;
CC       p150(glued) binds directly to microtubules and to cytoplasmic
CC       dynein. Interacts with the C-terminus of MAPRE1, MAPRE2 and
CC       MAPRE3. Interacts (via C-terminus) with SNX6. Interacts with CLN3,
CC       DYNAP, ECM29 and FBXL5. Interacts with MISP; this interaction
CC       regulates its distribution at the cell cortex. Interacts with
CC       CEP131. Interacts with CEP126 (PubMed:24867236). Interacts with
CC       CLIP1 (PubMed:17828275, PubMed:17828277, PubMed:26972003,
CC       PubMed:20679239). Interacts with dynein intermediate chain and
CC       dynein heavy chain (PubMed:25185702). Interacts with PLK1 (via
CC       POLO-box domain) (PubMed:20679239). Interacts with TBCB
CC       (PubMed:22777741). Binds preferentially to tyrosinated
CC       microtubules than to detyrosinated microtubules (PubMed:26972003,
CC       PubMed:26968983). Interacts with PARD6A (PubMed:20719959).
CC       Interacts with HPS6 (PubMed:25189619). Interacts with KIF3A.
CC       Interacts with BICD2 (By similarity). Interacts with DST (isoform
CC       9) (By similarity). Interacts with DST (isoform 1) (By
CC       similarity). Interacts with BCCIP (isoform 2/alpha)
CC       (PubMed:28394342). {ECO:0000250|UniProtKB:O08788,
CC       ECO:0000269|PubMed:14514668, ECO:0000269|PubMed:16109370,
CC       ECO:0000269|PubMed:16505168, ECO:0000269|PubMed:16949363,
CC       ECO:0000269|PubMed:17532294, ECO:0000269|PubMed:17828275,
CC       ECO:0000269|PubMed:17828277, ECO:0000269|PubMed:19935774,
CC       ECO:0000269|PubMed:20679239, ECO:0000269|PubMed:20682791,
CC       ECO:0000269|PubMed:20719959, ECO:0000269|PubMed:20978158,
CC       ECO:0000269|PubMed:22261744, ECO:0000269|PubMed:22777741,
CC       ECO:0000269|PubMed:22797915, ECO:0000269|PubMed:23509069,
CC       ECO:0000269|PubMed:23874158, ECO:0000269|PubMed:24867236,
CC       ECO:0000269|PubMed:25185702, ECO:0000269|PubMed:25189619,
CC       ECO:0000269|PubMed:26968983, ECO:0000269|PubMed:26972003,
CC       ECO:0000269|PubMed:28394342}.
CC   -!- INTERACTION:
CC       P42025:ACTR1B; NbExp=3; IntAct=EBI-724352, EBI-367493;
CC       Q96RK4:BBS4; NbExp=3; IntAct=EBI-724352, EBI-1805814;
CC       P30622-1:CLIP1; NbExp=7; IntAct=EBI-724352, EBI-9640673;
CC       P54256:Hap1 (xeno); NbExp=4; IntAct=EBI-724352, EBI-994539;
CC       Q15691:MAPRE1; NbExp=7; IntAct=EBI-724352, EBI-1004115;
CC       P10636-8:MAPT; NbExp=8; IntAct=EBI-724352, EBI-366233;
CC       Q9UNH7:SNX6; NbExp=2; IntAct=EBI-724352, EBI-949294;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17828277}.
CC       Cytoplasm, cytoskeleton {ECO:0000269|PubMed:17828277,
CC       ECO:0000269|PubMed:22777741, ECO:0000269|PubMed:25774020,
CC       ECO:0000269|PubMed:26972003}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:20719959,
CC       ECO:0000269|PubMed:23985322, ECO:0000269|PubMed:25774020}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center,
CC       centrosome, centriole {ECO:0000269|PubMed:23386061,
CC       ECO:0000269|PubMed:25774020}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:25774020}. Nucleus envelope
CC       {ECO:0000269|PubMed:20679239}. Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:22327364}. Note=Localizes to microtubule plus
CC       ends (PubMed:17828277, PubMed:22777741, PubMed:25774020).
CC       Localizes preferentially to the ends of tyrosinated microtubules
CC       (PubMed:26972003). Localization at centrosome is regulated by SLK-
CC       dependent phosphorylation (PubMed:23985322). Localizes to
CC       centrosome in a PARKDA-dependent manner (PubMed:20719959).
CC       Localizes to the subdistal appendage region of the centriole in a
CC       KIF3A-dependent manner (PubMed:23386061). PLK1-mediated
CC       phosphorylation at Ser-179 is essential for its localization in
CC       the nuclear envelope (PubMed:20679239).
CC       {ECO:0000269|PubMed:17828277, ECO:0000269|PubMed:20679239,
CC       ECO:0000269|PubMed:20719959, ECO:0000269|PubMed:22777741,
CC       ECO:0000269|PubMed:23386061, ECO:0000269|PubMed:23985322,
CC       ECO:0000269|PubMed:25774020, ECO:0000269|PubMed:26972003}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=p150;
CC         IsoId=Q14203-1; Sequence=Displayed;
CC       Name=p135;
CC         IsoId=Q14203-2; Sequence=VSP_000760;
CC       Name=3;
CC         IsoId=Q14203-3; Sequence=VSP_045392, VSP_045393, VSP_045394;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q14203-4; Sequence=VSP_045393, VSP_045394;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q14203-5; Sequence=VSP_000760, VSP_045394;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q14203-6; Sequence=VSP_047174;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Brain.
CC   -!- DOMAIN: The CAP-Gly domain is essential for interactions with
CC       microtubules and its binding partners and for its motion along the
CC       microtubules. Essential for its preferential binding to
CC       tyrosinated microtubules and for promoting the sustained
CC       interaction of the dynein motor with microtubules.
CC       {ECO:0000269|PubMed:25185702, ECO:0000269|PubMed:26968983,
CC       ECO:0000269|PubMed:26972003}.
CC   -!- PTM: Ubiquitinated by a SCF complex containing FBXL5, leading to
CC       its degradation by the proteasome. {ECO:0000269|PubMed:17532294}.
CC   -!- PTM: Phosphorylation by SLK at Thr-145, Thr-146 and Thr-147
CC       targets DCTN1 to the centrosome. It is uncertain if SLK
CC       phosphorylates all three threonines or one or two of them. PLK1-
CC       mediated phosphorylation at Ser-179 is essential for its
CC       localization in the nuclear envelope, promotes its dissociation
CC       from microtubules during early mitosis and positively regulates
CC       nuclear envelope breakdown during prophase.
CC       {ECO:0000269|PubMed:20679239, ECO:0000269|PubMed:23985322}.
CC   -!- DISEASE: Neuronopathy, distal hereditary motor, 7B (HMN7B)
CC       [MIM:607641]: A neuromuscular disorder. Distal hereditary motor
CC       neuronopathies constitute a heterogeneous group of neuromuscular
CC       disorders caused by selective degeneration of motor neurons in the
CC       anterior horn of the spinal cord, without sensory deficit in the
CC       posterior horn. The overall clinical picture consists of a
CC       classical distal muscular atrophy syndrome in the legs without
CC       clinical sensory loss. The disease starts with weakness and
CC       wasting of distal muscles of the anterior tibial and peroneal
CC       compartments of the legs. Later on, weakness and atrophy may
CC       expand to the proximal muscles of the lower limbs and/or to the
CC       distal upper limbs. {ECO:0000269|PubMed:12627231,
CC       ECO:0000269|PubMed:16505168, ECO:0000269|PubMed:19136952,
CC       ECO:0000269|PubMed:19279216, ECO:0000269|PubMed:22777741}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Amyotrophic lateral sclerosis (ALS) [MIM:105400]: A
CC       neurodegenerative disorder affecting upper motor neurons in the
CC       brain and lower motor neurons in the brain stem and spinal cord,
CC       resulting in fatal paralysis. Sensory abnormalities are absent.
CC       The pathologic hallmarks of the disease include pallor of the
CC       corticospinal tract due to loss of motor neurons, presence of
CC       ubiquitin-positive inclusions within surviving motor neurons, and
CC       deposition of pathologic aggregates. The etiology of amyotrophic
CC       lateral sclerosis is likely to be multifactorial, involving both
CC       genetic and environmental factors. The disease is inherited in 5-
CC       10% of the cases. {ECO:0000269|PubMed:15326253,
CC       ECO:0000269|PubMed:16240349}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Perry syndrome (PERRYS) [MIM:168605]: A neuropsychiatric
CC       disorder characterized by mental depression not responsive to
CC       antidepressant drugs or electroconvulsive therapy, sleep
CC       disturbances, exhaustion and marked weight loss. Parkinsonism
CC       develops later and respiratory failure occurred terminally.
CC       {ECO:0000269|PubMed:19136952, ECO:0000269|PubMed:23874158,
CC       ECO:0000269|PubMed:24676999, ECO:0000269|PubMed:24881494,
CC       ECO:0000269|PubMed:25185702, ECO:0000269|PubMed:26972003}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the dynactin 150 kDa subunit family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF064205; AAD55811.1; -; Genomic_DNA.
DR   EMBL; AF064203; AAD55811.1; JOINED; Genomic_DNA.
DR   EMBL; AF064204; AAD55811.1; JOINED; Genomic_DNA.
DR   EMBL; AF064205; AAD55812.1; -; Genomic_DNA.
DR   EMBL; AF064204; AAD55812.1; JOINED; Genomic_DNA.
DR   EMBL; AK297286; BAG59757.1; -; mRNA.
DR   EMBL; AK314352; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC005041; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAW99684.1; -; Genomic_DNA.
DR   EMBL; BC071583; AAH71583.1; -; mRNA.
DR   EMBL; X98801; CAA67333.1; -; mRNA.
DR   EMBL; AF086947; AAD03694.1; -; Genomic_DNA.
DR   EMBL; AF086927; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086928; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086929; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086930; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086931; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086932; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086933; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086934; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086935; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086936; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086937; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086938; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086939; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086940; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086941; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086942; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086943; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086944; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086945; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; AF086946; AAD03694.1; JOINED; Genomic_DNA.
DR   EMBL; BT006758; AAP35404.1; -; mRNA.
DR   CCDS; CCDS1939.1; -. [Q14203-1]
DR   CCDS; CCDS46341.1; -. [Q14203-4]
DR   CCDS; CCDS46342.1; -. [Q14203-5]
DR   CCDS; CCDS46343.1; -. [Q14203-2]
DR   CCDS; CCDS54368.1; -. [Q14203-3]
DR   CCDS; CCDS54369.1; -. [Q14203-6]
DR   RefSeq; NP_001128512.1; NM_001135040.2. [Q14203-4]
DR   RefSeq; NP_001128513.1; NM_001135041.2. [Q14203-5]
DR   RefSeq; NP_001177765.1; NM_001190836.1. [Q14203-3]
DR   RefSeq; NP_001177766.1; NM_001190837.1. [Q14203-6]
DR   RefSeq; NP_004073.2; NM_004082.4. [Q14203-1]
DR   RefSeq; NP_075408.1; NM_023019.3. [Q14203-2]
DR   UniGene; Hs.516111; -.
DR   PDB; 1TXQ; X-ray; 1.80 A; A=15-107.
DR   PDB; 2COY; NMR; -; A=1-99.
DR   PDB; 2HKN; X-ray; 1.87 A; A/B=18-111.
DR   PDB; 2HKQ; X-ray; 1.86 A; B=18-111.
DR   PDB; 2HL3; X-ray; 2.03 A; A/B=18-111.
DR   PDB; 2HL5; X-ray; 1.93 A; C/D=18-111.
DR   PDB; 2HQH; X-ray; 1.80 A; A/B/C/D=15-107.
DR   PDB; 3E2U; X-ray; 2.60 A; A/B/C/D=18-111.
DR   PDB; 3TQ7; X-ray; 2.30 A; P/Q=27-97.
DR   PDBsum; 1TXQ; -.
DR   PDBsum; 2COY; -.
DR   PDBsum; 2HKN; -.
DR   PDBsum; 2HKQ; -.
DR   PDBsum; 2HL3; -.
DR   PDBsum; 2HL5; -.
DR   PDBsum; 2HQH; -.
DR   PDBsum; 3E2U; -.
DR   PDBsum; 3TQ7; -.
DR   ProteinModelPortal; Q14203; -.
DR   SMR; Q14203; -.
DR   BioGrid; 108007; 247.
DR   CORUM; Q14203; -.
DR   DIP; DIP-31365N; -.
DR   IntAct; Q14203; 202.
DR   MINT; Q14203; -.
DR   STRING; 9606.ENSP00000354791; -.
DR   CarbonylDB; Q14203; -.
DR   iPTMnet; Q14203; -.
DR   PhosphoSitePlus; Q14203; -.
DR   SwissPalm; Q14203; -.
DR   BioMuta; DCTN1; -.
DR   DMDM; 17375490; -.
DR   OGP; Q14203; -.
DR   EPD; Q14203; -.
DR   MaxQB; Q14203; -.
DR   PaxDb; Q14203; -.
DR   PeptideAtlas; Q14203; -.
DR   PRIDE; Q14203; -.
DR   DNASU; 1639; -.
DR   Ensembl; ENST00000361874; ENSP00000354791; ENSG00000204843. [Q14203-1]
DR   Ensembl; ENST00000394003; ENSP00000377571; ENSG00000204843. [Q14203-6]
DR   Ensembl; ENST00000409240; ENSP00000386406; ENSG00000204843. [Q14203-3]
DR   Ensembl; ENST00000409438; ENSP00000387270; ENSG00000204843. [Q14203-5]
DR   Ensembl; ENST00000409567; ENSP00000386843; ENSG00000204843. [Q14203-4]
DR   Ensembl; ENST00000633691; ENSP00000487724; ENSG00000204843. [Q14203-2]
DR   GeneID; 1639; -.
DR   KEGG; hsa:1639; -.
DR   UCSC; uc002sku.4; human. [Q14203-1]
DR   CTD; 1639; -.
DR   DisGeNET; 1639; -.
DR   EuPathDB; HostDB:ENSG00000204843.12; -.
DR   GeneCards; DCTN1; -.
DR   GeneReviews; DCTN1; -.
DR   H-InvDB; HIX0204314; -.
DR   HGNC; HGNC:2711; DCTN1.
DR   HPA; CAB009108; -.
DR   HPA; HPA034635; -.
DR   MalaCards; DCTN1; -.
DR   MIM; 105400; phenotype.
DR   MIM; 168605; phenotype.
DR   MIM; 601143; gene.
DR   MIM; 607641; phenotype.
DR   neXtProt; NX_Q14203; -.
DR   OpenTargets; ENSG00000204843; -.
DR   Orphanet; 803; Amyotrophic lateral sclerosis.
DR   Orphanet; 139589; Distal hereditary motor neuropathy type 7.
DR   Orphanet; 178509; Perry syndrome.
DR   PharmGKB; PA27180; -.
DR   eggNOG; KOG0971; Eukaryota.
DR   eggNOG; COG5244; LUCA.
DR   GeneTree; ENSGT00760000119173; -.
DR   HOGENOM; HOG000015352; -.
DR   HOVERGEN; HBG004956; -.
DR   InParanoid; Q14203; -.
DR   KO; K04648; -.
DR   OMA; CLRQSCN; -.
DR   OrthoDB; EOG091G0WO0; -.
DR   PhylomeDB; Q14203; -.
DR   TreeFam; TF105246; -.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; Q14203; -.
DR   ChiTaRS; DCTN1; human.
DR   EvolutionaryTrace; Q14203; -.
DR   GeneWiki; DCTN1; -.
DR   GenomeRNAi; 1639; -.
DR   PMAP-CutDB; Q14203; -.
DR   PRO; PR:Q14203; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000204843; -.
DR   CleanEx; HS_DCTN1; -.
DR   ExpressionAtlas; Q14203; baseline and differential.
DR   Genevisible; Q14203; HS.
DR   GO; GO:0005938; C:cell cortex; IDA:UniProtKB.
DR   GO; GO:0099738; C:cell cortex region; IDA:UniProtKB.
DR   GO; GO:0031252; C:cell leading edge; IEA:Ensembl.
DR   GO; GO:0120103; C:centriolar subdistal appendage; IDA:GO_Central.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005869; C:dynactin complex; IEA:InterPro.
DR   GO; GO:0030286; C:dynein complex; IEA:UniProtKB-KW.
DR   GO; GO:0045111; C:intermediate filament cytoskeleton; IDA:HPA.
DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0035371; C:microtubule plus-end; IDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0070840; F:dynein complex binding; IEA:InterPro.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0003774; F:motor activity; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0015631; F:tubulin binding; IDA:UniProtKB.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0010457; P:centriole-centriole cohesion; IMP:UniProtKB.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome.
DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0032402; P:melanosome transport; IEA:Ensembl.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IMP:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; NAS:ProtInc.
DR   GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
DR   GO; GO:1905515; P:non-motile cilium assembly; IMP:UniProtKB.
DR   GO; GO:0051081; P:nuclear envelope disassembly; IMP:UniProtKB.
DR   GO; GO:0090063; P:positive regulation of microtubule nucleation; IDA:UniProtKB.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IDA:UniProtKB.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0060236; P:regulation of mitotic spindle organization; IMP:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   GO; GO:0010970; P:transport along microtubule; IEA:InterPro.
DR   Gene3D; 2.30.30.190; -; 1.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR027663; DCTN1.
DR   InterPro; IPR022157; Dynactin.
DR   PANTHER; PTHR18916:SF40; PTHR18916:SF40; 1.
DR   Pfam; PF01302; CAP_GLY; 1.
DR   Pfam; PF12455; Dynactin; 1.
DR   SMART; SM01052; CAP_GLY; 1.
DR   SUPFAM; SSF74924; SSF74924; 1.
DR   PROSITE; PS00845; CAP_GLY_1; 1.
DR   PROSITE; PS50245; CAP_GLY_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amyotrophic lateral sclerosis;
KW   Cell cycle; Cell division; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Dynein; Microtubule; Mitosis; Neurodegeneration;
KW   Neuropathy; Nucleus; Parkinsonism; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transport; Ubl conjugation.
FT   CHAIN         1   1278       Dynactin subunit 1.
FT                                /FTId=PRO_0000083518.
FT   DOMAIN       48     90       CAP-Gly. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00045}.
FT   REGION      911   1278       Interaction with HPS6.
FT                                {ECO:0000269|PubMed:25189619}.
FT   COILED      213    547       {ECO:0000255}.
FT   COILED      943   1049       {ECO:0000255}.
FT   COILED     1182   1211       {ECO:0000255}.
FT   COMPBIAS    164    191       Ser-rich.
FT   MOD_RES     108    108       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     145    145       Phosphothreonine; by SLK.
FT                                {ECO:0000269|PubMed:23985322}.
FT   MOD_RES     146    146       Phosphothreonine; by SLK.
FT                                {ECO:0000269|PubMed:23985322}.
FT   MOD_RES     147    147       Phosphothreonine; by SLK.
FT                                {ECO:0000269|PubMed:23985322}.
FT   MOD_RES     179    179       Phosphoserine; by PLK1.
FT                                {ECO:0000269|PubMed:20679239}.
FT   MOD_RES     212    212       Phosphoserine; by CDK1.
FT                                {ECO:0000269|PubMed:20679239}.
FT   VAR_SEQ       1    138       MAQSKRHVYSRTPSGSRMSAEASARPLRVGSRVEVIGKGHR
FT                                GTVAYVGATLFATGKWVGVILDEAKGKNDGTVQGRKYFTCD
FT                                EGHGIFVRQSQIQVFEDGADTTSPETPDSSASKVLKREGTD
FT                                TTAKTSKLRGLKPKK -> MMRQ (in isoform p135
FT                                and isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000760.
FT   VAR_SEQ       1     17       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045392.
FT   VAR_SEQ     132    151       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045393.
FT   VAR_SEQ     132    138       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:8856662}.
FT                                /FTId=VSP_047174.
FT   VAR_SEQ    1066   1070       Missing (in isoform 3, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045394.
FT   VARIANT      52     52       F -> L (in PERRYS; mutation carriers
FT                                either do not develop depression or they
FT                                do develop it late in the disease course;
FT                                dbSNP:rs886039227).
FT                                {ECO:0000269|PubMed:24676999}.
FT                                /FTId=VAR_071452.
FT   VARIANT      59     59       G -> S (in HMN7B; reduced affinity for
FT                                microtubules which has been suggested to
FT                                impair axonal transport; the effect is
FT                                identical to that of complete loss of the
FT                                CAP-Gly domain; decreased interaction
FT                                with MAPRE1; no effect on its interaction
FT                                with TBCB; dbSNP:rs121909342).
FT                                {ECO:0000269|PubMed:12627231,
FT                                ECO:0000269|PubMed:16505168,
FT                                ECO:0000269|PubMed:19136952,
FT                                ECO:0000269|PubMed:19279216,
FT                                ECO:0000269|PubMed:22777741}.
FT                                /FTId=VAR_015850.
FT   VARIANT      71     71       G -> A (in PERRYS; dbSNP:rs67586389).
FT                                {ECO:0000269|PubMed:19136952}.
FT                                /FTId=VAR_063867.
FT   VARIANT      71     71       G -> E (in PERRYS; dbSNP:rs67586389).
FT                                {ECO:0000269|PubMed:19136952}.
FT                                /FTId=VAR_063868.
FT   VARIANT      71     71       G -> R (in PERRYS; reduced microtubule
FT                                binding; results in the accumulation of
FT                                intracytoplasmic inclusions; loss of
FT                                interaction with CLIP1; significant
FT                                decrease in motility of dynein-dynactin
FT                                complex along microtubules;
FT                                dbSNP:rs72466485).
FT                                {ECO:0000269|PubMed:19136952,
FT                                ECO:0000269|PubMed:24881494,
FT                                ECO:0000269|PubMed:25185702,
FT                                ECO:0000269|PubMed:26972003}.
FT                                /FTId=VAR_063869.
FT   VARIANT      72     72       T -> P (in PERRYS; dbSNP:rs72466486).
FT                                {ECO:0000269|PubMed:19136952}.
FT                                /FTId=VAR_063870.
FT   VARIANT      74     74       Q -> P (in PERRYS; diminishes microtubule
FT                                binding and lead to intracytoplasmic
FT                                inclusions; significant decrease in
FT                                motility of dynein-dynactin complex along
FT                                microtubules; defective in inhibiting
FT                                microtubule catastrophe in neurons;
FT                                dbSNP:rs72466487).
FT                                {ECO:0000269|PubMed:19136952,
FT                                ECO:0000269|PubMed:23874158,
FT                                ECO:0000269|PubMed:25185702}.
FT                                /FTId=VAR_063871.
FT   VARIANT      78     78       Y -> C (in PERRYS; significantly reduced
FT                                microtubule binding; dbSNP:rs886039229).
FT                                {ECO:0000269|PubMed:24881494}.
FT                                /FTId=VAR_071453.
FT   VARIANT     163    163       A -> P.
FT                                /FTId=VAR_001373.
FT   VARIANT     196    196       I -> V (no effect of its interaction with
FT                                TBCB; no loss of localization to
FT                                microtubules; dbSNP:rs55862001).
FT                                {ECO:0000269|PubMed:17824900,
FT                                ECO:0000269|PubMed:22777741}.
FT                                /FTId=VAR_076920.
FT   VARIANT     287    287       L -> M (in dbSNP:rs13420401).
FT                                /FTId=VAR_048677.
FT   VARIANT     495    495       R -> Q (in dbSNP:rs17721059).
FT                                {ECO:0000269|PubMed:17824900}.
FT                                /FTId=VAR_048678.
FT   VARIANT     571    571       M -> T (in ALS; associated with disease
FT                                susceptibility; dbSNP:rs121909343).
FT                                {ECO:0000269|PubMed:15326253}.
FT                                /FTId=VAR_063872.
FT   VARIANT     670    670       Y -> F (found in a patient with
FT                                hereditary motor and sensory neuropathy;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:24627108}.
FT                                /FTId=VAR_073287.
FT   VARIANT     785    785       R -> W (in ALS; associated with disease
FT                                susceptibility; dbSNP:rs121909344).
FT                                {ECO:0000269|PubMed:15326253}.
FT                                /FTId=VAR_063873.
FT   VARIANT    1101   1101       R -> K (in ALS; associated with disease
FT                                susceptibility; dbSNP:rs121909345).
FT                                {ECO:0000269|PubMed:16240349}.
FT                                /FTId=VAR_063874.
FT   VARIANT    1249   1249       T -> I (in ALS; unknown pathological
FT                                significance; dbSNP:rs72466496).
FT                                {ECO:0000269|PubMed:15326253,
FT                                ECO:0000269|PubMed:17824900,
FT                                ECO:0000269|PubMed:19506225}.
FT                                /FTId=VAR_063875.
FT   MUTAGEN      68     68       K->A: Abolishes interaction with CLIP1.
FT                                {ECO:0000269|PubMed:17828275}.
FT   MUTAGEN      90     90       R->E: Abolishes interaction with CLIP1.
FT                                {ECO:0000269|PubMed:17828275}.
FT   MUTAGEN     145    145       T->A: Affects centrosomal localization;
FT                                when associated with A-146 and A-147.
FT                                {ECO:0000269|PubMed:23985322}.
FT   MUTAGEN     146    146       T->A: Affects centrosomal localization;
FT                                when associated with A-145 and A-147.
FT                                {ECO:0000269|PubMed:23985322}.
FT   MUTAGEN     147    147       T->A: Affects centrosomal localization;
FT                                when associated with A-145 and A-146.
FT                                {ECO:0000269|PubMed:23985322}.
FT   MUTAGEN     179    179       S->A: Non-phosphorylatable by PLK1.
FT                                Decreased nuclear envelope localization.
FT                                No loss of microtubule-binding. No effect
FT                                on its interaction with CLIP1.
FT                                {ECO:0000269|PubMed:20679239}.
FT   MUTAGEN     179    179       S->D: No loss of localization to nuclear
FT                                envelope. Decrease in microtubule-
FT                                binding. No effect on its interaction
FT                                with CLIP1.
FT                                {ECO:0000269|PubMed:20679239}.
FT   MUTAGEN     212    212       S->A: No effect on its interaction with
FT                                CLIP1 and PLK1.
FT                                {ECO:0000269|PubMed:20679239}.
FT   CONFLICT     10     10       S -> N (in Ref. 7; CAA67333).
FT                                {ECO:0000305}.
FT   CONFLICT    257    257       Q -> R (in Ref. 2; BAG59757).
FT                                {ECO:0000305}.
FT   CONFLICT    349    349       K -> R (in Ref. 2; AK314352).
FT                                {ECO:0000305}.
FT   CONFLICT    368    368       A -> V (in Ref. 2; AK314352).
FT                                {ECO:0000305}.
FT   CONFLICT    526    526       H -> N (in Ref. 5; AAH71583).
FT                                {ECO:0000305}.
FT   CONFLICT    618    618       K -> R (in Ref. 5; AAH71583).
FT                                {ECO:0000305}.
FT   CONFLICT    712    712       D -> V (in Ref. 7; CAA67333).
FT                                {ECO:0000305}.
FT   CONFLICT   1081   1081       V -> M (in Ref. 9; AAP35404).
FT                                {ECO:0000305}.
FT   CONFLICT   1261   1261       R -> Q (in Ref. 2; BAG59757).
FT                                {ECO:0000305}.
FT   CONFLICT   1274   1274       S -> I (in Ref. 5; AAH71583).
FT                                {ECO:0000305}.
FT   STRAND       17     19       {ECO:0000244|PDB:2COY}.
FT   STRAND       32     35       {ECO:0000244|PDB:1TXQ}.
FT   TURN         36     38       {ECO:0000244|PDB:1TXQ}.
FT   STRAND       41     48       {ECO:0000244|PDB:1TXQ}.
FT   STRAND       51     55       {ECO:0000244|PDB:1TXQ}.
FT   STRAND       57     65       {ECO:0000244|PDB:1TXQ}.
FT   STRAND       67     73       {ECO:0000244|PDB:1TXQ}.
FT   STRAND       76     78       {ECO:0000244|PDB:1TXQ}.
FT   TURN         83     85       {ECO:0000244|PDB:2HQH}.
FT   STRAND       86     89       {ECO:0000244|PDB:1TXQ}.
FT   HELIX        91     93       {ECO:0000244|PDB:1TXQ}.
FT   STRAND       94     96       {ECO:0000244|PDB:1TXQ}.
SQ   SEQUENCE   1278 AA;  141695 MW;  6DCEA5E67856E4BC CRC64;
     MAQSKRHVYS RTPSGSRMSA EASARPLRVG SRVEVIGKGH RGTVAYVGAT LFATGKWVGV
     ILDEAKGKND GTVQGRKYFT CDEGHGIFVR QSQIQVFEDG ADTTSPETPD SSASKVLKRE
     GTDTTAKTSK LRGLKPKKAP TARKTTTRRP KPTRPASTGV AGASSSLGPS GSASAGELSS
     SEPSTPAQTP LAAPIIPTPV LTSPGAVPPL PSPSKEEEGL RAQVRDLEEK LETLRLKRAE
     DKAKLKELEK HKIQLEQVQE WKSKMQEQQA DLQRRLKEAR KEAKEALEAK ERYMEEMADT
     ADAIEMATLD KEMAEERAES LQQEVEALKE RVDELTTDLE ILKAEIEEKG SDGAASSYQL
     KQLEEQNARL KDALVRMRDL SSSEKQEHVK LQKLMEKKNQ ELEVVRQQRE RLQEELSQAE
     STIDELKEQV DAALGAEEMV EMLTDRNLNL EEKVRELRET VGDLEAMNEM NDELQENARE
     TELELREQLD MAGARVREAQ KRVEAAQETV ADYQQTIKKY RQLTAHLQDV NRELTNQQEA
     SVERQQQPPP ETFDFKIKFA ETKAHAKAIE MELRQMEVAQ ANRHMSLLTA FMPDSFLRPG
     GDHDCVLVLL LMPRLICKAE LIRKQAQEKF ELSENCSERP GLRGAAGEQL SFAAGLVYSL
     SLLQATLHRY EHALSQCSVD VYKKVGSLYP EMSAHERSLD FLIELLHKDQ LDETVNVEPL
     TKAIKYYQHL YSIHLAEQPE DCTMQLADHI KFTQSALDCM SVEVGRLRAF LQGGQEATDI
     ALLLRDLETS CSDIRQFCKK IRRRMPGTDA PGIPAALAFG PQVSDTLLDC RKHLTWVVAV
     LQEVAAAAAQ LIAPLAENEG LLVAALEELA FKASEQIYGT PSSSPYECLR QSCNILISTM
     NKLATAMQEG EYDAERPPSK PPPVELRAAA LRAEITDAEG LGLKLEDRET VIKELKKSLK
     IKGEELSEAN VRLSLLEKKL DSAAKDADER IEKVQTRLEE TQALLRKKEK EFEETMDALQ
     ADIDQLEAEK AELKQRLNSQ SKRTIEGLRG PPPSGIATLV SGIAGEEQQR GAIPGQAPGS
     VPGPGLVKDS PLLLQQISAM RLHISQLQHE NSILKGAQMK ASLASLPPLH VAKLSHEGPG
     SELPAGALYR KTSQLLETLN QLSTHTHVVD ITRTSPAAKS PSAQLMEQVA QLKSLSDTVE
     KLKDEVLKET VSQRPGATVP TDFATFPSSA FLRAKEEQQD DTVYMGKVTF SCAAGFGQRH
     RLVLTQEQLH QLHSRLIS
//
ID   Q6MZZ3_HUMAN            Unreviewed;      1278 AA.
AC   Q6MZZ3;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   31-JAN-2018, entry version 84.
DE   SubName: Full=Uncharacterized protein DKFZp686I0746 {ECO:0000313|EMBL:CAE45882.1};
GN   Name=DKFZp686I0746 {ECO:0000313|EMBL:CAE45882.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAE45882.1};
RN   [1] {ECO:0000313|EMBL:CAE45882.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:CAE45882.1};
RG   The German cDNA Consortium;
RA   Ansorge W., Krieger S., Regiert T., Rittmueller C., Schwager B.,
RA   Mewes H.W., Weil B., Amid C., Osanger A., Fobo G., Han M., Wiemann S.;
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX640799; CAE45882.1; -; mRNA.
DR   RefSeq; NP_001177766.1; NM_001190837.1.
DR   RefSeq; NP_004073.2; NM_004082.4.
DR   UniGene; Hs.516111; -.
DR   ProteinModelPortal; Q6MZZ3; -.
DR   PeptideAtlas; Q6MZZ3; -.
DR   DNASU; 1639; -.
DR   GeneID; 1639; -.
DR   KEGG; hsa:1639; -.
DR   CTD; 1639; -.
DR   PharmGKB; PA27180; -.
DR   eggNOG; KOG0971; Eukaryota.
DR   eggNOG; COG5244; LUCA.
DR   HOVERGEN; HBG004956; -.
DR   KO; K04648; -.
DR   GenomeRNAi; 1639; -.
DR   Genevisible; Q6MZZ3; HS.
DR   GO; GO:0005869; C:dynactin complex; IEA:InterPro.
DR   GO; GO:0070840; F:dynein complex binding; IEA:InterPro.
DR   GO; GO:0010970; P:transport along microtubule; IEA:InterPro.
DR   Gene3D; 2.30.30.190; -; 1.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR027663; DCTN1.
DR   InterPro; IPR022157; Dynactin.
DR   PANTHER; PTHR18916:SF40; PTHR18916:SF40; 1.
DR   Pfam; PF01302; CAP_GLY; 1.
DR   Pfam; PF12455; Dynactin; 1.
DR   SMART; SM01052; CAP_GLY; 1.
DR   SUPFAM; SSF74924; SSF74924; 1.
DR   PROSITE; PS00845; CAP_GLY_1; 1.
DR   PROSITE; PS50245; CAP_GLY_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       48     90       CAP-Gly. {ECO:0000259|PROSITE:PS50245}.
FT   COILED      217    352       {ECO:0000256|SAM:Coils}.
FT   COILED      360    383       {ECO:0000256|SAM:Coils}.
FT   COILED      388    540       {ECO:0000256|SAM:Coils}.
FT   COILED      952   1043       {ECO:0000256|SAM:Coils}.
FT   COILED     1185   1205       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1278 AA;  141551 MW;  F2EC8478EF8899FE CRC64;
     MAQSKRHVYS RTPSGSRMSA EASARPLRVG SRVEVIGKGH RGTVAYVGAT LFATGKWVGV
     ILDEAKGKND GTVQGRKYFT CDEGHGIFVR QSQIQVFEDG ADTTSPETPD SSASKVLKRE
     GTDTTAKTSK LRGLKPKKAP TARKTTTRRP KPTRPASTGV AGASSSLGPS GSASAGELSS
     SEPSTPAQTP LAAPIIPTPV LTSPGAVPPL PSPSKEEEGL RAQVRDLEEK LETLRLKRAE
     DKAKLKELEK HKIQLEQVQE WKSKMQEQQA DLQRRLKEAR KEAKEALEAK ERYMEEMADT
     ADAIEMATLD KEMAEERAES LQQEVEALKE RVDELTTDLE ILKAEIEEKG SDGAASSYQL
     KQLEEQNARL KDALVRMRDL SSSEKQEHVK LQKLMEKKNQ ELEVVRQQRE RLQEELSQAE
     STIDELKEQV DAALGAEEMV EMLTDRNLNL EEKVRELRET VGDLEAMNEM NDELQENARE
     TELELREQLD MAGARVREAQ KRVEAAQETV ADYQQTIKKY RQLTAHLQDV NRELTNQQEA
     SVERQQQPPP ETFDFKIKFA ETKAHAKAIE MELRQMGVAQ ANRHMSLLTA FMPDSFLRPG
     GDHDCVLVLL LMPRLICKAE LIRKQAQEKF ELSENCSERP GLRGAAGEQL SFAAGLVYSL
     SLLQATLHRY EHALSQCSVD VYKKVGSLYP EMSAHERSLD FLIELLHKDQ LDETVNVEPL
     TKAIKYYQHL YSIHLAEQPE DCTMQLADHI KFTQSALDCM SVEVGRLRAF LQGGQEATDI
     ALLLRDLETS CSDIRQFCKK IRRRMPGTDA PGIPAALAFG PQVSDTLLDC RKHLTWVVAV
     LQEVAAAAAQ LIAPLAENEG LLVAALEELA FKASEQIYGT PSSSPYECLR QSCNILISTM
     NKLATAMQEG EYDAERPPSK PPPVELRAAA LRAEITDAEG LGLKLEDRET VIKELKKSLK
     IKGEELSEAN VRLSLLEKKL DSAAKDADER IEKVQTRLEE TQALLRKKEK GFEETMDALQ
     ADIDQLEAEK AELKQRLNSQ SKRTIEGLRG PPPSGIATLV SGIAGEEQQR GAIPGQAPGS
     VPGPGLVKDS PLLLQQISAM RLHISQLQHE NSILKGAQMK ASLASLPPLH VAKLSHEGPG
     SELPAGALYR KTSQLLETLN QLSTHTHVVD ITRTSPAAKS PSAQLMEQVA QLKSLSDTVE
     KLKDEVLKET VSQRPGATVP TDFATFPSSA FLRAKEEQQD DTVYMGKVTF SCAAGFGQRH
     RLVLTQEQLH QLHSRLIS
//
ID   DNJB1_HUMAN             Reviewed;         340 AA.
AC   P25685; B4DX52;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   28-FEB-2018, entry version 188.
DE   RecName: Full=DnaJ homolog subfamily B member 1;
DE   AltName: Full=DnaJ protein homolog 1;
DE   AltName: Full=Heat shock 40 kDa protein 1;
DE            Short=HSP40;
DE            Short=Heat shock protein 40;
DE   AltName: Full=Human DnaJ protein 1;
DE            Short=hDj-1;
GN   Name=DNAJB1; Synonyms=DNAJ1, HDJ1, HSPF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=1754405; DOI=10.1093/nar/19.23.6645;
RA   Raabe T., Manley J.L.;
RT   "A human homologue of the Escherichia coli DnaJ heat-shock protein.";
RL   Nucleic Acids Res. 19:6645-6645(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 2-48.
RC   TISSUE=Placenta;
RX   PubMed=8250930; DOI=10.1006/bbrc.1993.2466;
RA   Ohtsuka K.;
RT   "Cloning of a cDNA for heat-shock protein hsp40, a human homologue of
RT   bacterial DnaJ.";
RL   Biochem. Biophys. Res. Commun. 197:235-240(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8975727; DOI=10.1006/geno.1996.0653;
RA   Hata M., Okumura K., Seto M., Ohtsuka K.;
RT   "Genomic cloning of a human heat shock protein 40 (Hsp40) gene (HSPF1)
RT   and its chromosomal localization to 19p13.2.";
RL   Genomics 38:446-449(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-49, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=1586970;
RA   Hattori H., Liu Y.-C., Tohnai I., Ueda M., Kaneda T., Kobayashi T.,
RA   Tanabe K., Ohtsuka K.;
RT   "Intracellular localization and partial amino acid sequence of a
RT   stress-inducible 40-kDa protein in HeLa cells.";
RL   Cell Struct. Funct. 17:77-86(1992).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH HSF1.
RX   PubMed=9499401; DOI=10.1101/gad.12.5.654;
RA   Shi Y., Mosser D.D., Morimoto R.I.;
RT   "Molecular chaperones as HSF1-specific transcriptional repressors.";
RL   Genes Dev. 12:654-666(1998).
RN   [9]
RP   INTERACTION WITH DNAJC3.
RX   PubMed=9920933; DOI=10.1074/jbc.274.6.3797;
RA   Melville M.W., Tan S.-L., Wambach M., Song J., Morimoto R.I.,
RA   Katze M.G.;
RT   "The cellular inhibitor of the PKR protein kinase, P58(IPK), is an
RT   influenza virus-activated co-chaperone that modulates heat shock
RT   protein 70 activity.";
RL   J. Biol. Chem. 274:3797-3803(1999).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-307, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   FUNCTION.
RX   PubMed=24318877; DOI=10.1074/jbc.M113.521997;
RA   Rauch J.N., Gestwicki J.E.;
RT   "Binding of human nucleotide exchange factors to heat shock protein 70
RT   (Hsp70) generates functionally distinct complexes in vitro.";
RL   J. Biol. Chem. 289:1402-1414(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   STRUCTURE BY NMR OF 1-76.
RX   PubMed=8764402; DOI=10.1006/jmbi.1996.0394;
RA   Qian Y.Q., Patel D., Hartl F.-U., McColl D.J.;
RT   "Nuclear magnetic resonance solution structure of the human Hsp40
RT   (HDJ-1) J-domain.";
RL   J. Mol. Biol. 260:224-235(1996).
CC   -!- FUNCTION: Interacts with HSP70 and can stimulate its ATPase
CC       activity. Stimulates the association between HSC70 and HIP.
CC       Negatively regulates heat shock-induced HSF1 transcriptional
CC       activity during the attenuation and recovery phase period of the
CC       heat shock response (PubMed:9499401). Stimulates ATP hydrolysis
CC       and the folding of unfolded proteins mediated by HSPA1A/B (in
CC       vitro) (PubMed:24318877). {ECO:0000269|PubMed:24318877,
CC       ECO:0000269|PubMed:9499401}.
CC   -!- SUBUNIT: Interacts with DNAJC3 (PubMed:9920933). Interacts with
CC       HSF1 (via transactivation domain); this interaction results in the
CC       inhibition of heat shock- and HSF1-induced transcriptional
CC       activity during the attenuation and recovery phase period of the
CC       heat shock response (PubMed:9499401). {ECO:0000269|PubMed:9499401,
CC       ECO:0000269|PubMed:9920933}.
CC   -!- INTERACTION:
CC       Q62392:Phlda1 (xeno); NbExp=2; IntAct=EBI-357034, EBI-309727;
CC       P54274:TERF1; NbExp=2; IntAct=EBI-357034, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:1586970}.
CC       Nucleus {ECO:0000269|PubMed:1586970}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:1586970}. Note=Translocates rapidly from the
CC       cytoplasm to the nucleus, and especially to the nucleoli, upon
CC       heat shock.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P25685-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P25685-2; Sequence=VSP_056414;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: By heat shock. {ECO:0000269|PubMed:1586970}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA44287.1; Type=Frameshift; Positions=11, 28, 81, 136; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X62421; CAA44287.1; ALT_FRAME; mRNA.
DR   EMBL; D49547; BAA08495.1; -; mRNA.
DR   EMBL; D85429; BAA12819.1; -; Genomic_DNA.
DR   EMBL; AK301817; BAG63264.1; -; mRNA.
DR   EMBL; AC009004; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC012318; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002352; AAH02352.1; -; mRNA.
DR   EMBL; BC019827; AAH19827.1; -; mRNA.
DR   CCDS; CCDS12312.1; -. [P25685-1]
DR   CCDS; CCDS74295.1; -. [P25685-2]
DR   PIR; JN0912; JN0912.
DR   PIR; S20062; S20062.
DR   RefSeq; NP_001287843.1; NM_001300914.1. [P25685-2]
DR   RefSeq; NP_001300893.1; NM_001313964.1. [P25685-2]
DR   RefSeq; NP_006136.1; NM_006145.2. [P25685-1]
DR   RefSeq; XP_006722796.1; XM_006722733.1. [P25685-2]
DR   RefSeq; XP_006722797.1; XM_006722734.3. [P25685-2]
DR   RefSeq; XP_011526258.1; XM_011527956.2. [P25685-2]
DR   UniGene; Hs.515210; -.
DR   PDB; 1HDJ; NMR; -; A=1-76.
DR   PDB; 2QLD; X-ray; 2.70 A; A=158-340.
DR   PDB; 3AGX; X-ray; 1.85 A; A/B=161-340.
DR   PDB; 3AGY; X-ray; 1.85 A; A/B=161-340.
DR   PDB; 3AGZ; X-ray; 2.51 A; A/B=151-340.
DR   PDB; 4WB7; X-ray; 1.90 A; A/B=2-70.
DR   PDBsum; 1HDJ; -.
DR   PDBsum; 2QLD; -.
DR   PDBsum; 3AGX; -.
DR   PDBsum; 3AGY; -.
DR   PDBsum; 3AGZ; -.
DR   PDBsum; 4WB7; -.
DR   ProteinModelPortal; P25685; -.
DR   SMR; P25685; -.
DR   BioGrid; 109569; 106.
DR   CORUM; P25685; -.
DR   DIP; DIP-41180N; -.
DR   IntAct; P25685; 51.
DR   MINT; P25685; -.
DR   STRING; 9606.ENSP00000254322; -.
DR   iPTMnet; P25685; -.
DR   PhosphoSitePlus; P25685; -.
DR   BioMuta; DNAJB1; -.
DR   DMDM; 1706473; -.
DR   REPRODUCTION-2DPAGE; IPI00015947; -.
DR   EPD; P25685; -.
DR   PaxDb; P25685; -.
DR   PeptideAtlas; P25685; -.
DR   PRIDE; P25685; -.
DR   DNASU; 3337; -.
DR   Ensembl; ENST00000254322; ENSP00000254322; ENSG00000132002. [P25685-1]
DR   Ensembl; ENST00000396969; ENSP00000444212; ENSG00000132002. [P25685-2]
DR   GeneID; 3337; -.
DR   KEGG; hsa:3337; -.
DR   UCSC; uc010xnr.2; human. [P25685-1]
DR   CTD; 3337; -.
DR   DisGeNET; 3337; -.
DR   EuPathDB; HostDB:ENSG00000132002.7; -.
DR   GeneCards; DNAJB1; -.
DR   H-InvDB; HIX0014838; -.
DR   HGNC; HGNC:5270; DNAJB1.
DR   HPA; CAB017450; -.
DR   HPA; HPA063247; -.
DR   MalaCards; DNAJB1; -.
DR   MIM; 604572; gene.
DR   neXtProt; NX_P25685; -.
DR   OpenTargets; ENSG00000132002; -.
DR   Orphanet; 401920; Fibrolamellar hepatocellular carcinoma.
DR   PharmGKB; PA27412; -.
DR   eggNOG; KOG0714; Eukaryota.
DR   eggNOG; COG0484; LUCA.
DR   GeneTree; ENSGT00760000118947; -.
DR   HOGENOM; HOG000226718; -.
DR   HOVERGEN; HBG066727; -.
DR   InParanoid; P25685; -.
DR   KO; K09507; -.
DR   OMA; GAYTYQF; -.
DR   OrthoDB; EOG091G0DLS; -.
DR   PhylomeDB; P25685; -.
DR   TreeFam; TF105141; -.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   SIGNOR; P25685; -.
DR   ChiTaRS; DNAJB1; human.
DR   EvolutionaryTrace; P25685; -.
DR   GeneWiki; DNAJB1; -.
DR   GenomeRNAi; 3337; -.
DR   PRO; PR:P25685; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000132002; -.
DR   CleanEx; HS_DNAJB1; -.
DR   ExpressionAtlas; P25685; baseline and differential.
DR   Genevisible; P25685; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0001671; F:ATPase activator activity; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IPI:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:UniProtKB.
DR   GO; GO:0030544; F:Hsp70 protein binding; IPI:BHF-UCL.
DR   GO; GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IDA:UniProtKB.
DR   GO; GO:0090084; P:negative regulation of inclusion body assembly; IDA:UniProtKB.
DR   GO; GO:0097201; P:negative regulation of transcription from RNA polymerase II promoter in response to stress; IDA:UniProtKB.
DR   GO; GO:0032781; P:positive regulation of ATPase activity; IDA:BHF-UCL.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0006986; P:response to unfolded protein; TAS:ProtInc.
DR   CDD; cd06257; DnaJ; 1.
DR   Gene3D; 1.10.287.110; -; 1.
DR   InterPro; IPR002939; DnaJ_C.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR018253; DnaJ_domain_CS.
DR   InterPro; IPR008971; HSP40/DnaJ_pept-bd.
DR   InterPro; IPR036869; J_dom_sf.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF01556; DnaJ_C; 1.
DR   PRINTS; PR00625; JDOMAIN.
DR   SMART; SM00271; DnaJ; 1.
DR   SUPFAM; SSF46565; SSF46565; 1.
DR   SUPFAM; SSF49493; SSF49493; 2.
DR   PROSITE; PS00636; DNAJ_1; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chaperone; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Nucleus; Phosphoprotein;
KW   Reference proteome; Stress response.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:1586970,
FT                                ECO:0000269|PubMed:8250930}.
FT   CHAIN         2    340       DnaJ homolog subfamily B member 1.
FT                                /FTId=PRO_0000071016.
FT   DOMAIN        2     70       J. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00286}.
FT   MOD_RES     307    307       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    100       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056414.
FT   CONFLICT     68     68       G -> L (in Ref. 1; CAA44287).
FT                                {ECO:0000305}.
FT   CONFLICT    150    150       R -> C (in Ref. 1; CAA44287).
FT                                {ECO:0000305}.
FT   CONFLICT    183    183       M -> T (in Ref. 1; CAA44287).
FT                                {ECO:0000305}.
FT   CONFLICT    320    320       V -> A (in Ref. 1; CAA44287).
FT                                {ECO:0000305}.
FT   HELIX         5      9       {ECO:0000244|PDB:4WB7}.
FT   HELIX        17     31       {ECO:0000244|PDB:4WB7}.
FT   TURN         33     35       {ECO:0000244|PDB:4WB7}.
FT   HELIX        41     55       {ECO:0000244|PDB:4WB7}.
FT   HELIX        58     70       {ECO:0000244|PDB:4WB7}.
FT   STRAND      166    170       {ECO:0000244|PDB:3AGX}.
FT   HELIX       172    177       {ECO:0000244|PDB:3AGX}.
FT   STRAND      179    190       {ECO:0000244|PDB:3AGX}.
FT   TURN        191    193       {ECO:0000244|PDB:2QLD}.
FT   STRAND      197    208       {ECO:0000244|PDB:3AGX}.
FT   STRAND      217    220       {ECO:0000244|PDB:3AGX}.
FT   STRAND      228    230       {ECO:0000244|PDB:3AGX}.
FT   STRAND      235    241       {ECO:0000244|PDB:3AGX}.
FT   STRAND      248    250       {ECO:0000244|PDB:3AGX}.
FT   STRAND      253    261       {ECO:0000244|PDB:3AGX}.
FT   HELIX       262    267       {ECO:0000244|PDB:3AGX}.
FT   STRAND      269    274       {ECO:0000244|PDB:3AGX}.
FT   STRAND      280    285       {ECO:0000244|PDB:3AGX}.
FT   STRAND      294    297       {ECO:0000244|PDB:3AGX}.
FT   STRAND      305    307       {ECO:0000244|PDB:3AGX}.
FT   STRAND      314    321       {ECO:0000244|PDB:3AGX}.
FT   HELIX       328    337       {ECO:0000244|PDB:3AGX}.
SQ   SEQUENCE   340 AA;  38044 MW;  17545098B0C196DF CRC64;
     MGKDYYQTLG LARGASDEEI KRAYRRQALR YHPDKNKEPG AEEKFKEIAE AYDVLSDPRK
     REIFDRYGEE GLKGSGPSGG SGGGANGTSF SYTFHGDPHA MFAEFFGGRN PFDTFFGQRN
     GEEGMDIDDP FSGFPMGMGG FTNVNFGRSR SAQEPARKKQ DPPVTHDLRV SLEEIYSGCT
     KKMKISHKRL NPDGKSIRNE DKILTIEVKK GWKEGTKITF PKEGDQTSNN IPADIVFVLK
     DKPHNIFKRD GSDVIYPARI SLREALCGCT VNVPTLDGRT IPVVFKDVIR PGMRRKVPGE
     GLPLPKTPEK RGDLIIEFEV IFPERIPQTS RTVLEQVLPI
//
ID   Q6FHS4_HUMAN            Unreviewed;       340 AA.
AC   Q6FHS4;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 110.
DE   SubName: Full=DNAJB1 protein {ECO:0000313|EMBL:CAG46478.1};
DE   SubName: Full=DnaJ (Hsp40) homolog, subfamily B, member 1, isoform CRA_a {ECO:0000313|EMBL:EAW84432.1};
DE   SubName: Full=cDNA, FLJ93008, Homo sapiens DnaJ (Hsp40) homolog, subfamily B, member 1 (DNAJB1),mRNA {ECO:0000313|EMBL:BAG35510.1};
DE   Flags: Fragment;
GN   Name=DNAJB1 {ECO:0000313|EMBL:CAG46478.1};
GN   ORFNames=hCG_1776318 {ECO:0000313|EMBL:EAW84432.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG46478.1};
RN   [1] {ECO:0000313|EMBL:EAW84432.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:CAG46478.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW84432.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG35510.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Heart {ECO:0000313|EMBL:BAG35510.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK312624; BAG35510.1; -; mRNA.
DR   EMBL; CR541677; CAG46478.1; -; mRNA.
DR   EMBL; CH471106; EAW84432.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84433.1; -; Genomic_DNA.
DR   RefSeq; NP_006136.1; NM_006145.2.
DR   UniGene; Hs.515210; -.
DR   SMR; Q6FHS4; -.
DR   MaxQB; Q6FHS4; -.
DR   DNASU; 3337; -.
DR   GeneID; 3337; -.
DR   KEGG; hsa:3337; -.
DR   UCSC; uc002myz.2; human.
DR   CTD; 3337; -.
DR   EuPathDB; HostDB:ENSG00000132002.7; -.
DR   PharmGKB; PA27412; -.
DR   eggNOG; KOG0714; Eukaryota.
DR   eggNOG; COG0484; LUCA.
DR   HOVERGEN; HBG066727; -.
DR   KO; K09507; -.
DR   OMA; GAYTYQF; -.
DR   OrthoDB; EOG091G0DLS; -.
DR   ChiTaRS; DNAJB1; human.
DR   GenomeRNAi; 3337; -.
DR   Bgee; ENSG00000132002; -.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IEA:Ensembl.
DR   CDD; cd06257; DnaJ; 1.
DR   Gene3D; 1.10.287.110; -; 1.
DR   InterPro; IPR002939; DnaJ_C.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR018253; DnaJ_domain_CS.
DR   InterPro; IPR008971; HSP40/DnaJ_pept-bd.
DR   InterPro; IPR036869; J_dom_sf.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF01556; DnaJ_C; 1.
DR   PRINTS; PR00625; JDOMAIN.
DR   SMART; SM00271; DnaJ; 1.
DR   SUPFAM; SSF46565; SSF46565; 1.
DR   SUPFAM; SSF49493; SSF49493; 2.
DR   PROSITE; PS00636; DNAJ_1; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN        4     68       J. {ECO:0000259|PROSITE:PS50076}.
FT   NON_TER     340    340       {ECO:0000313|EMBL:CAG46478.1}.
SQ   SEQUENCE   340 AA;  38044 MW;  17545098B0C196DF CRC64;
     MGKDYYQTLG LARGASDEEI KRAYRRQALR YHPDKNKEPG AEEKFKEIAE AYDVLSDPRK
     REIFDRYGEE GLKGSGPSGG SGGGANGTSF SYTFHGDPHA MFAEFFGGRN PFDTFFGQRN
     GEEGMDIDDP FSGFPMGMGG FTNVNFGRSR SAQEPARKKQ DPPVTHDLRV SLEEIYSGCT
     KKMKISHKRL NPDGKSIRNE DKILTIEVKK GWKEGTKITF PKEGDQTSNN IPADIVFVLK
     DKPHNIFKRD GSDVIYPARI SLREALCGCT VNVPTLDGRT IPVVFKDVIR PGMRRKVPGE
     GLPLPKTPEK RGDLIIEFEV IFPERIPQTS RTVLEQVLPI
//
ID   IF4A2_HUMAN             Reviewed;         407 AA.
AC   Q14240; D3DNU9; Q53XJ6; Q96B90; Q96EA8;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2004, sequence version 2.
DT   28-FEB-2018, entry version 187.
DE   RecName: Full=Eukaryotic initiation factor 4A-II;
DE            Short=eIF-4A-II;
DE            Short=eIF4A-II;
DE            EC=3.6.4.13;
DE   AltName: Full=ATP-dependent RNA helicase eIF4A-2;
GN   Name=EIF4A2; Synonyms=DDX2B, EIF4F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=8521730;
RA   Sudo K., Takahashi E., Nakamura Y.;
RT   "Isolation and mapping of the human EIF4A2 gene homologous to the
RT   murine protein synthesis initiation factor 4A-II gene Eif4a2.";
RL   Cytogenet. Cell Genet. 71:385-388(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Bone marrow, Brain, Lymph, and Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH EIF4E.
RX   PubMed=11408474; DOI=10.1074/jbc.C100284200;
RA   Li W., Belsham G.J., Proud C.G.;
RT   "Eukaryotic initiation factors 4A (eIF4A) and 4G (eIF4G) mutually
RT   interact in a 1:1 ratio in vivo.";
RL   J. Biol. Chem. 276:29111-29115(2001).
RN   [7]
RP   POSSIBLE INTERACTION WITH NOM1.
RX   PubMed=15715967; DOI=10.1016/j.gene.2004.12.027;
RA   Simmons H.M., Ruis B.L., Kapoor M., Hudacek A.W., Conklin K.F.;
RT   "Identification of NOM1, a nucleolar, eIF4A binding protein encoded
RT   within the chromosome 7q36 breakpoint region targeted in cases of
RT   pediatric acute myeloid leukemia.";
RL   Gene 347:137-145(2005).
RN   [8]
RP   INTERACTION WITH HHV-1 VHS.
RX   PubMed=16014927; DOI=10.1128/JVI.79.15.9651-9664.2005;
RA   Feng P., Everly D.N. Jr., Read G.S.;
RT   "mRNA decay during herpes simplex virus (HSV) infections: protein-
RT   protein interactions involving the HSV virion host shutoff protein and
RT   translation factors eIF4H and eIF4A.";
RL   J. Virol. 79:9651-9664(2005).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-159, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 22-240.
RX   PubMed=20941364; DOI=10.1371/journal.pone.0012791;
RA   Schutz P., Karlberg T., van den Berg S., Collins R., Lehtio L.,
RA   Hogbom M., Holmberg-Schiavone L., Tempel W., Park H.W.,
RA   Hammarstrom M., Moche M., Thorsell A.G., Schuler H.;
RT   "Comparative structural analysis of human DEAD-box RNA helicases.";
RL   PLoS ONE 5:E12791-E12791(2010).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-181.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: ATP-dependent RNA helicase which is a subunit of the
CC       eIF4F complex involved in cap recognition and is required for mRNA
CC       binding to ribosome. In the current model of translation
CC       initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR
CC       of mRNAs which is necessary to allow efficient binding of the
CC       small ribosomal subunit, and subsequent scanning for the initiator
CC       codon.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC   -!- SUBUNIT: eIF4F is a multi-subunit complex, the composition of
CC       which varies with external and internal environmental conditions.
CC       It is composed of at least EIF4A, EIF4E and EIF4G1/EIFFG3 (By
CC       similarity). Interacts with EIF4E. May interact with NOM1.
CC       Interacts with HHV-1 Vhs. {ECO:0000250,
CC       ECO:0000269|PubMed:11408474, ECO:0000269|PubMed:16014927}.
CC   -!- INTERACTION:
CC       P27958:- (xeno); NbExp=4; IntAct=EBI-73473, EBI-6904388;
CC       Q7L190:DPPA4; NbExp=3; IntAct=EBI-10232522, EBI-710457;
CC       P04792:HSPB1; NbExp=2; IntAct=EBI-73473, EBI-352682;
CC       Q9UI26:IPO11; NbExp=3; IntAct=EBI-73473, EBI-748752;
CC       Q99750:MDFI; NbExp=3; IntAct=EBI-10232522, EBI-724076;
CC       Q53EL6:PDCD4; NbExp=5; IntAct=EBI-73473, EBI-935824;
CC       Q8WWB5:PIH1D2; NbExp=3; IntAct=EBI-10232522, EBI-10232538;
CC       Q7RTY1:SLC16A9; NbExp=3; IntAct=EBI-73473, EBI-10232636;
CC       Q9Y2D8:SSX2IP; NbExp=3; IntAct=EBI-73473, EBI-2212028;
CC       Q9NQ86:TRIM36; NbExp=3; IntAct=EBI-10232522, EBI-2341518;
CC       Q9HCM9:TRIM39; NbExp=3; IntAct=EBI-73473, EBI-739510;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14240-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14240-2; Sequence=VSP_009629;
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. eIF4A
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EIF4A2ID262.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D30655; BAA06336.1; -; mRNA.
DR   EMBL; BT009860; AAP88862.1; -; mRNA.
DR   EMBL; AC112907; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78172.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78177.1; -; Genomic_DNA.
DR   EMBL; BC012547; AAH12547.1; -; mRNA.
DR   EMBL; BC013708; AAH13708.1; -; mRNA.
DR   EMBL; BC015842; AAH15842.1; -; mRNA.
DR   EMBL; BC048105; AAH48105.1; -; mRNA.
DR   CCDS; CCDS3282.1; -. [Q14240-1]
DR   RefSeq; NP_001958.2; NM_001967.3. [Q14240-1]
DR   UniGene; Hs.518475; -.
DR   UniGene; Hs.599481; -.
DR   PDB; 3BOR; X-ray; 1.85 A; A=22-240.
DR   PDBsum; 3BOR; -.
DR   ProteinModelPortal; Q14240; -.
DR   SMR; Q14240; -.
DR   BioGrid; 108290; 64.
DR   IntAct; Q14240; 30.
DR   MINT; Q14240; -.
DR   STRING; 9606.ENSP00000326381; -.
DR   iPTMnet; Q14240; -.
DR   PhosphoSitePlus; Q14240; -.
DR   SwissPalm; Q14240; -.
DR   BioMuta; EIF4A2; -.
DR   DMDM; 45645183; -.
DR   EPD; Q14240; -.
DR   MaxQB; Q14240; -.
DR   PaxDb; Q14240; -.
DR   PeptideAtlas; Q14240; -.
DR   PRIDE; Q14240; -.
DR   DNASU; 1974; -.
DR   Ensembl; ENST00000323963; ENSP00000326381; ENSG00000156976. [Q14240-1]
DR   Ensembl; ENST00000440191; ENSP00000398370; ENSG00000156976. [Q14240-2]
DR   GeneID; 1974; -.
DR   KEGG; hsa:1974; -.
DR   UCSC; uc003fqs.4; human. [Q14240-1]
DR   CTD; 1974; -.
DR   DisGeNET; 1974; -.
DR   EuPathDB; HostDB:ENSG00000156976.14; -.
DR   GeneCards; EIF4A2; -.
DR   H-InvDB; HIX0003899; -.
DR   HGNC; HGNC:3284; EIF4A2.
DR   HPA; CAB011690; -.
DR   HPA; HPA068286; -.
DR   MIM; 601102; gene.
DR   neXtProt; NX_Q14240; -.
DR   OpenTargets; ENSG00000156976; -.
DR   PharmGKB; PA27712; -.
DR   eggNOG; KOG0327; Eukaryota.
DR   eggNOG; COG0513; LUCA.
DR   GeneTree; ENSGT00530000062880; -.
DR   HOGENOM; HOG000268797; -.
DR   HOVERGEN; HBG107989; -.
DR   InParanoid; Q14240; -.
DR   KO; K03257; -.
DR   OMA; FGCQALV; -.
DR   OrthoDB; EOG091G07OI; -.
DR   PhylomeDB; Q14240; -.
DR   TreeFam; TF101524; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-429947; Deadenylation of mRNA.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-72662; Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S.
DR   Reactome; R-HSA-72702; Ribosomal scanning and start codon recognition.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   SIGNOR; Q14240; -.
DR   ChiTaRS; EIF4A2; human.
DR   EvolutionaryTrace; Q14240; -.
DR   GeneWiki; EIF4A2; -.
DR   GenomeRNAi; 1974; -.
DR   PMAP-CutDB; Q14240; -.
DR   PRO; PR:Q14240; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000156976; -.
DR   CleanEx; HS_EIF4A2; -.
DR   ExpressionAtlas; Q14240; baseline and differential.
DR   Genevisible; Q14240; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016281; C:eukaryotic translation initiation factor 4F complex; TAS:ProtInc.
DR   GO; GO:0005730; C:nucleolus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:AgBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004004; F:ATP-dependent RNA helicase activity; IBA:GO_Central.
DR   GO; GO:0016887; F:ATPase activity; IDA:AgBase.
DR   GO; GO:0004386; F:helicase activity; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003743; F:translation initiation factor activity; TAS:ProtInc.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:1900260; P:negative regulation of RNA-directed 5'-3' RNA polymerase activity; IDA:AgBase.
DR   GO; GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome.
DR   GO; GO:0006446; P:regulation of translational initiation; TAS:ProtInc.
DR   GO; GO:0010501; P:RNA secondary structure unwinding; IBA:GO_Central.
DR   GO; GO:0006413; P:translational initiation; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd00079; HELICc; 1.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR037583; EIF4A.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000629; RNA-helicase_DEAD-box_CS.
DR   InterPro; IPR014014; RNA_helicase_DEAD_Q_motif.
DR   PANTHER; PTHR24031:SF226; PTHR24031:SF226; 1.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00039; DEAD_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS51195; Q_MOTIF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Helicase; Host-virus interaction; Hydrolase; Initiation factor;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Protein biosynthesis; Reference proteome; RNA-binding.
FT   CHAIN         1    407       Eukaryotic initiation factor 4A-II.
FT                                /FTId=PRO_0000054938.
FT   DOMAIN       64    235       Helicase ATP-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00541}.
FT   DOMAIN      246    407       Helicase C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00542}.
FT   NP_BIND      77     84       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00541}.
FT   MOTIF        33     61       Q motif.
FT   MOTIF       183    186       DEAD box.
FT   MOD_RES     159    159       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       9      9       N -> NS (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009629.
FT   VARIANT      93     93       Q -> H (in dbSNP:rs11538616).
FT                                /FTId=VAR_052158.
FT   VARIANT     181    181       V -> L (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035838.
FT   CONFLICT     27     27       N -> S (in Ref. 5; AAH15842).
FT                                {ECO:0000305}.
FT   CONFLICT    212    213       LL -> FA (in Ref. 1; BAA06336).
FT                                {ECO:0000305}.
FT   HELIX        35     37       {ECO:0000244|PDB:3BOR}.
FT   HELIX        42     51       {ECO:0000244|PDB:3BOR}.
FT   HELIX        58     68       {ECO:0000244|PDB:3BOR}.
FT   STRAND       73     75       {ECO:0000244|PDB:3BOR}.
FT   HELIX        81     94       {ECO:0000244|PDB:3BOR}.
FT   STRAND      104    107       {ECO:0000244|PDB:3BOR}.
FT   HELIX       111    124       {ECO:0000244|PDB:3BOR}.
FT   TURN        125    129       {ECO:0000244|PDB:3BOR}.
FT   STRAND      132    135       {ECO:0000244|PDB:3BOR}.
FT   STRAND      154    158       {ECO:0000244|PDB:3BOR}.
FT   HELIX       160    168       {ECO:0000244|PDB:3BOR}.
FT   STRAND      179    184       {ECO:0000244|PDB:3BOR}.
FT   HELIX       185    190       {ECO:0000244|PDB:3BOR}.
FT   HELIX       194    203       {ECO:0000244|PDB:3BOR}.
FT   STRAND      209    213       {ECO:0000244|PDB:3BOR}.
FT   HELIX       219    228       {ECO:0000244|PDB:3BOR}.
FT   STRAND      233    235       {ECO:0000244|PDB:3BOR}.
SQ   SEQUENCE   407 AA;  46402 MW;  FAA7D3BA9D8C6DA0 CRC64;
     MSGGSADYNR EHGGPEGMDP DGVIESNWNE IVDNFDDMNL KESLLRGIYA YGFEKPSAIQ
     QRAIIPCIKG YDVIAQAQSG TGKTATFAIS ILQQLEIEFK ETQALVLAPT RELAQQIQKV
     ILALGDYMGA TCHACIGGTN VRNEMQKLQA EAPHIVVGTP GRVFDMLNRR YLSPKWIKMF
     VLDEADEMLS RGFKDQIYEI FQKLNTSIQV VLLSATMPTD VLEVTKKFMR DPIRILVKKE
     ELTLEGIKQF YINVEREEWK LDTLCDLYET LTITQAVIFL NTRRKVDWLT EKMHARDFTV
     SALHGDMDQK ERDVIMREFR SGSSRVLITT DLLARGIDVQ QVSLVINYDL PTNRENYIHR
     IGRGGRFGRK GVAINFVTEE DKRILRDIET FYNTTVEEMP MNVADLI
//
ID   B5MBZ0_HUMAN            Unreviewed;       992 AA.
AC   B5MBZ0;
DT   14-OCT-2008, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 3.
DT   28-FEB-2018, entry version 82.
DE   SubName: Full=Echinoderm microtubule-associated protein-like 4 {ECO:0000313|Ensembl:ENSP00000384939};
GN   Name=EML4 {ECO:0000313|Ensembl:ENSP00000384939};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000384939, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000384939, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [6] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [8] {ECO:0000313|Ensembl:ENSP00000384939}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [9] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000384939}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC006038; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083949; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096668; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005264324.1; XM_005264267.1.
DR   UniGene; Hs.713173; -.
DR   ProteinModelPortal; B5MBZ0; -.
DR   EPD; B5MBZ0; -.
DR   MaxQB; B5MBZ0; -.
DR   PeptideAtlas; B5MBZ0; -.
DR   PRIDE; B5MBZ0; -.
DR   Ensembl; ENST00000401738; ENSP00000384939; ENSG00000143924.
DR   GeneID; 27436; -.
DR   UCSC; uc061iox.1; human.
DR   CTD; 27436; -.
DR   EuPathDB; HostDB:ENSG00000143924.18; -.
DR   HGNC; HGNC:1316; EML4.
DR   OpenTargets; ENSG00000143924; -.
DR   eggNOG; ENOG410ISA0; Eukaryota.
DR   eggNOG; COG2319; LUCA.
DR   GeneTree; ENSGT00550000074369; -.
DR   HOGENOM; HOG000294061; -.
DR   HOVERGEN; HBG051470; -.
DR   OMA; GHCADFH; -.
DR   OrthoDB; EOG091G04Z4; -.
DR   PhylomeDB; B5MBZ0; -.
DR   SignaLink; B5MBZ0; -.
DR   ChiTaRS; EML4; human.
DR   GenomeRNAi; 27436; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000143924; -.
DR   ExpressionAtlas; B5MBZ0; baseline and differential.
DR   Gene3D; 2.130.10.10; -; 3.
DR   InterPro; IPR005108; HELP.
DR   InterPro; IPR011047; Quinoprotein_ADH-like_supfam.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF03451; HELP; 1.
DR   Pfam; PF00400; WD40; 5.
DR   SMART; SM00320; WD40; 9.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   SUPFAM; SSF50998; SSF50998; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 4.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 3.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:B5MBZ0,
KW   ECO:0000213|MaxQB:B5MBZ0, ECO:0000213|PeptideAtlas:B5MBZ0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00756755};
KW   WD repeat {ECO:0000256|PROSITE-ProRule:PRU00221,
KW   ECO:0000256|SAAS:SAAS00756638}.
FT   DOMAIN      516    557       WD_REPEATS_REGION.
FT                                {ECO:0000259|PROSITE:PS50294}.
FT   REPEAT      516    548       WD. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00221}.
FT   DOMAIN      599    769       WD_REPEATS_REGION.
FT                                {ECO:0000259|PROSITE:PS50294}.
FT   REPEAT      599    631       WD. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00221}.
FT   REPEAT      728    769       WD. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00221}.
FT   DOMAIN      841    883       WD_REPEATS_REGION.
FT                                {ECO:0000259|PROSITE:PS50294}.
FT   REPEAT      841    875       WD. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00221}.
FT   COILED       17     51       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   992 AA;  110178 MW;  0F3A05B3B4663582 CRC64;
     MDGFAGSLDD SISAASTSDV QDRLSALESR VQQQEDEITV LKAALADVLR RLAISEDHVA
     SVKKSVSSKG QPSPRAVIPM SCITNGSGAN RKPSHTSAVS IAGKETLSSA AKSGTEKKKE
     KPQGQREKKE ESHSNDQSPQ IRASPSPQPS SQPLQIHRQT PESKNATPTK SIKRPSPAEK
     SHNSWENSDD SRNKLSKIPS TPKLIPKVTK TADKHKDVII NQAKMSTREK NSQEGEYIKM
     FMRGRPITMF IPSDVDNYDD IRTELPPEKL KLEWAYGYRG KDCRANVYLL PTGKIVYFIA
     SVVVLFNYEE RTQRHYLGHT DCVKCLAIHP DKIRIATGQI AGVDKDGRPL QPHVRVWDSV
     TLSTLQIIGL GTFERGVGCL DFSKADSGVH LCIIDDSNEH MLTVWDWQKK AKGAEIKTTN
     EVVLAVEFHP TDANTIITCG KSHIFFWTWS GNSLTRKQGI FGKYEKPKFV QCLAFLGNGD
     VLTGDSGGVM LIWSKTTVEP TPGKGPKGVY QISKQIKAHD GSVFTLCQMR NGMLLTGGGK
     DRKIILWDHD LNPEREIEVP DQYGTIRAVA EGKADQFLVG TSRNFILRGT FNDGFQIEVQ
     GHTDELWGLA THPFKDLLLT CAQDRQVCLW NSMEHRLEWT RLVDEPGHCA DFHPSGTVVA
     IGTHSGRWFV LDAETRDLVS IHTDGNEQLS VMRYSIDGTF LAVGSHDNFI YLYVVSENGR
     KYSRYGRCTG HSSYITHLDW SPDNKYIMSN SGDYEILYWD IPNGCKLIRN RSDCKDIDWT
     TYTCVLGFQV FGVWPEGSDG TDINALVRSH NRKVIAVADD FCKVHLFQYP CSKAKAPSHK
     YSAHSSHVTN VSFTHNDSHL ISTGGKDMSI IQWKLVEKLS LPQNETVADT TLTKAPVSST
     ESVIQSNTPT PPPSQPLNET AEEESRISSS PTLLENSLEQ TVEPSEDHSE EESEEGSGDL
     GEPLYEEPCN EISKEQAKAT LLEDQQDPSP SS
//
ID   EMAL4_HUMAN             Reviewed;         981 AA.
AC   Q9HC35; A6H8Y6; B2RBK3; B2RTW7; B5MCW9; Q3SWW0; Q53R29; Q53TW8;
AC   Q6PJ45; Q9NV40;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   28-FEB-2018, entry version 163.
DE   RecName: Full=Echinoderm microtubule-associated protein-like 4;
DE            Short=EMAP-4;
DE   AltName: Full=Restrictedly overexpressed proliferation-associated protein;
DE   AltName: Full=Ropp 120;
GN   Name=EML4; Synonyms=C2orf2, EMAPL4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   VARIANTS GLU-283 AND VAL-382.
RX   PubMed=10995578; DOI=10.1006/geno.2000.6301;
RA   Heidebrecht H.J., Buck F., Pollmann M., Siebert R., Parwaresch R.;
RT   "Cloning and localization of C2orf2(ropp120), a previously unknown WD
RT   repeat protein.";
RL   Genomics 68:348-350(2000).
RN   [2]
RP   SEQUENCE REVISION TO 121 AND 398.
RA   Heidebrecht H.J.;
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-283; VAL-382
RP   AND ARG-398.
RC   TISSUE=Hippocampus, and Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS GLU-283; VAL-382 AND ARG-398.
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-226, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-144; SER-146; SER-895;
RP   THR-897; THR-899 AND SER-903, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-897 AND THR-899, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-7; SER-13; SER-16; SER-61; SER-144; THR-899 AND
RP   SER-978, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-144; SER-146 AND
RP   SER-978, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-61; SER-144; SER-146;
RP   SER-171; SER-200; THR-201; THR-897 AND THR-899, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-96; THR-237; SER-891 AND
RP   THR-899, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May modify the assembly dynamics of microtubules, such
CC       that microtubules are slightly longer, but more dynamic.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HC35-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HC35-2; Sequence=VSP_047192;
CC         Note=No experimental confirmation available.;
CC   -!- DEVELOPMENTAL STAGE: Strongly overexpressed during mitosis.
CC   -!- SIMILARITY: Belongs to the WD repeat EMAP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI04648.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA91919.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EML4ID44353ch2p21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF177377; AAG09279.2; -; mRNA.
DR   EMBL; AK001804; BAA91919.1; ALT_INIT; mRNA.
DR   EMBL; AK314702; BAG37250.1; -; mRNA.
DR   EMBL; AC006038; AAY15086.1; -; Genomic_DNA.
DR   EMBL; AC083949; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096668; AAY14895.1; -; Genomic_DNA.
DR   EMBL; BC023522; AAH23522.1; -; mRNA.
DR   EMBL; BC104647; AAI04648.1; ALT_SEQ; mRNA.
DR   EMBL; BC140845; AAI40846.1; -; mRNA.
DR   EMBL; BC146799; AAI46800.1; -; mRNA.
DR   CCDS; CCDS1807.1; -. [Q9HC35-1]
DR   CCDS; CCDS46266.1; -. [Q9HC35-2]
DR   RefSeq; NP_001138548.1; NM_001145076.2.
DR   RefSeq; NP_061936.2; NM_019063.4.
DR   UniGene; Hs.713173; -.
DR   PDB; 4CGC; X-ray; 2.90 A; A/B/C=6-64.
DR   PDBsum; 4CGC; -.
DR   ProteinModelPortal; Q9HC35; -.
DR   SMR; Q9HC35; -.
DR   BioGrid; 118169; 25.
DR   IntAct; Q9HC35; 10.
DR   STRING; 9606.ENSP00000320663; -.
DR   iPTMnet; Q9HC35; -.
DR   PhosphoSitePlus; Q9HC35; -.
DR   BioMuta; EML4; -.
DR   DMDM; 296439364; -.
DR   EPD; Q9HC35; -.
DR   MaxQB; Q9HC35; -.
DR   PaxDb; Q9HC35; -.
DR   PeptideAtlas; Q9HC35; -.
DR   PRIDE; Q9HC35; -.
DR   Ensembl; ENST00000318522; ENSP00000320663; ENSG00000143924. [Q9HC35-1]
DR   Ensembl; ENST00000402711; ENSP00000385059; ENSG00000143924. [Q9HC35-2]
DR   GeneID; 27436; -.
DR   KEGG; hsa:27436; -.
DR   UCSC; uc002rsi.3; human. [Q9HC35-1]
DR   CTD; 27436; -.
DR   DisGeNET; 27436; -.
DR   EuPathDB; HostDB:ENSG00000143924.18; -.
DR   GeneCards; EML4; -.
DR   HGNC; HGNC:1316; EML4.
DR   HPA; HPA036687; -.
DR   HPA; HPA036688; -.
DR   HPA; HPA065337; -.
DR   MIM; 607442; gene.
DR   neXtProt; NX_Q9HC35; -.
DR   OpenTargets; ENSG00000143924; -.
DR   Orphanet; 357191; Selection of therapeutic option in non-small cell lung carcinoma.
DR   PharmGKB; PA27769; -.
DR   eggNOG; ENOG410ISA0; Eukaryota.
DR   eggNOG; COG2319; LUCA.
DR   GeneTree; ENSGT00550000074369; -.
DR   HOGENOM; HOG000294061; -.
DR   HOVERGEN; HBG051470; -.
DR   InParanoid; Q9HC35; -.
DR   KO; K15420; -.
DR   PhylomeDB; Q9HC35; -.
DR   TreeFam; TF317832; -.
DR   SignaLink; Q9HC35; -.
DR   ChiTaRS; EML4; human.
DR   GeneWiki; EML4; -.
DR   GenomeRNAi; 27436; -.
DR   PRO; PR:Q9HC35; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000143924; -.
DR   CleanEx; HS_EML4; -.
DR   ExpressionAtlas; Q9HC35; baseline and differential.
DR   Genevisible; Q9HC35; HS.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IBA:GO_Central.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0007017; P:microtubule-based process; NAS:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; NAS:UniProtKB.
DR   Gene3D; 2.130.10.10; -; 3.
DR   InterPro; IPR005108; HELP.
DR   InterPro; IPR011047; Quinoprotein_ADH-like_supfam.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF03451; HELP; 1.
DR   Pfam; PF00400; WD40; 5.
DR   SMART; SM00320; WD40; 9.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   SUPFAM; SSF50998; SSF50998; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 4.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing; Microtubule;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; WD repeat.
FT   CHAIN         1    981       Echinoderm microtubule-associated
FT                                protein-like 4.
FT                                /FTId=PRO_0000050963.
FT   REPEAT      307    356       WD 1.
FT   REPEAT      361    404       WD 2.
FT   REPEAT      407    448       WD 3.
FT   REPEAT      454    492       WD 4.
FT   REPEAT      507    546       WD 5.
FT   REPEAT      590    629       WD 6.
FT   REPEAT      673    712       WD 7.
FT   REPEAT      719    758       WD 8.
FT   REPEAT      832    872       WD 9.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES       7      7       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      16     16       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      61     61       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      96     96       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     144    144       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     146    146       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     171    171       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     200    200       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     201    201       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     226    226       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES     237    237       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     891    891       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     895    895       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     897    897       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     899    899       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     903    903       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     978    978       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   VAR_SEQ     112    169       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_047192.
FT   VARIANT     283    283       K -> E (in dbSNP:rs6736913).
FT                                {ECO:0000269|PubMed:10995578,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031726.
FT   VARIANT     382    382       I -> V (in dbSNP:rs10202624).
FT                                {ECO:0000269|PubMed:10995578,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031727.
FT   VARIANT     398    398       K -> R (in dbSNP:rs28651764).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031728.
FT   VARIANT     978    978       S -> L (in dbSNP:rs28364731).
FT                                /FTId=VAR_031729.
FT   CONFLICT    768    773       WTTYTC -> SSRPCW (in Ref. 4; AAY15086).
FT                                {ECO:0000305}.
FT   HELIX        18     43       {ECO:0000244|PDB:4CGC}.
SQ   SEQUENCE   981 AA;  108916 MW;  7E8F2585747736B9 CRC64;
     MDGFAGSLDD SISAASTSDV QDRLSALESR VQQQEDEITV LKAALADVLR RLAISEDHVA
     SVKKSVSSKG QPSPRAVIPM SCITNGSGAN RKPSHTSAVS IAGKETLSSA AKSGTEKKKE
     KPQGQREKKE ESHSNDQSPQ IRASPSPQPS SQPLQIHRQT PESKNATPTK SIKRPSPAEK
     SHNSWENSDD SRNKLSKIPS TPKLIPKVTK TADKHKDVII NQEGEYIKMF MRGRPITMFI
     PSDVDNYDDI RTELPPEKLK LEWAYGYRGK DCRANVYLLP TGKIVYFIAS VVVLFNYEER
     TQRHYLGHTD CVKCLAIHPD KIRIATGQIA GVDKDGRPLQ PHVRVWDSVT LSTLQIIGLG
     TFERGVGCLD FSKADSGVHL CIIDDSNEHM LTVWDWQKKA KGAEIKTTNE VVLAVEFHPT
     DANTIITCGK SHIFFWTWSG NSLTRKQGIF GKYEKPKFVQ CLAFLGNGDV LTGDSGGVML
     IWSKTTVEPT PGKGPKGVYQ ISKQIKAHDG SVFTLCQMRN GMLLTGGGKD RKIILWDHDL
     NPEREIEVPD QYGTIRAVAE GKADQFLVGT SRNFILRGTF NDGFQIEVQG HTDELWGLAT
     HPFKDLLLTC AQDRQVCLWN SMEHRLEWTR LVDEPGHCAD FHPSGTVVAI GTHSGRWFVL
     DAETRDLVSI HTDGNEQLSV MRYSIDGTFL AVGSHDNFIY LYVVSENGRK YSRYGRCTGH
     SSYITHLDWS PDNKYIMSNS GDYEILYWDI PNGCKLIRNR SDCKDIDWTT YTCVLGFQVF
     GVWPEGSDGT DINALVRSHN RKVIAVADDF CKVHLFQYPC SKAKAPSHKY SAHSSHVTNV
     SFTHNDSHLI STGGKDMSII QWKLVEKLSL PQNETVADTT LTKAPVSSTE SVIQSNTPTP
     PPSQPLNETA EEESRISSSP TLLENSLEQT VEPSEDHSEE ESEEGSGDLG EPLYEEPCNE
     ISKEQAKATL LEDQQDPSPS S
//
ID   G8JLD3_HUMAN            Unreviewed;      1086 AA.
AC   G8JLD3;
DT   25-JAN-2012, integrated into UniProtKB/TrEMBL.
DT   25-JAN-2012, sequence version 1.
DT   28-FEB-2018, entry version 48.
DE   SubName: Full=ELKS/Rab6-interacting/CAST family member 1 {ECO:0000313|Ensembl:ENSP00000347621};
GN   Name=ERC1 {ECO:0000313|Ensembl:ENSP00000347621};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000347621, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000347621, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RG   Baylor College of Medicine Human Genome Sequencing Center Sequence Production Team;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A., null.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [4] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [7] {ECO:0000313|Ensembl:ENSP00000347621}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2011) to UniProtKB.
RN   [8] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10] {ECO:0000313|Ensembl:ENSP00000489593}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2015) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000347621}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004671; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004672; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006561; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC234852; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877502; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455581; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001288177.1; NM_001301248.1.
DR   RefSeq; XP_016874557.1; XM_017019068.1.
DR   UniGene; Hs.601216; -.
DR   MaxQB; G8JLD3; -.
DR   PeptideAtlas; G8JLD3; -.
DR   Ensembl; ENST00000355446; ENSP00000347621; ENSG00000082805.
DR   Ensembl; ENST00000635531; ENSP00000489593; ENSG00000283017.
DR   GeneID; 23085; -.
DR   UCSC; uc001qjf.3; human.
DR   CTD; 23085; -.
DR   EuPathDB; HostDB:ENSG00000082805.19; -.
DR   HGNC; HGNC:17072; ERC1.
DR   OpenTargets; ENSG00000082805; -.
DR   eggNOG; KOG4809; Eukaryota.
DR   eggNOG; ENOG410Y4GU; LUCA.
DR   GeneTree; ENSGT00650000093320; -.
DR   ChiTaRS; ERC1; human.
DR   GenomeRNAi; 23085; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000082805; -.
DR   GO; GO:0048786; C:presynaptic active zone; IEA:InterPro.
DR   InterPro; IPR019323; ELKS/CAST.
DR   Pfam; PF10174; Cast; 3.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:G8JLD3,
KW   ECO:0000213|MaxQB:G8JLD3, ECO:0000213|PeptideAtlas:G8JLD3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   COILED      151    178       {ECO:0000256|SAM:Coils}.
FT   COILED      215    249       {ECO:0000256|SAM:Coils}.
FT   COILED      260    280       {ECO:0000256|SAM:Coils}.
FT   COILED      336    366       {ECO:0000256|SAM:Coils}.
FT   COILED      384    418       {ECO:0000256|SAM:Coils}.
FT   COILED      426    495       {ECO:0000256|SAM:Coils}.
FT   COILED      503    551       {ECO:0000256|SAM:Coils}.
FT   COILED      559    607       {ECO:0000256|SAM:Coils}.
FT   COILED      615    674       {ECO:0000256|SAM:Coils}.
FT   COILED      696    723       {ECO:0000256|SAM:Coils}.
FT   COILED      730    799       {ECO:0000256|SAM:Coils}.
FT   COILED      804    852       {ECO:0000256|SAM:Coils}.
FT   COILED      860    929       {ECO:0000256|SAM:Coils}.
FT   COILED      944    985       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1086 AA;  124820 MW;  871074DE74C65131 CRC64;
     MYGSARSVGK VEPSSQSPGR SPRLPRSPRL GHRRTNSTGG SSGSSVGGGS GKTLSMENIQ
     SLNAAYATSG PMYLSDHENV GSETPKSTMT LGRSGGRLPY GVRMTAMGSS PNIASSGVAS
     DTIAFGEHHL PPVSMASTVP HSLRQARDNT IMDLQTQLKE VLRENDLLRK DVEVKESKLS
     SSMNSIKTFW SPELKKERAL RKDEASKITI WKEQYRVVQE ENQHMQMTIQ ALQDELRIQR
     DLNQLFQQDS SSRTGEPCVA ELTEENFQRL HAEHERQAKE LFLLRKTLEE MELRIETQKQ
     TLNARDESIK KLLEMLQSKG LSAKATEEDH ERTRRLAEAE MHVHHLESLL EQKEKENSML
     REEMHRRFEN APDSAKTKAL QTVIEMKDSK ISSMERGLRD LEEEIQMLKS NGALSTEERE
     EEMKQMEVYR SHSKFMKNKV EQLKEELSSK EAQWEELKKK AAGLQAEIGQ VKQELSRKDT
     ELLALQTKLE TLTNQFSDSK QHIEVLKESL TAKEQRAAIL QTEVDALRLR LEEKETMLNK
     KTKQIQDMAE EKGTQAGEIH DLKDMLDVKE RKVNVLQKKI ENLQEQLRDK EKQMSSLKER
     VKSLQADTTN TDTALTTLEE ALAEKERTIE RLKEQRDRDE REKQEEIDNY KKDLKDLKEK
     VSLLQGDLSE KEASLLDLKE HASSLASSGL KKDSRLKTLE IALEQKKEEC LKMESQLKKA
     HEAALEARAS PEMSDRIQHL EREITRYKDE SSKAQAEVDR LLEILKEVEN EKNDKDKKIA
     ELERQVKDQN KKVANLKHKE QVEKKKSAQM LEEARRREDN LNDSSQQLQD SLRKKDDRIE
     ELEEALRESV QITAEREMVL AQEESARTNA EKQVEELLMA MEKVKQELES MKAKLSSTQQ
     SLAEKETHLT NLRAERRKHL EEVLEMKQEA LLAAISEKDA NIALLELSSS KKKTQEEVAA
     LKREKDRLVQ QLKQQTQNRM KLMADNYEDD HFKSSHSNQT NHKPSPDQII QPLLELDQNR
     SKLKLYIGHL TTLCHDRDPL ILRGLTPPAS YNLDDDQAAW ENELQKMTRG QNPLHPKAME
     KLPFFM
//
ID   RB6I2_HUMAN             Reviewed;        1116 AA.
AC   Q8IUD2; A2RU77; A7E295; D3DUP7; D3DUP8; Q6NVK2; Q8IUD3; Q8IUD4;
AC   Q8IUD5; Q8NAS1; Q9NXN5; Q9UIK7; Q9UPS1;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   28-FEB-2018, entry version 160.
DE   RecName: Full=ELKS/Rab6-interacting/CAST family member 1;
DE            Short=ERC-1;
DE   AltName: Full=Rab6-interacting protein 2;
GN   Name=ERC1; Synonyms=ELKS, KIAA1081, RAB6IP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND CHROMOSOMAL TRANSLOCATION
RP   WITH RET.
RX   PubMed=10337992;
RX   DOI=10.1002/(SICI)1098-2264(199906)25:2<97::AID-GCC4>3.0.CO;2-L;
RA   Nakata T., Kitamura Y., Shimizu K., Tanaka S., Fujimori M.,
RA   Yokoyama S., Ito K., Emi M.;
RT   "Fusion of a novel gene, ELKS, to RET due to translocation
RT   t(10;12)(q11;p13) in a papillary thyroid carcinoma.";
RL   Genes Chromosomes Cancer 25:97-103(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 5), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12203787; DOI=10.1002/gcc.10095;
RA   Nakata T., Yokota T., Emi M., Minami S.;
RT   "Differential expression of multiple isoforms of the ELKS mRNAs
RT   involved in a papillary thyroid carcinoma.";
RL   Genes Chromosomes Cancer 35:30-37(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-652 (ISOFORM 3).
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1061 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [6]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [7]
RP   PROTEIN SEQUENCE OF 254-269, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 733-1116 (ISOFORM 2), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 828-1116 (ISOFORMS 1/3).
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH CHUK; IKBKB; IKBKG AND NFKBIA.
RX   PubMed=15218148; DOI=10.1126/science.1098387;
RA   Ducut Sigala J.L., Bottero V., Young D.B., Shevchenko A., Mercurio F.,
RA   Verma I.M.;
RT   "Activation of transcription factor NF-kappaB requires ELKS, an
RT   IkappaB kinase regulatory subunit.";
RL   Science 304:1963-1967(2004).
RN   [10]
RP   INTERACTION WITH PPFIA1.
RX   PubMed=12923177; DOI=10.1074/jbc.M307561200;
RA   Ko J., Na M., Kim S., Lee J.R., Kim E.;
RT   "Interaction of the ERC family of RIM-binding proteins with the
RT   liprin-alpha family of multidomain proteins.";
RL   J. Biol. Chem. 278:42377-42385(2003).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-21 AND THR-1046,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17 AND SER-21, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37 AND THR-38, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Regulatory subunit of the IKK complex. Probably recruits
CC       IkappaBalpha/NFKBIA to the complex. May be involved in the
CC       organization of the cytomatrix at the nerve terminals active zone
CC       (CAZ) which regulates neurotransmitter release. May be involved in
CC       vesicle trafficking at the CAZ. May be involved in Rab-6 regulated
CC       endosomes to Golgi transport. {ECO:0000269|PubMed:15218148}.
CC   -!- SUBUNIT: Part of a complex with CHUK, IKBKB and IKBKG. Interacts
CC       with CHUK, IKBKB and IKBKG. The interaction with IKBKG is
CC       independent of CHUK and IKBKB. Interacts with NFKBIA. Isoform 4
CC       interacts with PPFIA1, and through its C-terminus with the PDZ
CC       domains of RIMS1 and RIMS2. Interacts with ERC2/CAST1. Interacts
CC       with the GTB-bound forms of RAB6A isoform 1 and isoform 2 and with
CC       RAB6B. The interaction was strongest with RAB6B, followed by RAB6A
CC       isoform 2 and weakest with RAB6A isoform 1 (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       P27958:- (xeno); NbExp=3; IntAct=EBI-9352501, EBI-3649474;
CC       Q8R0S4:Cacnb4 (xeno); NbExp=2; IntAct=EBI-6920871, EBI-3647752;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Golgi
CC       apparatus membrane {ECO:0000250}; Peripheral membrane protein
CC       {ECO:0000250}. Note=In neurons, localized closed to presynaptic
CC       membrane. Recruited on Golgi membranes by RAB6A in a GTP-dependent
CC       manner (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=ELKS epsilon;
CC         IsoId=Q8IUD2-1; Sequence=Displayed;
CC       Name=2; Synonyms=ELKS beta;
CC         IsoId=Q8IUD2-2; Sequence=VSP_011451, VSP_011452, VSP_011454,
CC                                  VSP_011455;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3; Synonyms=ELKS delta;
CC         IsoId=Q8IUD2-3; Sequence=VSP_011451;
CC       Name=4; Synonyms=ELKS alpha;
CC         IsoId=Q8IUD2-4; Sequence=VSP_011451, VSP_011452, VSP_011453,
CC                                  VSP_011454, VSP_011455;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=5; Synonyms=ELKS gamma;
CC         IsoId=Q8IUD2-5; Sequence=VSP_011450, VSP_011452, VSP_011454,
CC                                  VSP_011455;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Isoform 2 and isoform 4 are
CC       abundantly expressed in brain. Isoform 1 and isoform 3 are
CC       predominantly expressed in testis and thyroid, and isoform 1
CC       predominates in other tissues tested.
CC       {ECO:0000269|PubMed:12203787}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ERC1/RAB6IP2 is
CC       found in papillary thyroid carcinomas (PTCs). Translocation
CC       t(10;12)(q11;p13) involving RET. In vitro, isoform 1, isoform 3
CC       and isoform 5 participating in a ERC1-RET fusion protein activate
CC       tyrosine-protein kinase activity. {ECO:0000269|PubMed:10337992}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH68006.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA83033.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAA90975.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ELKSID503.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB015617; BAA88763.1; -; mRNA.
DR   EMBL; AB053469; BAC54108.1; -; mRNA.
DR   EMBL; AB053468; BAC54107.1; -; mRNA.
DR   EMBL; AB053470; BAC54109.1; -; mRNA.
DR   EMBL; AB053471; BAC54110.1; -; mRNA.
DR   EMBL; CH471116; EAW88932.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88934.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88936.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88938.1; -; Genomic_DNA.
DR   EMBL; BC068006; AAH68006.1; ALT_SEQ; mRNA.
DR   EMBL; BC132782; AAI32783.1; -; mRNA.
DR   EMBL; BC132784; AAI32785.1; -; mRNA.
DR   EMBL; BC150248; AAI50249.1; -; mRNA.
DR   EMBL; AB029004; BAA83033.2; ALT_INIT; mRNA.
DR   EMBL; AK000148; BAA90975.1; ALT_INIT; mRNA.
DR   EMBL; AK092201; BAC03827.1; -; mRNA.
DR   CCDS; CCDS53732.1; -. [Q8IUD2-3]
DR   CCDS; CCDS8508.1; -. [Q8IUD2-1]
DR   RefSeq; NP_829883.1; NM_178039.3. [Q8IUD2-3]
DR   RefSeq; NP_829884.1; NM_178040.3. [Q8IUD2-1]
DR   RefSeq; XP_011519243.1; XM_011520941.2. [Q8IUD2-1]
DR   RefSeq; XP_016874553.1; XM_017019064.1. [Q8IUD2-1]
DR   RefSeq; XP_016874556.1; XM_017019067.1. [Q8IUD2-3]
DR   UniGene; Hs.601216; -.
DR   ProteinModelPortal; Q8IUD2; -.
DR   SMR; Q8IUD2; -.
DR   BioGrid; 116714; 72.
DR   CORUM; Q8IUD2; -.
DR   IntAct; Q8IUD2; 44.
DR   MINT; Q8IUD2; -.
DR   STRING; 9606.ENSP00000354158; -.
DR   iPTMnet; Q8IUD2; -.
DR   PhosphoSitePlus; Q8IUD2; -.
DR   BioMuta; ERC1; -.
DR   DMDM; 51827892; -.
DR   EPD; Q8IUD2; -.
DR   MaxQB; Q8IUD2; -.
DR   PaxDb; Q8IUD2; -.
DR   PeptideAtlas; Q8IUD2; -.
DR   PRIDE; Q8IUD2; -.
DR   Ensembl; ENST00000347735; ENSP00000340054; ENSG00000082805. [Q8IUD2-4]
DR   Ensembl; ENST00000360905; ENSP00000354158; ENSG00000082805. [Q8IUD2-1]
DR   Ensembl; ENST00000397203; ENSP00000380386; ENSG00000082805. [Q8IUD2-3]
DR   Ensembl; ENST00000440394; ENSP00000410064; ENSG00000082805. [Q8IUD2-2]
DR   Ensembl; ENST00000543086; ENSP00000438546; ENSG00000082805. [Q8IUD2-3]
DR   Ensembl; ENST00000545948; ENSP00000442976; ENSG00000082805. [Q8IUD2-5]
DR   Ensembl; ENST00000589028; ENSP00000468263; ENSG00000082805. [Q8IUD2-1]
DR   Ensembl; ENST00000611180; ENSP00000479523; ENSG00000082805. [Q8IUD2-5]
DR   Ensembl; ENST00000634346; ENSP00000489059; ENSG00000283017. [Q8IUD2-4]
DR   Ensembl; ENST00000634945; ENSP00000489460; ENSG00000283017. [Q8IUD2-3]
DR   Ensembl; ENST00000635106; ENSP00000489601; ENSG00000283017. [Q8IUD2-5]
DR   Ensembl; ENST00000635345; ENSP00000489265; ENSG00000283017. [Q8IUD2-2]
DR   Ensembl; ENST00000635430; ENSP00000489361; ENSG00000283017. [Q8IUD2-1]
DR   Ensembl; ENST00000635459; ENSP00000489064; ENSG00000283017. [Q8IUD2-5]
DR   Ensembl; ENST00000635644; ENSP00000489120; ENSG00000283017. [Q8IUD2-1]
DR   Ensembl; ENST00000635703; ENSP00000489206; ENSG00000283017. [Q8IUD2-3]
DR   GeneID; 23085; -.
DR   KEGG; hsa:23085; -.
DR   UCSC; uc001qjb.3; human. [Q8IUD2-1]
DR   CTD; 23085; -.
DR   DisGeNET; 23085; -.
DR   EuPathDB; HostDB:ENSG00000082805.19; -.
DR   GeneCards; ERC1; -.
DR   HGNC; HGNC:17072; ERC1.
DR   HPA; HPA019513; -.
DR   HPA; HPA019523; -.
DR   HPA; HPA024130; -.
DR   MalaCards; ERC1; -.
DR   MIM; 607127; gene.
DR   neXtProt; NX_Q8IUD2; -.
DR   OpenTargets; ENSG00000082805; -.
DR   Orphanet; 280325; Distal monosomy 12p.
DR   Orphanet; 146; Papillary or follicular thyroid carcinoma.
DR   PharmGKB; PA134970875; -.
DR   eggNOG; KOG4809; Eukaryota.
DR   eggNOG; ENOG410Y4GU; LUCA.
DR   GeneTree; ENSGT00650000093320; -.
DR   HOVERGEN; HBG051496; -.
DR   InParanoid; Q8IUD2; -.
DR   KO; K16072; -.
DR   PhylomeDB; Q8IUD2; -.
DR   TreeFam; TF324969; -.
DR   SIGNOR; Q8IUD2; -.
DR   ChiTaRS; ERC1; human.
DR   GeneWiki; ERC1; -.
DR   GenomeRNAi; 23085; -.
DR   PRO; PR:Q8IUD2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000082805; -.
DR   ExpressionAtlas; Q8IUD2; baseline and differential.
DR   Genevisible; Q8IUD2; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008385; C:IkappaB kinase complex; IDA:UniProtKB.
DR   GO; GO:0048786; C:presynaptic active zone; IEA:InterPro.
DR   GO; GO:0042734; C:presynaptic membrane; TAS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0043522; F:leucine zipper domain binding; NAS:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0017137; F:Rab GTPase binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0007252; P:I-kappaB phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; NAS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; ISS:ParkinsonsUK-UCL.
DR   InterPro; IPR019323; ELKS/CAST.
DR   InterPro; IPR037245; FIP-RBD_C_sf.
DR   InterPro; IPR019018; Rab-bd_FIP-RBD.
DR   Pfam; PF10174; Cast; 3.
DR   Pfam; PF09457; RBD-FIP; 1.
DR   SUPFAM; SSF144270; SSF144270; 1.
DR   PROSITE; PS51511; FIP_RBD; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Coiled coil; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Golgi apparatus; Membrane; Phosphoprotein; Polymorphism;
KW   Protein transport; Reference proteome; Transport.
FT   CHAIN         1   1116       ELKS/Rab6-interacting/CAST family member
FT                                1.
FT                                /FTId=PRO_0000097176.
FT   DOMAIN     1046   1108       FIP-RBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00844}.
FT   COILED      144    988       {ECO:0000255}.
FT   COILED     1060   1100       {ECO:0000255}.
FT   SITE        719    720       Breakpoint for translocation to form
FT                                ERC1-RET oncogene.
FT   MOD_RES      10     10       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99MI1}.
FT   MOD_RES      17     17       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      21     21       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      38     38       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      55     55       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99MI1}.
FT   MOD_RES      75     75       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      94     94       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1005   1005       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q811U3}.
FT   MOD_RES    1046   1046       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ     224    523       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:12203787}.
FT                                /FTId=VSP_011450.
FT   VAR_SEQ     440    467       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:10337992,
FT                                ECO:0000303|PubMed:10470851,
FT                                ECO:0000303|PubMed:12203787,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011451.
FT   VAR_SEQ     783    783       E -> ESLTS (in isoform 2, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:10337992,
FT                                ECO:0000303|PubMed:10470851,
FT                                ECO:0000303|PubMed:12203787,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011452.
FT   VAR_SEQ     830    873       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:10337992}.
FT                                /FTId=VSP_011453.
FT   VAR_SEQ    1009   1016       IIQPLLEL -> DEEEGIWA (in isoform 2,
FT                                isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:10337992,
FT                                ECO:0000303|PubMed:10470851,
FT                                ECO:0000303|PubMed:12203787,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011454.
FT   VAR_SEQ    1017   1116       Missing (in isoform 2, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:10337992,
FT                                ECO:0000303|PubMed:10470851,
FT                                ECO:0000303|PubMed:12203787,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011455.
FT   VARIANT      50     50       S -> G (in dbSNP:rs35037408).
FT                                /FTId=VAR_051304.
FT   VARIANT    1032   1032       T -> A (in dbSNP:rs12319376).
FT                                /FTId=VAR_051305.
FT   CONFLICT    828    828       L -> G (in Ref. 8; BAA90975).
FT                                {ECO:0000305}.
FT   CONFLICT    892    892       K -> R (in Ref. 8; BAC03827).
FT                                {ECO:0000305}.
FT   CONFLICT    910    910       T -> I (in Ref. 8; BAC03827).
FT                                {ECO:0000305}.
FT   CONFLICT   1021   1021       S -> G (in Ref. 8; BAA90975).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1116 AA;  128086 MW;  CCB70380AA7C6E69 CRC64;
     MYGSARSVGK VEPSSQSPGR SPRLPRSPRL GHRRTNSTGG SSGSSVGGGS GKTLSMENIQ
     SLNAAYATSG PMYLSDHENV GSETPKSTMT LGRSGGRLPY GVRMTAMGSS PNIASSGVAS
     DTIAFGEHHL PPVSMASTVP HSLRQARDNT IMDLQTQLKE VLRENDLLRK DVEVKESKLS
     SSMNSIKTFW SPELKKERAL RKDEASKITI WKEQYRVVQE ENQHMQMTIQ ALQDELRIQR
     DLNQLFQQDS SSRTGEPCVA ELTEENFQRL HAEHERQAKE LFLLRKTLEE MELRIETQKQ
     TLNARDESIK KLLEMLQSKG LSAKATEEDH ERTRRLAEAE MHVHHLESLL EQKEKENSML
     REEMHRRFEN APDSAKTKAL QTVIEMKDSK ISSMERGLRD LEEEIQMLKS NGALSTEERE
     EEMKQMEVYR SHSKFMKNKV EQLKEELSSK EAQWEELKKK AAGLQAEIGQ VKQELSRKDT
     ELLALQTKLE TLTNQFSDSK QHIEVLKESL TAKEQRAAIL QTEVDALRLR LEEKETMLNK
     KTKQIQDMAE EKGTQAGEIH DLKDMLDVKE RKVNVLQKKI ENLQEQLRDK EKQMSSLKER
     VKSLQADTTN TDTALTTLEE ALAEKERTIE RLKEQRDRDE REKQEEIDNY KKDLKDLKEK
     VSLLQGDLSE KEASLLDLKE HASSLASSGL KKDSRLKTLE IALEQKKEEC LKMESQLKKA
     HEAALEARAS PEMSDRIQHL EREITRYKDE SSKAQAEVDR LLEILKEVEN EKNDKDKKIA
     ELERQVKDQN KKVANLKHKE QVEKKKSAQM LEEARRREDN LNDSSQQLQD SLRKKDDRIE
     ELEEALRESV QITAEREMVL AQEESARTNA EKQVEELLMA MEKVKQELES MKAKLSSTQQ
     SLAEKETHLT NLRAERRKHL EEVLEMKQEA LLAAISEKDA NIALLELSSS KKKTQEEVAA
     LKREKDRLVQ QLKQQTQNRM KLMADNYEDD HFKSSHSNQT NHKPSPDQII QPLLELDQNR
     SKLKLYIGHL TTLCHDRDPL ILRGLTPPAS YNLDDDQAAW ENELQKMTRG QLQDELEKGE
     RDNAELQEFA NAILQQIADH CPDILEQVVN ALEESS
//
ID   X6RLX0_HUMAN            Unreviewed;      1120 AA.
AC   X6RLX0;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   28-FEB-2018, entry version 38.
DE   SubName: Full=ELKS/Rab6-interacting/CAST family member 1 {ECO:0000313|Ensembl:ENSP00000442739};
GN   Name=ERC1 {ECO:0000313|Ensembl:ENSP00000442739};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000442739, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000442739, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RG   Baylor College of Medicine Human Genome Sequencing Center Sequence Production Team;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A., null.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [4] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [7] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9] {ECO:0000313|Ensembl:ENSP00000442739}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2014) to UniProtKB.
RN   [10] {ECO:0000313|Ensembl:ENSP00000489348}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2015) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000442739}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004671; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004672; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006561; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC234852; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877502; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455581; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_016874551.1; XM_017019062.1.
DR   UniGene; Hs.601216; -.
DR   PeptideAtlas; X6RLX0; -.
DR   Ensembl; ENST00000546231; ENSP00000442739; ENSG00000082805.
DR   Ensembl; ENST00000634365; ENSP00000489348; ENSG00000283017.
DR   GeneID; 23085; -.
DR   UCSC; uc058jrc.1; human.
DR   CTD; 23085; -.
DR   EuPathDB; HostDB:ENSG00000082805.19; -.
DR   HGNC; HGNC:17072; ERC1.
DR   OpenTargets; ENSG00000082805; -.
DR   eggNOG; KOG4809; Eukaryota.
DR   eggNOG; ENOG410Y4GU; LUCA.
DR   GeneTree; ENSGT00650000093320; -.
DR   OMA; TVWKEQY; -.
DR   OrthoDB; EOG091G01EN; -.
DR   ChiTaRS; ERC1; human.
DR   GenomeRNAi; 23085; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000082805; -.
DR   GO; GO:0048786; C:presynaptic active zone; IEA:InterPro.
DR   InterPro; IPR019323; ELKS/CAST.
DR   InterPro; IPR037245; FIP-RBD_C_sf.
DR   InterPro; IPR019018; Rab-bd_FIP-RBD.
DR   Pfam; PF10174; Cast; 3.
DR   Pfam; PF09457; RBD-FIP; 1.
DR   SUPFAM; SSF144270; SSF144270; 1.
DR   PROSITE; PS51511; FIP_RBD; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:X6RLX0,
KW   ECO:0000213|MaxQB:X6RLX0, ECO:0000213|PeptideAtlas:X6RLX0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN     1050   1112       FIP-RBD. {ECO:0000259|PROSITE:PS51511}.
FT   COILED      151    178       {ECO:0000256|SAM:Coils}.
FT   COILED      215    249       {ECO:0000256|SAM:Coils}.
FT   COILED      260    280       {ECO:0000256|SAM:Coils}.
FT   COILED      336    366       {ECO:0000256|SAM:Coils}.
FT   COILED      384    418       {ECO:0000256|SAM:Coils}.
FT   COILED      426    495       {ECO:0000256|SAM:Coils}.
FT   COILED      503    551       {ECO:0000256|SAM:Coils}.
FT   COILED      559    607       {ECO:0000256|SAM:Coils}.
FT   COILED      615    674       {ECO:0000256|SAM:Coils}.
FT   COILED      696    723       {ECO:0000256|SAM:Coils}.
FT   COILED      730    788       {ECO:0000256|SAM:Coils}.
FT   COILED      808    856       {ECO:0000256|SAM:Coils}.
FT   COILED      864    933       {ECO:0000256|SAM:Coils}.
FT   COILED      948    989       {ECO:0000256|SAM:Coils}.
FT   COILED     1073   1093       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1120 AA;  128475 MW;  E66981F91E9E9586 CRC64;
     MYGSARSVGK VEPSSQSPGR SPRLPRSPRL GHRRTNSTGG SSGSSVGGGS GKTLSMENIQ
     SLNAAYATSG PMYLSDHENV GSETPKSTMT LGRSGGRLPY GVRMTAMGSS PNIASSGVAS
     DTIAFGEHHL PPVSMASTVP HSLRQARDNT IMDLQTQLKE VLRENDLLRK DVEVKESKLS
     SSMNSIKTFW SPELKKERAL RKDEASKITI WKEQYRVVQE ENQHMQMTIQ ALQDELRIQR
     DLNQLFQQDS SSRTGEPCVA ELTEENFQRL HAEHERQAKE LFLLRKTLEE MELRIETQKQ
     TLNARDESIK KLLEMLQSKG LSAKATEEDH ERTRRLAEAE MHVHHLESLL EQKEKENSML
     REEMHRRFEN APDSAKTKAL QTVIEMKDSK ISSMERGLRD LEEEIQMLKS NGALSTEERE
     EEMKQMEVYR SHSKFMKNKV EQLKEELSSK EAQWEELKKK AAGLQAEIGQ VKQELSRKDT
     ELLALQTKLE TLTNQFSDSK QHIEVLKESL TAKEQRAAIL QTEVDALRLR LEEKETMLNK
     KTKQIQDMAE EKGTQAGEIH DLKDMLDVKE RKVNVLQKKI ENLQEQLRDK EKQMSSLKER
     VKSLQADTTN TDTALTTLEE ALAEKERTIE RLKEQRDRDE REKQEEIDNY KKDLKDLKEK
     VSLLQGDLSE KEASLLDLKE HASSLASSGL KKDSRLKTLE IALEQKKEEC LKMESQLKKA
     HEAALEARAS PEMSDRIQHL EREITRYKDE SSKAQAEVDR LLEILKEVEN EKNDKDKKIA
     ELESLTSRQV KDQNKKVANL KHKEQVEKKK SAQMLEEARR REDNLNDSSQ QLQDSLRKKD
     DRIEELEEAL RESVQITAER EMVLAQEESA RTNAEKQVEE LLMAMEKVKQ ELESMKAKLS
     STQQSLAEKE THLTNLRAER RKHLEEVLEM KQEALLAAIS EKDANIALLE LSSSKKKTQE
     EVAALKREKD RLVQQLKQQT QNRMKLMADN YEDDHFKSSH SNQTNHKPSP DQIIQPLLEL
     DQNRSKLKLY IGHLTTLCHD RDPLILRGLT PPASYNLDDD QAAWENELQK MTRGQLQDEL
     EKGERDNAEL QEFANAILQQ IADHCPDILE QVVNALEESS
//
ID   EZRI_HUMAN              Reviewed;         586 AA.
AC   P15311; E1P5A8; P23714; Q4VX75; Q96CU8; Q9NSJ4;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 4.
DT   28-FEB-2018, entry version 203.
DE   RecName: Full=Ezrin;
DE   AltName: Full=Cytovillin;
DE   AltName: Full=Villin-2;
DE   AltName: Full=p81;
GN   Name=EZR; Synonyms=VIL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND VARIANT
RP   VAL-532.
RX   PubMed=2591371;
RA   Gould K.L., Bretscher A., Esch F.S., Hunter T.;
RT   "cDNA cloning and sequencing of the protein-tyrosine kinase substrate,
RT   ezrin, reveals homology to band 4.1.";
RL   EMBO J. 8:4133-4142(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-532.
RC   TISSUE=Placenta;
RX   PubMed=2674140;
RA   Turunen O., Winqvist R., Pakkanen R., Grzeschik K.-H., Wahlstroem T.,
RA   Vaheri A.;
RT   "Cytovillin, a microvillar Mr 75,000 protein. cDNA sequence,
RT   prokaryotic expression, and chromosomal localization.";
RL   J. Biol. Chem. 264:16727-16732(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 172-180 AND 343-350.
RX   PubMed=8713105; DOI=10.1006/bbrc.1996.1082;
RA   Egerton M., Moritz R.L., Druker B., Kelso A., Simpson R.J.;
RT   "Identification of the 70kD heat shock cognate protein (Hsc70) and
RT   alpha-actinin-1 as novel phosphotyrosine-containing proteins in T
RT   lymphocytes.";
RL   Biochem. Biophys. Res. Commun. 224:666-674(1996).
RN   [8]
RP   PROTEIN SEQUENCE OF 264-273; 428-435 AND 530-542, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   PHOSPHORYLATION AT TYR-146 AND TYR-354 BY PDGFR.
RX   PubMed=1382070;
RA   Krieg J., Hunter T.;
RT   "Identification of the two major epidermal growth factor-induced
RT   tyrosine phosphorylation sites in the microvillar core protein
RT   ezrin.";
RL   J. Biol. Chem. 267:19258-19265(1992).
RN   [10]
RP   PHOSPHORYLATION.
RX   PubMed=1381389;
RA   Egerton M., Burgess W.H., Chen D., Druker B.J., Bretscher A.,
RA   Samelson L.E.;
RT   "Identification of ezrin as an 81-kDa tyrosine-phosphorylated protein
RT   in T cells.";
RL   J. Immunol. 149:1847-1852(1992).
RN   [11]
RP   INTERACTION WITH SLC9A3R1.
RX   PubMed=9314537; DOI=10.1083/jcb.139.1.169;
RA   Reczek D., Berryman M., Bretscher A.;
RT   "Identification of EBP50: a PDZ-containing phosphoprotein that
RT   associates with members of the ezrin-radixin-moesin family.";
RL   J. Cell Biol. 139:169-179(1997).
RN   [12]
RP   INTERACTION WITH SCYL3.
RC   TISSUE=Kidney;
RX   PubMed=12651155; DOI=10.1016/S0014-4827(02)00054-X;
RA   Sullivan A., Uff C.R., Isacke C.M., Thorne R.F.;
RT   "PACE-1, a novel protein that interacts with the C-terminal domain of
RT   ezrin.";
RL   Exp. Cell Res. 284:224-238(2003).
RN   [13]
RP   INTERACTION WITH S100P.
RX   PubMed=12808036; DOI=10.1091/mbc.E02-09-0553;
RA   Koltzscher M., Neumann C., Konig S., Gerke V.;
RT   "Ca2+-dependent binding and activation of dormant ezrin by dimeric
RT   S100P.";
RL   Mol. Biol. Cell 14:2372-2384(2003).
RN   [14]
RP   INTERACTION WITH TMEM8B.
RX   PubMed=15498789; DOI=10.1093/carcin/bgh312;
RA   Ma J., Zhou J., Fan S., Wang L.-L., Li X.-L., Yan Q., Zhou M.,
RA   Liu H.-Y., Zhang Q., Zhou H., Gan K., Li Z., Peng C., Xiong W.,
RA   Tan C., Shen S.-R., Yang J., Li J., Li G.-Y.;
RT   "Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion
RT   modulation in nasopharyngeal carcinoma cells.";
RL   Carcinogenesis 26:281-291(2005).
RN   [15]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=15797715; DOI=10.1016/j.mcn.2004.11.014;
RA   Groenholm M., Teesalu T., Tyynelaa J., Piltti K., Boehling T.,
RA   Wartiovaara K., Vaheri A., Carpen O.;
RT   "Characterization of the NF2 protein merlin and the ERM protein ezrin
RT   in human, rat, and mouse central nervous system.";
RL   Mol. Cell. Neurosci. 28:683-693(2005).
RN   [16]
RP   INTERACTION WITH PDPN.
RX   PubMed=17046996; DOI=10.1242/jcs.03218;
RA   Martin-Villar E., Megias D., Castel S., Yurrita M.M., Vilaro S.,
RA   Quintanilla M.;
RT   "Podoplanin binds ERM proteins to activate RhoA and promote
RT   epithelial-mesenchymal transition.";
RL   J. Cell Sci. 119:4541-4553(2006).
RN   [17]
RP   INTERACTION WITH PODXL.
RX   PubMed=17616675; DOI=10.1158/0008-5472.CAN-06-3575;
RA   Sizemore S., Cicek M., Sizemore N., Ng K.P., Casey G.;
RT   "Podocalyxin increases the aggressive phenotype of breast and prostate
RT   cancer cells in vitro through its interaction with ezrin.";
RL   Cancer Res. 67:6183-6191(2007).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH PLEKHG6.
RX   PubMed=17881735; DOI=10.1091/mbc.E06-12-1144;
RA   D'Angelo R., Aresta S., Blangy A., Del Maestro L., Louvard D.,
RA   Arpin M.;
RT   "Interaction of ezrin with the novel guanine nucleotide exchange
RT   factor PLEKHG6 promotes RhoG-dependent apical cytoskeleton
RT   rearrangements in epithelial cells.";
RL   Mol. Biol. Cell 18:4780-4793(2007).
RN   [19]
RP   INTERACTION WITH FES/FPS, PHOSPHORYLATION AT TYR-146 AND TYR-478, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=18046454; DOI=10.1038/sj.emboj.7601943;
RA   Naba A., Reverdy C., Louvard D., Arpin M.;
RT   "Spatial recruitment and activation of the Fes kinase by ezrin
RT   promotes HGF-induced cell scattering.";
RL   EMBO J. 27:38-50(2008).
RN   [20]
RP   FUNCTION, AND PHOSPHORYLATION AT THR-567.
RX   PubMed=18270268; DOI=10.1242/jcs.016246;
RA   Wald F.A., Oriolo A.S., Mashukova A., Fregien N.L., Langshaw A.H.,
RA   Salas P.J.;
RT   "Atypical protein kinase C (iota) activates ezrin in the apical domain
RT   of intestinal epithelial cells.";
RL   J. Cell Sci. 121:644-654(2008).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH S100P.
RX   PubMed=19111582; DOI=10.1016/j.bbamcr.2008.11.012;
RA   Austermann J., Nazmi A.R., Heil A., Fritz G., Kolinski M., Filipek S.,
RA   Gerke V.;
RT   "Generation and characterization of a novel, permanently active S100P
RT   mutant.";
RL   Biochim. Biophys. Acta 1793:1078-1085(2009).
RN   [22]
RP   INTERACTION WITH MCC.
RX   PubMed=19555689; DOI=10.1016/j.febslet.2009.06.034;
RA   Arnaud C., Sebbagh M., Nola S., Audebert S., Bidaut G., Hermant A.,
RA   Gayet O., Dusetti N.J., Ollendorff V., Santoni M.J., Borg J.P.,
RA   Lecine P.;
RT   "MCC, a new interacting protein for Scrib, is required for cell
RT   migration in epithelial cells.";
RL   FEBS Lett. 583:2326-2332(2009).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-60, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-366, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   S-NITROSYLATION, AND DOMAIN.
RX   PubMed=25417112; DOI=10.1016/j.cell.2014.09.032;
RA   Jia J., Arif A., Terenzi F., Willard B., Plow E.F., Hazen S.L.,
RA   Fox P.L.;
RT   "Target-selective protein S-nitrosylation by sequence motif
RT   recognition.";
RL   Cell 159:623-634(2014).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-297.
RX   PubMed=12429733; DOI=10.1074/jbc.M210601200;
RA   Smith W.J., Nassar N., Bretscher A., Cerione R.A., Karplus P.A.;
RT   "Structure of the active N-terminal domain of Ezrin. Conformational
RT   and mobility changes identify keystone interactions.";
RL   J. Biol. Chem. 278:4949-4956(2003).
CC   -!- FUNCTION: Probably involved in connections of major cytoskeletal
CC       structures to the plasma membrane. In epithelial cells, required
CC       for the formation of microvilli and membrane ruffles on the apical
CC       pole. Along with PLEKHG6, required for normal macropinocytosis.
CC       {ECO:0000269|PubMed:17881735, ECO:0000269|PubMed:18270268,
CC       ECO:0000269|PubMed:19111582}.
CC   -!- ENZYME REGULATION: A head-to-tail association, of the N-terminal
CC       and C-terminal halves results in a closed conformation (inactive
CC       form) which is incapable of actin or membrane-binding.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with MPP5 and SLC9A3R2. Found in a complex with
CC       EZR, PODXL and SLC9A3R2 (By similarity). Interacts with MCC,
CC       PLEKHG6, PODXL, SCYL3/PACE1, SLC9A3R1 and TMEM8B (PubMed:9314537,
CC       PubMed:12651155, PubMed:15498789, PubMed:17616675,
CC       PubMed:17881735, PubMed:19555689). Interacts (when phosphorylated)
CC       with FES/FPS (PubMed:18046454). Interacts with dimeric S100P, the
CC       interaction may be activating through unmasking of F-actin binding
CC       sites (PubMed:12808036, PubMed:19111582). Identified in complexes
CC       that contain VIM, EZR, AHNAK, BFSP1, BFSP2, ANK2, PLEC, PRX and
CC       spectrin (By similarity). Detected in a complex composed of at
CC       least EZR, AHNAK, PPL and PRX (By similarity). Interacts with PDPN
CC       (via cytoplasmic domain); activates RHOA and promotes epithelial-
CC       mesenchymal transition (PubMed:17046996). Interacts with SPN, CD44
CC       and ICAM2 (By similarity). {ECO:0000250|UniProtKB:P26040,
CC       ECO:0000250|UniProtKB:P31976, ECO:0000250|UniProtKB:P31977,
CC       ECO:0000250|UniProtKB:Q8HZQ5, ECO:0000269|PubMed:12651155,
CC       ECO:0000269|PubMed:12808036, ECO:0000269|PubMed:15498789,
CC       ECO:0000269|PubMed:17046996, ECO:0000269|PubMed:17616675,
CC       ECO:0000269|PubMed:17881735, ECO:0000269|PubMed:18046454,
CC       ECO:0000269|PubMed:19111582, ECO:0000269|PubMed:19555689,
CC       ECO:0000269|PubMed:9314537}.
CC   -!- INTERACTION:
CC       P07384:CAPN1; NbExp=2; IntAct=EBI-1056902, EBI-1542113;
CC       P07332:FES; NbExp=8; IntAct=EBI-1056902, EBI-1055635;
CC       Q00987:MDM2; NbExp=3; IntAct=EBI-1056902, EBI-389668;
CC       Q8IZE3:SCYL3; NbExp=4; IntAct=EBI-1056902, EBI-1380680;
CC       P55011:SLC12A2; NbExp=3; IntAct=EBI-1056902, EBI-2801449;
CC       O14745:SLC9A3R1; NbExp=2; IntAct=EBI-1056902, EBI-349787;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:18046454}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:18046454}; Cytoplasmic side
CC       {ECO:0000269|PubMed:18046454}. Cell projection
CC       {ECO:0000269|PubMed:18046454}. Cell projection, microvillus
CC       membrane {ECO:0000269|PubMed:18046454}; Peripheral membrane
CC       protein {ECO:0000269|PubMed:18046454}; Cytoplasmic side
CC       {ECO:0000269|PubMed:18046454}. Cell projection, ruffle membrane
CC       {ECO:0000269|PubMed:18046454}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:18046454}; Cytoplasmic side
CC       {ECO:0000269|PubMed:18046454}. Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:18046454}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:18046454}. Cell projection, microvillus
CC       {ECO:0000250|UniProtKB:P26040}. Note=Localization to the apical
CC       membrane of parietal cells depends on the interaction with MPP5.
CC       Localizes to cell extensions and peripheral processes of
CC       astrocytes (By similarity). Microvillar peripheral membrane
CC       protein (cytoplasmic side). {ECO:0000250|UniProtKB:P31977}.
CC   -!- TISSUE SPECIFICITY: Expressed in cerebral cortex, basal ganglia,
CC       hippocampus, hypophysis, and optic nerve. Weakly expressed in
CC       brain stem and diencephalon. Stronger expression was detected in
CC       gray matter of frontal lobe compared to white matter (at protein
CC       level). Component of the microvilli of intestinal epithelial
CC       cells. Preferentially expressed in astrocytes of hippocampus,
CC       frontal cortex, thalamus, parahippocampal cortex, amygdala,
CC       insula, and corpus callosum. Not detected in neurons in most
CC       tissues studied. {ECO:0000269|PubMed:15797715}.
CC   -!- DEVELOPMENTAL STAGE: Very strong staining is detected in the
CC       Purkinje cell layer and in part of the molecular layer of the
CC       infant brain compared to adult brain.
CC       {ECO:0000269|PubMed:15797715}.
CC   -!- DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for
CC       cysteine S-nitrosylation mediated by the iNOS-S100A8/A9
CC       transnitrosylase complex. {ECO:0000305|PubMed:25417112}.
CC   -!- PTM: Phosphorylated by tyrosine-protein kinases. Phosphorylation
CC       by ROCK2 suppresses the head-to-tail association of the N-terminal
CC       and C-terminal halves resulting in an opened conformation which is
CC       capable of actin and membrane-binding (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: S-nitrosylation is induced by interferon-gamma and
CC       oxidatively-modified low-densitity lipoprotein (LDL(ox)) possibly
CC       implicating the iNOS-S100A8/9 transnitrosylase complex.
CC       {ECO:0000305|PubMed:25417112}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA61278.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAB82418.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X51521; CAA35893.1; -; mRNA.
DR   EMBL; J05021; AAA61278.1; ALT_INIT; mRNA.
DR   EMBL; AL162086; CAB82418.1; ALT_INIT; mRNA.
DR   EMBL; AL589931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47647.1; -; Genomic_DNA.
DR   EMBL; BC013903; AAH13903.1; -; mRNA.
DR   CCDS; CCDS5258.1; -.
DR   PIR; A34400; A34400.
DR   RefSeq; NP_001104547.1; NM_001111077.1.
DR   RefSeq; NP_003370.2; NM_003379.4.
DR   UniGene; Hs.487027; -.
DR   PDB; 1NI2; X-ray; 2.30 A; A/B=2-297.
DR   PDB; 4RM8; X-ray; 1.90 A; A/B=1-586.
DR   PDB; 4RM9; X-ray; 2.00 A; A=1-586.
DR   PDB; 4RMA; X-ray; 1.75 A; A/B=1-296.
DR   PDBsum; 1NI2; -.
DR   PDBsum; 4RM8; -.
DR   PDBsum; 4RM9; -.
DR   PDBsum; 4RMA; -.
DR   DisProt; DP00775; -.
DR   ProteinModelPortal; P15311; -.
DR   SMR; P15311; -.
DR   BioGrid; 113271; 150.
DR   CORUM; P15311; -.
DR   DIP; DIP-38868N; -.
DR   ELM; P15311; -.
DR   IntAct; P15311; 40.
DR   MINT; P15311; -.
DR   STRING; 9606.ENSP00000338934; -.
DR   BindingDB; P15311; -.
DR   ChEMBL; CHEMBL1932896; -.
DR   iPTMnet; P15311; -.
DR   PhosphoSitePlus; P15311; -.
DR   SwissPalm; P15311; -.
DR   BioMuta; EZR; -.
DR   DMDM; 125987826; -.
DR   DOSAC-COBS-2DPAGE; P15311; -.
DR   REPRODUCTION-2DPAGE; IPI00843975; -.
DR   SWISS-2DPAGE; P15311; -.
DR   EPD; P15311; -.
DR   MaxQB; P15311; -.
DR   PaxDb; P15311; -.
DR   PeptideAtlas; P15311; -.
DR   PRIDE; P15311; -.
DR   TopDownProteomics; P15311; -.
DR   DNASU; 7430; -.
DR   Ensembl; ENST00000337147; ENSP00000338934; ENSG00000092820.
DR   Ensembl; ENST00000367075; ENSP00000356042; ENSG00000092820.
DR   GeneID; 7430; -.
DR   KEGG; hsa:7430; -.
DR   UCSC; uc003qrt.5; human.
DR   CTD; 7430; -.
DR   DisGeNET; 7430; -.
DR   EuPathDB; HostDB:ENSG00000092820.17; -.
DR   GeneCards; EZR; -.
DR   HGNC; HGNC:12691; EZR.
DR   HPA; CAB004035; -.
DR   HPA; CAB047324; -.
DR   HPA; HPA021616; -.
DR   MalaCards; EZR; -.
DR   MIM; 123900; gene.
DR   neXtProt; NX_P15311; -.
DR   OpenTargets; ENSG00000092820; -.
DR   PharmGKB; PA162385512; -.
DR   eggNOG; KOG3529; Eukaryota.
DR   eggNOG; ENOG410XQFP; LUCA.
DR   GeneTree; ENSGT00890000139341; -.
DR   HOGENOM; HOG000007113; -.
DR   HOVERGEN; HBG002185; -.
DR   InParanoid; P15311; -.
DR   KO; K08007; -.
DR   PhylomeDB; P15311; -.
DR   TreeFam; TF313935; -.
DR   Reactome; R-HSA-373752; Netrin-1 signaling.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   SIGNOR; P15311; -.
DR   ChiTaRS; EZR; human.
DR   EvolutionaryTrace; P15311; -.
DR   GeneWiki; Ezrin; -.
DR   GenomeRNAi; 7430; -.
DR   PRO; PR:P15311; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000092820; -.
DR   CleanEx; HS_EZR; -.
DR   ExpressionAtlas; P15311; baseline and differential.
DR   Genevisible; P15311; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005884; C:actin filament; IDA:HGNC.
DR   GO; GO:0045177; C:apical part of cell; IDA:BHF-UCL.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0097449; C:astrocyte projection; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005903; C:brush border; ISS:UniProtKB.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0071944; C:cell periphery; IDA:UniProtKB.
DR   GO; GO:0042995; C:cell projection; IDA:UniProtKB.
DR   GO; GO:0051286; C:cell tip; IEA:Ensembl.
DR   GO; GO:0036064; C:ciliary basal body; IEA:Ensembl.
DR   GO; GO:0030863; C:cortical cytoskeleton; TAS:HGNC.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0098592; C:cytoplasmic side of apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0019898; C:extrinsic component of membrane; IDA:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0030175; C:filopodium; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0001772; C:immunological synapse; IDA:UniProtKB.
DR   GO; GO:0071437; C:invadopodium; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0044393; C:microspike; IEA:Ensembl.
DR   GO; GO:0005902; C:microvillus; IDA:BHF-UCL.
DR   GO; GO:0031528; C:microvillus membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0044853; C:plasma membrane raft; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0001726; C:ruffle; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0097454; C:Schwann cell microvillus; IEA:Ensembl.
DR   GO; GO:0030315; C:T-tubule; IEA:Ensembl.
DR   GO; GO:0001931; C:uropod; IEA:Ensembl.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IPI:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL.
DR   GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.
DR   GO; GO:0008017; F:microtubule binding; IMP:UniProtKB.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0051018; F:protein kinase A binding; IPI:UniProtKB.
DR   GO; GO:0034236; F:protein kinase A catalytic subunit binding; IPI:UniProtKB.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0044548; F:S100 protein binding; IPI:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0051017; P:actin filament bundle assembly; IDA:UniProtKB.
DR   GO; GO:0030953; P:astral microtubule organization; IMP:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.
DR   GO; GO:0034629; P:cellular protein complex localization; IMP:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; IMP:UniProtKB.
DR   GO; GO:0043622; P:cortical microtubule organization; IMP:UniProtKB.
DR   GO; GO:0007016; P:cytoskeletal anchoring at plasma membrane; NAS:UniProtKB.
DR   GO; GO:0051660; P:establishment of centrosome localization; IMP:UniProtKB.
DR   GO; GO:0061028; P:establishment of endothelial barrier; IGI:UniProtKB.
DR   GO; GO:0035088; P:establishment or maintenance of apical/basal cell polarity; IEA:Ensembl.
DR   GO; GO:0046847; P:filopodium assembly; IMP:UniProtKB.
DR   GO; GO:0001951; P:intestinal D-glucose absorption; IEA:Ensembl.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IEP:BHF-UCL.
DR   GO; GO:0022614; P:membrane to membrane docking; IEP:BHF-UCL.
DR   GO; GO:0030033; P:microvillus assembly; IMP:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:1900041; P:negative regulation of interleukin-2 secretion; IMP:UniProtKB.
DR   GO; GO:1903753; P:negative regulation of p38MAPK cascade; IMP:UniProtKB.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IDA:UniProtKB.
DR   GO; GO:1903364; P:positive regulation of cellular protein catabolic process; IGI:UniProtKB.
DR   GO; GO:2000643; P:positive regulation of early endosome to late endosome transport; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IGI:UniProtKB.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:1902966; P:positive regulation of protein localization to early endosome; IGI:UniProtKB.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IEA:Ensembl.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IMP:UniProtKB.
DR   GO; GO:0010737; P:protein kinase A signaling; IMP:UniProtKB.
DR   GO; GO:0072697; P:protein localization to cell cortex; IMP:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IEA:Ensembl.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB.
DR   GO; GO:0032532; P:regulation of microvillus length; IEA:Ensembl.
DR   GO; GO:1902115; P:regulation of organelle assembly; IMP:UniProtKB.
DR   GO; GO:0003376; P:sphingosine-1-phosphate signaling pathway; IMP:UniProtKB.
DR   GO; GO:1902896; P:terminal web assembly; IEA:Ensembl.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR011174; ERM.
DR   InterPro; IPR011259; ERM_C_dom.
DR   InterPro; IPR000798; Ez/rad/moesin-like.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_sf.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR019747; FERM_CS.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR018979; FERM_N.
DR   InterPro; IPR018980; FERM_PH-like_C.
DR   InterPro; IPR008954; Moesin_tail_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00769; ERM; 1.
DR   Pfam; PF09380; FERM_C; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF09379; FERM_N; 1.
DR   PIRSF; PIRSF002305; ERM; 1.
DR   PRINTS; PR00935; BAND41.
DR   PRINTS; PR00661; ERMFAMILY.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM01196; FERM_C; 1.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF48678; SSF48678; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00660; FERM_1; 1.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell membrane; Cell projection; Cell shape;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome;
KW   S-nitrosylation.
FT   CHAIN         1    586       Ezrin.
FT                                /FTId=PRO_0000219408.
FT   DOMAIN        2    295       FERM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00084}.
FT   REGION      244    586       Interaction with SCYL3.
FT                                {ECO:0000269|PubMed:12651155}.
FT   MOTIF       115    120       [IL]-x-C-x-x-[DE] motif.
FT                                {ECO:0000305|PubMed:25417112}.
FT   MOD_RES      60     60       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      79     79       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P26038}.
FT   MOD_RES      83     83       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P26043}.
FT   MOD_RES     116    116       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P26038}.
FT   MOD_RES     117    117       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:P26038}.
FT   MOD_RES     139    139       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P26038}.
FT   MOD_RES     146    146       Phosphotyrosine; by PDGFR.
FT                                {ECO:0000269|PubMed:1382070,
FT                                ECO:0000269|PubMed:18046454}.
FT   MOD_RES     354    354       Phosphotyrosine; by PDGFR.
FT                                {ECO:0000269|PubMed:1382070}.
FT   MOD_RES     366    366       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     478    478       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:18046454}.
FT   MOD_RES     535    535       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P26040}.
FT   MOD_RES     536    536       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P26038}.
FT   MOD_RES     567    567       Phosphothreonine; by ROCK2 and PKC/PRKCI.
FT                                {ECO:0000305|PubMed:18270268}.
FT   VARIANT     180    180       R -> C (in dbSNP:rs3103004).
FT                                /FTId=VAR_030572.
FT   VARIANT     494    494       A -> P (in dbSNP:rs2230143).
FT                                /FTId=VAR_030573.
FT   VARIANT     532    532       L -> V. {ECO:0000269|PubMed:2591371,
FT                                ECO:0000269|PubMed:2674140}.
FT                                /FTId=VAR_015112.
FT   STRAND        5     10       {ECO:0000244|PDB:4RMA}.
FT   STRAND       15     20       {ECO:0000244|PDB:4RMA}.
FT   HELIX        26     37       {ECO:0000244|PDB:4RMA}.
FT   HELIX        42     44       {ECO:0000244|PDB:4RMA}.
FT   STRAND       45     51       {ECO:0000244|PDB:4RMA}.
FT   STRAND       56     58       {ECO:0000244|PDB:4RMA}.
FT   STRAND       61     64       {ECO:0000244|PDB:4RM8}.
FT   HELIX        65     67       {ECO:0000244|PDB:4RMA}.
FT   STRAND       74     84       {ECO:0000244|PDB:4RMA}.
FT   HELIX        89     92       {ECO:0000244|PDB:4RMA}.
FT   HELIX        96    111       {ECO:0000244|PDB:4RMA}.
FT   HELIX       119    134       {ECO:0000244|PDB:4RMA}.
FT   TURN        139    141       {ECO:0000244|PDB:4RMA}.
FT   TURN        144    149       {ECO:0000244|PDB:4RMA}.
FT   HELIX       155    159       {ECO:0000244|PDB:4RMA}.
FT   HELIX       165    178       {ECO:0000244|PDB:4RMA}.
FT   TURN        179    181       {ECO:0000244|PDB:4RMA}.
FT   HELIX       184    196       {ECO:0000244|PDB:4RMA}.
FT   TURN        199    202       {ECO:0000244|PDB:4RMA}.
FT   STRAND      204    210       {ECO:0000244|PDB:4RMA}.
FT   STRAND      215    221       {ECO:0000244|PDB:4RMA}.
FT   STRAND      224    229       {ECO:0000244|PDB:4RMA}.
FT   STRAND      233    235       {ECO:0000244|PDB:4RMA}.
FT   STRAND      237    241       {ECO:0000244|PDB:4RMA}.
FT   HELIX       242    244       {ECO:0000244|PDB:4RMA}.
FT   STRAND      245    251       {ECO:0000244|PDB:4RMA}.
FT   STRAND      254    261       {ECO:0000244|PDB:4RMA}.
FT   STRAND      267    270       {ECO:0000244|PDB:4RMA}.
FT   HELIX       274    295       {ECO:0000244|PDB:4RMA}.
FT   HELIX       520    523       {ECO:0000244|PDB:4RM8}.
FT   HELIX       525    539       {ECO:0000244|PDB:4RM8}.
FT   HELIX       544    546       {ECO:0000244|PDB:4RM8}.
FT   HELIX       549    559       {ECO:0000244|PDB:4RM8}.
FT   HELIX       564    571       {ECO:0000244|PDB:4RM8}.
FT   HELIX       576    585       {ECO:0000244|PDB:4RM8}.
SQ   SEQUENCE   586 AA;  69413 MW;  F1B592CF49A7CC46 CRC64;
     MPKPINVRVT TMDAELEFAI QPNTTGKQLF DQVVKTIGLR EVWYFGLHYV DNKGFPTWLK
     LDKKVSAQEV RKENPLQFKF RAKFYPEDVA EELIQDITQK LFFLQVKEGI LSDEIYCPPE
     TAVLLGSYAV QAKFGDYNKE VHKSGYLSSE RLIPQRVMDQ HKLTRDQWED RIQVWHAEHR
     GMLKDNAMLE YLKIAQDLEM YGINYFEIKN KKGTDLWLGV DALGLNIYEK DDKLTPKIGF
     PWSEIRNISF NDKKFVIKPI DKKAPDFVFY APRLRINKRI LQLCMGNHEL YMRRRKPDTI
     EVQQMKAQAR EEKHQKQLER QQLETEKKRR ETVEREKEQM MREKEELMLR LQDYEEKTKK
     AERELSEQIQ RALQLEEERK RAQEEAERLE ADRMAALRAK EELERQAVDQ IKSQEQLAAE
     LAEYTAKIAL LEEARRRKED EVEEWQHRAK EAQDDLVKTK EELHLVMTAP PPPPPPVYEP
     VSYHVQESLQ DEGAEPTGYS AELSSEGIRD DRNEEKRITE AEKNERVQRQ LLTLSSELSQ
     ARDENKRTHN DIIHNENMRQ GRDKYKTLRQ IRQGNTKQRI DEFEAL
//
ID   A0A087WV25_HUMAN        Unreviewed;       351 AA.
AC   A0A087WV25;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   28-FEB-2018, entry version 21.
DE   SubName: Full=FGFR1 oncogene partner {ECO:0000313|Ensembl:ENSP00000479115};
GN   Name=FGFR1OP {ECO:0000313|Ensembl:ENSP00000479115};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000479115, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000479115}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7] {ECO:0000313|Ensembl:ENSP00000479115}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000479115}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z94721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001265619.1; NM_001278690.1.
DR   UniGene; Hs.487175; -.
DR   ProteinModelPortal; A0A087WV25; -.
DR   EPD; A0A087WV25; -.
DR   PeptideAtlas; A0A087WV25; -.
DR   PRIDE; A0A087WV25; -.
DR   Ensembl; ENST00000622353; ENSP00000479115; ENSG00000213066.
DR   GeneID; 11116; -.
DR   UCSC; uc011egp.2; human.
DR   CTD; 11116; -.
DR   EuPathDB; HostDB:ENSG00000213066.11; -.
DR   HGNC; HGNC:17012; FGFR1OP.
DR   OpenTargets; ENSG00000213066; -.
DR   GeneTree; ENSGT00390000007441; -.
DR   ChiTaRS; FGFR1OP; human.
DR   GenomeRNAi; 11116; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000213066; -.
DR   ExpressionAtlas; A0A087WV25; baseline and differential.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0034453; P:microtubule anchoring; IEA:InterPro.
DR   InterPro; IPR018993; FOP_dimerisation-dom_N.
DR   InterPro; IPR006594; LisH.
DR   Pfam; PF09398; FOP_dimer; 1.
DR   PROSITE; PS50896; LISH; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WV25,
KW   ECO:0000213|MaxQB:A0A087WV25, ECO:0000213|PeptideAtlas:A0A087WV25};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       70    102       LisH. {ECO:0000259|PROSITE:PS50896}.
SQ   SEQUENCE   351 AA;  38100 MW;  E9CCF927D382B728 CRC64;
     MAATAAAVVA EEDTELRDLL VQTLENSGVL NRIKAELRAA VFLALEEQEK VENKTPLVNE
     SLKKFLNTKD GRLVASLVAE FLQFFNLDFT LAVFQPETST LQGLEGRENL ARDLGIIEAE
     GTVGGPLLLE VIRRCQQKEK GPTTGEKAND EANQSDTSVS LSEPKSKSSL HLLSHETKIG
     SFLSNRTLDG KDKAGLCPDE DDMEGDSFFD DPIPKPEKTY GLRKEPRKQA GSLASLSDAP
     PLKSGLSSLA GAPSLKDSES KRGNTVLKDL KLISDKIGSL GLGTGEDDDY VDDFNSTSHR
     SEKSEISIGE EIEEDLSVEI DDINTSDKTI TQLECLLSIG ALHFKNTADI F
//
ID   B4DH64_HUMAN            Unreviewed;       365 AA.
AC   B4DH64;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   07-JUN-2017, entry version 38.
DE   SubName: Full=cDNA FLJ52986, highly similar to FGFR1 oncogene partner {ECO:0000313|EMBL:BAG58025.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58025.1};
RN   [1] {ECO:0000313|EMBL:BAG58025.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG58025.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294950; BAG58025.1; -; mRNA.
DR   RefSeq; NP_001265619.1; NM_001278690.1.
DR   UniGene; Hs.487175; -.
DR   MaxQB; B4DH64; -.
DR   PeptideAtlas; B4DH64; -.
DR   PRIDE; B4DH64; -.
DR   GeneID; 11116; -.
DR   CTD; 11116; -.
DR   HOGENOM; HOG000007633; -.
DR   HOVERGEN; HBG081536; -.
DR   GenomeRNAi; 11116; -.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:InterPro.
DR   GO; GO:0034453; P:microtubule anchoring; IEA:InterPro.
DR   InterPro; IPR018993; FOP_dimerisation-dom_N.
DR   InterPro; IPR006594; LisH.
DR   Pfam; PF09398; FOP_dimer; 1.
DR   PROSITE; PS50896; LISH; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       70    102       LisH. {ECO:0000259|PROSITE:PS50896}.
SQ   SEQUENCE   365 AA;  39745 MW;  F739AF6C61913B7D CRC64;
     MAATAAAVVA EEDTELRDLL VQTLENSGVL NRIKAELRAA VFLPLEEQEK VENKTPLVNE
     SLKKFLNTKD GRLVASLVAE FLQFFNLDFT LAVFQPETST LQGLEGRENL ARDLGIIEAE
     GTVGGPLLLE VIRRCQQKEK GPTTGEKAND EANQSDTSVS LSEPKSKSSL HLLSHETKIG
     SFLSNRTLDG KDKAGLCPDE DDMEGDSFFD DPIPKPEKTY GLRKEPRKQA GSLASLSDAP
     PLKSGLSSLA GAPSLKDSES KRGNTVLKDL KLISDKIGSL GLGTGEDDDY VDDFNSTSHR
     SEKSEISIGE EIEEDLSVEI DDINTSDKTI TQLECLLSIG ALHFKNTADI FLKVIFILLN
     KILPI
//
ID   FR1OP_HUMAN             Reviewed;         399 AA.
AC   O95684; A8K1D1; B2R705; Q49AI0; Q5R3F6; Q96EW1;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   28-FEB-2018, entry version 140.
DE   RecName: Full=FGFR1 oncogene partner;
GN   Name=FGFR1OP; Synonyms=FOP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION WITH
RP   FGFR1, ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=9949182;
RA   Popovici C., Zhang B., Gregoire M.-J., Jonveaux P.,
RA   Lafage-Pochitaloff M., Birnbaum D., Pebusque M.-J.;
RT   "The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative
RT   disorder fuses a novel gene, FOP, to fibroblast growth factor receptor
RT   1.";
RL   Blood 93:1381-1389(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   ASN-271.
RC   TISSUE=Brain, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A.,
RA   Mann M.;
RT   "Proteomic characterization of the human centrosome by protein
RT   correlation profiling.";
RL   Nature 426:570-574(2003).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156 AND SER-160, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MAPRE1 AND
RP   CEP350.
RX   PubMed=16314388; DOI=10.1091/mbc.E05-08-0810;
RA   Yan X., Habedanck R., Nigg E.A.;
RT   "A complex of two centrosomal proteins, CAP350 and FOP, cooperates
RT   with EB1 in microtubule anchoring.";
RL   Mol. Biol. Cell 17:634-644(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-160 AND
RP   SER-202, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156 AND SER-160, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152; SER-156; SER-160;
RP   THR-170; SER-202; THR-234; SER-301 AND SER-326, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-143 AND SER-160, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, INTERACTION WITH CEP19 AND CEP350, SUBCELLULAR LOCATION, AND
RP   PHYLOGENETIC ANALYSIS.
RX   PubMed=28625565; DOI=10.1016/j.devcel.2017.05.016;
RA   Kanie T., Abbott K.L., Mooney N.A., Plowey E.D., Demeter J.,
RA   Jackson P.K.;
RT   "The CEP19-RABL2 GTPase complex binds IFT-B to initiate intraflagellar
RT   transport at the ciliary base.";
RL   Dev. Cell 42:1-15(2017).
RN   [18]
RP   INTERACTION WITH CEP19 AND CEP350, AND SUBCELLULAR LOCATION.
RX   PubMed=28428259; DOI=10.1091/mbc.E17-01-0017;
RA   Nishijima Y., Hagiya Y., Kubo T., Takei R., Katoh Y., Nakayama K.;
RT   "RABL2 interacts with the intraflagellar transport-B complex and CEP19
RT   and participates in ciliary assembly.";
RL   Mol. Biol. Cell 28:1652-1666(2017).
RN   [19]
RP   FUNCTION, INTERACTION WITH CEP19, AND SUBCELLULAR LOCATION.
RX   PubMed=28659385; DOI=10.1098/rsob.170114;
RA   Mojarad B.A., Gupta G.D., Hasegan M., Goudiam O., Basto R.,
RA   Gingras A.C., Pelletier L.;
RT   "CEP19 cooperates with FOP and CEP350 to drive early steps in the
RT   ciliogenesis programme.";
RL   Open Biol. 7:0-0(2017).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 54-134, MUTAGENESIS OF
RP   VAL-74, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=16690081; DOI=10.1016/j.jmb.2006.03.070;
RA   Mikolajka A., Yan X., Popowicz G.M., Smialowski P., Nigg E.A.,
RA   Holak T.A.;
RT   "Structure of the N-terminal domain of the FOP (FGFR1OP) protein and
RT   implications for its dimerization and centrosomal localization.";
RL   J. Mol. Biol. 359:863-875(2006).
CC   -!- FUNCTION: Required for anchoring microtubules to the centrosomes
CC       (PubMed:16314388, PubMed:28659385). Required for ciliation
CC       (PubMed:28625565, PubMed:28659385). {ECO:0000269|PubMed:16314388,
CC       ECO:0000269|PubMed:28625565, ECO:0000269|PubMed:28659385}.
CC   -!- SUBUNIT: Homodimer (PubMed:16690081). Part of a ternary complex
CC       that contains CEP350, FGFR1OP and MAPRE1. Interacts directly with
CC       CEP350 and MAPRE1 (PubMed:16314388). Interacts with CEP19
CC       (PubMed:28625565, PubMed:28428259, PubMed:28659385). Interacts
CC       (via N-terminus) with CEP350 (via C-terminus) (PubMed:28625565,
CC       PubMed:28428259). {ECO:0000269|PubMed:16314388,
CC       ECO:0000269|PubMed:16690081, ECO:0000269|PubMed:28428259,
CC       ECO:0000269|PubMed:28625565, ECO:0000269|PubMed:28659385}.
CC   -!- INTERACTION:
CC       Q96LK0:CEP19; NbExp=6; IntAct=EBI-1266334, EBI-741885;
CC       P50552:VASP; NbExp=3; IntAct=EBI-1266334, EBI-748201;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:14654843,
CC       ECO:0000269|PubMed:16314388, ECO:0000269|PubMed:16690081,
CC       ECO:0000269|PubMed:28659385}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome, centriole
CC       {ECO:0000269|PubMed:28428259, ECO:0000269|PubMed:28625565,
CC       ECO:0000269|PubMed:28659385}. Cytoplasm, cytoskeleton, cilium
CC       basal body {ECO:0000269|PubMed:28659385}. Note=Associated with
CC       gamma-tubulin (PubMed:16314388). Localizes on both mother and
CC       daughter centrioles (PubMed:28625565, PubMed:28428259). Localizes
CC       to an axial position on the mother centriole (PubMed:28625565).
CC       Localizes to the distal end of the centriole partly on the
CC       subdistal appendage region (PubMed:28659385).
CC       {ECO:0000269|PubMed:16314388, ECO:0000269|PubMed:28428259,
CC       ECO:0000269|PubMed:28625565, ECO:0000269|PubMed:28659385}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O95684-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=O95684-2; Sequence=VSP_018120;
CC       Name=3;
CC         IsoId=O95684-3; Sequence=VSP_018119, VSP_018121;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in heart, liver,
CC       muscle, kidney, intestine, colon, adrenal gland, prostate, testis,
CC       and pancreas. {ECO:0000269|PubMed:9949182}.
CC   -!- DISEASE: Note=A chromosomal aberration involving FGFR1OP may be a
CC       cause of stem cell myeloproliferative disorder (MPD).
CC       Translocation t(6;8)(q27;p11) with FGFR1. MPD is characterized by
CC       myeloid hyperplasia, eosinophilia and T-cell or B-cell
CC       lymphoblastic lymphoma. In general it progresses to acute myeloid
CC       leukemia. The fusion proteins FGFR1OP-FGFR1 or FGFR1-FGFR1OP may
CC       exhibit constitutive kinase activity and be responsible for the
CC       transforming activity (PubMed:9949182).
CC       {ECO:0000269|PubMed:9949182}.
CC   -!- SIMILARITY: Belongs to the FGFR1OP family. {ECO:0000305}.
CC   -!- CAUTION: Interacting region of CEP19 is conflicting: According to
CC       a report, interacts via N-terminus (PubMed:28428259). According to
CC       another report, interacts via C-terminus (PubMed:28659385).
CC       {ECO:0000269|PubMed:28428259, ECO:0000269|PubMed:28659385}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FOPID140.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y18046; CAA77020.1; -; mRNA.
DR   EMBL; AK289846; BAF82535.1; -; mRNA.
DR   EMBL; AK312791; BAG35652.1; -; mRNA.
DR   EMBL; Z94721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47509.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW47510.1; -; Genomic_DNA.
DR   EMBL; BC011902; AAH11902.1; -; mRNA.
DR   EMBL; BC037785; AAH37785.1; -; mRNA.
DR   CCDS; CCDS5296.1; -. [O95684-1]
DR   CCDS; CCDS5297.1; -. [O95684-2]
DR   RefSeq; NP_008976.1; NM_007045.3. [O95684-1]
DR   RefSeq; NP_919410.1; NM_194429.2. [O95684-2]
DR   UniGene; Hs.487175; -.
DR   PDB; 2D68; X-ray; 1.60 A; A/B=54-134.
DR   PDBsum; 2D68; -.
DR   ProteinModelPortal; O95684; -.
DR   SMR; O95684; -.
DR   BioGrid; 116291; 161.
DR   IntAct; O95684; 145.
DR   MINT; O95684; -.
DR   STRING; 9606.ENSP00000355812; -.
DR   iPTMnet; O95684; -.
DR   PhosphoSitePlus; O95684; -.
DR   BioMuta; FGFR1OP; -.
DR   EPD; O95684; -.
DR   MaxQB; O95684; -.
DR   PaxDb; O95684; -.
DR   PeptideAtlas; O95684; -.
DR   PRIDE; O95684; -.
DR   DNASU; 11116; -.
DR   Ensembl; ENST00000349556; ENSP00000230248; ENSG00000213066. [O95684-2]
DR   Ensembl; ENST00000366847; ENSP00000355812; ENSG00000213066. [O95684-1]
DR   GeneID; 11116; -.
DR   KEGG; hsa:11116; -.
DR   UCSC; uc003qvj.5; human. [O95684-1]
DR   CTD; 11116; -.
DR   DisGeNET; 11116; -.
DR   EuPathDB; HostDB:ENSG00000213066.11; -.
DR   GeneCards; FGFR1OP; -.
DR   HGNC; HGNC:17012; FGFR1OP.
DR   HPA; HPA071876; -.
DR   MIM; 605392; gene.
DR   neXtProt; NX_O95684; -.
DR   OpenTargets; ENSG00000213066; -.
DR   PharmGKB; PA134941638; -.
DR   eggNOG; ENOG410IH12; Eukaryota.
DR   eggNOG; ENOG4111J6Y; LUCA.
DR   GeneTree; ENSGT00390000007441; -.
DR   HOGENOM; HOG000007633; -.
DR   HOVERGEN; HBG081536; -.
DR   InParanoid; O95684; -.
DR   KO; K16546; -.
DR   OMA; KIPRYKG; -.
DR   OrthoDB; EOG091G0V88; -.
DR   PhylomeDB; O95684; -.
DR   TreeFam; TF331893; -.
DR   Reactome; R-HSA-1839117; Signaling by cytosolic FGFR1 fusion mutants.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5655302; Signaling by FGFR1 in disease.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; O95684; -.
DR   ChiTaRS; FGFR1OP; human.
DR   EvolutionaryTrace; O95684; -.
DR   GeneWiki; FGFR1OP; -.
DR   GenomeRNAi; 11116; -.
DR   PRO; PR:O95684; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000213066; -.
DR   CleanEx; HS_FGFR1OP; -.
DR   ExpressionAtlas; O95684; baseline and differential.
DR   Genevisible; O95684; HS.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW.
DR   GO; GO:0005814; C:centriole; IEA:UniProtKB-SubCell.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome.
DR   GO; GO:0030292; F:protein tyrosine kinase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0034453; P:microtubule anchoring; IEA:InterPro.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   InterPro; IPR018993; FOP_dimerisation-dom_N.
DR   InterPro; IPR006594; LisH.
DR   Pfam; PF09398; FOP_dimer; 1.
DR   PROSITE; PS50896; LISH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell projection;
KW   Chromosomal rearrangement; Cilium biogenesis/degradation;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    399       FGFR1 oncogene partner.
FT                                /FTId=PRO_0000233293.
FT   DOMAIN       70    102       LisH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00126}.
FT   SITE        173    174       Breakpoint for translocation to form
FT                                FGFR1OP-FGFR1 or FGFR1-FGFR1OP fusion
FT                                proteins.
FT   MOD_RES     143    143       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     152    152       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     156    156       Phosphoserine.
FT                                {ECO:0000244|PubMed:15144186,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     160    160       Phosphoserine.
FT                                {ECO:0000244|PubMed:15144186,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     170    170       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     202    202       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     234    234       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     301    301       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     337    337       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q66JX5}.
FT   VAR_SEQ       1    249       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_018119.
FT   VAR_SEQ     174    193       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_018120.
FT   VAR_SEQ     376    399       LDDLTQDLTVSQLSDVADYLEDVA -> TITQLECLLSIGA
FT                                LHFKNTADIF (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_018121.
FT   VARIANT     190    190       A -> G (in dbSNP:rs34617108).
FT                                /FTId=VAR_061651.
FT   VARIANT     271    271       K -> N (in dbSNP:rs17856382).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_051000.
FT   MUTAGEN      74     74       V->F: Abolishes homodimerization and
FT                                leads to aggregation.
FT                                {ECO:0000269|PubMed:16690081}.
FT   CONFLICT     63     63       K -> R (in Ref. 5; AAH11902).
FT                                {ECO:0000305}.
FT   HELIX        60     66       {ECO:0000244|PDB:2D68}.
FT   HELIX        69     84       {ECO:0000244|PDB:2D68}.
FT   HELIX        88     98       {ECO:0000244|PDB:2D68}.
FT   HELIX       107    113       {ECO:0000244|PDB:2D68}.
FT   TURN        120    124       {ECO:0000244|PDB:2D68}.
FT   HELIX       127    134       {ECO:0000244|PDB:2D68}.
SQ   SEQUENCE   399 AA;  43065 MW;  7A4B65F627B9D272 CRC64;
     MAATAAAVVA EEDTELRDLL VQTLENSGVL NRIKAELRAA VFLALEEQEK VENKTPLVNE
     SLKKFLNTKD GRLVASLVAE FLQFFNLDFT LAVFQPETST LQGLEGRENL ARDLGIIEAE
     GTVGGPLLLE VIRRCQQKEK GPTTGEGALD LSDVHSPPKS PEGKTSAQTT PSKIPRYKGQ
     GKKKTSGQKA GDKKANDEAN QSDTSVSLSE PKSKSSLHLL SHETKIGSFL SNRTLDGKDK
     AGLCPDEDDM EGDSFFDDPI PKPEKTYGLR KEPRKQAGSL ASLSDAPPLK SGLSSLAGAP
     SLKDSESKRG NTVLKDLKLI SDKIGSLGLG TGEDDDYVDD FNSTSHRSEK SEISIGEEIE
     EDLSVEIDDI NTSDKLDDLT QDLTVSQLSD VADYLEDVA
//
ID   FIP1_HUMAN              Reviewed;         594 AA.
AC   Q6UN15; B4DIR3; G3XAD6; Q0VGE0; Q499Y4; Q49AU3; Q7Z608; Q8WVN3;
AC   Q96F80; Q9H077;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 130.
DE   RecName: Full=Pre-mRNA 3'-end-processing factor FIP1;
DE            Short=hFip1;
DE   AltName: Full=FIP1-like 1 protein;
DE   AltName: Full=Factor interacting with PAP;
DE   AltName: Full=Rearranged in hypereosinophilia;
GN   Name=FIP1L1; Synonyms=FIP1, RHE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION IN PRE-MRNA 3'-END
RP   PROCESSING, IDENTIFICATION IN THE CPSF COMPLEX, IDENTIFICATION IN A
RP   COMPLEX WITH CPSF1 AND PAPOLA, INTERACTION WITH CPSF1; CPSF4; CSTF2;
RP   CSTF3 AND PAPOLA, RNA-BINDING, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Testis;
RX   PubMed=14749727; DOI=10.1038/sj.emboj.7600070;
RA   Kaufmann I., Martin G., Friedlein A., Langen H., Keller W.;
RT   "Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and
RT   stimulates poly(A) polymerase.";
RL   EMBO J. 23:616-626(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Brain, Eye, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-339, DISEASE, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY OF THE FIP1L1-PDGFRA FUSION PROTEIN.
RC   TISSUE=Eosinophil;
RX   PubMed=12808148; DOI=10.1073/pnas.0932698100;
RA   Griffin J.H., Leung J., Bruner R.J., Caligiuri M.A., Briesewitz R.;
RT   "Discovery of a fusion kinase in EOL-1 cells and idiopathic
RT   hypereosinophilic syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:7830-7835(2003).
RN   [8]
RP   RNA-BINDING.
RX   PubMed=15767428; DOI=10.1128/JVI.79.7.4270-4288.2005;
RA   Zhao X., Oeberg D., Rush M., Fay J., Lambkin H., Schwartz S.;
RT   "A 57-nucleotide upstream early polyadenylation element in human
RT   papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and
RT   polypyrimidine tract binding protein.";
RL   J. Virol. 79:4270-4288(2005).
RN   [9]
RP   DISEASE.
RX   PubMed=12660384; DOI=10.1056/NEJMoa025217;
RA   Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D.,
RA   Cortes J., Kutok J., Clark J., Galinsky I., Griffin J.D., Cross N.C.,
RA   Tefferi A., Malone J., Alam R., Schrier S.L., Schmid J., Rose M.,
RA   Vandenberghe P., Verhoef G., Boogaerts M., Wlodarska I.,
RA   Kantarjian H., Marynen P., Coutre S.E., Stone R., Gilliland D.G.;
RT   "A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as
RT   a therapeutic target of imatinib in idiopathic hypereosinophilic
RT   syndrome.";
RL   N. Engl. J. Med. 348:1201-1214(2003).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-426, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-500, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492; SER-496 AND
RP   SER-500, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   INTERACTION WITH AHCYL1 AND PAPOLA.
RX   PubMed=19224921; DOI=10.1074/jbc.M807136200;
RA   Kiefer H., Mizutani A., Iemura S., Natsume T., Ando H., Kuroda Y.,
RA   Mikoshiba K.;
RT   "Inositol 1,4,5-triphosphate receptor-binding protein released with
RT   inositol 1,4,5-triphosphate (IRBIT) associates with components of the
RT   mRNA 3' processing machinery in a phosphorylation-dependent manner and
RT   inhibits polyadenylation.";
RL   J. Biol. Chem. 284:10694-10705(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492; THR-494; SER-496
RP   AND SER-500, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492 AND SER-554, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492 AND SER-496, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492 AND SER-500, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-500 AND SER-554, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Component of the cleavage and polyadenylation
CC       specificity factor (CPSF) complex that plays a key role in pre-
CC       mRNA 3'-end formation, recognizing the AAUAAA signal sequence and
CC       interacting with poly(A) polymerase and other factors to bring
CC       about cleavage and poly(A) addition. FIP1L1 contributes to poly(A)
CC       site recognition and stimulates poly(A) addition. Binds to U-rich
CC       RNA sequence elements surrounding the poly(A) site. May act to
CC       tether poly(A) polymerase to the CPSF complex.
CC       {ECO:0000269|PubMed:14749727}.
CC   -!- SUBUNIT: Component of the cleavage and polyadenylation specificity
CC       factor (CPSF) complex, composed of CPSF1, CPSF2, CPSF3, CPSF4 and
CC       FIP1L1. Found in a complex with CPSF1, FIP1L1 and PAPOLA.
CC       Interacts with CPSF1, CPSF4, CSTF2 and CSTF3 (PubMed:14749727).
CC       Interacts with AHCYL1 (when phosphorylated); the interaction is
CC       direct and associates AHCYL1 with the CPSF complex and RNA
CC       (PubMed:19224921). Interacts with PAPOLA; the interaction seems to
CC       be increased by the interaction with AHCYL1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9D824, ECO:0000269|PubMed:14749727,
CC       ECO:0000269|PubMed:19224921}.
CC   -!- INTERACTION:
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-1021914, EBI-618309;
CC       P41227:NAA10; NbExp=3; IntAct=EBI-1021914, EBI-747693;
CC       Q96E35:ZMYND19; NbExp=3; IntAct=EBI-1021914, EBI-746595;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q6UN15-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=Q6UN15-3; Sequence=VSP_016728, VSP_016729, VSP_016730;
CC       Name=4;
CC         IsoId=Q6UN15-4; Sequence=VSP_016728, VSP_016731, VSP_016732;
CC       Name=5;
CC         IsoId=Q6UN15-5; Sequence=VSP_016728, VSP_046213;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Note=A chromosomal aberration involving FIP1L1 is found
CC       in some cases of hypereosinophilic syndrome. Interstitial
CC       chromosomal deletion del(4)(q12q12) causes the fusion of FIP1L1
CC       and PDGFRA (FIP1L1-PDGFRA). {ECO:0000269|PubMed:12660384,
CC       ECO:0000269|PubMed:12808148}.
CC   -!- SIMILARITY: Belongs to the FIP1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH24016.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC       Sequence=AAH52959.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY366510; AAQ88277.1; -; mRNA.
DR   EMBL; AL136910; CAB66844.1; -; mRNA.
DR   EMBL; AK295737; BAG58575.1; -; mRNA.
DR   EMBL; AC058822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC095040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098587; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098821; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105384; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110298; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110792; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138607; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138779; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471057; EAX05448.1; -; Genomic_DNA.
DR   EMBL; BC011543; AAH11543.1; -; mRNA.
DR   EMBL; BC017724; AAH17724.1; -; mRNA.
DR   EMBL; BC024016; AAH24016.1; ALT_SEQ; mRNA.
DR   EMBL; BC052959; AAH52959.1; ALT_SEQ; mRNA.
DR   EMBL; BC110383; AAI10384.1; -; mRNA.
DR   EMBL; AY229892; AAP69563.1; ALT_TERM; mRNA.
DR   CCDS; CCDS3491.1; -. [Q6UN15-1]
DR   CCDS; CCDS47055.1; -. [Q6UN15-5]
DR   CCDS; CCDS47056.1; -. [Q6UN15-3]
DR   RefSeq; NP_001128409.1; NM_001134937.1. [Q6UN15-5]
DR   RefSeq; NP_001128410.1; NM_001134938.1. [Q6UN15-3]
DR   RefSeq; NP_112179.2; NM_030917.3. [Q6UN15-1]
DR   UniGene; Hs.555109; -.
DR   UniGene; Hs.624245; -.
DR   ProteinModelPortal; Q6UN15; -.
DR   BioGrid; 123545; 61.
DR   CORUM; Q6UN15; -.
DR   DIP; DIP-42503N; -.
DR   IntAct; Q6UN15; 52.
DR   MINT; Q6UN15; -.
DR   STRING; 9606.ENSP00000336752; -.
DR   iPTMnet; Q6UN15; -.
DR   PhosphoSitePlus; Q6UN15; -.
DR   BioMuta; FIP1L1; -.
DR   DMDM; 74749365; -.
DR   EPD; Q6UN15; -.
DR   MaxQB; Q6UN15; -.
DR   PaxDb; Q6UN15; -.
DR   PeptideAtlas; Q6UN15; -.
DR   PRIDE; Q6UN15; -.
DR   DNASU; 81608; -.
DR   Ensembl; ENST00000306932; ENSP00000302993; ENSG00000145216. [Q6UN15-3]
DR   Ensembl; ENST00000337488; ENSP00000336752; ENSG00000145216. [Q6UN15-1]
DR   Ensembl; ENST00000358575; ENSP00000351383; ENSG00000145216. [Q6UN15-5]
DR   Ensembl; ENST00000507922; ENSP00000425456; ENSG00000145216. [Q6UN15-4]
DR   GeneID; 81608; -.
DR   KEGG; hsa:81608; -.
DR   UCSC; uc003gzx.5; human. [Q6UN15-1]
DR   CTD; 81608; -.
DR   DisGeNET; 81608; -.
DR   EuPathDB; HostDB:ENSG00000145216.15; -.
DR   GeneCards; FIP1L1; -.
DR   HGNC; HGNC:19124; FIP1L1.
DR   HPA; HPA037475; -.
DR   HPA; HPA058202; -.
DR   MalaCards; FIP1L1; -.
DR   MIM; 607685; phenotype.
DR   MIM; 607686; gene.
DR   neXtProt; NX_Q6UN15; -.
DR   OpenTargets; ENSG00000145216; -.
DR   Orphanet; 520; Acute promyelocytic leukemia.
DR   Orphanet; 314950; Primary hypereosinophilic syndrome.
DR   PharmGKB; PA134875694; -.
DR   eggNOG; KOG1049; Eukaryota.
DR   eggNOG; COG5213; LUCA.
DR   GeneTree; ENSGT00730000111028; -.
DR   HOGENOM; HOG000004854; -.
DR   HOVERGEN; HBG059889; -.
DR   KO; K14405; -.
DR   OMA; GNNIQVI; -.
DR   PhylomeDB; Q6UN15; -.
DR   TreeFam; TF318610; -.
DR   Reactome; R-HSA-109688; Cleavage of Growing Transcript in the Termination Region.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72187; mRNA 3'-end processing.
DR   Reactome; R-HSA-77595; Processing of Intronless Pre-mRNAs.
DR   SIGNOR; Q6UN15; -.
DR   ChiTaRS; FIP1L1; human.
DR   GeneWiki; FIP1L1; -.
DR   GenomeRNAi; 81608; -.
DR   PMAP-CutDB; Q6UN15; -.
DR   PRO; PR:Q6UN15; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000145216; -.
DR   CleanEx; HS_FIP1L1; -.
DR   ExpressionAtlas; Q6UN15; baseline and differential.
DR   Genevisible; Q6UN15; HS.
DR   GO; GO:0005847; C:mRNA cleavage and polyadenylation specificity factor complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031124; P:mRNA 3'-end processing; TAS:Reactome.
DR   GO; GO:0006406; P:mRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0006378; P:mRNA polyadenylation; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0098789; P:pre-mRNA cleavage required for polyadenylation; IBA:GO_Central.
DR   GO; GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome.
DR   InterPro; IPR007854; Fip1.
DR   Pfam; PF05182; Fip1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; mRNA processing; Nucleus;
KW   Phosphoprotein; Reference proteome; RNA-binding.
FT   CHAIN         1    594       Pre-mRNA 3'-end-processing factor FIP1.
FT                                /FTId=PRO_0000215037.
FT   REGION        1    356       Necessary for stimulating PAPOLA
FT                                activity.
FT   REGION        1    111       Sufficient for interaction with PAPOLA.
FT   REGION      137    243       Sufficient for interaction with CPSF4.
FT                                {ECO:0000269|PubMed:14749727}.
FT   REGION      443    594       Sufficient for interaction with CPSF1 and
FT                                CSTF3. {ECO:0000269|PubMed:14749727}.
FT   COMPBIAS    356    406       Pro-rich.
FT   COMPBIAS    456    562       Arg-rich.
FT   COMPBIAS    478    594       Glu-rich.
FT   SITE        339    340       Breakpoint for interstitial deletion to
FT                                form the FIP1L1-PDGFRA fusion protein.
FT   MOD_RES      85     85       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D824}.
FT   MOD_RES      87     87       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D824}.
FT   MOD_RES      89     89       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D824}.
FT   MOD_RES     304    304       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D824}.
FT   MOD_RES     426    426       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES     492    492       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     494    494       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     496    496       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     500    500       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     554    554       Phosphoserine.
FT                                {ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      29     43       Missing (in isoform 3, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:11230166,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016728.
FT   VAR_SEQ     213    235       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_016729.
FT   VAR_SEQ     272    307       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_016730.
FT   VAR_SEQ     389    389       P -> PPPGIPITVP (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046213.
FT   VAR_SEQ     393    393       F -> K (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016731.
FT   VAR_SEQ     394    594       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016732.
FT   CONFLICT    118    118       V -> I (in Ref. 3; BAG58575).
FT                                {ECO:0000305}.
FT   CONFLICT    312    312       G -> R (in Ref. 6; AAH24016/AAH52959).
FT                                {ECO:0000305}.
FT   CONFLICT    524    524       K -> R (in Ref. 6; AAH52959).
FT                                {ECO:0000305}.
SQ   SEQUENCE   594 AA;  66526 MW;  B391D142419ED061 CRC64;
     MSAGEVERLV SELSGGTGGD EEEEWLYGGP WDVHVHSDLA KDLDENEVER PEEENASANP
     PSGIEDETAE NGVPKPKVTE TEDDSDSDSD DDEDDVHVTI GDIKTGAPQY GSYGTAPVNL
     NIKTGGRVYG TTGTKVKGVD LDAPGSINGV PLLEVDLDSF EDKPWRKPGA DLSDYFNYGF
     NEDTWKAYCE KQKRIRMGLE VIPVTSTTNK ITAEDCTMEV TPGAEIQDGR FNLFKVQQGR
     TGNSEKETAL PSTKAEFTSP PSLFKTGLPP SRNSTSSQSQ TSTASRKANS SVGKWQDRYG
     RAESPDLRRL PGAIDVIGQT ITISRVEGRR RANENSNIQV LSERSATEVD NNFSKPPPFF
     PPGAPPTHLP PPPFLPPPPT VSTAPPLIPP PGFPPPPGAP PPSLIPTIES GHSSGYDSRS
     ARAFPYGNVA FPHLPGSAPS WPSLVDTSKQ WDYYARREKD RDRERDRDRE RDRDRDRERE
     RTRERERERD HSPTPSVFNS DEERYRYREY AERGYERHRA SREKEERHRE RRHREKEETR
     HKSSRSNSRR RHESEEGDSH RRHKHKKSKR SKEGKEAGSE PAPEQESTEA TPAE
//
ID   GAS7_HUMAN              Reviewed;         476 AA.
AC   O60861; A8KAC2; B2RCK9; O43144; Q53Y77; Q7Z571;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 3.
DT   28-FEB-2018, entry version 170.
DE   RecName: Full=Growth arrest-specific protein 7;
DE            Short=GAS-7;
GN   Name=GAS7; Synonyms=KIAA0394;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RA   Chao C.C.-K., Kuo J.T., Ju Y.-T., Lin-Chao S.;
RT   "Human gas7: conservation of a mammalian growth-arrest-specific
RT   gene.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Brain;
RX   PubMed=9455477; DOI=10.1093/dnares/4.5.307;
RA   Ishikawa K., Nagase T., Nakajima D., Seki N., Ohira M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VIII.
RT   78 new cDNA clones from brain which code for large proteins in
RT   vitro.";
RL   DNA Res. 4:307-313(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Shan Y.X., Yu L.;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Thalamus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH
RP   KMT2A/MLL1.
RX   PubMed=10706619; DOI=10.1073/pnas.050397097;
RA   Megonigal M.D., Cheung N.-K.V., Rappaport E.F., Nowell P.C.,
RA   Wilson R.B., Jones D.H., Addya K., Leonard D.G.B., Kushner B.H.,
RA   Williams T.M., Lange B.J., Felix C.A.;
RT   "Detection of leukemia-associated MLL-GAS7 translocation early during
RT   chemotherapy with DNA topoisomerase II inhibitors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:2814-2819(2000).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-117, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   STRUCTURE BY NMR OF 79-111.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the WW domain from the human growth-arrest-
RT   specific protein 7, GAS-7.";
RL   Submitted (OCT-2007) to the PDB data bank.
CC   -!- FUNCTION: May play a role in promoting maturation and
CC       morphological differentiation of cerebellar neurons.
CC   -!- INTERACTION:
CC       Q16543:CDC37; NbExp=4; IntAct=EBI-11745923, EBI-295634;
CC       Q96HA8:WDYHV1; NbExp=4; IntAct=EBI-11745923, EBI-741158;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=3;
CC         IsoId=O60861-3; Sequence=Displayed;
CC       Name=1;
CC         IsoId=O60861-1; Sequence=VSP_035988;
CC       Name=2; Synonyms=GAS7-CB;
CC         IsoId=O60861-2; Sequence=VSP_006802, VSP_006803;
CC       Name=4;
CC         IsoId=O60861-4; Sequence=VSP_044294, VSP_044295;
CC   -!- DISEASE: Note=A chromosomal aberration involving GAS7 is found in
CC       acute myeloid leukemia. Translocation t(11;17)(q23;p13) with
CC       KMT2A/MLL1. {ECO:0000269|PubMed:10706619}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA23690.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GAS7ID257.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ224876; CAA12177.1; -; mRNA.
DR   EMBL; AB007854; BAA23690.2; ALT_INIT; mRNA.
DR   EMBL; AY327406; AAP92798.1; -; mRNA.
DR   EMBL; BT006891; AAP35537.1; -; mRNA.
DR   EMBL; AK292987; BAF85676.1; -; mRNA.
DR   EMBL; AK315162; BAG37606.1; -; mRNA.
DR   EMBL; AC000003; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005747; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026591; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083783; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107938; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471108; EAW90013.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90011.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90012.1; -; Genomic_DNA.
DR   EMBL; BC001152; AAH01152.1; -; mRNA.
DR   EMBL; BC006454; AAH06454.2; -; mRNA.
DR   EMBL; AF231998; AAG26332.2; ALT_SEQ; mRNA.
DR   CCDS; CCDS11152.1; -. [O60861-3]
DR   CCDS; CCDS42263.1; -. [O60861-4]
DR   CCDS; CCDS45611.1; -. [O60861-2]
DR   CCDS; CCDS58518.1; -. [O60861-1]
DR   RefSeq; NP_001124303.1; NM_001130831.1. [O60861-1]
DR   RefSeq; NP_003635.2; NM_003644.2. [O60861-2]
DR   RefSeq; NP_958836.1; NM_201432.1. [O60861-4]
DR   RefSeq; NP_958839.1; NM_201433.1. [O60861-3]
DR   RefSeq; XP_005256888.1; XM_005256831.3. [O60861-1]
DR   RefSeq; XP_005256889.1; XM_005256832.3. [O60861-1]
DR   RefSeq; XP_011522346.1; XM_011524044.2. [O60861-1]
DR   RefSeq; XP_016880728.1; XM_017025239.1. [O60861-1]
DR   UniGene; Hs.462214; -.
DR   PDB; 2LX7; NMR; -; A=1-60.
DR   PDB; 2YSH; NMR; -; A=79-111.
DR   PDBsum; 2LX7; -.
DR   PDBsum; 2YSH; -.
DR   ProteinModelPortal; O60861; -.
DR   SMR; O60861; -.
DR   BioGrid; 114094; 23.
DR   IntAct; O60861; 21.
DR   MINT; O60861; -.
DR   STRING; 9606.ENSP00000407552; -.
DR   iPTMnet; O60861; -.
DR   PhosphoSitePlus; O60861; -.
DR   BioMuta; GAS7; -.
DR   PaxDb; O60861; -.
DR   PeptideAtlas; O60861; -.
DR   PRIDE; O60861; -.
DR   DNASU; 8522; -.
DR   Ensembl; ENST00000323816; ENSP00000322608; ENSG00000007237. [O60861-4]
DR   Ensembl; ENST00000432992; ENSP00000407552; ENSG00000007237. [O60861-3]
DR   Ensembl; ENST00000437099; ENSP00000410108; ENSG00000007237. [O60861-1]
DR   Ensembl; ENST00000542249; ENSP00000443265; ENSG00000007237. [O60861-1]
DR   Ensembl; ENST00000579158; ENSP00000463527; ENSG00000007237. [O60861-1]
DR   Ensembl; ENST00000580865; ENSP00000463873; ENSG00000007237. [O60861-2]
DR   Ensembl; ENST00000585266; ENSP00000464240; ENSG00000007237. [O60861-4]
DR   GeneID; 8522; -.
DR   KEGG; hsa:8522; -.
DR   UCSC; uc002gmg.2; human. [O60861-3]
DR   CTD; 8522; -.
DR   DisGeNET; 8522; -.
DR   EuPathDB; HostDB:ENSG00000007237.18; -.
DR   GeneCards; GAS7; -.
DR   HGNC; HGNC:4169; GAS7.
DR   HPA; HPA004838; -.
DR   HPA; HPA064678; -.
DR   MIM; 603127; gene.
DR   neXtProt; NX_O60861; -.
DR   OpenTargets; ENSG00000007237; -.
DR   PharmGKB; PA28583; -.
DR   eggNOG; KOG0940; Eukaryota.
DR   eggNOG; KOG2398; Eukaryota.
DR   eggNOG; ENOG410Z5NV; LUCA.
DR   GeneTree; ENSGT00860000133756; -.
DR   HOGENOM; HOG000294146; -.
DR   HOVERGEN; HBG001320; -.
DR   InParanoid; O60861; -.
DR   KO; K18618; -.
DR   OMA; HMSLRKS; -.
DR   OrthoDB; EOG091G077K; -.
DR   PhylomeDB; O60861; -.
DR   TreeFam; TF328986; -.
DR   SignaLink; O60861; -.
DR   SIGNOR; O60861; -.
DR   ChiTaRS; GAS7; human.
DR   EvolutionaryTrace; O60861; -.
DR   GeneWiki; GAS7; -.
DR   GenomeRNAi; 8522; -.
DR   PRO; PR:O60861; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000007237; -.
DR   CleanEx; HS_GAS7; -.
DR   ExpressionAtlas; O60861; baseline and differential.
DR   Genevisible; O60861; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:ProtInc.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   CDD; cd07649; F-BAR_GAS7; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR037957; GAS7_F-BAR.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   Pfam; PF00397; WW; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00456; WW; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF51045; SSF51045; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS01159; WW_DOMAIN_1; 1.
DR   PROSITE; PS50020; WW_DOMAIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement;
KW   Coiled coil; Complete proteome; Cytoplasm; Developmental protein;
KW   Differentiation; Neurogenesis; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; SH3 domain.
FT   CHAIN         1    476       Growth arrest-specific protein 7.
FT                                /FTId=PRO_0000076057.
FT   DOMAIN        1     62       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN       77    110       WW. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN      196    456       F-BAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01077}.
FT   COILED      309    419       {ECO:0000255}.
FT   COMPBIAS     67     70       Poly-Pro.
FT   MOD_RES     117    117       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     163    163       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60780}.
FT   VAR_SEQ       1    140       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_006802.
FT   VAR_SEQ       1     64       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9455477,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_035988.
FT   VAR_SEQ       1     60       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:9455477}.
FT                                /FTId=VSP_044294.
FT   VAR_SEQ      61     61       E -> M (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:9455477}.
FT                                /FTId=VSP_044295.
FT   VAR_SEQ     141    156       PPETAHMSVRKSTGDS -> MSNMENSFDDVSCLSP (in
FT                                isoform 2). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_006803.
FT   CONFLICT    301    301       E -> D (in Ref. 1; CAA12177).
FT                                {ECO:0000305}.
FT   STRAND        5      9       {ECO:0000244|PDB:2LX7}.
FT   STRAND       28     32       {ECO:0000244|PDB:2LX7}.
FT   STRAND       40     43       {ECO:0000244|PDB:2LX7}.
FT   STRAND       49     52       {ECO:0000244|PDB:2LX7}.
FT   HELIX        54     56       {ECO:0000244|PDB:2LX7}.
FT   STRAND       57     59       {ECO:0000244|PDB:2LX7}.
FT   STRAND       84     87       {ECO:0000244|PDB:2YSH}.
FT   STRAND       93     96       {ECO:0000244|PDB:2YSH}.
FT   STRAND       98    100       {ECO:0000244|PDB:2YSH}.
FT   STRAND      103    107       {ECO:0000244|PDB:2YSH}.
SQ   SEQUENCE   476 AA;  54371 MW;  57BFB99907652745 CRC64;
     MSGARCRTLY PFSGERHGQG LRFAAGELIT LLQVPDGGWW EGEKEDGLRG WFPASYVQLL
     EKPGMVPPPP GEESQTVILP PGWQSYLSPQ GRRYYVNTTT NETTWERPSS SPGIPASPGS
     HRSSLPPTVN GYHASGTPAH PPETAHMSVR KSTGDSQNLG SSSPSKKQSK ENTITINCVT
     FPHPDTMPEQ QLLKPTEWSY CDYFWADKKD PQGNGTVAGF ELLLQKQLKG KQMQKEMSEF
     IRERIKIEED YAKNLAKLSQ NSLASQEEGS LGEAWAQVKK SLADEAEVHL KFSAKLHSEV
     EKPLMNFREN FKKDMKKCDH HIADLRKQLA SRYASVEKAR KALTERQRDL EMKTQQLEIK
     LSNKTEEDIK KARRKSTQAG DDLMRCVDLY NQAQSKWFEE MVTTTLELER LEVERVEMIR
     QHLCQYTQLR HETDMFNQST VEPVDQLLRK VDPAKDRELW VREHKTGNIR PVDMEI
//
ID   GOGA5_HUMAN             Reviewed;         731 AA.
AC   Q8TBA6; C9JRU1; O95287; Q03962; Q2TS49; Q9UQQ7;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   28-FEB-2018, entry version 140.
DE   RecName: Full=Golgin subfamily A member 5;
DE   AltName: Full=Cell proliferation-inducing gene 31 protein;
DE   AltName: Full=Golgin-84;
DE   AltName: Full=Protein Ret-II;
DE   AltName: Full=RET-fused gene 5 protein;
GN   Name=GOLGA5; Synonyms=RETII, RFG5; ORFNames=PIG31;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION,
RP   TOPOLOGY, DIMERIZATION, INTERACTION WITH OCRL1, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=9915833; DOI=10.1074/jbc.274.5.2953;
RA   Bascom R.A., Srinivasan S., Nussbaum R.L.;
RT   "Identification and characterization of golgin-84, a novel Golgi
RT   integral membrane protein with a cytoplasmic coiled-coil domain.";
RL   J. Biol. Chem. 274:2953-2962(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kim J.W.;
RT   "Identification of a human cell proliferation gene.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLY-67.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-497 (ISOFORM 1), AND CHROMOSOMAL
RP   TRANSLOCATION WITH RET.
RC   TISSUE=Fibroblast;
RX   PubMed=2734021;
RA   Ishizaka Y., Ochiai M., Tahira T., Suhimura T., Nahao M.;
RT   "Activation of the ret-II oncogene without a sequence encoding a
RT   transmembrane domain and transforming activity of two ret-II oncogene
RT   products differing in carboxy-termini due to alternative splicing.";
RL   Oncogene 4:789-794(1989).
RN   [7]
RP   ERRATUM.
RA   Ishizaka Y., Ochiai M., Tahira T., Suhimura T., Nahao M.;
RL   Oncogene 4:1415-1415(1989).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-585, AND CHROMOSOMAL TRANSLOCATION
RP   WITH RET.
RC   TISSUE=Thyroid;
RX   PubMed=9443391;
RA   Klugbauer S., Demidchik E.P., Lengfelder E., Rabes H.M.;
RT   "Detection of a novel type of Ret rearrangement (PTC5) in thyroid
RT   carcinomas after Chernobyl and analysis of the involved Ret-fused gene
RT   RFG5.";
RL   Cancer Res. 58:198-203(1998).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 576-731 (ISOFORM 2).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   FUNCTION, PHOSPHORYLATION, AND INTERACTION WITH RAB1A.
RX   PubMed=12538640; DOI=10.1083/jcb.200207045;
RA   Diao A., Rahman D., Pappin D.J.C., Lucocq J., Lowe M.;
RT   "The coiled-coil membrane protein golgin-84 is a novel rab effector
RT   required for Golgi ribbon formation.";
RL   J. Cell Biol. 160:201-212(2003).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH CUX1.
RX   PubMed=15718469; DOI=10.1126/science.1108061;
RA   Malsam J., Satoh A., Pelletier L., Warren G.;
RT   "Golgin tethers define subpopulations of COPI vesicles.";
RL   Science 307:1095-1098(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Involved in maintaining Golgi structure. Stimulates the
CC       formation of Golgi stacks and ribbons. Involved in intra-Golgi
CC       retrograde transport. {ECO:0000269|PubMed:12538640,
CC       ECO:0000269|PubMed:15718469}.
CC   -!- SUBUNIT: Homodimer. Interacts with RAB1A that has been activated
CC       by GTP-binding, and possibly also with OCRL1. Interacts with
CC       isoform CASP of CUX1. {ECO:0000269|PubMed:12538640,
CC       ECO:0000269|PubMed:15718469, ECO:0000269|PubMed:9915833}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:9915833}; Single-pass type IV membrane protein
CC       {ECO:0000269|PubMed:9915833}. Note=Found throughout the Golgi,
CC       both on cisternae and, at higher abundance, on the tubulo-
CC       vesicular structures of the cis-Golgi network.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TBA6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TBA6-2; Sequence=VSP_007731, VSP_007732;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in seminiferous
CC       tubules and Leydig cells in testis, and detected at much lower
CC       levels in the other tissues tested. Expression is very low or not
CC       detectable in spermatozoa. {ECO:0000269|PubMed:9915833}.
CC   -!- PTM: Highly phosphorylated during mitosis. Phosphorylation is
CC       barely detectable during interphase.
CC       {ECO:0000269|PubMed:12538640}.
CC   -!- DISEASE: Note=A chromosomal aberration involving GOLGA5 is found
CC       in papillary thyroid carcinomas (PTCs). Translocation
CC       t(10;14)(q11;q32) with RET. The translocation generates the
CC       RET/GOLGA5 (PTC5) oncogene. {ECO:0000269|PubMed:2734021,
CC       ECO:0000269|PubMed:9443391}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA33787.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA. A chimeric cDNA originating from chromosomes 14 and 10.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF085199; AAD09753.1; -; mRNA.
DR   EMBL; AY644768; AAV85456.1; -; mRNA.
DR   EMBL; AL132987; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81502.1; -; Genomic_DNA.
DR   EMBL; BC023021; AAH23021.1; -; mRNA.
DR   EMBL; X15786; CAA33787.1; ALT_SEQ; mRNA.
DR   EMBL; AJ132949; CAB36967.1; -; mRNA.
DR   EMBL; BX248744; CAD66551.1; -; mRNA.
DR   CCDS; CCDS9905.1; -. [Q8TBA6-1]
DR   PIR; I38153; I38153.
DR   RefSeq; NP_005104.3; NM_005113.3.
DR   RefSeq; XP_011535722.1; XM_011537420.2. [Q8TBA6-2]
DR   UniGene; Hs.104320; -.
DR   ProteinModelPortal; Q8TBA6; -.
DR   SMR; Q8TBA6; -.
DR   BioGrid; 115275; 91.
DR   IntAct; Q8TBA6; 10.
DR   STRING; 9606.ENSP00000163416; -.
DR   iPTMnet; Q8TBA6; -.
DR   PhosphoSitePlus; Q8TBA6; -.
DR   DMDM; 296439337; -.
DR   EPD; Q8TBA6; -.
DR   MaxQB; Q8TBA6; -.
DR   PaxDb; Q8TBA6; -.
DR   PeptideAtlas; Q8TBA6; -.
DR   PRIDE; Q8TBA6; -.
DR   Ensembl; ENST00000163416; ENSP00000163416; ENSG00000066455. [Q8TBA6-1]
DR   GeneID; 9950; -.
DR   KEGG; hsa:9950; -.
DR   UCSC; uc001yaz.3; human. [Q8TBA6-1]
DR   CTD; 9950; -.
DR   DisGeNET; 9950; -.
DR   EuPathDB; HostDB:ENSG00000066455.12; -.
DR   GeneCards; GOLGA5; -.
DR   H-InvDB; HIX0011907; -.
DR   HGNC; HGNC:4428; GOLGA5.
DR   HPA; HPA000992; -.
DR   HPA; HPA063876; -.
DR   MalaCards; GOLGA5; -.
DR   MIM; 606918; gene.
DR   neXtProt; NX_Q8TBA6; -.
DR   OpenTargets; ENSG00000066455; -.
DR   Orphanet; 146; Papillary or follicular thyroid carcinoma.
DR   PharmGKB; PA28809; -.
DR   eggNOG; KOG4677; Eukaryota.
DR   eggNOG; ENOG410XR4F; LUCA.
DR   GeneTree; ENSGT00390000018470; -.
DR   HOGENOM; HOG000273871; -.
DR   HOVERGEN; HBG051755; -.
DR   InParanoid; Q8TBA6; -.
DR   OMA; NRVDQGA; -.
DR   OrthoDB; EOG091G0HP5; -.
DR   PhylomeDB; Q8TBA6; -.
DR   TreeFam; TF319468; -.
DR   Reactome; R-HSA-6811438; Intra-Golgi traffic.
DR   ChiTaRS; GOLGA5; human.
DR   GeneWiki; GOLGA5; -.
DR   GenomeRNAi; 9950; -.
DR   PRO; PR:Q8TBA6; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000066455; -.
DR   CleanEx; HS_GOLGA5; -.
DR   ExpressionAtlas; Q8TBA6; baseline and differential.
DR   Genevisible; Q8TBA6; HS.
DR   GO; GO:0005801; C:cis-Golgi network; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0031985; C:Golgi cisterna; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0030133; C:transport vesicle; TAS:Reactome.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0017137; F:Rab GTPase binding; IDA:UniProtKB.
DR   GO; GO:0007030; P:Golgi organization; IMP:UniProtKB.
DR   GO; GO:0048193; P:Golgi vesicle transport; IMP:UniProtKB.
DR   GO; GO:0000301; P:retrograde transport, vesicle recycling within Golgi; IBA:GO_Central.
DR   InterPro; IPR019177; Golgin_subfamily_A_member_5.
DR   Pfam; PF09787; Golgin_A5; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Coiled coil; Complete proteome; Golgi apparatus; Membrane;
KW   Methylation; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    731       Golgin subfamily A member 5.
FT                                /FTId=PRO_0000190061.
FT   TOPO_DOM      2    698       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    699    719       Helical; Anchor for type IV membrane
FT                                protein. {ECO:0000255}.
FT   TOPO_DOM    720    731       Lumenal. {ECO:0000255}.
FT   COILED      216    632       {ECO:0000255}.
FT   SITE        497    498       Breakpoint for translocation to form RET-
FT                                GOLGA5 oncogene.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   MOD_RES      89     89       Dimethylated arginine; alternate.
FT                                {ECO:0000250|UniProtKB:Q3ZU82}.
FT   MOD_RES      89     89       Omega-N-methylated arginine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES     116    116       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     684    691       SIRLGIFL -> RLCFTSGS (in isoform 2).
FT                                {ECO:0000303|Ref.9}.
FT                                /FTId=VSP_007731.
FT   VAR_SEQ     692    731       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.9}.
FT                                /FTId=VSP_007732.
FT   VARIANT      67     67       A -> G (in dbSNP:rs17128572).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_055859.
FT   VARIANT     486    486       M -> V (in dbSNP:rs34139657).
FT                                /FTId=VAR_055860.
FT   CONFLICT    350    350       F -> L (in Ref. 1; AAD09753, 2; AAV85456,
FT                                4; EAW81502, 5; AAH23021, 6; CAA33787 and
FT                                8; CAB36967). {ECO:0000305}.
FT   CONFLICT    584    585       QS -> PV (in Ref. 8; CAB36967).
FT                                {ECO:0000305}.
SQ   SEQUENCE   731 AA;  83024 MW;  650B5D46096A2DDE CRC64;
     MSWFVDLAGK AEDLLNRVDQ GAATALSRKD NASNIYSKNT DYTELHQQNT DLIYQTGPKS
     TYISSAADNI RNQKATILAG TANVKVGSRT PVEASHPVEN ASVPRPSSHF VRRKKSEPDD
     ELLFDFLNSS QKEPTGRVEI RKEKGKTPVF QSSQTSSVSS VNPSVTTIKT IEENSFGSQT
     HEAASNSDSS HEGQEESSKE NVSSNAACPD HTPTPNDDGK SHELSNLRLE NQLLRNEVQS
     LNQEMASLLQ RSKETQEELN KARARVEKWN ADHSKSDRMT RGLRAQVDDL TEAVAAKDSQ
     LAVLKVRLQE ADQLLSTRTE ALEALQSEKS RIMQDQSEGN SLQNQALQTF QERLHEADAT
     LKREQESYKQ MQSEFAARLN KVEMERQNLA EAITLAERKY SDEKKRVDEL QQQVKLYKLN
     LESSKQELID YKQKATRILQ SKEKLINSLK EGSGFEGLDS STASSMELEE LRHEKEMQRE
     EIQKLMGQIH QLRSELQDME AQQVNEAESA REQLQDLHDQ IAGQKASKQE LETELERLKQ
     EFHYIEEDLY RTKNTLQSRI KDRDEEIQKL RNQLTNKTLS NSSQSELENR LHQLTETLIQ
     KQTMLESLST EKNSLVFQLE RLEQQMNSAS GSSSNGSSIN MSGIDNGEGT RLRNVPVLFN
     DTETNLAGMY GKVRKAASSI DQFSIRLGIF LRRYPIARVF VIIYMALLHL WVMIVLLTYT
     PEMHHDQPYG K
//
ID   GOPC_HUMAN              Reviewed;         462 AA.
AC   Q9HD26; A6NM30; Q59FS4; Q969U8;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-FEB-2018, entry version 156.
DE   RecName: Full=Golgi-associated PDZ and coiled-coil motif-containing protein;
DE   AltName: Full=CFTR-associated ligand;
DE   AltName: Full=Fused in glioblastoma;
DE   AltName: Full=PDZ protein interacting specifically with TC10;
DE            Short=PIST;
GN   Name=GOPC; Synonyms=CAL, FIG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11162552; DOI=10.1006/bbrc.2000.4160;
RA   Neudauer C.L., Joberty G., Macara I.G.;
RT   "PIST: a novel PDZ/coiled-coil domain binding partner for the rho-
RT   family GTPase TC10.";
RL   Biochem. Biophys. Res. Commun. 280:541-547(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, INTERACTION WITH STX6, AND MUTAGENESIS OF
RP   LEU-175; LEU-182; LEU-189 AND LEU-196.
RC   TISSUE=Myeloid leukemia cell;
RX   PubMed=11384996; DOI=10.1074/jbc.M104137200;
RA   Charest A., Lane K., McMahon K., Housman D.E.;
RT   "Association of a novel PDZ domain-containing peripheral Golgi protein
RT   with the Q-SNARE (Q-soluble N-ethylmaleimide-sensitive fusion protein
RT   (NSF) attachment protein receptor) protein syntaxin 6.";
RL   J. Biol. Chem. 276:29456-29465(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, OLIGOMERIZATION, INTERACTION WITH CFTR, AND
RP   DOMAIN.
RC   TISSUE=Lung;
RX   PubMed=11707463; DOI=10.1074/jbc.M110177200;
RA   Cheng J., Moyer B.D., Milewski M., Loffing J., Ikeda M., Mickle J.E.,
RA   Cutting G.R., Li M., Stanton B.A., Guggino W.B.;
RT   "A Golgi-associated PDZ domain protein modulates cystic fibrosis
RT   transmembrane regulator plasma membrane expression.";
RL   J. Biol. Chem. 277:3520-3529(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH ROS1.
RX   PubMed=12661006; DOI=10.1002/gcc.10207;
RA   Charest A., Lane K., McMahon K., Park J., Preisinger E., Conroy H.,
RA   Housman D.;
RT   "Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma
RT   with an interstitial del(6)(q21q21).";
RL   Genes Chromosomes Cancer 37:58-71(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [10]
RP   FUNCTION.
RX   PubMed=14570915; DOI=10.1074/jbc.M308640200;
RA   Cheng J., Wang H., Guggino W.B.;
RT   "Modulation of mature cystic fibrosis transmembrane regulator protein
RT   by the PDZ domain protein CAL.";
RL   J. Biol. Chem. 279:1892-1898(2004).
RN   [11]
RP   INTERACTION WITH ASIC3.
RX   PubMed=15317815; DOI=10.1074/jbc.M405874200;
RA   Hruska-Hageman A.M., Benson C.J., Leonard A.S., Price M.P.,
RA   Welsh M.J.;
RT   "PSD-95 and Lin-7b interact with acid-sensing ion channel-3 and have
RT   opposite effects on H+- gated current.";
RL   J. Biol. Chem. 279:46962-46968(2004).
RN   [12]
RP   INTERACTION WITH ADRB1, DOMAIN, AND FUNCTION.
RX   PubMed=15358775; DOI=10.1074/jbc.M404876200;
RA   He J., Bellini M., Xu J., Castleberry A.M., Hall R.A.;
RT   "Interaction with cystic fibrosis transmembrane conductance regulator-
RT   associated ligand (CAL) inhibits beta1-adrenergic receptor surface
RT   expression.";
RL   J. Biol. Chem. 279:50190-50196(2004).
RN   [13]
RP   INTERACTION WITH RHOQ.
RX   PubMed=15546864; DOI=10.1074/jbc.M410026200;
RA   Cheng J., Wang H., Guggino W.B.;
RT   "Regulation of cystic fibrosis transmembrane regulator trafficking and
RT   protein expression by a Rho family small GTPase TC10.";
RL   J. Biol. Chem. 280:3731-3739(2005).
RN   [14]
RP   INTERACTION WITH GOLGA3, AND SUBCELLULAR LOCATION.
RX   PubMed=15951434; DOI=10.1074/jbc.M504937200;
RA   Hicks S.W., Machamer C.E.;
RT   "Isoform-specific interaction of golgin-160 with the Golgi-associated
RT   protein PIST.";
RL   J. Biol. Chem. 280:28944-28951(2005).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   STRUCTURE BY NMR OF 278-371, AND INTERACTION WITH NLGN1 AND FZD8.
RX   PubMed=16882988; DOI=10.1110/ps.062087506;
RA   Li X., Zhang J., Cao Z., Wu J., Shi Y.;
RT   "Solution structure of GOPC PDZ domain and its interaction with the C-
RT   terminal motif of neuroligin.";
RL   Protein Sci. 15:2149-2158(2006).
CC   -!- FUNCTION: Plays a role in intracellular protein trafficking and
CC       degradation. May regulate CFTR chloride currents and acid-induced
CC       ASIC3 currents by modulating cell surface expression of both
CC       channels. May also regulate the intracellular trafficking of the
CC       ADR1B receptor. May play a role in autophagy. Overexpression
CC       results in CFTR intracellular retention and degradation in the
CC       lysosomes. {ECO:0000269|PubMed:11707463,
CC       ECO:0000269|PubMed:14570915, ECO:0000269|PubMed:15358775}.
CC   -!- SUBUNIT: Homooligomer. Interacts with FZD5, FZD8, GRID2, BECN1,
CC       CSPG5 and CLCN3. May interact with CACNG2 (By similarity).
CC       Interacts with STX6, CFTR, ASIC3, GOLGA3, NLGN1 and RHOQ.
CC       {ECO:0000250, ECO:0000269|PubMed:11384996,
CC       ECO:0000269|PubMed:11707463, ECO:0000269|PubMed:15317815,
CC       ECO:0000269|PubMed:15358775, ECO:0000269|PubMed:15546864,
CC       ECO:0000269|PubMed:15951434, ECO:0000269|PubMed:16882988}.
CC   -!- INTERACTION:
CC       Q9H9L7:AKIRIN1; NbExp=3; IntAct=EBI-349832, EBI-10309796;
CC       Q16520:BATF; NbExp=3; IntAct=EBI-349832, EBI-749503;
CC       Q0P5P2:C17orf67; NbExp=3; IntAct=EBI-349832, EBI-10226540;
CC       Q68D86:CCDC102B; NbExp=3; IntAct=EBI-349832, EBI-10171570;
CC       Q12882:DPYD; NbExp=3; IntAct=EBI-349832, EBI-2839838;
CC       Q86YD7:FAM90A1; NbExp=3; IntAct=EBI-349832, EBI-6658203;
CC       P15408:FOSL2; NbExp=3; IntAct=EBI-349832, EBI-3893419;
CC       P08631:HCK; NbExp=3; IntAct=EBI-349832, EBI-346340;
CC       V9HWD0:HEL-S-42; NbExp=4; IntAct=EBI-349832, EBI-10330219;
CC       P05412:JUN; NbExp=3; IntAct=EBI-349832, EBI-852823;
CC       Q6UWP7:LCLAT1; NbExp=3; IntAct=EBI-349832, EBI-10254507;
CC       Q9R0W0:mGluR1a (xeno); NbExp=7; IntAct=EBI-349832, EBI-8505383;
CC       Q8WVZ3:MORN4; NbExp=3; IntAct=EBI-349832, EBI-10277137;
CC       Q9BYD6:MRPL1; NbExp=3; IntAct=EBI-349832, EBI-5325394;
CC       Q2TAK8-2:MUM1; NbExp=3; IntAct=EBI-349832, EBI-10239402;
CC       Q15746:MYLK; NbExp=3; IntAct=EBI-349832, EBI-968482;
CC       Q8IZQ8:MYOCD; NbExp=3; IntAct=EBI-349832, EBI-493384;
CC       Q99497:PARK7; NbExp=3; IntAct=EBI-349832, EBI-1164361;
CC       Q7Z2X4:PID1; NbExp=3; IntAct=EBI-349832, EBI-10256685;
CC       Q86X10:RALGAPB; NbExp=4; IntAct=EBI-11102276, EBI-1755842;
CC       Q96D59:RNF183; NbExp=4; IntAct=EBI-11102276, EBI-743938;
CC       Q9BWG1:RNF220; NbExp=3; IntAct=EBI-349832, EBI-10300482;
CC       Q9NTN9:SEMA4G; NbExp=3; IntAct=EBI-349832, EBI-6447340;
CC       Q9H1K4:SLC25A18; NbExp=3; IntAct=EBI-349832, EBI-6269587;
CC       Q6RVD6:SPATA8; NbExp=3; IntAct=EBI-349832, EBI-8635958;
CC       O43805:SSNA1; NbExp=3; IntAct=EBI-349832, EBI-2515299;
CC       Q14849:STARD3; NbExp=3; IntAct=EBI-349832, EBI-9819324;
CC       P04004:VTN; NbExp=3; IntAct=EBI-349832, EBI-1036653;
CC       Q6ZSB9:ZBTB49; NbExp=3; IntAct=EBI-349832, EBI-2859943;
CC       Q32MK9:ZNF509; NbExp=3; IntAct=EBI-349832, EBI-10239929;
CC       Q8TBZ8:ZNF564; NbExp=3; IntAct=EBI-349832, EBI-10273713;
CC       Q9P0T4:ZNF581; NbExp=3; IntAct=EBI-349832, EBI-745520;
CC       Q96SQ5:ZNF587; NbExp=3; IntAct=EBI-349832, EBI-6427977;
CC       Q8NBB4:ZSCAN1; NbExp=3; IntAct=EBI-349832, EBI-5292994;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Golgi apparatus membrane;
CC       Peripheral membrane protein. Golgi apparatus, trans-Golgi network
CC       membrane; Peripheral membrane protein. Cell junction, synapse
CC       {ECO:0000250}. Cell junction, synapse, postsynaptic cell membrane,
CC       postsynaptic density {ECO:0000250}. Cell projection, dendrite
CC       {ECO:0000250}. Note=Enriched in synaptosomal and postsynaptic
CC       densities (PSD) fractions. Expressed in cell bodies and dendrites
CC       of Purkinje cells. Localized at the trans-Golgi network (TGN) of
CC       spermatids and the medulla of round spermatides. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HD26-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HD26-2; Sequence=VSP_016062;
CC       Name=3;
CC         IsoId=Q9HD26-3; Sequence=VSP_016063, VSP_016064;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:11162552, ECO:0000269|PubMed:11384996,
CC       ECO:0000269|PubMed:11707463}.
CC   -!- DOMAIN: The PDZ domain mediates interactions with FZD5, FZD8,
CC       ASIC3, GRID2, CLCN3 (By similarity). Mediates also interaction
CC       with CFTR and ADRB1. {ECO:0000250, ECO:0000269|PubMed:11707463,
CC       ECO:0000269|PubMed:15358775}.
CC   -!- DOMAIN: The coiled-coil region probably mediates association to
CC       membranes, targeting to the Golgi, and interactions with GOLGA3,
CC       and STX6. May also mediate interaction with RHOQ (By similarity).
CC       {ECO:0000250}.
CC   -!- DISEASE: Note=A chromosomal aberration involving GOPC is found in
CC       a glioblastoma multiforme sample. An intra-chromosomal deletion
CC       del(6)(q21q21) is responsible for the formation of GOPC-ROS1
CC       chimeric protein which has a constitutive receptor tyrosine kinase
CC       activity. {ECO:0000269|PubMed:12661006}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92622.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF287894; AAG00572.1; -; mRNA.
DR   EMBL; AY033606; AAK57733.1; -; mRNA.
DR   EMBL; AF450008; AAL47160.1; -; mRNA.
DR   EMBL; AB209385; BAD92622.1; ALT_INIT; mRNA.
DR   EMBL; AL589939; CAH70198.1; -; Genomic_DNA.
DR   EMBL; Z85999; CAH70198.1; JOINED; Genomic_DNA.
DR   EMBL; AL589939; CAH70199.1; -; Genomic_DNA.
DR   EMBL; Z85999; CAH70199.1; JOINED; Genomic_DNA.
DR   EMBL; Z85999; CAI43172.1; -; Genomic_DNA.
DR   EMBL; AL589939; CAI43172.1; JOINED; Genomic_DNA.
DR   EMBL; Z85999; CAI43173.1; -; Genomic_DNA.
DR   EMBL; AL589939; CAI43173.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW48205.1; -; Genomic_DNA.
DR   EMBL; BC009553; AAH09553.1; -; mRNA.
DR   CCDS; CCDS34523.1; -. [Q9HD26-2]
DR   CCDS; CCDS5117.1; -. [Q9HD26-1]
DR   RefSeq; NP_001017408.1; NM_001017408.2. [Q9HD26-2]
DR   RefSeq; NP_065132.1; NM_020399.3. [Q9HD26-1]
DR   UniGene; Hs.191539; -.
DR   PDB; 2DC2; NMR; -; A=278-371.
DR   PDB; 2LOB; NMR; -; A=286-370.
DR   PDB; 4E34; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4E35; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4JOE; X-ray; 1.14 A; A/B=284-370.
DR   PDB; 4JOF; X-ray; 1.20 A; A/B=284-370.
DR   PDB; 4JOG; X-ray; 1.46 A; A/B=284-370.
DR   PDB; 4JOH; X-ray; 1.47 A; A/B=284-370.
DR   PDB; 4JOJ; X-ray; 1.20 A; A/B=284-370.
DR   PDB; 4JOK; X-ray; 1.09 A; A/B=284-370.
DR   PDB; 4JOP; X-ray; 1.80 A; A/B=284-370.
DR   PDB; 4JOR; X-ray; 1.34 A; A/B=284-370.
DR   PDB; 4K6Y; X-ray; 1.48 A; A/B=284-370.
DR   PDB; 4K72; X-ray; 1.90 A; A/B=284-370.
DR   PDB; 4K75; X-ray; 1.50 A; A=284-370.
DR   PDB; 4K76; X-ray; 1.75 A; A/B/C/D=284-370.
DR   PDB; 4K78; X-ray; 1.80 A; A=284-370.
DR   PDB; 4NMO; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4NMP; X-ray; 1.30 A; A/B=284-370.
DR   PDB; 4NMQ; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4NMR; X-ray; 1.55 A; A/B=284-370.
DR   PDB; 4NMS; X-ray; 1.70 A; A/B=284-370.
DR   PDB; 4NMT; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4NMV; X-ray; 1.40 A; A/B=284-370.
DR   PDB; 4Q6H; X-ray; 1.90 A; A=284-370.
DR   PDB; 4Q6S; X-ray; 1.45 A; A/B=284-370.
DR   PDB; 5IC3; X-ray; 1.70 A; A/B=284-370.
DR   PDB; 5K4F; X-ray; 1.36 A; A/B=284-370.
DR   PDBsum; 2DC2; -.
DR   PDBsum; 2LOB; -.
DR   PDBsum; 4E34; -.
DR   PDBsum; 4E35; -.
DR   PDBsum; 4JOE; -.
DR   PDBsum; 4JOF; -.
DR   PDBsum; 4JOG; -.
DR   PDBsum; 4JOH; -.
DR   PDBsum; 4JOJ; -.
DR   PDBsum; 4JOK; -.
DR   PDBsum; 4JOP; -.
DR   PDBsum; 4JOR; -.
DR   PDBsum; 4K6Y; -.
DR   PDBsum; 4K72; -.
DR   PDBsum; 4K75; -.
DR   PDBsum; 4K76; -.
DR   PDBsum; 4K78; -.
DR   PDBsum; 4NMO; -.
DR   PDBsum; 4NMP; -.
DR   PDBsum; 4NMQ; -.
DR   PDBsum; 4NMR; -.
DR   PDBsum; 4NMS; -.
DR   PDBsum; 4NMT; -.
DR   PDBsum; 4NMV; -.
DR   PDBsum; 4Q6H; -.
DR   PDBsum; 4Q6S; -.
DR   PDBsum; 5IC3; -.
DR   PDBsum; 5K4F; -.
DR   ProteinModelPortal; Q9HD26; -.
DR   SMR; Q9HD26; -.
DR   BioGrid; 121384; 132.
DR   IntAct; Q9HD26; 70.
DR   MINT; Q9HD26; -.
DR   STRING; 9606.ENSP00000357484; -.
DR   iPTMnet; Q9HD26; -.
DR   PhosphoSitePlus; Q9HD26; -.
DR   BioMuta; GOPC; -.
DR   DMDM; 74762751; -.
DR   EPD; Q9HD26; -.
DR   MaxQB; Q9HD26; -.
DR   PaxDb; Q9HD26; -.
DR   PeptideAtlas; Q9HD26; -.
DR   PRIDE; Q9HD26; -.
DR   DNASU; 57120; -.
DR   Ensembl; ENST00000052569; ENSP00000052569; ENSG00000047932. [Q9HD26-2]
DR   Ensembl; ENST00000368498; ENSP00000357484; ENSG00000047932. [Q9HD26-1]
DR   GeneID; 57120; -.
DR   KEGG; hsa:57120; -.
DR   UCSC; uc003pxu.4; human. [Q9HD26-1]
DR   CTD; 57120; -.
DR   DisGeNET; 57120; -.
DR   EuPathDB; HostDB:ENSG00000047932.13; -.
DR   GeneCards; GOPC; -.
DR   HGNC; HGNC:17643; GOPC.
DR   HPA; HPA019477; -.
DR   HPA; HPA024018; -.
DR   MIM; 606845; gene.
DR   neXtProt; NX_Q9HD26; -.
DR   OpenTargets; ENSG00000047932; -.
DR   PharmGKB; PA134904944; -.
DR   eggNOG; ENOG410ITAF; Eukaryota.
DR   eggNOG; ENOG410XT8J; LUCA.
DR   GeneTree; ENSGT00550000074581; -.
DR   HOGENOM; HOG000280727; -.
DR   HOVERGEN; HBG057507; -.
DR   InParanoid; Q9HD26; -.
DR   OMA; LHSLYHK; -.
DR   OrthoDB; EOG091G0DXX; -.
DR   PhylomeDB; Q9HD26; -.
DR   TreeFam; TF317932; -.
DR   Reactome; R-HSA-5627083; RHO GTPases regulate CFTR trafficking.
DR   SIGNOR; Q9HD26; -.
DR   ChiTaRS; GOPC; human.
DR   EvolutionaryTrace; Q9HD26; -.
DR   GeneWiki; GOPC; -.
DR   GenomeRNAi; 57120; -.
DR   PRO; PR:Q9HD26; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000047932; -.
DR   CleanEx; HS_GOPC; -.
DR   ExpressionAtlas; Q9HD26; baseline and differential.
DR   Genevisible; Q9HD26; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030660; C:Golgi-associated vesicle membrane; TAS:Reactome.
DR   GO; GO:0005765; C:lysosomal membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0030140; C:trans-Golgi network transport vesicle; IDA:UniProtKB.
DR   GO; GO:0005109; F:frizzled binding; IEA:Ensembl.
DR   GO; GO:0030695; F:GTPase regulator activity; IEA:Ensembl.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0045176; P:apical protein localization; NAS:UniProtKB.
DR   GO; GO:0043004; P:cytoplasmic sequestering of CFTR protein; IMP:UniProtKB.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; NAS:UniProtKB.
DR   GO; GO:0006893; P:Golgi to plasma membrane transport; NAS:UniProtKB.
DR   GO; GO:0010360; P:negative regulation of anion channel activity; IMP:UniProtKB.
DR   GO; GO:2000009; P:negative regulation of protein localization to cell surface; IMP:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IPI:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0007289; P:spermatid nucleus differentiation; IEA:Ensembl.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   Pfam; PF00595; PDZ; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell junction;
KW   Cell membrane; Cell projection; Chromosomal rearrangement;
KW   Coiled coil; Complete proteome; Cytoplasm; Golgi apparatus; Membrane;
KW   Postsynaptic cell membrane; Protein transport; Reference proteome;
KW   Synapse; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    462       Golgi-associated PDZ and coiled-coil
FT                                motif-containing protein.
FT                                /FTId=PRO_0000087542.
FT   DOMAIN      288    371       PDZ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00143}.
FT   COILED       83    200       {ECO:0000255}.
FT   SITE        419    420       Breakpoint for translocation to form
FT                                GOPC-ROS1 fusion protein.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   VAR_SEQ     150    157       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11384996,
FT                                ECO:0000303|PubMed:11707463,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016062.
FT   VAR_SEQ     305    319       GGKEHGVPILISEIH -> VRSSTSSIIFYSYLV (in
FT                                isoform 3). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_016063.
FT   VAR_SEQ     320    462       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_016064.
FT   MUTAGEN     175    175       L->V: No effect on subcellular location;
FT                                when associated with V-182; V-189 and V-
FT                                196. {ECO:0000269|PubMed:11384996}.
FT   MUTAGEN     182    182       L->V: No effect on subcellular location;
FT                                when associated with V-175; V-189 and V-
FT                                196. {ECO:0000269|PubMed:11384996}.
FT   MUTAGEN     189    189       L->V: No effect on subcellular location;
FT                                when associated with V-175; V-182 and V-
FT                                196. {ECO:0000269|PubMed:11384996}.
FT   MUTAGEN     196    196       L->V: No effect on subcellular location;
FT                                when associated with V-175; V-182 and V-
FT                                189. {ECO:0000269|PubMed:11384996}.
FT   STRAND      287    292       {ECO:0000244|PDB:4JOK}.
FT   STRAND      295    297       {ECO:0000244|PDB:4NMO}.
FT   STRAND      301    306       {ECO:0000244|PDB:4JOK}.
FT   HELIX       307    309       {ECO:0000244|PDB:4JOK}.
FT   STRAND      311    318       {ECO:0000244|PDB:4JOK}.
FT   HELIX       323    327       {ECO:0000244|PDB:4JOK}.
FT   STRAND      334    339       {ECO:0000244|PDB:4JOK}.
FT   STRAND      342    344       {ECO:0000244|PDB:2DC2}.
FT   STRAND      346    348       {ECO:0000244|PDB:2LOB}.
FT   HELIX       349    357       {ECO:0000244|PDB:4JOK}.
FT   STRAND      361    369       {ECO:0000244|PDB:4JOK}.
SQ   SEQUENCE   462 AA;  50520 MW;  8A19DDC376DCD0F4 CRC64;
     MSAGGPCPAA AGGGPGGASC SVGAPGGVSM FRWLEVLEKE FDKAFVDVDL LLGEIDPDQA
     DITYEGRQKM TSLSSCFAQL CHKAQSVSQI NHKLEAQLVD LKSELTETQA EKVVLEKEVH
     DQLLQLHSIQ LQLHAKTGQS ADSGTIKAKL SGPSVEELER ELEANKKEKM KEAQLEAEVK
     LLRKENEALR RHIAVLQAEV YGARLAAKYL DKELAGRVQQ IQLLGRDMKG PAHDKLWNQL
     EAEIHLHRHK TVIRACRGRN DLKRPMQAPP GHDQDSLKKS QGVGPIRKVL LLKEDHEGLG
     ISITGGKEHG VPILISEIHP GQPADRCGGL HVGDAILAVN GVNLRDTKHK EAVTILSQQR
     GEIEFEVVYV APEVDSDDEN VEYEDESGHR YRLYLDELEG GGNPGASCKD TSGEIKVLQG
     FNKKAVTDTH ENGDLGTASE TPLDDGASKL DDLHTLYHKK SY
//
ID   GEPH_HUMAN              Reviewed;         736 AA.
AC   Q9NQX3; Q96KU4; Q9H4E9; Q9P2G2;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 168.
DE   RecName: Full=Gephyrin {ECO:0000303|PubMed:10839351};
DE   Includes:
DE     RecName: Full=Molybdopterin adenylyltransferase;
DE              Short=MPT adenylyltransferase;
DE              EC=2.7.7.75 {ECO:0000305|PubMed:26613940};
DE     AltName: Full=Domain G;
DE   Includes:
DE     RecName: Full=Molybdopterin molybdenumtransferase;
DE              Short=MPT Mo-transferase;
DE              EC=2.10.1.1 {ECO:0000305|PubMed:22040219, ECO:0000305|PubMed:26613940};
DE     AltName: Full=Domain E;
GN   Name=GPHN {ECO:0000312|HGNC:HGNC:15465}; Synonyms=GPH, KIAA1385;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=10839351; DOI=10.1016/S0896-6273(00)81165-4;
RA   Butler M.H., Hayashi A., Okoshi N., Villmann C., Becker C.M., Feng G.,
RA   De Camilli P., Solimena M.;
RT   "Autoimmunity to gephyrin in Stiff-Man syndrome.";
RL   Neuron 26:307-312(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INVOLVEMENT IN MOCODC, AND
RP   PATHWAY.
RX   PubMed=11095995; DOI=10.1086/316941;
RA   Reiss J., Gross-Hardt S., Christensen E., Schmidt P., Mendel R.R.,
RA   Schwarz G.;
RT   "A mutation in the gene for the neurotransmitter receptor-clustering
RT   protein gephyrin causes a novel form of molybdenum cofactor
RT   deficiency.";
RL   Am. J. Hum. Genet. 68:208-213(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=11418245; DOI=10.1016/S0378-1119(01)00511-X;
RA   David-Watine B.;
RT   "The human gephyrin (GPHN) gene: structure, chromosome localization
RT   and expression in non-neuronal cells.";
RL   Gene 271:239-245(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-266, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188 AND SER-194, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188 AND SER-194, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188; SER-194; THR-198
RP   AND SER-305, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 1-181, AND SUBUNIT.
RX   PubMed=11554796; DOI=10.1006/jmbi.2001.4952;
RA   Schwarz G., Schrader N., Mendel R.R., Hecht H.-J., Schindelin H.;
RT   "Crystal structures of human gephyrin and plant Cnx1 G domains:
RT   comparative analysis and functional implications.";
RL   J. Mol. Biol. 312:405-418(2001).
RN   [15]
RP   VARIANT TYR-10, CHARACTERIZATION OF VARIANT TYR-10, AND INTERACTION
RP   WITH GLRB.
RX   PubMed=12684523; DOI=10.1074/jbc.M301070200;
RA   Rees M.I., Harvey K., Ward H., White J.H., Evans L., Duguid I.C.,
RA   Hsu C.-C., Coleman S.L., Miller J., Baer K., Waldvogel H.J.,
RA   Gibbon F., Smart T.G., Owen M.J., Harvey R.J., Snell R.G.;
RT   "Isoform heterogeneity of the human gephyrin gene (GPHN), binding
RT   domains to the glycine receptor, and mutation analysis in
RT   hyperekplexia.";
RL   J. Biol. Chem. 278:24688-24696(2003).
RN   [16]
RP   VARIANT MOCODC ALA-580, AND PATHWAY.
RX   PubMed=22040219; DOI=10.1111/j.1399-0004.2011.01709.x;
RA   Reiss J., Lenz U., Aquaviva-Bourdain C., Joriot-Chekaf S.,
RA   Mention-Mulliez K., Holder-Espinasse M.;
RT   "A GPHN point mutation leading to molybdenum cofactor deficiency.";
RL   Clin. Genet. 80:598-599(2011).
RN   [17]
RP   VARIANT MOCODC ASP-375, CHARACTERIZATION OF MOCODC VARIANTS ASP-375
RP   AND ALA-580, INTERACTION WITH GABRA3 AND GLRB, SUBCELLULAR LOCATION,
RP   SUBUNIT, FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=26613940; DOI=10.15252/emmm.201505323;
RG   EuroEPINOMICS Dravet working group;
RA   Dejanovic B., Djemie T., Gruenewald N., Suls A., Kress V., Hetsch F.,
RA   Craiu D., Zemel M., Gormley P., Lal D., Myers C.T., Mefford H.C.,
RA   Palotie A., Helbig I., Meier J.C., De Jonghe P., Weckhuysen S.,
RA   Schwarz G.;
RT   "Simultaneous impairment of neuronal and metabolic function of mutated
RT   gephyrin in a patient with epileptic encephalopathy.";
RL   EMBO Mol. Med. 7:1580-1594(2015).
CC   -!- FUNCTION: Microtubule-associated protein involved in membrane
CC       protein-cytoskeleton interactions. It is thought to anchor the
CC       inhibitory glycine receptor (GLYR) to subsynaptic microtubules.
CC       Catalyzes two steps in the biosynthesis of the molybdenum
CC       cofactor. In the first step, molybdopterin is adenylated.
CC       Subsequently, molybdate is inserted into adenylated molybdopterin
CC       and AMP is released. {ECO:0000269|PubMed:26613940}.
CC   -!- CATALYTIC ACTIVITY: ATP + molybdopterin = diphosphate + adenylyl-
CC       molybdopterin. {ECO:0000305|PubMed:26613940}.
CC   -!- CATALYTIC ACTIVITY: Adenylyl-molybdopterin + molybdate =
CC       molybdenum cofactor + AMP. {ECO:0000305|PubMed:22040219,
CC       ECO:0000305|PubMed:26613940}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Inhibited by copper and tungsten.
CC       {ECO:0000250}.
CC   -!- PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis.
CC       {ECO:0000269|PubMed:11095995, ECO:0000269|PubMed:22040219,
CC       ECO:0000269|PubMed:26613940}.
CC   -!- SUBUNIT: Homotrimer, homodimer and homooligomer (PubMed:26613940).
CC       Interacts with GABARAP (By similarity). Interacts with SRGAP2 (via
CC       SH3 domain) (By similarity). Interacts with GABRA3
CC       (PubMed:26613940). Interacts with GLRB (PubMed:26613940,
CC       PubMed:12684523). GABRA3 and GLRB occupy overlapping binding sites
CC       (By similarity). {ECO:0000250|UniProtKB:Q03555,
CC       ECO:0000250|UniProtKB:Q8BUV3, ECO:0000269|PubMed:12684523,
CC       ECO:0000269|PubMed:26613940}.
CC   -!- INTERACTION:
CC       P63167:DYNLL1; NbExp=2; IntAct=EBI-2371891, EBI-349105;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q03555}. Cell junction, synapse,
CC       postsynaptic cell membrane {ECO:0000269|PubMed:26613940};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:Q03555};
CC       Cytoplasmic side {ECO:0000250|UniProtKB:Q03555}. Cytoplasm,
CC       cytoskeleton {ECO:0000250|UniProtKB:Q03555}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q03555}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q03555}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q03555}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:26613940}. Note=Cytoplasmic face of
CC       glycinergic postsynaptic membranes.
CC       {ECO:0000250|UniProtKB:Q03555}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NQX3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NQX3-2; Sequence=VSP_021769;
CC   -!- DISEASE: Molybdenum cofactor deficiency, complementation group C
CC       (MOCODC) [MIM:615501]: A form of molybdenum cofactor deficiency,
CC       an autosomal recessive metabolic disorder leading to the
CC       pleiotropic loss of molybdoenzyme activities. It is clinically
CC       characterized by onset in infancy of poor feeding, intractable
CC       seizures, severe psychomotor retardation, and death in early
CC       childhood in most patients. {ECO:0000269|PubMed:11095995,
CC       ECO:0000269|PubMed:22040219, ECO:0000269|PubMed:26613940}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the MoaB/Mog
CC       family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the MoeA family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92623.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GPHNID317.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ272033; CAC81240.1; -; mRNA.
DR   EMBL; AF272663; AAF81785.1; -; mRNA.
DR   EMBL; AJ272343; CAC10537.1; -; mRNA.
DR   EMBL; AB037806; BAA92623.1; ALT_INIT; mRNA.
DR   EMBL; BC030016; AAH30016.1; -; mRNA.
DR   CCDS; CCDS32103.1; -. [Q9NQX3-1]
DR   CCDS; CCDS9777.1; -. [Q9NQX3-2]
DR   RefSeq; NP_001019389.1; NM_001024218.1. [Q9NQX3-1]
DR   RefSeq; NP_065857.1; NM_020806.4. [Q9NQX3-2]
DR   UniGene; Hs.208765; -.
DR   PDB; 1JLJ; X-ray; 1.60 A; A/B/C=1-181.
DR   PDBsum; 1JLJ; -.
DR   ProteinModelPortal; Q9NQX3; -.
DR   SMR; Q9NQX3; -.
DR   BioGrid; 115537; 35.
DR   DIP; DIP-41076N; -.
DR   IntAct; Q9NQX3; 14.
DR   MINT; Q9NQX3; -.
DR   STRING; 9606.ENSP00000417901; -.
DR   DrugBank; DB01942; Formic Acid.
DR   DrugBank; DB03766; Propanoic Acid.
DR   MoonProt; Q9NQX3; -.
DR   iPTMnet; Q9NQX3; -.
DR   PhosphoSitePlus; Q9NQX3; -.
DR   BioMuta; GPHN; -.
DR   DMDM; 13431554; -.
DR   EPD; Q9NQX3; -.
DR   MaxQB; Q9NQX3; -.
DR   PaxDb; Q9NQX3; -.
DR   PeptideAtlas; Q9NQX3; -.
DR   PRIDE; Q9NQX3; -.
DR   DNASU; 10243; -.
DR   Ensembl; ENST00000315266; ENSP00000312771; ENSG00000171723. [Q9NQX3-1]
DR   Ensembl; ENST00000478722; ENSP00000417901; ENSG00000171723. [Q9NQX3-2]
DR   GeneID; 10243; -.
DR   KEGG; hsa:10243; -.
DR   UCSC; uc001xix.4; human. [Q9NQX3-1]
DR   CTD; 10243; -.
DR   DisGeNET; 10243; -.
DR   EuPathDB; HostDB:ENSG00000171723.15; -.
DR   GeneCards; GPHN; -.
DR   GeneReviews; GPHN; -.
DR   HGNC; HGNC:15465; GPHN.
DR   HPA; CAB004419; -.
DR   HPA; HPA003116; -.
DR   HPA; HPA024694; -.
DR   MalaCards; GPHN; -.
DR   MIM; 603930; gene.
DR   MIM; 615501; phenotype.
DR   neXtProt; NX_Q9NQX3; -.
DR   OpenTargets; ENSG00000171723; -.
DR   Orphanet; 3197; Hereditary hyperekplexia.
DR   Orphanet; 308400; Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C.
DR   PharmGKB; PA28840; -.
DR   eggNOG; KOG2371; Eukaryota.
DR   eggNOG; COG0303; LUCA.
DR   eggNOG; COG0521; LUCA.
DR   GeneTree; ENSGT00390000016577; -.
DR   HOGENOM; HOG000280651; -.
DR   HOVERGEN; HBG005828; -.
DR   InParanoid; Q9NQX3; -.
DR   KO; K15376; -.
DR   PhylomeDB; Q9NQX3; -.
DR   TreeFam; TF300902; -.
DR   BioCyc; MetaCyc:ENSG00000171723-MONOMER; -.
DR   Reactome; R-HSA-947581; Molybdenum cofactor biosynthesis.
DR   SIGNOR; Q9NQX3; -.
DR   UniPathway; UPA00344; -.
DR   ChiTaRS; GPHN; human.
DR   EvolutionaryTrace; Q9NQX3; -.
DR   GeneWiki; GPHN; -.
DR   GenomeRNAi; 10243; -.
DR   PRO; PR:Q9NQX3; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000171723; -.
DR   CleanEx; HS_GPHN; -.
DR   ExpressionAtlas; Q9NQX3; baseline and differential.
DR   Genevisible; Q9NQX3; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061598; F:molybdopterin adenylyltransferase activity; IBA:GO_Central.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; IDA:CAFA.
DR   GO; GO:0061599; F:molybdopterin molybdotransferase activity; IBA:GO_Central.
DR   GO; GO:0008940; F:nitrate reductase activity; IMP:CAFA.
DR   GO; GO:0097112; P:gamma-aminobutyric acid receptor clustering; IDA:UniProtKB.
DR   GO; GO:0072579; P:glycine receptor clustering; IBA:GO_Central.
DR   GO; GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IBA:GO_Central.
DR   GO; GO:0018315; P:molybdenum incorporation into molybdenum-molybdopterin complex; IBA:GO_Central.
DR   GO; GO:0032324; P:molybdopterin cofactor biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0010038; P:response to metal ion; IMP:CAFA.
DR   CDD; cd00886; MogA_MoaB; 1.
DR   Gene3D; 2.40.340.10; -; 1.
DR   Gene3D; 3.40.980.10; -; 2.
DR   InterPro; IPR036425; MoaB/Mog-like_dom_sf.
DR   InterPro; IPR001453; MoaB/Mog_dom.
DR   InterPro; IPR008284; MoCF_biosynth_CS.
DR   InterPro; IPR005111; MoeA_C_domain_IV.
DR   InterPro; IPR036688; MoeA_C_domain_IV_sf.
DR   InterPro; IPR005110; MoeA_linker/N.
DR   InterPro; IPR036135; MoeA_linker/N_sf.
DR   Pfam; PF00994; MoCF_biosynth; 2.
DR   Pfam; PF03454; MoeA_C; 1.
DR   Pfam; PF03453; MoeA_N; 1.
DR   SMART; SM00852; MoCF_biosynth; 2.
DR   SUPFAM; SSF53218; SSF53218; 2.
DR   SUPFAM; SSF63867; SSF63867; 1.
DR   SUPFAM; SSF63882; SSF63882; 1.
DR   TIGRFAMs; TIGR00177; molyb_syn; 2.
DR   PROSITE; PS01078; MOCF_BIOSYNTHESIS_1; 1.
DR   PROSITE; PS01079; MOCF_BIOSYNTHESIS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell junction;
KW   Cell membrane; Cell projection; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Disease mutation; Magnesium; Membrane; Metal-binding;
KW   Molybdenum; Molybdenum cofactor biosynthesis; Multifunctional enzyme;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Postsynaptic cell membrane; Reference proteome; Synapse; Transferase.
FT   CHAIN         1    736       Gephyrin.
FT                                /FTId=PRO_0000170964.
FT   REGION       14    166       MPT Mo-transferase.
FT   REGION      140    316       Interaction with GABARAP. {ECO:0000250}.
FT   REGION      326    736       MPT adenylyltransferase.
FT   MOD_RES     188    188       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     194    194       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     198    198       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     200    200       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BUV3}.
FT   MOD_RES     262    262       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BUV3}.
FT   MOD_RES     265    265       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8BUV3}.
FT   MOD_RES     266    266       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243}.
FT   MOD_RES     268    268       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BUV3}.
FT   MOD_RES     270    270       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BUV3}.
FT   MOD_RES     305    305       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     243    243       K -> KKHPFYTSPAVVMAHGEQPIPGLINYSHHSTDER
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:11418245,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_021769.
FT   VARIANT      10     10       N -> Y (found in a patient with
FT                                hyperekplexia; unknown pathological
FT                                significance; does not disrupt GLRB-GPHN
FT                                interactions; does not affect the
FT                                structural lattices formed by GPHN;
FT                                dbSNP:rs121908539).
FT                                {ECO:0000269|PubMed:12684523}.
FT                                /FTId=VAR_044162.
FT   VARIANT     375    375       G -> D (in MOCODC; patient phenotype
FT                                resembling Dravet syndrome; abolishes
FT                                postsynaptic clustering of GPHN;
FT                                decreases cell-surface expression of GABA
FT                                receptors; impairs postsynaptic currents;
FT                                catalytically inactive; decreases binding
FT                                affinity toward GABRA3; decreases binding
FT                                affinity toward GLRB).
FT                                {ECO:0000269|PubMed:26613940}.
FT                                /FTId=VAR_075626.
FT   VARIANT     580    580       D -> A (in MOCODC; lacks molybdenum
FT                                cofactor synthesis activity;
FT                                dbSNP:rs397518420).
FT                                {ECO:0000269|PubMed:22040219,
FT                                ECO:0000269|PubMed:26613940}.
FT                                /FTId=VAR_070275.
FT   CONFLICT    261    261       A -> V (in Ref. 1; CAC81240).
FT                                {ECO:0000305}.
FT   STRAND       16     22       {ECO:0000244|PDB:1JLJ}.
FT   HELIX        24     27       {ECO:0000244|PDB:1JLJ}.
FT   HELIX        34     44       {ECO:0000244|PDB:1JLJ}.
FT   TURN         46     49       {ECO:0000244|PDB:1JLJ}.
FT   STRAND       52     59       {ECO:0000244|PDB:1JLJ}.
FT   HELIX        63     75       {ECO:0000244|PDB:1JLJ}.
FT   STRAND       80     86       {ECO:0000244|PDB:1JLJ}.
FT   STRAND       89     91       {ECO:0000244|PDB:1JLJ}.
FT   HELIX        96    103       {ECO:0000244|PDB:1JLJ}.
FT   STRAND      105    107       {ECO:0000244|PDB:1JLJ}.
FT   HELIX       109    122       {ECO:0000244|PDB:1JLJ}.
FT   HELIX       124    128       {ECO:0000244|PDB:1JLJ}.
FT   STRAND      133    136       {ECO:0000244|PDB:1JLJ}.
FT   STRAND      139    144       {ECO:0000244|PDB:1JLJ}.
FT   HELIX       148    158       {ECO:0000244|PDB:1JLJ}.
FT   HELIX       159    161       {ECO:0000244|PDB:1JLJ}.
FT   HELIX       162    169       {ECO:0000244|PDB:1JLJ}.
FT   HELIX       175    178       {ECO:0000244|PDB:1JLJ}.
SQ   SEQUENCE   736 AA;  79748 MW;  E2BDA3AD3AB962C0 CRC64;
     MATEGMILTN HDHQIRVGVL TVSDSCFRNL AEDRSGINLK DLVQDPSLLG GTISAYKIVP
     DEIEEIKETL IDWCDEKELN LILTTGGTGF APRDVTPEAT KEVIEREAPG MALAMLMGSL
     NVTPLGMLSR PVCGIRGKTL IINLPGSKKG SQECFQFILP ALPHAIDLLR DAIVKVKEVH
     DELEDLPSPP PPLSPPPTTS PHKQTEDKGV QCEEEEEEKK DSGVASTEDS SSSHITAAAI
     AAKIPDSIIS RGVQVLPRDT ASLSTTPSES PRAQATSRLS TASCPTPKVQ SRCSSKENIL
     RASHSAVDIT KVARRHRMSP FPLTSMDKAF ITVLEMTPVL GTEIINYRDG MGRVLAQDVY
     AKDNLPPFPA SVKDGYAVRA ADGPGDRFII GESQAGEQPT QTVMPGQVMR VTTGAPIPCG
     ADAVVQVEDT ELIRESDDGT EELEVRILVQ ARPGQDIRPI GHDIKRGECV LAKGTHMGPS
     EIGLLATVGV TEVEVNKFPV VAVMSTGNEL LNPEDDLLPG KIRDSNRSTL LATIQEHGYP
     TINLGIVGDN PDDLLNALNE GISRADVIIT SGGVSMGEKD YLKQVLDIDL HAQIHFGRVF
     MKPGLPTTFA TLDIDGVRKI IFALPGNPVS AVVTCNLFVV PALRKMQGIL DPRPTIIKAR
     LSCDVKLDPR PEYHRCILTW HHQEPLPWAQ STGNQMSSRL MSMRSANGLL MLPPKTEQYV
     ELHKGEVVDV MVIGRL
//
ID   A4UAE9_HUMAN            Unreviewed;       275 AA.
AC   A4UAE9;
DT   15-MAY-2007, integrated into UniProtKB/TrEMBL.
DT   15-MAY-2007, sequence version 1.
DT   31-JAN-2018, entry version 49.
DE   SubName: Full=Homocysteine-inducible endoplasmic reticulum stress-inducible ubiquitin-like domain member 1 protein {ECO:0000313|EMBL:ABI18163.1};
GN   Name=HERPUD1 {ECO:0000313|EMBL:ABI18163.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABI18163.1};
RN   [1] {ECO:0000313|EMBL:ABI18163.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=17420289; DOI=10.1083/jcb.200611036;
RA   Tuvia S., Taglicht D., Erez O., Alroy I., Alchanati I., Bicoviski V.,
RA   Dori-Bachash M., Ben-Avraham D., Reiss Y.;
RT   "The ubiquitin E3 ligase POSH regulates calcium homeostasis through
RT   spatial control of Herp.";
RL   J. Cell Biol. 177:51-61(2007).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ837586; ABI18163.1; -; mRNA.
DR   RefSeq; NP_001259032.1; NM_001272103.1.
DR   UniGene; Hs.146393; -.
DR   MaxQB; A4UAE9; -.
DR   PeptideAtlas; A4UAE9; -.
DR   PRIDE; A4UAE9; -.
DR   GeneID; 9709; -.
DR   CTD; 9709; -.
DR   eggNOG; KOG4583; Eukaryota.
DR   eggNOG; ENOG410ZJAF; LUCA.
DR   HOVERGEN; HBG051899; -.
DR   ChiTaRS; HERPUD1; human.
DR   GenomeRNAi; 9709; -.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       10     72       Ubiquitin-like.
FT                                {ECO:0000259|PROSITE:PS50053}.
SQ   SEQUENCE   275 AA;  30635 MW;  2C9917ED99406C9B CRC64;
     MESETEPEPV TLLVKSPNQR HRDLELSGDR GWSVGHLKAH LSRVYPERPR PEDQRLIYSG
     KLLLDHQCLR DLLPKQEKRH VLHLVCNVKS PSKMPEINAK VAESTEEPAG SNRGQYPEDS
     SSDGLRQREV LRNLSSPGWE NISRPEAAQQ AFQGLGPGFS GYTPYGWLQL SWFQQIYARQ
     YYMQYLAATA ASGAFVPPPS AQEIPVVSAP APAPIHNQFP AENQPANQNA APQVVVNPGA
     NQNLRMNAQG ITLGGFHLDR GRFRTSQMMV LLLTL
//
ID   HERP1_HUMAN             Reviewed;         391 AA.
AC   Q15011; E9PGD1; O60644; Q6IAN8; Q96D92;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   28-FEB-2018, entry version 167.
DE   RecName: Full=Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein;
DE   AltName: Full=Methyl methanesulfonate (MMF)-inducible fragment protein 1;
GN   Name=HERPUD1; Synonyms=HERP, KIAA0025, MIF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, SUBCELLULAR
RP   LOCATION, AND MEMBRANE TOPOLOGY.
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=10922362; DOI=10.1074/jbc.M002063200;
RA   Kokame K., Agarwala K.L., Kato H., Miyata T.;
RT   "Herp, a new ubiquitin-like membrane protein induced by endoplasmic
RT   reticulum stress.";
RL   J. Biol. Chem. 275:32846-32853(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y.,
RA   Sato S., Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I.
RT   The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by
RT   analysis of randomly sampled cDNA clones from human immature myeloid
RT   cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11112790; DOI=10.1074/jbc.M010486200;
RA   Kokame K., Kato H., Miyata T.;
RT   "Identification of ERSE-II, a new cis-acting element responsible for
RT   the ATF6-dependent mammalian unfolded protein response.";
RL   J. Biol. Chem. 276:9199-9205(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, Eye, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH PSEN1 AND PSEN2.
RX   PubMed=11799129; DOI=10.1074/jbc.M112372200;
RA   Sai X., Kawamura Y., Kokame K., Yamaguchi H., Shiraishi H., Suzuki R.,
RA   Suzuki T., Kawaichi M., Miyata T., Kitamura T., De Strooper B.,
RA   Yanagisawa K., Komano H.;
RT   "Endoplasmic reticulum stress-inducible protein, Herp, enhances
RT   presenilin-mediated generation of amyloid beta-protein.";
RL   J. Biol. Chem. 277:12915-12920(2002).
RN   [9]
RP   CHARACTERIZATION.
RC   TISSUE=Skin fibroblast;
RX   PubMed=10708769; DOI=10.1016/S0014-5793(00)01253-9;
RA   van Laar T., Schouten T., Hoogervorst E., van Eck M., van der Eb A.J.,
RA   Terleth C.;
RT   "The novel MMS-inducible gene Mif1/KIAA0025 is a target of the
RT   unfolded protein response pathway.";
RL   FEBS Lett. 469:123-131(2000).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH SYVN1.
RX   PubMed=16289116; DOI=10.1016/j.jmb.2005.10.020;
RA   Schulze A., Standera S., Buerger E., Kikkert M., van Voorden S.,
RA   Wiertz E., Koning F., Kloetzel P.-M., Seeger M.;
RT   "The ubiquitin-domain protein HERP forms a complex with components of
RT   the endoplasmic reticulum associated degradation pathway.";
RL   J. Mol. Biol. 354:1021-1027(2005).
RN   [11]
RP   INDUCTION.
RX   PubMed=16940180; DOI=10.1128/MCB.01046-06;
RA   Liang G., Audas T.E., Li Y., Cockram G.P., Dean J.D., Martyn A.C.,
RA   Kokame K., Lu R.;
RT   "Luman/CREB3 induces transcription of the endoplasmic reticulum (ER)
RT   stress response protein Herp through an ER stress response element.";
RL   Mol. Cell. Biol. 26:7999-8010(2006).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH UBQLN1; UBQLN2 AND UBQLN4.
RX   PubMed=18307982; DOI=10.1016/j.bbrc.2008.02.086;
RA   Kim T.Y., Kim E., Yoon S.K., Yoon J.B.;
RT   "Herp enhances ER-associated protein degradation by recruiting
RT   ubiquilins.";
RL   Biochem. Biophys. Res. Commun. 369:741-746(2008).
RN   [13]
RP   INTERACTION WITH UBXN6.
RX   PubMed=18656546; DOI=10.1016/j.biocel.2008.06.008;
RA   Madsen L., Andersen K.M., Prag S., Moos T., Semple C.A., Seeger M.,
RA   Hartmann-Petersen R.;
RT   "Ubxd1 is a novel co-factor of the human p97 ATPase.";
RL   Int. J. Biochem. Cell Biol. 40:2927-2942(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   STRUCTURE BY NMR OF 10-90.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the UBL-domain of HERP.";
RL   Submitted (NOV-2004) to the PDB data bank.
CC   -!- FUNCTION: Component of the endoplasmic reticulum quality control
CC       (ERQC) system also called ER-associated degradation (ERAD)
CC       involved in ubiquitin-dependent degradation of misfolded
CC       endoplasmic reticulum proteins. Could enhance presenilin-mediated
CC       amyloid-beta protein 40 generation. Binds to ubiquilins and this
CC       interaction is required for efficient degradation of CD3D via the
CC       ERAD pathway (PubMed:18307982). {ECO:0000269|PubMed:16289116,
CC       ECO:0000269|PubMed:18307982}.
CC   -!- SUBUNIT: Interacts with PSEN1 and PSEN2. Interacts with SYVN1 and
CC       UBXN6. Interacts with UBQLN1, UBQLN2 and UBQLN4.
CC       {ECO:0000269|PubMed:11799129, ECO:0000269|PubMed:16289116,
CC       ECO:0000269|PubMed:18307982, ECO:0000269|PubMed:18656546}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10922362}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10922362}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=1;
CC         IsoId=Q15011-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15011-2; Sequence=VSP_006708;
CC       Name=3;
CC         IsoId=Q15011-3; Sequence=VSP_006708, VSP_006709;
CC       Name=4;
CC         IsoId=Q15011-4; Sequence=VSP_047333;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed; in the brain, expression
CC       seems to be restricted to neurons and vascular smooth muscle
CC       cells. Present in activated microglia in senile plaques in the
CC       brain of patients with Alzheimer disease.
CC   -!- INDUCTION: Up-regulated by endoplasmic reticulum stress and CREB3.
CC       {ECO:0000269|PubMed:10922362, ECO:0000269|PubMed:16940180}.
CC   -!- MISCELLANEOUS: Although the precise topology is not known,
CC       experimental data suggest that both the N- and C-termini face the
CC       cytosol.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB034989; BAB07891.1; -; mRNA.
DR   EMBL; D14695; BAA03521.1; -; mRNA.
DR   EMBL; AF055001; AAC09355.1; -; mRNA.
DR   EMBL; AF055003; AAC09357.1; -; mRNA.
DR   EMBL; AB034990; BAB19010.1; -; Genomic_DNA.
DR   EMBL; CR457116; CAG33397.1; -; mRNA.
DR   EMBL; AC012181; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000086; AAH00086.1; -; mRNA.
DR   EMBL; BC008320; AAH08320.1; -; mRNA.
DR   EMBL; BC009739; AAH09739.1; -; mRNA.
DR   EMBL; BC032673; AAH32673.1; -; mRNA.
DR   CCDS; CCDS10771.1; -. [Q15011-1]
DR   CCDS; CCDS45492.1; -. [Q15011-2]
DR   RefSeq; NP_001010989.1; NM_001010989.2. [Q15011-2]
DR   RefSeq; NP_001259032.1; NM_001272103.1.
DR   RefSeq; NP_055500.1; NM_014685.3. [Q15011-1]
DR   UniGene; Hs.146393; -.
DR   PDB; 1WGD; NMR; -; A=10-90.
DR   PDBsum; 1WGD; -.
DR   ProteinModelPortal; Q15011; -.
DR   SMR; Q15011; -.
DR   BioGrid; 115060; 30.
DR   DIP; DIP-46662N; -.
DR   IntAct; Q15011; 11.
DR   MINT; Q15011; -.
DR   STRING; 9606.ENSP00000409555; -.
DR   iPTMnet; Q15011; -.
DR   PhosphoSitePlus; Q15011; -.
DR   DMDM; 3123034; -.
DR   EPD; Q15011; -.
DR   MaxQB; Q15011; -.
DR   PaxDb; Q15011; -.
DR   PeptideAtlas; Q15011; -.
DR   PRIDE; Q15011; -.
DR   DNASU; 9709; -.
DR   Ensembl; ENST00000300302; ENSP00000300302; ENSG00000051108. [Q15011-2]
DR   Ensembl; ENST00000344114; ENSP00000340931; ENSG00000051108. [Q15011-3]
DR   Ensembl; ENST00000379792; ENSP00000369118; ENSG00000051108. [Q15011-4]
DR   Ensembl; ENST00000439977; ENSP00000409555; ENSG00000051108. [Q15011-1]
DR   GeneID; 9709; -.
DR   KEGG; hsa:9709; -.
DR   UCSC; uc002eke.3; human. [Q15011-1]
DR   CTD; 9709; -.
DR   DisGeNET; 9709; -.
DR   EuPathDB; HostDB:ENSG00000051108.14; -.
DR   GeneCards; HERPUD1; -.
DR   HGNC; HGNC:13744; HERPUD1.
DR   HPA; CAB037041; -.
DR   HPA; CAB037104; -.
DR   HPA; HPA040754; -.
DR   HPA; HPA041219; -.
DR   MIM; 608070; gene.
DR   neXtProt; NX_Q15011; -.
DR   OpenTargets; ENSG00000051108; -.
DR   PharmGKB; PA29252; -.
DR   eggNOG; KOG4583; Eukaryota.
DR   eggNOG; ENOG410ZJAF; LUCA.
DR   GeneTree; ENSGT00390000017671; -.
DR   HOGENOM; HOG000252989; -.
DR   HOVERGEN; HBG051899; -.
DR   InParanoid; Q15011; -.
DR   KO; K14027; -.
DR   OMA; TAWVFFK; -.
DR   OrthoDB; EOG091G0P9J; -.
DR   PhylomeDB; Q15011; -.
DR   TreeFam; TF324319; -.
DR   Reactome; R-HSA-380994; ATF4 activates genes.
DR   SIGNOR; Q15011; -.
DR   ChiTaRS; HERPUD1; human.
DR   EvolutionaryTrace; Q15011; -.
DR   GeneWiki; HERPUD1; -.
DR   GenomeRNAi; 9709; -.
DR   PRO; PR:Q15011; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000051108; -.
DR   CleanEx; HS_HERPUD1; -.
DR   ExpressionAtlas; Q15011; baseline and differential.
DR   Genevisible; Q15011; HS.
DR   GO; GO:0034704; C:calcium channel complex; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:1990037; C:Lewy body core; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0036499; P:PERK-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:1903071; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0032092; P:positive regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IEA:Ensembl.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0006986; P:response to unfolded protein; IEP:UniProtKB.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Endoplasmic reticulum; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix;
KW   Unfolded protein response.
FT   CHAIN         1    391       Homocysteine-responsive endoplasmic
FT                                reticulum-resident ubiquitin-like domain
FT                                member 1 protein.
FT                                /FTId=PRO_0000114920.
FT   TOPO_DOM      1    263       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TOPO_DOM    285    289       Lumenal. {ECO:0000255}.
FT   TRANSMEM    290    310       Helical. {ECO:0000255}.
FT   TOPO_DOM    311    391       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       10     72       Ubiquitin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   REGION      115    200       Interaction with UBQLN1.
FT                                {ECO:0000269|PubMed:18307982}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     135    135       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      75     99       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_047333.
FT   VAR_SEQ      76     76       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_006708.
FT   VAR_SEQ     145    302       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006709.
FT   VARIANT      50     50       R -> H (in dbSNP:rs2217332).
FT                                /FTId=VAR_024277.
FT   STRAND       11     15       {ECO:0000244|PDB:1WGD}.
FT   STRAND       17     20       {ECO:0000244|PDB:1WGD}.
FT   STRAND       24     27       {ECO:0000244|PDB:1WGD}.
FT   HELIX        34     44       {ECO:0000244|PDB:1WGD}.
FT   TURN         51     53       {ECO:0000244|PDB:1WGD}.
FT   STRAND       55     58       {ECO:0000244|PDB:1WGD}.
FT   STRAND       65     67       {ECO:0000244|PDB:1WGD}.
FT   HELIX        69     72       {ECO:0000244|PDB:1WGD}.
FT   STRAND       75     77       {ECO:0000244|PDB:1WGD}.
FT   STRAND       79     85       {ECO:0000244|PDB:1WGD}.
SQ   SEQUENCE   391 AA;  43720 MW;  3CA827DC7EF0ED22 CRC64;
     MESETEPEPV TLLVKSPNQR HRDLELSGDR GWSVGHLKAH LSRVYPERPR PEDQRLIYSG
     KLLLDHQCLR DLLPKQEKRH VLHLVCNVKS PSKMPEINAK VAESTEEPAG SNRGQYPEDS
     SSDGLRQREV LRNLSSPGWE NISRPEAAQQ AFQGLGPGFS GYTPYGWLQL SWFQQIYARQ
     YYMQYLAATA ASGAFVPPPS AQEIPVVSAP APAPIHNQFP AENQPANQNA APQVVVNPGA
     NQNLRMNAQG GPIVEEDDEI NRDWLDWTYS AATFSVFLSI LYFYSSLSRF LMVMGATVVM
     YLHHVGWFPF RPRPVQNFPN DGPPPDVVNQ DPNNNLQEGT DPETEDPNHL PPDRDVLDGE
     QTSPSFMSTA WLVFKTFFAS LLPEGPPAIA N
//
ID   Q53FP9_HUMAN            Unreviewed;       391 AA.
AC   Q53FP9;
DT   24-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   24-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 56.
DE   SubName: Full=Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 variant {ECO:0000313|EMBL:BAD96953.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD96953.1};
RN   [1] {ECO:0000313|EMBL:BAD96953.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Stomach mucosa {ECO:0000313|EMBL:BAD96953.1};
RX   PubMed=8125298; DOI=10.1016/0378-1119(94)90802-8;
RA   Maruyama K., Sugano S.;
RT   "Oligo-capping: a simple method to replace the cap structure of
RT   eukaryotic mRNAs with oligoribonucleotides.";
RL   Gene 138:171-174(1994).
RN   [2] {ECO:0000313|EMBL:BAD96953.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Stomach mucosa {ECO:0000313|EMBL:BAD96953.1};
RX   PubMed=9373149; DOI=10.1016/S0378-1119(97)00411-3;
RA   Suzuki Y., Yoshitomo K., Maruyama K., Suyama A., Sugano S.;
RT   "Construction and characterization of a full length-enriched and a 5'-
RT   end-enriched cDNA library.";
RL   Gene 200:149-156(1997).
RN   [3] {ECO:0000313|EMBL:BAD96953.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Stomach mucosa {ECO:0000313|EMBL:BAD96953.1};
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK223233; BAD96953.1; -; mRNA.
DR   RefSeq; NP_055500.1; NM_014685.3.
DR   UniGene; Hs.146393; -.
DR   PeptideAtlas; Q53FP9; -.
DR   GeneID; 9709; -.
DR   KEGG; hsa:9709; -.
DR   CTD; 9709; -.
DR   eggNOG; KOG4583; Eukaryota.
DR   eggNOG; ENOG410ZJAF; LUCA.
DR   HOVERGEN; HBG051899; -.
DR   KO; K14027; -.
DR   GenomeRNAi; 9709; -.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       10     72       Ubiquitin-like.
FT                                {ECO:0000259|PROSITE:PS50053}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAD96953.1}.
SQ   SEQUENCE   391 AA;  43692 MW;  23A737C371E0ED22 CRC64;
     MESETEPEPV TLLVKSPNQR HRDLELSGDR GWSVGHLKAH LSRVYPERPR PEDQRLIYSG
     KLLLDHQCLR DLLPKQEKRH VLHLVCNVKS PSKMPEINAK VAESTEEPAG SNRGQYPEDS
     SSDGLRQREV LRNLSSPGWE NISRPEAAQQ AFQGLGPGFS GYTPYGWLQL SWFQQIYARQ
     YYMQYLAATA ASGAFVPPPS AQEIPVVSAP APAPIHNQFP AENQPANQNA APQVVVNPGA
     NQNLRMNAQG GPIVEEDDEI NRDWLDWTYS AATFSVFLSI LYFYSSLSRF LMVMGATVVM
     YLHHVGWFPF RPRPVQNFPN DGPPPDAVNQ DPNNNLQEGT DPETEDPNHL PPDRDVLDGE
     QTSPSFMSTA WLVFKTFFAS LLPEGPPAIA N
//
ID   B2R4R0_HUMAN            Unreviewed;       103 AA.
AC   B2R4R0;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   28-FEB-2018, entry version 101.
DE   RecName: Full=Histone H4 {ECO:0000256|RuleBase:RU000528};
GN   Name=HIST1H4H {ECO:0000313|EMBL:EAW55556.1};
GN   Synonyms=HIST1H4J {ECO:0000313|EMBL:AAI48272.1},
GN   HIST1H4L {ECO:0000313|EMBL:BAG70273.1};
GN   ORFNames=hCG_1640981 {ECO:0000313|EMBL:EAW55556.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG34857.1};
RN   [1] {ECO:0000313|EMBL:EAW55556.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAI48272.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000313|EMBL:EAW55556.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG34857.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Corpus callosum {ECO:0000313|EMBL:BAG35087.1},
RC   Tongue {ECO:0000313|EMBL:BAG34965.1}, and
RC   Uterus {ECO:0000313|EMBL:BAG34857.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BAG38150.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Esophagus {ECO:0000313|EMBL:BAG38150.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (FEB-2008) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:BAG70273.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J.-I., Kimura K., Nishikawa T., Andoh T.,
RA   Iida Y., Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K.,
RA   Kawakami B., Kenmochi K.-I., Kimura R., Kobayashi M., Kuroita T.,
RA   Kuwayama H., Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J.-I., Watanabe S., Nomura N.;
RT   "Human Protein Factory: an infrastructure to convert the human
RT   transcriptome into the in vitro-expressed human proteome of versatile
RT   utility.";
RL   Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and
CC       compact DNA into chromatin, limiting DNA accessibility to the
CC       cellular machineries which require DNA as a template. Histones
CC       thereby play a central role in transcription regulation, DNA
CC       repair, DNA replication and chromosomal stability. DNA
CC       accessibility is regulated via a complex set of post-translational
CC       modifications of histones, also called histone code, and
CC       nucleosome remodeling. {ECO:0000256|RuleBase:RU000528,
CC       ECO:0000256|SAAS:SAAS00581158}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two
CC       molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4
CC       heterotetramer and two H2A-H2B heterodimers. The octamer wraps
CC       approximately 147 bp of DNA. {ECO:0000256|RuleBase:RU000528,
CC       ECO:0000256|SAAS:SAAS00581166}.
CC   -!- SUBCELLULAR LOCATION: Chromosome {ECO:0000256|SAAS:SAAS00846060}.
CC       Nucleus {ECO:0000256|SAAS:SAAS00846055}.
CC   -!- SIMILARITY: Belongs to the histone H4 family.
CC       {ECO:0000256|RuleBase:RU000528, ECO:0000256|SAAS:SAAS00581172}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC148271; AAI48272.1; -; mRNA.
DR   EMBL; AK311916; BAG34857.1; -; mRNA.
DR   EMBL; AK312028; BAG34965.1; -; mRNA.
DR   EMBL; AK312153; BAG35087.1; -; mRNA.
DR   EMBL; AK316561; BAG38150.1; -; mRNA.
DR   EMBL; AB451459; BAG70273.1; -; mRNA.
DR   EMBL; CH471087; EAW55556.1; -; Genomic_DNA.
DR   RefSeq; NP_001029249.1; NM_001034077.4.
DR   RefSeq; NP_003486.1; NM_003495.2.
DR   RefSeq; NP_003529.1; NM_003538.3.
DR   RefSeq; NP_003530.1; NM_003539.3.
DR   RefSeq; NP_003531.1; NM_003540.3.
DR   RefSeq; NP_003532.1; NM_003541.2.
DR   RefSeq; NP_003533.1; NM_003542.3.
DR   RefSeq; NP_003534.1; NM_003543.3.
DR   RefSeq; NP_003535.1; NM_003544.2.
DR   RefSeq; NP_003536.1; NM_003545.3.
DR   RefSeq; NP_003537.1; NM_003546.2.
DR   RefSeq; NP_003539.1; NM_003548.2.
DR   RefSeq; NP_068803.1; NM_021968.3.
DR   RefSeq; NP_778224.1; NM_175054.2.
DR   UniGene; Hs.143080; -.
DR   UniGene; Hs.247816; -.
DR   UniGene; Hs.248172; -.
DR   UniGene; Hs.248178; -.
DR   UniGene; Hs.248179; -.
DR   UniGene; Hs.278483; -.
DR   UniGene; Hs.46423; -.
DR   UniGene; Hs.528055; -.
DR   UniGene; Hs.533295; -.
DR   UniGene; Hs.55468; -.
DR   UniGene; Hs.591790; -.
DR   UniGene; Hs.655235; -.
DR   UniGene; Hs.662174; -.
DR   UniGene; Hs.706635; -.
DR   UniGene; Hs.745457; -.
DR   SMR; B2R4R0; -.
DR   IntAct; B2R4R0; 1.
DR   MINT; B2R4R0; -.
DR   DNASU; 8294; -.
DR   DNASU; 8360; -.
DR   DNASU; 8362; -.
DR   DNASU; 8363; -.
DR   DNASU; 8364; -.
DR   DNASU; 8365; -.
DR   DNASU; 8366; -.
DR   DNASU; 8367; -.
DR   DNASU; 8368; -.
DR   DNASU; 8370; -.
DR   GeneID; 121504; -.
DR   GeneID; 554313; -.
DR   GeneID; 8294; -.
DR   GeneID; 8359; -.
DR   GeneID; 8360; -.
DR   GeneID; 8361; -.
DR   GeneID; 8362; -.
DR   GeneID; 8363; -.
DR   GeneID; 8364; -.
DR   GeneID; 8365; -.
DR   GeneID; 8366; -.
DR   GeneID; 8367; -.
DR   GeneID; 8368; -.
DR   GeneID; 8370; -.
DR   KEGG; hsa:121504; -.
DR   KEGG; hsa:554313; -.
DR   KEGG; hsa:8294; -.
DR   KEGG; hsa:8359; -.
DR   KEGG; hsa:8360; -.
DR   KEGG; hsa:8361; -.
DR   KEGG; hsa:8362; -.
DR   KEGG; hsa:8363; -.
DR   KEGG; hsa:8364; -.
DR   KEGG; hsa:8365; -.
DR   KEGG; hsa:8366; -.
DR   KEGG; hsa:8367; -.
DR   KEGG; hsa:8368; -.
DR   KEGG; hsa:8370; -.
DR   CTD; 121504; -.
DR   CTD; 554313; -.
DR   CTD; 8294; -.
DR   CTD; 8359; -.
DR   CTD; 8360; -.
DR   CTD; 8361; -.
DR   CTD; 8362; -.
DR   CTD; 8363; -.
DR   CTD; 8364; -.
DR   CTD; 8365; -.
DR   CTD; 8366; -.
DR   CTD; 8367; -.
DR   CTD; 8368; -.
DR   CTD; 8370; -.
DR   EuPathDB; HostDB:ENSG00000158406.4; -.
DR   EuPathDB; HostDB:ENSG00000197061.4; -.
DR   EuPathDB; HostDB:ENSG00000197238.4; -.
DR   EuPathDB; HostDB:ENSG00000197837.3; -.
DR   EuPathDB; HostDB:ENSG00000270276.2; -.
DR   EuPathDB; HostDB:ENSG00000270882.2; -.
DR   EuPathDB; HostDB:ENSG00000273542.1; -.
DR   EuPathDB; HostDB:ENSG00000274618.1; -.
DR   EuPathDB; HostDB:ENSG00000275126.1; -.
DR   EuPathDB; HostDB:ENSG00000276180.1; -.
DR   EuPathDB; HostDB:ENSG00000276966.2; -.
DR   EuPathDB; HostDB:ENSG00000277157.1; -.
DR   EuPathDB; HostDB:ENSG00000278637.1; -.
DR   EuPathDB; HostDB:ENSG00000278705.1; -.
DR   PharmGKB; PA29169; -.
DR   eggNOG; KOG3467; Eukaryota.
DR   eggNOG; COG2036; LUCA.
DR   HOVERGEN; HBG051878; -.
DR   KO; K11254; -.
DR   OMA; YEEVRVV; -.
DR   OrthoDB; EOG09370I2I; -.
DR   Bgee; ENSG00000158406; -.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   CDD; cd00076; H4; 1.
DR   InterPro; IPR035425; CENP-T/H4_C.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR001951; Histone_H4.
DR   InterPro; IPR019809; Histone_H4_CS.
DR   InterPro; IPR004823; TAF_TATA-bd.
DR   Pfam; PF15511; CENP-T_C; 1.
DR   PRINTS; PR00623; HISTONEH4.
DR   SMART; SM00417; H4; 1.
DR   SMART; SM00803; TAF; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00047; HISTONE_H4; 1.
PE   2: Evidence at transcript level;
KW   Chromosome {ECO:0000256|RuleBase:RU000528,
KW   ECO:0000256|SAAS:SAAS00108758};
KW   DNA-binding {ECO:0000256|RuleBase:RU000528,
KW   ECO:0000256|SAAS:SAAS00108758};
KW   Nucleosome core {ECO:0000256|RuleBase:RU000528,
KW   ECO:0000256|SAAS:SAAS00108758};
KW   Nucleus {ECO:0000256|RuleBase:RU000528,
KW   ECO:0000256|SAAS:SAAS00846057}.
FT   DOMAIN       28     93       TAF. {ECO:0000259|SMART:SM00803}.
FT   NON_TER     103    103       {ECO:0000313|EMBL:BAG70273.1}.
SQ   SEQUENCE   103 AA;  11367 MW;  A9E5DFD3F8B97598 CRC64;
     MSGRGKGGKG LGKGGAKRHR KVLRDNIQGI TKPAIRRLAR RGGVKRISGL IYEETRGVLK
     VFLENVIRDA VTYTEHAKRK TVTAMDVVYA LKRQGRTLYG FGG
//
ID   H4_HUMAN                Reviewed;         103 AA.
AC   P62805; A2VCL0; P02304; P02305; Q6DRA9; Q6FGB8; Q6NWP7;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   28-FEB-2018, entry version 177.
DE   RecName: Full=Histone H4;
GN   Name=HIST1H4A; Synonyms=H4/A, H4FA;
GN   and
GN   Name=HIST1H4B; Synonyms=H4/I, H4FI;
GN   and
GN   Name=HIST1H4C; Synonyms=H4/G, H4FG;
GN   and
GN   Name=HIST1H4D; Synonyms=H4/B, H4FB;
GN   and
GN   Name=HIST1H4E; Synonyms=H4/J, H4FJ;
GN   and
GN   Name=HIST1H4F; Synonyms=H4/C, H4FC;
GN   and
GN   Name=HIST1H4H; Synonyms=H4/H, H4FH;
GN   and
GN   Name=HIST1H4I; Synonyms=H4/M, H4FM;
GN   and
GN   Name=HIST1H4J; Synonyms=H4/E, H4FE;
GN   and
GN   Name=HIST1H4K; Synonyms=H4/D, H4FD;
GN   and
GN   Name=HIST1H4L; Synonyms=H4/K, H4FK;
GN   and
GN   Name=HIST2H4A; Synonyms=H4/N, H4F2, H4FN, HIST2H4;
GN   and
GN   Name=HIST2H4B; Synonyms=H4/O, H4FO;
GN   and
GN   Name=HIST4H4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6314274; DOI=10.1093/nar/11.20.7069;
RA   Sierra F., Stein G., Stein J.;
RT   "Structure and in vitro transcription of a human H4 histone gene.";
RL   Nucleic Acids Res. 11:7069-7086(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3035717; DOI=10.1126/science.3035717;
RA   Pauli U., Chrysogelos S., Stein G., Stein J., Nick H.;
RT   "Protein-DNA interactions in vivo upstream of a cell cycle-regulated
RT   human H4 histone gene.";
RL   Science 236:1308-1311(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=1916825; DOI=10.1016/0888-7543(91)90183-F;
RA   Albig W., Kardalinou E., Drabent B., Zimmer A., Doenecke D.;
RT   "Isolation and characterization of two human H1 histone genes within
RT   clusters of core histone genes.";
RL   Genomics 10:940-948(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7626218; DOI=10.1089/dna.1995.14.591;
RA   Drabent B., Kardalinou E., Bode C., Doenecke D.;
RT   "Association of histone H4 genes with the mammalian testis-specific
RT   H1t histone gene.";
RL   DNA Cell Biol. 14:591-597(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9031620; DOI=10.1016/S0378-1119(96)00582-3;
RA   Albig W., Meergans T., Doenecke D.;
RT   "Characterization of the H1.5 gene completes the set of human H1
RT   subtype genes.";
RL   Gene 184:141-148(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9439656; DOI=10.1007/s004390050630;
RA   Albig W., Doenecke D.;
RT   "The human histone gene cluster at the D6S105 locus.";
RL   Hum. Genet. 101:284-294(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9119399; DOI=10.1006/geno.1996.4592;
RA   Albig W., Kioschis P., Poustka A., Meergans K., Doenecke D.;
RT   "Human histone gene organization: nonregular arrangement within a
RT   large cluster.";
RL   Genomics 40:314-322(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HIST1H4A; HIST1H4B; HIST1H4C;
RP   HIST1H4D; HIST1H4E; HIST1H4F; HIST1H4H; HIST1H4I; HIST1H4J; HIST1H4K;
RP   HIST1H4L; HIST2H4A AND HIST4H4).
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8988030;
RA   Akasaka T., Miura I., Takahashi N., Akasaka H., Yonetani N., Ohno H.,
RA   Fukuhara S., Okuma M.;
RT   "A recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma
RT   results in replacement of the 5' regulatory region of BCL6 with a
RT   novel H4 histone gene.";
RL   Cancer Res. 57:7-12(1997).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15527963; DOI=10.1016/j.gene.2004.07.036;
RA   Braastad C.D., Hovhannisyan H., van Wijnen A.J., Stein J.L.,
RA   Stein G.S.;
RT   "Functional characterization of a human histone gene cluster
RT   duplication.";
RL   Gene 342:35-40(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (HIST1H4F; HIST1H4H AND
RP   HIST2H4A).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (HIST1H4A; HIST1H4B;
RP   HIST1H4C; HIST1H4D; HIST1H4E; HIST1H4F; HIST1H4H; HIST1H4I; HIST1H4J;
RP   HIST1H4K AND HIST1H4L).
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum, Eye, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   PROTEIN SEQUENCE OF 25-36; 47-56; 61-78 AND 81-93, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAR-2005) to UniProtKB.
RN   [16]
RP   ACETYLATION AT LYS-6; LYS-9; LYS-13 AND LYS-17.
RX   PubMed=7664735;
RA   O'Neill L.P., Turner B.M.;
RT   "Histone H4 acetylation distinguishes coding regions of the human
RT   genome from heterochromatin in a differentiation-dependent but
RT   transcription-independent manner.";
RL   EMBO J. 14:3946-3957(1995).
RN   [17]
RP   DNA-BINDING REGION.
RX   PubMed=3340182; DOI=10.1038/331365a0;
RA   Ebralidse K.K., Grachev S.A., Mirzabekov A.D.;
RT   "A highly basic histone H4 domain bound to the sharply bent region of
RT   nucleosomal DNA.";
RL   Nature 331:365-367(1988).
RN   [18]
RP   ACETYLATION AT LYS-6; LYS-9; LYS-13 AND LYS-17.
RX   PubMed=2474456; DOI=10.1016/0014-5793(89)80947-0;
RA   Turner B.M., O'Neill L.P., Allan I.M.;
RT   "Histone H4 acetylation in human cells. Frequency of acetylation at
RT   different sites defined by immunolabeling with site-specific
RT   antibodies.";
RL   FEBS Lett. 253:141-145(1989).
RN   [19]
RP   METHYLATION AT ARG-4.
RX   PubMed=11448779; DOI=10.1016/S0960-9822(01)00294-9;
RA   Strahl B.D., Briggs S.D., Brame C.J., Caldwell J.A., Koh S.S., Ma H.,
RA   Cook R.G., Shabanowitz J., Hunt D.F., Stallcup M.R., Allis C.D.;
RT   "Methylation of histone H4 at arginine 3 occurs in vivo and is
RT   mediated by the nuclear receptor coactivator PRMT1.";
RL   Curr. Biol. 11:996-1000(2001).
RN   [20]
RP   METHYLATION AT ARG-4.
RX   PubMed=11387442; DOI=10.1126/science.1060781;
RA   Wang H., Huang Z.-Q., Xia L., Feng Q., Erdjument-Bromage H.,
RA   Strahl B.D., Briggs S.D., Allis C.D., Wong J., Tempst P., Zhang Y.;
RT   "Methylation of histone H4 at arginine 3 facilitating transcriptional
RT   activation by nuclear hormone receptor.";
RL   Science 293:853-857(2001).
RN   [21]
RP   INVOLVEMENT IN B-CELL NON-HODGKIN LYMPHOMA, AND CHROMOSOMAL
RP   TRANSLOCATION WITH BCL6.
RX   PubMed=12414651;
RA   Kurata M., Maesako Y., Ueda C., Nishikori M., Akasaka T., Uchiyama T.,
RA   Ohno H.;
RT   "Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-
RT   Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion
RT   gene, leading to altered expression of Bcl-6.";
RL   Cancer Res. 62:6224-6230(2002).
RN   [22]
RP   METHYLATION AT LYS-21.
RX   PubMed=12086618; DOI=10.1016/S1097-2765(02)00548-8;
RA   Nishioka K., Rice J.C., Sarma K., Erdjument-Bromage H., Werner J.,
RA   Wang Y., Chuikov S., Valenzuela P., Tempst P., Steward R., Lis J.T.,
RA   Allis C.D., Reinberg D.;
RT   "PR-Set7 is a nucleosome-specific methyltransferase that modifies
RT   lysine 20 of histone H4 and is associated with silent chromatin.";
RL   Mol. Cell 9:1201-1213(2002).
RN   [23]
RP   SUMOYLATION.
RX   PubMed=14578449; DOI=10.1073/pnas.1735528100;
RA   Shiio Y., Eisenman R.N.;
RT   "Histone sumoylation is associated with transcriptional repression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:13225-13230(2003).
RN   [24]
RP   CITRULLINATION AT ARG-4, AND METHYLATION AT ARG-4.
RX   PubMed=15345777; DOI=10.1126/science.1101400;
RA   Wang Y., Wysocka J., Sayegh J., Lee Y.-H., Perlin J.R., Leonelli L.,
RA   Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G.,
RA   Clarke S., Stallcup M.R., Allis C.D., Coonrod S.A.;
RT   "Human PAD4 regulates histone arginine methylation levels via
RT   demethylimination.";
RL   Science 306:279-283(2004).
RN   [25]
RP   METHYLATION AT LYS-21.
RX   PubMed=15964846; DOI=10.1074/jbc.M501691200;
RA   Yin Y., Liu C., Tsai S.N., Zhou B., Ngai S.M., Zhu G.;
RT   "SET8 recognizes the sequence RHRK20VLRDN within the N terminus of
RT   histone H4 and mono-methylates lysine 20.";
RL   J. Biol. Chem. 280:30025-30031(2005).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-52, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [28]
RP   UBIQUITINATION.
RX   PubMed=16678110; DOI=10.1016/j.molcel.2006.03.035;
RA   Wang H., Zhai L., Xu J., Joo H.-Y., Jackson S., Erdjument-Bromage H.,
RA   Tempst P., Xiong Y., Zhang Y.;
RT   "Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin
RT   ligase facilitates cellular response to DNA damage.";
RL   Mol. Cell 22:383-394(2006).
RN   [29]
RP   CITRULLINATION AT ARG-4.
RX   PubMed=16567635; DOI=10.1073/pnas.0509639103;
RA   Arita K., Shimizu T., Hashimoto H., Hidaka Y., Yamada M., Sato M.;
RT   "Structural basis for histone N-terminal recognition by human
RT   peptidylarginine deiminase 4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5291-5296(2006).
RN   [30]
RP   ACETYLATION AT SER-2; LYS-13 AND LYS-17, PHOSPHORYLATION AT SER-2, AND
RP   METHYLATION AT LYS-21.
RX   PubMed=17967882; DOI=10.1128/MCB.01517-07;
RA   Pesavento J.J., Yang H., Kelleher N.L., Mizzen C.A.;
RT   "Certain and progressive methylation of histone H4 at lysine 20 during
RT   the cell cycle.";
RL   Mol. Cell. Biol. 28:468-486(2008).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [32]
RP   ACETYLATION AT LYS-92, AND UBIQUITINATION AT LYS-92.
RX   PubMed=19818714; DOI=10.1016/j.molcel.2009.08.019;
RA   Yan Q., Dutt S., Xu R., Graves K., Juszczynski P., Manis J.P.,
RA   Shipp M.A.;
RT   "BBAP monoubiquitylates histone H4 at lysine 91 and selectively
RT   modulates the DNA damage response.";
RL   Mol. Cell 36:110-120(2009).
RN   [33]
RP   PROPIONYLATION AT LYS-9; LYS-17; LYS-32; LYS-45; LYS-78; LYS-80 AND
RP   LYS-92, AND BUTYRYLATION AT LYS-9; LYS-17; LYS-32; LYS-45; LYS-78;
RP   LYS-80 AND LYS-92.
RX   PubMed=17267393; DOI=10.1074/mcp.M700021-MCP200;
RA   Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C.,
RA   Falck J.R., Peng J., Gu W., Zhao Y.;
RT   "Lysine propionylation and butyrylation are novel post-translational
RT   modifications in histones.";
RL   Mol. Cell. Proteomics 6:812-819(2007).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [35]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-9; LYS-13; LYS-17 AND
RP   LYS-32, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND TYR-52, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [37]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [38]
RP   CROTONYLATION AT LYS-6; LYS-9 AND LYS-13.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q.,
RA   Wysocka J., Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation
RT   as a new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [39]
RP   PHOSPHORYLATION AT SER-48.
RX   PubMed=21724829; DOI=10.1101/gad.2055511;
RA   Kang B., Pu M., Hu G., Wen W., Dong Z., Zhao K., Stillman B.,
RA   Zhang Z.;
RT   "Phosphorylation of H4 Ser 47 promotes HIRA-mediated nucleosome
RT   assembly.";
RL   Genes Dev. 25:1359-1364(2011).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [41]
RP   SUCCINYLATION AT LYS-13; LYS-32; LYS-78 AND LYS-92.
RX   PubMed=22389435; DOI=10.1074/mcp.M111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [42]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND TYR-89, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [44]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-9; LYS-13; LYS-17; LYS-32; LYS-45;
RP   LYS-60; LYS-78; LYS-80 AND LYS-92.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H.,
RA   Debernardi A., Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z.,
RA   Allis C.D., Ren B., Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active
RT   histone mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [45]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-13, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [46]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [47]
RP   BUTYRYLATION AT LYS-6; LYS-9; LYS-13 AND LYS-17.
RX   PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014;
RA   Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z.,
RA   Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J.,
RA   Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C.,
RA   Panne D., Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.;
RT   "Dynamic competing histone H4 K5K8 acetylation and butyrylation are
RT   hallmarks of highly active gene promoters.";
RL   Mol. Cell 62:169-180(2016).
RN   [48]
RP   HYDROXYBUTYRYLATION AT LYS-9; LYS-13; LYS-32; LYS-78 AND LYS-92.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
RN   [49]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-21; LYS-32; LYS-60; LYS-80
RP   AND LYS-92, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=15951514; DOI=10.1093/nar/gki663;
RA   Tsunaka Y., Kajimura N., Tate S., Morikawa K.;
RT   "Alteration of the nucleosomal DNA path in the crystal structure of a
RT   human nucleosome core particle.";
RL   Nucleic Acids Res. 33:3424-3434(2005).
RN   [51]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-64.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and
CC       compact DNA into chromatin, limiting DNA accessibility to the
CC       cellular machineries which require DNA as a template. Histones
CC       thereby play a central role in transcription regulation, DNA
CC       repair, DNA replication and chromosomal stability. DNA
CC       accessibility is regulated via a complex set of post-translational
CC       modifications of histones, also called histone code, and
CC       nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two
CC       molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4
CC       heterotetramer and two H2A-H2B heterodimers. The octamer wraps
CC       approximately 147 bp of DNA.
CC   -!- INTERACTION:
CC       P35609:ACTN2; NbExp=3; IntAct=EBI-302023, EBI-77797;
CC       Q9Y294:ASF1A; NbExp=19; IntAct=EBI-302023, EBI-749553;
CC       Q12830:BPTF; NbExp=3; IntAct=EBI-302023, EBI-1560273;
CC       Q12830-4:BPTF; NbExp=16; IntAct=EBI-302023, EBI-4288838;
CC       P25440:BRD2; NbExp=5; IntAct=EBI-302023, EBI-2874802;
CC       O60885-1:BRD4; NbExp=10; IntAct=EBI-302023, EBI-9345088;
CC       P55201:BRPF1; NbExp=8; IntAct=EBI-302023, EBI-2837428;
CC       P49450:CENPA; NbExp=6; IntAct=EBI-302023, EBI-1751979;
CC       P49450-1:CENPA; NbExp=2; IntAct=EBI-302023, EBI-15826012;
CC       Q96DZ9-2:CMTM5; NbExp=4; IntAct=EBI-302023, EBI-11522780;
CC       Q9NQ92:COPRS; NbExp=3; IntAct=EBI-302023, EBI-1642558;
CC       Q92793:CREBBP; NbExp=6; IntAct=EBI-302023, EBI-81215;
CC       P45481:Crebbp (xeno); NbExp=2; IntAct=EBI-302023, EBI-296306;
CC       P84243:H3F3B; NbExp=12; IntAct=EBI-302023, EBI-120658;
CC       O14929:HAT1; NbExp=7; IntAct=EBI-302023, EBI-2339359;
CC       Q13547:HDAC1; NbExp=3; IntAct=EBI-302023, EBI-301834;
CC       P68431:HIST1H3D; NbExp=6; IntAct=EBI-302023, EBI-79722;
CC       Q71DI3:HIST2H3A; NbExp=3; IntAct=EBI-302023, EBI-750650;
CC       Q16695:HIST3H3; NbExp=2; IntAct=EBI-302023, EBI-358900;
CC       Q9H9V9:JMJD4; NbExp=3; IntAct=EBI-302023, EBI-2866290;
CC       O75164:KDM4A; NbExp=7; IntAct=EBI-302023, EBI-936709;
CC       Q9NQR1:KMT5A; NbExp=5; IntAct=EBI-302023, EBI-1268946;
CC       Q9Y468:L3MBTL1; NbExp=4; IntAct=EBI-302023, EBI-1265089;
CC       P49736:MCM2; NbExp=8; IntAct=EBI-302023, EBI-374819;
CC       P25205:MCM3; NbExp=2; IntAct=EBI-302023, EBI-355153;
CC       P33992:MCM5; NbExp=2; IntAct=EBI-302023, EBI-359410;
CC       Q86UY6-1:NAA40; NbExp=3; IntAct=EBI-302023, EBI-16140302;
CC       Q9BVI0:PHF20; NbExp=3; IntAct=EBI-302023, EBI-2560802;
CC       A8MW92:PHF20L1; NbExp=2; IntAct=EBI-302023, EBI-2560834;
CC       Q99873:PRMT1; NbExp=2; IntAct=EBI-302023, EBI-78738;
CC       O14744:PRMT5; NbExp=6; IntAct=EBI-302023, EBI-351098;
CC       Q582G4:PRMT7 (xeno); NbExp=4; IntAct=EBI-302023, EBI-16101095;
CC       Q16576:RBBP7; NbExp=8; IntAct=EBI-302023, EBI-352227;
CC       P38890:SET5 (xeno); NbExp=2; IntAct=EBI-302023, EBI-24263;
CC       Q9VK33:Sfmbt (xeno); NbExp=10; IntAct=EBI-302023, EBI-117801;
CC       Q8IUQ4:SIAH1; NbExp=3; IntAct=EBI-302023, EBI-747107;
CC       O60264:SMARCA5; NbExp=2; IntAct=EBI-302023, EBI-352588;
CC       Q04724:TLE1; NbExp=6; IntAct=EBI-302023, EBI-711424;
CC       Q12888:TP53BP1; NbExp=11; IntAct=EBI-302023, EBI-396540;
CC       Q12888-1:TP53BP1; NbExp=3; IntAct=EBI-302023, EBI-8022649;
CC       P63104:YWHAZ; NbExp=3; IntAct=EBI-302023, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Acetylation at Lys-6 (H4K5ac), Lys-9 (H4K8ac), Lys-13
CC       (H4K12ac) and Lys-17 (H4K16ac) occurs in coding regions of the
CC       genome but not in heterochromatin. {ECO:0000269|PubMed:17967882,
CC       ECO:0000269|PubMed:2474456, ECO:0000269|PubMed:7664735}.
CC   -!- PTM: Citrullination at Arg-4 (H4R3ci) by PADI4 impairs
CC       methylation. {ECO:0000269|PubMed:11387442,
CC       ECO:0000269|PubMed:11448779, ECO:0000269|PubMed:15345777,
CC       ECO:0000269|PubMed:16567635}.
CC   -!- PTM: Monomethylation and asymmetric dimethylation at Arg-4
CC       (H4R3me1 and H4R3me2a, respectively) by PRMT1 favors acetylation
CC       at Lys-9 (H4K8ac) and Lys-13 (H4K12ac). Demethylation is performed
CC       by JMJD6. Symmetric dimethylation on Arg-4 (H4R3me2s) by the
CC       PRDM1/PRMT5 complex may play a crucial role in the germ-cell
CC       lineage. {ECO:0000269|PubMed:11387442,
CC       ECO:0000269|PubMed:11448779, ECO:0000269|PubMed:15345777}.
CC   -!- PTM: Monomethylated, dimethylated or trimethylated at Lys-21
CC       (H4K20me1, H4K20me2, H4K20me3). Monomethylation is performed by
CC       SET8. Trimethylation is performed by KMT5B and KMT5C and induces
CC       gene silencing. {ECO:0000269|PubMed:12086618,
CC       ECO:0000269|PubMed:15964846, ECO:0000269|PubMed:17967882}.
CC   -!- PTM: Phosphorylated by PAK2 at Ser-48 (H4S47ph). This
CC       phosphorylation increases the association of H3.3-H4 with the
CC       histone chaperone HIRA, thus promoting nucleosome assembly of
CC       H3.3-H4 and inhibiting nucleosome assembly of H3.1-H4.
CC       {ECO:0000269|PubMed:17967882, ECO:0000269|PubMed:21724829}.
CC   -!- PTM: Ubiquitinated by the CUL4-DDB-RBX1 complex in response to
CC       ultraviolet irradiation. This may weaken the interaction between
CC       histones and DNA and facilitate DNA accessibility to repair
CC       proteins. Monoubiquitinated at Lys-92 of histone H4 (H4K91ub1) in
CC       response to DNA damage. The exact role of H4K91ub1 in DNA damage
CC       response is still unclear but it may function as a licensing
CC       signal for additional histone H4 post-translational modifications
CC       such as H4 Lys-21 methylation (H4K20me).
CC       {ECO:0000269|PubMed:12086618, ECO:0000269|PubMed:15964846,
CC       ECO:0000269|PubMed:16678110, ECO:0000269|PubMed:17967882,
CC       ECO:0000269|PubMed:19818714}.
CC   -!- PTM: Sumoylated, which is associated with transcriptional
CC       repression. {ECO:0000269|PubMed:14578449}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ
CC       cells and marks testis-specific genes in post-meiotic cells,
CC       including X-linked genes that escape sex chromosome inactivation
CC       in haploid cells. Crotonylation marks active promoters and
CC       enhancers and confers resistance to transcriptional repressors. It
CC       is also associated with post-meiotically activated genes on
CC       autosomes. {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: Butyrylation of histones marks active promoters and competes
CC       with histone acetylation. {ECO:0000250|UniProtKB:P62806}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving HISTONE H4 is a
CC       cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation
CC       t(3;6)(q27;p21), with BCL6. {ECO:0000269|PubMed:12414651}.
CC   -!- SIMILARITY: Belongs to the histone H4 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI28106.1; Type=Frameshift; Positions=3; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00038; CAA24918.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M16707; AAA52652.1; -; Genomic_DNA.
DR   EMBL; M60749; AAA63188.1; -; Genomic_DNA.
DR   EMBL; X60481; CAA43011.1; -; Genomic_DNA.
DR   EMBL; X60482; CAA43012.1; -; Genomic_DNA.
DR   EMBL; X60483; CAA43013.1; -; Genomic_DNA.
DR   EMBL; X60484; CAA43014.1; -; Genomic_DNA.
DR   EMBL; X60486; CAA43016.1; -; Genomic_DNA.
DR   EMBL; X60487; CAA43017.1; -; Genomic_DNA.
DR   EMBL; X67081; CAA47464.1; -; Genomic_DNA.
DR   EMBL; Z80787; CAB02549.1; -; Genomic_DNA.
DR   EMBL; X83548; CAA58538.1; -; Genomic_DNA.
DR   EMBL; AF525682; AAM83108.1; -; Genomic_DNA.
DR   EMBL; AY128653; AAN01438.1; -; Genomic_DNA.
DR   EMBL; AY128654; AAN01439.1; -; Genomic_DNA.
DR   EMBL; AY128655; AAN01440.1; -; Genomic_DNA.
DR   EMBL; AY128656; AAN01441.1; -; Genomic_DNA.
DR   EMBL; AY128657; AAN01442.1; -; Genomic_DNA.
DR   EMBL; AY128658; AAN01443.1; -; Genomic_DNA.
DR   EMBL; AY128659; AAN01444.1; -; Genomic_DNA.
DR   EMBL; AY128661; AAN01446.1; -; Genomic_DNA.
DR   EMBL; AY128662; AAN01447.1; -; Genomic_DNA.
DR   EMBL; AY128663; AAN01448.1; -; Genomic_DNA.
DR   EMBL; AY128664; AAN01449.1; -; Genomic_DNA.
DR   EMBL; AY128665; AAN01450.1; -; Genomic_DNA.
DR   EMBL; AB000905; BAA19208.1; -; Genomic_DNA.
DR   EMBL; AY648850; AAT68253.1; -; Genomic_DNA.
DR   EMBL; CR542169; CAG46966.1; -; mRNA.
DR   EMBL; CR542172; CAG46969.1; -; mRNA.
DR   EMBL; CR542180; CAG46977.1; -; mRNA.
DR   EMBL; CR542187; CAG46984.1; -; mRNA.
DR   EMBL; CR542189; CAG46986.1; -; mRNA.
DR   EMBL; AL021807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL021917; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL031777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL049822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353759; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z98744; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591493; CAI12560.1; -; Genomic_DNA.
DR   EMBL; AL591493; CAI12567.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55509.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55510.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55538.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55549.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55555.1; -; Genomic_DNA.
DR   EMBL; CH471094; EAW96325.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03086.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03111.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03112.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03121.1; -; Genomic_DNA.
DR   EMBL; BC017361; AAH17361.1; -; mRNA.
DR   EMBL; BC054014; AAH54014.1; -; mRNA.
DR   EMBL; BC066248; AAH66248.1; -; mRNA.
DR   EMBL; BC066249; AAH66249.1; -; mRNA.
DR   EMBL; BC066250; AAH66250.1; -; mRNA.
DR   EMBL; BC067495; AAH67495.1; -; mRNA.
DR   EMBL; BC067496; AAH67496.1; -; mRNA.
DR   EMBL; BC067497; AAH67497.1; -; mRNA.
DR   EMBL; BC069288; AAH69288.1; -; mRNA.
DR   EMBL; BC069392; AAH69392.1; -; mRNA.
DR   EMBL; BC069467; AAH69467.1; -; mRNA.
DR   EMBL; BC069654; AAH69654.1; -; mRNA.
DR   EMBL; BC093763; AAH93763.1; -; mRNA.
DR   EMBL; BC093765; AAH93765.1; -; mRNA.
DR   EMBL; BC093969; AAH93969.1; -; mRNA.
DR   EMBL; BC111093; AAI11094.1; -; mRNA.
DR   EMBL; BC111434; AAI11435.1; -; mRNA.
DR   EMBL; BC112193; AAI12194.1; -; mRNA.
DR   EMBL; BC120939; AAI20940.1; -; mRNA.
DR   EMBL; BC128104; AAI28105.1; -; mRNA.
DR   EMBL; BC128105; AAI28106.1; ALT_FRAME; mRNA.
DR   EMBL; BC130558; AAI30559.1; -; mRNA.
DR   EMBL; BC130560; AAI30561.1; -; mRNA.
DR   EMBL; BC143045; AAI43046.1; -; mRNA.
DR   CCDS; CCDS30847.1; -.
DR   CCDS; CCDS30851.1; -.
DR   CCDS; CCDS4571.1; -.
DR   CCDS; CCDS4572.1; -.
DR   CCDS; CCDS4583.1; -.
DR   CCDS; CCDS4589.1; -.
DR   CCDS; CCDS4593.1; -.
DR   CCDS; CCDS4598.1; -.
DR   CCDS; CCDS4604.1; -.
DR   CCDS; CCDS4620.1; -.
DR   CCDS; CCDS4630.1; -.
DR   CCDS; CCDS4631.1; -.
DR   CCDS; CCDS4637.1; -.
DR   CCDS; CCDS8665.1; -.
DR   PIR; D40335; HSHU4.
DR   RefSeq; NP_001029249.1; NM_001034077.4.
DR   RefSeq; NP_003486.1; NM_003495.2.
DR   RefSeq; NP_003529.1; NM_003538.3.
DR   RefSeq; NP_003530.1; NM_003539.3.
DR   RefSeq; NP_003531.1; NM_003540.3.
DR   RefSeq; NP_003532.1; NM_003541.2.
DR   RefSeq; NP_003533.1; NM_003542.3.
DR   RefSeq; NP_003534.1; NM_003543.3.
DR   RefSeq; NP_003535.1; NM_003544.2.
DR   RefSeq; NP_003536.1; NM_003545.3.
DR   RefSeq; NP_003537.1; NM_003546.2.
DR   RefSeq; NP_003539.1; NM_003548.2.
DR   RefSeq; NP_068803.1; NM_021968.3.
DR   RefSeq; NP_778224.1; NM_175054.2.
DR   UniGene; Hs.143080; -.
DR   UniGene; Hs.247816; -.
DR   UniGene; Hs.248172; -.
DR   UniGene; Hs.248178; -.
DR   UniGene; Hs.248179; -.
DR   UniGene; Hs.278483; -.
DR   UniGene; Hs.46423; -.
DR   UniGene; Hs.528055; -.
DR   UniGene; Hs.533295; -.
DR   UniGene; Hs.55468; -.
DR   UniGene; Hs.591790; -.
DR   UniGene; Hs.655235; -.
DR   UniGene; Hs.662174; -.
DR   UniGene; Hs.706635; -.
DR   UniGene; Hs.745457; -.
DR   PDB; 1ZKK; X-ray; 1.45 A; E/F/G/H=16-25.
DR   PDB; 2BQZ; X-ray; 1.50 A; B/F=18-26.
DR   PDB; 2CV5; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 2IG0; X-ray; 1.70 A; B=17-26.
DR   PDB; 2KWN; NMR; -; B=10-24.
DR   PDB; 2KWO; NMR; -; B=2-21.
DR   PDB; 2LVM; NMR; -; B=15-28.
DR   PDB; 2QQS; X-ray; 2.82 A; C/D=17-26.
DR   PDB; 2RJE; X-ray; 1.86 A; P/Q=16-26.
DR   PDB; 2RNY; NMR; -; B=14-28.
DR   PDB; 2RS9; NMR; -; A=2-11.
DR   PDB; 3A6N; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AFA; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 3AN2; X-ray; 3.60 A; B/F=1-103.
DR   PDB; 3AV1; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 3AV2; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 3AYW; X-ray; 2.90 A; B/F=1-103.
DR   PDB; 3AZE; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 3AZF; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AZG; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 3AZH; X-ray; 3.49 A; B/F=1-103.
DR   PDB; 3AZI; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AZJ; X-ray; 2.89 A; B/F=1-103.
DR   PDB; 3AZK; X-ray; 3.20 A; B/F=1-103.
DR   PDB; 3AZL; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 3AZM; X-ray; 2.89 A; B/F=1-103.
DR   PDB; 3AZN; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 3CFS; X-ray; 2.40 A; E=28-42.
DR   PDB; 3CFV; X-ray; 2.60 A; E/F=25-42.
DR   PDB; 3F9W; X-ray; 1.60 A; E/F/G/H=16-25.
DR   PDB; 3F9X; X-ray; 1.25 A; E/F/G/H=16-25.
DR   PDB; 3F9Y; X-ray; 1.50 A; E/F=16-25.
DR   PDB; 3F9Z; X-ray; 1.60 A; E/F/G/H=16-25.
DR   PDB; 3IJ1; X-ray; 2.10 A; B=16-26.
DR   PDB; 3JPX; X-ray; 2.05 A; B=14-28.
DR   PDB; 3NQJ; X-ray; 2.10 A; B=21-103.
DR   PDB; 3NQU; X-ray; 2.50 A; B=1-103.
DR   PDB; 3O36; X-ray; 1.70 A; D/E=15-20.
DR   PDB; 3QBY; X-ray; 1.95 A; H=16-26.
DR   PDB; 3QZS; X-ray; 1.80 A; C/D=13-22.
DR   PDB; 3QZT; X-ray; 1.50 A; B=13-22.
DR   PDB; 3QZV; X-ray; 2.00 A; C=8-18.
DR   PDB; 3R45; X-ray; 2.60 A; B=1-103.
DR   PDB; 3UVW; X-ray; 1.37 A; B=2-12.
DR   PDB; 3UVX; X-ray; 1.91 A; B=12-22.
DR   PDB; 3UVY; X-ray; 2.02 A; B=16-26.
DR   PDB; 3UW9; X-ray; 2.30 A; E/F=8-18.
DR   PDB; 3W96; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 3W97; X-ray; 3.20 A; B/F=1-103.
DR   PDB; 3W98; X-ray; 3.42 A; B/F=1-103.
DR   PDB; 3W99; X-ray; 3.00 A; B/F=17-103.
DR   PDB; 3WA9; X-ray; 3.07 A; B/F=1-103.
DR   PDB; 3WAA; X-ray; 3.20 A; B/F=1-103.
DR   PDB; 3WKJ; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 3WTP; X-ray; 2.67 A; B/F=1-103.
DR   PDB; 3X1S; X-ray; 2.81 A; B/F=2-103.
DR   PDB; 3X1T; X-ray; 2.81 A; B/F=2-103.
DR   PDB; 3X1U; X-ray; 3.25 A; B/F=2-103.
DR   PDB; 3X1V; X-ray; 2.92 A; B/F=2-103.
DR   PDB; 4GQB; X-ray; 2.06 A; C=2-22.
DR   PDB; 4H9N; X-ray; 1.95 A; B=2-103.
DR   PDB; 4H9O; X-ray; 2.05 A; B=2-103.
DR   PDB; 4H9P; X-ray; 2.20 A; B=2-103.
DR   PDB; 4H9Q; X-ray; 1.95 A; B=2-103.
DR   PDB; 4H9R; X-ray; 2.20 A; B=2-103.
DR   PDB; 4H9S; X-ray; 2.60 A; C/D=21-103.
DR   PDB; 4HGA; X-ray; 2.80 A; C=1-103.
DR   PDB; 4M38; X-ray; 2.20 A; E/F=2-22.
DR   PDB; 4N3W; X-ray; 1.90 A; C=14-28.
DR   PDB; 4N4F; X-ray; 1.83 A; C=6-26.
DR   PDB; 4QUT; X-ray; 1.70 A; B=10-16.
DR   PDB; 4QUU; X-ray; 1.80 A; B=4-16.
DR   PDB; 4QYD; X-ray; 1.94 A; B=5-18.
DR   PDB; 4U9W; X-ray; 2.49 A; E/F/G/H=2-6.
DR   PDB; 4YM5; X-ray; 4.00 A; B/F=1-103.
DR   PDB; 4YM6; X-ray; 3.51 A; B/F=1-103.
DR   PDB; 4YY6; X-ray; 1.45 A; Z=2-12.
DR   PDB; 4YYD; X-ray; 1.52 A; Z=2-12.
DR   PDB; 4YYG; X-ray; 2.10 A; B=2-12.
DR   PDB; 4YYH; X-ray; 1.74 A; Y/Z=2-12.
DR   PDB; 4YYI; X-ray; 1.50 A; C/F=2-12.
DR   PDB; 4YYJ; X-ray; 1.85 A; C/F=2-12.
DR   PDB; 4YYK; X-ray; 1.79 A; C/F=2-12.
DR   PDB; 4YYM; X-ray; 1.50 A; Z=2-12.
DR   PDB; 4YYN; X-ray; 1.85 A; Z=2-12.
DR   PDB; 4Z2M; X-ray; 2.98 A; H/J=1-103.
DR   PDB; 4Z5T; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 5AV5; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 5AV6; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5AV8; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5AV9; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5AVB; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 5AVC; X-ray; 2.40 A; B/F=1-103.
DR   PDB; 5AY8; X-ray; 2.80 A; B/F=1-103.
DR   PDB; 5B0Y; X-ray; 2.56 A; B/F=1-103.
DR   PDB; 5B0Z; X-ray; 1.99 A; B/F=1-103.
DR   PDB; 5B24; X-ray; 3.60 A; B/F=1-103.
DR   PDB; 5B2I; X-ray; 3.00 A; B/F=1-103.
DR   PDB; 5B2J; X-ray; 2.60 A; B/F=1-103.
DR   PDB; 5B31; X-ray; 2.20 A; B/F=1-103.
DR   PDB; 5B32; X-ray; 2.35 A; B/F=1-103.
DR   PDB; 5B33; X-ray; 2.92 A; B/F=1-103.
DR   PDB; 5B40; X-ray; 3.33 A; B/F=1-103.
DR   PDB; 5BNV; X-ray; 2.79 A; B/E=2-103.
DR   PDB; 5BNX; X-ray; 2.31 A; B=2-103.
DR   PDB; 5BO0; X-ray; 2.91 A; B=2-103.
DR   PDB; 5C3I; X-ray; 3.50 A; C/G/K/O/S/W=1-103.
DR   PDB; 5CPI; X-ray; 2.90 A; B/F=1-103.
DR   PDB; 5CPJ; X-ray; 3.15 A; B/F=1-103.
DR   PDB; 5CPK; X-ray; 2.63 A; B/F=1-103.
DR   PDB; 5FA5; X-ray; 2.34 A; C=2-21.
DR   PDB; 5FFW; X-ray; 1.50 A; C=2-11.
DR   PDB; 5FWE; X-ray; 2.05 A; C/D=2-16.
DR   PDB; 5GSE; X-ray; 3.14 A; B/F/L/P=1-103.
DR   PDB; 5GSU; X-ray; 3.10 A; B/F=2-103.
DR   PDB; 5GT0; X-ray; 2.82 A; B/F=2-103.
DR   PDB; 5GT3; X-ray; 2.91 A; B/F=2-103.
DR   PDB; 5GTC; X-ray; 2.70 A; B/F=1-103.
DR   PDB; 5GXQ; X-ray; 2.85 A; B/F=1-103.
DR   PDB; 5JA4; X-ray; 2.42 A; B=2-103.
DR   PDB; 5JRG; X-ray; 2.50 A; B/F=1-103.
DR   PDB; 5KDM; X-ray; 3.50 A; B=2-103.
DR   PDB; 5TEG; X-ray; 1.30 A; D/E=17-24.
DR   PDB; 5X7X; X-ray; 2.18 A; B/F=1-103.
DR   PDB; 5XF3; X-ray; 2.60 A; B/F=1-103.
DR   PDB; 5XF4; X-ray; 2.87 A; B/F=1-103.
DR   PDB; 5XF5; X-ray; 2.82 A; B/F=1-103.
DR   PDB; 6BUZ; EM; 3.92 A; B/F=1-103.
DR   PDB; 6C0W; EM; 4.00 A; B/F=1-102.
DR   PDBsum; 1ZKK; -.
DR   PDBsum; 2BQZ; -.
DR   PDBsum; 2CV5; -.
DR   PDBsum; 2IG0; -.
DR   PDBsum; 2KWN; -.
DR   PDBsum; 2KWO; -.
DR   PDBsum; 2LVM; -.
DR   PDBsum; 2QQS; -.
DR   PDBsum; 2RJE; -.
DR   PDBsum; 2RNY; -.
DR   PDBsum; 2RS9; -.
DR   PDBsum; 3A6N; -.
DR   PDBsum; 3AFA; -.
DR   PDBsum; 3AN2; -.
DR   PDBsum; 3AV1; -.
DR   PDBsum; 3AV2; -.
DR   PDBsum; 3AYW; -.
DR   PDBsum; 3AZE; -.
DR   PDBsum; 3AZF; -.
DR   PDBsum; 3AZG; -.
DR   PDBsum; 3AZH; -.
DR   PDBsum; 3AZI; -.
DR   PDBsum; 3AZJ; -.
DR   PDBsum; 3AZK; -.
DR   PDBsum; 3AZL; -.
DR   PDBsum; 3AZM; -.
DR   PDBsum; 3AZN; -.
DR   PDBsum; 3CFS; -.
DR   PDBsum; 3CFV; -.
DR   PDBsum; 3F9W; -.
DR   PDBsum; 3F9X; -.
DR   PDBsum; 3F9Y; -.
DR   PDBsum; 3F9Z; -.
DR   PDBsum; 3IJ1; -.
DR   PDBsum; 3JPX; -.
DR   PDBsum; 3NQJ; -.
DR   PDBsum; 3NQU; -.
DR   PDBsum; 3O36; -.
DR   PDBsum; 3QBY; -.
DR   PDBsum; 3QZS; -.
DR   PDBsum; 3QZT; -.
DR   PDBsum; 3QZV; -.
DR   PDBsum; 3R45; -.
DR   PDBsum; 3UVW; -.
DR   PDBsum; 3UVX; -.
DR   PDBsum; 3UVY; -.
DR   PDBsum; 3UW9; -.
DR   PDBsum; 3W96; -.
DR   PDBsum; 3W97; -.
DR   PDBsum; 3W98; -.
DR   PDBsum; 3W99; -.
DR   PDBsum; 3WA9; -.
DR   PDBsum; 3WAA; -.
DR   PDBsum; 3WKJ; -.
DR   PDBsum; 3WTP; -.
DR   PDBsum; 3X1S; -.
DR   PDBsum; 3X1T; -.
DR   PDBsum; 3X1U; -.
DR   PDBsum; 3X1V; -.
DR   PDBsum; 4GQB; -.
DR   PDBsum; 4H9N; -.
DR   PDBsum; 4H9O; -.
DR   PDBsum; 4H9P; -.
DR   PDBsum; 4H9Q; -.
DR   PDBsum; 4H9R; -.
DR   PDBsum; 4H9S; -.
DR   PDBsum; 4HGA; -.
DR   PDBsum; 4M38; -.
DR   PDBsum; 4N3W; -.
DR   PDBsum; 4N4F; -.
DR   PDBsum; 4QUT; -.
DR   PDBsum; 4QUU; -.
DR   PDBsum; 4QYD; -.
DR   PDBsum; 4U9W; -.
DR   PDBsum; 4YM5; -.
DR   PDBsum; 4YM6; -.
DR   PDBsum; 4YY6; -.
DR   PDBsum; 4YYD; -.
DR   PDBsum; 4YYG; -.
DR   PDBsum; 4YYH; -.
DR   PDBsum; 4YYI; -.
DR   PDBsum; 4YYJ; -.
DR   PDBsum; 4YYK; -.
DR   PDBsum; 4YYM; -.
DR   PDBsum; 4YYN; -.
DR   PDBsum; 4Z2M; -.
DR   PDBsum; 4Z5T; -.
DR   PDBsum; 5AV5; -.
DR   PDBsum; 5AV6; -.
DR   PDBsum; 5AV8; -.
DR   PDBsum; 5AV9; -.
DR   PDBsum; 5AVB; -.
DR   PDBsum; 5AVC; -.
DR   PDBsum; 5AY8; -.
DR   PDBsum; 5B0Y; -.
DR   PDBsum; 5B0Z; -.
DR   PDBsum; 5B24; -.
DR   PDBsum; 5B2I; -.
DR   PDBsum; 5B2J; -.
DR   PDBsum; 5B31; -.
DR   PDBsum; 5B32; -.
DR   PDBsum; 5B33; -.
DR   PDBsum; 5B40; -.
DR   PDBsum; 5BNV; -.
DR   PDBsum; 5BNX; -.
DR   PDBsum; 5BO0; -.
DR   PDBsum; 5C3I; -.
DR   PDBsum; 5CPI; -.
DR   PDBsum; 5CPJ; -.
DR   PDBsum; 5CPK; -.
DR   PDBsum; 5FA5; -.
DR   PDBsum; 5FFW; -.
DR   PDBsum; 5FWE; -.
DR   PDBsum; 5GSE; -.
DR   PDBsum; 5GSU; -.
DR   PDBsum; 5GT0; -.
DR   PDBsum; 5GT3; -.
DR   PDBsum; 5GTC; -.
DR   PDBsum; 5GXQ; -.
DR   PDBsum; 5JA4; -.
DR   PDBsum; 5JRG; -.
DR   PDBsum; 5KDM; -.
DR   PDBsum; 5TEG; -.
DR   PDBsum; 5X7X; -.
DR   PDBsum; 5XF3; -.
DR   PDBsum; 5XF4; -.
DR   PDBsum; 5XF5; -.
DR   PDBsum; 6BUZ; -.
DR   PDBsum; 6C0W; -.
DR   ProteinModelPortal; P62805; -.
DR   SMR; P62805; -.
DR   BioGrid; 113899; 24.
DR   BioGrid; 113955; 182.
DR   BioGrid; 113956; 17.
DR   BioGrid; 113957; 30.
DR   BioGrid; 113958; 16.
DR   BioGrid; 113959; 20.
DR   BioGrid; 113960; 16.
DR   BioGrid; 113961; 20.
DR   BioGrid; 113962; 16.
DR   BioGrid; 113963; 21.
DR   BioGrid; 113964; 18.
DR   BioGrid; 113966; 49.
DR   BioGrid; 125732; 88.
DR   BioGrid; 299853; 18.
DR   CORUM; P62805; -.
DR   DIP; DIP-33079N; -.
DR   IntAct; P62805; 130.
DR   MINT; P62805; -.
DR   STRING; 9606.ENSP00000367034; -.
DR   BindingDB; P62805; -.
DR   ChEMBL; CHEMBL5876; -.
DR   iPTMnet; P62805; -.
DR   PhosphoSitePlus; P62805; -.
DR   SwissPalm; P62805; -.
DR   BioMuta; HIST1H4A; -.
DR   DMDM; 51317339; -.
DR   SWISS-2DPAGE; P62805; -.
DR   EPD; P62805; -.
DR   MaxQB; P62805; -.
DR   PaxDb; P62805; -.
DR   PeptideAtlas; P62805; -.
DR   PRIDE; P62805; -.
DR   TopDownProteomics; P62805; -.
DR   DNASU; 8294; -.
DR   DNASU; 8360; -.
DR   DNASU; 8362; -.
DR   DNASU; 8363; -.
DR   DNASU; 8364; -.
DR   DNASU; 8365; -.
DR   DNASU; 8366; -.
DR   DNASU; 8367; -.
DR   DNASU; 8368; -.
DR   DNASU; 8370; -.
DR   Ensembl; ENST00000244537; ENSP00000244537; ENSG00000274618.
DR   Ensembl; ENST00000355057; ENSP00000347168; ENSG00000197238.
DR   Ensembl; ENST00000358064; ENSP00000350767; ENSG00000197837.
DR   Ensembl; ENST00000377727; ENSP00000366956; ENSG00000158406.
DR   Ensembl; ENST00000377745; ENSP00000366974; ENSG00000278705.
DR   Ensembl; ENST00000377803; ENSP00000367034; ENSG00000197061.
DR   Ensembl; ENST00000539745; ENSP00000443017; ENSG00000197837.
DR   Ensembl; ENST00000578186; ENSP00000462667; ENSG00000270882.
DR   Ensembl; ENST00000579512; ENSP00000462355; ENSG00000270276.
DR   Ensembl; ENST00000611927; ENSP00000479794; ENSG00000273542.
DR   Ensembl; ENST00000612061; ENSP00000482412; ENSG00000270276.
DR   Ensembl; ENST00000613412; ENSP00000481343; ENSG00000270882.
DR   Ensembl; ENST00000614247; ENSP00000479461; ENSG00000277157.
DR   Ensembl; ENST00000614272; ENSP00000478519; ENSG00000270882.
DR   Ensembl; ENST00000615164; ENSP00000484789; ENSG00000276966.
DR   Ensembl; ENST00000615353; ENSP00000481486; ENSG00000276180.
DR   Ensembl; ENST00000617569; ENSP00000479106; ENSG00000278637.
DR   Ensembl; ENST00000618193; ENSP00000478786; ENSG00000270882.
DR   Ensembl; ENST00000618305; ENSP00000480960; ENSG00000275126.
DR   Ensembl; ENST00000621520; ENSP00000481507; ENSG00000270276.
DR   Ensembl; ENST00000634560; ENSP00000489319; ENSG00000158406.
DR   Ensembl; ENST00000634956; ENSP00000489567; ENSG00000158406.
DR   Ensembl; ENST00000635491; ENSP00000489236; ENSG00000158406.
DR   GeneID; 121504; -.
DR   GeneID; 554313; -.
DR   GeneID; 8294; -.
DR   GeneID; 8359; -.
DR   GeneID; 8360; -.
DR   GeneID; 8361; -.
DR   GeneID; 8362; -.
DR   GeneID; 8363; -.
DR   GeneID; 8364; -.
DR   GeneID; 8365; -.
DR   GeneID; 8366; -.
DR   GeneID; 8367; -.
DR   GeneID; 8368; -.
DR   GeneID; 8370; -.
DR   KEGG; hsa:121504; -.
DR   KEGG; hsa:554313; -.
DR   KEGG; hsa:8294; -.
DR   KEGG; hsa:8359; -.
DR   KEGG; hsa:8360; -.
DR   KEGG; hsa:8361; -.
DR   KEGG; hsa:8362; -.
DR   KEGG; hsa:8363; -.
DR   KEGG; hsa:8364; -.
DR   KEGG; hsa:8365; -.
DR   KEGG; hsa:8366; -.
DR   KEGG; hsa:8367; -.
DR   KEGG; hsa:8368; -.
DR   KEGG; hsa:8370; -.
DR   UCSC; uc001ess.4; human.
DR   CTD; 121504; -.
DR   CTD; 554313; -.
DR   CTD; 8294; -.
DR   CTD; 8359; -.
DR   CTD; 8360; -.
DR   CTD; 8361; -.
DR   CTD; 8362; -.
DR   CTD; 8363; -.
DR   CTD; 8364; -.
DR   CTD; 8365; -.
DR   CTD; 8366; -.
DR   CTD; 8367; -.
DR   CTD; 8368; -.
DR   CTD; 8370; -.
DR   DisGeNET; 121504; -.
DR   DisGeNET; 554313; -.
DR   DisGeNET; 8294; -.
DR   DisGeNET; 8359; -.
DR   DisGeNET; 8360; -.
DR   DisGeNET; 8361; -.
DR   DisGeNET; 8362; -.
DR   DisGeNET; 8363; -.
DR   DisGeNET; 8364; -.
DR   DisGeNET; 8365; -.
DR   DisGeNET; 8366; -.
DR   DisGeNET; 8367; -.
DR   DisGeNET; 8368; -.
DR   DisGeNET; 8370; -.
DR   EuPathDB; HostDB:ENSG00000158406.4; -.
DR   EuPathDB; HostDB:ENSG00000197061.4; -.
DR   EuPathDB; HostDB:ENSG00000197238.4; -.
DR   EuPathDB; HostDB:ENSG00000197837.3; -.
DR   EuPathDB; HostDB:ENSG00000270276.2; -.
DR   EuPathDB; HostDB:ENSG00000270882.2; -.
DR   EuPathDB; HostDB:ENSG00000273542.1; -.
DR   EuPathDB; HostDB:ENSG00000274618.1; -.
DR   EuPathDB; HostDB:ENSG00000275126.1; -.
DR   EuPathDB; HostDB:ENSG00000276180.1; -.
DR   EuPathDB; HostDB:ENSG00000276966.2; -.
DR   EuPathDB; HostDB:ENSG00000277157.1; -.
DR   EuPathDB; HostDB:ENSG00000278637.1; -.
DR   EuPathDB; HostDB:ENSG00000278705.1; -.
DR   GeneCards; HIST1H4A; -.
DR   GeneCards; HIST1H4B; -.
DR   GeneCards; HIST1H4C; -.
DR   GeneCards; HIST1H4D; -.
DR   GeneCards; HIST1H4E; -.
DR   GeneCards; HIST1H4F; -.
DR   GeneCards; HIST1H4H; -.
DR   GeneCards; HIST1H4I; -.
DR   GeneCards; HIST1H4J; -.
DR   GeneCards; HIST1H4K; -.
DR   GeneCards; HIST1H4L; -.
DR   GeneCards; HIST2H4A; -.
DR   GeneCards; HIST2H4B; -.
DR   GeneCards; HIST4H4; -.
DR   HGNC; HGNC:4781; HIST1H4A.
DR   HGNC; HGNC:4789; HIST1H4B.
DR   HGNC; HGNC:4787; HIST1H4C.
DR   HGNC; HGNC:4782; HIST1H4D.
DR   HGNC; HGNC:4790; HIST1H4E.
DR   HGNC; HGNC:4783; HIST1H4F.
DR   HGNC; HGNC:4788; HIST1H4H.
DR   HGNC; HGNC:4793; HIST1H4I.
DR   HGNC; HGNC:4785; HIST1H4J.
DR   HGNC; HGNC:4784; HIST1H4K.
DR   HGNC; HGNC:4791; HIST1H4L.
DR   HGNC; HGNC:4794; HIST2H4A.
DR   HGNC; HGNC:29607; HIST2H4B.
DR   HGNC; HGNC:20510; HIST4H4.
DR   HPA; CAB011503; -.
DR   HPA; CAB021887; -.
DR   HPA; CAB037279; -.
DR   HPA; HPA042201; -.
DR   MIM; 142750; gene.
DR   MIM; 602822; gene.
DR   MIM; 602823; gene.
DR   MIM; 602824; gene.
DR   MIM; 602825; gene.
DR   MIM; 602826; gene.
DR   MIM; 602827; gene.
DR   MIM; 602828; gene.
DR   MIM; 602829; gene.
DR   MIM; 602830; gene.
DR   MIM; 602831; gene.
DR   MIM; 602833; gene.
DR   MIM; 615069; gene.
DR   neXtProt; NX_P62805; -.
DR   OpenTargets; ENSG00000158406; -.
DR   OpenTargets; ENSG00000197061; -.
DR   OpenTargets; ENSG00000197238; -.
DR   OpenTargets; ENSG00000197837; -.
DR   OpenTargets; ENSG00000270276; -.
DR   OpenTargets; ENSG00000270882; -.
DR   OpenTargets; ENSG00000273542; -.
DR   OpenTargets; ENSG00000274618; -.
DR   OpenTargets; ENSG00000275126; -.
DR   OpenTargets; ENSG00000276180; -.
DR   OpenTargets; ENSG00000276966; -.
DR   OpenTargets; ENSG00000277157; -.
DR   OpenTargets; ENSG00000278637; -.
DR   OpenTargets; ENSG00000278705; -.
DR   PharmGKB; PA29169; -.
DR   eggNOG; KOG3467; Eukaryota.
DR   eggNOG; COG2036; LUCA.
DR   GeneTree; ENSGT00760000119019; -.
DR   HOGENOM; HOG000234654; -.
DR   HOVERGEN; HBG051878; -.
DR   InParanoid; P62805; -.
DR   KO; K11254; -.
DR   OMA; YEEVRVV; -.
DR   OrthoDB; EOG09370I2I; -.
DR   PhylomeDB; P62805; -.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-171306; Packaging Of Telomere Ends.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-HSA-3214842; HDMs demethylate histones.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-HSA-73777; RNA Polymerase I Chain Elongation.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-912446; Meiotic recombination.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   SIGNOR; P62805; -.
DR   ChiTaRS; HIST1H4A; human.
DR   ChiTaRS; HIST1H4E; human.
DR   ChiTaRS; HIST1H4F; human.
DR   ChiTaRS; HIST2H4A; human.
DR   EvolutionaryTrace; P62805; -.
DR   GeneWiki; HIST1H4A; -.
DR   GeneWiki; HIST1H4B; -.
DR   GeneWiki; HIST1H4C; -.
DR   GeneWiki; HIST1H4D; -.
DR   GeneWiki; HIST1H4E; -.
DR   GeneWiki; HIST1H4F; -.
DR   GeneWiki; HIST1H4H; -.
DR   GeneWiki; HIST1H4I; -.
DR   GeneWiki; HIST1H4J; -.
DR   GeneWiki; HIST1H4K; -.
DR   GeneWiki; HIST1H4L; -.
DR   GeneWiki; HIST2H4A; -.
DR   GeneWiki; HIST4H4; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000158406; -.
DR   CleanEx; HS_HIST1H4A; -.
DR   CleanEx; HS_HIST1H4B; -.
DR   CleanEx; HS_HIST1H4C; -.
DR   CleanEx; HS_HIST1H4D; -.
DR   CleanEx; HS_HIST1H4E; -.
DR   CleanEx; HS_HIST1H4F; -.
DR   CleanEx; HS_HIST1H4H; -.
DR   CleanEx; HS_HIST1H4I; -.
DR   CleanEx; HS_HIST1H4L; -.
DR   CleanEx; HS_HIST2H4A; -.
DR   CleanEx; HS_HIST2H4B; -.
DR   CleanEx; HS_HIST4H4; -.
DR   ExpressionAtlas; P62805; baseline and differential.
DR   Genevisible; P62805; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0000228; C:nuclear chromosome; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0000788; C:nuclear nucleosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0042393; F:histone binding; IBA:GO_Central.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:1904837; P:beta-catenin-TCF complex assembly; TAS:Reactome.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0034080; P:CENP-A containing nucleosome assembly; TAS:Reactome.
DR   GO; GO:0000183; P:chromatin silencing at rDNA; TAS:Reactome.
DR   GO; GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0045653; P:negative regulation of megakaryocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; IDA:UniProtKB.
DR   GO; GO:0045815; P:positive regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0051290; P:protein heterotetramerization; IDA:UniProtKB.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:1902036; P:regulation of hematopoietic stem cell differentiation; TAS:Reactome.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:0016233; P:telomere capping; TAS:Reactome.
DR   GO; GO:0032200; P:telomere organization; TAS:BHF-UCL.
DR   CDD; cd00076; H4; 1.
DR   InterPro; IPR035425; CENP-T/H4_C.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR001951; Histone_H4.
DR   InterPro; IPR019809; Histone_H4_CS.
DR   InterPro; IPR004823; TAF_TATA-bd.
DR   Pfam; PF15511; CENP-T_C; 1.
DR   PRINTS; PR00623; HISTONEH4.
DR   SMART; SM00417; H4; 1.
DR   SMART; SM00803; TAF; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00047; HISTONE_H4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosomal rearrangement; Chromosome;
KW   Citrullination; Complete proteome; Direct protein sequencing;
KW   DNA-binding; Hydroxylation; Isopeptide bond; Methylation;
KW   Nucleosome core; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:17967882}.
FT   CHAIN         2    103       Histone H4.
FT                                /FTId=PRO_0000158320.
FT   DNA_BIND     17     21
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000269|PubMed:17967882}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000269|PubMed:17967882}.
FT   MOD_RES       4      4       Asymmetric dimethylarginine; by PRMT1;
FT                                alternate. {ECO:0000269|PubMed:11387442,
FT                                ECO:0000269|PubMed:11448779,
FT                                ECO:0000269|PubMed:15345777}.
FT   MOD_RES       4      4       Citrulline; alternate.
FT                                {ECO:0000269|PubMed:15345777,
FT                                ECO:0000269|PubMed:16567635}.
FT   MOD_RES       4      4       Omega-N-methylarginine; by PRMT1;
FT                                alternate. {ECO:0000269|PubMed:11387442,
FT                                ECO:0000269|PubMed:11448779,
FT                                ECO:0000269|PubMed:15345777}.
FT   MOD_RES       4      4       Symmetric dimethylarginine; by PRMT5 and
FT                                PRMT7; alternate.
FT                                {ECO:0000250|UniProtKB:P62806}.
FT   MOD_RES       6      6       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES       6      6       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:2474456,
FT                                ECO:0000269|PubMed:7664735}.
FT   MOD_RES       6      6       N6-butyryllysine; alternate.
FT                                {ECO:0000269|PubMed:27105113}.
FT   MOD_RES       6      6       N6-crotonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21925322}.
FT   MOD_RES       9      9       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES       9      9       N6-(beta-hydroxybutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:27105115}.
FT   MOD_RES       9      9       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:2474456,
FT                                ECO:0000269|PubMed:7664735}.
FT   MOD_RES       9      9       N6-butyryllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393,
FT                                ECO:0000269|PubMed:27105113}.
FT   MOD_RES       9      9       N6-crotonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21925322}.
FT   MOD_RES       9      9       N6-propionyllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      13     13       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      13     13       N6-(beta-hydroxybutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:27105115}.
FT   MOD_RES      13     13       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:17967882,
FT                                ECO:0000269|PubMed:2474456,
FT                                ECO:0000269|PubMed:7664735}.
FT   MOD_RES      13     13       N6-butyryllysine; alternate.
FT                                {ECO:0000269|PubMed:27105113}.
FT   MOD_RES      13     13       N6-crotonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21925322}.
FT   MOD_RES      13     13       N6-succinyllysine; alternate.
FT                                {ECO:0000269|PubMed:22389435}.
FT   MOD_RES      17     17       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      17     17       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:17967882,
FT                                ECO:0000269|PubMed:2474456,
FT                                ECO:0000269|PubMed:7664735}.
FT   MOD_RES      17     17       N6-butyryllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393,
FT                                ECO:0000269|PubMed:27105113}.
FT   MOD_RES      17     17       N6-crotonyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P62806}.
FT   MOD_RES      17     17       N6-propionyllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      21     21       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:12086618,
FT                                ECO:0000269|PubMed:15964846,
FT                                ECO:0000269|PubMed:17967882}.
FT   MOD_RES      21     21       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:12086618,
FT                                ECO:0000269|PubMed:15964846,
FT                                ECO:0000269|PubMed:17967882}.
FT   MOD_RES      21     21       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:12086618,
FT                                ECO:0000269|PubMed:15964846,
FT                                ECO:0000269|PubMed:17967882}.
FT   MOD_RES      32     32       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      32     32       N6-(beta-hydroxybutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:27105115}.
FT   MOD_RES      32     32       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      32     32       N6-butyryllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      32     32       N6-propionyllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      32     32       N6-succinyllysine; alternate.
FT                                {ECO:0000269|PubMed:22389435}.
FT   MOD_RES      45     45       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      45     45       N6-butyryllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      45     45       N6-propionyllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      48     48       Phosphoserine; by PAK2.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:21724829}.
FT   MOD_RES      52     52       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES      60     60       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      78     78       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      78     78       N6-(beta-hydroxybutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:27105115}.
FT   MOD_RES      78     78       N6-butyryllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      78     78       N6-propionyllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      78     78       N6-succinyllysine; alternate.
FT                                {ECO:0000269|PubMed:22389435}.
FT   MOD_RES      80     80       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      80     80       N6-butyryllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      80     80       N6-propionyllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      80     80       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P62806}.
FT   MOD_RES      81     81       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P62806}.
FT   MOD_RES      89     89       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      92     92       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      92     92       N6-(beta-hydroxybutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:27105115}.
FT   MOD_RES      92     92       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:19818714}.
FT   MOD_RES      92     92       N6-butyryllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      92     92       N6-propionyllysine; alternate.
FT                                {ECO:0000269|PubMed:17267393}.
FT   MOD_RES      92     92       N6-succinyllysine; alternate.
FT                                {ECO:0000269|PubMed:22389435}.
FT   CROSSLNK     13     13       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447}.
FT   CROSSLNK     21     21       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     32     32       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     60     60       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     80     80       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     92     92       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     92     92       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin);
FT                                alternate. {ECO:0000269|PubMed:19818714}.
FT   VARIANT      64     64       E -> Q (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs747622981).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036206.
FT   CONFLICT     71     71       V -> A (in Ref. 14; AAH67496).
FT                                {ECO:0000305}.
FT   CONFLICT     77     77       A -> P (in Ref. 11; CAG46986).
FT                                {ECO:0000305}.
FT   TURN          7     10       {ECO:0000244|PDB:4YYM}.
FT   STRAND       21     23       {ECO:0000244|PDB:3F9X}.
FT   STRAND       28     30       {ECO:0000244|PDB:4H9N}.
FT   HELIX        32     41       {ECO:0000244|PDB:4H9N}.
FT   STRAND       45     47       {ECO:0000244|PDB:5CPK}.
FT   HELIX        49     76       {ECO:0000244|PDB:4H9N}.
FT   STRAND       80     82       {ECO:0000244|PDB:4H9N}.
FT   HELIX        84     91       {ECO:0000244|PDB:4H9N}.
FT   STRAND       94     96       {ECO:0000244|PDB:4H9N}.
FT   TURN         97    102       {ECO:0000244|PDB:4H9N}.
SQ   SEQUENCE   103 AA;  11367 MW;  A9E5DFD3F8B97598 CRC64;
     MSGRGKGGKG LGKGGAKRHR KVLRDNIQGI TKPAIRRLAR RGGVKRISGL IYEETRGVLK
     VFLENVIRDA VTYTEHAKRK TVTAMDVVYA LKRQGRTLYG FGG
//
ID   B1PKY1_HUMAN            Unreviewed;       365 AA.
AC   B1PKY1;
DT   29-APR-2008, integrated into UniProtKB/TrEMBL.
DT   29-APR-2008, sequence version 1.
DT   28-FEB-2018, entry version 96.
DE   SubName: Full=MHC class I antigen {ECO:0000313|EMBL:ACA34992.1, ECO:0000313|EMBL:CUV66664.1};
GN   Name=HLA-A {ECO:0000313|EMBL:ACA34992.1};
GN   Synonyms=HLA {ECO:0000313|EMBL:ASU50328.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACA34992.1};
RN   [1] {ECO:0000313|EMBL:ACA34992.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=19735485; DOI=10.1111/j.1744-313X.2009.00874.x;
RA   Zhu F., He Y., Zhang W., He J., He J., Xu X., Yan L.;
RT   "Analysis of the complete genomic sequence of HLA-A alleles in the
RT   Chinese Han population.";
RL   Int. J. Immunogenet. 36:351-360(2009).
RN   [2] {ECO:0000313|EMBL:ADE80887.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Xu Y.P., Deng Z.H., Yang B.C.;
RT   "Characterization and polymorphism analyses of HLA-A genomic full
RT   length in Chinese Han population.";
RL   Submitted (FEB-2010) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAN59802.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=23714642; DOI=10.1186/1471-2164-14-355;
RA   Hosomichi K., Jinam T.A., Mitsunaga S., Nakaoka H., Inoue I.;
RT   "Phase-defined complete sequencing of the HLA genes by next-generation
RT   sequencing.";
RL   BMC Genomics 14:355-355(2013).
RN   [4] {ECO:0000313|EMBL:CDG23669.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Blood {ECO:0000313|EMBL:CDG23669.1};
RA   Voorter C.;
RL   Submitted (JUN-2013) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:CDG23669.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Blood {ECO:0000313|EMBL:CDG23669.1};
RA   Gerritsen K.E.H., Groeneweg M., Olieslagers T.I., Palusci F.,
RA   Crijns V.B.G., Voorter C.E.M., Tilanus M.G.J.;
RT   "Identification of full length polymorphism of HLA class I by an RNA
RT   approach on peripheral blood lymphocytes.";
RL   Submitted (AUG-2013) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:CDK41199.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Peripheral blood {ECO:0000313|EMBL:CDK41205.1}, and
RC   Saliva collection {ECO:0000313|EMBL:CDK41199.1};
RA   McWhinnie A.J., Robinson J.;
RT   "Confirmatory sequencing of HLA-A*03:01:01:01.";
RL   Submitted (NOV-2013) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000313|EMBL:ALO24306.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A.M., Masaberg C., Hou L., Hurley C.K.;
RT   "Novel HLA class I allele.";
RL   Submitted (JUN-2015) to the EMBL/GenBank/DDBJ databases.
RN   [8] {ECO:0000313|EMBL:ALP46208.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Noorani M.;
RL   Submitted (JUL-2015) to the EMBL/GenBank/DDBJ databases.
RN   [9] {ECO:0000313|EMBL:AMO26194.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A.M., Hou L., Hurley C.K.;
RT   "Novel HLA class I allele.";
RL   Submitted (SEP-2015) to the EMBL/GenBank/DDBJ databases.
RN   [10] {ECO:0000313|EMBL:ALZ40810.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Bravo-Egana V., Clark P., Monos D.;
RT   "Generation of high confidence HLA genotyping and consensus sequences
RT   for Class I HLA loci using the NGS-based Omixon Holotype HLA typing
RT   system and the Illumina MiSeq platform.";
RL   Submitted (DEC-2015) to the EMBL/GenBank/DDBJ databases.
RN   [11] {ECO:0000313|EMBL:CZQ50133.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Peripheral blood {ECO:0000313|EMBL:CZQ50133.1};
RA   Zakharova V.V.;
RT   "Novel HLA-A*03:01:new allele.";
RL   Submitted (FEB-2016) to the EMBL/GenBank/DDBJ databases.
RN   [12] {ECO:0000313|EMBL:CZQ50133.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Peripheral blood {ECO:0000313|EMBL:CZQ50133.1};
RA   Wen L., He K., Yang H.;
RL   Submitted (FEB-2016) to the EMBL/GenBank/DDBJ databases.
RN   [13] {ECO:0000313|EMBL:SAI65262.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Zakharova V.V.;
RT   "Novel HLA-A*03:01:new allele.";
RL   Submitted (APR-2016) to the EMBL/GenBank/DDBJ databases.
RN   [14] {ECO:0000313|EMBL:ARX77874.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Florea S., Webb J.S., Jaromczyk J., Schardl C.L.;
RL   Submitted (JUL-2016) to the EMBL/GenBank/DDBJ databases.
RN   [15] {ECO:0000313|EMBL:ARX98023.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lazaro A.M., Hou L., Hurley C.K.;
RT   "Novel HLA class I allele.";
RL   Submitted (AUG-2016) to the EMBL/GenBank/DDBJ databases.
RN   [16] {ECO:0000313|EMBL:CUA55065.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Marsh S.G.E.;
RT   "Full-length genomic HLA sequences.";
RL   Submitted (SEP-2016) to the EMBL/GenBank/DDBJ databases.
RN   [17] {ECO:0000313|EMBL:APO40931.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ameen R.M.;
RT   "Establishment of Stem cell and cord blood registry in Kuwait.";
RL   Submitted (OCT-2016) to the EMBL/GenBank/DDBJ databases.
RN   [18] {ECO:0000313|EMBL:AQN67170.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Moya R., Balas A.;
RT   "Sequence of a novel A*03 allele.";
RL   Submitted (NOV-2016) to the EMBL/GenBank/DDBJ databases.
RN   [19] {ECO:0000313|EMBL:ASA47542.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Jaros S., Januszkiewicz K., Wedrychowicz H.;
RL   Submitted (NOV-2016) to the EMBL/GenBank/DDBJ databases.
RN   [20] {ECO:0000313|EMBL:ASA47563.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Song W.-J., Kurnit D.M.;
RL   Submitted (DEC-2016) to the EMBL/GenBank/DDBJ databases.
RN   [21] {ECO:0000313|EMBL:CUV66664.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=28547825; DOI=.1111/tan.13057;
RA   Albrecht V., Zweiniger C., Surendranath V., Lang K., Schofl G.,
RA   Dahl A., Winkler S., Lange V., Bohme I., Schmidt A.H.;
RT   "Dual redundant sequencing strategy: Full-length gene characterisation
RT   of 1056 novel and confirmatory HLA alleles.";
RL   HLA. 90:79-87(2017).
RN   [22] {ECO:0000313|EMBL:ASU50328.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Balz V., Krause S., Enczmann J., Fischer J.;
RT   "More than 130 novel variants of HLA class 1 genes detected in German
RT   Stem Cell Donor Registry and Terasaki samples.";
RL   Submitted (JAN-2017) to the EMBL/GenBank/DDBJ databases.
RN   [23] {ECO:0000313|EMBL:SLM20096.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Afonso C.L., Miller P.J., Scott M.A., Spackman E., Goraichik I.,
RA   Dimitrov K.M., Suarez D.L., Swayne D.E.;
RL   Submitted (MAR-2017) to the EMBL/GenBank/DDBJ databases.
RN   [24] {ECO:0000313|EMBL:SLM20096.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Polvi A., Perasaari J., Linjama T., Saarinen T., Koskela S.,
RA   Jaatinen T., Voorter C.E.M., Tilanus M.G.J.;
RT   "Description of four new HLA alleles in the Finnish population.";
RL   Submitted (JUN-2017) to the EMBL/GenBank/DDBJ databases.
RN   [25] {ECO:0000313|EMBL:SNQ25992.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kim H.J., Triplett B.A.;
RL   Submitted (JUN-2017) to the EMBL/GenBank/DDBJ databases.
RN   [26] {ECO:0000313|EMBL:ASU61671.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Sun Z.S., Albrecht U., Echele G., Lee C.C.;
RL   Submitted (JUL-2017) to the EMBL/GenBank/DDBJ databases.
RN   [27] {ECO:0000313|EMBL:SNQ25992.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Groeneweg M., Matern B., Palusci F., Meertens C., Tilanus M.G.J.,
RA   Voorter C.E.M.;
RT   "Group specific, unambiguous full-length gene HLA Class I typing by
RT   Sanger sequencing: a robust SSBT Strategy for typing and a golden
RT   reference for next generation sequencing approaches.";
RL   Submitted (AUG-2017) to the EMBL/GenBank/DDBJ databases.
RN   [28] {ECO:0000313|EMBL:AUF72633.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Banno H., Chua N.-H.;
RL   Submitted (OCT-2017) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system. {ECO:0000256|SAAS:SAAS00291881}.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC       {ECO:0000256|RuleBase:RU004439, ECO:0000256|SAAS:SAAS00560993}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU445472; ACA34992.1; -; Genomic_DNA.
DR   EMBL; GU812296; ADE80887.1; -; Genomic_DNA.
DR   EMBL; KT156722; ALO24306.1; -; Genomic_DNA.
DR   EMBL; KT266701; ALP46208.1; -; Genomic_DNA.
DR   EMBL; KT266702; ALP46209.1; -; Genomic_DNA.
DR   EMBL; KU528595; ALZ40810.1; -; Genomic_DNA.
DR   EMBL; KT819308; AMO26194.1; -; Genomic_DNA.
DR   EMBL; KX962567; APO40931.1; -; Genomic_DNA.
DR   EMBL; KY072923; AQN67170.1; -; Genomic_DNA.
DR   EMBL; KX583634; ARX77874.1; -; Genomic_DNA.
DR   EMBL; KX686515; ARX98023.1; -; Genomic_DNA.
DR   EMBL; KY235394; ASA47542.1; -; Genomic_DNA.
DR   EMBL; KY368782; ASA47563.1; -; Genomic_DNA.
DR   EMBL; KY368783; ASA47564.1; -; Genomic_DNA.
DR   EMBL; KY419437; ASU50328.1; -; Genomic_DNA.
DR   EMBL; KY419438; ASU50329.1; -; Genomic_DNA.
DR   EMBL; MF474221; ASU61671.1; -; Genomic_DNA.
DR   EMBL; MF474222; ASU61672.1; -; Genomic_DNA.
DR   EMBL; MG199209; AUF72633.1; -; Genomic_DNA.
DR   EMBL; AB774956; BAN59802.1; -; Genomic_DNA.
DR   EMBL; AB774974; BAN59820.1; -; Genomic_DNA.
DR   EMBL; HG327114; CDG23669.1; -; mRNA.
DR   EMBL; HG794390; CDK41199.1; -; Genomic_DNA.
DR   EMBL; HG794396; CDK41205.1; -; Genomic_DNA.
DR   EMBL; LN877322; CUA55065.1; -; Genomic_DNA.
DR   EMBL; LN994612; CUV66664.1; -; Genomic_DNA.
DR   EMBL; LN994664; CUV66716.1; -; Genomic_DNA.
DR   EMBL; LN994669; CUV66721.1; -; Genomic_DNA.
DR   EMBL; LN994733; CUV66785.1; -; Genomic_DNA.
DR   EMBL; LN999578; CUX90971.1; -; Genomic_DNA.
DR   EMBL; LN999594; CUX90987.1; -; Genomic_DNA.
DR   EMBL; LT219465; CZQ50133.1; -; Genomic_DNA.
DR   EMBL; LT546644; SAI65262.1; -; Genomic_DNA.
DR   EMBL; LT599184; SBW38405.1; -; Genomic_DNA.
DR   EMBL; LT827023; SLM20096.1; -; Genomic_DNA.
DR   EMBL; LT898182; SNQ25992.1; -; Genomic_DNA.
DR   RefSeq; NP_002107.3; NM_002116.7.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   DNASU; 3105; -.
DR   GeneID; 3105; -.
DR   CTD; 3105; -.
DR   EuPathDB; HostDB:ENSG00000206503.11; -.
DR   PharmGKB; PA35055; -.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   HOVERGEN; HBG016709; -.
DR   ChiTaRS; HLA-A; human.
DR   GenomeRNAi; 3105; -.
DR   Bgee; ENSG00000206503; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00447792};
KW   Immunity {ECO:0000256|SAAS:SAAS00446101};
KW   Membrane {ECO:0000256|SAAS:SAAS00447790};
KW   MHC I {ECO:0000256|SAAS:SAAS00446101};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00447790};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00447790}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25    365       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5013519493.
FT   DOMAIN      209    295       Ig-like. {ECO:0000259|PROSITE:PS50835}.
SQ   SEQUENCE   365 AA;  40841 MW;  DEDFCEC4450E0580 CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHEAEQL
     RAYLDGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   B2R7U3_HUMAN            Unreviewed;       365 AA.
AC   B2R7U3;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   28-FEB-2018, entry version 76.
DE   SubName: Full=cDNA, FLJ93604, highly similar to Homo sapiens major histocompatibility complex, class I, A (HLA-A),mRNA {ECO:0000313|EMBL:BAG35940.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG35940.1};
RN   [1] {ECO:0000313|EMBL:BAG35940.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cord blood {ECO:0000313|EMBL:BAG35940.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system. {ECO:0000256|SAAS:SAAS00291881}.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC       {ECO:0000256|RuleBase:RU004439, ECO:0000256|SAAS:SAAS00560993}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK313119; BAG35940.1; -; mRNA.
DR   RefSeq; NP_002107.3; NM_002116.7.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   PRIDE; B2R7U3; -.
DR   DNASU; 3105; -.
DR   GeneID; 3105; -.
DR   CTD; 3105; -.
DR   PharmGKB; PA35055; -.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   HOVERGEN; HBG016709; -.
DR   GenomeRNAi; 3105; -.
DR   Genevisible; B2R7U3; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00447792};
KW   Immunity {ECO:0000256|SAAS:SAAS00446101};
KW   Membrane {ECO:0000256|SAAS:SAAS00447790, ECO:0000256|SAM:Phobius};
KW   MHC I {ECO:0000256|SAAS:SAAS00446101};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00447790,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00447790,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25    365       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002780129.
FT   TRANSMEM    306    332       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      209    295       Ig-like. {ECO:0000259|PROSITE:PS50835}.
SQ   SEQUENCE   365 AA;  40827 MW;  8EC0D1C4450E128B CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHEAEQL
     RAYLDGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG VIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   O78126_HUMAN            Unreviewed;       362 AA.
AC   O78126;
DT   01-NOV-1998, integrated into UniProtKB/TrEMBL.
DT   01-NOV-1998, sequence version 1.
DT   28-FEB-2018, entry version 138.
DE   SubName: Full=MHC class I HLA-A {ECO:0000313|EMBL:AAC24825.1};
GN   Name=MHC class I HLA-A {ECO:0000313|EMBL:AAC24825.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAC24825.1};
RN   [1] {ECO:0000313|EMBL:AAC24825.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=10727083;
RA   Hampe A., Coriton O., Andrieux N., Carn G., Lepourcelet M.,
RA   Mottier S., Dreano S., Gatius M.T., Hitte C., Soriano N., Galibert F.;
RT   "A 356-Kb sequence of the subtelomeric part of the MHC class I
RT   region.";
RL   DNA Seq. 10:263-299(1999).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system. {ECO:0000256|SAAS:SAAS00291881}.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC       {ECO:0000256|RuleBase:RU004439, ECO:0000256|SAAS:SAAS00560993}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF055066; AAC24825.1; -; Genomic_DNA.
DR   RefSeq; XP_016885777.1; XM_017030288.1.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   ProteinModelPortal; O78126; -.
DR   PRIDE; O78126; -.
DR   GeneID; 3105; -.
DR   CTD; 3105; -.
DR   HOVERGEN; HBG016709; -.
DR   GenomeRNAi; 3105; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   3: Inferred from homology;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00447792};
KW   Immunity {ECO:0000256|SAAS:SAAS00446101};
KW   Membrane {ECO:0000256|SAAS:SAAS00447790, ECO:0000256|SAM:Phobius};
KW   MHC I {ECO:0000256|SAAS:SAAS00446101};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00447790,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00447790,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     21       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        22    362       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004160084.
FT   TRANSMEM    305    329       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      206    292       Ig-like. {ECO:0000259|PROSITE:PS50835}.
SQ   SEQUENCE   362 AA;  40620 MW;  C736072B75CD48A9 CRC64;
     MAPRTLVLLL SGALALTQTW AGSHSMRYFF TSVSRPGRGE PRFIAVGYVD DTQFVRFDSD
     AASQRMEPRA PWIEQEGPEY WDGETRKVKA HSQTHRVDLG TLRGYYNQSE AGSHTVQRMY
     GCDVGSDWRF LRGYHQYAYD GKDYIALKED LRSWTAADMA AQTTKHKWEA AHVAEQLRAY
     LEGTCVEWLR RYLENGKETL QRTDAPKTHM THHAVSDHEA TLRCWALSFY PAEITLTWQR
     DGEDQTQDTE LVETRPAGDG TFQKWAAVVV PSGQEQRYTC HVQHEGLPKP LTLRWEPSSQ
     PTIPIVGIIA GLVLFGAVIT GAVVAAVMWR RKSSDRKGGS YSQAASSDSA QGSDVSLTAC
     KV
//
ID   1A03_HUMAN              Reviewed;         365 AA.
AC   P04439; O19546; O19756; Q65A82; Q9GJE6; Q9GJE7; Q9GJE8; Q9MYE6;
AC   Q9MYG4; Q9TPR8;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   28-FEB-2018, entry version 175.
DE   RecName: Full=HLA class I histocompatibility antigen, A-3 alpha chain;
DE   AltName: Full=MHC class I antigen A*3;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*03:01).
RX   PubMed=6609814;
RA   Strachan T., Sodoyer R., Damotte M., Jordan B.R.;
RT   "Complete nucleotide sequence of a functional class I HLA gene, HLA-
RT   A3: implications for the evolution of HLA genes.";
RL   EMBO J. 3:887-894(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*03:01).
RA   Ellexson M.E., Hildebrand W.H.;
RL   Submitted (JUL-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE A*03:01).
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*03:02).
RX   PubMed=2993417;
RA   Cowan E.P., Jordan B.E., Coligan J.E.;
RT   "Molecular cloning and DNA sequence analysis of genes encoding
RT   cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype.";
RL   J. Immunol. 135:2835-2841(1985).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*03:02).
RA   Bettinotti M.P., Hadzikadic L., Adams S., Marincola F.M.;
RT   "Complete coding sequence of HLA-A*0302.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Mayor N.P.;
RT   "Full length sequence of an HLA-A*0301 intron 2 variant.";
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-341 (ALLELE A*03:04).
RX   PubMed=10079303; DOI=10.1007/s002510050506;
RA   Santos S., Balas A., Garcia-Sanchez F., Lillo R., Merino J.L.,
RA   Vicario J.L.;
RT   "Complete cDNA coding sequence of a new HLA-A3 subtype (A*0304) with a
RT   new HLA polymorphism at exon 3.";
RL   Immunogenetics 49:360-361(1999).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*03:05).
RA   Becher M.P., Wu J., Williams T.;
RT   "Novel human HLA-A alleles identified in potential bone marrow
RT   donors.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-298 (ALLELE A*03:05).
RC   TISSUE=Blood;
RA   Poli F., Frison S., Crespiatico L., Longhi E.;
RT   "Identification of a HLA-A*03 new variant.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*03:06).
RX   PubMed=12135434; DOI=10.1034/j.1399-0039.2002.590413.x;
RA   Bradshaw D., Gans C.P., Jones P., Rizzuto G., Steiner N., Mitton W.,
RA   Ng J., Koester R., Hartzman R.J., Hurley C.K.;
RT   "Novel HLA-A locus alleles including A*01012, A*0306, A*0308, A*2616,
RT   A*2617, A*3009, A*3206, A*3403, A*3602 and A*6604.";
RL   Tissue Antigens 59:325-327(2002).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352; SER-356 AND
RP   SER-359, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 25-298 (ALLELE A*03:01) IN
RP   COMPLEX WITH PLP1 ANTIGENIC PEPTIDE, AND DISULFIDE BONDS.
RX   PubMed=21543847; DOI=10.1107/S0907444911007888;
RA   McMahon R.M., Friis L., Siebold C., Friese M.A., Fugger L.,
RA   Jones E.Y.;
RT   "Structure of HLA-A*0301 in complex with a peptide of proteolipid
RT   protein: insights into the role of HLA-A alleles in susceptibility to
RT   multiple sclerosis.";
RL   Acta Crystallogr. D 67:447-454(2011).
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-166, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Dimer of alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in a post ER compartment by interaction
CC       with human herpesvirus 8 MIR1 protein. This targets the protein
CC       for rapid degradation via the ubiquitin system (By similarity).
CC       {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of A-3 are known: A*03:01 (A-
CC       3.1), A*03:02, A*03:04, A*03:05 and A*03:06. The sequence shown is
CC       that of A*03:01.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00492; CAA25162.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; U32184; AAB63980.1; -; mRNA.
DR   EMBL; BA000025; BAB63400.1; -; Genomic_DNA.
DR   EMBL; AF217561; AAF28734.1; -; mRNA.
DR   EMBL; AF015930; AAB66582.1; -; mRNA.
DR   EMBL; AH008295; AAF03243.1; -; Genomic_DNA.
DR   EMBL; AJ401085; CAC06086.1; -; Genomic_DNA.
DR   EMBL; AJ401086; CAC06087.1; -; Genomic_DNA.
DR   EMBL; AJ401087; CAC06088.1; -; Genomic_DNA.
DR   EMBL; AJ748743; CAG38621.1; -; Genomic_DNA.
DR   EMBL; AL671277; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AH009116; AAF29557.1; -; Genomic_DNA.
DR   CCDS; CCDS34373.1; -.
DR   PIR; A02192; HLHUA3.
DR   RefSeq; NP_002107.3; NM_002116.7.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   PDB; 2XPG; X-ray; 2.60 A; A=25-298.
DR   PDB; 3RL1; X-ray; 2.00 A; A=25-298.
DR   PDB; 3RL2; X-ray; 2.39 A; A=25-298.
DR   PDB; 6ENY; EM; 5.80 A; F=25-365.
DR   PDBsum; 2XPG; -.
DR   PDBsum; 3RL1; -.
DR   PDBsum; 3RL2; -.
DR   PDBsum; 6ENY; -.
DR   ProteinModelPortal; P04439; -.
DR   SMR; P04439; -.
DR   BioGrid; 109350; 89.
DR   IntAct; P04439; 10.
DR   STRING; 9606.ENSP00000366005; -.
DR   BindingDB; P04439; -.
DR   ChEMBL; CHEMBL2632; -.
DR   iPTMnet; P04439; -.
DR   SwissPalm; P04439; -.
DR   BioMuta; PIKFYVE; -.
DR   DMDM; 34223717; -.
DR   MaxQB; P04439; -.
DR   PaxDb; P04439; -.
DR   PeptideAtlas; P04439; -.
DR   PRIDE; P04439; -.
DR   DNASU; 3105; -.
DR   Ensembl; ENST00000376809; ENSP00000366005; ENSG00000206503.
DR   Ensembl; ENST00000396634; ENSP00000379873; ENSG00000206503.
DR   GeneID; 3105; -.
DR   CTD; 3105; -.
DR   DisGeNET; 3105; -.
DR   EuPathDB; HostDB:ENSG00000206503.11; -.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   HPA; CAB078470; -.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P04439; -.
DR   OpenTargets; ENSG00000206503; -.
DR   PharmGKB; PA35055; -.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   GeneTree; ENSGT00760000118960; -.
DR   HOVERGEN; HBG016709; -.
DR   PhylomeDB; P04439; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; HLA-A; human.
DR   GeneWiki; HLA-A; -.
DR   GenomeRNAi; 3105; -.
DR   PMAP-CutDB; P04439; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000206503; -.
DR   CleanEx; HS_HLA-A; -.
DR   ExpressionAtlas; P04439; baseline and differential.
DR   Genevisible; P04439; HS.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0055038; C:recycling endosome membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0046977; F:TAP binding; IDA:UniProtKB.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Membrane; MHC I; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-3 alpha chain.
FT                                /FTId=PRO_0000018815.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000250}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:21543847}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:21543847}.
FT   VARIANT      89     89       R -> G (in dbSNP:rs199474430).
FT                                /FTId=VAR_050310.
FT   VARIANT      94     94       Q -> H (in dbSNP:rs78306866).
FT                                /FTId=VAR_050311.
FT   VARIANT     101    101       D -> N (in dbSNP:rs1136688).
FT                                /FTId=VAR_050312.
FT   VARIANT     121    121       I -> M (in dbSNP:rs1136695).
FT                                /FTId=VAR_050313.
FT   VARIANT     129    129       S -> P (in dbSNP:rs1136700).
FT                                /FTId=VAR_050314.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_050315.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_050316.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_050317.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                {ECO:0000244|PubMed:21269460}.
FT                                /FTId=VAR_050318.
FT   VARIANT     169    169       R -> H (in dbSNP:rs1059520).
FT                                /FTId=VAR_050319.
FT   VARIANT     176    176       E -> V (in allele A*03:02;
FT                                dbSNP:rs9256983).
FT                                /FTId=VAR_004351.
FT   VARIANT     180    180       L -> Q (in allele A*03:02).
FT                                /FTId=VAR_004352.
FT   VARIANT     185    185       D -> E (in allele A*03:05;
FT                                dbSNP:rs1059542).
FT                                /FTId=VAR_016604.
FT   VARIANT     186    186       G -> A (in allele A*03:06;
FT                                dbSNP:rs41545519).
FT                                /FTId=VAR_033149.
FT   VARIANT     199    199       G -> R (in allele A*03:04;
FT                                dbSNP:rs41559916).
FT                                /FTId=VAR_016605.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_050320.
FT   CONFLICT    319    319       G -> A (in Ref. 8; AAB66582).
FT                                {ECO:0000305}.
FT   STRAND       27     36       {ECO:0000244|PDB:3RL1}.
FT   STRAND       41     43       {ECO:0000244|PDB:3RL1}.
FT   STRAND       45     52       {ECO:0000244|PDB:3RL1}.
FT   STRAND       55     61       {ECO:0000244|PDB:3RL1}.
FT   STRAND       64     66       {ECO:0000244|PDB:3RL1}.
FT   HELIX        74     76       {ECO:0000244|PDB:3RL1}.
FT   HELIX        81    108       {ECO:0000244|PDB:3RL1}.
FT   STRAND      113    115       {ECO:0000244|PDB:3RL1}.
FT   STRAND      118    127       {ECO:0000244|PDB:3RL1}.
FT   STRAND      133    142       {ECO:0000244|PDB:3RL1}.
FT   STRAND      145    150       {ECO:0000244|PDB:3RL1}.
FT   STRAND      157    161       {ECO:0000244|PDB:3RL1}.
FT   HELIX       162    173       {ECO:0000244|PDB:3RL1}.
FT   HELIX       176    184       {ECO:0000244|PDB:3RL1}.
FT   HELIX       187    198       {ECO:0000244|PDB:3RL1}.
FT   HELIX       200    203       {ECO:0000244|PDB:3RL1}.
FT   STRAND      210    217       {ECO:0000244|PDB:3RL1}.
FT   STRAND      219    235       {ECO:0000244|PDB:3RL1}.
FT   STRAND      238    243       {ECO:0000244|PDB:3RL1}.
FT   STRAND      251    254       {ECO:0000244|PDB:3RL1}.
FT   STRAND      261    263       {ECO:0000244|PDB:3RL1}.
FT   STRAND      265    274       {ECO:0000244|PDB:3RL1}.
FT   HELIX       278    280       {ECO:0000244|PDB:3RL1}.
FT   STRAND      281    286       {ECO:0000244|PDB:3RL1}.
FT   STRAND      290    292       {ECO:0000244|PDB:3RL2}.
FT   STRAND      294    297       {ECO:0000244|PDB:3RL1}.
SQ   SEQUENCE   365 AA;  40841 MW;  DEDFCEC4450E0580 CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ
     IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHEAEQL
     RAYLDGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   1A01_HUMAN              Reviewed;         365 AA.
AC   P30443; O77964; O78171; Q9MYA3; Q9TP25; Q9TQP5;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   28-FEB-2018, entry version 164.
DE   RecName: Full=HLA class I histocompatibility antigen, A-1 alpha chain;
DE   AltName: Full=MHC class I antigen A*1;
DE   Flags: Precursor;
GN   Name=HLA-A; Synonyms=HLAA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*01:01).
RX   PubMed=3375250; DOI=10.1073/pnas.85.11.4005;
RA   Parham P., Lomen C.E., Lawlor D.A., Ways J.P., Holmes N., Coppin H.L.,
RA   Salter R.D., Wan A.M., Ennis P.D.;
RT   "Nature of polymorphism in HLA-A, -B, and -C molecules.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:4005-4009(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*01:01).
RX   PubMed=2715640;
RA   Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.;
RT   "Diversity and diversification of HLA-A,B,C alleles.";
RL   J. Immunol. 142:3937-3950(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*01:01).
RA   Warren E.;
RL   Submitted (APR-1989) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*01:01).
RX   PubMed=2251137; DOI=10.1093/nar/18.22.6701;
RA   Girdlestone J.;
RT   "Nucleotide sequence of an HLA-A1 gene.";
RL   Nucleic Acids Res. 18:6701-6701(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*01:01).
RX   PubMed=9349617; DOI=10.1111/j.1399-0039.1997.tb02885.x;
RA   Laforet M., Froelich N., Parissiadis A., Pfeiffer B., Schell A.,
RA   Faller B., Woehl-Jaegle M.L., Cazenave J.-P., Tongio M.M.;
RT   "A nucleotide insertion in exon 4 is responsible for the absence of
RT   expression of an HLA-A*01 allele.";
RL   Tissue Antigens 50:347-350(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ALLELE A*01:01).
RA   Waller M.J., Robinson J., Marsh S.G.E.;
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE A*01:01).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*01:02).
RX   PubMed=7761977; DOI=10.1111/j.1399-0039.1995.tb02437.x;
RA   Browning M.J., Madrigal J.A., Krausa P., Kowalski H., Allsopp C.E.,
RA   Little A.-M., Turner S., Adams E.J., Arnett K.L., Bodmer W.F.,
RA   Parham P.;
RT   "The HLA-A,B,C genotype of the class I negative cell line Daudi
RT   reveals novel HLA-A and -B alleles.";
RL   Tissue Antigens 45:177-187(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*01:03).
RX   PubMed=9438203; DOI=10.1016/S0198-8859(97)00204-8;
RA   Sitha S., Scheltinga S.A., Johnston-Dow L.A., White C.B.,
RA   der van Zwan A.W., Bakema J.E., Rozemuller E.H., van der Tweel J.G.,
RA   Kronink M.N., Tilanus M.G.J.;
RT   "A generic sequencing based typing approach for the identification of
RT   HLA-A diversity.";
RL   Hum. Immunol. 57:120-128(1997).
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*01:03).
RC   TISSUE=Blood;
RX   PubMed=11182232; DOI=10.1016/S0198-8859(00)00238-X;
RA   Poland G.A., Sohni Y., Domanico M., Kroning C.M., DeGoey S.R.,
RA   Jimale M., Jacobson R.M., Moore S.B.;
RT   "High frequency of HLA-A*0103 allele in a Somali population.";
RL   Hum. Immunol. 62:197-200(2001).
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*01:06).
RX   PubMed=10852390; DOI=10.1034/j.1399-0039.2000.550412.x;
RA   Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R.,
RA   Ng J., Hartzman R.J., Hurley C.K.;
RT   "Seventeen more novel HLA-A locus alleles.";
RL   Tissue Antigens 55:369-373(2000).
RN   [12]
RP   NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*01:07).
RA   Tamouza R., Fortier C., Mahfoudh N., Schaeffer V., Poirier J.C.,
RA   Marzais F., Gautreau C., Charron D.;
RT   "A new HLA-A*01 allele.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   SULFATION.
RX   PubMed=3121736;
RA   Sant A.J., Zacheis M., Rumbarger T., Giacoletto K.S., Schwartz B.D.;
RT   "Human Ia alpha- and beta-chains are sulfated.";
RL   J. Immunol. 140:155-160(1988).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352; SER-356 AND
RP   SER-359, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 25-298 IN COMPLEX WITH MAGE
RP   ANTIGENIC PEPTIDE AND ANTIBODY, AND DISULFIDE BONDS.
RX   PubMed=15537658; DOI=10.1074/jbc.M411323200;
RA   Hulsmeyer M., Chames P., Hillig R.C., Stanfield R.L., Held G.,
RA   Coulie P.G., Alings C., Wille G., Saenger W., Uchanska-Ziegler B.,
RA   Hoogenboom H.R., Ziegler A.;
RT   "A major histocompatibility complex-peptide-restricted antibody and t
RT   cell receptor molecules recognize their target by distinct binding
RT   modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1
RT   in complex with FAB-HYB3.";
RL   J. Biol. Chem. 280:2972-2980(2005).
RN   [18]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-166, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Dimer of alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with human herpesvirus 8 MIR1 protein
CC       (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q14943:KIR3DS1; NbExp=2; IntAct=EBI-8561769, EBI-15316524;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Sulfated. {ECO:0000269|PubMed:3121736}.
CC   -!- PTM: Polyubiquitinated in a post ER compartment through
CC       interaction with human herpesvirus 8 MIR1 protein. This targets
CC       the protein for rapid degradation via the ubiquitin system (By
CC       similarity). {ECO:0000250}.
CC   -!- POLYMORPHISM: The following alleles of A-1 are known: A*01:01,
CC       A*01:02, A*01:03, A*01:06 and A*01:07. The sequence shown is that
CC       of A*01:01. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24043; AAA59652.1; -; Genomic_DNA.
DR   EMBL; X55710; CAA39243.1; -; Genomic_DNA.
DR   EMBL; Z93949; CAB07989.1; -; Genomic_DNA.
DR   EMBL; AJ278305; CAB93537.1; -; Genomic_DNA.
DR   EMBL; BC003069; AAH03069.1; -; mRNA.
DR   EMBL; U07161; AAA80569.1; -; mRNA.
DR   EMBL; Y12469; CAA73072.1; -; Genomic_DNA.
DR   EMBL; Y12470; CAA73073.1; -; Genomic_DNA.
DR   EMBL; AH008863; AAF19525.1; -; Genomic_DNA.
DR   EMBL; AH007762; AAD33894.1; -; Genomic_DNA.
DR   EMBL; AH009407; AAF73862.1; -; Genomic_DNA.
DR   PIR; I38518; I38518.
DR   PIR; I61856; I61856.
DR   RefSeq; NP_001229687.1; NM_001242758.1.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   PDB; 1W72; X-ray; 2.15 A; A/D=25-298.
DR   PDB; 3BO8; X-ray; 1.80 A; A=25-298.
DR   PDB; 4NQV; X-ray; 2.39 A; A/C/E/G/I/K=25-298.
DR   PDB; 4NQX; X-ray; 2.00 A; A/C/E/G/I/K=25-308.
DR   PDB; 5BRZ; X-ray; 2.62 A; A=25-298.
DR   PDB; 5BS0; X-ray; 2.40 A; A=25-298.
DR   PDBsum; 1W72; -.
DR   PDBsum; 3BO8; -.
DR   PDBsum; 4NQV; -.
DR   PDBsum; 4NQX; -.
DR   PDBsum; 5BRZ; -.
DR   PDBsum; 5BS0; -.
DR   ProteinModelPortal; P30443; -.
DR   SMR; P30443; -.
DR   BioGrid; 109350; 89.
DR   IntAct; P30443; 6.
DR   MINT; P30443; -.
DR   iPTMnet; P30443; -.
DR   PhosphoSitePlus; P30443; -.
DR   SwissPalm; P30443; -.
DR   DMDM; 231347; -.
DR   PeptideAtlas; P30443; -.
DR   PRIDE; P30443; -.
DR   DNASU; 3105; -.
DR   Ensembl; ENST00000431930; ENSP00000406366; ENSG00000229215.
DR   Ensembl; ENST00000443552; ENSP00000404678; ENSG00000224320.
DR   Ensembl; ENST00000549869; ENSP00000447635; ENSG00000224320.
DR   Ensembl; ENST00000552193; ENSP00000447614; ENSG00000229215.
DR   GeneID; 3105; -.
DR   KEGG; hsa:3105; -.
DR   CTD; 3105; -.
DR   DisGeNET; 3105; -.
DR   GeneCards; HLA-A; -.
DR   HGNC; HGNC:4931; HLA-A.
DR   MalaCards; HLA-A; -.
DR   MIM; 142800; gene.
DR   neXtProt; NX_P30443; -.
DR   Orphanet; 179; Birdshot chorioretinopathy.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   HOVERGEN; HBG016709; -.
DR   KO; K06751; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   SIGNOR; P30443; -.
DR   ChiTaRS; HLA-A; human.
DR   EvolutionaryTrace; P30443; -.
DR   GenomeRNAi; 3105; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   CleanEx; HS_HLA-A; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0042612; C:MHC class I protein complex; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0055038; C:recycling endosome membrane; TAS:Reactome.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0046977; F:TAP binding; IDA:UniProtKB.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0016045; P:detection of bacterium; IMP:UniProtKB.
DR   GO; GO:0006955; P:immune response; IMP:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host-virus interaction; Immunity; Immunoglobulin domain; Membrane;
KW   MHC I; Phosphoprotein; Polymorphism; Reference proteome; Signal;
KW   Sulfation; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24
FT   CHAIN        25    365       HLA class I histocompatibility antigen,
FT                                A-1 alpha chain.
FT                                /FTId=PRO_0000018813.
FT   TOPO_DOM     25    308       Extracellular. {ECO:0000255}.
FT   TRANSMEM    309    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    365       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    295       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    308       Connecting peptide.
FT   MOD_RES      83     83       Sulfotyrosine. {ECO:0000255}.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     344    344       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18462}.
FT   MOD_RES     350    350       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01892}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:15537658}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:15537658}.
FT   VARIANT      33     33       F -> S (in allele A*01:02;
FT                                dbSNP:rs2075684).
FT                                {ECO:0000269|PubMed:7761977}.
FT                                /FTId=VAR_004332.
FT   VARIANT      41     41       R -> S (in allele A*01:02;
FT                                dbSNP:rs1059423).
FT                                {ECO:0000269|PubMed:7761977}.
FT                                /FTId=VAR_004333.
FT   VARIANT      80     80       G -> R (in allele A*01:07;
FT                                dbSNP:rs1059449). {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_016719.
FT   VARIANT      89     89       R -> G (in dbSNP:rs199474430).
FT                                {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_056247.
FT   VARIANT      91     91       M -> V (in allele A*01:07;
FT                                dbSNP:rs79361534). {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_016720.
FT   VARIANT     100    100       A -> E (in allele A*01:07;
FT                                dbSNP:rs1071742). {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_016721.
FT   VARIANT     114    114       D -> A (in allele A*01:07;
FT                                dbSNP:rs1136692). {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_016722.
FT   VARIANT     121    121       I -> M (in allele A*01:03;
FT                                dbSNP:rs1136695).
FT                                {ECO:0000269|PubMed:11182232,
FT                                ECO:0000269|PubMed:9438203}.
FT                                /FTId=VAR_016723.
FT   VARIANT     131    131       G -> W (in dbSNP:rs1136702).
FT                                /FTId=VAR_056248.
FT   VARIANT     133    133       F -> L (in dbSNP:rs1059488).
FT                                /FTId=VAR_056249.
FT   VARIANT     151    151       N -> K (in dbSNP:rs1059509).
FT                                /FTId=VAR_056250.
FT   VARIANT     166    166       I -> T (in dbSNP:rs1059516).
FT                                {ECO:0000244|PubMed:21269460}.
FT                                /FTId=VAR_056251.
FT   VARIANT     169    169       R -> H (in dbSNP:rs1059520).
FT                                /FTId=VAR_056252.
FT   VARIANT     180    180       R -> L (in allele A*01:06;
FT                                dbSNP:rs9260156).
FT                                {ECO:0000269|PubMed:10852390}.
FT                                /FTId=VAR_016724.
FT   VARIANT     182    182       V -> A (in allele A*01:06;
FT                                dbSNP:rs9260157).
FT                                {ECO:0000269|PubMed:10852390}.
FT                                /FTId=VAR_016725.
FT   VARIANT     205    205       R -> H (in dbSNP:rs17185861).
FT                                /FTId=VAR_056253.
FT   STRAND       27     36       {ECO:0000244|PDB:3BO8}.
FT   STRAND       41     43       {ECO:0000244|PDB:3BO8}.
FT   STRAND       45     52       {ECO:0000244|PDB:3BO8}.
FT   STRAND       55     61       {ECO:0000244|PDB:3BO8}.
FT   STRAND       64     66       {ECO:0000244|PDB:3BO8}.
FT   STRAND       70     73       {ECO:0000244|PDB:1W72}.
FT   HELIX        74     76       {ECO:0000244|PDB:3BO8}.
FT   HELIX        81    109       {ECO:0000244|PDB:3BO8}.
FT   STRAND      113    115       {ECO:0000244|PDB:1W72}.
FT   STRAND      118    127       {ECO:0000244|PDB:3BO8}.
FT   STRAND      133    142       {ECO:0000244|PDB:3BO8}.
FT   STRAND      145    150       {ECO:0000244|PDB:3BO8}.
FT   STRAND      157    159       {ECO:0000244|PDB:3BO8}.
FT   HELIX       162    173       {ECO:0000244|PDB:3BO8}.
FT   HELIX       176    185       {ECO:0000244|PDB:3BO8}.
FT   HELIX       187    198       {ECO:0000244|PDB:3BO8}.
FT   HELIX       200    203       {ECO:0000244|PDB:3BO8}.
FT   STRAND      210    217       {ECO:0000244|PDB:3BO8}.
FT   STRAND      219    235       {ECO:0000244|PDB:3BO8}.
FT   STRAND      238    243       {ECO:0000244|PDB:3BO8}.
FT   STRAND      246    248       {ECO:0000244|PDB:4NQX}.
FT   HELIX       249    251       {ECO:0000244|PDB:3BO8}.
FT   STRAND      252    254       {ECO:0000244|PDB:4NQX}.
FT   STRAND      261    263       {ECO:0000244|PDB:3BO8}.
FT   STRAND      265    274       {ECO:0000244|PDB:3BO8}.
FT   HELIX       278    280       {ECO:0000244|PDB:3BO8}.
FT   STRAND      281    286       {ECO:0000244|PDB:3BO8}.
FT   STRAND      290    292       {ECO:0000244|PDB:4NQX}.
FT   STRAND      294    296       {ECO:0000244|PDB:3BO8}.
SQ   SEQUENCE   365 AA;  40846 MW;  8667AFF3F06C4932 CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQKME PRAPWIEQEG PEYWDQETRN MKAHSQTDRA NLGTLRGYYN QSEDGSHTIQ
     IMYGCDVGPD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAVHAAEQR
     RVYLEGRCVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   Q5SUL5_HUMAN            Unreviewed;       365 AA.
AC   Q5SUL5;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 133.
DE   SubName: Full=MHC class I antigen {ECO:0000313|EMBL:AAX94768.1};
GN   Name=HLA-A {ECO:0000313|EMBL:AAX94768.1};
GN   Synonyms=HLA {ECO:0000313|EMBL:ASU50316.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAX94768.1};
RN   [1] {ECO:0000313|EMBL:CAD61867.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Dunn P., Downing J., Hammond L., Darke C.;
RT   "Characterization of 4 HLA null alleles identified by disparities in
RT   the serological and molecular typing of 6,000 potential bone marrow
RT   donors.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:CAD61867.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Dunn P.P.;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AAX94768.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Vicario J.L., Alonso-Nieto M.;
RT   "Eight new HLA class I alleles.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ACA34990.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=19735485; DOI=10.1111/j.1744-313X.2009.00874.x;
RA   Zhu F., He Y., Zhang W., He J., He J., Xu X., Yan L.;
RT   "Analysis of the complete genomic sequence of HLA-A alleles in the
RT   Chinese Han population.";
RL   Int. J. Immunogenet. 36:351-360(2009).
RN   [5] {ECO:0000313|EMBL:ADE80886.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Xu Y.P., Deng Z.H., Yang B.C.;
RT   "Characterization and polymorphism analyses of HLA-A genomic full
RT   length in Chinese Han population.";
RL   Submitted (FEB-2010) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:BAN59796.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=23714642; DOI=10.1186/1471-2164-14-355;
RA   Hosomichi K., Jinam T.A., Mitsunaga S., Nakaoka H., Inoue I.;
RT   "Phase-defined complete sequencing of the HLA genes by next-generation
RT   sequencing.";
RL   BMC Genomics 14:355-355(2013).
RN   [7] {ECO:0000313|EMBL:CDK41182.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Lymphoblastoid cell line {ECO:0000313|EMBL:CDK41182.1};
RA   McWhinnie A.J., Robinson J.;
RT   "Confirmatory sequencing of HLA-A*01:01:01:01.";
RL   Submitted (NOV-2013) to the EMBL/GenBank/DDBJ databases.
RN   [8] {ECO:0000313|EMBL:CUV66801.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Albrecht V., Boehme I., Schmidt A.H.;
RT   "Characterisation and Confirmation of new HLA-Alleles found by DKMS
RT   Life Science Lab.";
RL   Submitted (DEC-2015) to the EMBL/GenBank/DDBJ databases.
RN   [9] {ECO:0000313|EMBL:ALZ40812.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Bravo-Egana V., Clark P., Monos D.;
RT   "Generation of high confidence HLA genotyping and consensus sequences
RT   for Class I HLA loci using the NGS-based Omixon Holotype HLA typing
RT   system and the Illumina MiSeq platform.";
RL   Submitted (DEC-2015) to the EMBL/GenBank/DDBJ databases.
RN   [10] {ECO:0000313|EMBL:SBL08149.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ploux O.;
RL   Submitted (MAR-2016) to the EMBL/GenBank/DDBJ databases.
RN   [11] {ECO:0000313|EMBL:SBL08864.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Lavstsen T., Jespersen J.S.;
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [12] {ECO:0000313|EMBL:SCB63957.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kjaerup R.B., Dalgaard T.S., Juul-Madsen H.R.;
RL   Submitted (JUN-2016) to the EMBL/GenBank/DDBJ databases.
RN   [13] {ECO:0000313|EMBL:SCB63957.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Groeneweg M., Matern B., Palusci F., Meertens C., Tilanus M.G.J.,
RA   Voorter C.E.M.;
RT   "Group specific, unambiguous full-length gene HLA Class I typing by
RT   Sanger sequencing: a robust SSBT Strategy for typing and a golden
RT   reference for next generation sequencing approaches.";
RL   Submitted (SEP-2016) to the EMBL/GenBank/DDBJ databases.
RN   [14] {ECO:0000313|EMBL:ASA47538.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Jaros S., Januszkiewicz K., Wedrychowicz H.;
RL   Submitted (NOV-2016) to the EMBL/GenBank/DDBJ databases.
RN   [15] {ECO:0000313|EMBL:ASA47555.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Song W.-J., Kurnit D.M.;
RL   Submitted (DEC-2016) to the EMBL/GenBank/DDBJ databases.
RN   [16] {ECO:0000313|EMBL:CUV66767.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=28547825; DOI=.1111/tan.13057;
RA   Albrecht V., Zweiniger C., Surendranath V., Lang K., Schofl G.,
RA   Dahl A., Winkler S., Lange V., Bohme I., Schmidt A.H.;
RT   "Dual redundant sequencing strategy: Full-length gene characterisation
RT   of 1056 novel and confirmatory HLA alleles.";
RL   HLA. 90:79-87(2017).
RN   [17] {ECO:0000313|EMBL:ASU50316.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Balz V., Krause S., Enczmann J., Fischer J.;
RT   "More than 130 novel variants of HLA class 1 genes detected in German
RT   Stem Cell Donor Registry and Terasaki samples.";
RL   Submitted (JAN-2017) to the EMBL/GenBank/DDBJ databases.
RN   [18] {ECO:0000313|EMBL:SBL08149.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Marsh S.G.E.;
RT   "Full-length genomic HLA sequences.";
RL   Submitted (MAR-2017) to the EMBL/GenBank/DDBJ databases.
RN   [19] {ECO:0000313|EMBL:AST08336.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kim H.J., Triplett B.A.;
RL   Submitted (JUN-2017) to the EMBL/GenBank/DDBJ databases.
RN   [20] {ECO:0000313|EMBL:ASU61665.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Sun Z.S., Albrecht U., Echele G., Lee C.C.;
RL   Submitted (JUL-2017) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system. {ECO:0000256|SAAS:SAAS00291881}.
CC   -!- SIMILARITY: Belongs to the MHC class I family.
CC       {ECO:0000256|RuleBase:RU004439, ECO:0000256|SAAS:SAAS00560993}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY973959; AAX94768.1; -; Genomic_DNA.
DR   EMBL; EU445470; ACA34990.1; -; Genomic_DNA.
DR   EMBL; GU812295; ADE80886.1; -; Genomic_DNA.
DR   EMBL; KU528597; ALZ40812.1; -; Genomic_DNA.
DR   EMBL; KY235390; ASA47538.1; -; Genomic_DNA.
DR   EMBL; KY235393; ASA47541.1; -; Genomic_DNA.
DR   EMBL; KY350872; ASA47555.1; -; Genomic_DNA.
DR   EMBL; MF382100; AST08336.1; -; Genomic_DNA.
DR   EMBL; KY419425; ASU50316.1; -; Genomic_DNA.
DR   EMBL; KY419426; ASU50317.1; -; Genomic_DNA.
DR   EMBL; KY419427; ASU50318.1; -; Genomic_DNA.
DR   EMBL; MF474215; ASU61665.1; -; Genomic_DNA.
DR   EMBL; AB774950; BAN59796.1; -; Genomic_DNA.
DR   EMBL; AJ538348; CAD61867.1; -; Genomic_DNA.
DR   EMBL; HG794373; CDK41182.1; -; Genomic_DNA.
DR   EMBL; LN994715; CUV66767.1; -; Genomic_DNA.
DR   EMBL; LN994725; CUV66777.1; -; Genomic_DNA.
DR   EMBL; LN994749; CUV66801.1; -; Genomic_DNA.
DR   EMBL; LN999564; CUX90957.1; -; Genomic_DNA.
DR   EMBL; LN999604; CUX90997.1; -; Genomic_DNA.
DR   EMBL; LT575515; SBL08149.1; -; Genomic_DNA.
DR   EMBL; LT575612; SBL08864.1; -; Genomic_DNA.
DR   EMBL; LT599170; SBW38391.1; -; Genomic_DNA.
DR   EMBL; LT604086; SCB63957.1; -; Genomic_DNA.
DR   RefSeq; NP_001229687.1; NM_001242758.1.
DR   UniGene; Hs.181244; -.
DR   UniGene; Hs.713441; -.
DR   DNASU; 3105; -.
DR   GeneID; 3105; -.
DR   KEGG; hsa:3105; -.
DR   UCSC; uc011ejq.2; human.
DR   CTD; 3105; -.
DR   H-InvDB; HIX0165925; -.
DR   H-InvDB; HIX0166103; -.
DR   eggNOG; ENOG410II5V; Eukaryota.
DR   eggNOG; ENOG4111K8F; LUCA.
DR   HOVERGEN; HBG016709; -.
DR   KO; K06751; -.
DR   ChiTaRS; HLA-A; human.
DR   GenomeRNAi; 3105; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   3: Inferred from homology;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00447792};
KW   Immunity {ECO:0000256|SAAS:SAAS00446101};
KW   Membrane {ECO:0000256|SAAS:SAAS00447790, ECO:0000256|SAM:Phobius};
KW   MHC I {ECO:0000256|SAAS:SAAS00446101};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00447790,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00447790,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25    365       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5013532537.
FT   TRANSMEM    308    332       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      209    295       Ig-like. {ECO:0000259|PROSITE:PS50835}.
SQ   SEQUENCE   365 AA;  40846 MW;  8667AFF3F06C4932 CRC64;
     MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF
     DSDAASQKME PRAPWIEQEG PEYWDQETRN MKAHSQTDRA NLGTLRGYYN QSEDGSHTIQ
     IMYGCDVGPD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAVHAAEQR
     RVYLEGRCVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT
     WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL
     SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL
     TACKV
//
ID   HOOK3_HUMAN             Reviewed;         718 AA.
AC   Q86VS8; D3DSY8; Q8NBH0; Q9BY13;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 2.
DT   28-FEB-2018, entry version 134.
DE   RecName: Full=Protein Hook homolog 3;
DE            Short=h-hook3;
DE            Short=hHK3;
GN   Name=HOOK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH MICROTUBULES,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=11238449; DOI=10.1083/jcb.152.5.923;
RA   Walenta J.H., Didier A.J., Liu X., Kraemer H.;
RT   "The Golgi-associated hook3 protein is a member of a novel family of
RT   microtubule-binding proteins.";
RL   J. Cell Biol. 152:923-934(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix, and Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 346-718.
RC   TISSUE=Astrocyte;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH MSR1.
RX   PubMed=17237231; DOI=10.1074/jbc.M611537200;
RA   Sano H., Ishino M., Kraemer H., Shimizu T., Mitsuzawa H.,
RA   Nishitani C., Kuroki Y.;
RT   "The microtubule-binding protein Hook3 interacts with a cytoplasmic
RT   domain of scavenger receptor A.";
RL   J. Biol. Chem. 282:7973-7981(2007).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE FHF
RP   COMPLEX, FUNCTION, SELF-ASSOCIATION, AND INTERACTION WITH AKTIP;
RP   HOOK1; HOOK2; VPS16 AND VPS41.
RX   PubMed=18799622; DOI=10.1091/mbc.E08-05-0473;
RA   Xu L., Sowa M.E., Chen J., Li X., Gygi S.P., Harper J.W.;
RT   "An FTS/Hook/p107(FHIP) complex interacts with and promotes endosomal
RT   clustering by the homotypic vacuolar protein sorting complex.";
RL   Mol. Biol. Cell 19:5059-5071(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-6; SER-238;
RP   SER-693 AND SER-707, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH DYNEIN INTERMEDIATE CHAIN AND DCTN1.
RX   PubMed=25035494; DOI=10.1126/science.1254198;
RA   McKenney R.J., Huynh W., Tanenbaum M.E., Bhabha G., Vale R.D.;
RT   "Activation of cytoplasmic dynein motility by dynactin-cargo adapter
RT   complexes.";
RL   Science 345:337-341(2014).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-221.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Probably serves as a target for the spiC protein from
CC       Salmonella typhimurium, which inactivates it, leading to a strong
CC       alteration in cellular trafficking (By similarity). Component of
CC       the FTS/Hook/FHIP complex (FHF complex). The FHF complex may
CC       function to promote vesicle trafficking and/or fusion via the
CC       homotypic vesicular protein sorting complex (the HOPS complex).
CC       May regulate clearance of endocytosed receptors such as MSR1.
CC       Participates in defining the architecture and localization of the
CC       Golgi complex. Acts as an adapter protein linking the dynein motor
CC       complex to various cargos and converts dynein from a non-
CC       processive to a highly processive motor in the presence of
CC       dynactin. Facilitates the interaction between dynein and dynactin
CC       and activates dynein processivity (the ability to move along a
CC       microtubule for a long distance without falling off the track)
CC       (PubMed:25035494). {ECO:0000250|UniProtKB:Q8BUK6,
CC       ECO:0000269|PubMed:11238449, ECO:0000269|PubMed:17237231,
CC       ECO:0000269|PubMed:18799622, ECO:0000269|PubMed:25035494}.
CC   -!- SUBUNIT: Interacts with Salmonella typhimurium spiC (By
CC       similarity). Self-associates. Component of the FTS/Hook/FHIP
CC       complex (FHF complex), composed of AKTIP/FTS, FAM160A2, and one or
CC       more members of the Hook family of proteins HOOK1, HOOK2, and
CC       HOOK3. May interact directly with AKTIP/FTS, HOOK1 and HOOK2.
CC       Associates with several subunits of the homotypic vesicular
CC       sorting complex (the HOPS complex) including VPS16 and VPS41;
CC       these interactions may be indirect (PubMed:18799622). Interacts
CC       with MSR1, and this association is stimulated by ligand binding to
CC       MSR1 (PubMed:17237231). Interacts with microtubules
CC       (PubMed:11238449). Interacts with dynein intermediate chain and
CC       dynactin (DCTN1) (PubMed:25035494). Interacts with CCDC181 (By
CC       similarity). Interacts with LRGUK (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BUK6, ECO:0000269|PubMed:11238449,
CC       ECO:0000269|PubMed:17237231, ECO:0000269|PubMed:18799622,
CC       ECO:0000269|PubMed:25035494}.
CC   -!- INTERACTION:
CC       P50222:MEOX2; NbExp=4; IntAct=EBI-1777078, EBI-748397;
CC       P21757:MSR1; NbExp=4; IntAct=EBI-1777078, EBI-1776976;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:11238449}. Golgi apparatus
CC       {ECO:0000269|PubMed:11238449}. Note=Enriched at the cis-face of
CC       the Golgi complex. Localizes to microtubule asters in prophase
CC       (PubMed:11238449). Localizes to the manchette in elongating
CC       spermatids (By similarity). {ECO:0000250|UniProtKB:Q8BUK6,
CC       ECO:0000269|PubMed:11238449}.
CC   -!- SIMILARITY: Belongs to the hook family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH48304.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF241830; AAK29204.1; -; mRNA.
DR   EMBL; CH471080; EAW63197.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63198.1; -; Genomic_DNA.
DR   EMBL; BC048304; AAH48304.1; ALT_SEQ; mRNA.
DR   EMBL; BC056146; AAH56146.1; -; mRNA.
DR   EMBL; AK090540; BAC03473.1; -; mRNA.
DR   CCDS; CCDS6139.1; -.
DR   RefSeq; NP_115786.1; NM_032410.3.
DR   UniGene; Hs.162852; -.
DR   PDB; 5J8E; X-ray; 1.70 A; A/B=1-160.
DR   PDBsum; 5J8E; -.
DR   ProteinModelPortal; Q86VS8; -.
DR   SMR; Q86VS8; -.
DR   BioGrid; 124068; 37.
DR   CORUM; Q86VS8; -.
DR   IntAct; Q86VS8; 15.
DR   STRING; 9606.ENSP00000305699; -.
DR   iPTMnet; Q86VS8; -.
DR   PhosphoSitePlus; Q86VS8; -.
DR   BioMuta; HOOK3; -.
DR   DMDM; 41688581; -.
DR   EPD; Q86VS8; -.
DR   MaxQB; Q86VS8; -.
DR   PaxDb; Q86VS8; -.
DR   PeptideAtlas; Q86VS8; -.
DR   PRIDE; Q86VS8; -.
DR   Ensembl; ENST00000307602; ENSP00000305699; ENSG00000168172.
DR   GeneID; 84376; -.
DR   KEGG; hsa:84376; -.
DR   UCSC; uc003xpr.4; human.
DR   CTD; 84376; -.
DR   DisGeNET; 84376; -.
DR   EuPathDB; HostDB:ENSG00000168172.8; -.
DR   GeneCards; HOOK3; -.
DR   HGNC; HGNC:23576; HOOK3.
DR   HPA; HPA024756; -.
DR   MIM; 607825; gene.
DR   neXtProt; NX_Q86VS8; -.
DR   OpenTargets; ENSG00000168172; -.
DR   PharmGKB; PA134961305; -.
DR   eggNOG; ENOG410IG1M; Eukaryota.
DR   eggNOG; ENOG410XQ3G; LUCA.
DR   GeneTree; ENSGT00690000101702; -.
DR   HOGENOM; HOG000294112; -.
DR   HOVERGEN; HBG051920; -.
DR   InParanoid; Q86VS8; -.
DR   KO; K16536; -.
DR   OMA; DELKCGQ; -.
DR   OrthoDB; EOG091G06O9; -.
DR   PhylomeDB; Q86VS8; -.
DR   TreeFam; TF320231; -.
DR   SIGNOR; Q86VS8; -.
DR   ChiTaRS; HOOK3; human.
DR   GeneWiki; HOOK3; -.
DR   GenomeRNAi; 84376; -.
DR   PRO; PR:Q86VS8; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000168172; -.
DR   CleanEx; HS_HOOK3; -.
DR   ExpressionAtlas; Q86VS8; baseline and differential.
DR   Genevisible; Q86VS8; HS.
DR   GO; GO:0034451; C:centriolar satellite; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; ISS:BHF-UCL.
DR   GO; GO:0005801; C:cis-Golgi network; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:GOC.
DR   GO; GO:0070695; C:FHF complex; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0000242; C:pericentriolar material; ISS:BHF-UCL.
DR   GO; GO:0051959; F:dynein light intermediate chain binding; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0031122; P:cytoplasmic microtubule organization; IMP:UniProtKB.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; IBA:GO_Central.
DR   GO; GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB.
DR   GO; GO:0007032; P:endosome organization; IMP:UniProtKB.
DR   GO; GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB.
DR   GO; GO:0051645; P:Golgi localization; IMP:UniProtKB.
DR   GO; GO:0022027; P:interkinetic nuclear migration; ISS:BHF-UCL.
DR   GO; GO:0007040; P:lysosome organization; IMP:UniProtKB.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; ISS:BHF-UCL.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; ISS:BHF-UCL.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0071539; P:protein localization to centrosome; ISS:BHF-UCL.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR008636; Hook-like_fam.
DR   PANTHER; PTHR18947; PTHR18947; 1.
DR   Pfam; PF05622; HOOK; 1.
DR   PROSITE; PS50021; CH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Golgi apparatus; Microtubule; Phosphoprotein;
KW   Polymorphism; Protein transport; Reference proteome; Transport.
FT   CHAIN         1    718       Protein Hook homolog 3.
FT                                /FTId=PRO_0000219197.
FT   DOMAIN       10    126       Calponin-homology (CH).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00044}.
FT   REGION        1    164       Sufficient for interaction with
FT                                microtubules.
FT   REGION      553    718       Required for association with Golgi.
FT   REGION      556    718       Required for interaction with MSR1.
FT                                {ECO:0000269|PubMed:17237231}.
FT   COILED      167    433       {ECO:0000255}.
FT   COILED      462    667       {ECO:0000255}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     238    238       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     693    693       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     707    707       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     221    221       Q -> R (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035710.
FT   VARIANT     670    670       Y -> S (in dbSNP:rs34131505).
FT                                /FTId=VAR_049363.
FT   CONFLICT    348    348       M -> V (in Ref. 4; BAC03473).
FT                                {ECO:0000305}.
FT   HELIX        10     20       {ECO:0000244|PDB:5J8E}.
FT   HELIX        21     23       {ECO:0000244|PDB:5J8E}.
FT   HELIX        32     35       {ECO:0000244|PDB:5J8E}.
FT   HELIX        39     48       {ECO:0000244|PDB:5J8E}.
FT   TURN         50     52       {ECO:0000244|PDB:5J8E}.
FT   HELIX        55     58       {ECO:0000244|PDB:5J8E}.
FT   HELIX        69     89       {ECO:0000244|PDB:5J8E}.
FT   HELIX       103    109       {ECO:0000244|PDB:5J8E}.
FT   HELIX       112    128       {ECO:0000244|PDB:5J8E}.
FT   HELIX       132    157       {ECO:0000244|PDB:5J8E}.
SQ   SEQUENCE   718 AA;  83126 MW;  9528EC9C854D39FA CRC64;
     MFSVESLERA ELCESLLTWI QTFNVDAPCQ TVEDLTNGVV MAQVLQKIDP AYFDENWLNR
     IKTEVGDNWR LKISNLKKIL KGILDYNHEI LGQQINDFTL PDVNLIGEHS DAAELGRMLQ
     LILGCAVNCE QKQEYIQAIM MMEESVQHVV MTAIQELMSK ESPVSAGNDA YVDLDRQLKK
     TTEELNEALS AKEEIAQRCH ELDMQVAALQ EEKSSLLAEN QVLMERLNQS DSIEDPNSPA
     GRRHLQLQTQ LEQLQEETFR LEAAKDDYRI RCEELEKEIS ELRQQNDELT TLADEAQSLK
     DEIDVLRHSS DKVSKLEGQV ESYKKKLEDL GDLRRQVKLL EEKNTMYMQN TVSLEEELRK
     ANAARSQLET YKRQVVELQN RLSEESKKAD KLDFEYKRLK EKVDSLQKEK DRLRTERDSL
     KETIEELRCV QAQEGQLTTQ GLMPLGSQES SDSLAAEIVT PEIREKLIRL QHENKMLKLN
     QEGSDNEKIA LLQSLLDDAN LRKNELETEN RLVNQRLLEV QSQVEELQKS LQDQGSKAED
     SVLLKKKLEE HLEKLHEANN ELQKKRAIIE DLEPRFNNSS LKIEELQEAL RKKEEEMKQM
     EERYKKYLEK AKSVIRTLDP KQNQGAAPEI QALKNQLQER DRLFHSLEKE YEKTKSQREM
     EEKYIVSAWY NMGMTLHKKA AEDRLASTGS GQSFLARQRQ ATSSRRSYPG HVQPATAR
//
ID   K9JA46_HUMAN            Unreviewed;       732 AA.
AC   K9JA46;
DT   06-MAR-2013, integrated into UniProtKB/TrEMBL.
DT   06-MAR-2013, sequence version 1.
DT   28-FEB-2018, entry version 48.
DE   SubName: Full=Epididymis luminal secretory protein 52 {ECO:0000313|EMBL:ADD71695.1};
DE   SubName: Full=Epididymis secretory sperm binding protein Li 65p {ECO:0000313|EMBL:ACV87205.1};
DE   SubName: Full=Heat shock protein 90kDa alpha (Cytosolic), class A member 1, isoform CRA_a {ECO:0000313|EMBL:EAW81766.1};
GN   Name=EL52 {ECO:0000313|EMBL:ADD71695.1};
GN   Synonyms=HEL-S-65p {ECO:0000313|EMBL:ACV87205.1},
GN   HSP90AA1 {ECO:0000313|EMBL:EAW81766.1};
GN   ORFNames=hCG_1814169 {ECO:0000313|EMBL:EAW81766.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADD71695.1};
RN   [1] {ECO:0000313|EMBL:EAW81766.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW81766.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADD71695.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human epididymis cDNA library.";
RL   Submitted (MAY-2009) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ACV87205.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Sahoo P.;
RL   Submitted (AUG-2009) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ472230; ACV87205.1; -; mRNA.
DR   EMBL; GQ149083; ADD71695.1; -; mRNA.
DR   EMBL; CH471061; EAW81766.1; -; Genomic_DNA.
DR   RefSeq; NP_005339.3; NM_005348.3.
DR   UniGene; Hs.525600; -.
DR   SMR; K9JA46; -.
DR   IntAct; K9JA46; 14.
DR   GeneID; 3320; -.
DR   KEGG; hsa:3320; -.
DR   CTD; 3320; -.
DR   EuPathDB; HostDB:ENSG00000080824.18; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   KO; K04079; -.
DR   ChiTaRS; HSP90AA1; human.
DR   GenomeRNAi; 3320; -.
DR   Bgee; ENSG00000080824; -.
DR   GO; GO:0005737; C:cytoplasm; ISS:AgBase.
DR   GO; GO:0005634; C:nucleus; ISS:AgBase.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0046677; P:response to antibiotic; ISS:AgBase.
DR   GO; GO:0009409; P:response to cold; ISS:AgBase.
DR   GO; GO:0009408; P:response to heat; ISS:AgBase.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Stress response {ECO:0000313|EMBL:EAW81766.1}.
FT   DOMAIN       40    194       HATPase_c. {ECO:0000259|SMART:SM00387}.
FT   COILED      228    255       {ECO:0000256|SAM:Coils}.
FT   COILED      263    283       {ECO:0000256|SAM:Coils}.
FT   COILED      551    571       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   732 AA;  84660 MW;  969F65FCC0BC86FD CRC64;
     MPEETQTQDQ PMEEEEVETF AFQAEIAQLM SLIINTFYSN KEIFLRELIS NSSDALDKIR
     YESLTDPSKL DSGKELHINL IPNKQDRTLT IVDTGIGMTK ADLINNLGTI AKSGTKAFME
     ALQAGADISM IGQFGVGFYS AYLVAEKVTV ITKHNDDEQY AWESSAGGSF TVRTDTGEPM
     GRGTKVILHL KEDQTEYLEE RRIKEIVKKH SQFIGYPITL FVEKERDKEV SDDEAEEKED
     KEEEKEKEEK ESEDKPEIED VGSDEEEEKK DGDKKKKKKI KEKYIDQEEL NKTKPIWTRN
     PDDITNEEYG EFYKSLTNDW EDHLAVKHFS VEGQLEFRAL LFVPRRAPFD LFENRKKKNN
     IKLYVRRVFI MDNCEELIPE YLNFIRGVVD SEDLPLNISR EMLQQSKILK VIRKNLVKKC
     LELFTELAED KENYKKFYEQ FSKNIKLGIH EDSQNRKKLS ELLRYYTSAS GDEMVSLKDY
     CTRMKENQKH IYYITGETKD QVANSAFVER LRKHGLEVIY MIEPIDEYCV QQLKEFEGKT
     LVSVTKEGLE LPEDEEEKKK QEEKKTKFEN LCKIMKDILE KKVEKVVVSN RLVTSPCCIV
     TSTYGWTANM ERIMKAQALR DNSTMGYMAA KKHLEINPDH SIIETLRQKA EADKNDKSVK
     DLVILLYETA LLSSGFSLED PQTHANRIYR MIKLGLGIDE DDPTADDTSA AVTEEMPPLE
     GDDDTSRMEE VD
//
ID   HS90A_HUMAN             Reviewed;         732 AA.
AC   P07900; A8K500; B3KPJ9; Q2PP14; Q5CAQ6; Q5CAQ7; Q9BVQ5;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   28-FEB-2018, entry version 233.
DE   RecName: Full=Heat shock protein HSP 90-alpha;
DE   AltName: Full=Heat shock 86 kDa;
DE            Short=HSP 86;
DE            Short=HSP86;
DE   AltName: Full=Lipopolysaccharide-associated protein 2;
DE            Short=LAP-2;
DE            Short=LPS-associated protein 2;
DE   AltName: Full=Renal carcinoma antigen NY-REN-38;
GN   Name=HSP90AA1; Synonyms=HSP90A, HSPC1, HSPCA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=2780322; DOI=10.1093/nar/17.17.7108;
RA   Soeda E., Yokoyama K., Yamazaki M., Akaogi K., Miwa T., Imai T.;
RT   "Nucleotide sequence of a full-length cDNA for 90 kDa heat-shock
RT   protein from human peripheral blood lymphocytes.";
RL   Nucleic Acids Res. 17:7108-7108(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1368637; DOI=10.1271/bbb1961.54.3163;
RA   Yamazaki M., Tashiro H., Yokoyama K., Soeda E.;
RT   "Molecular cloning of cDNA encoding a human heat-shock protein whose
RT   expression is induced by adenovirus type 12 E1A in HeLa cells.";
RL   Agric. Biol. Chem. 54:3163-3170(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=2527334; DOI=10.1128/MCB.9.6.2615;
RA   Hickey E., Brandon S.E., Smale G., Lloyd D., Weber L.A.;
RT   "Sequence and regulation of a gene encoding a human 89-kilodalton heat
RT   shock protein.";
RL   Mol. Cell. Biol. 9:2615-2626(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND NOMENCLATURE.
RX   PubMed=16269234; DOI=10.1016/j.ygeno.2005.08.012;
RA   Chen B., Piel W.H., Gui L., Bruford E., Monteiro A.;
RT   "The HSP90 family of genes in the human genome: insights into their
RT   divergence and evolution.";
RL   Genomics 86:627-637(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-312.
RX   PubMed=2469626; DOI=10.1016/0378-1119(88)90182-5;
RA   Hoffmann T., Hovemann B.;
RT   "Heat-shock proteins, Hsp84 and Hsp86, of mice and men: two related
RT   genes encode formerly identified tumour-specific transplantation
RT   antigens.";
RL   Gene 74:491-501(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-312.
RX   PubMed=2591742; DOI=10.1016/0378-1119(89)90408-3;
RA   Walter T., Drabent B., Krebs H., Tomalak M., Heiss S., Benecke B.J.J.;
RT   "Cloning and analysis of a human 86-kDa heat-shock-protein-encoding
RT   gene.";
RL   Gene 83:105-115(1989).
RN   [11]
RP   PROTEIN SEQUENCE OF 101-112; 210-224; 300-314; 328-338; 346-355;
RP   387-400; 465-478 AND 633-647, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 185-732.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 539-732.
RC   TISSUE=Heart;
RA   Tanaka M., Tanaka T., Mitsui Y., Yamamoto M., Wood J.N.;
RT   "The analysis of the genes reactive to monoclonal antibody, CE5.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   PROTEIN SEQUENCE OF 2-21, AND PHOSPHORYLATION AT SER-231 AND SER-263.
RX   PubMed=2492519;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "Two human 90-kDa heat shock proteins are phosphorylated in vivo at
RT   conserved serines that are phosphorylated in vitro by casein kinase
RT   II.";
RL   J. Biol. Chem. 264:2431-2437(1989).
RN   [15]
RP   PROTEIN SEQUENCE OF 154-163 AND 186-191, AND INTERACTION WITH KSR1.
RX   PubMed=10409742; DOI=10.1128/MCB.19.8.5523;
RA   Stewart S., Sundaram M., Zhang Y., Lee J., Han M., Guan K.L.;
RT   "Kinase suppressor of Ras forms a multiprotein signaling complex and
RT   modulates MEK localization.";
RL   Mol. Cell. Biol. 19:5523-5534(1999).
RN   [16]
RP   PROTEIN SEQUENCE OF 592-612, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS
RP   OF CYS-598, AND S-NITROSYLATION AT CYS-598.
RX   PubMed=15937123; DOI=10.1073/pnas.0407294102;
RA   Martinez-Ruiz A., Villanueva L., Gonzalez de Orduna C.,
RA   Lopez-Ferrer D., Higueras M.A., Tarin C., Rodriguez-Crespo I.,
RA   Vazquez J., Lamas S.;
RT   "S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and
RT   endothelial nitric oxide synthase regulatory activities.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:8525-8530(2005).
RN   [17]
RP   PHOSPHORYLATION AT THR-5 AND THR-7.
RX   PubMed=2507541;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "The human double-stranded DNA-activated protein kinase phosphorylates
RT   the 90-kDa heat-shock protein, hsp90 alpha at two NH2-terminal
RT   threonine residues.";
RL   J. Biol. Chem. 264:17275-17280(1989).
RN   [18]
RP   HOMODIMERIZATION.
RX   PubMed=8289821; DOI=10.1128/MCB.14.2.1459;
RA   Minami Y., Kimura Y., Kawasaki H., Suzuki K., Yahara I.;
RT   "The carboxy-terminal region of mammalian HSP90 is required for its
RT   dimerization and function in vivo.";
RL   Mol. Cell. Biol. 14:1459-1464(1994).
RN   [19]
RP   SUBUNIT.
RX   PubMed=7588731; DOI=10.1111/j.1432-1033.1995.001_1.x;
RA   Nemoto T., Ohara-Nemoto Y., Ota M., Takagi T., Yokoyama K.;
RT   "Mechanism of dimer formation of the 90-kDa heat-shock protein.";
RL   Eur. J. Biochem. 233:1-8(1995).
RN   [20]
RP   IDENTIFICATION IN A COMPLEX WITH NR3C1 AND FKBP4; PPID; PPP5C OR
RP   STIP1.
RX   PubMed=9195923; DOI=10.1074/jbc.272.26.16224;
RA   Silverstein A.M., Galigniana M.D., Chen M.S., Owens-Grillo J.K.,
RA   Chinkers M., Pratt W.B.;
RT   "Protein phosphatase 5 is a major component of glucocorticoid
RT   receptor.hsp90 complexes with properties of an FK506-binding
RT   immunophilin.";
RL   J. Biol. Chem. 272:16224-16230(1997).
RN   [21]
RP   INTERACTION WITH TOM34.
RX   PubMed=9660753; DOI=10.1074/jbc.273.29.18007;
RA   Young J.C., Obermann W.M., Hartl F.U.;
RT   "Specific binding of tetratricopeptide repeat proteins to the C-
RT   terminal 12-kDa domain of hsp90.";
RL   J. Biol. Chem. 273:18007-18010(1998).
RN   [22]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [23]
RP   INTERACTION WITH TERT, AND FUNCTION AS A CO-CHAPERONE IN TELOMERASE
RP   HOLOENZYME ASSEMBLY.
RX   PubMed=11274138; DOI=10.1074/jbc.C100055200;
RA   Forsythe H.L., Jarvis J.L., Turner J.W., Elmore L.W., Holt S.E.;
RT   "Stable association of hsp90 and p23, but Not hsp70, with active human
RT   telomerase.";
RL   J. Biol. Chem. 276:15571-15574(2001).
RN   [24]
RP   INTERACTION WITH HSF1.
RX   PubMed=11583998; DOI=10.1074/jbc.M105931200;
RA   Guo Y., Guettouche T., Fenna M., Boellmann F., Pratt W.B., Toft D.O.,
RA   Smith D.F., Voellmy R.;
RT   "Evidence for a mechanism of repression of heat shock factor 1
RT   transcriptional activity by a multichaperone complex.";
RL   J. Biol. Chem. 276:45791-45799(2001).
RN   [25]
RP   FUNCTION, IDENTIFICATION AS LPS RECEPTOR, INTERACTION WITH CXCR4; GDF5
RP   AND HSPA8, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11276205; DOI=10.1038/86342;
RA   Triantafilou K., Triantafilou M., Dedrick R.L.;
RT   "A CD14-independent LPS receptor cluster.";
RL   Nat. Immunol. 2:338-345(2001).
RN   [26]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=12853476; DOI=10.1093/emboj/cdg362;
RA   Brychzy A., Rein T., Winklhofer K.F., Hartl F.U., Young J.C.,
RA   Obermann W.M.;
RT   "Cofactor Tpr2 combines two TPR domains and a J domain to regulate the
RT   Hsp70/Hsp90 chaperone system.";
RL   EMBO J. 22:3613-3623(2003).
RN   [27]
RP   INTERACTION WITH AHSA1.
RX   PubMed=12604615; DOI=10.1074/jbc.M212761200;
RA   Lotz G.P., Lin H., Harst A., Obermann W.M.J.;
RT   "Aha1 binds to the middle domain of Hsp90, contributes to client
RT   protein activation, and stimulates the ATPase activity of the
RT   molecular chaperone.";
RL   J. Biol. Chem. 278:17228-17235(2003).
RN   [28]
RP   INTERACTION WITH SMYD3.
RX   PubMed=15235609; DOI=10.1038/ncb1151;
RA   Hamamoto R., Furukawa Y., Morita M., Iimura Y., Silva F.P., Li M.,
RA   Yagyu R., Nakamura Y.;
RT   "SMYD3 encodes a histone methyltransferase involved in the
RT   proliferation of cancer cells.";
RL   Nat. Cell Biol. 6:731-740(2004).
RN   [29]
RP   INTERACTION WITH SGTA AND TTC1.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [30]
RP   INTERACTION WITH PPP5C, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15383005; DOI=10.1042/BJ20040690;
RA   Zeke T., Morrice N., Vazquez-Martin C., Cohen P.T.;
RT   "Human protein phosphatase 5 dissociates from heat-shock proteins and
RT   is proteolytically activated in response to arachidonic acid and the
RT   microtubule-depolymerizing drug nocodazole.";
RL   Biochem. J. 385:45-56(2005).
RN   [31]
RP   FUNCTION, AND INTERACTION WITH PPP5C.
RX   PubMed=15577939; DOI=10.1038/sj.emboj.7600496;
RA   Yang J., Roe S.M., Cliff M.J., Williams M.A., Ladbury J.E.,
RA   Cohen P.T., Barford D.;
RT   "Molecular basis for TPR domain-mediated regulation of protein
RT   phosphatase 5.";
RL   EMBO J. 24:1-10(2005).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [34]
RP   INTERACTION WITH PPP5C.
RX   PubMed=16531226; DOI=10.1016/j.str.2005.12.009;
RA   Cliff M.J., Harris R., Barford D., Ladbury J.E., Williams M.A.;
RT   "Conformational diversity in the TPR domain-mediated interaction of
RT   protein phosphatase 5 with Hsp90.";
RL   Structure 14:415-426(2006).
RN   [35]
RP   SUBUNIT, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=18400751; DOI=10.1074/jbc.M800540200;
RA   Richter K., Soroka J., Skalniak L., Leskovar A., Hessling M.,
RA   Reinstein J., Buchner J.;
RT   "Conserved conformational changes in the ATPase cycle of human
RT   Hsp90.";
RL   J. Biol. Chem. 283:17757-17765(2008).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [41]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [42]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [43]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-443; LYS-458; LYS-489 AND
RP   LYS-585, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [44]
RP   INTERACTION WITH CHORDC1.
RX   PubMed=19875381; DOI=10.1074/mcp.M900261-MCP200;
RA   Gano J.J., Simon J.A.;
RT   "A proteomic investigation of ligand-dependent HSP90 complexes reveals
RT   CHORDC1 as a novel ADP-dependent HSP90-interacting protein.";
RL   Mol. Cell. Proteomics 9:255-270(2010).
RN   [45]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [46]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [47]
RP   INTERACTION WITH FNIP1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17028174; DOI=10.1073/pnas.0603781103;
RA   Baba M., Hong S.-B., Sharma N., Warren M.B., Nickerson M.L.,
RA   Iwamatsu A., Esposito D., Gillette W.K., Hopkins R.F. III,
RA   Hartley J.L., Furihata M., Oishi S., Zhen W., Burke T.R. Jr.,
RA   Linehan W.M., Schmidt L.S., Zbar B.;
RT   "Folliculin encoded by the BHD gene interacts with a binding protein,
RT   FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:15552-15557(2006).
RN   [48]
RP   MUTAGENESIS OF GLY-97.
RX   PubMed=18256191; DOI=10.1242/dev.018150;
RA   Hawkins T.A., Haramis A.P., Etard C., Prodromou C., Vaughan C.K.,
RA   Ashworth R., Ray S., Behra M., Holder N., Talbot W.S., Pearl L.H.,
RA   Strahle U., Wilson S.W.;
RT   "The ATPase-dependent chaperoning activity of Hsp90a regulates thick
RT   filament formation and integration during skeletal muscle
RT   myofibrillogenesis.";
RL   Development 135:1147-1156(2008).
RN   [49]
RP   MUTAGENESIS OF CYS-598.
RX   PubMed=19696785; DOI=10.1038/embor.2009.153;
RA   Retzlaff M., Stahl M., Eberl H.C., Lagleder S., Beck J., Kessler H.,
RA   Buchner J.;
RT   "Hsp90 is regulated by a switch point in the C-terminal domain.";
RL   EMBO Rep. 10:1147-1153(2009).
RN   [50]
RP   INTERACTION WITH HSP90AB1.
RX   PubMed=20353823; DOI=10.1016/j.cellsig.2010.03.012;
RA   Cheng M.B., Zhang Y., Zhong X., Sutter B., Cao C.Y., Chen X.S.,
RA   Cheng X.K., Zhang Y., Xiao L., Shen Y.F.;
RT   "Stat1 mediates an auto-regulation of hsp90beta gene in heat shock
RT   response.";
RL   Cell. Signal. 22:1206-1213(2010).
RN   [51]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [52]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [53]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [54]
RP   INTERACTION WITH CDC37.
RX   PubMed=23569206; DOI=10.1074/jbc.M112.439257;
RA   Eckl J.M., Rutz D.A., Haslbeck V., Zierer B.K., Reinstein J.,
RA   Richter K.;
RT   "Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein
RT   90) motility by interaction with N-terminal and middle domain binding
RT   sites.";
RL   J. Biol. Chem. 288:16032-16042(2013).
RN   [55]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231; SER-252; SER-263;
RP   SER-476 AND SER-641, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [56]
RP   FUNCTION, AND INTERACTION WITH STUB1 AND SMAD3.
RX   PubMed=24613385; DOI=10.1016/j.bbrc.2014.02.124;
RA   Shang Y., Xu X., Duan X., Guo J., Wang Y., Ren F., He D., Chang Z.;
RT   "Hsp70 and Hsp90 oppositely regulate TGF-beta signaling through
RT   CHIP/Stub1.";
RL   Biochem. Biophys. Res. Commun. 446:387-392(2014).
RN   [57]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [58]
RP   INTERACTION WITH NWD1.
RX   PubMed=24681825;
RA   Correa R.G., Krajewska M., Ware C.F., Gerlic M., Reed J.C.;
RT   "The NLR-related protein NWD1 is associated with prostate cancer and
RT   modulates androgen receptor signaling.";
RL   Oncotarget 5:1666-1682(2014).
RN   [59]
RP   REVIEW.
RX   PubMed=25973397; DOI=10.3389/fonc.2015.00100;
RA   Khurana N., Bhattacharyya S.;
RT   "Hsp90, the concertmaster: tuning transcription.";
RL   Front. Oncol. 5:100-100(2015).
RN   [60]
RP   INTERACTION WITH SMYD3.
RX   PubMed=25738358; DOI=10.18632/oncotarget.2970;
RA   Brown M.A., Foreman K., Harriss J., Das C., Zhu L., Edwards M.,
RA   Shaaban S., Tucker H.;
RT   "C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif
RT   in oncogenesis.";
RL   Oncotarget 6:4005-4019(2015).
RN   [61]
RP   INTERACTION WITH HSF1; HIF1A; ERBB2; MET; KEAP1 AND RHOBTB2, AND
RP   MUTAGENESIS OF GLU-47 AND ASP-93.
RX   PubMed=26517842; DOI=10.1371/journal.pone.0141786;
RA   Prince T.L., Kijima T., Tatokoro M., Lee S., Tsutsumi S., Yim K.,
RA   Rivas C., Alarcon S., Schwartz H., Khamit-Kush K., Scroggins B.T.,
RA   Beebe K., Trepel J.B., Neckers L.;
RT   "Client proteins and small molecule inhibitors display distinct
RT   binding preferences for constitutive and stress-induced HSP90 isoforms
RT   and their conformationally restricted mutants.";
RL   PLoS ONE 10:E0141786-E0141786(2015).
RN   [62]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [63]
RP   REVIEW.
RX   PubMed=27295069; DOI=10.1016/j.biochi.2016.05.018;
RA   Verma S., Goyal S., Jamal S., Singh A., Grover A.;
RT   "Hsp90: Friends, clients and natural foes.";
RL   Biochimie 127:227-240(2016).
RN   [64]
RP   REVIEW.
RX   PubMed=26991466; DOI=10.1002/bip.22835;
RA   Pearl L.H.;
RT   "Review: The HSP90 molecular chaperone-an enigmatic ATPase.";
RL   Biopolymers 105:594-607(2016).
RN   [65]
RP   FUNCTION, AND INTERACTION WITH FLCN; AHSA1; HSP70; CDC37; FNIP1;
RP   FNIP2; STUB1; STIP1; PTGES3 AND PPP5C.
RX   PubMed=27353360; DOI=10.1038/ncomms12037;
RA   Woodford M.R., Dunn D.M., Blanden A.R., Capriotti D., Loiselle D.,
RA   Prodromou C., Panaretou B., Hughes P.F., Smith A., Ackerman W.,
RA   Haystead T.A., Loh S.N., Bourboulia D., Schmidt L.S.,
RA   Marston Linehan W., Bratslavsky G., Mollapour M.;
RT   "The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and
RT   enhance drug binding.";
RL   Nat. Commun. 7:12037-12037(2016).
RN   [66]
RP   INTERACTION WITH HSF1.
RX   PubMed=26754925; DOI=10.1038/srep19174;
RA   Asano Y., Kawase T., Okabe A., Tsutsumi S., Ichikawa H., Tatebe S.,
RA   Kitabayashi I., Tashiro F., Namiki H., Kondo T., Semba K.,
RA   Aburatani H., Taya Y., Nakagama H., Ohki R.;
RT   "IER5 generates a novel hypo-phosphorylated active form of HSF1 and
RT   contributes to tumorigenesis.";
RL   Sci. Rep. 6:19174-19174(2016).
RN   [67]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 11-223 IN COMPLEX WITH
RP   GELDANAMYCIN.
RX   PubMed=9108479; DOI=10.1016/S0092-8674(00)80203-2;
RA   Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl F.U.,
RA   Pavletich N.P.;
RT   "Crystal structure of an Hsp90-geldanamycin complex: targeting of a
RT   protein chaperone by an antitumor agent.";
RL   Cell 89:239-250(1997).
RN   [68]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 11-223 IN COMPLEX WITH ADP,
RP   CATALYTIC ACTIVITY, AND INTERACTION WITH PTGES3.
RX   PubMed=9817749; DOI=10.1083/jcb.143.4.901;
RA   Obermann W.M., Sondermann H., Russo A.A., Pavletich N.P., Hartl F.U.;
RT   "In vivo function of Hsp90 is dependent on ATP binding and ATP
RT   hydrolysis.";
RL   J. Cell Biol. 143:901-910(1998).
RN   [69]
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 724-732 IN COMPLEX WITH
RP   STUB1, INTERACTION WITH STUB1 AND UBE2N, AND MOTIF TPR REPEAT-BINDING.
RX   PubMed=16307917; DOI=10.1016/j.molcel.2005.09.023;
RA   Zhang M., Windheim M., Roe S.M., Peggie M., Cohen P., Prodromou C.,
RA   Pearl L.H.;
RT   "Chaperoned ubiquitylation -- crystal structures of the CHIP U box E3
RT   ubiquitin ligase and a CHIP-Ubc13-Uev1a complex.";
RL   Mol. Cell 20:525-538(2005).
CC   -!- FUNCTION: Molecular chaperone that promotes the maturation,
CC       structural maintenance and proper regulation of specific target
CC       proteins involved for instance in cell cycle control and signal
CC       transduction. Undergoes a functional cycle that is linked to its
CC       ATPase activity which is essential for its chaperone activity.
CC       This cycle probably induces conformational changes in the client
CC       proteins, thereby causing their activation. Interacts dynamically
CC       with various co-chaperones that modulate its substrate
CC       recognition, ATPase cycle and chaperone function (PubMed:11274138,
CC       PubMed:15577939, PubMed:15937123, PubMed:27353360). Engages with a
CC       range of client protein classes via its interaction with various
CC       co-chaperone proteins or complexes, that act as adapters,
CC       simultaneously able to interact with the specific client and the
CC       central chaperone itself. Recruitment of ATP and co-chaperone
CC       followed by client protein forms a functional chaperone. After the
CC       completion of the chaperoning process, properly folded client
CC       protein and co-chaperone leave HSP90 in an ADP-bound partially
CC       open conformation and finally, ADP is released from HSP90 which
CC       acquires an open conformation for the next cycle (PubMed:27295069,
CC       PubMed:26991466). Apart from its chaperone activity, it also plays
CC       a role in the regulation of the transcription machinery. HSP90 and
CC       its co-chaperones modulate transcription at least at three
CC       different levels. In the first place, they alter the steady-state
CC       levels of certain transcription factors in response to various
CC       physiological cues. Second, they modulate the activity of certain
CC       epigenetic modifiers, such as histone deacetylases or DNA methyl
CC       transferases, and thereby respond to the change in the
CC       environment. Third, they participate in the eviction of histones
CC       from the promoter region of certain genes and thereby turn on gene
CC       expression (PubMed:25973397). Binds bacterial lipopolysaccharide
CC       (LPS) and mediates LPS-induced inflammatory response, including
CC       TNF secretion by monocytes (PubMed:11276205). Antagonizes STUB1-
CC       mediated inhibition of TGF-beta signaling via inhibition of STUB1-
CC       mediated SMAD3 ubiquitination and degradation (PubMed:24613385).
CC       {ECO:0000269|PubMed:11274138, ECO:0000269|PubMed:11276205,
CC       ECO:0000269|PubMed:15577939, ECO:0000269|PubMed:15937123,
CC       ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27353360,
CC       ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466,
CC       ECO:0000303|PubMed:27295069}.
CC   -!- ENZYME REGULATION: In the resting state, through the dimerization
CC       of its C-terminal domain, HSP90 forms a homodimer which is defined
CC       as the open conformation. Upon ATP-binding, the N-terminal domain
CC       undergoes significant conformational changes and comes in contact
CC       to form an active closed conformation. After HSP90 finishes its
CC       chaperoning tasks of assisting the proper folding, stabilization
CC       and activation of client proteins under the active state, ATP
CC       molecule is hydrolyzed to ADP which then dissociates from HSP90
CC       and directs the protein back to the resting state.
CC       {ECO:0000269|PubMed:18400751}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=300 uM for ATP {ECO:0000269|PubMed:18400751};
CC   -!- SUBUNIT: Homodimer (PubMed:7588731, PubMed:8289821,
CC       PubMed:18400751). Identified in NR3C1/GCR steroid receptor-
CC       chaperone complexes formed at least by NR3C1, HSP90AA1 and a
CC       variety of proteins containing TPR repeats such as FKBP4, FKBP5,
CC       PPID, PPP5C or STIP1 (PubMed:15383005, PubMed:9195923). Interacts
CC       with TOM34 (PubMed:9660753). Interacts with TERT; the interaction,
CC       together with PTGES3, is required for correct assembly and
CC       stabilization of the TERT holoenzyme complex (PubMed:11274138,
CC       PubMed:9817749). Interacts with CHORDC1 and DNAJC7
CC       (PubMed:12853476, PubMed:19875381). Interacts with STUB1 and
CC       UBE2N; may couple the chaperone and ubiquitination systems
CC       (PubMed:16307917, PubMed:27353360). Interacts (via TPR repeat-
CC       binding motif) with PPP5C (via TPR repeats); the interaction is
CC       direct and activates PPP5C phosphatase activity (PubMed:15383005,
CC       PubMed:15577939, PubMed:16531226, PubMed:27353360). Following LPS
CC       binding, may form a complex with CXCR4, GDF5 and HSPA8
CC       (PubMed:11276205). Interacts with KSR1 (PubMed:10409742).
CC       Interacts with co-chaperone CDC37 (via C-terminus); the
CC       interaction inhibits HSP90AA1 ATPase activity (PubMed:23569206,
CC       PubMed:27353360). May interact with NWD1 (PubMed:24681825).
CC       Interacts with FNIP1 and FNIP2; the interaction inhibits HSP90AA1
CC       ATPase activity (PubMed:17028174, PubMed:27353360). Interacts with
CC       AHSA1; the interaction activates HSP90AA1 ATPase activity
CC       (PubMed:12604615, PubMed:27353360). Interacts with FLCN in the
CC       presence of FNIP1. Interacts with HSP70, STIP1 and PTGES3
CC       (PubMed:27353360). Interacts with SMYD3; this interaction enhances
CC       SMYD3 histone-lysine N-methyltransferase (PubMed:15235609,
CC       PubMed:25738358). Interacts with SGTA (via TPR repeats)
CC       (PubMed:15708368). Interacts with TTC1 (via TPR repeats)
CC       (PubMed:15708368). Interacts with HSF1 in an ATP-dependent manner
CC       (PubMed:11583998. PubMed:26517842). Interacts with MET; the
CC       interaction suppresses MET kinase activity. Interacts with ERBB2
CC       in an ATP-dependent manner; the interaction suppresses ERBB2
CC       kinase activity. Interacts with HIF1A, KEAP1 and RHOBTB2
CC       (PubMed:26517842). Interacts with HSF1; this interaction is
CC       decreased in a IER5-dependent manner, promoting HSF1 accumulation
CC       in the nucleus, homotrimerization and DNA-binding activities
CC       (PubMed:26754925). Interacts with STUB1 and SMAD3
CC       (PubMed:24613385). Interacts with HSP90AB1; interaction is
CC       constitutive (PubMed:20353823). Interacts with HECTD1 (via N-
CC       terminus) (By similarity). {ECO:0000250|UniProtKB:P07901,
CC       ECO:0000269|PubMed:10409742, ECO:0000269|PubMed:11274138,
CC       ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:11583998,
CC       ECO:0000269|PubMed:12604615, ECO:0000269|PubMed:12853476,
CC       ECO:0000269|PubMed:15235609, ECO:0000269|PubMed:15383005,
CC       ECO:0000269|PubMed:15577939, ECO:0000269|PubMed:15708368,
CC       ECO:0000269|PubMed:16307917, ECO:0000269|PubMed:16531226,
CC       ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18400751,
CC       ECO:0000269|PubMed:19875381, ECO:0000269|PubMed:20353823,
CC       ECO:0000269|PubMed:23569206, ECO:0000269|PubMed:24613385,
CC       ECO:0000269|PubMed:24681825, ECO:0000269|PubMed:25738358,
CC       ECO:0000269|PubMed:26517842, ECO:0000269|PubMed:26754925,
CC       ECO:0000269|PubMed:27353360, ECO:0000269|PubMed:7588731,
CC       ECO:0000269|PubMed:8289821, ECO:0000269|PubMed:9195923,
CC       ECO:0000269|PubMed:9660753, ECO:0000269|PubMed:9817749}.
CC   -!- INTERACTION:
CC       Self; NbExp=6; IntAct=EBI-296047, EBI-296047;
CC       O95433:AHSA1; NbExp=4; IntAct=EBI-296047, EBI-448610;
CC       Q8IWD4:CCDC117; NbExp=5; IntAct=EBI-296047, EBI-3387963;
CC       Q16543:CDC37; NbExp=14; IntAct=EBI-296047, EBI-295634;
CC       Q7L3B6:CDC37L1; NbExp=2; IntAct=EBI-296047, EBI-2841876;
CC       P50750:CDK9; NbExp=2; IntAct=EBI-296047, EBI-1383449;
CC       Q96G23:CERS2; NbExp=2; IntAct=EBI-296047, EBI-1057080;
CC       Q9UHD1:CHORDC1; NbExp=8; IntAct=EBI-296047, EBI-2550959;
CC       O15111:CHUK; NbExp=3; IntAct=EBI-296047, EBI-81249;
CC       P00533:EGFR; NbExp=5; IntAct=EBI-296047, EBI-297353;
CC       P04626:ERBB2; NbExp=5; IntAct=EBI-296047, EBI-641062;
CC       Q02790:FKBP4; NbExp=8; IntAct=EBI-296047, EBI-1047444;
CC       Q14318:FKBP8; NbExp=7; IntAct=EBI-296047, EBI-724839;
CC       Q6PK50:HSP90AB1; NbExp=2; IntAct=EBI-296047, EBI-9356629;
CC       Q9Y6K9:IKBKG; NbExp=3; IntAct=EBI-296047, EBI-81279;
CC       Q9UHH9:IP6K2; NbExp=2; IntAct=EBI-296047, EBI-747509;
CC       P05412:JUN; NbExp=4; IntAct=EBI-296047, EBI-852823;
CC       Q6VAB6:KSR2; NbExp=5; IntAct=EBI-296047, EBI-6424389;
CC       O43318-2:MAP3K7; NbExp=5; IntAct=EBI-296047, EBI-358700;
CC       P04150:NR3C1; NbExp=7; IntAct=EBI-296047, EBI-493507;
CC       Q8WVJ2:NUDCD2; NbExp=4; IntAct=EBI-296047, EBI-1052153;
CC       P43034:PAFAH1B1; NbExp=5; IntAct=EBI-296047, EBI-720620;
CC       P26882:PPID (xeno); NbExp=4; IntAct=EBI-296047, EBI-6477155;
CC       P53041:PPP5C; NbExp=11; IntAct=EBI-296047, EBI-716663;
CC       Q15185:PTGES3; NbExp=6; IntAct=EBI-296047, EBI-1049387;
CC       Q9H6T3:RPAP3; NbExp=6; IntAct=EBI-296047, EBI-356928;
CC       P61247:RPS3A; NbExp=3; IntAct=EBI-296047, EBI-352378;
CC       P35467:S100a1 (xeno); NbExp=4; IntAct=EBI-296047, EBI-6477109;
CC       Q15831:STK11; NbExp=2; IntAct=EBI-296047, EBI-306838;
CC       Q9UNE7:STUB1; NbExp=9; IntAct=EBI-296047, EBI-357085;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P07901}.
CC       Cytoplasm {ECO:0000250|UniProtKB:P07901}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Cell membrane
CC       {ECO:0000269|PubMed:11276205}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=HSP90AA1-1, HSP90-alpha 2;
CC         IsoId=P07900-1; Sequence=Displayed;
CC       Name=2; Synonyms=HSP90AA1-2;
CC         IsoId=P07900-2; Sequence=VSP_026604;
CC         Note=Variant in position: 71:M->L (in dbSNP:rs8005905).;
CC   -!- DOMAIN: The TPR repeat-binding motif mediates interaction with TPR
CC       repeat-containing proteins like the co-chaperone STUB1.
CC       {ECO:0000269|PubMed:16307917}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: S-nitrosylated; negatively regulates the ATPase activity and
CC       the activation of eNOS by HSP90AA1. {ECO:0000269|PubMed:15937123}.
CC   -!- PTM: Ubiquitinated via 'Lys-63'-linked polyubiquitination by
CC       HECTD1. Ubiquitination promotes translocation into the cytoplasm
CC       away from the membrane and secretory pathways.
CC       {ECO:0000250|UniProtKB:P07901}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 90 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X15183; CAA33259.1; -; mRNA.
DR   EMBL; M27024; AAA63194.1; -; Genomic_DNA.
DR   EMBL; AJ890082; CAI64495.1; -; mRNA.
DR   EMBL; AJ890083; CAI64496.1; -; mRNA.
DR   EMBL; DQ314871; ABC40730.1; -; Genomic_DNA.
DR   EMBL; AK056446; BAG51711.1; -; mRNA.
DR   EMBL; AK291115; BAF83804.1; -; mRNA.
DR   EMBL; AK291607; BAF84296.1; -; mRNA.
DR   EMBL; AL133223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81765.1; -; Genomic_DNA.
DR   EMBL; X07270; CAA30255.1; -; mRNA.
DR   EMBL; M30626; AAA36023.1; -; Genomic_DNA.
DR   EMBL; BC000987; AAH00987.1; -; mRNA.
DR   EMBL; BC121062; AAI21063.1; -; mRNA.
DR   EMBL; D87666; BAA13430.1; -; mRNA.
DR   EMBL; D87666; BAA13431.1; -; mRNA.
DR   CCDS; CCDS32160.1; -. [P07900-2]
DR   CCDS; CCDS9967.1; -. [P07900-1]
DR   PIR; A32319; HHHU86.
DR   RefSeq; NP_001017963.2; NM_001017963.2. [P07900-2]
DR   RefSeq; NP_005339.3; NM_005348.3. [P07900-1]
DR   UniGene; Hs.525600; -.
DR   PDB; 1BYQ; X-ray; 1.50 A; A=9-236.
DR   PDB; 1OSF; X-ray; 1.75 A; A=9-223.
DR   PDB; 1UY6; X-ray; 1.90 A; A=2-236.
DR   PDB; 1UY7; X-ray; 1.90 A; A=2-236.
DR   PDB; 1UY8; X-ray; 1.98 A; A=2-236.
DR   PDB; 1UY9; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYC; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYD; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYE; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYF; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYG; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYH; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYI; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYK; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYL; X-ray; 1.40 A; A=2-236.
DR   PDB; 1YC1; X-ray; 1.70 A; A=9-236.
DR   PDB; 1YC3; X-ray; 2.12 A; A=9-236.
DR   PDB; 1YC4; X-ray; 1.81 A; A=9-236.
DR   PDB; 1YER; X-ray; 1.65 A; A=9-236.
DR   PDB; 1YES; X-ray; 2.20 A; A=9-236.
DR   PDB; 1YET; X-ray; 1.90 A; A=9-236.
DR   PDB; 2BSM; X-ray; 2.05 A; A=2-236.
DR   PDB; 2BT0; X-ray; 1.90 A; A/B=2-236.
DR   PDB; 2BUG; NMR; -; B=728-732.
DR   PDB; 2BYH; X-ray; 1.90 A; A=11-236.
DR   PDB; 2BYI; X-ray; 1.60 A; A=11-236.
DR   PDB; 2BZ5; X-ray; 1.90 A; A/B=2-236.
DR   PDB; 2C2L; X-ray; 3.30 A; E/F/G/H=724-732.
DR   PDB; 2CCS; X-ray; 1.79 A; A=1-236.
DR   PDB; 2CCT; X-ray; 2.30 A; A=1-236.
DR   PDB; 2CCU; X-ray; 2.70 A; A=1-236.
DR   PDB; 2FWY; X-ray; 2.10 A; A=1-236.
DR   PDB; 2FWZ; X-ray; 2.10 A; A=1-236.
DR   PDB; 2H55; X-ray; 2.00 A; A=1-236.
DR   PDB; 2JJC; X-ray; 1.95 A; A=9-223.
DR   PDB; 2K5B; NMR; -; A=14-223.
DR   PDB; 2QF6; X-ray; 3.10 A; A/B/C/D=17-223.
DR   PDB; 2QFO; X-ray; 1.68 A; A/B=17-223.
DR   PDB; 2QG0; X-ray; 1.85 A; A/B=17-223.
DR   PDB; 2QG2; X-ray; 1.80 A; A=17-223.
DR   PDB; 2UWD; X-ray; 1.90 A; A=2-236.
DR   PDB; 2VCI; X-ray; 2.00 A; A=1-236.
DR   PDB; 2VCJ; X-ray; 2.50 A; A=1-236.
DR   PDB; 2WI1; X-ray; 2.30 A; A=1-236.
DR   PDB; 2WI2; X-ray; 2.09 A; A/B=1-236.
DR   PDB; 2WI3; X-ray; 1.90 A; A=1-236.
DR   PDB; 2WI4; X-ray; 2.40 A; A=1-236.
DR   PDB; 2WI5; X-ray; 2.10 A; A=1-236.
DR   PDB; 2WI6; X-ray; 2.18 A; A=1-236.
DR   PDB; 2WI7; X-ray; 2.50 A; A=1-236.
DR   PDB; 2XAB; X-ray; 1.90 A; A/B=9-236.
DR   PDB; 2XDK; X-ray; 1.97 A; A=9-236.
DR   PDB; 2XDL; X-ray; 1.98 A; A=9-236.
DR   PDB; 2XDS; X-ray; 1.97 A; A=9-236.
DR   PDB; 2XDU; X-ray; 1.74 A; A=14-224.
DR   PDB; 2XDX; X-ray; 2.42 A; A=9-236.
DR   PDB; 2XHR; X-ray; 2.20 A; A=9-236.
DR   PDB; 2XHT; X-ray; 2.27 A; A=9-236.
DR   PDB; 2XHX; X-ray; 2.80 A; A=9-236.
DR   PDB; 2XJG; X-ray; 2.25 A; A=9-236.
DR   PDB; 2XJJ; X-ray; 1.90 A; A/B=9-236.
DR   PDB; 2XJX; X-ray; 1.66 A; A=9-236.
DR   PDB; 2XK2; X-ray; 1.95 A; A=9-236.
DR   PDB; 2YE2; X-ray; 1.90 A; A=9-236.
DR   PDB; 2YE3; X-ray; 1.95 A; A=9-236.
DR   PDB; 2YE4; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YE5; X-ray; 1.73 A; A=9-236.
DR   PDB; 2YE6; X-ray; 2.56 A; A=9-236.
DR   PDB; 2YE7; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YE8; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YE9; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YEA; X-ray; 1.73 A; A=9-236.
DR   PDB; 2YEB; X-ray; 2.40 A; A=9-236.
DR   PDB; 2YEC; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YED; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YEE; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YEF; X-ray; 1.55 A; A=9-236.
DR   PDB; 2YEG; X-ray; 2.50 A; A/B=9-236.
DR   PDB; 2YEH; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YEI; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YEJ; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YI0; X-ray; 1.60 A; A=1-229.
DR   PDB; 2YI5; X-ray; 2.50 A; A=1-229.
DR   PDB; 2YI6; X-ray; 1.80 A; A=1-229.
DR   PDB; 2YI7; X-ray; 1.40 A; A=1-229.
DR   PDB; 2YJW; X-ray; 1.61 A; A=18-223.
DR   PDB; 2YJX; X-ray; 1.83 A; A=18-223.
DR   PDB; 2YK2; X-ray; 1.74 A; A=18-223.
DR   PDB; 2YK9; X-ray; 1.32 A; A=18-223.
DR   PDB; 2YKB; X-ray; 1.93 A; A=18-223.
DR   PDB; 2YKC; X-ray; 1.67 A; A=18-223.
DR   PDB; 2YKE; X-ray; 1.43 A; A=18-223.
DR   PDB; 2YKI; X-ray; 1.67 A; A=18-223.
DR   PDB; 2YKJ; X-ray; 1.46 A; A=18-223.
DR   PDB; 3B24; X-ray; 1.70 A; A/B=9-236.
DR   PDB; 3B25; X-ray; 1.75 A; A=9-236.
DR   PDB; 3B26; X-ray; 2.10 A; A/B=9-236.
DR   PDB; 3B27; X-ray; 1.50 A; A=9-236.
DR   PDB; 3B28; X-ray; 1.35 A; A/B=9-236.
DR   PDB; 3BM9; X-ray; 1.60 A; A=14-236.
DR   PDB; 3BMY; X-ray; 1.60 A; A=14-236.
DR   PDB; 3D0B; X-ray; 1.74 A; A=1-232.
DR   PDB; 3EKO; X-ray; 1.55 A; A/B=9-225.
DR   PDB; 3EKR; X-ray; 2.00 A; A/B=9-225.
DR   PDB; 3FT5; X-ray; 1.90 A; A=9-236.
DR   PDB; 3FT8; X-ray; 2.00 A; A=9-236.
DR   PDB; 3HEK; X-ray; 1.95 A; A/B=9-225.
DR   PDB; 3HHU; X-ray; 1.59 A; A/B=1-224.
DR   PDB; 3HYY; X-ray; 1.90 A; A=9-236.
DR   PDB; 3HYZ; X-ray; 2.30 A; A/B=9-236.
DR   PDB; 3HZ1; X-ray; 2.30 A; A=9-236.
DR   PDB; 3HZ5; X-ray; 1.90 A; A=9-236.
DR   PDB; 3INW; X-ray; 1.95 A; A=10-236.
DR   PDB; 3INX; X-ray; 1.75 A; A=10-236.
DR   PDB; 3K97; X-ray; 1.95 A; A=9-236.
DR   PDB; 3K98; X-ray; 2.40 A; A/B=9-225.
DR   PDB; 3K99; X-ray; 2.10 A; A/B/C/D=9-225.
DR   PDB; 3MNR; X-ray; 1.90 A; P=1-232.
DR   PDB; 3O0I; X-ray; 1.47 A; A=1-236.
DR   PDB; 3OW6; X-ray; 1.80 A; A=17-223.
DR   PDB; 3OWB; X-ray; 2.05 A; A=17-223.
DR   PDB; 3OWD; X-ray; 1.63 A; A=17-223.
DR   PDB; 3Q6M; X-ray; 3.00 A; A/B/C=293-732.
DR   PDB; 3Q6N; X-ray; 3.05 A; A/B/C/D/E/F=293-732.
DR   PDB; 3QDD; X-ray; 1.79 A; A=1-236.
DR   PDB; 3QTF; X-ray; 1.57 A; A=14-236.
DR   PDB; 3R4M; X-ray; 1.70 A; A=9-236.
DR   PDB; 3R4N; X-ray; 2.00 A; A/B=9-225.
DR   PDB; 3R4O; X-ray; 2.65 A; A/B=9-225.
DR   PDB; 3R4P; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3R91; X-ray; 1.58 A; A=14-236.
DR   PDB; 3R92; X-ray; 1.58 A; A=14-236.
DR   PDB; 3RKZ; X-ray; 1.57 A; A=14-236.
DR   PDB; 3RLP; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3RLQ; X-ray; 1.90 A; A/B=9-225.
DR   PDB; 3RLR; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3T0H; X-ray; 1.20 A; A=9-236.
DR   PDB; 3T0Z; X-ray; 2.19 A; A=9-236.
DR   PDB; 3T10; X-ray; 1.24 A; A=9-236.
DR   PDB; 3T1K; X-ray; 1.50 A; A/B=9-236.
DR   PDB; 3T2S; X-ray; 1.50 A; A/B=9-236.
DR   PDB; 3TUH; X-ray; 1.80 A; A/B=16-224.
DR   PDB; 3VHA; X-ray; 1.39 A; A=9-236.
DR   PDB; 3VHC; X-ray; 1.41 A; A=9-236.
DR   PDB; 3VHD; X-ray; 1.52 A; A/B=9-236.
DR   PDB; 3WHA; X-ray; 1.30 A; A/B=9-236.
DR   PDB; 3WQ9; X-ray; 1.80 A; A=1-236.
DR   PDB; 4AIF; X-ray; 2.01 A; D/E=726-732.
DR   PDB; 4AWO; X-ray; 1.70 A; A/B=9-236.
DR   PDB; 4AWP; X-ray; 1.82 A; A/B=9-236.
DR   PDB; 4AWQ; X-ray; 1.60 A; A/B=9-236.
DR   PDB; 4B7P; X-ray; 1.70 A; A=9-236.
DR   PDB; 4BQG; X-ray; 1.90 A; A=9-236.
DR   PDB; 4BQJ; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CGQ; X-ray; 2.00 A; Q=726-732.
DR   PDB; 4CGU; X-ray; 2.11 A; C=726-732.
DR   PDB; 4CGV; X-ray; 2.54 A; E/F=726-732.
DR   PDB; 4CGW; X-ray; 3.00 A; C/D=726-732.
DR   PDB; 4CWF; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWN; X-ray; 1.80 A; A=9-236.
DR   PDB; 4CWO; X-ray; 2.31 A; A=9-236.
DR   PDB; 4CWP; X-ray; 1.95 A; A=9-236.
DR   PDB; 4CWQ; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWR; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWS; X-ray; 2.30 A; A=9-236.
DR   PDB; 4CWT; X-ray; 1.90 A; A=9-236.
DR   PDB; 4EEH; X-ray; 1.60 A; A=9-236.
DR   PDB; 4EFT; X-ray; 2.12 A; A=9-236.
DR   PDB; 4EFU; X-ray; 2.00 A; A=9-236.
DR   PDB; 4EGH; X-ray; 1.60 A; A=9-236.
DR   PDB; 4EGI; X-ray; 1.79 A; A=9-236.
DR   PDB; 4EGK; X-ray; 1.69 A; A=9-236.
DR   PDB; 4FCP; X-ray; 2.00 A; A/B=1-236.
DR   PDB; 4FCQ; X-ray; 2.15 A; A=1-236.
DR   PDB; 4FCR; X-ray; 1.70 A; A=1-236.
DR   PDB; 4HY6; X-ray; 1.65 A; A=9-236.
DR   PDB; 4JQL; X-ray; 1.72 A; A=9-236.
DR   PDB; 4L8Z; X-ray; 1.70 A; A=9-236.
DR   PDB; 4L90; X-ray; 2.00 A; A=9-236.
DR   PDB; 4L91; X-ray; 1.75 A; A=9-236.
DR   PDB; 4L93; X-ray; 1.84 A; A/B=9-236.
DR   PDB; 4L94; X-ray; 1.65 A; A=9-236.
DR   PDB; 4LWE; X-ray; 1.50 A; A=17-224.
DR   PDB; 4LWF; X-ray; 1.75 A; A=17-224.
DR   PDB; 4LWG; X-ray; 1.60 A; A=17-224.
DR   PDB; 4LWH; X-ray; 1.70 A; A=16-224.
DR   PDB; 4LWI; X-ray; 1.70 A; A=17-224.
DR   PDB; 4NH7; X-ray; 2.00 A; A/B=9-236.
DR   PDB; 4NH8; X-ray; 1.65 A; A=9-236.
DR   PDB; 4O04; X-ray; 1.82 A; A=9-236.
DR   PDB; 4O05; X-ray; 1.79 A; A=9-236.
DR   PDB; 4O07; X-ray; 1.86 A; A=9-236.
DR   PDB; 4O09; X-ray; 1.96 A; A=9-236.
DR   PDB; 4O0B; X-ray; 1.93 A; A=9-236.
DR   PDB; 4R3M; X-ray; 1.80 A; A=16-224.
DR   PDB; 4U93; X-ray; 1.55 A; A=1-236.
DR   PDB; 4W7T; X-ray; 1.80 A; A=1-236.
DR   PDB; 4XIP; X-ray; 1.70 A; A=9-236.
DR   PDB; 4XIQ; X-ray; 1.84 A; A=9-236.
DR   PDB; 4XIR; X-ray; 1.70 A; A=9-236.
DR   PDB; 4XIT; X-ray; 1.86 A; A=9-236.
DR   PDB; 4YKQ; X-ray; 1.91 A; A=2-236.
DR   PDB; 4YKR; X-ray; 1.61 A; A=2-236.
DR   PDB; 4YKT; X-ray; 1.85 A; A=2-236.
DR   PDB; 4YKU; X-ray; 1.70 A; A=2-236.
DR   PDB; 4YKW; X-ray; 1.85 A; A/B=2-236.
DR   PDB; 4YKX; X-ray; 1.80 A; A=2-236.
DR   PDB; 4YKY; X-ray; 1.78 A; A=2-236.
DR   PDB; 4YKZ; X-ray; 1.85 A; A=2-236.
DR   PDB; 5CF0; X-ray; 1.80 A; A=9-236.
DR   PDB; 5FNC; X-ray; 2.20 A; A=1-236.
DR   PDB; 5FND; X-ray; 2.00 A; A=1-236.
DR   PDB; 5FNF; X-ray; 2.10 A; A=1-236.
DR   PDB; 5GGZ; X-ray; 2.02 A; A/B/C/D=16-225.
DR   PDB; 5J20; X-ray; 1.76 A; A=17-223.
DR   PDB; 5J27; X-ray; 1.70 A; A=16-224.
DR   PDB; 5J2V; X-ray; 1.59 A; A=17-223.
DR   PDB; 5J2X; X-ray; 1.22 A; A=17-224.
DR   PDB; 5J64; X-ray; 1.38 A; A=9-236.
DR   PDB; 5J6L; X-ray; 1.75 A; A=9-236.
DR   PDB; 5J6M; X-ray; 1.64 A; A=9-234.
DR   PDB; 5J6N; X-ray; 1.90 A; A=9-234.
DR   PDB; 5J80; X-ray; 1.17 A; A=9-233.
DR   PDB; 5J82; X-ray; 2.17 A; A=9-233.
DR   PDB; 5J86; X-ray; 1.87 A; A=9-233.
DR   PDB; 5J8M; X-ray; 1.90 A; A/B=9-233.
DR   PDB; 5J8U; X-ray; 1.75 A; A/B=9-233.
DR   PDB; 5J9X; X-ray; 1.80 A; A=9-233.
DR   PDB; 5LNY; X-ray; 1.88 A; A=9-236.
DR   PDB; 5LNZ; X-ray; 1.54 A; A=9-236.
DR   PDB; 5LO0; X-ray; 2.30 A; A=9-236.
DR   PDB; 5LO1; X-ray; 2.70 A; A=9-236.
DR   PDB; 5LO5; X-ray; 1.44 A; A=9-236.
DR   PDB; 5LO6; X-ray; 2.40 A; A=9-236.
DR   PDB; 5LQ9; X-ray; 1.90 A; A=17-223.
DR   PDB; 5LR1; X-ray; 1.44 A; A=18-223.
DR   PDB; 5LR7; X-ray; 1.86 A; A=18-223.
DR   PDB; 5LRL; X-ray; 1.33 A; A=18-223.
DR   PDB; 5LRZ; X-ray; 2.00 A; A=18-223.
DR   PDB; 5LS1; X-ray; 1.85 A; A=17-223.
DR   PDB; 5M4E; X-ray; 1.90 A; A=9-236.
DR   PDB; 5M4H; X-ray; 2.00 A; A=9-236.
DR   PDB; 5T21; X-ray; 2.10 A; A=18-223.
DR   PDBsum; 1BYQ; -.
DR   PDBsum; 1OSF; -.
DR   PDBsum; 1UY6; -.
DR   PDBsum; 1UY7; -.
DR   PDBsum; 1UY8; -.
DR   PDBsum; 1UY9; -.
DR   PDBsum; 1UYC; -.
DR   PDBsum; 1UYD; -.
DR   PDBsum; 1UYE; -.
DR   PDBsum; 1UYF; -.
DR   PDBsum; 1UYG; -.
DR   PDBsum; 1UYH; -.
DR   PDBsum; 1UYI; -.
DR   PDBsum; 1UYK; -.
DR   PDBsum; 1UYL; -.
DR   PDBsum; 1YC1; -.
DR   PDBsum; 1YC3; -.
DR   PDBsum; 1YC4; -.
DR   PDBsum; 1YER; -.
DR   PDBsum; 1YES; -.
DR   PDBsum; 1YET; -.
DR   PDBsum; 2BSM; -.
DR   PDBsum; 2BT0; -.
DR   PDBsum; 2BUG; -.
DR   PDBsum; 2BYH; -.
DR   PDBsum; 2BYI; -.
DR   PDBsum; 2BZ5; -.
DR   PDBsum; 2C2L; -.
DR   PDBsum; 2CCS; -.
DR   PDBsum; 2CCT; -.
DR   PDBsum; 2CCU; -.
DR   PDBsum; 2FWY; -.
DR   PDBsum; 2FWZ; -.
DR   PDBsum; 2H55; -.
DR   PDBsum; 2JJC; -.
DR   PDBsum; 2K5B; -.
DR   PDBsum; 2QF6; -.
DR   PDBsum; 2QFO; -.
DR   PDBsum; 2QG0; -.
DR   PDBsum; 2QG2; -.
DR   PDBsum; 2UWD; -.
DR   PDBsum; 2VCI; -.
DR   PDBsum; 2VCJ; -.
DR   PDBsum; 2WI1; -.
DR   PDBsum; 2WI2; -.
DR   PDBsum; 2WI3; -.
DR   PDBsum; 2WI4; -.
DR   PDBsum; 2WI5; -.
DR   PDBsum; 2WI6; -.
DR   PDBsum; 2WI7; -.
DR   PDBsum; 2XAB; -.
DR   PDBsum; 2XDK; -.
DR   PDBsum; 2XDL; -.
DR   PDBsum; 2XDS; -.
DR   PDBsum; 2XDU; -.
DR   PDBsum; 2XDX; -.
DR   PDBsum; 2XHR; -.
DR   PDBsum; 2XHT; -.
DR   PDBsum; 2XHX; -.
DR   PDBsum; 2XJG; -.
DR   PDBsum; 2XJJ; -.
DR   PDBsum; 2XJX; -.
DR   PDBsum; 2XK2; -.
DR   PDBsum; 2YE2; -.
DR   PDBsum; 2YE3; -.
DR   PDBsum; 2YE4; -.
DR   PDBsum; 2YE5; -.
DR   PDBsum; 2YE6; -.
DR   PDBsum; 2YE7; -.
DR   PDBsum; 2YE8; -.
DR   PDBsum; 2YE9; -.
DR   PDBsum; 2YEA; -.
DR   PDBsum; 2YEB; -.
DR   PDBsum; 2YEC; -.
DR   PDBsum; 2YED; -.
DR   PDBsum; 2YEE; -.
DR   PDBsum; 2YEF; -.
DR   PDBsum; 2YEG; -.
DR   PDBsum; 2YEH; -.
DR   PDBsum; 2YEI; -.
DR   PDBsum; 2YEJ; -.
DR   PDBsum; 2YI0; -.
DR   PDBsum; 2YI5; -.
DR   PDBsum; 2YI6; -.
DR   PDBsum; 2YI7; -.
DR   PDBsum; 2YJW; -.
DR   PDBsum; 2YJX; -.
DR   PDBsum; 2YK2; -.
DR   PDBsum; 2YK9; -.
DR   PDBsum; 2YKB; -.
DR   PDBsum; 2YKC; -.
DR   PDBsum; 2YKE; -.
DR   PDBsum; 2YKI; -.
DR   PDBsum; 2YKJ; -.
DR   PDBsum; 3B24; -.
DR   PDBsum; 3B25; -.
DR   PDBsum; 3B26; -.
DR   PDBsum; 3B27; -.
DR   PDBsum; 3B28; -.
DR   PDBsum; 3BM9; -.
DR   PDBsum; 3BMY; -.
DR   PDBsum; 3D0B; -.
DR   PDBsum; 3EKO; -.
DR   PDBsum; 3EKR; -.
DR   PDBsum; 3FT5; -.
DR   PDBsum; 3FT8; -.
DR   PDBsum; 3HEK; -.
DR   PDBsum; 3HHU; -.
DR   PDBsum; 3HYY; -.
DR   PDBsum; 3HYZ; -.
DR   PDBsum; 3HZ1; -.
DR   PDBsum; 3HZ5; -.
DR   PDBsum; 3INW; -.
DR   PDBsum; 3INX; -.
DR   PDBsum; 3K97; -.
DR   PDBsum; 3K98; -.
DR   PDBsum; 3K99; -.
DR   PDBsum; 3MNR; -.
DR   PDBsum; 3O0I; -.
DR   PDBsum; 3OW6; -.
DR   PDBsum; 3OWB; -.
DR   PDBsum; 3OWD; -.
DR   PDBsum; 3Q6M; -.
DR   PDBsum; 3Q6N; -.
DR   PDBsum; 3QDD; -.
DR   PDBsum; 3QTF; -.
DR   PDBsum; 3R4M; -.
DR   PDBsum; 3R4N; -.
DR   PDBsum; 3R4O; -.
DR   PDBsum; 3R4P; -.
DR   PDBsum; 3R91; -.
DR   PDBsum; 3R92; -.
DR   PDBsum; 3RKZ; -.
DR   PDBsum; 3RLP; -.
DR   PDBsum; 3RLQ; -.
DR   PDBsum; 3RLR; -.
DR   PDBsum; 3T0H; -.
DR   PDBsum; 3T0Z; -.
DR   PDBsum; 3T10; -.
DR   PDBsum; 3T1K; -.
DR   PDBsum; 3T2S; -.
DR   PDBsum; 3TUH; -.
DR   PDBsum; 3VHA; -.
DR   PDBsum; 3VHC; -.
DR   PDBsum; 3VHD; -.
DR   PDBsum; 3WHA; -.
DR   PDBsum; 3WQ9; -.
DR   PDBsum; 4AIF; -.
DR   PDBsum; 4AWO; -.
DR   PDBsum; 4AWP; -.
DR   PDBsum; 4AWQ; -.
DR   PDBsum; 4B7P; -.
DR   PDBsum; 4BQG; -.
DR   PDBsum; 4BQJ; -.
DR   PDBsum; 4CGQ; -.
DR   PDBsum; 4CGU; -.
DR   PDBsum; 4CGV; -.
DR   PDBsum; 4CGW; -.
DR   PDBsum; 4CWF; -.
DR   PDBsum; 4CWN; -.
DR   PDBsum; 4CWO; -.
DR   PDBsum; 4CWP; -.
DR   PDBsum; 4CWQ; -.
DR   PDBsum; 4CWR; -.
DR   PDBsum; 4CWS; -.
DR   PDBsum; 4CWT; -.
DR   PDBsum; 4EEH; -.
DR   PDBsum; 4EFT; -.
DR   PDBsum; 4EFU; -.
DR   PDBsum; 4EGH; -.
DR   PDBsum; 4EGI; -.
DR   PDBsum; 4EGK; -.
DR   PDBsum; 4FCP; -.
DR   PDBsum; 4FCQ; -.
DR   PDBsum; 4FCR; -.
DR   PDBsum; 4HY6; -.
DR   PDBsum; 4JQL; -.
DR   PDBsum; 4L8Z; -.
DR   PDBsum; 4L90; -.
DR   PDBsum; 4L91; -.
DR   PDBsum; 4L93; -.
DR   PDBsum; 4L94; -.
DR   PDBsum; 4LWE; -.
DR   PDBsum; 4LWF; -.
DR   PDBsum; 4LWG; -.
DR   PDBsum; 4LWH; -.
DR   PDBsum; 4LWI; -.
DR   PDBsum; 4NH7; -.
DR   PDBsum; 4NH8; -.
DR   PDBsum; 4O04; -.
DR   PDBsum; 4O05; -.
DR   PDBsum; 4O07; -.
DR   PDBsum; 4O09; -.
DR   PDBsum; 4O0B; -.
DR   PDBsum; 4R3M; -.
DR   PDBsum; 4U93; -.
DR   PDBsum; 4W7T; -.
DR   PDBsum; 4XIP; -.
DR   PDBsum; 4XIQ; -.
DR   PDBsum; 4XIR; -.
DR   PDBsum; 4XIT; -.
DR   PDBsum; 4YKQ; -.
DR   PDBsum; 4YKR; -.
DR   PDBsum; 4YKT; -.
DR   PDBsum; 4YKU; -.
DR   PDBsum; 4YKW; -.
DR   PDBsum; 4YKX; -.
DR   PDBsum; 4YKY; -.
DR   PDBsum; 4YKZ; -.
DR   PDBsum; 5CF0; -.
DR   PDBsum; 5FNC; -.
DR   PDBsum; 5FND; -.
DR   PDBsum; 5FNF; -.
DR   PDBsum; 5GGZ; -.
DR   PDBsum; 5J20; -.
DR   PDBsum; 5J27; -.
DR   PDBsum; 5J2V; -.
DR   PDBsum; 5J2X; -.
DR   PDBsum; 5J64; -.
DR   PDBsum; 5J6L; -.
DR   PDBsum; 5J6M; -.
DR   PDBsum; 5J6N; -.
DR   PDBsum; 5J80; -.
DR   PDBsum; 5J82; -.
DR   PDBsum; 5J86; -.
DR   PDBsum; 5J8M; -.
DR   PDBsum; 5J8U; -.
DR   PDBsum; 5J9X; -.
DR   PDBsum; 5LNY; -.
DR   PDBsum; 5LNZ; -.
DR   PDBsum; 5LO0; -.
DR   PDBsum; 5LO1; -.
DR   PDBsum; 5LO5; -.
DR   PDBsum; 5LO6; -.
DR   PDBsum; 5LQ9; -.
DR   PDBsum; 5LR1; -.
DR   PDBsum; 5LR7; -.
DR   PDBsum; 5LRL; -.
DR   PDBsum; 5LRZ; -.
DR   PDBsum; 5LS1; -.
DR   PDBsum; 5M4E; -.
DR   PDBsum; 5M4H; -.
DR   PDBsum; 5T21; -.
DR   ProteinModelPortal; P07900; -.
DR   SMR; P07900; -.
DR   BioGrid; 109552; 820.
DR   CORUM; P07900; -.
DR   DIP; DIP-27595N; -.
DR   IntAct; P07900; 240.
DR   MINT; P07900; -.
DR   STRING; 9606.ENSP00000335153; -.
DR   BindingDB; P07900; -.
DR   ChEMBL; CHEMBL3880; -.
DR   DrugBank; DB07317; (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one.
DR   DrugBank; DB03080; 17-Dmag.
DR   DrugBank; DB08786; 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine.
DR   DrugBank; DB03809; 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine.
DR   DrugBank; DB03899; 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine.
DR   DrugBank; DB05134; CNF1010.
DR   DrugBank; DB02424; Geldanamycin.
DR   DrugBank; DB07325; N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE.
DR   DrugBank; DB00716; Nedocromil.
DR   DrugBank; DB00615; Rifabutin.
DR   DrugBank; DB06070; SNX-5422.
DR   GuidetoPHARMACOLOGY; 2905; -.
DR   CarbonylDB; P07900; -.
DR   iPTMnet; P07900; -.
DR   PhosphoSitePlus; P07900; -.
DR   SwissPalm; P07900; -.
DR   BioMuta; HSP90AA1; -.
DR   DMDM; 92090606; -.
DR   OGP; P07900; -.
DR   REPRODUCTION-2DPAGE; IPI00784295; -.
DR   EPD; P07900; -.
DR   MaxQB; P07900; -.
DR   PaxDb; P07900; -.
DR   PeptideAtlas; P07900; -.
DR   PRIDE; P07900; -.
DR   TopDownProteomics; P07900-1; -. [P07900-1]
DR   Ensembl; ENST00000216281; ENSP00000216281; ENSG00000080824. [P07900-1]
DR   Ensembl; ENST00000334701; ENSP00000335153; ENSG00000080824. [P07900-2]
DR   GeneID; 3320; -.
DR   KEGG; hsa:3320; -.
DR   UCSC; uc001yku.5; human. [P07900-1]
DR   CTD; 3320; -.
DR   DisGeNET; 3320; -.
DR   EuPathDB; HostDB:ENSG00000080824.18; -.
DR   GeneCards; HSP90AA1; -.
DR   HGNC; HGNC:5253; HSP90AA1.
DR   HPA; CAB002058; -.
DR   MIM; 140571; gene.
DR   neXtProt; NX_P07900; -.
DR   OpenTargets; ENSG00000080824; -.
DR   PharmGKB; PA29519; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   GeneTree; ENSGT00910000144050; -.
DR   HOVERGEN; HBG007374; -.
DR   InParanoid; P07900; -.
DR   KO; K04079; -.
DR   OMA; YESFGKN; -.
DR   OrthoDB; EOG091G0270; -.
DR   PhylomeDB; P07900; -.
DR   TreeFam; TF300686; -.
DR   Reactome; R-HSA-1227986; Signaling by ERBB2.
DR   Reactome; R-HSA-1236382; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants.
DR   Reactome; R-HSA-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-HSA-192905; vRNP Assembly.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-203615; eNOS activation.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-3000484; Scavenging by Class F Receptors.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371511; HSF1 activation.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-5336415; Uptake and function of diphtheria toxin.
DR   Reactome; R-HSA-5601884; PIWI-interacting RNA (piRNA) biogenesis.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5637810; Constitutive Signaling by EGFRvIII.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   SIGNOR; P07900; -.
DR   ChiTaRS; HSP90AA1; human.
DR   EvolutionaryTrace; P07900; -.
DR   GenomeRNAi; 3320; -.
DR   PMAP-CutDB; P07900; -.
DR   PRO; PR:P07900; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000080824; -.
DR   CleanEx; HS_HSP90AA1; -.
DR   ExpressionAtlas; P07900; baseline and differential.
DR   Genevisible; P07900; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:CAFA.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0071682; C:endocytic vesicle lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IEA:Ensembl.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0070182; F:DNA polymerase binding; IPI:BHF-UCL.
DR   GO; GO:0051020; F:GTPase binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0030235; F:nitric-oxide synthase regulator activity; IDA:UniProtKB.
DR   GO; GO:0000166; F:nucleotide binding; TAS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; TAS:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; EXP:Reactome.
DR   GO; GO:1990782; F:protein tyrosine kinase binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:UniProtKB.
DR   GO; GO:0030911; F:TPR domain binding; IDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IDA:BHF-UCL.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0051186; P:cofactor metabolic process; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0038128; P:ERBB2 signaling pathway; TAS:Reactome.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0006839; P:mitochondrial transport; TAS:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IDA:BHF-UCL.
DR   GO; GO:0045040; P:protein import into mitochondrial outer membrane; IDA:BHF-UCL.
DR   GO; GO:0042026; P:protein refolding; TAS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   GO; GO:0043335; P:protein unfolding; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome.
DR   GO; GO:0043254; P:regulation of protein complex assembly; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0046677; P:response to antibiotic; ISS:AgBase.
DR   GO; GO:0009409; P:response to cold; ISS:AgBase.
DR   GO; GO:0009408; P:response to heat; ISS:AgBase.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   GO; GO:1905323; P:telomerase holoenzyme complex assembly; IDA:BHF-UCL.
DR   GO; GO:0007004; P:telomere maintenance via telomerase; IDA:BHF-UCL.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell membrane; Chaperone; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Membrane; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; S-nitrosylation; Stress response;
KW   Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:2492519}.
FT   CHAIN         2    732       Heat shock protein HSP 90-alpha.
FT                                /FTId=PRO_0000062911.
FT   REGION      284    732       Interaction with FLCN and FNIP1.
FT                                {ECO:0000269|PubMed:27353360}.
FT   REGION      284    620       Interaction with FNIP2.
FT                                {ECO:0000269|PubMed:27353360}.
FT   REGION      682    732       Required for homodimerization.
FT                                {ECO:0000269|PubMed:8289821}.
FT   REGION      728    732       Essential for interaction with SMYD3.
FT                                {ECO:0000269|PubMed:25738358}.
FT   REGION      729    732       Essential for interaction with SGTA and
FT                                TTC1. {ECO:0000269|PubMed:15708368}.
FT   MOTIF       723    732       TPR repeat-binding.
FT                                {ECO:0000269|PubMed:16307917}.
FT   BINDING      51     51       ATP.
FT   BINDING      93     93       ATP.
FT   BINDING     112    112       ATP. {ECO:0000250}.
FT   BINDING     138    138       ATP; via amide nitrogen.
FT   BINDING     400    400       ATP. {ECO:0000250}.
FT   MOD_RES       5      5       Phosphothreonine; by PRKDC.
FT                                {ECO:0000269|PubMed:2507541}.
FT   MOD_RES       7      7       Phosphothreonine; by PRKDC.
FT                                {ECO:0000269|PubMed:2507541}.
FT   MOD_RES      58     58       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P07901}.
FT   MOD_RES      84     84       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P07901}.
FT   MOD_RES     231    231       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:2492519}.
FT   MOD_RES     252    252       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     263    263       Phosphoserine.
FT                                {ECO:0000244|PubMed:16807684,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:2492519}.
FT   MOD_RES     313    313       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P07901}.
FT   MOD_RES     443    443       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     453    453       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P82995}.
FT   MOD_RES     458    458       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     476    476       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     489    489       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     492    492       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P07901}.
FT   MOD_RES     585    585       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     598    598       S-nitrosocysteine.
FT                                {ECO:0000269|PubMed:15937123}.
FT   MOD_RES     641    641       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1      1       M -> MPPCSGGDGSTPPGPSLRDRDCPAQSAEYPRDRLDP
FT                                RPGSPSEASSPPFLRSRAPVNWYQEKAQVFLWHLMVSGSTT
FT                                LLCLWKQPFHVSAFPVTASLAFRQSQGAGQHLYKDLQPFIL
FT                                LRLLM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:16269234}.
FT                                /FTId=VSP_026604.
FT   MUTAGEN      47     47       E->A: Strong ATP-binding. Strong
FT                                interaction with HSF1, HIF1A, ERBB2, MET,
FT                                KEAP1 and RHOBTB2.
FT                                {ECO:0000269|PubMed:26517842}.
FT   MUTAGEN      93     93       D->A: Impaired ATP-binding. Strong
FT                                interaction with HIF1A, MET, KEAP1 and
FT                                RHOBTB2. Loss of interaction with HSF1
FT                                and ERBB2. {ECO:0000269|PubMed:26517842}.
FT   MUTAGEN      97     97       G->D: Abolishes ATPase activity.
FT                                {ECO:0000269|PubMed:18256191}.
FT   MUTAGEN     598    598       C->A,N,D: Reduces ATPase activity and
FT                                client protein activation.
FT                                {ECO:0000269|PubMed:15937123,
FT                                ECO:0000269|PubMed:19696785}.
FT   MUTAGEN     598    598       C->S: Loss of S-nitrosylation.
FT                                {ECO:0000269|PubMed:15937123,
FT                                ECO:0000269|PubMed:19696785}.
FT   CONFLICT     63     63       S -> T (in Ref. 1; CAA33259).
FT                                {ECO:0000305}.
FT   CONFLICT     74     74       K -> R (in Ref. 4; CAI64495 and 6;
FT                                BAG51711). {ECO:0000305}.
FT   CONFLICT     86     86       D -> G (in Ref. 4; CAI64495 and 6;
FT                                BAG51711). {ECO:0000305}.
FT   CONFLICT    162    162       W -> D (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       18     21       {ECO:0000244|PDB:5J80}.
FT   HELIX        24     35       {ECO:0000244|PDB:5J80}.
FT   HELIX        43     65       {ECO:0000244|PDB:5J80}.
FT   HELIX        67     70       {ECO:0000244|PDB:5J80}.
FT   STRAND       78     83       {ECO:0000244|PDB:5J80}.
FT   TURN         84     87       {ECO:0000244|PDB:5J80}.
FT   STRAND       88     93       {ECO:0000244|PDB:5J80}.
FT   HELIX       100    104       {ECO:0000244|PDB:5J80}.
FT   TURN        105    108       {ECO:0000244|PDB:5J80}.
FT   HELIX       111    123       {ECO:0000244|PDB:5J80}.
FT   HELIX       128    134       {ECO:0000244|PDB:5J80}.
FT   HELIX       137    143       {ECO:0000244|PDB:5J80}.
FT   STRAND      145    153       {ECO:0000244|PDB:5J80}.
FT   STRAND      155    157       {ECO:0000244|PDB:2WI6}.
FT   STRAND      160    164       {ECO:0000244|PDB:5J80}.
FT   STRAND      169    174       {ECO:0000244|PDB:5J80}.
FT   STRAND      181    190       {ECO:0000244|PDB:5J80}.
FT   HELIX       192    198       {ECO:0000244|PDB:5J80}.
FT   HELIX       200    210       {ECO:0000244|PDB:5J80}.
FT   STRAND      212    216       {ECO:0000244|PDB:3VHC}.
FT   STRAND      218    220       {ECO:0000244|PDB:5J80}.
FT   TURN        221    224       {ECO:0000244|PDB:3T1K}.
FT   STRAND      225    227       {ECO:0000244|PDB:3T1K}.
FT   HELIX       228    230       {ECO:0000244|PDB:2XJX}.
FT   HELIX       296    298       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       306    317       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      324    331       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      333    335       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      337    343       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      361    365       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      368    372       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       380    382       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      386    392       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       408    427       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       431    451       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       453    455       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       456    460       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      464    467       {ECO:0000244|PDB:3Q6M}.
FT   TURN        468    472       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       477    482       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      490    495       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       499    503       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       506    508       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       509    514       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      518    521       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       525    529       {ECO:0000244|PDB:3Q6M}.
FT   TURN        530    532       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      539    543       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       555    567       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       569    578       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       580    582       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      584    588       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      593    601       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      603    605       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       608    613       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      632    636       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       641    652       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       657    673       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       681    694       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      728    730       {ECO:0000244|PDB:4CGW}.
SQ   SEQUENCE   732 AA;  84660 MW;  969F65FCC0BC86FD CRC64;
     MPEETQTQDQ PMEEEEVETF AFQAEIAQLM SLIINTFYSN KEIFLRELIS NSSDALDKIR
     YESLTDPSKL DSGKELHINL IPNKQDRTLT IVDTGIGMTK ADLINNLGTI AKSGTKAFME
     ALQAGADISM IGQFGVGFYS AYLVAEKVTV ITKHNDDEQY AWESSAGGSF TVRTDTGEPM
     GRGTKVILHL KEDQTEYLEE RRIKEIVKKH SQFIGYPITL FVEKERDKEV SDDEAEEKED
     KEEEKEKEEK ESEDKPEIED VGSDEEEEKK DGDKKKKKKI KEKYIDQEEL NKTKPIWTRN
     PDDITNEEYG EFYKSLTNDW EDHLAVKHFS VEGQLEFRAL LFVPRRAPFD LFENRKKKNN
     IKLYVRRVFI MDNCEELIPE YLNFIRGVVD SEDLPLNISR EMLQQSKILK VIRKNLVKKC
     LELFTELAED KENYKKFYEQ FSKNIKLGIH EDSQNRKKLS ELLRYYTSAS GDEMVSLKDY
     CTRMKENQKH IYYITGETKD QVANSAFVER LRKHGLEVIY MIEPIDEYCV QQLKEFEGKT
     LVSVTKEGLE LPEDEEEKKK QEEKKTKFEN LCKIMKDILE KKVEKVVVSN RLVTSPCCIV
     TSTYGWTANM ERIMKAQALR DNSTMGYMAA KKHLEINPDH SIIETLRQKA EADKNDKSVK
     DLVILLYETA LLSSGFSLED PQTHANRIYR MIKLGLGIDE DDPTADDTSA AVTEEMPPLE
     GDDDTSRMEE VD
//
ID   Q86SX1_HUMAN            Unreviewed;       262 AA.
AC   Q86SX1;
DT   01-JUN-2003, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2003, sequence version 1.
DT   31-JAN-2018, entry version 93.
DE   SubName: Full=Full-length cDNA 5-PRIME end of clone CS0DN005YI08 of Adult brain of Homo sapiens (human) {ECO:0000313|EMBL:CAD66568.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAD66568.1};
RN   [1] {ECO:0000313|EMBL:CAD66568.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adult brain {ECO:0000313|EMBL:CAD66568.1};
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:CAD66568.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adult brain {ECO:0000313|EMBL:CAD66568.1};
RA   Genoscope;
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX248761; CAD66568.1; -; mRNA.
DR   RefSeq; NP_001017963.2; NM_001017963.2.
DR   UniGene; Hs.525600; -.
DR   ProteinModelPortal; Q86SX1; -.
DR   IntAct; Q86SX1; 14.
DR   PeptideAtlas; Q86SX1; -.
DR   PRIDE; Q86SX1; -.
DR   GeneID; 3320; -.
DR   CTD; 3320; -.
DR   PharmGKB; PA29519; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   GenomeRNAi; 3320; -.
DR   Genevisible; Q86SX1; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0006950; P:response to stress; IEA:InterPro.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN      162    260       HATPase_c. {ECO:0000259|Pfam:PF02518}.
FT   NON_TER     262    262       {ECO:0000313|EMBL:CAD66568.1}.
SQ   SEQUENCE   262 AA;  29031 MW;  886BBF5DEE3BFF29 CRC64;
     MPPCSGGDGS TPPGPSLRDR DCPAQSAEYP RDRLDPRPGS PSEASSPPFL RSRAPVNWYQ
     EKAQVFLWHL MVSGSTTLLC LWKQPFHVSA FPVTASLAFR QSQGAGQHLY KDLQPFILLR
     LLMPEETQTQ DQPMEEEEVE TFAFQAEIAQ LMSLIINTFY SNKEIFLREL ISNSSDALDK
     IRYESLTDPS KLDSGKELHI NLIPNKQDRT LTIVDTGIGM TKADLINNLG TIAKSGTKAF
     MEALQAGADI SMIGQFGVGF YS
//
ID   A0A024RD80_HUMAN        Unreviewed;       724 AA.
AC   A0A024RD80;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 34.
DE   SubName: Full=Heat shock protein 90kDa alpha (Cytosolic), class B member 1, isoform CRA_a {ECO:0000313|EMBL:EAX04260.1};
GN   Name=HSP90AB1 {ECO:0000313|EMBL:EAX04260.1};
GN   ORFNames=hCG_19001 {ECO:0000313|EMBL:EAX04260.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX04260.1};
RN   [1] {ECO:0000313|EMBL:EAX04260.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX04260.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471081; EAX04258.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04260.1; -; Genomic_DNA.
DR   RefSeq; NP_001258898.1; NM_001271969.1.
DR   RefSeq; NP_001258899.1; NM_001271970.1.
DR   RefSeq; NP_031381.2; NM_007355.3.
DR   UniGene; Hs.509736; -.
DR   SMR; A0A024RD80; -.
DR   GeneID; 3326; -.
DR   KEGG; hsa:3326; -.
DR   CTD; 3326; -.
DR   EuPathDB; HostDB:ENSG00000096384.19; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   KO; K04079; -.
DR   OMA; LRYHSSQ; -.
DR   OrthoDB; EOG091G0270; -.
DR   ChiTaRS; HSP90AB1; human.
DR   GenomeRNAi; 3326; -.
DR   Bgee; ENSG00000096384; -.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016234; C:inclusion body; IEA:Ensembl.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:1990917; C:ooplasm; IEA:Ensembl.
DR   GO; GO:1990913; C:sperm head plasma membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:Ensembl.
DR   GO; GO:0002135; F:CTP binding; IEA:Ensembl.
DR   GO; GO:0032564; F:dATP binding; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; IEA:Ensembl.
DR   GO; GO:0044325; F:ion channel binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0019887; F:protein kinase regulator activity; IEA:Ensembl.
DR   GO; GO:0017098; F:sulfonylurea receptor binding; IEA:Ensembl.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0002134; F:UTP binding; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:1903660; P:negative regulation of complement-dependent cytotoxicity; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:0045793; P:positive regulation of cell size; IEA:Ensembl.
DR   GO; GO:0032092; P:positive regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IEA:Ensembl.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0009651; P:response to salt stress; IEA:Ensembl.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   3: Inferred from homology;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Stress response {ECO:0000313|EMBL:EAX04260.1}.
FT   DOMAIN       35    189       HATPase_c. {ECO:0000259|SMART:SM00387}.
FT   COILED      543    563       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   724 AA;  83264 MW;  A93118C214D03810 CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRYESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     ADISMIGQFG VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGEPIGRGTK
     VILHLKEDQT EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE
     DKDDEEKPKI EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE
     YGEFYKSLTN DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFENKKKK NNIKLYVRRV
     FIMDSCDELI PEYLNFIRGV VDSEDLPLNI SREMLQQSKI LKVIRKNIVK KCLELFSELA
     EDKENYKKFY EAFSKNLKLG IHEDSTNRRR LSELLRYHTS QSGDEMTSLS EYVSRMKETQ
     KSIYYITGES KEQVANSAFV ERVRKRGFEV VYMTEPIDEY CVQQLKEFDG KSLVSVTKEG
     LELPEDEEEK KKMEESKAKF ENLCKLMKEI LDKKVEKVTI SNRLVSSPCC IVTSTYGWTA
     NMERIMKAQA LRDNSTMGYM MAKKHLEINP DHPIVETLRQ KAEADKNDKA VKDLVVLLFE
     TALLSSGFSL EDPQTHSNRI YRMIKLGLGI DEDEVAAEEP NAAVPDEIPP LEGDEDASRM
     EEVD
//
ID   B4DGL0_HUMAN            Unreviewed;       714 AA.
AC   B4DGL0;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 62.
DE   SubName: Full=cDNA FLJ53619, highly similar to Heat shock protein HSP 90-beta {ECO:0000313|EMBL:BAG57821.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG57821.1};
RN   [1] {ECO:0000313|EMBL:BAG57821.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG57821.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294643; BAG57821.1; -; mRNA.
DR   RefSeq; NP_001258901.1; NM_001271972.1.
DR   UniGene; Hs.509736; -.
DR   ProteinModelPortal; B4DGL0; -.
DR   PeptideAtlas; B4DGL0; -.
DR   PRIDE; B4DGL0; -.
DR   GeneID; 3326; -.
DR   CTD; 3326; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   HOVERGEN; HBG007374; -.
DR   GenomeRNAi; 3326; -.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0006950; P:response to stress; IEA:InterPro.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Stress response {ECO:0000313|EMBL:BAG57821.1}.
FT   DOMAIN       35    179       HATPase_c. {ECO:0000259|SMART:SM00387}.
FT   COILED      533    553       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   714 AA;  82170 MW;  1C7927E5F1D9509F CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRCESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGDPIGRGTK VILHLKEDQT
     EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE DKDDEEKPKI
     EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE YGEFYKSLTN
     DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFENKKKK NNIKLYVRRV FIMDSCDELI
     PEYLNFIRGV VDSEDLPLNI SREMLQQSKI LKVIRKNIVK KCLELFSELA EDKENYKKFY
     EAFSKNLKLG IHEDSTNRRR LSELLRYHTS QSGDEMTSLS EYVSRMKETQ KSIYYITGES
     KEQVANSAFV ERVRKRGFEV VYMTEPIDEY CVQQLKEFDG KSLVSVTKEG LELPEDEEEK
     KKMEESKAKF ENLCKLMKEI LDKKVEKVTI SNRLVSSPCC IVTSTYGWTA NMERIMKAQA
     LRDNSTMGYM MAKKHLEINP DHPIVETLRQ KAEADKNDKA VKDLVVLLFE TALLSSGFSL
     EDPQTHSNRI YRMIKLGLGI DEDEVAAEEP NAAVPDEIPP LEGDEDASRM EEVD
//
ID   HS90B_HUMAN             Reviewed;         724 AA.
AC   P08238; B2R5P0; Q5T9W7; Q9NQW0; Q9NTK6;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   28-FEB-2018, entry version 228.
DE   RecName: Full=Heat shock protein HSP 90-beta;
DE            Short=HSP 90;
DE   AltName: Full=Heat shock 84 kDa;
DE            Short=HSP 84;
DE            Short=HSP84;
GN   Name=HSP90AB1; Synonyms=HSP90B, HSPC2, HSPCB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3301534; DOI=10.1016/0378-1119(87)90012-6;
RA   Rebbe N.F., Ware J., Bertina R.M., Modrich P., Stafford D.W.;
RT   "Nucleotide sequence of a cDNA for a member of the human 90-kDa heat-
RT   shock protein family.";
RL   Gene 53:235-245(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2768249;
RA   Rebbe N.F., Hickman W.S., Ley T.J., Stafford D.W., Hickman S.;
RT   "Nucleotide sequence and regulation of a human 90-kDa heat shock
RT   protein gene.";
RL   J. Biol. Chem. 264:15006-15011(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2469626; DOI=10.1016/0378-1119(88)90182-5;
RA   Hoffmann T., Hovemann B.;
RT   "Heat-shock proteins, Hsp84 and Hsp86, of mice and men: two related
RT   genes encode formerly identified tumour-specific transplantation
RT   antigens.";
RL   Gene 74:491-501(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RA   Lu L., Huang X.Y., Yin L.L., Xu M., Li J.M., Zhou Z.M., Sha J.H.;
RT   "Cloning a new isoform of heat shock 90kDa in testis.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, Lymph, Muscle, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-21, AND PHOSPHORYLATION.
RX   PubMed=2492519;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "Two human 90-kDa heat shock proteins are phosphorylated in vivo at
RT   conserved serines that are phosphorylated in vitro by casein kinase
RT   II.";
RL   J. Biol. Chem. 264:2431-2437(1989).
RN   [12]
RP   PROTEIN SEQUENCE OF 42-107; 149-168; 181-197; 204-221; 250-265;
RP   274-284; 292-348; 360-392; 412-427; 439-448; 450-475; 482-502;
RP   506-526; 539-551; 584-604; 613-639 AND 653-679, PHOSPHORYLATION AT
RP   SER-255, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 50-118.
RX   PubMed=8180474; DOI=10.1007/BF00292342;
RA   Takahashi I., Tanuma R., Hirata M., Hashimoto K.;
RT   "A cosmid clone at the D6S182 locus on human chromosome 6p12 contains
RT   the 90-kDa heat shock protein beta gene (HSP90 beta).";
RL   Mamm. Genome 5:121-122(1994).
RN   [14]
RP   SEQUENCE REVISION.
RA   Takahashi I., Tanuma R., Hirata M., Hashimoto K.;
RL   Submitted (JUL-2011) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   PROTEIN SEQUENCE OF 54-64 AND 187-199.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9150948; DOI=10.1002/elps.1150180344;
RA   Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
RT   "A two-dimensional gel database of human colon carcinoma proteins.";
RL   Electrophoresis 18:605-613(1997).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 93-724.
RC   TISSUE=Pancreas;
RA   Mason A., O'Connor D., Greenhalf W.;
RT   "Novel sequence for human Hsp90 beta giving a substitution of R55T
RT   (R147 in original sequence) and M85R (M177 in original sequence).";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   HOMODIMERIZATION.
RX   PubMed=7588731; DOI=10.1111/j.1432-1033.1995.001_1.x;
RA   Nemoto T., Ohara-Nemoto Y., Ota M., Takagi T., Yokoyama K.;
RT   "Mechanism of dimer formation of the 90-kDa heat-shock protein.";
RL   Eur. J. Biochem. 233:1-8(1995).
RN   [18]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CDK6 AND CDC37.
RX   PubMed=9482106; DOI=10.1038/sj.onc.1201570;
RA   Mahony D., Parry D.A., Lees E.;
RT   "Active cdk6 complexes are predominantly nuclear and represent only a
RT   minority of the cdk6 in T cells.";
RL   Oncogene 16:603-611(1998).
RN   [19]
RP   PHOSPHORYLATION AT SER-226 AND SER-255, MUTAGENESIS OF SER-226 AND
RP   SER-255, AND INTERACTION WITH AHR.
RX   PubMed=15581363; DOI=10.1021/bi048736m;
RA   Ogiso H., Kagi N., Matsumoto E., Nishimoto M., Arai R., Shirouzu M.,
RA   Mimura J., Fujii-Kuriyama Y., Yokoyama S.;
RT   "Phosphorylation analysis of 90 kDa heat shock protein within the
RT   cytosolic arylhydrocarbon receptor complex.";
RL   Biochemistry 43:15510-15519(2004).
RN   [20]
RP   INTERACTION WITH TP53, AND REGION.
RX   PubMed=15358771; DOI=10.1074/jbc.M407687200;
RA   Mueller L., Schaupp A., Walerych D., Wegele H., Buchner J.;
RT   "Hsp90 regulates the activity of wild type p53 under physiological and
RT   elevated temperatures.";
RL   J. Biol. Chem. 279:48846-48854(2004).
RN   [21]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [23]
RP   INTERACTION WITH SGTA, AND SUBCELLULAR LOCATION.
RX   PubMed=16580629; DOI=10.1016/j.bbrc.2006.03.090;
RA   Yin H., Wang H., Zong H., Chen X., Wang Y., Yun X., Wu Y., Wang J.,
RA   Gu J.;
RT   "SGT, a Hsp90beta binding partner, is accumulated in the nucleus
RT   during cell apoptosis.";
RL   Biochem. Biophys. Res. Commun. 343:1153-1158(2006).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [25]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH UNC45A.
RX   PubMed=16478993; DOI=10.1128/MCB.26.5.1722-1730.2006;
RA   Chadli A., Graham J.D., Abel M.G., Jackson T.A., Gordon D.F.,
RA   Wood W.M., Felts S.J., Horwitz K.B., Toft D.;
RT   "GCUNC-45 is a novel regulator for the progesterone receptor/hsp90
RT   chaperoning pathway.";
RL   Mol. Cell. Biol. 26:1722-1730(2006).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-297, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [28]
RP   UBIQUITINATION.
RX   PubMed=18042044; DOI=10.1042/BJ20071338;
RA   Windheim M., Peggie M., Cohen P.;
RT   "Two different classes of E2 ubiquitin-conjugating enzymes are
RT   required for the mono-ubiquitination of proteins and elongation by
RT   polyubiquitin chains with a specific topology.";
RL   Biochem. J. 409:723-729(2008).
RN   [29]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=18620420; DOI=10.1021/bi800770g;
RA   Moffatt N.S., Bruinsma E., Uhl C., Obermann W.M., Toft D.;
RT   "Role of the cochaperone Tpr2 in Hsp90 chaperoning.";
RL   Biochemistry 47:8203-8213(2008).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH BIRC2,
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=18239673; DOI=10.1038/cdd.2008.5;
RA   Didelot C., Lanneau D., Brunet M., Bouchot A., Cartier J., Jacquel A.,
RA   Ducoroy P., Cathelin S., Decologne N., Chiosis G., Dubrez-Daloz L.,
RA   Solary E., Garrido C.;
RT   "Interaction of heat-shock protein 90 beta isoform (HSP90 beta) with
RT   cellular inhibitor of apoptosis 1 (c-IAP1) is required for cell
RT   differentiation.";
RL   Cell Death Differ. 15:859-866(2008).
RN   [31]
RP   SUBUNIT, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=18400751; DOI=10.1074/jbc.M800540200;
RA   Richter K., Soroka J., Skalniak L., Leskovar A., Hessling M.,
RA   Reinstein J., Buchner J.;
RT   "Conserved conformational changes in the ATPase cycle of human
RT   Hsp90.";
RL   J. Biol. Chem. 283:17757-17765(2008).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [35]
RP   FUNCTION, S-NITROSYLATION AT CYS-590, AND MUTAGENESIS OF CYS-590.
RX   PubMed=19696785; DOI=10.1038/embor.2009.153;
RA   Retzlaff M., Stahl M., Eberl H.C., Lagleder S., Beck J., Kessler H.,
RA   Buchner J.;
RT   "Hsp90 is regulated by a switch point in the C-terminal domain.";
RL   EMBO Rep. 10:1147-1153(2009).
RN   [36]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-435 AND LYS-481, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [37]
RP   INTERACTION WITH TGFB1 PROCESSED FORM (LAP), AND SUBCELLULAR LOCATION.
RX   PubMed=20599762; DOI=10.1016/j.bbrc.2010.06.112;
RA   Suzuki S., Kulkarni A.B.;
RT   "Extracellular heat shock protein HSP90beta secreted by MG63
RT   osteosarcoma cells inhibits activation of latent TGF-beta1.";
RL   Biochem. Biophys. Res. Commun. 398:525-531(2010).
RN   [38]
RP   INTERACTION WITH HSP90AA1; JAK2 AND PRKCE, INDUCTION, AND FUNCTION.
RX   PubMed=20353823; DOI=10.1016/j.cellsig.2010.03.012;
RA   Cheng M.B., Zhang Y., Zhong X., Sutter B., Cao C.Y., Chen X.S.,
RA   Cheng X.K., Zhang Y., Xiao L., Shen Y.F.;
RT   "Stat1 mediates an auto-regulation of hsp90beta gene in heat shock
RT   response.";
RL   Cell. Signal. 22:1206-1213(2010).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [40]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [41]
RP   MALONYLATION AT LYS-399.
RX   PubMed=21908771; DOI=10.1074/mcp.M111.012658;
RA   Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,
RA   He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,
RA   Dai J., Verdin E., Ye Y., Zhao Y.;
RT   "The first identification of lysine malonylation substrates and its
RT   regulatory enzyme.";
RL   Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
RN   [42]
RP   INTERACTION WITH AHSA1 AND XPO1.
RX   PubMed=22022502; DOI=10.1371/journal.pone.0026044;
RA   Echeverria P.C., Bernthaler A., Dupuis P., Mayer B., Picard D.;
RT   "An interaction network predicted from public data as a discovery
RT   tool: application to the Hsp90 molecular chaperone machine.";
RL   PLoS ONE 6:E26044-E26044(2011).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [44]
RP   PHOSPHORYLATION AT SER-718 BY PLK2 AND PLK3.
RX   PubMed=22828320; DOI=10.1016/j.bbapap.2012.07.003;
RA   Salvi M., Trashi E., Cozza G., Franchin C., Arrigoni G., Pinna L.A.;
RT   "Investigation on PLK2 and PLK3 substrate recognition.";
RL   Biochim. Biophys. Acta 1824:1366-1373(2012).
RN   [45]
RP   INTERACTION WITH CDC25A.
RX   PubMed=22843495; DOI=10.1093/hmg/dds303;
RA   Giessrigl B., Krieger S., Rosner M., Huttary N., Saiko P., Alami M.,
RA   Messaoudi S., Peyrat J.F., Maciuk A., Gollinger M., Kopf S.,
RA   Kazlauskas E., Mazal P., Szekeres T., Hengstschlaeger M., Matulis D.,
RA   Jaeger W., Krupitza G.;
RT   "Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A
RT   degradation and cell-cycle attenuation in pancreatic carcinoma
RT   cells.";
RL   Hum. Mol. Genet. 21:4615-4627(2012).
RN   [46]
RP   PROTEIN CLEAVAGE, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22848402; DOI=10.1371/journal.pone.0040795;
RA   Beck R., Dejeans N., Glorieux C., Creton M., Delaive E., Dieu M.,
RA   Raes M., Leveque P., Gallez B., Depuydt M., Collet J.F.,
RA   Calderon P.B., Verrax J.;
RT   "Hsp90 is cleaved by reactive oxygen species at a highly conserved N-
RT   terminal amino acid motif.";
RL   PLoS ONE 7:E40795-E40795(2012).
RN   [47]
RP   INTERACTION WITH NOS3, MUTAGENESIS OF TYR-301, AND PHOSPHORYLATION AT
RP   TYR-301 BY SRC.
RX   PubMed=23585225; DOI=10.1152/ajplung.00419.2012;
RA   Barabutis N., Handa V., Dimitropoulou C., Rafikov R., Snead C.,
RA   Kumar S., Joshi A., Thangjam G., Fulton D., Black S.M., Patel V.,
RA   Catravas J.D.;
RT   "LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in
RT   lung vascular endothelial cells and mouse lung.";
RL   Am. J. Physiol. 304:L883-L893(2013).
RN   [48]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226; SER-255; THR-297;
RP   SER-445 AND THR-479, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [49]
RP   INTERACTION WITH MAPK7.
RX   PubMed=23428871; DOI=10.1128/MCB.01246-12;
RA   Erazo T., Moreno A., Ruiz-Babot G., Rodriguez-Asiain A., Morrice N.A.,
RA   Espadamala J., Bayascas J.R., Gomez N., Lizcano J.M.;
RT   "Canonical and kinase activity-independent mechanisms for
RT   extracellular signal-regulated kinase 5 (ERK5) nuclear translocation
RT   require dissociation of Hsp90 from the ERK5-Cdc37 complex.";
RL   Mol. Cell. Biol. 33:1671-1686(2013).
RN   [50]
RP   INTERACTION WITH KCNQ4.
RX   PubMed=23431407; DOI=10.1371/journal.pone.0057282;
RA   Gao Y., Yechikov S., Vazquez A.E., Chen D., Nie L.;
RT   "Distinct roles of molecular chaperones HSP90alpha and HSP90beta in
RT   the biogenesis of KCNQ4 channels.";
RL   PLoS ONE 8:E57282-E57282(2013).
RN   [51]
RP   FUNCTION, AND INTERACTION WITH STUB1 AND SMAD3.
RX   PubMed=24613385; DOI=10.1016/j.bbrc.2014.02.124;
RA   Shang Y., Xu X., Duan X., Guo J., Wang Y., Ren F., He D., Chang Z.;
RT   "Hsp70 and Hsp90 oppositely regulate TGF-beta signaling through
RT   CHIP/Stub1.";
RL   Biochem. Biophys. Res. Commun. 446:387-392(2014).
RN   [52]
RP   METHYLATION AT LYS-531 AND LYS-574 BY SMYD2, IDENTIFICATION BY MASS
RP   SPECTROMETRY, MUTAGENESIS OF LYS-531 AND LYS-574, INTERACTION WITH
RP   STIP1 AND CDC37, AND SUBCELLULAR LOCATION.
RX   PubMed=24880080; DOI=10.1016/j.canlet.2014.05.014;
RA   Hamamoto R., Toyokawa G., Nakakido M., Ueda K., Nakamura Y.;
RT   "SMYD2-dependent HSP90 methylation promotes cancer cell proliferation
RT   by regulating the chaperone complex formation.";
RL   Cancer Lett. 351:126-133(2014).
RN   [53]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-669, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [54]
RP   INTERACTION WITH NWD1.
RX   PubMed=24681825;
RA   Correa R.G., Krajewska M., Ware C.F., Gerlic M., Reed J.C.;
RT   "The NLR-related protein NWD1 is associated with prostate cancer and
RT   modulates androgen receptor signaling.";
RL   Oncotarget 5:1666-1682(2014).
RN   [55]
RP   INTERACTION WITH AHSA1; BIRC2 AND CDC37, AND REGION.
RX   PubMed=25486457; DOI=10.1016/j.bbamcr.2014.11.026;
RA   Synoradzki K., Bieganowski P.;
RT   "Middle domain of human Hsp90 isoforms differentially binds Aha1 in
RT   human cells and alters Hsp90 activity in yeast.";
RL   Biochim. Biophys. Acta 1853:445-452(2015).
RN   [56]
RP   REVIEW.
RX   PubMed=25973397; DOI=10.3389/fonc.2015.00100;
RA   Khurana N., Bhattacharyya S.;
RT   "Hsp90, the concertmaster: tuning transcription.";
RL   Front. Oncol. 5:100-100(2015).
RN   [57]
RP   INTERACTION WITH HSF1; HIF1A; ERBB2; MET; KEAP1 AND RHOBTB2, AND
RP   MUTAGENESIS OF GLU-42 AND ASP-88.
RX   PubMed=26517842; DOI=10.1371/journal.pone.0141786;
RA   Prince T.L., Kijima T., Tatokoro M., Lee S., Tsutsumi S., Yim K.,
RA   Rivas C., Alarcon S., Schwartz H., Khamit-Kush K., Scroggins B.T.,
RA   Beebe K., Trepel J.B., Neckers L.;
RT   "Client proteins and small molecule inhibitors display distinct
RT   binding preferences for constitutive and stress-induced HSP90 isoforms
RT   and their conformationally restricted mutants.";
RL   PLoS ONE 10:E0141786-E0141786(2015).
RN   [58]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [59]
RP   REVIEW.
RX   PubMed=27295069; DOI=10.1016/j.biochi.2016.05.018;
RA   Verma S., Goyal S., Jamal S., Singh A., Grover A.;
RT   "Hsp90: Friends, clients and natural foes.";
RL   Biochimie 127:227-240(2016).
RN   [60]
RP   REVIEW.
RX   PubMed=26991466; DOI=10.1002/bip.22835;
RA   Pearl L.H.;
RT   "Review: The HSP90 molecular chaperone-an enigmatic ATPase.";
RL   Biopolymers 105:594-607(2016).
RN   [61]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 1-221 IN COMPLEX WITH PURINE
RP   ANALOG.
RX   PubMed=15217611; DOI=10.1016/j.chembiol.2004.03.033;
RA   Wright L., Barril X., Dymock B., Sheridan L., Surgenor A., Beswick M.,
RA   Drysdale M., Collier A., Massey A., Davies N., Fink A., Fromont C.,
RA   Aherne W., Boxall K., Sharp S., Workman P., Hubbard R.E.;
RT   "Structure-activity relationships in purine-based inhibitor binding to
RT   HSP90 isoforms.";
RL   Chem. Biol. 11:775-785(2004).
RN   [62]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 720-724 IN COMPLEX WITH
RP   FKBP4.
RX   PubMed=15159550; DOI=10.1073/pnas.0305969101;
RA   Wu B., Li P., Liu Y., Lou Z., Ding Y., Shu C., Ye S., Bartlam M.,
RA   Shen B., Rao Z.;
RT   "3D structure of human FK506-binding protein 52: implications for the
RT   assembly of the glucocorticoid receptor/Hsp90/immunophilin
RT   heterocomplex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:8348-8353(2004).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 284-543.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the middle domain of human hsp90-beta.";
RL   Submitted (DEC-2010) to the PDB data bank.
CC   -!- FUNCTION: Molecular chaperone that promotes the maturation,
CC       structural maintenance and proper regulation of specific target
CC       proteins involved for instance in cell cycle control and signal
CC       transduction. Undergoes a functional cycle that is linked to its
CC       ATPase activity. This cycle probably induces conformational
CC       changes in the client proteins, thereby causing their activation.
CC       Interacts dynamically with various co-chaperones that modulate its
CC       substrate recognition, ATPase cycle and chaperone function
CC       (PubMed:16478993, PubMed:19696785). Engages with a range of client
CC       protein classes via its interaction with various co-chaperone
CC       proteins or complexes, that act as adapters, simultaneously able
CC       to interact with the specific client and the central chaperone
CC       itself. Recruitment of ATP and co-chaperone followed by client
CC       protein forms a functional chaperone. After the completion of the
CC       chaperoning process, properly folded client protein and co-
CC       chaperone leave HSP90 in an ADP-bound partially open conformation
CC       and finally, ADP is released from HSP90 which acquires an open
CC       conformation for the next cycle (PubMed:27295069,
CC       PubMed:26991466). Apart from its chaperone activity, it also plays
CC       a role in the regulation of the transcription machinery. HSP90 and
CC       its co-chaperones modulate transcription at least at three
CC       different levels. In the first place, they alter the steady-state
CC       levels of certain transcription factors in response to various
CC       physiological cues. Second, they modulate the activity of certain
CC       epigenetic modifiers, such as histone deacetylases or DNA methyl
CC       transferases, and thereby respond to the change in the
CC       environment. Third, they participate in the eviction of histones
CC       from the promoter region of certain genes and thereby turn on gene
CC       expression (PubMed:25973397). Antagonizes STUB1-mediated
CC       inhibition of TGF-beta signaling via inhibition of STUB1-mediated
CC       SMAD3 ubiquitination and degradation (PubMed:24613385). Promotes
CC       cell differentiation by chaperoning BIRC2 and thereby protecting
CC       from auto-ubiquitination and degradation by the proteasomal
CC       machinery (PubMed:18239673). Main chaperone that is involved in
CC       the phosphorylation/activation of the STAT1 by chaperoning both
CC       JAK2 and PRKCE under heat shock and in turn, activates its own
CC       transcription (PubMed:20353823). {ECO:0000269|PubMed:16478993,
CC       ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:19696785,
CC       ECO:0000269|PubMed:20353823, ECO:0000269|PubMed:24613385,
CC       ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466,
CC       ECO:0000303|PubMed:27295069}.
CC   -!- ENZYME REGULATION: In the resting state, through the dimerization
CC       of its C-terminal domain, HSP90 forms a homodimer which is defined
CC       as the open conformation. Upon ATP-binding, the N-terminal domain
CC       undergoes significant conformational changes and comes in contact
CC       to form an active closed conformation. After HSP90 finishes its
CC       chaperoning tasks of assisting the proper folding, stabilization
CC       and activation of client proteins under the active state, ATP
CC       molecule is hydrolyzed to ADP which then dissociates from HSP90
CC       and directs the protein back to the resting state.
CC       {ECO:0000269|PubMed:18400751}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=300 uM for ATP {ECO:0000269|PubMed:18400751};
CC   -!- SUBUNIT: Monomer (PubMed:24880080). Homodimer (PubMed:7588731,
CC       PubMed:18400751). Forms a complex with CDK6 and CDC37
CC       (PubMed:9482106, PubMed:25486457). Interacts with UNC45A; binding
CC       to UNC45A involves 2 UNC45A monomers per HSP90AB1 dimer
CC       (PubMed:16478993). Interacts with CHORDC1 (By similarity).
CC       Interacts with DNAJC7 (PubMed:18620420). Interacts with FKBP4
CC       (PubMed:15159550). May interact with NWD1 (PubMed:24681825).
CC       Interacts with SGTA (PubMed:16580629). Interacts with HSF1 in an
CC       ATP-dependent manner. Interacts with MET; the interaction
CC       suppresses MET kinase activity. Interacts with ERBB2 in an ATP-
CC       dependent manner; the interaction suppresses ERBB2 kinase
CC       activity. Interacts with HIF1A, KEAP1 and RHOBTB2
CC       (PubMed:26517842). Interacts with STUB1 and SMAD3
CC       (PubMed:24613385). Interacts with XPO1 and AHSA1 (PubMed:22022502,
CC       PubMed:25486457). Interacts with BIRC2 (PubMed:25486457).
CC       Interacts with KCNQ4; promotes cell surface expression of KCNQ4
CC       (PubMed:23431407). Interacts with BIRC2; prevents auto-
CC       ubiquitination and degradation of its client protein BIRC2
CC       (PubMed:18239673). Interacts with NOS3 (PubMed:23585225).
CC       Interacts with AHR; interaction is inhibited by HSP90AB1
CC       phosphorylation on Ser-226 and Ser-255 (PubMed:15581363).
CC       Interacts with STIP1 and CDC37; upon SMYD2-dependent methylation
CC       (PubMed:24880080). Interacts with JAK2 and PRKCE; promotes
CC       functional activation in a heat shock-dependent manner
CC       (PubMed:20353823). Interacts with HSP90AA1; interaction is
CC       constitutive (PubMed:20353823). HSP90AB1-CDC37 chaperone complex
CC       interacts with inactive MAPK7 (via N-terminal half) in resting
CC       cells; the interaction is MAP2K5-independent and prevents from
CC       ubiquitination and proteasomal degradation (PubMed:23428871).
CC       Interacts with CDC25A; prevents heat shock-mediated CDC25A
CC       degradation and contributes to cell cycle progression
CC       (PubMed:22843495). Interacts with TP53 (via DNA binding domain);
CC       suppresses TP53 aggregation and prevents from irreversible thermal
CC       inactivation (PubMed:15358771). Interacts with TGFB1 processed
CC       form (LAP); inhibits latent TGFB1 activation (PubMed:20599762).
CC       Interacts with TRIM8; prevents nucleus translocation of
CC       phosphorylated STAT3 and HSP90AB1 (By similarity).
CC       {ECO:0000250|UniProtKB:P11499, ECO:0000269|PubMed:15159550,
CC       ECO:0000269|PubMed:15358771, ECO:0000269|PubMed:15581363,
CC       ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:16580629,
CC       ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:18400751,
CC       ECO:0000269|PubMed:18620420, ECO:0000269|PubMed:20353823,
CC       ECO:0000269|PubMed:20599762, ECO:0000269|PubMed:22022502,
CC       ECO:0000269|PubMed:22843495, ECO:0000269|PubMed:23428871,
CC       ECO:0000269|PubMed:23431407, ECO:0000269|PubMed:23585225,
CC       ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:24681825,
CC       ECO:0000269|PubMed:24880080, ECO:0000269|PubMed:25486457,
CC       ECO:0000269|PubMed:26517842, ECO:0000269|PubMed:7588731,
CC       ECO:0000269|PubMed:9482106}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-352572, EBI-352572;
CC       P36896:ACVR1B; NbExp=2; IntAct=EBI-352572, EBI-1384128;
CC       Q9UL18:AGO1; NbExp=3; IntAct=EBI-352572, EBI-527363;
CC       O95433:AHSA1; NbExp=3; IntAct=EBI-352572, EBI-448610;
CC       O00170:AIP; NbExp=6; IntAct=EBI-352572, EBI-704197;
CC       P31751:AKT2; NbExp=2; IntAct=EBI-352572, EBI-296058;
CC       Q9UM73:ALK; NbExp=2; IntAct=EBI-352572, EBI-357361;
CC       Q16671:AMHR2; NbExp=2; IntAct=EBI-352572, EBI-6423788;
CC       Q01432:AMPD3; NbExp=2; IntAct=EBI-352572, EBI-1223554;
CC       P10398:ARAF; NbExp=6; IntAct=EBI-352572, EBI-365961;
CC       Q96GD4:AURKB; NbExp=2; IntAct=EBI-352572, EBI-624291;
CC       P15056:BRAF; NbExp=2; IntAct=EBI-352572, EBI-365980;
CC       Q06187:BTK; NbExp=2; IntAct=EBI-352572, EBI-624835;
CC       Q13555:CAMK2G; NbExp=2; IntAct=EBI-352572, EBI-1383465;
CC       Q16543:CDC37; NbExp=11; IntAct=EBI-352572, EBI-295634;
CC       Q7L3B6:CDC37L1; NbExp=5; IntAct=EBI-352572, EBI-2841876;
CC       Q15131:CDK10; NbExp=2; IntAct=EBI-352572, EBI-1646959;
CC       O94921:CDK14; NbExp=2; IntAct=EBI-352572, EBI-1043945;
CC       Q96Q40:CDK15; NbExp=2; IntAct=EBI-352572, EBI-1051975;
CC       P11802:CDK4; NbExp=3; IntAct=EBI-352572, EBI-295644;
CC       Q00534:CDK6; NbExp=2; IntAct=EBI-352572, EBI-295663;
CC       P50750:CDK9; NbExp=2; IntAct=EBI-352572, EBI-1383449;
CC       O14757:CHEK1; NbExp=3; IntAct=EBI-352572, EBI-974488;
CC       Q9UHD1:CHORDC1; NbExp=3; IntAct=EBI-352572, EBI-2550959;
CC       P49674:CSNK1E; NbExp=2; IntAct=EBI-352572, EBI-749343;
CC       Q13618:CUL3; NbExp=2; IntAct=EBI-352572, EBI-456129;
CC       Q16832:DDR2; NbExp=2; IntAct=EBI-352572, EBI-1381484;
CC       P00533:EGFR; NbExp=8; IntAct=EBI-352572, EBI-297353;
CC       P29317:EPHA2; NbExp=2; IntAct=EBI-352572, EBI-702104;
CC       P04626:ERBB2; NbExp=3; IntAct=EBI-352572, EBI-641062;
CC       P21860:ERBB3; NbExp=3; IntAct=EBI-352572, EBI-720706;
CC       Q15303:ERBB4; NbExp=2; IntAct=EBI-352572, EBI-80371;
CC       Q96A26:FAM162A; NbExp=3; IntAct=EBI-352572, EBI-6123466;
CC       Q9UKC9:FBXL2; NbExp=2; IntAct=EBI-352572, EBI-724253;
CC       O75426:FBXO24; NbExp=2; IntAct=EBI-352572, EBI-6425658;
CC       Q9UKT8:FBXW2; NbExp=2; IntAct=EBI-352572, EBI-914727;
CC       P22607:FGFR3; NbExp=2; IntAct=EBI-352572, EBI-348399;
CC       P09769:FGR; NbExp=2; IntAct=EBI-352572, EBI-1383732;
CC       Q02790:FKBP4; NbExp=5; IntAct=EBI-352572, EBI-1047444;
CC       Q13451:FKBP5; NbExp=4; IntAct=EBI-352572, EBI-306914;
CC       P21333:FLNA; NbExp=2; IntAct=EBI-352572, EBI-350432;
CC       P35916:FLT4; NbExp=2; IntAct=EBI-352572, EBI-1005467;
CC       P06241:FYN; NbExp=2; IntAct=EBI-352572, EBI-515315;
CC       P49840:GSK3A; NbExp=2; IntAct=EBI-352572, EBI-1044067;
CC       Q8TF76:HASPIN; NbExp=2; IntAct=EBI-352572, EBI-1237328;
CC       Q9UPZ9:ICK; NbExp=2; IntAct=EBI-352572, EBI-6381479;
CC       O14920:IKBKB; NbExp=2; IntAct=EBI-352572, EBI-81266;
CC       Q14164:IKBKE; NbExp=2; IntAct=EBI-352572, EBI-307369;
CC       Q9Y6K9:IKBKG; NbExp=3; IntAct=EBI-352572, EBI-81279;
CC       Q2WGJ6:KLHL38; NbExp=3; IntAct=EBI-352572, EBI-6426443;
CC       P06239:LCK; NbExp=2; IntAct=EBI-352572, EBI-1348;
CC       P53671:LIMK2; NbExp=2; IntAct=EBI-352572, EBI-1384350;
CC       Q99558:MAP3K14; NbExp=2; IntAct=EBI-352572, EBI-358011;
CC       P41279:MAP3K8; NbExp=2; IntAct=EBI-352572, EBI-354900;
CC       P80192:MAP3K9; NbExp=2; IntAct=EBI-352572, EBI-3951604;
CC       P31152:MAPK4; NbExp=2; IntAct=EBI-352572, EBI-3906061;
CC       P10636-8:MAPT; NbExp=4; IntAct=EBI-352572, EBI-366233;
CC       P42679:MATK; NbExp=2; IntAct=EBI-352572, EBI-751664;
CC       O15146:MUSK; NbExp=2; IntAct=EBI-352572, EBI-6423196;
CC       Q8TD19:NEK9; NbExp=2; IntAct=EBI-352572, EBI-1044009;
CC       P19838:NFKB1; NbExp=3; IntAct=EBI-352572, EBI-300010;
CC       O75469:NR1I2; NbExp=2; IntAct=EBI-352572, EBI-3905991;
CC       Q9P215:POGK; NbExp=2; IntAct=EBI-352572, EBI-2555775;
CC       P53041:PPP5C; NbExp=7; IntAct=EBI-352572, EBI-716663;
CC       Q13131:PRKAA1; NbExp=2; IntAct=EBI-352572, EBI-1181405;
CC       P22694:PRKACB; NbExp=2; IntAct=EBI-352572, EBI-2679622;
CC       Q02156:PRKCE; NbExp=2; IntAct=EBI-352572, EBI-706254;
CC       Q05513:PRKCZ; NbExp=2; IntAct=EBI-352572, EBI-295351;
CC       Q15139:PRKD1; NbExp=2; IntAct=EBI-352572, EBI-1181072;
CC       P51817:PRKX; NbExp=2; IntAct=EBI-352572, EBI-4302903;
CC       P11801:PSKH1; NbExp=2; IntAct=EBI-352572, EBI-3922781;
CC       Q15185:PTGES3; NbExp=4; IntAct=EBI-352572, EBI-1049387;
CC       P04049:RAF1; NbExp=3; IntAct=EBI-352572, EBI-365996;
CC       P49758:RGS6; NbExp=2; IntAct=EBI-352572, EBI-6426927;
CC       Q01974:ROR2; NbExp=2; IntAct=EBI-352572, EBI-6422642;
CC       P62913:RPL11; NbExp=2; IntAct=EBI-352572, EBI-354380;
CC       Q15418:RPS6KA1; NbExp=2; IntAct=EBI-352572, EBI-963034;
CC       P31948:STIP1; NbExp=3; IntAct=EBI-352572, EBI-1054052;
CC       Q15831:STK11; NbExp=3; IntAct=EBI-352572, EBI-306838;
CC       Q15208:STK38; NbExp=2; IntAct=EBI-352572, EBI-458376;
CC       Q9UNE7:STUB1; NbExp=5; IntAct=EBI-352572, EBI-357085;
CC       Q9Y2Z0-2:SUGT1; NbExp=2; IntAct=EBI-352572, EBI-10768076;
CC       Q9UHD2:TBK1; NbExp=2; IntAct=EBI-352572, EBI-356402;
CC       Q96S53:TESK2; NbExp=2; IntAct=EBI-352572, EBI-1384110;
CC       Q9BXA6:TSSK6; NbExp=3; IntAct=EBI-352572, EBI-851883;
CC       P29597:TYK2; NbExp=2; IntAct=EBI-352572, EBI-1383454;
CC       Q8IWX7:UNC45B; NbExp=2; IntAct=EBI-352572, EBI-9363363;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16580629,
CC       ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:24880080,
CC       ECO:0000269|PubMed:9482106}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Nucleus
CC       {ECO:0000269|PubMed:18239673}. Secreted
CC       {ECO:0000269|PubMed:20599762}. Cell membrane
CC       {ECO:0000269|PubMed:20599762}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV
CC       (PubMed:17081065). Translocates with BIRC2 from the nucleus to the
CC       cytoplasm during differentiation (PubMed:18239673). Secreted when
CC       associated with TGFB1 processed form (LAP) (PubMed:20599762).
CC       {ECO:0000269|PubMed:17081065, ECO:0000269|PubMed:18239673,
CC       ECO:0000269|PubMed:20599762}.
CC   -!- INDUCTION: By heat shock. {ECO:0000269|PubMed:20353823}.
CC   -!- DOMAIN: The TPR repeat-binding motif mediates interaction with TPR
CC       repeat-containing proteins. {ECO:0000250|UniProtKB:P07900}.
CC   -!- PTM: Ubiquitinated in the presence of STUB1-UBE2D1 complex (in
CC       vitro). {ECO:0000269|PubMed:18042044}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: S-nitrosylated; negatively regulates the ATPase activity.
CC       {ECO:0000305|PubMed:19696785}.
CC   -!- PTM: Phosphorylation at Tyr-301 by SRC is induced by
CC       lipopolysaccharide (PubMed:23585225). Phosphorylation at Ser-226
CC       and Ser-255 inhibits AHR interaction (PubMed:15581363).
CC       {ECO:0000269|PubMed:15581363, ECO:0000269|PubMed:23585225}.
CC   -!- PTM: Methylated by SMYD2; facilitates dimerization and chaperone
CC       complex formation; promotes cancer cell proliferation.
CC       {ECO:0000269|PubMed:24880080}.
CC   -!- PTM: Cleaved following oxidative stress resulting in HSP90AB1
CC       protein radicals formation; disrupts the chaperoning function and
CC       the degradation of its client proteins.
CC       {ECO:0000269|PubMed:22848402}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 90 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD14062.3; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAB66478.1; Type=Frameshift; Positions=709; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M16660; AAA36025.1; -; mRNA.
DR   EMBL; J04988; AAA36026.1; -; Genomic_DNA.
DR   EMBL; AY359878; AAQ63401.1; -; mRNA.
DR   EMBL; AL136543; CAB66478.1; ALT_FRAME; mRNA.
DR   EMBL; AK312255; BAG35187.1; -; mRNA.
DR   EMBL; DQ314872; ABC40731.1; -; Genomic_DNA.
DR   EMBL; AL139392; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX04257.1; -; Genomic_DNA.
DR   EMBL; BC004928; AAH04928.1; -; mRNA.
DR   EMBL; BC009206; AAH09206.2; -; mRNA.
DR   EMBL; BC012807; AAH12807.1; -; mRNA.
DR   EMBL; BC014485; AAH14485.1; -; mRNA.
DR   EMBL; BC016753; AAH16753.1; -; mRNA.
DR   EMBL; BC068474; AAH68474.1; -; mRNA.
DR   EMBL; AH007358; AAD14062.3; ALT_INIT; Genomic_DNA.
DR   EMBL; AF275719; AAF82792.1; -; mRNA.
DR   CCDS; CCDS4909.1; -.
DR   PIR; A29461; HHHU84.
DR   PIR; T46243; T46243.
DR   RefSeq; NP_001258898.1; NM_001271969.1.
DR   RefSeq; NP_001258899.1; NM_001271970.1.
DR   RefSeq; NP_001258900.1; NM_001271971.1.
DR   RefSeq; NP_031381.2; NM_007355.3.
DR   UniGene; Hs.509736; -.
DR   PDB; 1QZ2; X-ray; 3.00 A; G/H=720-724.
DR   PDB; 1UYM; X-ray; 2.45 A; A=2-221.
DR   PDB; 2L6J; NMR; -; B=720-724.
DR   PDB; 3FWV; X-ray; 2.20 A; C/D=719-723.
DR   PDB; 3NMQ; X-ray; 2.20 A; A=1-223.
DR   PDB; 3PRY; X-ray; 2.28 A; A/B/C=284-543.
DR   PDB; 3UQ3; X-ray; 2.60 A; B/C=720-724.
DR   PDB; 5FWK; EM; 3.90 A; A/B=1-724.
DR   PDB; 5FWL; EM; 9.00 A; A/B=1-724.
DR   PDB; 5FWM; EM; 8.00 A; A/B=1-724.
DR   PDB; 5FWP; EM; 7.20 A; A/B=1-724.
DR   PDB; 5UC4; X-ray; 2.05 A; A/B/C/D=1-218.
DR   PDB; 5UCH; X-ray; 2.65 A; A/B/C/D=1-218.
DR   PDB; 5UCI; X-ray; 2.70 A; A/B/C/D=1-218.
DR   PDB; 5UCJ; X-ray; 1.69 A; A/B/C/D=1-218.
DR   PDBsum; 1QZ2; -.
DR   PDBsum; 1UYM; -.
DR   PDBsum; 2L6J; -.
DR   PDBsum; 3FWV; -.
DR   PDBsum; 3NMQ; -.
DR   PDBsum; 3PRY; -.
DR   PDBsum; 3UQ3; -.
DR   PDBsum; 5FWK; -.
DR   PDBsum; 5FWL; -.
DR   PDBsum; 5FWM; -.
DR   PDBsum; 5FWP; -.
DR   PDBsum; 5UC4; -.
DR   PDBsum; 5UCH; -.
DR   PDBsum; 5UCI; -.
DR   PDBsum; 5UCJ; -.
DR   ProteinModelPortal; P08238; -.
DR   SMR; P08238; -.
DR   BioGrid; 109558; 336.
DR   CORUM; P08238; -.
DR   DIP; DIP-413N; -.
DR   IntAct; P08238; 531.
DR   MINT; P08238; -.
DR   STRING; 9606.ENSP00000325875; -.
DR   BindingDB; P08238; -.
DR   ChEMBL; CHEMBL4303; -.
DR   DrugBank; DB05134; CNF1010.
DR   DrugBank; DB02424; Geldanamycin.
DR   DrugBank; DB03758; Radicicol.
DR   DrugBank; DB06070; SNX-5422.
DR   GuidetoPHARMACOLOGY; 2907; -.
DR   CarbonylDB; P08238; -.
DR   iPTMnet; P08238; -.
DR   PhosphoSitePlus; P08238; -.
DR   SwissPalm; P08238; -.
DR   DMDM; 17865718; -.
DR   OGP; P08238; -.
DR   EPD; P08238; -.
DR   MaxQB; P08238; -.
DR   PaxDb; P08238; -.
DR   PeptideAtlas; P08238; -.
DR   PRIDE; P08238; -.
DR   TopDownProteomics; P08238; -.
DR   DNASU; 3326; -.
DR   Ensembl; ENST00000353801; ENSP00000325875; ENSG00000096384.
DR   Ensembl; ENST00000371554; ENSP00000360609; ENSG00000096384.
DR   Ensembl; ENST00000371646; ENSP00000360709; ENSG00000096384.
DR   Ensembl; ENST00000620073; ENSP00000481908; ENSG00000096384.
DR   GeneID; 3326; -.
DR   KEGG; hsa:3326; -.
DR   UCSC; uc003oxa.3; human.
DR   CTD; 3326; -.
DR   DisGeNET; 3326; -.
DR   EuPathDB; HostDB:ENSG00000096384.19; -.
DR   GeneCards; HSP90AB1; -.
DR   H-InvDB; HIX0031498; -.
DR   H-InvDB; HIX0057380; -.
DR   HGNC; HGNC:5258; HSP90AB1.
DR   HPA; CAB005230; -.
DR   HPA; HPA055729; -.
DR   MIM; 140572; gene.
DR   neXtProt; NX_P08238; -.
DR   OpenTargets; ENSG00000096384; -.
DR   PharmGKB; PA29524; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   GeneTree; ENSGT00910000144050; -.
DR   HOGENOM; HOG000031988; -.
DR   HOVERGEN; HBG007374; -.
DR   InParanoid; P08238; -.
DR   KO; K04079; -.
DR   OMA; LRYHSSQ; -.
DR   OrthoDB; EOG091G0270; -.
DR   PhylomeDB; P08238; -.
DR   TreeFam; TF300686; -.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371511; HSF1 activation.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-HSA-5336415; Uptake and function of diphtheria toxin.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-844456; The NLRP3 inflammasome.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8937144; Aryl hydrocarbon receptor signalling.
DR   SIGNOR; P08238; -.
DR   ChiTaRS; HSP90AB1; human.
DR   EvolutionaryTrace; P08238; -.
DR   GeneWiki; HSP90AB1; -.
DR   GenomeRNAi; 3326; -.
DR   PRO; PR:P08238; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000096384; -.
DR   CleanEx; HS_HSP90AB1; -.
DR   ExpressionAtlas; P08238; baseline and differential.
DR   Genevisible; P08238; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0034751; C:aryl hydrocarbon receptor complex; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0016234; C:inclusion body; IEA:Ensembl.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:Ensembl.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:1990917; C:ooplasm; IEA:Ensembl.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:1990913; C:sperm head plasma membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IDA:CAFA.
DR   GO; GO:0043008; F:ATP-dependent protein binding; IPI:CAFA.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0002135; F:CTP binding; IEA:Ensembl.
DR   GO; GO:0032564; F:dATP binding; IEA:Ensembl.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0070182; F:DNA polymerase binding; IPI:BHF-UCL.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0005525; F:GTP binding; IEA:Ensembl.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:1990226; F:histone methyltransferase binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0044325; F:ion channel binding; IEA:Ensembl.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0030235; F:nitric-oxide synthase regulator activity; ISS:UniProtKB.
DR   GO; GO:0042277; F:peptide binding; IPI:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:CAFA.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0019887; F:protein kinase regulator activity; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0017098; F:sulfonylurea receptor binding; IEA:Ensembl.
DR   GO; GO:0030911; F:TPR domain binding; ISS:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0002134; F:UTP binding; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IDA:CAFA.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0071157; P:negative regulation of cell cycle arrest; IMP:UniProtKB.
DR   GO; GO:1903660; P:negative regulation of complement-dependent cytotoxicity; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:1901389; P:negative regulation of transforming growth factor beta activation; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IMP:UniProtKB.
DR   GO; GO:0045793; P:positive regulation of cell size; IEA:Ensembl.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0032092; P:positive regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl.
DR   GO; GO:2000010; P:positive regulation of protein localization to cell surface; IDA:UniProtKB.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IEA:Ensembl.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IDA:BHF-UCL.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0050821; P:protein stabilization; TAS:Reactome.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; IMP:MGI.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0060338; P:regulation of type I interferon-mediated signaling pathway; IMP:MGI.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0009651; P:response to salt stress; IEA:Ensembl.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   GO; GO:0097435; P:supramolecular fiber organization; IMP:CACAO.
DR   GO; GO:1905323; P:telomerase holoenzyme complex assembly; IDA:BHF-UCL.
DR   GO; GO:0007004; P:telomere maintenance via telomerase; IDA:BHF-UCL.
DR   GO; GO:0019062; P:virion attachment to host cell; IMP:CACAO.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cell membrane; Chaperone;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Glycoprotein;
KW   Membrane; Methylation; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; S-nitrosylation; Secreted;
KW   Stress response; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:2492519}.
FT   CHAIN         2    724       Heat shock protein HSP 90-beta.
FT                                /FTId=PRO_0000062917.
FT   REGION        2    527       Interaction with TP53.
FT                                {ECO:0000269|PubMed:15358771}.
FT   REGION        2    214       Interaction with BIRC2.
FT                                {ECO:0000269|PubMed:25486457}.
FT   REGION      215    552       Interaction with AHSA1.
FT                                {ECO:0000269|PubMed:25486457}.
FT   MOTIF       720    724       TPR repeat-binding.
FT   BINDING      46     46       ATP. {ECO:0000250}.
FT   BINDING      88     88       ATP.
FT   BINDING     107    107       ATP. {ECO:0000250}.
FT   BINDING     133    133       ATP; via amide nitrogen. {ECO:0000250}.
FT   BINDING     392    392       ATP. {ECO:0000250}.
FT   SITE        126    127       Cleaved under oxidative stress.
FT                                {ECO:0000269|PubMed:22848402}.
FT   MOD_RES     219    219       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     226    226       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     255    255       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|Ref.12}.
FT   MOD_RES     261    261       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     297    297       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     301    301       Phosphotyrosine; by SRC.
FT                                {ECO:0000269|PubMed:23585225}.
FT   MOD_RES     305    305       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     307    307       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     399    399       N6-malonyllysine.
FT                                {ECO:0000269|PubMed:21908771}.
FT   MOD_RES     435    435       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     445    445       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     479    479       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     481    481       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     484    484       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     531    531       N6-methylated lysine; alternate.
FT                                {ECO:0000269|PubMed:24880080}.
FT   MOD_RES     531    531       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     574    574       N6-methylated lysine.
FT                                {ECO:0000269|PubMed:24880080}.
FT   MOD_RES     577    577       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     590    590       S-nitrosocysteine.
FT                                {ECO:0000305|PubMed:19696785}.
FT   MOD_RES     624    624       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     669    669       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     718    718       Phosphoserine; by PLK2 and PLK3.
FT                                {ECO:0000269|PubMed:22828320}.
FT   CARBOHYD    434    434       O-linked (GlcNAc) serine. {ECO:0000250}.
FT   CARBOHYD    452    452       O-linked (GlcNAc) serine. {ECO:0000250}.
FT   VARIANT     349    349       K -> E (in dbSNP:rs11538975).
FT                                /FTId=VAR_049624.
FT   MUTAGEN      42     42       E->A: Strong ATP-binding. Strong
FT                                interaction with HSF1, HIF1A, ERBB2, MET,
FT                                KEAP1 and RHOBTB2.
FT                                {ECO:0000269|PubMed:26517842}.
FT   MUTAGEN      88     88       D->A: Impaired ATP-binding. Strong
FT                                interaction with HIF1A, MET, KEAP1 and
FT                                RHOBTB2. Loss of interaction with HSF1
FT                                and ERBB2. {ECO:0000269|PubMed:26517842}.
FT   MUTAGEN     226    226       S->A: Increases the binding affinity for
FT                                AHR; when associated with A-255.
FT                                Increases AHR transcription activity;
FT                                when associated with A-255.
FT                                {ECO:0000269|PubMed:15581363}.
FT   MUTAGEN     226    226       S->E: No effect on the interaction with
FT                                AHR; when associated with E-255.
FT                                {ECO:0000269|PubMed:15581363}.
FT   MUTAGEN     255    255       S->A: Increases the binding affinity for
FT                                AHR; when associated with A-226.
FT                                Increases AHR transcription activity;
FT                                when associated with A-226.
FT                                {ECO:0000269|PubMed:15581363}.
FT   MUTAGEN     255    255       S->E: No effect on the interaction with
FT                                AHR; when associated with E-226.
FT                                {ECO:0000269|PubMed:15581363}.
FT   MUTAGEN     301    301       Y->F: Decreases interaction with NOS3 and
FT                                SRC. impairs resists LPS-induced tyrosine
FT                                phosphorylation. Does not block LPS-
FT                                induced pp60src phosphorylation.
FT                                {ECO:0000269|PubMed:23585225}.
FT   MUTAGEN     531    531       K->A: Highly decreases the signal of
FT                                SMYD2-dependent HSP90AB1 methylation;
FT                                when associated with A-574. Diminishes
FT                                dimerized form; when associated with A-
FT                                574. Reduces interaction with STIP1 or
FT                                CDC37; when associated with A-574.
FT                                {ECO:0000269|PubMed:24880080}.
FT   MUTAGEN     574    574       K->A: Decreases the signal of SMYD2-
FT                                dependent HSP90AB1 methylation. Highly
FT                                decreases the signal of SMYD2-dependent
FT                                HSP90AB1 methylation; when associated
FT                                with A-531. Diminishes dimerized form;
FT                                when associated with A-531. Reduces
FT                                interaction with STIP1 or CDC37; when
FT                                associated with A-531.
FT                                {ECO:0000269|PubMed:24880080}.
FT   MUTAGEN     590    590       C->A,N,D: Reduced ATPase activity and
FT                                client protein activation.
FT                                {ECO:0000269|PubMed:19696785}.
FT   CONFLICT    147    147       T -> R (in Ref. 1; AAA36025).
FT                                {ECO:0000305}.
FT   CONFLICT    177    177       R -> M (in Ref. 1; AAA36025).
FT                                {ECO:0000305}.
FT   CONFLICT    403    403       V -> A (in Ref. 5; CAB66478).
FT                                {ECO:0000305}.
FT   STRAND       13     16       {ECO:0000244|PDB:3NMQ}.
FT   HELIX        19     30       {ECO:0000244|PDB:3NMQ}.
FT   HELIX        38     60       {ECO:0000244|PDB:3NMQ}.
FT   HELIX        62     65       {ECO:0000244|PDB:3NMQ}.
FT   STRAND       73     78       {ECO:0000244|PDB:3NMQ}.
FT   TURN         79     82       {ECO:0000244|PDB:3NMQ}.
FT   STRAND       83     88       {ECO:0000244|PDB:3NMQ}.
FT   HELIX        95     99       {ECO:0000244|PDB:3NMQ}.
FT   HELIX       101    118       {ECO:0000244|PDB:3NMQ}.
FT   HELIX       123    129       {ECO:0000244|PDB:3NMQ}.
FT   HELIX       132    138       {ECO:0000244|PDB:3NMQ}.
FT   STRAND      140    148       {ECO:0000244|PDB:3NMQ}.
FT   STRAND      155    159       {ECO:0000244|PDB:3NMQ}.
FT   STRAND      164    169       {ECO:0000244|PDB:3NMQ}.
FT   STRAND      176    185       {ECO:0000244|PDB:3NMQ}.
FT   HELIX       187    193       {ECO:0000244|PDB:3NMQ}.
FT   HELIX       195    205       {ECO:0000244|PDB:3NMQ}.
FT   STRAND      213    215       {ECO:0000244|PDB:3NMQ}.
FT   HELIX       288    290       {ECO:0000244|PDB:3PRY}.
FT   HELIX       293    295       {ECO:0000244|PDB:3PRY}.
FT   HELIX       298    309       {ECO:0000244|PDB:3PRY}.
FT   STRAND      316    323       {ECO:0000244|PDB:3PRY}.
FT   STRAND      325    327       {ECO:0000244|PDB:3PRY}.
FT   STRAND      329    335       {ECO:0000244|PDB:3PRY}.
FT   STRAND      353    357       {ECO:0000244|PDB:3PRY}.
FT   STRAND      360    364       {ECO:0000244|PDB:3PRY}.
FT   HELIX       367    369       {ECO:0000244|PDB:3PRY}.
FT   HELIX       372    374       {ECO:0000244|PDB:3PRY}.
FT   STRAND      378    386       {ECO:0000244|PDB:3PRY}.
FT   HELIX       395    420       {ECO:0000244|PDB:3PRY}.
FT   HELIX       423    443       {ECO:0000244|PDB:3PRY}.
FT   HELIX       445    447       {ECO:0000244|PDB:3PRY}.
FT   HELIX       448    453       {ECO:0000244|PDB:3PRY}.
FT   STRAND      456    459       {ECO:0000244|PDB:3PRY}.
FT   TURN        460    464       {ECO:0000244|PDB:3PRY}.
FT   HELIX       469    474       {ECO:0000244|PDB:3PRY}.
FT   STRAND      482    486       {ECO:0000244|PDB:3PRY}.
FT   HELIX       491    495       {ECO:0000244|PDB:3PRY}.
FT   HELIX       498    504       {ECO:0000244|PDB:3PRY}.
FT   TURN        505    507       {ECO:0000244|PDB:3PRY}.
FT   STRAND      510    512       {ECO:0000244|PDB:3PRY}.
FT   HELIX       518    525       {ECO:0000244|PDB:3PRY}.
FT   STRAND      531    535       {ECO:0000244|PDB:3PRY}.
SQ   SEQUENCE   724 AA;  83264 MW;  A93118C214D03810 CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRYESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     ADISMIGQFG VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGEPIGRGTK
     VILHLKEDQT EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE
     DKDDEEKPKI EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE
     YGEFYKSLTN DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFENKKKK NNIKLYVRRV
     FIMDSCDELI PEYLNFIRGV VDSEDLPLNI SREMLQQSKI LKVIRKNIVK KCLELFSELA
     EDKENYKKFY EAFSKNLKLG IHEDSTNRRR LSELLRYHTS QSGDEMTSLS EYVSRMKETQ
     KSIYYITGES KEQVANSAFV ERVRKRGFEV VYMTEPIDEY CVQQLKEFDG KSLVSVTKEG
     LELPEDEEEK KKMEESKAKF ENLCKLMKEI LDKKVEKVTI SNRLVSSPCC IVTSTYGWTA
     NMERIMKAQA LRDNSTMGYM MAKKHLEINP DHPIVETLRQ KAEADKNDKA VKDLVVLLFE
     TALLSSGFSL EDPQTHSNRI YRMIKLGLGI DEDEVAAEEP NAAVPDEIPP LEGDEDASRM
     EEVD
//
ID   Q6PK50_HUMAN            Unreviewed;       351 AA.
AC   Q6PK50;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 81.
DE   SubName: Full=HSP90AB1 protein {ECO:0000313|EMBL:AAH07327.1};
DE   Flags: Fragment;
GN   Name=HSP90AB1 {ECO:0000313|EMBL:AAH07327.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH07327.1};
RN   [1] {ECO:0000313|EMBL:AAH07327.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas {ECO:0000313|EMBL:AAH07327.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       Q7L3B6:CDC37L1; NbExp=2; IntAct=EBI-9356629, EBI-2841876;
CC       P00533:EGFR; NbExp=2; IntAct=EBI-9356629, EBI-297353;
CC       P07900:HSP90AA1; NbExp=2; IntAct=EBI-9356629, EBI-296047;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC007327; AAH07327.1; -; mRNA.
DR   RefSeq; NP_001258901.1; NM_001271972.1.
DR   UniGene; Hs.509736; -.
DR   ProteinModelPortal; Q6PK50; -.
DR   IntAct; Q6PK50; 99.
DR   PeptideAtlas; Q6PK50; -.
DR   PRIDE; Q6PK50; -.
DR   GeneID; 3326; -.
DR   CTD; 3326; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   HOVERGEN; HBG007374; -.
DR   ChiTaRS; HSP90AB1; human.
DR   GenomeRNAi; 3326; -.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0006950; P:response to stress; IEA:InterPro.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   1: Evidence at protein level;
FT   DOMAIN       35    189       HATPase_c. {ECO:0000259|SMART:SM00387}.
FT   NON_TER     351    351       {ECO:0000313|EMBL:AAH07327.1}.
SQ   SEQUENCE   351 AA;  40295 MW;  5CA7AFC5181A33A5 CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRYESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     ADISMIGQFG VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGEPIGRGTK
     VILHLKEDQT EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE
     DKDDEEKPKI EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE
     YGEFYKSLTN DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFEKKKKK K
//
ID   IL2_HUMAN               Reviewed;         153 AA.
AC   P60568; P01585;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   28-FEB-2018, entry version 160.
DE   RecName: Full=Interleukin-2;
DE            Short=IL-2;
DE   AltName: Full=T-cell growth factor;
DE            Short=TCGF;
DE   AltName: INN=Aldesleukin;
DE   Flags: Precursor;
GN   Name=IL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6312994; DOI=10.1016/S0006-291X(83)80040-0;
RA   Maeda S., Nishino N., Obaru K., Mita S., Nomiyama H., Shimada K.,
RA   Fujimoto K., Teranishi T., Hirano T., Onoue K.;
RT   "Cloning of interleukin 2 mRNAs from human tonsils.";
RL   Biochem. Biophys. Res. Commun. 115:1040-1047(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=6403867; DOI=10.1038/302305a0;
RA   Taniguchi T., Matsui H., Fujita T., Takaoka C., Kashima N.,
RA   Yoshimoto R., Hamuro J.;
RT   "Structure and expression of a cloned cDNA for human interleukin-2.";
RL   Nature 302:305-310(1983).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6306584; DOI=10.1093/nar/11.13.4307;
RA   Devos R., Plaetinck G., Cheroutre H., Simons G., Degrave W.,
RA   Tavernier J., Remaut E., Fiers W.;
RT   "Molecular cloning of human interleukin 2 cDNA and its expression in
RT   E. coli.";
RL   Nucleic Acids Res. 11:4307-4323(1983).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6324170; DOI=10.1073/pnas.80.24.7437;
RA   Fujita T., Takaoka C., Matsui H., Taniguchi T.;
RT   "Structure of the human interleukin 2 gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:7437-7441(1983).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6330695; DOI=10.1093/nar/12.12.5005;
RA   Holbrook N.J., Lieber M., Crabtree G.R.;
RT   "DNA sequence of the 5' flanking region of the human interleukin 2
RT   gene: homologies with adult T-cell leukemia virus.";
RL   Nucleic Acids Res. 12:5005-5013(1984).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6608729; DOI=10.1073/pnas.81.6.1634;
RA   Holbrook N.J., Smith K.A., Fornace A.J. Jr., Comeau C.M.,
RA   Wiskocil R.L., Crabtree G.R.;
RT   "T-cell growth factor: complete nucleotide sequence and organization
RT   of the gene in normal and malignant cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:1634-1638(1984).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7722480;
RA   Eizenberg O., Faber-Elman A., Lotan M., Schwartz M.;
RT   "Interleukin-2 transcripts in human and rodent brains: possible
RT   expression by astrocytes.";
RL   J. Neurochem. 64:1928-1936(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=8824916;
RX   DOI=10.1002/(SICI)1098-2795(199602)43:2<180::AID-MRD7>3.0.CO;2-N;
RA   Chernicky C.L., Tan H., Burfeind P., Ilan J., Ilan J.;
RT   "Sequence of interleukin-2 isolated from human placental poly A+ RNA:
RT   possible role in maintenance of fetal allograft.";
RL   Mol. Reprod. Dev. 43:180-186(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-68.
RA   Nishino N., Obaru K., Maeda S., Shimada K., Onoue K.;
RT   "Organization of the DNA regions flanking the human interleukin 2
RT   gene.";
RL   Biomed. Res. 6:197-205(1985).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-69.
RX   PubMed=3491296; DOI=10.1128/MCB.6.9.3042;
RA   Siebenlist U., Durand D.B., Bressler P., Holbrook N.J., Norris C.A.,
RA   Kamoun M., Kant J.A., Crabtree G.R.;
RT   "Promoter region of interleukin-2 gene undergoes chromatin structure
RT   changes and confers inducibility on chloramphenicol acetyltransferase
RT   gene during activation of T cells.";
RL   Mol. Cell. Biol. 6:3042-3049(1986).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 21-153.
RX   PubMed=3264184; DOI=10.1021/bi00418a034;
RA   Weir M.P., Chaplin M.A., Wallace D.M., Dykes C.W., Hobden A.N.;
RT   "Structure-activity relationships of recombinant human interleukin
RT   2.";
RL   Biochemistry 27:6883-6892(1988).
RN   [14]
RP   PROTEIN SEQUENCE OF 21-153, DISULFIDE BOND, AND GLYCOSYLATION AT
RP   THR-23.
RX   PubMed=6333684; DOI=10.1073/pnas.81.20.6486;
RA   Robb R.J., Kutny R.M., Panico M., Morris H.R., Chowdhry V.;
RT   "Amino acid sequence and post-translational modification of human
RT   interleukin 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:6486-6490(1984).
RN   [15]
RP   GLYCOSYLATION AT THR-23.
RX   PubMed=2793860;
RA   Conradt H.S., Nimtz M., Dittmar K.E.J., Lindenmaier W., Hoppe J.,
RA   Hauser H.;
RT   "Expression of human interleukin-2 in recombinant baby hamster kidney,
RT   Ltk-, and Chinese hamster ovary cells. Structure of O-linked
RT   carbohydrate chains and their location within the polypeptide.";
RL   J. Biol. Chem. 264:17368-17373(1989).
RN   [16]
RP   CHROMOSOMAL TRANSLOCATION WITH TNFRSF17.
RX   PubMed=1396583;
RA   Laabi Y., Gras M.P., Carbonnel F., Brouet J.C., Berger R.,
RA   Larsen C.-J., Tsapis A.;
RT   "A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene
RT   by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma.";
RL   EMBO J. 11:3897-3904(1992).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=3500515; DOI=10.1126/science.3500515;
RA   Brandhuber B.J., Boone T., Kenney W.C., McKay D.B.;
RT   "Three-dimensional structure of interleukin-2.";
RL   Science 238:1707-1709(1987).
RN   [18]
RP   COMPARISON OF X-RAY STRUCTURES.
RX   PubMed=1631562; DOI=10.1126/science.1631562;
RA   Bazan J.F.;
RT   "Unraveling the structure of IL-2.";
RL   Science 257:410-412(1992).
RN   [19]
RP   RESPONSE TO PUBMED:1631562.
RA   McKay D.B.;
RL   Science 257:412-413(1992).
RN   [20]
RP   STRUCTURE BY NMR.
RX   PubMed=1510960; DOI=10.1021/bi00148a040;
RA   Mott H.R., Driscoll P.C., Boyd J., Cooke R.M., Weir M.P.,
RA   Campbell I.D.;
RT   "Secondary structure of human interleukin 2 from 3D heteronuclear NMR
RT   experiments.";
RL   Biochemistry 31:7741-7744(1992).
RN   [21]
RP   3D-STRUCTURE MODELING.
RX   PubMed=7529123; DOI=10.1016/S0969-2126(94)00085-9;
RA   Bamborough P., Hedgecock C.J., Richards W.G.;
RT   "The interleukin-2 and interleukin-4 receptors studied by molecular
RT   modelling.";
RL   Structure 2:839-851(1994).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 21-153 IN COMPLEX WITH IL2RA;
RP   IL2RB AND IL2RC.
RX   PubMed=16293754; DOI=10.1126/science.1117893;
RA   Wang X., Rickert M., Garcia K.C.;
RT   "Structure of the quaternary complex of interleukin-2 with its alpha,
RT   beta, and gammac receptors.";
RL   Science 310:1159-1163(2005).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 21-153 IN COMPLEX WITH IL2RA;
RP   IL2RB AND IL2RC, AND DISULFIDE BOND.
RX   PubMed=16477002; DOI=10.1073/pnas.0511161103;
RA   Stauber D.J., Debler E.W., Horton P.A., Smith K.A., Wilson I.A.;
RT   "Crystal structure of the IL-2 signaling complex: paradigm for a
RT   heterotrimeric cytokine receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:2788-2793(2006).
CC   -!- FUNCTION: Produced by T-cells in response to antigenic or
CC       mitogenic stimulation, this protein is required for T-cell
CC       proliferation and other activities crucial to regulation of the
CC       immune response. Can stimulate B-cells, monocytes, lymphokine-
CC       activated killer cells, natural killer cells, and glioma cells.
CC   -!- INTERACTION:
CC       P01589:IL2RA; NbExp=3; IntAct=EBI-12508717, EBI-8614302;
CC       P14784:IL2RB; NbExp=5; IntAct=EBI-12508717, EBI-2866779;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- DISEASE: Note=A chromosomal aberration involving IL2 is found in a
CC       form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation
CC       t(4;16)(q26;p13) with involves TNFRSF17.
CC       {ECO:0000269|PubMed:1396583}.
CC   -!- PHARMACEUTICAL: Available under the name Proleukin (Chiron). Used
CC       in patients with renal cell carcinoma or metastatic melanoma.
CC   -!- SIMILARITY: Belongs to the IL-2 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA59140.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Interleukin-2 entry;
CC       URL="https://en.wikipedia.org/wiki/Interleukin_2";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/il2/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=IL2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00695; CAA25292.1; -; Genomic_DNA.
DR   EMBL; V00564; CAA23827.1; -; mRNA.
DR   EMBL; X01586; CAA25742.1; -; mRNA.
DR   EMBL; J00264; AAD48509.1; -; Genomic_DNA.
DR   EMBL; K02056; AAA98792.1; -; Genomic_DNA.
DR   EMBL; S77834; AAD14263.2; -; mRNA.
DR   EMBL; S82692; AAB46883.1; -; mRNA.
DR   EMBL; AF359939; AAK26665.1; -; Genomic_DNA.
DR   EMBL; BC066255; AAH66255.1; -; mRNA.
DR   EMBL; BC066257; AAH66257.1; -; mRNA.
DR   EMBL; BC070338; AAH70338.1; -; mRNA.
DR   EMBL; M33199; AAA59139.1; -; Genomic_DNA.
DR   EMBL; M13879; AAA59141.1; -; Genomic_DNA.
DR   EMBL; M22005; AAA59140.1; ALT_INIT; Genomic_DNA.
DR   CCDS; CCDS3726.1; -.
DR   PIR; A01849; ICHU2.
DR   RefSeq; NP_000577.2; NM_000586.3.
DR   UniGene; Hs.89679; -.
DR   PDB; 1ILM; Model; -; 2=26-153.
DR   PDB; 1ILN; Model; -; 2=26-153.
DR   PDB; 1IRL; NMR; -; A=21-153.
DR   PDB; 1M47; X-ray; 1.99 A; A=21-153.
DR   PDB; 1M48; X-ray; 1.95 A; A/B=21-153.
DR   PDB; 1M49; X-ray; 2.00 A; A/B=21-153.
DR   PDB; 1M4A; X-ray; 2.18 A; A=21-153.
DR   PDB; 1M4B; X-ray; 2.15 A; A=21-153.
DR   PDB; 1M4C; X-ray; 2.40 A; A/B=21-153.
DR   PDB; 1NBP; X-ray; 2.20 A; A=21-153.
DR   PDB; 1PW6; X-ray; 2.60 A; A/B=21-153.
DR   PDB; 1PY2; X-ray; 2.80 A; A/B/C/D=21-152.
DR   PDB; 1QVN; X-ray; 2.70 A; A/B/C/D=21-152.
DR   PDB; 1Z92; X-ray; 2.80 A; A=21-153.
DR   PDB; 2B5I; X-ray; 2.30 A; A=21-153.
DR   PDB; 2ERJ; X-ray; 3.00 A; D/H=21-153.
DR   PDB; 3INK; X-ray; 2.50 A; C/D=21-153.
DR   PDB; 3QAZ; X-ray; 3.80 A; A/D/G/J/M/P/S/V/Y/b/e/h=21-153.
DR   PDB; 3QB1; X-ray; 3.10 A; A/B/C/D/E/F/G/H=21-153.
DR   PDB; 4NEJ; X-ray; 1.92 A; A=24-153.
DR   PDB; 4NEM; X-ray; 1.93 A; A=24-153.
DR   PDB; 5LQB; X-ray; 1.95 A; A=22-153.
DR   PDB; 5M5E; X-ray; 2.30 A; D=8-153.
DR   PDBsum; 1ILM; -.
DR   PDBsum; 1ILN; -.
DR   PDBsum; 1IRL; -.
DR   PDBsum; 1M47; -.
DR   PDBsum; 1M48; -.
DR   PDBsum; 1M49; -.
DR   PDBsum; 1M4A; -.
DR   PDBsum; 1M4B; -.
DR   PDBsum; 1M4C; -.
DR   PDBsum; 1NBP; -.
DR   PDBsum; 1PW6; -.
DR   PDBsum; 1PY2; -.
DR   PDBsum; 1QVN; -.
DR   PDBsum; 1Z92; -.
DR   PDBsum; 2B5I; -.
DR   PDBsum; 2ERJ; -.
DR   PDBsum; 3INK; -.
DR   PDBsum; 3QAZ; -.
DR   PDBsum; 3QB1; -.
DR   PDBsum; 4NEJ; -.
DR   PDBsum; 4NEM; -.
DR   PDBsum; 5LQB; -.
DR   PDBsum; 5M5E; -.
DR   ProteinModelPortal; P60568; -.
DR   SMR; P60568; -.
DR   BioGrid; 109773; 2.
DR   CORUM; P60568; -.
DR   DIP; DIP-475N; -.
DR   IntAct; P60568; 3.
DR   STRING; 9606.ENSP00000226730; -.
DR   BindingDB; P60568; -.
DR   ChEMBL; CHEMBL5880; -.
DR   DrugBank; DB03455; (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid.
DR   DrugBank; DB04278; 2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide.
DR   DrugBank; DB05676; Apremilast.
DR   DrugBank; DB05299; keyhole limpet hemocyanin.
DR   DrugBank; DB00852; Pseudoephedrine.
DR   DrugBank; DB03957; SP2456.
DR   DrugBank; DB02555; SP4160.
DR   DrugBank; DB05304; WX-G250.
DR   iPTMnet; P60568; -.
DR   PhosphoSitePlus; P60568; -.
DR   UniCarbKB; P60568; -.
DR   BioMuta; IL2; -.
DR   DMDM; 45593462; -.
DR   PaxDb; P60568; -.
DR   PeptideAtlas; P60568; -.
DR   PRIDE; P60568; -.
DR   DNASU; 3558; -.
DR   Ensembl; ENST00000226730; ENSP00000226730; ENSG00000109471.
DR   GeneID; 3558; -.
DR   KEGG; hsa:3558; -.
DR   CTD; 3558; -.
DR   DisGeNET; 3558; -.
DR   EuPathDB; HostDB:ENSG00000109471.4; -.
DR   GeneCards; IL2; -.
DR   HGNC; HGNC:6001; IL2.
DR   HPA; CAB010310; -.
DR   MIM; 147680; gene.
DR   neXtProt; NX_P60568; -.
DR   OpenTargets; ENSG00000109471; -.
DR   PharmGKB; PA195; -.
DR   eggNOG; ENOG410J049; Eukaryota.
DR   eggNOG; ENOG41119SF; LUCA.
DR   GeneTree; ENSGT00390000003555; -.
DR   HOVERGEN; HBG007496; -.
DR   InParanoid; P60568; -.
DR   KO; K05429; -.
DR   OMA; KWITFCQ; -.
DR   OrthoDB; EOG091G0VTZ; -.
DR   PhylomeDB; P60568; -.
DR   TreeFam; TF338200; -.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-392451; G beta:gamma signalling through PI3Kgamma.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-8877330; RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs).
DR   Reactome; R-HSA-9020558; Interleukin-2 signaling.
DR   Reactome; R-HSA-912526; Interleukin receptor SHC signaling.
DR   SignaLink; P60568; -.
DR   SIGNOR; P60568; -.
DR   ChiTaRS; IL2; human.
DR   EvolutionaryTrace; P60568; -.
DR   GeneWiki; Interleukin_2; -.
DR   GenomeRNAi; 3558; -.
DR   PRO; PR:P60568; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000109471; -.
DR   CleanEx; HS_IL2; -.
DR   ExpressionAtlas; P60568; baseline and differential.
DR   Genevisible; P60568; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; TAS:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:Ensembl.
DR   GO; GO:0005125; F:cytokine activity; IDA:MGI.
DR   GO; GO:0043208; F:glycosphingolipid binding; IEA:Ensembl.
DR   GO; GO:0008083; F:growth factor activity; TAS:UniProtKB.
DR   GO; GO:0005134; F:interleukin-2 receptor binding; IDA:MGI.
DR   GO; GO:0031851; F:kappa-type opioid receptor binding; IEA:Ensembl.
DR   GO; GO:0019209; F:kinase activator activity; TAS:UniProtKB.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; TAS:UniProtKB.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; TAS:UniProtKB.
DR   GO; GO:0038110; P:interleukin-2-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0002366; P:leukocyte activation involved in immune response; IDA:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0030101; P:natural killer cell activation; TAS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0002903; P:negative regulation of B cell apoptotic process; IDA:MGI.
DR   GO; GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0050672; P:negative regulation of lymphocyte proliferation; IEA:Ensembl.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:2000320; P:negative regulation of T-helper 17 cell differentiation; IEA:Ensembl.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; IDA:MGI.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; IDA:MGI.
DR   GO; GO:0030307; P:positive regulation of cell growth; TAS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IEA:Ensembl.
DR   GO; GO:0051024; P:positive regulation of immunoglobulin secretion; IEA:Ensembl.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; IDA:BHF-UCL.
DR   GO; GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl.
DR   GO; GO:0045591; P:positive regulation of regulatory T cell differentiation; IEA:Ensembl.
DR   GO; GO:0034105; P:positive regulation of tissue remodeling; IC:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IDA:BHF-UCL.
DR   GO; GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0045589; P:regulation of regulatory T cell differentiation; TAS:Reactome.
DR   GO; GO:0046013; P:regulation of T cell homeostatic proliferation; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0030217; P:T cell differentiation; TAS:UniProtKB.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR000779; IL-2.
DR   InterPro; IPR030477; IL-2_CS.
DR   PANTHER; PTHR45426; PTHR45426; 1.
DR   Pfam; PF00715; IL2; 1.
DR   PRINTS; PR00265; INTERLEUKIN2.
DR   ProDom; PD003649; Interleukin-2; 1.
DR   SMART; SM00189; IL2; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00424; INTERLEUKIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Chromosomal rearrangement;
KW   Complete proteome; Cytokine; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Growth factor; Immunity; Pharmaceutical;
KW   Proto-oncogene; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     20       {ECO:0000269|PubMed:6333684}.
FT   CHAIN        21    153       Interleukin-2.
FT                                /FTId=PRO_0000015484.
FT   CARBOHYD     23     23       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:2793860,
FT                                ECO:0000269|PubMed:6333684}.
FT                                /FTId=CAR_000051.
FT   DISULFID     78    125       {ECO:0000269|PubMed:16477002,
FT                                ECO:0000269|PubMed:6333684}.
FT   VARIANT      21     21       Missing (in FT-IL2-A and FT-IL2-B).
FT                                /FTId=VAR_003967.
FT   VARIANT      22     22       Missing (in FT-IL2-B).
FT                                /FTId=VAR_003968.
FT   HELIX        25     49       {ECO:0000244|PDB:4NEJ}.
FT   HELIX        53     59       {ECO:0000244|PDB:4NEJ}.
FT   HELIX        60     62       {ECO:0000244|PDB:1IRL}.
FT   STRAND       64     68       {ECO:0000244|PDB:3INK}.
FT   HELIX        73     76       {ECO:0000244|PDB:4NEJ}.
FT   HELIX        77     93       {ECO:0000244|PDB:4NEJ}.
FT   TURN         95     97       {ECO:0000244|PDB:1M48}.
FT   STRAND       98    100       {ECO:0000244|PDB:3INK}.
FT   HELIX       105    117       {ECO:0000244|PDB:4NEJ}.
FT   HELIX       120    122       {ECO:0000244|PDB:5LQB}.
FT   STRAND      127    132       {ECO:0000244|PDB:3INK}.
FT   HELIX       134    149       {ECO:0000244|PDB:4NEJ}.
FT   TURN        150    152       {ECO:0000244|PDB:4NEJ}.
SQ   SEQUENCE   153 AA;  17628 MW;  59E2F40F25860F84 CRC64;
     MYRMQLLSCI ALSLALVTNS APTSSSTKKT QLQLEHLLLD LQMILNGINN YKNPKLTRML
     TFKFYMPKKA TELKHLQCLE EELKPLEEVL NLAQSKNFHL RPRDLISNIN VIVLELKGSE
     TTFMCEYADE TATIVEFLNR WITFCQSIIS TLT
//
ID   Q0GK43_HUMAN            Unreviewed;       153 AA.
AC   Q0GK43;
DT   03-OCT-2006, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2006, sequence version 1.
DT   31-JAN-2018, entry version 102.
DE   RecName: Full=Interleukin-2 {ECO:0000256|RuleBase:RU363134};
DE            Short=IL-2 {ECO:0000256|RuleBase:RU363134};
GN   Name=IL2 {ECO:0000256|RuleBase:RU363134, ECO:0000313|EMBL:BAG70139.1};
GN   ORFNames=hCG_38828 {ECO:0000313|EMBL:EAX05227.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABI20697.1};
RN   [1] {ECO:0000313|EMBL:EAX05227.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX05227.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ABI20697.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Saxena A., Rai A., Salunkhe S.S., Gupta P.K., Tiwari A.K., Kumar S.,
RA   Ahi Y.S., Sandey M.;
RT   "Cloning of human interleukin-2 gene in a mammalian expression
RT   vector.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG70139.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J.-I., Kimura K., Nishikawa T., Andoh T.,
RA   Iida Y., Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K.,
RA   Kawakami B., Kenmochi K.-I., Kimura R., Kobayashi M., Kuroita T.,
RA   Kuwayama H., Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J.-I., Watanabe S., Nomura N.;
RT   "Human Protein Factory: an infrastructure to convert the human
RT   transcriptome into the in vitro-expressed human proteome of versatile
RT   utility.";
RL   Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Produced by T-cells in response to antigenic or
CC       mitogenic stimulation, this protein is required for T-cell
CC       proliferation and other activities crucial to regulation of the
CC       immune response. {ECO:0000256|RuleBase:RU363134}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|RuleBase:RU363134}.
CC   -!- SIMILARITY: Belongs to the IL-2 family.
CC       {ECO:0000256|RuleBase:RU363134}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ861285; ABI20697.1; -; mRNA.
DR   EMBL; AB451325; BAG70139.1; -; mRNA.
DR   EMBL; AB451454; BAG70268.1; -; mRNA.
DR   EMBL; CH471056; EAX05227.1; -; Genomic_DNA.
DR   RefSeq; NP_000577.2; NM_000586.3.
DR   UniGene; Hs.89679; -.
DR   SMR; Q0GK43; -.
DR   DNASU; 3558; -.
DR   GeneID; 3558; -.
DR   KEGG; hsa:3558; -.
DR   UCSC; uc003ier.4; human.
DR   CTD; 3558; -.
DR   EuPathDB; HostDB:ENSG00000109471.4; -.
DR   PharmGKB; PA195; -.
DR   eggNOG; ENOG410J049; Eukaryota.
DR   eggNOG; ENOG41119SF; LUCA.
DR   HOVERGEN; HBG007496; -.
DR   KO; K05429; -.
DR   OMA; KWITFCQ; -.
DR   OrthoDB; EOG091G0VTZ; -.
DR   ChiTaRS; IL2; human.
DR   GenomeRNAi; 3558; -.
DR   Bgee; ENSG00000109471; -.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:Ensembl.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0043208; F:glycosphingolipid binding; IEA:Ensembl.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005134; F:interleukin-2 receptor binding; IEA:Ensembl.
DR   GO; GO:0031851; F:kappa-type opioid receptor binding; IEA:Ensembl.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR   GO; GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0050672; P:negative regulation of lymphocyte proliferation; IEA:Ensembl.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:2000320; P:negative regulation of T-helper 17 cell differentiation; IEA:Ensembl.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IEA:Ensembl.
DR   GO; GO:0051024; P:positive regulation of immunoglobulin secretion; IEA:Ensembl.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl.
DR   GO; GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl.
DR   GO; GO:0045591; P:positive regulation of regulatory T cell differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IEA:Ensembl.
DR   GO; GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0046013; P:regulation of T cell homeostatic proliferation; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR000779; IL-2.
DR   InterPro; IPR030477; IL-2_CS.
DR   PANTHER; PTHR45426; PTHR45426; 1.
DR   Pfam; PF00715; IL2; 1.
DR   PRINTS; PR00265; INTERLEUKIN2.
DR   ProDom; PD003649; Interleukin-2; 1.
DR   SMART; SM00189; IL2; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00424; INTERLEUKIN_2; 1.
PE   2: Evidence at transcript level;
KW   Adaptive immunity {ECO:0000256|RuleBase:RU363134};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Cytokine {ECO:0000256|RuleBase:RU363134};
KW   Disulfide bond {ECO:0000256|RuleBase:RU363134};
KW   Growth factor {ECO:0000256|RuleBase:RU363134};
KW   Immunity {ECO:0000256|RuleBase:RU363134};
KW   Secreted {ECO:0000256|RuleBase:RU363134};
KW   Signal {ECO:0000256|RuleBase:RU363134}.
FT   SIGNAL        1     20       {ECO:0000256|RuleBase:RU363134}.
FT   CHAIN        21    153       Interleukin-2.
FT                                {ECO:0000256|RuleBase:RU363134}.
FT                                /FTId=PRO_5011326775.
FT   COILED       76     96       {ECO:0000256|SAM:Coils}.
FT   NON_TER     153    153       {ECO:0000313|EMBL:BAG70268.1}.
SQ   SEQUENCE   153 AA;  17628 MW;  59E2F40F25860F84 CRC64;
     MYRMQLLSCI ALSLALVTNS APTSSSTKKT QLQLEHLLLD LQMILNGINN YKNPKLTRML
     TFKFYMPKKA TELKHLQCLE EELKPLEEVL NLAQSKNFHL RPRDLISNIN VIVLELKGSE
     TTFMCEYADE TATIVEFLNR WITFCQSIIS TLT
//
ID   IL21R_HUMAN             Reviewed;         538 AA.
AC   Q9HBE5; A8K9E8; D3DWF7; Q96HZ1; Q9HB91;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-FEB-2018, entry version 159.
DE   RecName: Full=Interleukin-21 receptor;
DE            Short=IL-21 receptor;
DE            Short=IL-21R;
DE   AltName: Full=Novel interleukin receptor;
DE   AltName: CD_antigen=CD360;
DE   Flags: Precursor;
GN   Name=IL21R; Synonyms=NILR; ORFNames=UNQ3121/PRO10273;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11081504; DOI=10.1038/35040504;
RA   Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C.,
RA   Gross J.A., Johnston J., Madden K., Xu W., West J., Schrader S.,
RA   Burkhead S., Heipel M., Brandt C., Kuijper J.L., Kramer J.,
RA   Conklin D., Presnell S.R., Berry J., Shiota F., Bort S., Hambly K.,
RA   Mudri S., Clegg C., Moore M., Grant F.J., Lofton-Day C., Gilbert T.,
RA   Raymond F., Ching A., Yao L., Smith D., Webster P., Whitmore T.,
RA   Maurer M., Kaushansky K., Holly R.D., Foster D.;
RT   "Interleukin 21 and its receptor are involved in NK cell expansion and
RT   regulation of lymphocyte function.";
RL   Nature 408:57-63(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11016959; DOI=10.1073/pnas.200360997;
RA   Ozaki K., Kikly K., Michalovich D., Young P.R., Leonard W.J.;
RT   "Cloning of a type I cytokine receptor most related to the IL-2
RT   receptor beta chain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:11439-11444(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-191; ARG-318 AND
RP   SER-484.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=B-cell, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 20-34.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [9]
RP   INVOLVEMENT IN B-CELL NON-HODGKIN LYMPHOMA, AND CHROMOSOMAL
RP   TRANSLOCATION WITH BCL6.
RX   PubMed=11821949; DOI=10.1038/sj.onc.1205099;
RA   Ueda C., Akasaka T., Kurata M., Maesako Y., Nishikori M.,
RA   Ichinohasama R., Imada K., Uchiyama T., Ohno H.;
RT   "The gene for interleukin-21 receptor is the partner of BCL6 in
RT   t(3;16)(q27;p11), which is recurrently observed in diffuse large B-
RT   cell lymphoma.";
RL   Oncogene 21:368-376(2002).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 20-232 IN COMPLEX WITH IL21,
RP   DOMAIN WSXWS MOTIF, GLYCOSYLATION AT ASN-73 AND TRP-214, DOMAINS
RP   FIBRONECTIN, AND DISULFIDE BONDS.
RX   PubMed=22235133; DOI=10.1074/jbc.M111.311084;
RA   Hamming O.J., Kang L., Svensson A., Karlsen J.L., Rahbek-Nielsen H.,
RA   Paludan S.R., Hjorth S.A., Bondensgaard K., Hartmann R.;
RT   "Crystal structure of interleukin-21 receptor (IL-21R) bound to IL-21
RT   reveals that sugar chain interacting with WSXWS motif is integral part
RT   of IL-21R.";
RL   J. Biol. Chem. 287:9454-9460(2012).
RN   [11]
RP   VARIANTS IL21RID 81-CYS-HIS-82 DEL AND LEU-201, AND CHARACTERIZATION
RP   VARIANT IL21RID LEU-201.
RX   PubMed=23440042; DOI=10.1084/jem.20111229;
RA   Kotlarz D., Zietara N., Uzel G., Weidemann T., Braun C.J.,
RA   Diestelhorst J., Krawitz P.M., Robinson P.N., Hecht J., Puchalka J.,
RA   Gertz E.M., Schaeffer A.A., Lawrence M.G., Kardava L., Pfeifer D.,
RA   Baumann U., Pfister E.D., Hanson E.P., Schambach A., Jacobs R.,
RA   Kreipe H., Moir S., Milner J.D., Schwille P., Mundlos S., Klein C.;
RT   "Loss-of-function mutations in the IL-21 receptor gene cause a primary
RT   immunodeficiency syndrome.";
RL   J. Exp. Med. 210:433-443(2013).
CC   -!- FUNCTION: This is a receptor for interleukin-21.
CC   -!- SUBUNIT: Heterodimer with the common gamma subunit. Associates
CC       with JAK1. {ECO:0000269|PubMed:22235133}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Selectively expressed in lymphoid tissues.
CC       Most highly expressed in thymus and spleen.
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-
CC       surface receptor binding. {ECO:0000269|PubMed:22235133}.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation. {ECO:0000269|PubMed:22235133}.
CC   -!- PTM: C-mannosylated at Trp-214 in the WSXWS motif, the sugar chain
CC       makes extensive hydrogen bonds with Asn-73 sugar, and bridges the
CC       two fibronectin domains transforming the V-shaped receptor into an
CC       A-frame.
CC   -!- DISEASE: IL21R immunodeficiency (IL21RID) [MIM:615207]: An
CC       autosomal recessive primary immunodeficiency characterized by
CC       B- and T-cell defects and variable dysfunction of NK cells.
CC       Patients tend to have normal numbers of lymphocytes, but show
CC       defective class-switched B-cells, low IgG, defective antibody
CC       response, and defective T-cell responses to certain antigens.
CC       {ECO:0000269|PubMed:23440042}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Chromosomal aberrations involving IL21R is a cause
CC       of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation
CC       t(3;16)(q27;p11), with BCL6.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 4
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/IL21RID40955ch16p12.html";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/il21r/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF254067; AAG29346.1; -; mRNA.
DR   EMBL; AF269133; AAG23419.1; -; mRNA.
DR   EMBL; AY358826; AAQ89185.1; -; mRNA.
DR   EMBL; AY064474; AAL39168.1; -; Genomic_DNA.
DR   EMBL; AK292663; BAF85352.1; -; mRNA.
DR   EMBL; CH471145; EAW55746.1; -; Genomic_DNA.
DR   EMBL; CH471145; EAW55747.1; -; Genomic_DNA.
DR   EMBL; CH471145; EAW55748.1; -; Genomic_DNA.
DR   EMBL; BC004348; AAH04348.1; -; mRNA.
DR   EMBL; BC007946; AAH07946.2; -; mRNA.
DR   CCDS; CCDS10630.1; -.
DR   RefSeq; NP_068570.1; NM_021798.3.
DR   RefSeq; NP_851564.1; NM_181078.2.
DR   RefSeq; NP_851565.4; NM_181079.4.
DR   RefSeq; XP_016878746.1; XM_017023257.1.
DR   UniGene; Hs.210546; -.
DR   PDB; 3TGX; X-ray; 2.80 A; A/C/E/G/I/K/M/O=20-232.
DR   PDB; 4NZD; X-ray; 2.75 A; A/B/C=20-232.
DR   PDBsum; 3TGX; -.
DR   PDBsum; 4NZD; -.
DR   ProteinModelPortal; Q9HBE5; -.
DR   SMR; Q9HBE5; -.
DR   BioGrid; 119095; 2.
DR   STRING; 9606.ENSP00000338010; -.
DR   iPTMnet; Q9HBE5; -.
DR   PhosphoSitePlus; Q9HBE5; -.
DR   BioMuta; IL21R; -.
DR   DMDM; 20454997; -.
DR   MaxQB; Q9HBE5; -.
DR   PaxDb; Q9HBE5; -.
DR   PeptideAtlas; Q9HBE5; -.
DR   PRIDE; Q9HBE5; -.
DR   DNASU; 50615; -.
DR   Ensembl; ENST00000337929; ENSP00000338010; ENSG00000103522.
DR   Ensembl; ENST00000395754; ENSP00000379103; ENSG00000103522.
DR   Ensembl; ENST00000564089; ENSP00000456707; ENSG00000103522.
DR   GeneID; 50615; -.
DR   KEGG; hsa:50615; -.
DR   UCSC; uc002doq.2; human.
DR   CTD; 50615; -.
DR   DisGeNET; 50615; -.
DR   EuPathDB; HostDB:ENSG00000103522.15; -.
DR   GeneCards; IL21R; -.
DR   H-InvDB; HIX0012914; -.
DR   HGNC; HGNC:6006; IL21R.
DR   HPA; HPA042296; -.
DR   MalaCards; IL21R; -.
DR   MIM; 605383; gene.
DR   MIM; 615207; phenotype.
DR   neXtProt; NX_Q9HBE5; -.
DR   OpenTargets; ENSG00000103522; -.
DR   Orphanet; 357329; Cryptosporidiosis - chronic cholangitis - liver disease.
DR   PharmGKB; PA29821; -.
DR   eggNOG; ENOG410IEDJ; Eukaryota.
DR   eggNOG; ENOG41128NP; LUCA.
DR   GeneTree; ENSGT00510000048783; -.
DR   HOGENOM; HOG000013192; -.
DR   HOVERGEN; HBG052105; -.
DR   InParanoid; Q9HBE5; -.
DR   KO; K05075; -.
DR   OMA; FKKWVGA; -.
DR   OrthoDB; EOG091G0374; -.
DR   PhylomeDB; Q9HBE5; -.
DR   TreeFam; TF337874; -.
DR   Reactome; R-HSA-9020958; Interleukin-21 signaling.
DR   SignaLink; Q9HBE5; -.
DR   SIGNOR; Q9HBE5; -.
DR   ChiTaRS; IL21R; human.
DR   GeneWiki; Interleukin-21_receptor; -.
DR   GenomeRNAi; 50615; -.
DR   PRO; PR:Q9HBE5; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103522; -.
DR   CleanEx; HS_IL21R; -.
DR   Genevisible; Q9HBE5; HS.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0001532; F:interleukin-21 receptor activity; NAS:UniProtKB.
DR   GO; GO:0038114; P:interleukin-21-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0030101; P:natural killer cell activation; NAS:UniProtKB.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR003531; Hempt_rcpt_S_F1_CS.
DR   InterPro; IPR013783; Ig-like_fold.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS01355; HEMATOPO_REC_S_F1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromosomal rearrangement; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Membrane; Polymorphism; Receptor; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     19       {ECO:0000269|PubMed:15340161}.
FT   CHAIN        20    538       Interleukin-21 receptor.
FT                                /FTId=PRO_0000010881.
FT   TOPO_DOM     20    232       Extracellular. {ECO:0000255}.
FT   TRANSMEM    233    253       Helical. {ECO:0000255}.
FT   TOPO_DOM    254    538       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       21    118       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      119    228       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   MOTIF       214    218       WSXWS motif.
FT   MOTIF       266    274       Box 1 motif.
FT   CARBOHYD     73     73       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22235133}.
FT   CARBOHYD     97     97       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    104    104       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    125    125       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    135    135       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    214    214       C-linked (Man) tryptophan.
FT                                {ECO:0000269|PubMed:22235133}.
FT   DISULFID     20    109       {ECO:0000269|PubMed:22235133}.
FT   DISULFID     25     35       {ECO:0000269|PubMed:22235133}.
FT   DISULFID     65     81       {ECO:0000269|PubMed:22235133}.
FT   VARIANT      81     82       Missing (in IL21RID; loss of function
FT                                mutation). {ECO:0000269|PubMed:23440042}.
FT                                /FTId=VAR_069898.
FT   VARIANT     191    191       R -> C (in dbSNP:rs3093370).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014360.
FT   VARIANT     201    201       R -> L (in IL21RID; loss of function
FT                                mutation; the mutation results in
FT                                defective trafficking of the protein,
FT                                with misfolding, impaired processing and
FT                                abnormal subcellular distribution rather
FT                                than proper expression at the plasma
FT                                membrane; dbSNP:rs397514685).
FT                                {ECO:0000269|PubMed:23440042}.
FT                                /FTId=VAR_069899.
FT   VARIANT     318    318       S -> R (in dbSNP:rs3093385).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014361.
FT   VARIANT     484    484       G -> S (in dbSNP:rs3093386).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014362.
FT   CONFLICT    386    386       G -> R (in Ref. 2; AAG23419).
FT                                {ECO:0000305}.
FT   STRAND       22     27       {ECO:0000244|PDB:4NZD}.
FT   STRAND       29     31       {ECO:0000244|PDB:4NZD}.
FT   STRAND       33     38       {ECO:0000244|PDB:4NZD}.
FT   STRAND       40     43       {ECO:0000244|PDB:3TGX}.
FT   STRAND       46     51       {ECO:0000244|PDB:3TGX}.
FT   STRAND       68     72       {ECO:0000244|PDB:4NZD}.
FT   STRAND       77     80       {ECO:0000244|PDB:4NZD}.
FT   HELIX        85     87       {ECO:0000244|PDB:3TGX}.
FT   STRAND       93     99       {ECO:0000244|PDB:4NZD}.
FT   STRAND      106    113       {ECO:0000244|PDB:4NZD}.
FT   HELIX       114    116       {ECO:0000244|PDB:4NZD}.
FT   STRAND      124    139       {ECO:0000244|PDB:4NZD}.
FT   HELIX       141    143       {ECO:0000244|PDB:3TGX}.
FT   TURN        149    153       {ECO:0000244|PDB:4NZD}.
FT   STRAND      154    162       {ECO:0000244|PDB:4NZD}.
FT   STRAND      172    176       {ECO:0000244|PDB:4NZD}.
FT   STRAND      181    185       {ECO:0000244|PDB:4NZD}.
FT   HELIX       187    189       {ECO:0000244|PDB:4NZD}.
FT   STRAND      195    204       {ECO:0000244|PDB:4NZD}.
FT   TURN        206    209       {ECO:0000244|PDB:4NZD}.
FT   STRAND      221    224       {ECO:0000244|PDB:4NZD}.
SQ   SEQUENCE   538 AA;  59130 MW;  414079CCB974850A CRC64;
     MPRGWAAPLL LLLLQGGWGC PDLVCYTDYL QTVICILEMW NLHPSTLTLT WQDQYEELKD
     EATSCSLHRS AHNATHATYT CHMDVFHFMA DDIFSVNITD QSGNYSQECG SFLLAESIKP
     APPFNVTVTF SGQYNISWRS DYEDPAFYML KGKLQYELQY RNRGDPWAVS PRRKLISVDS
     RSVSLLPLEF RKDSSYELQV RAGPMPGSSY QGTWSEWSDP VIFQTQSEEL KEGWNPHLLL
     LLLLVIVFIP AFWSLKTHPL WRLWKKIWAV PSPERFFMPL YKGCSGDFKK WVGAPFTGSS
     LELGPWSPEV PSTLEVYSCH PPRSPAKRLQ LTELQEPAEL VESDGVPKPS FWPTAQNSGG
     SAYSEERDRP YGLVSIDTVT VLDAEGPCTW PCSCEDDGYP ALDLDAGLEP SPGLEDPLLD
     AGTTVLSCGC VSAGSPGLGG PLGSLLDRLK PPLADGEDWA GGLPWGGRSP GGVSESEAGS
     PLAGLDMDTF DSGFVGSDCS SPVECDFTSP GDEGPPRSYL RQWVVIPPPL SSPGPQAS
//
ID   ITK_HUMAN               Reviewed;         620 AA.
AC   Q08881; B2R752; Q32ML7;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   28-FEB-2018, entry version 194.
DE   RecName: Full=Tyrosine-protein kinase ITK/TSK;
DE            EC=2.7.10.2;
DE   AltName: Full=Interleukin-2-inducible T-cell kinase;
DE            Short=IL-2-inducible T-cell kinase;
DE   AltName: Full=Kinase EMT;
DE   AltName: Full=T-cell-specific kinase;
DE   AltName: Full=Tyrosine-protein kinase Lyk;
GN   Name=ITK; Synonyms=EMT, LYK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RX   PubMed=8504851; DOI=10.1016/0014-5793(93)81520-A;
RA   Tanaka N., Asao H., Ohtani K., Nakamura M., Sugamura K.;
RT   "A novel human tyrosine kinase gene inducible in T cells by
RT   interleukin 2.";
RL   FEBS Lett. 324:1-5(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Thymus;
RX   PubMed=8364206;
RA   Gibson S., Leung B., Squire J.A., Hill M., Arima N., Goss P., Hogg D.,
RA   Mills G.B.;
RT   "Identification, cloning, and characterization of a novel human T-
RT   cell-specific tyrosine kinase located at the hematopoietin complex on
RT   chromosome 5q.";
RL   Blood 82:1561-1572(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 171-192, AND PHOSPHORYLATION AT TYR-180.
RX   PubMed=12573241; DOI=10.1016/S1570-9639(02)00524-1;
RA   Nore B.F., Mattsson P.T., Antonsson P., Backesjo C.-M., Westlund A.,
RA   Lennartsson J., Hansson H., Low P., Ronnstrand L., Smith C.I.E.;
RT   "Identification of phosphorylation sites within the SH3 domains of Tec
RT   family tyrosine kinases.";
RL   Biochim. Biophys. Acta 1645:123-132(2003).
RN   [7]
RP   PHOSPHORYLATION BY LCK.
RX   PubMed=9312162; DOI=10.1074/jbc.272.40.25401;
RA   Heyeck S.D., Wilcox H.M., Bunnell S.C., Berg L.J.;
RT   "Lck phosphorylates the activation loop tyrosine of the Itk kinase
RT   domain and activates Itk kinase activity.";
RL   J. Biol. Chem. 272:25401-25408(1997).
RN   [8]
RP   INDUCTION.
RX   PubMed=9701039; DOI=10.1093/intimm/10.7.1009;
RA   King P.D., Sadra A., Teng J.M., Bell G.M., Dupont B.;
RT   "CD2-mediated activation of the Tec-family tyrosine kinase ITK is
RT   controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail.";
RL   Int. Immunol. 10:1009-1016(1998).
RN   [9]
RP   DOMAIN.
RX   PubMed=10795735; DOI=10.1016/S1074-7613(00)80189-2;
RA   Yang W.C., Collette Y., Nunes J.A., Olive D.;
RT   "Tec kinases: a family with multiple roles in immunity.";
RL   Immunity 12:373-382(2000).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF LAT.
RX   PubMed=12186560; DOI=10.1021/bi025554o;
RA   Perez-Villar J.J., Whitney G.S., Sitnick M.T., Dunn R.J.,
RA   Venkatesan S., O'Day K., Schieven G.L., Lin T.A., Kanner S.B.;
RT   "Phosphorylation of the linker for activation of T-cells by Itk
RT   promotes recruitment of Vav.";
RL   Biochemistry 41:10732-10740(2002).
RN   [11]
RP   FUNCTION.
RX   PubMed=12682224; DOI=10.4049/jimmunol.170.8.3971;
RA   Grasis J.A., Browne C.D., Tsoukas C.D.;
RT   "Inducible T cell tyrosine kinase regulates actin-dependent
RT   cytoskeletal events induced by the T cell antigen receptor.";
RL   J. Immunol. 170:3971-3976(2003).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [13]
RP   INTERACTION WITH PPIA/CYPA, AND MUTAGENESIS OF PRO-288.
RX   PubMed=15308100; DOI=10.1016/j.immuni.2004.07.005;
RA   Colgan J., Asmal M., Neagu M., Yu B., Schneidkraut J., Lee Y.,
RA   Sokolskaja E., Andreotti A., Luban J.;
RT   "Cyclophilin A regulates TCR signal strength in CD4+ T cells via a
RT   proline-directed conformational switch in Itk.";
RL   Immunity 21:189-201(2004).
RN   [14]
RP   INTERACTION WITH VAV1.
RX   PubMed=15661896; DOI=10.4049/jimmunol.174.3.1385;
RA   Dombroski D., Houghtling R.A., Labno C.M., Precht P., Takesono A.,
RA   Caplen N.J., Billadeau D.D., Wange R.L., Burkhardt J.K.,
RA   Schwartzberg P.L.;
RT   "Kinase-independent functions for Itk in TCR-induced regulation of Vav
RT   and the actin cytoskeleton.";
RL   J. Immunol. 174:1385-1392(2005).
RN   [15]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17060314; DOI=10.1074/jbc.M609180200;
RA   Qi Q., Sahu N., August A.;
RT   "Tec kinase Itk forms membrane clusters specifically in the vicinity
RT   of recruiting receptors.";
RL   J. Biol. Chem. 281:38529-38534(2006).
RN   [16]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL
RT   (CD178) by phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [17]
RP   AUTOPHOSPHORYLATION.
RX   PubMed=19523959; DOI=10.1016/j.jmb.2009.06.023;
RA   Joseph R.E., Severin A., Min L., Fulton D.B., Andreotti A.H.;
RT   "SH2-dependent autophosphorylation within the Tec family kinase Itk.";
RL   J. Mol. Biol. 391:164-177(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-512 AND SER-565, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   UBIQUITINATION.
RX   PubMed=20596523; DOI=10.1371/journal.pone.0011332;
RA   Del Rincon S.V., Rogers J., Widschwendter M., Sun D., Sieburg H.B.,
RA   Spruck C.;
RT   "Development and validation of a method for profiling post-
RT   translational modification activities using protein microarrays.";
RL   PLoS ONE 5:E11332-E11332(2010).
RN   [20]
RP   FUNCTION IN PHOSPHORYLATION OF LCP2.
RX   PubMed=21725281; DOI=10.1038/emboj.2011.213;
RA   Sela M., Bogin Y., Beach D., Oellerich T., Lehne J.,
RA   Smith-Garvin J.E., Okumura M., Starosvetsky E., Kosoff R., Libman E.,
RA   Koretzky G., Kambayashi T., Urlaub H., Wienands J., Chernoff J.,
RA   Yablonski D.;
RT   "Sequential phosphorylation of SLP-76 at tyrosine 173 is required for
RT   activation of T and mast cells.";
RL   EMBO J. 30:3160-3172(2011).
RN   [21]
RP   STRUCTURE BY NMR OF 113-239.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the BTK motif and the SH3 domain of tyrosine-
RT   protein kinase ITK from human.";
RL   Submitted (OCT-2007) to the PDB data bank.
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-19; LEU-23; GLN-451; TRP-581 AND
RP   ILE-587.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [23]
RP   VARIANT LPFS1 TRP-335, AND CHARACTERIZATION OF VARIANT LPSA1 TRP-335.
RX   PubMed=19425169; DOI=10.1172/JCI37901;
RA   Huck K., Feyen O., Niehues T., Rueschendorf F., Huebner N.,
RA   Laws H.-J., Telieps T., Knapp S., Wacker H.-H., Meindl A., Jumaa H.,
RA   Borkhardt A.;
RT   "Girls homozygous for an IL-2-inducible T cell kinase mutation that
RT   leads to protein deficiency develop fatal EBV-associated
RT   lymphoproliferation.";
RL   J. Clin. Invest. 119:1350-1358(2009).
CC   -!- FUNCTION: Tyrosine kinase that plays an essential role in
CC       regulation of the adaptive immune response. Regulates the
CC       development, function and differentiation of conventional T-cells
CC       and nonconventional NKT-cells. When antigen presenting cells (APC)
CC       activate T-cell receptor (TCR), a series of phosphorylation lead
CC       to the recruitment of ITK to the cell membrane, in the vicinity of
CC       the stimulated TCR receptor, where it is phosphorylated by LCK.
CC       Phosphorylation leads to ITK autophosphorylation and full
CC       activation. Once activated, phosphorylates PLCG1, leading to the
CC       activation of this lipase and subsequent cleavage of its
CC       substrates. In turn, the endoplasmic reticulum releases calcium in
CC       the cytoplasm and the nuclear activator of activated T-cells
CC       (NFAT) translocates into the nucleus to perform its
CC       transcriptional duty. Phosphorylates 2 essential adapter proteins:
CC       the linker for activation of T-cells/LAT protein and LCP2. Then, a
CC       large number of signaling molecules such as VAV1 are recruited and
CC       ultimately lead to lymphokine production, T-cell proliferation and
CC       differentiation (PubMed:12186560, PubMed:12682224,
CC       PubMed:21725281). Phosphorylates TBX21 at 'Tyr-530' and mediates
CC       its interaction with GATA3 (By similarity).
CC       {ECO:0000250|UniProtKB:Q03526, ECO:0000269|PubMed:12186560,
CC       ECO:0000269|PubMed:12682224, ECO:0000269|PubMed:21725281}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Homooligomerizes; this association negatively regulates
CC       kinase activity (By similarity). Interacts with PPIA/CYPA; this
CC       interaction regulates TCR signal strength via a proline-directed
CC       conformational switch in ITK. Interacts with THEMIS (By
CC       similarity). Interacts with FASLG. Interacts with VAV1; this
CC       interaction is important for VAV1 localization and TCR-induced
CC       actin polarization. Interacts with TBX21 (By similarity).
CC       {ECO:0000250|UniProtKB:Q03526, ECO:0000269|PubMed:15308100,
CC       ECO:0000269|PubMed:15661896, ECO:0000269|PubMed:19807924}.
CC   -!- INTERACTION:
CC       P04626:ERBB2; NbExp=2; IntAct=EBI-968552, EBI-641062;
CC       P48023:FASLG; NbExp=3; IntAct=EBI-968552, EBI-495538;
CC       Q13094:LCP2; NbExp=3; IntAct=EBI-968552, EBI-346946;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17060314}.
CC       Nucleus {ECO:0000250|UniProtKB:Q03526}. Note=Localizes in the
CC       vicinity of cell surface receptors in the plasma membrane after
CC       receptor stimulation.
CC   -!- TISSUE SPECIFICITY: T-cell lines and natural killer cell lines.
CC   -!- INDUCTION: Through a myriad of surface receptors including the
CC       TCR/CD3 signaling complex, coreceptors, or chemokine receptors.
CC       {ECO:0000269|PubMed:8504851, ECO:0000269|PubMed:9701039}.
CC   -!- DOMAIN: The N-terminal PH domain allows ITK to be recruited to the
CC       plasma membrane by an activated PI3 kinase. This domain contains
CC       also a proline-rich region (PRR). The adjoining domain is a SH3
CC       domain, which binds to PRR (from itself or from other proteins).
CC       Next, a SH2 domain is required for binding tyrosine-phosphorylated
CC       substrates. In the C-terminal region, the kinase domain is
CC       required for tyrosine phosphorylation.
CC       {ECO:0000269|PubMed:10795735}.
CC   -!- PTM: Phosphorylated at Tyr-512 in the activation loop of the
CC       kinase domain by LCK. Subsequent autophosphorylation at Tyr-180
CC       leads to the kinase activation. The autophosphorylated Tyr-180
CC       lies within the substrate binding sequence of the SH3 domain.
CC       {ECO:0000269|PubMed:12573241, ECO:0000269|PubMed:9312162}.
CC   -!- PTM: Ubiquitinated. {ECO:0000269|PubMed:20596523}.
CC   -!- DISEASE: Lymphoproliferative syndrome 1 (LPFS1) [MIM:613011]: A
CC       rare immunodeficiency characterized by extreme susceptibility to
CC       infection with Epstein-Barr virus (EBV). Inadequate immune
CC       response to EBV can have a fatal outcome. Clinical features
CC       include splenomegaly, lymphadenopathy, anemia, thrombocytopenia,
CC       pancytopenia, recurrent infections. There is an increased risk for
CC       lymphoma. {ECO:0000269|PubMed:19425169}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. TEC subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ITKID43329ch5q33.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D13720; BAA02873.1; -; mRNA.
DR   EMBL; L10717; AAA36748.1; -; mRNA.
DR   EMBL; S65186; AAB28072.2; -; mRNA.
DR   EMBL; AK312846; BAG35699.1; -; mRNA.
DR   EMBL; CH471062; EAW61608.1; -; Genomic_DNA.
DR   EMBL; BC109077; AAI09078.1; -; mRNA.
DR   EMBL; BC109078; AAI09079.1; -; mRNA.
DR   CCDS; CCDS4336.1; -.
DR   PIR; S33253; S33253.
DR   RefSeq; NP_005537.3; NM_005546.3.
DR   UniGene; Hs.558348; -.
DR   PDB; 1SM2; X-ray; 2.30 A; A/B=357-620.
DR   PDB; 1SNU; X-ray; 2.50 A; A/B=357-620.
DR   PDB; 1SNX; X-ray; 3.20 A; A/B=357-620.
DR   PDB; 2E6I; NMR; -; A=113-169.
DR   PDB; 2LMJ; NMR; -; A=171-231.
DR   PDB; 2YUQ; NMR; -; A=162-239.
DR   PDB; 3MIY; X-ray; 1.67 A; A/B=357-620.
DR   PDB; 3MJ1; X-ray; 1.72 A; A=357-620.
DR   PDB; 3MJ2; X-ray; 1.90 A; A=357-620.
DR   PDB; 3QGW; X-ray; 2.10 A; A/B=357-620.
DR   PDB; 3QGY; X-ray; 2.10 A; A/B=357-620.
DR   PDB; 3T9T; X-ray; 1.65 A; A=354-620.
DR   PDB; 3V5J; X-ray; 2.59 A; A/B=357-620.
DR   PDB; 3V5L; X-ray; 1.86 A; A/B/C/D=357-620.
DR   PDB; 3V8T; X-ray; 2.00 A; A/B=357-620.
DR   PDB; 3V8W; X-ray; 2.27 A; A/B=357-620.
DR   PDB; 4HCT; X-ray; 1.48 A; A=354-620.
DR   PDB; 4HCU; X-ray; 1.43 A; A=354-620.
DR   PDB; 4HCV; X-ray; 1.48 A; A=354-620.
DR   PDB; 4KIO; X-ray; 2.18 A; A/B/C/D=357-620.
DR   PDB; 4L7S; X-ray; 2.03 A; A/B=357-620.
DR   PDB; 4M0Y; X-ray; 1.70 A; A=354-620.
DR   PDB; 4M0Z; X-ray; 2.00 A; A=354-620.
DR   PDB; 4M12; X-ray; 2.15 A; A=354-620.
DR   PDB; 4M13; X-ray; 1.85 A; A=354-620.
DR   PDB; 4M14; X-ray; 1.55 A; A=354-620.
DR   PDB; 4M15; X-ray; 1.52 A; A=354-620.
DR   PDB; 4MF0; X-ray; 2.67 A; A/B=357-620.
DR   PDB; 4MF1; X-ray; 2.11 A; A/B=357-620.
DR   PDB; 4PP9; X-ray; 2.58 A; A/B=357-620.
DR   PDB; 4PPA; X-ray; 2.67 A; A/B=357-620.
DR   PDB; 4PPB; X-ray; 2.82 A; A/B=357-620.
DR   PDB; 4PPC; X-ray; 2.95 A; A/B=357-620.
DR   PDB; 4PQN; X-ray; 1.71 A; A=357-620.
DR   PDB; 4QD6; X-ray; 2.45 A; A/B=357-620.
DR   PDB; 4RFM; X-ray; 2.10 A; A=357-620.
DR   PDBsum; 1SM2; -.
DR   PDBsum; 1SNU; -.
DR   PDBsum; 1SNX; -.
DR   PDBsum; 2E6I; -.
DR   PDBsum; 2LMJ; -.
DR   PDBsum; 2YUQ; -.
DR   PDBsum; 3MIY; -.
DR   PDBsum; 3MJ1; -.
DR   PDBsum; 3MJ2; -.
DR   PDBsum; 3QGW; -.
DR   PDBsum; 3QGY; -.
DR   PDBsum; 3T9T; -.
DR   PDBsum; 3V5J; -.
DR   PDBsum; 3V5L; -.
DR   PDBsum; 3V8T; -.
DR   PDBsum; 3V8W; -.
DR   PDBsum; 4HCT; -.
DR   PDBsum; 4HCU; -.
DR   PDBsum; 4HCV; -.
DR   PDBsum; 4KIO; -.
DR   PDBsum; 4L7S; -.
DR   PDBsum; 4M0Y; -.
DR   PDBsum; 4M0Z; -.
DR   PDBsum; 4M12; -.
DR   PDBsum; 4M13; -.
DR   PDBsum; 4M14; -.
DR   PDBsum; 4M15; -.
DR   PDBsum; 4MF0; -.
DR   PDBsum; 4MF1; -.
DR   PDBsum; 4PP9; -.
DR   PDBsum; 4PPA; -.
DR   PDBsum; 4PPB; -.
DR   PDBsum; 4PPC; -.
DR   PDBsum; 4PQN; -.
DR   PDBsum; 4QD6; -.
DR   PDBsum; 4RFM; -.
DR   ProteinModelPortal; Q08881; -.
DR   SMR; Q08881; -.
DR   BioGrid; 109907; 35.
DR   CORUM; Q08881; -.
DR   DIP; DIP-29974N; -.
DR   IntAct; Q08881; 13.
DR   MINT; Q08881; -.
DR   STRING; 9606.ENSP00000398655; -.
DR   BindingDB; Q08881; -.
DR   ChEMBL; CHEMBL2959; -.
DR   DrugBank; DB06589; Pazopanib.
DR   DrugBank; DB02010; Staurosporine.
DR   GuidetoPHARMACOLOGY; 2046; -.
DR   iPTMnet; Q08881; -.
DR   PhosphoSitePlus; Q08881; -.
DR   BioMuta; ITK; -.
DR   DMDM; 585361; -.
DR   MaxQB; Q08881; -.
DR   PaxDb; Q08881; -.
DR   PeptideAtlas; Q08881; -.
DR   PRIDE; Q08881; -.
DR   DNASU; 3702; -.
DR   Ensembl; ENST00000422843; ENSP00000398655; ENSG00000113263.
DR   GeneID; 3702; -.
DR   KEGG; hsa:3702; -.
DR   UCSC; uc003lwo.2; human.
DR   CTD; 3702; -.
DR   DisGeNET; 3702; -.
DR   EuPathDB; HostDB:ENSG00000113263.12; -.
DR   GeneCards; ITK; -.
DR   HGNC; HGNC:6171; ITK.
DR   MalaCards; ITK; -.
DR   MIM; 186973; gene.
DR   MIM; 613011; phenotype.
DR   neXtProt; NX_Q08881; -.
DR   OpenTargets; ENSG00000113263; -.
DR   Orphanet; 238505; Autosomal recessive lymphoproliferative disease.
DR   PharmGKB; PA29968; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000119011; -.
DR   HOGENOM; HOG000233859; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; Q08881; -.
DR   KO; K07363; -.
DR   OMA; RYPVCSW; -.
DR   OrthoDB; EOG091G0D46; -.
DR   PhylomeDB; Q08881; -.
DR   TreeFam; TF351634; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-202433; Generation of second messenger molecules.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   SignaLink; Q08881; -.
DR   SIGNOR; Q08881; -.
DR   ChiTaRS; ITK; human.
DR   EvolutionaryTrace; Q08881; -.
DR   GeneWiki; ITK_(gene); -.
DR   GenomeRNAi; 3702; -.
DR   PRO; PR:Q08881; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113263; -.
DR   CleanEx; HS_ITK; -.
DR   ExpressionAtlas; Q08881; baseline and differential.
DR   Genevisible; Q08881; HS.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007202; P:activation of phospholipase C activity; ISS:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; ISS:UniProtKB.
DR   GO; GO:0006968; P:cellular defense response; TAS:ProtInc.
DR   GO; GO:0001816; P:cytokine production; ISS:UniProtKB.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0032609; P:interferon-gamma production; IEA:Ensembl.
DR   GO; GO:0032633; P:interleukin-4 production; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0001865; P:NK T cell differentiation; IBA:GO_Central.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IBA:GO_Central.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0042110; P:T cell activation; TAS:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   CDD; cd11908; SH3_ITK; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR035583; ITK_SH3.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001562; Znf_Btk_motif.
DR   Pfam; PF00779; BTK; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00107; BTK; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS51113; ZF_BTK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; ATP-binding; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Disease mutation; Immunity;
KW   Kinase; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; SH2 domain; SH3 domain; Transferase;
KW   Tyrosine-protein kinase; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    620       Tyrosine-protein kinase ITK/TSK.
FT                                /FTId=PRO_0000088106.
FT   DOMAIN        4    111       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      171    231       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      239    338       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      363    615       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ZN_FING     113    149       Btk-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00432}.
FT   NP_BIND     369    377       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    482    482       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   METAL       121    121       Zinc. {ECO:0000250}.
FT   METAL       132    132       Zinc. {ECO:0000250}.
FT   METAL       133    133       Zinc. {ECO:0000250}.
FT   METAL       143    143       Zinc. {ECO:0000250}.
FT   BINDING     391    391       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     180    180       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:12573241}.
FT   MOD_RES     512    512       Phosphotyrosine; by LCK.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     565    565       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   VARIANT      19     19       R -> K (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041710.
FT   VARIANT      23     23       P -> L (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041711.
FT   VARIANT     193    193       R -> Q (in dbSNP:rs17054374).
FT                                /FTId=VAR_051696.
FT   VARIANT     335    335       R -> W (in LPFS1; shows nearly
FT                                undetectable mutant ITK protein
FT                                consistent with severe protein
FT                                instability; dbSNP:rs121908191).
FT                                {ECO:0000269|PubMed:19425169}.
FT                                /FTId=VAR_063424.
FT   VARIANT     451    451       R -> Q (in a gastric adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs779372373).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041712.
FT   VARIANT     581    581       R -> W (in dbSNP:rs34482255).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041713.
FT   VARIANT     587    587       V -> I (in dbSNP:rs56005928).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041714.
FT   MUTAGEN     288    288       P->G: Complete loss of interaction with
FT                                PPIA/CYPA. {ECO:0000269|PubMed:15308100}.
FT   CONFLICT    171    172       PE -> GS (in Ref. 6; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    331    331       V -> W (in Ref. 2; AAB28072).
FT                                {ECO:0000305}.
FT   STRAND      127    133       {ECO:0000244|PDB:2E6I}.
FT   STRAND      148    152       {ECO:0000244|PDB:2E6I}.
FT   STRAND      171    173       {ECO:0000244|PDB:2YUQ}.
FT   STRAND      175    180       {ECO:0000244|PDB:2LMJ}.
FT   STRAND      187    189       {ECO:0000244|PDB:2YUQ}.
FT   STRAND      197    205       {ECO:0000244|PDB:2LMJ}.
FT   STRAND      208    212       {ECO:0000244|PDB:2LMJ}.
FT   STRAND      214    216       {ECO:0000244|PDB:2LMJ}.
FT   STRAND      218    221       {ECO:0000244|PDB:2LMJ}.
FT   HELIX       223    225       {ECO:0000244|PDB:2LMJ}.
FT   STRAND      226    228       {ECO:0000244|PDB:2LMJ}.
FT   HELIX       360    362       {ECO:0000244|PDB:4HCU}.
FT   STRAND      363    371       {ECO:0000244|PDB:4HCU}.
FT   STRAND      373    375       {ECO:0000244|PDB:4KIO}.
FT   STRAND      376    382       {ECO:0000244|PDB:4HCU}.
FT   TURN        383    385       {ECO:0000244|PDB:4HCU}.
FT   STRAND      386    393       {ECO:0000244|PDB:4HCU}.
FT   TURN        395    397       {ECO:0000244|PDB:3T9T}.
FT   HELIX       400    411       {ECO:0000244|PDB:4HCU}.
FT   STRAND      421    425       {ECO:0000244|PDB:4HCU}.
FT   STRAND      427    436       {ECO:0000244|PDB:4HCU}.
FT   HELIX       443    448       {ECO:0000244|PDB:4HCU}.
FT   TURN        449    452       {ECO:0000244|PDB:4HCU}.
FT   HELIX       456    475       {ECO:0000244|PDB:4HCU}.
FT   HELIX       485    487       {ECO:0000244|PDB:4HCU}.
FT   STRAND      488    490       {ECO:0000244|PDB:4HCU}.
FT   HELIX       492    494       {ECO:0000244|PDB:4HCU}.
FT   STRAND      496    498       {ECO:0000244|PDB:4HCU}.
FT   HELIX       503    506       {ECO:0000244|PDB:4HCU}.
FT   HELIX       510    513       {ECO:0000244|PDB:4HCU}.
FT   HELIX       522    524       {ECO:0000244|PDB:4HCU}.
FT   HELIX       527    532       {ECO:0000244|PDB:4HCU}.
FT   HELIX       537    552       {ECO:0000244|PDB:4HCU}.
FT   TURN        553    555       {ECO:0000244|PDB:4PQN}.
FT   TURN        558    561       {ECO:0000244|PDB:4HCU}.
FT   HELIX       564    572       {ECO:0000244|PDB:4HCU}.
FT   STRAND      581    583       {ECO:0000244|PDB:3V8W}.
FT   HELIX       585    594       {ECO:0000244|PDB:4HCU}.
FT   HELIX       599    601       {ECO:0000244|PDB:4HCU}.
FT   HELIX       605    617       {ECO:0000244|PDB:4HCU}.
SQ   SEQUENCE   620 AA;  71831 MW;  DAE396BD2309319D CRC64;
     MNNFILLEEQ LIKKSQQKRR TSPSNFKVRF FVLTKASLAY FEDRHGKKRT LKGSIELSRI
     KCVEIVKSDI SIPCHYKYPF QVVHDNYLLY VFAPDRESRQ RWVLALKEET RNNNSLVPKY
     HPNFWMDGKW RCCSQLEKLA TGCAQYDPTK NASKKPLPPT PEDNRRPLWE PEETVVIALY
     DYQTNDPQEL ALRRNEEYCL LDSSEIHWWR VQDRNGHEGY VPSSYLVEKS PNNLETYEWY
     NKSISRDKAE KLLLDTGKEG AFMVRDSRTA GTYTVSVFTK AVVSENNPCI KHYHIKETND
     NPKRYYVAEK YVFDSIPLLI NYHQHNGGGL VTRLRYPVCF GRQKAPVTAG LRYGKWVIDP
     SELTFVQEIG SGQFGLVHLG YWLNKDKVAI KTIREGAMSE EDFIEEAEVM MKLSHPKLVQ
     LYGVCLEQAP ICLVFEFMEH GCLSDYLRTQ RGLFAAETLL GMCLDVCEGM AYLEEACVIH
     RDLAARNCLV GENQVIKVSD FGMTRFVLDD QYTSSTGTKF PVKWASPEVF SFSRYSSKSD
     VWSFGVLMWE VFSEGKIPYE NRSNSEVVED ISTGFRLYKP RLASTHVYQI MNHCWKERPE
     DRPAFSRLLR QLAEIAESGL
//
ID   A0A024R292_HUMAN        Unreviewed;       332 AA.
AC   A0A024R292;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 27.
DE   SubName: Full=Follicular lymphoma variant translocation 1, isoform CRA_a {ECO:0000313|EMBL:EAW63141.1};
GN   Name=FVT1 {ECO:0000313|EMBL:EAW63141.1};
GN   ORFNames=hCG_34091 {ECO:0000313|EMBL:EAW63141.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW63141.1};
RN   [1] {ECO:0000313|EMBL:EAW63141.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW63141.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. {ECO:0000256|RuleBase:RU000363}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471096; EAW63141.1; -; Genomic_DNA.
DR   RefSeq; NP_002026.1; NM_002035.2.
DR   UniGene; Hs.74050; -.
DR   ProteinModelPortal; A0A024R292; -.
DR   SMR; A0A024R292; -.
DR   PRIDE; A0A024R292; -.
DR   GeneID; 2531; -.
DR   KEGG; hsa:2531; -.
DR   CTD; 2531; -.
DR   EuPathDB; HostDB:ENSG00000119537.15; -.
DR   eggNOG; KOG1210; Eukaryota.
DR   eggNOG; ENOG410YF8M; LUCA.
DR   KO; K04708; -.
DR   OMA; NCAGMAI; -.
DR   OrthoDB; EOG091G0CEK; -.
DR   PhylomeDB; A0A024R292; -.
DR   ChiTaRS; KDSR; human.
DR   GenomeRNAi; 2531; -.
DR   Bgee; ENSG00000119537; -.
DR   ExpressionAtlas; A0A024R292; baseline and differential.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; IEA:Ensembl.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   3: Inferred from homology;
KW   Coiled coil {ECO:0000256|SAM:Coils}; Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     25       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        26    332       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001536577.
FT   COILED       91    111       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   332 AA;  36187 MW;  CB4BA5D020858F0C CRC64;
     MLLLAAAFLV AFVLLLYMVS PLISPKPLAL PGAHVVVTGG SSGIGKCIAI ECYKQGAFIT
     LVARNEDKLL QAKKEIEMHS INDKQVVLCI SVDVSQDYNQ VENVIKQAQE KLGPVDMLVN
     CAGMAVSGKF EDLEVSTFER LMSINYLGSV YPSRAVITTM KERRVGRIVF VSSQAGQLGL
     FGFTAYSASK FAIRGLAEAL QMEVKPYNVY ITVAYPPDTD TPGFAEENRT KPLETRLISE
     TTSVCKPEQV AKQIVKDAIQ GNFNSSLGSD GYMLSALTCG MAPVTSITEG LQQVVTMGLF
     RTIALFYLGS FDSIVRRCMM QREKSENADK TA
//
ID   KDSR_HUMAN              Reviewed;         332 AA.
AC   Q06136; B2R5Y1; B4DMX0;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   28-FEB-2018, entry version 169.
DE   RecName: Full=3-ketodihydrosphingosine reductase;
DE            Short=KDS reductase;
DE            EC=1.1.1.102;
DE   AltName: Full=3-dehydrosphinganine reductase;
DE   AltName: Full=Follicular variant translocation protein 1;
DE            Short=FVT-1;
DE   AltName: Full=Short chain dehydrogenase/reductase family 35C member 1;
DE   Flags: Precursor;
GN   Name=KDSR; Synonyms=FVT1, SDR35C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION
RP   WITH KDSR.
RX   PubMed=8417785;
RA   Rimokh R., Gadoux M., Bertheas M.-F., Berger F., Garoscio M.,
RA   Deleage G., Germain D., Magaud J.-P.;
RT   "FVT-1, a novel human transcription unit affected by variant
RT   translocation t(2;18)(p11;q21) of follicular lymphoma.";
RL   Blood 81:136-142(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Amygdala, and Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND MEMBRANE TOPOLOGY.
RX   PubMed=15328338; DOI=10.1074/jbc.M405915200;
RA   Kihara A., Igarashi Y.;
RT   "FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with an
RT   active site that faces the cytosolic side of the endoplasmic reticulum
RT   membrane.";
RL   J. Biol. Chem. 279:49243-49250(2004).
RN   [8]
RP   VARIANTS EKVP4 55-GLN-GLY-56 DELINS ARG; 86-VAL--GLN-107 DEL; PHE-186
RP   AND 260-GLN--GLN-293 DEL, CHARACTERIZATION OF VARIANTS EKVP4
RP   55-GLN-GLY-56 DELINS ARG; 86-VAL--GLN-107 DEL AND 260-GLN--GLN-293
RP   DEL, AND FUNCTION.
RX   PubMed=28575652; DOI=10.1016/j.ajhg.2017.05.003;
RA   Boyden L.M., Vincent N.G., Zhou J., Hu R., Craiglow B.G.,
RA   Bayliss S.J., Rosman I.S., Lucky A.W., Diaz L.A., Goldsmith L.A.,
RA   Paller A.S., Lifton R.P., Baserga S.J., Choate K.A.;
RT   "Mutations in KDSR cause recessive progressive symmetric
RT   erythrokeratoderma.";
RL   Am. J. Hum. Genet. 100:978-984(2017).
CC   -!- FUNCTION: Catalyzes the reduction of 3-ketodihydrosphingosine
CC       (KDS) to dihydrosphingosine (DHS). {ECO:0000269|PubMed:28575652}.
CC   -!- CATALYTIC ACTIVITY: Sphinganine + NADP(+) = 3-dehydrosphinganine +
CC       NADPH. {ECO:0000269|PubMed:15328338}.
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15328338}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15328338}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q06136-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q06136-2; Sequence=VSP_056641;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined. Highest
CC       expression in placenta. High expression in lung, kidney, stomach
CC       and small intestine, low expression in heart, spleen and skeletal
CC       muscle. Weakly expressed in normal hematopoietic tissues. Higher
CC       expression in some T-cell malignancies and PHA-stimulated
CC       lymphocytes.
CC   -!- DISEASE: Note=A chromosomal aberration involving KDSR is a cause
CC       of follicular lymphoma; also known as type II chronic lymphatic
CC       leukemia. Translocation t(2;18)(p11;q21) with a Ig J kappa chain
CC       region (PubMed:8417785). {ECO:0000269|PubMed:8417785}.
CC   -!- DISEASE: Erythrokeratodermia variabilis et progressiva 4 (EKVP4)
CC       [MIM:617526]: A form of erythrokeratodermia variabilis et
CC       progressiva, a genodermatosis characterized by the coexistence of
CC       two independent skin lesions: transient erythema and
CC       hyperkeratosis that is usually localized but occasionally occurs
CC       in its generalized form. Clinical presentation varies
CC       significantly within a family and from one family to another.
CC       Palmoplantar keratoderma is present in around 50% of cases.
CC       {ECO:0000269|PubMed:28575652}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X63657; CAA45197.1; -; mRNA.
DR   EMBL; BT006782; AAP35428.1; -; mRNA.
DR   EMBL; AK297670; BAG60032.1; -; mRNA.
DR   EMBL; AK312360; BAG35278.1; -; mRNA.
DR   EMBL; AC021803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC036176; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471096; EAW63140.1; -; Genomic_DNA.
DR   EMBL; BC008797; AAH08797.1; -; mRNA.
DR   CCDS; CCDS11982.1; -. [Q06136-1]
DR   PIR; S37652; S37652.
DR   RefSeq; NP_002026.1; NM_002035.2. [Q06136-1]
DR   UniGene; Hs.74050; -.
DR   ProteinModelPortal; Q06136; -.
DR   SMR; Q06136; -.
DR   BioGrid; 108807; 24.
DR   IntAct; Q06136; 7.
DR   MINT; Q06136; -.
DR   STRING; 9606.ENSP00000385083; -.
DR   SwissLipids; SLP:000000155; -.
DR   iPTMnet; Q06136; -.
DR   PhosphoSitePlus; Q06136; -.
DR   SwissPalm; Q06136; -.
DR   BioMuta; KDSR; -.
DR   DMDM; 544358; -.
DR   EPD; Q06136; -.
DR   MaxQB; Q06136; -.
DR   PaxDb; Q06136; -.
DR   PeptideAtlas; Q06136; -.
DR   PRIDE; Q06136; -.
DR   DNASU; 2531; -.
DR   Ensembl; ENST00000326575; ENSP00000312939; ENSG00000119537. [Q06136-2]
DR   Ensembl; ENST00000406396; ENSP00000385083; ENSG00000119537. [Q06136-1]
DR   GeneID; 2531; -.
DR   KEGG; hsa:2531; -.
DR   UCSC; uc010dpw.4; human. [Q06136-1]
DR   CTD; 2531; -.
DR   DisGeNET; 2531; -.
DR   EuPathDB; HostDB:ENSG00000119537.15; -.
DR   GeneCards; KDSR; -.
DR   HGNC; HGNC:4021; KDSR.
DR   HPA; CAB003673; -.
DR   HPA; HPA044884; -.
DR   MIM; 136440; gene.
DR   MIM; 617526; phenotype.
DR   neXtProt; NX_Q06136; -.
DR   OpenTargets; ENSG00000119537; -.
DR   PharmGKB; PA162392777; -.
DR   eggNOG; KOG1210; Eukaryota.
DR   eggNOG; ENOG410YF8M; LUCA.
DR   GeneTree; ENSGT00910000143991; -.
DR   HOVERGEN; HBG005757; -.
DR   InParanoid; Q06136; -.
DR   KO; K04708; -.
DR   OMA; NCAGMAI; -.
DR   OrthoDB; EOG091G0CEK; -.
DR   PhylomeDB; Q06136; -.
DR   TreeFam; TF105430; -.
DR   BioCyc; MetaCyc:HS04306-MONOMER; -.
DR   BRENDA; 1.1.1.102; 2681.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   UniPathway; UPA00222; -.
DR   ChiTaRS; KDSR; human.
DR   GeneWiki; 3-dehydrosphinganine_reductase; -.
DR   GenomeRNAi; 2531; -.
DR   PRO; PR:Q06136; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000119537; -.
DR   CleanEx; HS_KDSR; -.
DR   ExpressionAtlas; Q06136; baseline and differential.
DR   Genevisible; Q06136; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0047560; F:3-dehydrosphinganine reductase activity; IDA:MGI.
DR   GO; GO:0006666; P:3-keto-sphinganine metabolic process; IDA:MGI.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Complete proteome;
KW   Disease mutation; Endoplasmic reticulum; Lipid metabolism; Membrane;
KW   NADP; Oxidoreductase; Palmoplantar keratoderma; Proto-oncogene;
KW   Reference proteome; Signal; Sphingolipid metabolism; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    332       3-ketodihydrosphingosine reductase.
FT                                /FTId=PRO_0000031982.
FT   TOPO_DOM     26    270       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical. {ECO:0000255}.
FT   TOPO_DOM    292    293       Lumenal. {ECO:0000255}.
FT   TRANSMEM    294    314       Helical. {ECO:0000255}.
FT   TOPO_DOM    315    332       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND      36     60       NADP. {ECO:0000305}.
FT   ACT_SITE    186    186       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10001}.
FT   ACT_SITE    190    190       {ECO:0000305}.
FT   BINDING     173    173       Substrate. {ECO:0000250}.
FT   VAR_SEQ     139    202       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056641.
FT   VARIANT      55     56       QG -> R (in EKVP4; loss of 3-
FT                                dehydrosphinganine reductase activity).
FT                                {ECO:0000269|PubMed:28575652}.
FT                                /FTId=VAR_079185.
FT   VARIANT      86    107       Missing (in EKVP4; loss of 3-
FT                                dehydrosphinganine reductase activity).
FT                                {ECO:0000269|PubMed:28575652}.
FT                                /FTId=VAR_079186.
FT   VARIANT     186    186       Y -> F (in EKVP4).
FT                                {ECO:0000269|PubMed:28575652}.
FT                                /FTId=VAR_079187.
FT   VARIANT     260    293       Missing (in EKVP4; loss of 3-
FT                                dehydrosphinganine reductase activity).
FT                                {ECO:0000269|PubMed:28575652}.
FT                                /FTId=VAR_079188.
SQ   SEQUENCE   332 AA;  36187 MW;  CB4BA5D020858F0C CRC64;
     MLLLAAAFLV AFVLLLYMVS PLISPKPLAL PGAHVVVTGG SSGIGKCIAI ECYKQGAFIT
     LVARNEDKLL QAKKEIEMHS INDKQVVLCI SVDVSQDYNQ VENVIKQAQE KLGPVDMLVN
     CAGMAVSGKF EDLEVSTFER LMSINYLGSV YPSRAVITTM KERRVGRIVF VSSQAGQLGL
     FGFTAYSASK FAIRGLAEAL QMEVKPYNVY ITVAYPPDTD TPGFAEENRT KPLETRLISE
     TTSVCKPEQV AKQIVKDAIQ GNFNSSLGSD GYMLSALTCG MAPVTSITEG LQQVVTMGLF
     RTIALFYLGS FDSIVRRCMM QREKSENADK TA
//
ID   KINH_HUMAN              Reviewed;         963 AA.
AC   P33176; A0AVB2; Q5VZ85;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   28-FEB-2018, entry version 182.
DE   RecName: Full=Kinesin-1 heavy chain;
DE   AltName: Full=Conventional kinesin heavy chain;
DE   AltName: Full=Ubiquitous kinesin heavy chain;
DE            Short=UKHC;
GN   Name=KIF5B; Synonyms=KNS, KNS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=1607388; DOI=10.1083/jcb.117.6.1263;
RA   Navone F., Niclas J., Hom-Booher N., Sparks L., Bernstein H.D.,
RA   McCaffrey G., Vale R.D.;
RT   "Cloning and expression of a human kinesin heavy chain gene:
RT   interaction of the COOH-terminal domain with cytoplasmic microtubules
RT   in transfected CV-1 cells.";
RL   J. Cell Biol. 117:1263-1275(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH SYBU.
RX   PubMed=15459722; DOI=10.1038/ncb1169;
RA   Su Q., Cai Q., Gerwin C., Smith C.L., Sheng Z.-H.;
RT   "Syntabulin is a microtubule-associated protein implicated in syntaxin
RT   transport in neurons.";
RL   Nat. Cell Biol. 6:941-953(2004).
RN   [5]
RP   INTERACTION WITH PLEKHM2.
RX   PubMed=15905402; DOI=10.1126/science.1110225;
RA   Boucrot E., Henry T., Borg J.-P., Gorvel J.-P., Meresse S.;
RT   "The intracellular fate of Salmonella depends on the recruitment of
RT   kinesin.";
RL   Science 308:1174-1178(2005).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   INTERACTION WITH JAKMIP1.
RX   PubMed=17532644; DOI=10.1016/j.mcn.2007.04.008;
RA   Vidal R.L., Ramirez O.A., Sandoval L., Koenig-Robert R., Haertel S.,
RA   Couve A.;
RT   "Marlin-1 and conventional kinesin link GABAB receptors to the
RT   cytoskeleton and regulate receptor transport.";
RL   Mol. Cell. Neurosci. 35:501-512(2007).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   INTERACTION WITH ECM29.
RX   PubMed=20682791; DOI=10.1074/jbc.M110.154120;
RA   Gorbea C., Pratt G., Ustrell V., Bell R., Sahasrabudhe S.,
RA   Hughes R.E., Rechsteiner M.;
RT   "A protein interaction network for Ecm29 links the 26 S proteasome to
RT   molecular motors and endosomal components.";
RL   J. Biol. Chem. 285:31616-31633(2010).
RN   [10]
RP   FUNCTION.
RX   PubMed=20386726; DOI=10.1371/journal.pbio.1000350;
RA   Splinter D., Tanenbaum M.E., Lindqvist A., Jaarsma D., Flotho A.,
RA   Yu K.L., Grigoriev I., Engelsma D., Haasdijk E.D., Keijzer N.,
RA   Demmers J., Fornerod M., Melchior F., Hoogenraad C.C., Medema R.H.,
RA   Akhmanova A.;
RT   "Bicaudal D2, dynein, and kinesin-1 associate with nuclear pore
RT   complexes and regulate centrosome and nuclear positioning during
RT   mitotic entry.";
RL   PLoS Biol. 8:E1000350-E1000350(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-933, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-956, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-213, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-349 IN COMPLEX WITH ADP.
RX   PubMed=8606779; DOI=10.1038/380550a0;
RA   Kull F.J., Sablin E.P., Lau R., Fletterick R.J., Vale R.D.;
RT   "Crystal structure of the kinesin motor domain reveals a structural
RT   similarity to myosin.";
RL   Nature 380:550-555(1996).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1-349 IN COMPLEX WITH ADP.
RX   PubMed=12368902; DOI=10.1038/nsb852;
RA   Sindelar C.V., Budny M.J., Rice S., Naber N., Fletterick R., Cooke R.;
RT   "Two conformations in the human kinesin power stroke defined by X-ray
RT   crystallography and EPR spectroscopy.";
RL   Nat. Struct. Biol. 9:844-848(2002).
RN   [20]
RP   STRUCTURE BY ELECTRON MICROSCOPY (9.0 ANGSTROMS) OF 1-325.
RX   PubMed=17470637; DOI=10.1083/jcb.200612090;
RA   Sindelar C.V., Downing K.H.;
RT   "The beginning of kinesin's force-generating cycle visualized at 9-A
RT   resolution.";
RL   J. Cell Biol. 177:377-385(2007).
CC   -!- FUNCTION: Microtubule-dependent motor required for normal
CC       distribution of mitochondria and lysosomes. Can induce formation
CC       of neurite-like membrane protrusions in non-neuronal cells in a
CC       ZFYVE27-dependent manner (By similarity). Regulates centrosome and
CC       nuclear positioning during mitotic entry. During the G2 phase of
CC       the cell cycle in a BICD2-dependent manner, antagonizes dynein
CC       function and drives the separation of nuclei and centrosomes
CC       (PubMed:20386726). {ECO:0000250|UniProtKB:Q61768,
CC       ECO:0000269|PubMed:20386726}.
CC   -!- SUBUNIT: Oligomer composed of two heavy chains and two light
CC       chains. Interacts with GRIP1 and PPP1R42 (By similarity).
CC       Interacts with SYBU. Interacts with JAKMIP1. Interacts with
CC       PLEKHM2. Interacts with ECM29. Interacts with ZFYVE27 (By
CC       similarity). {ECO:0000250|UniProtKB:Q61768,
CC       ECO:0000269|PubMed:12368902, ECO:0000269|PubMed:15459722,
CC       ECO:0000269|PubMed:15905402, ECO:0000269|PubMed:17532644,
CC       ECO:0000269|PubMed:20682791, ECO:0000269|PubMed:8606779}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-355878, EBI-355878;
CC       Q14192:FHL2; NbExp=4; IntAct=EBI-355878, EBI-701903;
CC       Q9BQS8:FYCO1; NbExp=3; IntAct=EBI-355878, EBI-2869338;
CC       Q8CII8:Syne4 (xeno); NbExp=2; IntAct=EBI-355878, EBI-15752280;
CC       P68619:VACWR159 (xeno); NbExp=3; IntAct=EBI-355878, EBI-7133540;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q2PQA9}. Note=Uniformly distributed between
CC       soma and neurites in hippocampal neurons.
CC       {ECO:0000250|UniProtKB:Q2PQA9}.
CC   -!- DOMAIN: Composed of three structural domains: a large globular N-
CC       terminal domain which is responsible for the motor activity of
CC       kinesin (it hydrolyzes ATP and binds microtubule), a central
CC       alpha-helical coiled coil domain that mediates the heavy chain
CC       dimerization; and a small globular C-terminal domain which
CC       interacts with other proteins (such as the kinesin light chains),
CC       vesicles and membranous organelles.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Kinesin family. Kinesin subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00283}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X65873; CAA46703.1; -; mRNA.
DR   EMBL; AL161932; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC126279; AAI26280.1; -; mRNA.
DR   EMBL; BC126281; AAI26282.1; -; mRNA.
DR   CCDS; CCDS7171.1; -.
DR   PIR; A41919; A41919.
DR   RefSeq; NP_004512.1; NM_004521.2.
DR   UniGene; Hs.327736; -.
DR   PDB; 1BG2; X-ray; 1.80 A; A=1-325.
DR   PDB; 1MKJ; X-ray; 2.70 A; A=1-349.
DR   PDB; 2P4N; EM; 9.00 A; K=1-325.
DR   PDB; 3J8X; EM; 5.00 A; K=1-349.
DR   PDB; 3J8Y; EM; 5.00 A; K=1-349.
DR   PDB; 4HNA; X-ray; 3.19 A; K=1-349.
DR   PDB; 4LNU; X-ray; 2.19 A; K=1-325.
DR   PDB; 5LT0; X-ray; 2.00 A; A=1-325.
DR   PDB; 5LT1; X-ray; 1.95 A; A/B=1-325.
DR   PDB; 5LT2; X-ray; 2.60 A; A/B/C/D/E/K=1-325.
DR   PDB; 5LT3; X-ray; 2.59 A; A/B/C/D/E/K=1-325.
DR   PDB; 5LT4; X-ray; 2.88 A; A/B/C/D/E/K=1-325.
DR   PDBsum; 1BG2; -.
DR   PDBsum; 1MKJ; -.
DR   PDBsum; 2P4N; -.
DR   PDBsum; 3J8X; -.
DR   PDBsum; 3J8Y; -.
DR   PDBsum; 4HNA; -.
DR   PDBsum; 4LNU; -.
DR   PDBsum; 5LT0; -.
DR   PDBsum; 5LT1; -.
DR   PDBsum; 5LT2; -.
DR   PDBsum; 5LT3; -.
DR   PDBsum; 5LT4; -.
DR   ProteinModelPortal; P33176; -.
DR   SMR; P33176; -.
DR   BioGrid; 110000; 112.
DR   CORUM; P33176; -.
DR   DIP; DIP-29244N; -.
DR   IntAct; P33176; 60.
DR   MINT; P33176; -.
DR   STRING; 9606.ENSP00000307078; -.
DR   BindingDB; P33176; -.
DR   ChEMBL; CHEMBL5864; -.
DR   CarbonylDB; P33176; -.
DR   iPTMnet; P33176; -.
DR   PhosphoSitePlus; P33176; -.
DR   SwissPalm; P33176; -.
DR   BioMuta; KIF5B; -.
DR   DMDM; 417216; -.
DR   EPD; P33176; -.
DR   PaxDb; P33176; -.
DR   PeptideAtlas; P33176; -.
DR   PRIDE; P33176; -.
DR   Ensembl; ENST00000302418; ENSP00000307078; ENSG00000170759.
DR   GeneID; 3799; -.
DR   KEGG; hsa:3799; -.
DR   CTD; 3799; -.
DR   DisGeNET; 3799; -.
DR   EuPathDB; HostDB:ENSG00000170759.10; -.
DR   GeneCards; KIF5B; -.
DR   HGNC; HGNC:6324; KIF5B.
DR   HPA; CAB009846; -.
DR   HPA; HPA037589; -.
DR   HPA; HPA037590; -.
DR   MIM; 602809; gene.
DR   neXtProt; NX_P33176; -.
DR   OpenTargets; ENSG00000170759; -.
DR   PharmGKB; PA30108; -.
DR   eggNOG; KOG0240; Eukaryota.
DR   eggNOG; COG5059; LUCA.
DR   GeneTree; ENSGT00910000144010; -.
DR   HOVERGEN; HBG006210; -.
DR   InParanoid; P33176; -.
DR   KO; K10396; -.
DR   OMA; NDCAKKI; -.
DR   OrthoDB; EOG091G02A2; -.
DR   PhylomeDB; P33176; -.
DR   TreeFam; TF105225; -.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-264876; Insulin processing.
DR   Reactome; R-HSA-5625970; RHO GTPases activate KTN1.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-983189; Kinesins.
DR   SIGNOR; P33176; -.
DR   ChiTaRS; KIF5B; human.
DR   EvolutionaryTrace; P33176; -.
DR   GeneWiki; KIF5B; -.
DR   GenomeRNAi; 3799; -.
DR   PRO; PR:P33176; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000170759; -.
DR   CleanEx; HS_KIF5B; -.
DR   ExpressionAtlas; P33176; baseline and differential.
DR   Genevisible; P33176; HS.
DR   GO; GO:0044295; C:axonal growth cone; IEA:Ensembl.
DR   GO; GO:0035253; C:ciliary rootlet; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005871; C:kinesin complex; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:HGNC.
DR   GO; GO:0045335; C:phagocytic vesicle; IEA:Ensembl.
DR   GO; GO:0031982; C:vesicle; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008574; F:ATP-dependent microtubule motor activity, plus-end-directed; IBA:GO_Central.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008432; F:JUN kinase binding; IEA:Ensembl.
DR   GO; GO:0008017; F:microtubule binding; ISS:HGNC.
DR   GO; GO:0099609; F:microtubule lateral binding; IEA:Ensembl.
DR   GO; GO:0003777; F:microtubule motor activity; ISS:HGNC.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl.
DR   GO; GO:0051642; P:centrosome localization; IMP:UniProtKB.
DR   GO; GO:0007028; P:cytoplasm organization; IEA:Ensembl.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; IBA:GO_Central.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0007018; P:microtubule-based movement; TAS:ProtInc.
DR   GO; GO:0072383; P:plus-end-directed vesicle transport along microtubule; IEA:Ensembl.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; IEA:Ensembl.
DR   GO; GO:0043268; P:positive regulation of potassium ion transport; IDA:BHF-UCL.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl.
DR   GO; GO:0031340; P:positive regulation of vesicle fusion; IEA:Ensembl.
DR   GO; GO:1905152; P:positive regulation of voltage-gated sodium channel activity; IEA:Ensembl.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL.
DR   GO; GO:0035617; P:stress granule disassembly; ISS:BHF-UCL.
DR   GO; GO:0047496; P:vesicle transport along microtubule; ISS:HGNC.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR027640; Kinesin-like_fam.
DR   InterPro; IPR019821; Kinesin_motor_CS.
DR   InterPro; IPR001752; Kinesin_motor_dom.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24115; PTHR24115; 1.
DR   Pfam; PF00225; Kinesin; 1.
DR   PRINTS; PR00380; KINESINHEAVY.
DR   SMART; SM00129; KISc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR   PROSITE; PS50067; KINESIN_MOTOR_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Isopeptide bond;
KW   Methylation; Microtubule; Motor protein; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    963       Kinesin-1 heavy chain.
FT                                /FTId=PRO_0000125351.
FT   DOMAIN        8    325       Kinesin motor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00283}.
FT   NP_BIND      85     92       ATP.
FT   REGION      915    963       Globular.
FT   COILED      329    914
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     933    933       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     956    956       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   CROSSLNK    213    213       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   STRAND        8     15       {ECO:0000244|PDB:1BG2}.
FT   HELIX        20     25       {ECO:0000244|PDB:1BG2}.
FT   STRAND       32     34       {ECO:0000244|PDB:1BG2}.
FT   TURN         35     37       {ECO:0000244|PDB:1BG2}.
FT   STRAND       38     41       {ECO:0000244|PDB:1BG2}.
FT   STRAND       44     47       {ECO:0000244|PDB:1BG2}.
FT   STRAND       49     52       {ECO:0000244|PDB:1BG2}.
FT   HELIX        58     65       {ECO:0000244|PDB:1BG2}.
FT   HELIX        67     74       {ECO:0000244|PDB:1BG2}.
FT   STRAND       79     84       {ECO:0000244|PDB:1BG2}.
FT   HELIX        91     95       {ECO:0000244|PDB:1BG2}.
FT   TURN        102    104       {ECO:0000244|PDB:1BG2}.
FT   HELIX       107    122       {ECO:0000244|PDB:1BG2}.
FT   STRAND      124    138       {ECO:0000244|PDB:1BG2}.
FT   STRAND      141    146       {ECO:0000244|PDB:1BG2}.
FT   STRAND      155    157       {ECO:0000244|PDB:1BG2}.
FT   STRAND      163    165       {ECO:0000244|PDB:1BG2}.
FT   STRAND      171    173       {ECO:0000244|PDB:1BG2}.
FT   HELIX       176    189       {ECO:0000244|PDB:1BG2}.
FT   TURN        190    193       {ECO:0000244|PDB:1BG2}.
FT   HELIX       197    203       {ECO:0000244|PDB:1BG2}.
FT   STRAND      204    216       {ECO:0000244|PDB:1BG2}.
FT   TURN        217    219       {ECO:0000244|PDB:1BG2}.
FT   STRAND      222    231       {ECO:0000244|PDB:1BG2}.
FT   HELIX       238    241       {ECO:0000244|PDB:4HNA}.
FT   STRAND      242    244       {ECO:0000244|PDB:1BG2}.
FT   HELIX       256    269       {ECO:0000244|PDB:1BG2}.
FT   HELIX       277    279       {ECO:0000244|PDB:1BG2}.
FT   HELIX       281    285       {ECO:0000244|PDB:1BG2}.
FT   HELIX       286    288       {ECO:0000244|PDB:1BG2}.
FT   STRAND      290    293       {ECO:0000244|PDB:1BG2}.
FT   STRAND      295    302       {ECO:0000244|PDB:1BG2}.
FT   HELIX       306    308       {ECO:0000244|PDB:1BG2}.
FT   HELIX       309    320       {ECO:0000244|PDB:1BG2}.
FT   STRAND      326    329       {ECO:0000244|PDB:1MKJ}.
FT   HELIX       337    348       {ECO:0000244|PDB:1MKJ}.
SQ   SEQUENCE   963 AA;  109685 MW;  A1FE5760C3250C8B CRC64;
     MADLAECNIK VMCRFRPLNE SEVNRGDKYI AKFQGEDTVV IASKPYAFDR VFQSSTSQEQ
     VYNDCAKKIV KDVLEGYNGT IFAYGQTSSG KTHTMEGKLH DPEGMGIIPR IVQDIFNYIY
     SMDENLEFHI KVSYFEIYLD KIRDLLDVSK TNLSVHEDKN RVPYVKGCTE RFVCSPDEVM
     DTIDEGKSNR HVAVTNMNEH SSRSHSIFLI NVKQENTQTE QKLSGKLYLV DLAGSEKVSK
     TGAEGAVLDE AKNINKSLSA LGNVISALAE GSTYVPYRDS KMTRILQDSL GGNCRTTIVI
     CCSPSSYNES ETKSTLLFGQ RAKTIKNTVC VNVELTAEQW KKKYEKEKEK NKILRNTIQW
     LENELNRWRN GETVPIDEQF DKEKANLEAF TVDKDITLTN DKPATAIGVI GNFTDAERRK
     CEEEIAKLYK QLDDKDEEIN QQSQLVEKLK TQMLDQEELL ASTRRDQDNM QAELNRLQAE
     NDASKEEVKE VLQALEELAV NYDQKSQEVE DKTKEYELLS DELNQKSATL ASIDAELQKL
     KEMTNHQKKR AAEMMASLLK DLAEIGIAVG NNDVKQPEGT GMIDEEFTVA RLYISKMKSE
     VKTMVKRCKQ LESTQTESNK KMEENEKELA ACQLRISQHE AKIKSLTEYL QNVEQKKRQL
     EESVDALSEE LVQLRAQEKV HEMEKEHLNK VQTANEVKQA VEQQIQSHRE THQKQISSLR
     DEVEAKAKLI TDLQDQNQKM MLEQERLRVE HEKLKATDQE KSRKLHELTV MQDRREQARQ
     DLKGLEETVA KELQTLHNLR KLFVQDLATR VKKSAEIDSD DTGGSAAQKQ KISFLENNLE
     QLTKVHKQLV RDNADLRCEL PKLEKRLRAT AERVKALESA LKEAKENASR DRKRYQQEVD
     RIKEAVRSKN MARRGHSAQI AKPIRPGQHP AASPTHPSAI RGGGAFVQNS QPVAVRGGGG
     KQV
//
ID   Q6P164_HUMAN            Unreviewed;       345 AA.
AC   Q6P164;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 91.
DE   RecName: Full=Kinesin-like protein {ECO:0000256|RuleBase:RU000394};
DE   Flags: Fragment;
GN   Name=KIF5B {ECO:0000313|EMBL:AAH65267.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH65267.1};
RN   [1] {ECO:0000313|EMBL:AAH65267.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus {ECO:0000313|EMBL:AAH65267.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Kinesin family. {ECO:0000256|RuleBase:RU000394,
CC       ECO:0000256|SAAS:SAAS00583243}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC065267; AAH65267.1; -; mRNA.
DR   RefSeq; NP_004512.1; NM_004521.2.
DR   UniGene; Hs.327736; -.
DR   ProteinModelPortal; Q6P164; -.
DR   PeptideAtlas; Q6P164; -.
DR   GeneID; 3799; -.
DR   KEGG; hsa:3799; -.
DR   CTD; 3799; -.
DR   PharmGKB; PA30108; -.
DR   eggNOG; KOG0240; Eukaryota.
DR   eggNOG; COG5059; LUCA.
DR   HOVERGEN; HBG052252; -.
DR   KO; K10396; -.
DR   ChiTaRS; KIF5B; human.
DR   GenomeRNAi; 3799; -.
DR   Genevisible; Q6P164; HS.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0008017; F:microtubule binding; IEA:InterPro.
DR   GO; GO:0003777; F:microtubule motor activity; IEA:InterPro.
DR   GO; GO:0007018; P:microtubule-based movement; IEA:InterPro.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR027640; Kinesin-like_fam.
DR   InterPro; IPR019821; Kinesin_motor_CS.
DR   InterPro; IPR001752; Kinesin_motor_dom.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24115; PTHR24115; 1.
DR   Pfam; PF00225; Kinesin; 1.
DR   PRINTS; PR00380; KINESINHEAVY.
DR   SMART; SM00129; KISc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR   PROSITE; PS50067; KINESIN_MOTOR_2; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU000394,
KW   ECO:0000256|SAAS:SAAS00427985};
KW   Microtubule {ECO:0000256|RuleBase:RU000394};
KW   Motor protein {ECO:0000256|RuleBase:RU000394};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000394,
KW   ECO:0000256|SAAS:SAAS00427985}.
FT   DOMAIN        8    325       Kinesin motor.
FT                                {ECO:0000259|PROSITE:PS50067}.
FT   NP_BIND      85     92       ATP. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00283}.
FT   NON_TER     345    345       {ECO:0000313|EMBL:AAH65267.1}.
SQ   SEQUENCE   345 AA;  38716 MW;  133721DA5C8697BE CRC64;
     MADLAECNIK VMCRFRPLNE SEVNRGDKYI AKFQGEDTVV IASKPYAFDR VFQSSTSQEQ
     VYNDCAKKIV KDVLEGYNGT IFAYGQTSSG KTHTMEGKLH DPEGMGIIPR IVQDIFNYIY
     SMDENLEFHI KVSYFEIYLD KIRDLLDVSK TNLSVHEDKN RVPYVKGCTE RFVCSPDEVM
     DTIDEGKSNR HVAVTNMNEH SSRSHSIFLI NVKQENTQTE QKLSGKLYLV DLAGSEKVSK
     TGAEGAVLDE AKNINKSLSA LGNVISALAE GSTYVPYRDS KMTRILQDSL GGNCRTTIVI
     CCSPSSYNES ETKSTLLFGQ RAKTIKNTVC VNVELTAEQW KKKKK
//
ID   V9HW29_HUMAN            Unreviewed;       963 AA.
AC   V9HW29;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   28-FEB-2018, entry version 38.
DE   RecName: Full=Kinesin-like protein {ECO:0000256|RuleBase:RU000394};
GN   Name=HEL-S-61 {ECO:0000313|EMBL:ACI46016.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI46016.1};
RN   [1] {ECO:0000313|EMBL:ACI46016.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J., Wang H., Liu J., Liu F.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Kinesin family. {ECO:0000256|RuleBase:RU000394,
CC       ECO:0000256|SAAS:SAAS00583243}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ224324; ACI46016.1; -; mRNA.
DR   RefSeq; NP_004512.1; NM_004521.2.
DR   UniGene; Hs.327736; -.
DR   ProteinModelPortal; V9HW29; -.
DR   SMR; V9HW29; -.
DR   IntAct; V9HW29; 4.
DR   MaxQB; V9HW29; -.
DR   PRIDE; V9HW29; -.
DR   GeneID; 3799; -.
DR   KEGG; hsa:3799; -.
DR   UCSC; uc001iwe.5; human.
DR   CTD; 3799; -.
DR   EuPathDB; HostDB:ENSG00000170759.10; -.
DR   eggNOG; KOG0240; Eukaryota.
DR   eggNOG; COG5059; LUCA.
DR   KO; K10396; -.
DR   OMA; NDCAKKI; -.
DR   OrthoDB; EOG091G02A2; -.
DR   PhylomeDB; V9HW29; -.
DR   ChiTaRS; KIF5B; human.
DR   GenomeRNAi; 3799; -.
DR   Bgee; ENSG00000170759; -.
DR   ExpressionAtlas; V9HW29; baseline and differential.
DR   GO; GO:0044295; C:axonal growth cone; IEA:Ensembl.
DR   GO; GO:0035253; C:ciliary rootlet; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0045335; C:phagocytic vesicle; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0008432; F:JUN kinase binding; IEA:Ensembl.
DR   GO; GO:0099609; F:microtubule lateral binding; IEA:Ensembl.
DR   GO; GO:0003777; F:microtubule motor activity; IEA:Ensembl.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl.
DR   GO; GO:0007028; P:cytoplasm organization; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0072383; P:plus-end-directed vesicle transport along microtubule; IEA:Ensembl.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; IEA:Ensembl.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl.
DR   GO; GO:0031340; P:positive regulation of vesicle fusion; IEA:Ensembl.
DR   GO; GO:1905152; P:positive regulation of voltage-gated sodium channel activity; IEA:Ensembl.
DR   GO; GO:0035617; P:stress granule disassembly; IEA:Ensembl.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR027640; Kinesin-like_fam.
DR   InterPro; IPR019821; Kinesin_motor_CS.
DR   InterPro; IPR001752; Kinesin_motor_dom.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24115; PTHR24115; 1.
DR   Pfam; PF00225; Kinesin; 1.
DR   PRINTS; PR00380; KINESINHEAVY.
DR   SMART; SM00129; KISc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR   PROSITE; PS50067; KINESIN_MOTOR_2; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU000394,
KW   ECO:0000256|SAAS:SAAS00625543}; Coiled coil {ECO:0000256|SAM:Coils};
KW   Microtubule {ECO:0000256|RuleBase:RU000394};
KW   Motor protein {ECO:0000256|RuleBase:RU000394};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000394,
KW   ECO:0000256|SAAS:SAAS00625543}.
FT   DOMAIN        8    325       Kinesin motor.
FT                                {ECO:0000259|PROSITE:PS50067}.
FT   NP_BIND      85     92       ATP. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00283}.
FT   COILED      330    364       {ECO:0000256|SAM:Coils}.
FT   COILED      418    543       {ECO:0000256|SAM:Coils}.
FT   COILED      594    684       {ECO:0000256|SAM:Coils}.
FT   COILED      691    711       {ECO:0000256|SAM:Coils}.
FT   COILED      716    757       {ECO:0000256|SAM:Coils}.
FT   COILED      768    802       {ECO:0000256|SAM:Coils}.
FT   COILED      825    912       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   963 AA;  109685 MW;  A1FE5760C3250C8B CRC64;
     MADLAECNIK VMCRFRPLNE SEVNRGDKYI AKFQGEDTVV IASKPYAFDR VFQSSTSQEQ
     VYNDCAKKIV KDVLEGYNGT IFAYGQTSSG KTHTMEGKLH DPEGMGIIPR IVQDIFNYIY
     SMDENLEFHI KVSYFEIYLD KIRDLLDVSK TNLSVHEDKN RVPYVKGCTE RFVCSPDEVM
     DTIDEGKSNR HVAVTNMNEH SSRSHSIFLI NVKQENTQTE QKLSGKLYLV DLAGSEKVSK
     TGAEGAVLDE AKNINKSLSA LGNVISALAE GSTYVPYRDS KMTRILQDSL GGNCRTTIVI
     CCSPSSYNES ETKSTLLFGQ RAKTIKNTVC VNVELTAEQW KKKYEKEKEK NKILRNTIQW
     LENELNRWRN GETVPIDEQF DKEKANLEAF TVDKDITLTN DKPATAIGVI GNFTDAERRK
     CEEEIAKLYK QLDDKDEEIN QQSQLVEKLK TQMLDQEELL ASTRRDQDNM QAELNRLQAE
     NDASKEEVKE VLQALEELAV NYDQKSQEVE DKTKEYELLS DELNQKSATL ASIDAELQKL
     KEMTNHQKKR AAEMMASLLK DLAEIGIAVG NNDVKQPEGT GMIDEEFTVA RLYISKMKSE
     VKTMVKRCKQ LESTQTESNK KMEENEKELA ACQLRISQHE AKIKSLTEYL QNVEQKKRQL
     EESVDALSEE LVQLRAQEKV HEMEKEHLNK VQTANEVKQA VEQQIQSHRE THQKQISSLR
     DEVEAKAKLI TDLQDQNQKM MLEQERLRVE HEKLKATDQE KSRKLHELTV MQDRREQARQ
     DLKGLEETVA KELQTLHNLR KLFVQDLATR VKKSAEIDSD DTGGSAAQKQ KISFLENNLE
     QLTKVHKQLV RDNADLRCEL PKLEKRLRAT AERVKALESA LKEAKENASR DRKRYQQEVD
     RIKEAVRSKN MARRGHSAQI AKPIRPGQHP AASPTHPSAI RGGGAFVQNS QPVAVRGGGG
     KQV
//
ID   A0A024R4J4_HUMAN        Unreviewed;       261 AA.
AC   A0A024R4J4;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 37.
DE   SubName: Full=Kallikrein 2, prostatic, isoform CRA_a {ECO:0000313|EMBL:EAW71940.1};
DE   SubName: Full=Kallikrein A3 {ECO:0000313|EMBL:SFW93199.1};
GN   Name=KLK2 {ECO:0000313|EMBL:EAW71940.1};
GN   Synonyms=KLNA3 {ECO:0000313|EMBL:SFW93199.1};
GN   ORFNames=hCG_22932 {ECO:0000313|EMBL:EAW71940.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW71940.1};
RN   [1] {ECO:0000313|EMBL:EAW71940.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW71940.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:SFW93199.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=28224083; DOI=10.1016/j.ymgmr.2017.01.009;
RA   Premzl M.;
RT   "Comparative genomic analysis of eutherian kallikrein genes.";
RL   Mol. Genet. Metab. Rep. 10:96-99(2017).
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000256|SAAS:SAAS00559343}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471135; EAW71937.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW71940.1; -; Genomic_DNA.
DR   EMBL; LT631552; SFW93199.1; -; Genomic_DNA.
DR   RefSeq; NP_005542.1; NM_005551.4.
DR   UniGene; Hs.515560; -.
DR   SMR; A0A024R4J4; -.
DR   Allergome; 2836; Hom s PSA.
DR   GeneID; 3817; -.
DR   KEGG; hsa:3817; -.
DR   CTD; 3817; -.
DR   EuPathDB; HostDB:ENSG00000167751.12; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   KO; K01325; -.
DR   OMA; GWECERH; -.
DR   OrthoDB; EOG091G0DF7; -.
DR   ChiTaRS; KLK2; human.
DR   GenomeRNAi; 3817; -.
DR   Bgee; ENSG00000167751; -.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   3: Inferred from homology;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00037407};
KW   Hydrolase {ECO:0000256|RuleBase:RU363034};
KW   Protease {ECO:0000256|RuleBase:RU363034};
KW   Serine protease {ECO:0000256|RuleBase:RU363034};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     17       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        18    261       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5011337021.
FT   DOMAIN       25    258       Peptidase S1.
FT                                {ECO:0000259|PROSITE:PS50240}.
SQ   SEQUENCE   261 AA;  28671 MW;  9CF7F4A1162EF42D CRC64;
     MWDLVLSIAL SVGCTGAVPL IQSRIVGGWE CEKHSQPWQV AVYSHGWAHC GGVLVHPQWV
     LTAAHCLKKN SQVWLGRHNL FEPEDTGQRV PVSHSFPHPL YNMSLLKHQS LRPDEDSSHD
     LMLLRLSEPA KITDVVKVLG LPTQEPALGT TCYASGWGSI EPEEFLRPRS LQCVSLHLLS
     NDMCARAYSE KVTEFMLCAG LWTGGKDTCG GDSGGPLVCN GVLQGITSWG PEPCALPEKP
     AVYTKVVHYR KWIKDTIAAN P
//
ID   A0A024R4N3_HUMAN        Unreviewed;       223 AA.
AC   A0A024R4N3;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 36.
DE   SubName: Full=Kallikrein 2, prostatic, isoform CRA_b {ECO:0000313|EMBL:EAW71939.1};
GN   Name=KLK2 {ECO:0000313|EMBL:EAW71939.1};
GN   ORFNames=hCG_22932 {ECO:0000313|EMBL:EAW71939.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW71939.1};
RN   [1] {ECO:0000313|EMBL:EAW71939.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW71939.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000256|SAAS:SAAS00559343}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471135; EAW71938.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW71939.1; -; Genomic_DNA.
DR   RefSeq; NP_001002231.1; NM_001002231.2.
DR   UniGene; Hs.515560; -.
DR   SMR; A0A024R4N3; -.
DR   Allergome; 2836; Hom s PSA.
DR   GeneID; 3817; -.
DR   CTD; 3817; -.
DR   EuPathDB; HostDB:ENSG00000167751.12; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   ChiTaRS; KLK2; human.
DR   GenomeRNAi; 3817; -.
DR   Bgee; ENSG00000167751; -.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
PE   3: Inferred from homology;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00037407};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     17       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        18    223       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5011337022.
FT   DOMAIN       25    209       Peptidase S1.
FT                                {ECO:0000259|PROSITE:PS50240}.
SQ   SEQUENCE   223 AA;  24674 MW;  051F76900C2AFEA9 CRC64;
     MWDLVLSIAL SVGCTGAVPL IQSRIVGGWE CEKHSQPWQV AVYSHGWAHC GGVLVHPQWV
     LTAAHCLKKN SQVWLGRHNL FEPEDTGQRV PVSHSFPHPL YNMSLLKHQS LRPDEDSSHD
     LMLLRLSEPA KITDVVKVLG LPTQEPALGT TCYASGWGSI EPEEFLRPRS LQCVSLHLLS
     NDMCARAYSE KVTEFMLCAG LWTGGKDTCG VSHPYSQHLE GKG
//
ID   B4DU77_HUMAN            Unreviewed;       244 AA.
AC   B4DU77;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 46.
DE   SubName: Full=cDNA FLJ52279, highly similar to Kallikrein-2 (EC 3.4.21.35) {ECO:0000313|EMBL:BAG62239.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG62239.1};
RN   [1] {ECO:0000313|EMBL:BAG62239.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Prostate {ECO:0000313|EMBL:BAG62239.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000256|SAAS:SAAS00733161}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK300527; BAG62239.1; -; mRNA.
DR   RefSeq; NP_001002231.1; NM_001002231.2.
DR   RefSeq; NP_001243009.1; NM_001256080.1.
DR   RefSeq; NP_005542.1; NM_005551.4.
DR   UniGene; Hs.515560; -.
DR   ProteinModelPortal; B4DU77; -.
DR   SMR; B4DU77; -.
DR   PeptideAtlas; B4DU77; -.
DR   PRIDE; B4DU77; -.
DR   GeneID; 3817; -.
DR   KEGG; hsa:3817; -.
DR   CTD; 3817; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   HOVERGEN; HBG013304; -.
DR   KO; K01325; -.
DR   GenomeRNAi; 3817; -.
DR   Genevisible; B4DU77; HS.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00731840}.
FT   DOMAIN        1    241       Peptidase S1.
FT                                {ECO:0000259|PROSITE:PS50240}.
SQ   SEQUENCE   244 AA;  26421 MW;  078D1FB643B276AD CRC64;
     MGTLWGCPGA PPVGAHSCPL PKEVSRTLGS GEGMAVSHRN NSGMLPPGSL LRNSQVWLGR
     HNLFEPEDTG RRVPVSHSFP HPLYNMSLLK HQSLRPDEDS SHDLMLLRLS EPAKITDVVK
     VLGLPTQEPA LGTTCYASGW GSIEPEEFLR PRSLQCVSLH LLSNDMCARA YSEKVTEFML
     CAGLWTGGKD TCGGDSGGPL VCNGVLQGIT SWGPEPCALP EKPAVYTKVV HYRKWIKDTI
     AANP
//
ID   KLK2_HUMAN              Reviewed;         261 AA.
AC   P20151; B4DU93; B4DUB0; F5H8L3; Q15946; Q9UJZ9;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   28-FEB-2018, entry version 175.
DE   RecName: Full=Kallikrein-2;
DE            EC=3.4.21.35;
DE   AltName: Full=Glandular kallikrein-1;
DE            Short=hGK-1;
DE   AltName: Full=Tissue kallikrein-2;
DE   Flags: Precursor;
GN   Name=KLK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=2824146; DOI=10.1089/dna.1987.6.429;
RA   Schedlich L.J., Bennetts B.H., Morris B.J.;
RT   "Primary structure of a human glandular kallikrein gene.";
RL   DNA 6:429-437(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Prostate;
RX   PubMed=1726490; DOI=10.1016/0303-7207(91)90272-T;
RA   Riegman P.H., Vlietstra R.J., der Korput H.A., Romijn J.C.,
RA   Trapman J.;
RT   "Identification and androgen-regulated expression of two major human
RT   glandular kallikrein-1 (hGK-1) mRNA species.";
RL   Mol. Cell. Endocrinol. 76:181-190(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RX   PubMed=10544017; DOI=10.1006/bbrc.1999.1595;
RA   Liu X.F., Essand M., Vasmatzis G., Lee B., Pastan I.;
RT   "Identification of three new alternate human kallikrein 2 transcripts:
RT   evidence of long transcript and alternative splicing.";
RL   Biochem. Biophys. Res. Commun. 264:833-839(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11054574; DOI=10.1016/S0378-1119(00)00382-6;
RA   Gan L., Lee I., Smith R., Argonza-Barrett R., Lei H., McCuaig J.,
RA   Moss P., Paeper B., Wang K.;
RT   "Sequencing and expression analysis of the serine protease gene
RT   cluster located in chromosome 19q13 region.";
RL   Gene 257:119-130(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Prostate;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [10]
RP   VARIANT LEU-18.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [11]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: Glandular kallikreins cleave Met-Lys and Arg-Ser bonds
CC       in kininogen to release Lys-bradykinin.
CC   -!- CATALYTIC ACTIVITY: Preferential cleavage of Arg-|-Xaa bonds in
CC       small molecule substrates. Highly selective action to release
CC       kallidin (lysyl-bradykinin) from kininogen involves hydrolysis of
CC       Met-|-Xaa or Leu-|-Xaa.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P20151-1; Sequence=Displayed;
CC       Name=2; Synonyms=PGK-10A;
CC         IsoId=P20151-2; Sequence=VSP_005399;
CC         Note=Ref.6 (BAG62272) sequence is in conflict in position:
CC         223:G->GE. {ECO:0000305};
CC       Name=3;
CC         IsoId=P20151-3; Sequence=VSP_005400;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=4;
CC         IsoId=P20151-4; Sequence=VSP_044709;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the peptidase S1 family. Kallikrein
CC       subfamily. {ECO:0000255|PROSITE-ProRule:PRU00274}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD13817.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M18156; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M18157; AAA74454.1; -; Genomic_DNA.
DR   EMBL; S39329; AAD13816.1; -; mRNA.
DR   EMBL; S39329; AAD13817.1; ALT_SEQ; mRNA.
DR   EMBL; AF188745; AAF08275.1; -; mRNA.
DR   EMBL; AF188746; AAF08276.1; -; mRNA.
DR   EMBL; AF188747; AAF08277.1; -; mRNA.
DR   EMBL; AF243527; AAG33356.1; -; Genomic_DNA.
DR   EMBL; BT006650; AAP35296.1; -; mRNA.
DR   EMBL; AK300549; BAG62255.1; -; mRNA.
DR   EMBL; AK300566; BAG62272.1; -; mRNA.
DR   EMBL; AC037199; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC005196; AAH05196.1; -; mRNA.
DR   CCDS; CCDS12808.1; -. [P20151-1]
DR   CCDS; CCDS42597.1; -. [P20151-2]
DR   CCDS; CCDS58675.1; -. [P20151-4]
DR   PIR; A29586; A29586.
DR   RefSeq; NP_001002231.1; NM_001002231.2. [P20151-2]
DR   RefSeq; NP_001243009.1; NM_001256080.1. [P20151-4]
DR   RefSeq; NP_005542.1; NM_005551.4. [P20151-1]
DR   UniGene; Hs.515560; -.
DR   PDB; 4NFE; X-ray; 1.90 A; A=25-261.
DR   PDB; 4NFF; X-ray; 1.90 A; A=25-261.
DR   PDBsum; 4NFE; -.
DR   PDBsum; 4NFF; -.
DR   ProteinModelPortal; P20151; -.
DR   SMR; P20151; -.
DR   BioGrid; 110017; 11.
DR   STRING; 9606.ENSP00000313581; -.
DR   BindingDB; P20151; -.
DR   ChEMBL; CHEMBL2442; -.
DR   GuidetoPHARMACOLOGY; 2372; -.
DR   Allergome; 2836; Hom s PSA.
DR   MEROPS; S01.161; -.
DR   iPTMnet; P20151; -.
DR   PhosphoSitePlus; P20151; -.
DR   BioMuta; KLK2; -.
DR   DMDM; 125174; -.
DR   MaxQB; P20151; -.
DR   PaxDb; P20151; -.
DR   PeptideAtlas; P20151; -.
DR   PRIDE; P20151; -.
DR   DNASU; 3817; -.
DR   Ensembl; ENST00000325321; ENSP00000313581; ENSG00000167751. [P20151-1]
DR   Ensembl; ENST00000358049; ENSP00000350748; ENSG00000167751. [P20151-2]
DR   Ensembl; ENST00000391810; ENSP00000375686; ENSG00000167751. [P20151-4]
DR   Ensembl; ENST00000597439; ENSP00000471214; ENSG00000167751. [P20151-3]
DR   GeneID; 3817; -.
DR   KEGG; hsa:3817; -.
DR   UCSC; uc002ptu.4; human. [P20151-1]
DR   CTD; 3817; -.
DR   DisGeNET; 3817; -.
DR   EuPathDB; HostDB:ENSG00000167751.12; -.
DR   GeneCards; KLK2; -.
DR   HGNC; HGNC:6363; KLK2.
DR   HPA; HPA000764; -.
DR   MIM; 147960; gene.
DR   neXtProt; NX_P20151; -.
DR   OpenTargets; ENSG00000167751; -.
DR   PharmGKB; PA30152; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   GeneTree; ENSGT00910000144067; -.
DR   HOGENOM; HOG000251820; -.
DR   HOVERGEN; HBG013304; -.
DR   InParanoid; P20151; -.
DR   KO; K01325; -.
DR   OMA; GWECERH; -.
DR   OrthoDB; EOG091G0DF7; -.
DR   PhylomeDB; P20151; -.
DR   TreeFam; TF331065; -.
DR   Reactome; R-HSA-1592389; Activation of Matrix Metalloproteinases.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   SIGNOR; P20151; -.
DR   ChiTaRS; KLK2; human.
DR   GenomeRNAi; 3817; -.
DR   PMAP-CutDB; P20151; -.
DR   PRO; PR:P20151; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000167751; -.
DR   CleanEx; HS_KLK2; -.
DR   ExpressionAtlas; P20151; baseline and differential.
DR   Genevisible; P20151; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Glycoprotein; Hydrolase; Polymorphism; Protease; Reference proteome;
KW   Serine protease; Signal; Zymogen.
FT   SIGNAL        1     18       {ECO:0000305}.
FT   PROPEP       19     24       Activation peptide. {ECO:0000305}.
FT                                /FTId=PRO_0000027929.
FT   CHAIN        25    261       Kallikrein-2.
FT                                /FTId=PRO_0000027930.
FT   DOMAIN       25    258       Peptidase S1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00274}.
FT   ACT_SITE     65     65       Charge relay system.
FT   ACT_SITE    120    120       Charge relay system.
FT   ACT_SITE    213    213       Charge relay system.
FT   CARBOHYD    102    102       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     31    173       {ECO:0000255|PROSITE-ProRule:PRU00274}.
FT   DISULFID     50     66       {ECO:0000255|PROSITE-ProRule:PRU00274}.
FT   DISULFID    152    219       {ECO:0000255|PROSITE-ProRule:PRU00274}.
FT   DISULFID    184    198       {ECO:0000255|PROSITE-ProRule:PRU00274}.
FT   DISULFID    209    234       {ECO:0000255|PROSITE-ProRule:PRU00274}.
FT   VAR_SEQ       1    102       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044709.
FT   VAR_SEQ     165    261       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_005400.
FT   VAR_SEQ     211    261       GDSGGPLVCNGVLQGITSWGPEPCALPEKPAVYTKVVHYRK
FT                                WIKDTIAANP -> VSHPYSQHLEGKG (in isoform
FT                                2). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:1726490}.
FT                                /FTId=VSP_005399.
FT   VARIANT      18     18       V -> L (in dbSNP:rs6072).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_014164.
FT   VARIANT     250    250       R -> W (in dbSNP:rs198977).
FT                                /FTId=VAR_020178.
FT   VARIANT     255    255       D -> A (in dbSNP:rs60268688).
FT                                /FTId=VAR_061775.
FT   CONFLICT    143    143       T -> A (in Ref. 6; BAG62255).
FT                                {ECO:0000305}.
FT   STRAND       39     44       {ECO:0000244|PDB:4NFE}.
FT   STRAND       47     56       {ECO:0000244|PDB:4NFE}.
FT   STRAND       59     62       {ECO:0000244|PDB:4NFE}.
FT   HELIX        64     66       {ECO:0000244|PDB:4NFE}.
FT   STRAND       72     76       {ECO:0000244|PDB:4NFE}.
FT   STRAND       88     97       {ECO:0000244|PDB:4NFE}.
FT   HELIX       103    105       {ECO:0000244|PDB:4NFF}.
FT   STRAND      122    128       {ECO:0000244|PDB:4NFE}.
FT   STRAND      134    136       {ECO:0000244|PDB:4NFF}.
FT   STRAND      151    158       {ECO:0000244|PDB:4NFE}.
FT   STRAND      160    164       {ECO:0000244|PDB:4NFE}.
FT   STRAND      172    179       {ECO:0000244|PDB:4NFE}.
FT   HELIX       181    187       {ECO:0000244|PDB:4NFE}.
FT   STRAND      196    200       {ECO:0000244|PDB:4NFE}.
FT   STRAND      216    219       {ECO:0000244|PDB:4NFE}.
FT   STRAND      222    229       {ECO:0000244|PDB:4NFE}.
FT   STRAND      241    245       {ECO:0000244|PDB:4NFE}.
FT   HELIX       246    249       {ECO:0000244|PDB:4NFE}.
FT   HELIX       250    259       {ECO:0000244|PDB:4NFE}.
SQ   SEQUENCE   261 AA;  28671 MW;  9CF7F4A1162EF42D CRC64;
     MWDLVLSIAL SVGCTGAVPL IQSRIVGGWE CEKHSQPWQV AVYSHGWAHC GGVLVHPQWV
     LTAAHCLKKN SQVWLGRHNL FEPEDTGQRV PVSHSFPHPL YNMSLLKHQS LRPDEDSSHD
     LMLLRLSEPA KITDVVKVLG LPTQEPALGT TCYASGWGSI EPEEFLRPRS LQCVSLHLLS
     NDMCARAYSE KVTEFMLCAG LWTGGKDTCG GDSGGPLVCN GVLQGITSWG PEPCALPEKP
     AVYTKVVHYR KWIKDTIAAN P
//
ID   A0A024R663_HUMAN        Unreviewed;      1357 AA.
AC   A0A024R663;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 31.
DE   SubName: Full=Kinectin 1 (Kinesin receptor), isoform CRA_a {ECO:0000313|EMBL:EAW80681.1};
DE   SubName: Full=Kinectin 1 (Kinesin receptor), isoform CRA_b {ECO:0000313|EMBL:EAW80684.1};
GN   Name=KTN1 {ECO:0000313|EMBL:EAW80684.1};
GN   ORFNames=hCG_22120 {ECO:0000313|EMBL:EAW80684.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW80684.1};
RN   [1] {ECO:0000313|EMBL:EAW80684.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW80684.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471061; EAW80681.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW80682.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW80684.1; -; Genomic_DNA.
DR   RefSeq; NP_001072989.1; NM_001079521.1.
DR   RefSeq; XP_006720201.1; XM_006720138.2.
DR   RefSeq; XP_011535053.1; XM_011536751.2.
DR   RefSeq; XP_016876767.1; XM_017021278.1.
DR   UniGene; Hs.509414; -.
DR   UniGene; Hs.687012; -.
DR   SMR; A0A024R663; -.
DR   GeneID; 3895; -.
DR   KEGG; hsa:3895; -.
DR   CTD; 3895; -.
DR   EuPathDB; HostDB:ENSG00000126777.17; -.
DR   eggNOG; ENOG410IIAW; Eukaryota.
DR   eggNOG; ENOG410YAE3; LUCA.
DR   KO; K17975; -.
DR   OMA; KEHNVFQ; -.
DR   OrthoDB; EOG091G12OH; -.
DR   ChiTaRS; KTN1; human.
DR   GenomeRNAi; 3895; -.
DR   Bgee; ENSG00000126777; -.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019894; F:kinesin binding; IEA:InterPro.
DR   GO; GO:0007018; P:microtubule-based movement; IEA:InterPro.
DR   InterPro; IPR024854; Kinectin.
DR   PANTHER; PTHR18864; PTHR18864; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:EAW80684.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM      7     29       Helical. {ECO:0000256|SAM:Phobius}.
FT   COILED      341    368       {ECO:0000256|SAM:Coils}.
FT   COILED      405    432       {ECO:0000256|SAM:Coils}.
FT   COILED      441    496       {ECO:0000256|SAM:Coils}.
FT   COILED      564    591       {ECO:0000256|SAM:Coils}.
FT   COILED      602    643       {ECO:0000256|SAM:Coils}.
FT   COILED      651    674       {ECO:0000256|SAM:Coils}.
FT   COILED      686    720       {ECO:0000256|SAM:Coils}.
FT   COILED      730    753       {ECO:0000256|SAM:Coils}.
FT   COILED      758    785       {ECO:0000256|SAM:Coils}.
FT   COILED      796    851       {ECO:0000256|SAM:Coils}.
FT   COILED      862    920       {ECO:0000256|SAM:Coils}.
FT   COILED      928    955       {ECO:0000256|SAM:Coils}.
FT   COILED      963    983       {ECO:0000256|SAM:Coils}.
FT   COILED     1015   1035       {ECO:0000256|SAM:Coils}.
FT   COILED     1115   1163       {ECO:0000256|SAM:Coils}.
FT   COILED     1175   1275       {ECO:0000256|SAM:Coils}.
FT   COILED     1332   1357       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1357 AA;  156275 MW;  971FCDF8AA8FC88E CRC64;
     MEFYESAYFI VLIPSIVITV IFLFFWLFMK ETLYDEVLAK QKREQKLIPT KTDKKKAEKK
     KNKKKEIQNG NLHESDSESV PRDFKLSDAL AVEDDQVAPV PLNVVETSSS VRERKKKEKK
     QKPVLEEQVI KESDASKIPG KKVEPVPVTK QPTPPSEAAA SKKKPGQKKS KNGSDDQDKK
     VETLMVPSKR QEALPLHQET KQESGSGKKK ASSKKQKTEN VFVDEPLIHA TTYIPLMDNA
     DSSPVVDKRE VIDLLKPDQV EGIQKSGTKK LKTETDKENA EVKFKDFLLS LKTMMFSEDE
     ALCVVDLLKE KSGVIQDALK KSSKGELTTL IHQLQEKDKL LAAVKEDAAA TKDRCKQLTQ
     EMMTEKERSN VVITRMKDRI GTLEKEHNVF QNKIHVSYQE TQQMQMKFQQ VREQMEAEIA
     HLKQENGILR DAVSNTTNQL ESKQSAELNK LRQDYARLVN ELTEKTGKLQ QEEVQKKNAE
     QAATQLKVQL QEAERRWEEV QSYIRKRTAE HEAAQQDLQS KFVAKENEVQ SLHSKLTDTL
     VSKQQLEQRL MQLMESEQKR VNKEESLQMQ VQDILEQNEA LKAQIQQFHS QIAAQTSASV
     LAEELHKVIA EKDKQIKQTE DSLASERDRL TSKEEELKDI QNMNFLLKAE VQKLQALANE
     QAAAAHELEK MQQSVYVKDD KIRLLEEQLQ HEISNKMEEF KILNDQNKAL KSEVQKLQTL
     VSEQPNKDVV EQMEKCIQEK DEKLKTVEEL LETGLIQVAT KEEELNAIRT ENSSLTKEVQ
     DLKAKQNDQV SFASLVEELK KVIHEKDGKI KSVEELLEAE LLKVANKEKT VQDLKQEIKA
     LKEEIGNVQL EKAQQLSITS KVQELQNLLK GKEEQMNTMK AVLEEKEKDL ANTGKWLQDL
     QEENESLKAH VQEVAQHNLK EASSASQFEE LEIVLKEKEN ELKRLEAMLK ERESDLSSKT
     QLLQDVQDEN KLFKSQIEQL KQQNYQQASS FPPHEELLKV ISEREKEISG LWNELDSLKD
     AVEHQRKKNN DLREKNWEAM EALASTEKML QDKVNKTSKE RQQQVEAVEL EAKEVLKKLF
     PKVSVPSNLS YGEWLHGFEK KAKECMAGTS GSEEVKVLEH KLKEADEMHT LLQLECEKYK
     SVLAETEGIL QKLQRSVEQE ENKWKVKVDE SHKTIKQMQS SFTSSEQELE RLRSENKDIE
     NLRREREHLE MELEKAEMER STYVTEVREL KDLLTELQKK LDDSYSEAVR QNEELNLLKA
     QLNETLTKLR TEQNERQKVA GDLHKAQQSL ELIQSKIVKA AGDTTVIENS DVSPETESSE
     KETMSVSLNQ TVTQLQQLLQ AVNQQLTKEK EHYQVLE
//
ID   KTN1_HUMAN              Reviewed;        1357 AA.
AC   Q86UP2; B4DZ88; Q13999; Q14707; Q15387; Q17RZ5; Q5GGW3; Q86W57;
DT   15-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   28-FEB-2018, entry version 149.
DE   RecName: Full=Kinectin;
DE   AltName: Full=CG-1 antigen;
DE   AltName: Full=Kinesin receptor;
GN   Name=KTN1; Synonyms=CG1, KIAA0004;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lymphoid tissue;
RX   PubMed=7787243; DOI=10.1091/mbc.6.2.161;
RA   Fuetterer A., Kruppa G., Kraemer B., Lemke H., Kroenke M.;
RT   "Molecular cloning and characterization of human kinectin.";
RL   Mol. Biol. Cell 6:161-170(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=8039706; DOI=10.1016/0378-1119(94)90381-6;
RA   Print C.G., Leung E., Harrison J.E.B., Watson J.D., Krissansen G.W.;
RT   "Cloning of a gene encoding a human leukocyte protein characterised by
RT   extensive heptad repeats.";
RL   Gene 144:221-228(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wang H.-C., Chen W.-F., Su Y.-R.;
RT   "Identification of a variant of Homo sapiens kinectin mRNA.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y.,
RA   Sato S., Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I.
RT   The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by
RT   analysis of randomly sampled cDNA clones from human immature myeloid
RT   cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-870 (ISOFORMS 1/2).
RC   TISSUE=Cerebellum, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 191-195; 395-405; 545-554; 747-761 AND 811-823.
RX   PubMed=11973345;
RA   Tran H., Pankov R., Tran S.D., Hampton B., Burgess W.H., Yamada K.M.;
RT   "Integrin clustering induces kinectin accumulation.";
RL   J. Cell Sci. 115:2031-2040(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 538-1357.
RC   TISSUE=Embryonic rhabdomyosarcoma;
RA   Behrends U., Gotz C., Mautner J.;
RT   "SEREX-defined rhabdomyosarcoma antigens.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   CHROMOSOMAL LOCATION.
RX   PubMed=8575822; DOI=10.1007/s002510050050;
RA   Print C.G., Morris C.M., Spurr N.K., Rooke L., Krissansen G.W.;
RT   "The CG-1 gene, a member of the kinectin and ES/130 family, maps to
RT   human chromosome band 14q22.";
RL   Immunogenetics 43:227-229(1996).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-153, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; THR-153 AND SER-156,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75 AND THR-153, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; SER-77; THR-153 AND
RP   SER-1313, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   PHOSPHORYLATION AT SER-75.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-226 AND PRO-1316.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [22]
RP   VARIANT MET-1233.
RX   PubMed=27932480; DOI=10.1681/ASN.2016040387;
RG   NephroS;
RG   UK study of Nephrotic Syndrome;
RA   Bierzynska A., Soderquest K., Dean P., Colby E., Rollason R.,
RA   Jones C., Inward C.D., McCarthy H.J., Simpson M.A., Lord G.M.,
RA   Williams M., Welsh G.I., Koziell A.B., Saleem M.A.;
RT   "MAGI2 mutations cause congenital nephrotic syndrome.";
RL   J. Am. Soc. Nephrol. 28:1614-1621(2017).
CC   -!- FUNCTION: Receptor for kinesin thus involved in kinesin-driven
CC       vesicle motility. Accumulates in integrin-based adhesion complexes
CC       (IAC) upon integrin aggregation by fibronectin.
CC   -!- SUBUNIT: Parallel homodimers formed between the membrane-bound and
CC       the cytosolic form, and also between 2 cytosolic forms.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q12983:BNIP3; NbExp=3; IntAct=EBI-359761, EBI-749464;
CC       Q9BXN2:CLEC7A; NbExp=3; IntAct=EBI-359761, EBI-3939278;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-359761, EBI-748397;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-359761, EBI-347996;
CC       Q8N205:SYNE4; NbExp=3; IntAct=EBI-359761, EBI-7131783;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       type II membrane protein. Note=Vesicle membrane protein anchored
CC       to the endoplasmic reticulum.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q86UP2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86UP2-2; Sequence=VSP_007981, VSP_007982;
CC       Name=3;
CC         IsoId=Q86UP2-3; Sequence=VSP_043207, VSP_007982;
CC       Name=4;
CC         IsoId=Q86UP2-4; Sequence=VSP_007982;
CC   -!- TISSUE SPECIFICITY: High levels in peripheral blood lymphocytes,
CC       testis and ovary, lower levels in spleen, thymus, prostate, small
CC       intestine and colon.
CC   -!- SIMILARITY: Belongs to the kinectin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH50555.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA02794.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z22551; CAA80271.1; -; mRNA.
DR   EMBL; L25616; AAB65853.1; -; mRNA.
DR   EMBL; AY264265; AAP20418.1; -; mRNA.
DR   EMBL; D13629; BAA02794.2; ALT_INIT; mRNA.
DR   EMBL; AK302797; BAG64000.1; -; mRNA.
DR   EMBL; AL138499; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355773; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC050555; AAH50555.1; ALT_SEQ; mRNA.
DR   EMBL; BC112337; AAI12338.1; -; mRNA.
DR   EMBL; BC117132; AAI17133.1; -; mRNA.
DR   EMBL; BC143720; AAI43721.1; -; mRNA.
DR   EMBL; AY536375; AAT66048.1; -; mRNA.
DR   CCDS; CCDS41957.1; -. [Q86UP2-1]
DR   CCDS; CCDS41958.1; -. [Q86UP2-2]
DR   CCDS; CCDS41959.1; -. [Q86UP2-3]
DR   PIR; I53799; I53799.
DR   PIR; S32763; S32763.
DR   RefSeq; NP_001072989.1; NM_001079521.1. [Q86UP2-1]
DR   RefSeq; NP_001072990.1; NM_001079522.1. [Q86UP2-3]
DR   RefSeq; NP_001257943.1; NM_001271014.1. [Q86UP2-4]
DR   RefSeq; NP_004977.2; NM_004986.3. [Q86UP2-2]
DR   RefSeq; XP_006720201.1; XM_006720138.2. [Q86UP2-1]
DR   RefSeq; XP_006720202.1; XM_006720139.2. [Q86UP2-4]
DR   RefSeq; XP_011535053.1; XM_011536751.2. [Q86UP2-1]
DR   RefSeq; XP_011535055.1; XM_011536753.1. [Q86UP2-3]
DR   RefSeq; XP_016876767.1; XM_017021278.1. [Q86UP2-1]
DR   RefSeq; XP_016876771.1; XM_017021282.1. [Q86UP2-2]
DR   RefSeq; XP_016876772.1; XM_017021283.1. [Q86UP2-2]
DR   UniGene; Hs.509414; -.
DR   UniGene; Hs.687012; -.
DR   ProteinModelPortal; Q86UP2; -.
DR   SMR; Q86UP2; -.
DR   BioGrid; 110092; 61.
DR   CORUM; Q86UP2; -.
DR   DIP; DIP-27585N; -.
DR   IntAct; Q86UP2; 37.
DR   MINT; Q86UP2; -.
DR   STRING; 9606.ENSP00000378720; -.
DR   iPTMnet; Q86UP2; -.
DR   PhosphoSitePlus; Q86UP2; -.
DR   SwissPalm; Q86UP2; -.
DR   BioMuta; KTN1; -.
DR   DMDM; 34098465; -.
DR   EPD; Q86UP2; -.
DR   MaxQB; Q86UP2; -.
DR   PaxDb; Q86UP2; -.
DR   PeptideAtlas; Q86UP2; -.
DR   PRIDE; Q86UP2; -.
DR   DNASU; 3895; -.
DR   Ensembl; ENST00000395308; ENSP00000378719; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000395309; ENSP00000378720; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000395311; ENSP00000378722; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000395314; ENSP00000378725; ENSG00000126777. [Q86UP2-1]
DR   Ensembl; ENST00000413890; ENSP00000394992; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000438792; ENSP00000391964; ENSG00000126777. [Q86UP2-2]
DR   Ensembl; ENST00000459737; ENSP00000432149; ENSG00000126777. [Q86UP2-1]
DR   GeneID; 3895; -.
DR   KEGG; hsa:3895; -.
DR   UCSC; uc001xcb.4; human. [Q86UP2-1]
DR   CTD; 3895; -.
DR   DisGeNET; 3895; -.
DR   EuPathDB; HostDB:ENSG00000126777.17; -.
DR   GeneCards; KTN1; -.
DR   HGNC; HGNC:6467; KTN1.
DR   HPA; CAB015331; -.
DR   HPA; HPA003178; -.
DR   HPA; HPA017876; -.
DR   MIM; 600381; gene.
DR   neXtProt; NX_Q86UP2; -.
DR   OpenTargets; ENSG00000126777; -.
DR   PharmGKB; PA30256; -.
DR   eggNOG; ENOG410IIAW; Eukaryota.
DR   eggNOG; ENOG410YAE3; LUCA.
DR   GeneTree; ENSGT00530000063895; -.
DR   HOGENOM; HOG000113267; -.
DR   HOVERGEN; HBG007851; -.
DR   InParanoid; Q86UP2; -.
DR   KO; K17975; -.
DR   OMA; KEHNVFQ; -.
DR   OrthoDB; EOG091G12OH; -.
DR   PhylomeDB; Q86UP2; -.
DR   TreeFam; TF333579; -.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-5625970; RHO GTPases activate KTN1.
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   SIGNOR; Q86UP2; -.
DR   ChiTaRS; KTN1; human.
DR   GeneWiki; KTN1; -.
DR   GenomeRNAi; 3895; -.
DR   PRO; PR:Q86UP2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000126777; -.
DR   CleanEx; HS_KTN1; -.
DR   ExpressionAtlas; Q86UP2; baseline and differential.
DR   Genevisible; Q86UP2; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0019894; F:kinesin binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0007018; P:microtubule-based movement; NAS:ProtInc.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   InterPro; IPR024854; Kinectin.
DR   PANTHER; PTHR18864; PTHR18864; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome;
KW   Direct protein sequencing; Endoplasmic reticulum; Glycoprotein;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome;
KW   Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1   1357       Kinectin.
FT                                /FTId=PRO_0000084337.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     29       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     30   1357       Lumenal. {ECO:0000255}.
FT   COILED      330   1356       {ECO:0000255}.
FT   MOD_RES      75     75       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES      77     77       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     153    153       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     156    156       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1084   1084       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1313   1313       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    172    172       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    435    435       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    772    772       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    904    904       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1055   1055       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1088   1088       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1263   1263       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1329   1329       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     832    854       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043207.
FT   VAR_SEQ    1031   1059       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7584026,
FT                                ECO:0000303|PubMed:8039706}.
FT                                /FTId=VSP_007981.
FT   VAR_SEQ    1232   1259       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7584026,
FT                                ECO:0000303|PubMed:8039706}.
FT                                /FTId=VSP_007982.
FT   VARIANT     226    226       P -> R (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035931.
FT   VARIANT     282    282       V -> M (in dbSNP:rs2274073).
FT                                /FTId=VAR_016206.
FT   VARIANT    1233   1233       L -> M (in dbSNP:rs372815686).
FT                                {ECO:0000269|PubMed:27932480}.
FT                                /FTId=VAR_079266.
FT   VARIANT    1316   1316       T -> P (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035932.
FT   CONFLICT     15     15       S -> P (in Ref. 4; BAA02794).
FT                                {ECO:0000305}.
FT   CONFLICT    210    210       Missing (in Ref. 1; CAA80271).
FT                                {ECO:0000305}.
FT   CONFLICT    373    373       I -> M (in Ref. 1; CAA80271).
FT                                {ECO:0000305}.
FT   CONFLICT    939    939       E -> G (in Ref. 1; CAA80271).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1357 AA;  156275 MW;  971FCDF8AA8FC88E CRC64;
     MEFYESAYFI VLIPSIVITV IFLFFWLFMK ETLYDEVLAK QKREQKLIPT KTDKKKAEKK
     KNKKKEIQNG NLHESDSESV PRDFKLSDAL AVEDDQVAPV PLNVVETSSS VRERKKKEKK
     QKPVLEEQVI KESDASKIPG KKVEPVPVTK QPTPPSEAAA SKKKPGQKKS KNGSDDQDKK
     VETLMVPSKR QEALPLHQET KQESGSGKKK ASSKKQKTEN VFVDEPLIHA TTYIPLMDNA
     DSSPVVDKRE VIDLLKPDQV EGIQKSGTKK LKTETDKENA EVKFKDFLLS LKTMMFSEDE
     ALCVVDLLKE KSGVIQDALK KSSKGELTTL IHQLQEKDKL LAAVKEDAAA TKDRCKQLTQ
     EMMTEKERSN VVITRMKDRI GTLEKEHNVF QNKIHVSYQE TQQMQMKFQQ VREQMEAEIA
     HLKQENGILR DAVSNTTNQL ESKQSAELNK LRQDYARLVN ELTEKTGKLQ QEEVQKKNAE
     QAATQLKVQL QEAERRWEEV QSYIRKRTAE HEAAQQDLQS KFVAKENEVQ SLHSKLTDTL
     VSKQQLEQRL MQLMESEQKR VNKEESLQMQ VQDILEQNEA LKAQIQQFHS QIAAQTSASV
     LAEELHKVIA EKDKQIKQTE DSLASERDRL TSKEEELKDI QNMNFLLKAE VQKLQALANE
     QAAAAHELEK MQQSVYVKDD KIRLLEEQLQ HEISNKMEEF KILNDQNKAL KSEVQKLQTL
     VSEQPNKDVV EQMEKCIQEK DEKLKTVEEL LETGLIQVAT KEEELNAIRT ENSSLTKEVQ
     DLKAKQNDQV SFASLVEELK KVIHEKDGKI KSVEELLEAE LLKVANKEKT VQDLKQEIKA
     LKEEIGNVQL EKAQQLSITS KVQELQNLLK GKEEQMNTMK AVLEEKEKDL ANTGKWLQDL
     QEENESLKAH VQEVAQHNLK EASSASQFEE LEIVLKEKEN ELKRLEAMLK ERESDLSSKT
     QLLQDVQDEN KLFKSQIEQL KQQNYQQASS FPPHEELLKV ISEREKEISG LWNELDSLKD
     AVEHQRKKNN DLREKNWEAM EALASTEKML QDKVNKTSKE RQQQVEAVEL EAKEVLKKLF
     PKVSVPSNLS YGEWLHGFEK KAKECMAGTS GSEEVKVLEH KLKEADEMHT LLQLECEKYK
     SVLAETEGIL QKLQRSVEQE ENKWKVKVDE SHKTIKQMQS SFTSSEQELE RLRSENKDIE
     NLRREREHLE MELEKAEMER STYVTEVREL KDLLTELQKK LDDSYSEAVR QNEELNLLKA
     QLNETLTKLR TEQNERQKVA GDLHKAQQSL ELIQSKIVKA AGDTTVIENS DVSPETESSE
     KETMSVSLNQ TVTQLQQLLQ AVNQQLTKEK EHYQVLE
//
ID   A0A024R1S8_HUMAN        Unreviewed;       261 AA.
AC   A0A024R1S8;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 36.
DE   SubName: Full=LIM and SH3 protein 1, isoform CRA_b {ECO:0000313|EMBL:EAW60545.1};
GN   Name=LASP1 {ECO:0000313|EMBL:EAW60545.1};
GN   ORFNames=hCG_31400 {ECO:0000313|EMBL:EAW60545.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW60545.1};
RN   [1] {ECO:0000313|EMBL:EAW60545.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW60545.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471152; EAW60544.1; -; Genomic_DNA.
DR   EMBL; CH471152; EAW60545.1; -; Genomic_DNA.
DR   RefSeq; NP_006139.1; NM_006148.3.
DR   UniGene; Hs.741156; -.
DR   SMR; A0A024R1S8; -.
DR   GeneID; 3927; -.
DR   KEGG; hsa:3927; -.
DR   CTD; 3927; -.
DR   EuPathDB; HostDB:ENSG00000002834.17; -.
DR   eggNOG; KOG1702; Eukaryota.
DR   eggNOG; ENOG4111GQ8; LUCA.
DR   OMA; YGYKEPA; -.
DR   OrthoDB; EOG091G0U2O; -.
DR   ChiTaRS; LASP1; human.
DR   GenomeRNAi; 3927; -.
DR   Bgee; ENSG00000002834; -.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
DR   GO; GO:0015075; F:ion transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   CDD; cd11934; SH3_Lasp1_C; 1.
DR   InterPro; IPR035630; Lasp1_SH3.
DR   InterPro; IPR000900; Nebulin_repeat.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 1.
DR   Pfam; PF00880; Nebulin; 2.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00132; LIM; 1.
DR   SMART; SM00227; NEBU; 2.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 1.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 1.
DR   PROSITE; PS51216; NEBULIN; 2.
DR   PROSITE; PS50002; SH3; 1.
PE   4: Predicted;
KW   LIM domain {ECO:0000256|PROSITE-ProRule:PRU00125,
KW   ECO:0000256|SAAS:SAAS00113461};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00125,
KW   ECO:0000256|SAAS:SAAS00113461};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00125,
KW   ECO:0000256|SAAS:SAAS00113461}.
FT   DOMAIN        3     63       LIM zinc-binding.
FT                                {ECO:0000259|PROSITE:PS50023}.
FT   DOMAIN      202    261       SH3. {ECO:0000259|PROSITE:PS50002}.
SQ   SEQUENCE   261 AA;  29717 MW;  3B89B988605B3639 CRC64;
     MNPNCARCGK IVYPTEKVNC LDKFWHKACF HCETCKMTLN MKNYKGYEKK PYCNAHYPKQ
     SFTMVADTPE NLRLKQQSEL QSQVRYKEEF EKNKGKGFSV VADTPELQRI KKTQDQISNI
     KYHEEFEKSR MGPSGGEGME PERRDSQDGS SYRRPLEQQQ PHHIPTSAPV YQQPQQQPVA
     QSYGGYKEPA APVSIQRSAP GGGGKRYRAV YDYSAADEDE VSFQDGDTIV NVQQIDDGWM
     YGTVERTGDT GMLPANYVEA I
//
ID   B4DIC4_HUMAN            Unreviewed;       125 AA.
AC   B4DIC4;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 58.
DE   SubName: Full=cDNA FLJ52195, highly similar to LIM and SH3 domain protein 1 {ECO:0000313|EMBL:BAG58436.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58436.1};
RN   [1] {ECO:0000313|EMBL:BAG58436.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:BAG58436.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK295522; BAG58436.1; -; mRNA.
DR   RefSeq; NP_001258537.1; NM_001271608.1.
DR   UniGene; Hs.741156; -.
DR   ProteinModelPortal; B4DIC4; -.
DR   MaxQB; B4DIC4; -.
DR   PeptideAtlas; B4DIC4; -.
DR   PRIDE; B4DIC4; -.
DR   GeneID; 3927; -.
DR   CTD; 3927; -.
DR   eggNOG; KOG1702; Eukaryota.
DR   eggNOG; ENOG4111GQ8; LUCA.
DR   GenomeRNAi; 3927; -.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   InterPro; IPR000900; Nebulin_repeat.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 1.
DR   Pfam; PF00880; Nebulin; 1.
DR   SMART; SM00132; LIM; 1.
DR   SMART; SM00227; NEBU; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 1.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 1.
DR   PROSITE; PS51216; NEBULIN; 2.
PE   2: Evidence at transcript level;
KW   LIM domain {ECO:0000256|PROSITE-ProRule:PRU00125,
KW   ECO:0000256|SAAS:SAAS00113461};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00125,
KW   ECO:0000256|SAAS:SAAS00113461};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00125,
KW   ECO:0000256|SAAS:SAAS00113461}.
FT   DOMAIN        3     63       LIM zinc-binding.
FT                                {ECO:0000259|PROSITE:PS50023}.
SQ   SEQUENCE   125 AA;  14598 MW;  900F5D3C3D145534 CRC64;
     MNPNCARCGK IVYPTEKVNC LDKFWHKACF HCETCKMTLN MKNYKGYEKK PYCNAHYPKQ
     SFTMVADTPE NLRLKQQSEL QSQVRYKEEF EKNKGKGFSV VADTPELQRS SLGFLWNEIP
     PSPHL
//
ID   LASP1_HUMAN             Reviewed;         261 AA.
AC   Q14847; B4DGQ0; Q96ED2; Q96IG0;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 2.
DT   28-FEB-2018, entry version 176.
DE   RecName: Full=LIM and SH3 domain protein 1;
DE            Short=LASP-1;
DE   AltName: Full=Metastatic lymph node gene 50 protein;
DE            Short=MLN 50;
GN   Name=LASP1; Synonyms=MLN50;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=7490069; DOI=10.1006/geno.1995.1163;
RA   Tomasetto C.L., Regnier C.H., Moog-Lutz C., Mattei M.-G.,
RA   Chenard M.-P., Lidereau R., Basset P., Rio M.-C.;
RT   "Identification of four novel human genes amplified and overexpressed
RT   in breast carcinoma and localized to the q11-q21.3 region of
RT   chromosome 17.";
RL   Genomics 28:367-376(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Liver, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 1-7, AND ACETYLATION AT MET-1.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [6]
RP   DOMAINS.
RX   PubMed=7589475; DOI=10.1016/0014-5793(95)01040-L;
RA   Tomasetto C., Moog-Lutz C., Regnier C.H., Schreiber V., Basset P.,
RA   Rio M.-C.;
RT   "Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by
RT   the association of LIM and SH3 domains.";
RL   FEBS Lett. 373:245-249(1995).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-104, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68; THR-104 AND SER-146,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   INTERACTION WITH KBTBD10.
RX   PubMed=19726686; DOI=10.1074/jbc.M109.023259;
RA   Gray C.H., McGarry L.C., Spence H.J., Riboldi-Tunnicliffe A.,
RA   Ozanne B.W.;
RT   "Novel beta-propeller of the BTB-Kelch protein Krp1 provides a binding
RT   site for Lasp-1 that is necessary for pseudopodial extension.";
RL   J. Biol. Chem. 284:30498-30507(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68 AND THR-104, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-42, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68; THR-104; SER-118 AND
RP   SER-146, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68; SER-99; THR-104;
RP   SER-134 AND SER-146, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-75, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Plays an important role in the regulation of dynamic
CC       actin-based, cytoskeletal activities. Agonist-dependent changes in
CC       LASP1 phosphorylation may also serve to regulate actin-associated
CC       ion transport activities, not only in the parietal cell but also
CC       in certain other F-actin-rich secretory epithelial cell types (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with F-actin (By similarity). Interacts with
CC       ANKRD54 (By similarity). Interacts with KBTBD10. {ECO:0000250,
CC       ECO:0000269|PubMed:19726686}.
CC   -!- INTERACTION:
CC       D3DTR7:ARHGEF15; NbExp=3; IntAct=EBI-742828, EBI-10176602;
CC       Q03989:ARID5A; NbExp=4; IntAct=EBI-9088686, EBI-948603;
CC       Q5BKX5-3:C19orf54; NbExp=4; IntAct=EBI-9088686, EBI-11976299;
CC       Q5T4B2:CERCAM; NbExp=4; IntAct=EBI-9088686, EBI-12261896;
CC       A8MQ03:CYSRT1; NbExp=4; IntAct=EBI-9088686, EBI-3867333;
CC       P51116:FXR2; NbExp=3; IntAct=EBI-742828, EBI-740459;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-742828, EBI-618309;
CC       Q9BYR5:KRTAP4-2; NbExp=3; IntAct=EBI-742828, EBI-10172511;
CC       Q93052:LPP; NbExp=3; IntAct=EBI-742828, EBI-718388;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-742828, EBI-741037;
CC       Q99750:MDFI; NbExp=3; IntAct=EBI-742828, EBI-724076;
CC       P28069:POU1F1; NbExp=4; IntAct=EBI-9088686, EBI-8673859;
CC       P25788:PSMA3; NbExp=3; IntAct=EBI-742828, EBI-348380;
CC       Q93062-3:RBPMS; NbExp=6; IntAct=EBI-9088686, EBI-740343;
CC       Q04864:REL; NbExp=3; IntAct=EBI-742828, EBI-307352;
CC       Q9BQY4:RHOXF2; NbExp=3; IntAct=EBI-742828, EBI-372094;
CC       Q9UH03:SEPT3; NbExp=3; IntAct=EBI-742828, EBI-727037;
CC       Q9NP31:SH2D2A; NbExp=2; IntAct=EBI-742828, EBI-490630;
CC       Q16637-3:SMN2; NbExp=4; IntAct=EBI-9088686, EBI-395447;
CC       O43597:SPRY2; NbExp=3; IntAct=EBI-742828, EBI-742487;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-742828, EBI-533224;
CC       Q9NVV9:THAP1; NbExp=3; IntAct=EBI-742828, EBI-741515;
CC       Q9UDY2:TJP2; NbExp=9; IntAct=EBI-742828, EBI-1042602;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-742828, EBI-719493;
CC       Q15645:TRIP13; NbExp=7; IntAct=EBI-742828, EBI-358993;
CC       P07947:YES1; NbExp=4; IntAct=EBI-9088686, EBI-515331;
CC       Q96C00:ZBTB9; NbExp=3; IntAct=EBI-742828, EBI-395708;
CC       Q96GY0:ZC2HC1A; NbExp=3; IntAct=EBI-742828, EBI-5458880;
CC       Q8IUH5:ZDHHC17; NbExp=3; IntAct=EBI-9088686, EBI-524753;
CC       Q15942:ZYX; NbExp=5; IntAct=EBI-742828, EBI-444225;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cell cortex {ECO:0000250}.
CC       Cytoplasm, cytoskeleton {ECO:0000250}. Note=Associated with the F-
CC       actin rich cortical cytoskeleton. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q14847-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14847-2; Sequence=VSP_016554;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q14847-3; Sequence=VSP_054611;
CC         Note=No experimental confirmation available.;
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/Lasp1ID203.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X82456; CAA57833.1; -; mRNA.
DR   EMBL; AK294704; BAG57861.1; -; mRNA.
DR   EMBL; AC006441; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110749; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007560; AAH07560.1; -; mRNA.
DR   EMBL; BC012460; AAH12460.1; -; mRNA.
DR   CCDS; CCDS11331.1; -. [Q14847-1]
DR   CCDS; CCDS62164.1; -. [Q14847-3]
DR   PIR; S68234; S68234.
DR   RefSeq; NP_001258537.1; NM_001271608.1. [Q14847-3]
DR   RefSeq; NP_006139.1; NM_006148.3. [Q14847-1]
DR   UniGene; Hs.741156; -.
DR   PDB; 3I35; X-ray; 1.40 A; A=202-261.
DR   PDBsum; 3I35; -.
DR   ProteinModelPortal; Q14847; -.
DR   SMR; Q14847; -.
DR   BioGrid; 110120; 88.
DR   IntAct; Q14847; 114.
DR   MINT; Q14847; -.
DR   STRING; 9606.ENSP00000325240; -.
DR   iPTMnet; Q14847; -.
DR   PhosphoSitePlus; Q14847; -.
DR   SwissPalm; Q14847; -.
DR   DMDM; 3122342; -.
DR   OGP; Q14847; -.
DR   SWISS-2DPAGE; Q14847; -.
DR   EPD; Q14847; -.
DR   MaxQB; Q14847; -.
DR   PaxDb; Q14847; -.
DR   PeptideAtlas; Q14847; -.
DR   PRIDE; Q14847; -.
DR   DNASU; 3927; -.
DR   Ensembl; ENST00000318008; ENSP00000325240; ENSG00000002834. [Q14847-1]
DR   Ensembl; ENST00000433206; ENSP00000401048; ENSG00000002834. [Q14847-3]
DR   Ensembl; ENST00000435347; ENSP00000392853; ENSG00000002834. [Q14847-1]
DR   GeneID; 3927; -.
DR   KEGG; hsa:3927; -.
DR   UCSC; uc002hra.3; human. [Q14847-1]
DR   CTD; 3927; -.
DR   DisGeNET; 3927; -.
DR   EuPathDB; HostDB:ENSG00000002834.17; -.
DR   GeneCards; LASP1; -.
DR   HGNC; HGNC:6513; LASP1.
DR   HPA; CAB022049; -.
DR   HPA; HPA012072; -.
DR   MIM; 602920; gene.
DR   neXtProt; NX_Q14847; -.
DR   OpenTargets; ENSG00000002834; -.
DR   PharmGKB; PA30298; -.
DR   eggNOG; KOG1702; Eukaryota.
DR   eggNOG; ENOG4111GQ8; LUCA.
DR   GeneTree; ENSGT00530000062924; -.
DR   HOGENOM; HOG000006616; -.
DR   HOVERGEN; HBG054636; -.
DR   InParanoid; Q14847; -.
DR   OMA; YGYKEPA; -.
DR   OrthoDB; EOG091G0U2O; -.
DR   PhylomeDB; Q14847; -.
DR   TreeFam; TF319104; -.
DR   SIGNOR; Q14847; -.
DR   ChiTaRS; LASP1; human.
DR   EvolutionaryTrace; Q14847; -.
DR   GeneWiki; LASP1; -.
DR   GenomeRNAi; 3927; -.
DR   PRO; PR:Q14847; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000002834; -.
DR   CleanEx; HS_LASP1; -.
DR   ExpressionAtlas; Q14847; baseline and differential.
DR   Genevisible; Q14847; HS.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0015075; F:ion transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc.
DR   GO; GO:0006811; P:ion transport; ISS:UniProtKB.
DR   CDD; cd11934; SH3_Lasp1_C; 1.
DR   InterPro; IPR035630; Lasp1_SH3.
DR   InterPro; IPR000900; Nebulin_repeat.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 1.
DR   Pfam; PF00880; Nebulin; 2.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00132; LIM; 1.
DR   SMART; SM00227; NEBU; 2.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 1.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 1.
DR   PROSITE; PS51216; NEBULIN; 2.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Ion transport; LIM domain; Metal-binding; Methylation; Phosphoprotein;
KW   Reference proteome; Repeat; SH3 domain; Transport; Zinc.
FT   CHAIN         1    261       LIM and SH3 domain protein 1.
FT                                /FTId=PRO_0000075761.
FT   DOMAIN        5     56       LIM zinc-binding. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   REPEAT       61     95       Nebulin 1.
FT   REPEAT       97    131       Nebulin 2.
FT   DOMAIN      202    261       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   COMPBIAS    201    204       Poly-Gly.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000269|PubMed:12665801}.
FT   MOD_RES      42     42       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      68     68       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      75     75       N6-methyllysine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES      99     99       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     104    104       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     112    112       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q61792}.
FT   MOD_RES     118    118       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     134    134       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     146    146       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1     83       MNPNCARCGKIVYPTEKVNCLDKFWHKACFHCETCKMTLNM
FT                                KNYKGYEKKPYCNAHYPKQSFTMVADTPENLRLKQQSELQS
FT                                Q -> MLPLRDLQDDTEHEELQGLREEALLQR (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054611.
FT   VAR_SEQ     201    261       GGGGKRYRAVYDYSAADEDEVSFQDGDTIVNVQQIDDGWMY
FT                                GTVERTGDTGMLPANYVEAI -> ICLQHIPRHRIRPGRDP
FT                                SILQCLCFLKPATACDSYPSSSFFCQLKPSSATSAGSLLWQ
FT                                ASPLIDFLVFSLDGTGMGLSGGGRGPWGRAGMGDLLACGPH
FT                                LPLCSLPSHPPAQLLTYPHIPGLG (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016554.
FT   CONFLICT     79     79       E -> R (in Ref. 4; AAH12460).
FT                                {ECO:0000305}.
FT   CONFLICT    210    210       V -> A (in Ref. 4; AAH12460).
FT                                {ECO:0000305}.
FT   CONFLICT    220    220       E -> A (in Ref. 4; AAH12460).
FT                                {ECO:0000305}.
FT   STRAND      207    211       {ECO:0000244|PDB:3I35}.
FT   STRAND      228    236       {ECO:0000244|PDB:3I35}.
FT   STRAND      239    244       {ECO:0000244|PDB:3I35}.
FT   TURN        245    248       {ECO:0000244|PDB:3I35}.
FT   STRAND      249    254       {ECO:0000244|PDB:3I35}.
FT   HELIX       255    257       {ECO:0000244|PDB:3I35}.
FT   STRAND      258    260       {ECO:0000244|PDB:3I35}.
SQ   SEQUENCE   261 AA;  29717 MW;  3B89B988605B3639 CRC64;
     MNPNCARCGK IVYPTEKVNC LDKFWHKACF HCETCKMTLN MKNYKGYEKK PYCNAHYPKQ
     SFTMVADTPE NLRLKQQSEL QSQVRYKEEF EKNKGKGFSV VADTPELQRI KKTQDQISNI
     KYHEEFEKSR MGPSGGEGME PERRDSQDGS SYRRPLEQQQ PHHIPTSAPV YQQPQQQPVA
     QSYGGYKEPA APVSIQRSAP GGGGKRYRAV YDYSAADEDE VSFQDGDTIV NVQQIDDGWM
     YGTVERTGDT GMLPANYVEA I
//
ID   A8K1Z4_HUMAN            Unreviewed;      1097 AA.
AC   A8K1Z4;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   28-FEB-2018, entry version 58.
DE   SubName: Full=cDNA FLJ76704, highly similar to Homo sapiens leukemia inhibitory factor receptor (LIFR), mRNA {ECO:0000313|EMBL:BAF82748.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF82748.1};
RN   [1] {ECO:0000313|EMBL:BAF82748.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:BAF82748.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK290059; BAF82748.1; -; mRNA.
DR   RefSeq; NP_001121143.1; NM_001127671.1.
DR   UniGene; Hs.133421; -.
DR   UniGene; Hs.657602; -.
DR   ProteinModelPortal; A8K1Z4; -.
DR   PeptideAtlas; A8K1Z4; -.
DR   PRIDE; A8K1Z4; -.
DR   DNASU; 3977; -.
DR   GeneID; 3977; -.
DR   KEGG; hsa:3977; -.
DR   CTD; 3977; -.
DR   PharmGKB; PA30371; -.
DR   eggNOG; ENOG410IF1V; Eukaryota.
DR   eggNOG; ENOG410ZMDF; LUCA.
DR   HOVERGEN; HBG006266; -.
DR   KO; K05058; -.
DR   GenomeRNAi; 3977; -.
DR   Genevisible; A8K1Z4; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004896; F:cytokine receptor activity; IEA:InterPro.
DR   CDD; cd00063; FN3; 3.
DR   Gene3D; 2.60.40.10; -; 8.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR003529; Hematopoietin_rcpt_Gp130_CS.
DR   InterPro; IPR013783; Ig-like_fold.
DR   Pfam; PF00041; fn3; 1.
DR   SMART; SM00060; FN3; 5.
DR   SUPFAM; SSF49265; SSF49265; 4.
DR   PROSITE; PS50853; FN3; 5.
DR   PROSITE; PS01353; HEMATOPO_REC_L_F2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:BAF82748.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    834    859       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       49    138       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      335    434       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      435    534       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      538    629       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      724    833       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
SQ   SEQUENCE   1097 AA;  123831 MW;  5E600CB2EE929FF6 CRC64;
     MMDIYVCLKR PSWMVDNKRM RTASNFQWLL STFILLYLMN QVNSQKKGAP HDLKCVTNNL
     QVWNCSWKAP SGTGRGTDYE VCIENRSRSC YQLEKTSIKI PALSHGDYEI TINSLHDFGS
     STSKFTLNEQ NVSLIPDTPE ILNLSADFST STLYLKWNDR GSVFPHRSNV IWEIKVLRKE
     SMELVKLVTH NTTLNGKDTL HHWSWASDMP LECAIHFVEI RCYIDNLHFS GLEEWSDWSP
     VRNISWIPDS QTKVFPQDKV ILVGSDITFC CVSQEKVLSA LIGHTNCPLI HLDGENVAIK
     IRNISVSASS GTNVVFTTED NIFGTVIFAG YPPDTPQQLN CETHDLKEII CSWNPGRVTA
     LVGPRATSYT LVESFSGKYV RLKRAEAPTN ESYQLLFQML PNQEIYNFTL NAHNPLGRSQ
     STILVNITEK VYPHTPTSFK VKDINSTAVK LSWHLPGNFA KINFLCEIEI KKSNSVQEQR
     NVTIKGVENS SYLVALDKLN PYTLYTFRIR CSTETFWKWS KWSNKKQHLT TEASPSKGPD
     TWREWSSDGK NLIIYWKPLP INEANGKILS YNVSCSSDEE TQSLSEIPDP QHKAEIRLDK
     NDYIISVVAK NSVGSSPPSK IASMEIPNDD LKIEQVVGMG KGILLTWHYD PNMTCDYVIK
     WCNSSRSEPC LMDWRKVPSN STETVIESDE FRPGIRYNFF LYGCRNQGYQ LLRSMIGYIE
     ELAPIVAPNF TVEDTSADSI LVKWEDIPVE ELRGFLRGYL FYFGKGERDT SKMRVLESGR
     SDIKVKNITD ISQKTLRIAD LQGKTSYHLV LRAYTDGGVG PEKSMYVVTK ENSVGLIIAI
     LIPVAVAVIV GVVTSILCYR KREWIKETFY PDIPNPENCK ALQFQKSVCE GSSALKTLEM
     NPCTPNNVEV LETRSAFPKI EDTEIISPVA ERPEDRSDAE PENHVVVSYC PPIIEEEIPN
     PAADEAGGTA QVIYIDVQSM YQPQAKPEEE QENDPVGGAG YKPQMHLPIN STVEDIAAEE
     DLDKTAGYRP QANVNTWNLV SPDSPRSIDS NSEIVSFGSP CSINSRQFLI PPKDEDFPKS
     NGGGWSFTNF FQNKPND
//
ID   LIFR_HUMAN              Reviewed;        1097 AA.
AC   P42702; Q6LCD9;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   28-FEB-2018, entry version 173.
DE   RecName: Full=Leukemia inhibitory factor receptor;
DE            Short=LIF receptor;
DE            Short=LIF-R;
DE   AltName: CD_antigen=CD118;
DE   Flags: Precursor;
GN   Name=LIFR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=1915266;
RA   Gearing D.P., Thut C.J., Vanden Bos T., Gimpel S.D., Delaney P.B.,
RA   King J., Price V., Cosman D., Beckmann M.P.;
RT   "Leukemia inhibitory factor receptor is structurally related to the
RT   IL-6 signal transducer, gp130.";
RL   EMBO J. 10:2839-2848(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 942-1097.
RA   Wang Z., Melmed S.;
RT   "Human LIF receptor 3' non-coding region.";
RL   Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   CHROMOSOMAL TRANSLOCATION WITH PLAG1.
RX   PubMed=9525740; DOI=10.1038/sj.onc.1201660;
RA   Voz M.L., Astrom A.-K., Kas K., Mark J., Stenman G.,
RA   Van de Ven W.J.M.;
RT   "The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas
RT   results in upregulation of PLAG1 gene expression under control of the
RT   LIFR promoter.";
RL   Oncogene 16:1409-1416(1998).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-927, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 52-534, IDENTIFICATION IN A
RP   COMPLEX WITH IL6ST; CNTF AND CNTFR, GLYCOSYLATION AT ASN-131; ASN-303;
RP   ASN-407 AND ASN-426, DISULFIDE BONDS, ELECTRON MICROSCOPY, AND
RP   SUBUNIT.
RX   PubMed=18775332; DOI=10.1016/j.molcel.2008.08.011;
RA   Skiniotis G., Lupardus P.J., Martick M., Walz T., Garcia K.C.;
RT   "Structural organization of a full-length gp130/LIF-R cytokine
RT   receptor transmembrane complex.";
RL   Mol. Cell 31:737-748(2008).
RN   [6]
RP   VARIANT STWS PRO-279.
RX   PubMed=14740318; DOI=10.1086/381715;
RA   Dagoneau N., Scheffer D., Huber C., Al-Gazali L.I., Di Rocco M.,
RA   Godard A., Martinovic J., Raas-Rothschild A., Sigaudy S., Unger S.,
RA   Nicole S., Fontaine B., Taupin J.-L., Moreau J.-F., Superti-Furga A.,
RA   Le Merrer M., Bonaventure J., Munnich A., Legeai-Mallet L.,
RA   Cormier-Daire V.;
RT   "Null leukemia inhibitory factor receptor (LIFR) mutations in Stueve-
RT   Wiedemann/Schwartz-Jampel type 2 syndrome.";
RL   Am. J. Hum. Genet. 74:298-305(2004).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-1068.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Signal-transducing molecule. May have a common pathway
CC       with IL6ST. The soluble form inhibits the biological activity of
CC       LIF by blocking its binding to receptors on target cells.
CC   -!- SUBUNIT: Heterodimer composed of LIFR and IL6ST. The heterodimer
CC       formed by LIFR and IL6ST interacts with the complex formed by CNTF
CC       and CNTFR. {ECO:0000269|PubMed:18775332}.
CC   -!- INTERACTION:
CC       P26441:CNTF; NbExp=9; IntAct=EBI-7702162, EBI-1050897;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Membrane;
CC         IsoId=P42702-1; Sequence=Displayed;
CC       Name=2; Synonyms=Secreted;
CC         IsoId=P42702-2; Sequence=Not described;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-
CC       surface receptor binding.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation.
CC   -!- DISEASE: Stueve-Wiedemann syndrome (STWS) [MIM:601559]: Severe
CC       autosomal recessive condition and belongs to the group of the
CC       bent-bone dysplasias. SWS is characterized by bowing of the lower
CC       limbs, with internal cortical thickening, wide metaphyses with
CC       abnormal trabecular pattern, and camptodactyly. Additional
CC       features include feeding and swallowing difficulties, as well as
CC       respiratory distress and hyperthermic episodes, which cause death
CC       in the first months of life. The rare survivors develop
CC       progressive scoliosis, spontaneous fractures, bowing of the lower
CC       limbs, with prominent joints and dysautonomia symptoms, including
CC       temperature instability, absent corneal and patellar reflexes, and
CC       smooth tongue. {ECO:0000269|PubMed:14740318}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving LIFR is found in
CC       salivary gland pleiomorphic adenomas, the most common benign
CC       epithelial tumors of the salivary gland. Translocation
CC       t(5;8)(p13;q12) with PLAG1.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 2
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/LIFRID410ch5p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61615; CAA43805.1; -; mRNA.
DR   EMBL; U66563; AAB61897.1; -; mRNA.
DR   CCDS; CCDS3927.1; -. [P42702-1]
DR   PIR; S17308; S17308.
DR   RefSeq; NP_001121143.1; NM_001127671.1. [P42702-1]
DR   RefSeq; NP_002301.1; NM_002310.5. [P42702-1]
DR   RefSeq; XP_011512342.1; XM_011514040.2. [P42702-1]
DR   RefSeq; XP_011512344.1; XM_011514042.2. [P42702-1]
DR   RefSeq; XP_016864952.1; XM_017009463.1. [P42702-1]
DR   UniGene; Hs.133421; -.
DR   UniGene; Hs.657602; -.
DR   PDB; 3E0G; X-ray; 3.10 A; A=52-534.
DR   PDBsum; 3E0G; -.
DR   ProteinModelPortal; P42702; -.
DR   SMR; P42702; -.
DR   BioGrid; 110165; 15.
DR   CORUM; P42702; -.
DR   DIP; DIP-5770N; -.
DR   IntAct; P42702; 8.
DR   MINT; P42702; -.
DR   STRING; 9606.ENSP00000263409; -.
DR   iPTMnet; P42702; -.
DR   PhosphoSitePlus; P42702; -.
DR   BioMuta; LIFR; -.
DR   DMDM; 1170784; -.
DR   PaxDb; P42702; -.
DR   PeptideAtlas; P42702; -.
DR   PRIDE; P42702; -.
DR   DNASU; 3977; -.
DR   Ensembl; ENST00000263409; ENSP00000263409; ENSG00000113594. [P42702-1]
DR   Ensembl; ENST00000453190; ENSP00000398368; ENSG00000113594. [P42702-1]
DR   GeneID; 3977; -.
DR   KEGG; hsa:3977; -.
DR   UCSC; uc003jli.3; human. [P42702-1]
DR   CTD; 3977; -.
DR   DisGeNET; 3977; -.
DR   EuPathDB; HostDB:ENSG00000113594.9; -.
DR   GeneCards; LIFR; -.
DR   HGNC; HGNC:6597; LIFR.
DR   HPA; CAB010252; -.
DR   HPA; HPA004478; -.
DR   MalaCards; LIFR; -.
DR   MIM; 151443; gene.
DR   MIM; 601559; phenotype.
DR   neXtProt; NX_P42702; -.
DR   OpenTargets; ENSG00000113594; -.
DR   Orphanet; 3206; Stuve-Wiedemann syndrome.
DR   PharmGKB; PA30371; -.
DR   eggNOG; ENOG410IF1V; Eukaryota.
DR   eggNOG; ENOG410ZMDF; LUCA.
DR   GeneTree; ENSGT00550000074436; -.
DR   HOGENOM; HOG000113324; -.
DR   HOVERGEN; HBG006266; -.
DR   InParanoid; P42702; -.
DR   KO; K05058; -.
DR   OMA; FYPDIPN; -.
DR   OrthoDB; EOG091G00RF; -.
DR   PhylomeDB; P42702; -.
DR   TreeFam; TF338122; -.
DR   Reactome; R-HSA-6788467; IL-6-type cytokine receptor ligand interactions.
DR   Reactome; R-HSA-8939247; RUNX1 regulates transcription of genes involved in interleukin signaling.
DR   SignaLink; P42702; -.
DR   SIGNOR; P42702; -.
DR   ChiTaRS; LIFR; human.
DR   EvolutionaryTrace; P42702; -.
DR   GeneWiki; Leukemia_inhibitory_factor_receptor; -.
DR   GenomeRNAi; 3977; -.
DR   PRO; PR:P42702; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113594; -.
DR   CleanEx; HS_LIFR; -.
DR   ExpressionAtlas; P42702; baseline and differential.
DR   Genevisible; P42702; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:BHF-UCL.
DR   GO; GO:0005127; F:ciliary neurotrophic factor receptor binding; IPI:BHF-UCL.
DR   GO; GO:0019838; F:growth factor binding; IPI:BHF-UCL.
DR   GO; GO:0004923; F:leukemia inhibitory factor receptor activity; IDA:MGI.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0070120; P:ciliary neurotrophic factor-mediated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IDA:MGI.
DR   GO; GO:0048861; P:leukemia inhibitory factor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0038165; P:oncostatin-M-mediated signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0001959; P:regulation of cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0034097; P:response to cytokine; IDA:BHF-UCL.
DR   CDD; cd00063; FN3; 3.
DR   Gene3D; 2.60.40.10; -; 8.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR003529; Hematopoietin_rcpt_Gp130_CS.
DR   InterPro; IPR013783; Ig-like_fold.
DR   Pfam; PF00041; fn3; 1.
DR   SMART; SM00060; FN3; 5.
DR   SUPFAM; SSF49265; SSF49265; 4.
DR   PROSITE; PS50853; FN3; 5.
DR   PROSITE; PS01353; HEMATOPO_REC_L_F2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane;
KW   Chromosomal rearrangement; Complete proteome; Disease mutation;
KW   Disulfide bond; Glycoprotein; Membrane; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     44       {ECO:0000255}.
FT   CHAIN        45   1097       Leukemia inhibitory factor receptor.
FT                                /FTId=PRO_0000010902.
FT   TOPO_DOM     45    833       Extracellular. {ECO:0000255}.
FT   TRANSMEM    834    858       Helical. {ECO:0000255}.
FT   TOPO_DOM    859   1097       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       49    138       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      335    434       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      435    534       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      538    629       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      627    719       Fibronectin type-III 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      724    833       Fibronectin type-III 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   MOTIF       519    523       WSXWS motif.
FT   MOTIF       869    877       Box 1 motif.
FT   MOD_RES     927    927       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1044   1044       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P42703}.
FT   CARBOHYD     64     64       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     85     85       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    131    131       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18775332}.
FT   CARBOHYD    143    143       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    191    191       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    243    243       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    303    303       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18775332}.
FT   CARBOHYD    390    390       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    407    407       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18775332}.
FT   CARBOHYD    426    426       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18775332}.
FT   CARBOHYD    445    445       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    481    481       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    489    489       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    572    572       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    652    652       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    663    663       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    680    680       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    729    729       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    787    787       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     55     65       {ECO:0000269|PubMed:18775332}.
FT   DISULFID     82     90       {ECO:0000269|PubMed:18775332}.
FT   DISULFID    213    270       {ECO:0000269|PubMed:18775332}.
FT   DISULFID    341    351       {ECO:0000269|PubMed:18775332}.
FT   DISULFID    466    511       {ECO:0000269|PubMed:18775332}.
FT   VARIANT     116    116       H -> Y (in dbSNP:rs3729734).
FT                                /FTId=VAR_029109.
FT   VARIANT     279    279       S -> P (in STWS).
FT                                {ECO:0000269|PubMed:14740318}.
FT                                /FTId=VAR_025666.
FT   VARIANT     578    578       D -> N (in dbSNP:rs3729740).
FT                                /FTId=VAR_029110.
FT   VARIANT     633    633       I -> M (in dbSNP:rs2303743).
FT                                /FTId=VAR_021996.
FT   VARIANT     664    664       S -> L (in dbSNP:rs3729744).
FT                                /FTId=VAR_038626.
FT   VARIANT     785    785       V -> I (in dbSNP:rs3110234).
FT                                /FTId=VAR_029111.
FT   VARIANT    1068   1068       F -> L (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036166.
FT   STRAND       55     59       {ECO:0000244|PDB:3E0G}.
FT   STRAND       62     66       {ECO:0000244|PDB:3E0G}.
FT   STRAND       71     73       {ECO:0000244|PDB:3E0G}.
FT   STRAND       79     83       {ECO:0000244|PDB:3E0G}.
FT   STRAND       85     87       {ECO:0000244|PDB:3E0G}.
FT   STRAND       89     97       {ECO:0000244|PDB:3E0G}.
FT   STRAND      104    106       {ECO:0000244|PDB:3E0G}.
FT   STRAND      110    113       {ECO:0000244|PDB:3E0G}.
FT   STRAND      145    147       {ECO:0000244|PDB:3E0G}.
FT   TURN        148    151       {ECO:0000244|PDB:3E0G}.
FT   STRAND      152    159       {ECO:0000244|PDB:3E0G}.
FT   HELIX       161    163       {ECO:0000244|PDB:3E0G}.
FT   STRAND      169    181       {ECO:0000244|PDB:3E0G}.
FT   STRAND      183    192       {ECO:0000244|PDB:3E0G}.
FT   HELIX       194    196       {ECO:0000244|PDB:3E0G}.
FT   STRAND      199    206       {ECO:0000244|PDB:3E0G}.
FT   STRAND      216    225       {ECO:0000244|PDB:3E0G}.
FT   STRAND      231    233       {ECO:0000244|PDB:3E0G}.
FT   STRAND      242    244       {ECO:0000244|PDB:3E0G}.
FT   STRAND      254    256       {ECO:0000244|PDB:3E0G}.
FT   STRAND      258    262       {ECO:0000244|PDB:3E0G}.
FT   STRAND      267    271       {ECO:0000244|PDB:3E0G}.
FT   STRAND      277    284       {ECO:0000244|PDB:3E0G}.
FT   STRAND      293    295       {ECO:0000244|PDB:3E0G}.
FT   STRAND      297    301       {ECO:0000244|PDB:3E0G}.
FT   STRAND      312    320       {ECO:0000244|PDB:3E0G}.
FT   STRAND      322    330       {ECO:0000244|PDB:3E0G}.
FT   STRAND      337    345       {ECO:0000244|PDB:3E0G}.
FT   STRAND      348    354       {ECO:0000244|PDB:3E0G}.
FT   HELIX       363    365       {ECO:0000244|PDB:3E0G}.
FT   STRAND      368    373       {ECO:0000244|PDB:3E0G}.
FT   TURN        374    376       {ECO:0000244|PDB:3E0G}.
FT   STRAND      379    382       {ECO:0000244|PDB:3E0G}.
FT   STRAND      393    398       {ECO:0000244|PDB:3E0G}.
FT   STRAND      406    413       {ECO:0000244|PDB:3E0G}.
FT   STRAND      418    425       {ECO:0000244|PDB:3E0G}.
FT   HELIX       427    430       {ECO:0000244|PDB:3E0G}.
FT   STRAND      437    441       {ECO:0000244|PDB:3E0G}.
FT   STRAND      444    448       {ECO:0000244|PDB:3E0G}.
FT   STRAND      451    454       {ECO:0000244|PDB:3E0G}.
FT   STRAND      467    471       {ECO:0000244|PDB:3E0G}.
FT   STRAND      473    475       {ECO:0000244|PDB:3E0G}.
FT   STRAND      479    481       {ECO:0000244|PDB:3E0G}.
FT   STRAND      488    491       {ECO:0000244|PDB:3E0G}.
FT   STRAND      501    504       {ECO:0000244|PDB:3E0G}.
FT   STRAND      506    510       {ECO:0000244|PDB:3E0G}.
SQ   SEQUENCE   1097 AA;  123743 MW;  C8602897E359FCE5 CRC64;
     MMDIYVCLKR PSWMVDNKRM RTASNFQWLL STFILLYLMN QVNSQKKGAP HDLKCVTNNL
     QVWNCSWKAP SGTGRGTDYE VCIENRSRSC YQLEKTSIKI PALSHGDYEI TINSLHDFGS
     STSKFTLNEQ NVSLIPDTPE ILNLSADFST STLYLKWNDR GSVFPHRSNV IWEIKVLRKE
     SMELVKLVTH NTTLNGKDTL HHWSWASDMP LECAIHFVEI RCYIDNLHFS GLEEWSDWSP
     VKNISWIPDS QTKVFPQDKV ILVGSDITFC CVSQEKVLSA LIGHTNCPLI HLDGENVAIK
     IRNISVSASS GTNVVFTTED NIFGTVIFAG YPPDTPQQLN CETHDLKEII CSWNPGRVTA
     LVGPRATSYT LVESFSGKYV RLKRAEAPTN ESYQLLFQML PNQEIYNFTL NAHNPLGRSQ
     STILVNITEK VYPHTPTSFK VKDINSTAVK LSWHLPGNFA KINFLCEIEI KKSNSVQEQR
     NVTIKGVENS SYLVALDKLN PYTLYTFRIR CSTETFWKWS KWSNKKQHLT TEASPSKGPD
     TWREWSSDGK NLIIYWKPLP INEANGKILS YNVSCSSDEE TQSLSEIPDP QHKAEIRLDK
     NDYIISVVAK NSVGSSPPSK IASMEIPNDD LKIEQVVGMG KGILLTWHYD PNMTCDYVIK
     WCNSSRSEPC LMDWRKVPSN STETVIESDE FRPGIRYNFF LYGCRNQGYQ LLRSMIGYIE
     ELAPIVAPNF TVEDTSADSI LVKWEDIPVE ELRGFLRGYL FYFGKGERDT SKMRVLESGR
     SDIKVKNITD ISQKTLRIAD LQGKTSYHLV LRAYTDGGVG PEKSMYVVTK ENSVGLIIAI
     LIPVAVAVIV GVVTSILCYR KREWIKETFY PDIPNPENCK ALQFQKSVCE GSSALKTLEM
     NPCTPNNVEV LETRSAFPKI EDTEIISPVA ERPEDRSDAE PENHVVVSYC PPIIEEEIPN
     PAADEAGGTA QVIYIDVQSM YQPQAKPEEE QENDPVGGAG YKPQMHLPIN STVEDIAAEE
     DLDKTAGYRP QANVNTWNLV SPDSPRSIDS NSEIVSFGSP CSINSRQFLI PPKDEDSPKS
     NGGGWSFTNF FQNKPND
//
ID   LMNA_HUMAN              Reviewed;         664 AA.
AC   P02545; B4DI32; D3DVB0; D6RAQ3; E7EUI9; P02546; Q5I6Y4; Q5I6Y6;
AC   Q5TCJ2; Q5TCJ3; Q6UYC3; Q969I8; Q96JA2;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-1987, sequence version 1.
DT   28-FEB-2018, entry version 235.
DE   RecName: Full=Prelamin-A/C;
DE   Contains:
DE     RecName: Full=Lamin-A/C;
DE     AltName: Full=70 kDa lamin;
DE     AltName: Full=Renal carcinoma antigen NY-REN-32;
DE   Flags: Precursor;
GN   Name=LMNA; Synonyms=LMN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND C).
RX   PubMed=3453101; DOI=10.1038/319463a0;
RA   McKeon F.D., Kirschner M.W., Caput D.;
RT   "Homologies in both primary and secondary structure between nuclear
RT   envelope and intermediate filament proteins.";
RL   Nature 319:463-468(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND C), AND PROTEIN SEQUENCE OF
RP   583-644.
RX   PubMed=3462705; DOI=10.1073/pnas.83.17.6450;
RA   Fisher D.Z., Chaudhary N., Blobel G.;
RT   "cDNA sequencing of nuclear lamins A and C reveals primary and
RT   secondary structural homology to intermediate filament proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:6450-6454(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), SUBCELLULAR LOCATION (ISOFORM
RP   C), VARIANTS CMD1A TRP-190; GLY-192 AND SER-541, AND CHARACTERIZATION
RP   OF VARIANTS CMD1A GLY-192 AND SER-541.
RX   PubMed=16061563; DOI=10.1136/jmg.2004.023283;
RA   Sylvius N., Bilinska Z.T., Veinot J.P., Fidzianska A., Bolongo P.M.,
RA   Poon S., McKeown P., Davies R.A., Chan K.-L., Tang A.S.L., Dyack S.,
RA   Grzybowski J., Ruzyllo W., McBride H., Tesson F.;
RT   "In vivo and in vitro examination of the functional significances of
RT   novel lamin gene mutations in heart failure patients.";
RL   J. Med. Genet. 42:639-647(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6).
RA   Csoka A.B.;
RT   "The progerin allele of lamin A disrupts chromatin organization.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Corpus callosum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND C).
RC   TISSUE=Kidney, Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 12-25; 29-90; 102-117; 120-166; 172-189; 197-216;
RP   226-233; 241-260; 281-316; 320-329; 352-386; 440-453; 456-482;
RP   472-482; 516-542; 585-624 AND 628-644, PHOSPHORYLATION AT SER-22, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.,
RA   Norman J.C.;
RL   Submitted (OCT-2009) to UniProtKB.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 375-664 (ISOFORM ADELTA10).
RC   TISSUE=Colon;
RX   PubMed=8621584; DOI=10.1074/jbc.271.16.9249;
RA   Machiels B.M., Zorenc A.H., Endert J.M., Kuijpers H.J., van Eys G.J.,
RA   Ramaekers F.C., Broers J.L.;
RT   "An alternative splicing product of the lamin A/C gene lacks exon
RT   10.";
RL   J. Biol. Chem. 271:9249-9253(1996).
RN   [11]
RP   PROTEOLYTIC CLEAVAGE, ISOPRENYLATION AT CYS-661, AND METHYLATION AT
RP   CYS-661.
RX   PubMed=8175923;
RA   Sinensky M., Fantle K., Trujillo M., McLain T., Kupfer A., Dalton M.;
RT   "The processing pathway of prelamin A.";
RL   J. Cell Sci. 107:61-67(1994).
RN   [12]
RP   PROTEOLYTIC CLEAVAGE, ISOPRENYLATION AT CYS-661, AND METHYLATION AT
RP   CYS-661.
RX   PubMed=9030603; DOI=10.1074/jbc.272.8.5298;
RA   Kilic F., Dalton M.B., Burrell S.K., Mayer J.P., Patterson S.D.,
RA   Sinensky M.;
RT   "In vitro assay and characterization of the farnesylation-dependent
RT   prelamin A endoprotease.";
RL   J. Biol. Chem. 272:5298-5304(1997).
RN   [13]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [14]
RP   INTERACTION WITH NARF, AND MUTAGENESIS OF CYS-661.
RX   PubMed=10514485; DOI=10.1074/jbc.274.42.30008;
RA   Barton R.M., Worman H.J.;
RT   "Prenylated prelamin A interacts with Narf, a novel nuclear protein.";
RL   J. Biol. Chem. 274:30008-30018(1999).
RN   [15]
RP   INTERACTION WITH TMPO-ALPHA AND RB1.
RX   PubMed=12475961; DOI=10.1091/mbc.E02-07-0450;
RA   Markiewicz E., Dechat T., Foisner R., Quinlan R.A., Hutchison C.J.;
RT   "Lamin A/C binding protein LAP2alpha is required for nuclear anchorage
RT   of retinoblastoma protein.";
RL   Mol. Biol. Cell 13:4401-4413(2002).
RN   [16]
RP   ALTERNATIVE SPLICING, INVOLVEMENT IN HGPS (ISOFORM 6), AND VARIANTS
RP   HGPS LYS-145 AND SER-608.
RX   PubMed=12714972; DOI=10.1038/nature01629;
RA   Eriksson M., Brown W.T., Gordon L.B., Glynn M.W., Singer J., Scott L.,
RA   Erdos M.R., Robbins C.M., Moses T.Y., Berglund P., Dutra A., Pak E.,
RA   Durkin S., Csoka A.B., Boehnke M., Glover T.W., Collins F.S.;
RT   "Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford
RT   progeria syndrome.";
RL   Nature 423:293-298(2003).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-22; SER-390;
RP   SER-392; SER-395; SER-628; SER-632 AND SER-636, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-628, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [20]
RP   SUBCELLULAR LOCATION, SUMOYLATION AT LYS-201, MUTAGENESIS OF LYS-201,
RP   AND CHARACTERIZATION OF VARIANTS CMD1A GLY-203 AND LYS-203.
RX   PubMed=18606848; DOI=10.1083/jcb.200712124;
RA   Zhang Y.Q., Sarge K.D.;
RT   "Sumoylation regulates lamin A function and is lost in lamin A mutants
RT   associated with familial cardiomyopathies.";
RL   J. Cell Biol. 182:35-39(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-628, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-632, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-18; THR-19;
RP   SER-22; SER-301; SER-390; SER-392; SER-395; SER-458; SER-628; SER-632;
RP   SER-636 AND SER-652, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [25]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH EMD.
RX   PubMed=19323649; DOI=10.1042/BC20080175;
RA   Capanni C., Del Coco R., Mattioli E., Camozzi D., Columbaro M.,
RA   Schena E., Merlini L., Squarzoni S., Maraldi N.M., Lattanzi G.;
RT   "Emerin-prelamin A interplay in human fibroblasts.";
RL   Biol. Cell 101:541-554(2009).
RN   [26]
RP   SUBCELLULAR LOCATION, AND CHARACTERIZATION OF VARIANTS FPLD2 CYS-439
RP   AND TRP-482.
RX   PubMed=19220582; DOI=10.1111/j.1582-4934.2009.00690.x;
RA   Verstraeten V.L., Caputo S., van Steensel M.A., Duband-Goulet I.,
RA   Zinn-Justin S., Kamps M., Kuijpers H.J., Ostlund C., Worman H.J.,
RA   Briede J.J., Le Dour C., Marcelis C.L., van Geel M., Steijlen P.M.,
RA   van den Wijngaard A., Ramaekers F.C., Broers J.L.;
RT   "The R439C mutation in LMNA causes lamin oligomerization and
RT   susceptibility to oxidative stress.";
RL   J. Cell. Mol. Med. 13:959-971(2009).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-108; LYS-270; LYS-311 AND
RP   LYS-450, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [28]
RP   FUNCTION.
RX   PubMed=20079404; DOI=10.1016/j.bbagen.2010.01.002;
RA   De Vos W.H., Houben F., Hoebe R.A., Hennekam R., van Engelen B.,
RA   Manders E.M., Ramaekers F.C., Broers J.L., Van Oostveldt P.;
RT   "Increased plasticity of the nuclear envelope and hypermobility of
RT   telomeres due to the loss of A-type lamins.";
RL   Biochim. Biophys. Acta 1800:448-458(2010).
RN   [29]
RP   SUBCELLULAR LOCATION, AND VARIANTS CMD1A LEU-89; PRO-101; PRO-166;
RP   GLN-190; LYS-203; SER-210; PRO-215; THR-318; HIS-388; CYS-399 AND
RP   HIS-471.
RX   PubMed=20160190; DOI=10.1161/CIRCGENETICS.109.905422;
RA   Cowan J., Li D., Gonzalez-Quintana J., Morales A., Hershberger R.E.;
RT   "Morphological analysis of 13 LMNA variants identified in a cohort of
RT   324 unrelated patients with idiopathic or familial dilated
RT   cardiomyopathy.";
RL   Circ. Cardiovasc. Genet. 3:6-14(2010).
RN   [30]
RP   FUNCTION, PROTEOLYTIC PROCESSING, AND TISSUE SPECIFICITY.
RX   PubMed=20458013; DOI=10.1161/CIRCULATIONAHA.109.902056;
RA   Ragnauth C.D., Warren D.T., Liu Y., McNair R., Tajsic T., Figg N.,
RA   Shroff R., Skepper J., Shanahan C.M.;
RT   "Prelamin A acts to accelerate smooth muscle cell senescence and is a
RT   novel biomarker of human vascular aging.";
RL   Circulation 121:2200-2210(2010).
RN   [31]
RP   INTERACTION WITH SUN1, CHARACTERIZATION OF VARIANTS EDMD2 PRO-527 AND
RP   PRO-530, AND CHARACTERIZATION OF VARIANT HGPS SER-608.
RX   PubMed=19933576; DOI=10.1074/jbc.M109.071910;
RA   Haque F., Mazzeo D., Patel J.T., Smallwood D.T., Ellis J.A.,
RA   Shanahan C.M., Shackleton S.;
RT   "Mammalian SUN protein interaction networks at the inner nuclear
RT   membrane and their role in laminopathy disease processes.";
RL   J. Biol. Chem. 285:3487-3498(2010).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT THR-3; SER-12; THR-19; SER-22; SER-212; SER-277;
RP   SER-301; SER-390; SER-392; SER-395; SER-404; SER-414; SER-431;
RP   SER-458; SER-463; THR-505; SER-628; SER-632; SER-636 AND SER-652, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [34]
RP   INTERACTION WITH MLIP.
RX   PubMed=21498514; DOI=10.1074/jbc.M110.165548;
RA   Ahmady E., Deeke S.A., Rabaa S., Kouri L., Kenney L., Stewart A.F.,
RA   Burgon P.G.;
RT   "Identification of a novel muscle enriched A-type Lamin interacting
RT   protein (MLIP).";
RL   J. Biol. Chem. 286:19702-19713(2011).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-390; SER-392; SER-404;
RP   SER-414; SER-458 AND SER-636, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [36]
RP   MUTAGENESIS OF ARG-644; LEU-647; LEU-648; ASN-650 AND CYS-661, AND
RP   CHARACTERIZATION OF VARIANT HGPS CYS-644.
RX   PubMed=22355414; DOI=10.1371/journal.pone.0032120;
RA   Barrowman J., Hamblet C., Kane M.S., Michaelis S.;
RT   "Requirements for efficient proteolytic cleavage of prelamin A by
RT   ZMPSTE24.";
RL   PLoS ONE 7:E32120-E32120(2012).
RN   [37]
RP   FUNCTION, SUBCELLULAR LOCATION, INVOLVEMENT IN HGPS, VARIANT HGPS
RP   GLY-300, AND CHARACTERIZATION OF VARIANT HGPS GLY-300.
RX   PubMed=23666920; DOI=10.1002/ajmg.a.35971;
RA   Kane M.S., Lindsay M.E., Judge D.P., Barrowman J., Ap Rhys C.,
RA   Simonson L., Dietz H.C., Michaelis S.;
RT   "LMNA-associated cardiocutaneous progeria: An inherited autosomal
RT   dominant premature aging syndrome with late onset.";
RL   Am. J. Med. Genet. A 161:1599-1611(2013).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; THR-19; SER-22;
RP   SER-51; SER-66; SER-71; SER-107; SER-212; SER-301; SER-390; SER-392;
RP   SER-398; SER-429; SER-458; SER-463; SER-533; SER-613; SER-619;
RP   SER-628; SER-632 AND SER-636, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [39]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SUV39H1.
RX   PubMed=23695662; DOI=10.1038/ncomms2885;
RA   Liu B., Wang Z., Zhang L., Ghosh S., Zheng H., Zhou Z.;
RT   "Depleting the methyltransferase Suv39h1 improves DNA repair and
RT   extends lifespan in a progeria mouse model.";
RL   Nat. Commun. 4:1868-1868(2013).
RN   [40]
RP   INTERACTION WITH DMPK.
RX   PubMed=21949239; DOI=10.1074/jbc.M111.241455;
RA   Harmon E.B., Harmon M.L., Larsen T.D., Yang J., Glasford J.W.,
RA   Perryman M.B.;
RT   "Myotonic dystrophy protein kinase is critical for nuclear envelope
RT   integrity.";
RL   J. Biol. Chem. 286:40296-40306(2011).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; THR-19; SER-22;
RP   SER-212; SER-301; SER-307; SER-390; SER-395; SER-403; SER-404;
RP   SER-414; SER-458; SER-463; SER-612 AND SER-636, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [42]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-97; LYS-208; LYS-233;
RP   LYS-311; LYS-378; LYS-417 AND LYS-420, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [43]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-233 AND LYS-597, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [44]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-97; LYS-311; LYS-378 AND
RP   LYS-420, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [45]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-233; LYS-260; LYS-270;
RP   LYS-378; LYS-417 AND LYS-420, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [46]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [47]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-32; LYS-97; LYS-171;
RP   LYS-201; LYS-208; LYS-219; LYS-233; LYS-260; LYS-270; LYS-311;
RP   LYS-366; LYS-378; LYS-417; LYS-420; LYS-450; LYS-470; LYS-486 AND
RP   LYS-597, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 435-552.
RX   PubMed=11901143; DOI=10.1074/jbc.C200038200;
RA   Dhe-Paganon S., Werner E.D., Chi Y.I., Shoelson S.E.;
RT   "Structure of the globular tail of nuclear lamin.";
RL   J. Biol. Chem. 277:17381-17384(2002).
RN   [49]
RP   STRUCTURE BY NMR OF 428-549.
RX   PubMed=12057196; DOI=10.1016/S0969-2126(02)00777-3;
RA   Krimm I., Ostlund C., Gilquin B., Couprie J., Hossenlopp P.,
RA   Mornon J.-P., Bonne G., Courvalin J.-C., Worman H.J., Zinn-Justin S.;
RT   "The Ig-like structure of the C-terminal domain of lamin A/C, mutated
RT   in muscular dystrophies, cardiomyopathy, and partial lipodystrophy.";
RL   Structure 10:811-823(2002).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 305-387.
RX   PubMed=15476822; DOI=10.1016/j.jmb.2004.08.093;
RA   Strelkov S.V., Schumacher J., Burkhard P., Aebi U., Herrmann H.;
RT   "Crystal structure of the human lamin A coil 2B dimer: implications
RT   for the head-to-tail association of nuclear lamins.";
RL   J. Mol. Biol. 343:1067-1080(2004).
RN   [51]
RP   VARIANTS EDMD2 TRP-453; PRO-527 AND PRO-530, AND FUNCTION.
RX   PubMed=10080180; DOI=10.1038/6799;
RA   Bonne G., Di Barletta M.R., Varnous S., Becane H.-M., Hammouda E.-H.,
RA   Merlini L., Muntoni F., Greenberg C.R., Gary F., Urtizberea J.-A.,
RA   Duboc D., Fardeau M., Toniolo D., Schwartz K.;
RT   "Mutations in the gene encoding lamin A/C cause autosomal dominant
RT   Emery-Dreifuss muscular dystrophy.";
RL   Nat. Genet. 21:285-288(1999).
RN   [52]
RP   VARIANTS CMD1A GLY-60; ARG-85; LYS-195 AND GLY-203, AND FUNCTION.
RX   PubMed=10580070; DOI=10.1056/NEJM199912023412302;
RA   Fatkin D., MacRae C., Sasaki T., Wolff M.R., Porcu M., Frenneaux M.,
RA   Atherton J., Vidaillet H.J. Jr., Spudich S., De Girolami U.,
RA   Seidman J.G., Seidman C.E.;
RT   "Missense mutations in the rod domain of the lamin A/C gene as causes
RT   of dilated cardiomyopathy and conduction-system disease.";
RL   N. Engl. J. Med. 341:1715-1724(1999).
RN   [53]
RP   VARIANTS FPLD2 ASP-465; GLN-482; TRP-482 AND HIS-582.
RX   PubMed=10739751; DOI=10.1086/302836;
RA   Speckman R.A., Garg A., Du F., Bennett L., Veile R., Arioglu E.,
RA   Taylor S.I., Lovett M., Bowcock A.M.;
RT   "Mutational and haplotype analyses of families with familial partial
RT   lipodystrophy (Dunnigan variety) reveal recurrent missense mutations
RT   in the globular C-terminal domain of lamin A/C.";
RL   Am. J. Hum. Genet. 66:1192-1198(2000).
RN   [54]
RP   ERRATUM.
RA   Speckman R.A., Garg A., Du F., Bennett L., Veile R., Arioglu E.,
RA   Taylor S.I., Lovett M., Bowcock A.M.;
RL   Am. J. Hum. Genet. 67:775-775(2000).
RN   [55]
RP   VARIANTS EDMD2 TYR-222; GLN-249; GLN-336; TRP-453; THR-469; PRO-527
RP   AND LYS-528.
RX   PubMed=10739764; DOI=10.1086/302869;
RA   Raffaele di Barletta M., Ricci E., Galluzzi G., Tonali P., Mora M.,
RA   Morandi L., Romorini A., Voit T., Orstavik K.H., Merlini L.,
RA   Trevisan C., Biancalana V., Housmanowa-Petrusewicz I., Bione S.,
RA   Ricotti R., Schwartz K., Bonne G., Toniolo D.;
RT   "Different mutations in the LMNA gene cause autosomal dominant and
RT   autosomal recessive Emery-Dreifuss muscular dystrophy.";
RL   Am. J. Hum. Genet. 66:1407-1412(2000).
RN   [56]
RP   VARIANTS EDMD2 CYS-45; PRO-50; SER-63; GLU-112 DEL; PRO-222; GLU-232;
RP   GLN-249; LYS-261 DEL; PRO-294; LYS-358; LYS-371; LYS-386; TRP-453;
RP   LYS-456; SER-520; PRO-527 AND LYS-528.
RX   PubMed=10939567;
RX   DOI=10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J;
RA   Bonne G., Mercuri E., Muchir A., Urtizberea A., Becane H.M., Recan D.,
RA   Merlini L., Wehnert M., Boor R., Reuner U., Vorgerd M., Wicklein E.M.,
RA   Eymard B., Duboc D., Penisson-Besnier I., Cuisset J.M., Ferrer X.,
RA   Desguerre I., Lacombe D., Bushby K., Pollitt C., Toniolo D.,
RA   Fardeau M., Schwartz K., Muntoni F.;
RT   "Clinical and molecular genetic spectrum of autosomal dominant Emery-
RT   Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.";
RL   Ann. Neurol. 48:170-180(2000).
RN   [57]
RP   VARIANT FPLD2 GLN-482.
RX   PubMed=10587585; DOI=10.1093/hmg/9.1.109;
RA   Cao H., Hegele R.A.;
RT   "Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-
RT   type familial partial lipodystrophy.";
RL   Hum. Mol. Genet. 9:109-112(2000).
RN   [58]
RP   VARIANTS LGMD1B LYS-208 DEL AND HIS-377, AND FUNCTION.
RX   PubMed=10814726; DOI=10.1093/hmg/9.9.1453;
RA   Muchir A., Bonne G., van der Kooi A.J., van Meegen M., Baas F.,
RA   Bolhuis P.A., de Visser M., Schwartz K.;
RT   "Identification of mutations in the gene encoding lamins A/C in
RT   autosomal dominant limb girdle muscular dystrophy with
RT   atrioventricular conduction disturbances (LGMD1B).";
RL   Hum. Mol. Genet. 9:1453-1459(2000).
RN   [59]
RP   VARIANTS FPLD2 LEU-482 AND TRP-482.
RX   PubMed=10655060; DOI=10.1038/72807;
RA   Shackleton S., Lloyd D.J., Jackson S.N.J., Evans R., Niermeijer M.F.,
RA   Singh B.M., Schmidt H., Brabant G., Kumar S., Durrington P.N.,
RA   Gregory S., O'Rahilly S., Trembath R.C.;
RT   "LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.";
RL   Nat. Genet. 24:153-156(2000).
RN   [60]
RP   VARIANTS EDMD2 PRO-150 AND LYS-261 DEL.
RX   PubMed=10908904; DOI=10.1212/WNL.55.2.275;
RA   Felice K.J., Schwartz R.C., Brown C.A., Leicher C.R., Grunnet M.L.;
RT   "Autosomal dominant Emery-Dreifuss dystrophy due to mutations in rod
RT   domain of the lamin A/C gene.";
RL   Neurology 55:275-280(2000).
RN   [61]
RP   VARIANTS EDMD2 PRO-25; THR-43; SER-50; PRO-133; 196-ARG--THR-199
RP   DELINS SER; GLN-249; LYS-261 DEL; LYS-358; TRP-453; ILE-456; PRO-527
RP   AND HIS-624.
RX   PubMed=11503164; DOI=10.1002/ajmg.1463;
RA   Brown C.A., Lanning R.W., McKinney K.Q., Salvino A.R., Cherniske E.,
RA   Crowe C.A., Darras B.T., Gominak S., Greenberg C.R., Grosmann C.,
RA   Heydemann P., Mendell J.R., Pober B.R., Sasaki T., Shapiro F.,
RA   Simpson D.A., Suchowersky O., Spence J.E.;
RT   "Novel and recurrent mutations in lamin A/C in patients with Emery-
RT   Dreifuss muscular dystrophy.";
RL   Am. J. Med. Genet. 102:359-367(2001).
RN   [62]
RP   VARIANT CMD1A LYS-203.
RX   PubMed=11561226; DOI=10.1054/jcaf.2001.26339;
RA   Jakobs P.M., Hanson E.L., Crispell K.A., Toy W., Keegan H.,
RA   Schilling K., Icenogle T.B., Litt M., Hershberger R.E.;
RT   "Novel lamin A/C mutations in two families with dilated cardiomyopathy
RT   and conduction system disease.";
RL   J. Card. Fail. 7:249-256(2001).
RN   [63]
RP   CHARACTERIZATION OF VARIANTS CMD1A GLY-60; ARG-85; LYS-195 AND
RP   GLY-203, CHARACTERIZATION OF VARIANTS EDMD2 LYS-358; LYS-371; LYS-386;
RP   TRP-453; SER-520; PRO-527; LYS-528 AND PRO-530, AND CHARACTERIZATION
RP   OF VARIANTS FPLD2 GLN-482; TRP-482 AND ASN-486.
RX   PubMed=11792809;
RA   Oestlund C., Bonne G., Schwartz K., Worman H.J.;
RT   "Properties of lamin A mutants found in Emery-Dreifuss muscular
RT   dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy.";
RL   J. Cell Sci. 114:4435-4445(2001).
RN   [64]
RP   VARIANT LGMD1B HIS-481.
RX   PubMed=11525883; DOI=10.1016/S0960-8966(01)00207-3;
RA   Kitaguchi T., Matsubara S., Sato M., Miyamoto K., Hirai S.,
RA   Schwartz K., Bonne G.;
RT   "A missense mutation in the exon 8 of lamin A/C gene in a Japanese
RT   case of autosomal dominant limb-girdle muscular dystrophy and cardiac
RT   conduction block.";
RL   Neuromuscul. Disord. 11:542-546(2001).
RN   [65]
RP   VARIANT CMD1A PRO-215.
RX   PubMed=12486434; DOI=10.1067/mhj.2002.126737;
RA   Hershberger R.E., Hanson E.L., Jakobs P.M., Keegan H., Coates K.,
RA   Bousman S., Litt M.;
RT   "A novel lamin A/C mutation in a family with dilated cardiomyopathy,
RT   prominent conduction system disease, and need for permanent pacemaker
RT   implantation.";
RL   Am. Heart J. 144:1081-1086(2002).
RN   [66]
RP   VARIANT CMT2B1 CYS-298, AND FUNCTION.
RX   PubMed=11799477; DOI=10.1086/339274;
RA   De Sandre-Giovannoli A., Chaouch M., Kozlov S., Vallat J.-M.,
RA   Tazir M., Kassouri N., Szepetowski P., Hammadouche T.,
RA   Vandenberghe A., Stewart C.L., Grid D., Levy N.;
RT   "Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope
RT   proteins, cause autosomal recessive axonal neuropathy in human
RT   (Charcot-Marie-Tooth disorder type 2) and mouse.";
RL   Am. J. Hum. Genet. 70:726-736(2002).
RN   [67]
RP   ERRATUM.
RA   De Sandre-Giovannoli A., Chaouch M., Kozlov S., Vallat J.-M.,
RA   Tazir M., Kassouri N., Szepetowski P., Hammadouche T.,
RA   Vandenberghe A., Stewart C.L., Grid D., Levy N.;
RL   Am. J. Hum. Genet. 70:1075-1075(2002).
RN   [68]
RP   VARIANT MADA HIS-527, AND FUNCTION.
RX   PubMed=12075506; DOI=10.1086/341908;
RA   Novelli G., Muchir A., Sangiuolo F., Helbling-Leclerc A.,
RA   D'Apice M.R., Massart C., Capon F., Sbraccia P., Federici M.,
RA   Lauro R., Tudisco C., Pallotta R., Scarano G., Dallapiccola B.,
RA   Merlini L., Bonne G.;
RT   "Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding
RT   lamin A/C.";
RL   Am. J. Hum. Genet. 71:426-431(2002).
RN   [69]
RP   VARIANTS FPLD2 TRP-28 AND GLY-62.
RX   PubMed=12015247; DOI=10.1016/S0002-9343(02)01070-7;
RA   Garg A., Speckman R.A., Bowcock A.M.;
RT   "Multisystem dystrophy syndrome due to novel missense mutations in the
RT   amino-terminal head and alpha-helical rod domains of the lamin A/C
RT   gene.";
RL   Am. J. Med. 112:549-555(2002).
RN   [70]
RP   VARIANTS CMD1A GLU-97; TRP-190 AND LYS-317.
RX   PubMed=11897440; DOI=10.1016/S0735-1097(02)01724-2;
RA   Arbustini E., Pilotto A., Repetto A., Grasso M., Negri A., Diegoli M.,
RA   Campana C., Scelsi L., Baldini E., Gavazzi A., Tavazzi L.;
RT   "Autosomal dominant dilated cardiomyopathy with atrioventricular
RT   block: a lamin A/C defect-related disease.";
RL   J. Am. Coll. Cardiol. 39:981-990(2002).
RN   [71]
RP   VARIANT EDMD2 GLN-249, AND VARIANT LGMD1B LEU-377.
RX   PubMed=12032588; DOI=10.1007/s100380200029;
RA   Ki C.-S., Hong J.S., Jeong G.-Y., Ahn K.J., Choi K.-M., Kim D.-K.,
RA   Kim J.-W.;
RT   "Identification of lamin A/C (LMNA) gene mutations in Korean patients
RT   with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-
RT   girdle muscular dystrophy 1B.";
RL   J. Hum. Genet. 47:225-228(2002).
RN   [72]
RP   VARIANTS FPLD2 GLY-60 AND PRO-527.
RX   PubMed=12196663; DOI=10.1212/WNL.59.4.620;
RA   van der Kooi A.J., Bonne G., Eymard B., Duboc D., Talim B.,
RA   Van der Valk M., Reiss P., Richard P., Demay L., Merlini L.,
RA   Schwartz K., Busch H.F.M., de Visser M.;
RT   "Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and
RT   muscular dystrophy.";
RL   Neurology 59:620-623(2002).
RN   [73]
RP   VARIANTS EDMD2 LYS-32 DEL; ASN-63; GLN-336; GLN-343 AND CYS-401.
RX   PubMed=12467752; DOI=10.1016/S0960-8966(02)00178-5;
RA   Vytopil M., Ricci E., Dello Russo A., Hanisch F., Neudecker S.,
RA   Zierz S., Ricotti R., Demay L., Richard P., Wehnert M., Bonne G.,
RA   Merlini L., Toniolo D.;
RT   "Frequent low penetrance mutations in the Lamin A/C gene, causing
RT   Emery Dreifuss muscular dystrophy.";
RL   Neuromuscul. Disord. 12:958-963(2002).
RN   [74]
RP   VARIANT APICAL LEFT VENTRICULAR ANEURYSM CYS-541.
RX   PubMed=14675861; DOI=10.1016/S1388-9842(03)00149-1;
RA   Forissier J.-F., Bonne G., Bouchier C., Duboscq-Bidot L., Richard P.,
RA   Wisnewski C., Briault S., Moraine C., Dubourg O., Schwartz K.,
RA   Komajda M.;
RT   "Apical left ventricular aneurysm without atrio-ventricular block due
RT   to a lamin A/C gene mutation.";
RL   Eur. J. Heart Fail. 5:821-825(2003).
RN   [75]
RP   VARIANT LGMD1B HIS-377.
RX   PubMed=12673789; DOI=10.1002/humu.10170;
RA   Charniot J.-C., Pascal C., Bouchier C., Sebillon P., Salama J.,
RA   Duboscq-Bidot L., Peuchmaurd M., Desnos M., Artigou J.-Y., Komajda M.;
RT   "Functional consequences of an LMNA mutation associated with a new
RT   cardiac and non-cardiac phenotype.";
RL   Hum. Mutat. 21:473-481(2003).
RN   [76]
RP   VARIANTS CMD1A LEU-89; HIS-377 AND LEU-573.
RX   PubMed=12628721; DOI=10.1016/S0735-1097(02)02954-6;
RG   Familial dilated cardiomyopathy registry research group;
RA   Taylor M.R.G., Fain P.R., Sinagra G., Robinson M.L., Robertson A.D.,
RA   Carniel E., Di Lenarda A., Bohlmeyer T.J., Ferguson D.A.,
RA   Brodsky G.L., Boucek M.M., Lascor J., Moss A.C., Li W.-L.P.,
RA   Stetler G.L., Muntoni F., Bristow M.R., Mestroni L.;
RT   "Natural history of dilated cardiomyopathy due to lamin A/C gene
RT   mutations.";
RL   J. Am. Coll. Cardiol. 41:771-780(2003).
RN   [77]
RP   ERRATUM.
RG   Familial dilated cardiomyopathy registry research group;
RA   Taylor M.R.G., Fain P.R., Sinagra G., Robinson M.L., Robertson A.D.,
RA   Carniel E., Di Lenarda A., Bohlmeyer T.J., Ferguson D.A.,
RA   Brodsky G.L., Boucek M.M., Lascor J., Moss A.C., Li W.-L.P.,
RA   Stetler G.L., Muntoni F., Bristow M.R., Mestroni L.;
RL   J. Am. Coll. Cardiol. 42:590-590(2003).
RN   [78]
RP   VARIANT FPLD2 LEU-133.
RX   PubMed=12629077; DOI=10.1210/jc.2002-021506;
RA   Caux F., Dubosclard E., Lascols O., Buendia B., Chazouilleres O.,
RA   Cohen A., Courvalin J.-C., Laroche L., Capeau J., Vigouroux C.,
RA   Christin-Maitre S.;
RT   "A new clinical condition linked to a novel mutation in lamins A and C
RT   with generalized lipoatrophy, insulin-resistant diabetes, disseminated
RT   leukomelanodermic papules, liver steatosis, and cardiomyopathy.";
RL   J. Clin. Endocrinol. Metab. 88:1006-1013(2003).
RN   [79]
RP   VARIANTS HGPS CYS-471; CYS-527 AND SER-608.
RX   PubMed=12768443; DOI=10.1007/s10038-003-0025-3;
RA   Cao H., Hegele R.A.;
RT   "LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not
RT   in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090).";
RL   J. Hum. Genet. 48:271-274(2003).
RN   [80]
RP   VARIANT CMD1A LYS-161.
RX   PubMed=12920062; DOI=10.1136/jmg.40.8.560;
RA   Sebillon P., Bouchier C., Bidot L.D., Bonne G., Ahamed K., Charron P.,
RA   Drouin-Garraud V., Millaire A., Desrumeaux G., Benaiche A.,
RA   Charniot J.-C., Schwartz K., Villard E., Komajda M.;
RT   "Expanding the phenotype of LMNA mutations in dilated cardiomyopathy
RT   and functional consequences of these mutations.";
RL   J. Med. Genet. 40:560-567(2003).
RN   [81]
RP   VARIANTS EDMD2 GLY-25; LYS-32 DEL; VAL-35; GLY-65; GLU-112 DEL;
RP   PRO-248; GLN-249; CYS-267; VAL-446; TRP-453; ARG-528 AND HIS-541, AND
RP   VARIANT CMD1A CYS-435.
RX   PubMed=14684700; DOI=10.1136/jmg.40.12.e132;
RA   Vytopil M., Benedetti S., Ricci E., Galluzzi G., Dello Russo A.,
RA   Merlini L., Boriani G., Gallina M., Morandi L., Politano L.,
RA   Moggio M., Chiveri L., Hausmanova-Petrusewicz I., Ricotti R.,
RA   Vohanka S., Toman J., Toniolo D.;
RT   "Mutation analysis of the lamin A/C gene (LMNA) among patients with
RT   different cardiomuscular phenotypes.";
RL   J. Med. Genet. 40:E132-E132(2003).
RN   [82]
RP   VARIANT CMDHH PRO-57, VARIANT HGPS ARG-140, AND FUNCTION.
RX   PubMed=12927431; DOI=10.1016/S0140-6736(03)14069-X;
RA   Chen L., Lee L., Kudlow B.A., Dos Santos H.G., Sletvold O.,
RA   Shafeghati Y., Botha E.G., Garg A., Hanson N.B., Martin G.M.,
RA   Mian I.S., Kennedy B.K., Oshima J.;
RT   "LMNA mutations in atypical Werner's syndrome.";
RL   Lancet 362:440-445(2003).
RN   [83]
RP   VARIANTS EDMD2 ASN-63; PRO-140; GLN-249; LEU-377; LYS-386 AND PRO-527.
RX   PubMed=12649505; DOI=10.1161/01.STR.0000064322.47667.49;
RA   Boriani G., Gallina M., Merlini L., Bonne G., Toniolo D., Amati S.,
RA   Biffi M., Martignani C., Frabetti L., Bonvicini M., Rapezzi C.,
RA   Branzi A.;
RT   "Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker
RT   implant, and heart failure in Emery-Dreifuss muscular dystrophy: a
RT   long-term longitudinal study.";
RL   Stroke 34:901-908(2003).
RN   [84]
RP   VARIANTS CMD1A TRP-190 AND LEU-349.
RX   PubMed=15219508; DOI=10.1016/j.amjcard.2004.03.029;
RA   Hermida-Prieto M., Monserrat L., Castro-Beiras A., Laredo R.,
RA   Soler R., Peteiro J., Rodriguez E., Bouzas B., Alvarez N., Muniz J.,
RA   Crespo-Leiro M.;
RT   "Familial dilated cardiomyopathy and isolated left ventricular
RT   noncompaction associated with lamin A/C gene mutations.";
RL   Am. J. Cardiol. 94:50-54(2004).
RN   [85]
RP   VARIANT CMD1A PRO-143.
RX   PubMed=15140538; DOI=10.1016/j.ehj.2004.01.020;
RA   Kaerkkaeinen S., Helioe T., Miettinen R., Tuomainen P., Peltola P.,
RA   Rummukainen J., Ylitalo K., Kaartinen M., Kuusisto J., Toivonen L.,
RA   Nieminen M.S., Laakso M., Peuhkurinen K.;
RT   "A novel mutation, Ser143Pro, in the lamin A/C gene is common in
RT   Finnish patients with familial dilated cardiomyopathy.";
RL   Eur. Heart J. 25:885-893(2004).
RN   [86]
RP   INVOLVEMENT IN LTSCS, AND FUNCTION.
RX   PubMed=15317753; DOI=10.1093/hmg/ddh265;
RA   Navarro C.L., De Sandre-Giovannoli A., Bernard R., Boccaccio I.,
RA   Boyer A., Genevieve D., Hadj-Rabia S., Gaudy-Marqueste C., Smitt H.S.,
RA   Vabres P., Faivre L., Verloes A., Van Essen T., Flori E., Hennekam R.,
RA   Beemer F.A., Laurent N., Le Merrer M., Cau P., Levy N.;
RT   "Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization
RT   and identify restrictive dermopathy as a lethal neonatal
RT   laminopathy.";
RL   Hum. Mol. Genet. 13:2493-2503(2004).
RN   [87]
RP   VARIANT HGPS CYS-644, AND VARIANTS ILE-10 AND VAL-578.
RX   PubMed=15060110; DOI=10.1136/jmg.2003.015651;
RA   Csoka A.B., Cao H., Sammak P.J., Constantinescu D., Schatten G.P.,
RA   Hegele R.A.;
RT   "Novel lamin A/C gene (LMNA) mutations in atypical progeroid
RT   syndromes.";
RL   J. Med. Genet. 41:304-308(2004).
RN   [88]
RP   VARIANT HGPS ASN-542.
RX   PubMed=15286156; DOI=10.1136/jmg.2004.019661;
RA   Plasilova M., Chattopadhyay C., Pal P., Schaub N.A., Buechner S.A.,
RA   Mueller H., Miny P., Ghosh A., Heinimann K.;
RT   "Homozygous missense mutation in the lamin A/C gene causes autosomal
RT   recessive Hutchinson-Gilford progeria syndrome.";
RL   J. Med. Genet. 41:609-614(2004).
RN   [89]
RP   VARIANT CMT2 ASP-33, AND VARIANT EDMD2 GLY-33.
RX   PubMed=14985400; DOI=10.1136/jmg.2003.013383;
RA   Goizet C., Yaou R.B., Demay L., Richard P., Bouillot S., Rouanet M.,
RA   Hermosilla E., Le Masson G., Lagueny A., Bonne G., Ferrer X.;
RT   "A new mutation of the lamin A/C gene leading to autosomal dominant
RT   axonal neuropathy, muscular dystrophy, cardiac disease, and
RT   leuconychia.";
RL   J. Med. Genet. 41:E29-E29(2004).
RN   [90]
RP   VARIANT HGPS PHE-143.
RX   PubMed=15622532; DOI=10.1002/ana.20359;
RA   Kirschner J., Brune T., Wehnert M., Denecke J., Wasner C., Feuer A.,
RA   Marquardt T., Ketelsen U.-P., Wieacker P., Boennemann C.G.,
RA   Korinthenberg R.;
RT   "p.S143F mutation in lamin A/C: a new phenotype combining myopathy and
RT   progeria.";
RL   Ann. Neurol. 57:148-151(2005).
RN   [91]
RP   VARIANT CMDA1 ASN-260.
RX   PubMed=16156025;
RA   Arbustini Eloisa A.E., Pilotto A., Pasotti M., Grasso M., Diegoli M.,
RA   Campana C., Gavazzi A., Alessandra R., Tavazzi L.;
RT   "Gene symbol: LMNA. Disease: cardiomyopathy, dilated, with conduction
RT   defect 1.";
RL   Hum. Genet. 117:298-298(2005).
RN   [92]
RP   VARIANT MADA VAL-529.
RX   PubMed=15998779; DOI=10.1210/jc.2004-2560;
RA   Garg A., Cogulu O., Ozkinay F., Onay H., Agarwal A.K.;
RT   "A novel homozygous Ala529Val LMNA mutation in Turkish patients with
RT   mandibuloacral dysplasia.";
RL   J. Clin. Endocrinol. Metab. 90:5259-5264(2005).
RN   [93]
RP   VARIANT LGMD1B HIS-377, AND VARIANTS EDMD2 ASN-63; PRO-140; GLN-190;
RP   GLN-249 AND PRO-527.
RX   PubMed=15744034; DOI=10.1136/jmg.2004.026112;
RA   Cenni V., Sabatelli P., Mattioli E., Marmiroli S., Capanni C.,
RA   Ognibene A., Squarzoni S., Maraldi N.M., Bonne G., Columbaro M.,
RA   Merlini L., Lattanzi G.;
RT   "Lamin A N-terminal phosphorylation is associated with myoblast
RT   activation: impairment in Emery-Dreifuss muscular dystrophy.";
RL   J. Med. Genet. 42:214-220(2005).
RN   [94]
RP   VARIANT MADA LEU-573.
RX   PubMed=16278265; DOI=10.1210/jc.2005-1297;
RA   Van Esch H., Agarwal A.K., Debeer P., Fryns J.-P., Garg A.;
RT   "A homozygous mutation in the lamin A/C gene associated with a novel
RT   syndrome of arthropathy, tendinous calcinosis, and progeroid
RT   features.";
RL   J. Clin. Endocrinol. Metab. 91:517-521(2006).
RN   [95]
RP   VARIANT CMDHH ARG-59.
RX   PubMed=17150192; DOI=10.1016/j.bbrc.2006.11.070;
RA   Nguyen D., Leistritz D.F., Turner L., MacGregor D., Ohson K.,
RA   Dancey P., Martin G.M., Oshima J.;
RT   "Collagen expression in fibroblasts with a novel LMNA mutation.";
RL   Biochem. Biophys. Res. Commun. 352:603-608(2007).
RN   [96]
RP   VARIANTS FPLD2 ASN-230; CYS-399 AND LEU-573.
RX   PubMed=17250669; DOI=10.1111/j.1399-0004.2007.00740.x;
RA   Lanktree M., Cao H., Rabkin S.W., Hanna A., Hegele R.A.;
RT   "Novel LMNA mutations seen in patients with familial partial
RT   lipodystrophy subtype 2 (FPLD2; MIM 151660).";
RL   Clin. Genet. 71:183-186(2007).
RN   [97]
RP   VARIANT LGMD1B HIS-377.
RX   PubMed=17136397; DOI=10.1007/s10048-006-0070-0;
RA   Rudnik-Schoeneborn S., Botzenhart E., Eggermann T., Senderek J.,
RA   Schoser B.G.H., Schroeder R., Wehnert M., Wirth B., Zerres K.;
RT   "Mutations of the LMNA gene can mimic autosomal dominant proximal
RT   spinal muscular atrophy.";
RL   Neurogenetics 8:137-142(2007).
RN   [98]
RP   VARIANT PRO-421.
RX   PubMed=17711925; DOI=10.1210/jc.2007-0654;
RA   Decaudain A., Vantyghem M.C., Guerci B., Hecart A.C., Auclair M.,
RA   Reznik Y., Narbonne H., Ducluzeau P.H., Donadille B., Lebbe C.,
RA   Bereziat V., Capeau J., Lascols O., Vigouroux C.;
RT   "New metabolic phenotypes in laminopathies: LMNA mutations in patients
RT   with severe metabolic syndrome.";
RL   J. Clin. Endocrinol. Metab. 92:4835-4844(2007).
RN   [99]
RP   VARIANTS MDCL SER-39; PRO-50; TRP-249; PRO-302; LYS-358; SER-380;
RP   PRO-453; PRO-455 AND ASP-456.
RX   PubMed=18551513; DOI=10.1002/ana.21417;
RA   Quijano-Roy S., Mbieleu B., Bonnemann C.G., Jeannet P.Y., Colomer J.,
RA   Clarke N.F., Cuisset J.M., Roper H., De Meirleir L., D'Amico A.,
RA   Ben Yaou R., Nascimento A., Barois A., Demay L., Bertini E.,
RA   Ferreiro A., Sewry C.A., Romero N.B., Ryan M., Muntoni F.,
RA   Guicheney P., Richard P., Bonne G., Estournet B.;
RT   "De novo LMNA mutations cause a new form of congenital muscular
RT   dystrophy.";
RL   Ann. Neurol. 64:177-186(2008).
RN   [100]
RP   INVOLVEMENT IN HHS-SLOVENIAN, AND FUNCTION.
RX   PubMed=18611980; DOI=10.1136/jmg.2008.060020;
RA   Renou L., Stora S., Yaou R.B., Volk M., Sinkovec M., Demay L.,
RA   Richard P., Peterlin B., Bonne G.;
RT   "Heart-hand syndrome of Slovenian type: a new kind of laminopathy.";
RL   J. Med. Genet. 45:666-671(2008).
RN   [101]
RP   VARIANT CMDHH ARG-59.
RX   PubMed=19283854; DOI=10.1002/ajmg.a.32627;
RA   McPherson E., Turner L., Zador I., Reynolds K., Macgregor D.,
RA   Giampietro P.F.;
RT   "Ovarian failure and dilated cardiomyopathy due to a novel lamin
RT   mutation.";
RL   Am. J. Med. Genet. A 149:567-572(2009).
RN   [102]
RP   VARIANTS SER-125; ILE-415 AND PRO-488.
RX   PubMed=19427440; DOI=10.1016/j.amjcard.2009.01.354;
RA   Brauch K.M., Chen L.Y., Olson T.M.;
RT   "Comprehensive mutation scanning of LMNA in 268 patients with lone
RT   atrial fibrillation.";
RL   Am. J. Cardiol. 103:1426-1428(2009).
RN   [103]
RP   VARIANTS CMD1A PHE-92; LYS-161; LYS-317 AND ARG-523.
RX   PubMed=21846512; DOI=10.1016/j.ejmg.2011.07.005;
RA   Millat G., Bouvagnet P., Chevalier P., Sebbag L., Dulac A.,
RA   Dauphin C., Jouk P.S., Delrue M.A., Thambo J.B., Le Metayer P.,
RA   Seronde M.F., Faivre L., Eicher J.C., Rousson R.;
RT   "Clinical and mutational spectrum in a cohort of 105 unrelated
RT   patients with dilated cardiomyopathy.";
RL   Eur. J. Med. Genet. 54:E570-E575(2011).
RN   [104]
RP   VARIANT HGPS LYS-138.
RX   PubMed=21791255; DOI=10.1016/j.ejmg.2011.06.012;
RA   Gonzalez-Quereda L., Delgadillo V., Juan-Mateu J., Verdura E.,
RA   Rodriguez M.J., Baiget M., Pineda M., Gallano P.;
RT   "LMNA mutation in progeroid syndrome in association with strokes.";
RL   Eur. J. Med. Genet. 54:E576-E579(2011).
RN   [105]
RP   VARIANTS EDMD2 SER-39; CYS-45; PRO-150; PRO-189; ARG-190 INS; LEU-206;
RP   TRP-249; GLN-249; PRO-268; PRO-271; PRO-294; PRO-295; PRO-303; GLN-355
RP   DEL; LYS-358; LYS-361; LYS-386; ASP-449; TRP-453; PRO-454; TYR-461;
RP   ARG-467; PRO-527; LYS-528; ARG-528; SER-541; PRO-541; SER-602 AND
RP   CYS-644, AND CHARACTERIZATION OF VARIANTS EDMD2 PRO-25; TRP-249;
RP   ILE-456 AND PRO-541.
RX   PubMed=20848652; DOI=10.1002/humu.21361;
RA   Scharner J., Brown C.A., Bower M., Iannaccone S.T., Khatri I.A.,
RA   Escolar D., Gordon E., Felice K., Crowe C.A., Grosmann C.,
RA   Meriggioli M.N., Asamoah A., Gordon O., Gnocchi V.F., Ellis J.A.,
RA   Mendell J.R., Zammit P.S.;
RT   "Novel LMNA mutations in patients with Emery-Dreifuss muscular
RT   dystrophy and functional characterization of four LMNA mutations.";
RL   Hum. Mutat. 32:152-167(2011).
RN   [106]
RP   VARIANTS ASP-411 AND ASP-631.
RX   PubMed=21724554; DOI=10.1093/hmg/ddr294;
RA   Dutour A., Roll P., Gaborit B., Courrier S., Alessi M.C.,
RA   Tregouet D.A., Angelis F., Robaglia-Schlupp A., Lesavre N., Cau P.,
RA   Levy N., Badens C., Morange P.E.;
RT   "High prevalence of laminopathies among patients with metabolic
RT   syndrome.";
RL   Hum. Mol. Genet. 20:3779-3786(2011).
RN   [107]
RP   VARIANT EDMD3 GLN-225, AND FUNCTION.
RX   PubMed=22431096; DOI=10.1002/mus.22324;
RA   Jimenez-Escrig A., Gobernado I., Garcia-Villanueva M.,
RA   Sanchez-Herranz A.;
RT   "Autosomal recessive Emery-Dreifuss muscular dystrophy caused by a
RT   novel mutation (R225Q) in the lamin A/C gene identified by exome
RT   sequencing.";
RL   Muscle Nerve 45:605-610(2012).
RN   [108]
RP   CHARACTERIZATION OF VARIANTS CYS-401; ASP-411; CYS-413; ILE-415;
RP   CYS-419; PRO-421 AND GLY-427, AND INTERACTION WITH SYNE2.
RX   PubMed=23977161; DOI=10.1371/journal.pone.0071850;
RA   Yang L., Munck M., Swamvdinathan K., Kapinos L.E., Noegel A.A.,
RA   Neumann S.;
RT   "Mutations in LMNA modulate the lamin A--Nesprin-2 interaction and
RT   cause LINC complex alterations.";
RL   PLoS ONE 8:E71850-E71850(2013).
RN   [109]
RP   VARIANT FPLD2 GLU-515.
RX   PubMed=24485160; DOI=10.1016/j.diabet.2013.12.008;
RA   Chirico V., Ferrau V., Loddo I., Briuglia S., Amorini M.,
RA   Salpietro V., Lacquaniti A., Salpietro C., Arrigo T.;
RT   "LMNA gene mutation as a model of cardiometabolic dysfunction: from
RT   genetic analysis to treatment response.";
RL   Diabetes Metab. 40:224-228(2014).
RN   [110]
RP   VARIANT EDMD3 SER-24, AND VARIANT LGMD1B CYS-259.
RX   PubMed=27234031; DOI=10.1111/cge.12810;
RA   Fattahi Z., Kalhor Z., Fadaee M., Vazehan R., Parsimehr E.,
RA   Abolhassani A., Beheshtian M., Zamani G., Nafissi S., Nilipour Y.,
RA   Akbari M.R., Kahrizi K., Kariminejad A., Najmabadi H.;
RT   "Improved diagnostic yield of neuromuscular disorders applying
RT   clinical exome sequencing in patients arising from a consanguineous
RT   population.";
RL   Clin. Genet. 91:386-402(2017).
CC   -!- FUNCTION: Lamins are components of the nuclear lamina, a fibrous
CC       layer on the nucleoplasmic side of the inner nuclear membrane,
CC       which is thought to provide a framework for the nuclear envelope
CC       and may also interact with chromatin. Lamin A and C are present in
CC       equal amounts in the lamina of mammals. Plays an important role in
CC       nuclear assembly, chromatin organization, nuclear membrane and
CC       telomere dynamics. Required for normal development of peripheral
CC       nervous system and skeletal muscle and for muscle satellite cell
CC       proliferation (PubMed:10080180, PubMed:22431096, PubMed:10814726,
CC       PubMed:11799477, PubMed:18551513). Required for osteoblastogenesis
CC       and bone formation (PubMed:12075506, PubMed:15317753,
CC       PubMed:18611980). Also prevents fat infiltration of muscle and
CC       bone marrow, helping to maintain the volume and strength of
CC       skeletal muscle and bone (PubMed:10587585). Required for cardiac
CC       homeostasis (PubMed:10580070, PubMed:12927431, PubMed:18611980,
CC       PubMed:23666920). {ECO:0000269|PubMed:10080180,
CC       ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:10587585,
CC       ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:11799477,
CC       ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:12927431,
CC       ECO:0000269|PubMed:15317753, ECO:0000269|PubMed:18551513,
CC       ECO:0000269|PubMed:18611980, ECO:0000269|PubMed:22431096,
CC       ECO:0000269|PubMed:23666920}.
CC   -!- FUNCTION: Prelamin-A/C can accelerate smooth muscle cell
CC       senescence. It acts to disrupt mitosis and induce DNA damage in
CC       vascular smooth muscle cells (VSMCs), leading to mitotic failure,
CC       genomic instability, and premature senescence.
CC   -!- SUBUNIT: Homodimer of lamin A and lamin C. Interacts with lamin-
CC       associated polypeptides IA, IB and TMPO-alpha, RB1 and with
CC       emerin. Interacts with SREBF1, SREBF2, SUN2 and TMEM43. Interacts
CC       with TMEM201 (By similarity). Proteolytically processed isoform A
CC       interacts with NARF. Interacts with SUN1. Prelamin-A/C interacts
CC       with EMD. Interacts with MLIP. Interacts with DMPK; may regulate
CC       nuclear envelope stability. Interacts with SUV39H1; the
CC       interaction increases stability of SUV39H1. Interacts with SYNE2.
CC       {ECO:0000250, ECO:0000269|PubMed:10514485,
CC       ECO:0000269|PubMed:12475961, ECO:0000269|PubMed:19323649,
CC       ECO:0000269|PubMed:19933576, ECO:0000269|PubMed:21498514,
CC       ECO:0000269|PubMed:21949239, ECO:0000269|PubMed:23695662,
CC       ECO:0000269|PubMed:23977161}.
CC   -!- INTERACTION:
CC       P18054:ALOX12; NbExp=4; IntAct=EBI-351935, EBI-1633210;
CC       Q9UII6:DUSP13; NbExp=3; IntAct=EBI-351935, EBI-749800;
CC       P16104:H2AFX; NbExp=3; IntAct=EBI-351935, EBI-494830;
CC       Q71DI3:HIST2H3A; NbExp=6; IntAct=EBI-351935, EBI-750650;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-351935, EBI-10172290;
CC       P20700:LMNB1; NbExp=5; IntAct=EBI-351949, EBI-968218;
CC       P10215:NEC1 (xeno); NbExp=2; IntAct=EBI-351935, EBI-7183650;
CC       P10218:NEC2 (xeno); NbExp=2; IntAct=EBI-351935, EBI-7183680;
CC       Q96RG2:PASK; NbExp=2; IntAct=EBI-351935, EBI-1042651;
CC       Q9UH99:SUN2; NbExp=4; IntAct=EBI-351935, EBI-1044964;
CC       Q8N0S2:SYCE1; NbExp=3; IntAct=EBI-351953, EBI-6872807;
CC       P63104:YWHAZ; NbExp=2; IntAct=EBI-351935, EBI-347088;
CC       O75844:ZMPSTE24; NbExp=2; IntAct=EBI-351949, EBI-1056377;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus envelope. Nucleus lamina.
CC       Nucleus, nucleoplasm. Note=Farnesylation of prelamin-A/C
CC       facilitates nuclear envelope targeting and subsequent cleaveage by
CC       ZMPSTE24/FACE1 to remove the farnesyl group produces mature lamin-
CC       A/C, which can then be inserted into the nuclear lamina. EMD is
CC       required for proper localization of non-farnesylated prelamin-A/C.
CC   -!- SUBCELLULAR LOCATION: Isoform C: Nucleus speckle
CC       {ECO:0000269|PubMed:16061563}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=A; Synonyms=Lamin A;
CC         IsoId=P02545-1; Sequence=Displayed;
CC       Name=C; Synonyms=Lamin C;
CC         IsoId=P02545-2; Sequence=VSP_002469, VSP_002470;
CC       Name=ADelta10; Synonyms=Lamin ADelta10;
CC         IsoId=P02545-3; Sequence=VSP_002468;
CC       Name=4;
CC         IsoId=P02545-4; Sequence=VSP_045977, VSP_045978, VSP_045979;
CC         Note=No experimental confirmation available. Ref.5 (BAG58344)
CC         sequence is in conflict in position: 556:G->R. {ECO:0000305};
CC       Name=5;
CC         IsoId=P02545-5; Sequence=VSP_053503, VSP_053504;
CC         Note=No experimental confirmation available.;
CC       Name=6; Synonyms=Progerin;
CC         IsoId=P02545-6; Sequence=VSP_053505;
CC         Note=Disease-associated isoform. Polymorphism at codon 608
CC         results in activation of a cryptic splice donor site within exon
CC         11, resulting in a truncated protein product that lacks the site
CC         for endoproteolytic cleavage.;
CC   -!- TISSUE SPECIFICITY: In the arteries, prelamin-A/C accumulation is
CC       not observed in young healthy vessels but is prevalent in medial
CC       vascular smooth muscle cells (VSMCs) from aged individuals and in
CC       atherosclerotic lesions, where it often colocalizes with senescent
CC       and degenerate VSMCs. Prelamin-A/C expression increases with age
CC       and disease. In normal aging, the accumulation of prelamin-A/C is
CC       caused in part by the down-regulation of ZMPSTE24/FACE1 in
CC       response to oxidative stress. {ECO:0000269|PubMed:20458013}.
CC   -!- PTM: Increased phosphorylation of the lamins occurs before
CC       envelope disintegration and probably plays a role in regulating
CC       lamin associations. {ECO:0000269|Ref.9}.
CC   -!- PTM: Proteolytic cleavage of the C-terminal of 18 residues of
CC       prelamin-A/C results in the production of lamin-A/C. The prelamin-
CC       A/C maturation pathway includes farnesylation of CAAX motif,
CC       ZMPSTE24/FACE1 mediated cleavage of the last three amino acids,
CC       methylation of the C-terminal cysteine and endoproteolytic removal
CC       of the last 15 C-terminal amino acids. Proteolytic cleavage
CC       requires prior farnesylation and methylation, and absence of these
CC       blocks cleavage. {ECO:0000269|PubMed:20458013,
CC       ECO:0000269|PubMed:8175923, ECO:0000269|PubMed:9030603}.
CC   -!- PTM: Sumoylation is necessary for the localization to the nuclear
CC       envelope. {ECO:0000269|PubMed:18606848}.
CC   -!- PTM: Farnesylation of prelamin-A/C facilitates nuclear envelope
CC       targeting.
CC   -!- DISEASE: Emery-Dreifuss muscular dystrophy 2, autosomal dominant
CC       (EDMD2) [MIM:181350]: A form of Emery-Dreifuss muscular dystrophy,
CC       a degenerative myopathy characterized by weakness and atrophy of
CC       muscle without involvement of the nervous system, early
CC       contractures of the elbows, Achilles tendons and spine, and
CC       cardiomyopathy associated with cardiac conduction defects.
CC       {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10739764,
CC       ECO:0000269|PubMed:10908904, ECO:0000269|PubMed:10939567,
CC       ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:11792809,
CC       ECO:0000269|PubMed:12032588, ECO:0000269|PubMed:12467752,
CC       ECO:0000269|PubMed:12649505, ECO:0000269|PubMed:14684700,
CC       ECO:0000269|PubMed:14985400, ECO:0000269|PubMed:15744034,
CC       ECO:0000269|PubMed:19933576, ECO:0000269|PubMed:20848652}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Emery-Dreifuss muscular dystrophy 3, autosomal recessive
CC       (EDMD3) [MIM:616516]: A form of Emery-Dreifuss muscular dystrophy,
CC       a degenerative myopathy characterized by weakness and atrophy of
CC       muscle without involvement of the nervous system, early
CC       contractures of the elbows, Achilles tendons and spine, and
CC       cardiomyopathy associated with cardiac conduction defects.
CC       {ECO:0000269|PubMed:22431096, ECO:0000269|PubMed:27234031}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]: A
CC       disorder characterized by ventricular dilation and impaired
CC       systolic function, resulting in congestive heart failure and
CC       arrhythmia. Patients are at risk of premature death.
CC       {ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:11561226,
CC       ECO:0000269|PubMed:11792809, ECO:0000269|PubMed:11897440,
CC       ECO:0000269|PubMed:12486434, ECO:0000269|PubMed:12628721,
CC       ECO:0000269|PubMed:12920062, ECO:0000269|PubMed:14684700,
CC       ECO:0000269|PubMed:15140538, ECO:0000269|PubMed:15219508,
CC       ECO:0000269|PubMed:16061563, ECO:0000269|PubMed:18606848,
CC       ECO:0000269|PubMed:20160190, ECO:0000269|PubMed:21846512}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]:
CC       A disorder characterized by the loss of subcutaneous adipose
CC       tissue in the lower parts of the body (limbs, buttocks, trunk). It
CC       is accompanied by an accumulation of adipose tissue in the face
CC       and neck causing a double chin, fat neck, or cushingoid
CC       appearance. Adipose tissue may also accumulate in the axillae,
CC       back, labia majora, and intraabdominal region. Affected patients
CC       are insulin-resistant and may develop glucose intolerance and
CC       diabetes mellitus after age 20 years, hypertriglyceridemia, and
CC       low levels of high density lipoprotein cholesterol.
CC       {ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10655060,
CC       ECO:0000269|PubMed:10739751, ECO:0000269|PubMed:11792809,
CC       ECO:0000269|PubMed:12015247, ECO:0000269|PubMed:12196663,
CC       ECO:0000269|PubMed:12629077, ECO:0000269|PubMed:17250669,
CC       ECO:0000269|PubMed:19220582, ECO:0000269|PubMed:24485160}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Limb-girdle muscular dystrophy 1B (LGMD1B) [MIM:159001]:
CC       An autosomal dominant degenerative myopathy with age-related
CC       atrioventricular cardiac conduction disturbances, dilated
CC       cardiomyopathy, and the absence of early contractures.
CC       Characterized by slowly progressive skeletal muscle weakness of
CC       the hip and shoulder girdles. Muscle biopsy shows mild dystrophic
CC       changes. {ECO:0000269|PubMed:10814726,
CC       ECO:0000269|PubMed:11525883, ECO:0000269|PubMed:12032588,
CC       ECO:0000269|PubMed:12673789, ECO:0000269|PubMed:15744034,
CC       ECO:0000269|PubMed:17136397, ECO:0000269|PubMed:27234031}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 2B1 (CMT2B1) [MIM:605588]: A
CC       recessive axonal form of Charcot-Marie-Tooth disease, a disorder
CC       of the peripheral nervous system, characterized by progressive
CC       weakness and atrophy, initially of the peroneal muscles and later
CC       of the distal muscles of the arms. Charcot-Marie-Tooth disease is
CC       classified in two main groups on the basis of electrophysiologic
CC       properties and histopathology: primary peripheral demyelinating
CC       neuropathies (designated CMT1 when they are dominantly inherited)
CC       and primary peripheral axonal neuropathies (CMT2). Neuropathies of
CC       the CMT2 group are characterized by signs of axonal degeneration
CC       in the absence of obvious myelin alterations, normal or slightly
CC       reduced nerve conduction velocities, and progressive distal muscle
CC       weakness and atrophy. Nerve conduction velocities are normal or
CC       slightly reduced. {ECO:0000269|PubMed:11799477}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]:
CC       Rare genetic disorder characterized by features reminiscent of
CC       marked premature aging. {ECO:0000269|PubMed:12714972,
CC       ECO:0000269|PubMed:12768443, ECO:0000269|PubMed:12927431,
CC       ECO:0000269|PubMed:15060110, ECO:0000269|PubMed:15286156,
CC       ECO:0000269|PubMed:15622532, ECO:0000269|PubMed:19933576,
CC       ECO:0000269|PubMed:21791255, ECO:0000269|PubMed:22355414,
CC       ECO:0000269|PubMed:23666920}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry. HGPS is
CC       caused by the toxic accumulation of a truncated form of lamin-A/C.
CC       This mutant protein, called progerin (isoform 6), acts to
CC       deregulate mitosis and DNA damage signaling, leading to premature
CC       cell death and senescence. The mutant form is mainly generated by
CC       a silent or missense mutation at codon 608 of prelamin A that
CC       causes activation of a cryptic splice donor site, resulting in
CC       production of isoform 6 with a deletion of 50 amino acids near the
CC       C terminus. Progerin lacks the conserved ZMPSTE24/FACE1 cleavage
CC       site and therefore remains permanently farnesylated. Thus,
CC       although it can enter the nucleus and associate with the nuclear
CC       envelope, it cannot incorporate normally into the nuclear lamina
CC       (PubMed:12714972). {ECO:0000269|PubMed:12714972}.
CC   -!- DISEASE: Cardiomyopathy, dilated, with hypergonadotropic
CC       hypogonadism (CMDHH) [MIM:212112]: A disorder characterized by the
CC       association of genital anomalies, hypergonadotropic hypogonadism
CC       and dilated cardiomyopathy. Patients can present other variable
CC       clinical manifestations including mental retardation, skeletal
CC       anomalies, scleroderma-like skin, graying and thinning of hair,
CC       osteoporosis. Dilated cardiomyopathy is characterized by
CC       ventricular dilation and impaired systolic function, resulting in
CC       congestive heart failure and arrhythmia.
CC       {ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:17150192,
CC       ECO:0000269|PubMed:19283854}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Mandibuloacral dysplasia with type A lipodystrophy (MADA)
CC       [MIM:248370]: A disorder characterized by mandibular and
CC       clavicular hypoplasia, acroosteolysis, delayed closure of the
CC       cranial suture, progeroid appearance, partial alopecia, soft
CC       tissue calcinosis, joint contractures, and partial lipodystrophy
CC       with loss of subcutaneous fat from the extremities. Adipose tissue
CC       in the face, neck and trunk is normal or increased.
CC       {ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:15998779,
CC       ECO:0000269|PubMed:16278265}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Lethal tight skin contracture syndrome (LTSCS)
CC       [MIM:275210]: Rare disorder mainly characterized by intrauterine
CC       growth retardation, tight and rigid skin with erosions, prominent
CC       superficial vasculature and epidermal hyperkeratosis, facial
CC       features (small mouth, small pinched nose and micrognathia),
CC       sparse/absent eyelashes and eyebrows, mineralization defects of
CC       the skull, thin dysplastic clavicles, pulmonary hypoplasia,
CC       multiple joint contractures and an early neonatal lethal course.
CC       Liveborn children usually die within the first week of life. The
CC       overall prevalence of consanguineous cases suggested an autosomal
CC       recessive inheritance. {ECO:0000269|PubMed:15317753}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Heart-hand syndrome Slovenian type (HHS-Slovenian)
CC       [MIM:610140]: Heart-hand syndrome (HHS) is a clinically and
CC       genetically heterogeneous disorder characterized by the co-
CC       occurrence of a congenital cardiac disease and limb malformations.
CC       {ECO:0000269|PubMed:18611980}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Muscular dystrophy congenital LMNA-related (MDCL)
CC       [MIM:613205]: A form of congenital muscular dystrophy. Patients
CC       present at birth, or within the first few months of life, with
CC       hypotonia, muscle weakness and often with joint contractures.
CC       {ECO:0000269|PubMed:18551513}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Defects in LMNA may cause a late-onset
CC       cardiocutaneous progeria syndrome characterized by cutaneous
CC       manifestations of aging appearing in the third decade of life,
CC       cardiac valve calcification and dysfunction, prominent
CC       atherosclerosis, and cardiomyopathy, leading to death on average
CC       in the fourth decade. {ECO:0000269|PubMed:23666920}.
CC   -!- MISCELLANEOUS: There are three types of lamins in human cells: A,
CC       B, and C.
CC   -!- MISCELLANEOUS: The structural integrity of the lamina is strictly
CC       controlled by the cell cycle, as seen by the disintegration and
CC       formation of the nuclear envelope in prophase and telophase,
CC       respectively.
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA27173.1; Type=Frameshift; Positions=582; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Human Intermediate Filament Mutation Database;
CC       URL="http://www.interfil.org";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03444; CAA27173.1; ALT_FRAME; mRNA.
DR   EMBL; X03445; CAA27174.1; -; mRNA.
DR   EMBL; M13451; AAA36164.1; -; mRNA.
DR   EMBL; M13452; AAA36160.1; -; mRNA.
DR   EMBL; AY847597; AAW32540.1; -; mRNA.
DR   EMBL; AY847595; AAW32538.1; -; mRNA.
DR   EMBL; AY357727; AAR29466.1; -; mRNA.
DR   EMBL; AK295390; BAG58344.1; -; mRNA.
DR   EMBL; AL135927; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355388; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356734; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW52997.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52999.1; -; Genomic_DNA.
DR   EMBL; BC000511; AAH00511.1; -; mRNA.
DR   EMBL; BC003162; AAH03162.1; -; mRNA.
DR   EMBL; BC014507; AAH14507.1; -; mRNA.
DR   EMBL; AF381029; AAK59326.1; -; mRNA.
DR   CCDS; CCDS1129.1; -. [P02545-1]
DR   CCDS; CCDS1131.1; -. [P02545-2]
DR   CCDS; CCDS58038.1; -. [P02545-4]
DR   CCDS; CCDS72941.1; -. [P02545-6]
DR   PIR; A02961; VEHULA.
DR   PIR; A02962; VEHULC.
DR   RefSeq; NP_001244303.1; NM_001257374.2. [P02545-4]
DR   RefSeq; NP_001269553.1; NM_001282624.1.
DR   RefSeq; NP_001269554.1; NM_001282625.1. [P02545-2]
DR   RefSeq; NP_001269555.1; NM_001282626.1. [P02545-6]
DR   RefSeq; NP_005563.1; NM_005572.3. [P02545-2]
DR   RefSeq; NP_733821.1; NM_170707.3. [P02545-1]
DR   RefSeq; NP_733822.1; NM_170708.3. [P02545-3]
DR   UniGene; Hs.594444; -.
DR   UniGene; Hs.706897; -.
DR   UniGene; Hs.733671; -.
DR   PDB; 1IFR; X-ray; 1.40 A; A=436-552.
DR   PDB; 1IVT; NMR; -; A=428-549.
DR   PDB; 1X8Y; X-ray; 2.20 A; A=305-387.
DR   PDB; 2XV5; X-ray; 2.40 A; A/B=328-398.
DR   PDB; 2YPT; X-ray; 3.80 A; F/G/H/I=661-664.
DR   PDB; 3GEF; X-ray; 1.50 A; A/B/C/D=436-552.
DR   PDB; 3V4Q; X-ray; 3.06 A; A=313-386.
DR   PDB; 3V4W; X-ray; 3.70 A; A=313-386.
DR   PDB; 3V5B; X-ray; 3.00 A; A=313-386.
DR   PDBsum; 1IFR; -.
DR   PDBsum; 1IVT; -.
DR   PDBsum; 1X8Y; -.
DR   PDBsum; 2XV5; -.
DR   PDBsum; 2YPT; -.
DR   PDBsum; 3GEF; -.
DR   PDBsum; 3V4Q; -.
DR   PDBsum; 3V4W; -.
DR   PDBsum; 3V5B; -.
DR   DisProt; DP00716; -.
DR   ProteinModelPortal; P02545; -.
DR   SMR; P02545; -.
DR   BioGrid; 110186; 243.
DR   CORUM; P02545; -.
DR   DIP; DIP-32948N; -.
DR   DIP; DIP-58162N; -.
DR   IntAct; P02545; 72.
DR   MINT; P02545; -.
DR   STRING; 9606.ENSP00000357283; -.
DR   ChEMBL; CHEMBL1293235; -.
DR   iPTMnet; P02545; -.
DR   PhosphoSitePlus; P02545; -.
DR   SwissPalm; P02545; -.
DR   BioMuta; LMNA; -.
DR   DMDM; 125962; -.
DR   REPRODUCTION-2DPAGE; IPI00021405; -.
DR   REPRODUCTION-2DPAGE; IPI00216952; -.
DR   REPRODUCTION-2DPAGE; P02545; -.
DR   SWISS-2DPAGE; P02545; -.
DR   EPD; P02545; -.
DR   MaxQB; P02545; -.
DR   PaxDb; P02545; -.
DR   PeptideAtlas; P02545; -.
DR   PRIDE; P02545; -.
DR   TopDownProteomics; P02545-1; -. [P02545-1]
DR   TopDownProteomics; P02545-2; -. [P02545-2]
DR   TopDownProteomics; P02545-4; -. [P02545-4]
DR   DNASU; 4000; -.
DR   Ensembl; ENST00000347559; ENSP00000292304; ENSG00000160789. [P02545-3]
DR   Ensembl; ENST00000368299; ENSP00000357282; ENSG00000160789. [P02545-6]
DR   Ensembl; ENST00000368300; ENSP00000357283; ENSG00000160789. [P02545-1]
DR   Ensembl; ENST00000368301; ENSP00000357284; ENSG00000160789. [P02545-2]
DR   Ensembl; ENST00000448611; ENSP00000395597; ENSG00000160789. [P02545-4]
DR   Ensembl; ENST00000473598; ENSP00000421821; ENSG00000160789. [P02545-5]
DR   GeneID; 4000; -.
DR   KEGG; hsa:4000; -.
DR   UCSC; uc001fnf.3; human. [P02545-1]
DR   CTD; 4000; -.
DR   DisGeNET; 4000; -.
DR   EuPathDB; HostDB:ENSG00000160789.19; -.
DR   GeneCards; LMNA; -.
DR   GeneReviews; LMNA; -.
DR   HGNC; HGNC:6636; LMNA.
DR   HPA; CAB004022; -.
DR   HPA; HPA006660; -.
DR   MalaCards; LMNA; -.
DR   MIM; 115200; phenotype.
DR   MIM; 150330; gene.
DR   MIM; 151660; phenotype.
DR   MIM; 159001; phenotype.
DR   MIM; 176670; phenotype.
DR   MIM; 181350; phenotype.
DR   MIM; 212112; phenotype.
DR   MIM; 248370; phenotype.
DR   MIM; 275210; phenotype.
DR   MIM; 605588; phenotype.
DR   MIM; 610140; phenotype.
DR   MIM; 613205; phenotype.
DR   MIM; 616516; phenotype.
DR   neXtProt; NX_P02545; -.
DR   OpenTargets; ENSG00000160789; -.
DR   Orphanet; 79474; Atypical Werner syndrome.
DR   Orphanet; 280365; Autosomal codominant severe lipodystrophic laminopathy.
DR   Orphanet; 98853; Autosomal dominant Emery-Dreifuss muscular dystrophy.
DR   Orphanet; 264; Autosomal dominant limb-girdle muscular dystrophy type 1B.
DR   Orphanet; 98855; Autosomal recessive Emery-Dreifuss muscular dystrophy.
DR   Orphanet; 98856; Charcot-Marie-Tooth disease type 2B1.
DR   Orphanet; 157973; Congenital muscular dystrophy due to LMNA mutation.
DR   Orphanet; 2229; Dilated cardiomyopathy - hypergonadotropic hypogonadism.
DR   Orphanet; 300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation.
DR   Orphanet; 293899; Familial isolated arrhythmogenic ventricular dysplasia, biventricular form.
DR   Orphanet; 293888; Familial isolated arrhythmogenic ventricular dysplasia, left dominant form.
DR   Orphanet; 293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form.
DR   Orphanet; 2348; Familial partial lipodystrophy, Dunnigan type.
DR   Orphanet; 79084; Familial partial lipodystrophy, Kobberling type.
DR   Orphanet; 168796; Heart-hand syndrome, Slovenian type.
DR   Orphanet; 740; Hutchinson-Gilford progeria syndrome.
DR   Orphanet; 137871; Laminopathy type Decaudain-Vigouroux.
DR   Orphanet; 54260; Left ventricular noncompaction.
DR   Orphanet; 1662; Lethal restrictive dermopathy.
DR   Orphanet; 363618; LMNA-related cardiocutaneous progeria syndrome.
DR   Orphanet; 90153; Mandibuloacral dysplasia with type A lipodystrophy.
DR   Orphanet; 99706; Progeria-associated arthropathy.
DR   PharmGKB; PA231; -.
DR   eggNOG; KOG0977; Eukaryota.
DR   eggNOG; ENOG410Y2H6; LUCA.
DR   GeneTree; ENSGT00910000143989; -.
DR   HOGENOM; HOG000007711; -.
DR   HOVERGEN; HBG013015; -.
DR   InParanoid; P02545; -.
DR   KO; K12641; -.
DR   OMA; SHVSRHR; -.
DR   OrthoDB; EOG091G063B; -.
DR   PhylomeDB; P02545; -.
DR   TreeFam; TF101181; -.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-2993913; Clearance of Nuclear Envelope Membranes from Chromatin.
DR   Reactome; R-HSA-2995383; Initiation of Nuclear Envelope Reformation.
DR   Reactome; R-HSA-352238; Breakdown of the nuclear lamina.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   Reactome; R-HSA-4419969; Depolymerisation of the Nuclear Lamina.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-8862803; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models.
DR   SIGNOR; P02545; -.
DR   ChiTaRS; LMNA; human.
DR   EvolutionaryTrace; P02545; -.
DR   GeneWiki; LMNA; -.
DR   GenomeRNAi; 4000; -.
DR   PMAP-CutDB; P02545; -.
DR   PRO; PR:P02545; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000160789; -.
DR   CleanEx; HS_LMNA; -.
DR   ExpressionAtlas; P02545; baseline and differential.
DR   Genevisible; P02545; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0005882; C:intermediate filament; TAS:UniProtKB.
DR   GO; GO:0005638; C:lamin filament; TAS:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0005652; C:nuclear lamina; TAS:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; HDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:CAFA.
DR   GO; GO:0005634; C:nucleus; IDA:ARUK-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005198; F:structural molecule activity; TAS:UniProtKB.
DR   GO; GO:0034613; P:cellular protein localization; IMP:CAFA.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB.
DR   GO; GO:0030951; P:establishment or maintenance of microtubule cytoskeleton polarity; ISS:BHF-UCL.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome.
DR   GO; GO:0007084; P:mitotic nuclear envelope reassembly; TAS:Reactome.
DR   GO; GO:0007517; P:muscle organ development; IMP:UniProtKB.
DR   GO; GO:1903243; P:negative regulation of cardiac muscle hypertrophy in response to stress; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:CAFA.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0072201; P:negative regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IEA:Ensembl.
DR   GO; GO:0006998; P:nuclear envelope organization; IMP:CAFA.
DR   GO; GO:0090343; P:positive regulation of cell aging; IDA:UniProtKB.
DR   GO; GO:0034504; P:protein localization to nucleus; ISS:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; ISS:BHF-UCL.
DR   GO; GO:1900180; P:regulation of protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0032204; P:regulation of telomere maintenance; IMP:BHF-UCL.
DR   GO; GO:0035105; P:sterol regulatory element binding protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl.
DR   Gene3D; 2.60.40.1260; -; 1.
DR   InterPro; IPR001664; IF.
DR   InterPro; IPR018039; Intermediate_filament_CS.
DR   InterPro; IPR001322; Lamin_tail_dom.
DR   InterPro; IPR036415; Lamin_tail_dom_sf.
DR   PANTHER; PTHR23239; PTHR23239; 1.
DR   Pfam; PF00038; Filament; 1.
DR   Pfam; PF00932; LTD; 1.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF74853; SSF74853; 1.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
DR   PROSITE; PS51841; LTD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cardiomyopathy;
KW   Charcot-Marie-Tooth disease; Coiled coil; Complete proteome;
KW   Congenital muscular dystrophy; Direct protein sequencing;
KW   Disease mutation; Emery-Dreifuss muscular dystrophy;
KW   Intermediate filament; Isopeptide bond;
KW   Limb-girdle muscular dystrophy; Lipoprotein; Methylation;
KW   Neurodegeneration; Neuropathy; Nucleus; Phosphoprotein; Polymorphism;
KW   Prenylation; Reference proteome; Ubl conjugation.
FT   CHAIN         1    661       Prelamin-A/C.
FT                                /FTId=PRO_0000398835.
FT   CHAIN         1    646       Lamin-A/C.
FT                                /FTId=PRO_0000063810.
FT   PROPEP      647    661       Removed in Lamin-A/C form.
FT                                /FTId=PRO_0000398836.
FT   PROPEP      662    664       Removed in Prelamin-A/C form and in
FT                                Lamin-A/C form.
FT                                /FTId=PRO_0000403442.
FT   DOMAIN       31    387       IF rod. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01188}.
FT   DOMAIN      428    545       LTD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01187}.
FT   REGION        1    130       Interaction with MLIP.
FT                                {ECO:0000269|PubMed:21498514}.
FT   REGION        1     33       Head.
FT   REGION       34     70       Coil 1A.
FT   REGION       71     80       Linker 1.
FT   REGION       81    218       Coil 1B.
FT   REGION      219    242       Linker 2.
FT   REGION      243    383       Coil 2.
FT   REGION      384    664       Tail.
FT   MOTIF       417    422       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   SITE        266    266       Heptad change of phase.
FT   SITE        325    325       Stutter. {ECO:0000250}.
FT   SITE        330    330       Heptad change of phase.
FT   SITE        646    647       Cleavage; by endoprotease.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES       3      3       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      12     12       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      18     18       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      19     19       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      22     22       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|Ref.9}.
FT   MOD_RES      32     32       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES      32     32       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES      51     51       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      66     66       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      71     71       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     107    107       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     108    108       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     123    123       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     135    135       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     155    155       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     171    171       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     171    171       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     201    201       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     212    212       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     260    260       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     270    270       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     277    277       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     301    301       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     307    307       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     311    311       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     390    390       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     392    392       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     395    395       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     398    398       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     403    403       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     404    404       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     407    407       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     414    414       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     429    429       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     431    431       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     450    450       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     457    457       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     458    458       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     463    463       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     496    496       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P48679}.
FT   MOD_RES     505    505       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     510    510       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P48679}.
FT   MOD_RES     533    533       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     546    546       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     548    548       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     568    568       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     571    571       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     612    612       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     613    613       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     616    616       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P48678}.
FT   MOD_RES     619    619       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     628    628       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     632    632       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     636    636       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     652    652       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     661    661       Cysteine methyl ester.
FT                                {ECO:0000269|PubMed:8175923,
FT                                ECO:0000269|PubMed:9030603}.
FT   LIPID       661    661       S-farnesyl cysteine.
FT                                {ECO:0000269|PubMed:8175923,
FT                                ECO:0000269|PubMed:9030603}.
FT   CROSSLNK     32     32       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     97     97       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    171    171       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    201    201       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    201    201       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    208    208       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    219    219       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    233    233       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    260    260       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    270    270       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    311    311       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    366    366       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    378    378       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    417    417       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    420    420       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    450    450       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    470    470       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    486    486       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    597    597       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    597    597       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1     99       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_053503.
FT   VAR_SEQ       1      7       METPSQR -> MGNSEGC (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045977.
FT   VAR_SEQ       8    119       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045978.
FT   VAR_SEQ     100    119       ARLQLELSKVREEFKELKAR -> MDLEAWDPHLEPDAEAM
FT                                VDG (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_053504.
FT   VAR_SEQ     537    566       Missing (in isoform ADelta10).
FT                                {ECO:0000303|PubMed:8621584}.
FT                                /FTId=VSP_002468.
FT   VAR_SEQ     567    572       GSHCSS -> VSGSRR (in isoform C).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:3453101,
FT                                ECO:0000303|PubMed:3462705}.
FT                                /FTId=VSP_002469.
FT   VAR_SEQ     573    664       Missing (in isoform C).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:3453101,
FT                                ECO:0000303|PubMed:3462705}.
FT                                /FTId=VSP_002470.
FT   VAR_SEQ     607    656       Missing (in isoform 6).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_053505.
FT   VAR_SEQ     664    664       M -> IQEMGMRWEVEEGRRKVSLSCLP (in isoform
FT                                4). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045979.
FT   VARIANT      10     10       T -> I (in an atypical progeroid patient;
FT                                diagnosed as Seip syndrome;
FT                                dbSNP:rs57077886).
FT                                {ECO:0000269|PubMed:15060110}.
FT                                /FTId=VAR_039745.
FT   VARIANT      24     24       T -> S (in EDMD3).
FT                                {ECO:0000269|PubMed:27234031}.
FT                                /FTId=VAR_076562.
FT   VARIANT      25     25       R -> G (in EDMD2; dbSNP:rs58327533).
FT                                {ECO:0000269|PubMed:14684700}.
FT                                /FTId=VAR_039746.
FT   VARIANT      25     25       R -> P (in EDMD2; mis-localized in the
FT                                nucleus; causes nuclear deformations and
FT                                LMNB1 redistribution; dbSNP:rs61578124).
FT                                {ECO:0000269|PubMed:11503164,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_039747.
FT   VARIANT      28     28       R -> W (in FPLD2; dbSNP:rs59914820).
FT                                {ECO:0000269|PubMed:12015247}.
FT                                /FTId=VAR_039748.
FT   VARIANT      32     32       Missing (in EDMD2).
FT                                {ECO:0000269|PubMed:12467752,
FT                                ECO:0000269|PubMed:14684700}.
FT                                /FTId=VAR_039749.
FT   VARIANT      33     33       E -> D (in CMT2; autosomal dominant form;
FT                                dbSNP:rs57966821).
FT                                {ECO:0000269|PubMed:14985400}.
FT                                /FTId=VAR_039750.
FT   VARIANT      33     33       E -> G (in EDMD2; dbSNP:rs267607614).
FT                                {ECO:0000269|PubMed:14985400}.
FT                                /FTId=VAR_039751.
FT   VARIANT      35     35       L -> V (in EDMD2; dbSNP:rs56694480).
FT                                {ECO:0000269|PubMed:14684700}.
FT                                /FTId=VAR_039752.
FT   VARIANT      39     39       N -> S (in MDCL and EDMD2;
FT                                dbSNP:rs57983345).
FT                                {ECO:0000269|PubMed:18551513,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_063588.
FT   VARIANT      43     43       A -> T (in EDMD2; dbSNP:rs60446065).
FT                                {ECO:0000269|PubMed:11503164}.
FT                                /FTId=VAR_039753.
FT   VARIANT      45     45       Y -> C (in EDMD2; dbSNP:rs58436778).
FT                                {ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_009971.
FT   VARIANT      50     50       R -> P (in EDMD2 and MDCL;
FT                                dbSNP:rs60695352).
FT                                {ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:18551513}.
FT                                /FTId=VAR_009972.
FT   VARIANT      50     50       R -> S (in EDMD2; dbSNP:rs59931416).
FT                                {ECO:0000269|PubMed:11503164}.
FT                                /FTId=VAR_039754.
FT   VARIANT      57     57       A -> P (in CMDHH; phenotype originally
FT                                designated as atypical Werner syndrome;
FT                                dbSNP:rs28928903).
FT                                {ECO:0000269|PubMed:12927431}.
FT                                /FTId=VAR_017656.
FT   VARIANT      59     59       L -> R (in CMDHH; dbSNP:rs58922911).
FT                                {ECO:0000269|PubMed:17150192,
FT                                ECO:0000269|PubMed:19283854}.
FT                                /FTId=VAR_064055.
FT   VARIANT      60     60       R -> G (in CMD1A and FPLD2; interacts
FT                                with itself and with wild-type LMNA and
FT                                LMNB1; no decrease in the stability
FT                                compared with wild-type;
FT                                dbSNP:rs28928900).
FT                                {ECO:0000269|PubMed:10580070,
FT                                ECO:0000269|PubMed:11792809,
FT                                ECO:0000269|PubMed:12196663}.
FT                                /FTId=VAR_034706.
FT   VARIANT      62     62       R -> G (in FPLD2; dbSNP:rs56793579).
FT                                {ECO:0000269|PubMed:12015247}.
FT                                /FTId=VAR_039755.
FT   VARIANT      63     63       I -> N (in EDMD2; dbSNP:rs57793737).
FT                                {ECO:0000269|PubMed:12467752,
FT                                ECO:0000269|PubMed:12649505,
FT                                ECO:0000269|PubMed:15744034}.
FT                                /FTId=VAR_039756.
FT   VARIANT      63     63       I -> S (in EDMD2; dbSNP:rs57793737).
FT                                {ECO:0000269|PubMed:10939567}.
FT                                /FTId=VAR_009974.
FT   VARIANT      65     65       E -> G (in EDMD2).
FT                                {ECO:0000269|PubMed:14684700}.
FT                                /FTId=VAR_039757.
FT   VARIANT      85     85       L -> R (in CMD1A; interacts with itself
FT                                and with wild-type LMNA and LMNB1; no
FT                                decrease in the stability compared with
FT                                wild-type; dbSNP:rs28933090).
FT                                {ECO:0000269|PubMed:10580070,
FT                                ECO:0000269|PubMed:11792809}.
FT                                /FTId=VAR_009975.
FT   VARIANT      89     89       R -> L (in CMD1A; dramatically aberrant
FT                                localization with almost no nuclear rim
FT                                staining and formation of intranuclear
FT                                foci; dbSNP:rs59040894).
FT                                {ECO:0000269|PubMed:12628721,
FT                                ECO:0000269|PubMed:20160190}.
FT                                /FTId=VAR_039758.
FT   VARIANT      92     92       L -> F (in CMD1A; dbSNP:rs267607560).
FT                                {ECO:0000269|PubMed:21846512}.
FT                                /FTId=VAR_067257.
FT   VARIANT      97     97       K -> E (in CMD1A; dbSNP:rs59065411).
FT                                {ECO:0000269|PubMed:11897440}.
FT                                /FTId=VAR_039759.
FT   VARIANT     101    101       R -> P (in CMD1A; dramatically aberrant
FT                                localization with almost no nuclear rim
FT                                staining and formation of intranuclear
FT                                foci; dbSNP:rs267607568).
FT                                {ECO:0000269|PubMed:20160190}.
FT                                /FTId=VAR_070174.
FT   VARIANT     112    112       Missing (in EDMD2).
FT                                {ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:14684700}.
FT                                /FTId=VAR_009976.
FT   VARIANT     125    125       G -> S (polymorphism; found in patients
FT                                with atrial fibrillation;
FT                                dbSNP:rs267607605).
FT                                {ECO:0000269|PubMed:19427440}.
FT                                /FTId=VAR_072817.
FT   VARIANT     133    133       R -> L (in FPLD2; dbSNP:rs60864230).
FT                                {ECO:0000269|PubMed:12629077}.
FT                                /FTId=VAR_016913.
FT   VARIANT     133    133       R -> P (in EDMD2; dbSNP:rs60864230).
FT                                {ECO:0000269|PubMed:11503164}.
FT                                /FTId=VAR_017657.
FT   VARIANT     138    138       E -> K (in HGPS; might be associated with
FT                                early and severe strokes;
FT                                dbSNP:rs267607649).
FT                                {ECO:0000269|PubMed:21791255}.
FT                                /FTId=VAR_070175.
FT   VARIANT     140    140       L -> P (in EDMD2; dbSNP:rs60652225).
FT                                {ECO:0000269|PubMed:12649505,
FT                                ECO:0000269|PubMed:15744034}.
FT                                /FTId=VAR_039760.
FT   VARIANT     140    140       L -> R (in HGPS; phenotype originally
FT                                designated as atypical Werner syndrome;
FT                                dbSNP:rs60652225).
FT                                {ECO:0000269|PubMed:12927431}.
FT                                /FTId=VAR_017658.
FT   VARIANT     143    143       S -> F (in HGPS; dbSNP:rs58912633).
FT                                {ECO:0000269|PubMed:15622532}.
FT                                /FTId=VAR_034707.
FT   VARIANT     143    143       S -> P (in CMD1A; dbSNP:rs61661343).
FT                                {ECO:0000269|PubMed:15140538}.
FT                                /FTId=VAR_039761.
FT   VARIANT     145    145       E -> K (in HGPS; atypical;
FT                                dbSNP:rs60310264).
FT                                {ECO:0000269|PubMed:12714972}.
FT                                /FTId=VAR_017659.
FT   VARIANT     150    150       T -> P (in EDMD2; dbSNP:rs58917027).
FT                                {ECO:0000269|PubMed:10908904,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_039762.
FT   VARIANT     161    161       E -> K (in CMD1A; dbSNP:rs28933093).
FT                                {ECO:0000269|PubMed:12920062,
FT                                ECO:0000269|PubMed:21846512}.
FT                                /FTId=VAR_017660.
FT   VARIANT     166    166       R -> P (in CMD1A; dramatically aberrant
FT                                localization with almost no nuclear rim
FT                                staining and formation of intranuclear
FT                                foci; dbSNP:rs267607570).
FT                                {ECO:0000269|PubMed:20160190}.
FT                                /FTId=VAR_070176.
FT   VARIANT     189    189       R -> P (in EDMD2; found also in a patient
FT                                with limb-girdle muscular dystrophy;
FT                                sporadic; dbSNP:rs267607643).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064962.
FT   VARIANT     190    190       R -> Q (in EDMD2 and CMD1A; aberrant
FT                                localization with decreased nuclear rim
FT                                staining and increased formation of
FT                                intranuclear foci; dbSNP:rs267607571).
FT                                {ECO:0000269|PubMed:15744034,
FT                                ECO:0000269|PubMed:20160190}.
FT                                /FTId=VAR_039763.
FT   VARIANT     190    190       R -> RR (in EDMD2).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064963.
FT   VARIANT     190    190       R -> W (in CMD1A; dbSNP:rs59026483).
FT                                {ECO:0000269|PubMed:11897440,
FT                                ECO:0000269|PubMed:15219508,
FT                                ECO:0000269|PubMed:16061563}.
FT                                /FTId=VAR_039764.
FT   VARIANT     192    192       D -> G (in CMD1A; dramatically increases
FT                                the size of intranuclear speckles and
FT                                reduces their number; this phenotype is
FT                                only partially reversed by coexpression
FT                                of the G-192 mutation and wild-type
FT                                lamin-C; precludes insertion of lamin-C
FT                                into the nuclear envelope when co-
FT                                transfected with the G-192 LMNA; G-192
FT                                lamin-C expression totally disrupts the
FT                                SUMO1 pattern; dbSNP:rs57045855).
FT                                {ECO:0000269|PubMed:16061563}.
FT                                /FTId=VAR_039765.
FT   VARIANT     195    195       N -> K (in CMD1A; dramatically aberrant
FT                                localization with decreased nuclear rim
FT                                staining and formation of intranuclear
FT                                foci; distribution of endogenous LMNA,
FT                                LMNB1 and LMNB2 are altered in cells
FT                                expressing this mutant; causes an
FT                                increased loss of endogenous EMD from the
FT                                nuclear envelope; interacts with itself
FT                                and with wild-type LMNA and LMNB1; no
FT                                decrease in the stability compared with
FT                                wild-type; dbSNP:rs28933091).
FT                                {ECO:0000269|PubMed:10580070,
FT                                ECO:0000269|PubMed:11792809}.
FT                                /FTId=VAR_009977.
FT   VARIANT     196    199       RLQT -> S (in EDMD2).
FT                                {ECO:0000269|PubMed:11503164}.
FT                                /FTId=VAR_039766.
FT   VARIANT     203    203       E -> G (in CMD1A; interacts with itself
FT                                and with wild-type LMNA and LMNB1; no
FT                                decrease in the stability compared with
FT                                wild-type; decreased sumoylation;
FT                                aberrant localization with decreased
FT                                nuclear rim staining and formation of
FT                                intranuclear foci; associated with
FT                                increased cell death; dbSNP:rs28933092).
FT                                {ECO:0000269|PubMed:10580070,
FT                                ECO:0000269|PubMed:11792809,
FT                                ECO:0000269|PubMed:18606848}.
FT                                /FTId=VAR_009978.
FT   VARIANT     203    203       E -> K (in CMD1A; decreased sumoylation;
FT                                aberrant localization with decreased
FT                                nuclear rim staining and formation of
FT                                intranuclear foci; associated with
FT                                increased cell death; dbSNP:rs61195471).
FT                                {ECO:0000269|PubMed:11561226,
FT                                ECO:0000269|PubMed:18606848,
FT                                ECO:0000269|PubMed:20160190}.
FT                                /FTId=VAR_039767.
FT   VARIANT     206    206       F -> L (in EDMD2; dbSNP:rs267607629).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064964.
FT   VARIANT     208    208       Missing (in LGMD1B).
FT                                {ECO:0000269|PubMed:10814726}.
FT                                /FTId=VAR_034708.
FT   VARIANT     210    210       I -> S (in CMD1A; dramatically aberrant
FT                                localization with almost no nuclear rim
FT                                staining and increased formation of
FT                                intranuclear foci; dbSNP:rs267607572).
FT                                {ECO:0000269|PubMed:20160190}.
FT                                /FTId=VAR_070177.
FT   VARIANT     215    215       L -> P (in CMD1A; aberrant localization
FT                                with decreased nuclear rim staining and
FT                                formation of intranuclear foci;
FT                                dbSNP:rs61295588).
FT                                {ECO:0000269|PubMed:12486434,
FT                                ECO:0000269|PubMed:20160190}.
FT                                /FTId=VAR_039768.
FT   VARIANT     222    222       H -> P (in EDMD2; dbSNP:rs58034145).
FT                                {ECO:0000269|PubMed:10939567}.
FT                                /FTId=VAR_039769.
FT   VARIANT     222    222       H -> Y (in EDMD2; dbSNP:rs28928901).
FT                                {ECO:0000269|PubMed:10739764}.
FT                                /FTId=VAR_009979.
FT   VARIANT     225    225       R -> Q (in EDMD3; dbSNP:rs199474724).
FT                                {ECO:0000269|PubMed:22431096}.
FT                                /FTId=VAR_067697.
FT   VARIANT     230    230       D -> N (in FPLD2; dbSNP:rs61214927).
FT                                {ECO:0000269|PubMed:17250669}.
FT                                /FTId=VAR_039770.
FT   VARIANT     232    232       G -> E (in EDMD2; dbSNP:rs57207746).
FT                                {ECO:0000269|PubMed:10939567}.
FT                                /FTId=VAR_039771.
FT   VARIANT     248    248       L -> P (in EDMD2; dbSNP:rs58850446).
FT                                {ECO:0000269|PubMed:14684700}.
FT                                /FTId=VAR_039772.
FT   VARIANT     249    249       R -> Q (in EDMD2; dbSNP:rs59332535).
FT                                {ECO:0000269|PubMed:10739764,
FT                                ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:11503164,
FT                                ECO:0000269|PubMed:12032588,
FT                                ECO:0000269|PubMed:12649505,
FT                                ECO:0000269|PubMed:14684700,
FT                                ECO:0000269|PubMed:15744034,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_009980.
FT   VARIANT     249    249       R -> W (in MDCL and EDMD2; mislocalized
FT                                in the nucleus; causes nuclear
FT                                deformations and LMNB1 redistribution;
FT                                dbSNP:rs121912496).
FT                                {ECO:0000269|PubMed:18551513,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_063589.
FT   VARIANT     259    259       Y -> C (in LGMD1B).
FT                                {ECO:0000269|PubMed:27234031}.
FT                                /FTId=VAR_076563.
FT   VARIANT     260    260       K -> N (in CMDA1).
FT                                {ECO:0000269|PubMed:16156025}.
FT                                /FTId=VAR_039773.
FT   VARIANT     261    261       Missing (in EDMD2).
FT                                {ECO:0000269|PubMed:10908904,
FT                                ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:11503164}.
FT                                /FTId=VAR_009981.
FT   VARIANT     267    267       Y -> C (in EDMD2; dbSNP:rs57048196).
FT                                {ECO:0000269|PubMed:14684700}.
FT                                /FTId=VAR_039774.
FT   VARIANT     268    268       S -> P (in EDMD2; dbSNP:rs267607630).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064965.
FT   VARIANT     271    271       L -> P (in EDMD2; dbSNP:rs267607641).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064966.
FT   VARIANT     294    294       Q -> P (in EDMD2; dbSNP:rs61616775).
FT                                {ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_009982.
FT   VARIANT     295    295       S -> P (in EDMD2; dbSNP:rs267607633).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064967.
FT   VARIANT     298    298       R -> C (in CMT2B1; dbSNP:rs59885338).
FT                                {ECO:0000269|PubMed:11799477}.
FT                                /FTId=VAR_017661.
FT   VARIANT     300    300       D -> G (in HGPS; atypical form with late
FT                                onset; abnormal nuclear morphology with
FT                                single or multple blebs, lobulation and
FT                                occasional ringed or donut shaped nuclei;
FT                                dbSNP:rs79907212).
FT                                {ECO:0000269|PubMed:23666920}.
FT                                /FTId=VAR_070178.
FT   VARIANT     302    302       L -> P (in MDCL; dbSNP:rs267607596).
FT                                {ECO:0000269|PubMed:18551513}.
FT                                /FTId=VAR_063590.
FT   VARIANT     303    303       S -> P (in EDMD2; dbSNP:rs61527854).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064968.
FT   VARIANT     317    317       E -> K (in CMD1A; dbSNP:rs56816490).
FT                                {ECO:0000269|PubMed:11897440,
FT                                ECO:0000269|PubMed:21846512}.
FT                                /FTId=VAR_039775.
FT   VARIANT     318    318       A -> T (in CMD1A; no effect on nuclear
FT                                morphology and lamin A localization;
FT                                dbSNP:rs267607574).
FT                                {ECO:0000269|PubMed:20160190}.
FT                                /FTId=VAR_070179.
FT   VARIANT     336    336       R -> Q (in EDMD2; dbSNP:rs58105277).
FT                                {ECO:0000269|PubMed:10739764,
FT                                ECO:0000269|PubMed:12467752}.
FT                                /FTId=VAR_009983.
FT   VARIANT     343    343       R -> Q (in EDMD2; dbSNP:rs61177390).
FT                                {ECO:0000269|PubMed:12467752}.
FT                                /FTId=VAR_009984.
FT   VARIANT     349    349       R -> L (in CMD1A; dbSNP:rs58789393).
FT                                {ECO:0000269|PubMed:15219508}.
FT                                /FTId=VAR_039776.
FT   VARIANT     355    355       Missing (in EDMD2).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064969.
FT   VARIANT     358    358       E -> K (in EDMD2 and MDCL; aberrant
FT                                localization with decreased nuclear rim
FT                                staining and formation of intranuclear
FT                                foci; distribution of endogenous LMNA,
FT                                LMNB1 and LMNB2 are altered in cells
FT                                expressing this mutant; interacts with
FT                                itself and with wild-type LMNA and LMNB1;
FT                                no decrease in the stability compared
FT                                with wild-type; dbSNP:rs60458016).
FT                                {ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:11503164,
FT                                ECO:0000269|PubMed:11792809,
FT                                ECO:0000269|PubMed:18551513,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_009985.
FT   VARIANT     361    361       E -> K (in EDMD2; dbSNP:rs267607634).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064970.
FT   VARIANT     371    371       M -> K (in EDMD2; dramatically aberrant
FT                                localization with decreased nuclear rim
FT                                staining and formation of intranuclear
FT                                foci; distribution of endogenous LMNA,
FT                                LMNB1 and LMNB2 are altered in cells
FT                                expressing this mutant; causes an
FT                                increased loss of endogenous EMD from the
FT                                nuclear envelope; interacts with itself
FT                                and with wild-type LMNA and LMNB1; no
FT                                decrease in the stability compared with
FT                                wild-type; dbSNP:rs59653062).
FT                                {ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:11792809}.
FT                                /FTId=VAR_009986.
FT   VARIANT     377    377       R -> H (in LGMD1B; dbSNP:rs61672878).
FT                                {ECO:0000269|PubMed:10814726,
FT                                ECO:0000269|PubMed:12628721,
FT                                ECO:0000269|PubMed:12673789,
FT                                ECO:0000269|PubMed:15744034,
FT                                ECO:0000269|PubMed:17136397}.
FT                                /FTId=VAR_016205.
FT   VARIANT     377    377       R -> L (in EDMD2 and LGMD1B;
FT                                dbSNP:rs61672878).
FT                                {ECO:0000269|PubMed:12032588,
FT                                ECO:0000269|PubMed:12649505}.
FT                                /FTId=VAR_039777.
FT   VARIANT     380    380       L -> S (in MDCL; dbSNP:rs121912495).
FT                                {ECO:0000269|PubMed:18551513}.
FT                                /FTId=VAR_063591.
FT   VARIANT     386    386       R -> K (in EDMD2; dramatically aberrant
FT                                localization with decreased nuclear rim
FT                                staining and formation of intranuclear
FT                                foci; distribution of endogenous LMNA,
FT                                LMNB1 and LMNB2 are altered in cells
FT                                expressing this mutant; causes an
FT                                increased loss of endogenous EMD from the
FT                                nuclear envelope; interacts with itself
FT                                and with wild-type LMNA and LMNB1; no
FT                                decrease in the stability compared with
FT                                wild-type; dbSNP:rs267607545).
FT                                {ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:11792809,
FT                                ECO:0000269|PubMed:12649505,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_009987.
FT   VARIANT     388    388       R -> H (in CMD1A; no effect on nuclear
FT                                morphology but restricts lamin A to the
FT                                cytoplasm; dbSNP:rs267607576).
FT                                {ECO:0000269|PubMed:20160190}.
FT                                /FTId=VAR_070180.
FT   VARIANT     399    399       R -> C (in FPLD2 and CMD1A; no effect on
FT                                nuclear morphology and lamin A
FT                                localization; dbSNP:rs58672172).
FT                                {ECO:0000269|PubMed:17250669,
FT                                ECO:0000269|PubMed:20160190}.
FT                                /FTId=VAR_039778.
FT   VARIANT     401    401       R -> C (in EDMD2; no effect on nuclear
FT                                lamin A localization; enhances the
FT                                interaction with SYNE2;
FT                                dbSNP:rs61094188).
FT                                {ECO:0000269|PubMed:12467752,
FT                                ECO:0000269|PubMed:23977161}.
FT                                /FTId=VAR_072818.
FT   VARIANT     411    411       G -> D (probable disease-associated
FT                                mutation found in patients with metabolic
FT                                syndromes; probable lipodystrophy causing
FT                                mutation; no effect on nuclear lamin A
FT                                localization; no effect on the
FT                                interaction with SYNE2;
FT                                dbSNP:rs267607647).
FT                                {ECO:0000269|PubMed:21724554,
FT                                ECO:0000269|PubMed:23977161}.
FT                                /FTId=VAR_072819.
FT   VARIANT     413    413       G -> C (polymorphism; found in patients
FT                                with skeletal and cardiac muscular
FT                                dystrophies; no effect on nuclear lamin A
FT                                localization; no effect on the
FT                                interaction with SYNE2;
FT                                dbSNP:rs766811975).
FT                                {ECO:0000269|PubMed:23977161}.
FT                                /FTId=VAR_072820.
FT   VARIANT     415    415       V -> I (rare variant; found in patients
FT                                with atrial fibrillation; unknown
FT                                pathological significance; no effect on
FT                                nuclear lamin A localization; enhances
FT                                the interaction with SYNE2; causes
FT                                nuclear deformations in heat shock
FT                                experiments; dbSNP:rs267607606).
FT                                {ECO:0000269|PubMed:19427440,
FT                                ECO:0000269|PubMed:23977161}.
FT                                /FTId=VAR_072821.
FT   VARIANT     419    419       R -> C (polymorphism; found in patients
FT                                with lipodystrophy; no effect on nuclear
FT                                lamin A localization; no effect on the
FT                                interaction with SYNE2;
FT                                dbSNP:rs755686359).
FT                                {ECO:0000269|PubMed:23977161}.
FT                                /FTId=VAR_072822.
FT   VARIANT     421    421       L -> P (disease-associated mutation found
FT                                in patient with severe metabolic
FT                                syndrome; probable lipodystrophy causing
FT                                mutation; no effect on nuclear lamin A
FT                                localization; no effect on the
FT                                interaction with SYNE2;
FT                                dbSNP:rs267607564).
FT                                {ECO:0000269|PubMed:17711925,
FT                                ECO:0000269|PubMed:23977161}.
FT                                /FTId=VAR_072823.
FT   VARIANT     427    427       R -> G (polymorphism; found in patients
FT                                with skeletal and cardiac muscular
FT                                dystrophies; no effect on nuclear lamin A
FT                                localization; no effect on the
FT                                interaction with SYNE2).
FT                                {ECO:0000269|PubMed:23977161}.
FT                                /FTId=VAR_072824.
FT   VARIANT     435    435       R -> C (in CMD1A; dbSNP:rs150840924).
FT                                {ECO:0000269|PubMed:14684700}.
FT                                /FTId=VAR_039779.
FT   VARIANT     439    439       R -> C (in FPLD2; increase in nuclear
FT                                blebbing and formation of honeycomb-like
FT                                structures in the nuclei with no
FT                                accumulation of prelamin A in skin
FT                                fibroblasts; causes oligomerization of
FT                                the C-terminal globular domain of lamins
FT                                A and C under no-reducing conditions and
FT                                increases binding affinity for DNA;
FT                                increases sensitivity to oxidative
FT                                stress; no significant differences in
FT                                stability and structure compared with the
FT                                wild-type; dbSNP:rs62636506).
FT                                {ECO:0000269|PubMed:19220582}.
FT                                /FTId=VAR_070181.
FT   VARIANT     446    446       D -> V (in EDMD2; dbSNP:rs58541611).
FT                                {ECO:0000269|PubMed:14684700}.
FT                                /FTId=VAR_039780.
FT   VARIANT     449    449       G -> D (in EDMD2; dbSNP:rs267607637).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064971.
FT   VARIANT     453    453       R -> P (in MDCL; dbSNP:rs267607598).
FT                                {ECO:0000269|PubMed:18551513}.
FT                                /FTId=VAR_063592.
FT   VARIANT     453    453       R -> W (in EDMD2; interacts with itself
FT                                and with wild-type LMNA and LMNB1; no
FT                                decrease in the stability compared with
FT                                wild-type; dbSNP:rs58932704).
FT                                {ECO:0000269|PubMed:10080180,
FT                                ECO:0000269|PubMed:10739764,
FT                                ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:11503164,
FT                                ECO:0000269|PubMed:11792809,
FT                                ECO:0000269|PubMed:14684700,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_009988.
FT   VARIANT     454    454       L -> P (in EDMD2; dbSNP:rs267607638).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064972.
FT   VARIANT     455    455       R -> P (in MDCL; dbSNP:rs267607597).
FT                                {ECO:0000269|PubMed:18551513}.
FT                                /FTId=VAR_063593.
FT   VARIANT     456    456       N -> D (in MDCL; dbSNP:rs267607599).
FT                                {ECO:0000269|PubMed:18551513}.
FT                                /FTId=VAR_063594.
FT   VARIANT     456    456       N -> I (in EDMD2; mislocalized in the
FT                                nucleus; does not alter nuclear size or
FT                                shape; dbSNP:rs60992550).
FT                                {ECO:0000269|PubMed:11503164,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_039781.
FT   VARIANT     456    456       N -> K (in EDMD2; dbSNP:rs61235244).
FT                                {ECO:0000269|PubMed:10939567}.
FT                                /FTId=VAR_039782.
FT   VARIANT     461    461       D -> Y (in EDMD2; dbSNP:rs267607642).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064973.
FT   VARIANT     465    465       G -> D (in FPLD2; dbSNP:rs61282106).
FT                                {ECO:0000269|PubMed:10739751}.
FT                                /FTId=VAR_009989.
FT   VARIANT     467    467       W -> R (in EDMD2; dbSNP:rs267607639).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064974.
FT   VARIANT     469    469       I -> T (in EDMD2; dbSNP:rs57394692).
FT                                {ECO:0000269|PubMed:10739764}.
FT                                /FTId=VAR_009990.
FT   VARIANT     471    471       R -> C (in HGPS; dbSNP:rs28928902).
FT                                {ECO:0000269|PubMed:12768443}.
FT                                /FTId=VAR_017662.
FT   VARIANT     471    471       R -> H (in CMD1A; no effect on nuclear
FT                                morphology and lamin A localization;
FT                                dbSNP:rs267607578).
FT                                {ECO:0000269|PubMed:20160190}.
FT                                /FTId=VAR_070182.
FT   VARIANT     481    481       Y -> H (in LGMD1B; dbSNP:rs57747780).
FT                                {ECO:0000269|PubMed:11525883}.
FT                                /FTId=VAR_039783.
FT   VARIANT     482    482       R -> L (in FPLD2; dbSNP:rs11575937).
FT                                {ECO:0000269|PubMed:10655060}.
FT                                /FTId=VAR_009991.
FT   VARIANT     482    482       R -> Q (in FPLD2; interacts with itself
FT                                and with wild-type LMNA and LMNB1; no
FT                                decrease in the stability compared with
FT                                wild-type; dbSNP:rs11575937).
FT                                {ECO:0000269|PubMed:10587585,
FT                                ECO:0000269|PubMed:10739751,
FT                                ECO:0000269|PubMed:11792809}.
FT                                /FTId=VAR_009992.
FT   VARIANT     482    482       R -> W (in FPLD2; interacts with itself
FT                                and with wild-type LMNA and LMNB1; no
FT                                decrease in the stability compared with
FT                                wild-type; decreases binding affinity for
FT                                DNA; increases sensitivity to oxidative
FT                                stress; dbSNP:rs57920071).
FT                                {ECO:0000269|PubMed:10655060,
FT                                ECO:0000269|PubMed:10739751,
FT                                ECO:0000269|PubMed:11792809,
FT                                ECO:0000269|PubMed:19220582}.
FT                                /FTId=VAR_009993.
FT   VARIANT     486    486       K -> N (in FPLD2; interacts with itself
FT                                and with wild-type LMNA and LMNB1; no
FT                                decrease in the stability compared with
FT                                wild-type; dbSNP:rs59981161).
FT                                {ECO:0000269|PubMed:11792809}.
FT                                /FTId=VAR_009994.
FT   VARIANT     488    488       T -> P (polymorphism; found in patient
FT                                with atrial fibrillation;
FT                                dbSNP:rs267607607).
FT                                {ECO:0000269|PubMed:19427440}.
FT                                /FTId=VAR_072825.
FT   VARIANT     515    515       K -> E (in FPLD2).
FT                                {ECO:0000269|PubMed:24485160}.
FT                                /FTId=VAR_071968.
FT   VARIANT     520    520       W -> S (in EDMD2; interacts with itself
FT                                and with wild-type LMNA and LMNB1; no
FT                                decrease in the stability compared with
FT                                wild-type; dbSNP:rs58362413).
FT                                {ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:11792809}.
FT                                /FTId=VAR_039784.
FT   VARIANT     523    523       G -> R (in CMD1A; dbSNP:rs201583907).
FT                                {ECO:0000269|PubMed:21846512}.
FT                                /FTId=VAR_067258.
FT   VARIANT     527    527       R -> C (in HGPS; dbSNP:rs57318642).
FT                                {ECO:0000269|PubMed:12768443}.
FT                                /FTId=VAR_017663.
FT   VARIANT     527    527       R -> H (in MADA; dbSNP:rs57520892).
FT                                {ECO:0000269|PubMed:12075506}.
FT                                /FTId=VAR_018727.
FT   VARIANT     527    527       R -> P (in EDMD2 and FPLD2; interacts
FT                                with itself and with wild-type LMNA and
FT                                LMNB1; reduced binding to SUN1; no
FT                                decrease in the stability compared with
FT                                wild-type; dbSNP:rs57520892).
FT                                {ECO:0000269|PubMed:10080180,
FT                                ECO:0000269|PubMed:10739764,
FT                                ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:11503164,
FT                                ECO:0000269|PubMed:11792809,
FT                                ECO:0000269|PubMed:12196663,
FT                                ECO:0000269|PubMed:12649505,
FT                                ECO:0000269|PubMed:15744034,
FT                                ECO:0000269|PubMed:19933576,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_009995.
FT   VARIANT     528    528       T -> K (in EDMD2; interacts with itself
FT                                and with wild-type LMNA and LMNB1; no
FT                                decrease in the stability compared with
FT                                wild-type; dbSNP:rs57629361).
FT                                {ECO:0000269|PubMed:10739764,
FT                                ECO:0000269|PubMed:10939567,
FT                                ECO:0000269|PubMed:11792809,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_009996.
FT   VARIANT     528    528       T -> R (in EDMD2; dbSNP:rs57629361).
FT                                {ECO:0000269|PubMed:14684700,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_039785.
FT   VARIANT     529    529       A -> V (in MADA; dbSNP:rs60580541).
FT                                {ECO:0000269|PubMed:15998779}.
FT                                /FTId=VAR_034709.
FT   VARIANT     530    530       L -> P (in EDMD2; interacts with itself
FT                                and with wild-type LMNA and LMNB1;
FT                                reduced binding to SUN1; no decrease in
FT                                the stability compared with wild-type;
FT                                dbSNP:rs60934003).
FT                                {ECO:0000269|PubMed:10080180,
FT                                ECO:0000269|PubMed:11792809,
FT                                ECO:0000269|PubMed:19933576}.
FT                                /FTId=VAR_009997.
FT   VARIANT     541    541       R -> C (in apical left ventricular
FT                                aneurysm; dbSNP:rs56984562).
FT                                {ECO:0000269|PubMed:14675861}.
FT                                /FTId=VAR_039786.
FT   VARIANT     541    541       R -> H (in EDMD2; dbSNP:rs61444459).
FT                                {ECO:0000269|PubMed:14684700}.
FT                                /FTId=VAR_039787.
FT   VARIANT     541    541       R -> P (in EDMD2; mis-localized in the
FT                                nucleus; does not alter nuclear size or
FT                                shape; dbSNP:rs61444459).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064975.
FT   VARIANT     541    541       R -> S (in EDMD2 and CMD1A; modest and
FT                                non-specific nuclear membrane
FT                                alterations; the phenotype is entirely
FT                                reversed by coexpression of the S-541
FT                                mutation and wild-type lamin-C;
FT                                dbSNP:rs56984562).
FT                                {ECO:0000269|PubMed:16061563,
FT                                ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_039788.
FT   VARIANT     542    542       K -> N (in HGPS; dbSNP:rs56673169).
FT                                {ECO:0000269|PubMed:15286156}.
FT                                /FTId=VAR_034710.
FT   VARIANT     573    573       S -> L (in CMD1A, FPLD2 and MADA;
FT                                dbSNP:rs60890628).
FT                                {ECO:0000269|PubMed:12628721,
FT                                ECO:0000269|PubMed:16278265,
FT                                ECO:0000269|PubMed:17250669}.
FT                                /FTId=VAR_039789.
FT   VARIANT     578    578       E -> V (in an atypical progeroid patient;
FT                                diagnosed as Werner syndrome;
FT                                dbSNP:rs61224243).
FT                                {ECO:0000269|PubMed:15060110}.
FT                                /FTId=VAR_039790.
FT   VARIANT     582    582       R -> H (in FPLD2; dbSNP:rs57830985).
FT                                {ECO:0000269|PubMed:10739751}.
FT                                /FTId=VAR_009998.
FT   VARIANT     602    602       G -> S (in EDMD2; dbSNP:rs60662302).
FT                                {ECO:0000269|PubMed:20848652}.
FT                                /FTId=VAR_064976.
FT   VARIANT     608    608       G -> S (in HGPS; reduced binding to SUN1;
FT                                may affect splicing by activating a
FT                                cryptic splice donor site;
FT                                dbSNP:rs61064130).
FT                                {ECO:0000269|PubMed:12714972,
FT                                ECO:0000269|PubMed:12768443,
FT                                ECO:0000269|PubMed:19933576}.
FT                                /FTId=VAR_017664.
FT   VARIANT     624    624       R -> H (in EDMD2; dbSNP:rs13768).
FT                                {ECO:0000269|PubMed:11503164}.
FT                                /FTId=VAR_039791.
FT   VARIANT     631    631       G -> D (probable disease-associated
FT                                mutation found in a patient with
FT                                metabolic syndrome; dbSNP:rs267607648).
FT                                {ECO:0000269|PubMed:21724554}.
FT                                /FTId=VAR_072826.
FT   VARIANT     644    644       R -> C (in HGPS and EDMD2; partially
FT                                inhibits tail cleavage;
FT                                dbSNP:rs142000963).
FT                                {ECO:0000269|PubMed:15060110,
FT                                ECO:0000269|PubMed:20848652,
FT                                ECO:0000269|PubMed:22355414}.
FT                                /FTId=VAR_039792.
FT   MUTAGEN     201    201       K->L: Decreased sumoylation; aberrant
FT                                localization with decreased nuclear rim
FT                                staining and formation of intranuclear
FT                                foci; associated with increased cell
FT                                death. {ECO:0000269|PubMed:18606848}.
FT   MUTAGEN     644    644       R->A: Does not affect tail cleavage.
FT                                {ECO:0000269|PubMed:22355414}.
FT   MUTAGEN     647    647       L->R: Completely inhibits tail cleavage.
FT                                {ECO:0000269|PubMed:22355414}.
FT   MUTAGEN     648    648       L->A: Completely inhibits tail cleavage.
FT                                {ECO:0000269|PubMed:22355414}.
FT   MUTAGEN     650    650       N->A: Partially inhibits tail cleavage.
FT                                {ECO:0000269|PubMed:22355414}.
FT   MUTAGEN     661    661       C->S: Loss of interaction with NARF.
FT                                Abolishes farnesylation.
FT                                {ECO:0000269|PubMed:10514485,
FT                                ECO:0000269|PubMed:22355414}.
FT   CONFLICT    340    340       E -> K (in Ref. 5; BAG58344).
FT                                {ECO:0000305}.
FT   HELIX       316    384       {ECO:0000244|PDB:1X8Y}.
FT   STRAND      430    436       {ECO:0000244|PDB:1IVT}.
FT   STRAND      438    445       {ECO:0000244|PDB:1IFR}.
FT   STRAND      449    456       {ECO:0000244|PDB:1IFR}.
FT   STRAND      458    460       {ECO:0000244|PDB:1IFR}.
FT   HELIX       464    466       {ECO:0000244|PDB:1IVT}.
FT   STRAND      468    473       {ECO:0000244|PDB:1IFR}.
FT   STRAND      479    482       {ECO:0000244|PDB:1IFR}.
FT   STRAND      494    499       {ECO:0000244|PDB:1IFR}.
FT   HELIX       500    502       {ECO:0000244|PDB:3GEF}.
FT   TURN        508    510       {ECO:0000244|PDB:1IFR}.
FT   STRAND      511    514       {ECO:0000244|PDB:1IFR}.
FT   STRAND      526    531       {ECO:0000244|PDB:1IFR}.
FT   STRAND      537    543       {ECO:0000244|PDB:1IFR}.
SQ   SEQUENCE   664 AA;  74139 MW;  E0855F7699F0318B CRC64;
     METPSQRRAT RSGAQASSTP LSPTRITRLQ EKEDLQELND RLAVYIDRVR SLETENAGLR
     LRITESEEVV SREVSGIKAA YEAELGDARK TLDSVAKERA RLQLELSKVR EEFKELKARN
     TKKEGDLIAA QARLKDLEAL LNSKEAALST ALSEKRTLEG ELHDLRGQVA KLEAALGEAK
     KQLQDEMLRR VDAENRLQTM KEELDFQKNI YSEELRETKR RHETRLVEID NGKQREFESR
     LADALQELRA QHEDQVEQYK KELEKTYSAK LDNARQSAER NSNLVGAAHE ELQQSRIRID
     SLSAQLSQLQ KQLAAKEAKL RDLEDSLARE RDTSRRLLAE KEREMAEMRA RMQQQLDEYQ
     ELLDIKLALD MEIHAYRKLL EGEEERLRLS PSPTSQRSRG RASSHSSQTQ GGGSVTKKRK
     LESTESRSSF SQHARTSGRV AVEEVDEEGK FVRLRNKSNE DQSMGNWQIK RQNGDDPLLT
     YRFPPKFTLK AGQVVTIWAA GAGATHSPPT DLVWKAQNTW GCGNSLRTAL INSTGEEVAM
     RKLVRSVTVV EDDEDEDGDD LLHHHHGSHC SSSGDPAEYN LRSRTVLCGT CGQPADKASA
     SGSGAQVGGP ISSGSSASSV TVTRSYRSVG GSGGGSFGDN LVTRSYLLGN SSPRTQSPQN
     CSIM
//
ID   Q5TCI8_HUMAN            Unreviewed;       491 AA.
AC   Q5TCI8;
DT   21-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   21-DEC-2004, sequence version 1.
DT   28-FEB-2018, entry version 108.
DE   SubName: Full=Prelamin-A/C {ECO:0000313|Ensembl:ENSP00000357280};
GN   Name=LMNA {ECO:0000313|Ensembl:ENSP00000357280};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000357280, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000357280}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [3] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [4] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5] {ECO:0000213|PubMed:17924679}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [6] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [10] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [12] {ECO:0000313|Ensembl:ENSP00000357280}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [13] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15] {ECO:0000213|PubMed:25218447}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [16] {ECO:0000213|PubMed:25114211}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [17] {ECO:0000213|PubMed:25772364}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [18] {ECO:0000213|PubMed:25755297}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurethsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide Analysis of SUMOylation Dynamics in Response to
RT   Replication Stress Reveals Novel Small Ubiquitin-like Modified Target
RT   Proteins and Acceptor Lysines Relevant for Genome Stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [19] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000256|RuleBase:RU000685, ECO:0000256|SAAS:SAAS00953091}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000357280}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL135927; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355388; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356734; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001269553.1; NM_001282624.1.
DR   UniGene; Hs.594444; -.
DR   UniGene; Hs.706897; -.
DR   UniGene; Hs.733671; -.
DR   ProteinModelPortal; Q5TCI8; -.
DR   MaxQB; Q5TCI8; -.
DR   PeptideAtlas; Q5TCI8; -.
DR   PRIDE; Q5TCI8; -.
DR   Ensembl; ENST00000368297; ENSP00000357280; ENSG00000160789.
DR   GeneID; 4000; -.
DR   UCSC; uc001fnj.5; human.
DR   CTD; 4000; -.
DR   EuPathDB; HostDB:ENSG00000160789.19; -.
DR   HGNC; HGNC:6636; LMNA.
DR   OpenTargets; ENSG00000160789; -.
DR   eggNOG; KOG0977; Eukaryota.
DR   eggNOG; ENOG410Y2H6; LUCA.
DR   GeneTree; ENSGT00910000143989; -.
DR   HOGENOM; HOG000007711; -.
DR   HOVERGEN; HBG013015; -.
DR   ChiTaRS; LMNA; human.
DR   GenomeRNAi; 4000; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000160789; -.
DR   ExpressionAtlas; Q5TCI8; baseline and differential.
DR   GO; GO:0005882; C:intermediate filament; IEA:UniProtKB-KW.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   Gene3D; 2.60.40.1260; -; 1.
DR   InterPro; IPR001664; IF.
DR   InterPro; IPR018039; Intermediate_filament_CS.
DR   InterPro; IPR001322; Lamin_tail_dom.
DR   InterPro; IPR036415; Lamin_tail_dom_sf.
DR   PANTHER; PTHR23239; PTHR23239; 1.
DR   Pfam; PF00038; Filament; 1.
DR   Pfam; PF00932; LTD; 1.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF74853; SSF74853; 1.
DR   PROSITE; PS00226; IF; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00031873, ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Intermediate filament {ECO:0000256|RuleBase:RU000685,
KW   ECO:0000256|SAAS:SAAS00953085};
KW   Proteomics identification {ECO:0000213|EPD:Q5TCI8,
KW   ECO:0000213|MaxQB:Q5TCI8, ECO:0000213|PeptideAtlas:Q5TCI8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      354    459       LTD. {ECO:0000259|Pfam:PF00932}.
FT   COILED       39    140       {ECO:0000256|SAM:Coils}.
FT   COILED      161    188       {ECO:0000256|SAM:Coils}.
FT   COILED      211    288       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   491 AA;  55762 MW;  620B6533D9D65D70 CRC64;
     MQPLLCLGNL EDARERTGTL LAQHPAWGRT RAKPGSPLNT KKEGDLIAAQ ARLKDLEALL
     NSKEAALSTA LSEKRTLEGE LHDLRGQVAK LEAALGEAKK QLQDEMLRRV DAENRLQTMK
     EELDFQKNIY SEELRETKRR HETRLVEIDN GKQREFESRL ADALQELRAQ HEDQVEQYKK
     ELEKTYSAKL DNARQSAERN SNLVGAAHEE LQQSRIRIDS LSAQLSQLQK QLAAKEAKLR
     DLEDSLARER DTSRRLLAEK EREMAEMRAR MQQQLDEYQE LLDIKLALDM EIHAYRKLLE
     GEEERLRLSP SPTSQRSRGR ASSHSSQTQG GGSVTKKRKL ESTESRSSFS QHARTSGRVA
     VEEVDEEGKF VRLRNKSNED QSMGNWQIKR QNGDDPLLTY RFPPKFTLKA GQVVTIWAAG
     AGATHSPPTD LVWKAQNTWG CGNSLRTALI NSTGEEVAMR KLVRSVTVVE DDEDEDGDDL
     LHHHHVSGSR R
//
ID   ENL_HUMAN               Reviewed;         559 AA.
AC   Q03111; Q14768;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   22-NOV-2017, entry version 159.
DE   RecName: Full=Protein ENL;
DE   AltName: Full=YEATS domain-containing protein 1;
GN   Name=MLLT1; Synonyms=ENL, LTG19, YEATS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1423624; DOI=10.1016/0092-8674(92)90602-9;
RA   Tkachuk D.C., Kohler S., Cleary M.L.;
RT   "Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal
RT   translocations in acute leukemias.";
RL   Cell 71:691-700(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8378076;
RA   Yamamoto K., Seto M., Komatsu H., Iida S., Akao Y., Kojima S.,
RA   Kodera Y., Nakazawa S., Ariyoshi Y., Takahashi T., Ueda R.;
RT   "Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19)
RT   leukemia.";
RL   Oncogene 8:2617-2625(1993).
RN   [3]
RP   CHARACTERIZATION.
RX   PubMed=8080983;
RA   Rubnitz J.E., Morrissey J., Savage P.A., Cleary M.L.;
RT   "ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear
RT   protein with transcriptional activation potential in lymphoid and
RT   myeloid cells.";
RL   Blood 84:1747-1752(1994).
RN   [4]
RP   IDENTIFICATION IN A SWI/SNF-LIKE EBAFB COMPLEX.
RX   PubMed=12665591; DOI=10.1128/MCB.23.8.2942-2952.2003;
RA   Nie Z., Yan Z., Chen E.H., Sechi S., Ling C., Zhou S., Xue Y.,
RA   Yang D., Murray D., Kanakubo E., Cleary M.L., Wang W.;
RT   "Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage
RT   leukemia chromosomal translocation partner.";
RL   Mol. Cell. Biol. 23:2942-2952(2003).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292 AND SER-296, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-155, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20471948; DOI=10.1016/j.molcel.2010.04.013;
RA   He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J.,
RA   Alber T., Zhou Q.;
RT   "HIV-1 Tat and host AFF4 recruit two transcription elongation factors
RT   into a bifunctional complex for coordinated activation of HIV-1
RT   transcription.";
RL   Mol. Cell 38:428-438(2010).
RN   [11]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20159561; DOI=10.1016/j.molcel.2010.01.026;
RA   Lin C., Smith E.R., Takahashi H., Lai K.C., Martin-Brown S.,
RA   Florens L., Washburn M.P., Conaway J.W., Conaway R.C., Shilatifard A.;
RT   "AFF4, a component of the ELL/P-TEFb elongation complex and a shared
RT   subunit of MLL chimeras, can link transcription elongation to
RT   leukemia.";
RL   Mol. Cell 37:429-437(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292; SER-296; SER-359
RP   AND SER-361, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=22195968; DOI=10.1016/j.molcel.2011.12.008;
RA   Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D.,
RA   Jackson J., Saraf A., Swanson S.K., Seidel C., Florens L.,
RA   Washburn M.P., Eissenberg J.C., Shilatifard A.;
RT   "The little elongation complex regulates small nuclear RNA
RT   transcription.";
RL   Mol. Cell 44:954-965(2011).
RN   [14]
RP   INTERACTION WITH ALKBH4.
RX   PubMed=23145062; DOI=10.1371/journal.pone.0049045;
RA   Bjornstad L.G., Meza T.J., Otterlei M., Olafsrud S.M.,
RA   Meza-Zepeda L.A., Falnes P.O.;
RT   "Human ALKBH4 interacts with proteins associated with transcription.";
RL   PLoS ONE 7:E49045-E49045(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-240; LYS-262 AND LYS-342,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Component of the super elongation complex (SEC), a
CC       complex required to increase the catalytic rate of RNA polymerase
CC       II transcription by suppressing transient pausing by the
CC       polymerase at multiple sites along the DNA.
CC       {ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948}.
CC   -!- SUBUNIT: Component of the super elongation complex (SEC), at least
CC       composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the
CC       P-TEFb complex and ELL (ELL, ELL2 or ELL3). Interacts with ALKBH4.
CC       Component of a SWI/SNF-like EBAFb complex, at least composed of
CC       SMARCA4/BRG1/BAF190A, SMARCB1/BAF47/SNF5, ACTL6A/BAF53A,
CC       SMARCE1/BAF57, SMARCD1/BAF60A, SMARCD2/BAF60B, SMARCC1/BAF155,
CC       SMARCC2/BAF170, ARID1B/BAF250B, MLLT1/ENL and actin
CC       (PubMed:12665591). {ECO:0000269|PubMed:12665591,
CC       ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948,
CC       ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:23145062}.
CC   -!- INTERACTION:
CC       Q9UHB7:AFF4; NbExp=8; IntAct=EBI-1384215, EBI-395282;
CC       Q8TEK3:DOT1L; NbExp=6; IntAct=EBI-1384215, EBI-2619253;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLLT1 is
CC       associated with acute leukemias. Translocation t(11;19)(q23;p13.3)
CC       with KMT2A/MLL1. The result is a rogue activator protein.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ENLID9.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L04285; AAA58457.1; -; mRNA.
DR   EMBL; D14539; BAA03406.1; -; mRNA.
DR   CCDS; CCDS12160.1; -.
DR   PIR; B44265; B44265.
DR   RefSeq; NP_005925.2; NM_005934.3.
DR   UniGene; Hs.10095; -.
DR   PDB; 5J9S; X-ray; 2.70 A; A=1-148.
DR   PDBsum; 5J9S; -.
DR   ProteinModelPortal; Q03111; -.
DR   SMR; Q03111; -.
DR   BioGrid; 110444; 51.
DR   CORUM; Q03111; -.
DR   IntAct; Q03111; 20.
DR   STRING; 9606.ENSP00000252674; -.
DR   iPTMnet; Q03111; -.
DR   PhosphoSitePlus; Q03111; -.
DR   BioMuta; MLLT1; -.
DR   DMDM; 116241350; -.
DR   EPD; Q03111; -.
DR   MaxQB; Q03111; -.
DR   PaxDb; Q03111; -.
DR   PeptideAtlas; Q03111; -.
DR   PRIDE; Q03111; -.
DR   DNASU; 4298; -.
DR   Ensembl; ENST00000252674; ENSP00000252674; ENSG00000130382.
DR   GeneID; 4298; -.
DR   KEGG; hsa:4298; -.
DR   UCSC; uc002mek.4; human.
DR   CTD; 4298; -.
DR   DisGeNET; 4298; -.
DR   EuPathDB; HostDB:ENSG00000130382.8; -.
DR   GeneCards; MLLT1; -.
DR   HGNC; HGNC:7134; MLLT1.
DR   HPA; HPA031166; -.
DR   MIM; 159556; gene.
DR   neXtProt; NX_Q03111; -.
DR   OpenTargets; ENSG00000130382; -.
DR   PharmGKB; PA30848; -.
DR   eggNOG; KOG3149; Eukaryota.
DR   eggNOG; COG5033; LUCA.
DR   GeneTree; ENSGT00440000039936; -.
DR   HOGENOM; HOG000033834; -.
DR   HOVERGEN; HBG004191; -.
DR   InParanoid; Q03111; -.
DR   KO; K15187; -.
DR   OMA; CFTYDLF; -.
DR   OrthoDB; EOG091G06LN; -.
DR   PhylomeDB; Q03111; -.
DR   TreeFam; TF314586; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   SIGNOR; Q03111; -.
DR   ChiTaRS; MLLT1; human.
DR   GeneWiki; MLLT1; -.
DR   GenomeRNAi; 4298; -.
DR   PRO; PR:Q03111; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000130382; -.
DR   CleanEx; HS_MLLT1; -.
DR   Genevisible; Q03111; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome.
DR   InterPro; IPR005033; YEATS.
DR   PANTHER; PTHR23195; PTHR23195; 1.
DR   Pfam; PF03366; YEATS; 1.
DR   PROSITE; PS51037; YEATS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Chromosomal rearrangement;
KW   Complete proteome; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Proto-oncogene; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1    559       Protein ENL.
FT                                /FTId=PRO_0000215938.
FT   DOMAIN        8    112       YEATS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00376}.
FT   COMPBIAS    272    280       Poly-Pro.
FT   COMPBIAS    319    325       Poly-Ser.
FT   COMPBIAS    374    389       Poly-Ser.
FT   COMPBIAS    457    460       Poly-Pro.
FT   COMPBIAS    463    466       Poly-Pro.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     155    155       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     292    292       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     296    296       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     361    361       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   CROSSLNK    240    240       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    262    262       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    342    342       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CONFLICT    269    270       KG -> NP (in Ref. 1; AAA58457).
FT                                {ECO:0000305}.
FT   STRAND        6     19       {ECO:0000244|PDB:5J9S}.
FT   STRAND       30     37       {ECO:0000244|PDB:5J9S}.
FT   HELIX        44     46       {ECO:0000244|PDB:5J9S}.
FT   STRAND       48     54       {ECO:0000244|PDB:5J9S}.
FT   STRAND       59     61       {ECO:0000244|PDB:5J9S}.
FT   STRAND       63     90       {ECO:0000244|PDB:5J9S}.
FT   STRAND       92     94       {ECO:0000244|PDB:5J9S}.
FT   STRAND       97    104       {ECO:0000244|PDB:5J9S}.
FT   STRAND      114    126       {ECO:0000244|PDB:5J9S}.
FT   HELIX       129    136       {ECO:0000244|PDB:5J9S}.
FT   TURN        137    139       {ECO:0000244|PDB:5J9S}.
FT   STRAND      141    143       {ECO:0000244|PDB:5J9S}.
SQ   SEQUENCE   559 AA;  62056 MW;  A8480BA0F8742173 CRC64;
     MDNQCTVQVR LELGHRAQLR KKPTTEGFTH DWMVFVRGPE QCDIQHFVEK VVFWLHDSFP
     KPRRVCKEPP YKVEESGYAG FIMPIEVHFK NKEEPRKVCF TYDLFLNLEG NPPVNHLRCE
     KLTFNNPTTE FRYKLLRAGG VMVMPEGADT VSRPSPDYPM LPTIPLSAFS DPKKTKPSHG
     SKDANKESSK TSKPHKVTKE HRERPRKDSE SKSSSKELER EQAKSSKDTS RKLGEGRLPK
     EEKAPPPKAA FKEPKMALKE TKLESTSPKG GPPPPPPPPP RASSKRPATA DSPKPSAKKQ
     KKSSSKGSRS APGTSPRTSS SSSFSDKKPA KDKSSTRGEK VKAESEPREA KKALEVEESN
     SEDEASFKSE SAQSSPSNSS SSSDSSSDSD FEPSQNHSQG PLRSMVEDLQ SEESDEDDSS
     SGEEAAGKTN PGRDSRLSFS DSESDNSADS SLPSREPPPP QKPPPPNSKV SGRRSPESCS
     KPEKILKKGT YDKAYTDELV ELHRRLMALR ERNVLQQIVN LIEETGHFNV TNTTFDFDLF
     SLDETTVRKL QSCLEAVAT
//
ID   AF1Q_HUMAN              Reviewed;          90 AA.
AC   Q13015;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   28-FEB-2018, entry version 129.
DE   RecName: Full=Protein AF1q;
GN   Name=MLLT11; Synonyms=AF1Q;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHROMOSOMAL REARRANGEMENT, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=7833468;
RA   Tse W., Zhu W., Chen H.S., Cohen A.;
RT   "A novel gene, AF1q, fused to MLL in t(1;11)(q21;q23), is specifically
RT   expressed in leukemic and immature hematopoietic cells.";
RL   Blood 85:650-656(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow, Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF 24-LEU--LEU-32,
RP   UBIQUITINATION, AND NUCLEAR EXPORT SIGNAL.
RX   PubMed=21715312; DOI=10.1182/blood-2011-01-333179;
RA   Parcelier A., Maharzi N., Delord M., Robledo-Sarmiento M., Nelson E.,
RA   Belakhdar-Mekid H., Pla M., Kuranda K., Parietti V., Goodhardt M.,
RA   Legrand N., Bernstein I.D., Gluckman J.C., Sigaux F., Canque B.;
RT   "AF1q/MLLT11 regulates the emergence of human prothymocytes through
RT   cooperative interaction with the Notch signaling pathway.";
RL   Blood 118:1784-1796(2011).
RN   [8]
RP   INTERACTION WITH HSPA8 AND LAMP2.
RX   PubMed=24880125; DOI=10.1016/j.yexcr.2014.05.013;
RA   Li P., Ji M., Lu F., Zhang J., Li H., Cui T., Li Wang X., Tang D.,
RA   Ji C.;
RT   "Degradation of AF1Q by chaperone-mediated autophagy.";
RL   Exp. Cell Res. 327:48-56(2014).
RN   [9]
RP   FUNCTION, INTERACTION WITH TCF7, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=26079538;
RA   Park J., Schlederer M., Schreiber M., Ice R., Merkel O., Bilban M.,
RA   Hofbauer S., Kim S., Addison J., Zou J., Ji C., Bunting S.T., Wang Z.,
RA   Shoham M., Huang G., Bago-Horvath Z., Gibson L.F., Rojanasakul Y.,
RA   Remick S., Ivanov A., Pugacheva E., Bunting K.D., Moriggl R.,
RA   Kenner L., Tse W.;
RT   "AF1q is a novel TCF7 co-factor which activates CD44 and promotes
RT   breast cancer metastasis.";
RL   Oncotarget 6:20697-20710(2015).
CC   -!- FUNCTION: Cofactor for the transcription factor TCF7
CC       (PubMed:26079538). Involved in regulation of lymphoid development
CC       by driving multipotent hematopoietic progenitor cells towards a T
CC       cell fate (PubMed:21715312). {ECO:0000269|PubMed:21715312,
CC       ECO:0000269|PubMed:26079538}.
CC   -!- SUBUNIT: Interacts with HSPA8 and LAMP2 isoform A; the interaction
CC       may target MLLT11 for degradation via chaperone-mediated autophagy
CC       (PubMed:24880125). Interacts with TCF7 (PubMed:26079538).
CC       {ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:26079538}.
CC   -!- INTERACTION:
CC       P36402:TCF7; NbExp=2; IntAct=EBI-6269719, EBI-2119465;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21715312,
CC       ECO:0000269|PubMed:26079538}. Cytoplasm
CC       {ECO:0000269|PubMed:21715312, ECO:0000269|PubMed:26079538}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:21715312}. Note=Continuous nuclear export is
CC       followed by degradation. {ECO:0000269|PubMed:21715312}.
CC   -!- TISSUE SPECIFICITY: Expressed in myoepithelial cells of normal
CC       breast tissue (at protein level) (PubMed:26079538). Highly
CC       expressed in thymus (PubMed:7833468). Expressed in colon, small
CC       intestine, prostate and ovary. Not detected in peripheral blood
CC       lymphocytes and spleen (PubMed:7833468).
CC       {ECO:0000269|PubMed:26079538, ECO:0000269|PubMed:7833468}.
CC   -!- PTM: Ubiquitinated, leading to degradation.
CC       {ECO:0000269|PubMed:21715312}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLLT11 is found
CC       in acute leukemias. Translocation t(1;11)(q21;q23) with
CC       KMT2A/MLL1.
CC   -!- SIMILARITY: Belongs to the MLLT11 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF1qID12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U16954; AAA70088.1; -; mRNA.
DR   EMBL; BT006799; AAP35445.1; -; mRNA.
DR   EMBL; CR456879; CAG33160.1; -; mRNA.
DR   EMBL; AL590133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006471; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC008445; AAH08445.1; -; mRNA.
DR   EMBL; BC009624; AAH09624.1; -; mRNA.
DR   EMBL; BC019253; AAH19253.1; -; mRNA.
DR   EMBL; BC021703; AAH21703.1; -; mRNA.
DR   EMBL; BC022448; AAH22448.1; -; mRNA.
DR   CCDS; CCDS982.1; -.
DR   PIR; I38889; I38889.
DR   RefSeq; NP_006809.1; NM_006818.3.
DR   UniGene; Hs.75823; -.
DR   ProteinModelPortal; Q13015; -.
DR   BioGrid; 116161; 6.
DR   IntAct; Q13015; 5.
DR   MINT; Q13015; -.
DR   STRING; 9606.ENSP00000357917; -.
DR   iPTMnet; Q13015; -.
DR   PhosphoSitePlus; Q13015; -.
DR   BioMuta; MLLT11; -.
DR   EPD; Q13015; -.
DR   PaxDb; Q13015; -.
DR   PeptideAtlas; Q13015; -.
DR   PRIDE; Q13015; -.
DR   TopDownProteomics; Q13015; -.
DR   DNASU; 10962; -.
DR   Ensembl; ENST00000368921; ENSP00000357917; ENSG00000213190.
DR   GeneID; 10962; -.
DR   KEGG; hsa:10962; -.
DR   CTD; 10962; -.
DR   DisGeNET; 10962; -.
DR   EuPathDB; HostDB:ENSG00000213190.3; -.
DR   GeneCards; MLLT11; -.
DR   HGNC; HGNC:16997; MLLT11.
DR   HPA; HPA000540; -.
DR   MalaCards; MLLT11; -.
DR   MIM; 604684; gene.
DR   neXtProt; NX_Q13015; -.
DR   OpenTargets; ENSG00000213190; -.
DR   PharmGKB; PA142671347; -.
DR   eggNOG; ENOG410IZF7; Eukaryota.
DR   eggNOG; ENOG4112CHF; LUCA.
DR   GeneTree; ENSGT00390000009895; -.
DR   HOGENOM; HOG000033833; -.
DR   InParanoid; Q13015; -.
DR   OMA; KMTGQAT; -.
DR   OrthoDB; EOG091G10XZ; -.
DR   PhylomeDB; Q13015; -.
DR   TreeFam; TF336906; -.
DR   ChiTaRS; MLLT11; human.
DR   GenomeRNAi; 10962; -.
DR   PRO; PR:Q13015; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000213190; -.
DR   CleanEx; HS_MLLT11; -.
DR   ExpressionAtlas; Q13015; baseline and differential.
DR   Genevisible; Q13015; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005622; C:intracellular; IDA:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0097193; P:intrinsic apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0051901; P:positive regulation of mitochondrial depolarization; IDA:UniProtKB.
DR   GO; GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   InterPro; IPR026778; MLLT11_fam.
DR   InterPro; IPR033461; WRNPLPNID.
DR   PANTHER; PTHR15404; PTHR15404; 1.
DR   Pfam; PF15017; WRNPLPNID; 1.
PE   1: Evidence at protein level;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Nucleus; Phosphoprotein; Proto-oncogene; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN         1     90       Protein AF1q.
FT                                /FTId=PRO_0000064471.
FT   MOTIF        24     32       Nuclear export signal.
FT                                {ECO:0000269|PubMed:21715312}.
FT   MOD_RES      84     84       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97783}.
FT   MUTAGEN      24     32       LSELEGLGL->ASEAEGAGA: Constitutive
FT                                nuclear sequestration.
FT                                {ECO:0000269|PubMed:21715312}.
SQ   SEQUENCE   90 AA;  10061 MW;  B37C6F7303C9EBF8 CRC64;
     MRDPVSSQYS SFLFWRMPIP ELDLSELEGL GLSDTATYKV KDSSVGKMIG QATAADQEKN
     PEGDGLLEYS TFNFWRAPIA SIHSFELDLL
//
ID   Q6FGF7_HUMAN            Unreviewed;        90 AA.
AC   Q6FGF7;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 100.
DE   SubName: Full=AF1Q protein {ECO:0000313|EMBL:CAG46947.1};
DE   SubName: Full=Myeloid/lymphoid or mixed-lineage leukemia (Trithorax homolog, Drosophila) translocated to, 11 {ECO:0000313|EMBL:AAH06471.1};
DE   SubName: Full=cDNA FLJ31527 fis, clone NT2RI2000344, highly similar to Protein AF1q {ECO:0000313|EMBL:BAG51620.1};
DE   Flags: Fragment;
GN   Name=AF1Q {ECO:0000313|EMBL:CAG46947.1};
GN   Synonyms=MLLT11 {ECO:0000313|EMBL:AAH06471.1};
GN   ORFNames=hCG_1778767 {ECO:0000313|EMBL:EAW53476.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG46947.1};
RN   [1] {ECO:0000313|EMBL:EAW53476.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAH06471.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung {ECO:0000313|EMBL:AAH06471.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000313|EMBL:BAG51620.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000313|EMBL:CAG46947.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:EAW53476.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC006471; AAH06471.1; -; mRNA.
DR   EMBL; AK056089; BAG51620.1; -; mRNA.
DR   EMBL; CR542150; CAG46947.1; -; mRNA.
DR   EMBL; CH471121; EAW53476.1; -; Genomic_DNA.
DR   RefSeq; NP_006809.1; NM_006818.3.
DR   UniGene; Hs.75823; -.
DR   MaxQB; Q6FGF7; -.
DR   DNASU; 10962; -.
DR   GeneID; 10962; -.
DR   KEGG; hsa:10962; -.
DR   UCSC; uc001ewq.4; human.
DR   CTD; 10962; -.
DR   EuPathDB; HostDB:ENSG00000213190.3; -.
DR   PharmGKB; PA142671347; -.
DR   eggNOG; ENOG410IZF7; Eukaryota.
DR   eggNOG; ENOG4112CHF; LUCA.
DR   OMA; KMTGQAT; -.
DR   OrthoDB; EOG091G10XZ; -.
DR   ChiTaRS; MLLT11; human.
DR   GenomeRNAi; 10962; -.
DR   Bgee; ENSG00000213190; -.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IEA:InterPro.
DR   InterPro; IPR026778; MLLT11_fam.
DR   InterPro; IPR033461; WRNPLPNID.
DR   PANTHER; PTHR15404; PTHR15404; 1.
DR   Pfam; PF15017; WRNPLPNID; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN        7     79       WRNPLPNID. {ECO:0000259|Pfam:PF15017}.
FT   NON_TER      90     90       {ECO:0000313|EMBL:CAG46947.1}.
SQ   SEQUENCE   90 AA;  10061 MW;  B37C6F7303C9EBF8 CRC64;
     MRDPVSSQYS SFLFWRMPIP ELDLSELEGL GLSDTATYKV KDSSVGKMIG QATAADQEKN
     PEGDGLLEYS TFNFWRAPIA SIHSFELDLL
//
ID   A0A0S2Z448_HUMAN        Unreviewed;       568 AA.
AC   A0A0S2Z448;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 13.
DE   SubName: Full=Myeloid/lymphoid or mixed-lineage leukemia translocated to 3 isoform 1 {ECO:0000313|EMBL:ALQ33647.1};
DE   Flags: Fragment;
GN   Name=MLLT3 {ECO:0000313|EMBL:ALQ33647.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33647.1};
RN   [1] {ECO:0000313|EMBL:ALQ33647.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00376}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178189; ALQ33647.1; -; mRNA.
DR   RefSeq; NP_004520.2; NM_004529.3.
DR   UniGene; Hs.317248; -.
DR   UniGene; Hs.591085; -.
DR   ProteinModelPortal; A0A0S2Z448; -.
DR   SMR; A0A0S2Z448; -.
DR   GeneID; 4300; -.
DR   KEGG; hsa:4300; -.
DR   CTD; 4300; -.
DR   KO; K15187; -.
DR   OMA; MSKEPKS; -.
DR   PhylomeDB; A0A0S2Z448; -.
DR   ChiTaRS; MLLT3; human.
DR   ExpressionAtlas; A0A0S2Z448; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0007379; P:segment specification; IEA:Ensembl.
DR   InterPro; IPR005033; YEATS.
DR   PANTHER; PTHR23195; PTHR23195; 1.
DR   Pfam; PF03366; YEATS; 1.
DR   PROSITE; PS51037; YEATS; 1.
PE   2: Evidence at transcript level;
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00376}.
FT   NON_TER     568    568       {ECO:0000313|EMBL:ALQ33647.1}.
SQ   SEQUENCE   568 AA;  63351 MW;  0A020B7FB34132F9 CRC64;
     MASSCAVQVK LELGHRAQVR KKPTVEGFTH DWMVFVRGPE HSNIQHFVEK VVFHLHESFP
     RPKRVCKDPP YKVEESGYAG FILPIEVYFK NKEEPRKVRF DYDLFLHLEG HPPVNHLRCE
     KLTFNNPTED FRRKLLKAGG DPNRSIHTSS SSSSSSSSSS SSSSSSSSSS SSSSSSSSSS
     SSSSSSSSSS TSFSKPHKLM KEHKEKPSKD SREHKSAFKE PSRDHNKSSK ESSKKPKENK
     PLKEEKIVPK MAFKEPKPMS KEPKPDSNLL TITSGQDKKA PSKRPPISDS EELSAKKRKK
     SSSEALFKSF SSAPPLILTC SADKKQIKDK SHVKMGKVKI ESETSEKKKS TLPPFDDIVD
     PNDSDVEENI SSKSDSEQPS PASSSSSSSS SFTPSQTRQQ GPLRSIMKDL HSDDNEEESD
     EVEDNDNDSE MERPVNRGGS RSRRVSLSDG SDSESSSASS PLHHEPPPPL LKTNNNQILE
     VKSPIKQSKS DKQIKNGECD KAYLDELVEL HRRLMTLRER HILQQIVNLI EETGHFHITN
     TTFDFDLCSL DKTTVRKLQS YLETSGTS
//
ID   AF9_HUMAN               Reviewed;         568 AA.
AC   P42568; B1AMQ2; B2R7B3; B7Z755; D3DRJ8; Q8IVB0;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   28-FEB-2018, entry version 154.
DE   RecName: Full=Protein AF-9;
DE   AltName: Full=ALL1-fused gene from chromosome 9 protein;
DE   AltName: Full=Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein;
DE   AltName: Full=YEATS domain-containing protein 3;
GN   Name=MLLT3 {ECO:0000312|HGNC:HGNC:7136}; Synonyms=AF9, YEATS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION
RP   WITH KMT2A.
RX   PubMed=8506309; DOI=10.1073/pnas.90.10.4631;
RA   Nakamura T., Alder H., Gu Y., Prasad R., Canaani O., Kamada N.,
RA   Gale R.P., Lange B., Crist W.M., Nowell P.C., Croce C.M., Canaani E.;
RT   "Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in
RT   acute leukemia share sequence homology and/or common motifs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:4631-4635(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH BCOR.
RX   PubMed=10898795;
RA   Huynh K.D., Fischle W., Verdin E., Bardwell V.J.;
RT   "BCoR, a novel corepressor involved in BCL-6 repression.";
RL   Genes Dev. 14:1810-1823(2000).
RN   [7]
RP   CHROMOSOMAL TRANSLOCATION.
RX   PubMed=10861294;
RA   Strissel P.L., Strick R., Tomek R.J., Roe B.A., Rowley J.D.,
RA   Zeleznik-Le N.J.;
RT   "DNA structural properties of AF9 are similar to MLL and could act as
RT   recombination hot spots resulting in MLL/AF9 translocations and
RT   leukemogenesis.";
RL   Hum. Mol. Genet. 9:1671-1679(2000).
RN   [8]
RP   INTERACTION WITH CBX8.
RX   PubMed=11313972; DOI=10.1038/sj.onc.1204108;
RA   Garcia-Cuellar M.P., Zilles O., Schreiner S.A., Birke M.,
RA   Winkler T.H., Slany R.K.;
RT   "The ENL moiety of the childhood leukemia-associated MLL-ENL
RT   oncoprotein recruits human Polycomb 3.";
RL   Oncogene 20:411-419(2001).
RN   [9]
RP   CHROMOSOMAL TRANSLOCATION.
RX   PubMed=16001262; DOI=10.1007/s00439-005-0004-1;
RA   Pramparo T., Grosso S., Messa J., Zatterale A., Bonaglia M.C.,
RA   Chessa L., Balestri P., Rocchi M., Zuffardi O., Giorda R.;
RT   "Loss-of-function mutation of the AF9/MLLT3 gene in a girl with
RT   neuromotor development delay, cerebellar ataxia, and epilepsy.";
RL   Hum. Genet. 118:76-81(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294 AND SER-483, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-288; SER-294 AND
RP   SER-483, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412 AND SER-419, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20471948; DOI=10.1016/j.molcel.2010.04.013;
RA   He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J.,
RA   Alber T., Zhou Q.;
RT   "HIV-1 Tat and host AFF4 recruit two transcription elongation factors
RT   into a bifunctional complex for coordinated activation of HIV-1
RT   transcription.";
RL   Mol. Cell 38:428-438(2010).
RN   [15]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20159561; DOI=10.1016/j.molcel.2010.01.026;
RA   Lin C., Smith E.R., Takahashi H., Lai K.C., Martin-Brown S.,
RA   Florens L., Washburn M.P., Conaway J.W., Conaway R.C., Shilatifard A.;
RT   "AFF4, a component of the ELL/P-TEFb elongation complex and a shared
RT   subunit of MLL chimeras, can link transcription elongation to
RT   leukemia.";
RL   Mol. Cell 37:429-437(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=22195968; DOI=10.1016/j.molcel.2011.12.008;
RA   Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D.,
RA   Jackson J., Saraf A., Swanson S.K., Seidel C., Florens L.,
RA   Washburn M.P., Eissenberg J.C., Shilatifard A.;
RT   "The little elongation complex regulates small nuclear RNA
RT   transcription.";
RL   Mol. Cell 44:954-965(2011).
RN   [18]
RP   REVIEW ON THE SUPER ELONGATION COMPLEX.
RX   PubMed=22895430; DOI=10.1038/nrm3417;
RA   Luo Z., Lin C., Shilatifard A.;
RT   "The super elongation complex (SEC) family in transcriptional
RT   control.";
RL   Nat. Rev. Mol. Cell Biol. 13:543-547(2012).
RN   [19]
RP   INTERACTION WITH ALKBH4.
RX   PubMed=23145062; DOI=10.1371/journal.pone.0049045;
RA   Bjornstad L.G., Meza T.J., Otterlei M., Olafsrud S.M.,
RA   Meza-Zepeda L.A., Falnes P.O.;
RT   "Human ALKBH4 interacts with proteins associated with transcription.";
RL   PLoS ONE 7:E49045-E49045(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294 AND SER-483, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [23]
RP   STRUCTURE BY NMR OF 490-568 IN COMPLEX WITH AFF1.
RX   PubMed=23260655; DOI=10.1016/j.str.2012.11.011;
RA   Leach B.I., Kuntimaddi A., Schmidt C.R., Cierpicki T., Johnson S.A.,
RA   Bushweller J.H.;
RT   "Leukemia fusion target AF9 is an intrinsically disordered
RT   transcriptional regulator that recruits multiple partners via coupled
RT   folding and binding.";
RL   Structure 21:176-183(2013).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1-138 IN COMPLEX WITH H3K9AC
RP   PEPTIDE, FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF
RP   PHE-28; HIS-56; SER-58; PHE-59; GLY-77; TYR-78; PHE-81 AND ASP-103.
RX   PubMed=25417107; DOI=10.1016/j.cell.2014.09.049;
RA   Li Y., Wen H., Xi Y., Tanaka K., Wang H., Peng D., Ren Y., Jin Q.,
RA   Dent S.Y., Li W., Li H., Shi X.;
RT   "AF9 YEATS domain links histone acetylation to DOT1L-mediated H3K79
RT   methylation.";
RL   Cell 159:558-571(2014).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 1-138 IN COMPLEX WITH H3K9CR
RP   PEPTIDE, FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF
RP   PHE-28; HIS-56; SER-58; PHE-59; GLY-77 AND TYR-78.
RX   PubMed=27105114; DOI=10.1016/j.molcel.2016.03.028;
RA   Li Y., Sabari B.R., Panchenko T., Wen H., Zhao D., Guan H., Wan L.,
RA   Huang H., Tang Z., Zhao Y., Roeder R.G., Shi X., Allis C.D., Li H.;
RT   "Molecular coupling of histone crotonylation and active transcription
RT   by AF9 YEATS domain.";
RL   Mol. Cell 62:181-193(2016).
RN   [26]
RP   STRUCTURE BY NMR OF 1-138, FUNCTION, DOMAIN, AND MUTAGENESIS OF PHE-59
RP   AND TYR-78.
RX   PubMed=27545619; DOI=10.1016/j.str.2016.05.023;
RA   Zhang Q., Zeng L., Zhao C., Ju Y., Konuma T., Zhou M.M.;
RT   "Structural insights into histone crotonyl-lysine recognition by the
RT   AF9 YEATS domain.";
RL   Structure 24:1606-1612(2016).
CC   -!- FUNCTION: Chromatin reader component of the super elongation
CC       complex (SEC), a complex required to increase the catalytic rate
CC       of RNA polymerase II transcription by suppressing transient
CC       pausing by the polymerase at multiple sites along the DNA
CC       (PubMed:20159561, PubMed:20471948, PubMed:25417107,
CC       PubMed:27105114, PubMed:27545619). Specifically recognizes and
CC       binds acylated histone H3, with a marked preference for histone H3
CC       that is crotonylated (PubMed:25417107, PubMed:27105114,
CC       PubMed:27545619). Crotonylation marks active promoters and
CC       enhancers and confers resistance to transcriptional repressors
CC       (PubMed:25417107, PubMed:27105114, PubMed:27545619). Recognizes
CC       and binds histone H3 crotonylated at 'Lys-9' (H3K9cr), and with
CC       slightly lower affinity histone H3 crotonylated at 'Lys-18'
CC       (H3K18cr) (PubMed:27105114). Also recognizes and binds histone H3
CC       acetylated at 'Lys-9' (H3K9ac), but with lower affinity than
CC       crotonylated histone H3 (PubMed:25417107, PubMed:27105114). In the
CC       SEC complex, MLLT3 is required to recruit the complex to
CC       crotonylated histones (PubMed:27105114, PubMed:27545619).
CC       {ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948,
CC       ECO:0000269|PubMed:25417107, ECO:0000269|PubMed:27105114,
CC       ECO:0000269|PubMed:27545619}.
CC   -!- SUBUNIT: Component of the super elongation complex (SEC), at least
CC       composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the
CC       P-TEFb complex and ELL (ELL, ELL2 or ELL3) (PubMed:20159561,
CC       PubMed:20471948, PubMed:22195968, PubMed:23260655,
CC       PubMed:25417107). Interacts with BCOR (PubMed:10898795). Interacts
CC       with CBX8 (PubMed:11313972). Interacts with ALKBH4
CC       (PubMed:23145062). {ECO:0000269|PubMed:10898795,
CC       ECO:0000269|PubMed:11313972, ECO:0000269|PubMed:20159561,
CC       ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:22195968,
CC       ECO:0000269|PubMed:23145062, ECO:0000269|PubMed:23260655,
CC       ECO:0000269|PubMed:25417107}.
CC   -!- INTERACTION:
CC       P51825:AFF1; NbExp=7; IntAct=EBI-716132, EBI-2610180;
CC       Q9UHB7:AFF4; NbExp=4; IntAct=EBI-716132, EBI-395282;
CC       Q9NXW9:ALKBH4; NbExp=4; IntAct=EBI-716132, EBI-8637516;
CC       Q92624:APPBP2; NbExp=3; IntAct=EBI-716132, EBI-743771;
CC       Q6W2J9-1:BCOR; NbExp=2; IntAct=EBI-716132, EBI-16028932;
CC       Q9HC52:CBX8; NbExp=2; IntAct=EBI-716132, EBI-712912;
CC       Q8TEK3:DOT1L; NbExp=6; IntAct=EBI-716132, EBI-2619253;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00376, ECO:0000269|PubMed:27105114}. Chromosome
CC       {ECO:0000269|PubMed:25417107, ECO:0000269|PubMed:27105114}.
CC       Note=Colocalizes with acylated histone H3 (PubMed:25417107,
CC       PubMed:27105114). Colocalizes with histone H3 crotonylated at
CC       'Lys-18' (H3K18cr) (PubMed:27105114).
CC       {ECO:0000269|PubMed:25417107, ECO:0000269|PubMed:27105114}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P42568-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P42568-2; Sequence=VSP_054924;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The YEATS domain specifically recognizes and binds
CC       acylated histones, with a marked preference histones that are
CC       crotonylated (PubMed:27105114, PubMed:27545619). Also binds
CC       histone H3 acetylated at 'Lys-9' (H3K9ac), but with lower affinity
CC       (PubMed:25417107, PubMed:27105114). {ECO:0000269|PubMed:25417107,
CC       ECO:0000269|PubMed:27105114, ECO:0000269|PubMed:27545619}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLLT3 is
CC       associated with acute leukemias. Translocation t(9;11)(p22;q23)
CC       with KMT2A/MLL1. The result is a rogue activator protein.
CC       {ECO:0000269|PubMed:10861294, ECO:0000269|PubMed:8506309}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLLT3 was
CC       observed in a patient with neuromotor development delay,
CC       cerebellar ataxia and epilepsy. Translocation t(4;9)(q35;p22).
CC       {ECO:0000269|PubMed:16001262}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF9ID5.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L13744; AAA58361.1; -; mRNA.
DR   EMBL; AK301474; BAH13491.1; -; mRNA.
DR   EMBL; AK312914; BAG35760.1; -; mRNA.
DR   EMBL; AL512635; CAH70705.1; -; Genomic_DNA.
DR   EMBL; AL354879; CAH70705.1; JOINED; Genomic_DNA.
DR   EMBL; AL513498; CAH70705.1; JOINED; Genomic_DNA.
DR   EMBL; AL354879; CAI14771.1; -; Genomic_DNA.
DR   EMBL; AL512635; CAI14771.1; JOINED; Genomic_DNA.
DR   EMBL; AL513498; CAI14771.1; JOINED; Genomic_DNA.
DR   EMBL; AL163193; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL627410; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58631.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58632.1; -; Genomic_DNA.
DR   EMBL; BC036089; AAH36089.1; -; mRNA.
DR   CCDS; CCDS6494.1; -. [P42568-1]
DR   CCDS; CCDS69579.1; -. [P42568-2]
DR   PIR; I39411; I39411.
DR   RefSeq; NP_001273620.1; NM_001286691.1. [P42568-2]
DR   RefSeq; NP_004520.2; NM_004529.3. [P42568-1]
DR   UniGene; Hs.317248; -.
DR   UniGene; Hs.591085; -.
DR   PDB; 2LM0; NMR; -; A=490-568.
DR   PDB; 2MV7; NMR; -; A=500-568.
DR   PDB; 2N4Q; NMR; -; B=500-568.
DR   PDB; 2NDF; NMR; -; A=1-138.
DR   PDB; 2NDG; NMR; -; A=1-138.
DR   PDB; 4TMP; X-ray; 2.30 A; A/C=1-138.
DR   PDB; 5HJB; X-ray; 2.70 A; A=1-138.
DR   PDB; 5HJD; X-ray; 2.81 A; A/C/E/G/K/N/Q/T=1-138.
DR   PDBsum; 2LM0; -.
DR   PDBsum; 2MV7; -.
DR   PDBsum; 2N4Q; -.
DR   PDBsum; 2NDF; -.
DR   PDBsum; 2NDG; -.
DR   PDBsum; 4TMP; -.
DR   PDBsum; 5HJB; -.
DR   PDBsum; 5HJD; -.
DR   DisProt; DP01070; -.
DR   ProteinModelPortal; P42568; -.
DR   SMR; P42568; -.
DR   BioGrid; 110446; 61.
DR   CORUM; P42568; -.
DR   DIP; DIP-56409N; -.
DR   IntAct; P42568; 35.
DR   STRING; 9606.ENSP00000369695; -.
DR   iPTMnet; P42568; -.
DR   PhosphoSitePlus; P42568; -.
DR   DMDM; 215273971; -.
DR   EPD; P42568; -.
DR   MaxQB; P42568; -.
DR   PaxDb; P42568; -.
DR   PeptideAtlas; P42568; -.
DR   PRIDE; P42568; -.
DR   Ensembl; ENST00000380338; ENSP00000369695; ENSG00000171843. [P42568-1]
DR   Ensembl; ENST00000630269; ENSP00000485996; ENSG00000171843. [P42568-2]
DR   GeneID; 4300; -.
DR   KEGG; hsa:4300; -.
DR   UCSC; uc003zoe.3; human. [P42568-1]
DR   CTD; 4300; -.
DR   DisGeNET; 4300; -.
DR   EuPathDB; HostDB:ENSG00000171843.15; -.
DR   GeneCards; MLLT3; -.
DR   HGNC; HGNC:7136; MLLT3.
DR   HPA; HPA001824; -.
DR   MalaCards; MLLT3; -.
DR   MIM; 159558; gene.
DR   neXtProt; NX_P42568; -.
DR   OpenTargets; ENSG00000171843; -.
DR   Orphanet; 402017; 'Acute myeloid leukemia with t(9;11)(p22;q23)'.
DR   PharmGKB; PA30852; -.
DR   eggNOG; KOG3149; Eukaryota.
DR   eggNOG; COG5033; LUCA.
DR   GeneTree; ENSGT00440000039936; -.
DR   HOVERGEN; HBG004191; -.
DR   InParanoid; P42568; -.
DR   KO; K15187; -.
DR   OMA; MSKEPKS; -.
DR   OrthoDB; EOG091G06LN; -.
DR   PhylomeDB; P42568; -.
DR   TreeFam; TF314586; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   SIGNOR; P42568; -.
DR   ChiTaRS; MLLT3; human.
DR   GeneWiki; MLLT3; -.
DR   GenomeRNAi; 4300; -.
DR   PRO; PR:P42568; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000171843; -.
DR   CleanEx; HS_MLLT3; -.
DR   ExpressionAtlas; P42568; baseline and differential.
DR   Genevisible; P42568; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IDA:UniProtKB.
DR   GO; GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB.
DR   GO; GO:0140030; F:modification-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; IGI:MGI.
DR   GO; GO:0007379; P:segment specification; IEA:Ensembl.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome.
DR   InterPro; IPR005033; YEATS.
DR   PANTHER; PTHR23195; PTHR23195; 1.
DR   Pfam; PF03366; YEATS; 1.
DR   PROSITE; PS51037; YEATS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing;
KW   Chromosomal rearrangement; Chromosome; Complete proteome;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN         1    568       Protein AF-9.
FT                                /FTId=PRO_0000215921.
FT   DOMAIN        8    112       YEATS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00376}.
FT   REGION       78     80       Histone H3K9cr binding.
FT                                {ECO:0000244|PDB:5HJB,
FT                                ECO:0000244|PDB:5HJD,
FT                                ECO:0000269|PubMed:27105114}.
FT   REGION      106    108       Histone H3K9cr binding.
FT                                {ECO:0000244|PDB:5HJB,
FT                                ECO:0000244|PDB:5HJD,
FT                                ECO:0000269|PubMed:27105114}.
FT   MOTIF       295    300       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    149    194       Poly-Ser.
FT   COMPBIAS    383    391       Poly-Ser.
FT   COMPBIAS    466    469       Poly-Pro.
FT   BINDING      58     58       Histone H3K9cr. {ECO:0000244|PDB:5HJB,
FT                                ECO:0000244|PDB:5HJD,
FT                                ECO:0000269|PubMed:27105114}.
FT   BINDING     103    103       Histone H3K9cr. {ECO:0000244|PDB:5HJB,
FT                                ECO:0000244|PDB:5HJD,
FT                                ECO:0000269|PubMed:27105114}.
FT   SITE        375    375       KMT2A/MLL1 fusion point (in acute myeloid
FT                                leukemia patient CO).
FT                                {ECO:0000269|PubMed:8506309}.
FT   SITE        481    481       KMT2A/MLL1 fusion point (in acute myeloid
FT                                leukemia patient F1).
FT                                {ECO:0000269|PubMed:8506309}.
FT   MOD_RES     288    288       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     294    294       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     412    412       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     419    419       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     483    483       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    339    339       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1      4       MASS -> M (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054924.
FT   MUTAGEN      28     28       F->A: Decreased binding to crotonylated
FT                                histone H3. Decreased binding to
FT                                acetylated histone H3.
FT                                {ECO:0000269|PubMed:25417107,
FT                                ECO:0000269|PubMed:27105114}.
FT   MUTAGEN      56     56       H->A: Decreased binding to crotonylated
FT                                histone H3. Decreased binding to
FT                                acetylated histone H3.
FT                                {ECO:0000269|PubMed:25417107,
FT                                ECO:0000269|PubMed:27105114}.
FT   MUTAGEN      58     58       S->A: Decreased binding to crotonylated
FT                                histone H3. Decreased binding to
FT                                acetylated histone H3.
FT                                {ECO:0000269|PubMed:25417107,
FT                                ECO:0000269|PubMed:27105114}.
FT   MUTAGEN      59     59       F->A: Strongly decreased binding to
FT                                crotonylated histone H3. Decreased
FT                                binding to acetylated histone H3.
FT                                {ECO:0000269|PubMed:25417107,
FT                                ECO:0000269|PubMed:27105114,
FT                                ECO:0000269|PubMed:27545619}.
FT   MUTAGEN      77     77       G->A: Decreased binding to crotonylated
FT                                histone H3. Decreased binding to
FT                                acetylated histone H3.
FT                                {ECO:0000269|PubMed:25417107,
FT                                ECO:0000269|PubMed:27105114}.
FT   MUTAGEN      78     78       Y->A: Strongly decreased binding to
FT                                crotonylated histone H3. Decreased
FT                                binding to acetylated histone H3.
FT                                {ECO:0000269|PubMed:25417107,
FT                                ECO:0000269|PubMed:27105114,
FT                                ECO:0000269|PubMed:27545619}.
FT   MUTAGEN      81     81       F->A: Decreased binding to acetylated
FT                                histone H3.
FT                                {ECO:0000269|PubMed:25417107}.
FT   MUTAGEN     103    103       D->A: Decreased binding to acetylated
FT                                histone H3.
FT                                {ECO:0000269|PubMed:25417107}.
FT   CONFLICT      6      6       A -> S (in Ref. 1; AAA58361 and 2;
FT                                BAG35760). {ECO:0000305}.
FT   CONFLICT    173    173       S -> G (in Ref. 5; AAH36089).
FT                                {ECO:0000305}.
FT   CONFLICT    419    419       S -> P (in Ref. 2; BAG35760).
FT                                {ECO:0000305}.
FT   STRAND        3     19       {ECO:0000244|PDB:4TMP}.
FT   STRAND       30     37       {ECO:0000244|PDB:4TMP}.
FT   HELIX        39     41       {ECO:0000244|PDB:4TMP}.
FT   HELIX        44     46       {ECO:0000244|PDB:4TMP}.
FT   STRAND       48     54       {ECO:0000244|PDB:4TMP}.
FT   STRAND       59     61       {ECO:0000244|PDB:4TMP}.
FT   STRAND       63     90       {ECO:0000244|PDB:4TMP}.
FT   STRAND       92     94       {ECO:0000244|PDB:4TMP}.
FT   STRAND       97    104       {ECO:0000244|PDB:4TMP}.
FT   STRAND      114    126       {ECO:0000244|PDB:4TMP}.
FT   HELIX       129    137       {ECO:0000244|PDB:4TMP}.
FT   HELIX       504    515       {ECO:0000244|PDB:2LM0}.
FT   HELIX       523    531       {ECO:0000244|PDB:2LM0}.
FT   STRAND      536    538       {ECO:0000244|PDB:2LM0}.
FT   STRAND      543    545       {ECO:0000244|PDB:2LM0}.
FT   TURN        547    549       {ECO:0000244|PDB:2LM0}.
FT   HELIX       552    561       {ECO:0000244|PDB:2LM0}.
SQ   SEQUENCE   568 AA;  63351 MW;  0A020B7FB34132F9 CRC64;
     MASSCAVQVK LELGHRAQVR KKPTVEGFTH DWMVFVRGPE HSNIQHFVEK VVFHLHESFP
     RPKRVCKDPP YKVEESGYAG FILPIEVYFK NKEEPRKVRF DYDLFLHLEG HPPVNHLRCE
     KLTFNNPTED FRRKLLKAGG DPNRSIHTSS SSSSSSSSSS SSSSSSSSSS SSSSSSSSSS
     SSSSSSSSSS TSFSKPHKLM KEHKEKPSKD SREHKSAFKE PSRDHNKSSK ESSKKPKENK
     PLKEEKIVPK MAFKEPKPMS KEPKPDSNLL TITSGQDKKA PSKRPPISDS EELSAKKRKK
     SSSEALFKSF SSAPPLILTC SADKKQIKDK SHVKMGKVKI ESETSEKKKS TLPPFDDIVD
     PNDSDVEENI SSKSDSEQPS PASSSSSSSS SFTPSQTRQQ GPLRSIMKDL HSDDNEEESD
     EVEDNDNDSE MERPVNRGGS RSRRVSLSDG SDSESSSASS PLHHEPPPPL LKTNNNQILE
     VKSPIKQSKS DKQIKNGECD KAYLDELVEL HRRLMTLRER HILQQIVNLI EETGHFHITN
     TTFDFDLCSL DKTTVRKLQS YLETSGTS
//
ID   A0A087WW39_HUMAN        Unreviewed;      1093 AA.
AC   A0A087WW39;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   28-FEB-2018, entry version 37.
DE   SubName: Full=Protein AF-17 {ECO:0000313|Ensembl:ENSP00000479910};
GN   Name=MLLT6 {ECO:0000313|Ensembl:ENSP00000479910};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000479910, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000479910, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [3] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4] {ECO:0000313|Ensembl:ENSP00000479910}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
RN   [5] {ECO:0000313|Ensembl:ENSP00000477969}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUN-2015) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000479910}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC006449; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456275; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_005928.2; NM_005937.3.
DR   UniGene; Hs.91531; -.
DR   SMR; A0A087WW39; -.
DR   Ensembl; ENST00000618876; ENSP00000477969; ENSG00000275851.
DR   Ensembl; ENST00000621332; ENSP00000479910; ENSG00000275023.
DR   GeneID; 4302; -.
DR   KEGG; hsa:4302; -.
DR   UCSC; uc002hqi.5; human.
DR   CTD; 4302; -.
DR   EuPathDB; HostDB:ENSG00000275023.4; -.
DR   HGNC; HGNC:7138; MLLT6.
DR   OpenTargets; ENSG00000275023; -.
DR   eggNOG; KOG0956; Eukaryota.
DR   eggNOG; COG5141; LUCA.
DR   GeneTree; ENSGT00740000114866; -.
DR   OMA; FGPIMRF; -.
DR   OrthoDB; EOG091G069E; -.
DR   ChiTaRS; MLLT6; human.
DR   GenomeRNAi; 4302; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000275023; -.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:2001161; P:negative regulation of histone H3-K79 methylation; IEA:Ensembl.
DR   GO; GO:0035811; P:negative regulation of urine volume; IEA:Ensembl.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0036359; P:renal potassium excretion; IEA:Ensembl.
DR   GO; GO:0035812; P:renal sodium excretion; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 2.
DR   InterPro; IPR034732; EPHD.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   SMART; SM00249; PHD; 2.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS51805; EPHD; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077};
KW   Proteomics identification {ECO:0000213|MaxQB:A0A087WW39,
KW   ECO:0000213|PeptideAtlas:A0A087WW39};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077}.
FT   DOMAIN        5     57       PHD-type. {ECO:0000259|PROSITE:PS50016}.
FT   DOMAIN       62    181       PHD-type. {ECO:0000259|PROSITE:PS51805}.
FT   COILED      719    753       {ECO:0000256|SAM:Coils}.
FT   COILED      933    953       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1093 AA;  112048 MW;  C55F0801D9A0A5C1 CRC64;
     MKEMVGGCCV CSDERGWAEN PLVYCDGHAC SVAVHQACYG IVQVPTGPWF CRKCESQERA
     ARVRCELCPH KDGALKRTDN GGWAHVVCAL YIPEVQFANV LTMEPIVLQY VPHDRFNKTC
     YICEEQGRES KAASGACMTC NRHGCRQAFH VTCAQMAGLL CEEEVLEVDN VKYCGYCKYH
     FSKMKTSRHS SGGGGGGAGG GGGSMGGGGS GFISGRRSRS ASPSTQQEKH PTHHERGQKK
     SRKDKERLKQ KHKKRPESPP SILTPPVVPT ADKVSSSASS SSHHEASTQE TSESSRESKG
     KKSSSHSLSH KGKKLSSGKG VSSFTSASSS SSSSSSSSGG PFQPAVSSLQ SSPDFSAFPK
     LEQPEEDKYS KPTAPAPSAP PSPSAPEPPK ADLFEQKVVF SGFGPIMRFS TTTSSSGRAR
     APSPGDYKSP HVTGSGASAG THKRMPALSA TPVPADETPE TGLKEKKHKA SKRSRHGPGR
     PKGSRNKEGT GGPAAPSLPS AQLAGFTATA ASPFSGGSLV SSGLGGLSSR TFGPSGSLPS
     LSLESPLLGA GIYTSNKDPI SHSGGMLRAV CSTPLSSSLL GPPGTSALPR LSRSPFTSTL
     PSSSASISTT QVFSLAGSTF SLPSTHIFGT PMGAVNPLLS QAESSHTEPD LEDCSFRCRG
     TSPQESLSSM SPISSLPALF DQTASAPCGG GQLDPAAPGT TNMEQLLEKQ GDGEAGVNIV
     EMLKALHALQ KENQRLQEQI LSLTAKKERL QILNVQLSVP FPALPAALPA ANGPVPGPYG
     LPPQAGSSDS LSTSKSPPGK SSLGLDNSLS TSSEDPHSGC PSRSSSSLSF HSTPPPLPLL
     QQSPATLPLA LPGAPAPLPP QPQNGLGRAP GAAGLGAMPM AEGLLGGLAG SGGLPLNGLL
     GGLNGAAAPN PASLSQAGGA PTLQLPGCLN SLTEQQRHLL QQQEQQLQQL QQLLASPQLT
     PEHQTVVYQM IQQIQQKREL QRLQMAGGSQ LPMASLLAGS STPLLSAGTP GLLPTASAPP
     LLPAGALVAP SLGNNTSLMA AAAAAAAVAA AGGPPVLTAQ TNPFLSLSGA EGSGGGPKGG
     TADKGASANQ EKG
//
ID   AF17_HUMAN              Reviewed;        1093 AA.
AC   P55198; Q59F28; Q96IU3; Q9H5F6; Q9UF49;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   28-FEB-2018, entry version 146.
DE   RecName: Full=Protein AF-17;
DE   AltName: Full=ALL1-fused gene from chromosome 17 protein;
GN   Name=MLLT6; Synonyms=AF17;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH
RP   KMT2A/MLL1.
RX   PubMed=8058765; DOI=10.1073/pnas.91.17.8107;
RA   Prasad R., Leshkowitz D., Gu Y., Alder H., Nakamura T., Saito H.,
RA   Huebner K., Berger R., Croce C.M., Canaani E.;
RT   "Leucine-zipper dimerization motif encoded by the AF17 gene fused to
RT   ALL-1 (MLL) in acute leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:8107-8111(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 5-1093.
RC   TISSUE=Ileal mucosa;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 5-1093.
RC   TISSUE=Spleen;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 624-1093.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 648-1093.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-451, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258; SER-378 AND
RP   SER-423, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- INTERACTION:
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-740216, EBI-10173939;
CC       Q9NRR5:UBQLN4; NbExp=2; IntAct=EBI-740216, EBI-711226;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLLT6 is
CC       associated with acute leukemias. Translocation t(11;17)(q23;q21)
CC       with KMT2A/MLL1. The result is a rogue activator protein.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH07237.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB15670.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF17ID7.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U07932; AAA21145.1; -; mRNA.
DR   EMBL; AC006449; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK027133; BAB15670.1; ALT_INIT; mRNA.
DR   EMBL; AB209633; BAD92870.1; -; mRNA.
DR   EMBL; BC007237; AAH07237.1; ALT_INIT; mRNA.
DR   EMBL; AL133659; CAB63772.2; -; mRNA.
DR   CCDS; CCDS11327.1; -.
DR   PIR; I38533; I38533.
DR   RefSeq; NP_005928.2; NM_005937.3.
DR   UniGene; Hs.91531; -.
DR   ProteinModelPortal; P55198; -.
DR   SMR; P55198; -.
DR   BioGrid; 110448; 50.
DR   IntAct; P55198; 22.
DR   STRING; 9606.ENSP00000316426; -.
DR   iPTMnet; P55198; -.
DR   PhosphoSitePlus; P55198; -.
DR   BioMuta; MLLT6; -.
DR   DMDM; 215273929; -.
DR   EPD; P55198; -.
DR   MaxQB; P55198; -.
DR   PaxDb; P55198; -.
DR   PeptideAtlas; P55198; -.
DR   PRIDE; P55198; -.
DR   GeneID; 4302; -.
DR   KEGG; hsa:4302; -.
DR   CTD; 4302; -.
DR   DisGeNET; 4302; -.
DR   GeneCards; MLLT6; -.
DR   HGNC; HGNC:7138; MLLT6.
DR   HPA; HPA004021; -.
DR   MIM; 600328; gene.
DR   neXtProt; NX_P55198; -.
DR   PharmGKB; PA30854; -.
DR   eggNOG; KOG0956; Eukaryota.
DR   eggNOG; COG5141; LUCA.
DR   HOGENOM; HOG000033831; -.
DR   HOVERGEN; HBG004186; -.
DR   InParanoid; P55198; -.
DR   PhylomeDB; P55198; -.
DR   TreeFam; TF316118; -.
DR   ChiTaRS; MLLT6; human.
DR   GenomeRNAi; 4302; -.
DR   PRO; PR:P55198; -.
DR   Proteomes; UP000005640; Unplaced.
DR   CleanEx; HS_MLLT6; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc.
DR   Gene3D; 3.30.40.10; -; 2.
DR   InterPro; IPR034732; EPHD.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   SMART; SM00249; PHD; 2.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS51805; EPHD; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 1.
PE   1: Evidence at protein level;
KW   Chromosomal rearrangement; Complete proteome; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome;
KW   Repeat; Zinc; Zinc-finger.
FT   CHAIN         1   1093       Protein AF-17.
FT                                /FTId=PRO_0000215937.
FT   ZN_FING       5     57       PHD-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00146}.
FT   ZN_FING      62     95       C2HC pre-PHD-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01146}.
FT   ZN_FING     118    181       PHD-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01146}.
FT   REGION      729    764       Leucine-zipper.
FT   COMPBIAS    190    211       Gly/Ser-rich.
FT   COMPBIAS    275    282       Poly-Ser.
FT   COMPBIAS    326    338       Poly-Ser.
FT   COMPBIAS    822    829       Poly-Ser.
FT   COMPBIAS    834    862       Pro-rich.
FT   COMPBIAS    935    984       Gln-rich.
FT   COMPBIAS   1040   1051       Poly-Ala.
FT   COMPBIAS   1069   1080       Gly-rich.
FT   SITE        551    551       KMT2A/MLL1 fusion point (in acute myeloid
FT                                leukemia patient).
FT   MOD_RES     258    258       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     378    378       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     423    423       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     451    451       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   VARIANT     198    198       A -> T (in dbSNP:rs2241012).
FT                                /FTId=VAR_022076.
FT   CONFLICT     33     33       V -> A (in Ref. 1; AAA21145 and 4;
FT                                BAD92870). {ECO:0000305}.
FT   CONFLICT    126    126       Q -> T (in Ref. 1; AAA21145).
FT                                {ECO:0000305}.
FT   CONFLICT    735    735       R -> W (in Ref. 4; BAD92870).
FT                                {ECO:0000305}.
FT   CONFLICT   1065   1065       L -> P (in Ref. 3; BAB15670).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1093 AA;  112076 MW;  DF61DE3AD82C14BB CRC64;
     MKEMVGGCCV CSDERGWAEN PLVYCDGHAC SVVVHQACYG IVQVPTGPWF CRKCESQERA
     ARVRCELCPH KDGALKRTDN GGWAHVVCAL YIPEVQFANV LTMEPIVLQY VPHDRFNKTC
     YICEEQGRES KAASGACMTC NRHGCRQAFH VTCAQMAGLL CEEEVLEVDN VKYCGYCKYH
     FSKMKTSRHS SGGGGGGAGG GGGSMGGGGS GFISGRRSRS ASPSTQQEKH PTHHERGQKK
     SRKDKERLKQ KHKKRPESPP SILTPPVVPT ADKVSSSASS SSHHEASTQE TSESSRESKG
     KKSSSHSLSH KGKKLSSGKG VSSFTSASSS SSSSSSSSGG PFQPAVSSLQ SSPDFSAFPK
     LEQPEEDKYS KPTAPAPSAP PSPSAPEPPK ADLFEQKVVF SGFGPIMRFS TTTSSSGRAR
     APSPGDYKSP HVTGSGASAG THKRMPALSA TPVPADETPE TGLKEKKHKA SKRSRHGPGR
     PKGSRNKEGT GGPAAPSLPS AQLAGFTATA ASPFSGGSLV SSGLGGLSSR TFGPSGSLPS
     LSLESPLLGA GIYTSNKDPI SHSGGMLRAV CSTPLSSSLL GPPGTSALPR LSRSPFTSTL
     PSSSASISTT QVFSLAGSTF SLPSTHIFGT PMGAVNPLLS QAESSHTEPD LEDCSFRCRG
     TSPQESLSSM SPISSLPALF DQTASAPCGG GQLDPAAPGT TNMEQLLEKQ GDGEAGVNIV
     EMLKALHALQ KENQRLQEQI LSLTAKKERL QILNVQLSVP FPALPAALPA ANGPVPGPYG
     LPPQAGSSDS LSTSKSPPGK SSLGLDNSLS TSSEDPHSGC PSRSSSSLSF HSTPPPLPLL
     QQSPATLPLA LPGAPAPLPP QPQNGLGRAP GAAGLGAMPM AEGLLGGLAG SGGLPLNGLL
     GGLNGAAAPN PASLSQAGGA PTLQLPGCLN SLTEQQRHLL QQQEQQLQQL QQLLASPQLT
     PEHQTVVYQM IQQIQQKREL QRLQMAGGSQ LPMASLLAGS STPLLSAGTP GLLPTASAPP
     LLPAGALVAP SLGNNTSLMA AAAAAAAVAA AGGPPVLTAQ TNPFLSLSGA EGSGGGPKGG
     TADKGASANQ EKG
//
ID   MOES_HUMAN              Reviewed;         577 AA.
AC   P26038;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-FEB-2018, entry version 204.
DE   RecName: Full=Moesin {ECO:0000303|PubMed:1924289};
DE   AltName: Full=Membrane-organizing extension spike protein;
GN   Name=MSN {ECO:0000312|HGNC:HGNC:7373};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 2-16; 54-60 AND
RP   414-435.
RC   TISSUE=Placenta;
RX   PubMed=1924289; DOI=10.1073/pnas.88.19.8297;
RA   Lankes W.T., Furthmayr H.;
RT   "Moesin: a member of the protein 4.1-talin-ezrin family of proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:8297-8301(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-8.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [5]
RP   INTERACTION WITH SLC9A3R1.
RX   PubMed=9314537; DOI=10.1083/jcb.139.1.169;
RA   Reczek D., Berryman M., Bretscher A.;
RT   "Identification of EBP50: a PDZ-containing phosphoprotein that
RT   associates with members of the ezrin-radixin-moesin family.";
RL   J. Cell Biol. 139:169-179(1997).
RN   [6]
RP   INTERACTION WITH SELPLG AND SYK.
RX   PubMed=12387735; DOI=10.1016/S1074-7613(02)00420-X;
RA   Urzainqui A., Serrador J.M., Viedma F., Yanez-Mo M., Rodriguez A.,
RA   Corbi A.L., Alonso-Lebrero J.L., Luque A., Deckert M., Vazquez J.,
RA   Sanchez-Madrid F.;
RT   "ITAM-based interaction of ERM proteins with Syk mediates signaling by
RT   the leukocyte adhesion receptor PSGL-1.";
RL   Immunity 17:401-412(2002).
RN   [7]
RP   INTERACTION WITH PDPN.
RX   PubMed=17046996; DOI=10.1242/jcs.03218;
RA   Martin-Villar E., Megias D., Castel S., Yurrita M.M., Vilaro S.,
RA   Quintanilla M.;
RT   "Podoplanin binds ERM proteins to activate RhoA and promote
RT   epithelial-mesenchymal transition.";
RL   J. Cell Sci. 119:4541-4553(2006).
RN   [8]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PPP1R16B.
RX   PubMed=18586956; DOI=10.1152/ajplung.00325.2007;
RA   Csortos C., Czikora I., Bogatcheva N.V., Adyshev D.M., Poirier C.,
RA   Olah G., Verin A.D.;
RT   "TIMAP is a positive regulator of pulmonary endothelial barrier
RT   function.";
RL   Am. J. Physiol. 295:L440-L450(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION AT THR-558, AND MUTAGENESIS OF TYR-556 AND THR-558.
RX   PubMed=19255442; DOI=10.1073/pnas.0805963106;
RA   Belkina N.V., Liu Y., Hao J.J., Karasuyama H., Shaw S.;
RT   "LOK is a major ERM kinase in resting lymphocytes and regulates
RT   cytoskeletal rearrangement through ERM phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:4707-4712(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-116, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-79 AND LYS-139, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH MSN.
RX   PubMed=21549406; DOI=10.1016/j.virol.2011.04.006;
RA   Henning M.S., Stiedl P., Barry D.S., McMahon R., Morham S.G.,
RA   Walsh D., Naghavi M.H.;
RT   "PDZD8 is a novel moesin-interacting cytoskeletal regulatory protein
RT   that suppresses infection by herpes simplex virus type 1.";
RL   Virology 415:114-121(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74; SER-407 AND SER-527,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   S-NITROSYLATION AT CYS-117, MUTAGENESIS OF ILE-115 AND GLU-120, AND
RP   DOMAIN.
RX   PubMed=25417112; DOI=10.1016/j.cell.2014.09.032;
RA   Jia J., Arif A., Terenzi F., Willard B., Plow E.F., Hazen S.L.,
RA   Fox P.L.;
RT   "Target-selective protein S-nitrosylation by sequence motif
RT   recognition.";
RL   Cell 159:623-634(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 4-577.
RX   PubMed=10847681; DOI=10.1016/S0092-8674(00)80836-3;
RA   Pearson M.A., Reczek D., Bretscher A., Karplus P.A.;
RT   "Structure of the ERM protein moesin reveals the FERM domain fold
RT   masked by an extended actin binding tail domain.";
RL   Cell 101:259-270(2000).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1-346.
RX   PubMed=11401550; DOI=10.1021/bi010419h;
RA   Edwards S.D., Keep N.H.;
RT   "The 2.7 A crystal structure of the activated FERM domain of moesin:
RT   an analysis of structural changes on activation.";
RL   Biochemistry 40:7061-7068(2001).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 1-297 IN COMPLEX WITH
RP   SLC9A3R1.
RX   PubMed=15020681; DOI=10.1242/jcs.01038;
RA   Finnerty C.M., Chambers D., Ingraffea J., Faber H.R., Karplus P.A.,
RA   Bretscher A.;
RT   "The EBP50-moesin interaction involves a binding site regulated by
RT   direct masking on the FERM domain.";
RL   J. Cell Sci. 117:1547-1552(2004).
RN   [23]
RP   VARIANT IMD50 TRP-171, CHARACTERIZATION OF VARIANT IMD50 TRP-171, AND
RP   FUNCTION.
RX   PubMed=27405666; DOI=10.1016/j.jaci.2016.04.032;
RA   Lagresle-Peyrou C., Luce S., Ouchani F., Soheili T.S., Sadek H.,
RA   Chouteau M., Durand A., Pic I., Majewski J., Brouzes C., Lambert N.,
RA   Bohineust A., Verhoeyen E., Cosset F.L., Magerus-Chatinet A.,
RA   Rieux-Laucat F., Gandemer V., Monnier D., Heijmans C., van Gijn M.,
RA   Dalm V.A., Mahlaoui N., Stephan J.L., Picard C., Durandy A.,
RA   Kracker S., Hivroz C., Jabado N., de Saint Basile G., Fischer A.,
RA   Cavazzana M., Andre-Schmutz I.;
RT   "X-linked primary immunodeficiency associated with hemizygous
RT   mutations in the moesin (MSN) gene.";
RL   J. Allergy Clin. Immunol. 138:1681-1689(2016).
CC   -!- FUNCTION: Probably involved in connections of major cytoskeletal
CC       structures to the plasma membrane. May inhibit herpes simplex
CC       virus 1 infection at an early stage. Plays a role in regulating
CC       the proliferation, migration, and adhesion of human lymphoid cells
CC       and participates in immunologic synapse formation
CC       (PubMed:27405666). {ECO:0000269|PubMed:21549406,
CC       ECO:0000269|PubMed:27405666}.
CC   -!- ENZYME REGULATION: A head-to-tail association, of the N-terminal
CC       and C-terminal halves results in a closed conformation (inactive
CC       form) which is incapable of actin or membrane-binding.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: In resting T-cells, part of a PAG1-SLC9A3R1-MSN complex
CC       which is disrupted upon TCR activation (By similarity). Binds
CC       SLC9A3R1. Interacts with PPP1R16B. Interacts with PDZD8. Interacts
CC       with SELPLG and SYK; mediates the activation of SYK by SELPLG.
CC       Interacts with PDPN (via cytoplasmic domain); activates RHOA and
CC       promotes epithelial-mesenchymal transition (PubMed:17046996).
CC       Interacts with SPN, CD44 and ICAM2 (By similarity).
CC       {ECO:0000250|UniProtKB:P26041, ECO:0000269|PubMed:12387735,
CC       ECO:0000269|PubMed:15020681, ECO:0000269|PubMed:17046996,
CC       ECO:0000269|PubMed:18586956, ECO:0000269|PubMed:21549406,
CC       ECO:0000269|PubMed:9314537}.
CC   -!- INTERACTION:
CC       P16070:CD44; NbExp=6; IntAct=EBI-528768, EBI-490245;
CC       Q5S007:LRRK2; NbExp=17; IntAct=EBI-528768, EBI-5323863;
CC       Q5S006:Lrrk2 (xeno); NbExp=2; IntAct=EBI-528768, EBI-2693710;
CC       P97820:Map4k4 (xeno); NbExp=2; IntAct=EBI-528768, EBI-644181;
CC       O14745:SLC9A3R1; NbExp=4; IntAct=EBI-528768, EBI-349787;
CC       P54274:TERF1; NbExp=2; IntAct=EBI-528768, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18586956};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:P26041};
CC       Cytoplasmic side {ECO:0000250|UniProtKB:P26041}. Cytoplasm,
CC       cytoskeleton {ECO:0000250|UniProtKB:P26041}. Apical cell membrane
CC       {ECO:0000250|UniProtKB:P26041}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P26041}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P26041}. Cell projection, microvillus
CC       membrane {ECO:0000250|UniProtKB:P26041}; Peripheral membrane
CC       protein {ECO:0000250|UniProtKB:P26041}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P26041}. Cell projection, microvillus
CC       {ECO:0000250|UniProtKB:P26041}. Note=Phosphorylated form is
CC       enriched in microvilli-like structures at apical membrane.
CC       Increased cell membrane localization of both phosphorylated and
CC       non-phosphorylated forms seen after thrombin treatment (By
CC       similarity). {ECO:0000250|UniProtKB:P26041,
CC       ECO:0000269|PubMed:18586956}.
CC   -!- TISSUE SPECIFICITY: In all tissues and cultured cells studied.
CC   -!- DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for
CC       cysteine S-nitrosylation mediated by the iNOS-S100A8/A9
CC       transnitrosylase complex. {ECO:0000305|PubMed:25417112}.
CC   -!- PTM: Phosphorylation on Thr-558 is crucial for the formation of
CC       microvilli-like structures. Phosphorylation by ROCK2 suppresses
CC       the head-to-tail association of the N-terminal and C-terminal
CC       halves resulting in an opened conformation which is capable of
CC       actin and membrane-binding (By similarity). Phosphorylation on
CC       Thr-558 by STK10 negatively regulates lymphocyte migration and
CC       polarization. {ECO:0000250, ECO:0000269|PubMed:19255442}.
CC   -!- PTM: S-nitrosylation of Cys-117 is induced by interferon-gamma and
CC       oxidatively-modified low-densitity lipoprotein (LDL(ox))
CC       implicating the iNOS-S100A8/9 transnitrosylase complex.
CC       {ECO:0000269|PubMed:25417112}.
CC   -!- DISEASE: Immunodeficiency 50 (IMD50) [MIM:300988]: A primary
CC       immunodeficiency disorder characterized by onset of recurrent
CC       bacterial or varicella zoster virus infections in early childhood,
CC       profound lymphopenia, hypogammaglobulinemia, fluctuating
CC       monocytopenia and neutropenia, and a poor immune response to
CC       vaccine antigens. {ECO:0000269|PubMed:27405666}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MSNID363.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M69066; AAA36322.1; -; mRNA.
DR   EMBL; Z98946; CAB46379.1; -; Genomic_DNA.
DR   EMBL; BC017293; AAH17293.1; -; mRNA.
DR   CCDS; CCDS14382.1; -.
DR   PIR; A41289; A41289.
DR   RefSeq; NP_002435.1; NM_002444.2.
DR   UniGene; Hs.713679; -.
DR   UniGene; Hs.87752; -.
DR   PDB; 1E5W; X-ray; 2.70 A; A=2-346.
DR   PDB; 1EF1; X-ray; 1.90 A; A/B=4-297, C/D=488-577.
DR   PDB; 1SGH; X-ray; 3.50 A; A=1-297.
DR   PDBsum; 1E5W; -.
DR   PDBsum; 1EF1; -.
DR   PDBsum; 1SGH; -.
DR   ProteinModelPortal; P26038; -.
DR   SMR; P26038; -.
DR   BioGrid; 110584; 132.
DR   DIP; DIP-33841N; -.
DR   IntAct; P26038; 27.
DR   MINT; P26038; -.
DR   STRING; 9606.ENSP00000353408; -.
DR   iPTMnet; P26038; -.
DR   PhosphoSitePlus; P26038; -.
DR   SwissPalm; P26038; -.
DR   BioMuta; MSN; -.
DR   DMDM; 127234; -.
DR   OGP; P26038; -.
DR   EPD; P26038; -.
DR   PaxDb; P26038; -.
DR   PeptideAtlas; P26038; -.
DR   PRIDE; P26038; -.
DR   TopDownProteomics; P26038; -.
DR   DNASU; 4478; -.
DR   Ensembl; ENST00000360270; ENSP00000353408; ENSG00000147065.
DR   GeneID; 4478; -.
DR   KEGG; hsa:4478; -.
DR   CTD; 4478; -.
DR   DisGeNET; 4478; -.
DR   EuPathDB; HostDB:ENSG00000147065.16; -.
DR   GeneCards; MSN; -.
DR   HGNC; HGNC:7373; MSN.
DR   HPA; CAB010898; -.
DR   HPA; CAB047336; -.
DR   HPA; CAB047338; -.
DR   HPA; HPA000263; -.
DR   HPA; HPA011135; -.
DR   HPA; HPA011227; -.
DR   MalaCards; MSN; -.
DR   MIM; 300988; phenotype.
DR   MIM; 309845; gene.
DR   neXtProt; NX_P26038; -.
DR   OpenTargets; ENSG00000147065; -.
DR   PharmGKB; PA31178; -.
DR   eggNOG; KOG3529; Eukaryota.
DR   eggNOG; ENOG410XQFP; LUCA.
DR   GeneTree; ENSGT00890000139341; -.
DR   HOGENOM; HOG000007113; -.
DR   HOVERGEN; HBG002185; -.
DR   InParanoid; P26038; -.
DR   KO; K05763; -.
DR   OMA; MKNQEHL; -.
DR   OrthoDB; EOG091G06UO; -.
DR   PhylomeDB; P26038; -.
DR   TreeFam; TF313935; -.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-8950505; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation.
DR   SIGNOR; P26038; -.
DR   ChiTaRS; MSN; human.
DR   EvolutionaryTrace; P26038; -.
DR   GeneWiki; Moesin; -.
DR   GenomeRNAi; 4478; -.
DR   PMAP-CutDB; P26038; -.
DR   PRO; PR:P26038; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000147065; -.
DR   CleanEx; HS_MSN; -.
DR   ExpressionAtlas; P26038; baseline and differential.
DR   Genevisible; P26038; HS.
DR   GO; GO:0045177; C:apical part of cell; IDA:BHF-UCL.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0071944; C:cell periphery; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:CAFA.
DR   GO; GO:0005737; C:cytoplasm; HDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0071437; C:invadopodium; IDA:UniProtKB.
DR   GO; GO:0005902; C:microvillus; IDA:BHF-UCL.
DR   GO; GO:0031528; C:microvillus membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0031143; C:pseudopodium; IDA:UniProtKB.
DR   GO; GO:0001931; C:uropod; IEA:Ensembl.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IEA:InterPro.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0019899; F:enzyme binding; IPI:CAFA.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc.
DR   GO; GO:0071394; P:cellular response to testosterone stimulus; IDA:UniProtKB.
DR   GO; GO:0061028; P:establishment of endothelial barrier; IGI:UniProtKB.
DR   GO; GO:0045198; P:establishment of epithelial cell apical/basal polarity; IMP:UniProtKB.
DR   GO; GO:0022612; P:gland morphogenesis; IMP:UniProtKB.
DR   GO; GO:0001771; P:immunological synapse formation; IDA:UniProtKB.
DR   GO; GO:0035722; P:interleukin-12-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IEP:BHF-UCL.
DR   GO; GO:0050900; P:leukocyte migration; IEP:BHF-UCL.
DR   GO; GO:0022614; P:membrane to membrane docking; IEP:BHF-UCL.
DR   GO; GO:0006928; P:movement of cell or subcellular component; TAS:UniProtKB.
DR   GO; GO:1903364; P:positive regulation of cellular protein catabolic process; IGI:UniProtKB.
DR   GO; GO:2000643; P:positive regulation of early endosome to late endosome transport; IGI:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IGI:UniProtKB.
DR   GO; GO:0071803; P:positive regulation of podosome assembly; IEA:Ensembl.
DR   GO; GO:1902966; P:positive regulation of protein localization to early endosome; IGI:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB.
DR   GO; GO:0008361; P:regulation of cell size; IMP:UniProtKB.
DR   GO; GO:2000401; P:regulation of lymphocyte migration; IMP:UniProtKB.
DR   GO; GO:1902115; P:regulation of organelle assembly; IGI:UniProtKB.
DR   GO; GO:0070489; P:T cell aggregation; IDA:UniProtKB.
DR   GO; GO:0072678; P:T cell migration; IDA:UniProtKB.
DR   GO; GO:0042098; P:T cell proliferation; IDA:UniProtKB.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR011174; ERM.
DR   InterPro; IPR011259; ERM_C_dom.
DR   InterPro; IPR000798; Ez/rad/moesin-like.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_sf.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR019747; FERM_CS.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR018979; FERM_N.
DR   InterPro; IPR018980; FERM_PH-like_C.
DR   InterPro; IPR008954; Moesin_tail_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00769; ERM; 1.
DR   Pfam; PF09380; FERM_C; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF09379; FERM_N; 1.
DR   PIRSF; PIRSF002305; ERM; 1.
DR   PRINTS; PR00935; BAND41.
DR   PRINTS; PR00661; ERMFAMILY.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM01196; FERM_C; 1.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF48678; SSF48678; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00660; FERM_1; 1.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell membrane; Cell projection;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Disease mutation; Membrane; Phosphoprotein; Reference proteome;
KW   S-nitrosylation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:1924289}.
FT   CHAIN         2    577       Moesin.
FT                                /FTId=PRO_0000219416.
FT   DOMAIN        2    295       FERM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00084}.
FT   MOTIF       115    120       [IL]-x-C-x-x-[DE] motif.
FT                                {ECO:0000305|PubMed:25417112}.
FT   MOD_RES      60     60       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P15311}.
FT   MOD_RES      74     74       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      79     79       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      83     83       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P26043}.
FT   MOD_RES     116    116       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     117    117       S-nitrosocysteine.
FT                                {ECO:0000269|PubMed:25417112}.
FT   MOD_RES     139    139       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     146    146       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P15311}.
FT   MOD_RES     165    165       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P26041}.
FT   MOD_RES     407    407       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     527    527       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     558    558       Phosphothreonine; by ROCK2 and STK10.
FT                                {ECO:0000269|PubMed:19255442}.
FT   VARIANT     171    171       R -> W (in IMD50; decreased protein
FT                                abundance in T cell; loss of T cell
FT                                proliferation after T cell activation;
FT                                does not affect immunologic synapses
FT                                formation; decreased T cell migration in
FT                                response to activation by chemokines;
FT                                increased T cell adhesion in response to
FT                                activation by integrins;
FT                                dbSNP:rs1057519074).
FT                                {ECO:0000269|PubMed:27405666}.
FT                                /FTId=VAR_078026.
FT   MUTAGEN     115    115       I->M: Inhibits S-nitrosylation of Cys-
FT                                117; when associated with M-120.
FT                                {ECO:0000269|PubMed:25417112}.
FT   MUTAGEN     120    120       E->M: Inhibits S-nitrosylation of Cys-
FT                                117; when associated with M-115.
FT                                {ECO:0000269|PubMed:25417112}.
FT   MUTAGEN     556    556       Y->R: Impairs phosphorylation by STK10.
FT                                {ECO:0000269|PubMed:19255442}.
FT   MUTAGEN     558    558       T->A: Abolishes phosphorylation by STK10.
FT                                {ECO:0000269|PubMed:19255442}.
FT   MUTAGEN     558    558       T->D: Phosphomimetic mutant.
FT                                {ECO:0000269|PubMed:19255442}.
FT   STRAND        5     11       {ECO:0000244|PDB:1EF1}.
FT   STRAND       14     20       {ECO:0000244|PDB:1EF1}.
FT   HELIX        26     37       {ECO:0000244|PDB:1EF1}.
FT   HELIX        42     44       {ECO:0000244|PDB:1EF1}.
FT   STRAND       45     51       {ECO:0000244|PDB:1EF1}.
FT   STRAND       56     58       {ECO:0000244|PDB:1EF1}.
FT   STRAND       61     64       {ECO:0000244|PDB:1EF1}.
FT   HELIX        65     67       {ECO:0000244|PDB:1EF1}.
FT   STRAND       74     84       {ECO:0000244|PDB:1EF1}.
FT   HELIX        89     92       {ECO:0000244|PDB:1EF1}.
FT   HELIX        96    111       {ECO:0000244|PDB:1EF1}.
FT   HELIX       119    134       {ECO:0000244|PDB:1EF1}.
FT   TURN        139    141       {ECO:0000244|PDB:1EF1}.
FT   TURN        144    149       {ECO:0000244|PDB:1EF1}.
FT   HELIX       155    160       {ECO:0000244|PDB:1EF1}.
FT   HELIX       165    178       {ECO:0000244|PDB:1EF1}.
FT   TURN        179    181       {ECO:0000244|PDB:1EF1}.
FT   HELIX       184    195       {ECO:0000244|PDB:1EF1}.
FT   TURN        199    202       {ECO:0000244|PDB:1EF1}.
FT   STRAND      204    209       {ECO:0000244|PDB:1EF1}.
FT   STRAND      215    221       {ECO:0000244|PDB:1EF1}.
FT   STRAND      224    229       {ECO:0000244|PDB:1EF1}.
FT   STRAND      233    235       {ECO:0000244|PDB:1EF1}.
FT   STRAND      237    241       {ECO:0000244|PDB:1EF1}.
FT   HELIX       242    244       {ECO:0000244|PDB:1EF1}.
FT   STRAND      245    251       {ECO:0000244|PDB:1EF1}.
FT   STRAND      254    264       {ECO:0000244|PDB:1EF1}.
FT   STRAND      267    270       {ECO:0000244|PDB:1EF1}.
FT   HELIX       274    295       {ECO:0000244|PDB:1EF1}.
FT   HELIX       301    343       {ECO:0000244|PDB:1E5W}.
FT   HELIX       504    507       {ECO:0000244|PDB:1EF1}.
FT   HELIX       511    514       {ECO:0000244|PDB:1EF1}.
FT   HELIX       516    530       {ECO:0000244|PDB:1EF1}.
FT   HELIX       540    550       {ECO:0000244|PDB:1EF1}.
FT   HELIX       555    562       {ECO:0000244|PDB:1EF1}.
FT   HELIX       567    575       {ECO:0000244|PDB:1EF1}.
SQ   SEQUENCE   577 AA;  67820 MW;  865A6C5CB14AE586 CRC64;
     MPKTISVRVT TMDAELEFAI QPNTTGKQLF DQVVKTIGLR EVWFFGLQYQ DTKGFSTWLK
     LNKKVTAQDV RKESPLLFKF RAKFYPEDVS EELIQDITQR LFFLQVKEGI LNDDIYCPPE
     TAVLLASYAV QSKYGDFNKE VHKSGYLAGD KLLPQRVLEQ HKLNKDQWEE RIQVWHEEHR
     GMLREDAVLE YLKIAQDLEM YGVNYFSIKN KKGSELWLGV DALGLNIYEQ NDRLTPKIGF
     PWSEIRNISF NDKKFVIKPI DKKAPDFVFY APRLRINKRI LALCMGNHEL YMRRRKPDTI
     EVQQMKAQAR EEKHQKQMER AMLENEKKKR EMAEKEKEKI EREKEELMER LKQIEEQTKK
     AQQELEEQTR RALELEQERK RAQSEAEKLA KERQEAEEAK EALLQASRDQ KKTQEQLALE
     MAELTARISQ LEMARQKKES EAVEWQQKAQ MVQEDLEKTR AELKTAMSTP HVAEPAENEQ
     DEQDENGAEA SADLRADAMA KDRSEEERTT EAEKNERVQK HLKALTSELA NARDESKKTA
     NDMIHAENMR LGRDKYKTLR QIRQGNTKQR IDEFESM
//
ID   V9HWC0_HUMAN            Unreviewed;       577 AA.
AC   V9HWC0;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   28-FEB-2018, entry version 41.
DE   SubName: Full=Epididymis luminal protein 70 {ECO:0000313|EMBL:ACJ13690.1};
DE   SubName: Full=Moesin, isoform CRA_a {ECO:0000313|EMBL:EAX05398.1};
GN   Name=HEL70 {ECO:0000313|EMBL:ACJ13690.1};
GN   Synonyms=MSN {ECO:0000313|EMBL:EAX05398.1};
GN   ORFNames=hCG_18939 {ECO:0000313|EMBL:EAX05398.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ13690.1};
RN   [1] {ECO:0000313|EMBL:EAX05398.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX05398.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACJ13690.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU794636; ACJ13690.1; -; mRNA.
DR   EMBL; CH471132; EAX05398.1; -; Genomic_DNA.
DR   RefSeq; NP_002435.1; NM_002444.2.
DR   UniGene; Hs.713679; -.
DR   UniGene; Hs.87752; -.
DR   SMR; V9HWC0; -.
DR   MaxQB; V9HWC0; -.
DR   GeneID; 4478; -.
DR   KEGG; hsa:4478; -.
DR   UCSC; uc004dwf.4; human.
DR   CTD; 4478; -.
DR   EuPathDB; HostDB:ENSG00000147065.16; -.
DR   eggNOG; KOG3529; Eukaryota.
DR   eggNOG; ENOG410XQFP; LUCA.
DR   KO; K05763; -.
DR   OMA; MKNQEHL; -.
DR   OrthoDB; EOG091G06UO; -.
DR   ChiTaRS; MSN; human.
DR   GenomeRNAi; 4478; -.
DR   Bgee; ENSG00000147065; -.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005856; C:cytoskeleton; IEA:InterPro.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0001931; C:uropod; IEA:Ensembl.
DR   GO; GO:0003779; F:actin binding; IEA:InterPro.
DR   GO; GO:0071803; P:positive regulation of podosome assembly; IEA:Ensembl.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR011174; ERM.
DR   InterPro; IPR011259; ERM_C_dom.
DR   InterPro; IPR000798; Ez/rad/moesin-like.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_sf.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR019747; FERM_CS.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR018979; FERM_N.
DR   InterPro; IPR018980; FERM_PH-like_C.
DR   InterPro; IPR008954; Moesin_tail_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00769; ERM; 1.
DR   Pfam; PF09380; FERM_C; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF09379; FERM_N; 1.
DR   PIRSF; PIRSF002305; ERM; 1.
DR   PRINTS; PR00935; BAND41.
DR   PRINTS; PR00661; ERMFAMILY.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM01196; FERM_C; 1.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF48678; SSF48678; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00660; FERM_1; 1.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN        5    295       FERM. {ECO:0000259|PROSITE:PS50057}.
FT   COILED      158    178       {ECO:0000256|SAM:Coils}.
FT   COILED      306    469       {ECO:0000256|SAM:Coils}.
FT   COILED      515    542       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   577 AA;  67820 MW;  865A6C5CB14AE586 CRC64;
     MPKTISVRVT TMDAELEFAI QPNTTGKQLF DQVVKTIGLR EVWFFGLQYQ DTKGFSTWLK
     LNKKVTAQDV RKESPLLFKF RAKFYPEDVS EELIQDITQR LFFLQVKEGI LNDDIYCPPE
     TAVLLASYAV QSKYGDFNKE VHKSGYLAGD KLLPQRVLEQ HKLNKDQWEE RIQVWHEEHR
     GMLREDAVLE YLKIAQDLEM YGVNYFSIKN KKGSELWLGV DALGLNIYEQ NDRLTPKIGF
     PWSEIRNISF NDKKFVIKPI DKKAPDFVFY APRLRINKRI LALCMGNHEL YMRRRKPDTI
     EVQQMKAQAR EEKHQKQMER AMLENEKKKR EMAEKEKEKI EREKEELMER LKQIEEQTKK
     AQQELEEQTR RALELEQERK RAQSEAEKLA KERQEAEEAK EALLQASRDQ KKTQEQLALE
     MAELTARISQ LEMARQKKES EAVEWQQKAQ MVQEDLEKTR AELKTAMSTP HVAEPAENEQ
     DEQDENGAEA SADLRADAMA KDRSEEERTT EAEKNERVQK HLKALTSELA NARDESKKTA
     NDMIHAENMR LGRDKYKTLR QIRQGNTKQR IDEFESM
//
ID   A0A087X0L2_HUMAN        Unreviewed;       239 AA.
AC   A0A087X0L2;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   28-FEB-2018, entry version 27.
DE   SubName: Full=Mucin-1 {ECO:0000313|Ensembl:ENSP00000483482};
GN   Name=MUC1 {ECO:0000313|Ensembl:ENSP00000483482};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000483482, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000483482}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4] {ECO:0000313|Ensembl:ENSP00000483482}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000483482}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC234582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001191221.1; NM_001204292.1.
DR   UniGene; Hs.89603; -.
DR   ProteinModelPortal; A0A087X0L2; -.
DR   SMR; A0A087X0L2; -.
DR   EPD; A0A087X0L2; -.
DR   PeptideAtlas; A0A087X0L2; -.
DR   PRIDE; A0A087X0L2; -.
DR   Ensembl; ENST00000610359; ENSP00000483482; ENSG00000185499.
DR   GeneID; 4582; -.
DR   UCSC; uc009wpx.4; human.
DR   CTD; 4582; -.
DR   EuPathDB; HostDB:ENSG00000185499.16; -.
DR   HGNC; HGNC:7508; MUC1.
DR   OpenTargets; ENSG00000185499; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185499; -.
DR   ExpressionAtlas; A0A087X0L2; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:A0A087X0L2,
KW   ECO:0000213|MaxQB:A0A087X0L2, ECO:0000213|PeptideAtlas:A0A087X0L2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    239       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001832146.
FT   TRANSMEM    143    168       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   239 AA;  25405 MW;  2D7880F01A8FD2BD CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAIPAPTTTK SCRETFLKWP GSVVVQLTLA FREGTINVHD VETQFNQYKT EAASRYNLTI
     SDVSVSDVPF PFSAQSGAGV PGWGIALLVL VCVLVALAIV YLIALAVCQC RRKNYGQLDI
     FPARDTYHPM SEYPTYHTHG RYVPPSSTDR SPYEKVSAGN GGSSLSYTNP AVAATSANL
//
ID   A0A087X2A4_HUMAN        Unreviewed;       484 AA.
AC   A0A087X2A4;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   28-FEB-2018, entry version 26.
DE   SubName: Full=Mucin-1 {ECO:0000313|Ensembl:ENSP00000484824};
GN   Name=MUC1 {ECO:0000313|Ensembl:ENSP00000484824};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000484824, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000484824}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4] {ECO:0000313|Ensembl:ENSP00000484824}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000484824}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC234582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001191215.1; NM_001204286.1.
DR   UniGene; Hs.89603; -.
DR   ProteinModelPortal; A0A087X2A4; -.
DR   SMR; A0A087X2A4; -.
DR   PeptideAtlas; A0A087X2A4; -.
DR   PRIDE; A0A087X2A4; -.
DR   Ensembl; ENST00000612778; ENSP00000484824; ENSG00000185499.
DR   GeneID; 4582; -.
DR   KEGG; hsa:4582; -.
DR   UCSC; uc057lmt.1; human.
DR   CTD; 4582; -.
DR   EuPathDB; HostDB:ENSG00000185499.16; -.
DR   HGNC; HGNC:7508; MUC1.
DR   OpenTargets; ENSG00000185499; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   KO; K06568; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185499; -.
DR   ExpressionAtlas; A0A087X2A4; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:A0A087X2A4,
KW   ECO:0000213|MaxQB:A0A087X2A4, ECO:0000213|PeptideAtlas:A0A087X2A4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    484       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001832227.
FT   TRANSMEM    388    413       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      268    377       SEA. {ECO:0000259|PROSITE:PS50024}.
SQ   SEQUENCE   484 AA;  50063 MW;  FE0B2FC6FB205D29 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAVSMTSSVL SSHSPGSGSS TTQGQDVTLA PATEPASGSA ATWGQDVTSV PVTRPALGST
     TPPAHDVTSA PDNKPAPGST APPAHGVTSA PDTRPAPGST APPAHGVTSA PDNRPALGST
     APPVHNVTSA SGSASGSAST LVHNGTSARA TTTPASKSTP FSIPSHHSDT PTTLASHSTK
     TDASSTHHST VPPLTSSNHS TSPQLSTGVS FFFLSFHISN LQFNSSLEDP STDYYQELQR
     DISEMFLQIY KQGGFLGLSN IKFRPGSVVV QLTLAFREGT INVHDVETQF NQYKTEAASR
     YNLTISDVSV SDVPFPFSAQ SGAGVPGWGI ALLVLVCVLV ALAIVYLIAL AVCQCRRKNY
     GQLDIFPARD TYHPMSEYPT YHTHGRYVPP SSTDRSPYEK VSAGNGGSSL SYTNPAVAAT
     SANL
//
ID   A0A0A0MRB3_HUMAN        Unreviewed;       241 AA.
AC   A0A0A0MRB3;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   28-FEB-2018, entry version 27.
DE   SubName: Full=Mucin-1 {ECO:0000313|Ensembl:ENSP00000343482};
GN   Name=MUC1 {ECO:0000313|Ensembl:ENSP00000343482};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000343482, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000343482}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4] {ECO:0000313|Ensembl:ENSP00000343482}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000343482}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC234582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001191220.1; NM_001204291.1.
DR   UniGene; Hs.89603; -.
DR   ProteinModelPortal; A0A0A0MRB3; -.
DR   SMR; A0A0A0MRB3; -.
DR   PeptideAtlas; A0A0A0MRB3; -.
DR   PRIDE; A0A0A0MRB3; -.
DR   Ensembl; ENST00000338684; ENSP00000343482; ENSG00000185499.
DR   GeneID; 4582; -.
DR   UCSC; uc009wpt.4; human.
DR   CTD; 4582; -.
DR   EuPathDB; HostDB:ENSG00000185499.16; -.
DR   HGNC; HGNC:7508; MUC1.
DR   OpenTargets; ENSG00000185499; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185499; -.
DR   ExpressionAtlas; A0A0A0MRB3; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MRB3,
KW   ECO:0000213|MaxQB:A0A0A0MRB3, ECO:0000213|PeptideAtlas:A0A0A0MRB3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    241       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001967087.
FT   TRANSMEM    145    170       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       26    134       SEA. {ECO:0000259|PROSITE:PS50024}.
SQ   SEQUENCE   241 AA;  25655 MW;  F919FE9E3F664EE2 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAFLQIYKQG GFLGLSNIKF RPGSVVVQLT LAFREGTINV HDVETQFNQY KTEAASRYNL
     TISDVSVSDV PFPFSAQSGA GVPGWGIALL VLVCVLVALA IVYLIALAVC QCRRKNYGQL
     DIFPARDTYH PMSEYPTYHT HGRYVPPSST DRSPYEKVSA GNGGSSLSYT NPAVAATSAN
     L
//
ID   A0A0C4DGW3_HUMAN        Unreviewed;       475 AA.
AC   A0A0C4DGW3;
DT   01-APR-2015, integrated into UniProtKB/TrEMBL.
DT   01-APR-2015, sequence version 1.
DT   28-FEB-2018, entry version 23.
DE   SubName: Full=Mucin-1 {ECO:0000313|Ensembl:ENSP00000481231};
GN   Name=MUC1 {ECO:0000313|Ensembl:ENSP00000481231};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000481231, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000481231}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4] {ECO:0000313|Ensembl:ENSP00000481231}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2015) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000481231}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC234582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001191214.1; NM_001204285.1.
DR   UniGene; Hs.89603; -.
DR   ProteinModelPortal; A0A0C4DGW3; -.
DR   SMR; A0A0C4DGW3; -.
DR   MEROPS; S71.001; -.
DR   PeptideAtlas; A0A0C4DGW3; -.
DR   Ensembl; ENST00000620103; ENSP00000481231; ENSG00000185499.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   EuPathDB; HostDB:ENSG00000185499.16; -.
DR   HGNC; HGNC:7508; MUC1.
DR   OpenTargets; ENSG00000185499; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   PhylomeDB; A0A0C4DGW3; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185499; -.
DR   ExpressionAtlas; A0A0C4DGW3; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:A0A0C4DGW3,
KW   ECO:0000213|MaxQB:A0A0C4DGW3, ECO:0000213|PeptideAtlas:A0A0C4DGW3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    475       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002181428.
FT   TRANSMEM    379    404       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      259    368       SEA. {ECO:0000259|PROSITE:PS50024}.
SQ   SEQUENCE   475 AA;  49224 MW;  CB64D56690818614 CRC64;
     MTPGTQSPFF LLLLLTVLTV VTGSGHASST PGGEKETSAT QRSSVPSSTE KNAVSMTSSV
     LSSHSPGSGS STTQGQDVTL APATEPASGS AATWGQDVTS VPVTRPALGS TTPPAHDVTS
     APDNKPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDNRPALGS TAPPVHNVTS
     ASGSASGSAS TLVHNGTSAR ATTTPASKST PFSIPSHHSD TPTTLASHST KTDASSTHHS
     TVPPLTSSNH STSPQLSTGV SFFFLSFHIS NLQFNSSLED PSTDYYQELQ RDISEMFLQI
     YKQGGFLGLS NIKFRPGSVV VQLTLAFREG TINVHDVETQ FNQYKTEAAS RYNLTISDVS
     VSDVPFPFSA QSGAGVPGWG IALLVLVCVL VALAIVYLIA LAVCQCRRKN YGQLDIFPAR
     DTYHPMSEYP TYHTHGRYVP PSSTDRSPYE KVSAGNGGSS LSYTNPAVAA TSANL
//
ID   A5YRU5_HUMAN            Unreviewed;       282 AA.
AC   A5YRU5;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   25-OCT-2017, entry version 66.
DE   SubName: Full=MUC1 isoform Z-LSP {ECO:0000313|EMBL:ABQ59622.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABQ59622.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ59622.1};
RN   [1] {ECO:0000313|EMBL:ABQ59622.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF583647; ABQ59622.1; -; mRNA.
DR   RefSeq; NP_001191216.1; NM_001204287.1.
DR   UniGene; Hs.89603; -.
DR   ProteinModelPortal; A5YRU5; -.
DR   MaxQB; A5YRU5; -.
DR   PeptideAtlas; A5YRU5; -.
DR   PRIDE; A5YRU5; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   HOGENOM; HOG000290201; -.
DR   HOVERGEN; HBG003075; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A5YRU5; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    282       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002690093.
FT   TRANSMEM    186    211       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       66    175       SEA. {ECO:0000259|PROSITE:PS50024}.
SQ   SEQUENCE   282 AA;  30431 MW;  2E431D8053353D57 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NALSTGVSFF FLSFHISNLQ FNSSLEDPST DYYQELQRDI SEMFLQIYKQ GGFLGLSNIK
     FRPGSVVVQL TLAFREGTIN VHDVETQFNQ YKTEAASRYN LTISDVSVSD VPFPFSAQSG
     AGVPGWGIAL LVLVCVLVAL AIVYLIALAV CQCRRKNYGQ LDIFPARDTY HPMSEYPTYH
     THGRYVPPSS TDRSPYEKVS AGNGGSSLSY TNPAVAATSA NL
//
ID   A5YRU7_HUMAN            Unreviewed;       219 AA.
AC   A5YRU7;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   25-OCT-2017, entry version 53.
DE   SubName: Full=MUC1 isoform T7 {ECO:0000313|EMBL:ABQ59624.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABQ59624.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ59624.1};
RN   [1] {ECO:0000313|EMBL:ABQ59624.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF583649; ABQ59624.1; -; mRNA.
DR   RefSeq; NP_001191217.1; NM_001204288.1.
DR   UniGene; Hs.89603; -.
DR   ProteinModelPortal; A5YRU7; -.
DR   SMR; A5YRU7; -.
DR   PeptideAtlas; A5YRU7; -.
DR   PRIDE; A5YRU7; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   HOVERGEN; HBG003075; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A5YRU7; HS.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    219       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002690152.
FT   DOMAIN       44    157       SEA. {ECO:0000259|PROSITE:PS50024}.
SQ   SEQUENCE   219 AA;  23466 MW;  C0DB674812B59BB5 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAFNSSLEDP STDYYQELQR DISEMFLQIY KQGGFLGLSN IKFRPGSVVV QLTLAFREGT
     INVHDVETQF NQYKTEAASR YNLTISDVSV WGWGARLGHR AAGAGLCSGC AGHCLSHCLG
     CLSVPPKELR AAGHLSSPGY LPSYERVPHL PHPWALCAP
//
ID   A5YRV0_HUMAN            Unreviewed;       238 AA.
AC   A5YRV0;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   31-JAN-2018, entry version 60.
DE   SubName: Full=MUC1 isoform G-LSP {ECO:0000313|EMBL:ABQ59627.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABQ59627.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ59627.1};
RN   [1] {ECO:0000313|EMBL:ABQ59627.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF583652; ABQ59627.1; -; mRNA.
DR   RefSeq; NP_001191218.1; NM_001204289.1.
DR   UniGene; Hs.89603; -.
DR   ProteinModelPortal; A5YRV0; -.
DR   SMR; A5YRV0; -.
DR   MEROPS; S71.001; -.
DR   PeptideAtlas; A5YRV0; -.
DR   PRIDE; A5YRV0; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   HOVERGEN; HBG003075; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A5YRV0; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    238       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002690095.
FT   TRANSMEM    142    167       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       19    131       SEA. {ECO:0000259|PROSITE:PS50024}.
SQ   SEQUENCE   238 AA;  25267 MW;  253AFB230AE79A8D CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAIYKQGGFL GLSNIKFRPG SVVVQLTLAF REGTINVHDV ETQFNQYKTE AASRYNLTIS
     DVSVSDVPFP FSAQSGAGVP GWGIALLVLV CVLVALAIVY LIALAVCQCR RKNYGQLDIF
     PARDTYHPMS EYPTYHTHGR YVPPSSTDRS PYEKVSAGNG GSSLSYTNPA VAATSANL
//
ID   A5YRV2_HUMAN            Unreviewed;       217 AA.
AC   A5YRV2;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   31-JAN-2018, entry version 60.
DE   SubName: Full=MUC1 isoform T11 {ECO:0000313|EMBL:ABQ59629.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABQ59629.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ59629.1};
RN   [1] {ECO:0000313|EMBL:ABQ59629.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF583654; ABQ59629.1; -; mRNA.
DR   RefSeq; NP_001191219.1; NM_001204290.1.
DR   UniGene; Hs.89603; -.
DR   ProteinModelPortal; A5YRV2; -.
DR   SMR; A5YRV2; -.
DR   MaxQB; A5YRV2; -.
DR   PeptideAtlas; A5YRV2; -.
DR   PRIDE; A5YRV2; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   HOVERGEN; HBG003075; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A5YRV2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     21       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        22    217       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002690021.
FT   TRANSMEM    121    146       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN        1    110       SEA. {ECO:0000259|PROSITE:PS50024}.
SQ   SEQUENCE   217 AA;  23346 MW;  A890B6A231FB3A22 CRC64;
     MTPGTQSPFF LLLLLTVLTG GEKETSATQR SSVPSSTEKN AIYKQGGFLG LSNIKFRPGS
     VVVQLTLAFR EGTINVHDVE TQFNQYKTEA ASRYNLTISD VSVSDVPFPF SAQSGAGVPG
     WGIALLVLVC VLVALAIVYL IALAVCQCRR KNYGQLDIFP ARDTYHPMSE YPTYHTHGRY
     VPPSSTDRSP YEKVSAGNGG SSLSYTNPAV AATSANL
//
ID   A6ZID6_HUMAN            Unreviewed;       241 AA.
AC   A6ZID6;
DT   21-AUG-2007, integrated into UniProtKB/TrEMBL.
DT   21-AUG-2007, sequence version 1.
DT   31-JAN-2018, entry version 59.
DE   SubName: Full=MUC1 isoform M3 {ECO:0000313|EMBL:ABS01295.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABS01295.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABS01295.1};
RN   [1] {ECO:0000313|EMBL:ABS01295.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF670708; ABS01295.1; -; mRNA.
DR   RefSeq; NP_001191220.1; NM_001204291.1.
DR   UniGene; Hs.89603; -.
DR   SMR; A6ZID6; -.
DR   PeptideAtlas; A6ZID6; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   HOGENOM; HOG000290201; -.
DR   HOVERGEN; HBG003075; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A6ZID6; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    241       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002705887.
FT   TRANSMEM    145    170       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       26    134       SEA. {ECO:0000259|PROSITE:PS50024}.
SQ   SEQUENCE   241 AA;  25656 MW;  F4AFFB0837464EE2 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAFLQIYKQG GFLGLSNIKF RPGSVVVQLT LAFREGTINV HDVETQFNQY ETEAASRYNL
     TISDVSVSDV PFPFSAQSGA GVPGWGIALL VLVCVLVALA IVYLIALAVC QCRRKNYGQL
     DIFPARDTYH PMSEYPTYHT HGRYVPPSST DRSPYEKVSA GNGGSSLSYT NPAVAATSAN
     L
//
ID   A6ZID7_HUMAN            Unreviewed;       239 AA.
AC   A6ZID7;
DT   21-AUG-2007, integrated into UniProtKB/TrEMBL.
DT   21-AUG-2007, sequence version 1.
DT   31-JAN-2018, entry version 60.
DE   SubName: Full=MUC1 isoform M4 {ECO:0000313|EMBL:ABS01296.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABS01296.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABS01296.1};
RN   [1] {ECO:0000313|EMBL:ABS01296.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF670709; ABS01296.1; -; mRNA.
DR   RefSeq; NP_001191221.1; NM_001204292.1.
DR   UniGene; Hs.89603; -.
DR   SMR; A6ZID7; -.
DR   MEROPS; S71.001; -.
DR   PeptideAtlas; A6ZID7; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   HOGENOM; HOG000290201; -.
DR   HOVERGEN; HBG003075; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A6ZID7; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    239       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002703655.
FT   TRANSMEM    143    168       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   239 AA;  25378 MW;  B47880EA33840BAC CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAIPAPTTTK SCRETFLKWP GSVVVQLTLA FREGTINVHD VETQFSQYKT EAASRYNLTI
     SDVSVSDVPF PFSAQSGAGV PGWGIALLVL VCVLVALAIV YLIALAVCQC RRKNYGQLDI
     FPARDTYHPM SEYPTYHTHG RYVPPSSTDR SPYEKVSAGN GGSSLSYTNP AVAATSANL
//
ID   A6ZIE4_HUMAN            Unreviewed;       189 AA.
AC   A6ZIE4;
DT   21-AUG-2007, integrated into UniProtKB/TrEMBL.
DT   21-AUG-2007, sequence version 1.
DT   28-FEB-2018, entry version 68.
DE   SubName: Full=MUC1 isoform M10 {ECO:0000313|EMBL:ABS01303.1};
DE   SubName: Full=Mucin-1 {ECO:0000313|Ensembl:ENSP00000483473};
GN   Name=MUC1 {ECO:0000313|EMBL:ABS01303.1,
GN   ECO:0000313|Ensembl:ENSP00000483473};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABS01303.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000483473}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000313|EMBL:ABS01303.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
RN   [4] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [5] {ECO:0000313|Ensembl:ENSP00000483473}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC234582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; EF670716; ABS01303.1; -; mRNA.
DR   RefSeq; NP_001191224.1; NM_001204295.1.
DR   UniGene; Hs.89603; -.
DR   SMR; A6ZIE4; -.
DR   MEROPS; S71.001; -.
DR   PeptideAtlas; A6ZIE4; -.
DR   DNASU; 4582; -.
DR   Ensembl; ENST00000615517; ENSP00000483473; ENSG00000185499.
DR   GeneID; 4582; -.
DR   UCSC; uc009wpl.4; human.
DR   CTD; 4582; -.
DR   EuPathDB; HostDB:ENSG00000185499.16; -.
DR   HGNC; HGNC:7508; MUC1.
DR   OpenTargets; ENSG00000185499; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   HOGENOM; HOG000290201; -.
DR   HOVERGEN; HBG003075; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185499; -.
DR   ExpressionAtlas; A6ZIE4; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR036364; SEA_dom_sf.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:A6ZIE4,
KW   ECO:0000213|MaxQB:A6ZIE4, ECO:0000213|PeptideAtlas:A6ZIE4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    189       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5010103420.
FT   TRANSMEM     93    118       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   189 AA;  20037 MW;  C617B22043CAD95A CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAFNSSLEDP STDYYQELQR DISEMSGAGV PGWGIALLVL VCVLVALAIV YLIALAVCQC
     RRKNYGQLDI FPARDTYHPM SEYPTYHTHG RYVPPSSTDR SPYEKVSAGN GGSSLSYTNP
     AVAATSANL
//
ID   A6ZIE6_HUMAN            Unreviewed;       177 AA.
AC   A6ZIE6;
DT   21-AUG-2007, integrated into UniProtKB/TrEMBL.
DT   21-AUG-2007, sequence version 1.
DT   31-JAN-2018, entry version 62.
DE   SubName: Full=MUC1 isoform S-LSP {ECO:0000313|EMBL:ABS01305.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ABS01305.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABS01305.1};
RN   [1] {ECO:0000313|EMBL:ABS01305.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF670718; ABS01305.1; -; mRNA.
DR   RefSeq; NP_001191226.1; NM_001204297.1.
DR   UniGene; Hs.89603; -.
DR   ProteinModelPortal; A6ZIE6; -.
DR   MEROPS; S71.001; -.
DR   PeptideAtlas; A6ZIE6; -.
DR   PRIDE; A6ZIE6; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   HOGENOM; HOG000290201; -.
DR   HOVERGEN; HBG003075; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; A6ZIE6; HS.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    177       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002705839.
FT   DOMAIN       66    103       SEA. {ECO:0000259|PROSITE:PS50024}.
SQ   SEQUENCE   177 AA;  19116 MW;  2C60A683BB1643A0 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NALSTGVSFF FLSFHISNLQ FNSSLEDPST DYYQELQRDI SEMAVCQCRR KNYGQLDIFP
     ARDTYHPMSE YPTYHTHGRY VPPSSTDRSP YEKVSAGNGG SSLSYTNPAV AATSANL
//
ID   B6ECB3_HUMAN            Unreviewed;       212 AA.
AC   B6ECB3;
DT   25-NOV-2008, integrated into UniProtKB/TrEMBL.
DT   25-NOV-2008, sequence version 1.
DT   31-JAN-2018, entry version 53.
DE   SubName: Full=MUC1 isoform J24 {ECO:0000313|EMBL:ACI25184.1};
GN   Name=MUC1 {ECO:0000313|EMBL:ACI25184.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI25184.1};
RN   [1] {ECO:0000313|EMBL:ACI25184.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ226053; ACI25184.1; -; mRNA.
DR   RefSeq; NP_001191225.1; NM_001204296.1.
DR   UniGene; Hs.89603; -.
DR   ProteinModelPortal; B6ECB3; -.
DR   SMR; B6ECB3; -.
DR   MaxQB; B6ECB3; -.
DR   PeptideAtlas; B6ECB3; -.
DR   PRIDE; B6ECB3; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   HOGENOM; HOG000290201; -.
DR   HOVERGEN; HBG003075; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; B6ECB3; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    212       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002844348.
FT   TRANSMEM    116    141       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   212 AA;  22395 MW;  FF70E57FCE3318E9 CRC64;
     MTPGTQSPFF LLLLLTVLTA TTAPKPATVV TGSGHASSTP GGEKETSATQ RSSVPSSTEK
     NAIPAPTTTK SCRETFLKCF CRFINKGVFW ASPILSSVSD VPFPFSAQSG AGVPGWGIAL
     LVLVCVLVAL AIVYLIALAV CQCRRKNYGQ LDIFPARDTY HPMSEYPTYH THGRYVPPSS
     TDRSPYEKVS AGNGGSSLSY TNPAVAATSA NL
//
ID   MUC1_HUMAN              Reviewed;        1255 AA.
AC   P15941; A5YRV1; A6ZID9; A6ZIE0; B1AVQ8; B1AVR0; B6ECA1; E7ESE5;
AC   E7EUG9; P13931; P15942; P17626; Q0VAP5; Q0VAP6; Q14128; Q14876;
AC   Q16437; Q16442; Q16615; Q6S4Y3; Q7Z547; Q7Z548; Q7Z550; Q7Z552;
AC   Q9BXA4; Q9UE75; Q9UE76; Q9UQL1; Q9Y4J2;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   28-FEB-2018, entry version 202.
DE   RecName: Full=Mucin-1;
DE            Short=MUC-1;
DE   AltName: Full=Breast carcinoma-associated antigen DF3;
DE   AltName: Full=Cancer antigen 15-3;
DE            Short=CA 15-3;
DE   AltName: Full=Carcinoma-associated mucin;
DE   AltName: Full=Episialin;
DE   AltName: Full=H23AG;
DE   AltName: Full=Krebs von den Lungen-6;
DE            Short=KL-6;
DE   AltName: Full=PEMT;
DE   AltName: Full=Peanut-reactive urinary mucin;
DE            Short=PUM;
DE   AltName: Full=Polymorphic epithelial mucin;
DE            Short=PEM;
DE   AltName: Full=Tumor-associated epithelial membrane antigen;
DE            Short=EMA;
DE   AltName: Full=Tumor-associated mucin;
DE   AltName: CD_antigen=CD227;
DE   Contains:
DE     RecName: Full=Mucin-1 subunit alpha;
DE              Short=MUC1-NT;
DE              Short=MUC1-alpha;
DE   Contains:
DE     RecName: Full=Mucin-1 subunit beta;
DE              Short=MUC1-beta;
DE     AltName: Full=MUC1-CT;
DE   Flags: Precursor;
GN   Name=MUC1; Synonyms=PUM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Pancreatic carcinoma;
RX   PubMed=2394722;
RA   Lan M.S., Batra S.K., Qi W.-N., Metzgar R.S., Hollingsworth M.A.;
RT   "Cloning and sequencing of a human pancreatic tumor mucin cDNA.";
RL   J. Biol. Chem. 265:15294-15299(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=2318825;
RA   Ligtenberg M.J.L., Vos H.L., Gennissen A.M.C., Hilkens J.;
RT   "Episialin, a carcinoma-associated mucin, is generated by a
RT   polymorphic gene encoding splice variants with alternative amino
RT   termini.";
RL   J. Biol. Chem. 265:5573-5578(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=1697589;
RA   Gendler S.J., Lancaster C.A., Taylor-Papadimitriou J., Duhig T.,
RA   Peat N., Burchell J., Pemberton L., Lalani E.-N., Wilson D.;
RT   "Molecular cloning and expression of human tumor-associated
RT   polymorphic epithelial mucin.";
RL   J. Biol. Chem. 265:15286-15293(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=2268309; DOI=10.1016/S0006-291X(05)80888-5;
RA   Lancaster C.A., Peat N., Duhig T., Wilson D., Taylor-Papadimitriou J.,
RA   Gendler S.J.;
RT   "Structure and expression of the human polymorphic epithelial mucin
RT   gene: an expressed VNTR unit.";
RL   Biochem. Biophys. Res. Commun. 173:1019-1029(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=2351132; DOI=10.1111/j.1432-1033.1990.tb15511.x;
RA   Wreschner D.H., Hareuveni M., Tsarfaty I., Smorodinsky N., Horev J.,
RA   Zaretsky J., Kotkes P., Weiss M., Lathe R., Dion A., Keydar I.;
RT   "Human epithelial tumor antigen cDNA sequences. Differential splicing
RT   may generate multiple protein forms.";
RL   Eur. J. Biochem. 189:463-473(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary carcinoma;
RX   PubMed=2112460; DOI=10.1111/j.1432-1033.1990.tb15512.x;
RA   Hareuveni M., Tsarfaty I., Zaretsky J., Kotkes P., Horev J.,
RA   Zrihan S., Weiss M., Green S., Lathe R., Keydar I., Wreschner D.H.;
RT   "A transcribed gene, containing a variable number of tandem repeats,
RT   codes for a human epithelial tumor antigen. cDNA cloning, expression
RT   of the transfected gene and over-expression in breast cancer tissue.";
RL   Eur. J. Biochem. 189:475-486(1990).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=1688329; DOI=10.1016/0378-1119(90)90242-J;
RA   Tsarfaty I., Hareuveni M., Horev J., Zaretsky J., Weiss M.,
RA   Jeltsch J.-M., Garnier J.-M., Lathe R., Keydar I., Wreschner D.H.;
RT   "Isolation and characterization of an expressed hypervariable gene
RT   coding for a breast-cancer-associated antigen.";
RL   Gene 93:313-318(1990).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM Y).
RX   PubMed=7925397; DOI=10.1111/j.1432-1033.1994.00787.x;
RA   Zrihan-Licht S., Vos H.L., Baruch A., Elroy-Stein O., Sagiv D.,
RA   Keydar I., Hilkens J., Wreschner D.H.;
RT   "Characterization and molecular cloning of a novel MUC1 protein,
RT   devoid of tandem repeats, expressed in human breast cancer tissue.";
RL   Eur. J. Biochem. 224:787-795(1994).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; Y AND 8), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9212228;
RX   DOI=10.1002/(SICI)1097-0215(19970703)72:1<87::AID-IJC13>3.0.CO;2-7;
RA   Oosterkamp H.M., Scheiner L., Stefanova M.C., Lloyd K.O.,
RA   Finstad C.L.;
RT   "Comparison of MUC-1 mucin expression in epithelial and non-epithelial
RT   cancer cell lines and demonstration of a new short variant form (MUC-
RT   1/Z).";
RL   Int. J. Cancer 72:87-94(1997).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ZD).
RX   PubMed=15623537; DOI=10.1074/jbc.M406943200;
RA   Levitin F., Baruch A., Weiss M., Stiegman K., Hartmann M.L.,
RA   Yoeli-Lerner M., Ziv R., Zrihan-Licht S., Shina S., Gat A.,
RA   Lifschitz B., Simha M., Stadler Y., Cholostoy A., Gil B., Greaves D.,
RA   Keydar I., Zaretsky J., Smorodinsky N., Wreschner D.H.;
RT   "A novel protein derived from the MUC1 gene by alternative splicing
RT   and frameshifting.";
RL   J. Biol. Chem. 280:10655-10663(2005).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; E2; J13; M6; S2; T10; Y-LSP
RP   AND ZD), ALTERNATIVE SPLICING, AND VARIANT MET-1117.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 9).
RC   TISSUE=Carcinoma;
RA   Zhang L.X., Li C.H., Sun L.Y., Yue W.;
RT   "Cloning of a new potential secreted short variant form of MUC1 mucin
RT   in epithelial cancer cell line.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM Y), AND VARIANT MET-1117.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15969018;
RA   Zhang L.X., Li C.H., Sun L.Y., Wang M., Lu H.J.;
RT   "Soluble expression of peptide containing MUC1/Y-specific epitope in
RT   Escherichia coli and preparation of the antibody.";
RL   Sheng Wu Gong Cheng Xue Bao 19:337-342(2003).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F).
RA   Zhang L.X., Lu H.J.;
RT   "Cloning of a new MUC1 short variant mRNA F from HeLa cells.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM S2).
RA   Zhang L.X., Lu H.J.;
RT   "Cloning of a new MUC1 short variant mRNA S2 from HeLa cells.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM M6).
RA   Zhang L., Finn O.J.;
RT   "Isolation of MUC1 isoforms from MCF7 cells.";
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS MET-1117 AND ASN-1142.
RG   NIEHS SNPs program;
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
RN   [18]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [20]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS Y AND Y-LSP).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [21]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3417635;
RA   Gendler S.J., Taylor-Papadimitriou J., Duhig T., Rothbard J.,
RA   Burchell J.;
RT   "A highly immunogenic region of a human polymorphic epithelial mucin
RT   expressed by carcinomas is made up of tandem repeats.";
RL   J. Biol. Chem. 263:12820-12823(1988).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-160 (ISOFORM 2).
RX   PubMed=2597151; DOI=10.1016/S0006-291X(89)80014-2;
RA   Abe M., Siddiqui J., Kufe D.;
RT   "Sequence analysis of the 5' region of the human DF3 breast carcinoma-
RT   associated antigen gene.";
RL   Biochem. Biophys. Res. Commun. 165:644-649(1989).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-109 (ISOFORM 2).
RC   TISSUE=Thyroid;
RX   PubMed=8608966;
RX   DOI=10.1002/(SICI)1097-0215(19960328)66:1<55::AID-IJC10>3.0.CO;2-A;
RA   Weiss M., Baruch A., Keydar I., Wreschner D.H.;
RT   "Preoperative diagnosis of thyroid papillary carcinoma by reverse
RT   transcriptase polymerase chain reaction of the MUC1 gene.";
RL   Int. J. Cancer 66:55-59(1996).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-89.
RC   TISSUE=Lung;
RX   PubMed=8604237;
RA   Yu C.J., Yang P.C., Shew J.Y., Hong T.M., Yang S.C., Lee Y.C.,
RA   Lee L.N., Luh K.T., Wu C.W.;
RT   "Mucin mRNA expression in lung adenocarcinoma cell lines and
RT   tissues.";
RL   Oncology 53:118-126(1996).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-46 (ISOFORMS 3 AND 4).
RC   TISSUE=Mammary carcinoma;
RA   Buluwela L., Liu Q., Luqmani Y.A., Gomm J.J., Coombes R.C.;
RL   Submitted (OCT-1992) to the EMBL/GenBank/DDBJ databases.
RN   [26]
RP   PROTEIN SEQUENCE OF 24-33; 28-37 AND 1098-1107, AND PROTEOLYTIC
RP   PROCESSING.
RX   PubMed=11341784; DOI=10.1006/bbrc.2001.4775;
RA   Parry S., Silverman H.S., McDermott K., Willis A., Hollingsworth M.A.,
RA   Harris A.;
RT   "Identification of MUC1 proteolytic cleavage sites in vivo.";
RL   Biochem. Biophys. Res. Commun. 283:715-720(2001).
RN   [27]
RP   PROTEIN SEQUENCE OF 1098-1111, PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS
RP   OF SER-1098.
RX   PubMed=15987679; DOI=10.1074/jbc.M506047200;
RA   Levitin F., Stern O., Weiss M., Gil-Henn C., Ziv R., Prokocimer Z.,
RA   Smorodinsky N.I., Rubinstein D.B., Wreschner D.H.;
RT   "The MUC1 SEA module is a self-cleaving domain.";
RL   J. Biol. Chem. 280:33374-33386(2005).
RN   [28]
RP   PROTEIN SEQUENCE OF TANDEM REPEAT, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND GLYCOSYLATION.
RX   PubMed=10373415; DOI=10.1074/jbc.274.26.18165;
RA   Mueller S., Alving K., Peter-Katalinic J., Zachara N., Gooley A.A.,
RA   Hanisch F.-G.;
RT   "High density O-glycosylation on tandem repeat peptide from secretory
RT   MUC1 of T47D breast cancer cells.";
RL   J. Biol. Chem. 274:18165-18172(1999).
RN   [29]
RP   PHOSPHORYLATION.
RX   PubMed=7988707; DOI=10.1016/0014-5793(94)01251-2;
RA   Zrihan-Licht S., Baruch A., Elroy-Stein O., Keydar I., Wreschner D.H.;
RT   "Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins.
RT   Cytokine receptor-like molecules.";
RL   FEBS Lett. 356:130-136(1994).
RN   [30]
RP   IDENTIFICATION IN A COMPLEX WITH SOS1 AND GRB2, INTERACTION WITH GRB2
RP   AND SOS1, AND PHOSPHORYLATION.
RX   PubMed=7664271;
RA   Pandey P., Kharbanda S., Kufe D.;
RT   "Association of the DF3/MUC1 breast cancer antigen with Grb2 and the
RT   Sos/Ras exchange protein.";
RL   Cancer Res. 55:4000-4003(1995).
RN   [31]
RP   GLYCOSYLATION AT THR-131 AND THR-139, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=7744025; DOI=10.1111/j.1432-1033.1995.0140l.x;
RA   Stadie T.R., Chai W., Lawson A.M., Byfield P.G., Hanisch F.G.;
RT   "Studies on the order and site specificity of GalNAc transfer to MUC1
RT   tandem repeats by UDP-GalNAc: polypeptide N-
RT   acetylgalactosaminyltransferase from milk or mammary carcinoma
RT   cells.";
RL   Eur. J. Biochem. 229:140-147(1995).
RN   [32]
RP   INTERACTION WITH CTNNB1 AND JUP, AND FUNCTION.
RX   PubMed=9139698; DOI=10.1074/jbc.272.19.12492;
RA   Yamamoto M., Bharti A., Li Y., Kufe D.;
RT   "Interaction of the DF3/MUC1 breast carcinoma-associated antigen and
RT   beta-catenin in cell adhesion.";
RL   J. Biol. Chem. 272:12492-12494(1997).
RN   [33]
RP   GLYCOSYLATION WITHIN TANDEM REPEAT.
RX   PubMed=9312074; DOI=10.1074/jbc.272.40.24780;
RA   Mueller S., Goletz S., Packer N.H., Gooley A.A., Lawson A.M.,
RA   Hanisch F.-G.;
RT   "Localization of O-glycosylation sites on glycopeptide fragments from
RT   lactation-associated MUC1. All putative sites within the tandem repeat
RT   are glycosylation targets in vivo.";
RL   J. Biol. Chem. 272:24780-24793(1997).
RN   [34]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=9536947; DOI=10.1136/gut.42.2.220;
RA   Reid C.J., Harris A.;
RT   "Developmental expression of mucin genes in the human gastrointestinal
RT   system.";
RL   Gut 42:220-226(1998).
RN   [35]
RP   GLYCOSYLATION AT THR-131 AND THR-139, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=9597769;
RX   DOI=10.1002/(SICI)1096-9888(199804)33:4<358::AID-JMS642>3.0.CO;2-3;
RA   Hanisch F.G., Green B.N., Bateman R., Peter-Katalinic J.;
RT   "Localization of O-glycosylation sites of MUC1 tandem repeats by QTOF
RT   ESI mass spectrometry.";
RL   J. Mass Spectrom. 33:358-362(1998).
RN   [36]
RP   INTERACTION WITH GSK3B AND CTNNB1, PHOSPHORYLATION AT SER-1227, AND
RP   MUTAGENESIS OF SER-1223 AND SER-1227.
RX   PubMed=9819408; DOI=10.1128/MCB.18.12.7216;
RA   Li Y., Bharti A., Chen D., Gong J., Kufe D.;
RT   "Interaction of glycogen synthase kinase 3beta with the DF3/MUC1
RT   carcinoma-associated antigen and beta-catenin.";
RL   Mol. Cell. Biol. 18:7216-7224(1998).
RN   [37]
RP   CHARACTERIZATION (ISOFORM Y), AND MUTAGENESIS OF ASP-1116.
RX   PubMed=10197628;
RA   Baruch A., Hartmann M.-L., Yoeli M., Adereth Y., Greenstein S.,
RA   Stadler Y., Skornik Y., Zaretsky J., Smorodinsky N.I., Keydar I.,
RA   Wreschner D.H.;
RT   "The breast cancer-associated MUC1 gene generates both a receptor and
RT   its cognate binding protein.";
RL   Cancer Res. 59:1552-1561(1999).
RN   [38]
RP   INTERACTION WITH ICAM1.
RX   PubMed=11173916; DOI=10.1159/000051917;
RA   Hayashi T., Takahashi T., Motoya S., Ishida T., Itoh F., Adachi M.,
RA   Hinoda Y., Imai K.;
RT   "MUC1 mucin core protein binds to the domain 1 of ICAM-1.";
RL   Digestion 63 Suppl. 1:87-92(2001).
RN   [39]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11118479; DOI=10.1177/002215540104900107;
RA   Bennett R. Jr., Jaervelae T., Engelhardt P., Kostamovaara L.,
RA   Sparks P., Carpen O., Turunen O., Vaheri A.;
RT   "Mucin MUC1 is seen in cell surface protrusions together with ezrin in
RT   immunoelectron tomography and is concentrated at tips of filopodial
RT   protrusions in MCF-7 breast carcinoma cells.";
RL   J. Histochem. Cytochem. 49:67-77(2001).
RN   [40]
RP   INTERACTION WITH SRC; GSK3B AND CTNNB1, PHOSPHORYLATION AT TYR-1229,
RP   AND MUTAGENESIS OF TYR-1229.
RX   PubMed=11152665; DOI=10.1074/jbc.C000754200;
RA   Li Y., Kuwahara H., Ren J., Wen G., Kufe D.;
RT   "The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1
RT   carcinoma-associated antigen with GSK3 beta and beta-catenin.";
RL   J. Biol. Chem. 276:6061-6064(2001).
RN   [41]
RP   POLYMORPHISM WITHIN THE REPEAT.
RX   PubMed=11350974; DOI=10.1074/jbc.M103187200;
RA   Engelmann K., Baldus S.E., Hanisch F.-G.;
RT   "Identification and topology of variant sequences within individual
RT   repeat domains of the human epithelial tumor mucin MUC1.";
RL   J. Biol. Chem. 276:27764-27769(2001).
RN   [42]
RP   INTERACTION WITH EGFR, PHOSPHORYLATION AT TYR-1229 BY EGFR, AND
RP   MUTAGENESIS OF TYR-1191; TYR-1203; TYR-1209; TYR-1218 AND TYR-1229.
RX   PubMed=11483589; DOI=10.1074/jbc.C100359200;
RA   Li Y., Ren J., Yu W., Li Q., Kuwahara H., Yin L., Carraway K.L. III,
RA   Kufe D.;
RT   "The epidermal growth factor receptor regulates interaction of the
RT   human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.";
RL   J. Biol. Chem. 276:35239-35242(2001).
RN   [43]
RP   PHOSPHORYLATION AT THR-1224, INTERACTION WITH PRKCD, FUNCTION, AND
RP   MUTAGENESIS OF SER-1223; THR-1224 AND SER-1227.
RX   PubMed=11877440; DOI=10.1074/jbc.M200436200;
RA   Ren J., Li Y., Kufe D.;
RT   "Protein kinase C delta regulates function of the DF3/MUC1 carcinoma
RT   antigen in beta-catenin signaling.";
RL   J. Biol. Chem. 277:17616-17622(2002).
RN   [44]
RP   PHOSPHORYLATION AT TYR-1203; TYR-1212; TYR-1229 AND TYR-1243.
RX   PubMed=14521915; DOI=10.1016/j.bbrc.2003.09.030;
RA   Wang H., Lillehoj E.P., Kim K.C.;
RT   "Identification of four sites of stimulated tyrosine phosphorylation
RT   in the MUC1 cytoplasmic tail.";
RL   Biochem. Biophys. Res. Commun. 310:341-346(2003).
RN   [45]
RP   INTERACTION WITH LYN, AND PHOSPHORYLATION.
RX   PubMed=12750561; DOI=10.4161/cbt.2.2.282;
RA   Li Y., Chen W., Ren J., Yu W.H., Li Q., Yoshida K., Kufe D.;
RT   "DF3/MUC1 signaling in multiple myeloma cells is regulated by
RT   interleukin-7.";
RL   Cancer Biol. Ther. 2:187-193(2003).
RN   [46]
RP   INTERACTION WITH CTNNB1, FUNCTION, AND MUTAGENESIS OF TYR-1229.
RX   PubMed=14688481;
RA   Huang L., Ren J., Chen D., Li Y., Kharbanda S., Kufe D.;
RT   "MUC1 cytoplasmic domain coactivates Wnt target gene transcription and
RT   confers transformation.";
RL   Cancer Biol. Ther. 2:702-706(2003).
RN   [47]
RP   INTERACTION WITH ADAM17, AND CLEAVAGE.
RX   PubMed=12441351; DOI=10.1074/jbc.M208326200;
RA   Thathiah A., Blobel C.P., Carson D.D.;
RT   "Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1
RT   shedding.";
RL   J. Biol. Chem. 278:3386-3394(2003).
RN   [48]
RP   INTERACTION WITH CTNNB1, AND SUBCELLULAR LOCATION.
RX   PubMed=12832415; DOI=10.1074/jbc.M304333200;
RA   Wen Y., Caffrey T.C., Wheelock M.J., Johnson K.R., Hollingsworth M.A.;
RT   "Nuclear association of the cytoplasmic tail of MUC1 and beta-
RT   catenin.";
RL   J. Biol. Chem. 278:38029-38039(2003).
RN   [49]
RP   INTERACTION WITH ERBB2; ERBB3 AND ERBB4, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF 1187-ARG--LYS-1189.
RX   PubMed=12939402;
RA   Li Y., Yu W.-H., Ren J., Chen W., Huang L., Kharbanda S., Loda M.,
RA   Kufe D.;
RT   "Heregulin targets gamma-catenin to the nucleolus by a mechanism
RT   dependent on the DF3/MUC1 oncoprotein.";
RL   Mol. Cancer Res. 1:765-775(2003).
RN   [50]
RP   INTERACTION WITH AP1S2 AND GRB2, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF TYR-1191; TYR-1203; TYR-1229 AND TYR-1243.
RX   PubMed=15471854; DOI=10.1074/jbc.M409360200;
RA   Kinlough C.L., Poland P.A., Bruns J.B., Harkleroad K.L., Hughey R.P.;
RT   "MUC1 membrane trafficking is modulated by multiple interactions.";
RL   J. Biol. Chem. 279:53071-53077(2004).
RN   [51]
RP   INTERACTION WITH TP53, AND FUNCTION.
RX   PubMed=15710329; DOI=10.1016/j.ccr.2005.01.008;
RA   Wei X., Xu H., Kufe D.;
RT   "Human MUC1 oncoprotein regulates p53-responsive gene transcription in
RT   the genotoxic stress response.";
RL   Cancer Cell 7:167-178(2005).
RN   [52]
RP   INTERACTION WITH GSK3B, PHOSPHORYLATION, AND FUNCTION.
RX   PubMed=16288032; DOI=10.1158/0008-5472.CAN-05-2474;
RA   Huang L., Chen D., Liu D., Yin L., Kharbanda S., Kufe D.;
RT   "MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated
RT   phosphorylation and degradation of beta-catenin.";
RL   Cancer Res. 65:10413-10422(2005).
RN   [53]
RP   ERRATUM.
RA   Kinlough C.L., Poland P.A., Bruns J.B., Harkleroad K.L., Hughey R.P.;
RL   J. Biol. Chem. 280:28827-28827(2005).
RN   [54]
RP   STRUCTURE OF CARBOHYDRATES, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15972891; DOI=10.1093/glycob/cwi099;
RA   Engelmann K., Kinlough C.L., Muller S., Razawi H., Baldus S.E.,
RA   Hughey R.P., Hanisch F.-G.;
RT   "Transmembrane and secreted MUC1 probes show trafficking-dependent
RT   changes in O-glycan core profiles.";
RL   Glycobiology 15:1111-1124(2005).
RN   [55]
RP   INTERACTION WITH LCK, PHOSPHORYLATION, FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15513966; DOI=10.1189/jlb.0604333;
RA   Mukherjee P., Tinder T.L., Basu G.D., Gendler S.J.;
RT   "MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma
RT   cells and normal T cells.";
RL   J. Leukoc. Biol. 77:90-99(2005).
RN   [56]
RP   PALMITOYLATION AT CYS-1184 AND CYS-1186, SUBCELLULAR LOCATION,
RP   INTERACTION WITH AP1S1 AND AP1S2, AND MUTAGENESIS OF CYS-1184;
RP   CYS-1186; TYR-1203 AND 1187-ARG--LYS-1189.
RX   PubMed=16507569; DOI=10.1074/jbc.M512996200;
RA   Kinlough C.L., McMahan R.J., Poland P.A., Bruns J.B., Harkleroad K.L.,
RA   Stremple R.J., Kashlan O.B., Weixel K.M., Weisz O.A., Hughey R.P.;
RT   "Recycling of MUC1 is dependent on its palmitoylation.";
RL   J. Biol. Chem. 281:12112-12122(2006).
RN   [57]
RP   INTERACTION WITH ESR1.
RX   PubMed=16427018; DOI=10.1016/j.molcel.2005.11.030;
RA   Wei X., Xu H., Kufe D.;
RT   "MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.";
RL   Mol. Cell 21:295-305(2006).
RN   [58]
RP   INTERACTION WITH CTNNB1, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=17524503; DOI=10.1016/j.bbamcr.2007.04.009;
RA   Lillehoj E.P., Lu W., Kiser T., Goldblum S.E., Kim K.C.;
RT   "MUC1 inhibits cell proliferation by a beta-catenin-dependent
RT   mechanism.";
RL   Biochim. Biophys. Acta 1773:1028-1038(2007).
RN   [59]
RP   INTERACTION WITH KLF4, AND FUNCTION.
RX   PubMed=17308127; DOI=10.1158/0008-5472.CAN-06-3063;
RA   Wei X., Xu H., Kufe D.;
RT   "Human mucin 1 oncoprotein represses transcription of the p53 tumor
RT   suppressor gene.";
RL   Cancer Res. 67:1853-1858(2007).
RN   [60]
RP   PHOSPHORYLATION AT TYR-1203; TYR-1218 AND TYR-1229, MUTAGENESIS OF
RP   TYR-1203 AND TYR-1218, SUBCELLULAR LOCATION, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=17545600; DOI=10.1158/0008-5472.CAN-06-4647;
RA   Singh P.K., Wen Y., Swanson B.J., Shanmugam K., Kazlauskas A.,
RA   Cerny R.L., Gendler S.J., Hollingsworth M.A.;
RT   "Platelet-derived growth factor receptor beta-mediated phosphorylation
RT   of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells.";
RL   Cancer Res. 67:5201-5210(2007).
RN   [61]
RP   INTERACTION WITH EGFR, AND FUNCTION.
RX   PubMed=16983337; DOI=10.1038/sj.onc.1209976;
RA   Pochampalli M.R., el Bejjani R.M., Schroeder J.A.;
RT   "MUC1 is a novel regulator of ErbB1 receptor trafficking.";
RL   Oncogene 26:1693-1701(2007).
RN   [62]
RP   MARKER IN BREAST CANCER.
RX   PubMed=20816948; DOI=10.1016/j.cca.2010.08.039;
RA   Duffy M.J., Evoy D., McDermott E.W.;
RT   "CA 15-3: uses and limitation as a biomarker for breast cancer.";
RL   Clin. Chim. Acta 411:1869-1874(2010).
RN   [63]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1227, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [64]
RP   INVOLVEMENT IN MCKD1.
RX   PubMed=23396133; DOI=10.1038/ng.2543;
RA   Kirby A., Gnirke A., Jaffe D.B., Baresova V., Pochet N.,
RA   Blumenstiel B., Ye C., Aird D., Stevens C., Robinson J.T.,
RA   Cabili M.N., Gat-Viks I., Kelliher E., Daza R., DeFelice M.,
RA   Hulkova H., Sovova J., Vylet'al P., Antignac C., Guttman M.,
RA   Handsaker R.E., Perrin D., Steelman S., Sigurdsson S., Scheinman S.J.,
RA   Sougnez C., Cibulskis K., Parkin M., Green T., Rossin E., Zody M.C.,
RA   Xavier R.J., Pollak M.R., Alper S.L., Lindblad-Toh K., Gabriel S.,
RA   Hart P.S., Regev A., Nusbaum C., Kmoch S., Bleyer A.J., Lander E.S.,
RA   Daly M.J.;
RT   "Mutations causing medullary cystic kidney disease type 1 lie in a
RT   large VNTR in MUC1 missed by massively parallel sequencing.";
RL   Nat. Genet. 45:299-303(2013).
RN   [65]
RP   STRUCTURE BY NMR OF 1041-1097 AND 1098-1152 OF WILD TYPE AND MUTANT
RP   ALA-1098, IDENTIFICATION BY MASS SPECTROMETRY, STRUCTURE OF
RP   CARBOHYDRATES, AND AUTOCATALYTIC CLEAVAGE.
RX   PubMed=16585136; DOI=10.1093/glycob/cwj110;
RA   Parry S., Hanisch F.G., Leir S.H., Sutton-Smith M., Morris H.R.,
RA   Dell A., Harris A.;
RT   "N-glycosylation of the MUC1 mucin in epithelial cells and
RT   secretions.";
RL   Glycobiology 16:623-634(2006).
CC   -!- FUNCTION: The alpha subunit has cell adhesive properties. Can act
CC       both as an adhesion and an anti-adhesion protein. May provide a
CC       protective layer on epithelial cells against bacterial and enzyme
CC       attack.
CC   -!- FUNCTION: The beta subunit contains a C-terminal domain which is
CC       involved in cell signaling, through phosphorylations and protein-
CC       protein interactions. Modulates signaling in ERK, SRC and NF-
CC       kappa-B pathways. In activated T-cells, influences directly or
CC       indirectly the Ras/MAPK pathway. Promotes tumor progression.
CC       Regulates TP53-mediated transcription and determines cell fate in
CC       the genotoxic stress response. Binds, together with KLF4, the PE21
CC       promoter element of TP53 and represses TP53 activity.
CC   -!- SUBUNIT: The alpha subunit forms a tight, non-covalent
CC       heterodimeric complex with the proteolytically-released beta-
CC       subunit. Interaction, via the tandem repeat region, with domain 1
CC       of ICAM1 is implicated in cell migration and metastases. Isoform 1
CC       binds directly the SH2 domain of GRB2, and forms a MUC1/GRB2/SOS1
CC       complex involved in RAS signaling. The cytoplasmic tail (MUC1CT)
CC       interacts with several proteins such as SRC, CTNNB1 and ERBs.
CC       Interaction with the SH2 domain of CSK decreases interaction with
CC       GSK3B. Interacts with CTNNB1/beta-catenin and JUP/gamma-catenin
CC       and promotes cell adhesion. Interaction with JUP/gamma-catenin is
CC       induced by heregulin. Binds PRKCD, ERBB2, ERBB3 and ERBB4.
CC       Heregulin (HRG) stimulates the interaction with ERBB2 and, to a
CC       much lesser extent, the interaction with ERBB3 and ERBB4.
CC       Interacts with P53 in response to DNA damage. Interacts with KLF4.
CC       Interacts with estrogen receptor alpha/ESR1, through its DNA-
CC       binding domain, and stimulates its transcription activity. Binds
CC       ADAM17. Isoform ZD forms disulfide-linked oligomers.
CC       {ECO:0000269|PubMed:11152665, ECO:0000269|PubMed:11173916,
CC       ECO:0000269|PubMed:11483589, ECO:0000269|PubMed:11877440,
CC       ECO:0000269|PubMed:12441351, ECO:0000269|PubMed:12750561,
CC       ECO:0000269|PubMed:12832415, ECO:0000269|PubMed:12939402,
CC       ECO:0000269|PubMed:14688481, ECO:0000269|PubMed:15471854,
CC       ECO:0000269|PubMed:15513966, ECO:0000269|PubMed:15710329,
CC       ECO:0000269|PubMed:16288032, ECO:0000269|PubMed:16427018,
CC       ECO:0000269|PubMed:16507569, ECO:0000269|PubMed:16983337,
CC       ECO:0000269|PubMed:17308127, ECO:0000269|PubMed:17524503,
CC       ECO:0000269|PubMed:7664271, ECO:0000269|PubMed:9139698,
CC       ECO:0000269|PubMed:9819408}.
CC   -!- INTERACTION:
CC       P00519:ABL1; NbExp=8; IntAct=EBI-2804728, EBI-375543;
CC       P17676:CEBPB; NbExp=8; IntAct=EBI-10053698, EBI-969696;
CC       P00533:EGFR; NbExp=3; IntAct=EBI-2804728, EBI-297353;
CC       P08581:MET; NbExp=2; IntAct=EBI-2804728, EBI-1039152;
CC       P15941-7:MUC1; NbExp=2; IntAct=EBI-2804728, EBI-4396776;
CC       P26368:U2AF2; NbExp=2; IntAct=EBI-2804728, EBI-742339;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:11118479, ECO:0000269|PubMed:12832415,
CC       ECO:0000269|PubMed:12939402, ECO:0000269|PubMed:15471854,
CC       ECO:0000269|PubMed:15972891, ECO:0000269|PubMed:16507569,
CC       ECO:0000269|PubMed:17524503, ECO:0000269|PubMed:17545600}; Single-
CC       pass type I membrane protein {ECO:0000269|PubMed:11118479,
CC       ECO:0000269|PubMed:12832415, ECO:0000269|PubMed:12939402,
CC       ECO:0000269|PubMed:15471854, ECO:0000269|PubMed:15972891,
CC       ECO:0000269|PubMed:16507569, ECO:0000269|PubMed:17524503,
CC       ECO:0000269|PubMed:17545600}. Note=Exclusively located in the
CC       apical domain of the plasma membrane of highly polarized
CC       epithelial cells. After endocytosis, internalized and recycled to
CC       the cell membrane. Located to microvilli and to the tips of long
CC       filopodial protusions.
CC   -!- SUBCELLULAR LOCATION: Isoform 5: Secreted.
CC   -!- SUBCELLULAR LOCATION: Isoform Y: Secreted.
CC   -!- SUBCELLULAR LOCATION: Isoform 9: Secreted.
CC   -!- SUBCELLULAR LOCATION: Mucin-1 subunit beta: Cell membrane.
CC       Cytoplasm. Nucleus. Note=On EGF and PDGFRB stimulation,
CC       transported to the nucleus through interaction with CTNNB1, a
CC       process which is stimulated by phosphorylation. On HRG
CC       stimulation, colocalizes with JUP/gamma-catenin at the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=17;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=A;
CC         IsoId=P15941-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=P15941-2; Sequence=VSP_003280;
CC       Name=3; Synonyms=C;
CC         IsoId=P15941-3; Sequence=VSP_003281;
CC       Name=4; Synonyms=D;
CC         IsoId=P15941-4; Sequence=VSP_003282;
CC       Name=5; Synonyms=SEC;
CC         IsoId=P15941-5; Sequence=VSP_003288, VSP_003289;
CC       Name=6; Synonyms=X;
CC         IsoId=P15941-6; Sequence=VSP_003283, VSP_003284;
CC       Name=Y; Synonyms=MUC1/Y;
CC         IsoId=P15941-7; Sequence=VSP_003285;
CC       Name=8; Synonyms=Z;
CC         IsoId=P15941-8; Sequence=VSP_003286;
CC       Name=9; Synonyms=S;
CC         IsoId=P15941-9; Sequence=VSP_003286, VSP_003287;
CC       Name=F;
CC         IsoId=P15941-10; Sequence=VSP_035046, VSP_035047;
CC       Name=Y-LSP;
CC         IsoId=P15941-11; Sequence=VSP_003280, VSP_003285;
CC         Note=Lacks the mucin repeats.;
CC       Name=S2;
CC         IsoId=P15941-12; Sequence=VSP_003280, VSP_003285, VSP_003287;
CC       Name=M6;
CC         IsoId=P15941-13; Sequence=VSP_003286, VSP_046962, VSP_046963;
CC       Name=ZD; Synonyms=J19;
CC         IsoId=P15941-14; Sequence=VSP_047575, VSP_047576;
CC         Note=Lacks the mucin repeats. Exists as a disulfide-linked
CC         oligomer.;
CC       Name=T10;
CC         IsoId=P15941-15; Sequence=VSP_003280, VSP_047873;
CC       Name=E2;
CC         IsoId=P15941-16; Sequence=VSP_003280, VSP_047872;
CC       Name=J13;
CC         IsoId=P15941-17; Sequence=VSP_003280, VSP_003285, VSP_047874;
CC   -!- TISSUE SPECIFICITY: Expressed on the apical surface of epithelial
CC       cells, especially of airway passages, breast and uterus. Also
CC       expressed in activated and unactivated T-cells. Overexpressed in
CC       epithelial tumors, such as breast or ovarian cancer and also in
CC       non-epithelial tumor cells. Isoform Y is expressed in tumor cells
CC       only. {ECO:0000269|PubMed:15513966, ECO:0000269|PubMed:9212228}.
CC   -!- DEVELOPMENTAL STAGE: During fetal development, expressed at low
CC       levels in the colonic epithelium from 13 weeks of gestation.
CC       {ECO:0000269|PubMed:9536947}.
CC   -!- PTM: Highly glycosylated (N- and O-linked carbohydrates and sialic
CC       acid). O-glycosylated to a varying degree on serine and threonine
CC       residues within each tandem repeat, ranging from mono- to penta-
CC       glycosylation. The average density ranges from about 50% in human
CC       milk to over 90% in T47D breast cancer cells. Further sialylation
CC       occurs during recycling. Membrane-shed glycoproteins from kidney
CC       and breast cancer cells have preferentially sialyated core 1
CC       structures, while secreted forms from the same tissues display
CC       mainly core 2 structures. The O-glycosylated content is
CC       overlapping in both these tissues with terminal fucose and
CC       galactose, 2- and 3-linked galactose, 3- and 3,6-linked GalNAc-ol
CC       and 4-linked GlcNAc predominating. Differentially O-glycosylated
CC       in breast carcinomas with 3,4-linked GlcNAc. N-glycosylation
CC       consists of high-mannose, acidic complex-type and hybrid glycans
CC       in the secreted form MUC1/SEC, and neutral complex-type in the
CC       transmembrane form, MUC1/TM. {ECO:0000269|PubMed:10373415,
CC       ECO:0000269|PubMed:7744025, ECO:0000269|PubMed:9312074,
CC       ECO:0000269|PubMed:9597769}.
CC   -!- PTM: Proteolytic cleavage in the SEA domain occurs in the
CC       endoplasmic reticulum by an autoproteolytic mechanism and requires
CC       the full-length SEA domain as well as requiring a Ser, Thr or Cys
CC       residue at the P + 1 site. Cleavage at this site also occurs on
CC       isoform MUC1/X but not on isoform MUC1/Y. Ectodomain shedding is
CC       mediated by ADAM17. {ECO:0000269|PubMed:11341784,
CC       ECO:0000269|PubMed:12441351, ECO:0000269|PubMed:15987679}.
CC   -!- PTM: Dual palmitoylation on cysteine residues in the CQC motif is
CC       required for recycling from endosomes back to the plasma membrane.
CC       {ECO:0000269|PubMed:16507569}.
CC   -!- PTM: Phosphorylated on tyrosines and serine residues in the C-
CC       terminal. Phosphorylation on tyrosines in the C-terminal increases
CC       the nuclear location of MUC1 and beta-catenin. Phosphorylation by
CC       PKC delta induces binding of MUC1 to beta-catenin/CTNNB1 and thus
CC       decreases the formation of the beta-catenin/E-cadherin complex.
CC       Src-mediated phosphorylation inhibits interaction with GSK3B.
CC       Src- and EGFR-mediated phosphorylation on Tyr-1229 increases
CC       binding to beta-catenin/CTNNB1. GSK3B-mediated phosphorylation on
CC       Ser-1227 decreases this interaction but restores the formation of
CC       the beta-cadherin/E-cadherin complex. On T-cell receptor
CC       activation, phosphorylated by LCK. PDGFR-mediated phosphorylation
CC       increases nuclear colocalization of MUC1CT and CTNNB1.
CC       {ECO:0000269|PubMed:11152665, ECO:0000269|PubMed:11483589,
CC       ECO:0000269|PubMed:11877440, ECO:0000269|PubMed:12750561,
CC       ECO:0000269|PubMed:14521915, ECO:0000269|PubMed:15513966,
CC       ECO:0000269|PubMed:16288032, ECO:0000269|PubMed:17545600,
CC       ECO:0000269|PubMed:7664271, ECO:0000269|PubMed:7988707,
CC       ECO:0000269|PubMed:9819408}.
CC   -!- PTM: The N-terminal sequence has been shown to begin at position
CC       24 or 28. {ECO:0000269|PubMed:11341784}.
CC   -!- POLYMORPHISM: The number of repeats is highly polymorphic. It
CC       varies from 21 to 125 in the northern European population. The
CC       most frequent alleles contains 41 and 85 repeats. The tandemly
CC       repeated icosapeptide underlies polymorphism at three positions:
CC       PAPGSTAP[PAQT]AHGVTSAP[DT/ES]R, DT -> ES and the single
CC       replacements P -> A, P -> Q and P-> T. The most frequent
CC       replacement DT -> ES occurs in up to 50% of the repeats.
CC   -!- DISEASE: Note=MUC1/CA 15-3 is used as a serological clinical
CC       marker of breast cancer to monitor response to breast cancer
CC       treatment and disease recurrence (PubMed:20816948). Decreased
CC       levels over time may be indicative of a positive response to
CC       treatment. Conversely, increased levels may indicate disease
CC       progression. At an early stage disease, only 21% of patients
CC       exhibit high MUC1/CA 15-3 levels, that is why CA 15-3 is not a
CC       useful screening test. Most antibodies target the highly
CC       immunodominant core peptide domain of 20 amino acid
CC       (APDTRPAPGSTAPPAHGVTS) tandem repeats. Some antibodies recognize
CC       glycosylated epitopes. {ECO:0000269|PubMed:20816948}.
CC   -!- DISEASE: Medullary cystic kidney disease 1 (MCKD1) [MIM:174000]: A
CC       form of tubulointerstitial nephropathy characterized by formation
CC       of renal cysts at the corticomedullary junction. It is
CC       characterized by adult onset of impaired renal function and salt
CC       wasting resulting in end-stage renal failure by the sixth decade.
CC       {ECO:0000269|PubMed:23396133}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The name KL-6 was originally that of a murine
CC       monoclonal antibody reacting with pulmonary adenocarcinoma cell
CC       lines and pulmonary epithelial cells. This antibody recognizes a
CC       sialylated carbohydrate chain on MUC1.
CC   -!- CAUTION: O-glycosylation sites are annotated in first sequence
CC       repeat only. Residues at similar position are probably
CC       glycosylated in all repeats. Experimental sites were determined in
CC       a synthetic peptide glycosylated in vitro (PubMed:7744025,
CC       PubMed:9597769). {ECO:0000305|PubMed:7744025,
CC       ECO:0000305|PubMed:9597769}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD14369.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAD14376.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mucin database;
CC       URL="http://www.medkem.gu.se/mucinbiology/databases/";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/muc1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05582; AAA60019.1; -; mRNA.
DR   EMBL; M32738; AAA35804.1; -; mRNA.
DR   EMBL; M32739; AAA35806.1; -; mRNA.
DR   EMBL; M34089; AAA35807.1; -; mRNA.
DR   EMBL; M34088; AAA35805.1; -; mRNA.
DR   EMBL; J05581; AAA59876.1; -; mRNA.
DR   EMBL; M61170; AAB53150.1; -; Genomic_DNA.
DR   EMBL; X52229; CAA36478.1; ALT_SEQ; mRNA.
DR   EMBL; X52228; CAA36477.1; ALT_SEQ; mRNA.
DR   EMBL; M35093; AAB59612.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X80761; CAA56734.1; -; mRNA.
DR   EMBL; U60259; AAD10856.1; -; mRNA.
DR   EMBL; U60260; AAD10857.1; -; mRNA.
DR   EMBL; U60261; AAD10858.1; -; mRNA.
DR   EMBL; AF125525; AAD27842.1; -; mRNA.
DR   EMBL; AY466157; AAR28764.1; -; mRNA.
DR   EMBL; AY327582; AAP97013.1; -; mRNA.
DR   EMBL; AY327584; AAP97015.1; -; mRNA.
DR   EMBL; AY327586; AAP97017.1; -; mRNA.
DR   EMBL; AY327587; AAP97018.1; -; mRNA.
DR   EMBL; EF583653; ABQ59628.1; -; mRNA.
DR   EMBL; EF670711; ABS01298.1; -; mRNA.
DR   EMBL; EF670712; ABS01299.1; -; mRNA.
DR   EMBL; FJ226040; ACI25172.1; -; mRNA.
DR   EMBL; FJ226047; ACI25179.1; -; mRNA.
DR   EMBL; AF348143; AAK30142.1; -; mRNA.
DR   EMBL; AY463543; AAR18816.1; -; Genomic_DNA.
DR   EMBL; AL713999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53116.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53117.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53118.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53119.1; -; Genomic_DNA.
DR   EMBL; BC120974; AAI20975.1; -; mRNA.
DR   EMBL; BC120975; AAI20976.1; -; mRNA.
DR   EMBL; Z17324; CAA78972.1; -; mRNA.
DR   EMBL; Z17325; CAA78973.1; -; mRNA.
DR   EMBL; M31823; AAA35757.1; -; mRNA.
DR   EMBL; S81781; AAD14376.1; ALT_INIT; mRNA.
DR   EMBL; S81736; AAD14369.1; ALT_INIT; mRNA.
DR   EMBL; M21868; AAA59874.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS1098.1; -. [P15941-8]
DR   CCDS; CCDS30882.1; -. [P15941-11]
DR   CCDS; CCDS30883.1; -. [P15941-7]
DR   CCDS; CCDS41408.1; -. [P15941-12]
DR   CCDS; CCDS41409.1; -. [P15941-10]
DR   CCDS; CCDS55641.1; -. [P15941-6]
DR   CCDS; CCDS55642.1; -. [P15941-13]
DR   PIR; A35175; A35175.
DR   RefSeq; NP_001018016.1; NM_001018016.2. [P15941-11]
DR   RefSeq; NP_001018017.1; NM_001018017.2. [P15941-7]
DR   RefSeq; NP_001037855.1; NM_001044390.2. [P15941-10]
DR   RefSeq; NP_001037856.1; NM_001044391.2.
DR   RefSeq; NP_001037857.1; NM_001044392.2. [P15941-12]
DR   RefSeq; NP_001037858.1; NM_001044393.2.
DR   RefSeq; NP_001191214.1; NM_001204285.1.
DR   RefSeq; NP_001191215.1; NM_001204286.1.
DR   RefSeq; NP_001191216.1; NM_001204287.1.
DR   RefSeq; NP_001191217.1; NM_001204288.1.
DR   RefSeq; NP_001191218.1; NM_001204289.1.
DR   RefSeq; NP_001191219.1; NM_001204290.1.
DR   RefSeq; NP_001191220.1; NM_001204291.1.
DR   RefSeq; NP_001191221.1; NM_001204292.1.
DR   RefSeq; NP_001191222.1; NM_001204293.1. [P15941-13]
DR   RefSeq; NP_001191223.1; NM_001204294.1. [P15941-6]
DR   RefSeq; NP_001191224.1; NM_001204295.1.
DR   RefSeq; NP_001191225.1; NM_001204296.1.
DR   RefSeq; NP_001191226.1; NM_001204297.1.
DR   RefSeq; NP_002447.4; NM_002456.5. [P15941-8]
DR   UniGene; Hs.89603; -.
DR   PDB; 1SM3; X-ray; 1.95 A; P=919-931.
DR   PDB; 2ACM; NMR; -; A=1042-1097, B=1098-1152.
DR   PDB; 2FO4; X-ray; 2.70 A; P=140-146.
DR   PDB; 5T6P; X-ray; 1.97 A; E/F=921-928.
DR   PDB; 5T78; X-ray; 2.20 A; E/F=921-928.
DR   PDBsum; 1SM3; -.
DR   PDBsum; 2ACM; -.
DR   PDBsum; 2FO4; -.
DR   PDBsum; 5T6P; -.
DR   PDBsum; 5T78; -.
DR   ProteinModelPortal; P15941; -.
DR   SMR; P15941; -.
DR   BioGrid; 110669; 44.
DR   DIP; DIP-41890N; -.
DR   IntAct; P15941; 11.
DR   MINT; P15941; -.
DR   STRING; 9606.ENSP00000357380; -.
DR   ChEMBL; CHEMBL3580494; -.
DR   MEROPS; S71.001; -.
DR   iPTMnet; P15941; -.
DR   PhosphoSitePlus; P15941; -.
DR   SwissPalm; P15941; -.
DR   UniCarbKB; P15941; -.
DR   BioMuta; MUC1; -.
DR   DMDM; 296439295; -.
DR   MaxQB; P15941; -.
DR   PaxDb; P15941; -.
DR   PeptideAtlas; P15941; -.
DR   PRIDE; P15941; -.
DR   DNASU; 4582; -.
DR   Ensembl; ENST00000337604; ENSP00000338983; ENSG00000185499. [P15941-8]
DR   Ensembl; ENST00000342482; ENSP00000342814; ENSG00000185499. [P15941-16]
DR   Ensembl; ENST00000343256; ENSP00000339690; ENSG00000185499. [P15941-10]
DR   Ensembl; ENST00000368389; ENSP00000357374; ENSG00000185499. [P15941-9]
DR   Ensembl; ENST00000368390; ENSP00000357375; ENSG00000185499. [P15941-7]
DR   Ensembl; ENST00000368392; ENSP00000357377; ENSG00000185499. [P15941-11]
DR   Ensembl; ENST00000368393; ENSP00000357378; ENSG00000185499. [P15941-13]
DR   Ensembl; ENST00000368396; ENSP00000357381; ENSG00000185499. [P15941-12]
DR   Ensembl; ENST00000368398; ENSP00000357383; ENSG00000185499. [P15941-6]
DR   GeneID; 4582; -.
DR   KEGG; hsa:4582; -.
DR   UCSC; uc001fia.4; human. [P15941-1]
DR   CTD; 4582; -.
DR   DisGeNET; 4582; -.
DR   EuPathDB; HostDB:ENSG00000185499.16; -.
DR   GeneCards; MUC1; -.
DR   GeneReviews; MUC1; -.
DR   HGNC; HGNC:7508; MUC1.
DR   HPA; CAB000036; -.
DR   HPA; CAB001986; -.
DR   HPA; HPA004179; -.
DR   HPA; HPA007235; -.
DR   HPA; HPA008855; -.
DR   MalaCards; MUC1; -.
DR   MIM; 113720; gene.
DR   MIM; 158340; gene.
DR   MIM; 174000; phenotype.
DR   neXtProt; NX_P15941; -.
DR   OpenTargets; ENSG00000185499; -.
DR   Orphanet; 34149; Autosomal dominant medullary cystic kidney disease with or without hyperuricemia.
DR   PharmGKB; PA31309; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   GeneTree; ENSGT00710000106874; -.
DR   HOGENOM; HOG000290201; -.
DR   HOVERGEN; HBG003075; -.
DR   InParanoid; P15941; -.
DR   KO; K06568; -.
DR   PhylomeDB; P15941; -.
DR   Reactome; R-HSA-5083625; Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC).
DR   Reactome; R-HSA-5083632; Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS).
DR   Reactome; R-HSA-5083636; Defective GALNT12 causes colorectal cancer 1 (CRCS1).
DR   Reactome; R-HSA-5621480; Dectin-2 family.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   Reactome; R-HSA-977068; Termination of O-glycan biosynthesis.
DR   SIGNOR; P15941; -.
DR   ChiTaRS; MUC1; human.
DR   EvolutionaryTrace; P15941; -.
DR   GeneWiki; MUC1; -.
DR   GenomeRNAi; 4582; -.
DR   PRO; PR:P15941; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185499; -.
DR   ExpressionAtlas; P15941; baseline and differential.
DR   Genevisible; P15941; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; IPI:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0003712; F:transcription cofactor activity; IDA:BHF-UCL.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:BHF-UCL.
DR   GO; GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:BHF-UCL.
DR   GO; GO:0033629; P:negative regulation of cell adhesion mediated by integrin; IDA:CACAO.
DR   GO; GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:BHF-UCL.
DR   GO; GO:0010944; P:negative regulation of transcription by competitive promoter binding; IDA:BHF-UCL.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0090240; P:positive regulation of histone H4 acetylation; IDA:BHF-UCL.
DR   GO; GO:0036003; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; IDA:BHF-UCL.
DR   GO; GO:0043618; P:regulation of transcription from RNA polymerase II promoter in response to stress; IDA:BHF-UCL.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   Pfam; PF01390; SEA; 1.
DR   SMART; SM00200; SEA; 1.
DR   SUPFAM; SSF82671; SSF82671; 1.
DR   PROSITE; PS50024; SEA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autocatalytic cleavage;
KW   Cell membrane; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Lipoprotein;
KW   Membrane; Nucleus; Palmitate; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix; Tumor suppressor.
FT   SIGNAL        1     23       {ECO:0000269|PubMed:10373415,
FT                                ECO:0000269|PubMed:11341784}.
FT   CHAIN        24   1255       Mucin-1.
FT                                /FTId=PRO_0000019277.
FT   CHAIN        24   1097       Mucin-1 subunit alpha.
FT                                /FTId=PRO_0000317446.
FT   CHAIN      1098   1255       Mucin-1 subunit beta.
FT                                /FTId=PRO_0000317447.
FT   TOPO_DOM     24   1158       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1159   1181       Helical. {ECO:0000255}.
FT   TOPO_DOM   1182   1255       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       61     80       1; approximate.
FT                                {ECO:0000269|PubMed:11350974}.
FT   REPEAT       81    100       2; approximate.
FT                                {ECO:0000269|PubMed:11350974}.
FT   REPEAT      101    120       3. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      121    140       4. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      141    160       5. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      161    180       6. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      181    200       7. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      201    220       8. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      221    240       9. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      241    260       10. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      261    280       11. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      281    300       12. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      301    320       13. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      321    340       14. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      341    360       15. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      361    380       16. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      381    400       17. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      401    420       18. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      421    440       19. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      441    460       20. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      461    480       21. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      481    500       22. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      501    520       23. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      521    540       24. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      541    560       25. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      561    580       26. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      581    600       27. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      601    620       28. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      621    640       29. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      641    660       30. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      661    680       31. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      681    700       32. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      701    720       33. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      721    740       34. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      741    760       35. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      761    780       36. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      781    800       37. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      801    820       38. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      821    840       39. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      841    860       40. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      861    880       41. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      881    900       42. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      901    920       43. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      921    940       44. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      941    960       45. {ECO:0000269|PubMed:11350974}.
FT   REPEAT      961    980       46; approximate.
FT                                {ECO:0000269|PubMed:11350974}.
FT   REPEAT      981   1000       47; approximate.
FT                                {ECO:0000269|PubMed:11350974}.
FT   REPEAT     1001   1020       48; approximate.
FT                                {ECO:0000269|PubMed:11350974}.
FT   DOMAIN     1039   1148       SEA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REGION      126    965       42 X 20 AA approximate tandem repeats of
FT                                P-A-P-G-S-T-A-P-P-A-H-G-V-T-S-A-P-D-T-R.
FT   REGION     1192   1228       Interaction with P53.
FT   REGION     1223   1230       Required for interaction with GSK3B.
FT   REGION     1233   1241       Required for interaction with beta- and
FT                                gamma-catenins.
FT   MOTIF      1203   1206       Interaction with GRB2.
FT   MOTIF      1229   1232       Interaction with SRC and ESR1.
FT   MOTIF      1243   1246       Required for interaction with AP1S2.
FT   SITE       1097   1098       Cleavage; by autolysis.
FT   MOD_RES    1203   1203       Phosphotyrosine; by PDGFR.
FT                                {ECO:0000269|PubMed:14521915,
FT                                ECO:0000269|PubMed:17545600}.
FT   MOD_RES    1212   1212       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:14521915}.
FT   MOD_RES    1218   1218       Phosphotyrosine; by PDGFR.
FT                                {ECO:0000269|PubMed:17545600}.
FT   MOD_RES    1224   1224       Phosphothreonine; by PKC/PRKCD.
FT                                {ECO:0000269|PubMed:11877440}.
FT   MOD_RES    1227   1227       Phosphoserine; by GSK3-beta.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:9819408}.
FT   MOD_RES    1229   1229       Phosphotyrosine; by CSK, EGFR and SRC.
FT                                {ECO:0000269|PubMed:11152665,
FT                                ECO:0000269|PubMed:11483589,
FT                                ECO:0000269|PubMed:14521915,
FT                                ECO:0000269|PubMed:17545600}.
FT   MOD_RES    1243   1243       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:14521915}.
FT   LIPID      1184   1184       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:16507569}.
FT   LIPID      1186   1186       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:16507569}.
FT   CARBOHYD    131    131       O-linked (GalNAc...) threonine.
FT                                {ECO:0000305|PubMed:7744025,
FT                                ECO:0000305|PubMed:9597769}.
FT   CARBOHYD    139    139       O-linked (GalNAc...) threonine.
FT                                {ECO:0000305|PubMed:7744025,
FT                                ECO:0000305|PubMed:9597769}.
FT   CARBOHYD    140    140       O-linked (GalNAc...) serine.
FT                                {ECO:0000255}.
FT   CARBOHYD    144    144       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD    957    957       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    975    975       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1029   1029       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1055   1055       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1133   1133       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      19     21       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.25}.
FT                                /FTId=VSP_003281.
FT   VAR_SEQ      19     19       T -> TATTAPKPAT (in isoform 2, isoform Y-
FT                                LSP, isoform E2, isoform J13, isoform S2
FT                                and isoform T10).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:22941036,
FT                                ECO:0000303|PubMed:2318825,
FT                                ECO:0000303|PubMed:2597151,
FT                                ECO:0000303|PubMed:8608966,
FT                                ECO:0000303|Ref.15}.
FT                                /FTId=VSP_003280.
FT   VAR_SEQ      20     31       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.25}.
FT                                /FTId=VSP_003282.
FT   VAR_SEQ      54   1151       Missing (in isoform E2).
FT                                {ECO:0000303|PubMed:22941036}.
FT                                /FTId=VSP_047872.
FT   VAR_SEQ      54   1093       Missing (in isoform T10).
FT                                {ECO:0000303|PubMed:22941036}.
FT                                /FTId=VSP_047873.
FT   VAR_SEQ      54   1053       Missing (in isoform J13, isoform Y,
FT                                isoform Y-LSP and isoform S2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:15969018,
FT                                ECO:0000303|PubMed:22941036,
FT                                ECO:0000303|PubMed:7925397,
FT                                ECO:0000303|PubMed:9212228,
FT                                ECO:0000303|Ref.15}.
FT                                /FTId=VSP_003285.
FT   VAR_SEQ      54   1035       Missing (in isoform 8, isoform 9 and
FT                                isoform M6).
FT                                {ECO:0000303|PubMed:22941036,
FT                                ECO:0000303|PubMed:9212228,
FT                                ECO:0000303|Ref.12, ECO:0000303|Ref.16}.
FT                                /FTId=VSP_003286.
FT   VAR_SEQ      54     96       VSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPASGSAATW
FT                                GQ -> IPAPTTTKSCRETFLKCFCRFINKGVFWASPILSS
FT                                GQDLWWYN (in isoform ZD).
FT                                {ECO:0000303|PubMed:15623537,
FT                                ECO:0000303|PubMed:22941036}.
FT                                /FTId=VSP_047575.
FT   VAR_SEQ      54     87       VSMTSSVLSSHSPGSGSSTTQGQDVTLAPATEPA -> IPA
FT                                PTTTKSCRETFLKCFCRFINKGVFWASPILS (in
FT                                isoform F). {ECO:0000303|Ref.14}.
FT                                /FTId=VSP_035046.
FT   VAR_SEQ      54     70       VSMTSSVLSSHSPGSGS -> IPAPTTTKSCRETFLKW
FT                                (in isoform 6).
FT                                {ECO:0000303|PubMed:22941036,
FT                                ECO:0000303|PubMed:9212228}.
FT                                /FTId=VSP_003283.
FT   VAR_SEQ      71   1095       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:22941036,
FT                                ECO:0000303|PubMed:9212228}.
FT                                /FTId=VSP_003284.
FT   VAR_SEQ      88   1139       Missing (in isoform F).
FT                                {ECO:0000303|Ref.14}.
FT                                /FTId=VSP_035047.
FT   VAR_SEQ      97   1255       Missing (in isoform ZD).
FT                                {ECO:0000303|PubMed:15623537,
FT                                ECO:0000303|PubMed:22941036}.
FT                                /FTId=VSP_047576.
FT   VAR_SEQ    1077   1181       Missing (in isoform 9 and isoform S2).
FT                                {ECO:0000303|PubMed:22941036,
FT                                ECO:0000303|Ref.12, ECO:0000303|Ref.15}.
FT                                /FTId=VSP_003287.
FT   VAR_SEQ    1077   1087       FLQIYKQGGFL -> VSIGLSFPMLP (in isoform
FT                                5). {ECO:0000303|PubMed:2351132}.
FT                                /FTId=VSP_003288.
FT   VAR_SEQ    1088   1255       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:2351132}.
FT                                /FTId=VSP_003289.
FT   VAR_SEQ    1141   1180       VSDVPFPFSAQSGAGVPGWGIALLVLVCVLVALAIVYLIA
FT                                -> GCLSVPPKELRAAGHLSSPGYLPSYERVPHLPHPWALC
FT                                AP (in isoform M6).
FT                                {ECO:0000303|PubMed:22941036,
FT                                ECO:0000303|Ref.16}.
FT                                /FTId=VSP_046962.
FT   VAR_SEQ    1181   1255       Missing (in isoform M6).
FT                                {ECO:0000303|PubMed:22941036,
FT                                ECO:0000303|Ref.16}.
FT                                /FTId=VSP_046963.
FT   VAR_SEQ    1232   1255       VSAGNGGSSLSYTNPAVAATSANL -> RQNGWSTMPRGAL
FT                                PEESQG (in isoform J13).
FT                                {ECO:0000303|PubMed:22941036}.
FT                                /FTId=VSP_047874.
FT   VARIANT    1117   1117       V -> M (in dbSNP:rs1611770).
FT                                {ECO:0000269|PubMed:15969018,
FT                                ECO:0000269|PubMed:22941036,
FT                                ECO:0000269|Ref.17}.
FT                                /FTId=VAR_019390.
FT   VARIANT    1142   1142       S -> N (in dbSNP:rs11465207).
FT                                {ECO:0000269|Ref.17}.
FT                                /FTId=VAR_019391.
FT   MUTAGEN    1098   1098       S->A,D,E,F,G,H,I,K,L,M,N,P,Q,R,V,W,Y:
FT                                Completely abrogates cleavage.
FT                                {ECO:0000269|PubMed:15987679}.
FT   MUTAGEN    1098   1098       S->C,T: Almost complete cleavage.
FT                                {ECO:0000269|PubMed:15987679}.
FT   MUTAGEN    1116   1116       D->A: Greatly reduced formation of
FT                                isoform 5/isoform Y complex.
FT                                {ECO:0000269|PubMed:10197628}.
FT   MUTAGEN    1116   1116       D->E: No effect on formation of isoform
FT                                5/isoform Y complex.
FT                                {ECO:0000269|PubMed:10197628}.
FT   MUTAGEN    1184   1184       C->A: S-palmitoylation reduced by 50%.
FT                                Complete loss of palmitoylation, no
FT                                effect on endocytosis, recycling
FT                                inhibited and AP1S1 binding reduced by
FT                                30%; when associated with C-1186.
FT                                Accumulates in intracellular
FT                                compartments; when associated with C-1186
FT                                and N-1203.
FT                                {ECO:0000269|PubMed:16507569}.
FT   MUTAGEN    1186   1186       C->A: S-palmitoylation reduced by 50%.
FT                                Complete loss of palmitoylation, no
FT                                effect on endocytosis, recycling
FT                                inhibited, and AP1S1 binding reduced by
FT                                30%; when associated with C-1184.
FT                                Accumulates in intracellular
FT                                compartments; when associated with C-1184
FT                                and N-1203.
FT                                {ECO:0000269|PubMed:16507569}.
FT   MUTAGEN    1187   1189       RRK->AAA: No nuclear targeting of HRG-
FT                                stimulated MUC1 C-terminal nor JUP/gamma-
FT                                catenin. No effect on interaction with
FT                                JUP/gamma-catenin.
FT                                {ECO:0000269|PubMed:12939402,
FT                                ECO:0000269|PubMed:16507569}.
FT   MUTAGEN    1187   1189       RRK->QQQ: No effect on palmitoylation.
FT                                {ECO:0000269|PubMed:12939402,
FT                                ECO:0000269|PubMed:16507569}.
FT   MUTAGEN    1191   1191       Y->F: No effect on EGFR-mediated
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:11483589,
FT                                ECO:0000269|PubMed:15471854}.
FT   MUTAGEN    1191   1191       Y->N: No effect on endocytosis.
FT                                {ECO:0000269|PubMed:11483589,
FT                                ECO:0000269|PubMed:15471854}.
FT   MUTAGEN    1203   1203       Y->E: No effect on nuclear colocalization
FT                                of MUC1CT and CTNNB1. No effect on in
FT                                vitro PDFGR-induced cell invasiveness.
FT                                {ECO:0000269|PubMed:11483589,
FT                                ECO:0000269|PubMed:15471854,
FT                                ECO:0000269|PubMed:16507569,
FT                                ECO:0000269|PubMed:17545600}.
FT   MUTAGEN    1203   1203       Y->F: No effect on EGFR-mediated
FT                                phosphorylation. No nuclear localization
FT                                of MUC1CT. Reduced in vitro PDGFR-induced
FT                                cell invasiveness.
FT                                {ECO:0000269|PubMed:11483589,
FT                                ECO:0000269|PubMed:15471854,
FT                                ECO:0000269|PubMed:16507569,
FT                                ECO:0000269|PubMed:17545600}.
FT   MUTAGEN    1203   1203       Y->N: Reduced endocytosis by 30%. Greatly
FT                                reduced binding to AP1S2 and GRB2.
FT                                Binding AP1S1 reduced by 25%. Reduced
FT                                endocytosis by 77%; when associated with
FT                                N-1243. Accumulates in intracellular
FT                                compartments; when associated with C-1184
FT                                and C-1186. {ECO:0000269|PubMed:11483589,
FT                                ECO:0000269|PubMed:15471854,
FT                                ECO:0000269|PubMed:16507569,
FT                                ECO:0000269|PubMed:17545600}.
FT   MUTAGEN    1209   1209       Y->F: Some reduction in EGFR-mediated
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:11483589}.
FT   MUTAGEN    1218   1218       Y->F: No effect on EGFR-mediated
FT                                phosphorylation. No nuclear
FT                                colocalization of MUC1CT and CTNNB1.
FT                                {ECO:0000269|PubMed:11483589,
FT                                ECO:0000269|PubMed:17545600}.
FT   MUTAGEN    1223   1223       S->A: No change in PRKCD- nor GSK3B-
FT                                mediated phosphorylation.
FT                                {ECO:0000269|PubMed:11877440,
FT                                ECO:0000269|PubMed:9819408}.
FT   MUTAGEN    1224   1224       T->A: Loss of PRKCD-mediated
FT                                phosphorylation. Decreased PRKCD binding.
FT                                No increased binding to CTNNB1 in the
FT                                presence of autophosphorylated PRKCD.
FT                                Increases formation of E-cadherin/beta-
FT                                catenin complex.
FT                                {ECO:0000269|PubMed:11877440}.
FT   MUTAGEN    1227   1227       S->A: No change in PRKCD-mediated
FT                                phosphorylation. Loss of GSK3B-mediated
FT                                phosphorylation. CTNNB1.
FT                                {ECO:0000269|PubMed:11877440,
FT                                ECO:0000269|PubMed:9819408}.
FT   MUTAGEN    1229   1229       Y->F: Greatly reduced EGFR- and Src-
FT                                mediated phosphorylation. No nuclear
FT                                localization of MUC1CT. Reduced in vitro
FT                                PDGFR-mediated phosphorylation. Decreased
FT                                Src-binding.
FT                                {ECO:0000269|PubMed:11152665,
FT                                ECO:0000269|PubMed:11483589,
FT                                ECO:0000269|PubMed:14688481,
FT                                ECO:0000269|PubMed:15471854}.
FT   MUTAGEN    1229   1229       Y->N: No effect on endocytosis.
FT                                {ECO:0000269|PubMed:11152665,
FT                                ECO:0000269|PubMed:11483589,
FT                                ECO:0000269|PubMed:14688481,
FT                                ECO:0000269|PubMed:15471854}.
FT   MUTAGEN    1243   1243       Y->N: Reduces binding to AP1S2 by 33%.
FT                                Greatly reduced binding to GRB2. Reduced
FT                                endocytosis by 50%. Reduced endocytosis
FT                                by 77%; when associated with N-1203.
FT                                {ECO:0000269|PubMed:15471854}.
FT   CONFLICT      2      2       T -> A (in Ref. 24; AAD14369).
FT                                {ECO:0000305}.
FT   CONFLICT    134    134       P -> Q (in Ref. 22; AAA35757).
FT                                {ECO:0000305}.
FT   CONFLICT    154    154       P -> Q (in Ref. 22; AAA35757).
FT                                {ECO:0000305}.
FT   CONFLICT   1021   1021       S -> T (in Ref. 2; AAA35805/AAA35807 and
FT                                3; AAA59876). {ECO:0000305}.
FT   CONFLICT   1143   1143       D -> G (in Ref. 11; AAP97018).
FT                                {ECO:0000305}.
FT   CONFLICT   1193   1193       Q -> L (in Ref. 13; AAK30142).
FT                                {ECO:0000305}.
FT   CONFLICT   1231   1231       K -> T (in Ref. 9; AAD10858).
FT                                {ECO:0000305}.
FT   CONFLICT   1251   1251       T -> A (in Ref. 1; AAA60019).
FT                                {ECO:0000305}.
FT   STRAND     1042   1052       {ECO:0000244|PDB:2ACM}.
FT   HELIX      1056   1059       {ECO:0000244|PDB:2ACM}.
FT   HELIX      1064   1080       {ECO:0000244|PDB:2ACM}.
FT   TURN       1082   1085       {ECO:0000244|PDB:2ACM}.
FT   STRAND     1086   1096       {ECO:0000244|PDB:2ACM}.
FT   STRAND     1099   1107       {ECO:0000244|PDB:2ACM}.
FT   TURN       1109   1111       {ECO:0000244|PDB:2ACM}.
FT   HELIX      1114   1132       {ECO:0000244|PDB:2ACM}.
FT   STRAND     1136   1142       {ECO:0000244|PDB:2ACM}.
SQ   SEQUENCE   1255 AA;  122102 MW;  5E28DFC4C20D9A82 CRC64;
     MTPGTQSPFF LLLLLTVLTV VTGSGHASST PGGEKETSAT QRSSVPSSTE KNAVSMTSSV
     LSSHSPGSGS STTQGQDVTL APATEPASGS AATWGQDVTS VPVTRPALGS TTPPAHDVTS
     APDNKPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS
     APDTRPAPGS TAPPAHGVTS APDTRPAPGS TAPPAHGVTS APDNRPALGS TAPPVHNVTS
     ASGSASGSAS TLVHNGTSAR ATTTPASKST PFSIPSHHSD TPTTLASHST KTDASSTHHS
     SVPPLTSSNH STSPQLSTGV SFFFLSFHIS NLQFNSSLED PSTDYYQELQ RDISEMFLQI
     YKQGGFLGLS NIKFRPGSVV VQLTLAFREG TINVHDVETQ FNQYKTEAAS RYNLTISDVS
     VSDVPFPFSA QSGAGVPGWG IALLVLVCVL VALAIVYLIA LAVCQCRRKN YGQLDIFPAR
     DTYHPMSEYP TYHTHGRYVP PSSTDRSPYE KVSAGNGGSS LSYTNPAVAA TSANL
//
ID   Q7Z538_HUMAN            Unreviewed;       158 AA.
AC   Q7Z538;
DT   01-OCT-2003, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2003, sequence version 1.
DT   31-JAN-2018, entry version 55.
DE   SubName: Full=Mucin short variant PC2 {ECO:0000313|EMBL:AAP97027.1};
GN   Name=MUC1 {ECO:0000313|EMBL:AAP97027.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAP97027.1};
RN   [1] {ECO:0000313|EMBL:AAP97027.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Zhang L.X., Lu H.J.;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:AAP97027.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY327598; AAP97027.1; -; mRNA.
DR   RefSeq; NP_001037858.1; NM_001044393.2.
DR   UniGene; Hs.89603; -.
DR   PeptideAtlas; Q7Z538; -.
DR   PRIDE; Q7Z538; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   HOVERGEN; HBG003075; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; Q7Z538; HS.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    158       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004296928.
SQ   SEQUENCE   158 AA;  16632 MW;  2FDFC9E30A99E41E CRC64;
     MTPGTQSPFF LLLLLTVLTV VTGSGHASST PGGEKETSAT QRSSVLSSTE KNAIPAPTTT
     KSCRETFLKC FCRFINKGVF WASPILSSVW GWGARLGHRA AGAGLCSGCA GHCLSHCLGC
     LSVPPKELRA AGHLSSPGYL PSYERVPHLP HPWALCAP
//
ID   Q7Z551_HUMAN            Unreviewed;       150 AA.
AC   Q7Z551;
DT   01-OCT-2003, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2003, sequence version 1.
DT   28-FEB-2018, entry version 70.
DE   SubName: Full=Mucin short variant S1 {ECO:0000313|EMBL:AAP97014.1};
GN   Name=MUC1 {ECO:0000313|EMBL:AAP97014.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAP97014.1};
RN   [1] {ECO:0000313|EMBL:AAP97014.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Zhang L.X., Lu H.J.;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:AAP97014.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22941036; DOI=10.1007/s00262-012-1325-2;
RA   Zhang L., Vlad A., Milcarek C., Finn O.J.;
RT   "Human mucin MUC1 RNA undergoes different types of alternative
RT   splicing resulting in multiple isoforms.";
RL   Cancer Immunol. Immunother. 62:423-435(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY327583; AAP97014.1; -; mRNA.
DR   RefSeq; NP_001037856.1; NM_001044391.2.
DR   UniGene; Hs.89603; -.
DR   MEROPS; S71.001; -.
DR   PeptideAtlas; Q7Z551; -.
DR   DNASU; 4582; -.
DR   GeneID; 4582; -.
DR   CTD; 4582; -.
DR   PharmGKB; PA31309; -.
DR   eggNOG; ENOG410IX6R; Eukaryota.
DR   eggNOG; ENOG410ZQ7Z; LUCA.
DR   HOVERGEN; HBG003075; -.
DR   ChiTaRS; MUC1; human.
DR   GenomeRNAi; 4582; -.
DR   Genevisible; Q7Z551; HS.
DR   Gene3D; 3.30.70.960; -; 1.
DR   InterPro; IPR036364; SEA_dom_sf.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    150       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004296931.
SQ   SEQUENCE   150 AA;  16223 MW;  99A1BD4C2504A0FF CRC64;
     MTPGTQSPFF LLLLLTVLTV VTGSGHASST PGGEKETSAT QRSSVPSSTE KNAFNSSLED
     PSTDYYQELQ RDISEMAVCQ CRRKNYGQLD IFPARDTYHP MSEYPTYHTH GRYAPPSSTD
     RSPYEKVSAG NGGSSLSYTN PAVAATSANL
//
ID   A0A024QZJ4_HUMAN        Unreviewed;      1972 AA.
AC   A0A024QZJ4;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 33.
DE   SubName: Full=Myosin, heavy polypeptide 11, smooth muscle, isoform CRA_a {ECO:0000313|EMBL:EAW53925.1};
GN   Name=MYH11 {ECO:0000313|EMBL:EAW53925.1};
GN   ORFNames=hCG_19652 {ECO:0000313|EMBL:EAW53925.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW53925.1};
RN   [1] {ECO:0000313|EMBL:EAW53925.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW53925.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000256|PROSITE-ProRule:PRU00782,
CC       ECO:0000256|SAAS:SAAS00912437}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471226; EAW53925.1; -; Genomic_DNA.
DR   RefSeq; NP_002465.1; NM_002474.2.
DR   UniGene; Hs.460109; -.
DR   ProteinModelPortal; A0A024QZJ4; -.
DR   SMR; A0A024QZJ4; -.
DR   PRIDE; A0A024QZJ4; -.
DR   GeneID; 4629; -.
DR   KEGG; hsa:4629; -.
DR   CTD; 4629; -.
DR   EuPathDB; HostDB:ENSG00000133392.16; -.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   KO; K10352; -.
DR   PhylomeDB; A0A024QZJ4; -.
DR   ChiTaRS; MYH11; human.
DR   GenomeRNAi; 4629; -.
DR   Bgee; ENSG00000133392; -.
DR   ExpressionAtlas; A0A024QZJ4; baseline and differential.
DR   GO; GO:0016459; C:myosin complex; IEA:UniProtKB-KW.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003774; F:motor activity; IEA:InterPro.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 3.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF50084; SSF50084; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
PE   3: Inferred from homology;
KW   Actin-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00912434};
KW   ATP-binding {ECO:0000256|SAAS:SAAS00966798};
KW   Coiled coil {ECO:0000256|SAAS:SAAS00099041, ECO:0000256|SAM:Coils};
KW   Motor protein {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00966753};
KW   Myosin {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00966753};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00966798}.
FT   DOMAIN       85    783       Myosin motor.
FT                                {ECO:0000259|PROSITE:PS51456}.
FT   NP_BIND     178    185       ATP. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00782}.
FT   REGION      661    683       Actin-binding. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00782}.
FT   COILED      844   1161       {ECO:0000256|SAM:Coils}.
FT   COILED     1180   1575       {ECO:0000256|SAM:Coils}.
FT   COILED     1577   1719       {ECO:0000256|SAM:Coils}.
FT   COILED     1724   1807       {ECO:0000256|SAM:Coils}.
FT   COILED     1809   1927       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1972 AA;  227339 MW;  67665BB2AECE1277 CRC64;
     MAQKGQLSDD EKFLFVDKNF INSPVAQADW AAKRLVWVPS EKQGFEAASI KEEKGDEVVV
     ELVENGKKVT VGKDDIQKMN PPKFSKVEDM AELTCLNEAS VLHNLRERYF SGLIYTYSGL
     FCVVVNPYKH LPIYSEKIVD MYKGKKRHEM PPHIYAIADT AYRSMLQDRE DQSILCTGES
     GAGKTENTKK VIQYLAVVAS SHKGKKDTSI TGELEKQLLQ ANPILEAFGN AKTVKNDNSS
     RFGKFIRINF DVTGYIVGAN IETYLLEKSR AIRQARDERT FHIFYYMIAG AKEKMRSDLL
     LEGFNNYTFL SNGFVPIPAA QDDEMFQETV EAMAIMGFSE EEQLSILKVV SSVLQLGNIV
     FKKERNTDQA SMPDNTAAQK VCHLMGINVT DFTRSILTPR IKVGRDVVQK AQTKEQADFA
     VEALAKATYE RLFRWILTRV NKALDKTHRQ GASFLGILDI AGFEIFEVNS FEQLCINYTN
     EKLQQLFNHT MFILEQEEYQ REGIEWNFID FGLDLQPCIE LIERPNNPPG VLALLDEECW
     FPKATDKSFV EKLCTEQGSH PKFQKPKQLK DKTEFSIIHY AGKVDYNASA WLTKNMDPLN
     DNVTSLLNAS SDKFVADLWK DVDRIVGLDQ MAKMTESSLP SASKTKKGMF RTVGQLYKEQ
     LGKLMTTLRN TTPNFVRCII PNHEKRSGKL DAFLVLEQLR CNGVLEGIRI CRQGFPNRIV
     FQEFRQRYEI LAANAIPKGF MDGKQACILM IKALELDPNL YRIGQSKIFF RTGVLAHLEE
     ERDLKITDVI MAFQAMCRGY LARKAFAKRQ QQLTAMKVIQ RNCAAYLKLR NWQWWRLFTK
     VKPLLQVTRQ EEEMQAKEDE LQKTKERQQK AENELKELEQ KHSQLTEEKN LLQEQLQAET
     ELYAEAEEMR VRLAAKKQEL EEILHEMEAR LEEEEDRGQQ LQAERKKMAQ QMLDLEEQLE
     EEEAARQKLQ LEKVTAEAKI KKLEDEILVM DDQNNKLSKE RKLLEERISD LTTNLAEEEE
     KAKNLTKLKN KHESMISELE VRLKKEEKSR QELEKLKRKL EGDASDFHEQ IADLQAQIAE
     LKMQLAKKEE ELQAALARLD DEIAQKNNAL KKIRELEGHI SDLQEDLDSE RAARNKAEKQ
     KRDLGEELEA LKTELEDTLD STATQQELRA KREQEVTVLK KALDEETRSH EAQVQEMRQK
     HAQAVEELTE QLEQFKRAKA NLDKNKQTLE KENADLAGEL RVLGQAKQEV EHKKKKLEAQ
     VQELQSKCSD GERARAELND KVHKLQNEVE SVTGMLNEAE GKAIKLAKDV ASLSSQLQDT
     QELLQEETRQ KLNVSTKLRQ LEEERNSLQD QLDEEMEAKQ NLERHISTLN IQLSDSKKKL
     QDFASTVEAL EEGKKRFQKE IENLTQQYEE KAAAYDKLEK TKNRLQQELD DLVVDLDNQR
     QLVSNLEKKQ RKFDQLLAEE KNISSKYADE RDRAEAEARE KETKALSLAR ALEEALEAKE
     ELERTNKMLK AEMEDLVSSK DDVGKNVHEL EKSKRALETQ MEEMKTQLEE LEDELQATED
     AKLRLEVNMQ ALKGQFERDL QARDEQNEEK RRQLQRQLHE YETELEDERK QRALAAAAKK
     KLEGDLKDLE LQADSAIKGR EEAIKQLRKL QAQMKDFQRE LEDARASRDE IFATAKENEK
     KAKSLEADLM QLQEDLAAAE RARKQADLEK EELAEELASS LSGRNALQDE KRRLEARIAQ
     LEEELEEEQG NMEAMSDRVR KATQQAEQLS NELATERSTA QKNESARQQL ERQNKELRSK
     LHEMEGAVKS KFKSTIAALE AKIAQLEEQV EQEAREKQAA TKSLKQKDKK LKEILLQVED
     ERKMAEQYKE QAEKGNARVK QLKRQLEEAE EESQRINANR RKLQRELDEA TESNEAMGRE
     VNALKSKLRR GNETSFVPSR RSGGRRVIEN ADGSEEETDT RDADFNGTKA SE
//
ID   A0A024QZJ6_HUMAN        Unreviewed;      1938 AA.
AC   A0A024QZJ6;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 32.
DE   SubName: Full=Myosin, heavy polypeptide 11, smooth muscle, isoform CRA_b {ECO:0000313|EMBL:EAW53930.1};
GN   Name=MYH11 {ECO:0000313|EMBL:EAW53930.1};
GN   ORFNames=hCG_19652 {ECO:0000313|EMBL:EAW53930.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW53930.1};
RN   [1] {ECO:0000313|EMBL:EAW53930.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW53930.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000256|PROSITE-ProRule:PRU00782,
CC       ECO:0000256|SAAS:SAAS00912437}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471226; EAW53930.1; -; Genomic_DNA.
DR   RefSeq; NP_074035.1; NM_022844.2.
DR   UniGene; Hs.460109; -.
DR   ProteinModelPortal; A0A024QZJ6; -.
DR   SMR; A0A024QZJ6; -.
DR   PRIDE; A0A024QZJ6; -.
DR   GeneID; 4629; -.
DR   CTD; 4629; -.
DR   EuPathDB; HostDB:ENSG00000133392.16; -.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   ChiTaRS; MYH11; human.
DR   GenomeRNAi; 4629; -.
DR   Bgee; ENSG00000133392; -.
DR   ExpressionAtlas; A0A024QZJ6; baseline and differential.
DR   GO; GO:0016459; C:myosin complex; IEA:UniProtKB-KW.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003774; F:motor activity; IEA:InterPro.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 3.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF50084; SSF50084; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
PE   3: Inferred from homology;
KW   Actin-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00912434};
KW   ATP-binding {ECO:0000256|SAAS:SAAS00966798};
KW   Coiled coil {ECO:0000256|SAAS:SAAS00099041, ECO:0000256|SAM:Coils};
KW   Motor protein {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00966753};
KW   Myosin {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00966753};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00966798}.
FT   DOMAIN       85    783       Myosin motor.
FT                                {ECO:0000259|PROSITE:PS51456}.
FT   NP_BIND     178    185       ATP. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00782}.
FT   REGION      661    683       Actin-binding. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00782}.
FT   COILED      844   1161       {ECO:0000256|SAM:Coils}.
FT   COILED     1180   1575       {ECO:0000256|SAM:Coils}.
FT   COILED     1577   1719       {ECO:0000256|SAM:Coils}.
FT   COILED     1724   1807       {ECO:0000256|SAM:Coils}.
FT   COILED     1809   1927       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1938 AA;  223577 MW;  61D4A502A155BEC0 CRC64;
     MAQKGQLSDD EKFLFVDKNF INSPVAQADW AAKRLVWVPS EKQGFEAASI KEEKGDEVVV
     ELVENGKKVT VGKDDIQKMN PPKFSKVEDM AELTCLNEAS VLHNLRERYF SGLIYTYSGL
     FCVVVNPYKH LPIYSEKIVD MYKGKKRHEM PPHIYAIADT AYRSMLQDRE DQSILCTGES
     GAGKTENTKK VIQYLAVVAS SHKGKKDTSI TGELEKQLLQ ANPILEAFGN AKTVKNDNSS
     RFGKFIRINF DVTGYIVGAN IETYLLEKSR AIRQARDERT FHIFYYMIAG AKEKMRSDLL
     LEGFNNYTFL SNGFVPIPAA QDDEMFQETV EAMAIMGFSE EEQLSILKVV SSVLQLGNIV
     FKKERNTDQA SMPDNTAAQK VCHLMGINVT DFTRSILTPR IKVGRDVVQK AQTKEQADFA
     VEALAKATYE RLFRWILTRV NKALDKTHRQ GASFLGILDI AGFEIFEVNS FEQLCINYTN
     EKLQQLFNHT MFILEQEEYQ REGIEWNFID FGLDLQPCIE LIERPNNPPG VLALLDEECW
     FPKATDKSFV EKLCTEQGSH PKFQKPKQLK DKTEFSIIHY AGKVDYNASA WLTKNMDPLN
     DNVTSLLNAS SDKFVADLWK DVDRIVGLDQ MAKMTESSLP SASKTKKGMF RTVGQLYKEQ
     LGKLMTTLRN TTPNFVRCII PNHEKRSGKL DAFLVLEQLR CNGVLEGIRI CRQGFPNRIV
     FQEFRQRYEI LAANAIPKGF MDGKQACILM IKALELDPNL YRIGQSKIFF RTGVLAHLEE
     ERDLKITDVI MAFQAMCRGY LARKAFAKRQ QQLTAMKVIQ RNCAAYLKLR NWQWWRLFTK
     VKPLLQVTRQ EEEMQAKEDE LQKTKERQQK AENELKELEQ KHSQLTEEKN LLQEQLQAET
     ELYAEAEEMR VRLAAKKQEL EEILHEMEAR LEEEEDRGQQ LQAERKKMAQ QMLDLEEQLE
     EEEAARQKLQ LEKVTAEAKI KKLEDEILVM DDQNNKLSKE RKLLEERISD LTTNLAEEEE
     KAKNLTKLKN KHESMISELE VRLKKEEKSR QELEKLKRKL EGDASDFHEQ IADLQAQIAE
     LKMQLAKKEE ELQAALARLD DEIAQKNNAL KKIRELEGHI SDLQEDLDSE RAARNKAEKQ
     KRDLGEELEA LKTELEDTLD STATQQELRA KREQEVTVLK KALDEETRSH EAQVQEMRQK
     HAQAVEELTE QLEQFKRAKA NLDKNKQTLE KENADLAGEL RVLGQAKQEV EHKKKKLEAQ
     VQELQSKCSD GERARAELND KVHKLQNEVE SVTGMLNEAE GKAIKLAKDV ASLSSQLQDT
     QELLQEETRQ KLNVSTKLRQ LEEERNSLQD QLDEEMEAKQ NLERHISTLN IQLSDSKKKL
     QDFASTVEAL EEGKKRFQKE IENLTQQYEE KAAAYDKLEK TKNRLQQELD DLVVDLDNQR
     QLVSNLEKKQ RKFDQLLAEE KNISSKYADE RDRAEAEARE KETKALSLAR ALEEALEAKE
     ELERTNKMLK AEMEDLVSSK DDVGKNVHEL EKSKRALETQ MEEMKTQLEE LEDELQATED
     AKLRLEVNMQ ALKGQFERDL QARDEQNEEK RRQLQRQLHE YETELEDERK QRALAAAAKK
     KLEGDLKDLE LQADSAIKGR EEAIKQLRKL QAQMKDFQRE LEDARASRDE IFATAKENEK
     KAKSLEADLM QLQEDLAAAE RARKQADLEK EELAEELASS LSGRNALQDE KRRLEARIAQ
     LEEELEEEQG NMEAMSDRVR KATQQAEQLS NELATERSTA QKNESARQQL ERQNKELRSK
     LHEMEGAVKS KFKSTIAALE AKIAQLEEQV EQEAREKQAA TKSLKQKDKK LKEILLQVED
     ERKMAEQYKE QAEKGNARVK QLKRQLEEAE EESQRINANR RKLQRELDEA TESNEAMGRE
     VNALKSKLRG PPPQETSQ
//
ID   MYH11_HUMAN             Reviewed;        1972 AA.
AC   P35749; D2JYH7; O00396; O94944; P78422; Q3MIV8; Q3MNF0; Q3MNF1;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 3.
DT   28-FEB-2018, entry version 189.
DE   RecName: Full=Myosin-11;
DE   AltName: Full=Myosin heavy chain 11;
DE   AltName: Full=Myosin heavy chain, smooth muscle isoform;
DE   AltName: Full=SMMHC;
GN   Name=MYH11; Synonyms=KIAA0866;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), AND TISSUE SPECIFICITY.
RX   PubMed=16000639; DOI=10.1152/ajpcell.00244.2004;
RA   Leguillette R., Gil F.R., Zitouni N., Lajoie-Kadoch S., Sobieszek A.,
RA   Lauzon A.M.;
RT   "(+)Insert smooth muscle myosin heavy chain (SM-B) isoform expression
RT   in human tissues.";
RL   Am. J. Physiol. 289:C1277-C1285(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R.,
RA   Fuhrmann J., Mason T., Crosby M.L., Barnstead M., Cronin L.,
RA   Mays A.D., Cao Y., Xu R.X., Kang H.-L., Mitchell S., Eichler E.E.,
RA   Harris P.C., Venter J.C., Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from
RT   human chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [4]
RP   SEQUENCE REVISION.
RA   Nagase T., Kikuno R., Yamakawa H., Ohara O.;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 885-1972 (ISOFORM 1/2).
RX   PubMed=7684189; DOI=10.1002/ajmg.1320460110;
RA   Matsuoka R., Yoshida M.C., Furutani Y., Imamura S., Kanda N.,
RA   Yanagisawa M., Masaki T., Takao A.;
RT   "Human smooth muscle myosin heavy chain gene mapped to chromosomal
RT   region 16q12.";
RL   Am. J. Med. Genet. 46:61-67(1993).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1093-1972 (ISOFORM 1/2).
RC   TISSUE=Hippocampus;
RA   Okajima K.;
RL   Submitted (NOV-1992) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1954, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8; SER-23; SER-1954 AND
RP   THR-1958, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   VARIANTS AAT4 1241-ARG--LEU-1264 DEL AND GLN-1758.
RX   PubMed=16444274; DOI=10.1038/ng1721;
RA   Zhu L., Vranckx R., Khau Van Kien P., Lalande A., Boisset N.,
RA   Mathieu F., Wegman M., Glancy L., Gasc J.-M., Brunotte F.,
RA   Bruneval P., Wolf J.-E., Michel J.-B., Jeunemaitre X.;
RT   "Mutations in myosin heavy chain 11 cause a syndrome associating
RT   thoracic aortic aneurysm/aortic dissection and patent ductus
RT   arteriosus.";
RL   Nat. Genet. 38:343-349(2006).
CC   -!- FUNCTION: Muscle contraction.
CC   -!- SUBUNIT: Muscle myosin is a hexameric protein that consists of 2
CC       heavy chain subunits (MHC), 2 alkali light chain subunits (MLC)
CC       and 2 regulatory light chain subunits (MLC-2).
CC   -!- INTERACTION:
CC       O14950:MYL12B; NbExp=2; IntAct=EBI-1052928, EBI-1642165;
CC   -!- SUBCELLULAR LOCATION: Melanosome {ECO:0000269|PubMed:17081065}.
CC       Note=Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV. Thick filaments of the myofibrils.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=SM-A;
CC         IsoId=P35749-1; Sequence=Displayed;
CC       Name=2; Synonyms=SM-B1;
CC         IsoId=P35749-2; Sequence=VSP_043017;
CC         Note=This isoform with a 7 AA insert in the head domain is
CC         predominantly expressed in rapidly contracting phasic muscles.;
CC       Name=3; Synonyms=SM-B2;
CC         IsoId=P35749-3; Sequence=VSP_043017, VSP_043018;
CC         Note=This isoform with a 7 AA insert in the head domain is
CC         predominantly expressed in rapidly contracting phasic muscles.;
CC       Name=4;
CC         IsoId=P35749-4; Sequence=VSP_043018;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Smooth muscle; expressed in the umbilical
CC       artery, bladder, esophagus and trachea. Isoform 1 is mostly found
CC       in slowly contracting tonic muscles.
CC       {ECO:0000269|PubMed:16000639}.
CC   -!- DOMAIN: The rodlike tail sequence is highly repetitive, showing
CC       cycles of a 28-residue repeat pattern composed of 4 heptapeptides,
CC       characteristic for alpha-helical coiled coils.
CC   -!- DOMAIN: Limited proteolysis of myosin heavy chain produces 1 light
CC       meromyosin (LMM) and 1 heavy meromyosin (HMM). HMM can be further
CC       cleaved into 2 globular subfragments (S1) and 1 rod-shaped
CC       subfragment (S2). {ECO:0000305}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MYH11 is found in
CC       acute myeloid leukemia of M4EO subtype. Pericentric inversion
CC       inv(16)(p13;q22). The inversion produces a fusion protein
CC       consisting of the 165 N-terminal residues of CBF-beta (PEPB2) and
CC       the tail region of MYH11.
CC   -!- DISEASE: Aortic aneurysm, familial thoracic 4 (AAT4) [MIM:132900]:
CC       A disease characterized by permanent dilation of the thoracic
CC       aorta usually due to degenerative changes in the aortic wall. It
CC       is primarily associated with a characteristic histologic
CC       appearance known as 'medial necrosis' or 'Erdheim cystic medial
CC       necrosis' in which there is degeneration and fragmentation of
CC       elastic fibers, loss of smooth muscle cells, and an accumulation
CC       of basophilic ground substance. {ECO:0000269|PubMed:16444274}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74889.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MYH11ID43.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY520816; AAS98910.1; -; mRNA.
DR   EMBL; AY520817; AAS98911.1; -; mRNA.
DR   EMBL; AF001548; AAC31665.1; -; Genomic_DNA.
DR   EMBL; U91323; AAC35212.1; -; Genomic_DNA.
DR   EMBL; AB020673; BAA74889.2; ALT_INIT; mRNA.
DR   EMBL; GU143399; ACZ58373.1; -; Genomic_DNA.
DR   EMBL; GU143400; ACZ58374.1; -; Genomic_DNA.
DR   EMBL; AC024120; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026401; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC130651; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471226; EAW53924.1; -; Genomic_DNA.
DR   EMBL; CH471226; EAW53926.1; -; Genomic_DNA.
DR   EMBL; BC101677; AAI01678.1; -; mRNA.
DR   EMBL; BC104906; AAI04907.1; -; mRNA.
DR   EMBL; BC143364; AAI43365.1; -; mRNA.
DR   EMBL; D10667; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; X69292; CAA49154.1; -; mRNA.
DR   CCDS; CCDS10565.1; -. [P35749-1]
DR   CCDS; CCDS10566.1; -. [P35749-4]
DR   CCDS; CCDS45423.1; -. [P35749-2]
DR   CCDS; CCDS45424.1; -. [P35749-3]
DR   RefSeq; NP_001035202.1; NM_001040113.1. [P35749-3]
DR   RefSeq; NP_001035203.1; NM_001040114.1. [P35749-2]
DR   RefSeq; NP_002465.1; NM_002474.2. [P35749-1]
DR   RefSeq; NP_074035.1; NM_022844.2. [P35749-4]
DR   RefSeq; XP_016878739.1; XM_017023250.1. [P35749-3]
DR   UniGene; Hs.460109; -.
DR   ProteinModelPortal; P35749; -.
DR   SMR; P35749; -.
DR   BioGrid; 110714; 59.
DR   DIP; DIP-47268N; -.
DR   IntAct; P35749; 32.
DR   MINT; P35749; -.
DR   STRING; 9606.ENSP00000379616; -.
DR   DrugBank; DB04444; Tetrafluoroaluminate Ion.
DR   iPTMnet; P35749; -.
DR   PhosphoSitePlus; P35749; -.
DR   SwissPalm; P35749; -.
DR   BioMuta; MYH11; -.
DR   DMDM; 13432177; -.
DR   MaxQB; P35749; -.
DR   PaxDb; P35749; -.
DR   PeptideAtlas; P35749; -.
DR   PRIDE; P35749; -.
DR   Ensembl; ENST00000300036; ENSP00000300036; ENSG00000133392. [P35749-1]
DR   Ensembl; ENST00000396324; ENSP00000379616; ENSG00000133392. [P35749-2]
DR   Ensembl; ENST00000452625; ENSP00000407821; ENSG00000133392. [P35749-3]
DR   Ensembl; ENST00000576790; ENSP00000458731; ENSG00000133392. [P35749-4]
DR   Ensembl; ENST00000612165; ENSP00000478092; ENSG00000276480. [P35749-3]
DR   Ensembl; ENST00000616422; ENSP00000478816; ENSG00000276480. [P35749-4]
DR   Ensembl; ENST00000621545; ENSP00000478109; ENSG00000276480. [P35749-2]
DR   Ensembl; ENST00000634050; ENSP00000488461; ENSG00000276480. [P35749-1]
DR   GeneID; 4629; -.
DR   KEGG; hsa:4629; -.
DR   UCSC; uc002ddv.4; human. [P35749-1]
DR   CTD; 4629; -.
DR   DisGeNET; 4629; -.
DR   EuPathDB; HostDB:ENSG00000133392.16; -.
DR   GeneCards; MYH11; -.
DR   GeneReviews; MYH11; -.
DR   HGNC; HGNC:7569; MYH11.
DR   HPA; CAB002302; -.
DR   HPA; HPA014539; -.
DR   HPA; HPA015310; -.
DR   MalaCards; MYH11; -.
DR   MIM; 132900; phenotype.
DR   MIM; 160745; gene.
DR   neXtProt; NX_P35749; -.
DR   OpenTargets; ENSG00000133392; -.
DR   Orphanet; 98829; 'Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)'.
DR   Orphanet; 229; Familial aortic dissection.
DR   Orphanet; 91387; Familial thoracic aortic aneurysm and aortic dissection.
DR   PharmGKB; PA31367; -.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   GeneTree; ENSGT00760000118919; -.
DR   HOGENOM; HOG000173958; -.
DR   HOVERGEN; HBG004704; -.
DR   InParanoid; P35749; -.
DR   KO; K10352; -.
DR   OMA; TQQYEEK; -.
DR   PhylomeDB; P35749; -.
DR   TreeFam; TF333601; -.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-416572; Sema4D induced cell migration and growth-cone collapse.
DR   Reactome; R-HSA-445355; Smooth Muscle Contraction.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5625900; RHO GTPases activate CIT.
DR   Reactome; R-HSA-5627117; RHO GTPases Activate ROCKs.
DR   Reactome; R-HSA-5627123; RHO GTPases activate PAKs.
DR   ChiTaRS; MYH11; human.
DR   GeneWiki; MYH11; -.
DR   GenomeRNAi; 4629; -.
DR   PRO; PR:P35749; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000133392; -.
DR   CleanEx; HS_MYH11; -.
DR   ExpressionAtlas; P35749; baseline and differential.
DR   Genevisible; P35749; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005859; C:muscle myosin complex; TAS:ProtInc.
DR   GO; GO:0032982; C:myosin filament; IEA:UniProtKB-KW.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0003774; F:motor activity; IEA:InterPro.
DR   GO; GO:0008307; F:structural constituent of muscle; IMP:UniProtKB.
DR   GO; GO:0048739; P:cardiac muscle fiber development; IMP:UniProtKB.
DR   GO; GO:0048251; P:elastic fiber assembly; IMP:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; TAS:Reactome.
DR   GO; GO:0030241; P:skeletal muscle myosin thick filament assembly; ISS:UniProtKB.
DR   GO; GO:0006939; P:smooth muscle contraction; ISS:UniProtKB.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 3.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF50084; SSF50084; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   1: Evidence at protein level;
KW   Actin-binding; Alternative splicing; Aortic aneurysm; ATP-binding;
KW   Calmodulin-binding; Chromosomal rearrangement; Coiled coil;
KW   Complete proteome; Disease mutation; Methylation; Motor protein;
KW   Muscle protein; Myosin; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome; Thick filament.
FT   CHAIN         1   1972       Myosin-11.
FT                                /FTId=PRO_0000123424.
FT   DOMAIN       31     81       Myosin N-terminal SH3-like.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01190}.
FT   DOMAIN       85    783       Myosin motor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00782}.
FT   DOMAIN      786    815       IQ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   NP_BIND     178    185       ATP. {ECO:0000255}.
FT   REGION      661    683       Actin-binding. {ECO:0000250}.
FT   REGION      762    776       Actin-binding. {ECO:0000250}.
FT   REGION     1935   1972       C-terminal.
FT   COILED      844   1934       {ECO:0000255}.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      23     23       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      40     40       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7Z406}.
FT   MOD_RES     129    129       N6,N6,N6-trimethyllysine. {ECO:0000255}.
FT   MOD_RES    1177   1177       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q7Z406}.
FT   MOD_RES    1684   1684       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63862}.
FT   MOD_RES    1722   1722       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63862}.
FT   MOD_RES    1954   1954       Phosphoserine.
FT                                {ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1958   1958       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1971   1971       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O08638}.
FT   VAR_SEQ     211    211       T -> TQGPSFAY (in isoform 2 and isoform
FT                                3). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16000639}.
FT                                /FTId=VSP_043017.
FT   VAR_SEQ    1930   1972       RGNETSFVPSRRSGGRRVIENADGSEEETDTRDADFNGTKA
FT                                SE -> GPPPQETSQ (in isoform 3 and isoform
FT                                4). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16000639}.
FT                                /FTId=VSP_043018.
FT   VARIANT    1104   1104       A -> T (in dbSNP:rs34263860).
FT                                /FTId=VAR_050205.
FT   VARIANT    1234   1234       A -> T (in dbSNP:rs16967494).
FT                                /FTId=VAR_030239.
FT   VARIANT    1241   1264       Missing (in AAT4).
FT                                {ECO:0000269|PubMed:16444274}.
FT                                /FTId=VAR_031734.
FT   VARIANT    1289   1289       V -> A (in dbSNP:rs16967510).
FT                                /FTId=VAR_030240.
FT   VARIANT    1310   1310       V -> M (in dbSNP:rs7196804).
FT                                /FTId=VAR_030241.
FT   VARIANT    1508   1508       M -> V (in dbSNP:rs35176378).
FT                                /FTId=VAR_050206.
FT   VARIANT    1758   1758       R -> Q (in AAT4; dbSNP:rs142546324).
FT                                {ECO:0000269|PubMed:16444274}.
FT                                /FTId=VAR_031735.
FT   CONFLICT    887    889       EEK -> NSE (in Ref. 9; D10667).
FT                                {ECO:0000305}.
FT   CONFLICT   1558   1558       T -> S (in Ref. 9; D10667).
FT                                {ECO:0000305}.
FT   CONFLICT   1610   1611       KQ -> NE (in Ref. 9; D10667).
FT                                {ECO:0000305}.
FT   CONFLICT   1786   1786       A -> S (in Ref. 10; CAA49154).
FT                                {ECO:0000305}.
FT   CONFLICT   1958   1958       T -> L (in Ref. 9; D10667).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1972 AA;  227339 MW;  67665BB2AECE1277 CRC64;
     MAQKGQLSDD EKFLFVDKNF INSPVAQADW AAKRLVWVPS EKQGFEAASI KEEKGDEVVV
     ELVENGKKVT VGKDDIQKMN PPKFSKVEDM AELTCLNEAS VLHNLRERYF SGLIYTYSGL
     FCVVVNPYKH LPIYSEKIVD MYKGKKRHEM PPHIYAIADT AYRSMLQDRE DQSILCTGES
     GAGKTENTKK VIQYLAVVAS SHKGKKDTSI TGELEKQLLQ ANPILEAFGN AKTVKNDNSS
     RFGKFIRINF DVTGYIVGAN IETYLLEKSR AIRQARDERT FHIFYYMIAG AKEKMRSDLL
     LEGFNNYTFL SNGFVPIPAA QDDEMFQETV EAMAIMGFSE EEQLSILKVV SSVLQLGNIV
     FKKERNTDQA SMPDNTAAQK VCHLMGINVT DFTRSILTPR IKVGRDVVQK AQTKEQADFA
     VEALAKATYE RLFRWILTRV NKALDKTHRQ GASFLGILDI AGFEIFEVNS FEQLCINYTN
     EKLQQLFNHT MFILEQEEYQ REGIEWNFID FGLDLQPCIE LIERPNNPPG VLALLDEECW
     FPKATDKSFV EKLCTEQGSH PKFQKPKQLK DKTEFSIIHY AGKVDYNASA WLTKNMDPLN
     DNVTSLLNAS SDKFVADLWK DVDRIVGLDQ MAKMTESSLP SASKTKKGMF RTVGQLYKEQ
     LGKLMTTLRN TTPNFVRCII PNHEKRSGKL DAFLVLEQLR CNGVLEGIRI CRQGFPNRIV
     FQEFRQRYEI LAANAIPKGF MDGKQACILM IKALELDPNL YRIGQSKIFF RTGVLAHLEE
     ERDLKITDVI MAFQAMCRGY LARKAFAKRQ QQLTAMKVIQ RNCAAYLKLR NWQWWRLFTK
     VKPLLQVTRQ EEEMQAKEDE LQKTKERQQK AENELKELEQ KHSQLTEEKN LLQEQLQAET
     ELYAEAEEMR VRLAAKKQEL EEILHEMEAR LEEEEDRGQQ LQAERKKMAQ QMLDLEEQLE
     EEEAARQKLQ LEKVTAEAKI KKLEDEILVM DDQNNKLSKE RKLLEERISD LTTNLAEEEE
     KAKNLTKLKN KHESMISELE VRLKKEEKSR QELEKLKRKL EGDASDFHEQ IADLQAQIAE
     LKMQLAKKEE ELQAALARLD DEIAQKNNAL KKIRELEGHI SDLQEDLDSE RAARNKAEKQ
     KRDLGEELEA LKTELEDTLD STATQQELRA KREQEVTVLK KALDEETRSH EAQVQEMRQK
     HAQAVEELTE QLEQFKRAKA NLDKNKQTLE KENADLAGEL RVLGQAKQEV EHKKKKLEAQ
     VQELQSKCSD GERARAELND KVHKLQNEVE SVTGMLNEAE GKAIKLAKDV ASLSSQLQDT
     QELLQEETRQ KLNVSTKLRQ LEEERNSLQD QLDEEMEAKQ NLERHISTLN IQLSDSKKKL
     QDFASTVEAL EEGKKRFQKE IENLTQQYEE KAAAYDKLEK TKNRLQQELD DLVVDLDNQR
     QLVSNLEKKQ RKFDQLLAEE KNISSKYADE RDRAEAEARE KETKALSLAR ALEEALEAKE
     ELERTNKMLK AEMEDLVSSK DDVGKNVHEL EKSKRALETQ MEEMKTQLEE LEDELQATED
     AKLRLEVNMQ ALKGQFERDL QARDEQNEEK RRQLQRQLHE YETELEDERK QRALAAAAKK
     KLEGDLKDLE LQADSAIKGR EEAIKQLRKL QAQMKDFQRE LEDARASRDE IFATAKENEK
     KAKSLEADLM QLQEDLAAAE RARKQADLEK EELAEELASS LSGRNALQDE KRRLEARIAQ
     LEEELEEEQG NMEAMSDRVR KATQQAEQLS NELATERSTA QKNESARQQL ERQNKELRSK
     LHEMEGAVKS KFKSTIAALE AKIAQLEEQV EQEAREKQAA TKSLKQKDKK LKEILLQVED
     ERKMAEQYKE QAEKGNARVK QLKRQLEEAE EESQRINANR RKLQRELDEA TESNEAMGRE
     VNALKSKLRR GNETSFVPSR RSGGRRVIEN ADGSEEETDT RDADFNGTKA SE
//
ID   A8CDT9_HUMAN            Unreviewed;      1828 AA.
AC   A8CDT9;
DT   13-NOV-2007, integrated into UniProtKB/TrEMBL.
DT   13-NOV-2007, sequence version 1.
DT   28-FEB-2018, entry version 61.
DE   SubName: Full=MYO5A variant protein {ECO:0000313|EMBL:BAF80583.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF80583.1};
RN   [1] {ECO:0000313|EMBL:BAF80583.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAF80583.1};
RA   Yamakawa H., Kikuno R.F., Nagase T., Ohara O.;
RT   "Multiplex amplification and cloning of 5'-ends of cDNA by ligase-free
RT   recombination: Preparation of full-lemgth cDNA clones encoding motor
RT   proteins.";
RL   Submitted (JAN-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000256|PROSITE-ProRule:PRU00782,
CC       ECO:0000256|SAAS:SAAS00912437}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB290180; BAF80583.1; -; mRNA.
DR   RefSeq; NP_001135967.1; NM_001142495.1.
DR   UniGene; Hs.21213; -.
DR   UniGene; Hs.596221; -.
DR   ProteinModelPortal; A8CDT9; -.
DR   PRIDE; A8CDT9; -.
DR   GeneID; 4644; -.
DR   CTD; 4644; -.
DR   PharmGKB; PA31407; -.
DR   eggNOG; KOG0160; Eukaryota.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   HOGENOM; HOG000171839; -.
DR   HOVERGEN; HBG052556; -.
DR   GenomeRNAi; 4644; -.
DR   Genevisible; A8CDT9; HS.
DR   GO; GO:0016459; C:myosin complex; IEA:UniProtKB-KW.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003774; F:motor activity; IEA:InterPro.
DR   CDD; cd15478; Myo5a_CBD; 1.
DR   CDD; cd01380; MYSc_Myo5; 1.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 3.
DR   InterPro; IPR002710; Dilute_dom.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR037988; Myo5a_CBD.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR036103; MYSc_Myo5.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF01843; DIL; 1.
DR   Pfam; PF00612; IQ; 6.
DR   Pfam; PF00063; Myosin_head; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM01132; DIL; 1.
DR   SMART; SM00015; IQ; 6.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF52540; SSF52540; 3.
DR   PROSITE; PS50096; IQ; 6.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
PE   2: Evidence at transcript level;
KW   Actin-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00912434};
KW   ATP-binding {ECO:0000256|SAAS:SAAS00966798};
KW   Coiled coil {ECO:0000256|SAAS:SAAS00983235, ECO:0000256|SAM:Coils};
KW   Motor protein {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00966753};
KW   Myosin {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00966753};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00966798}.
FT   DOMAIN       69    763       Myosin motor.
FT                                {ECO:0000259|PROSITE:PS51456}.
FT   NP_BIND     163    170       ATP. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00782}.
FT   REGION      643    665       Actin-binding. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00782}.
FT   COILED      915    949       {ECO:0000256|SAM:Coils}.
FT   COILED      971   1098       {ECO:0000256|SAM:Coils}.
FT   COILED     1155   1189       {ECO:0000256|SAM:Coils}.
FT   COILED     1196   1231       {ECO:0000256|SAM:Coils}.
FT   COILED     1323   1364       {ECO:0000256|SAM:Coils}.
FT   COILED     1371   1412       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1828 AA;  212259 MW;  F8ADE83570ED0B76 CRC64;
     MAASELYTKF ARVWIPDPEE VWKSAELLKD YKPGDKVLLL HLEEGKDLEY HLDPKTKELP
     HLRNPDILVG ENDLTALSYL HEPAVLHNLR VRFIDSKLIY TYCGIVLVAI NPYEQLPIYG
     EDIINAYSGQ NMGDMDPHIF AVAEEAYKQM ARDERNQSII VSGESGAGKT VSAKYAMRYF
     ATVSGSASEA NVEEKVLASN PIMESIGNAK TTRNDNSSRF GKYIEIGFDK RYRIIGANMR
     TYLLEKSRVV FQAEEERNYH IFYQLCASAK LPEFKMLRLG NADNFNYTKQ GGSPVIEGVD
     DAKEMAHTRQ ACTLLGISES HQMGIFRILA GILHLGNVGF TSRDADSCTI PPKHEPLCIF
     CDLMGVDYEE MCHWLCHRKL ATATETYIKP ISKLQATNAR DALAKHIYAK LFNWIVDNVN
     QALHSAVKQH SFIGVLDIYG FETFEINSFE QFCINYANEK LQQQFNMHVF KLEQEEYMKE
     QIPWTLIDFY DNQPCINLIE SKLGILDLLD EECKMPKGTD DTWAQKLYNT HLNKCALFEK
     PRLSNKAFII QHFADKVEYQ CEGFLEKNKD TVFEEQIKVL KSSKFKMLPE LFQDDEKAIS
     PTSATSSGRT PLTRTPAKPT KGRPGQMAKE HKKTVGHQFR NSLHLLMETL NATTPHYVRC
     IKPNDFKFPF TFDEKRAVQQ LRACGVLETI RISAAGFPSR WTYQEFFSRY RVLMKQKDVL
     SDRKQTCKNV LEKLILDKDK YQFGKTKIFF RAGQVAYLEK LRADKLRAAC IRIQKTIRGW
     LLRKKYLRMR KAAITMQRYV RGYQARCYAK FLRRTKAATI IQKYWRMYVV RRRYKIRRAA
     TIVLQSYLRG FLARNRYRKI LREHKAVIIQ KRVRGWLART HYKRSMHAII YLQCCFRRMM
     AKRELKKLKI EARSVERYKK LHIGMENKIM QLQRKVDEQN KDYKCLVEKL TNLEGIYNSE
     TEKLRSDLER LQLSEEEAKV ATGRVLSLQE EIAKLRKDLE QTRSEKKCIE EHADRYKQET
     EQLVSNLKEE NTLLKQEKEA LNHRIVQQAK EMTETMEKKL VEETKQLELD LNDERLRYQN
     LLNEFSRLEE RYDDLKEEMT LMVHVPKPGH KRTDSTHSSN ESEYIFSSEI AEMEDIPSRT
     EEPSEKKVPL DMSLFLKLQK RVTELEQEKQ VMQDELDRKE EQVLRSKAKE EERPQIRGAE
     LEYESLKRQE LESENKKLKN ELNELRKALS EKSAPEVTAP GAPAYRVLME QLTSVSEELD
     VRKEEVLILR SQLVSQKEAI QPKDDKNTMT DSTILLEDVQ KMKDKGEIAQ AYIGLKETNR
     LLESQLQSQK RSHENEAEAL RGEIQSLKEE NNRQQQLLAQ NLQLPPEARI EASLQHEITR
     LTNENLDLME QLEKQDKTVR KLKKQLKVFA KKIGELEVGQ MENISPGQII DEPIRPVNIP
     RKEKDFQGML EYKKEDEQKL VKNLILELKP RGVAVNLIPG LPAYILFMCV RHADYLNDDQ
     KVRSLLTSTI NSIKKVLKKR GDDFETVSFW LSNTCRFLHC LKQYSGEEGF MKHNTSRQNE
     HCLTNFDLAE YRQVLSDLAI QIYQQLVRVL ENILQPMIVS GMLEHETIQG VSGVKPTGLR
     KRTSSIADEG TYTLDSILRQ LNSFHSVMCQ HGMDPELIKQ VVKQMFYIIG AITLNNLLLR
     KDMCSWSKGM QIRYNVSQLE EWLRDKNLMN SGAKETLEPL IQAAQLLQVK KKTDDDAEAI
     CSMCNALTTA QIVKVLNLYT PVNEFEERVS VSFIRTIQMR LRDRKDSPQL LMDAKHIFPV
     TFPFNPSSLA LETIQIPASL GLGFISRV
//
ID   Q9UES4_HUMAN            Unreviewed;       206 AA.
AC   Q9UES4;
DT   01-MAY-2000, integrated into UniProtKB/TrEMBL.
DT   01-MAY-2000, sequence version 1.
DT   31-JAN-2018, entry version 67.
DE   SubName: Full=Myosin V {ECO:0000313|EMBL:AAC83703.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAC83703.1};
RN   [1] {ECO:0000313|EMBL:AAC83703.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Skin {ECO:0000313|EMBL:AAC83703.1};
RX   PubMed=9826529; DOI=10.1006/bbrc.1998.9644;
RA   Lambert J., Naeyaert J.M., Callens T., De Paepe A., Messiaen L.;
RT   "Human myosin V gene produces different transcripts in a cell type-
RT   specific manner.";
RL   Biochem. Biophys. Res. Commun. 252:329-333(1998).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF090426; AAC83703.1; -; mRNA.
DR   RefSeq; NP_000250.3; NM_000259.3.
DR   UniGene; Hs.21213; -.
DR   UniGene; Hs.596221; -.
DR   PeptideAtlas; Q9UES4; -.
DR   PRIDE; Q9UES4; -.
DR   GeneID; 4644; -.
DR   KEGG; hsa:4644; -.
DR   CTD; 4644; -.
DR   PharmGKB; PA31407; -.
DR   eggNOG; KOG0160; Eukaryota.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   KO; K10357; -.
DR   GenomeRNAi; 4644; -.
DR   Genevisible; Q9UES4; HS.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED        1     24       {ECO:0000256|SAM:Coils}.
FT   COILED      132    184       {ECO:0000256|SAM:Coils}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAC83703.1}.
FT   NON_TER     206    206       {ECO:0000313|EMBL:AAC83703.1}.
SQ   SEQUENCE   206 AA;  23612 MW;  4E445C84828A95D9 CRC64;
     RQELESENKK LKNELNELRK ALSEKSAPEV TAPGAPAYRV LMEQLTSVSE ELDVRKEEVL
     ILRSQLVSQK EAIQPKDDKN TMTDSTILLE DVQKMKDKGE IAQAYIGLKE TNRSSALDYH
     ELNEDGELWL VYEGLKQANR LLESQLQSQK RSHENEAEAL RGEIQSLKEE NNRQQQLLAQ
     NLQLPPEARI EASLQHEITR LTNENL
//
ID   MYO5A_HUMAN             Reviewed;        1855 AA.
AC   Q9Y4I1; A8MZC5; O60653; Q07902; Q16249; Q9UE30; Q9UE31;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   28-FEB-2018, entry version 178.
DE   RecName: Full=Unconventional myosin-Va;
DE   AltName: Full=Dilute myosin heavy chain, non-muscle;
DE   AltName: Full=Myosin heavy chain 12;
DE   AltName: Full=Myosin-12;
DE   AltName: Full=Myoxin;
GN   Name=MYO5A; Synonyms=MYH12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Skin;
RA   Meurers B.H., Zimmermann R., Vosberg H.P.;
RT   "The complete cDNA for human myosin heavy chain 12, a class V
RT   myosin.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT CYS-1246.
RX   PubMed=9207796; DOI=10.1038/ng0797-289;
RA   Pastural E., Barrat F.J., Dufourcq-Lagelouse R., Certain S., Sanal O.,
RA   Jabado N., Seger R., Griscelli C., Fischer A., de Saint Basile G.;
RT   "Griscelli disease maps to chromosome 15q21 and is associated with
RT   mutations in the myosin-Va gene.";
RL   Nat. Genet. 16:289-292(1997).
RN   [3]
RP   ERRATUM.
RA   Pastural E., Barrat F.J., Dufourcq-Lagelouse R., Certain S., Sanal O.,
RA   Jabado N., Seger R., Griscelli C., Fischer A., de Saint Basile G.;
RL   Nat. Genet. 23:373-373(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 638-1477 (ISOFORM 2).
RC   TISSUE=Fetal brain;
RX   PubMed=8188282; DOI=10.1006/geno.1994.1088;
RA   Engle L.J., Kennett R.H.;
RT   "Cloning, analysis, and chromosomal localization of myoxin (MYH12),
RT   the human homologue to the mouse dilute gene.";
RL   Genomics 19:407-416(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1061-1498 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=7835087;
RA   Moore K.J., Testa J.R., Francke U., Milatovich A., Copeland N.G.,
RA   Jenkins N.A.;
RT   "Cloning and regional assignment of the human myosin heavy chain 12
RT   (MYH12) gene to chromosome band 15q21.";
RL   Cytogenet. Cell Genet. 69:53-58(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1358-1460 (ISOFORM 3).
RA   Edgar A.J., Bennett J.P.;
RT   "Inhibition of dendrite formation in melanocytes transiently
RT   transfected with antisense DNA to myosin V.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION.
RX   PubMed=10448864; DOI=10.1038/23072;
RA   Mehta A.D., Rock R.S., Rief M., Spudich J.A., Mooseker M.S.,
RA   Cheney R.E.;
RT   "Myosin-V is a processive actin-based motor.";
RL   Nature 400:590-593(1999).
RN   [9]
RP   INTERACTION WITH MLPH.
RX   PubMed=12062444; DOI=10.1016/S0014-5793(02)02634-0;
RA   Nagashima K., Torii S., Yi Z., Igarashi M., Okamoto K., Takeuchi T.,
RA   Izumi T.;
RT   "Melanophilin directly links Rab27a and myosin Va through its distinct
RT   coiled-coil regions.";
RL   FEBS Lett. 517:233-238(2002).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1452, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   INTERACTION WITH RAB10.
RX   PubMed=22908308; DOI=10.1083/jcb.201111091;
RA   Chen Y., Wang Y., Zhang J., Deng Y., Jiang L., Song E., Wu X.S.,
RA   Hammer J.A., Xu T., Lippincott-Schwartz J.;
RT   "Rab10 and myosin-Va mediate insulin-stimulated GLUT4 storage vesicle
RT   translocation in adipocytes.";
RL   J. Cell Biol. 198:545-560(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-600 AND SER-1652, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   VARIANT CYS-1246.
RX   PubMed=10733681; DOI=10.1046/j.1523-1747.2000.00933.x;
RA   Lambert J., Naeyaert J.-M., De Paepe A., Van Coster R., Ferster A.,
RA   Song M., Messiaen L.;
RT   "Arg-Cys substitution at codon 1246 of the human myosin Va gene is not
RT   associated with Griscelli syndrome.";
RL   J. Invest. Dermatol. 114:731-733(2000).
RN   [19]
RP   INVOLVEMENT IN GS1.
RX   PubMed=10704277; DOI=10.1006/geno.1999.6081;
RA   Pastural E., Ersoy F., Yalman N., Wulffraat N., Grillo E., Ozkinay F.,
RA   Tezcan I., Gedikoglu G., Philippe N., Fischer A., de Saint Basile G.;
RT   "Two genes are responsible for Griscelli syndrome at the same 15q21
RT   locus.";
RL   Genomics 63:299-306(2000).
RN   [20]
RP   INVOLVEMENT IN ELEJAS.
RX   PubMed=12058346; DOI=10.1086/341606;
RA   Anikster Y., Huizing M., Anderson P.D., Fitzpatrick D.L., Klar A.,
RA   Gross-Kieselstein E., Berkun Y., Shazberg G., Gahl W.A., Hurvitz H.;
RT   "Evidence that Griscelli syndrome with neurological involvement is
RT   caused by mutations in RAB27A, not MYO5A.";
RL   Am. J. Hum. Genet. 71:407-414(2002).
RN   [21]
RP   ERRATUM.
RA   Anikster Y., Huizing M., Anderson P.D., Fitzpatrick D.L., Klar A.,
RA   Gross-Kieselstein E., Berkun Y., Shazberg G., Gahl W.A., Hurvitz H.;
RL   Am. J. Hum. Genet. 71:1007-1007(2002).
RN   [22]
RP   INVOLVEMENT IN GS3.
RX   PubMed=12897212; DOI=10.1172/JCI200318264;
RA   Menasche G., Ho C.H., Sanal O., Feldmann J., Tezcan I., Ersoy F.,
RA   Houdusse A., Fischer A., de Saint Basile G.;
RT   "Griscelli syndrome restricted to hypopigmentation results from a
RT   melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1).";
RL   J. Clin. Invest. 112:450-456(2003).
CC   -!- FUNCTION: Processive actin-based motor that can move in large
CC       steps approximating the 36-nm pseudo-repeat of the actin filament.
CC       Involved in melanosome transport. Also mediates the transport of
CC       vesicles to the plasma membrane. May also be required for some
CC       polarization process involved in dendrite formation.
CC       {ECO:0000269|PubMed:10448864}.
CC   -!- SUBUNIT: May be a homodimer, which associates with multiple
CC       calmodulin or myosin light chains (By similarity). Interacts with
CC       RIPL2, the interaction is required for its role in dendrite
CC       formation (By similarity). Interacts with MLPH (PubMed:12062444).
CC       Interacts with SYTL4 (By similarity). Interacts with MYRIP (By
CC       similarity). Interacts with RAB10; mediates the transport to the
CC       plasma membrane of SLC2A4/GLUT4 storage vesicles
CC       (PubMed:22908308). Interacts with FMR1; this interaction occurs in
CC       association with polyribosome (By similarity).
CC       {ECO:0000250|UniProtKB:Q99104, ECO:0000269|PubMed:12062444,
CC       ECO:0000269|PubMed:22908308}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y4I1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y4I1-2; Sequence=VSP_003351;
CC       Name=3;
CC         IsoId=Q9Y4I1-3; Sequence=VSP_003352;
CC   -!- TISSUE SPECIFICITY: Detected in melanocytes.
CC   -!- DISEASE: Griscelli syndrome 1 (GS1) [MIM:214450]: Rare autosomal
CC       recessive disorder that results in pigmentary dilution of the skin
CC       and hair, the presence of large clumps of pigment in hair shafts,
CC       silvery-gray hair and accumulation of melanosomes in melanocytes.
CC       GS1 patients show developmental delay, hypotonia and mental
CC       retardation, without apparent immune abnormalities.
CC       {ECO:0000269|PubMed:10704277}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Griscelli syndrome 3 (GS3) [MIM:609227]: Rare autosomal
CC       recessive disorder characterized by pigmentary dilution of the
CC       skin and hair, the presence of large clumps of pigment in hair
CC       shafts, and an accumulation of melanosomes in melanocytes, without
CC       other clinical manifestations. {ECO:0000269|PubMed:12897212}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Elejalde syndrome (ELEJAS) [MIM:256710]: Autosomal
CC       recessive condition characterized by skin hypopigmentation, the
CC       presence of large clumps of pigment in hair shafts, silvery-gray
CC       hair, accumulation of melanosomes in melanocytes and primary
CC       neurological abnormalities. Elejalde syndrome may be the same
CC       entity as Griscelli syndrome type I.
CC       {ECO:0000269|PubMed:12058346}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=MYO5Abase; Note=MYO5A mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/MYO5Abase/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y07759; CAA69035.1; -; mRNA.
DR   EMBL; Y07759; CAA69036.1; -; mRNA.
DR   EMBL; U90942; AAD00702.1; -; mRNA.
DR   EMBL; AC010674; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC018902; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025917; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z22957; CAA80533.1; -; mRNA.
DR   EMBL; S74799; AAB33211.1; -; mRNA.
DR   EMBL; AF055459; AAC14188.1; -; mRNA.
DR   CCDS; CCDS42037.1; -. [Q9Y4I1-1]
DR   CCDS; CCDS45262.1; -. [Q9Y4I1-2]
DR   PIR; A53016; A53016.
DR   PIR; A59254; A59254.
DR   PIR; B59254; B59254.
DR   PIR; I52966; I52966.
DR   RefSeq; NP_000250.3; NM_000259.3.
DR   RefSeq; XP_005254454.1; XM_005254397.3. [Q9Y4I1-3]
DR   UniGene; Hs.21213; -.
DR   UniGene; Hs.596221; -.
DR   PDB; 4D07; X-ray; 1.85 A; B=1275-1297.
DR   PDB; 4J5L; X-ray; 2.20 A; A/B=1448-1855.
DR   PDB; 4LLI; X-ray; 2.20 A; A/B=1467-1855.
DR   PDB; 4LX1; X-ray; 1.87 A; A/B=1464-1855.
DR   PDB; 4LX2; X-ray; 1.50 A; A=1464-1855.
DR   PDB; 5JCY; X-ray; 1.80 A; A=1464-1855.
DR   PDB; 5JCZ; X-ray; 2.06 A; B/C/E=1464-1855.
DR   PDBsum; 4D07; -.
DR   PDBsum; 4J5L; -.
DR   PDBsum; 4LLI; -.
DR   PDBsum; 4LX1; -.
DR   PDBsum; 4LX2; -.
DR   PDBsum; 5JCY; -.
DR   PDBsum; 5JCZ; -.
DR   ProteinModelPortal; Q9Y4I1; -.
DR   SMR; Q9Y4I1; -.
DR   BioGrid; 110728; 79.
DR   IntAct; Q9Y4I1; 31.
DR   MINT; Q9Y4I1; -.
DR   STRING; 9606.ENSP00000382177; -.
DR   CarbonylDB; Q9Y4I1; -.
DR   iPTMnet; Q9Y4I1; -.
DR   PhosphoSitePlus; Q9Y4I1; -.
DR   SwissPalm; Q9Y4I1; -.
DR   BioMuta; MYO5A; -.
DR   DMDM; 296439234; -.
DR   EPD; Q9Y4I1; -.
DR   PaxDb; Q9Y4I1; -.
DR   PeptideAtlas; Q9Y4I1; -.
DR   PRIDE; Q9Y4I1; -.
DR   Ensembl; ENST00000356338; ENSP00000348693; ENSG00000197535. [Q9Y4I1-2]
DR   Ensembl; ENST00000399231; ENSP00000382177; ENSG00000197535. [Q9Y4I1-1]
DR   GeneID; 4644; -.
DR   KEGG; hsa:4644; -.
DR   UCSC; uc002abx.5; human. [Q9Y4I1-1]
DR   CTD; 4644; -.
DR   DisGeNET; 4644; -.
DR   EuPathDB; HostDB:ENSG00000197535.14; -.
DR   GeneCards; MYO5A; -.
DR   HGNC; HGNC:7602; MYO5A.
DR   HPA; HPA001356; -.
DR   MalaCards; MYO5A; -.
DR   MIM; 160777; gene.
DR   MIM; 214450; phenotype.
DR   MIM; 256710; phenotype.
DR   MIM; 609227; phenotype.
DR   neXtProt; NX_Q9Y4I1; -.
DR   OpenTargets; ENSG00000197535; -.
DR   Orphanet; 79476; Griscelli disease type 1.
DR   Orphanet; 79478; Griscelli disease type 3.
DR   Orphanet; 33445; Neuroectodermal melanolysosomal disease.
DR   PharmGKB; PA31407; -.
DR   eggNOG; KOG0160; Eukaryota.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   GeneTree; ENSGT00900000140810; -.
DR   HOVERGEN; HBG052556; -.
DR   InParanoid; Q9Y4I1; -.
DR   KO; K10357; -.
DR   OMA; IVYLQCC; -.
DR   PhylomeDB; Q9Y4I1; -.
DR   TreeFam; TF328771; -.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-264876; Insulin processing.
DR   ChiTaRS; MYO5A; human.
DR   GeneWiki; MYO5A; -.
DR   GenomeRNAi; 4644; -.
DR   PRO; PR:Q9Y4I1; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000197535; -.
DR   CleanEx; HS_MYO5A; -.
DR   ExpressionAtlas; Q9Y4I1; baseline and differential.
DR   Genevisible; Q9Y4I1; HS.
DR   GO; GO:0042641; C:actomyosin; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0032433; C:filopodium tip; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0030426; C:growth cone; NAS:UniProtKB.
DR   GO; GO:0032593; C:insulin-responsive compartment; ISS:UniProtKB.
DR   GO; GO:0005882; C:intermediate filament; IEA:Ensembl.
DR   GO; GO:0042470; C:melanosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0035371; C:microtubule plus-end; IEA:Ensembl.
DR   GO; GO:0043005; C:neuron projection; NAS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0001750; C:photoreceptor outer segment; IEA:Ensembl.
DR   GO; GO:0001726; C:ruffle; IDA:UniProtKB.
DR   GO; GO:0016461; C:unconventional myosin complex; IEA:Ensembl.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:Ensembl.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0000146; F:microfilament motor activity; NAS:UniProtKB.
DR   GO; GO:0017137; F:Rab GTPase binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0030048; P:actin filament-based movement; NAS:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; IEA:Ensembl.
DR   GO; GO:0099089; P:establishment of endoplasmic reticulum localization to postsynapse; IEA:Ensembl.
DR   GO; GO:0006887; P:exocytosis; IEA:Ensembl.
DR   GO; GO:0048820; P:hair follicle maturation; IEA:Ensembl.
DR   GO; GO:0030073; P:insulin secretion; IEA:Ensembl.
DR   GO; GO:0031987; P:locomotion involved in locomotory behavior; IEA:Ensembl.
DR   GO; GO:0042759; P:long-chain fatty acid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0042438; P:melanin biosynthetic process; IEA:Ensembl.
DR   GO; GO:0030318; P:melanocyte differentiation; IEA:Ensembl.
DR   GO; GO:0032402; P:melanosome transport; NAS:UniProtKB.
DR   GO; GO:0042552; P:myelination; IEA:Ensembl.
DR   GO; GO:0042476; P:odontogenesis; IEA:Ensembl.
DR   GO; GO:0006892; P:post-Golgi vesicle-mediated transport; IMP:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB.
DR   GO; GO:0031585; P:regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IEA:Ensembl.
DR   GO; GO:0032252; P:secretory granule localization; IEA:Ensembl.
DR   GO; GO:0050808; P:synapse organization; IEA:Ensembl.
DR   GO; GO:0030050; P:vesicle transport along actin filament; IMP:UniProtKB.
DR   GO; GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB.
DR   GO; GO:0007601; P:visual perception; IEA:Ensembl.
DR   CDD; cd15478; Myo5a_CBD; 1.
DR   CDD; cd01380; MYSc_Myo5; 1.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 3.
DR   InterPro; IPR002710; Dilute_dom.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR037988; Myo5a_CBD.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR036103; MYSc_Myo5.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF01843; DIL; 1.
DR   Pfam; PF00612; IQ; 6.
DR   Pfam; PF00063; Myosin_head; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM01132; DIL; 1.
DR   SMART; SM00015; IQ; 6.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF52540; SSF52540; 3.
DR   PROSITE; PS51126; DILUTE; 1.
DR   PROSITE; PS50096; IQ; 6.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   ATP-binding; Calmodulin-binding; Coiled coil; Complete proteome;
KW   Motor protein; Myosin; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Protein transport; Reference proteome; Repeat;
KW   Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2   1855       Unconventional myosin-Va.
FT                                /FTId=PRO_0000123456.
FT   DOMAIN        8     60       Myosin N-terminal SH3-like.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01190}.
FT   DOMAIN       69    763       Myosin motor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00782}.
FT   DOMAIN      766    788       IQ 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN      789    818       IQ 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN      814    836       IQ 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN      837    861       IQ 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN      862    883       IQ 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN      885    914       IQ 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN     1534   1810       Dilute. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00503}.
FT   NP_BIND     163    170       ATP. {ECO:0000255}.
FT   REGION      643    665       Actin-binding. {ECO:0000255}.
FT   COILED      914   1237       {ECO:0000255}.
FT   COILED     1338   1445       {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     600    600       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1032   1032       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9QYF3}.
FT   MOD_RES    1452   1452       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1652   1652       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1760   1760       Phosphothreonine. {ECO:0000255}.
FT   VAR_SEQ    1321   1347       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7835087,
FT                                ECO:0000303|PubMed:8188282,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_003351.
FT   VAR_SEQ    1413   1413       L -> LYFEELYADDPKKYQSYRISLYKRMI (in
FT                                isoform 3). {ECO:0000303|Ref.7}.
FT                                /FTId=VSP_003352.
FT   VARIANT     627    627       M -> T (in dbSNP:rs16964944).
FT                                /FTId=VAR_056180.
FT   VARIANT    1246   1246       R -> C (in dbSNP:rs1058219).
FT                                {ECO:0000269|PubMed:10733681,
FT                                ECO:0000269|PubMed:9207796}.
FT                                /FTId=VAR_010645.
FT   VARIANT    1673   1673       S -> L (in dbSNP:rs9282796).
FT                                /FTId=VAR_056181.
FT   CONFLICT    198    198       A -> T (in Ref. 1; CAA69035/CAA69036 and
FT                                2; AAD00702). {ECO:0000305}.
FT   CONFLICT    362    362       E -> D (in Ref. 1; CAA69035/CAA69036 and
FT                                2; AAD00702). {ECO:0000305}.
FT   CONFLICT    668    668       F -> L (in Ref. 1; CAA69035/CAA69036).
FT                                {ECO:0000305}.
FT   CONFLICT    833    833       Missing (in Ref. 5; CAA80533).
FT                                {ECO:0000305}.
FT   CONFLICT    863    863       E -> G (in Ref. 1; CAA69035/CAA69036).
FT                                {ECO:0000305}.
FT   CONFLICT    922    922       H -> R (in Ref. 1; CAA69035/CAA69036).
FT                                {ECO:0000305}.
FT   CONFLICT   1061   1061       V -> L (in Ref. 6; AAB33211).
FT                                {ECO:0000305}.
FT   CONFLICT   1089   1089       E -> Q (in Ref. 5; CAA80533).
FT                                {ECO:0000305}.
FT   CONFLICT   1177   1177       D -> E (in Ref. 6; AAB33211).
FT                                {ECO:0000305}.
FT   CONFLICT   1465   1477       NIPRKEKDFQGML -> SVLCACCVSVTVR (in Ref.
FT                                5; CAA80533). {ECO:0000305}.
FT   CONFLICT   1471   1471       K -> N (in Ref. 6; AAB33211).
FT                                {ECO:0000305}.
FT   CONFLICT   1484   1484       E -> D (in Ref. 6; AAB33211).
FT                                {ECO:0000305}.
FT   STRAND     1285   1289       {ECO:0000244|PDB:4D07}.
FT   STRAND     1475   1478       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1481   1483       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1484   1491       {ECO:0000244|PDB:4LX2}.
FT   TURN       1492   1494       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1500   1502       {ECO:0000244|PDB:4LX2}.
FT   TURN       1505   1507       {ECO:0000244|PDB:4LLI}.
FT   HELIX      1508   1522       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1526   1547       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1551   1570       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1575   1577       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1583   1586       {ECO:0000244|PDB:4LX2}.
FT   STRAND     1591   1594       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1596   1621       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1622   1624       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1625   1629       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1661   1677       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1682   1706       {ECO:0000244|PDB:4LX2}.
FT   STRAND     1708   1710       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1713   1732       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1740   1743       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1745   1755       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1761   1770       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1776   1785       {ECO:0000244|PDB:4LX2}.
FT   STRAND     1790   1792       {ECO:0000244|PDB:5JCZ}.
FT   HELIX      1798   1807       {ECO:0000244|PDB:4LX2}.
FT   TURN       1808   1810       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1838   1840       {ECO:0000244|PDB:4LX2}.
FT   HELIX      1845   1847       {ECO:0000244|PDB:4LX2}.
FT   STRAND     1852   1855       {ECO:0000244|PDB:4LX2}.
SQ   SEQUENCE   1855 AA;  215405 MW;  78FD3B1D08D90A0A CRC64;
     MAASELYTKF ARVWIPDPEE VWKSAELLKD YKPGDKVLLL HLEEGKDLEY HLDPKTKELP
     HLRNPDILVG ENDLTALSYL HEPAVLHNLR VRFIDSKLIY TYCGIVLVAI NPYEQLPIYG
     EDIINAYSGQ NMGDMDPHIF AVAEEAYKQM ARDERNQSII VSGESGAGKT VSAKYAMRYF
     ATVSGSASEA NVEEKVLASN PIMESIGNAK TTRNDNSSRF GKYIEIGFDK RYRIIGANMR
     TYLLEKSRVV FQAEEERNYH IFYQLCASAK LPEFKMLRLG NADNFNYTKQ GGSPVIEGVD
     DAKEMAHTRQ ACTLLGISES HQMGIFRILA GILHLGNVGF TSRDADSCTI PPKHEPLCIF
     CELMGVDYEE MCHWLCHRKL ATATETYIKP ISKLQATNAR DALAKHIYAK LFNWIVDNVN
     QALHSAVKQH SFIGVLDIYG FETFEINSFE QFCINYANEK LQQQFNMHVF KLEQEEYMKE
     QIPWTLIDFY DNQPCINLIE SKLGILDLLD EECKMPKGTD DTWAQKLYNT HLNKCALFEK
     PRLSNKAFII QHFADKVEYQ CEGFLEKNKD TVFEEQIKVL KSSKFKMLPE LFQDDEKAIS
     PTSATSSGRT PLTRTPAKPT KGRPGQMAKE HKKTVGHQFR NSLHLLMETL NATTPHYVRC
     IKPNDFKFPF TFDEKRAVQQ LRACGVLETI RISAAGFPSR WTYQEFFSRY RVLMKQKDVL
     SDRKQTCKNV LEKLILDKDK YQFGKTKIFF RAGQVAYLEK LRADKLRAAC IRIQKTIRGW
     LLRKKYLRMR KAAITMQRYV RGYQARCYAK FLRRTKAATI IQKYWRMYVV RRRYKIRRAA
     TIVLQSYLRG FLARNRYRKI LREHKAVIIQ KRVRGWLART HYKRSMHAII YLQCCFRRMM
     AKRELKKLKI EARSVERYKK LHIGMENKIM QLQRKVDEQN KDYKCLVEKL TNLEGIYNSE
     TEKLRSDLER LQLSEEEAKV ATGRVLSLQE EIAKLRKDLE QTRSEKKCIE EHADRYKQET
     EQLVSNLKEE NTLLKQEKEA LNHRIVQQAK EMTETMEKKL VEETKQLELD LNDERLRYQN
     LLNEFSRLEE RYDDLKEEMT LMVHVPKPGH KRTDSTHSSN ESEYIFSSEI AEMEDIPSRT
     EEPSEKKVPL DMSLFLKLQK RVTELEQEKQ VMQDELDRKE EQVLRSKAKE EERPQIRGAE
     LEYESLKRQE LESENKKLKN ELNELRKALS EKSAPEVTAP GAPAYRVLME QLTSVSEELD
     VRKEEVLILR SQLVSQKEAI QPKDDKNTMT DSTILLEDVQ KMKDKGEIAQ AYIGLKETNR
     SSALDYHELN EDGELWLVYE GLKQANRLLE SQLQSQKRSH ENEAEALRGE IQSLKEENNR
     QQQLLAQNLQ LPPEARIEAS LQHEITRLTN ENLDLMEQLE KQDKTVRKLK KQLKVFAKKI
     GELEVGQMEN ISPGQIIDEP IRPVNIPRKE KDFQGMLEYK KEDEQKLVKN LILELKPRGV
     AVNLIPGLPA YILFMCVRHA DYLNDDQKVR SLLTSTINSI KKVLKKRGDD FETVSFWLSN
     TCRFLHCLKQ YSGEEGFMKH NTSRQNEHCL TNFDLAEYRQ VLSDLAIQIY QQLVRVLENI
     LQPMIVSGML EHETIQGVSG VKPTGLRKRT SSIADEGTYT LDSILRQLNS FHSVMCQHGM
     DPELIKQVVK QMFYIIGAIT LNNLLLRKDM CSWSKGMQIR YNVSQLEEWL RDKNLMNSGA
     KETLEPLIQA AQLLQVKKKT DDDAEAICSM CNALTTAQIV KVLNLYTPVN EFEERVSVSF
     IRTIQMRLRD RKDSPQLLMD AKHIFPVTFP FNPSSLALET IQIPASLGLG FISRV
//
ID   NCOA1_HUMAN             Reviewed;        1441 AA.
AC   Q15788; O00150; O43792; O43793; Q13071; Q13420; Q2T9G5; Q53SX3;
AC   Q6GVI5; Q7KYV3;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 3.
DT   28-FEB-2018, entry version 172.
DE   RecName: Full=Nuclear receptor coactivator 1;
DE            Short=NCoA-1;
DE            EC=2.3.1.48;
DE   AltName: Full=Class E basic helix-loop-helix protein 74;
DE            Short=bHLHe74;
DE   AltName: Full=Protein Hin-2;
DE   AltName: Full=RIP160;
DE   AltName: Full=Renal carcinoma antigen NY-REN-52;
DE   AltName: Full=Steroid receptor coactivator 1;
DE            Short=SRC-1;
GN   Name=NCOA1; Synonyms=BHLHE74, SRC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), INTERACTION WITH GTF2B, AND
RP   VARIANTS LYS-457; LYS-466; PRO-474; THR-591; ALA-685; PHE-999 AND
RP   THR-1154.
RX   PubMed=8754792; DOI=10.1210/endo.137.8.8754792;
RA   Takeshita A., Yen P.M., Misiti S., Cardona G.R., Liu Y., Chin W.W.;
RT   "Molecular cloning and properties of a full-length putative thyroid
RT   hormone receptor coactivator.";
RL   Endocrinology 137:3594-3597(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF 636-LEU-LEU-637; 693-LEU-LEU-694 AND
RP   752-LEU-LEU-753.
RX   PubMed=9427757; DOI=10.1093/emboj/17.1.232;
RA   Kalkhoven E., Valentine J.E., Heery D.M., Parker M.G.;
RT   "Isoforms of steroid receptor coactivator 1 differ in their ability to
RT   potentiate transcription by the oestrogen receptor.";
RL   EMBO J. 17:232-243(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS LYS-457; LYS-466;
RP   PRO-474; THR-591; ALA-685; PHE-999 AND THR-1154.
RC   TISSUE=Heart muscle, and Skeletal muscle;
RX   PubMed=9575154; DOI=10.1074/jbc.273.20.12101;
RA   Onate S.A., Boonyaratanakornkit V., Spencer T.E., Tsai S.Y.,
RA   Tsai M.-J., Edwards D.P., O'Malley B.W.;
RT   "The steroid receptor coactivator-1 contains multiple receptor
RT   interacting and activation domains that cooperatively enhance the
RT   activation function 1 (AF1) and AF2 domains of steroid receptors.";
RL   J. Biol. Chem. 273:12101-12108(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-1238 AND SER-1272.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 363-1441 (ISOFORM 1), FUNCTION,
RP   INTERACTION WITH ESR1; RXRA; GCCR; PGR AND THRA, AND VARIANTS LYS-457;
RP   LYS-466; PRO-474; THR-591; ALA-685; ALA-794; PHE-999 AND THR-1154.
RX   PubMed=7481822; DOI=10.1126/science.270.5240.1354;
RA   Onate S.A., Tsai S.Y., Tsai M.-J., O'Malley B.W.;
RT   "Sequence and characterization of a coactivator for the steroid
RT   hormone receptor superfamily.";
RL   Science 270:1354-1357(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 865-1441 (ISOFORM 2).
RX   PubMed=11831720; DOI=10.1006/viro.1995.1161;
RA   Raineri I., Soler M., Senn H.-P.;
RT   "Analysis of human immunodeficiency virus type 1 promoter insertion in
RT   vivo.";
RL   Virology 208:359-364(1995).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 868-1441 (ISOFORM 2), CHROMOSOMAL
RP   TRANSLOCATION WITH PAX3, AND TISSUE SPECIFICITY.
RX   PubMed=15313887; DOI=10.1158/0008-5472.CAN-04-0844;
RA   Wachtel M., Dettling M., Koscielniak E., Stegmaier S., Treuner J.,
RA   Simon-Klingenstein K., Buehlmann P., Niggli F.K., Schaefer B.W.;
RT   "Gene expression signatures identify rhabdomyosarcoma subtypes and
RT   detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.";
RL   Cancer Res. 64:5539-5545(2004).
RN   [11]
RP   IDENTIFICATION (ISOFORM 2), FUNCTION, AND ALTERNATIVE SPLICING.
RX   PubMed=9223431; DOI=10.1006/bbrc.1997.6911;
RA   Hayashi Y., Ohmori S., Ito T., Seo H.;
RT   "A splicing variant of steroid receptor coactivator-1 (SRC-1E): the
RT   major isoform of SRC-1 to mediate thyroid hormone action.";
RL   Biochem. Biophys. Res. Commun. 236:83-87(1997).
RN   [12]
RP   FUNCTION AS A HISTONE ACETYLTRANSFERASE, AND INTERACTION WITH PCAF.
RX   PubMed=9296499; DOI=10.1038/38304;
RA   Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J.,
RA   Mizzen C.A., McKenna N.J., Onate S.A., Tsai S.Y., Tsai M.-J.,
RA   O'Malley B.W.;
RT   "Steroid receptor coactivator-1 is a histone acetyltransferase.";
RL   Nature 389:194-198(1997).
RN   [13]
RP   FUNCTION.
RX   PubMed=9223281; DOI=10.1073/pnas.94.15.7879;
RA   Jenster G., Spencer T.E., Burcin M.M., Tsai S.Y., Tsai M.-J.,
RA   O'Malley B.W.;
RT   "Steroid receptor induction of gene transcription: a two-step model.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7879-7884(1997).
RN   [14]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [15]
RP   INTERACTION WITH NCOA6.
RX   PubMed=10567404; DOI=10.1074/jbc.274.48.34283;
RA   Lee S.-K., Anzick S.L., Choi J.-E., Bubendorf L., Guan X.-Y.,
RA   Jung Y.-K., Kallioniemi O.-P., Kononen J., Trent J.M., Azorsa D.,
RA   Jhun B.-H., Cheong J.H., Lee Y.C., Meltzer P.S., Lee J.W.;
RT   "A nuclear factor ASC-2, as a cancer-amplified transcriptional
RT   coactivator essential for ligand-dependent transactivation by nuclear
RT   receptors in vivo.";
RL   J. Biol. Chem. 274:34283-34293(1999).
RN   [16]
RP   FUNCTION.
RX   PubMed=10449719; DOI=10.1073/pnas.96.17.9485;
RA   Liu Z., Wong J., Tsai S.Y., Tsai M.-J., O'Malley B.W.;
RT   "Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and
RT   receptor-dependent cell-free transcription of chromatin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:9485-9490(1999).
RN   [17]
RP   PHOSPHORYLATION AT SER-372; SER-395; SER-517; SER-569; SER-1033;
RP   THR-1179 AND SER-1185.
RX   PubMed=10660621; DOI=10.1074/jbc.275.6.4475;
RA   Rowan B.G., Weigel N.L., O'Malley B.W.;
RT   "Phosphorylation of steroid receptor coactivator-1. Identification of
RT   the phosphorylation sites and phosphorylation through the mitogen-
RT   activated protein kinase pathway.";
RL   J. Biol. Chem. 275:4475-4483(2000).
RN   [18]
RP   INTERACTION WITH COPS5.
RX   PubMed=10722692; DOI=10.1074/jbc.275.12.8540;
RA   Chauchereau A., Georgiakaki M., Perrin-Wolff M., Milgrom E.,
RA   Loosfelt H.;
RT   "JAB1 interacts with both the progesterone receptor and SRC-1.";
RL   J. Biol. Chem. 275:8540-8548(2000).
RN   [19]
RP   INTERACTION WITH NCOA2.
RX   PubMed=10594042; DOI=10.1128/MCB.20.1.402-415.2000;
RA   Carrero P., Okamoto K., Coumailleau P., O'Brien S., Tanaka H.,
RA   Poellinger L.;
RT   "Redox-regulated recruitment of the transcriptional coactivators CREB-
RT   binding protein and SRC-1 to hypoxia-inducible factor 1alpha.";
RL   Mol. Cell. Biol. 20:402-415(2000).
RN   [20]
RP   INTERACTION WITH DDX5.
RX   PubMed=11250900; DOI=10.1093/emboj/20.6.1341;
RA   Watanabe M., Yanagisawa J., Kitagawa H., Takeyama K., Ogawa S.,
RA   Arao Y., Suzawa M., Kobayashi Y., Yano T., Yoshikawa H., Masuhiro Y.,
RA   Kato S.;
RT   "A subfamily of RNA-binding DEAD-box proteins acts as an estrogen
RT   receptor alpha coactivator through the N-terminal activation domain
RT   (AF-1) with an RNA coactivator, SRA.";
RL   EMBO J. 20:1341-1352(2001).
RN   [21]
RP   INTERACTION WITH STAT3.
RX   PubMed=11773079; DOI=10.1074/jbc.M111486200;
RA   Giraud S., Bienvenu F., Avril S., Gascan H., Heery D.M., Coqueret O.;
RT   "Functional interaction of STAT3 transcription factor with the
RT   coactivator NcoA/SRC1a.";
RL   J. Biol. Chem. 277:8004-8011(2002).
RN   [22]
RP   INTERACTION WITH PRMT2.
RX   PubMed=12039952; DOI=10.1074/jbc.M201053200;
RA   Qi C., Chang J., Zhu Y., Yeldandi A.V., Rao S.M., Zhu Y.-J.;
RT   "Identification of protein arginine methyltransferase 2 as a
RT   coactivator for estrogen receptor alpha.";
RL   J. Biol. Chem. 277:28624-28630(2002).
RN   [23]
RP   INTERACTION WITH STAT6.
RX   PubMed=12138096; DOI=10.1074/jbc.M203556200;
RA   Litterst C.M., Pfitzner E.;
RT   "An LXXLL motif in the transactivation domain of STAT6 mediates
RT   recruitment of NCoA-1/SRC-1.";
RL   J. Biol. Chem. 277:36052-36060(2002).
RN   [24]
RP   SUMOYLATION AT LYS-732 AND LYS-774, UBIQUITINATION, AND MUTAGENESIS OF
RP   LYS-732; LYS-774; LYS-800; LYS-846 AND LYS-1378.
RX   PubMed=12529333; DOI=10.1074/jbc.M207148200;
RA   Chauchereau A., Amazit L., Quesne M., Guiochon-Mantel A., Milgrom E.;
RT   "Sumoylation of the progesterone receptor and of the steroid receptor
RT   coactivator SRC-1.";
RL   J. Biol. Chem. 278:12335-12343(2003).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH STAT5A AND STAT5B.
RX   PubMed=12954634; DOI=10.1074/jbc.M303644200;
RA   Litterst C.M., Kliem S., Marilley D., Pfitzner E.;
RT   "NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the
RT   FDL motif in the alpha-helical region of the STAT5 transactivation
RT   domain.";
RL   J. Biol. Chem. 278:45340-45351(2003).
RN   [26]
RP   INTERACTION WITH NR3C1.
RX   PubMed=12917342; DOI=10.1128/MCB.23.17.6210-6220.2003;
RA   Hsiao P.W., Fryer C.J., Trotter K.W., Wang W., Archer T.K.;
RT   "BAF60a mediates critical interactions between nuclear receptors and
RT   the BRG1 chromatin-remodeling complex for transactivation.";
RL   Mol. Cell. Biol. 23:6210-6220(2003).
RN   [27]
RP   INTERACTION WITH UBE2L3.
RX   PubMed=15367689; DOI=10.1128/MCB.24.19.8716-8726.2004;
RA   Verma S., Ismail A., Gao X., Fu G., Li X., O'Malley B.W., Nawaz Z.;
RT   "The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for
RT   steroid hormone receptors.";
RL   Mol. Cell. Biol. 24:8716-8726(2004).
RN   [28]
RP   INTERACTION WITH PSMB9.
RX   PubMed=16957778; DOI=10.1038/sj.emboj.7601306;
RA   Zhang H., Sun L., Liang J., Yu W., Zhang Y., Wang Y., Chen Y., Li R.,
RA   Sun X., Shang Y.;
RT   "The catalytic subunit of the proteasome is engaged in the entire
RT   process of estrogen receptor-regulated transcription.";
RL   EMBO J. 25:4223-4233(2006).
RN   [29]
RP   INTERACTION WITH ASXL1.
RX   PubMed=16606617; DOI=10.1074/jbc.M512616200;
RA   Cho Y.S., Kim E.J., Park U.H., Sin H.S., Um S.J.;
RT   "Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts
RT   as a ligand-dependent coactivator for retinoic acid receptor.";
RL   J. Biol. Chem. 281:17588-17598(2006).
RN   [30]
RP   INTERACTION WITH TTLL5.
RC   TISSUE=Testis;
RX   PubMed=17116691; DOI=10.1128/MCB.01360-06;
RA   He Y., Simons S.S. Jr.;
RT   "STAMP, a novel predicted factor assisting TIF2 actions in
RT   glucocorticoid receptor-mediated induction and repression.";
RL   Mol. Cell. Biol. 27:1467-1485(2007).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [33]
RP   INTERACTION WITH RXRA.
RX   PubMed=19786558; DOI=10.1124/mol.109.057000;
RA   Cho Y., Noshiro M., Choi M., Morita K., Kawamoto T., Fujimoto K.,
RA   Kato Y., Makishima M.;
RT   "The basic helix-loop-helix proteins differentiated embryo chondrocyte
RT   (DEC) 1 and DEC2 function as corepressors of retinoid X receptors.";
RL   Mol. Pharmacol. 76:1360-1369(2009).
RN   [34]
RP   INTERACTION WITH PRMT6.
RX   PubMed=20047962; DOI=10.1093/nar/gkp1203;
RA   Harrison M.J., Tang Y.H., Dowhan D.H.;
RT   "Protein arginine methyltransferase 6 regulates multiple aspects of
RT   gene expression.";
RL   Nucleic Acids Res. 38:2201-2216(2010).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-395, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22; SER-372; SER-395;
RP   SER-698 AND SER-1372, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [37]
RP   INTERACTION WITH TRIP4.
RX   PubMed=25219498; DOI=10.1016/j.molcel.2014.08.007;
RA   Yoo H.M., Kang S.H., Kim J.Y., Lee J.E., Seong M.W., Lee S.W.,
RA   Ka S.H., Sou Y.S., Komatsu M., Tanaka K., Lee S.T., Noh D.Y.,
RA   Baek S.H., Jeon Y.J., Chung C.H.;
RT   "Modification of ASC1 by UFM1 is crucial for ERalpha transactivation
RT   and breast cancer development.";
RL   Mol. Cell 56:261-274(2014).
RN   [38]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-846, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [39]
RP   INTERACTION WITH VDR.
RX   PubMed=28698609; DOI=10.1038/s41598-017-05081-x;
RA   Tamura M., Ishizawa M., Isojima T., Oezen S., Oka A., Makishima M.,
RA   Kitanaka S.;
RT   "Functional analyses of a novel missense and other mutations of the
RT   vitamin D receptor in association with alopecia.";
RL   Sci. Rep. 7:5102-5102(2017).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 623-710 IN COMPLEX WITH
RP   PPARG.
RX   PubMed=9744270; DOI=10.1038/25931;
RA   Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H.,
RA   Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., Milburn M.V.;
RT   "Ligand binding and co-activator assembly of the peroxisome
RT   proliferator-activated receptor-gamma.";
RL   Nature 395:137-143(1998).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 687-696 IN COMPLEX WITH
RP   PPARA.
RX   PubMed=11698662; DOI=10.1073/pnas.241410198;
RA   Xu H.E., Lambert M.H., Montana V.G., Plunket K.D., Moore L.B.,
RA   Collins J.L., Oplinger J.A., Kliewer S.A., Gampe R.T. Jr., McKee D.D.,
RA   Moore J.T., Willson T.M.;
RT   "Structural determinants of ligand binding selectivity between the
RT   peroxisome proliferator-activated receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:13919-13924(2001).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 686-700 IN COMPLEX WITH
RP   ESRRG.
RX   PubMed=11864604; DOI=10.1016/S1097-2765(02)00444-6;
RA   Greschik H., Wurtz J.-M., Sanglier S., Bourguet W., van Dorsselaer A.,
RA   Moras D., Renaud J.-P.;
RT   "Structural and functional evidence for ligand-independent
RT   transcriptional activation by the estrogen-related receptor 3.";
RL   Mol. Cell 9:303-313(2002).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 257-385 IN COMPLEX WITH
RP   795-808 OF STAT6.
RX   PubMed=14757047; DOI=10.1016/j.jmb.2003.12.057;
RA   Razeto A., Ramakrishnan V., Litterst C.M., Giller K., Griesinger C.,
RA   Carlomagno T., Lakomek N., Heimburg T., Lodrini M., Pfitzner E.,
RA   Becker S.;
RT   "Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif
RT   of the STAT6 transactivation domain.";
RL   J. Mol. Biol. 336:319-329(2004).
CC   -!- FUNCTION: Nuclear receptor coactivator that directly binds nuclear
CC       receptors and stimulates the transcriptional activities in a
CC       hormone-dependent fashion. Involved in the coactivation of
CC       different nuclear receptors, such as for steroids (PGR, GR and
CC       ER), retinoids (RXRs), thyroid hormone (TRs) and prostanoids
CC       (PPARs). Also involved in coactivation mediated by STAT3, STAT5A,
CC       STAT5B and STAT6 transcription factors. Displays histone
CC       acetyltransferase activity toward H3 and H4; the relevance of such
CC       activity remains however unclear. Plays a central role in creating
CC       multisubunit coactivator complexes that act via remodeling of
CC       chromatin, and possibly acts by participating in both chromatin
CC       remodeling and recruitment of general transcription factors.
CC       Required with NCOA2 to control energy balance between white and
CC       brown adipose tissues. Required for mediating steroid hormone
CC       response. Isoform 2 has a higher thyroid hormone-dependent
CC       transactivation activity than isoform 1 and isoform 3.
CC       {ECO:0000269|PubMed:10449719, ECO:0000269|PubMed:12954634,
CC       ECO:0000269|PubMed:7481822, ECO:0000269|PubMed:9223281,
CC       ECO:0000269|PubMed:9223431, ECO:0000269|PubMed:9296499,
CC       ECO:0000269|PubMed:9427757}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-acetyl-L-lysine.
CC   -!- SUBUNIT: Interacts with the methyltransferase CARM1 (By
CC       similarity). Interacts with NCOA6 and NCOA2. Interacts with the
CC       FDL motif of STAT5A and STAT5B. Interacts with the LXXLL motif of
CC       STAT6. Interacts with STAT3 following IL-6 stimulation. Interacts
CC       with the basal transcription factor GTF2B. Interacts with the
CC       histone acetyltransferases EP300 and CREBBP. Interacts with PCAF,
CC       COPS5, NR3C1 and TTLL5/STAMP. Interacts with PSMB9. Interacts with
CC       UBE2L3; they functionally interact to regulate progesterone
CC       receptor transcriptional activity. Interacts with PRMT2 and DDX5.
CC       Interacts with ASXL1. Interacts with PRMT6. Interacts (via LXXLL
CC       1, 2 and 3 motifs) with RORC (via AF-2 motif). Interacts in a
CC       ligand-dependent fashion with RXRA. Interacts with TRIP4.
CC       Interacts with NR4A3 (By similarity). Interacts with VDR.
CC       {ECO:0000250|UniProtKB:P70365, ECO:0000269|PubMed:10567404,
CC       ECO:0000269|PubMed:10594042, ECO:0000269|PubMed:10722692,
CC       ECO:0000269|PubMed:11250900, ECO:0000269|PubMed:11698662,
CC       ECO:0000269|PubMed:11773079, ECO:0000269|PubMed:11864604,
CC       ECO:0000269|PubMed:12039952, ECO:0000269|PubMed:12138096,
CC       ECO:0000269|PubMed:12917342, ECO:0000269|PubMed:12954634,
CC       ECO:0000269|PubMed:14757047, ECO:0000269|PubMed:15367689,
CC       ECO:0000269|PubMed:16606617, ECO:0000269|PubMed:16957778,
CC       ECO:0000269|PubMed:17116691, ECO:0000269|PubMed:19786558,
CC       ECO:0000269|PubMed:20047962, ECO:0000269|PubMed:25219498,
CC       ECO:0000269|PubMed:28698609, ECO:0000269|PubMed:7481822,
CC       ECO:0000269|PubMed:8754792, ECO:0000269|PubMed:9296499,
CC       ECO:0000269|PubMed:9744270}.
CC   -!- INTERACTION:
CC       P59598:Asxl1 (xeno); NbExp=2; IntAct=EBI-455189, EBI-5743705;
CC       P03372:ESR1; NbExp=7; IntAct=EBI-455189, EBI-78473;
CC       P19785:Esr1 (xeno); NbExp=2; IntAct=EBI-455189, EBI-346765;
CC       Q63ZY3:KANK2; NbExp=4; IntAct=EBI-455189, EBI-2556193;
CC       P25799:Nfkb1 (xeno); NbExp=2; IntAct=EBI-455189, EBI-643958;
CC       Q13133:NR1H3; NbExp=15; IntAct=EBI-455189, EBI-781356;
CC       Q96RI1:NR1H4; NbExp=4; IntAct=EBI-455189, EBI-1250177;
CC       Q96RI1-2:NR1H4; NbExp=5; IntAct=EBI-455189, EBI-9640524;
CC       O75469:NR1I2; NbExp=5; IntAct=EBI-455189, EBI-3905991;
CC       P06536:Nr3c1 (xeno); NbExp=2; IntAct=EBI-455189, EBI-1187143;
CC       Q9BTK6:PAGR1; NbExp=4; IntAct=EBI-455189, EBI-2372223;
CC       P28065:PSMB9; NbExp=3; IntAct=EBI-455189, EBI-603300;
CC       P10276:RARA; NbExp=7; IntAct=EBI-455189, EBI-413374;
CC       P51449:RORC; NbExp=2; IntAct=EBI-455189, EBI-3908771;
CC       P19793:RXRA; NbExp=14; IntAct=EBI-455189, EBI-78598;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00981}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=SRC-1A, SRC1a;
CC         IsoId=Q15788-1; Sequence=Displayed;
CC       Name=2; Synonyms=SRC-1E, SRC1e;
CC         IsoId=Q15788-2; Sequence=VSP_011739;
CC         Note=Major form. Contains a domain at its C-terminus (1241-1399)
CC         that is able to mediate transactivation.;
CC       Name=3; Synonyms=SRC-1 (-Q);
CC         IsoId=Q15788-3; Sequence=VSP_011738;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:15313887, ECO:0000269|PubMed:9427757}.
CC   -!- DOMAIN: The C-terminal (1107-1441) part mediates the histone
CC       acetyltransferase (HAT) activity.
CC   -!- DOMAIN: Contains 7 Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. LXXLL
CC       motifs 3, 4 and 5 are essential for the association with nuclear
CC       receptors. LXXLL motif 7, which is not present in isoform 2,
CC       increases the affinity for steroid receptors in vitro.
CC   -!- PTM: Sumoylated; sumoylation increases its interaction with PGR
CC       and prolongs its retention in the nucleus. It does not prevent its
CC       ubiquitination and does not exert a clear effect on the stability
CC       of the protein. {ECO:0000269|PubMed:12529333}.
CC   -!- PTM: Ubiquitinated; leading to proteasome-mediated degradation.
CC       Ubiquitination and sumoylation take place at different sites.
CC       {ECO:0000269|PubMed:12529333}.
CC   -!- DISEASE: Note=A chromosomal aberration involving NCOA1 is a cause
CC       of rhabdomyosarcoma. Translocation t(2;2)(q35;p23) with PAX3
CC       generates the NCOA1-PAX3 oncogene consisting of the N-terminus
CC       part of PAX3 and the C-terminus part of NCOA1. The fusion protein
CC       acts as a transcriptional activator. Rhabdomyosarcoma is the most
CC       common soft tissue carcinoma in childhood, representing 5-8% of
CC       all malignancies in children. {ECO:0000269|PubMed:15313887}.
CC   -!- SIMILARITY: Belongs to the SRC/p160 nuclear receptor coactivator
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA64187.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAC50305.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/ncoa1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U59302; AAC50631.1; -; mRNA.
DR   EMBL; AJ000881; CAA04371.1; -; mRNA.
DR   EMBL; AJ000882; CAA04372.1; -; mRNA.
DR   EMBL; U90661; AAB50242.1; -; mRNA.
DR   EMBL; EF660499; ABS29266.1; -; Genomic_DNA.
DR   EMBL; AC013459; AAX93184.1; -; Genomic_DNA.
DR   EMBL; AC093798; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAX00746.1; -; Genomic_DNA.
DR   EMBL; BC111533; AAI11534.1; -; mRNA.
DR   EMBL; BC111534; AAI11535.1; -; mRNA.
DR   EMBL; U40396; AAC50305.1; ALT_INIT; mRNA.
DR   EMBL; U19179; AAA64187.1; ALT_INIT; mRNA.
DR   EMBL; AY633656; AAT47737.1; -; mRNA.
DR   CCDS; CCDS1712.1; -. [Q15788-1]
DR   CCDS; CCDS1713.1; -. [Q15788-2]
DR   CCDS; CCDS42660.1; -. [Q15788-3]
DR   PIR; A57620; A57620.
DR   PIR; PC4363; PC4363.
DR   PIR; PC4364; PC4364.
DR   RefSeq; NP_003734.3; NM_003743.4. [Q15788-1]
DR   RefSeq; NP_671756.1; NM_147223.2. [Q15788-2]
DR   RefSeq; NP_671766.1; NM_147233.2. [Q15788-3]
DR   RefSeq; XP_005264682.1; XM_005264625.1. [Q15788-1]
DR   RefSeq; XP_005264683.1; XM_005264626.1. [Q15788-3]
DR   RefSeq; XP_005264685.1; XM_005264628.1. [Q15788-2]
DR   RefSeq; XP_016860657.1; XM_017005168.1. [Q15788-2]
DR   RefSeq; XP_016860658.1; XM_017005169.1. [Q15788-2]
DR   UniGene; Hs.596314; -.
DR   PDB; 1FM6; X-ray; 2.10 A; B/E/V/Y=676-700.
DR   PDB; 1FM9; X-ray; 2.10 A; B/E=676-700.
DR   PDB; 1K4W; X-ray; 1.90 A; B=686-700.
DR   PDB; 1K74; X-ray; 2.30 A; B/E=676-700.
DR   PDB; 1K7L; X-ray; 2.50 A; B/D/F/H=680-700.
DR   PDB; 1KV6; X-ray; 2.70 A; C/D=686-700.
DR   PDB; 1N4H; X-ray; 2.10 A; B=686-700.
DR   PDB; 1NQ7; X-ray; 1.50 A; B=687-696.
DR   PDB; 1NRL; X-ray; 2.00 A; C/D=676-700.
DR   PDB; 1P8D; X-ray; 2.80 A; C/D=676-700.
DR   PDB; 1PZL; X-ray; 2.10 A; B=687-700.
DR   PDB; 1RDT; X-ray; 2.40 A; B=676-700.
DR   PDB; 1TFC; X-ray; 2.40 A; C/D=686-700.
DR   PDB; 1U3R; X-ray; 2.21 A; C/D=630-640.
DR   PDB; 1U3S; X-ray; 2.50 A; C/D=630-640.
DR   PDB; 1X76; X-ray; 2.20 A; C/D=630-640.
DR   PDB; 1X78; X-ray; 2.30 A; C/D=630-640.
DR   PDB; 1X7B; X-ray; 2.30 A; C/D=630-640.
DR   PDB; 1X7J; X-ray; 2.30 A; C/D=630-640.
DR   PDB; 1XIU; X-ray; 2.50 A; E/F=686-700.
DR   PDB; 1XV9; X-ray; 2.70 A; E/F/G/H=685-697.
DR   PDB; 1XVP; X-ray; 2.60 A; E/F/G/H=685-697.
DR   PDB; 1YY4; X-ray; 2.70 A; C/D=630-640.
DR   PDB; 1YYE; X-ray; 2.03 A; C/D=630-640.
DR   PDB; 1ZAF; X-ray; 2.20 A; C/D=630-640.
DR   PDB; 2A3I; X-ray; 1.95 A; B=1430-1441.
DR   PDB; 2C52; NMR; -; B=920-970.
DR   PDB; 2FVJ; X-ray; 1.99 A; B=628-640.
DR   PDB; 2GTK; X-ray; 2.10 A; B=631-640.
DR   PDB; 2HBH; X-ray; 2.65 A; B=686-700.
DR   PDB; 2HC4; X-ray; 2.20 A; B=686-700.
DR   PDB; 2HCD; X-ray; 2.60 A; B=686-700.
DR   PDB; 2HFP; X-ray; 2.00 A; B=680-700.
DR   PDB; 2NPA; X-ray; 2.30 A; B/D=683-697.
DR   PDB; 2NV7; X-ray; 2.10 A; C/D=631-640.
DR   PDB; 2P54; X-ray; 1.79 A; B=686-696.
DR   PDB; 2PRG; X-ray; 2.30 A; C=623-710.
DR   PDB; 3BEJ; X-ray; 1.90 A; E/F=676-700.
DR   PDB; 3BQD; X-ray; 2.50 A; B=1429-1441.
DR   PDB; 3CTB; X-ray; 2.00 A; A/B=678-700.
DR   PDB; 3CWD; X-ray; 2.40 A; C/D=685-700.
DR   PDB; 3DCT; X-ray; 2.50 A; B=741-761.
DR   PDB; 3DCU; X-ray; 2.95 A; B=741-761.
DR   PDB; 3DR1; X-ray; 2.70 A; B=686-700.
DR   PDB; 3ET1; X-ray; 2.50 A; P/Q=681-696.
DR   PDB; 3ET3; X-ray; 1.95 A; P=680-695.
DR   PDB; 3FEI; X-ray; 2.40 A; Z=744-756.
DR   PDB; 3FEJ; X-ray; 2.01 A; B=628-640.
DR   PDB; 3FUR; X-ray; 2.30 A; H=629-640.
DR   PDB; 3FXV; X-ray; 2.26 A; B=744-756.
DR   PDB; 3G8I; X-ray; 2.20 A; Z=744-756.
DR   PDB; 3G9E; X-ray; 2.30 A; B=628-640.
DR   PDB; 3GYT; X-ray; 2.40 A; B=1429-1441.
DR   PDB; 3GYU; X-ray; 2.40 A; B=1429-1441.
DR   PDB; 3H0A; X-ray; 2.10 A; B/E=629-640.
DR   PDB; 3HC5; X-ray; 2.60 A; B=741-761.
DR   PDB; 3HC6; X-ray; 3.20 A; B=741-761.
DR   PDB; 3HVL; X-ray; 2.10 A; A/B=678-700.
DR   PDB; 3IPQ; X-ray; 2.00 A; B=676-700.
DR   PDB; 3IPS; X-ray; 2.26 A; C/D=676-700.
DR   PDB; 3IPU; X-ray; 2.40 A; C/D=676-700.
DR   PDB; 3KMR; X-ray; 1.80 A; C=686-698.
DR   PDB; 3LMP; X-ray; 1.90 A; C=686-700.
DR   PDB; 3OKH; X-ray; 2.50 A; B=744-757.
DR   PDB; 3OKI; X-ray; 2.00 A; B/D=744-757.
DR   PDB; 3OLF; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 3OLL; X-ray; 1.50 A; C/D=683-701.
DR   PDB; 3OLS; X-ray; 2.20 A; C/D=683-701.
DR   PDB; 3OMK; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 3OMM; X-ray; 2.10 A; B/D=744-757.
DR   PDB; 3OMO; X-ray; 2.21 A; C/D=683-701.
DR   PDB; 3OMP; X-ray; 2.05 A; C/D=683-701.
DR   PDB; 3OMQ; X-ray; 1.97 A; C/D=683-701.
DR   PDB; 3OOF; X-ray; 2.29 A; B/D=744-757.
DR   PDB; 3OOK; X-ray; 2.29 A; B/D=744-757.
DR   PDB; 3P88; X-ray; 2.95 A; B=745-755.
DR   PDB; 3P89; X-ray; 2.30 A; B=745-755.
DR   PDB; 3QT0; X-ray; 2.50 A; C=685-700.
DR   PDB; 3RUT; X-ray; 3.00 A; B=745-755.
DR   PDB; 3RUU; X-ray; 2.50 A; B=745-755.
DR   PDB; 3RVF; X-ray; 3.10 A; B=741-761.
DR   PDB; 3S9S; X-ray; 2.55 A; B=685-697.
DR   PDB; 3T03; X-ray; 2.10 A; C/D=683-700.
DR   PDB; 3UU7; X-ray; 2.20 A; F/G=686-698.
DR   PDB; 3UUA; X-ray; 2.05 A; F/G=686-698.
DR   PDB; 3UUD; X-ray; 1.60 A; C/D=686-698.
DR   PDB; 3V9Y; X-ray; 2.10 A; B=686-700.
DR   PDB; 3VN2; X-ray; 2.18 A; C=685-700.
DR   PDB; 4DK7; X-ray; 2.45 A; B/D=745-756.
DR   PDB; 4DK8; X-ray; 2.75 A; B/D=745-756.
DR   PDB; 4DM6; X-ray; 1.90 A; E/F=676-700.
DR   PDB; 4DM8; X-ray; 2.30 A; C/D=676-700.
DR   PDB; 4DQM; X-ray; 2.75 A; B/D=1432-1441.
DR   PDB; 4F9M; X-ray; 1.90 A; C=686-700.
DR   PDB; 4FGY; X-ray; 2.84 A; B=686-696.
DR   PDB; 4G1D; X-ray; 2.90 A; B=686-700.
DR   PDB; 4G1Y; X-ray; 2.85 A; B=686-700.
DR   PDB; 4G1Z; X-ray; 2.50 A; B=686-700.
DR   PDB; 4G20; X-ray; 2.90 A; B=686-700.
DR   PDB; 4G21; X-ray; 2.90 A; B=686-700.
DR   PDB; 4G2H; X-ray; 2.50 A; B=686-700.
DR   PDB; 4HEE; X-ray; 2.50 A; Y=676-700.
DR   PDB; 4J5X; X-ray; 2.80 A; A/B/C/D=678-700.
DR   PDB; 4JYG; X-ray; 2.35 A; F/G=686-698.
DR   PDB; 4JYH; X-ray; 2.60 A; C/G=686-698.
DR   PDB; 4JYI; X-ray; 1.90 A; F/G=686-698.
DR   PDB; 4MG5; X-ray; 2.05 A; C/D=686-698.
DR   PDB; 4MG6; X-ray; 2.10 A; C/D=686-698.
DR   PDB; 4MG7; X-ray; 2.15 A; C/D=686-698.
DR   PDB; 4MG8; X-ray; 1.85 A; C/D=686-698.
DR   PDB; 4MG9; X-ray; 2.00 A; F/G=686-698.
DR   PDB; 4MGA; X-ray; 1.80 A; C/D=686-698.
DR   PDB; 4MGB; X-ray; 1.85 A; C/D=686-698.
DR   PDB; 4MGC; X-ray; 2.15 A; F/G=686-698.
DR   PDB; 4MGD; X-ray; 1.90 A; F/G=686-698.
DR   PDB; 4RUJ; X-ray; 2.35 A; B=686-700.
DR   PDB; 4RUP; X-ray; 2.75 A; B=686-700.
DR   PDB; 4TUZ; X-ray; 1.90 A; F/G=686-698.
DR   PDB; 4TV1; X-ray; 1.85 A; C/D=686-698.
DR   PDB; 4UDA; X-ray; 2.03 A; B=1427-1441.
DR   PDB; 4UDB; X-ray; 2.36 A; B=1427-1441.
DR   PDB; 4Y29; X-ray; 1.98 A; B=1432-1441.
DR   PDB; 5A86; X-ray; 2.25 A; C/D=682-698.
DR   PDB; 5AVI; X-ray; 2.70 A; B/D=676-700.
DR   PDB; 5AVL; X-ray; 2.80 A; B=676-700.
DR   PDB; 5AZT; X-ray; 3.45 A; C=683-697.
DR   PDB; 5DSH; X-ray; 2.95 A; B=685-700.
DR   PDB; 5DV3; X-ray; 2.75 A; B=685-700.
DR   PDB; 5DV6; X-ray; 2.80 A; B=685-700.
DR   PDB; 5DV8; X-ray; 2.75 A; B=685-700.
DR   PDB; 5DVC; X-ray; 2.30 A; B=685-700.
DR   PDB; 5DWL; X-ray; 2.20 A; B=685-700.
DR   PDB; 5E7V; X-ray; 2.40 A; B=686-700.
DR   PDB; 5GTN; X-ray; 1.85 A; B=685-700.
DR   PDB; 5GTO; X-ray; 2.10 A; B=685-700.
DR   PDB; 5GTP; X-ray; 2.35 A; B=685-700.
DR   PDB; 5HJS; X-ray; 1.72 A; C/D=676-700.
DR   PDB; 5JI0; X-ray; 1.98 A; E/F=676-700.
DR   PDB; 5JMM; X-ray; 2.10 A; F/G=686-698.
DR   PDB; 5L7E; X-ray; 1.86 A; B=1432-1441.
DR   PDB; 5L7G; X-ray; 2.01 A; B=1432-1441.
DR   PDB; 5L7H; X-ray; 1.84 A; B=1432-1441.
DR   PDB; 5MX7; X-ray; 1.98 A; B1=686-700.
DR   PDB; 5NKY; X-ray; 2.10 A; B=686-700.
DR   PDB; 5NMA; X-ray; 2.80 A; B=686-700.
DR   PDB; 5NMB; X-ray; 2.50 A; B2=686-700.
DR   PDB; 5NWM; NMR; -; A=257-385.
DR   PDB; 5Q0J; X-ray; 2.00 A; B/D=744-757.
DR   PDB; 5Q0K; X-ray; 1.80 A; B=744-757.
DR   PDB; 5Q0L; X-ray; 2.50 A; B/D=744-757.
DR   PDB; 5Q0M; X-ray; 2.20 A; B=744-757.
DR   PDB; 5Q0N; X-ray; 2.40 A; B/D=744-757.
DR   PDB; 5Q0O; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 5Q0P; X-ray; 1.80 A; B/D=744-757.
DR   PDB; 5Q0Q; X-ray; 2.60 A; B/D=744-757.
DR   PDB; 5Q0R; X-ray; 1.91 A; B=744-757.
DR   PDB; 5Q0S; X-ray; 2.50 A; B/D=744-757.
DR   PDB; 5Q0T; X-ray; 2.14 A; B=744-757.
DR   PDB; 5Q0U; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 5Q0V; X-ray; 1.87 A; B/D=744-757.
DR   PDB; 5Q0W; X-ray; 1.90 A; B=744-757.
DR   PDB; 5Q0X; X-ray; 2.26 A; B=744-757.
DR   PDB; 5Q0Y; X-ray; 2.20 A; B/D=744-757.
DR   PDB; 5Q0Z; X-ray; 2.26 A; B/D=744-757.
DR   PDB; 5Q10; X-ray; 2.20 A; B=744-757.
DR   PDB; 5Q11; X-ray; 2.20 A; B=744-757.
DR   PDB; 5Q12; X-ray; 2.00 A; B=744-757.
DR   PDB; 5Q13; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 5Q14; X-ray; 1.85 A; B/D=744-757.
DR   PDB; 5Q15; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 5Q16; X-ray; 2.00 A; B/D=744-757.
DR   PDB; 5Q18; X-ray; 1.90 A; B/D=744-757.
DR   PDB; 5Q19; X-ray; 1.98 A; B/D=744-757.
DR   PDB; 5Q1A; X-ray; 2.00 A; B/D=744-757.
DR   PDB; 5Q1B; X-ray; 2.30 A; B/D=744-757.
DR   PDB; 5Q1C; X-ray; 2.30 A; B/D=744-757.
DR   PDB; 5Q1D; X-ray; 1.89 A; B/D=744-757.
DR   PDB; 5Q1E; X-ray; 1.85 A; B=744-757.
DR   PDB; 5Q1F; X-ray; 2.30 A; B/D=744-757.
DR   PDB; 5Q1G; X-ray; 2.00 A; B=744-757.
DR   PDB; 5Q1H; X-ray; 2.20 A; B/D/F/H=744-757.
DR   PDB; 5Q1I; X-ray; 1.95 A; B=744-757.
DR   PDB; 5X0R; X-ray; 2.67 A; C/D=676-700.
DR   PDB; 5X8U; X-ray; 2.00 A; B=686-700.
DR   PDB; 5X8W; X-ray; 2.30 A; B=686-700.
DR   PDB; 6BNS; X-ray; 2.56 A; A/B=678-710.
DR   PDBsum; 1FM6; -.
DR   PDBsum; 1FM9; -.
DR   PDBsum; 1K4W; -.
DR   PDBsum; 1K74; -.
DR   PDBsum; 1K7L; -.
DR   PDBsum; 1KV6; -.
DR   PDBsum; 1N4H; -.
DR   PDBsum; 1NQ7; -.
DR   PDBsum; 1NRL; -.
DR   PDBsum; 1P8D; -.
DR   PDBsum; 1PZL; -.
DR   PDBsum; 1RDT; -.
DR   PDBsum; 1TFC; -.
DR   PDBsum; 1U3R; -.
DR   PDBsum; 1U3S; -.
DR   PDBsum; 1X76; -.
DR   PDBsum; 1X78; -.
DR   PDBsum; 1X7B; -.
DR   PDBsum; 1X7J; -.
DR   PDBsum; 1XIU; -.
DR   PDBsum; 1XV9; -.
DR   PDBsum; 1XVP; -.
DR   PDBsum; 1YY4; -.
DR   PDBsum; 1YYE; -.
DR   PDBsum; 1ZAF; -.
DR   PDBsum; 2A3I; -.
DR   PDBsum; 2C52; -.
DR   PDBsum; 2FVJ; -.
DR   PDBsum; 2GTK; -.
DR   PDBsum; 2HBH; -.
DR   PDBsum; 2HC4; -.
DR   PDBsum; 2HCD; -.
DR   PDBsum; 2HFP; -.
DR   PDBsum; 2NPA; -.
DR   PDBsum; 2NV7; -.
DR   PDBsum; 2P54; -.
DR   PDBsum; 2PRG; -.
DR   PDBsum; 3BEJ; -.
DR   PDBsum; 3BQD; -.
DR   PDBsum; 3CTB; -.
DR   PDBsum; 3CWD; -.
DR   PDBsum; 3DCT; -.
DR   PDBsum; 3DCU; -.
DR   PDBsum; 3DR1; -.
DR   PDBsum; 3ET1; -.
DR   PDBsum; 3ET3; -.
DR   PDBsum; 3FEI; -.
DR   PDBsum; 3FEJ; -.
DR   PDBsum; 3FUR; -.
DR   PDBsum; 3FXV; -.
DR   PDBsum; 3G8I; -.
DR   PDBsum; 3G9E; -.
DR   PDBsum; 3GYT; -.
DR   PDBsum; 3GYU; -.
DR   PDBsum; 3H0A; -.
DR   PDBsum; 3HC5; -.
DR   PDBsum; 3HC6; -.
DR   PDBsum; 3HVL; -.
DR   PDBsum; 3IPQ; -.
DR   PDBsum; 3IPS; -.
DR   PDBsum; 3IPU; -.
DR   PDBsum; 3KMR; -.
DR   PDBsum; 3LMP; -.
DR   PDBsum; 3OKH; -.
DR   PDBsum; 3OKI; -.
DR   PDBsum; 3OLF; -.
DR   PDBsum; 3OLL; -.
DR   PDBsum; 3OLS; -.
DR   PDBsum; 3OMK; -.
DR   PDBsum; 3OMM; -.
DR   PDBsum; 3OMO; -.
DR   PDBsum; 3OMP; -.
DR   PDBsum; 3OMQ; -.
DR   PDBsum; 3OOF; -.
DR   PDBsum; 3OOK; -.
DR   PDBsum; 3P88; -.
DR   PDBsum; 3P89; -.
DR   PDBsum; 3QT0; -.
DR   PDBsum; 3RUT; -.
DR   PDBsum; 3RUU; -.
DR   PDBsum; 3RVF; -.
DR   PDBsum; 3S9S; -.
DR   PDBsum; 3T03; -.
DR   PDBsum; 3UU7; -.
DR   PDBsum; 3UUA; -.
DR   PDBsum; 3UUD; -.
DR   PDBsum; 3V9Y; -.
DR   PDBsum; 3VN2; -.
DR   PDBsum; 4DK7; -.
DR   PDBsum; 4DK8; -.
DR   PDBsum; 4DM6; -.
DR   PDBsum; 4DM8; -.
DR   PDBsum; 4DQM; -.
DR   PDBsum; 4F9M; -.
DR   PDBsum; 4FGY; -.
DR   PDBsum; 4G1D; -.
DR   PDBsum; 4G1Y; -.
DR   PDBsum; 4G1Z; -.
DR   PDBsum; 4G20; -.
DR   PDBsum; 4G21; -.
DR   PDBsum; 4G2H; -.
DR   PDBsum; 4HEE; -.
DR   PDBsum; 4J5X; -.
DR   PDBsum; 4JYG; -.
DR   PDBsum; 4JYH; -.
DR   PDBsum; 4JYI; -.
DR   PDBsum; 4MG5; -.
DR   PDBsum; 4MG6; -.
DR   PDBsum; 4MG7; -.
DR   PDBsum; 4MG8; -.
DR   PDBsum; 4MG9; -.
DR   PDBsum; 4MGA; -.
DR   PDBsum; 4MGB; -.
DR   PDBsum; 4MGC; -.
DR   PDBsum; 4MGD; -.
DR   PDBsum; 4RUJ; -.
DR   PDBsum; 4RUP; -.
DR   PDBsum; 4TUZ; -.
DR   PDBsum; 4TV1; -.
DR   PDBsum; 4UDA; -.
DR   PDBsum; 4UDB; -.
DR   PDBsum; 4Y29; -.
DR   PDBsum; 5A86; -.
DR   PDBsum; 5AVI; -.
DR   PDBsum; 5AVL; -.
DR   PDBsum; 5AZT; -.
DR   PDBsum; 5DSH; -.
DR   PDBsum; 5DV3; -.
DR   PDBsum; 5DV6; -.
DR   PDBsum; 5DV8; -.
DR   PDBsum; 5DVC; -.
DR   PDBsum; 5DWL; -.
DR   PDBsum; 5E7V; -.
DR   PDBsum; 5GTN; -.
DR   PDBsum; 5GTO; -.
DR   PDBsum; 5GTP; -.
DR   PDBsum; 5HJS; -.
DR   PDBsum; 5JI0; -.
DR   PDBsum; 5JMM; -.
DR   PDBsum; 5L7E; -.
DR   PDBsum; 5L7G; -.
DR   PDBsum; 5L7H; -.
DR   PDBsum; 5MX7; -.
DR   PDBsum; 5NKY; -.
DR   PDBsum; 5NMA; -.
DR   PDBsum; 5NMB; -.
DR   PDBsum; 5NWM; -.
DR   PDBsum; 5Q0J; -.
DR   PDBsum; 5Q0K; -.
DR   PDBsum; 5Q0L; -.
DR   PDBsum; 5Q0M; -.
DR   PDBsum; 5Q0N; -.
DR   PDBsum; 5Q0O; -.
DR   PDBsum; 5Q0P; -.
DR   PDBsum; 5Q0Q; -.
DR   PDBsum; 5Q0R; -.
DR   PDBsum; 5Q0S; -.
DR   PDBsum; 5Q0T; -.
DR   PDBsum; 5Q0U; -.
DR   PDBsum; 5Q0V; -.
DR   PDBsum; 5Q0W; -.
DR   PDBsum; 5Q0X; -.
DR   PDBsum; 5Q0Y; -.
DR   PDBsum; 5Q0Z; -.
DR   PDBsum; 5Q10; -.
DR   PDBsum; 5Q11; -.
DR   PDBsum; 5Q12; -.
DR   PDBsum; 5Q13; -.
DR   PDBsum; 5Q14; -.
DR   PDBsum; 5Q15; -.
DR   PDBsum; 5Q16; -.
DR   PDBsum; 5Q18; -.
DR   PDBsum; 5Q19; -.
DR   PDBsum; 5Q1A; -.
DR   PDBsum; 5Q1B; -.
DR   PDBsum; 5Q1C; -.
DR   PDBsum; 5Q1D; -.
DR   PDBsum; 5Q1E; -.
DR   PDBsum; 5Q1F; -.
DR   PDBsum; 5Q1G; -.
DR   PDBsum; 5Q1H; -.
DR   PDBsum; 5Q1I; -.
DR   PDBsum; 5X0R; -.
DR   PDBsum; 5X8U; -.
DR   PDBsum; 5X8W; -.
DR   PDBsum; 6BNS; -.
DR   ProteinModelPortal; Q15788; -.
DR   SMR; Q15788; -.
DR   BioGrid; 114200; 114.
DR   CORUM; Q15788; -.
DR   DIP; DIP-30877N; -.
DR   IntAct; Q15788; 33.
DR   MINT; Q15788; -.
DR   STRING; 9606.ENSP00000320940; -.
DR   BindingDB; Q15788; -.
DR   ChEMBL; CHEMBL1615387; -.
DR   DrugBank; DB07119; 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL.
DR   DrugBank; DB06875; 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE.
DR   DrugBank; DB07236; 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL.
DR   DrugBank; DB07230; 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE.
DR   DrugBank; DB07724; 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid.
DR   DrugBank; DB07150; 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME.
DR   DrugBank; DB07198; 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE.
DR   DrugBank; DB06927; [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE.
DR   DrugBank; DB08915; Aleglitazar.
DR   DrugBank; DB01645; Genistein.
DR   DrugBank; DB08231; MYRISTIC ACID.
DR   GuidetoPHARMACOLOGY; 2693; -.
DR   iPTMnet; Q15788; -.
DR   PhosphoSitePlus; Q15788; -.
DR   BioMuta; NCOA1; -.
DR   DMDM; 158518533; -.
DR   EPD; Q15788; -.
DR   MaxQB; Q15788; -.
DR   PaxDb; Q15788; -.
DR   PeptideAtlas; Q15788; -.
DR   PRIDE; Q15788; -.
DR   Ensembl; ENST00000288599; ENSP00000288599; ENSG00000084676. [Q15788-2]
DR   Ensembl; ENST00000348332; ENSP00000320940; ENSG00000084676. [Q15788-1]
DR   Ensembl; ENST00000395856; ENSP00000379197; ENSG00000084676. [Q15788-3]
DR   Ensembl; ENST00000405141; ENSP00000385097; ENSG00000084676. [Q15788-2]
DR   Ensembl; ENST00000406961; ENSP00000385216; ENSG00000084676. [Q15788-1]
DR   GeneID; 8648; -.
DR   KEGG; hsa:8648; -.
DR   UCSC; uc002rfj.4; human. [Q15788-1]
DR   CTD; 8648; -.
DR   DisGeNET; 8648; -.
DR   EuPathDB; HostDB:ENSG00000084676.15; -.
DR   GeneCards; NCOA1; -.
DR   HGNC; HGNC:7668; NCOA1.
DR   HPA; CAB019402; -.
DR   HPA; HPA070213; -.
DR   HPA; HPA070520; -.
DR   MIM; 602691; gene.
DR   neXtProt; NX_Q15788; -.
DR   OpenTargets; ENSG00000084676; -.
DR   PharmGKB; PA31470; -.
DR   eggNOG; ENOG410IQ5S; Eukaryota.
DR   eggNOG; ENOG410XPF9; LUCA.
DR   GeneTree; ENSGT00530000063109; -.
DR   HOVERGEN; HBG052583; -.
DR   InParanoid; Q15788; -.
DR   KO; K09101; -.
DR   OMA; MVPMPIP; -.
DR   OrthoDB; EOG091G00US; -.
DR   PhylomeDB; Q15788; -.
DR   TreeFam; TF332652; -.
DR   Reactome; R-HSA-1368082; RORA activates gene expression.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-159418; Recycling of bile acids and salts.
DR   Reactome; R-HSA-192105; Synthesis of bile acids and bile salts.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-193807; Synthesis of bile acids and bile salts via 27-hydroxycholesterol.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2032785; YAP1- and WWTR1 (TAZ)-stimulated gene expression.
DR   Reactome; R-HSA-211976; Endogenous sterols.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-400206; Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha).
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-8951671; RUNX3 regulates YAP1-mediated transcription.
DR   SignaLink; Q15788; -.
DR   SIGNOR; Q15788; -.
DR   ChiTaRS; NCOA1; human.
DR   EvolutionaryTrace; Q15788; -.
DR   GeneWiki; Nuclear_receptor_coactivator_1; -.
DR   GenomeRNAi; 8648; -.
DR   PRO; PR:Q15788; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000084676; -.
DR   ExpressionAtlas; Q15788; baseline and differential.
DR   Genevisible; Q15788; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0043234; C:protein complex; IMP:CAFA.
DR   GO; GO:0050681; F:androgen receptor binding; NAS:UniProtKB.
DR   GO; GO:0017162; F:aryl hydrocarbon receptor binding; IPI:CAFA.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0030331; F:estrogen receptor binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:UniProtKB.
DR   GO; GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0035257; F:nuclear hormone receptor binding; IDA:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0001105; F:RNA polymerase II transcription coactivator activity; NAS:BHF-UCL.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0015721; P:bile acid and bile salt transport; TAS:Reactome.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IBA:GO_Central.
DR   GO; GO:1904017; P:cellular response to Thyroglobulin triiodothyronine; IEA:Ensembl.
DR   GO; GO:0043967; P:histone H4 acetylation; IEA:Ensembl.
DR   GO; GO:0030522; P:intracellular receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0060713; P:labyrinthine layer morphogenesis; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0000435; P:positive regulation of transcription from RNA polymerase II promoter by galactose; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:2001038; P:regulation of cellular response to drug; IEA:Ensembl.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; TAS:Reactome.
DR   GO; GO:0002155; P:regulation of thyroid hormone mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB.
DR   CDD; cd00083; HLH; 1.
DR   CDD; cd00130; PAS; 1.
DR   Gene3D; 1.10.287.1070; -; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR010011; DUF1518.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR028819; NCOA1.
DR   InterPro; IPR009110; Nuc_rcpt_coact.
DR   InterPro; IPR014920; Nuc_rcpt_coact_Ncoa-typ.
DR   InterPro; IPR037077; Nuc_rcpt_coact_Ncoa_int_sf.
DR   InterPro; IPR017426; Nuclear_rcpt_coactivator.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR013767; PAS_fold.
DR   InterPro; IPR014935; SRC/p160_LXXLL.
DR   PANTHER; PTHR10684; PTHR10684; 1.
DR   PANTHER; PTHR10684:SF1; PTHR10684:SF1; 1.
DR   Pfam; PF07469; DUF1518; 2.
DR   Pfam; PF00010; HLH; 1.
DR   Pfam; PF08815; Nuc_rec_co-act; 1.
DR   Pfam; PF00989; PAS; 1.
DR   Pfam; PF08832; SRC-1; 1.
DR   PIRSF; PIRSF038181; Nuclear_receptor_coactivator; 1.
DR   SMART; SM01151; DUF1518; 2.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00091; PAS; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   SUPFAM; SSF55785; SSF55785; 2.
DR   SUPFAM; SSF69125; SSF69125; 1.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Acyltransferase;
KW   Alternative splicing; Chromosomal rearrangement; Complete proteome;
KW   Isopeptide bond; Methylation; Nucleus; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2   1441       Nuclear receptor coactivator 1.
FT                                /FTId=PRO_0000094400.
FT   DOMAIN       23     80       bHLH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00981}.
FT   DOMAIN      109    180       PAS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   REGION      361    567       Interaction with STAT3.
FT                                {ECO:0000269|PubMed:11773079}.
FT   REGION      781    988       Interaction with CREBBP.
FT   MOTIF        46     50       LXXLL motif 1.
FT   MOTIF       112    116       LXXLL motif 2.
FT   MOTIF       633    637       LXXLL motif 3.
FT   MOTIF       690    694       LXXLL motif 4.
FT   MOTIF       749    753       LXXLL motif 5.
FT   MOTIF       913    917       LXXLL motif 6.
FT   MOTIF      1435   1439       LXXLL motif 7.
FT   COMPBIAS    389    682       Ser-rich.
FT   COMPBIAS   1053   1138       Gln-rich.
FT   SITE        867    868       Breakpoint for translocation to form
FT                                PAX3-NCOA1 oncogene.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      22     22       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     372    372       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:10660621}.
FT   MOD_RES     395    395       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:10660621}.
FT   MOD_RES     517    517       Phosphoserine.
FT                                {ECO:0000269|PubMed:10660621}.
FT   MOD_RES     558    558       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70365}.
FT   MOD_RES     569    569       Phosphoserine.
FT                                {ECO:0000269|PubMed:10660621}.
FT   MOD_RES     698    698       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1033   1033       Phosphoserine.
FT                                {ECO:0000269|PubMed:10660621}.
FT   MOD_RES    1073   1073       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:P70365}.
FT   MOD_RES    1091   1091       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:P70365}.
FT   MOD_RES    1124   1124       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:P70365}.
FT   MOD_RES    1131   1131       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:P70365}.
FT   MOD_RES    1179   1179       Phosphothreonine.
FT                                {ECO:0000269|PubMed:10660621}.
FT   MOD_RES    1185   1185       Phosphoserine.
FT                                {ECO:0000269|PubMed:10660621}.
FT   MOD_RES    1372   1372       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    732    732       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:12529333}.
FT   CROSSLNK    774    774       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:12529333}.
FT   CROSSLNK    846    846       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ    1385   1385       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:8754792}.
FT                                /FTId=VSP_011738.
FT   VAR_SEQ    1386   1441       QVQQVQVFADVQCTVNLVGGDPYLNQPGPLGTQKPTSGPQT
FT                                PQAQQKSLLQQLLTE -> DKKTEEFFSVVTTD (in
FT                                isoform 2). {ECO:0000303|PubMed:11831720,
FT                                ECO:0000303|PubMed:15313887,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9427757}.
FT                                /FTId=VSP_011739.
FT   VARIANT     457    457       Q -> K (in dbSNP:rs1049015).
FT                                {ECO:0000269|PubMed:7481822,
FT                                ECO:0000269|PubMed:8754792,
FT                                ECO:0000269|PubMed:9575154}.
FT                                /FTId=VAR_019768.
FT   VARIANT     466    466       N -> K (in dbSNP:rs1049016).
FT                                {ECO:0000269|PubMed:7481822,
FT                                ECO:0000269|PubMed:8754792,
FT                                ECO:0000269|PubMed:9575154}.
FT                                /FTId=VAR_019769.
FT   VARIANT     474    474       S -> P (in dbSNP:rs1049018).
FT                                {ECO:0000269|PubMed:7481822,
FT                                ECO:0000269|PubMed:8754792,
FT                                ECO:0000269|PubMed:9575154}.
FT                                /FTId=VAR_019770.
FT   VARIANT     591    591       I -> T (in dbSNP:rs1049020).
FT                                {ECO:0000269|PubMed:7481822,
FT                                ECO:0000269|PubMed:8754792,
FT                                ECO:0000269|PubMed:9575154}.
FT                                /FTId=VAR_019771.
FT   VARIANT     685    685       E -> A (in dbSNP:rs1049021).
FT                                {ECO:0000269|PubMed:7481822,
FT                                ECO:0000269|PubMed:8754792,
FT                                ECO:0000269|PubMed:9575154}.
FT                                /FTId=VAR_019772.
FT   VARIANT     794    794       P -> A (in dbSNP:rs1049025).
FT                                {ECO:0000269|PubMed:7481822}.
FT                                /FTId=VAR_019773.
FT   VARIANT     999    999       S -> F (in dbSNP:rs1049032).
FT                                {ECO:0000269|PubMed:7481822,
FT                                ECO:0000269|PubMed:8754792,
FT                                ECO:0000269|PubMed:9575154}.
FT                                /FTId=VAR_019774.
FT   VARIANT    1154   1154       M -> T (in dbSNP:rs1049038).
FT                                {ECO:0000269|PubMed:7481822,
FT                                ECO:0000269|PubMed:8754792,
FT                                ECO:0000269|PubMed:9575154}.
FT                                /FTId=VAR_019775.
FT   VARIANT    1238   1238       V -> I (in dbSNP:rs56099330).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_038832.
FT   VARIANT    1272   1272       P -> S (in dbSNP:rs1804645).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_034882.
FT   MUTAGEN     636    637       LL->AA: Slightly affects interactions
FT                                with steroid receptors. Abolishes
FT                                interactions with steroid receptors; when
FT                                associated with A-693; A-694; A-752 and
FT                                A-753. {ECO:0000269|PubMed:9427757}.
FT   MUTAGEN     693    694       LL->AA: Slightly affects interactions
FT                                with steroid receptors. Abolishes
FT                                interactions with steroid receptors; when
FT                                associated with A-636; A-637; A-752 and
FT                                A-753. {ECO:0000269|PubMed:9427757}.
FT   MUTAGEN     732    732       K->R: Abolishes sumoylation; when
FT                                associated with R-774.
FT                                {ECO:0000269|PubMed:12529333}.
FT   MUTAGEN     752    753       LL->AA: Slightly affects interactions
FT                                with steroid receptors. Abolishes
FT                                interactions with steroid receptors; when
FT                                associated with A-636; A-637; A-693 and
FT                                A-694. {ECO:0000269|PubMed:9427757}.
FT   MUTAGEN     774    774       K->R: Abolishes sumoylation; when
FT                                associated with R-732.
FT                                {ECO:0000269|PubMed:12529333}.
FT   MUTAGEN     800    800       K->R: Does not affect sumoylation of the
FT                                protein. {ECO:0000269|PubMed:12529333}.
FT   MUTAGEN     846    846       K->R: Does not affect sumoylation of the
FT                                protein. {ECO:0000269|PubMed:12529333}.
FT   MUTAGEN    1378   1378       K->R: Does not affect sumoylation of the
FT                                protein. {ECO:0000269|PubMed:12529333}.
FT   CONFLICT   1035   1035       Missing (in Ref. 10; AAT47737).
FT                                {ECO:0000305}.
FT   CONFLICT   1370   1370       Q -> H (in Ref. 9; AAA64187).
FT                                {ECO:0000305}.
FT   CONFLICT   1382   1382       D -> G (in Ref. 10; AAT47737).
FT                                {ECO:0000305}.
FT   CONFLICT   1435   1435       L -> R (in Ref. 3; AAB50242).
FT                                {ECO:0000305}.
FT   STRAND      261    266       {ECO:0000244|PDB:5NWM}.
FT   STRAND      272    276       {ECO:0000244|PDB:5NWM}.
FT   HELIX       278    283       {ECO:0000244|PDB:5NWM}.
FT   HELIX       288    299       {ECO:0000244|PDB:5NWM}.
FT   HELIX       309    319       {ECO:0000244|PDB:5NWM}.
FT   STRAND      320    324       {ECO:0000244|PDB:5NWM}.
FT   STRAND      328    331       {ECO:0000244|PDB:5NWM}.
FT   STRAND      337    347       {ECO:0000244|PDB:5NWM}.
FT   STRAND      350    353       {ECO:0000244|PDB:5NWM}.
FT   STRAND      357    365       {ECO:0000244|PDB:5NWM}.
FT   HELIX       632    638       {ECO:0000244|PDB:2FVJ}.
FT   HELIX       684    686       {ECO:0000244|PDB:5HJS}.
FT   HELIX       688    695       {ECO:0000244|PDB:1NQ7}.
FT   HELIX       747    753       {ECO:0000244|PDB:5Q0K}.
FT   TURN        924    926       {ECO:0000244|PDB:2C52}.
FT   HELIX       929    941       {ECO:0000244|PDB:2C52}.
FT   HELIX       945    947       {ECO:0000244|PDB:2C52}.
FT   HELIX       952    954       {ECO:0000244|PDB:2C52}.
FT   TURN        958    962       {ECO:0000244|PDB:2C52}.
FT   STRAND      964    966       {ECO:0000244|PDB:2C52}.
FT   HELIX      1434   1440       {ECO:0000244|PDB:5L7H}.
SQ   SEQUENCE   1441 AA;  156757 MW;  25EF6F389489121E CRC64;
     MSGLGDSSSD PANPDSHKRK GSPCDTLASS TEKRRREQEN KYLEELAELL SANISDIDSL
     SVKPDKCKIL KKTVDQIQLM KRMEQEKSTT DDDVQKSDIS SSSQGVIEKE SLGPLLLEAL
     DGFFFVVNCE GRIVFVSENV TSYLGYNQEE LMNTSVYSIL HVGDHAEFVK NLLPKSLVNG
     VPWPQEATRR NSHTFNCRML IHPPDEPGTE NQEACQRYEV MQCFTVSQPK SIQEDGEDFQ
     SCLICIARRL PRPPAITGVE SFMTKQDTTG KIISIDTSSL RAAGRTGWED LVRKCIYAFF
     QPQGREPSYA RQLFQEVMTR GTASSPSYRF ILNDGTMLSA HTKCKLCYPQ SPDMQPFIMG
     IHIIDREHSG LSPQDDTNSG MSIPRVNPSV NPSISPAHGV ARSSTLPPSN SNMVSTRINR
     QQSSDLHSSS HSNSSNSQGS FGCSPGSQIV ANVALNQGQA SSQSSNPSLN LNNSPMEGTG
     ISLAQFMSPR RQVTSGLATR PRMPNNSFPP NISTLSSPVG MTSSACNNNN RSYSNIPVTS
     LQGMNEGPNN SVGFSASSPV LRQMSSQNSP SRLNIQPAKA ESKDNKEIAS ILNEMIQSDN
     SSSDGKPLDS GLLHNNDRLS DGDSKYSQTS HKLVQLLTTT AEQQLRHADI DTSCKDVLSC
     TGTSNSASAN SSGGSCPSSH SSLTERHKIL HRLLQEGSPS DITTLSVEPD KKDSASTSVS
     VTGQVQGNSS IKLELDASKK KESKDHQLLR YLLDKDEKDL RSTPNLSLDD VKVKVEKKEQ
     MDPCNTNPTP MTKPTPEEIK LEAQSQFTAD LDQFDQLLPT LEKAAQLPGL CETDRMDGAV
     TSVTIKSEIL PASLQSATAR PTSRLNRLPE LELEAIDNQF GQPGTGDQIP WTNNTVTAIN
     QSKSEDQCIS SQLDELLCPP TTVEGRNDEK ALLEQLVSFL SGKDETELAE LDRALGIDKL
     VQGGGLDVLS ERFPPQQATP PLIMEERPNL YSQPYSSPSP TANLPSPFQG MVRQKPSLGT
     MPVQVTPPRG AFSPGMGMQP RQTLNRPPAA PNQLRLQLQQ RLQGQQQLIH QNRQAILNQF
     AATAPVGINM RSGMQQQITP QPPLNAQMLA QRQRELYSQQ HRQRQLIQQQ RAMLMRQQSF
     GNNLPPSSGL PVQMGNPRLP QGAPQQFPYP PNYGTNPGTP PASTSPFSQL AANPEASLAN
     RNSMVSRGMT GNIGGQFGTG INPQMQQNVF QYPGAGMVPQ GEANFAPSLS PGSSMVPMPI
     PPPQSSLLQQ TPPASGYQSP DMKAWQQGAI GNNNVFSQAV QNQPTPAQPG VYNNMSITVS
     MAGGNTNVQN MNPMMAQMQM SSLQMPGMNT VCPEQINDPA LRHTGLYCNQ LSSTDLLKTE
     ADGTQQVQQV QVFADVQCTV NLVGGDPYLN QPGPLGTQKP TSGPQTPQAQ QKSLLQQLLT
     E
//
ID   A0A0A0MRX8_HUMAN        Unreviewed;       446 AA.
AC   A0A0A0MRX8;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   28-FEB-2018, entry version 31.
DE   RecName: Full=Nuclear factor 1 {ECO:0000256|RuleBase:RU000690};
GN   Name=NFIB {ECO:0000313|Ensembl:ENSP00000370321};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000370321, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000370321}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7] {ECO:0000313|Ensembl:ENSP00000370321}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in
CC       the origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00436, ECO:0000256|SAAS:SAAS00573677}.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00436}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000370321}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL441963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL449443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001177667.1; NM_001190738.1.
DR   UniGene; Hs.644095; -.
DR   ProteinModelPortal; A0A0A0MRX8; -.
DR   PeptideAtlas; A0A0A0MRX8; -.
DR   PRIDE; A0A0A0MRX8; -.
DR   Ensembl; ENST00000380934; ENSP00000370321; ENSG00000147862.
DR   GeneID; 4781; -.
DR   UCSC; uc022bdp.1; human.
DR   CTD; 4781; -.
DR   EuPathDB; HostDB:ENSG00000147862.14; -.
DR   HGNC; HGNC:7785; NFIB.
DR   OpenTargets; ENSG00000147862; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   eggNOG; ENOG410Y16G; LUCA.
DR   GeneTree; ENSGT00390000009905; -.
DR   ChiTaRS; NFIB; human.
DR   GenomeRNAi; 4781; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000147862; -.
DR   ExpressionAtlas; A0A0A0MRX8; baseline and differential.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniRule.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   1: Evidence at protein level;
KW   Activator {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   DNA replication {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00094706};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MRX8,
KW   ECO:0000213|MaxQB:A0A0A0MRX8, ECO:0000213|PeptideAtlas:A0A0A0MRX8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859}.
FT   DOMAIN       27    221       CTF/NF-I. {ECO:0000259|PROSITE:PS51080}.
FT   DNA_BIND     27    221       CTF/NF-I. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00436}.
SQ   SEQUENCE   446 AA;  50290 MW;  1EFD52F36D29368D CRC64;
     MERIPVSVDF WVVCCAVLKC NPGIPKRMST LCFGFSDEFH PFIEALLPHV RAIAYTWFNL
     QARKRKYFKK HEKRMSKDEE RAVKDELLSE KPEIKQKWAS RLLAKLRKDI RQEYREDFVL
     TVTGKKHPCC VLSNPDQKGK IRRIDCLRQA DKVWRLDLVM VILFKGIPLE STDGERLMKS
     PHCTNPALCV QPHHITVSVK ELDLFLAYYV QEQDSGQSGS PSHNDPAKNP PGYLEDSFVK
     SGVFNVSELV RVSRTPITQG TGVNFPIGEI PSQPYYHDMN SGVNLQRSLS SPPSSKRPKT
     ISIDENMEPS PTGDFYPSPS SPAAGSRTWH ERDQDMSSPT TMKKPEKPLF SSASPQDSSP
     RLSTFPQHHH PGIPGVAHSV ISTRTPPPPS PLPFPTQAIL PPAPSSYFSH PTIRYPPHLN
     PQDTLKNYVP SYDPSSPQTS QSWYLG
//
ID   A0A1B0GWB8_HUMAN        Unreviewed;       308 AA.
AC   A0A1B0GWB8;
DT   05-OCT-2016, integrated into UniProtKB/TrEMBL.
DT   05-OCT-2016, sequence version 1.
DT   28-FEB-2018, entry version 13.
DE   SubName: Full=Nuclear factor 1 B-type {ECO:0000313|Ensembl:ENSP00000490864};
GN   Name=NFIB {ECO:0000313|Ensembl:ENSP00000490864};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000490864, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000490864}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7] {ECO:0000313|Ensembl:ENSP00000490864}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2016) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000490864}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL441963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL449443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_016870231.1; XM_017014742.1.
DR   UniGene; Hs.644095; -.
DR   PeptideAtlas; A0A1B0GWB8; -.
DR   Ensembl; ENST00000636735; ENSP00000490864; ENSG00000147862.
DR   GeneID; 4781; -.
DR   CTD; 4781; -.
DR   HGNC; HGNC:7785; NFIB.
DR   OpenTargets; ENSG00000147862; -.
DR   GeneTree; ENSGT00390000009905; -.
DR   ChiTaRS; NFIB; human.
DR   Proteomes; UP000005640; Chromosome 9.
DR   ExpressionAtlas; A0A1B0GWB8; baseline and differential.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   InterPro; IPR000647; CTF/NFI.
DR   PANTHER; PTHR11492; PTHR11492; 2.
DR   Pfam; PF00859; CTF_NFI; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A1B0GWB8,
KW   ECO:0000213|MaxQB:A0A1B0GWB8, ECO:0000213|PeptideAtlas:A0A1B0GWB8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   308 AA;  33821 MW;  7FEF2189524329A1 CRC64;
     MLTFLWQRDS GQSGSPSHND PAKNPPGYLE DSFVKSGVFN VSELVRVSRT PITQGTGVNF
     PIGEIPSQPY YHDMNSGVNL QRSLSSPPSS KRPKTISIDE NMEPSPTGDF YPSPSSPAAG
     SRTWHERDQD MSSPTTMKKP EKPLFSSASP QDSSPRLSTF PQHHHPGIPG VAHSVISTRT
     PPPPSPLPFP TQAILPPAPS SYFSHPTIRY PPHLNPQDTL KNYVPSYDPS SPQTSQLRIC
     DWTMNQNGRH LYPSTSEDTL GITWQSPGTW ASLVPFQVSN RTPILPANVQ NYGLNIIGEP
     FLQAETSN
//
ID   NFIB_HUMAN              Reviewed;         420 AA.
AC   O00712; G3V1P1; H7BYE8; O00166; Q12858; Q5VW29; Q63HM5; Q6ZNF9;
AC   Q96J45;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2004, sequence version 2.
DT   28-FEB-2018, entry version 161.
DE   RecName: Full=Nuclear factor 1 B-type;
DE            Short=NF1-B;
DE            Short=Nuclear factor 1/B;
DE   AltName: Full=CCAAT-box-binding transcription factor;
DE            Short=CTF;
DE   AltName: Full=Nuclear factor I/B;
DE            Short=NF-I/B;
DE            Short=NFI-B;
DE   AltName: Full=TGGCA-binding protein;
GN   Name=NFIB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9484777; DOI=10.1038/sj.onc.1201609;
RA   Geurts J.M.W., Schoenmakers E.F.P.M., Roijer E., Astroem A.-K.,
RA   Stenman G., van de Ven W.J.M.;
RT   "Identification of NFIB as recurrent translocation partner gene of
RT   HMGIC in pleomorphic adenomas.";
RL   Oncogene 16:865-872(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Foreskin;
RX   PubMed=9099724; DOI=10.1074/jbc.272.16.10739;
RA   Liu Y., Bernard H.U., Apt D.;
RT   "NFI-B3, a novel transcriptional repressor of the nuclear factor I
RT   family, is generated by alternative RNA processing.";
RL   J. Biol. Chem. 272:10739-10745(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 6).
RC   TISSUE=Colon epithelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 20-283.
RX   PubMed=7590749; DOI=10.1006/geno.1995.1107;
RA   Qian F., Kruse U., Lichter P., Sippel A.E.;
RT   "Chromosomal localization of the four genes (NFIA, B, C, and X) for
RT   the human transcription factor nuclear factor I by FISH.";
RL   Genomics 28:66-73(1995).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-264 AND SER-328, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; SER-328 AND
RP   SER-333, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; SER-328 AND
RP   SER-333, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292 AND SER-295, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in
CC       the origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=O00712-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00712-3; Sequence=Not described;
CC       Name=3; Synonyms=NFI-B3;
CC         IsoId=O00712-2; Sequence=VSP_003545, VSP_003546;
CC       Name=4;
CC         IsoId=O00712-4; Sequence=VSP_044462;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=O00712-5; Sequence=VSP_045065;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=O00712-6; Sequence=VSP_054713, VSP_054714;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00436}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U85193; AAB41899.1; -; mRNA.
DR   EMBL; U70862; AAB51197.1; -; mRNA.
DR   EMBL; BT007266; AAP35930.1; -; mRNA.
DR   EMBL; AK131233; BAD18416.1; -; mRNA.
DR   EMBL; BX648416; CAH56156.1; -; mRNA.
DR   EMBL; BX648845; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL441963; CAH71971.1; -; Genomic_DNA.
DR   EMBL; AL136366; CAH71971.1; JOINED; Genomic_DNA.
DR   EMBL; AL136366; CAH73585.1; -; Genomic_DNA.
DR   EMBL; AL441963; CAH73585.1; JOINED; Genomic_DNA.
DR   EMBL; AL137017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL449443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58697.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58699.1; -; Genomic_DNA.
DR   EMBL; BC001283; AAH01283.1; -; mRNA.
DR   EMBL; U07810; AAA93125.1; -; mRNA.
DR   CCDS; CCDS55291.1; -. [O00712-5]
DR   CCDS; CCDS6474.1; -. [O00712-1]
DR   CCDS; CCDS65007.1; -. [O00712-6]
DR   RefSeq; NP_001177666.1; NM_001190737.1. [O00712-5]
DR   RefSeq; NP_001177667.1; NM_001190738.1.
DR   RefSeq; NP_001269716.1; NM_001282787.1. [O00712-6]
DR   RefSeq; NP_005587.2; NM_005596.3. [O00712-1]
DR   UniGene; Hs.644095; -.
DR   ProteinModelPortal; O00712; -.
DR   BioGrid; 110853; 14.
DR   DIP; DIP-61433N; -.
DR   IntAct; O00712; 6.
DR   STRING; 9606.ENSP00000370340; -.
DR   iPTMnet; O00712; -.
DR   PhosphoSitePlus; O00712; -.
DR   BioMuta; NFIB; -.
DR   EPD; O00712; -.
DR   PaxDb; O00712; -.
DR   PeptideAtlas; O00712; -.
DR   PRIDE; O00712; -.
DR   DNASU; 4781; -.
DR   Ensembl; ENST00000380953; ENSP00000370340; ENSG00000147862. [O00712-5]
DR   Ensembl; ENST00000380959; ENSP00000370346; ENSG00000147862. [O00712-1]
DR   Ensembl; ENST00000543693; ENSP00000442888; ENSG00000147862. [O00712-6]
DR   GeneID; 4781; -.
DR   KEGG; hsa:4781; -.
DR   UCSC; uc003zld.4; human. [O00712-1]
DR   CTD; 4781; -.
DR   DisGeNET; 4781; -.
DR   EuPathDB; HostDB:ENSG00000147862.14; -.
DR   GeneCards; NFIB; -.
DR   HGNC; HGNC:7785; NFIB.
DR   HPA; HPA003956; -.
DR   MIM; 600728; gene.
DR   neXtProt; NX_O00712; -.
DR   OpenTargets; ENSG00000147862; -.
DR   PharmGKB; PA31591; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   eggNOG; ENOG410Y16G; LUCA.
DR   GeneTree; ENSGT00390000009905; -.
DR   HOGENOM; HOG000013028; -.
DR   HOVERGEN; HBG006561; -.
DR   InParanoid; O00712; -.
DR   KO; K09169; -.
DR   PhylomeDB; O00712; -.
DR   TreeFam; TF313889; -.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   SignaLink; O00712; -.
DR   SIGNOR; O00712; -.
DR   ChiTaRS; NFIB; human.
DR   GeneWiki; NFIB_(gene); -.
DR   GenomeRNAi; 4781; -.
DR   PRO; PR:O00712; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000147862; -.
DR   CleanEx; HS_NFIB; -.
DR   ExpressionAtlas; O00712; baseline and differential.
DR   Genevisible; O00712; HS.
DR   GO; GO:0044300; C:cerebellar mossy fiber; ISS:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0021960; P:anterior commissure morphogenesis; ISS:UniProtKB.
DR   GO; GO:0060689; P:cell differentiation involved in salivary gland development; IEA:Ensembl.
DR   GO; GO:0002062; P:chondrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0060486; P:Clara cell differentiation; ISS:UniProtKB.
DR   GO; GO:0071679; P:commissural neuron axon guidance; ISS:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0010001; P:glial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0030902; P:hindbrain development; IEA:Ensembl.
DR   GO; GO:0061141; P:lung ciliated cell differentiation; ISS:UniProtKB.
DR   GO; GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB.
DR   GO; GO:2000795; P:negative regulation of epithelial cell proliferation involved in lung morphogenesis; ISS:UniProtKB.
DR   GO; GO:2000791; P:negative regulation of mesenchymal cell proliferation involved in lung development; ISS:UniProtKB.
DR   GO; GO:1902894; P:negative regulation of pri-miRNA transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0021740; P:principal sensory nucleus of trigeminal nerve development; ISS:UniProtKB.
DR   GO; GO:0060662; P:salivary gland cavitation; IEA:Ensembl.
DR   GO; GO:0060509; P:Type I pneumocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0060510; P:Type II pneumocyte differentiation; ISS:UniProtKB.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Complete proteome;
KW   DNA replication; DNA-binding; Methylation; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    420       Nuclear factor 1 B-type.
FT                                /FTId=PRO_0000100195.
FT   DNA_BIND      1    195       CTF/NF-I. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00436}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000250|UniProtKB:P08651}.
FT   MOD_RES     194    194       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08651}.
FT   MOD_RES     262    262       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70257}.
FT   MOD_RES     264    264       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     284    284       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08651}.
FT   MOD_RES     286    286       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P97863}.
FT   MOD_RES     292    292       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     294    294       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08651}.
FT   MOD_RES     295    295       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     312    312       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08651}.
FT   MOD_RES     328    328       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     332    332       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08651}.
FT   MOD_RES     333    333       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     335    335       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:P97863}.
FT   MOD_RES     358    358       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000250|UniProtKB:P08651}.
FT   MOD_RES     358    358       Omega-N-methylarginine; alternate.
FT                                {ECO:0000250|UniProtKB:P08651}.
FT   MOD_RES     388    388       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:P97863}.
FT   MOD_RES     416    416       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08651}.
FT   VAR_SEQ       1    252       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_054713.
FT   VAR_SEQ       1     10       MMYSPICLTQ -> MERIPVSVDFWVVCCAVLKCNPGIPME
FT                                RIPVSVDFWVVCCAVLKCNPGIPKRMSTLCFGFS (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044462.
FT   VAR_SEQ     187    188       QD -> AR (in isoform 3).
FT                                {ECO:0000303|PubMed:9099724}.
FT                                /FTId=VSP_003545.
FT   VAR_SEQ     189    420       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9099724}.
FT                                /FTId=VSP_003546.
FT   VAR_SEQ     416    420       SWYLG -> PNGSGQVVGKVPGHFTPVLAPSPHPSAVRPVT
FT                                LSMTDTKPITTSTEAYTASGTSQANRYVGLSPRDPSFLHQQ
FT                                QLRICDWTMNQNGRHLYPSTSEDTLGITWQSPGTWASLVPF
FT                                QVSNRTPILPANVQNYGLNIIGEPFLQAETSN (in
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_054714.
FT   VAR_SEQ     416    416       S -> PNGSGQVVGKVPGHFTPVLAPSPHPSAVRPVTLSMT
FT                                DTKPITTSTEAYTASGTSQANRYVGLSPRDPSFLHQQQS
FT                                (in isoform 5).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_045065.
FT   CONFLICT     17     17       I -> M (in Ref. 1; AAB41899).
FT                                {ECO:0000305}.
FT   CONFLICT     37     37       R -> G (in Ref. 4; BAD18416).
FT                                {ECO:0000305}.
FT   CONFLICT     74     74       S -> F (in Ref. 5; BX648845).
FT                                {ECO:0000305}.
FT   CONFLICT    198    198       N -> S (in Ref. 4; BAD18416).
FT                                {ECO:0000305}.
FT   CONFLICT    284    284       S -> R (in Ref. 5; BX648845).
FT                                {ECO:0000305}.
SQ   SEQUENCE   420 AA;  47442 MW;  0F71635FE9D64FA4 CRC64;
     MMYSPICLTQ DEFHPFIEAL LPHVRAIAYT WFNLQARKRK YFKKHEKRMS KDEERAVKDE
     LLSEKPEIKQ KWASRLLAKL RKDIRQEYRE DFVLTVTGKK HPCCVLSNPD QKGKIRRIDC
     LRQADKVWRL DLVMVILFKG IPLESTDGER LMKSPHCTNP ALCVQPHHIT VSVKELDLFL
     AYYVQEQDSG QSGSPSHNDP AKNPPGYLED SFVKSGVFNV SELVRVSRTP ITQGTGVNFP
     IGEIPSQPYY HDMNSGVNLQ RSLSSPPSSK RPKTISIDEN MEPSPTGDFY PSPSSPAAGS
     RTWHERDQDM SSPTTMKKPE KPLFSSASPQ DSSPRLSTFP QHHHPGIPGV AHSVISTRTP
     PPPSPLPFPT QAILPPAPSS YFSHPTIRYP PHLNPQDTLK NYVPSYDPSS PQTSQSWYLG
//
ID   Q5VW26_HUMAN            Unreviewed;       570 AA.
AC   Q5VW26;
DT   07-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   07-DEC-2004, sequence version 1.
DT   28-FEB-2018, entry version 124.
DE   RecName: Full=Nuclear factor 1 {ECO:0000256|RuleBase:RU000690};
GN   Name=NFIB {ECO:0000313|EMBL:EAW58698.1,
GN   ECO:0000313|Ensembl:ENSP00000380711};
GN   ORFNames=hCG_1742080 {ECO:0000313|EMBL:EAW58698.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000380711, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW58698.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000380711}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4] {ECO:0000313|EMBL:EAW58698.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [7] {ECO:0000313|Ensembl:ENSP00000380711}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [8] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in
CC       the origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00436, ECO:0000256|SAAS:SAAS00573677}.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00436}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL441963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL449443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58698.1; -; Genomic_DNA.
DR   RefSeq; XP_005251524.1; XM_005251467.2.
DR   UniGene; Hs.644095; -.
DR   MaxQB; Q5VW26; -.
DR   PeptideAtlas; Q5VW26; -.
DR   Ensembl; ENST00000397581; ENSP00000380711; ENSG00000147862.
DR   GeneID; 4781; -.
DR   UCSC; uc064sed.1; human.
DR   CTD; 4781; -.
DR   EuPathDB; HostDB:ENSG00000147862.14; -.
DR   HGNC; HGNC:7785; NFIB.
DR   OpenTargets; ENSG00000147862; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   eggNOG; ENOG410Y16G; LUCA.
DR   GeneTree; ENSGT00390000009905; -.
DR   HOGENOM; HOG000013028; -.
DR   HOVERGEN; HBG006561; -.
DR   OMA; SPSNNEP; -.
DR   OrthoDB; EOG091G0HVY; -.
DR   ChiTaRS; NFIB; human.
DR   GenomeRNAi; 4781; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000147862; -.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniRule.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   1: Evidence at protein level;
KW   Activator {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   DNA replication {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00094706};
KW   Proteomics identification {ECO:0000213|EPD:Q5VW26,
KW   ECO:0000213|MaxQB:Q5VW26, ECO:0000213|PeptideAtlas:Q5VW26};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859}.
FT   DOMAIN        2    195       CTF/NF-I. {ECO:0000259|PROSITE:PS51080}.
FT   DNA_BIND      2    195       CTF/NF-I. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00436}.
SQ   SEQUENCE   570 AA;  63433 MW;  0AC3ECE983FDD069 CRC64;
     MMYSPICLTQ DEFHPFIEAL LPHVRAIAYT WFNLQARKRK YFKKHEKRMS KDEERAVKDE
     LLSEKPEIKQ KWASRLLAKL RKDIRQEYRE DFVLTVTGKK HPCCVLSNPD QKGKIRRIDC
     LRQADKVWRL DLVMVILFKG IPLESTDGER LMKSPHCTNP ALCVQPHHIT VSVKELDLFL
     AYYVQEQDSG QSGSPSHNDP AKNPPGYLED SFVKSGVFNV SELVRVSRTP ITQGTGVNFP
     IGEIPSQPYY HDMNSGVNLQ RSLSSPPSSK RPKTISIDEN MEPSPTGDFY PSPSSPAAGS
     RTWHERDQDM SSPTTMKKPE KPLFSSASPQ DSSPRLSTFP QHHHPGIPGV AHSVISTRTP
     PPPSPLPFPT QAILPPAPSS YFSHPTIRYP PHLNPQDTLK NYVPSYDPSS PQTSQPNGSG
     QVVGKVPGHF TPVLAPSPHP SAVRPVTLSM TDTKPITTST EGEAASPTAT TYTASGTSQA
     NRYVGLSPRD PSFLHQQQLR ICDWTMNQNG RHLYPSTSED TLGITWQSPG TWASLVPFQV
     SNRTPILPAN VQNYGLNIIG EPFLQAETSN
//
ID   Q5VW27_HUMAN            Unreviewed;       487 AA.
AC   Q5VW27;
DT   07-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   07-DEC-2004, sequence version 1.
DT   28-FEB-2018, entry version 119.
DE   RecName: Full=Nuclear factor 1 {ECO:0000256|RuleBase:RU000690};
GN   Name=NFIB {ECO:0000313|EMBL:EAW58696.1,
GN   ECO:0000313|Ensembl:ENSP00000380709};
GN   ORFNames=hCG_1742080 {ECO:0000313|EMBL:EAW58696.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000380709, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW58696.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000380709}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4] {ECO:0000313|EMBL:EAW58696.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [7] {ECO:0000313|Ensembl:ENSP00000380709}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [8] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in
CC       the origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00436, ECO:0000256|SAAS:SAAS00573677}.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00436}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL441963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL449443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58696.1; -; Genomic_DNA.
DR   RefSeq; XP_005251527.1; XM_005251470.2.
DR   UniGene; Hs.644095; -.
DR   MaxQB; Q5VW27; -.
DR   PeptideAtlas; Q5VW27; -.
DR   Ensembl; ENST00000397579; ENSP00000380709; ENSG00000147862.
DR   GeneID; 4781; -.
DR   UCSC; uc011lmo.3; human.
DR   CTD; 4781; -.
DR   EuPathDB; HostDB:ENSG00000147862.14; -.
DR   HGNC; HGNC:7785; NFIB.
DR   OpenTargets; ENSG00000147862; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   eggNOG; ENOG410Y16G; LUCA.
DR   GeneTree; ENSGT00390000009905; -.
DR   HOGENOM; HOG000013028; -.
DR   HOVERGEN; HBG006561; -.
DR   ChiTaRS; NFIB; human.
DR   GenomeRNAi; 4781; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000147862; -.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniRule.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 2.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   1: Evidence at protein level;
KW   Activator {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   DNA replication {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00094706};
KW   Proteomics identification {ECO:0000213|EPD:Q5VW27,
KW   ECO:0000213|MaxQB:Q5VW27, ECO:0000213|PeptideAtlas:Q5VW27};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859}.
FT   DOMAIN        2    195       CTF/NF-I. {ECO:0000259|PROSITE:PS51080}.
FT   DNA_BIND      2    195       CTF/NF-I. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00436}.
FT   NON_TER     487    487       {ECO:0000313|EMBL:EAW58696.1}.
SQ   SEQUENCE   487 AA;  54878 MW;  50312568FB5F922F CRC64;
     MMYSPICLTQ DEFHPFIEAL LPHVRAIAYT WFNLQARKRK YFKKHEKRMS KDEERAVKDE
     LLSEKPEIKQ KWASRLLAKL RKDIRQEYRE DFVLTVTGKK HPCCVLSNPD QKGKIRRIDC
     LRQADKVWRL DLVMVILFKG IPLESTDGER LMKSPHCTNP ALCVQPHHIT VSVKELDLFL
     AYYVQEQDSG QSGSPSHNDP AKNPPGYLED SFVKSGVFNV SELVRVSRTP ITQGTGVNFP
     IGEIPSQPYY HDMNSGVNLQ RSLSSPPSSK RPKTISIDEN MEPSPTGDFY PSPSSPAAGS
     RTWHERDQDM SSPTTMKKPE KPLFSSASPQ DSSPRLSTFP QHHHPGIPGV AHSVISTRTP
     PPPSPLPFPT QAILPPAPSS YFSHPTIRYP PHLNPQDTLK NYVPSYDPSS PQTSQLRICD
     WTMNQNGRHL YPSTSEDTLG ITWQSPGTWA SLVPFQVSNR TPILPANVQN YGLNIIGEPF
     LQAETSN
//
ID   Q5VW28_HUMAN            Unreviewed;       420 AA.
AC   Q5VW28;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 120.
DE   RecName: Full=Nuclear factor 1 {ECO:0000256|RuleBase:RU000690};
GN   Name=NFIB {ECO:0000313|EMBL:ALQ33690.1};
GN   ORFNames=hCG_1742080 {ECO:0000313|EMBL:EAW58694.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF83292.1};
RN   [1] {ECO:0000313|EMBL:EAW58694.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW58694.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAF83292.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Heart {ECO:0000313|EMBL:BAF83292.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ALQ33690.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in
CC       the origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00436, ECO:0000256|SAAS:SAAS00573677}.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00436}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178232; ALQ33690.1; -; mRNA.
DR   EMBL; AK290603; BAF83292.1; -; mRNA.
DR   EMBL; CH471071; EAW58694.1; -; Genomic_DNA.
DR   RefSeq; NP_005587.2; NM_005596.3.
DR   UniGene; Hs.644095; -.
DR   MaxQB; Q5VW28; -.
DR   DNASU; 4781; -.
DR   GeneID; 4781; -.
DR   KEGG; hsa:4781; -.
DR   UCSC; uc003zle.4; human.
DR   CTD; 4781; -.
DR   EuPathDB; HostDB:ENSG00000147862.14; -.
DR   PharmGKB; PA31591; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   eggNOG; ENOG410Y16G; LUCA.
DR   HOVERGEN; HBG006561; -.
DR   KO; K09169; -.
DR   ChiTaRS; NFIB; human.
DR   GenomeRNAi; 4781; -.
DR   Bgee; ENSG00000147862; -.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniRule.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   2: Evidence at transcript level;
KW   Activator {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   DNA replication {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00094706};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859}.
FT   DOMAIN        2    195       CTF/NF-I. {ECO:0000259|PROSITE:PS51080}.
FT   DNA_BIND      2    195       CTF/NF-I. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00436}.
FT   NON_TER     420    420       {ECO:0000313|EMBL:ALQ33690.1}.
SQ   SEQUENCE   420 AA;  47442 MW;  0F71635FE9D64FA4 CRC64;
     MMYSPICLTQ DEFHPFIEAL LPHVRAIAYT WFNLQARKRK YFKKHEKRMS KDEERAVKDE
     LLSEKPEIKQ KWASRLLAKL RKDIRQEYRE DFVLTVTGKK HPCCVLSNPD QKGKIRRIDC
     LRQADKVWRL DLVMVILFKG IPLESTDGER LMKSPHCTNP ALCVQPHHIT VSVKELDLFL
     AYYVQEQDSG QSGSPSHNDP AKNPPGYLED SFVKSGVFNV SELVRVSRTP ITQGTGVNFP
     IGEIPSQPYY HDMNSGVNLQ RSLSSPPSSK RPKTISIDEN MEPSPTGDFY PSPSSPAAGS
     RTWHERDQDM SSPTTMKKPE KPLFSSASPQ DSSPRLSTFP QHHHPGIPGV AHSVISTRTP
     PPPSPLPFPT QAILPPAPSS YFSHPTIRYP PHLNPQDTLK NYVPSYDPSS PQTSQSWYLG
//
ID   Q5VW30_HUMAN            Unreviewed;       561 AA.
AC   Q5VW30;
DT   07-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   07-DEC-2004, sequence version 1.
DT   28-FEB-2018, entry version 121.
DE   RecName: Full=Nuclear factor 1 {ECO:0000256|RuleBase:RU000690};
GN   Name=NFIB {ECO:0000313|EMBL:EAW58695.1,
GN   ECO:0000313|Ensembl:ENSP00000380705};
GN   ORFNames=hCG_1742080 {ECO:0000313|EMBL:EAW58695.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000380705, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW58695.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000380705}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4] {ECO:0000313|EMBL:EAW58695.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [7] {ECO:0000313|Ensembl:ENSP00000380705}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [8] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in
CC       the origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00436, ECO:0000256|SAAS:SAAS00573677}.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00436}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL441963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL449443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58695.1; -; Genomic_DNA.
DR   RefSeq; XP_005251526.1; XM_005251469.2.
DR   UniGene; Hs.644095; -.
DR   MaxQB; Q5VW30; -.
DR   Ensembl; ENST00000397575; ENSP00000380705; ENSG00000147862.
DR   GeneID; 4781; -.
DR   UCSC; uc022bdo.2; human.
DR   CTD; 4781; -.
DR   EuPathDB; HostDB:ENSG00000147862.14; -.
DR   HGNC; HGNC:7785; NFIB.
DR   OpenTargets; ENSG00000147862; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   eggNOG; ENOG410Y16G; LUCA.
DR   GeneTree; ENSGT00390000009905; -.
DR   HOGENOM; HOG000013028; -.
DR   HOVERGEN; HBG006561; -.
DR   ChiTaRS; NFIB; human.
DR   GenomeRNAi; 4781; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000147862; -.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniRule.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   1: Evidence at protein level;
KW   Activator {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   DNA replication {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00094706};
KW   Proteomics identification {ECO:0000213|EPD:Q5VW30,
KW   ECO:0000213|MaxQB:Q5VW30, ECO:0000213|PeptideAtlas:Q5VW30};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859}.
FT   DOMAIN        2    195       CTF/NF-I. {ECO:0000259|PROSITE:PS51080}.
FT   DNA_BIND      2    195       CTF/NF-I. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00436}.
SQ   SEQUENCE   561 AA;  62617 MW;  B8C3BE6C90E45C45 CRC64;
     MMYSPICLTQ DEFHPFIEAL LPHVRAIAYT WFNLQARKRK YFKKHEKRMS KDEERAVKDE
     LLSEKPEIKQ KWASRLLAKL RKDIRQEYRE DFVLTVTGKK HPCCVLSNPD QKGKIRRIDC
     LRQADKVWRL DLVMVILFKG IPLESTDGER LMKSPHCTNP ALCVQPHHIT VSVKELDLFL
     AYYVQEQDSG QSGSPSHNDP AKNPPGYLED SFVKSGVFNV SELVRVSRTP ITQGTGVNFP
     IGEIPSQPYY HDMNSGVNLQ RSLSSPPSSK RPKTISIDEN MEPSPTGDFY PSPSSPAAGS
     RTWHERDQDM SSPTTMKKPE KPLFSSASPQ DSSPRLSTFP QHHHPGIPGV AHSVISTRTP
     PPPSPLPFPT QAILPPAPSS YFSHPTIRYP PHLNPQDTLK NYVPSYDPSS PQTSQPNGSG
     QVVGKVPGHF TPVLAPSPHP SAVRPVTLSM TDTKPITTST EAYTASGTSQ ANRYVGLSPR
     DPSFLHQQQL RICDWTMNQN GRHLYPSTSE DTLGITWQSP GTWASLVPFQ VSNRTPILPA
     NVQNYGLNII GEPFLQAETS N
//
ID   U3KQE8_HUMAN            Unreviewed;       416 AA.
AC   U3KQE8;
DT   13-NOV-2013, integrated into UniProtKB/TrEMBL.
DT   05-OCT-2016, sequence version 2.
DT   28-FEB-2018, entry version 30.
DE   RecName: Full=Nuclear factor 1 {ECO:0000256|RuleBase:RU000690};
GN   Name=NFIB {ECO:0000313|Ensembl:ENSP00000475813};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000475813, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000475813}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000313|Ensembl:ENSP00000475813}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2013) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in
CC       the origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC       {ECO:0000256|RuleBase:RU000690}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00436, ECO:0000256|SAAS:SAAS00573677}.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00436}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000475813}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL441963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL449443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_016870229.1; XM_017014740.1.
DR   UniGene; Hs.644095; -.
DR   PRIDE; U3KQE8; -.
DR   Ensembl; ENST00000606230; ENSP00000475813; ENSG00000147862.
DR   GeneID; 4781; -.
DR   UCSC; uc064sei.1; human.
DR   CTD; 4781; -.
DR   EuPathDB; HostDB:ENSG00000147862.14; -.
DR   HGNC; HGNC:7785; NFIB.
DR   OpenTargets; ENSG00000147862; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   eggNOG; ENOG410Y16G; LUCA.
DR   GeneTree; ENSGT00390000009905; -.
DR   ChiTaRS; NFIB; human.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000147862; -.
DR   ExpressionAtlas; U3KQE8; baseline and differential.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniRule.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   1: Evidence at protein level;
KW   Activator {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   DNA replication {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00436};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00094706};
KW   Proteomics identification {ECO:0000213|EPD:U3KQE8,
KW   ECO:0000213|MaxQB:U3KQE8, ECO:0000213|PeptideAtlas:U3KQE8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00436,
KW   ECO:0000256|SAAS:SAAS00464859}.
FT   DOMAIN        1    191       CTF/NF-I. {ECO:0000259|PROSITE:PS51080}.
FT   DNA_BIND      1    191       CTF/NF-I. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00436}.
SQ   SEQUENCE   416 AA;  46985 MW;  7F46A3E043635461 CRC64;
     MQYSAMDEFH PFIEALLPHV RAIAYTWFNL QARKRKYFKK HEKRMSKDEE RAVKDELLSE
     KPEIKQKWAS RLLAKLRKDI RQEYREDFVL TVTGKKHPCC VLSNPDQKGK IRRIDCLRQA
     DKVWRLDLVM VILFKGIPLE STDGERLMKS PHCTNPALCV QPHHITVSVK ELDLFLAYYV
     QEQDSGQSGS PSHNDPAKNP PGYLEDSFVK SGVFNVSELV RVSRTPITQG TGVNFPIGEI
     PSQPYYHDMN SGVNLQRSLS SPPSSKRPKT ISIDENMEPS PTGDFYPSPS SPAAGSRTWH
     ERDQDMSSPT TMKKPEKPLF SSASPQDSSP RLSTFPQHHH PGIPGVAHSV ISTRTPPPPS
     PLPFPTQAIL PPAPSSYFSH PTIRYPPHLN PQDTLKNYVP SYDPSSPQTS QSWYLG
//
ID   Q5XUU0_HUMAN            Unreviewed;      1989 AA.
AC   Q5XUU0;
DT   23-NOV-2004, integrated into UniProtKB/TrEMBL.
DT   23-NOV-2004, sequence version 1.
DT   28-FEB-2018, entry version 78.
DE   SubName: Full=Ninein isoform 6 {ECO:0000313|EMBL:AAU86898.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAU86898.1};
RN   [1] {ECO:0000313|EMBL:AAU86898.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hong Y.-R., Wu C.-H., Cheng T.-S.;
RT   "Characterization, expression and functional aspects of human ninein
RT   isoforms.";
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00448}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY736182; AAU86898.1; -; mRNA.
DR   RefSeq; NP_065972.3; NM_020921.3.
DR   RefSeq; NP_891989.2; NM_182944.2.
DR   UniGene; Hs.310429; -.
DR   UniGene; Hs.569387; -.
DR   ProteinModelPortal; Q5XUU0; -.
DR   PeptideAtlas; Q5XUU0; -.
DR   PRIDE; Q5XUU0; -.
DR   GeneID; 51199; -.
DR   CTD; 51199; -.
DR   PharmGKB; PA31630; -.
DR   eggNOG; ENOG410IK59; Eukaryota.
DR   eggNOG; ENOG410Z1RR; LUCA.
DR   HOVERGEN; HBG052623; -.
DR   GenomeRNAi; 51199; -.
DR   Genevisible; Q5XUU0; HS.
DR   GO; GO:0005813; C:centrosome; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IEA:InterPro.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR029664; NIN.
DR   PANTHER; PTHR18905:SF11; PTHR18905:SF11; 1.
DR   SUPFAM; SSF47473; SSF47473; 2.
DR   PROSITE; PS50222; EF_HAND_2; 5.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN        8     43       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN       60     77       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      182    217       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      219    252       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      317    352       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   COILED      362    403       {ECO:0000256|SAM:Coils}.
FT   COILED      423    472       {ECO:0000256|SAM:Coils}.
FT   COILED      480    514       {ECO:0000256|SAM:Coils}.
FT   COILED      530    564       {ECO:0000256|SAM:Coils}.
FT   COILED      633    689       {ECO:0000256|SAM:Coils}.
FT   COILED      698    721       {ECO:0000256|SAM:Coils}.
FT   COILED      767    809       {ECO:0000256|SAM:Coils}.
FT   COILED      833    882       {ECO:0000256|SAM:Coils}.
FT   COILED      905    925       {ECO:0000256|SAM:Coils}.
FT   COILED      962    982       {ECO:0000256|SAM:Coils}.
FT   COILED      998   1025       {ECO:0000256|SAM:Coils}.
FT   COILED     1074   1094       {ECO:0000256|SAM:Coils}.
FT   COILED     1186   1220       {ECO:0000256|SAM:Coils}.
FT   COILED     1252   1300       {ECO:0000256|SAM:Coils}.
FT   COILED     1318   1338       {ECO:0000256|SAM:Coils}.
FT   COILED     1447   1471       {ECO:0000256|SAM:Coils}.
FT   COILED     1488   1536       {ECO:0000256|SAM:Coils}.
FT   COILED     1558   1620       {ECO:0000256|SAM:Coils}.
FT   COILED     1630   1650       {ECO:0000256|SAM:Coils}.
FT   COILED     1709   1729       {ECO:0000256|SAM:Coils}.
FT   COILED     1754   1816       {ECO:0000256|SAM:Coils}.
FT   COILED     1856   1883       {ECO:0000256|SAM:Coils}.
FT   COILED     1929   1949       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1989 AA;  231106 MW;  E8B1DEA2ECDFD48C CRC64;
     MDEVEQDQHE ARLKELFDSF DTTGTGSLGQ EELTDLCHML SLEEVAPVLQ QTLLQDNLLG
     RVHFDQFKEA LILILSRTLS NEEHFQEPDC SLEAQPKYVR GGKRYGRRSL PEFQESVEEF
     PEVTVIEPLD EEARPSYIPA GDCSEHWKTQ RSEEYEAEGQ LRFWNPDDLN ASQSGSSPPQ
     DWIEEKLQEV CEDLGITRDG HLDRKKLVSI CEQYGLQNVD GEILEEVFHN LDPDGTMSVE
     DFFYGLFKNG KSLTPSASTP YRQLKRHLSM QSFDESGRRT TTSSAMTSTI GFRVISCLDD
     GMGHASVERI LDTWQEEGIE NSQEILKALD FSLDGNINLT ELTLALENEL LVTKNSIHQA
     ALASFKAEVR HLLERVDQVV REKEKLRSDL DKAEKLKSSM ASEVDDHHAA IERRNEYNLR
     KLDEEYKERI AALKNELRKE REQILQQAGK QRLELEQEIE KAKTEENYIR DRLALSLKEN
     SRLENELLEN AEKLAEYENL TNKLQRNLEN VLAEKFGDLD PSSAEFFLQE ERLTQMRNEY
     ERQCRVLQDQ VDELQSELEE YRAQGRVFRL PLKNSPSEEV EANSGGIEPE HGLGSEECNP
     LNMSIEAELV IEQMKEQHHR DICCLRLELE DKVRHYEKQL DETVVSCKKA QENMKQRHEN
     ETHTLEKQIS DLKNEIAELQ GQAAVLKEAH HEATCRHEEE KKQLQVKLEE EKTHLQEKLR
     LQHEMELKAR LTQAQASFER EREGLQSSAW TEEKVRGLTQ ELEQFHQEQL TSLVEKHTLE
     KEELRKELLE KHQRELQEGR EKMETECNRR TTQIEAQFQS DCQKVTERCE SALQSLEGRY
     RQELKDLQEQ QREEKSQWEF EKDELTQECA EAQELLKETL KREKTTSLVL TQEREMLEKT
     YKEHLNSMVV ERQQLLQDLE DLRNVSETQQ SLLSDQILEL KSSHIRELRE REEVLCQAGA
     SEQLASQRLE RLEMEHAQER QEMMSKLLAM ENIHKATCET ADRERAEMST EISRLQSKIK
     EMQQATSPLS MLQSGCQVIG EEEVEGDGAL SLLHQGEQLL EENGDVFLSL QRAHEQAVKE
     NVKMATEISR LQQRLQKLEP GLVMSSCLDE PATEFFGNTA EQTEPFLQQN RTKQVEGVTR
     RHVLSDLEDD EVRDLGSTGT SSVQRQEVKI EESEASVEGF SELENSEETR TESWELKNQI
     SQLQEQLMML CADCDRASEK KQDLLFDVSV LKKKLKMLER IPEASPKYKL LYEDVSREND
     CLQEELRMME TRYDEALENN KELTAEVFRL QDELKKMEEV TETFLSLEKS YDEVKIENEE
     LNVLVLRLQG KIEKLQESVV QRCDCCLWEA SLENLEIEPD GNILQLNQTL EECVPRVRSV
     HHVIEECKQE NQYLEGNTQL LEKVKAHEIA WLHGTIQTHQ ERPRVQNQVI LEENTTLLGF
     QDKHFQHQAT IAELELEKTK LQELTRKLKE RVTILVKQKD VLSHGEKEEE LKAMMHDLQI
     TCSEMQQKVE LLRYESEKLQ QENSILRNEI TTLNEEDSIS NLKLGTLNGS QEEMWQKTET
     VKQENAAVQK MVENLKKQIS ELKIKNQQLD LENTELSQKN SQNQEKLQEL NQRLTEMLCQ
     KEKEPGNSAL EEREQEKFNL KEELERCKVQ SSTLVSSLEA ELSEVKIQTH IVQQENHLLK
     DELEKMKQLH RCPDLSDFQQ KISSVLSYNE KLLKEKEALS EELNSCVDKL AKSSLLEHRI
     ATMKQEQKSW EHQSASLKSQ LVASQEKVQN LEDTVQNVNL QMSRMKSDLR VTQQEKEALK
     QEVMSLHKQL QNAGGKSWAP EIATHPSGLH NQQKRLSWDK LDHLMNEEQQ LLWQENERLQ
     TMVQNTKAEL THSREKVRQL ESNLLPKHQK HLNPSGTMNP TEQEKLSLKR ECDQFQKEQS
     PANRKVSQMN SLEQELETIH LENEGLKKKQ VKLDEQLMEN SVVGSSREGC SSLPEIVCED
     AAPEVHCDA
//
ID   NIN_HUMAN               Reviewed;        2090 AA.
AC   Q8N4C6; A6NDB8; B7WPA3; C9JSB6; C9JSG2; C9JXL2; Q5BKU3; Q6P0P6;
AC   Q9BWU6; Q9C012; Q9C013; Q9C014; Q9H5I6; Q9HAT7; Q9HBY5; Q9HCK7;
AC   Q9UH61;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 4.
DT   28-FEB-2018, entry version 147.
DE   RecName: Full=Ninein;
DE            Short=hNinein;
DE   AltName: Full=Glycogen synthase kinase 3 beta-interacting protein;
DE            Short=GSK3B-interacting protein;
GN   Name=NIN; Synonyms=KIAA1565;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, INTERACTION WITH GSK3B, AND VARIANTS PRO-1125 AND
RP   GLU-1320.
RC   TISSUE=Fetal liver;
RX   PubMed=11004522; DOI=10.1016/S0167-4781(00)00127-5;
RA   Hong Y.-R., Chen C.-H., Chang J.-H., Wang S.-K., Sy W.-D., Chou C.-K.,
RA   Howng S.-L.;
RT   "Cloning and characterization of a novel human ninein protein that
RT   interacts with the glycogen synthase kinase 3beta.";
RL   Biochim. Biophys. Acta 1492:513-516(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANTS PRO-1125 AND GLU-1320.
RX   PubMed=11162463; DOI=10.1006/bbrc.2000.4050;
RA   Hong Y.-R., Chen C.-H., Chuo M.-H., Liou S.-Y., Howng S.-L.;
RT   "Genomic organization and molecular characterization of the human
RT   ninein gene.";
RL   Biochem. Biophys. Res. Commun. 279:989-995(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 4), PARTIAL NUCLEOTIDE
RP   SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, ALTERNATIVE SPLICING,
RP   SUBCELLULAR LOCATION, AND VARIANTS PRO-1125 AND GLU-1320.
RC   TISSUE=Thymus;
RX   PubMed=15190203;
RA   Stillwell E.E., Zhou J., Joshi H.C.;
RT   "Human ninein is a centrosomal autoantigen recognized by CREST patient
RT   sera and plays a regulatory role in microtubule nucleation.";
RL   Cell Cycle 3:923-930(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [5]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 9), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-434 (ISOFORM 8), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1877-2090 (ISOFORM 4).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1561-2090 (ISOFORMS 1 AND 7).
RC   TISSUE=Bone marrow;
RA   Choquette M.C., de Medicis E.;
RT   "3' isoforms of human ninein.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1928-2090 (ISOFORM 7).
RC   TISSUE=Hepatoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11956314;
RA   Ou Y.Y., Mack G.J., Zhang M., Rattner J.B.;
RT   "CEP110 and ninein are located in a specific domain of the centrosome
RT   associated with centrosome maturation.";
RL   J. Cell Sci. 115:1825-1835(2002).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12403812; DOI=10.1083/jcb.200204023;
RA   Dammermann A., Merdes A.;
RT   "Assembly of centrosomal proteins and microtubule organization depends
RT   on PCM-1.";
RL   J. Cell Biol. 159:255-266(2002).
RN   [12]
RP   HOMOOLIGOMERIZATION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND
RP   PHOSPHORYLATION.
RX   PubMed=12927815; DOI=10.1016/S0006-291X(03)01510-9;
RA   Chen C.-H., Howng S.-L., Cheng T.-S., Chou M.-H., Huang C.-Y.,
RA   Hong Y.-R.;
RT   "Molecular characterization of human ninein protein: two distinct
RT   subdomains required for centrosomal targeting and regulating signals
RT   in cell cycle.";
RL   Biochem. Biophys. Res. Commun. 308:975-983(2003).
RN   [13]
RP   INTERACTION WITH C14ORF166.
RX   PubMed=15147888; DOI=10.1016/j.febslet.2004.04.024;
RA   Howng S.-L., Hsu H.-C., Cheng T.-S., Lee Y.-L., Chang L.-K., Lu P.-J.,
RA   Hong Y.-R.;
RT   "A novel ninein-interaction protein, CGI-99, blocks ninein
RT   phosphorylation by GSK3beta and is highly expressed in brain tumors.";
RL   FEBS Lett. 566:162-168(2004).
RN   [14]
RP   AUTOANTIBODY.
RX   PubMed=9506584;
RX   DOI=10.1002/1529-0131(199803)41:3<551::AID-ART22>3.0.CO;2-X;
RA   Mack G.J., Rees J., Sandblom O., Balczon R., Fritzler M.J.,
RA   Rattner J.B.;
RT   "Autoantibodies to a group of centrosomal proteins in human autoimmune
RT   sera reactive with the centrosome.";
RL   Arthritis Rheum. 41:551-558(1998).
RN   [15]
RP   AUTOANTIBODY.
RX   PubMed=14503922; DOI=10.1186/1471-2431-3-11;
RA   Fritzler M.J., Zhang M., Stinton L.M., Rattner J.B.;
RT   "Spectrum of centrosome autoantibodies in childhood varicella and
RT   post-varicella acute cerebellar ataxia.";
RL   BMC Pediatr. 3:11-11(2003).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1550, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1550, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   INTERACTION WITH AUNIP.
RX   PubMed=20596670;
RA   Lieu A.S., Cheng T.S., Chou C.H., Wu C.H., Hsu C.Y., Huang C.Y.,
RA   Chang L.K., Loh J.K., Chang C.S., Hsu C.M., Howng S.L., Hong Y.R.;
RT   "Functional characterization of AIBp, a novel Aurora-A binding protein
RT   in centrosome structure and spindle formation.";
RL   Int. J. Oncol. 37:429-436(2010).
RN   [19]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23386061; DOI=10.1038/emboj.2013.3;
RA   Kodani A., Salome Sirerol-Piquer M., Seol A., Garcia-Verdugo J.M.,
RA   Reiter J.F.;
RT   "Kif3a interacts with Dynactin subunit p150 Glued to organize
RT   centriole subdistal appendages.";
RL   EMBO J. 32:597-607(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152 AND SER-1550, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   INTERACTION WITH CCDC120.
RX   PubMed=28422092; DOI=10.1038/ncomms15057;
RA   Huang N., Xia Y., Zhang D., Wang S., Bao Y., He R., Teng J., Chen J.;
RT   "Hierarchical assembly of centriole subdistal appendages via
RT   centrosome binding proteins CCDC120 and CCDC68.";
RL   Nat. Commun. 8:15057-15057(2017).
RN   [22]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-1320.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J.,
RA   Heath S., Shannon W.D., Nagarajan R., Walter M.J., Link D.C.,
RA   Graubert T.A., DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
RN   [23]
RP   VARIANTS SCKL7 ARG-1222 AND SER-1709.
RX   PubMed=22933543; DOI=10.1210/jc.2012-2150;
RA   Dauber A., Lafranchi S.H., Maliga Z., Lui J.C., Moon J.E., McDeed C.,
RA   Henke K., Zonana J., Kingman G.A., Pers T.H., Baron J.,
RA   Rosenfeld R.G., Hirschhorn J.N., Harris M.P., Hwa V.;
RT   "Novel microcephalic primordial dwarfism disorder associated with
RT   variants in the centrosomal protein ninein.";
RL   J. Clin. Endocrinol. Metab. 97:E2140-E2151(2012).
CC   -!- FUNCTION: Centrosomal protein required in the positioning and
CC       anchorage of the microtubule minus-end in epithelial cells. May
CC       also act as a centrosome maturation factor. May play a role in
CC       microtubule nucleation. Overexpression does not perturb nucleation
CC       or elongation of microtubules but suppresses release of
CC       microtubules (PubMed:15190203). Required for centriole
CC       organization and microtubule anchoring at the mother centriole
CC       (PubMed:23386061). {ECO:0000269|PubMed:15190203,
CC       ECO:0000269|PubMed:23386061}.
CC   -!- SUBUNIT: Homooligomer. Interacts with GSK3B/GSK3-beta via its C-
CC       terminal domain (PubMed:11004522). Interacts with C14ORF166, such
CC       interaction may prevent its phosphorylation by GSK3B
CC       (PubMed:15147888). Interacts with AUNIP (via N-terminus)
CC       (PubMed:20596670). Identified in a complex with AUNIP and AURKA
CC       (PubMed:20596670). Interacts with CCDC120 (PubMed:28422092).
CC       {ECO:0000269|PubMed:11004522, ECO:0000269|PubMed:15147888,
CC       ECO:0000269|PubMed:20596670, ECO:0000269|PubMed:28422092}.
CC   -!- INTERACTION:
CC       Q9Y224:C14orf166; NbExp=4; IntAct=EBI-1164022, EBI-1104547;
CC       P49841:GSK3B; NbExp=3; IntAct=EBI-1164022, EBI-373586;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:11004522,
CC       ECO:0000269|PubMed:11956314, ECO:0000269|PubMed:12403812,
CC       ECO:0000269|PubMed:12927815, ECO:0000269|PubMed:15190203}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center,
CC       centrosome, centriole {ECO:0000269|PubMed:23386061}.
CC       Note=Component of the core centrosome. Arranged in a tubular
CC       conformation with an open and a closed end within the centrosome.
CC       In the mother centrosome, it localizes at both ends of the
CC       centrosome tube, including the site of centrosome duplication,
CC       while in the daughter centrosome it is present only at the closed
CC       end. Requires PCM1 for centrosome localization. Localizes to the
CC       subdistal appendage region of the centriole in a DCTN1-dependent
CC       manner. {ECO:0000269|PubMed:23386061}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=9;
CC       Name=1; Synonyms=Lm;
CC         IsoId=Q8N4C6-1; Sequence=Displayed;
CC       Name=2; Synonyms=Isotype 3;
CC         IsoId=Q8N4C6-2; Sequence=VSP_010952;
CC         Note=Dubious isoform produced through aberrant splice sites.;
CC       Name=3; Synonyms=Isotype 2;
CC         IsoId=Q8N4C6-10; Sequence=VSP_010952, VSP_010960;
CC         Note=Dubious isoform produced through aberrant splice sites.;
CC       Name=4; Synonyms=Isotype 1;
CC         IsoId=Q8N4C6-4; Sequence=VSP_010952, VSP_010957, VSP_010958;
CC         Note=Dubious isoform produced through aberrant splice sites.;
CC       Name=5;
CC         IsoId=Q8N4C6-5; Sequence=VSP_010950;
CC       Name=6;
CC         IsoId=Q8N4C6-6; Sequence=VSP_010953, VSP_010954, VSP_010955,
CC                                  VSP_010956;
CC         Note=No experimental confirmation available.;
CC       Name=7; Synonyms=B;
CC         IsoId=Q8N4C6-7; Sequence=VSP_010960;
CC         Note=No experimental confirmation available.;
CC       Name=8;
CC         IsoId=Q8N4C6-9; Sequence=VSP_040039;
CC         Note=No experimental confirmation available.;
CC       Name=9;
CC         IsoId=Q8N4C6-11; Sequence=VSP_010953;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in heart and
CC       skeletal muscle. Isoform 1 is more expressed than isoform 5.
CC       {ECO:0000269|PubMed:11004522, ECO:0000269|PubMed:11162463}.
CC   -!- DEVELOPMENTAL STAGE: In interphase cells, it is localized in the
CC       centrosome. Decreases in metaphase and anaphase and reappears in
CC       telophase. {ECO:0000269|PubMed:12927815}.
CC   -!- DOMAIN: The coiled coil region from Asn-1611 to Pro-1693 is
CC       necessary and sufficient for the targeting to centrosome.
CC   -!- PTM: Phosphorylated by AURKA/Aurora kinase A and PKA kinases but
CC       not CK2 or AURKB/ Aurora kinase B. {ECO:0000269|PubMed:12927815}.
CC   -!- DISEASE: Seckel syndrome 7 (SCKL7) [MIM:614851]: A rare autosomal
CC       recessive disorder characterized by proportionate dwarfism of
CC       prenatal onset associated with low birth weight, growth
CC       retardation, severe microcephaly with a bird-headed like
CC       appearance, and mental retardation. {ECO:0000269|PubMed:22933543}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: Antibodies against NIN are present in sera from
CC       patients with autoimmune diseases that developed autoantibodies
CC       against centrosomal proteins.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH65521.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAH65521.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAK00628.1; Type=Miscellaneous discrepancy; Note=Several sequencing errors.; Evidence={ECO:0000305};
CC       Sequence=AAK00629.1; Type=Miscellaneous discrepancy; Note=Several sequencing errors and frameshifts.; Evidence={ECO:0000305};
CC       Sequence=AAK00630.1; Type=Miscellaneous discrepancy; Note=Several sequencing errors.; Evidence={ECO:0000305};
CC       Sequence=BAB13391.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAB15640.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NINID176.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF212162; AAF23015.2; -; mRNA.
DR   EMBL; AF302773; AAG33512.2; -; mRNA.
DR   EMBL; AF223937; AAK00628.1; ALT_SEQ; mRNA.
DR   EMBL; AF223938; AAK00629.1; ALT_SEQ; mRNA.
DR   EMBL; AF223939; AAK00630.1; ALT_SEQ; mRNA.
DR   EMBL; AB046785; BAB13391.2; ALT_INIT; mRNA.
DR   EMBL; AL133485; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL606834; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034708; AAH34708.2; -; mRNA.
DR   EMBL; BC065521; AAH65521.1; ALT_SEQ; mRNA.
DR   EMBL; BC090932; AAH90932.1; -; mRNA.
DR   EMBL; AY027794; AAK27375.1; -; mRNA.
DR   EMBL; AY027795; AAK27376.1; -; mRNA.
DR   EMBL; AY027796; AAK27377.1; -; mRNA.
DR   EMBL; AF186776; AAG17027.1; -; mRNA.
DR   EMBL; AK027054; BAB15640.1; ALT_INIT; mRNA.
DR   CCDS; CCDS32078.2; -. [Q8N4C6-11]
DR   CCDS; CCDS32079.1; -. [Q8N4C6-1]
DR   RefSeq; NP_057434.4; NM_016350.4. [Q8N4C6-11]
DR   RefSeq; NP_065972.3; NM_020921.3.
DR   RefSeq; NP_891989.2; NM_182944.2.
DR   RefSeq; NP_891991.1; NM_182946.1.
DR   RefSeq; XP_011535125.1; XM_011536823.2. [Q8N4C6-5]
DR   UniGene; Hs.310429; -.
DR   UniGene; Hs.569387; -.
DR   ProteinModelPortal; Q8N4C6; -.
DR   SMR; Q8N4C6; -.
DR   BioGrid; 119372; 119.
DR   IntAct; Q8N4C6; 108.
DR   MINT; Q8N4C6; -.
DR   STRING; 9606.ENSP00000371472; -.
DR   iPTMnet; Q8N4C6; -.
DR   PhosphoSitePlus; Q8N4C6; -.
DR   BioMuta; NIN; -.
DR   DMDM; 311033487; -.
DR   EPD; Q8N4C6; -.
DR   MaxQB; Q8N4C6; -.
DR   PaxDb; Q8N4C6; -.
DR   PeptideAtlas; Q8N4C6; -.
DR   PRIDE; Q8N4C6; -.
DR   Ensembl; ENST00000245441; ENSP00000245441; ENSG00000100503. [Q8N4C6-7]
DR   Ensembl; ENST00000324330; ENSP00000324210; ENSG00000100503. [Q8N4C6-11]
DR   Ensembl; ENST00000382041; ENSP00000371472; ENSG00000100503. [Q8N4C6-1]
DR   Ensembl; ENST00000382043; ENSP00000371474; ENSG00000100503. [Q8N4C6-11]
DR   Ensembl; ENST00000530997; ENSP00000436092; ENSG00000100503. [Q8N4C6-7]
DR   GeneID; 51199; -.
DR   KEGG; hsa:51199; -.
DR   UCSC; uc001wyi.3; human. [Q8N4C6-1]
DR   CTD; 51199; -.
DR   DisGeNET; 51199; -.
DR   EuPathDB; HostDB:ENSG00000100503.23; -.
DR   GeneCards; NIN; -.
DR   GeneReviews; NIN; -.
DR   HGNC; HGNC:14906; NIN.
DR   HPA; HPA005939; -.
DR   HPA; HPA070691; -.
DR   MalaCards; NIN; -.
DR   MIM; 608684; gene.
DR   MIM; 614851; phenotype.
DR   neXtProt; NX_Q8N4C6; -.
DR   OpenTargets; ENSG00000100503; -.
DR   Orphanet; 319675; Microcephalic primordial dwarfism, Dauber type.
DR   PharmGKB; PA31630; -.
DR   eggNOG; ENOG410IK59; Eukaryota.
DR   eggNOG; ENOG410Z1RR; LUCA.
DR   GeneTree; ENSGT00660000095541; -.
DR   HOGENOM; HOG000293170; -.
DR   HOVERGEN; HBG052623; -.
DR   InParanoid; Q8N4C6; -.
DR   KO; K16476; -.
DR   OMA; TCSEMQQ; -.
DR   OrthoDB; EOG091G00XA; -.
DR   PhylomeDB; Q8N4C6; -.
DR   TreeFam; TF325139; -.
DR   SIGNOR; Q8N4C6; -.
DR   ChiTaRS; NIN; human.
DR   GeneWiki; NIN_(gene); -.
DR   GenomeRNAi; 51199; -.
DR   PRO; PR:Q8N4C6; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100503; -.
DR   ExpressionAtlas; Q8N4C6; baseline and differential.
DR   Genevisible; Q8N4C6; HS.
DR   GO; GO:0120103; C:centriolar subdistal appendage; IDA:GO_Central.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0097539; C:ciliary transition fiber; IBA:GO_Central.
DR   GO; GO:0036449; C:microtubule minus-end; IBA:GO_Central.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0097431; C:mitotic spindle pole; IBA:GO_Central.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0000242; C:pericentriolar material; IDA:MGI.
DR   GO; GO:0000922; C:spindle pole; IMP:MGI.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0010457; P:centriole-centriole cohesion; IMP:GO_Central.
DR   GO; GO:0051642; P:centrosome localization; TAS:HGNC.
DR   GO; GO:0090222; P:centrosome-templated microtubule nucleation; IBA:GO_Central.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IMP:UniProtKB.
DR   GO; GO:0008104; P:protein localization; IMP:GO_Central.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR029664; NIN.
DR   PANTHER; PTHR18905:SF11; PTHR18905:SF11; 1.
DR   SUPFAM; SSF47473; SSF47473; 2.
DR   PROSITE; PS50222; EF_HAND_2; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Disease mutation; Dwarfism; GTP-binding;
KW   Mental retardation; Microtubule; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat.
FT   CHAIN         1   2090       Ninein.
FT                                /FTId=PRO_0000096844.
FT   DOMAIN        8     43       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN       42     77       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      182    217       EF-hand 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      219    252       EF-hand 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      317    352       EF-hand 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   NP_BIND     245    252       GTP. {ECO:0000255}.
FT   NP_BIND     300    304       GTP. {ECO:0000255}.
FT   NP_BIND     420    423       GTP. {ECO:0000255}.
FT   COILED      357    570       {ECO:0000255}.
FT   COILED      625   1027       {ECO:0000255}.
FT   COILED     1068   1099       {ECO:0000255}.
FT   COILED     1181   1341       {ECO:0000255}.
FT   COILED     1441   1816       {ECO:0000255}.
FT   COILED     1854   1885       {ECO:0000255}.
FT   COILED     1922   2067       {ECO:0000255}.
FT   MOD_RES     152    152       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     269    269       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61043}.
FT   MOD_RES    1550   1550       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1837   1837       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61043}.
FT   VAR_SEQ       1     38       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040039.
FT   VAR_SEQ       1     35       MDEVEQDQHEARLKELFDSFDTTGTGSLGQEELTD -> MA
FT                                EVTVPRVYVVFGIHCIMAKASSDVQVSGFHRKIQHVKNE
FT                                (in isoform 5).
FT                                {ECO:0000303|PubMed:11004522}.
FT                                /FTId=VSP_010950.
FT   VAR_SEQ     492    508       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:15190203,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010952.
FT   VAR_SEQ     800   1512       Missing (in isoform 6 and isoform 9).
FT                                {ECO:0000303|PubMed:10997877,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010953.
FT   VAR_SEQ    1555   1555       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:10997877}.
FT                                /FTId=VSP_010954.
FT   VAR_SEQ    1960   1988       MQHLRSTATPSPSPHAWDLQLLQQQACPM -> NSVVGSSR
FT                                EGCSSLPEIVCEDAAPEVHCDA (in isoform 6).
FT                                {ECO:0000303|PubMed:10997877}.
FT                                /FTId=VSP_010955.
FT   VAR_SEQ    1989   2090       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:10997877}.
FT                                /FTId=VSP_010956.
FT   VAR_SEQ    2027   2046       GNQEQLVTVMEERMIEVEQK -> ALLPEQRAVHADSYRRI
FT                                GHL (in isoform 4).
FT                                {ECO:0000303|PubMed:15190203,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010957.
FT   VAR_SEQ    2047   2090       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15190203,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010958.
FT   VAR_SEQ    2065   2090       VSLPGHLCSPTSHSSFNSSFTSLYCH -> LCKNTKADAMV
FT                                KDLYVENAQLLKALEVTEQRQKTAEKKNYLLEEKIASLSNI
FT                                VRNLTPAPLTSTPPLRS (in isoform 3 and
FT                                isoform 7). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.8}.
FT                                /FTId=VSP_010960.
FT   VARIANT    1111   1111       P -> A (in dbSNP:rs2236316).
FT                                /FTId=VAR_019453.
FT   VARIANT    1125   1125       Q -> P (in dbSNP:rs12882191).
FT                                {ECO:0000269|PubMed:11004522,
FT                                ECO:0000269|PubMed:11162463,
FT                                ECO:0000269|PubMed:15190203}.
FT                                /FTId=VAR_051235.
FT   VARIANT    1222   1222       Q -> R (in SCKL7; does not disrupt
FT                                protein expression or localization or
FT                                affect mitotic functions in an obvious
FT                                way; dbSNP:rs187464517).
FT                                {ECO:0000269|PubMed:22933543}.
FT                                /FTId=VAR_069083.
FT   VARIANT    1320   1320       G -> E (in dbSNP:rs2073347).
FT                                {ECO:0000269|PubMed:11004522,
FT                                ECO:0000269|PubMed:11162463,
FT                                ECO:0000269|PubMed:15190203,
FT                                ECO:0000269|PubMed:18987736}.
FT                                /FTId=VAR_019454.
FT   VARIANT    1709   1709       N -> S (in SCKL7; does not disrupt
FT                                protein expression or localization or
FT                                affect mitotic functions in an obvious
FT                                way; dbSNP:rs387907308).
FT                                {ECO:0000269|PubMed:22933543}.
FT                                /FTId=VAR_069084.
FT   VARIANT    1837   1837       S -> T (in dbSNP:rs12717411).
FT                                /FTId=VAR_019455.
FT   VARIANT    1934   1934       Q -> E (in dbSNP:rs2295847).
FT                                /FTId=VAR_051236.
FT   CONFLICT    137    137       H -> Y (in Ref. 1; AAF23015 and 2;
FT                                AAG33512). {ECO:0000305}.
FT   CONFLICT    177    177       S -> F (in Ref. 1; AAF23015).
FT                                {ECO:0000305}.
FT   CONFLICT    203    203       N -> D (in Ref. 2; AAG33512).
FT                                {ECO:0000305}.
FT   CONFLICT    223    223       M -> I (in Ref. 2; AAG33512).
FT                                {ECO:0000305}.
FT   CONFLICT    295    295       F -> I (in Ref. 2; AAG33512).
FT                                {ECO:0000305}.
FT   CONFLICT    369    369       I -> V (in Ref. 2; AAG33512).
FT                                {ECO:0000305}.
FT   CONFLICT    399    399       L -> S (in Ref. 2; AAG33512).
FT                                {ECO:0000305}.
FT   CONFLICT    568    568       L -> F (in Ref. 2; AAG33512).
FT                                {ECO:0000305}.
FT   CONFLICT    809    809       R -> I (in Ref. 1; AAF23015).
FT                                {ECO:0000305}.
FT   CONFLICT    812    812       S -> T (in Ref. 2; AAG33512).
FT                                {ECO:0000305}.
FT   CONFLICT    945    945       K -> I (in Ref. 2; AAG33512).
FT                                {ECO:0000305}.
FT   CONFLICT    977    977       D -> A (in Ref. 2; AAG33512).
FT                                {ECO:0000305}.
FT   CONFLICT    980    980       R -> G (in Ref. 1; AAF23015).
FT                                {ECO:0000305}.
FT   CONFLICT   1054   1054       Q -> H (in Ref. 2; AAG33512).
FT                                {ECO:0000305}.
FT   CONFLICT   1067   1067       L -> F (in Ref. 2; AAG33512).
FT                                {ECO:0000305}.
FT   CONFLICT   1070   1070       L -> Q (in Ref. 1; AAF23015).
FT                                {ECO:0000305}.
FT   CONFLICT   1150   1150       D -> G (in Ref. 1; AAF23015).
FT                                {ECO:0000305}.
FT   CONFLICT   1237   1237       M -> I (in Ref. 1; AAF23015).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2090 AA;  243249 MW;  51D27CD38A369209 CRC64;
     MDEVEQDQHE ARLKELFDSF DTTGTGSLGQ EELTDLCHML SLEEVAPVLQ QTLLQDNLLG
     RVHFDQFKEA LILILSRTLS NEEHFQEPDC SLEAQPKYVR GGKRYGRRSL PEFQESVEEF
     PEVTVIEPLD EEARPSHIPA GDCSEHWKTQ RSEEYEAEGQ LRFWNPDDLN ASQSGSSPPQ
     DWIEEKLQEV CEDLGITRDG HLNRKKLVSI CEQYGLQNVD GEMLEEVFHN LDPDGTMSVE
     DFFYGLFKNG KSLTPSASTP YRQLKRHLSM QSFDESGRRT TTSSAMTSTI GFRVFSCLDD
     GMGHASVERI LDTWQEEGIE NSQEILKALD FSLDGNINLT ELTLALENEL LVTKNSIHQA
     ALASFKAEIR HLLERVDQVV REKEKLRSDL DKAEKLKSLM ASEVDDHHAA IERRNEYNLR
     KLDEEYKERI AALKNELRKE REQILQQAGK QRLELEQEIE KAKTEENYIR DRLALSLKEN
     SRLENELLEN AEKLAEYENL TNKLQRNLEN VLAEKFGDLD PSSAEFFLQE ERLTQMRNEY
     ERQCRVLQDQ VDELQSELEE YRAQGRVLRL PLKNSPSEEV EANSGGIEPE HGLGSEECNP
     LNMSIEAELV IEQMKEQHHR DICCLRLELE DKVRHYEKQL DETVVSCKKA QENMKQRHEN
     ETHTLEKQIS DLKNEIAELQ GQAAVLKEAH HEATCRHEEE KKQLQVKLEE EKTHLQEKLR
     LQHEMELKAR LTQAQASFER EREGLQSSAW TEEKVRGLTQ ELEQFHQEQL TSLVEKHTLE
     KEELRKELLE KHQRELQEGR EKMETECNRR TSQIEAQFQS DCQKVTERCE SALQSLEGRY
     RQELKDLQEQ QREEKSQWEF EKDELTQECA EAQELLKETL KREKTTSLVL TQEREMLEKT
     YKEHLNSMVV ERQQLLQDLE DLRNVSETQQ SLLSDQILEL KSSHKRELRE REEVLCQAGA
     SEQLASQRLE RLEMEHDQER QEMMSKLLAM ENIHKATCET ADRERAEMST EISRLQSKIK
     EMQQATSPLS MLQSGCQVIG EEEVEGDGAL SLLQQGEQLL EENGDVLLSL QRAHEQAVKE
     NVKMATEISR LQQRLQKLEP GLVMSSCLDE PATEFFGNTA EQTEQFLQQN RTKQVEGVTR
     RHVLSDLEDD EVRDLGSTGT SSVQRQEVKI EESEASVEGF SELENSEETR TESWELKNQI
     SQLQEQLMML CADCDRASEK KQDLLFDVSV LKKKLKMLER IPEASPKYKL LYEDVSREND
     CLQEELRMME TRYDEALENN KELTAEVFRL QDELKKMEEV TETFLSLEKS YDEVKIENEG
     LNVLVLRLQG KIEKLQESVV QRCDCCLWEA SLENLEIEPD GNILQLNQTL EECVPRVRSV
     HHVIEECKQE NQYLEGNTQL LEKVKAHEIA WLHGTIQTHQ ERPRVQNQVI LEENTTLLGF
     QDKHFQHQAT IAELELEKTK LQELTRKLKE RVTILVKQKD VLSHGEKEEE LKAMMHDLQI
     TCSEMQQKVE LLRYESEKLQ QENSILRNEI TTLNEEDSIS NLKLGTLNGS QEEMWQKTET
     VKQENAAVQK MVENLKKQIS ELKIKNQQLD LENTELSQKN SQNQEKLQEL NQRLTEMLCQ
     KEKEPGNSAL EEREQEKFNL KEELERCKVQ SSTLVSSLEA ELSEVKIQTH IVQQENHLLK
     DELEKMKQLH RCPDLSDFQQ KISSVLSYNE KLLKEKEALS EELNSCVDKL AKSSLLEHRI
     ATMKQEQKSW EHQSASLKSQ LVASQEKVQN LEDTVQNVNL QMSRMKSDLR VTQQEKEALK
     QEVMSLHKQL QNAGGKSWAP EIATHPSGLH NQQKRLSWDK LDHLMNEEQQ LLWQENERLQ
     TMVQNTKAEL THSREKVRQL ESNLLPKHQK HLNPSGTMNP TEQEKLSLKR ECDQFQKEQS
     PANRKVSQMN SLEQELETIH LENEGLKKKQ VKLDEQLMEM QHLRSTATPS PSPHAWDLQL
     LQQQACPMVP REQFLQLQRQ LLQAERINQH LQEELENRTS ETNTPQGNQE QLVTVMEERM
     IEVEQKLKLV KRLLQEKVNQ LKEQVSLPGH LCSPTSHSSF NSSFTSLYCH
//
ID   A0A0S2Z4Z9_HUMAN        Unreviewed;       471 AA.
AC   A0A0S2Z4Z9;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 15.
DE   SubName: Full=Non-POU domain containing octamer-binding isoform 1 {ECO:0000313|EMBL:ALQ33692.1};
DE   Flags: Fragment;
GN   Name=NONO {ECO:0000313|EMBL:ALQ33692.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33692.1};
RN   [1] {ECO:0000313|EMBL:ALQ33692.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178234; ALQ33692.1; -; mRNA.
DR   RefSeq; NP_001138880.1; NM_001145408.1.
DR   RefSeq; NP_001138881.1; NM_001145409.1.
DR   RefSeq; NP_031389.3; NM_007363.4.
DR   UniGene; Hs.533282; -.
DR   UniGene; Hs.700344; -.
DR   ProteinModelPortal; A0A0S2Z4Z9; -.
DR   SMR; A0A0S2Z4Z9; -.
DR   GeneID; 4841; -.
DR   KEGG; hsa:4841; -.
DR   CTD; 4841; -.
DR   KO; K13214; -.
DR   OMA; NQQYHKE; -.
DR   PhylomeDB; A0A0S2Z4Z9; -.
DR   ChiTaRS; NONO; human.
DR   ExpressionAtlas; A0A0S2Z4Z9; baseline and differential.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0001047; F:core promoter binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IEA:Ensembl.
DR   CDD; cd12588; RRM1_p54nrb; 1.
DR   CDD; cd12591; RRM2_p54nrb; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR012975; NOPS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034552; p54nrb_RRM1.
DR   InterPro; IPR034558; p54nrb_RRM2.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF08075; NOPS; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN       74    146       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      148    229       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   COILED      275    368       {ECO:0000256|SAM:Coils}.
FT   NON_TER     471    471       {ECO:0000313|EMBL:ALQ33692.1}.
SQ   SEQUENCE   471 AA;  54232 MW;  26BBD3828F5B9E49 CRC64;
     MQSNKTFNLE KQNHTPRKHH QHHHQQQHHQ QQQQQPPPPP IPANGQQASS QNEGLTIDLK
     NFRKPGEKTF TQRSRLFVGN LPPDITEEEM RKLFEKYGKA GEVFIHKDKG FGFIRLETRT
     LAEIAKVELD NMPLRGKQLR VRFACHSASL TVRNLPQYVS NELLEEAFSV FGQVERAVVI
     VDDRGRPSGK GIVEFSGKPA ARKALDRCSE GSFLLTTFPR PVTVEPMDQL DDEEGLPEKL
     VIKNQQFHKE REQPPRFAQP GSFEYEYAMR WKALIEMEKQ QQDQVDRNIK EAREKLEMEM
     EAARHEHQVM LMRQDLMRRQ EELRRMEELH NQEVQKRKQL ELRQEEERRR REEEMRRQQE
     EMMRRQQEGF KGTFPDAREQ EIRMGQMAMG GAMGINNRGA MPPAPVPAGT PAPPGPATMM
     PDGTLGLTPP TTERFGQAAT MEGIGAIGGT PPAFNRAAPG AEFAPNKRRR Y
//
ID   NONO_HUMAN              Reviewed;         471 AA.
AC   Q15233; B7Z4C2; D3DVV4; F5GYZ3; O00201; P30807; Q12786; Q9BQC5;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 4.
DT   28-FEB-2018, entry version 193.
DE   RecName: Full=Non-POU domain-containing octamer-binding protein;
DE            Short=NonO protein;
DE   AltName: Full=54 kDa nuclear RNA- and DNA-binding protein;
DE   AltName: Full=55 kDa nuclear protein;
DE   AltName: Full=DNA-binding p52/p100 complex, 52 kDa subunit;
DE   AltName: Full=NMT55;
DE   AltName: Full=p54(nrb);
DE            Short=p54nrb;
GN   Name=NONO; Synonyms=NRB54;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF
RP   252-267; 273-279 AND 283-289.
RX   PubMed=8371983; DOI=10.1093/nar/21.17.4085;
RA   Dong B., Horowitz D.S., Kobayashi R., Krainer A.R.;
RT   "Purification and cDNA cloning of HeLa cell p54nrb, a nuclear protein
RT   with two RNA recognition motifs and extensive homology to human
RT   splicing factor PSF and Drosophila NONA/BJ6.";
RL   Nucleic Acids Res. 21:4085-4092(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9360842; DOI=10.1097/00019606-199708000-00005;
RA   Traish A.M., Huang Y.-H., Ashba J., Pronovost M., Pavao M.,
RA   McAneny D.B., Moreland R.B.;
RT   "Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen
RT   receptor-negative human breast cancer.";
RL   Diagn. Mol. Pathol. 6:209-221(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Blood;
RX   PubMed=9341872; DOI=10.1007/s004390050553;
RA   Peters U., Haberhausen G., Kostrzewa M., Nolte D., Mueller U.;
RT   "AFX1 and p54nrb: fine mapping, genomic structure, and exclusion as
RT   candidate genes of X-linked dystonia parkinsonism.";
RL   Hum. Genet. 100:569-572(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Honore B., Rasmussen H.H., Celis J.E.;
RT   "54 kDa human protein.";
RL   Submitted (JAN-1994) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix, Kidney, Muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-21 AND 133-153, BLOCKAGE OF N-TERMINUS, AND
RP   SUBUNIT.
RX   PubMed=8439294; DOI=10.1042/bj2900267;
RA   Zhang W.-W., Zhang L.-X., Busch R.K., Farres J., Busch H.;
RT   "Purification and characterization of a DNA-binding heterodimer of 52
RT   and 100 kDa from HeLa cells.";
RL   Biochem. J. 290:267-272(1993).
RN   [11]
RP   PROTEIN SEQUENCE OF 76-91; 127-135; 177-184; 257-270 AND 435-456, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [12]
RP   CHROMOSOMAL TRANSLOCATION WITH TFE3.
RX   PubMed=9393982; DOI=10.1038/sj.onc.1201394;
RA   Clark J., Lu Y.-J., Sidhar S.K., Parker C., Gill S., Smedley D.,
RA   Hamoudi R., Linehan W.M., Shipley J., Cooper C.S.;
RT   "Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3
RT   gene in papillary renal cell carcinoma.";
RL   Oncogene 15:2233-2239(1997).
RN   [13]
RP   IDENTIFICATION IN A COMPLEX WITH SFPQ AND TOP1.
RX   PubMed=9756848; DOI=10.1074/jbc.273.41.26261;
RA   Straub T., Grue P., Uhse A., Lisby M., Knudsen B.R., Tange T.O.,
RA   Westergaard O., Boege F.;
RT   "The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity
RT   by a direct interaction.";
RL   J. Biol. Chem. 273:26261-26264(1998).
RN   [14]
RP   FUNCTION IN DNA UNWINDING.
RX   PubMed=10858305; DOI=10.1021/bi992898e;
RA   Straub T., Knudsen B.R., Boege F.;
RT   "PSF/p54(nrb) stimulates 'jumping' of DNA topoisomerase I between
RT   separate DNA helices.";
RL   Biochemistry 39:7552-7558(2000).
RN   [15]
RP   FUNCTION IN NUCLEAR RETENTION OF A-TO-I EDITED RNAS, AND
RP   IDENTIFICATION IN A COMPLEX WITH NONO AND MATR3.
RX   PubMed=11525732; DOI=10.1016/S0092-8674(01)00466-4;
RA   Zhang Z., Carmichael G.G.;
RT   "The fate of dsRNA in the nucleus: a p54(nrb)-containing complex
RT   mediates the nuclear retention of promiscuously A-to-I edited RNAs.";
RL   Cell 106:465-475(2001).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION IN TRANSCRIPTION
RP   REGULATION, AND IDENTIFICATION IN A COMPLEX WITH SFPQ AND NR5A1.
RX   PubMed=11897684; DOI=10.1210/endo.143.4.8748;
RA   Sewer M.B., Nguyen V.Q., Huang C.J., Tucker P.W., Kagawa N.,
RA   Waterman M.R.;
RT   "Transcriptional activation of human CYP17 in H295R adrenocortical
RT   cells depends on complex formation among p54(nrb)/NonO, protein-
RT   associated splicing factor, and SF-1, a complex that also participates
RT   in repression of transcription.";
RL   Endocrinology 143:1280-1290(2002).
RN   [17]
RP   INTERACTION WITH PSQF AND U5 SNRNA, AND IDENTIFICATION IN U5/4/6 SNRNP
RP   AND SPLICEOSOME COMPLEXES.
RX   PubMed=12403470; DOI=10.1017/S1355838202022070;
RA   Peng R., Dye B.T., Perez I., Barnard D.C., Thompson A.B., Patton J.G.;
RT   "PSF and p54nrb bind a conserved stem in U5 snRNA.";
RL   RNA 8:1334-1347(2002).
RN   [18]
RP   FUNCTION IN DNA REPAIR, IDENTIFICATION BY MASS SPECTROMETRY,
RP   DNA-BINDING, AND SUBUNIT.
RX   PubMed=15590677; DOI=10.1074/jbc.M412758200;
RA   Bladen C.L., Udayakumar D., Takeda Y., Dynan W.S.;
RT   "Identification of the polypyrimidine tract binding protein-associated
RT   splicing factor.p54(nrb) complex as a candidate DNA double-strand
RT   break rejoining factor.";
RL   J. Biol. Chem. 280:5205-5210(2005).
RN   [19]
RP   INTERACTION WITH PSPC1.
RX   PubMed=16148043; DOI=10.1091/mbc.E05-06-0587;
RA   Fox A.H., Bond C.S., Lamond A.I.;
RT   "P54nrb forms a heterodimer with PSP1 that localizes to paraspeckles
RT   in an RNA-dependent manner.";
RL   Mol. Biol. Cell 16:5304-5315(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-428 AND THR-450, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.M700120-MCP200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,
RA   Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate
RT   reductase M2 subunit phosphorylation at residue serine 20 in canonical
RT   Wnt signal transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-428 AND THR-450, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [27]
RP   INTERACTION WITH RNF43.
RX   PubMed=18655028; DOI=10.1002/pmic.200800083;
RA   Miyamoto K., Sakurai H., Sugiura T.;
RT   "Proteomic identification of a PSF/p54nrb heterodimer as RNF43
RT   oncoprotein-interacting proteins.";
RL   Proteomics 8:2907-2910(2008).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-428 AND THR-450, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5; LYS-11 AND LYS-198, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-147; THR-440 AND
RP   THR-450, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [34]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=22002106; DOI=10.1074/mcp.M111.013680;
RA   Ahmad Y., Boisvert F.M., Lundberg E., Uhlen M., Lamond A.I.;
RT   "Systematic analysis of protein pools, isoforms, and modifications
RT   affecting turnover and subcellular localization.";
RL   Mol. Cell. Proteomics 11:M111.013680.01-M111.013680.15(2012).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-6; SER-262 AND THR-450,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-450, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [37]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-456, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [38]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-5 AND LYS-371, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [40]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PRKDC; XRCC5;
RP   XRCC6; SFPQ; HEXIM1; PSPC1; RBM14 AND MATR3.
RX   PubMed=28712728; DOI=10.1016/j.molcel.2017.06.020;
RA   Morchikh M., Cribier A., Raffel R., Amraoui S., Cau J., Severac D.,
RA   Dubois E., Schwartz O., Bennasser Y., Benkirane M.;
RT   "HEXIM1 and NEAT1 Long non-coding RNA form a multi-subunit complex
RT   that regulates DNA-mediated innate immune response.";
RL   Mol. Cell 67:387-399(2017).
RN   [41]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-5; LYS-60; LYS-96; LYS-99;
RP   LYS-126; LYS-190; LYS-198; LYS-243; LYS-249; LYS-371 AND LYS-467, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 53-312 IN COMPLEX WITH PSPC1,
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF TYR-267 AND
RP   TRP-271.
RX   PubMed=22416126; DOI=10.1073/pnas.1120792109;
RA   Passon D.M., Lee M., Rackham O., Stanley W.A., Sadowska A.,
RA   Filipovska A., Fox A.H., Bond C.S.;
RT   "Structure of the heterodimer of human NONO and paraspeckle protein
RT   component 1 and analysis of its role in subnuclear body formation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:4846-4850(2012).
RN   [43]
RP   INVOLVEMENT IN MRXS34, AND FUNCTION.
RX   PubMed=26571461; DOI=10.1038/nn.4169;
RG   DDD Study;
RA   Mircsof D., Langouet M., Rio M., Moutton S., Siquier-Pernet K.,
RA   Bole-Feysot C., Cagnard N., Nitschke P., Gaspar L., Znidaric M.,
RA   Alibeu O., Fritz A.K., Wolfer D.P., Schroeter A., Bosshard G.,
RA   Rudin M., Koester C., Crestani F., Seebeck P., Boddaert N.,
RA   Prescott K., Hines R., Moss S.J., Fritschy J.M., Munnich A., Amiel J.,
RA   Brown S.A., Tyagarajan S.K., Colleaux L.;
RT   "Mutations in NONO lead to syndromic intellectual disability and
RT   inhibitory synaptic defects.";
RL   Nat. Neurosci. 18:1731-1736(2015).
CC   -!- FUNCTION: DNA- and RNA binding protein, involved in several
CC       nuclear processes. Binds the conventional octamer sequence in
CC       double-stranded DNA. Also binds single-stranded DNA and RNA at a
CC       site independent of the duplex site. Involved in pre-mRNA
CC       splicing, probably as a heterodimer with SFPQ. Interacts with U5
CC       snRNA, probably by binding to a purine-rich sequence located on
CC       the 3' side of U5 snRNA stem 1b. Together with PSPC1, required for
CC       the formation of nuclear paraspeckles. The SFPQ-NONO heteromer
CC       associated with MATR3 may play a role in nuclear retention of
CC       defective RNAs. The SFPQ-NONO heteromer may be involved in DNA
CC       unwinding by modulating the function of topoisomerase I/TOP1. The
CC       SFPQ-NONO heteromer may be involved in DNA non-homologous end
CC       joining (NHEJ) required for double-strand break repair and V(D)J
CC       recombination and may stabilize paired DNA ends. In vitro, the
CC       complex strongly stimulates DNA end joining, binds directly to the
CC       DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku)
CC       dimer to establish a functional preligation complex. NONO is
CC       involved in transcriptional regulation. The SFPQ-NONO-NR5A1
CC       complex binds to the CYP17 promoter and regulates basal and cAMP-
CC       dependent transcriptional activity. NONO binds to an enhancer
CC       element in long terminal repeats of endogenous intracisternal A
CC       particles (IAPs) and activates transcription. Regulates the
CC       circadian clock by repressing the transcriptional activator
CC       activity of the CLOCK-ARNTL/BMAL1 heterodimer. Important for the
CC       functional organization of GABAergic synapses. Plays a specific
CC       and important role in the regulation of synaptic RNAs and
CC       GPHN/gephyrin scaffold structure, through the regulation of GABRA2
CC       transcript. Plays a role in the regulation of DNA virus-mediated
CC       innate immune response by assembling into the HDP-RNP complex, a
CC       complex that serves as a platform for IRF3 phosphorylation and
CC       subsequent innate immune response activation through the cGAS-
CC       STING pathway (PubMed:28712728). {ECO:0000250|UniProtKB:Q99K48,
CC       ECO:0000269|PubMed:10858305, ECO:0000269|PubMed:11525732,
CC       ECO:0000269|PubMed:11897684, ECO:0000269|PubMed:15590677,
CC       ECO:0000269|PubMed:22416126, ECO:0000269|PubMed:26571461,
CC       ECO:0000269|PubMed:28712728}.
CC   -!- SUBUNIT: Interacts with CPNE4 (via VWFA domain) (By similarity).
CC       Monomer and component of the SFPQ-NONO complex, which is probably
CC       a heterotetramer of two 52 kDa (NONO) and two 100 kDa (SFPQ)
CC       subunits. NONO is a component of spliceosome and U5.4/6 snRNP
CC       complexes. Forms heterodimers with PSPC1; this involves formation
CC       of a coiled coil domain by helices from both proteins. Interacts
CC       with PSPC1 and SNRPA/U1A. Part of complex consisting of SFPQ, NONO
CC       and MATR3. Part of a complex consisting of SFPQ, NONO and NR5A1.
CC       Part of a complex consisting of SFPQ, NONO and TOP1. Interacts
CC       with SPI1. Interacts with RNF43. Interacts with PER1 and PER2.
CC       Part of the HDP-RNP complex composed of at least HEXIM1, PRKDC,
CC       XRCC5, XRCC6, paraspeckle proteins (SFPQ, NONO, PSPC1, RBM14, and
CC       MATR3) and NEAT1 RNA (PubMed:28712728).
CC       {ECO:0000250|UniProtKB:Q99K48, ECO:0000269|PubMed:11525732,
CC       ECO:0000269|PubMed:11897684, ECO:0000269|PubMed:12403470,
CC       ECO:0000269|PubMed:15590677, ECO:0000269|PubMed:16148043,
CC       ECO:0000269|PubMed:18655028, ECO:0000269|PubMed:22416126,
CC       ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:8439294,
CC       ECO:0000269|PubMed:9756848}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-350527, EBI-350527;
CC       Q9H3H3:C11orf68; NbExp=3; IntAct=EBI-350527, EBI-721765;
CC       Q53ET0:CRTC2; NbExp=2; IntAct=EBI-350527, EBI-1181987;
CC       P26196:DDX6; NbExp=3; IntAct=EBI-10203843, EBI-351257;
CC       Q8AZK7:EBNA-LP (xeno); NbExp=2; IntAct=EBI-350527, EBI-1185167;
CC       P61968:LMO4; NbExp=3; IntAct=EBI-10203843, EBI-2798728;
CC       Q13526:PIN1; NbExp=4; IntAct=EBI-350527, EBI-714158;
CC       P54646:PRKAA2; NbExp=3; IntAct=EBI-10203843, EBI-1383852;
CC       Q8WXF1:PSPC1; NbExp=11; IntAct=EBI-350527, EBI-1392258;
CC       Q8WXF1-1:PSPC1; NbExp=7; IntAct=EBI-350527, EBI-15974663;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus. Nucleus
CC       speckle. Note=Detected in punctate subnuclear structures often
CC       located adjacent to splicing speckles, called paraspeckles.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15233-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15233-2; Sequence=VSP_045470;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Heart, brain, placenta, lung, liver, skeletal
CC       muscle, kidney and pancreas. Also found in a number of breast
CC       tumor cell lines. {ECO:0000269|PubMed:9341872}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- DISEASE: Note=A chromosomal aberration involving NONO may be a
CC       cause of papillary renal cell carcinoma (PRCC). Translocation
CC       t(X;X)(p11.2;q13.1) with TFE3. {ECO:0000269|PubMed:9393982}.
CC   -!- DISEASE: Mental retardation, X-linked, syndromic, 34 (MRXS34)
CC       [MIM:300967]: A mental retardation syndrome characterized by
CC       intellectual deficit, delayed psychomotor development, poor
CC       speech, and dysmorphic features. Mental retardation is defined by
CC       significantly below average general intellectual functioning
CC       associated with impairments in adaptive behavior and manifested
CC       during the developmental period. {ECO:0000269|PubMed:26571461}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NONOID168.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L14599; AAC37578.1; -; mRNA.
DR   EMBL; U89867; AAC51852.1; -; mRNA.
DR   EMBL; Y11289; CAA72157.1; -; Genomic_DNA.
DR   EMBL; Y11290; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11291; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11292; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11293; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11294; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11295; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11296; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11297; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; Y11298; CAA72157.1; JOINED; Genomic_DNA.
DR   EMBL; U02493; AAA03427.1; -; mRNA.
DR   EMBL; AK297144; BAH12508.1; -; mRNA.
DR   EMBL; CR456761; CAG33042.1; -; mRNA.
DR   EMBL; AL590762; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471132; EAX05298.1; -; Genomic_DNA.
DR   EMBL; CH471132; EAX05299.1; -; Genomic_DNA.
DR   EMBL; CH471132; EAX05300.1; -; Genomic_DNA.
DR   EMBL; BC002364; AAH02364.1; -; mRNA.
DR   EMBL; BC003129; AAH03129.1; -; mRNA.
DR   EMBL; BC012141; AAH12141.1; -; mRNA.
DR   EMBL; BC028299; AAH28299.1; -; mRNA.
DR   EMBL; BC069616; AAH69616.1; -; mRNA.
DR   EMBL; BC069639; AAH69639.1; -; mRNA.
DR   CCDS; CCDS14410.1; -. [Q15233-1]
DR   CCDS; CCDS55445.1; -. [Q15233-2]
DR   PIR; G01211; G01211.
DR   PIR; S29769; S29769.
DR   PIR; S41768; S41768.
DR   RefSeq; NP_001138880.1; NM_001145408.1. [Q15233-1]
DR   RefSeq; NP_001138881.1; NM_001145409.1. [Q15233-1]
DR   RefSeq; NP_001138882.1; NM_001145410.1. [Q15233-2]
DR   RefSeq; NP_031389.3; NM_007363.4. [Q15233-1]
DR   UniGene; Hs.533282; -.
DR   UniGene; Hs.700344; -.
DR   PDB; 3SDE; X-ray; 1.90 A; B=53-312.
DR   PDB; 5IFM; X-ray; 2.60 A; A/B/C/D/E/F/G/H/I/J/K/L=53-312.
DR   PDBsum; 3SDE; -.
DR   PDBsum; 5IFM; -.
DR   ProteinModelPortal; Q15233; -.
DR   SMR; Q15233; -.
DR   BioGrid; 110904; 174.
DR   CORUM; Q15233; -.
DR   DIP; DIP-29951N; -.
DR   IntAct; Q15233; 56.
DR   MINT; Q15233; -.
DR   STRING; 9606.ENSP00000276079; -.
DR   iPTMnet; Q15233; -.
DR   PhosphoSitePlus; Q15233; -.
DR   SwissPalm; Q15233; -.
DR   BioMuta; NONO; -.
DR   DMDM; 67469924; -.
DR   REPRODUCTION-2DPAGE; IPI00304596; -.
DR   SWISS-2DPAGE; Q15233; -.
DR   EPD; Q15233; -.
DR   MaxQB; Q15233; -.
DR   PaxDb; Q15233; -.
DR   PeptideAtlas; Q15233; -.
DR   PRIDE; Q15233; -.
DR   TopDownProteomics; Q15233-1; -. [Q15233-1]
DR   DNASU; 4841; -.
DR   Ensembl; ENST00000276079; ENSP00000276079; ENSG00000147140. [Q15233-1]
DR   Ensembl; ENST00000373841; ENSP00000362947; ENSG00000147140. [Q15233-1]
DR   Ensembl; ENST00000373856; ENSP00000362963; ENSG00000147140. [Q15233-1]
DR   Ensembl; ENST00000535149; ENSP00000441364; ENSG00000147140. [Q15233-2]
DR   GeneID; 4841; -.
DR   KEGG; hsa:4841; -.
DR   UCSC; uc004dzn.5; human. [Q15233-1]
DR   CTD; 4841; -.
DR   DisGeNET; 4841; -.
DR   EuPathDB; HostDB:ENSG00000147140.15; -.
DR   GeneCards; NONO; -.
DR   HGNC; HGNC:7871; NONO.
DR   HPA; CAB022069; -.
DR   HPA; HPA054094; -.
DR   HPA; HPA054559; -.
DR   MalaCards; NONO; -.
DR   MIM; 300084; gene.
DR   MIM; 300967; phenotype.
DR   neXtProt; NX_Q15233; -.
DR   OpenTargets; ENSG00000147140; -.
DR   Orphanet; 319308; Translocation renal cell carcinoma.
DR   PharmGKB; PA31680; -.
DR   eggNOG; KOG0115; Eukaryota.
DR   eggNOG; ENOG410XQA0; LUCA.
DR   GeneTree; ENSGT00390000005004; -.
DR   HOGENOM; HOG000231095; -.
DR   HOVERGEN; HBG009801; -.
DR   InParanoid; Q15233; -.
DR   KO; K13214; -.
DR   OMA; NQQYHKE; -.
DR   OrthoDB; EOG091G09T7; -.
DR   PhylomeDB; Q15233; -.
DR   TreeFam; TF315795; -.
DR   SIGNOR; Q15233; -.
DR   ChiTaRS; NONO; human.
DR   GeneWiki; NONO; -.
DR   GenomeRNAi; 4841; -.
DR   PMAP-CutDB; Q15233; -.
DR   PRO; PR:Q15233; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000147140; -.
DR   CleanEx; HS_NONO; -.
DR   ExpressionAtlas; Q15233; baseline and differential.
DR   Genevisible; Q15233; HS.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; IDA:BHF-UCL.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0042382; C:paraspeckles; IDA:MGI.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; ISS:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; ISS:BHF-UCL.
DR   GO; GO:0001047; F:core promoter binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0002218; P:activation of innate immune response; IDA:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006397; P:mRNA processing; TAS:ProtInc.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:1903377; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd12588; RRM1_p54nrb; 1.
DR   CDD; cd12591; RRM2_p54nrb; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR012975; NOPS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034552; p54nrb_RRM1.
DR   InterPro; IPR034558; p54nrb_RRM2.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF08075; NOPS; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Biological rhythms; Chromosomal rearrangement; Coiled coil;
KW   Complete proteome; Direct protein sequencing; DNA damage;
KW   DNA recombination; DNA repair; DNA-binding; Immunity; Innate immunity;
KW   Isopeptide bond; Mental retardation; Methylation; mRNA processing;
KW   mRNA splicing; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; RNA-binding; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN         1    471       Non-POU domain-containing octamer-binding
FT                                protein.
FT                                /FTId=PRO_0000081683.
FT   DOMAIN       74    141       RRM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      148    229       RRM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   REGION       54    373       DBHS.
FT   COILED      268    372       {ECO:0000255}.
FT   COMPBIAS     30     35       Poly-Gln.
FT   COMPBIAS     36     42       Poly-Pro.
FT   COMPBIAS    348    351       Poly-Arg.
FT   SITE        377    378       Breakpoint for translocation to form
FT                                NONO-TFE3.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000250|UniProtKB:Q99K48}.
FT   MOD_RES       5      5       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES       6      6       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      11     11       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     147    147       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     198    198       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     262    262       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     295    295       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99K48}.
FT   MOD_RES     371    371       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K48}.
FT   MOD_RES     428    428       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     440    440       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     450    450       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:17693683,
FT                                ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     456    456       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   CROSSLNK      5      5       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     60     60       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     96     96       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     99     99       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    126    126       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    190    190       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    198    198       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    243    243       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    249    249       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    371    371       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    467    467       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1     89       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_045470.
FT   MUTAGEN     267    267       Y->A: Abolishes interaction with PSPC1
FT                                and localization in nuclear paraspeckles;
FT                                when associated with A-271.
FT                                {ECO:0000269|PubMed:22416126}.
FT   MUTAGEN     271    271       W->A: Abolishes interaction with PSPC1
FT                                and localization in nuclear paraspeckles;
FT                                when associated with A-267.
FT                                {ECO:0000269|PubMed:22416126}.
FT   CONFLICT    151    151       T -> H (in Ref. 1; AAC37578).
FT                                {ECO:0000305}.
FT   CONFLICT    358    359       QQ -> HE (in Ref. 3; CAA72157 and 4;
FT                                AAA03427). {ECO:0000305}.
FT   CONFLICT    366    367       QQ -> HE (in Ref. 3; CAA72157 and 4;
FT                                AAA03427). {ECO:0000305}.
FT   CONFLICT    387    387       M -> I (in Ref. 5; BAH12508).
FT                                {ECO:0000305}.
FT   STRAND       55     60       {ECO:0000244|PDB:5IFM}.
FT   HELIX        72     74       {ECO:0000244|PDB:3SDE}.
FT   STRAND       75     80       {ECO:0000244|PDB:3SDE}.
FT   HELIX        87     94       {ECO:0000244|PDB:3SDE}.
FT   HELIX        95     97       {ECO:0000244|PDB:3SDE}.
FT   STRAND      100    106       {ECO:0000244|PDB:3SDE}.
FT   TURN        107    110       {ECO:0000244|PDB:3SDE}.
FT   STRAND      111    118       {ECO:0000244|PDB:3SDE}.
FT   HELIX       119    129       {ECO:0000244|PDB:3SDE}.
FT   STRAND      140    143       {ECO:0000244|PDB:3SDE}.
FT   STRAND      149    154       {ECO:0000244|PDB:3SDE}.
FT   HELIX       161    168       {ECO:0000244|PDB:3SDE}.
FT   TURN        169    171       {ECO:0000244|PDB:5IFM}.
FT   STRAND      174    182       {ECO:0000244|PDB:3SDE}.
FT   STRAND      187    197       {ECO:0000244|PDB:3SDE}.
FT   HELIX       198    210       {ECO:0000244|PDB:3SDE}.
FT   STRAND      213    218       {ECO:0000244|PDB:3SDE}.
FT   STRAND      223    226       {ECO:0000244|PDB:3SDE}.
FT   STRAND      230    234       {ECO:0000244|PDB:5IFM}.
FT   HELIX       238    240       {ECO:0000244|PDB:3SDE}.
FT   HELIX       245    250       {ECO:0000244|PDB:3SDE}.
FT   STRAND      255    257       {ECO:0000244|PDB:3SDE}.
FT   HELIX       263    303       {ECO:0000244|PDB:3SDE}.
FT   HELIX       308    311       {ECO:0000244|PDB:5IFM}.
SQ   SEQUENCE   471 AA;  54232 MW;  26BBD3828F5B9E49 CRC64;
     MQSNKTFNLE KQNHTPRKHH QHHHQQQHHQ QQQQQPPPPP IPANGQQASS QNEGLTIDLK
     NFRKPGEKTF TQRSRLFVGN LPPDITEEEM RKLFEKYGKA GEVFIHKDKG FGFIRLETRT
     LAEIAKVELD NMPLRGKQLR VRFACHSASL TVRNLPQYVS NELLEEAFSV FGQVERAVVI
     VDDRGRPSGK GIVEFSGKPA ARKALDRCSE GSFLLTTFPR PVTVEPMDQL DDEEGLPEKL
     VIKNQQFHKE REQPPRFAQP GSFEYEYAMR WKALIEMEKQ QQDQVDRNIK EAREKLEMEM
     EAARHEHQVM LMRQDLMRRQ EELRRMEELH NQEVQKRKQL ELRQEEERRR REEEMRRQQE
     EMMRRQQEGF KGTFPDAREQ EIRMGQMAMG GAMGINNRGA MPPAPVPAGT PAPPGPATMM
     PDGTLGLTPP TTERFGQAAT MEGIGAIGGT PPAFNRAAPG AEFAPNKRRR Y
//
ID   NSD1_HUMAN              Reviewed;        2696 AA.
AC   Q96L73; Q96PD8; Q96RN7;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   28-FEB-2018, entry version 171.
DE   RecName: Full=Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific;
DE            EC=2.1.1.43;
DE   AltName: Full=Androgen receptor coactivator 267 kDa protein;
DE   AltName: Full=Androgen receptor-associated protein of 267 kDa;
DE   AltName: Full=H3-K36-HMTase;
DE   AltName: Full=H4-K20-HMTase;
DE   AltName: Full=Lysine N-methyltransferase 3B;
DE   AltName: Full=Nuclear receptor-binding SET domain-containing protein 1;
DE            Short=NR-binding SET domain-containing protein;
GN   Name=NSD1; Synonyms=ARA267, KMT3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND INTERACTION WITH
RP   AR.
RX   PubMed=11509567; DOI=10.1074/jbc.M104765200;
RA   Wang X., Yeh S., Wu G., Hsu C.-L., Wang L., Chang T., Yang Y., Guo Y.,
RA   Chang C.;
RT   "Identification and characterization of a novel androgen receptor
RT   coregulator ARA267-alpha in prostate cancer cells.";
RL   J. Biol. Chem. 276:40417-40423(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11733144; DOI=10.1016/S0378-1119(01)00750-8;
RA   Kurotaki N., Harada N., Yoshiura K., Sugano S., Niikawa N.,
RA   Matsumoto N.;
RT   "Molecular characterization of NSD1, a human homologue of the mouse
RT   Nsd1 gene.";
RL   Gene 279:197-204(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND CHROMOSOMAL TRANSLOCATION
RP   WITH NUP98.
RX   PubMed=11493482; DOI=10.1182/blood.V98.4.1264;
RA   Jaju R.J., Fidler C., Haas O.A., Strickson A.J., Watkins F., Clark K.,
RA   Cross N.C., Cheng J.F., Aplan P.D., Kearney L., Boultwood J.,
RA   Wainscoat J.S.;
RT   "A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de
RT   novo childhood acute myeloid leukemia.";
RL   Blood 98:1264-1267(2001).
RN   [4]
RP   INVOLVEMENT IN SOTOS1.
RX   PubMed=11896389; DOI=10.1038/ng863;
RA   Kurotaki N., Imaizumi K., Harada N., Masuno M., Kondoh T., Nagai T.,
RA   Ohashi H., Naritomi K., Tsukahara M., Makita Y., Sugimoto T.,
RA   Sonoda T., Hasegawa T., Chinen Y., Tomita Ha H.A., Kinoshita A.,
RA   Mizuguchi T., Yoshiura Ki K., Ohta T., Kishino T., Fukushima Y.,
RA   Niikawa N., Matsumoto N.;
RT   "Haploinsufficiency of NSD1 causes Sotos syndrome.";
RL   Nat. Genet. 30:365-366(2002).
RN   [5]
RP   INVOLVEMENT IN SOTOS1 AND BWS.
RX   PubMed=14997421; DOI=10.1086/383093;
RA   Baujat G., Rio M., Rossignol S., Sanlaville D., Lyonnet S.,
RA   Le Merrer M., Munnich A., Gicquel C., Cormier-Daire V., Colleaux L.;
RT   "Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15
RT   anomalies in Sotos syndrome.";
RL   Am. J. Hum. Genet. 74:715-720(2004).
RN   [6]
RP   INVOLVEMENT IN MYELODYSPLASTIC SYNDROME.
RX   PubMed=15382262; DOI=10.1002/gcc.20103;
RA   La Starza R., Gorello P., Rosati R., Riezzo A., Veronese A.,
RA   Ferrazzi E., Martelli M.F., Negrini M., Mecucci C.;
RT   "Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in
RT   adult refractory anemia with an excess of blasts.";
RL   Genes Chromosomes Cancer 41:395-399(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-766, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate
RT   cancer cells: identification of phosphoproteins in the LNCaP cell
RT   line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2471, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-2462, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483 AND SER-486, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483; SER-486; SER-2369
RP   AND SER-2471, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-2616, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-906 AND LYS-1339, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1852-2082 IN COMPLEX WITH
RP   S-ADENOSYL-L-METHIONINE AND ZINC IONS, FUNCTION, CATALYTIC ACTIVITY,
RP   MUTAGENESIS OF ARG-1914 AND ARG-1952, AND CHARACTERIZATION OF SOTOS1
RP   VARIANTS GLN-1984; GLN-2005 AND GLN-2017.
RX   PubMed=21196496; DOI=10.1074/jbc.M110.204115;
RA   Qiao Q., Li Y., Chen Z., Wang M., Reinberg D., Xu R.M.;
RT   "The structure of NSD1 reveals an autoregulatory mechanism underlying
RT   histone H3K36 methylation.";
RL   J. Biol. Chem. 286:8361-8368(2011).
RN   [17]
RP   VARIANTS SOTOS1 LEU-1616; PRO-1637; TRP-1674; VAL-1792; ARG-1925;
RP   GLN-2005; GLN-2017; GLN-2143 AND SER-2183, AND VARIANTS LEU-614;
RP   THR-691; PRO-726; PRO-1036; ILE-1091; ILE-2250 AND THR-2261.
RX   PubMed=12464997; DOI=10.1086/345647;
RA   Douglas J., Hanks S., Temple I.K., Davies S., Murray A., Upadhyaya M.,
RA   Tomkins S., Hughes H.E., Cole T.R.P., Rahman N.;
RT   "NSD1 mutations are the major cause of Sotos syndrome and occur in
RT   some cases of Weaver syndrome but are rare in other overgrowth
RT   phenotypes.";
RL   Am. J. Hum. Genet. 72:132-143(2003).
RN   [18]
RP   VARIANTS SOTOS1 ASN-1687; ASP-1955; GLN-1984; CYS-1997 AND TRP-2017.
RX   PubMed=12807965; DOI=10.1136/jmg.40.6.436;
RA   Rio M., Clech L., Amiel J., Faivre L., Lyonnet S., Le Merrer M.,
RA   Odent S., Lacombe D., Edery P., Brauner R., Raoul O., Gosset P.,
RA   Prieur M., Vekemans M., Munnich A., Colleaux L., Cormier-Daire V.;
RT   "Spectrum of NSD1 mutations in Sotos and Weaver syndromes.";
RL   J. Med. Genet. 40:436-440(2003).
RN   [19]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-726.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J.,
RA   Heath S., Shannon W.D., Nagarajan R., Walter M.J., Link D.C.,
RA   Graubert T.A., DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
CC   -!- FUNCTION: Histone methyltransferase. Preferentially methylates
CC       'Lys-36' of histone H3 and 'Lys-20' of histone H4 (in vitro).
CC       Transcriptional intermediary factor capable of both negatively or
CC       positively influencing transcription, depending on the cellular
CC       context. {ECO:0000269|PubMed:21196496}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + L-lysine-[histone] =
CC       S-adenosyl-L-homocysteine + N(6)-methyl-L-lysine-[histone].
CC       {ECO:0000269|PubMed:21196496}.
CC   -!- SUBUNIT: Interacts with the ligand-binding domains of RARA and
CC       THRA in the absence of ligand; in the presence of ligand the
CC       interaction is severely disrupted but some binding still occurs.
CC       Interacts with the ligand-binding domains of RXRA and ESRRA only
CC       in the presence of ligand. Interacts with ZNF496 (By similarity).
CC       Interacts with AR DNA- and ligand-binding domains. {ECO:0000250,
CC       ECO:0000269|PubMed:11509567, ECO:0000269|PubMed:21196496}.
CC   -!- INTERACTION:
CC       Q04206:RELA; NbExp=2; IntAct=EBI-2862434, EBI-73886;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=ARA267-beta;
CC         IsoId=Q96L73-1; Sequence=Displayed;
CC       Name=2; Synonyms=ARA267-alpha;
CC         IsoId=Q96L73-2; Sequence=VSP_007682, VSP_007683;
CC       Name=3;
CC         IsoId=Q96L73-3; Sequence=VSP_007684;
CC   -!- TISSUE SPECIFICITY: Expressed in the fetal/adult brain, kidney,
CC       skeletal muscle, spleen, and the thymus, and faintly in the lung.
CC   -!- DISEASE: Sotos syndrome 1 (SOTOS1) [MIM:117550]: A childhood
CC       overgrowth syndrome characterized by pre- and postnatal
CC       overgrowth, developmental delay, mental retardation, advanced bone
CC       age, and abnormal craniofacial morphology including
CC       macrodolichocephaly with frontal bossing, frontoparietal
CC       sparseness of hair, apparent hypertelorism, downslanting palpebral
CC       fissures, and facial flushing. Common oral findings include:
CC       premature eruption of teeth; high, arched palate; pointed chin
CC       and, more rarely, prognathism. {ECO:0000269|PubMed:11896389,
CC       ECO:0000269|PubMed:12464997, ECO:0000269|PubMed:12807965,
CC       ECO:0000269|PubMed:14997421}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Beckwith-Wiedemann syndrome (BWS) [MIM:130650]: A
CC       disorder characterized by anterior abdominal wall defects
CC       including exomphalos (omphalocele), pre- and postnatal overgrowth,
CC       and macroglossia. Additional less frequent complications include
CC       specific developmental defects and a predisposition to embryonal
CC       tumors. {ECO:0000269|PubMed:14997421}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving NSD1 is found in
CC       childhood acute myeloid leukemia. Translocation t(5;11)(q35;p15.5)
CC       with NUP98.
CC   -!- DISEASE: Note=A chromosomal aberration involving NSD1 is found in
CC       an adult form of myelodysplastic syndrome (MDS). Insertion of
CC       NUP98 into NSD1 generates a NUP98-NSD1 fusion product.
CC       {ECO:0000269|PubMed:15382262}.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding
CC       methyltransferase superfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00190}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NSD1ID356.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF380302; AAL27991.1; -; mRNA.
DR   EMBL; AY049721; AAL06645.1; -; mRNA.
DR   EMBL; AF395588; AAL40694.1; -; mRNA.
DR   EMBL; AF322907; AAK92049.1; -; mRNA.
DR   CCDS; CCDS4412.1; -. [Q96L73-1]
DR   CCDS; CCDS4413.1; -. [Q96L73-2]
DR   RefSeq; NP_071900.2; NM_022455.4. [Q96L73-1]
DR   RefSeq; NP_758859.1; NM_172349.2. [Q96L73-2]
DR   UniGene; Hs.106861; -.
DR   PDB; 3OOI; X-ray; 1.75 A; A=1852-2082.
DR   PDBsum; 3OOI; -.
DR   ProteinModelPortal; Q96L73; -.
DR   SMR; Q96L73; -.
DR   BioGrid; 122135; 38.
DR   DIP; DIP-58517N; -.
DR   IntAct; Q96L73; 10.
DR   STRING; 9606.ENSP00000395929; -.
DR   BindingDB; Q96L73; -.
DR   ChEMBL; CHEMBL3588738; -.
DR   iPTMnet; Q96L73; -.
DR   PhosphoSitePlus; Q96L73; -.
DR   BioMuta; NSD1; -.
DR   DMDM; 32469769; -.
DR   EPD; Q96L73; -.
DR   MaxQB; Q96L73; -.
DR   PaxDb; Q96L73; -.
DR   PeptideAtlas; Q96L73; -.
DR   PRIDE; Q96L73; -.
DR   Ensembl; ENST00000347982; ENSP00000343209; ENSG00000165671. [Q96L73-2]
DR   Ensembl; ENST00000354179; ENSP00000346111; ENSG00000165671. [Q96L73-2]
DR   Ensembl; ENST00000439151; ENSP00000395929; ENSG00000165671. [Q96L73-1]
DR   GeneID; 64324; -.
DR   KEGG; hsa:64324; -.
DR   UCSC; uc003mfr.5; human. [Q96L73-1]
DR   CTD; 64324; -.
DR   DisGeNET; 64324; -.
DR   EuPathDB; HostDB:ENSG00000165671.18; -.
DR   GeneCards; NSD1; -.
DR   GeneReviews; NSD1; -.
DR   HGNC; HGNC:14234; NSD1.
DR   HPA; HPA048431; -.
DR   HPA; HPA070333; -.
DR   MalaCards; NSD1; -.
DR   MIM; 117550; phenotype.
DR   MIM; 130650; phenotype.
DR   MIM; 606681; gene.
DR   neXtProt; NX_Q96L73; -.
DR   OpenTargets; ENSG00000165671; -.
DR   Orphanet; 228415; 5q35 microduplication syndrome.
DR   Orphanet; 238613; Beckwith-Wiedemann syndrome due to NSD1 mutation.
DR   Orphanet; 821; Sotos syndrome.
DR   Orphanet; 3447; Weaver syndrome.
DR   PharmGKB; PA31790; -.
DR   eggNOG; KOG1081; Eukaryota.
DR   eggNOG; COG2940; LUCA.
DR   GeneTree; ENSGT00780000121845; -.
DR   HOGENOM; HOG000113857; -.
DR   HOVERGEN; HBG007518; -.
DR   InParanoid; Q96L73; -.
DR   KO; K15588; -.
DR   OMA; VQKYPPT; -.
DR   OrthoDB; EOG091G00XD; -.
DR   PhylomeDB; Q96L73; -.
DR   TreeFam; TF329088; -.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   SIGNOR; Q96L73; -.
DR   ChiTaRS; NSD1; human.
DR   GenomeRNAi; 64324; -.
DR   PRO; PR:Q96L73; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000165671; -.
DR   CleanEx; HS_NSD1; -.
DR   ExpressionAtlas; Q96L73; baseline and differential.
DR   Genevisible; Q96L73; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0050681; F:androgen receptor binding; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0030331; F:estrogen receptor binding; ISS:UniProtKB.
DR   GO; GO:0046975; F:histone methyltransferase activity (H3-K36 specific); IDA:UniProtKB.
DR   GO; GO:0042799; F:histone methyltransferase activity (H4-K20 specific); ISS:UniProtKB.
DR   GO; GO:0018024; F:histone-lysine N-methyltransferase activity; TAS:Reactome.
DR   GO; GO:0042974; F:retinoic acid receptor binding; ISS:UniProtKB.
DR   GO; GO:0046965; F:retinoid X receptor binding; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0046966; F:thyroid hormone receptor binding; ISS:UniProtKB.
DR   GO; GO:0003712; F:transcription cofactor activity; IDA:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0016571; P:histone methylation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0000414; P:regulation of histone H3-K36 methylation; IMP:MGI.
DR   GO; GO:0033135; P:regulation of peptidyl-serine phosphorylation; IMP:MGI.
DR   GO; GO:1903025; P:regulation of RNA polymerase II regulatory region sequence-specific DNA binding; IMP:MGI.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.40.10; -; 4.
DR   InterPro; IPR006560; AWS_dom.
DR   InterPro; IPR003616; Post-SET_dom.
DR   InterPro; IPR000313; PWWP_dom.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF00855; PWWP; 2.
DR   Pfam; PF00856; SET; 1.
DR   SMART; SM00570; AWS; 1.
DR   SMART; SM00249; PHD; 5.
DR   SMART; SM00508; PostSET; 1.
DR   SMART; SM00293; PWWP; 2.
DR   SMART; SM00317; SET; 1.
DR   SUPFAM; SSF57903; SSF57903; 3.
DR   PROSITE; PS51215; AWS; 1.
DR   PROSITE; PS50868; POST_SET; 1.
DR   PROSITE; PS50812; PWWP; 2.
DR   PROSITE; PS50280; SET; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 2.
DR   PROSITE; PS50016; ZF_PHD_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Chromatin regulator;
KW   Chromosomal rearrangement; Chromosome; Complete proteome;
KW   Disease mutation; Isopeptide bond; Metal-binding; Methyltransferase;
KW   Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Repeat; Repressor; S-adenosyl-L-methionine;
KW   Transcription; Transcription regulation; Transferase; Ubl conjugation;
KW   Zinc; Zinc-finger.
FT   CHAIN         1   2696       Histone-lysine N-methyltransferase, H3
FT                                lysine-36 and H4 lysine-20 specific.
FT                                /FTId=PRO_0000186070.
FT   DOMAIN      323    388       PWWP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00162}.
FT   DOMAIN     1756   1818       PWWP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00162}.
FT   DOMAIN     1890   1940       AWS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00562}.
FT   DOMAIN     1942   2059       SET. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00190}.
FT   DOMAIN     2066   2082       Post-SET. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00155}.
FT   ZN_FING    1543   1589       PHD-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00146}.
FT   ZN_FING    1590   1646       PHD-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00146}.
FT   ZN_FING    1707   1751       PHD-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00146}.
FT   ZN_FING    2118   2165       PHD-type 4; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00146}.
FT   REGION     1952   1954       S-adenosyl-L-methionine binding.
FT   REGION     1994   1997       S-adenosyl-L-methionine binding.
FT   REGION     2020   2021       S-adenosyl-L-methionine binding.
FT   REGION     2060   2066       Inhibits enzyme activity in the absence
FT                                of bound histone.
FT   COMPBIAS   2207   2421       Pro-rich.
FT   BINDING    2065   2065       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00190,
FT                                ECO:0000269|PubMed:21196496}.
FT   BINDING    2071   2071       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00190,
FT                                ECO:0000269|PubMed:21196496}.
FT   MOD_RES     117    117       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88491}.
FT   MOD_RES     483    483       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     486    486       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     766    766       Phosphoserine.
FT                                {ECO:0000244|PubMed:17487921}.
FT   MOD_RES    1510   1510       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88491}.
FT   MOD_RES    2369   2369       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2462   2462       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES    2471   2471       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    906    906       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1339   1339       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   2616   2616       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   VAR_SEQ       1    269       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11509567}.
FT                                /FTId=VSP_007682.
FT   VAR_SEQ     270    279       QLNSINLSFQ -> MPLKTRTALS (in isoform 2).
FT                                {ECO:0000303|PubMed:11509567}.
FT                                /FTId=VSP_007683.
FT   VAR_SEQ     310    412       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11493482}.
FT                                /FTId=VSP_007684.
FT   VARIANT     614    614       V -> L (in dbSNP:rs3733875).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015775.
FT   VARIANT     691    691       A -> T (in dbSNP:rs28932177).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015776.
FT   VARIANT     726    726       S -> P (in dbSNP:rs28932178).
FT                                {ECO:0000269|PubMed:12464997,
FT                                ECO:0000269|PubMed:18987736}.
FT                                /FTId=VAR_015777.
FT   VARIANT    1036   1036       A -> P (in dbSNP:rs28932179).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015778.
FT   VARIANT    1091   1091       L -> I (in dbSNP:rs35597015).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015779.
FT   VARIANT    1616   1616       H -> L (in SOTOS1).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015780.
FT   VARIANT    1637   1637       L -> P (in SOTOS1).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015781.
FT   VARIANT    1674   1674       C -> W (in SOTOS1).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015782.
FT   VARIANT    1687   1687       I -> N (in SOTOS1).
FT                                {ECO:0000269|PubMed:12807965}.
FT                                /FTId=VAR_015783.
FT   VARIANT    1792   1792       G -> V (in SOTOS1).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015784.
FT   VARIANT    1925   1925       C -> R (in SOTOS1).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015785.
FT   VARIANT    1955   1955       G -> D (in SOTOS1).
FT                                {ECO:0000269|PubMed:12807965}.
FT                                /FTId=VAR_015786.
FT   VARIANT    1984   1984       R -> Q (in SOTOS1; loss of enzyme
FT                                activity; dbSNP:rs587784169).
FT                                {ECO:0000269|PubMed:12807965,
FT                                ECO:0000269|PubMed:21196496}.
FT                                /FTId=VAR_015787.
FT   VARIANT    1997   1997       Y -> C (in SOTOS1; dbSNP:rs797045825).
FT                                {ECO:0000269|PubMed:12807965}.
FT                                /FTId=VAR_015788.
FT   VARIANT    2005   2005       R -> Q (in SOTOS1; strongly reduced
FT                                enzyme activity; dbSNP:rs587784174).
FT                                {ECO:0000269|PubMed:12464997,
FT                                ECO:0000269|PubMed:21196496}.
FT                                /FTId=VAR_015789.
FT   VARIANT    2017   2017       R -> Q (in SOTOS1; loss of enzyme
FT                                activity; dbSNP:rs587784177).
FT                                {ECO:0000269|PubMed:12464997,
FT                                ECO:0000269|PubMed:21196496}.
FT                                /FTId=VAR_015790.
FT   VARIANT    2017   2017       R -> W (in SOTOS1; dbSNP:rs587784176).
FT                                {ECO:0000269|PubMed:12807965}.
FT                                /FTId=VAR_015791.
FT   VARIANT    2143   2143       H -> Q (in SOTOS1; dbSNP:rs121908068).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015792.
FT   VARIANT    2183   2183       C -> S (in SOTOS1; dbSNP:rs121908069).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015793.
FT   VARIANT    2250   2250       M -> I (in dbSNP:rs35848863).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015794.
FT   VARIANT    2261   2261       M -> T (in dbSNP:rs34165241).
FT                                {ECO:0000269|PubMed:12464997}.
FT                                /FTId=VAR_015795.
FT   MUTAGEN    1914   1914       R->C: Reduced enzyme activity.
FT                                {ECO:0000269|PubMed:21196496}.
FT   MUTAGEN    1952   1952       R->W: Nearly abolished enzyme activity.
FT                                {ECO:0000269|PubMed:21196496}.
FT   CONFLICT   1306   1306       H -> D (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   1397   1397       P -> Q (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   1478   1478       A -> V (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   1959   1960       KT -> QE (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   1963   1963       K -> R (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   1982   1982       R -> M (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   1986   1991       RYAQEH -> KHAHEN (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   1995   1995       N -> H (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2001   2001       L -> I (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2016   2016       A -> S (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2022   2022       C -> S (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2030   2030       Q -> L (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2033   2033       S -> T (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2045   2046       LS -> VC (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2049   2049       K -> P (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2061   2061       E -> D (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2066   2066       G -> E (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2071   2071       K -> R (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2075   2075       P -> S (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2304   2305       TK -> AQ (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2352   2352       R -> S (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2539   2539       L -> S (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2543   2543       P -> S (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2567   2591       PGPLSQSPGLVKQAKQMVGGQQLPA -> QGFFTKSPALVE
FT                                NKGKTKWVGRPTNYLH (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2597   2597       G -> W (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   CONFLICT   2608   2612       ASLPT -> PSSPN (in Ref. 3; AAK92049).
FT                                {ECO:0000305}.
FT   HELIX      1852   1863       {ECO:0000244|PDB:3OOI}.
FT   HELIX      1889   1891       {ECO:0000244|PDB:3OOI}.
FT   STRAND     1901   1903       {ECO:0000244|PDB:3OOI}.
FT   HELIX      1912   1915       {ECO:0000244|PDB:3OOI}.
FT   TURN       1922   1924       {ECO:0000244|PDB:3OOI}.
FT   HELIX      1928   1930       {ECO:0000244|PDB:3OOI}.
FT   HELIX      1935   1938       {ECO:0000244|PDB:3OOI}.
FT   STRAND     1944   1948       {ECO:0000244|PDB:3OOI}.
FT   STRAND     1950   1960       {ECO:0000244|PDB:3OOI}.
FT   STRAND     1967   1970       {ECO:0000244|PDB:3OOI}.
FT   STRAND     1973   1976       {ECO:0000244|PDB:3OOI}.
FT   HELIX      1978   1990       {ECO:0000244|PDB:3OOI}.
FT   STRAND     1998   2002       {ECO:0000244|PDB:3OOI}.
FT   STRAND     2005   2013       {ECO:0000244|PDB:3OOI}.
FT   HELIX      2015   2018       {ECO:0000244|PDB:3OOI}.
FT   STRAND     2026   2034       {ECO:0000244|PDB:3OOI}.
FT   STRAND     2037   2046       {ECO:0000244|PDB:3OOI}.
SQ   SEQUENCE   2696 AA;  296652 MW;  4E80E6DCD9A24C81 CRC64;
     MDQTCELPRR NCLLPFSNPV NLDAPEDKDS PFGNGQSNFS EPLNGCTMQL STVSGTSQNA
     YGQDSPSCYI PLRRLQDLAS MINVEYLNGS ADGSESFQDP EKSDSRAQTP IVCTSLSPGG
     PTALAMKQEP SCNNSPELQV KVTKTIKNGF LHFENFTCVD DADVDSEMDP EQPVTEDESI
     EEIFEETQTN ATCNYETKSE NGVKVAMGSE QDSTPESRHG AVKSPFLPLA PQTETQKNKQ
     RNEVDGSNEK AALLPAPFSL GDTNITIEEQ LNSINLSFQD DPDSSTSTLG NMLELPGTSS
     SSTSQELPFC QPKKKSTPLK YEVGDLIWAK FKRRPWWPCR ICSDPLINTH SKMKVSNRRP
     YRQYYVEAFG DPSERAWVAG KAIVMFEGRH QFEELPVLRR RGKQKEKGYR HKVPQKILSK
     WEASVGLAEQ YDVPKGSKNR KCIPGSIKLD SEEDMPFEDC TNDPESEHDL LLNGCLKSLA
     FDSEHSADEK EKPCAKSRAR KSSDNPKRTS VKKGHIQFEA HKDERRGKIP ENLGLNFISG
     DISDTQASNE LSRIANSLTG SNTAPGSFLF SSCGKNTAKK EFETSNGDSL LGLPEGALIS
     KCSREKNKPQ RSLVCGSKVK LCYIGAGDEE KRSDSISICT TSDDGSSDLD PIEHSSESDN
     SVLEIPDAFD RTENMLSMQK NEKIKYSRFA ATNTRVKAKQ KPLISNSHTD HLMGCTKSAE
     PGTETSQVNL SDLKASTLVH KPQSDFTNDA LSPKFNLSSS ISSENSLIKG GAANQALLHS
     KSKQPKFRSI KCKHKENPVM AEPPVINEEC SLKCCSSDTK GSPLASISKS GKVDGLKLLN
     NMHEKTRDSS DIETAVVKHV LSELKELSYR SLGEDVSDSG TSKPSKPLLF SSASSQNHIP
     IEPDYKFSTL LMMLKDMHDS KTKEQRLMTA QNLVSYRSPG RGDCSTNSPV GVSKVLVSGG
     STHNSEKKGD GTQNSANPSP SGGDSALSGE LSASLPGLLS DKRDLPASGK SRSDCVTRRN
     CGRSKPSSKL RDAFSAQMVK NTVNRKALKT ERKRKLNQLP SVTLDAVLQG DRERGGSLRG
     GAEDPSKEDP LQIMGHLTSE DGDHFSDVHF DSKVKQSDPG KISEKGLSFE NGKGPELDSV
     MNSENDELNG VNQVVPKKRW QRLNQRRTKP RKRMNRFKEK ENSECAFRVL LPSDPVQEGR
     DEFPEHRTPS ASILEEPLTE QNHADCLDSA GPRLNVCDKS SASIGDMEKE PGIPSLTPQA
     ELPEPAVRSE KKRLRKPSKW LLEYTEEYDQ IFAPKKKQKK VQEQVHKVSS RCEEESLLAR
     GRSSAQNKQV DENSLISTKE EPPVLEREAP FLEGPLAQSE LGGGHAELPQ LTLSVPVAPE
     VSPRPALESE ELLVKTPGNY ESKRQRKPTK KLLESNDLDP GFMPKKGDLG LSKKCYEAGH
     LENGITESCA TSYSKDFGGG TTKIFDKPRK RKRQRHAAAK MQCKKVKNDD SSKEIPGSEG
     ELMPHRTATS PKETVEEGVE HDPGMPASKK MQGERGGGAA LKENVCQNCE KLGELLLCEA
     QCCGAFHLEC LGLTEMPRGK FICNECRTGI HTCFVCKQSG EDVKRCLLPL CGKFYHEECV
     QKYPPTVMQN KGFRCSLHIC ITCHAANPAN VSASKGRLMR CVRCPVAYHA NDFCLAAGSK
     ILASNSIICP NHFTPRRGCR NHEHVNVSWC FVCSEGGSLL CCDSCPAAFH RECLNIDIPE
     GNWYCNDCKA GKKPHYREIV WVKVGRYRWW PAEICHPRAV PSNIDKMRHD VGEFPVLFFG
     SNDYLWTHQA RVFPYMEGDV SSKDKMGKGV DGTYKKALQE AAARFEELKA QKELRQLQED
     RKNDKKPPPY KHIKVNRPIG RVQIFTADLS EIPRCNCKAT DENPCGIDSE CINRMLLYEC
     HPTVCPAGGR CQNQCFSKRQ YPEVEIFRTL QRGWGLRTKT DIKKGEFVNE YVGELIDEEE
     CRARIRYAQE HDITNFYMLT LDKDRIIDAG PKGNYARFMN HCCQPNCETQ KWSVNGDTRV
     GLFALSDIKA GTELTFNYNL ECLGNGKTVC KCGAPNCSGF LGVRPKNQPI ATEEKSKKFK
     KKQQGKRRTQ GEITKEREDE CFSCGDAGQL VSCKKPGCPK VYHADCLNLT KRPAGKWECP
     WHQCDICGKE AASFCEMCPS SFCKQHREGM LFISKLDGRL SCTEHDPCGP NPLEPGEIRE
     YVPPPVPLPP GPSTHLAEQS TGMAAQAPKM SDKPPADTNQ MLSLSKKALA GTCQRPLLPE
     RPLERTDSRP QPLDKVRDLA GSGTKSQSLV SSQRPLDRPP AVAGPRPQLS DKPSPVTSPS
     SSPSVRSQPL ERPLGTADPR LDKSIGAASP RPQSLEKTSV PTGLRLPPPD RLLITSSPKP
     QTSDRPTDKP HASLSQRLPP PEKVLSAVVQ TLVAKEKALR PVDQNTQSKN RAALVMDLID
     LTPRQKERAA SPHQVTPQAD EKMPVLESSS WPASKGLGHM PRAVEKGCVS DPLQTSGKAA
     APSEDPWQAV KSLTQARLLS QPPAKAFLYE PTTQASGRAS AGAEQTPGPL SQSPGLVKQA
     KQMVGGQQLP ALAAKSGQSF RSLGKAPASL PTEEKKLVTT EQSPWALGKA SSRAGLWPIV
     AGQTLAQSCW SAGSTQTLAQ TCWSLGRGQD PKPEQNTLPA LNQAPSSHKC AESEQK
//
ID   Q96MN8_HUMAN            Unreviewed;       942 AA.
AC   Q96MN8;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   31-JAN-2018, entry version 73.
DE   SubName: Full=cDNA FLJ32105 fis, clone OCBBF2001402, moderately similar to Mus musculus NSD1 protein mRNA {ECO:0000313|EMBL:BAB71247.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAB71247.1};
RN   [1] {ECO:0000313|EMBL:BAB71247.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAB71247.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK056667; BAB71247.1; -; mRNA.
DR   RefSeq; NP_758859.1; NM_172349.2.
DR   UniGene; Hs.106861; -.
DR   ProteinModelPortal; Q96MN8; -.
DR   PeptideAtlas; Q96MN8; -.
DR   GeneID; 64324; -.
DR   CTD; 64324; -.
DR   PharmGKB; PA31790; -.
DR   eggNOG; KOG1081; Eukaryota.
DR   eggNOG; COG2940; LUCA.
DR   GenomeRNAi; 64324; -.
DR   Genevisible; Q96MN8; HS.
PE   2: Evidence at transcript level;
FT   NON_TER     942    942       {ECO:0000313|EMBL:BAB71247.1}.
SQ   SEQUENCE   942 AA;  103771 MW;  43C0991BD30CC527 CRC64;
     MKVSNRRPYR QYYVEAFGDP SERAWVAGKA IVMFEGRHQF EELPVLRRRG KQKEKGYRHK
     VPQKILSKWE ASVGLAEQYD VPKGSKNRKC IPGSIKLDSE EDMPFEDCTN DPESEHDLLL
     NGCLKSLAFD SEHSADEKEK PCAKSRARKS SDNPKRTSVK KGHIQFEAHK DERRGKIPEN
     LGLNFISGDI SDTQASNELS RIANSLTGSN TAPGSFLFSS CGKNTAKKEF ETSNGDSLLG
     LPEGALISKC SREKNKPQRS LVCGSKVKLC YIGAGDEEKR SDSISICTTS DDGSSDLDPI
     EHSSESDNSV LEIPDAFDRT ENMLSMQKNE KIKYSRFAAT NTRVKAKQKP LISNSHTDHL
     MGCTKSAEPG TETSQVNLSD LKASTLVHKP QSDFTNDALS PKFNLSSSIS SENSLIKGGA
     ANQALLHSKS KQPKFRSIKC KHKENPVMAE PPVINEECSL KCCSSDTKGS PLASISKSGK
     VDGLKLLNNM HEKTRDSSDI ETAVVKHVLS ELKELSYRSL GEDVSDSGTS KPSKPLLFSS
     ASSQNHIPIE PDYKFSTLLM MLKDMHDSKT KEQRLMTAQN LVSYRSPGRG DCSTNSPVGV
     SKVLVSGGST HNSEKKGDGT QNSANPSPSG GDSALSGELS ASLPGLLSDK RDLPASGKSR
     SDCVTRRNCG RSKPSSKLRD AFSAQMVKNT VNRKALKTER KRKLNQLPSV TLDAVLQGDR
     ERGGSLRGGA EDPSKEDPLQ IMGHLTSEDG DHFSDVHFDS KVKQSDPGKI SEKGLSFENG
     KGPELDSVMN SENDELNGVN QVVPKKRWQR LNQRRTKPRK RMNRFKEKEN SECAFRVLLP
     SDPVQEGRDE FPEHRTPSAS ILEEPLTEQN HADCLDSAGP RLNVCDKSSA SIGDMEKEPG
     IPSLTPQAEL PEPAVRSEKK RLRKPSKWLL EYTEEYDQIF AP
//
ID   A0A024R5M9_HUMAN        Unreviewed;      2101 AA.
AC   A0A024R5M9;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 33.
DE   SubName: Full=Nuclear mitotic apparatus protein 1, isoform CRA_a {ECO:0000313|EMBL:EAW74824.1};
GN   Name=NUMA1 {ECO:0000313|EMBL:EAW74824.1};
GN   ORFNames=hCG_2017131 {ECO:0000313|EMBL:EAW74824.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW74824.1};
RN   [1] {ECO:0000313|EMBL:EAW74824.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW74824.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471076; EAW74821.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74824.1; -; Genomic_DNA.
DR   RefSeq; NP_001273490.1; NM_001286561.1.
DR   RefSeq; XP_011543368.1; XM_011545066.1.
DR   RefSeq; XP_016873319.1; XM_017017830.1.
DR   RefSeq; XP_016873320.1; XM_017017831.1.
DR   UniGene; Hs.325978; -.
DR   UniGene; Hs.591967; -.
DR   SMR; A0A024R5M9; -.
DR   GeneID; 4926; -.
DR   CTD; 4926; -.
DR   EuPathDB; HostDB:ENSG00000137497.17; -.
DR   eggNOG; ENOG410IFJ8; Eukaryota.
DR   eggNOG; ENOG41125FF; LUCA.
DR   ChiTaRS; NUMA1; human.
DR   GenomeRNAi; 4926; -.
DR   Bgee; ENSG00000137497; -.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   InterPro; IPR026650; NUMA1.
DR   PANTHER; PTHR18902:SF24; PTHR18902:SF24; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED      216    250       {ECO:0000256|SAM:Coils}.
FT   COILED      278    319       {ECO:0000256|SAM:Coils}.
FT   COILED      327    400       {ECO:0000256|SAM:Coils}.
FT   COILED      415    449       {ECO:0000256|SAM:Coils}.
FT   COILED      468    491       {ECO:0000256|SAM:Coils}.
FT   COILED      500    777       {ECO:0000256|SAM:Coils}.
FT   COILED      789    823       {ECO:0000256|SAM:Coils}.
FT   COILED      828    862       {ECO:0000256|SAM:Coils}.
FT   COILED      867    922       {ECO:0000256|SAM:Coils}.
FT   COILED      967   1040       {ECO:0000256|SAM:Coils}.
FT   COILED     1066   1100       {ECO:0000256|SAM:Coils}.
FT   COILED     1122   1156       {ECO:0000256|SAM:Coils}.
FT   COILED     1171   1205       {ECO:0000256|SAM:Coils}.
FT   COILED     1213   1275       {ECO:0000256|SAM:Coils}.
FT   COILED     1280   1335       {ECO:0000256|SAM:Coils}.
FT   COILED     1367   1405       {ECO:0000256|SAM:Coils}.
FT   COILED     1409   1443       {ECO:0000256|SAM:Coils}.
FT   COILED     1462   1511       {ECO:0000256|SAM:Coils}.
FT   COILED     1516   1550       {ECO:0000256|SAM:Coils}.
FT   COILED     1558   1679       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   2101 AA;  236516 MW;  18D8C4A34409ADE9 CRC64;
     MTLHATRGAA LLSWVNSLHV ADPVEAVLQL QDCSIFIKII DRIHGTEEGQ QILKQPVSER
     LDFVCSFLQK NRKHPSSPEC LVSAQKVLEG SELELAKMTM LLLYHSTMSS KSPRDWEQFE
     YKIQAELAVI LKFVLDHEDG LNLNEDLENF LQKAPVPSTC SSTFPEELSP PSHQAKREIR
     FLELQKVASS SSGNNFLSGS PASPMGDILQ TPQFQMRRLK KQLADERSNR DELELELAEN
     RKLLTEKDAQ IAMMQQRIDR LALLNEKQAA SPLEPKELEE LRDKNESLTM RLHETLKQCQ
     DLKTEKSQMD RKINQLSEEN GDLSFKLREF ASHLQQLQDA LNELTEEHSK ATQEWLEKQA
     QLEKELSAAL QDKKCLEEKN EILQGKLSQL EEHLSQLQDN PPQEKGEVLG DVLQLETLKQ
     EAATLAANNT QLQARVEMLE TERGQQEAKL LAERGHFEEE KQQLSSLITD LQSSISNLSQ
     AKEELEQASQ AHGARLTAQV ASLTSELTTL NATIQQQDQE LAGLKQQAKE KQAQLAQTLQ
     QQEQASQGLR HQVEQLSSSL KQKEQQLKEV AEKQEATRQD HAQQLATAAE EREASLRERD
     AALKQLEALE KEKAAKLEIL QQQLQVANEA RDSAQTSVTQ AQREKAELSR KVEELQACVE
     TARQEQHEAQ AQVAELELQL RSEQQKATEK ERVAQEKDQL QEQLQALKES LKVTKGSLEE
     EKRRAADALE EQQRCISELK AETRSLVEQH KRERKELEEE RAGRKGLEAR LQQLGEAHQA
     ETEVLRRELA EAMAAQHTAE SECEQLVKEV AAWRERYEDS QQEEAQYGAM FQEQLMTLKE
     ECEKARQELQ EAKEKVAGIE SHSELQISRQ QNELAELHAN LARALQQVQE KEVRAQKLAD
     DLSTLQEKMA ATSKEVARLE TLVRKAGEQQ ETASRELVKE PARAGDRQPE WLEEQQGRQF
     CSTQAALQAM EREAEQMGNE LERLRAALME SQGQQQEERG QQEREVARLT QERGRAQADL
     ALEKAARAEL EMRLQNALNE QRVEFATLQE ALAHALTEKE GKDQELAKLR GLEAAQIKEL
     EELRQTVKQL KEQLAKKEKE HASGSGAQSE AAGRTEPTGP KLEALRAEVS KLEQQCQKQQ
     EQADSLERSL EAERASRAER DSALETLQGQ LEEKAQELGH SQSALASAQR ELAAFRTKVQ
     DHSKAEDEWK AQVARGRQEA ERKNSLISSL EEEVSILNRQ VLEKEGESKE LKRLVMAESE
     KSQKLEERLR LLQAETASNS ARAAERSSAL REEVQSLREE AEKQRVASEN LRQELTSQAE
     RAEELGQELK AWQEKFFQKE QALSTLQLEH TSTQALVSEL LPAKHLCQQL QAEQAAAEKR
     HREELEQSKQ AAGGLRAELL RAQRELGELI PLRQKVAEQE RTAQQLRAEK ASYAEQLSML
     KKAHGLLAEE NRGLGERANL GRQFLEVELD QAREKYVQEL AAVRADAETR LAEVQREAQS
     TARELEVMTA KYEGAKVKVL EERQRFQEER QKLTAQVEEL SKKLADSDQA SKVQQQKLKA
     VQAQGGESQQ EAQRLQAQLN ELQAQLSQKE QAAEHYKLQM EKAKTHYDAK KQQNQELQEQ
     LRSLEQLQKE NKELRAEAER LGHELQQAGL KTKEAEQTCR HLTAQVRSLE AQVAHADQQL
     RDLGKFQVAT DALKSREPQA KPQLDLSIDS LDLSCEEGTP LSITSKLPRT QPDGTSVPGE
     PASPISQRLP PKVESLESLY FTPIPARSQA PLESSLDSLG DVFLDSGRKT RSARRRTTQI
     INITMTKKLD VEEPDSANSS FYSTRSAPAS QASLRATSST QSLARLGSPD YGNSALLSLP
     GYRPTTRSSA RRSQAGVSSG APPGRNSFYM GTCQDEPEQL DDWNRIAELQ QRNRVCPPHL
     KTCYPLESRP SLSLGTITDE EMKTGDPQET LRRASMQPIQ IAEGTGITTR QQRKRVSLEP
     HQGPGTPESK KATSCFPRPM TPRDRHEGRK QSTTEAQKKA APASTKQADR RQSMAFSILN
     TPKKLGNSLL RRGASKKALS KASPNTRSGT RRSPRIATTT ASAATAAAIG ATPRAKGKAK
     H
//
ID   NUMA1_HUMAN             Reviewed;        2115 AA.
AC   Q14980; H0YH75; Q14981; Q9BTE9;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 2.
DT   28-FEB-2018, entry version 166.
DE   RecName: Full=Nuclear mitotic apparatus protein 1 {ECO:0000312|HGNC:HGNC:8059};
DE   AltName: Full=Nuclear matrix protein-22 {ECO:0000303|PubMed:9730450};
DE            Short=NMP-22 {ECO:0000303|PubMed:9730450};
DE   AltName: Full=Nuclear mitotic apparatus protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};
DE            Short=NuMA protein {ECO:0000303|PubMed:1541630, ECO:0000303|PubMed:1541636};
DE   AltName: Full=SP-H antigen {ECO:0000303|PubMed:8408288};
GN   Name=NUMA1 {ECO:0000312|HGNC:HGNC:8059};
GN   Synonyms=NMP22 {ECO:0000303|PubMed:9730450},
GN   NUMA {ECO:0000303|PubMed:1541630};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RX   PubMed=1541630; DOI=10.1083/jcb.116.6.1303;
RA   Yang C.H., Lambie E.J., Snyder M.;
RT   "NuMA: an unusually long coiled-coil related protein in the mammalian
RT   nucleus.";
RL   J. Cell Biol. 116:1303-1317(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND SUBCELLULAR LOCATION.
RX   PubMed=1541636; DOI=10.1083/jcb.116.6.1395;
RA   Compton D.A., Szilak I., Cleveland D.W.;
RT   "Primary structure of NuMA, an intranuclear protein that defines a
RT   novel pathway for segregation of proteins at mitosis.";
RL   J. Cell Biol. 116:1395-1408(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8408288;
RA   Maekawa T., Kuriyama R.;
RT   "Primary structure and microtubule-interacting domain of the SP-H
RT   antigen: a mitotic map located at the spindle pole characterized as a
RT   homologous protein to NuMA.";
RL   J. Cell Sci. 105:589-600(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1576-2115 (ISOFORM 1), NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 975-1776 (ISOFORM 3), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   610-1763 (ISOFORM 4), AND ALTERNATIVE SPLICING.
RX   PubMed=8505359;
RA   Tang T.K., Tang C.J., Chen Y.L., Wu C.W.;
RT   "Nuclear proteins of the bovine esophageal epithelium. II. The NuMA
RT   gene gives rise to multiple mRNAs and gene products reactive with
RT   monoclonal antibody W1.";
RL   J. Cell Sci. 104:249-260(1993).
RN   [8]
RP   SUBCELLULAR LOCATION (ISOFORMS 3 AND 4), ALTERNATIVE SPLICING
RP   (ISOFORMS 3 AND 4), MUTAGENESIS OF ARG-1984 AND LYS-1988, AND NUCLEAR
RP   LOCALIZATION SIGNAL.
RX   PubMed=7962183;
RA   Tang T.K., Tang C.J., Chao Y.J., Wu C.W.;
RT   "Nuclear mitotic apparatus protein (NuMA): spindle association,
RT   nuclear targeting and differential subcellular localization of various
RT   NuMA isoforms.";
RL   J. Cell Sci. 107:1389-1402(1994).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-2015; THR-2055;
RP   SER-2087 AND THR-2106, AND MUTAGENESIS OF THR-2015; THR-2055; SER-2087
RP   AND THR-2106.
RX   PubMed=7769006;
RA   Compton D.A., Luo C.;
RT   "Mutation of the predicted p34cdc2 phosphorylation sites in NuMA
RT   impair the assembly of the mitotic spindle and block mitosis.";
RL   J. Cell Sci. 108:621-633(1995).
RN   [10]
RP   USE IN DIAGNOSTIC TESTS.
RX   PubMed=9730450; DOI=10.1016/S0090-4295(98)00219-2;
RA   Landman J., Chang Y., Kavaler E., Droller M.J., Liu B.C.;
RT   "Sensitivity and specificity of NMP-22, telomerase, and BTA in the
RT   detection of human bladder cancer.";
RL   Urology 52:398-402(1998).
RN   [11]
RP   SUBCELLULAR LOCATION, AND ASSOCIATION WITH THE DYNEIN-DYNACTIN
RP   COMPLEX.
RX   PubMed=10811826;
RA   Merdes A., Heald R., Samejima K., Earnshaw W.C., Cleveland D.W.;
RT   "Formation of spindle poles by dynein/dynactin-dependent transport of
RT   NuMA.";
RL   J. Cell Biol. 149:851-862(2000).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH THE IMPORTIN ALPHA/IMPORTIN BETA
RP   RECEPTOR.
RX   PubMed=11163243;
RA   Nachury M.V., Maresca T.J., Salmon W.C., Waterman-Storer C.M.,
RA   Heald R., Weis K.;
RT   "Importin beta is a mitotic target of the small GTPase Ran in spindle
RT   assembly.";
RL   Cell 104:95-106(2001).
RN   [13]
RP   INTERACTION WITH GPSM2, AND SUBCELLULAR LOCATION.
RX   PubMed=11781568; DOI=10.1038/ncb1201-1069;
RA   Du Q., Stukenberg P.T., Macara I.G.;
RT   "A mammalian partner of inscuteable binds NuMA and regulates mitotic
RT   spindle organization.";
RL   Nat. Cell Biol. 3:1069-1075(2001).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH KPNB1.
RX   PubMed=11229403;
RA   Wiese C., Wilde A., Moore M.S., Adam S.A., Merdes A., Zheng Y.;
RT   "Role of importin-beta in coupling Ran to downstream targets in
RT   microtubule assembly.";
RL   Science 291:653-656(2001).
RN   [15]
RP   FUNCTION, INTERACTION WITH GPSM2 AND MICROTUBULES, SUBCELLULAR
RP   LOCATION, AND DOMAINS.
RX   PubMed=12445386;
RA   Du Q., Taylor L., Compton D.A., Macara I.G.;
RT   "LGN blocks the ability of NuMA to bind and stabilize microtubules. A
RT   mechanism for mitotic spindle assembly regulation.";
RL   Curr. Biol. 12:1928-1933(2002).
RN   [16]
RP   INTERACTION WITH TNKS AND TNKS2.
RX   PubMed=12080061; DOI=10.1074/jbc.M203916200;
RA   Sbodio J.I., Chi N.W.;
RT   "Identification of a tankyrase-binding motif shared by IRAP, TAB182,
RT   and human TRF1 but not mouse TRF1. NuMA contains this RXXPDG motif and
RT   is a novel tankyrase partner.";
RL   J. Biol. Chem. 277:31887-31892(2002).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH TUBULIN AND
RP   MICROTUBULES, AND TUBULIN-BINDING DOMAIN.
RX   PubMed=11956313;
RA   Haren L., Merdes A.;
RT   "Direct binding of NuMA to tubulin is mediated by a novel sequence
RT   motif in the tail domain that bundles and stabilizes microtubules.";
RL   J. Cell Sci. 115:1815-1824(2002).
RN   [18]
RP   FUNCTION, ADP-RIBOSYLATION, INTERACTION WITH TNKS, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=16076287; DOI=10.1042/BJ20050428;
RA   Chang W., Dynek J.N., Smith S.;
RT   "NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in
RT   mitosis.";
RL   Biochem. J. 391:177-184(2005).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1757, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1757; SER-1769;
RP   THR-1776; SER-1840 AND THR-2106, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH DYNEIN-DYNACTIN COMPLEX AND RAE1.
RX   PubMed=17172455; DOI=10.1073/pnas.0609582104;
RA   Wong R.W., Blobel G., Coutavas E.;
RT   "Rae1 interaction with NuMA is required for bipolar spindle
RT   formation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:19783-19787(2006).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2077, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-388; SER-395; SER-820;
RP   SER-1601; SER-1757 AND SER-1760, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1757, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1757, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-203; THR-211;
RP   SER-1721; SER-1724; SER-1728; SER-1757; SER-1769; SER-1772; TYR-1774;
RP   THR-1776; SER-1788; SER-1789; SER-1792; SER-1800; THR-1804; SER-1830;
RP   SER-1833; SER-1834; TYR-1836; SER-1840; SER-1862; SER-1887; SER-1969;
RP   SER-1991 AND THR-2000, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [29]
RP   FUNCTION.
RX   PubMed=19255246; DOI=10.1083/jcb.200810091;
RA   Silk A.D., Holland A.J., Cleveland D.W.;
RT   "Requirements for NuMA in maintenance and establishment of mammalian
RT   spindle poles.";
RL   J. Cell Biol. 184:677-690(2009).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203; SER-1225; SER-1757;
RP   SER-1769; THR-1776; SER-1788 AND SER-1800, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-379; LYS-891 AND LYS-1511,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [32]
RP   GLYCOSYLATION AT SER-1844.
RX   PubMed=20068230; DOI=10.1126/scisignal.2000526;
RA   Wang Z., Udeshi N.D., Slawson C., Compton P.D., Sakabe K.,
RA   Cheung W.D., Shabanowitz J., Hunt D.F., Hart G.W.;
RT   "Extensive crosstalk between O-GlcNAcylation and phosphorylation
RT   regulates cytokinesis.";
RL   Sci. Signal. 3:RA2-RA2(2010).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-203; THR-211;
RP   SER-271; SER-1187; SER-1225; SER-1757; SER-1769; SER-1830; SER-1862;
RP   SER-1969; SER-1991; THR-2000 AND SER-2003, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [34]
RP   REVIEW.
RX   PubMed=20137953; DOI=10.1016/j.tcb.2010.01.003;
RA   Radulescu A.E., Cleveland D.W.;
RT   "NuMA after 30 years: the matrix revisited.";
RL   Trends Cell Biol. 20:214-222(2010).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1757, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [37]
RP   FUNCTION, AND INTERACTION WITH DYNEIN-DYNACTIN COMPLEX.
RX   PubMed=23027904; DOI=10.1083/jcb.201203166;
RA   Kotak S., Busso C., Goenczy P.;
RT   "Cortical dynein is critical for proper spindle positioning in human
RT   cells.";
RL   J. Cell Biol. 199:97-110(2012).
RN   [38]
RP   FUNCTION, INTERACTION WITH GPSM2, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION AT THR-1047; SER-1769; SER-1772; SER-1789 AND SER-1834
RP   BY PLK1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22327364; DOI=10.1038/ncb2440;
RA   Kiyomitsu T., Cheeseman I.M.;
RT   "Chromosome- and spindle-pole-derived signals generate an intrinsic
RT   code for spindle position and orientation.";
RL   Nat. Cell Biol. 14:311-317(2012).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [40]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH EPB41 AND EPB41L2,
RP   PROBABLE PHOSPHORYLATION AT THR-2015; THR-2055 AND SER-2087 BY CDK1,
RP   AND MUTAGENESIS OF THR-2015; THR-2055 AND SER-2087.
RX   PubMed=23870127; DOI=10.1016/j.cell.2013.06.010;
RA   Kiyomitsu T., Cheeseman I.M.;
RT   "Cortical dynein and asymmetric membrane elongation coordinately
RT   position the spindle in anaphase.";
RL   Cell 154:391-402(2013).
RN   [41]
RP   FUNCTION, PHOSPHORYLATION AT THR-2015; THR-2055; SER-2087 AND
RP   THR-2106, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND MUTAGENESIS OF THR-2055.
RX   PubMed=23921553; DOI=10.1038/emboj.2013.172;
RA   Kotak S., Busso C., Goenczy P.;
RT   "NuMA phosphorylation by CDK1 couples mitotic progression with
RT   cortical dynein function.";
RL   EMBO J. 32:2517-2529(2013).
RN   [42]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-271; SER-1757;
RP   SER-1769; SER-1830; SER-1834; SER-1840; SER-1844; SER-1862; SER-1887;
RP   SER-1969; SER-1991; THR-2000; SER-2047; THR-2055 AND SER-2062, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [43]
RP   FUNCTION, INTERACTION WITH GPSM2, SUBCELLULAR LOCATION, DOMAIN, AND
RP   MUTAGENESIS OF THR-2055.
RX   PubMed=24109598; DOI=10.1091/mbc.E13-05-0277;
RA   Seldin L., Poulson N.D., Foote H.P., Lechler T.;
RT   "NuMA localization, stability, and function in spindle orientation
RT   involve 4.1 and Cdk1 interactions.";
RL   Mol. Biol. Cell 24:3651-3662(2013).
RN   [44]
RP   FUNCTION, INTERACTION WITH EPB41 AND EPB41L2,
RP   PHOSPHATIDYLINOSITOL-BINDING, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   THR-2055.
RX   PubMed=24996901; DOI=10.15252/embj.201488147;
RA   Kotak S., Busso C., Goenczy P.;
RT   "NuMA interacts with phosphoinositides and links the mitotic spindle
RT   with the plasma membrane.";
RL   EMBO J. 33:1815-1830(2014).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162; THR-163; SER-169;
RP   SER-271; SER-1225; SER-1757 AND SER-1788, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [46]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-2055, DOMAIN,
RP   PHOSPHATIDYLINOSITOL-BINDING, AND MUTAGENESIS OF THR-2055.
RX   PubMed=24371089; DOI=10.1091/mbc.E13-08-0474;
RA   Zheng Z., Wan Q., Meixiong G., Du Q.;
RT   "Cell cycle-regulated membrane binding of NuMA contributes to
RT   efficient anaphase chromosome separation.";
RL   Mol. Biol. Cell 25:606-619(2014).
RN   [47]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1766, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [48]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1766, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [49]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1766, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [50]
RP   FUNCTION, SUBUNIT, UBIQUITINATION, INTERACTION WITH ABRAXAS2; KPNB1
RP   AND DYNEIN-DYNACTIN COMPLEX, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=26195665; DOI=10.1083/jcb.201503039;
RA   Yan K., Li L., Wang X., Hong R., Zhang Y., Yang H., Lin M., Zhang S.,
RA   He Q., Zheng D., Tang J., Yin Y., Shao G.;
RT   "The deubiquitinating enzyme complex BRISC is required for proper
RT   mitotic spindle assembly in mammalian cells.";
RL   J. Cell Biol. 210:209-224(2015).
RN   [51]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25657325; DOI=10.1091/mbc.E14-09-1366;
RA   Ohta S., Wood L., Toramoto I., Yagyu K., Fukagawa T., Earnshaw W.C.;
RT   "CENP-32 is required to maintain centrosomal dominance in bipolar
RT   spindle assembly.";
RL   Mol. Biol. Cell 26:1225-1237(2015).
RN   [52]
RP   SUBCELLULAR LOCATION.
RX   PubMed=26562023; DOI=10.1371/journal.pone.0142798;
RA   Ohta S., Hamada M., Sato N., Toramoto I.;
RT   "Polyglutamylated tubulin binding protein C1orf96/CSAP is involved in
RT   microtubule stabilization in mitotic spindles.";
RL   PLoS ONE 10:E0142798-E0142798(2015).
RN   [53]
RP   IDENTIFICATION IN A SPINDLE ORIENTATION COMPLEX.
RX   PubMed=26766442; DOI=10.1016/j.devcel.2015.12.016;
RA   Chiu C.W., Monat C., Robitaille M., Lacomme M., Daulat A.M.,
RA   Macleod G., McNeill H., Cayouette M., Angers S.;
RT   "SAPCD2 controls spindle orientation and asymmetric divisions by
RT   negatively regulating the Galphai-LGN-NuMA ternary complex.";
RL   Dev. Cell 36:50-62(2016).
RN   [54]
RP   FUNCTION, INTERACTION WITH MICROTUBULES, SUBCELLULAR LOCATION, DOMAIN,
RP   AND NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=26765568; DOI=10.7554/eLife.12504;
RA   Seldin L., Muroyama A., Lechler T.;
RT   "NuMA-microtubule interactions are critical for spindle orientation
RT   and the morphogenesis of diverse epidermal structures.";
RL   Elife 5:0-0(2016).
RN   [55]
RP   FUNCTION, INTERACTION WITH GPSM2 AND SPAG5, AND SUBCELLULAR LOCATION.
RX   PubMed=27462074; DOI=10.1074/jbc.M116.724831;
RA   Chu X., Chen X., Wan Q., Zheng Z., Du Q.;
RT   "Nuclear mitotic apparatus (NuMA) interacts with and regulates astrin
RT   at the mitotic spindle.";
RL   J. Biol. Chem. 291:20055-20067(2016).
RN   [56]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1699; LYS-1766 AND LYS-1822,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [57]
RP   ELECTRON MICROSCOPY, SUBUNIT, SUBCELLULAR LOCATION, AND PUTATIVE
RP   STRUCTURAL FUNCTION.
RX   PubMed=10075938; DOI=10.1093/emboj/18.6.1689;
RA   Harborth J., Wang J., Gueth-Hallonet C., Weber K., Osborn M.;
RT   "Self assembly of NuMA: multiarm oligomers as structural units of a
RT   nuclear lattice.";
RL   EMBO J. 18:1689-1700(1999).
RN   [58]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1899-1926 IN COMPLEX WITH
RP   GPSM2, FUNCTION, INTERACTION WITH GPSM2, SUBCELLULAR LOCATION,
RP   MUTAGENESIS OF GLU-1910, AND DOMAIN.
RX   PubMed=21816348; DOI=10.1016/j.molcel.2011.07.011;
RA   Zhu J., Wen W., Zheng Z., Shang Y., Wei Z., Xiao Z., Pan Z., Du Q.,
RA   Wang W., Zhang M.;
RT   "LGN/mInsc and LGN/NuMA complex structures suggest distinct functions
RT   in asymmetric cell division for the Par3/mInsc/LGN and
RT   Galphai/LGN/NuMA pathways.";
RL   Mol. Cell 43:418-431(2011).
CC   -!- FUNCTION: Microtubule (MT)-binding protein that plays a role in
CC       the formation and maintenance of the spindle poles and the
CC       alignement and the segregation of chromosomes during mitotic cell
CC       division (PubMed:7769006, PubMed:17172455, PubMed:19255246,
CC       PubMed:24996901, PubMed:26195665, PubMed:27462074). Functions to
CC       tether the minus ends of MTs at the spindle poles, which is
CC       critical for the establishment and maintenance of the spindle
CC       poles (PubMed:12445386, PubMed:11956313). Plays a role in the
CC       establishment of the mitotic spindle orientation during metaphase
CC       and elongation during anaphase in a dynein-dynactin-dependent
CC       manner (PubMed:23870127, PubMed:24109598, PubMed:24996901,
CC       PubMed:26765568). In metaphase, part of a ternary complex composed
CC       of GPSM2 and G(i) alpha proteins, that regulates the recruitment
CC       and anchorage of the dynein-dynactin complex in the mitotic cell
CC       cortex regions situated above the two spindle poles, and hence
CC       regulates the correct oritentation of the mitotic spindle
CC       (PubMed:23027904, PubMed:22327364, PubMed:23921553). During
CC       anaphase, mediates the recruitment and accumulation of the dynein-
CC       dynactin complex at the cell membrane of the polar cortical region
CC       through direct association with phosphatidylinositol 4,5-
CC       bisphosphate (PI(4,5)P2), and hence participates in the regulation
CC       of the spindle elongation and chromosome segregation
CC       (PubMed:22327364, PubMed:23921553, PubMed:24996901,
CC       PubMed:24371089). Binds also to other polyanionic
CC       phosphoinositides, such as phosphatidylinositol 3-phosphate (PIP),
CC       lysophosphatidic acid (LPA) and phosphatidylinositol triphosphate
CC       (PIP3), in vitro (PubMed:24996901, PubMed:24371089). Also required
CC       for proper orientation of the mitotic spindle during asymmetric
CC       cell divisions (PubMed:21816348). Plays a role in mitotic MT aster
CC       assembly (PubMed:11163243, PubMed:11229403, PubMed:12445386).
CC       Involved in anastral spindle assembly (PubMed:25657325).
CC       Positively regulates TNKS protein localization to spindle poles in
CC       mitosis (PubMed:16076287). Highly abundant component of the
CC       nuclear matrix where it may serve a non-mitotic structural role,
CC       occupies the majority of the nuclear volume (PubMed:10075938).
CC       Required for epidermal differentiation and hair follicle
CC       morphogenesis (By similarity). {ECO:0000250|UniProtKB:E9Q7G0,
CC       ECO:0000269|PubMed:11163243, ECO:0000269|PubMed:11229403,
CC       ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12445386,
CC       ECO:0000269|PubMed:16076287, ECO:0000269|PubMed:17172455,
CC       ECO:0000269|PubMed:19255246, ECO:0000269|PubMed:22327364,
CC       ECO:0000269|PubMed:23027904, ECO:0000269|PubMed:23870127,
CC       ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24109598,
CC       ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901,
CC       ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:26195665,
CC       ECO:0000269|PubMed:26765568, ECO:0000269|PubMed:27462074,
CC       ECO:0000269|PubMed:7769006, ECO:0000305|PubMed:10075938,
CC       ECO:0000305|PubMed:21816348}.
CC   -!- SUBUNIT: Homodimer (PubMed:10075938). Also forms multiarm
CC       oligomers by association of C-terminal tail domains, oligomers may
CC       further assemble to form a hexagonal nuclear lattice-like network
CC       (PubMed:10075938). Associates with the dynein-dynactin complex;
CC       this association promotes the transport and accumulation of NUMA1
CC       at the mitotic spindle poles that is inhibited by the BRISC
CC       complex in a PLK1-dependent manner (PubMed:10811826,
CC       PubMed:17172455, PubMed:23027904, PubMed:22327364,
CC       PubMed:26195665). Part of a spindle orientation complex at least
CC       composed of GNAI1, GPSM2 and NUMA1 (PubMed:26766442). Interacts
CC       (via C-terminus) with microtubules (MTs); this interaction is
CC       direct and promotes both MT bundle formation and stability in a
CC       dynein-dynactin complex- and CDK1-independent manner
CC       (PubMed:12445386, PubMed:11956313, PubMed:26765568). Interacts
CC       with EPB41 and EPB41L2; these interactions are negatively
CC       regulated by CDK1 during metaphase and are important for anaphase-
CC       specific localization of NUMA1 in symmetrically dividing cells
CC       (PubMed:23870127, PubMed:24996901). Interacts (via C-terminus)
CC       with GPSM2 (via TPR repeats); this interaction is direct,
CC       prevented by competitive binding of INSC, is inhibited in a PLK1-
CC       dependent manner, blocks the association of NUMA1 with MTs and
CC       inhibits NUMA1-induced MT bundle formation, prevents the
CC       association of NUMA1 with SPAG5, induces mitotic spindle pole
CC       localization of GPSM2, both metaphase cell cortex localization of
CC       NUMA1 and mitotic spindle organization (PubMed:11781568,
CC       PubMed:12445386, PubMed:22327364, PubMed:24109598,
CC       PubMed:27462074, PubMed:21816348). Does not interact with GPSM2
CC       during anaphase (PubMed:23870127). Interacts (via C-terminus) with
CC       the nuclear importin alpha/importin beta receptor; this
CC       interaction is inhibited by RanGTP (PubMed:11163243). Interacts
CC       (via C-terminus) with KPNB1; this interaction is inhibited by
CC       RanGTP and the BRISC complex (PubMed:11229403, PubMed:26195665).
CC       Interacts with ABRAXAS2 and the BRISC complex; these interactions
CC       regulate mitotic spindle assembly (PubMed:26195665). Interacts
CC       (via N-terminal end of the coiled-coil domain) with RAE1; this
CC       interaction promotes mitotic spindle formation (PubMed:17172455).
CC       Interacts (via C-terminus) with SPAG5 (via C-terminus); this
CC       interaction promotes the recruitment of SPAG5 to the MTs at
CC       spindle poles in a dynein-dynactin-dependent manner and regulates
CC       mitotic spindle organization and proper chromosome alignment
CC       during mitosis (PubMed:27462074). Interacts with TNKS; this
CC       interaction occurs at the onset of mitosis (PubMed:12080061,
CC       PubMed:16076287). Interacts with TNKS2 (PubMed:12080061).
CC       Interacts with tubulin (PubMed:11956313).
CC       {ECO:0000269|PubMed:10075938, ECO:0000269|PubMed:10811826,
CC       ECO:0000269|PubMed:11163243, ECO:0000269|PubMed:11229403,
CC       ECO:0000269|PubMed:11781568, ECO:0000269|PubMed:11956313,
CC       ECO:0000269|PubMed:12080061, ECO:0000269|PubMed:12445386,
CC       ECO:0000269|PubMed:16076287, ECO:0000269|PubMed:17172455,
CC       ECO:0000269|PubMed:21816348, ECO:0000269|PubMed:22327364,
CC       ECO:0000269|PubMed:23027904, ECO:0000269|PubMed:23870127,
CC       ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24996901,
CC       ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26765568,
CC       ECO:0000269|PubMed:26766442, ECO:0000269|PubMed:27462074}.
CC   -!- INTERACTION:
CC       Q2TAC2:CCDC57; NbExp=3; IntAct=EBI-521611, EBI-2808286;
CC       Q53SE7:FLJ13057; NbExp=3; IntAct=EBI-521611, EBI-10172181;
CC       P63096:GNAI1; NbExp=4; IntAct=EBI-521611, EBI-618639;
CC       P81274:GPSM2; NbExp=6; IntAct=EBI-521611, EBI-618655;
CC       Q8VDU0:Gpsm2 (xeno); NbExp=2; IntAct=EBI-10981450, EBI-7575403;
CC       P78406:RAE1; NbExp=6; IntAct=EBI-521611, EBI-724495;
CC       Q9NYB0:TERF2IP; NbExp=2; IntAct=EBI-521611, EBI-750109;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:1541630,
CC       ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:27462074}.
CC       Nucleus, nucleoplasm {ECO:0000269|PubMed:10811826}. Nucleus matrix
CC       {ECO:0000269|PubMed:10075938, ECO:0000269|PubMed:11956313,
CC       ECO:0000269|PubMed:1541636, ECO:0000269|PubMed:7962183}.
CC       Chromosome {ECO:0000269|PubMed:1541630}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12445386,
CC       ECO:0000269|PubMed:26765568}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:10811826,
CC       ECO:0000269|PubMed:1541630, ECO:0000269|PubMed:1541636,
CC       ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:26562023,
CC       ECO:0000269|PubMed:26765568}. Cytoplasm, cytoskeleton, spindle
CC       pole {ECO:0000269|PubMed:10811826, ECO:0000269|PubMed:11781568,
CC       ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12445386,
CC       ECO:0000269|PubMed:1541630, ECO:0000269|PubMed:1541636,
CC       ECO:0000269|PubMed:16076287, ECO:0000269|PubMed:21816348,
CC       ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23870127,
CC       ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24109598,
CC       ECO:0000269|PubMed:24996901, ECO:0000269|PubMed:25657325,
CC       ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26562023,
CC       ECO:0000269|PubMed:27462074, ECO:0000269|PubMed:7769006,
CC       ECO:0000269|PubMed:7962183}. Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:21816348, ECO:0000269|PubMed:22327364,
CC       ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:23921553,
CC       ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24996901}. Cell
CC       membrane {ECO:0000269|PubMed:24371089,
CC       ECO:0000269|PubMed:24996901}; Lipid-anchor
CC       {ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901};
CC       Cytoplasmic side {ECO:0000269|PubMed:24371089,
CC       ECO:0000269|PubMed:24996901}. Lateral cell membrane
CC       {ECO:0000250|UniProtKB:E9Q7G0}. Note=Mitotic cell cycle-dependent
CC       shuttling protein that relocalizes from the interphase nucleus to
CC       the spindle poles and cell cortex (PubMed:1541636,
CC       PubMed:10811826). In interphase, resides in the nuclear matrix
CC       (PubMed:1541630, PubMed:1541636, PubMed:23921553). In prophase,
CC       restricted to the interchromatin or condensed chromosome space
CC       (PubMed:10811826). In prometaphase, after nuclear envelope
CC       disassembly, forms aggregates both in the spindle midzone and at
CC       duplicated centrosomes and astral microtubules (MTs) of the
CC       bipolar spindle apparatus (PubMed:10811826). Translocates from the
CC       spindle midzone towards the spindle poles along spindle fibers in
CC       a MT- and dynein-dynactin-dependent manner until the anaphase
CC       onset (PubMed:1541636, PubMed:10811826). In metaphase, recruited
CC       to the polar cortical region in a GPSM2- and GNAI1-dependent
CC       manner (PubMed:23870127, PubMed:24109598, PubMed:24996901).
CC       Excluded from the metaphase equatorial cortical region in a
CC       RanGTP-dependent manner (PubMed:22327364, PubMed:23870127).
CC       Phosphorylation on Thr-2055 by CDK1 results in its localization at
CC       spindle poles in metaphase, but not at the cell cortex
CC       (PubMed:23921553). In anaphase, recruited and anchored at the cell
CC       membrane of the polar cortical region in a EPB41-, EPB41L2-,
CC       phosphatidylinositol-dependent and GPSM2- and G(i) alpha proteins-
CC       independent manner (PubMed:23870127, PubMed:24996901,
CC       PubMed:24109598, PubMed:24371089). Excluded from the anaphase
CC       equatorial region of the cell cortex in a RACGAP1- and KIF23-
CC       dependent and RanGTP-independent manner (PubMed:24996901).
CC       Associated with astral MTs emanating from the spindle poles during
CC       anaphase (PubMed:12445386, PubMed:24996901). Nonphosphorylated
CC       Thr-2055 localizes at the cell cortex, weakly during metaphase and
CC       more prominently during anaphase in a phosphatase PPP2CA-dependent
CC       manner (PubMed:23921553). As mitosis progresses it reassociates
CC       with telophase chromosomes very early during nuclear reformation,
CC       before substantial accumulation of lamins on chromosomal surfaces
CC       is evident (PubMed:1541636). Localizes to the tips of cortical MTs
CC       in prometaphase (PubMed:26765568). Localizes along MTs and
CC       specifically to both MT plus and minus ends (PubMed:26765568).
CC       Accumulates also at MT tips near the cell periphery
CC       (PubMed:26765568). Colocalizes with GPSM2 at mitotic spindle poles
CC       during mitosis (PubMed:11781568, PubMed:21816348). Colocalizes
CC       with SPAG5 at mitotic spindle at prometaphase and at mitotic
CC       spindle poles at metaphase and anaphase (PubMed:27462074).
CC       Colocalizes with ABRO1 at mitotic spindle poles (PubMed:26195665).
CC       Colocalized with TNKS from prophase through to anaphase in mitosis
CC       (PubMed:16076287). Colocalizes with tubulin alpha
CC       (PubMed:12445386). CCSAP is essential for its centrosomal
CC       localization (PubMed:26562023). In horizontally retinal progenitor
CC       dividing cells, localized to the lateral cortical region (By
CC       similarity). {ECO:0000250|UniProtKB:E9Q7G0,
CC       ECO:0000269|PubMed:10811826, ECO:0000269|PubMed:11781568,
CC       ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:1541630,
CC       ECO:0000269|PubMed:1541636, ECO:0000269|PubMed:16076287,
CC       ECO:0000269|PubMed:21816348, ECO:0000269|PubMed:22327364,
CC       ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:23921553,
CC       ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24371089,
CC       ECO:0000269|PubMed:24996901, ECO:0000269|PubMed:26195665,
CC       ECO:0000269|PubMed:26562023, ECO:0000269|PubMed:26765568,
CC       ECO:0000269|PubMed:27462074}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:7962183}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:7962183}.
CC       Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000269|PubMed:7962183}. Note=During interphase, mainly
CC       clustered at the centrosomal region in the cytosol. After entry
CC       into mitosis, detected at mitotic spindle poles.
CC       {ECO:0000269|PubMed:7962183}.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:7962183}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:7962183}.
CC       Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000269|PubMed:7962183}. Note=During interphase, mainly
CC       clustered at the centrosomal region in the cytosol. After entry
CC       into mitosis, detected at mitotic spindle poles.
CC       {ECO:0000269|PubMed:7962183}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Numa-1, p230;
CC         IsoId=Q14980-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14980-2; Sequence=VSP_012910;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=Numa-m {ECO:0000303|PubMed:7962183}, p195;
CC         IsoId=Q14980-3; Sequence=VSP_044378;
CC       Name=4; Synonyms=Numa-s {ECO:0000303|PubMed:7962183}, p194;
CC         IsoId=Q14980-4; Sequence=VSP_044379;
CC       Name=5;
CC         IsoId=Q14980-5; Sequence=VSP_054146;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The C-terminal tubulin-binding domain mediates direct
CC       binding to microtubules, independently of dynein-dynactin complex,
CC       and induces their bundling and stabilization (PubMed:11956313).
CC       The 4.1-binding domain is necessary for its cortical stability and
CC       spindle orientation (PubMed:24109598).
CC       {ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:24109598}.
CC   -!- PTM: Phosphorylation and dephosphorylation on Thr-2055 regulates
CC       the extent of cortical NUMA1 and the dynein-dynactin complex
CC       localization during mitotic metaphase and anaphase
CC       (PubMed:23921553). In metaphase, phosphorylation on Thr-2055
CC       occurs in a kinase CDK1-dependent manner; this phosphorylation
CC       maintains low levels of cortical dynein-dynactin complex at
CC       metaphase, and hence proper spindle positioning (PubMed:7769006,
CC       PubMed:23921553, PubMed:24371089). In anaphase, dephosphorylated
CC       on Thr-2055 by phosphatase PPP2CA; this dephosphorylation
CC       stimulates its membrane association and with the dynein-dynactin
CC       complex its enrichment at the cell cortex, and hence robust
CC       spindle elongation (PubMed:23921553, PubMed:24371089). Probably
CC       also phosphorylated on Thr-2015 and Ser-2087 by CDK1; these
CC       phosphorylations may regulate its cell cortex recruitment during
CC       metaphase and anaphase (PubMed:23870127). Phosphorylated on Thr-
CC       1047, Ser-1769, Ser-1772, Ser-1789 and Ser-1834 by PLK1; these
CC       phosphorylations induce cortical dynein-dynactin complex
CC       dissociation from the NUMA1-GPSM2 complex and negatively regulates
CC       cortical dynein-dynactin complex localization (PubMed:22327364).
CC       {ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23870127,
CC       ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24371089,
CC       ECO:0000269|PubMed:7769006}.
CC   -!- PTM: ADP-ribosylated by TNKS at the onset of mitosis; ADP-
CC       ribosylation is not required for its localization to spindle poles
CC       (PubMed:16076287). {ECO:0000269|PubMed:16076287}.
CC   -!- PTM: O-glycosylated during cytokinesis at sites identical or close
CC       to phosphorylation sites, this interferes with the phosphorylation
CC       status (PubMed:20068230). {ECO:0000269|PubMed:20068230}.
CC   -!- PTM: Ubiquitinated with 'Lys-63'-linked polyubiquitin chains.
CC       Deubiquitination by the BRISC complex is important for the
CC       incorporation of NUMA1 into mitotic spindle poles and normal
CC       spindle pole function, probably by modulating interactions between
CC       NUMA1, dynein-dynactin complex and importin-beta.
CC       {ECO:0000269|PubMed:26195665}.
CC   -!- MISCELLANEOUS: Also known as nuclear matrix protein-22/NMP-
CC       22/NMP22, an antigen used in diagnostic tests of bladder cancer.
CC       {ECO:0000269|PubMed:9730450}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA77670.1; Type=Frameshift; Positions=1270, 1299; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NUMAID119.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z14227; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Z14228; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Z14229; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Z11583; CAA77669.1; -; mRNA.
DR   EMBL; Z11584; CAA77670.1; ALT_FRAME; mRNA.
DR   EMBL; AP002490; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74826.1; -; Genomic_DNA.
DR   EMBL; BC004165; AAH04165.1; -; mRNA.
DR   CCDS; CCDS31633.1; -. [Q14980-1]
DR   CCDS; CCDS66156.1; -. [Q14980-2]
DR   PIR; A42184; A42184.
DR   RefSeq; NP_001273490.1; NM_001286561.1. [Q14980-2]
DR   RefSeq; NP_006176.2; NM_006185.3. [Q14980-1]
DR   RefSeq; XP_006718627.1; XM_006718564.1. [Q14980-1]
DR   UniGene; Hs.325978; -.
DR   UniGene; Hs.591967; -.
DR   PDB; 3RO2; X-ray; 2.30 A; B=1899-1926.
DR   PDB; 5GXW; X-ray; 2.39 A; B=1984-2010.
DR   PDBsum; 3RO2; -.
DR   PDBsum; 5GXW; -.
DR   ProteinModelPortal; Q14980; -.
DR   SMR; Q14980; -.
DR   BioGrid; 110980; 106.
DR   CORUM; Q14980; -.
DR   DIP; DIP-32937N; -.
DR   ELM; Q14980; -.
DR   IntAct; Q14980; 41.
DR   MINT; Q14980; -.
DR   STRING; 9606.ENSP00000377298; -.
DR   CarbonylDB; Q14980; -.
DR   iPTMnet; Q14980; -.
DR   PhosphoSitePlus; Q14980; -.
DR   SwissPalm; Q14980; -.
DR   BioMuta; NUMA1; -.
DR   DMDM; 145559510; -.
DR   EPD; Q14980; -.
DR   MaxQB; Q14980; -.
DR   PaxDb; Q14980; -.
DR   PeptideAtlas; Q14980; -.
DR   PRIDE; Q14980; -.
DR   DNASU; 4926; -.
DR   Ensembl; ENST00000351960; ENSP00000260051; ENSG00000137497. [Q14980-5]
DR   Ensembl; ENST00000358965; ENSP00000351851; ENSG00000137497. [Q14980-2]
DR   Ensembl; ENST00000393695; ENSP00000377298; ENSG00000137497. [Q14980-1]
DR   Ensembl; ENST00000613205; ENSP00000480172; ENSG00000137497. [Q14980-5]
DR   Ensembl; ENST00000620566; ENSP00000478624; ENSG00000137497. [Q14980-2]
DR   GeneID; 4926; -.
DR   KEGG; hsa:4926; -.
DR   UCSC; uc001ork.3; human. [Q14980-1]
DR   CTD; 4926; -.
DR   DisGeNET; 4926; -.
DR   EuPathDB; HostDB:ENSG00000137497.17; -.
DR   GeneCards; NUMA1; -.
DR   H-InvDB; HIX0026234; -.
DR   HGNC; HGNC:8059; NUMA1.
DR   HPA; HPA019841; -.
DR   HPA; HPA019859; -.
DR   HPA; HPA029912; -.
DR   MalaCards; NUMA1; -.
DR   MIM; 164009; gene.
DR   neXtProt; NX_Q14980; -.
DR   OpenTargets; ENSG00000137497; -.
DR   Orphanet; 520; Acute promyelocytic leukemia.
DR   PharmGKB; PA31844; -.
DR   eggNOG; ENOG410IFJ8; Eukaryota.
DR   eggNOG; ENOG41125FF; LUCA.
DR   GeneTree; ENSGT00730000111158; -.
DR   HOGENOM; HOG000113889; -.
DR   HOVERGEN; HBG052694; -.
DR   InParanoid; Q14980; -.
DR   KO; K16808; -.
DR   OMA; HLTAQVR; -.
DR   OrthoDB; EOG091G00XV; -.
DR   PhylomeDB; Q14980; -.
DR   TreeFam; TF334442; -.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-68875; Mitotic Prophase.
DR   SIGNOR; Q14980; -.
DR   ChiTaRS; NUMA1; human.
DR   GeneWiki; Nuclear_mitotic_apparatus_protein_1; -.
DR   GenomeRNAi; 4926; -.
DR   PRO; PR:Q14980; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000137497; -.
DR   CleanEx; HS_NUMA1; -.
DR   ExpressionAtlas; Q14980; baseline and differential.
DR   Genevisible; Q14980; HS.
DR   GO; GO:0005938; C:cell cortex; IDA:UniProtKB.
DR   GO; GO:0099738; C:cell cortex region; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0055028; C:cortical microtubule; IDA:UniProtKB.
DR   GO; GO:1905720; C:cytoplasmic microtubule bundle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0019897; C:extrinsic component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:InterPro.
DR   GO; GO:0097575; C:lateral cell cortex; ISS:UniProtKB.
DR   GO; GO:0016328; C:lateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0097427; C:microtubule bundle; IDA:UniProtKB.
DR   GO; GO:0036449; C:microtubule minus-end; IDA:UniProtKB.
DR   GO; GO:0035371; C:microtubule plus-end; IDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0061673; C:mitotic spindle astral microtubule; IDA:UniProtKB.
DR   GO; GO:1990023; C:mitotic spindle midzone; IDA:UniProtKB.
DR   GO; GO:0097431; C:mitotic spindle pole; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; TAS:ProtInc.
DR   GO; GO:0005876; C:spindle microtubule; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0031616; C:spindle pole centrosome; IDA:UniProtKB.
DR   GO; GO:0097718; F:disordered domain specific binding; IMP:CAFA.
DR   GO; GO:0070840; F:dynein complex binding; IDA:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0051011; F:microtubule minus-end binding; IDA:UniProtKB.
DR   GO; GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB.
DR   GO; GO:0008022; F:protein C-terminus binding; IMP:CAFA.
DR   GO; GO:0032403; F:protein complex binding; IDA:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; TAS:ProtInc.
DR   GO; GO:0015631; F:tubulin binding; IDA:UniProtKB.
DR   GO; GO:0055048; P:anastral spindle assembly; IMP:UniProtKB.
DR   GO; GO:0030953; P:astral microtubule organization; IDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW.
DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IDA:UniProtKB.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:Ensembl.
DR   GO; GO:0001578; P:microtubule bundle formation; IMP:UniProtKB.
DR   GO; GO:0006997; P:nucleus organization; TAS:ProtInc.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProtKB.
DR   GO; GO:0051984; P:positive regulation of chromosome segregation; IMP:UniProtKB.
DR   GO; GO:1905820; P:positive regulation of chromosome separation; IMP:UniProtKB.
DR   GO; GO:0051798; P:positive regulation of hair follicle development; ISS:UniProtKB.
DR   GO; GO:0032388; P:positive regulation of intracellular transport; IMP:UniProtKB.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IMP:UniProtKB.
DR   GO; GO:1902846; P:positive regulation of mitotic spindle elongation; IMP:UniProtKB.
DR   GO; GO:1904778; P:positive regulation of protein localization to cell cortex; IMP:UniProtKB.
DR   GO; GO:1902365; P:positive regulation of protein localization to spindle pole body; IDA:UniProtKB.
DR   GO; GO:1905832; P:positive regulation of spindle assembly; IMP:UniProtKB.
DR   GO; GO:0090235; P:regulation of metaphase plate congression; IMP:UniProtKB.
DR   GO; GO:0060236; P:regulation of mitotic spindle organization; IDA:UniProtKB.
DR   InterPro; IPR026650; NUMA1.
DR   PANTHER; PTHR18902:SF24; PTHR18902:SF24; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ADP-ribosylation; Alternative splicing;
KW   Cell cycle; Cell division; Cell membrane; Chromosome;
KW   Chromosome partition; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Glycoprotein; Isopeptide bond; Lipid-binding;
KW   Lipoprotein; Membrane; Microtubule; Mitosis; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN         1   2115       Nuclear mitotic apparatus protein 1.
FT                                /FTId=PRO_0000057998.
FT   REGION        1    212       Head (Globular).
FT   REGION     1699   1876       Membrane-binding domain 1.
FT                                {ECO:0000269|PubMed:24996901}.
FT   REGION     1700   2115       Tail (Globular).
FT   REGION     1788   1810       4.1-binding domain.
FT                                {ECO:0000269|PubMed:24109598,
FT                                ECO:0000269|PubMed:24996901}.
FT   REGION     1882   1985       Tubulin-binding domain.
FT                                {ECO:0000269|PubMed:11956313,
FT                                ECO:0000269|PubMed:12445386}.
FT   REGION     1892   1926       GPSM2-binding domain.
FT                                {ECO:0000269|PubMed:11781568,
FT                                ECO:0000269|PubMed:12445386,
FT                                ECO:0000269|PubMed:21816348,
FT                                ECO:0000269|PubMed:24109598}.
FT   REGION     1981   2060       Membrane-binding domain 2.
FT                                {ECO:0000269|PubMed:24371089}.
FT   COILED      213   1699       {ECO:0000255}.
FT   MOTIF      1742   1748       Tankyrase-binding domain.
FT                                {ECO:0000269|PubMed:12080061}.
FT   MOTIF      1984   1989       Nuclear localization signal.
FT                                {ECO:0000269|PubMed:26765568,
FT                                ECO:0000269|PubMed:7962183}.
FT   MOD_RES     162    162       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     163    163       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     169    169       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     203    203       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     211    211       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     271    271       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     379    379       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     388    388       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     395    395       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     820    820       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     891    891       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1047   1047       Phosphothreonine; by PLK1.
FT                                {ECO:0000269|PubMed:22327364}.
FT   MOD_RES    1187   1187       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1225   1225       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1511   1511       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1601   1601       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES    1721   1721       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1724   1724       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1728   1728       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1757   1757       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1760   1760       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES    1769   1769       Phosphoserine; by PLK1.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:22327364}.
FT   MOD_RES    1772   1772       Phosphoserine; by PLK1.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000269|PubMed:22327364}.
FT   MOD_RES    1774   1774       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1776   1776       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1788   1788       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1789   1789       Phosphoserine; by PLK1.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000269|PubMed:22327364}.
FT   MOD_RES    1792   1792       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1800   1800       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1804   1804       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1830   1830       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1833   1833       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1834   1834       Phosphoserine; by PLK1.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:22327364}.
FT   MOD_RES    1836   1836       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1840   1840       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1844   1844       Phosphoserine; alternate.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1862   1862       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1887   1887       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1969   1969       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1991   1991       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2000   2000       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2003   2003       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES    2015   2015       Phosphothreonine; by CDK1.
FT                                {ECO:0000269|PubMed:23921553,
FT                                ECO:0000269|PubMed:7769006}.
FT   MOD_RES    2047   2047       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2055   2055       Phosphothreonine; by CDK1.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:23921553,
FT                                ECO:0000269|PubMed:7769006}.
FT   MOD_RES    2062   2062       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2077   2077       Phosphoserine.
FT                                {ECO:0000244|PubMed:17924679}.
FT   MOD_RES    2087   2087       Phosphoserine; by CDK1.
FT                                {ECO:0000269|PubMed:23921553,
FT                                ECO:0000269|PubMed:7769006}.
FT   MOD_RES    2106   2106       Phosphothreonine; by CDK1.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000269|PubMed:23921553,
FT                                ECO:0000269|PubMed:7769006}.
FT   CARBOHYD   1844   1844       O-linked (GlcNAc) serine; alternate.
FT                                {ECO:0000269|PubMed:20068230}.
FT   CROSSLNK   1699   1699       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1766   1766       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK   1766   1766       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1822   1822       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     414   1549       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054146.
FT   VAR_SEQ    1536   1549       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1541636}.
FT                                /FTId=VSP_012910.
FT   VAR_SEQ    1725   2115       LDLSCEEGTPLSITSKLPRTQPDGTSVPGEPASPISQRLPP
FT                                KVESLESLYFTPIPARSQAPLESSLDSLGDVFLDSGRKTRS
FT                                ARRRTTQIINITMTKKLDVEEPDSANSSFYSTRSAPASQAS
FT                                LRATSSTQSLARLGSPDYGNSALLSLPGYRPTTRSSARRSQ
FT                                AGVSSGAPPGRNSFYMGTCQDEPEQLDDWNRIAELQQRNRV
FT                                CPPHLKTCYPLESRPSLSLGTITDEEMKTGDPQETLRRASM
FT                                QPIQIAEGTGITTRQQRKRVSLEPHQGPGTPESKKATSCFP
FT                                RPMTPRDRHEGRKQSTTEAQKKAAPASTKQADRRQSMAFSI
FT                                LNTPKKLGNSLLRRGASKKALSKASPNTRSGTRRSPRIATT
FT                                TASAATAAAIGATPRAKGKAKH -> SQANSSQTPRDSDAC
FT                                PHPGLVPGPSLAPSRSWPRGPGAWTVWALSLPCLLFS (in
FT                                isoform 3). {ECO:0000303|PubMed:8505359}.
FT                                /FTId=VSP_044378.
FT   VAR_SEQ    1739   2115       SKLPRTQPDGTSVPGEPASPISQRLPPKVESLESLYFTPIP
FT                                ARSQAPLESSLDSLGDVFLDSGRKTRSARRRTTQIINITMT
FT                                KKLDVEEPDSANSSFYSTRSAPASQASLRATSSTQSLARLG
FT                                SPDYGNSALLSLPGYRPTTRSSARRSQAGVSSGAPPGRNSF
FT                                YMGTCQDEPEQLDDWNRIAELQQRNRVCPPHLKTCYPLESR
FT                                PSLSLGTITDEEMKTGDPQETLRRASMQPIQIAEGTGITTR
FT                                QQRKRVSLEPHQGPGTPESKKATSCFPRPMTPRDRHEGRKQ
FT                                STTEAQKKAAPASTKQADRRQSMAFSILNTPKKLGNSLLRR
FT                                GASKKALSKASPNTRSGTRRSPRIATTTASAATAAAIGATP
FT                                RAKGKAKH -> RSGGSLPPYVCLWSACCLSGCILVR (in
FT                                isoform 4). {ECO:0000303|PubMed:8505359}.
FT                                /FTId=VSP_044379.
FT   VARIANT     242    242       K -> R (in dbSNP:rs34239655).
FT                                /FTId=VAR_031679.
FT   VARIANT     794    794       A -> G (in dbSNP:rs3750913).
FT                                /FTId=VAR_031680.
FT   VARIANT    1153   1153       E -> D (in dbSNP:rs34311364).
FT                                /FTId=VAR_031681.
FT   VARIANT    1825   1825       V -> M (in dbSNP:rs7949430).
FT                                /FTId=VAR_031682.
FT   VARIANT    1836   1836       Y -> H (in dbSNP:rs35586429).
FT                                /FTId=VAR_031683.
FT   VARIANT    2049   2049       A -> T (in dbSNP:rs5743685).
FT                                /FTId=VAR_051248.
FT   MUTAGEN    1910   1910       E->A: Abolishes interaction with GPSM2.
FT                                {ECO:0000269|PubMed:21816348}.
FT   MUTAGEN    1984   1984       R->G: No effect on nuclear localization.
FT                                {ECO:0000269|PubMed:7962183}.
FT   MUTAGEN    1988   1988       K->E: Abolishes nuclear localization.
FT                                {ECO:0000269|PubMed:7962183}.
FT   MUTAGEN    2015   2015       T->A: Abolishes association with the
FT                                mitotic spindle. Increases premature
FT                                accumulation at the cell cortex during
FT                                metaphase; when associated with A-2055
FT                                and A-2087. {ECO:0000269|PubMed:23870127,
FT                                ECO:0000269|PubMed:7769006}.
FT   MUTAGEN    2055   2055       T->A: Increases premature accumulation at
FT                                the cell membrane of the polar cortical
FT                                region in prophase and metaphase. Reduces
FT                                association with the mitotic spindle.
FT                                Increased randomization of spindle
FT                                orientation. Increases premature
FT                                accumulation at the cell cortex during
FT                                metaphase; when associated with A-2015
FT                                and A-2087. {ECO:0000269|PubMed:23870127,
FT                                ECO:0000269|PubMed:23921553,
FT                                ECO:0000269|PubMed:24109598,
FT                                ECO:0000269|PubMed:24371089,
FT                                ECO:0000269|PubMed:24996901,
FT                                ECO:0000269|PubMed:7769006}.
FT   MUTAGEN    2055   2055       T->D: Increases localization at the
FT                                spindle poles. Decreases localization at
FT                                the cell cortex.
FT                                {ECO:0000269|PubMed:24109598}.
FT   MUTAGEN    2055   2055       T->E: Absence of cell membrane
FT                                association even in anaphase. Increased
FT                                localization at spindle poles and
FT                                chromosome congression defects. Does not
FT                                localize to the cortex in either
FT                                metaphase or anaphase. Increased
FT                                randomization of spindle orientation.
FT                                {ECO:0000269|PubMed:23921553,
FT                                ECO:0000269|PubMed:24371089}.
FT   MUTAGEN    2087   2087       S->A: Abolishes association with the
FT                                mitotic spindle. Increases premature
FT                                accumulation at the cell cortex during
FT                                metaphase; when associated with A-2015
FT                                and A-2055. {ECO:0000269|PubMed:23870127,
FT                                ECO:0000269|PubMed:7769006}.
FT   MUTAGEN    2106   2106       T->A: Abolishes association with the
FT                                mitotic spindle.
FT                                {ECO:0000269|PubMed:7769006}.
FT   CONFLICT    772    772       Q -> L (in Ref. 2; CAA77670).
FT                                {ECO:0000305}.
FT   CONFLICT    815    816       ER -> DG (in Ref. 2; CAA77670).
FT                                {ECO:0000305}.
FT   CONFLICT    873    873       E -> K (in Ref. 2; CAA77670).
FT                                {ECO:0000305}.
FT   CONFLICT   1589   1589       L -> F (in Ref. 2; CAA77670).
FT                                {ECO:0000305}.
FT   CONFLICT   1637   1637       S -> T (in Ref. 3; Z14227/Z14228).
FT                                {ECO:0000305}.
FT   CONFLICT   1682   1682       S -> T (in Ref. 3; Z14227/Z14228).
FT                                {ECO:0000305}.
FT   CONFLICT   1798   1798       L -> Q (in Ref. 3; CAA77669).
FT                                {ECO:0000305}.
FT   TURN       1917   1919       {ECO:0000244|PDB:3RO2}.
FT   HELIX      1920   1922       {ECO:0000244|PDB:3RO2}.
FT   STRAND     1995   1997       {ECO:0000244|PDB:5GXW}.
SQ   SEQUENCE   2115 AA;  238260 MW;  DE734EC85B812CC7 CRC64;
     MTLHATRGAA LLSWVNSLHV ADPVEAVLQL QDCSIFIKII DRIHGTEEGQ QILKQPVSER
     LDFVCSFLQK NRKHPSSPEC LVSAQKVLEG SELELAKMTM LLLYHSTMSS KSPRDWEQFE
     YKIQAELAVI LKFVLDHEDG LNLNEDLENF LQKAPVPSTC SSTFPEELSP PSHQAKREIR
     FLELQKVASS SSGNNFLSGS PASPMGDILQ TPQFQMRRLK KQLADERSNR DELELELAEN
     RKLLTEKDAQ IAMMQQRIDR LALLNEKQAA SPLEPKELEE LRDKNESLTM RLHETLKQCQ
     DLKTEKSQMD RKINQLSEEN GDLSFKLREF ASHLQQLQDA LNELTEEHSK ATQEWLEKQA
     QLEKELSAAL QDKKCLEEKN EILQGKLSQL EEHLSQLQDN PPQEKGEVLG DVLQLETLKQ
     EAATLAANNT QLQARVEMLE TERGQQEAKL LAERGHFEEE KQQLSSLITD LQSSISNLSQ
     AKEELEQASQ AHGARLTAQV ASLTSELTTL NATIQQQDQE LAGLKQQAKE KQAQLAQTLQ
     QQEQASQGLR HQVEQLSSSL KQKEQQLKEV AEKQEATRQD HAQQLATAAE EREASLRERD
     AALKQLEALE KEKAAKLEIL QQQLQVANEA RDSAQTSVTQ AQREKAELSR KVEELQACVE
     TARQEQHEAQ AQVAELELQL RSEQQKATEK ERVAQEKDQL QEQLQALKES LKVTKGSLEE
     EKRRAADALE EQQRCISELK AETRSLVEQH KRERKELEEE RAGRKGLEAR LQQLGEAHQA
     ETEVLRRELA EAMAAQHTAE SECEQLVKEV AAWRERYEDS QQEEAQYGAM FQEQLMTLKE
     ECEKARQELQ EAKEKVAGIE SHSELQISRQ QNELAELHAN LARALQQVQE KEVRAQKLAD
     DLSTLQEKMA ATSKEVARLE TLVRKAGEQQ ETASRELVKE PARAGDRQPE WLEEQQGRQF
     CSTQAALQAM EREAEQMGNE LERLRAALME SQGQQQEERG QQEREVARLT QERGRAQADL
     ALEKAARAEL EMRLQNALNE QRVEFATLQE ALAHALTEKE GKDQELAKLR GLEAAQIKEL
     EELRQTVKQL KEQLAKKEKE HASGSGAQSE AAGRTEPTGP KLEALRAEVS KLEQQCQKQQ
     EQADSLERSL EAERASRAER DSALETLQGQ LEEKAQELGH SQSALASAQR ELAAFRTKVQ
     DHSKAEDEWK AQVARGRQEA ERKNSLISSL EEEVSILNRQ VLEKEGESKE LKRLVMAESE
     KSQKLEERLR LLQAETASNS ARAAERSSAL REEVQSLREE AEKQRVASEN LRQELTSQAE
     RAEELGQELK AWQEKFFQKE QALSTLQLEH TSTQALVSEL LPAKHLCQQL QAEQAAAEKR
     HREELEQSKQ AAGGLRAELL RAQRELGELI PLRQKVAEQE RTAQQLRAEK ASYAEQLSML
     KKAHGLLAEE NRGLGERANL GRQFLEVELD QAREKYVQEL AAVRADAETR LAEVQREAQS
     TARELEVMTA KYEGAKVKVL EERQRFQEER QKLTAQVEQL EVFQREQTKQ VEELSKKLAD
     SDQASKVQQQ KLKAVQAQGG ESQQEAQRLQ AQLNELQAQL SQKEQAAEHY KLQMEKAKTH
     YDAKKQQNQE LQEQLRSLEQ LQKENKELRA EAERLGHELQ QAGLKTKEAE QTCRHLTAQV
     RSLEAQVAHA DQQLRDLGKF QVATDALKSR EPQAKPQLDL SIDSLDLSCE EGTPLSITSK
     LPRTQPDGTS VPGEPASPIS QRLPPKVESL ESLYFTPIPA RSQAPLESSL DSLGDVFLDS
     GRKTRSARRR TTQIINITMT KKLDVEEPDS ANSSFYSTRS APASQASLRA TSSTQSLARL
     GSPDYGNSAL LSLPGYRPTT RSSARRSQAG VSSGAPPGRN SFYMGTCQDE PEQLDDWNRI
     AELQQRNRVC PPHLKTCYPL ESRPSLSLGT ITDEEMKTGD PQETLRRASM QPIQIAEGTG
     ITTRQQRKRV SLEPHQGPGT PESKKATSCF PRPMTPRDRH EGRKQSTTEA QKKAAPASTK
     QADRRQSMAF SILNTPKKLG NSLLRRGASK KALSKASPNT RSGTRRSPRI ATTTASAATA
     AAIGATPRAK GKAKH
//
ID   Q3SYK8_HUMAN            Unreviewed;       691 AA.
AC   Q3SYK8;
DT   11-OCT-2005, integrated into UniProtKB/TrEMBL.
DT   11-OCT-2005, sequence version 1.
DT   28-FEB-2018, entry version 78.
DE   SubName: Full=NUMA1 protein {ECO:0000313|EMBL:AAI03766.1};
DE   Flags: Fragment;
GN   Name=NUMA1 {ECO:0000313|EMBL:AAI03766.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI03766.1};
RN   [1] {ECO:0000313|EMBL:AAI03766.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis {ECO:0000313|EMBL:AAH27493.1}, and
RC   Uterus {ECO:0000313|EMBL:AAI03766.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC027493; AAH27493.1; -; mRNA.
DR   EMBL; BC103765; AAI03766.1; -; mRNA.
DR   RefSeq; NP_006176.2; NM_006185.3.
DR   UniGene; Hs.325978; -.
DR   UniGene; Hs.591967; -.
DR   PeptideAtlas; Q3SYK8; -.
DR   DNASU; 4926; -.
DR   GeneID; 4926; -.
DR   KEGG; hsa:4926; -.
DR   CTD; 4926; -.
DR   PharmGKB; PA31844; -.
DR   eggNOG; ENOG410IFJ8; Eukaryota.
DR   eggNOG; ENOG41125FF; LUCA.
DR   HOVERGEN; HBG084534; -.
DR   KO; K16808; -.
DR   ChiTaRS; NUMA1; human.
DR   GenomeRNAi; 4926; -.
DR   GO; GO:0000139; C:Golgi membrane; IEA:InterPro.
DR   InterPro; IPR026650; NUMA1.
DR   PANTHER; PTHR18902:SF24; PTHR18902:SF24; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED      216    250       {ECO:0000256|SAM:Coils}.
FT   COILED      278    319       {ECO:0000256|SAM:Coils}.
FT   COILED      327    400       {ECO:0000256|SAM:Coils}.
FT   COILED      415    449       {ECO:0000256|SAM:Coils}.
FT   COILED      468    491       {ECO:0000256|SAM:Coils}.
FT   COILED      500    686       {ECO:0000256|SAM:Coils}.
FT   NON_TER     691    691       {ECO:0000313|EMBL:AAI03766.1}.
SQ   SEQUENCE   691 AA;  78315 MW;  06AB1952EDEE9A3D CRC64;
     MTLHATRGAA LLSWVNSLHV ADPVEAVLQL QDCSIFIKII DRIHGTEEGQ QILKQPVSER
     LDFVCSFLQK NRKHPSSPEC LVSAQKVLEG SELELAKMTM LLLYHSTMSS KSPRDWEQFE
     YKIQAELAVI LKFVLDHEDG LNLNEDLENF LQKAPVPSTC SSTFPEELSP PSHQAKREIR
     FLELQKVASS SSGNNFLSGS PASPMGDILQ TPQFQMRRLK KQLADERSNR DELELELAEN
     RKLLTEKDAQ IAMMQQRIDR LALLNEKQAA SPLEPKELEE LRDKNESLTM RLHETLKQCQ
     DLKTEKSQMD RKINQLSEEN GDLSFKLREF ASHLQQLQDA LNELTEEHSK ATQEWLEKQA
     QLEKELSAAL QDKKCLEEKN EILQGKLSQL EEHLSQLQDN PPQEKGEVLG DVLQLETLKQ
     EAATLAANNT QLQARVEMLE TERGQQEAKL LAERGHFEEE KQQLSSLITD LQSSISNLSQ
     AKEELEQASQ AHGARLTAQV ASLTSELTTL NATIQQQDQE LAGLKQQAKE KQAQLAQTLQ
     QQEQASQGLR HQVEQLSSSL KQKEQQLKEV AEKQEATRQD HAQQLATAAE EREASLRERD
     AALKQLEALE KEKAAKLEIL QQQLQVANEA RDSAQTSVTQ AQREKAELSR KVEELQACVE
     TARQEQHEAQ AQVAELELQL RSEQQKAKKK K
//
ID   Q4LE64_HUMAN            Unreviewed;      2121 AA.
AC   Q4LE64;
DT   02-AUG-2005, integrated into UniProtKB/TrEMBL.
DT   02-AUG-2005, sequence version 1.
DT   31-JAN-2018, entry version 75.
DE   SubName: Full=NUMA1 variant protein {ECO:0000313|EMBL:BAE06089.1};
DE   Flags: Fragment;
GN   Name=NUMA1 variant protein {ECO:0000313|EMBL:BAE06089.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAE06089.1};
RN   [1] {ECO:0000313|EMBL:BAE06089.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAE06089.1};
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M.,
RA   Ohara R., Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long
RT   cDNAs encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB210007; BAE06089.1; -; mRNA.
DR   RefSeq; NP_001273490.1; NM_001286561.1.
DR   RefSeq; NP_006176.2; NM_006185.3.
DR   RefSeq; XP_006718627.1; XM_006718564.1.
DR   UniGene; Hs.325978; -.
DR   UniGene; Hs.591967; -.
DR   ProteinModelPortal; Q4LE64; -.
DR   PRIDE; Q4LE64; -.
DR   DNASU; 4926; -.
DR   GeneID; 4926; -.
DR   KEGG; hsa:4926; -.
DR   CTD; 4926; -.
DR   PharmGKB; PA31844; -.
DR   eggNOG; ENOG410IFJ8; Eukaryota.
DR   eggNOG; ENOG41125FF; LUCA.
DR   HOGENOM; HOG000113889; -.
DR   HOVERGEN; HBG052694; -.
DR   KO; K16808; -.
DR   ChiTaRS; NUMA1; human.
DR   GenomeRNAi; 4926; -.
DR   Genevisible; Q4LE64; HS.
DR   GO; GO:0000139; C:Golgi membrane; IEA:InterPro.
DR   InterPro; IPR026650; NUMA1.
DR   PANTHER; PTHR18902:SF24; PTHR18902:SF24; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED      222    256       {ECO:0000256|SAM:Coils}.
FT   COILED      284    325       {ECO:0000256|SAM:Coils}.
FT   COILED      333    406       {ECO:0000256|SAM:Coils}.
FT   COILED      421    455       {ECO:0000256|SAM:Coils}.
FT   COILED      474    497       {ECO:0000256|SAM:Coils}.
FT   COILED      506    783       {ECO:0000256|SAM:Coils}.
FT   COILED      795    829       {ECO:0000256|SAM:Coils}.
FT   COILED      834    868       {ECO:0000256|SAM:Coils}.
FT   COILED      873    928       {ECO:0000256|SAM:Coils}.
FT   COILED      973   1046       {ECO:0000256|SAM:Coils}.
FT   COILED     1072   1106       {ECO:0000256|SAM:Coils}.
FT   COILED     1128   1162       {ECO:0000256|SAM:Coils}.
FT   COILED     1177   1211       {ECO:0000256|SAM:Coils}.
FT   COILED     1219   1281       {ECO:0000256|SAM:Coils}.
FT   COILED     1286   1341       {ECO:0000256|SAM:Coils}.
FT   COILED     1373   1411       {ECO:0000256|SAM:Coils}.
FT   COILED     1415   1449       {ECO:0000256|SAM:Coils}.
FT   COILED     1468   1517       {ECO:0000256|SAM:Coils}.
FT   COILED     1522   1549       {ECO:0000256|SAM:Coils}.
FT   COILED     1578   1699       {ECO:0000256|SAM:Coils}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAE06089.1}.
SQ   SEQUENCE   2121 AA;  238859 MW;  32080FE79C65BA1D CRC64;
     LSGITKMTLH ATRGAALLSW VNSLHVADPV EAVLQLQDCS IFIKIIDRIH GTEEGQQILK
     QPVSERLDFV CSFLQKNRKH PSSPECLVSA QKVLEGSELE LAKMTMLLLY HSTMSSKSPR
     DWEQFEYKIQ AELAVILKFV LDHEDGLNLN EDLENFLQKA PVPSTCSSTF PEELSPPSHQ
     AKREIRFLEL QKVASSSSGN NFLSGSPASP MGDILQTPQF QMRRLKKQLA DERSNRDELE
     LELAENRKLL TEKDAQIAMM QQRIDRLALL NEKQAASPLE PKELEELRDK NESLTMRLHE
     TLKQCQDLKT EKSQMDRKIN QLSEENGDLS FKLREFASHL QQLQDALNEL TEEHSKATQE
     WLEKQAQLEK ELSAALQDKK CLEEKNEILQ GKLSQLEEHL SQLQDNPPQE KGEVLGDVLQ
     LETLKQEAAT LAANNTQLQA RVEMLETERG QQEAKLLAER GHFEEEKQQL SSLITDLQSS
     ISNLSQAKEE LEQASQAHGA RLTAQVASLT SELTTLNATI QQQDQELAGL KQQAKEKQAQ
     LAQTLQQQEQ ASQGLRHQVE QLSSSLKQKE QQLKEVAEKQ EATRQDHAQQ LATAAEEREA
     SLRERDAALK QLEALEKEKA AKLEILQQQL QVANEARDSA QTSVTQAQRE KAELSRKVEE
     LQACVETARQ EQHEAQAQVA ELELQLRSEQ QKATEKERVA QEKDQLQEQL QALKESLKVT
     KGSLEEEKRR AADALEEQQR CISELKAETR SLVEQHKRER KELEEERAGR KGLEARLQQL
     GEAHQAETEV LRRELAEAMA AQHTAESECE QLVKEVAAWR ERYEDSQQEE AQYGAMFQEQ
     LMTLKEECEK ARQELQEAKE KVAGIESHSE LQISRQQNEL AELHANLARA LQQVQEKEVR
     AQKLADDLST LQEKMAATSK EVARLETLVR KAGEQQETAS RELVKEPARA GDRQPEWLEE
     QQGRQFCSTQ AALQAMEREA EQMGNELERL RAALMESQGQ QQEERGQQER EVARLTQERG
     RAQADLALEK AARAELEMRL QNALNEQRVE FATLQEALAH ALTEKEGKDQ ELAKLRGLEA
     AQIKELEELR QTVKQLKEQL AKKEKEHASG SGAQSEAAGR TEPTGPKLEA LRAEVSKLEQ
     QCQKQQEQAD SLERSLEAER ASRAERDSAL ETLQGQLEEK AQELGHSQSA LASAQRELAA
     FRTKVQDHSK AEDEWKAQVA RGRQEAERKN SLISSLEEEV SILNRQVLEK EGESKELKRL
     VMAESEKSQK LEERLRLLQA ETASNSARAA ERSSALREEV QSLREEAEKQ RVASENLRQE
     LTSQAERAEE LGQELKAWQE KFFQKEQALS TLQLEHTSTQ ALVSELLPAK HLCQQLQAEQ
     AAAEKRHREE LEQSKQAAGG LRAELLRAQR ELGELIPLRQ KVAEQERTAQ QLRAEKASYA
     EQLSMLKKAH GLLAEENRGL GERANLGRQF LEVELDQARE KYVQELAAVR ADAETRLAEV
     QREAQSTARE LEVMTAKYEG AKVKVLEERQ RFQEERQKLT AQVEQLEVFQ REQTKQVEEL
     SKKLADSDQA SKVQQQKLKA VQAQGGESQQ EAQRLQAQLN ELQAQLSQKE QAAEHYKLQM
     EKAKTHYDAK KQQNQELQEQ LRSLEQLQKE NKELRAEAER LGHELQQAGL KTKEAEQTCR
     HLTAQVRSLE AQVAHADQQL RDLGKFQVAT DALKSREPQA KPQLDLSIDS LDLSCEEGTP
     LSITSKLPRT QPDGTSVPGE PASPISQRLP PKVESLESLY FTPIPARSQA PLESSLDSLG
     DVFLDSGRKT RSARRRTTQI INITMTKKLD VEEPDSANSS FYSTRSAPAS QASLRATSST
     QSLARLGSPD YGNSALLSLP GYRPTTRSSA RRSQAGVSSG APPGRNSFYM GTCQDEPEQL
     DDWNRIAELQ QRNRVCPPHL KTCYPLESRP SLSLGTITDE EMKTGDPQET LRRASMQPIQ
     IAEGTGITTR QQRKRVSLEP HQGPGTPESK KATSCFPRPM TPRDRHEGRK QSTTEAQKKA
     APASTKQADR RQSMAFSILN TPKKLGNSLL RRGASKKALS KASPNTRSGT RRSPRIATTT
     ASAATAAAIG ATPRAKGKAK H
//
ID   B7ZAV2_HUMAN            Unreviewed;       916 AA.
AC   B7ZAV2;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   28-FEB-2018, entry version 66.
DE   SubName: Full=Nuclear pore complex protein Nup214 {ECO:0000313|Ensembl:ENSP00000436793};
DE   SubName: Full=cDNA, FLJ79316, highly similar to Nuclear pore complex protein Nup214 {ECO:0000313|EMBL:BAH14788.1};
GN   Name=NUP214 {ECO:0000313|Ensembl:ENSP00000436793};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH14788.1};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000436793}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [4] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5] {ECO:0000313|EMBL:BAH14788.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAH14788.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [7] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8] {ECO:0000313|Ensembl:ENSP00000436793}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [9] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL157938; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK316417; BAH14788.1; -; mRNA.
DR   RefSeq; NP_001305254.1; NM_001318325.1.
DR   UniGene; Hs.654530; -.
DR   MaxQB; B7ZAV2; -.
DR   PeptideAtlas; B7ZAV2; -.
DR   Ensembl; ENST00000483497; ENSP00000436793; ENSG00000126883.
DR   GeneID; 8021; -.
DR   UCSC; uc011mcg.4; human.
DR   CTD; 8021; -.
DR   EuPathDB; HostDB:ENSG00000126883.16; -.
DR   HGNC; HGNC:8064; NUP214.
DR   OpenTargets; ENSG00000126883; -.
DR   eggNOG; KOG3630; Eukaryota.
DR   eggNOG; ENOG410YBVS; LUCA.
DR   GeneTree; ENSGT00730000111045; -.
DR   HOVERGEN; HBG052683; -.
DR   ChiTaRS; NUP214; human.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000126883; -.
DR   InterPro; IPR026054; Nucleoporin.
DR   PANTHER; PTHR23193; PTHR23193; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:B7ZAV2,
KW   ECO:0000213|MaxQB:B7ZAV2, ECO:0000213|PeptideAtlas:B7ZAV2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   916 AA;  87973 MW;  B712583CB93F3592 CRC64;
     MKSSLLLRGV HFCFHLPGTA KIETAVTSTP SASGQFSKPF SFSPSGTGFN FGIITPTPSS
     NFTAAQGATP STKESSQPDA FSSGGGSKPS YEAIPESSPP SGITSASNTT PGEPAASSSR
     PVAPSGTALS TTSSKLETPP SKLGELLFPS SLAGETLGSF SGLRVGQADD STKPTNKASS
     TSLTSTQPTK TSGVPSGFNF TAPPVLGKHT EPPVTSSATT TSVAPPAATS TSSTAVFGSL
     PVTSAGSSGV ISFGGTSLSA GKTSFSFGSQ QTNSTVPPSA PPPTTAATPL PTSFPTLSFG
     SLLSSATTPS LPMSAGRSTE EATSSALPEK PGDSEVSASA ASLLEEQQSA QLPQAPPQTS
     DSVKKEPVLA QPAVSNSGTA ASSTSLVALS AEATPATTGV PDARTEAVPP ASSFSVPGQT
     AVTAAAISSA GPVAVETSST PIASSTTSIV APGPSAEAAA FGTVTSGSSV FAQPPAASSS
     SAFNQLTNNT ATAPSATPVF GQVAASTAPS LFGQQTGSTA STAAATPQVS SSGFSSPAFG
     TTAPGVFGQT TFGQASVFGQ SASSAASVFS FSQPGFSSVP AFGQPASSTP TSTSGSVFGA
     ASSTSSSSSF SFGQSSPNTG GGLFGQSNAP AFGQSPGFGQ GGSVFGGTSA ATTTAATSGF
     SFCQASGFGS SNTGSVFGQA ASTGGIVFGQ QSSSSSGSVF GSGNTGRGGG FFSGLGGKPS
     QDAANKNPFS SASGGFGSTA TSNTSNLFGN SGAKTFGGFA SSSFGEQKPT GTFSSGGGSV
     ASQGFGFSSP NKTGGFGAAP VFGSPPTFGG SPGFGGVPAF GSAPAFTSPL GSTGGKVFGE
     GTAAASAGGF GFGSSSNTTS FGTLASQNAP TFGSLSQQTS GFGTQSSGFS GFGSGTGGFS
     FGSNNSSVQG FGGWRS
//
ID   NU214_HUMAN             Reviewed;        2090 AA.
AC   P35658; A6NFQ0; Q15010; Q3KQZ0; Q5JUP7; Q75R47; Q86XD3;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   28-FEB-2018, entry version 184.
DE   RecName: Full=Nuclear pore complex protein Nup214;
DE   AltName: Full=214 kDa nucleoporin;
DE   AltName: Full=Nucleoporin Nup214;
DE   AltName: Full=Protein CAN;
GN   Name=NUP214; Synonyms=CAIN, CAN, KIAA0023;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION WITH
RP   DEK, AND VARIANT SER-574.
RC   TISSUE=Testis;
RX   PubMed=1549122;
RA   Von Lindern M., Fornerod M., Van Baal S., Jaegle M., De Wit T.,
RA   Buijs A., Grosveld G.;
RT   "The translocation (6;9), associated with a specific subtype of acute
RT   myeloid leukemia, results in the fusion of two genes, dek and can, and
RT   the expression of a chimeric, leukemia-specific dek-can mRNA.";
RL   Mol. Cell. Biol. 12:1687-1697(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Homo sapiens mRNA for KIAA0023 splice variant 1 protein.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y.,
RA   Sato S., Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I.
RT   The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by
RT   analysis of randomly sampled cDNA clones from human immature myeloid
RT   cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), AND VARIANT
RP   SER-574.
RC   TISSUE=Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH SET.
RX   PubMed=1630450;
RA   von Lindern M., van Baal S., Wiegant J., Raap A., Hagemeijer A.,
RA   Grosveld G.;
RT   "Can, a putative oncogene associated with myeloid leukemogenesis, may
RT   be activated by fusion of its 3' half to different genes:
RT   characterization of the set gene.";
RL   Mol. Cell. Biol. 12:3346-3355(1992).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=8108440; DOI=10.1073/pnas.91.4.1519;
RA   Kraemer D., Wozniak R.W., Blobel G., Radu A.;
RT   "The human CAN protein, a putative oncogene product associated with
RT   myeloid leukemogenesis, is a nuclear pore complex protein that faces
RT   the cytoplasm.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:1519-1523(1994).
RN   [8]
RP   INTERACTION WITH NUP88 AND XPO1.
RX   PubMed=9049309; DOI=10.1093/emboj/16.4.807;
RA   Fornerod M., van Deursen J.M., van Baal S., Reynolds A., Davis D.,
RA   Murti K.G., Fransen J., Grosveld G.;
RT   "The human homologue of yeast CRM1 is in a dynamic subcomplex with
RT   CAN/Nup214 and the novel nuclear pore component Nup88.";
RL   EMBO J. 16:807-816(1997).
RN   [9]
RP   INTERACTION WITH XPO5.
RX   PubMed=11777942; DOI=10.1083/jcb.200110082;
RA   Brownawell A.M., Macara I.G.;
RT   "Exportin-5, a novel karyopherin, mediates nuclear export of double-
RT   stranded RNA binding proteins.";
RL   J. Cell Biol. 156:53-64(2002).
RN   [10]
RP   INTERACTION WITH ZFP36.
RX   PubMed=14766228; DOI=10.1016/j.bbrc.2004.01.080;
RA   Carman J.A., Nadler S.G.;
RT   "Direct association of tristetraprolin with the nucleoporin
RT   CAN/Nup214.";
RL   Biochem. Biophys. Res. Commun. 315:445-449(2004).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-430 AND THR-439, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-651; SER-940 AND
RP   SER-1181, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-430; THR-434; THR-437;
RP   THR-439; SER-666; SER-970; SER-974; SER-1023 AND SER-1963, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   INTERACTION WITH HHV-1 PROTEIN UL25 (MICROBIAL INFECTION).
RX   PubMed=19386703; DOI=10.1128/JVI.02655-08;
RA   Pasdeloup D., Blondel D., Isidro A.L., Rixon F.J.;
RT   "Herpesvirus capsid association with the nuclear pore complex and
RT   viral DNA release involve the nucleoporin CAN/Nup214 and the capsid
RT   protein pUL25.";
RL   J. Virol. 83:6610-6623(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-430 AND SER-989, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-657; THR-670; SER-678;
RP   SER-940; SER-1045; SER-1081; THR-1134; THR-1150; THR-1156; THR-1312
RP   AND SER-1985, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433; THR-434; THR-437;
RP   SER-657; THR-670; SER-678 AND SER-940, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT GLY-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; THR-416; SER-421;
RP   SER-430; SER-433; THR-434; THR-437; SER-651; SER-657; SER-666;
RP   THR-670; SER-678; SER-760; SER-940; THR-1021; SER-1023; SER-1045;
RP   SER-1056; SER-1081; THR-1156 AND SER-1353, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-430; SER-433 AND
RP   SER-678, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1538, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 1-434, AND BETA-PROPELLER
RP   DOMAIN.
RX   PubMed=17264208; DOI=10.1073/pnas.0610828104;
RA   Napetschnig J., Blobel G., Hoelz A.;
RT   "Crystal structure of the N-terminal domain of the human protooncogene
RT   Nup214/CAN.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1783-1788(2007).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-405 IN COMPLEX WITH DDX19B,
RP   AND MUTAGENESIS OF VAL-353 AND ASP-359.
RX   PubMed=19219046; DOI=10.1038/nsmb.1561;
RA   von Moeller H., Basquin C., Conti E.;
RT   "The mRNA export protein DBP5 binds RNA and the cytoplasmic
RT   nucleoporin NUP214 in a mutually exclusive manner.";
RL   Nat. Struct. Mol. Biol. 16:247-254(2009).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.51 ANGSTROMS) OF 1-450 IN COMPLEX WITH
RP   DDX19B, AND COILED-COIL DOMAIN.
RX   PubMed=19208808; DOI=10.1073/pnas.0813267106;
RA   Napetschnig J., Kassube S.A., Debler E.W., Wong R.W., Blobel G.,
RA   Hoelz A.;
RT   "Structural and functional analysis of the interaction between the
RT   nucleoporin Nup214 and the DEAD-box helicase Ddx19.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:3089-3094(2009).
RN   [29]
RP   VARIANTS [LARGE SCALE ANALYSIS] ALA-424; LEU-1378 AND VAL-1392.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: May serve as a docking site in the receptor-mediated
CC       import of substrates across the nuclear pore complex.
CC       {ECO:0000303|PubMed:8108440}.
CC   -!- SUBUNIT: Homodimer. Interacts with ZFP36; this interaction
CC       increases upon lipopolysaccharide (LPS) stimulation
CC       (PubMed:14766228). Interacts with DDX19 (PubMed:19219046,
CC       PubMed:19208808). Interacts with NUP88 (PubMed:9049309). Interacts
CC       with XPO1 (PubMed:9049309). Interacts with XPO5 (PubMed:11777942).
CC       {ECO:0000269|PubMed:11777942, ECO:0000269|PubMed:14766228,
CC       ECO:0000269|PubMed:19208808, ECO:0000269|PubMed:19219046,
CC       ECO:0000269|PubMed:9049309}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human herpes virus 1
CC       (HHV-1) protein UL25; this interaction might be essential to the
CC       capsid docking onto the host nuclear pore.
CC       {ECO:0000269|PubMed:19386703}.
CC   -!- INTERACTION:
CC       Q9UMR2-1:DDX19B; NbExp=9; IntAct=EBI-15757000, EBI-5773937;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nuclear pore complex
CC       {ECO:0000269|PubMed:8108440}. Note=Cytoplasmic side of the nuclear
CC       pore complex. {ECO:0000269|PubMed:8108440}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P35658-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35658-2; Sequence=VSP_034896;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P35658-3; Sequence=VSP_034897;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P35658-4; Sequence=VSP_034896, VSP_034897;
CC       Name=5;
CC         IsoId=P35658-5; Sequence=VSP_034896, VSP_034898, VSP_034899;
CC   -!- TISSUE SPECIFICITY: Expressed in thymus, spleen, bone marrow,
CC       kidney, brain and testis, but hardly in all other tissues or in
CC       whole embryos during development.
CC   -!- DOMAIN: Contains FG repeats.
CC   -!- DOMAIN: The beta-propeller contains long interblade connector
CC       loops, and mediates interaction with DDX19B.
CC   -!- PTM: Probably glycosylated as it reacts with wheat germ agglutinin
CC       (WGA).
CC   -!- DISEASE: Note=A chromosomal aberration involving NUP214 is found
CC       in a subset of acute myeloid leukemia (AML); also known as acute
CC       non-lymphocytic leukemia. Translocation t(6;9)(p23;q34) with DEK.
CC       It results in the formation of a DEK-CAN fusion gene.
CC       {ECO:0000269|PubMed:1549122}.
CC   -!- DISEASE: Note=A chromosomal aberration involving NUP214 is found
CC       in some cases of acute undifferentiated leukemia (AUL).
CC       Translocation t(6;9)(q21;q34.1) with SET.
CC       {ECO:0000269|PubMed:1630450}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD07398.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CANID29.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X64228; CAA45535.1; -; mRNA.
DR   EMBL; AB159230; BAD07398.1; ALT_INIT; mRNA.
DR   EMBL; D14689; BAA03515.1; -; mRNA.
DR   EMBL; AL157938; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC045620; AAH45620.2; -; mRNA.
DR   EMBL; BC105998; AAI05999.1; -; mRNA.
DR   CCDS; CCDS6940.1; -. [P35658-1]
DR   CCDS; CCDS83429.1; -. [P35658-4]
DR   PIR; S26058; S26058.
DR   RefSeq; NP_001305253.1; NM_001318324.1. [P35658-4]
DR   RefSeq; NP_001305254.1; NM_001318325.1.
DR   RefSeq; NP_005076.3; NM_005085.3. [P35658-1]
DR   UniGene; Hs.654530; -.
DR   PDB; 2OIT; X-ray; 1.65 A; A=1-434.
DR   PDB; 3FHC; X-ray; 2.80 A; A=1-405.
DR   PDB; 3FMO; X-ray; 2.51 A; A=1-450.
DR   PDB; 3FMP; X-ray; 3.19 A; A/C=1-450.
DR   PDB; 5DIS; X-ray; 2.85 A; D=1916-2027.
DR   PDBsum; 2OIT; -.
DR   PDBsum; 3FHC; -.
DR   PDBsum; 3FMO; -.
DR   PDBsum; 3FMP; -.
DR   PDBsum; 5DIS; -.
DR   ProteinModelPortal; P35658; -.
DR   SMR; P35658; -.
DR   BioGrid; 113717; 80.
DR   CORUM; P35658; -.
DR   DIP; DIP-38367N; -.
DR   IntAct; P35658; 42.
DR   MINT; P35658; -.
DR   STRING; 9606.ENSP00000352400; -.
DR   TCDB; 1.I.1.1.3; the eukaryotic nuclear pore complex (e-npc) family.
DR   iPTMnet; P35658; -.
DR   PhosphoSitePlus; P35658; -.
DR   BioMuta; NUP214; -.
DR   DMDM; 205831380; -.
DR   EPD; P35658; -.
DR   MaxQB; P35658; -.
DR   PaxDb; P35658; -.
DR   PeptideAtlas; P35658; -.
DR   PRIDE; P35658; -.
DR   Ensembl; ENST00000359428; ENSP00000352400; ENSG00000126883. [P35658-1]
DR   Ensembl; ENST00000411637; ENSP00000396576; ENSG00000126883. [P35658-4]
DR   GeneID; 8021; -.
DR   KEGG; hsa:8021; -.
DR   UCSC; uc004cag.4; human. [P35658-1]
DR   CTD; 8021; -.
DR   DisGeNET; 8021; -.
DR   EuPathDB; HostDB:ENSG00000126883.16; -.
DR   GeneCards; NUP214; -.
DR   HGNC; HGNC:8064; NUP214.
DR   HPA; HPA048789; -.
DR   MalaCards; NUP214; -.
DR   MIM; 114350; gene.
DR   neXtProt; NX_P35658; -.
DR   OpenTargets; ENSG00000126883; -.
DR   Orphanet; 402014; 'Acute myeloid leukemia with t(6;9)(p23;q34)'.
DR   PharmGKB; PA31851; -.
DR   eggNOG; KOG3630; Eukaryota.
DR   eggNOG; ENOG410YBVS; LUCA.
DR   GeneTree; ENSGT00730000111045; -.
DR   HOVERGEN; HBG052683; -.
DR   InParanoid; P35658; -.
DR   KO; K14317; -.
DR   OMA; QNERNRD; -.
DR   OrthoDB; EOG091G02Y1; -.
DR   PhylomeDB; P35658; -.
DR   TreeFam; TF323517; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-159227; Transport of the SLBP independent Mature mRNA.
DR   Reactome; R-HSA-159230; Transport of the SLBP Dependant Mature mRNA.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-HSA-165054; Rev-mediated nuclear export of HIV RNA.
DR   Reactome; R-HSA-168271; Transport of Ribonucleoproteins into the Host Nucleus.
DR   Reactome; R-HSA-168276; NS1 Mediated Effects on Host Pathways.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-168333; NEP/NS2 Interacts with the Cellular Export Machinery.
DR   Reactome; R-HSA-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-HSA-180746; Nuclear import of Rev protein.
DR   Reactome; R-HSA-180910; Vpr-mediated nuclear import of PICs.
DR   Reactome; R-HSA-191859; snRNP Assembly.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-450520; HuR (ELAVL1) binds and stabilizes mRNA.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-6784531; tRNA processing in the nucleus.
DR   SignaLink; P35658; -.
DR   SIGNOR; P35658; -.
DR   ChiTaRS; NUP214; human.
DR   EvolutionaryTrace; P35658; -.
DR   GeneWiki; NUP214; -.
DR   GenomeRNAi; 8021; -.
DR   PRO; PR:P35658; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000126883; -.
DR   CleanEx; HS_NUP214; -.
DR   ExpressionAtlas; P35658; baseline and differential.
DR   Genevisible; P35658; HS.
DR   GO; GO:1990876; C:cytoplasmic side of nuclear pore; IDA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; IDA:HPA.
DR   GO; GO:0043657; C:host cell; IEA:GOC.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0044613; C:nuclear pore central transport channel; IBA:GO_Central.
DR   GO; GO:0044615; C:nuclear pore nuclear basket; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005049; F:nuclear export signal receptor activity; IDA:GO_Central.
DR   GO; GO:0008139; F:nuclear localization sequence binding; IBA:GO_Central.
DR   GO; GO:0005487; F:nucleocytoplasmic transporter activity; IEA:Ensembl.
DR   GO; GO:0017056; F:structural constituent of nuclear pore; IBA:GO_Central.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome.
DR   GO; GO:0006406; P:mRNA export from nucleus; IMP:UniProtKB.
DR   GO; GO:0006611; P:protein export from nucleus; IMP:MGI.
DR   GO; GO:0006606; P:protein import into nucleus; IBA:GO_Central.
DR   GO; GO:0016925; P:protein sumoylation; TAS:Reactome.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0006110; P:regulation of glycolytic process; TAS:Reactome.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0046822; P:regulation of nucleocytoplasmic transport; IMP:UniProtKB.
DR   GO; GO:0006405; P:RNA export from nucleus; IBA:GO_Central.
DR   GO; GO:0006409; P:tRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; TAS:Reactome.
DR   GO; GO:0019083; P:viral transcription; TAS:Reactome.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR026054; Nucleoporin.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   PANTHER; PTHR23193; PTHR23193; 1.
DR   SMART; SM00320; WD40; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Chromosomal rearrangement; Coiled coil; Complete proteome;
KW   Glycoprotein; Isopeptide bond; mRNA transport; Nuclear pore complex;
KW   Nucleus; Phosphoprotein; Polymorphism; Protein transport;
KW   Proto-oncogene; Reference proteome; Repeat; Translocation; Transport;
KW   Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895}.
FT   CHAIN         2   2090       Nuclear pore complex protein Nup214.
FT                                /FTId=PRO_0000204861.
FT   REPEAT       41     93       Blade 1.
FT   REPEAT       94    150       Blade 2.
FT   REPEAT      151    193       Blade 3.
FT   REPEAT      194    239       Blade 4.
FT   REPEAT      240    303       Blade 5.
FT   REPEAT      304    359       Blade 6.
FT   REPEAT      360    404       Blade 7.
FT   REGION       41    404       Seven-bladed beta propeller.
FT   REGION      481   2076       11 X 5 AA approximate repeats.
FT   REGION      740    768       Leucine-zipper 1.
FT   REGION      861    882       Leucine-zipper 2.
FT   REGION     1409   2084       18 X 4 AA approximate repeats.
FT   REGION     1427   2085       11 X 3 AA approximate repeats.
FT   COILED      680   1209       {ECO:0000269|PubMed:19208808}.
FT   COMPBIAS   1213   2090       Pro/Ser/Thr-rich.
FT   SITE        812    813       Breakpoint.
FT   MOD_RES       2      2       N-acetylglycine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   MOD_RES      30     30       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     416    416       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     421    421       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     430    430       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     433    433       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     434    434       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     437    437       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     439    439       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES     651    651       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     657    657       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     666    666       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     670    670       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     678    678       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     760    760       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     940    940       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     970    970       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     974    974       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     989    989       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1021   1021       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1023   1023       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1045   1045       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1056   1056       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1081   1081       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1134   1134       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1150   1150       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1156   1156       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1181   1181       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES    1312   1312       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1353   1353       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1963   1963       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1985   1985       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   CROSSLNK   1538   1538       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     590    601       KFTAAATSTPVS -> N (in isoform 2, isoform
FT                                4 and isoform 5).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7584026}.
FT                                /FTId=VSP_034896.
FT   VAR_SEQ     648    648       S -> SA (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034897.
FT   VAR_SEQ    1139   1148       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:7584026}.
FT                                /FTId=VSP_034898.
FT   VAR_SEQ    2026   2090       FGSSSNTTSFGTLASQNAPTFGSLSQQTSGFGTQSSGFSGF
FT                                GSGTGGFSFGSNNSSVQGFGGWRS -> SLAMSLSPTLKGR
FT                                LLLMRPKAGGGREQAAPGRKSNESRSLGHLCMERALTSPLK
FT                                VWEQQQHHILRHARESECPHFRITVPTDFWFWDPE (in
FT                                isoform 5). {ECO:0000303|PubMed:7584026}.
FT                                /FTId=VSP_034899.
FT   VARIANT     424    424       G -> A (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035856.
FT   VARIANT     574    574       P -> S (in dbSNP:rs103612).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1549122}.
FT                                /FTId=VAR_045691.
FT   VARIANT    1378   1378       P -> L (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs777822003).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035857.
FT   VARIANT    1392   1392       A -> V (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035858.
FT   VARIANT    1592   1592       G -> A (in dbSNP:rs28594669).
FT                                /FTId=VAR_061533.
FT   MUTAGEN     353    353       V->A: Reduced binding to DDX19B.
FT                                {ECO:0000269|PubMed:19219046}.
FT   MUTAGEN     359    359       D->R: Impairs interaction with DDX19B.
FT                                {ECO:0000269|PubMed:19219046}.
FT   CONFLICT    149    149       G -> A (in Ref. 1; CAA45535).
FT                                {ECO:0000305}.
FT   CONFLICT    175    175       A -> D (in Ref. 1; CAA45535).
FT                                {ECO:0000305}.
FT   CONFLICT   1091   1092       AA -> QL (in Ref. 1; CAA45535).
FT                                {ECO:0000305}.
FT   CONFLICT   1872   1872       S -> N (in Ref. 5; AAH45620).
FT                                {ECO:0000305}.
FT   STRAND        4      7       {ECO:0000244|PDB:2OIT}.
FT   STRAND       11     21       {ECO:0000244|PDB:2OIT}.
FT   STRAND       24     26       {ECO:0000244|PDB:2OIT}.
FT   STRAND       42     45       {ECO:0000244|PDB:2OIT}.
FT   TURN         46     49       {ECO:0000244|PDB:2OIT}.
FT   STRAND       50     55       {ECO:0000244|PDB:2OIT}.
FT   STRAND       58     63       {ECO:0000244|PDB:2OIT}.
FT   HELIX        64     67       {ECO:0000244|PDB:2OIT}.
FT   STRAND       80     82       {ECO:0000244|PDB:2OIT}.
FT   STRAND       87     89       {ECO:0000244|PDB:2OIT}.
FT   STRAND       95    100       {ECO:0000244|PDB:2OIT}.
FT   STRAND      106    113       {ECO:0000244|PDB:2OIT}.
FT   TURN        114    116       {ECO:0000244|PDB:2OIT}.
FT   STRAND      117    124       {ECO:0000244|PDB:2OIT}.
FT   HELIX       125    129       {ECO:0000244|PDB:2OIT}.
FT   STRAND      139    143       {ECO:0000244|PDB:2OIT}.
FT   HELIX       148    150       {ECO:0000244|PDB:2OIT}.
FT   STRAND      151    157       {ECO:0000244|PDB:2OIT}.
FT   STRAND      164    169       {ECO:0000244|PDB:2OIT}.
FT   STRAND      174    189       {ECO:0000244|PDB:2OIT}.
FT   HELIX       191    193       {ECO:0000244|PDB:2OIT}.
FT   STRAND      195    200       {ECO:0000244|PDB:2OIT}.
FT   STRAND      207    211       {ECO:0000244|PDB:2OIT}.
FT   STRAND      216    219       {ECO:0000244|PDB:2OIT}.
FT   STRAND      225    229       {ECO:0000244|PDB:2OIT}.
FT   STRAND      237    239       {ECO:0000244|PDB:3FMO}.
FT   STRAND      241    250       {ECO:0000244|PDB:2OIT}.
FT   STRAND      253    260       {ECO:0000244|PDB:2OIT}.
FT   STRAND      265    267       {ECO:0000244|PDB:2OIT}.
FT   STRAND      270    275       {ECO:0000244|PDB:2OIT}.
FT   STRAND      286    289       {ECO:0000244|PDB:2OIT}.
FT   STRAND      299    301       {ECO:0000244|PDB:2OIT}.
FT   STRAND      305    310       {ECO:0000244|PDB:2OIT}.
FT   HELIX       311    313       {ECO:0000244|PDB:2OIT}.
FT   STRAND      315    320       {ECO:0000244|PDB:2OIT}.
FT   STRAND      323    325       {ECO:0000244|PDB:3FMO}.
FT   STRAND      327    331       {ECO:0000244|PDB:2OIT}.
FT   STRAND      338    343       {ECO:0000244|PDB:2OIT}.
FT   HELIX       345    347       {ECO:0000244|PDB:2OIT}.
FT   STRAND      357    359       {ECO:0000244|PDB:3FMP}.
FT   STRAND      362    368       {ECO:0000244|PDB:2OIT}.
FT   STRAND      375    378       {ECO:0000244|PDB:2OIT}.
FT   STRAND      381    383       {ECO:0000244|PDB:2OIT}.
FT   STRAND      388    393       {ECO:0000244|PDB:2OIT}.
FT   STRAND      396    405       {ECO:0000244|PDB:2OIT}.
FT   HELIX      1925   1929       {ECO:0000244|PDB:5DIS}.
FT   STRAND     1937   1941       {ECO:0000244|PDB:5DIS}.
FT   TURN       1943   1945       {ECO:0000244|PDB:5DIS}.
FT   HELIX      2016   2019       {ECO:0000244|PDB:5DIS}.
SQ   SEQUENCE   2090 AA;  213620 MW;  EE6F0F3DE3D522C6 CRC64;
     MGDEMDAMIP EREMKDFQFR ALKKVRIFDS PEELPKERSS LLAVSNKYGL VFAGGASGLQ
     IFPTKNLLIQ NKPGDDPNKI VDKVQGLLVP MKFPIHHLAL SCDNLTLSAC MMSSEYGSII
     AFFDVRTFSN EAKQQKRPFA YHKLLKDAGG MVIDMKWNPT VPSMVAVCLA DGSIAVLQVT
     ETVKVCATLP STVAVTSVCW SPKGKQLAVG KQNGTVVQYL PTLQEKKVIP CPPFYESDHP
     VRVLDVLWIG TYVFAIVYAA ADGTLETSPD VVMALLPKKE EKHPEIFVNF MEPCYGSCTE
     RQHHYYLSYI EEWDLVLAAS AASTEVSILA RQSDQINWES WLLEDSSRAE LPVTDKSDDS
     LPMGVVVDYT NQVEITISDE KTLPPAPVLM LLSTDGVLCP FYMINQNPGV KSLIKTPERL
     SLEGERQPKS PGSTPTTPTS SQAPQKLDAS AAAAPASLPP SSPAAPIATF SLLPAGGAPT
     VFSFGSSSLK SSATVTGEPP SYSSGSDSSK AAPGPGPSTF SFVPPSKASL APTPAASPVA
     PSAASFSFGS SGFKPTLEST PVPSVSAPNI AMKPSFPPST SAVKVNLSEK FTAAATSTPV
     SSSQSAPPMS PFSSASKPAA SGPLSHPTPL SAPPSSVPLK SSVLPSPSGR SAQGSSSPVP
     SMVQKSPRIT PPAAKPGSPQ AKSLQPAVAE KQGHQWKDSD PVMAGIGEEI AHFQKELEEL
     KARTSKACFQ VGTSEEMKML RTESDDLHTF LLEIKETTES LHGDISSLKT TLLEGFAGVE
     EAREQNERNR DSGYLHLLYK RPLDPKSEAQ LQEIRRLHQY VKFAVQDVND VLDLEWDQHL
     EQKKKQRHLL VPERETLFNT LANNREIINQ QRKRLNHLVD SLQQLRLYKQ TSLWSLSSAV
     PSQSSIHSFD SDLESLCNAL LKTTIESHTK SLPKVPAKLS PMKQAQLRNF LAKRKTPPVR
     STAPASLSRS AFLSQRYYED LDEVSSTSSV SQSLESEDAR TSCKDDEAVV QAPRHAPVVR
     TPSIQPSLLP HAAPFAKSHL VHGSSPGVMG TSVATSASKI IPQGADSTML ATKTVKHGAP
     SPSHPISAPQ AAAAAALRRQ MASQAPAVNT LTESTLKNVP QVVNVQELKN NPATPSTAMG
     SSVPYSTAKT PHPVLTPVAA NQAKQGSLIN SLKPSGPTPA SGQLSSGDKA SGTAKIETAV
     TSTPSASGQF SKPFSFSPSG TGFNFGIITP TPSSNFTAAQ GATPSTKESS QPDAFSSGGG
     SKPSYEAIPE SSPPSGITSA SNTTPGEPAA SSSRPVAPSG TALSTTSSKL ETPPSKLGEL
     LFPSSLAGET LGSFSGLRVG QADDSTKPTN KASSTSLTST QPTKTSGVPS GFNFTAPPVL
     GKHTEPPVTS SATTTSVAPP AATSTSSTAV FGSLPVTSAG SSGVISFGGT SLSAGKTSFS
     FGSQQTNSTV PPSAPPPTTA ATPLPTSFPT LSFGSLLSSA TTPSLPMSAG RSTEEATSSA
     LPEKPGDSEV SASAASLLEE QQSAQLPQAP PQTSDSVKKE PVLAQPAVSN SGTAASSTSL
     VALSAEATPA TTGVPDARTE AVPPASSFSV PGQTAVTAAA ISSAGPVAVE TSSTPIASST
     TSIVAPGPSA EAAAFGTVTS GSSVFAQPPA ASSSSAFNQL TNNTATAPSA TPVFGQVAAS
     TAPSLFGQQT GSTASTAAAT PQVSSSGFSS PAFGTTAPGV FGQTTFGQAS VFGQSASSAA
     SVFSFSQPGF SSVPAFGQPA SSTPTSTSGS VFGAASSTSS SSSFSFGQSS PNTGGGLFGQ
     SNAPAFGQSP GFGQGGSVFG GTSAATTTAA TSGFSFCQAS GFGSSNTGSV FGQAASTGGI
     VFGQQSSSSS GSVFGSGNTG RGGGFFSGLG GKPSQDAANK NPFSSASGGF GSTATSNTSN
     LFGNSGAKTF GGFASSSFGE QKPTGTFSSG GGSVASQGFG FSSPNKTGGF GAAPVFGSPP
     TFGGSPGFGG VPAFGSAPAF TSPLGSTGGK VFGEGTAAAS AGGFGFGSSS NTTSFGTLAS
     QNAPTFGSLS QQTSGFGTQS SGFSGFGSGT GGFSFGSNNS SVQGFGGWRS
//
ID   NTM2A_HUMAN             Reviewed;         878 AA.
AC   Q8IVF1; A6NMX5; C9JDI1; Q5VZW1;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 4.
DT   27-SEP-2017, entry version 95.
DE   RecName: Full=NUT family member 2A;
GN   Name=NUTM2A; Synonyms=FAM22A, KIAA2020;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IVF1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IVF1-2; Sequence=VSP_034018, VSP_034020;
CC   -!- SIMILARITY: Belongs to the NUT family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC23116.1; Type=Frameshift; Positions=83; Evidence={ECO:0000305};
CC       Sequence=CAH72466.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB095940; BAC23116.1; ALT_FRAME; mRNA.
DR   EMBL; AL157893; CAH72466.1; ALT_SEQ; Genomic_DNA.
DR   CCDS; CCDS44452.1; -. [Q8IVF1-1]
DR   RefSeq; NP_001009610.1; NM_001009610.1.
DR   RefSeq; NP_001092808.1; NM_001099338.1. [Q8IVF1-1]
DR   RefSeq; XP_011538424.1; XM_011540122.2. [Q8IVF1-1]
DR   RefSeq; XP_016872096.1; XM_017016607.1. [Q8IVF1-2]
DR   UniGene; Hs.701044; -.
DR   UniGene; Hs.710565; -.
DR   ProteinModelPortal; Q8IVF1; -.
DR   IntAct; Q8IVF1; 1.
DR   STRING; 9606.ENSP00000371126; -.
DR   iPTMnet; Q8IVF1; -.
DR   PhosphoSitePlus; Q8IVF1; -.
DR   BioMuta; NUTM2A; -.
DR   DMDM; 269849751; -.
DR   PaxDb; Q8IVF1; -.
DR   PeptideAtlas; Q8IVF1; -.
DR   PRIDE; Q8IVF1; -.
DR   Ensembl; ENST00000381689; ENSP00000371107; ENSG00000184923. [Q8IVF1-2]
DR   Ensembl; ENST00000381707; ENSP00000371126; ENSG00000184923. [Q8IVF1-1]
DR   GeneID; 728118; -.
DR   GeneID; 728130; -.
DR   KEGG; hsa:728118; -.
DR   KEGG; hsa:728130; -.
DR   UCSC; uc001kek.4; human. [Q8IVF1-1]
DR   CTD; 728118; -.
DR   CTD; 728130; -.
DR   DisGeNET; 728118; -.
DR   EuPathDB; HostDB:ENSG00000184923.12; -.
DR   GeneCards; NUTM2A; -.
DR   HGNC; HGNC:23438; NUTM2A.
DR   HPA; HPA064635; -.
DR   MalaCards; NUTM2A; -.
DR   neXtProt; NX_Q8IVF1; -.
DR   OpenTargets; ENSG00000184923; -.
DR   PharmGKB; PA134875735; -.
DR   eggNOG; ENOG410J94Q; Eukaryota.
DR   eggNOG; ENOG4111C0H; LUCA.
DR   GeneTree; ENSGT00410000025793; -.
DR   HOGENOM; HOG000112470; -.
DR   HOVERGEN; HBG107898; -.
DR   InParanoid; Q8IVF1; -.
DR   OMA; SSQPQKR; -.
DR   OrthoDB; EOG091G034P; -.
DR   PhylomeDB; Q8IVF1; -.
DR   TreeFam; TF337728; -.
DR   GenomeRNAi; 728118; -.
DR   PRO; PR:Q8IVF1; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000184923; -.
DR   CleanEx; HS_FAM22A; -.
DR   CleanEx; HS_FAM22D; -.
DR   Genevisible; Q8IVF1; HS.
DR   InterPro; IPR024310; NUT.
DR   InterPro; IPR024309; NUT_N.
DR   PANTHER; PTHR22879; PTHR22879; 1.
DR   Pfam; PF12881; NUT; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Reference proteome.
FT   CHAIN         1    878       NUT family member 2A.
FT                                /FTId=PRO_0000266032.
FT   COMPBIAS    278    285       Poly-Pro.
FT   COMPBIAS    425    514       Pro-rich.
FT   VAR_SEQ     618    629       LVEKRLLPLKEK -> GAPSDAPGTDRC (in isoform
FT                                2). {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_034018.
FT   VAR_SEQ     630    878       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_034020.
FT   CONFLICT     47     47       K -> E (in Ref. 1; BAC23116).
FT                                {ECO:0000305}.
FT   CONFLICT    160    160       A -> T (in Ref. 1; BAC23116).
FT                                {ECO:0000305}.
FT   CONFLICT    546    546       E -> K (in Ref. 1; BAC23116).
FT                                {ECO:0000305}.
SQ   SEQUENCE   878 AA;  93890 MW;  B65B88FE85A912A1 CRC64;
     MEVKGPSGRS FCCESEGQFK SCLKRHTPSL LLPSSWKGNS GSCLMAKALH RMSPTPNSCP
     LPLPLCRMSG VLCSRNLFTF KFSLFQLDSG ASGEPGHSLG LTLGFSHCGN CQTAVVSAQP
     EGMASNGAYP ALGPGVTANP GTSLSVFTAL PFTTPAPGPA HGPLLVTAGA PPGGPLVLST
     LPSTPLVTEQ DGCGPSGAGA SNVFVQMRTE VGPVKAAQAQ TLVLTQAPLV WQAPGALCGG
     VVCPPPLLLA AAPVVPVMAA QVVGGTQACE GGWSQGLPLP PPPPPAAQLP PIVSQGNAGP
     WPQGAHGEGS LASSQAKAPP DDSCNPRSVY ENFRLWQHYK PLARRHLPQS PDTEALSCFL
     IPVLRSLARR KPTMTLEEGL WRAMREWQHT SNFDRMIFYE MAEKFLEFEA EEEMQIQKSQ
     WMKGPQCLPP PATPRLEPRG PPAPEVVKQP VYLPSKAGPK APTACLPPPR PQRPVTKARR
     PPPRPHRRAE TKARLPPPRP QRPAETKVPE EIPPEVVQEY VDIMEELLGP SLGATGEPEK
     QREEGEVKQP QEEDWTPPDP GLLSYTDKLC SQKDFVTKVE AVIHPQFLEE LLSPDPQMDF
     LALSQELEQE EGLTLAQLVE KRLLPLKEKQ HARAAPSRGT ARLDSSSSKF AAGQGAERDV
     PVPQQGVGME TCPPQTTARD SQGRGRAHTG MARSKDSVVL LGCQDSPGLR AARPTSPPQD
     HRPTCPGVGT KDALDLPGGS PVRESHGLAQ GSSEEEELPS LAFLLGSQHK LLPWWLPQSP
     VPASGLLSPE KWGPQGTHQF PSAERRGLNL APSPANKAKK RPLFGSLSPA EKTPHPGPGL
     RVSGEQSLTW GLGGPSQSQK RKGDPLVSRK EKKQRCSQ
//
ID   NTM2B_HUMAN             Reviewed;         878 AA.
AC   A6NNL0; A6NM73;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 2.
DT   27-SEP-2017, entry version 77.
DE   RecName: Full=NUT family member 2B;
GN   Name=NUTM2B; Synonyms=FAM22B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=A6NNL0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A6NNL0-2; Sequence=VSP_034025, VSP_034026, VSP_034027;
CC   -!- SIMILARITY: Belongs to the NUT family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAQ08562.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAQ08563.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL132656; CAQ08562.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL132656; CAQ08563.1; ALT_SEQ; Genomic_DNA.
DR   CCDS; CCDS60574.1; -. [A6NNL0-1]
DR   RefSeq; NP_001265424.1; NM_001278495.1. [A6NNL0-1]
DR   UniGene; Hs.742755; -.
DR   ProteinModelPortal; A6NNL0; -.
DR   BioGrid; 609665; 1.
DR   STRING; 9606.ENSP00000394623; -.
DR   iPTMnet; A6NNL0; -.
DR   PhosphoSitePlus; A6NNL0; -.
DR   PaxDb; A6NNL0; -.
DR   PRIDE; A6NNL0; -.
DR   Ensembl; ENST00000429828; ENSP00000394623; ENSG00000188199. [A6NNL0-1]
DR   GeneID; 729262; -.
DR   KEGG; hsa:729262; -.
DR   UCSC; uc031wmo.1; human. [A6NNL0-1]
DR   CTD; 729262; -.
DR   DisGeNET; 729262; -.
DR   EuPathDB; HostDB:ENSG00000188199.10; -.
DR   GeneCards; NUTM2B; -.
DR   HGNC; HGNC:23445; NUTM2B.
DR   HPA; HPA064635; -.
DR   MalaCards; NUTM2B; -.
DR   neXtProt; NX_A6NNL0; -.
DR   OpenTargets; ENSG00000188199; -.
DR   PharmGKB; PA134908712; -.
DR   eggNOG; ENOG410J94Q; Eukaryota.
DR   eggNOG; ENOG4111C0H; LUCA.
DR   GeneTree; ENSGT00410000025793; -.
DR   HOGENOM; HOG000112470; -.
DR   HOVERGEN; HBG107898; -.
DR   InParanoid; A6NNL0; -.
DR   OMA; QWMKEPQ; -.
DR   OrthoDB; EOG091G034P; -.
DR   PhylomeDB; A6NNL0; -.
DR   TreeFam; TF337728; -.
DR   GenomeRNAi; 729262; -.
DR   PRO; PR:A6NNL0; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000188199; -.
DR   CleanEx; HS_FAM22B; -.
DR   ExpressionAtlas; A6NNL0; baseline and differential.
DR   Genevisible; A6NNL0; HS.
DR   InterPro; IPR024310; NUT.
DR   InterPro; IPR024309; NUT_N.
DR   PANTHER; PTHR22879; PTHR22879; 1.
DR   Pfam; PF12881; NUT; 1.
PE   3: Inferred from homology;
KW   Alternative splicing; Complete proteome; Reference proteome.
FT   CHAIN         1    878       NUT family member 2B.
FT                                /FTId=PRO_0000337992.
FT   COMPBIAS    278    285       Poly-Pro.
FT   COMPBIAS    425    514       Pro-rich.
FT   VAR_SEQ     617    653       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_034025.
FT   VAR_SEQ     657    672       ERDVPDPQQGVGMETC -> PSDAPGTDRC (in
FT                                isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_034026.
FT   VAR_SEQ     673    878       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_034027.
SQ   SEQUENCE   878 AA;  93984 MW;  AE5AC5B8AA17750D CRC64;
     MEVKGPSGRS FCCESEGQFK SCLKRHTPSL LLPSSWKGNS GSCLMAEALH RTSPTPNSCP
     LPLPLCRMSG VLCSRNLFTF KFSLFQLDSG ASGEPGHSLG LTLGFSYCGN CQTAVVSAQP
     EGMASNGAYP VLGPGVTANP GTSLSVFTAL PFTTPAPGPA HGPLLVTAGA PPGGPLVLST
     FPSTPLVTEQ DGCGPSGAGA SNVFVQMRTE VGPVKAAQAQ TLVLTQAPLV WQAPGALCGG
     VVCPPPLLLA AAPVVPVMAA QVVGGTQACE GGWSQGLPLP PPPPPAAQLP PIVSQGNAGP
     WPQGAHGESS LASSQAKAPP DDSCNPRSVY ENFRLWQHYK PLARRHLPQS PDTEALSCFL
     IPVLRSLARR KPTMTLEEGL WRAMREWQHT SNFDRMIFYE MAEKFLEFEA EEEMQIQKSQ
     WMKGPQCLPP PATPRLEPRG PPAPEVVKQP VYLPSKAGPK APTACLPPPR PQRPVTKARR
     PPPRPHRRAE TKARLPPPRP QRPAETKVPE EIPPEVVQEY VDIMEELLGP SLGATGEPEK
     QREEGKVKQP QEEDWTPPDP GLLSYIDKLC SQKDFVTKVE AVIHPQFLEE LLSPDPQMDF
     LALSQDLEQE EGLTLAQLVE KRLPPLKEKQ HARAAPSRGT ARLDSSSSKF AAGQGAERDV
     PDPQQGVGME TCPPQMTARD SQGRGRAHTG MARSEDSVVL LGCQDSPGLR AAWPTSPPQD
     HRPTCPGVGT KDALDLPGGS PVRESHGLAQ GSSEEEELPS LAFLLGSQHK LLPWWLPQSP
     VPASGLLSPE KWGPQGTHQS PSAERRGLNL APSPANKAKK RPLFGSLSPA EKTPYPGPGL
     RVSGEQSLTW GLGGPSQSQK RKGDPLVSRK EKKQHCSQ
//
ID   PA1B2_HUMAN             Reviewed;         229 AA.
AC   P68402; A8DPS5; A8DPS6; A8DPS7; E9PEJ5; E9PLP3; O00687; Q29459;
AC   Q6IBR6;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   28-FEB-2018, entry version 144.
DE   RecName: Full=Platelet-activating factor acetylhydrolase IB subunit beta;
DE            EC=3.1.1.47;
DE   AltName: Full=PAF acetylhydrolase 30 kDa subunit;
DE            Short=PAF-AH 30 kDa subunit;
DE   AltName: Full=PAF-AH subunit beta;
DE            Short=PAFAH subunit beta;
GN   Name=PAFAH1B2; Synonyms=PAFAHB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal liver;
RX   PubMed=9144386; DOI=10.1006/bbrc.1997.6383;
RA   Adachi H., Tsujimoto M., Hattori M., Arai H., Inoue K.;
RT   "Differential tissue distribution of the beta- and gamma-subunits of
RT   human cytosolic platelet-activating factor acetylhydrolase (isoform
RT   I).";
RL   Biochem. Biophys. Res. Commun. 233:10-13(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), AND ALTERNATIVE
RP   SPLICING.
RC   TISSUE=Testis;
RX   PubMed=18155631; DOI=10.1016/j.prostaglandins.2007.10.005;
RA   Scott B.T., Olson N., Long G.L., Bovill E.G.;
RT   "Novel isoforms of intracellular platelet activating factor
RT   acetylhydrolase (PAFAH1b2) in human testis; encoded by alternatively
RT   spliced mRNAs.";
RL   Prostaglandins Other Lipid Mediat. 85:69-80(2008).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 61-79, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND SER-64, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Inactivates PAF by removing the acetyl group at the sn-2
CC       position. This is a catalytic subunit.
CC   -!- CATALYTIC ACTIVITY: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine +
CC       H(2)O = 1-alkyl-sn-glycero-3-phosphocholine + acetate.
CC   -!- SUBUNIT: Cytosolic PAF-AH IB is formed of three subunits of 45 kDa
CC       (alpha), 30 kDa (beta) and 29 kDa (gamma). The catalytic activity
CC       of the enzyme resides in the beta and gamma subunits, whereas the
CC       alpha subunit has regulatory activity. Trimer formation is not
CC       essential for the catalytic activity.
CC   -!- INTERACTION:
CC       Q15102:PAFAH1B3; NbExp=5; IntAct=EBI-713724, EBI-711522;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P68402-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P68402-2; Sequence=VSP_042896;
CC       Name=3;
CC         IsoId=P68402-3; Sequence=VSP_043217;
CC       Name=4;
CC         IsoId=P68402-4; Sequence=VSP_044680;
CC         Note=Ref.2 (ABI58227/ABI58228) sequences are in conflict in
CC         position: 151:V->M. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9144386}.
CC   -!- SIMILARITY: Belongs to the 'GDSL' lipolytic enzyme family.
CC       Platelet-activating factor acetylhydrolase IB beta/gamma subunits
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D63390; BAA19917.1; -; mRNA.
DR   EMBL; DQ836738; ABI58225.1; -; mRNA.
DR   EMBL; DQ836739; ABI58226.1; -; mRNA.
DR   EMBL; DQ836740; ABI58227.1; -; mRNA.
DR   EMBL; DQ836741; ABI58228.1; -; mRNA.
DR   EMBL; DQ836742; ABI58229.1; -; mRNA.
DR   EMBL; DQ836743; ABI58230.1; -; mRNA.
DR   EMBL; AK292973; BAF85662.1; -; mRNA.
DR   EMBL; CR456736; CAG33017.1; -; mRNA.
DR   EMBL; EF445007; ACA06040.1; -; Genomic_DNA.
DR   EMBL; AP005018; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67281.1; -; Genomic_DNA.
DR   EMBL; BC000398; AAH00398.1; -; mRNA.
DR   EMBL; BC019301; AAH19301.1; -; mRNA.
DR   CCDS; CCDS53713.1; -. [P68402-3]
DR   CCDS; CCDS53714.1; -. [P68402-4]
DR   CCDS; CCDS53715.1; -. [P68402-2]
DR   CCDS; CCDS8380.1; -. [P68402-1]
DR   PIR; JC5409; JC5409.
DR   RefSeq; NP_001171675.1; NM_001184746.1. [P68402-4]
DR   RefSeq; NP_001171676.1; NM_001184747.1. [P68402-2]
DR   RefSeq; NP_001171677.1; NM_001184748.1. [P68402-3]
DR   RefSeq; NP_001296360.1; NM_001309431.1.
DR   RefSeq; NP_002563.1; NM_002572.3. [P68402-1]
DR   UniGene; Hs.728488; -.
DR   PDB; 1VYH; X-ray; 3.40 A; A/B/E/F/I/J/M/N/Q/R=1-229.
DR   PDBsum; 1VYH; -.
DR   ProteinModelPortal; P68402; -.
DR   SMR; P68402; -.
DR   BioGrid; 111086; 54.
DR   IntAct; P68402; 18.
DR   STRING; 9606.ENSP00000435289; -.
DR   ChEMBL; CHEMBL4463; -.
DR   iPTMnet; P68402; -.
DR   PhosphoSitePlus; P68402; -.
DR   BioMuta; PAFAH1B2; -.
DR   DMDM; 55977294; -.
DR   REPRODUCTION-2DPAGE; IPI00026546; -.
DR   EPD; P68402; -.
DR   PaxDb; P68402; -.
DR   PeptideAtlas; P68402; -.
DR   PRIDE; P68402; -.
DR   Ensembl; ENST00000419197; ENSP00000388742; ENSG00000168092. [P68402-3]
DR   Ensembl; ENST00000527958; ENSP00000435289; ENSG00000168092. [P68402-1]
DR   Ensembl; ENST00000529887; ENSP00000434951; ENSG00000168092. [P68402-2]
DR   Ensembl; ENST00000530272; ENSP00000431365; ENSG00000168092. [P68402-4]
DR   GeneID; 5049; -.
DR   KEGG; hsa:5049; -.
DR   UCSC; uc009yzk.3; human. [P68402-1]
DR   CTD; 5049; -.
DR   DisGeNET; 5049; -.
DR   EuPathDB; HostDB:ENSG00000168092.13; -.
DR   GeneCards; PAFAH1B2; -.
DR   H-InvDB; HIX0022939; -.
DR   HGNC; HGNC:8575; PAFAH1B2.
DR   HPA; HPA051836; -.
DR   MIM; 602508; gene.
DR   neXtProt; NX_P68402; -.
DR   OpenTargets; ENSG00000168092; -.
DR   PharmGKB; PA32906; -.
DR   eggNOG; ENOG410IMK6; Eukaryota.
DR   eggNOG; ENOG410XPWQ; LUCA.
DR   GeneTree; ENSGT00390000016520; -.
DR   HOGENOM; HOG000232143; -.
DR   HOVERGEN; HBG053477; -.
DR   InParanoid; P68402; -.
DR   KO; K16795; -.
DR   OMA; RGQQPNK; -.
DR   OrthoDB; EOG091G0OII; -.
DR   PhylomeDB; P68402; -.
DR   TreeFam; TF323955; -.
DR   BRENDA; 3.1.1.47; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   SIGNOR; P68402; -.
DR   ChiTaRS; PAFAH1B2; human.
DR   EvolutionaryTrace; P68402; -.
DR   GeneWiki; PAFAH1B2; -.
DR   GenomeRNAi; 5049; -.
DR   PRO; PR:P68402; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000168092; -.
DR   CleanEx; HS_PAFAH1B2; -.
DR   ExpressionAtlas; P68402; baseline and differential.
DR   Genevisible; P68402; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004623; F:phospholipase A2 activity; TAS:Reactome.
DR   GO; GO:0047179; F:platelet-activating factor acetyltransferase activity; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IBA:GO_Central.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0016239; P:positive regulation of macroautophagy; IMP:BHF-UCL.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   Gene3D; 3.40.50.1110; -; 1.
DR   InterPro; IPR013830; SGNH_hydro.
DR   InterPro; IPR036514; SGNH_hydro_sf.
DR   Pfam; PF13472; Lipase_GDSL_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Phosphoprotein; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   CHAIN         2    229       Platelet-activating factor
FT                                acetylhydrolase IB subunit beta.
FT                                /FTId=PRO_0000058151.
FT   ACT_SITE     48     48       {ECO:0000250}.
FT   ACT_SITE    193    193       {ECO:0000250}.
FT   ACT_SITE    196    196       {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      64     64       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     220    220       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q61206}.
FT   VAR_SEQ     133    229       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:18155631}.
FT                                /FTId=VSP_043217.
FT   VAR_SEQ     138    229       GLLPRGEKPNPLRQKNAKVNQLLKVSLPKLANVQLLDTDGG
FT                                FVHSDGAISCHDMFDFLHLTGGGYAKICKPLHELIMQLLEE
FT                                TPEEKQTTIA -> IIYWQDEQDYHERKVQMD (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:18155631}.
FT                                /FTId=VSP_042896.
FT   VAR_SEQ     139    229       LLPRGEKPNPLRQKNAKVNQLLKVSLPKLANVQLLDTDGGF
FT                                VHSDGAISCHDMFDFLHLTGGGYAKICKPLHELIMQLLEET
FT                                PEEKQTTIA -> KAAASKYSISEIVRLEQGSVNWSIGTYP
FT                                DDTPATTRPAILQLFTGKMSRITMKEKSRWTEEILH (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:18155631}.
FT                                /FTId=VSP_044680.
FT   HELIX         8     10       {ECO:0000244|PDB:1VYH}.
FT   STRAND       19     21       {ECO:0000244|PDB:1VYH}.
FT   HELIX        23     37       {ECO:0000244|PDB:1VYH}.
FT   STRAND       41     47       {ECO:0000244|PDB:1VYH}.
FT   HELIX        48     53       {ECO:0000244|PDB:1VYH}.
FT   HELIX        57     62       {ECO:0000244|PDB:1VYH}.
FT   HELIX        64     66       {ECO:0000244|PDB:1VYH}.
FT   STRAND       68     72       {ECO:0000244|PDB:1VYH}.
FT   HELIX        78     86       {ECO:0000244|PDB:1VYH}.
FT   TURN         87     90       {ECO:0000244|PDB:1VYH}.
FT   STRAND       96    101       {ECO:0000244|PDB:1VYH}.
FT   HELIX       111    128       {ECO:0000244|PDB:1VYH}.
FT   STRAND      133    137       {ECO:0000244|PDB:1VYH}.
FT   STRAND      143    145       {ECO:0000244|PDB:1VYH}.
FT   HELIX       148    163       {ECO:0000244|PDB:1VYH}.
FT   STRAND      164    167       {ECO:0000244|PDB:1VYH}.
FT   STRAND      170    173       {ECO:0000244|PDB:1VYH}.
FT   TURN        188    190       {ECO:0000244|PDB:1VYH}.
FT   STRAND      194    197       {ECO:0000244|PDB:1VYH}.
FT   HELIX       199    219       {ECO:0000244|PDB:1VYH}.
SQ   SEQUENCE   229 AA;  25569 MW;  14CF5D48621AA504 CRC64;
     MSQGDSNPAA IPHAAEDIQG DDRWMSQHNR FVLDCKDKEP DVLFVGDSMV QLMQQYEIWR
     ELFSPLHALN FGIGGDTTRH VLWRLKNGEL ENIKPKVIVV WVGTNNHENT AEEVAGGIEA
     IVQLINTRQP QAKIIVLGLL PRGEKPNPLR QKNAKVNQLL KVSLPKLANV QLLDTDGGFV
     HSDGAISCHD MFDFLHLTGG GYAKICKPLH ELIMQLLEET PEEKQTTIA
//
ID   V9HW44_HUMAN            Unreviewed;       229 AA.
AC   V9HW44;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   28-FEB-2018, entry version 40.
DE   SubName: Full=Epididymis secretory protein Li 303 {ECO:0000313|EMBL:ACI46020.1};
DE   SubName: Full=Platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa, isoform CRA_a {ECO:0000313|EMBL:EAW67282.1};
GN   Name=HEL-S-303 {ECO:0000313|EMBL:ACI46020.1};
GN   Synonyms=PAFAH1B2 {ECO:0000313|EMBL:EAW67282.1};
GN   ORFNames=hCG_39271 {ECO:0000313|EMBL:EAW67282.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI46020.1};
RN   [1] {ECO:0000313|EMBL:EAW67282.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW67282.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACI46020.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J., Wang H., Liu J., Liu F.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ224328; ACI46020.1; -; mRNA.
DR   EMBL; CH471065; EAW67282.1; -; Genomic_DNA.
DR   RefSeq; NP_002563.1; NM_002572.3.
DR   UniGene; Hs.728488; -.
DR   SMR; V9HW44; -.
DR   MaxQB; V9HW44; -.
DR   GeneID; 5049; -.
DR   KEGG; hsa:5049; -.
DR   UCSC; uc001pqe.4; human.
DR   CTD; 5049; -.
DR   EuPathDB; HostDB:ENSG00000168092.13; -.
DR   eggNOG; ENOG410IMK6; Eukaryota.
DR   eggNOG; ENOG410XPWQ; LUCA.
DR   KO; K16795; -.
DR   OMA; RGQQPNK; -.
DR   OrthoDB; EOG091G0OII; -.
DR   ChiTaRS; PAFAH1B2; human.
DR   GenomeRNAi; 5049; -.
DR   Bgee; ENSG00000168092; -.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0047179; F:platelet-activating factor acetyltransferase activity; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   Gene3D; 3.40.50.1110; -; 1.
DR   InterPro; IPR013830; SGNH_hydro.
DR   InterPro; IPR036514; SGNH_hydro_sf.
DR   Pfam; PF13472; Lipase_GDSL_2; 1.
PE   2: Evidence at transcript level;
KW   Hydrolase {ECO:0000313|EMBL:EAW67282.1}.
FT   DOMAIN       44    203       SGNH_hydro. {ECO:0000259|Pfam:PF13472}.
SQ   SEQUENCE   229 AA;  25569 MW;  14CF5D48621AA504 CRC64;
     MSQGDSNPAA IPHAAEDIQG DDRWMSQHNR FVLDCKDKEP DVLFVGDSMV QLMQQYEIWR
     ELFSPLHALN FGIGGDTTRH VLWRLKNGEL ENIKPKVIVV WVGTNNHENT AEEVAGGIEA
     IVQLINTRQP QAKIIVLGLL PRGEKPNPLR QKNAKVNQLL KVSLPKLANV QLLDTDGGFV
     HSDGAISCHD MFDFLHLTGG GYAKICKPLH ELIMQLLEET PEEKQTTIA
//
ID   PAX7_HUMAN              Reviewed;         505 AA.
AC   P23759; E9PFV9; Q0VA99; Q2PJS5;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   24-JUN-2015, sequence version 4.
DT   28-FEB-2018, entry version 183.
DE   RecName: Full=Paired box protein Pax-7;
DE   AltName: Full=HuP1;
GN   Name=PAX7; Synonyms=HUP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=9339373; DOI=10.1006/geno.1997.4915;
RA   Vorobyov E., Mertsalov I., Dockhorn-Dworniczak B., Dworniczak B.,
RA   Horst J.;
RT   "The genomic organization and the full coding region of the human PAX7
RT   gene.";
RL   Genomics 45:168-174(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=16830101; DOI=10.1007/s00239-005-0163-7;
RA   Vorobyov E., Horst J.;
RT   "Getting the proto-Pax by the tail.";
RL   J. Mol. Evol. 63:153-164(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-467 (ISOFORMS 1/3).
RX   PubMed=7527137; DOI=10.1093/nar/22.22.4574;
RA   Schaefer B.W., Czerny T., Bernasconi M., Genini M., Busslinger M.;
RT   "Molecular cloning and characterization of a human PAX-7 cDNA
RT   expressed in normal and neoplastic myocytes.";
RL   Nucleic Acids Res. 22:4574-4582(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 30-195 (ISOFORM 2).
RX   PubMed=2501086;
RA   Burri M., Tromvoukis Y., Bopp D., Frigerio G., Noll M.;
RT   "Conservation of the paired domain in metazoans and its structure in
RT   three isolated human genes.";
RL   EMBO J. 8:1183-1190(1989).
RN   [8]
RP   INVOLVEMENT IN RMS2, AND CHROMOSOMAL TRANSLOCATION WITH FOXO1.
RX   PubMed=8187070;
RA   Davis R.J., D'Cruz C.M., Lovell M.A., Biegel J.A., Barr F.G.;
RT   "Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation
RT   in alveolar rhabdomyosarcoma.";
RL   Cancer Res. 54:2869-2872(1994).
RN   [9]
RP   INTERACTION WITH DAXX.
RX   PubMed=10393185; DOI=10.1093/emboj/18.13.3702;
RA   Hollenbach A.D., Sublett J.E., McPherson C.J., Grosveld G.;
RT   "The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated
RT   repressor hDaxx.";
RL   EMBO J. 18:3702-3711(1999).
CC   -!- FUNCTION: Transcription factor playing a role in myogenesis
CC       through regulation of muscle precursor cells proliferation.
CC       {ECO:0000250|UniProtKB:P47239}.
CC   -!- SUBUNIT: Can bind to DNA as a heterodimer with PAX3. Interacts
CC       with PAXBP1; the interaction links PAX7 to a WDR5-containing
CC       histone methyltransferase complex (By similarity). Interacts with
CC       DAXX (PubMed:10393185). {ECO:0000250|UniProtKB:P47239,
CC       ECO:0000269|PubMed:10393185}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P47239}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=3;
CC         IsoId=P23759-3; Sequence=Displayed;
CC       Name=1; Synonyms=Long;
CC         IsoId=P23759-1; Sequence=VSP_057679;
CC       Name=2; Synonyms=Short;
CC         IsoId=P23759-2; Sequence=VSP_057678, VSP_057679;
CC   -!- DISEASE: Rhabdomyosarcoma 2 (RMS2) [MIM:268220]: A form of
CC       rhabdomyosarcoma, a highly malignant tumor of striated muscle
CC       derived from primitive mesenchymal cells and exhibiting
CC       differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is
CC       one of the most frequently occurring soft tissue sarcomas and the
CC       most common in children. It occurs in four forms: alveolar,
CC       pleomorphic, embryonal and botryoidal rhabdomyosarcomas.
CC       {ECO:0000269|PubMed:8187070}. Note=The gene represented in this
CC       entry is involved in disease pathogenesis. A chromosomal
CC       aberration involving PAX7 is found in rhabdomyosarcoma.
CC       Translocation t(1;13)(p36;q14) with FOXO1. The resulting protein
CC       is a transcriptional activator. {ECO:0000269|PubMed:8187070}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X96743; CAA65520.1; -; mRNA.
DR   EMBL; X96744; CAA65521.1; -; Genomic_DNA.
DR   EMBL; X15042; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X15250; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X15251; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96745; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96746; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96747; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96748; CAA65521.1; JOINED; Genomic_DNA.
DR   EMBL; X96744; CAA65522.1; -; Genomic_DNA.
DR   EMBL; X15042; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X15250; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X15251; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96745; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96746; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96747; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; X96748; CAA65522.1; JOINED; Genomic_DNA.
DR   EMBL; DQ322591; ABC48797.1; -; mRNA.
DR   EMBL; AL021528; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471134; EAW94853.1; -; Genomic_DNA.
DR   EMBL; BC121165; AAI21166.1; -; mRNA.
DR   EMBL; BC121166; AAI21167.1; -; mRNA.
DR   EMBL; Z35141; CAA84513.1; -; mRNA.
DR   CCDS; CCDS186.1; -. [P23759-1]
DR   CCDS; CCDS44074.1; -. [P23759-3]
DR   CCDS; CCDS44075.1; -. [P23759-2]
DR   PIR; S78502; S78502.
DR   RefSeq; NP_001128726.1; NM_001135254.1. [P23759-3]
DR   RefSeq; NP_002575.1; NM_002584.2. [P23759-1]
DR   RefSeq; NP_039236.1; NM_013945.2. [P23759-2]
DR   UniGene; Hs.113253; -.
DR   ProteinModelPortal; P23759; -.
DR   SMR; P23759; -.
DR   BioGrid; 111115; 6.
DR   IntAct; P23759; 12.
DR   MINT; P23759; -.
DR   STRING; 9606.ENSP00000364524; -.
DR   iPTMnet; P23759; -.
DR   PhosphoSitePlus; P23759; -.
DR   BioMuta; PAX7; -.
DR   DMDM; 8247951; -.
DR   PaxDb; P23759; -.
DR   PeptideAtlas; P23759; -.
DR   PRIDE; P23759; -.
DR   Ensembl; ENST00000375375; ENSP00000364524; ENSG00000009709. [P23759-1]
DR   Ensembl; ENST00000400661; ENSP00000383502; ENSG00000009709. [P23759-2]
DR   Ensembl; ENST00000420770; ENSP00000403389; ENSG00000009709. [P23759-3]
DR   GeneID; 5081; -.
DR   KEGG; hsa:5081; -.
DR   UCSC; uc001bay.3; human. [P23759-3]
DR   CTD; 5081; -.
DR   DisGeNET; 5081; -.
DR   EuPathDB; HostDB:ENSG00000009709.11; -.
DR   GeneCards; PAX7; -.
DR   HGNC; HGNC:8621; PAX7.
DR   MalaCards; PAX7; -.
DR   MIM; 167410; gene.
DR   MIM; 268220; phenotype.
DR   neXtProt; NX_P23759; -.
DR   OpenTargets; ENSG00000009709; -.
DR   Orphanet; 99756; Alveolar rhabdomyosarcoma.
DR   PharmGKB; PA32961; -.
DR   eggNOG; KOG0849; Eukaryota.
DR   eggNOG; ENOG410XS01; LUCA.
DR   GeneTree; ENSGT00680000099553; -.
DR   HOGENOM; HOG000230939; -.
DR   HOVERGEN; HBG009115; -.
DR   InParanoid; P23759; -.
DR   KO; K09381; -.
DR   OMA; MKLGDHS; -.
DR   OrthoDB; EOG091G0S4E; -.
DR   TreeFam; TF351610; -.
DR   SIGNOR; P23759; -.
DR   ChiTaRS; PAX7; human.
DR   GeneWiki; PAX7; -.
DR   GenomeRNAi; 5081; -.
DR   PRO; PR:P23759; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000009709; -.
DR   CleanEx; HS_PAX7; -.
DR   Genevisible; P23759; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000983; F:transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0006338; P:chromatin remodeling; IEA:Ensembl.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0060415; P:muscle tissue morphogenesis; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc.
DR   GO; GO:0048663; P:neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0031062; P:positive regulation of histone methylation; IEA:Ensembl.
DR   GO; GO:2000288; P:positive regulation of myoblast proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0010453; P:regulation of cell fate commitment; IEA:Ensembl.
DR   GO; GO:0043393; P:regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0014813; P:skeletal muscle satellite cell commitment; IEA:Ensembl.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl.
DR   GO; GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR022106; Pax7_C.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF00292; PAX; 1.
DR   Pfam; PF12360; Pax7; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 2.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Complete proteome;
KW   Developmental protein; DNA-binding; Homeobox; Myogenesis; Nucleus;
KW   Paired box; Proto-oncogene; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    505       Paired box protein Pax-7.
FT                                /FTId=PRO_0000050194.
FT   DOMAIN       34    163       Paired. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00381}.
FT   DNA_BIND    217    276       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   REGION       27    210       Sufficient to mediate interaction with
FT                                PAXBP1. {ECO:0000250|UniProtKB:P47239}.
FT   MOTIF       479    491       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   VAR_SEQ     151    152       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_057678.
FT   VAR_SEQ     468    505       TAVDYLAKNVSLSTQRRMKLGEHSAVLGLLPVETGQAY ->
FT                                SECLVPWASPVPIPSPTPRASCLFMESYKVVSGWGMSISQM
FT                                EKLKSSQMEQFT (in isoform 1 and isoform
FT                                2). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9339373}.
FT                                /FTId=VSP_057679.
FT   CONFLICT    468    468       T -> S (in Ref. 2; ABC48797).
FT                                {ECO:0000305}.
SQ   SEQUENCE   505 AA;  55119 MW;  E51CF8B3E8D4C3D9 CRC64;
     MAALPGTVPR MMRPAPGQNY PRTGFPLEVS TPLGQGRVNQ LGGVFINGRP LPNHIRHKIV
     EMAHHGIRPC VISRQLRVSH GCVSKILCRY QETGSIRPGA IGGSKPRQVA TPDVEKKIEE
     YKRENPGMFS WEIRDRLLKD GHCDRSTVPS GLVSSISRVL RIKFGKKEEE DEADKKEDDG
     EKKAKHSIDG ILGDKGNRLD EGSDVESEPD LPLKRKQRRS RTTFTAEQLE ELEKAFERTH
     YPDIYTREEL AQRTKLTEAR VQVWFSNRRA RWRKQAGANQ LAAFNHLLPG GFPPTGMPTL
     PPYQLPDSTY PTTTISQDGG STVHRPQPLP PSTMHQGGLA AAAAAADTSS AYGARHSFSS
     YSDSFMNPAA PSNHMNPVSN GLSPQVMSIL GNPSAVPPQP QADFSISPLH GGLDSATSIS
     ASCSQRADSI KPGDSLPTSQ AYCPPTYSTT GYSVDPVAGY QYGQYGQTAV DYLAKNVSLS
     TQRRMKLGEH SAVLGLLPVE TGQAY
//
ID   A0A024R4X8_HUMAN        Unreviewed;       321 AA.
AC   A0A024R4X8;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 35.
DE   SubName: Full=Paired box gene 8, isoform CRA_c {ECO:0000313|EMBL:EAW73635.1};
GN   Name=PAX8 {ECO:0000313|EMBL:EAW73635.1};
GN   ORFNames=hCG_26667 {ECO:0000313|EMBL:EAW73635.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW73635.1};
RN   [1] {ECO:0000313|EMBL:EAW73635.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW73635.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00381, ECO:0000256|SAAS:SAAS00117811}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471217; EAW73631.1; -; Genomic_DNA.
DR   EMBL; CH471217; EAW73635.1; -; Genomic_DNA.
DR   RefSeq; NP_039247.1; NM_013953.3.
DR   UniGene; Hs.469728; -.
DR   SMR; A0A024R4X8; -.
DR   GeneID; 7849; -.
DR   CTD; 7849; -.
DR   EuPathDB; HostDB:ENSG00000125618.16; -.
DR   eggNOG; KOG3862; Eukaryota.
DR   eggNOG; ENOG410ZT0S; LUCA.
DR   ChiTaRS; PAX8; human.
DR   GenomeRNAi; 7849; -.
DR   Bgee; ENSG00000125618; -.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00292; PAX; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   4: Predicted;
KW   Developmental protein {ECO:0000256|SAAS:SAAS00117810};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117818};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117821};
KW   Paired box {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117809};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117816};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117816}.
FT   DOMAIN        9    135       Paired. {ECO:0000259|PROSITE:PS51057}.
SQ   SEQUENCE   321 AA;  34909 MW;  DE1BC715C6C75532 CRC64;
     MPHNSIRSGH GGLNQLGGAF VNGRPLPEVV RQRIVDLAHQ GVRPCDISRQ LRVSHGCVSK
     ILGRYYETGS IRPGVIGGSK PKVATPKVVE KIGDYKRQNP TMFAWEIRDR LLAEGVCDND
     TVPSVSSINR IIRTKVQQPF NLPMDSCVAT KSLSPGHTLI PSSAVTPPES PQSDSLGSTY
     SINGLLGIAQ PGSDKRKMDD SDQDSCRLSI DSQSSSSGPR KHLRTDAFSQ HHLEPLECPF
     ERQHYPEAYA SPSHTKGEQG ERWWGPRCPD THPTSPPADR AAMPPLPSQA WWQEVNTLAM
     PMATPPTPPT ARPGASPTPA C
//
ID   A0A024R524_HUMAN        Unreviewed;       398 AA.
AC   A0A024R524;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 35.
DE   SubName: Full=Paired box gene 8, isoform CRA_d {ECO:0000313|EMBL:EAW73638.1};
GN   Name=PAX8 {ECO:0000313|EMBL:EAW73638.1};
GN   ORFNames=hCG_26667 {ECO:0000313|EMBL:EAW73638.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW73638.1};
RN   [1] {ECO:0000313|EMBL:EAW73638.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW73638.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00381, ECO:0000256|SAAS:SAAS00117811}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471217; EAW73634.1; -; Genomic_DNA.
DR   EMBL; CH471217; EAW73638.1; -; Genomic_DNA.
DR   RefSeq; NP_039246.1; NM_013952.3.
DR   UniGene; Hs.469728; -.
DR   SMR; A0A024R524; -.
DR   GeneID; 7849; -.
DR   CTD; 7849; -.
DR   EuPathDB; HostDB:ENSG00000125618.16; -.
DR   eggNOG; KOG3862; Eukaryota.
DR   eggNOG; ENOG410ZT0S; LUCA.
DR   ChiTaRS; PAX8; human.
DR   GenomeRNAi; 7849; -.
DR   Bgee; ENSG00000125618; -.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00292; PAX; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   4: Predicted;
KW   Developmental protein {ECO:0000256|SAAS:SAAS00117810};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117818};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117821};
KW   Paired box {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117809};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117816};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117816}.
FT   DOMAIN        9    135       Paired. {ECO:0000259|PROSITE:PS51057}.
SQ   SEQUENCE   398 AA;  43028 MW;  B8A48B2C8916723C CRC64;
     MPHNSIRSGH GGLNQLGGAF VNGRPLPEVV RQRIVDLAHQ GVRPCDISRQ LRVSHGCVSK
     ILGRYYETGS IRPGVIGGSK PKVATPKVVE KIGDYKRQNP TMFAWEIRDR LLAEGVCDND
     TVPSVSSINR IIRTKVQQPF NLPMDSCVAT KSLSPGHTLI PSSAVTPPES PQSDSLGSTY
     SINGLLGIAQ PGSDKRKMDD SDQDSCRLSI DSQSSSSGPR KHLRTDAFSQ HHLEPLECPF
     ERQHYPEAYA SPSHTKGEQG LYPLPLLNST LDDGKATLTP SNTPLGRNLS THQTYPVVAA
     PPFWICSKSA PGSRPSMPFP MLPPCTGSSR ARPSSQGERW WGPRCPDTHP TSPPADRAAM
     PPLPSQAWWQ EVNTLAMPMA TPPTPPTARP GASPTPAC
//
ID   A0A024R531_HUMAN        Unreviewed;       387 AA.
AC   A0A024R531;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 29.
DE   SubName: Full=Paired box 8 isoform 2 {ECO:0000313|EMBL:ALQ33863.1};
DE   SubName: Full=Paired box gene 8, isoform CRA_f {ECO:0000313|EMBL:EAW73639.1};
GN   Name=PAX8 {ECO:0000313|EMBL:EAW73639.1};
GN   ORFNames=hCG_26667 {ECO:0000313|EMBL:EAW73639.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW73639.1};
RN   [1] {ECO:0000313|EMBL:EAW73639.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW73639.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33863.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00381, ECO:0000256|SAAS:SAAS00117811}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178405; ALQ33863.1; -; mRNA.
DR   EMBL; CH471217; EAW73637.1; -; Genomic_DNA.
DR   EMBL; CH471217; EAW73639.1; -; Genomic_DNA.
DR   RefSeq; XP_011510096.1; XM_011511794.1.
DR   UniGene; Hs.469728; -.
DR   SMR; A0A024R531; -.
DR   GeneID; 7849; -.
DR   CTD; 7849; -.
DR   eggNOG; KOG3862; Eukaryota.
DR   eggNOG; ENOG410ZT0S; LUCA.
DR   ChiTaRS; PAX8; human.
DR   GenomeRNAi; 7849; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR022130; Pax2_C.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00292; PAX; 1.
DR   Pfam; PF12403; Pax2_C; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   2: Evidence at transcript level;
KW   Developmental protein {ECO:0000256|SAAS:SAAS00117810};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117818};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117821};
KW   Paired box {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117809};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117816};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117816}.
FT   DOMAIN        9    135       Paired. {ECO:0000259|PROSITE:PS51057}.
FT   NON_TER     387    387       {ECO:0000313|EMBL:ALQ33863.1}.
SQ   SEQUENCE   387 AA;  41741 MW;  8618767656E83C39 CRC64;
     MPHNSIRSGH GGLNQLGGAF VNGRPLPEVV RQRIVDLAHQ GVRPCDISRQ LRVSHGCVSK
     ILGRYYETGS IRPGVIGGSK PKVATPKVVE KIGDYKRQNP TMFAWEIRDR LLAEGVCDND
     TVPSVSSINR IIRTKVQQPF NLPMDSCVAT KSLSPGHTLI PSSAVTPPES PQSDSLGSTY
     SINGLLGIAQ PGSDKRKMDD SDQDSCRLSI DSQSSSSGPR KHLRTDAFSQ HHLEPLECPF
     ERQHYPEAYA SPSHTKGEQG LYPLPLLNST LDDGKATLTP SNTPLGRNLS THQTYPVVAG
     REMVGPTLPG YPPHIPTSGQ GSYASSAIAG MVAGSEYSGN AYGHTPYSSY SEAWRFPNSS
     LLSSPYYYSS TSRPSAPPTT ATAFDHL
//
ID   PAX8_HUMAN              Reviewed;         450 AA.
AC   Q06710; Q09155; Q16337; Q16338; Q16339; Q4ZG35; Q96J49;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   31-JAN-2018, entry version 174.
DE   RecName: Full=Paired box protein Pax-8;
GN   Name=PAX8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT LEU-329.
RC   TISSUE=Kidney;
RX   PubMed=1337742;
RA   Poleev A., Fickenscher H., Mundlos S., Winterpacht A., Zabel B.,
RA   Fidler A., Gruss P., Plachov D.;
RT   "PAX8, a human paired box gene: isolation and expression in developing
RT   thyroid, kidney and Wilms' tumors.";
RL   Development 116:611-623(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND ALTERNATIVE SPLICING.
RC   TISSUE=Kidney;
RX   PubMed=8413205; DOI=10.1128/MCB.13.10.6024;
RA   Kozmik Z., Kurzbauer R., Doerfler P., Busslinger M.;
RT   "Alternative splicing of Pax-8 gene transcripts is developmentally
RT   regulated and generates isoforms with different transactivation
RT   properties.";
RL   Mol. Cell. Biol. 13:6024-6035(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3; 4 AND 5).
RX   PubMed=7737192; DOI=10.1111/j.1432-1033.1995.tb20338.x;
RA   Poleev A., Wendler F., Fickenscher H., Zannini M.S., Yaginuma K.,
RA   Abbott C., Plachov D.;
RT   "Distinct functional properties of three human paired-box-protein,
RT   PAX8, isoforms generated by alternative splicing in thyroid, kidney
RT   and Wilms' tumors.";
RL   Eur. J. Biochem. 228:899-911(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH WWTR1.
RX   PubMed=19010321; DOI=10.1016/j.yexcr.2008.10.016;
RA   Di Palma T., D'Andrea B., Liguori G.L., Liguoro A., de Cristofaro T.,
RA   Del Prete D., Pappalardo A., Mascia A., Zannini M.;
RT   "TAZ is a coactivator for Pax8 and TTF-1, two transcription factors
RT   involved in thyroid differentiation.";
RL   Exp. Cell Res. 315:162-175(2009).
RN   [9]
RP   VARIANTS CHNG2 HIS-31 AND ARG-62.
RX   PubMed=9590296; DOI=10.1038/ng0598-83;
RA   Macchia P.E., Lapi P., Krude H., Pirro M.T., Missero C., Chiovato L.,
RA   Souabni A., Baserga M., Tassi V., Pinchera A., Fenzi G., Gruters A.,
RA   Busslinger M., Di Lauro R.;
RT   "PAX8 mutations associated with congenital hypothyroidism caused by
RT   thyroid dysgenesis.";
RL   Nat. Genet. 19:83-86(1998).
RN   [10]
RP   VARIANT CHNG2 TYR-57.
RX   PubMed=11232006; DOI=10.1210/jcem.86.1.7140;
RA   Vilain C., Rydlewski C., Duprez L., Heinrichs C., Abramowicz M.,
RA   Malvaux P., Renneboog B., Parma J., Costagliola S., Vassart G.;
RT   "Autosomal dominant transmission of congenital thyroid hypoplasia due
RT   to loss-of-function mutation of PAX8.";
RL   J. Clin. Endocrinol. Metab. 86:234-238(2001).
RN   [11]
RP   VARIANT CHNG2 PRO-40.
RX   PubMed=11502839; DOI=10.1210/jcem.86.8.7765;
RA   Congdon T., Nguyen L.Q., Nogueira C.R., Habiby R.L., Medeiros-Neto G.,
RA   Kopp P.;
RT   "A novel mutation (Q40P) in PAX8 associated with congenital
RT   hypothyroidism and thyroid hypoplasia: evidence for phenotypic
RT   variability in mother and child.";
RL   J. Clin. Endocrinol. Metab. 86:3962-3967(2001).
RN   [12]
RP   STRUCTURE BY NMR OF 1-143.
RX   PubMed=18829450; DOI=10.1074/jbc.M805717200;
RA   Codutti L., van Ingen H., Vascotto C., Fogolari F., Corazza A.,
RA   Tell G., Quadrifoglio F., Viglino P., Boelens R., Esposito G.;
RT   "The solution structure of DNA-free Pax-8 paired box domain accounts
RT   for redox regulation of transcriptional activity in the pax protein
RT   family.";
RL   J. Biol. Chem. 283:33321-33328(2008).
CC   -!- FUNCTION: Transcription factor for the thyroid-specific expression
CC       of the genes exclusively expressed in the thyroid cell type,
CC       maintaining the functional differentiation of such cells.
CC   -!- SUBUNIT: Interacts with WWTR1. {ECO:0000269|PubMed:19010321}.
CC   -!- INTERACTION:
CC       P19338:NCL; NbExp=2; IntAct=EBI-2683132, EBI-346967;
CC       Q9NRX5:SERINC1; NbExp=2; IntAct=EBI-2683132, EBI-2683145;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Pax8a;
CC         IsoId=Q06710-1; Sequence=Displayed;
CC       Name=2; Synonyms=Pax8b;
CC         IsoId=Q06710-2; Sequence=VSP_002372;
CC       Name=3; Synonyms=Pax8c;
CC         IsoId=Q06710-3; Sequence=VSP_002373;
CC       Name=4; Synonyms=Pax8d;
CC         IsoId=Q06710-4; Sequence=VSP_002374;
CC       Name=5; Synonyms=Pax8e;
CC         IsoId=Q06710-5; Sequence=VSP_002375;
CC   -!- TISSUE SPECIFICITY: Expressed in the excretory system, thyroid
CC       gland and Wilms tumors.
CC   -!- DEVELOPMENTAL STAGE: In developing excretory system, during
CC       thyroid differentiation and in adult thyroid.
CC   -!- DISEASE: Hypothyroidism, congenital, non-goitrous, 2 (CHNG2)
CC       [MIM:218700]: A disease characterized by thyroid dysgenesis, the
CC       most frequent cause of congenital hypothyroidism, accounting for
CC       85% of case. The thyroid gland can be completely absent
CC       (athyreosis), ectopically located and/or severely hypoplastic.
CC       Ectopic thyroid gland is the most frequent malformation, with
CC       thyroid tissue being found most often at the base of the tongue.
CC       {ECO:0000269|PubMed:11232006, ECO:0000269|PubMed:11502839,
CC       ECO:0000269|PubMed:9590296}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PAX8ID382ch2q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X69699; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L19606; AAA03539.1; -; mRNA.
DR   EMBL; S77904; AAB34216.1; -; mRNA.
DR   EMBL; S77905; AAB34217.2; -; mRNA.
DR   EMBL; S77906; AAB34218.2; -; mRNA.
DR   EMBL; AK292191; BAF84880.1; -; mRNA.
DR   EMBL; AC016683; AAX88880.1; -; Genomic_DNA.
DR   EMBL; CH471217; EAW73629.1; -; Genomic_DNA.
DR   EMBL; BC001060; AAH01060.1; -; mRNA.
DR   CCDS; CCDS42735.1; -. [Q06710-5]
DR   CCDS; CCDS42736.1; -. [Q06710-4]
DR   CCDS; CCDS46398.1; -. [Q06710-1]
DR   CCDS; CCDS46399.1; -. [Q06710-3]
DR   PIR; A54429; A54429.
DR   PIR; I53340; I53340.
DR   RefSeq; NP_003457.1; NM_003466.3. [Q06710-1]
DR   RefSeq; NP_039246.1; NM_013952.3. [Q06710-3]
DR   RefSeq; NP_039247.1; NM_013953.3. [Q06710-4]
DR   RefSeq; NP_054698.1; NM_013992.3. [Q06710-5]
DR   UniGene; Hs.469728; -.
DR   PDB; 2K27; NMR; -; A=1-143.
DR   PDBsum; 2K27; -.
DR   ProteinModelPortal; Q06710; -.
DR   SMR; Q06710; -.
DR   BioGrid; 113604; 9.
DR   IntAct; Q06710; 23.
DR   STRING; 9606.ENSP00000395498; -.
DR   ChEMBL; CHEMBL2362980; -.
DR   iPTMnet; Q06710; -.
DR   PhosphoSitePlus; Q06710; -.
DR   BioMuta; PAX8; -.
DR   DMDM; 215273928; -.
DR   PaxDb; Q06710; -.
DR   PeptideAtlas; Q06710; -.
DR   PRIDE; Q06710; -.
DR   DNASU; 7849; -.
DR   Ensembl; ENST00000263334; ENSP00000263334; ENSG00000125618. [Q06710-1]
DR   Ensembl; ENST00000263335; ENSP00000263335; ENSG00000125618. [Q06710-4]
DR   Ensembl; ENST00000348715; ENSP00000314750; ENSG00000125618. [Q06710-3]
DR   Ensembl; ENST00000397647; ENSP00000380768; ENSG00000125618. [Q06710-5]
DR   Ensembl; ENST00000429538; ENSP00000395498; ENSG00000125618. [Q06710-1]
DR   GeneID; 7849; -.
DR   KEGG; hsa:7849; -.
DR   UCSC; uc002tjm.4; human. [Q06710-1]
DR   CTD; 7849; -.
DR   DisGeNET; 7849; -.
DR   EuPathDB; HostDB:ENSG00000125618.16; -.
DR   GeneCards; PAX8; -.
DR   HGNC; HGNC:8622; PAX8.
DR   HPA; HPA030062; -.
DR   HPA; HPA064554; -.
DR   MalaCards; PAX8; -.
DR   MIM; 167415; gene.
DR   MIM; 218700; phenotype.
DR   neXtProt; NX_Q06710; -.
DR   OpenTargets; ENSG00000125618; -.
DR   Orphanet; 95713; Athyreosis.
DR   Orphanet; 95720; Thyroid hypoplasia.
DR   PharmGKB; PA32962; -.
DR   eggNOG; KOG3862; Eukaryota.
DR   eggNOG; ENOG410ZT0S; LUCA.
DR   GeneTree; ENSGT00680000099553; -.
DR   HOVERGEN; HBG009115; -.
DR   InParanoid; Q06710; -.
DR   KO; K09293; -.
DR   OMA; DTFSQHH; -.
DR   OrthoDB; EOG091G0S4E; -.
DR   PhylomeDB; Q06710; -.
DR   TreeFam; TF315397; -.
DR   SIGNOR; Q06710; -.
DR   ChiTaRS; PAX8; human.
DR   EvolutionaryTrace; Q06710; -.
DR   GeneWiki; PAX8; -.
DR   GenomeRNAi; 7849; -.
DR   PRO; PR:Q06710; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000125618; -.
DR   CleanEx; HS_PAX8; -.
DR   ExpressionAtlas; Q06710; baseline and differential.
DR   Genevisible; Q06710; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0004996; F:thyroid-stimulating hormone receptor activity; TAS:ProtInc.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEP:UniProtKB.
DR   GO; GO:0071371; P:cellular response to gonadotropin stimulus; IDA:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; IEP:UniProtKB.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEP:UniProtKB.
DR   GO; GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; IEP:UniProtKB.
DR   GO; GO:0001823; P:mesonephros development; ISS:UniProtKB.
DR   GO; GO:0072278; P:metanephric comma-shaped body morphogenesis; IEP:UniProtKB.
DR   GO; GO:0072221; P:metanephric distal convoluted tubule development; ISS:UniProtKB.
DR   GO; GO:0072207; P:metanephric epithelium development; IEP:UniProtKB.
DR   GO; GO:0072289; P:metanephric nephron tubule formation; ISS:UniProtKB.
DR   GO; GO:0072284; P:metanephric S-shaped body morphogenesis; IEP:UniProtKB.
DR   GO; GO:1900215; P:negative regulation of apoptotic process involved in metanephric collecting duct development; ISS:UniProtKB.
DR   GO; GO:1900218; P:negative regulation of apoptotic process involved in metanephric nephron tubule development; ISS:UniProtKB.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0072305; P:negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis; ISS:UniProtKB.
DR   GO; GO:1900212; P:negative regulation of mesenchymal cell apoptotic process involved in metanephros development; ISS:UniProtKB.
DR   GO; GO:0071599; P:otic vesicle development; IEP:UniProtKB.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0072108; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:UniProtKB.
DR   GO; GO:2000594; P:positive regulation of metanephric DCT cell differentiation; ISS:UniProtKB.
DR   GO; GO:2000611; P:positive regulation of thyroid hormone generation; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0039003; P:pronephric field specification; ISS:UniProtKB.
DR   GO; GO:0048793; P:pronephros development; ISS:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0072307; P:regulation of metanephric nephron tubule epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:2000612; P:regulation of thyroid-stimulating hormone secretion; IMP:UniProtKB.
DR   GO; GO:0006790; P:sulfur compound metabolic process; IEA:Ensembl.
DR   GO; GO:0030878; P:thyroid gland development; IMP:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0001655; P:urogenital system development; ISS:UniProtKB.
DR   GO; GO:0003281; P:ventricular septum development; IEA:Ensembl.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR022130; Pax2_C.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00292; PAX; 1.
DR   Pfam; PF12403; Pax2_C; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Congenital hypothyroidism; Developmental protein; Differentiation;
KW   Disease mutation; DNA-binding; Nucleus; Paired box; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    450       Paired box protein Pax-8.
FT                                /FTId=PRO_0000050197.
FT   DOMAIN        9    135       Paired. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00381}.
FT   COMPBIAS    315    327       Ser-rich.
FT   MOD_RES     303    303       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q00288}.
FT   VAR_SEQ     260    450       GLYPLPLLNSTLDDGKATLTPSNTPLGRNLSTHQTYPVVAD
FT                                PHSPFAIKQETPEVSSSSSTPSSLSSSAFLDLQQVGSGVPP
FT                                FNAFPHAASVYGQFTGQALLSGREMVGPTLPGYPPHIPTSG
FT                                QGSYASSAIAGMVAGSEYSGNAYGHTPYSSYSEAWRFPNSS
FT                                LLSSPYYYSSTSRPSAPPTTATAFDHL -> GERWWGPRCP
FT                                DTHPTSPPADRAAMPPLPSQAWWQEVNTLAMPMATPPTPPT
FT                                ARPGASPTPAC (in isoform 4).
FT                                {ECO:0000303|PubMed:7737192}.
FT                                /FTId=VSP_002374.
FT   VAR_SEQ     260    450       GLYPLPLLNSTLDDGKATLTPSNTPLGRNLSTHQTYPVVAD
FT                                PHSPFAIKQETPEVSSSSSTPSSLSSSAFLDLQQVGSGVPP
FT                                FNAFPHAASVYGQFTGQALLSGREMVGPTLPGYPPHIPTSG
FT                                QGSYASSAIAGMVAGSEYSGNAYGHTPYSSYSEAWRFPNSS
FT                                LLSSPYYYSSTSRPSAPPTTATAFDHL -> EVNTLAMPMA
FT                                TPPTPPTARPGASPTPAC (in isoform 5).
FT                                {ECO:0000303|PubMed:7737192}.
FT                                /FTId=VSP_002375.
FT   VAR_SEQ     300    450       DPHSPFAIKQETPEVSSSSSTPSSLSSSAFLDLQQVGSGVP
FT                                PFNAFPHAASVYGQFTGQALLSGREMVGPTLPGYPPHIPTS
FT                                GQGSYASSAIAGMVAGSEYSGNAYGHTPYSSYSEAWRFPNS
FT                                SLLSSPYYYSSTSRPSAPPTTATAFDHL -> APPFWICSK
FT                                SAPGSRPSMPFPMLPPCTGSSRARPSSQGERWWGPRCPDTH
FT                                PTSPPADRAAMPPLPSQAWWQEVNTLAMPMATPPTPPTARP
FT                                GASPTPAC (in isoform 3).
FT                                {ECO:0000303|PubMed:7737192}.
FT                                /FTId=VSP_002373.
FT   VAR_SEQ     300    362       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1337742}.
FT                                /FTId=VSP_002372.
FT   VARIANT      31     31       R -> H (in CHNG2; loss of activity;
FT                                dbSNP:rs104893657).
FT                                {ECO:0000269|PubMed:9590296}.
FT                                /FTId=VAR_012769.
FT   VARIANT      40     40       Q -> P (in CHNG2; loss of activity;
FT                                dbSNP:rs104893656).
FT                                {ECO:0000269|PubMed:11502839}.
FT                                /FTId=VAR_012770.
FT   VARIANT      57     57       C -> Y (in CHNG2; loss of activity;
FT                                dbSNP:rs104893659).
FT                                {ECO:0000269|PubMed:11232006}.
FT                                /FTId=VAR_012771.
FT   VARIANT      62     62       L -> R (in CHNG2; loss of activity;
FT                                dbSNP:rs104893658).
FT                                {ECO:0000269|PubMed:9590296}.
FT                                /FTId=VAR_012772.
FT   VARIANT     329    329       F -> L (in dbSNP:rs3188996).
FT                                {ECO:0000269|PubMed:1337742}.
FT                                /FTId=VAR_012773.
FT   CONFLICT    305    305       F -> L (in Ref. 1; X69699).
FT                                {ECO:0000305}.
FT   CONFLICT    322    322       S -> C (in Ref. 1; X69699).
FT                                {ECO:0000305}.
FT   CONFLICT    418    418       R -> G (in Ref. 1; X69699).
FT                                {ECO:0000305}.
FT   STRAND       21     23       {ECO:0000244|PDB:2K27}.
FT   HELIX        28     40       {ECO:0000244|PDB:2K27}.
FT   HELIX        44     51       {ECO:0000244|PDB:2K27}.
FT   HELIX        56     62       {ECO:0000244|PDB:2K27}.
FT   HELIX        88     98       {ECO:0000244|PDB:2K27}.
FT   STRAND      100    102       {ECO:0000244|PDB:2K27}.
FT   HELIX       104    114       {ECO:0000244|PDB:2K27}.
FT   TURN        119    121       {ECO:0000244|PDB:2K27}.
FT   HELIX       125    135       {ECO:0000244|PDB:2K27}.
SQ   SEQUENCE   450 AA;  48218 MW;  7FDAFA8CEAF20A0E CRC64;
     MPHNSIRSGH GGLNQLGGAF VNGRPLPEVV RQRIVDLAHQ GVRPCDISRQ LRVSHGCVSK
     ILGRYYETGS IRPGVIGGSK PKVATPKVVE KIGDYKRQNP TMFAWEIRDR LLAEGVCDND
     TVPSVSSINR IIRTKVQQPF NLPMDSCVAT KSLSPGHTLI PSSAVTPPES PQSDSLGSTY
     SINGLLGIAQ PGSDKRKMDD SDQDSCRLSI DSQSSSSGPR KHLRTDAFSQ HHLEPLECPF
     ERQHYPEAYA SPSHTKGEQG LYPLPLLNST LDDGKATLTP SNTPLGRNLS THQTYPVVAD
     PHSPFAIKQE TPEVSSSSST PSSLSSSAFL DLQQVGSGVP PFNAFPHAAS VYGQFTGQAL
     LSGREMVGPT LPGYPPHIPT SGQGSYASSA IAGMVAGSEY SGNAYGHTPY SSYSEAWRFP
     NSSLLSSPYY YSSTSRPSAP PTTATAFDHL
//
ID   R9W7C9_HUMAN            Unreviewed;       450 AA.
AC   R9W7C9;
DT   18-SEP-2013, integrated into UniProtKB/TrEMBL.
DT   18-SEP-2013, sequence version 1.
DT   31-JAN-2018, entry version 41.
DE   SubName: Full=Paired box 8 isoform 1 {ECO:0000313|EMBL:ALQ33862.1};
DE   SubName: Full=Paired box 8 transcript variant F {ECO:0000313|EMBL:AGN95866.1};
DE   SubName: Full=Paired box gene 8, isoform CRA_a {ECO:0000313|EMBL:EAW73632.1};
GN   Name=PAX8 {ECO:0000313|EMBL:AGN95866.1};
GN   ORFNames=hCG_26667 {ECO:0000313|EMBL:EAW73632.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AGN95866.1};
RN   [1] {ECO:0000313|EMBL:EAW73632.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW73632.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AGN95866.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Szaflarski W.;
RT   "Alternative 3' acceptor site in the exon 2 of human PAX8 gene
RT   resulting in the expression of unknown mRNA variant found in thyroid
RT   hemiagenesis and some types of cancer.";
RL   Submitted (MAR-2013) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ALQ33862.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00381, ECO:0000256|SAAS:SAAS00117811}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KC733810; AGN95866.1; -; mRNA.
DR   EMBL; KU178404; ALQ33862.1; -; mRNA.
DR   EMBL; CH471217; EAW73632.1; -; Genomic_DNA.
DR   RefSeq; NP_003457.1; NM_003466.3.
DR   UniGene; Hs.469728; -.
DR   SMR; R9W7C9; -.
DR   GeneID; 7849; -.
DR   KEGG; hsa:7849; -.
DR   UCSC; uc010yxt.3; human.
DR   CTD; 7849; -.
DR   EuPathDB; HostDB:ENSG00000125618.16; -.
DR   eggNOG; KOG3862; Eukaryota.
DR   eggNOG; ENOG410ZT0S; LUCA.
DR   KO; K09293; -.
DR   OMA; DTFSQHH; -.
DR   OrthoDB; EOG091G0S4E; -.
DR   ChiTaRS; PAX8; human.
DR   GenomeRNAi; 7849; -.
DR   Bgee; ENSG00000125618; -.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0072164; P:mesonephric tubule development; IEA:Ensembl.
DR   GO; GO:0072221; P:metanephric distal convoluted tubule development; IEA:Ensembl.
DR   GO; GO:0072289; P:metanephric nephron tubule formation; IEA:Ensembl.
DR   GO; GO:1900215; P:negative regulation of apoptotic process involved in metanephric collecting duct development; IEA:Ensembl.
DR   GO; GO:1900218; P:negative regulation of apoptotic process involved in metanephric nephron tubule development; IEA:Ensembl.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0072305; P:negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis; IEA:Ensembl.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl.
DR   GO; GO:0072108; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; IEA:Ensembl.
DR   GO; GO:2000594; P:positive regulation of metanephric DCT cell differentiation; IEA:Ensembl.
DR   GO; GO:2000611; P:positive regulation of thyroid hormone generation; IEA:Ensembl.
DR   GO; GO:0039003; P:pronephric field specification; IEA:Ensembl.
DR   GO; GO:0072307; P:regulation of metanephric nephron tubule epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0072050; P:S-shaped body morphogenesis; IEA:Ensembl.
DR   GO; GO:0006790; P:sulfur compound metabolic process; IEA:Ensembl.
DR   GO; GO:0030878; P:thyroid gland development; IEA:Ensembl.
DR   GO; GO:0003281; P:ventricular septum development; IEA:Ensembl.
DR   CDD; cd00131; PAX; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001523; Paired_dom.
DR   InterPro; IPR022130; Pax2_C.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00292; PAX; 1.
DR   Pfam; PF12403; Pax2_C; 1.
DR   PRINTS; PR00027; PAIREDBOX.
DR   SMART; SM00351; PAX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00034; PAIRED_1; 1.
DR   PROSITE; PS51057; PAIRED_2; 1.
PE   2: Evidence at transcript level;
KW   Developmental protein {ECO:0000256|SAAS:SAAS00117810};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117818};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117821};
KW   Paired box {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117809};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117816};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00381,
KW   ECO:0000256|SAAS:SAAS00117816}.
FT   DOMAIN        9    135       Paired. {ECO:0000259|PROSITE:PS51057}.
FT   NON_TER     450    450       {ECO:0000313|EMBL:ALQ33862.1}.
SQ   SEQUENCE   450 AA;  48218 MW;  7FDAFA8CEAF20A0E CRC64;
     MPHNSIRSGH GGLNQLGGAF VNGRPLPEVV RQRIVDLAHQ GVRPCDISRQ LRVSHGCVSK
     ILGRYYETGS IRPGVIGGSK PKVATPKVVE KIGDYKRQNP TMFAWEIRDR LLAEGVCDND
     TVPSVSSINR IIRTKVQQPF NLPMDSCVAT KSLSPGHTLI PSSAVTPPES PQSDSLGSTY
     SINGLLGIAQ PGSDKRKMDD SDQDSCRLSI DSQSSSSGPR KHLRTDAFSQ HHLEPLECPF
     ERQHYPEAYA SPSHTKGEQG LYPLPLLNST LDDGKATLTP SNTPLGRNLS THQTYPVVAD
     PHSPFAIKQE TPEVSSSSST PSSLSSSAFL DLQQVGSGVP PFNAFPHAAS VYGQFTGQAL
     LSGREMVGPT LPGYPPHIPT SGQGSYASSA IAGMVAGSEY SGNAYGHTPY SSYSEAWRFP
     NSSLLSSPYY YSSTSRPSAP PTTATAFDHL
//
ID   A2RUU9_HUMAN            Unreviewed;      1859 AA.
AC   A2RUU9;
DT   06-MAR-2007, integrated into UniProtKB/TrEMBL.
DT   06-MAR-2007, sequence version 1.
DT   31-JAN-2018, entry version 53.
DE   SubName: Full=PCM1 protein {ECO:0000313|EMBL:AAI33053.1};
GN   Name=PCM1 {ECO:0000313|EMBL:AAI33053.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI33053.1};
RN   [1] {ECO:0000313|EMBL:AAI33053.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC133052; AAI33053.1; -; mRNA.
DR   RefSeq; NP_001302437.1; NM_001315508.1.
DR   RefSeq; NP_006188.3; NM_006197.3.
DR   UniGene; Hs.491148; -.
DR   PeptideAtlas; A2RUU9; -.
DR   PRIDE; A2RUU9; -.
DR   DNASU; 5108; -.
DR   GeneID; 5108; -.
DR   KEGG; hsa:5108; -.
DR   CTD; 5108; -.
DR   PharmGKB; PA33073; -.
DR   eggNOG; ENOG410IEGR; Eukaryota.
DR   eggNOG; ENOG410YNFX; LUCA.
DR   HOGENOM; HOG000115473; -.
DR   HOVERGEN; HBG053890; -.
DR   KO; K16537; -.
DR   ChiTaRS; PCM1; human.
DR   GenomeRNAi; 5108; -.
DR   Genevisible; A2RUU9; HS.
DR   GO; GO:0005813; C:centrosome; IEA:InterPro.
DR   GO; GO:0060271; P:cilium assembly; IEA:InterPro.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IEA:InterPro.
DR   GO; GO:0071539; P:protein localization to centrosome; IEA:InterPro.
DR   InterPro; IPR031446; PCM1_C.
DR   InterPro; IPR024138; Pericentriolar_Pcm1.
DR   PANTHER; PTHR14164; PTHR14164; 1.
DR   Pfam; PF15717; PCM1_C; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN     1317   1783       PCM1_C. {ECO:0000259|Pfam:PF15717}.
FT   DOMAIN     1781   1833       PCM1_C. {ECO:0000259|Pfam:PF15717}.
FT   COILED      270    293       {ECO:0000256|SAM:Coils}.
FT   COILED      403    423       {ECO:0000256|SAM:Coils}.
FT   COILED      493    530       {ECO:0000256|SAM:Coils}.
FT   COILED      652    682       {ECO:0000256|SAM:Coils}.
FT   COILED      732    769       {ECO:0000256|SAM:Coils}.
FT   COILED      826    853       {ECO:0000256|SAM:Coils}.
FT   COILED      989   1016       {ECO:0000256|SAM:Coils}.
FT   COILED     1065   1085       {ECO:0000256|SAM:Coils}.
FT   COILED     1462   1482       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1859 AA;  209906 MW;  707537DEE9210CF3 CRC64;
     MATGGGPFED GMNDQDLPNW SSENVDDRLN NMDWGAQQKK ANRSSEKNKK KFGVESDKRV
     TNDISPESSP GVGRRRTKTP HTFPHSRYMS QMSVPEQAEL EKLKQRINFS DLDQRSIGSD
     SQGRATAANN KRQLSENRKP FNFLPMQINT NKSKDASTNP PNRETIGSAQ CKELFASALS
     NDLLQNCQVS EEDGRGEPAM ESSQIVSRLV QIRDYITKAS SMREDLVEKN ERSANVERLT
     HLIDHLKEQE KSYMKFLKKI LARDPQQEPM EEIENLKKQH DLLKRMLQQQ EQLRALQGRQ
     AALLALQHKA EQAIAVMDDS VVAETAGSLS GVSITSELNE ELNDLIQRFH NQLRDSQPPA
     VPDNRRQAES LSLTREVSQS RKPSASERLP DEKVELFSKM RVLQEKKQKM DKLLGELHTL
     RDQHLNNSSS SPQRSVDQRS TSAPSASVGL APVVNGESNS LTSSVPYPTA SLVSQNESEN
     EGHLNPSEKL QKLNEVRKRL NELRELVHYY EQTSDMMTDA VNENRKAEET EESEYDSEHE
     NSEPVTNIRN PQVASTWNEV NSHSNAQCVS NNRDGRTVNS NCEINNRSAA NIRALNMPPS
     LADCRYNREG EQEIHVAQGE DDEEEEEAEE EGVSGASLSS HRSSLVDEHP EDAEFEQKIN
     RLMAAKQKLR QLQDLVAMVQ DDDAAQGVIS ASASNLDDFY PAEEDTKQNS NNTRGNANKT
     QKDTGVNEKA REKFYEAKLQ QQQRELKQLQ EERKKLIDIQ EKIQALQTAC PDLQLSAASV
     GNCPTKKYMP AVTSTPTVNQ HETSTSKSVF EPEDSSIVDN ELWSEMRRHE MLREELRQRR
     KQLEALMAEH QRRQGLAETA SPVAVSLRSD GSENLCTPQQ SRTEKTMATW GGSTQCALDE
     EGDEDGYLSE GIVRTDEEEE EEQDASSNDN FSVCPSNSVN HNSYNGKETK NRWKNDCPFS
     ADENYRPLAK TRQQNISMQR QENLRWVSEL SYVEEKEQWQ EQINQLKKQL DFSVSICQTL
     MQDQQTLSCL LQTLLTGPYS VMPSNVASPQ VHFIMHQLNQ CYTQLTWQQN NVQRLKQMLN
     ELMRQQNQHP EKPGGKERGS SASHPPSPSL FCPFSFPTQP VNLFNIPGFT NFSSFAPGMN
     FSPLFPSNFG DFSQNISTPS EQQQPLAQNS SGKTEYMAFP KPFESSSSIG AEKPRNKKLP
     EEEVESSRTP WLYEQEGEVE KPFIKTGFSV SAEKSTSSNR KNQLDTNGRR RQFDEESLES
     FSSMPDPVDP TTVTKTFKTR KASAQASLAS KDKTPKSKSK KRNSTQLKSR VKNIKTGSDF
     SMFEALRDTI YSEVATLISQ NESRPHFLIE LFHELQLLNT DYLRQRALYA LQDIVSRHIS
     ESHEKGENVK SVNSGTWIAS NSELTPSESL ATTDDETFEK NFERETHKIS EQNDADNASV
     LSVSSNFEPF ATDDLGNTVI HLDQALARMR EYERMKTEAE SNSNMRCTCR IIEDGDGAGA
     GTTVNNLEET PVIENRSSQQ PVSEVSTIPC PRIDTQQLDR QIKAIMKEVI PFLKEHMDEV
     CSSQLLTSVR RMVLTLTQQN DESKEFVKFF HKQLGSILQD SLAKFAGRKL KDCGEDLLVE
     ISEVLFNELA FFKLMQDLDN NSITVKQRCK RKIEATGVIQ SCAKEAKRIL EDHGSPAGEI
     DDEDKDKDET ETVKQTQTSE VYDGPKNVRS DISDQEEDEE SEGCPVSINL SKAETQALTN
     YGSGEDENED EEMEEFEEGP VDVQTSLQAN TEATEENEHD EQEAESGNIS QKSDEEDFVK
     VEDLPLKLTI YSEADLRKEM VEEEQKNHLS GEICEMQTEE LAGNSETLKE PETVGAQSI
//
ID   B9EIS5_HUMAN            Unreviewed;      2016 AA.
AC   B9EIS5;
DT   24-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   24-MAR-2009, sequence version 1.
DT   31-JAN-2018, entry version 43.
DE   SubName: Full=PCM1 protein {ECO:0000313|EMBL:AAI40947.1};
GN   Name=PCM1 {ECO:0000313|EMBL:AAI40947.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI40947.1};
RN   [1] {ECO:0000313|EMBL:AAI40947.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAI40947.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC140946; AAI40947.1; -; mRNA.
DR   RefSeq; NP_001302436.1; NM_001315507.1.
DR   UniGene; Hs.491148; -.
DR   PeptideAtlas; B9EIS5; -.
DR   PRIDE; B9EIS5; -.
DR   GeneID; 5108; -.
DR   CTD; 5108; -.
DR   eggNOG; ENOG410IEGR; Eukaryota.
DR   eggNOG; ENOG410YNFX; LUCA.
DR   HOGENOM; HOG000115473; -.
DR   HOVERGEN; HBG053890; -.
DR   ChiTaRS; PCM1; human.
DR   GO; GO:0005813; C:centrosome; IEA:InterPro.
DR   GO; GO:0060271; P:cilium assembly; IEA:InterPro.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IEA:InterPro.
DR   GO; GO:0071539; P:protein localization to centrosome; IEA:InterPro.
DR   InterPro; IPR031446; PCM1_C.
DR   InterPro; IPR024138; Pericentriolar_Pcm1.
DR   PANTHER; PTHR14164; PTHR14164; 1.
DR   Pfam; PF15717; PCM1_C; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN     1372   1990       PCM1_C. {ECO:0000259|Pfam:PF15717}.
FT   COILED      270    293       {ECO:0000256|SAM:Coils}.
FT   COILED      403    423       {ECO:0000256|SAM:Coils}.
FT   COILED      493    513       {ECO:0000256|SAM:Coils}.
FT   COILED      652    682       {ECO:0000256|SAM:Coils}.
FT   COILED      732    769       {ECO:0000256|SAM:Coils}.
FT   COILED      826    853       {ECO:0000256|SAM:Coils}.
FT   COILED      989   1016       {ECO:0000256|SAM:Coils}.
FT   COILED     1065   1085       {ECO:0000256|SAM:Coils}.
FT   COILED     1517   1537       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   2016 AA;  227672 MW;  992CBD7BBE2A343F CRC64;
     MATGGGPFED GMNDQDLPNW SNENVDDRLN NMDWGAQQKK ANRSSEKNKK KFGVESDKRV
     TNDISPESSP GVGRRRTKTP HTFPHSRYMS QMSVPEQAEL EKLKQRINFS DLDQRSIGSD
     SQGRATAANN KRQLSENRKP FNFLPMQINT NKSKDASTSP PNRETIGSAQ CKELFASALS
     NDLLQNCQVS EEDGRGEPAM ESSQIVSRLV QIRDYITKAS SMREDLVEKN ERSANVERLT
     HLIDHLKEQE KSYMKFLKKI LARDPQQEPM EEIENLKKQH DLLKRMLQQQ EQLRALQGRQ
     AALLALQHKA EQAIAVMDDS VVAETAGSLS GVSITSELNE ELNDLIQRFH NQLRDSQPPA
     VPDNRRQAES LSLTREVSQS RKPSASERLP DEKVELFSKM RVLQEKKQKM DKLLGELHTL
     RDQHLNNSSS SPQRSVDQRS TSAPSASVGL APVVNGESNS LTSSVPYPTA SLVSQNESEN
     EGHLNPSEKL QKLNEVRKRL NELRELVHYY EQTSDMMTDA VNENRKDEET EESEYDSEHE
     NSEPVTNIRN PQVASTWNEV NSHSNAQCVS NNRDGRTVNS NCEINNRSAA NIRALNVPPS
     LDCRYNREGE QEIHVAQGED DEEEEEEAEE EGVSGASLSS HRSSLVDEHP EDAEFEQKIN
     RLMAAKQKLR QLQDLVAMVQ DDDAAQGVIS ASASNLDDFY PAEEDTKQNS NNTRGNANKT
     QKDTGVNEKA REKFYEAKLQ QQQRELKQLQ EERKKLIDIQ EKIQALQTAC PDLQLSAASV
     GNCPTKKYMP AVTSTPTVNQ HETSTSKSVF EPEDSSIVDN ELWSEMRRHE MLREELRQRR
     KQLEALMAEH QRRQGLAETA SPVAVSLRSD GSENLCTPQQ SRTEKTMATW GGSTQCALDE
     EGDEDGYLSE GIVRTDEEEE EEQDASSNDN FSVCPSNSVN HNSYNGKETK NRWKNNCPFS
     ADENYRPLAK TRQQNISMQR QENLRWVSEL SYVEEKEQWQ EQINQLKKQL DFSVSICQTL
     MQDQQTLSCL LQTLLTGPYS VMPSNVASPQ VHFIMHQLNQ CYTQLTWQQN NVQRLKQMLN
     ELMRQQNQHP EKPGGKERGS SASHPPSPSL FCPFSFPTQP VNLFNIPGFT NFSSFAPGMN
     FSPLFPSNFG DFSQNISTPS EQQQPLAQNS SGKTEYMAFP KPFESSSSIG AEKPRNKKLP
     EEEVESSRTP WLYEQEGEVE KPFIKTGFSV SVEKSTSSNR KNQLDTNGRR RQFDEESLES
     FSSMPDPVDP TTVTKTFKTR KASAQASLAS KDKTPKSKSK KRNSTQLKSR VKNIRYESAS
     MSSTCEPCKS RNRHSAQTEE PVQAKVFSRK NHEQLEKIIK CNRSTEISSE TGSDFSMFEA
     LRDTIYSEVA TLISQNESRP HFLIELFHEL QLLNTDYLRQ RALYALQDIV SRHISESHEK
     GENVKSVNSG TWIASNSELT PSESLATTDD ETFEKNFERE THKISEQNDA DNASVLSVSS
     NFEPFATDDL GNTVIHLDQA LARMREYERM KTEAESNSNM RCTCRIIEDG DGAGAETPVI
     ENRSSQQPVS EVSTIPCPRI DTQQLDRQIK AIMKEVIPFL KEHMDEVCSS QLLTSVRRMV
     LTLTQQNDES KEFVKFFHKQ LGSILQDSLA KFAGRKLKDC GEDLLVEISE VLFNELAFFK
     LMQDLDNNSI TVKQRCKRKI EATGVIQSCA KEAKRILEDH GSPAGEIDDE DKDKDETETV
     KQTQTSEVYD GPKNVRSDIS DQEEDEESEG CPVSINLSKA ETQALTNYGS GEDENEDEEM
     EEFEEGPVDV QTSLQANTEA TEENEHDEQV LQRDFKKTAE SKNVPLEREA TSKNDQNNCP
     VKPCYLNILE DEQPLNSAAH KESPPTVDST QQPNPLPLRL PEMEPLVPRV KEVKSAQETP
     ESSLAGSPDT ESPVLVNDYE AESGNISQKS DEEDFVKVED LPLKLTIYSE ADLRKKMVEE
     EQKNHLSGEI CEMQTEELAG NSETLKEPET VGAQSI
//
ID   PCM1_HUMAN              Reviewed;        2024 AA.
AC   Q15154; Q58F13; Q6P1K7; Q8NB85; Q9BWC1; Q9H4A2;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 4.
DT   28-FEB-2018, entry version 142.
DE   RecName: Full=Pericentriolar material 1 protein;
DE            Short=PCM-1;
DE            Short=hPCM-1;
GN   Name=PCM1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   VARIANT VAL-597.
RC   TISSUE=Liver;
RX   PubMed=8120099; DOI=10.1083/jcb.124.5.783;
RA   Balczon R., Bao L., Zimmer W.E.;
RT   "PCM-1, A 228-kD centrosome autoantigen with a distinct cell cycle
RT   distribution.";
RL   J. Cell Biol. 124:783-793(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-597.
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-404 (ISOFORMS 1/2).
RC   TISSUE=Lung, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1244-2024 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1527-1610 (ISOFORMS 1/2), SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND CHROMOSOMAL TRANSLOCATION WITH RET.
RX   PubMed=10980597; DOI=10.1038/sj.onc.1203772;
RA   Corvi R., Berger N., Balczon R., Romeo G.;
RT   "RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma.";
RL   Oncogene 19:4236-4242(2000).
RN   [6]
RP   INTERACTION WITH HAP1.
RX   PubMed=9361024; DOI=10.1093/hmg/6.13.2205;
RA   Engelender S., Sharp A.H., Colomer V., Tokito M.K., Lanahan A.,
RA   Worley P., Holzbaur E.L.F., Ross C.A.;
RT   "Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued
RT   subunit of dynactin.";
RL   Hum. Mol. Genet. 6:2205-2212(1997).
RN   [7]
RP   FUNCTION, INTERACTION WITH CETN3, AND SUBCELLULAR LOCATION.
RX   PubMed=12403812; DOI=10.1083/jcb.200204023;
RA   Dammermann A., Merdes A.;
RT   "Assembly of centrosomal proteins and microtubule organization depends
RT   on PCM-1.";
RL   J. Cell Biol. 159:255-266(2002).
RN   [8]
RP   INTERACTION WITH BBS8, AND SUBCELLULAR LOCATION.
RX   PubMed=14520415; DOI=10.1038/nature02030;
RA   Ansley S.J., Badano J.L., Blacque O.E., Hill J., Hoskins B.E.,
RA   Leitch C.C., Kim J.C., Ross A.J., Eichers E.R., Teslovich T.M.,
RA   Mah A.K., Johnsen R.C., Cavender J.C., Lewis R.A., Leroux M.R.,
RA   Beales P.L., Katsanis N.;
RT   "Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl
RT   syndrome.";
RL   Nature 425:628-633(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [10]
RP   INTERACTION WITH BBS4, AND SUBCELLULAR LOCATION.
RX   PubMed=15107855; DOI=10.1038/ng1352;
RA   Kim J.C., Badano J.L., Sibold S., Esmail M.A., Hill J., Hoskins B.E.,
RA   Leitch C.C., Venner K., Ansley S.J., Ross A.J., Leroux M.R.,
RA   Katsanis N., Beales P.L.;
RT   "The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar
RT   region and is required for microtubule anchoring and cell cycle
RT   progression.";
RL   Nat. Genet. 36:462-470(2004).
RN   [11]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=15184884; DOI=10.1038/sj.onc.1207740;
RA   Armes J.E., Hammet F., de Silva M., Ciciulla J., Ramus S.J.,
RA   Soo W.-K., Mahoney A., Yarovaya N., Henderson M.A., Gish K.,
RA   Hutchins A.-M., Price G.R., Venter D.J.;
RT   "Candidate tumor-suppressor genes on chromosome arm 8p in early-onset
RT   and high-grade breast cancers.";
RL   Oncogene 23:5697-5702(2004).
RN   [12]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=16270321; DOI=10.1002/cncr.21538;
RA   Pils D., Horak P., Gleiss A., Sax C., Fabjani G., Moebus V.J.,
RA   Zielinski C., Reinthaller A., Zeillinger R., Krainer M.;
RT   "Five genes from chromosomal band 8p22 are significantly down-
RT   regulated in ovarian carcinoma: N33 and EFA6R have a potential impact
RT   on overall survival.";
RL   Cancer 104:2417-2429(2005).
RN   [13]
RP   CHROMOSOMAL TRANSLOCATION WITH JAK2.
RX   PubMed=15805263; DOI=10.1158/0008-5472.CAN-04-4263;
RA   Reiter A., Walz C., Watmore A., Schoch C., Blau I., Schlegelberger B.,
RA   Berger U., Telford N., Aruliah S., Yin J.A., Vanstraelen D.,
RA   Barker H.F., Taylor P.C., O'Driscoll A., Benedetti F., Rudolph C.,
RA   Kolb H.-J., Hochhaus A., Hehlmann R., Chase A., Cross N.C.P.;
RT   "The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute
RT   leukemia that fuses PCM1 to JAK2.";
RL   Cancer Res. 65:2662-2667(2005).
RN   [14]
RP   CHROMOSOMAL TRANSLOCATION WITH JAK2.
RX   PubMed=16034466; DOI=10.1038/sj.leu.2403879;
RA   Murati A., Gelsi-Boyer V., Adelaide J., Perot C., Talmant P.,
RA   Giraudier S., Lode L., Letessier A., Delaval B., Brunel V., Imbert M.,
RA   Garand R., Xerri L., Birnbaum D., Mozziconacci M.-J., Chaffanet M.;
RT   "PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid
RT   leukemia with t(8;9) translocation.";
RL   Leukemia 19:1692-1696(2005).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15659651; DOI=10.1091/mbc.E04-08-0688;
RA   Hames R.S., Crookes R.E., Straatman K.R., Merdes A., Hayes M.J.,
RA   Faragher A.J., Fry A.M.;
RT   "Dynamic recruitment of Nek2 kinase to the centrosome involves
RT   microtubules, PCM-1, and localized proteasomal degradation.";
RL   Mol. Biol. Cell 16:1711-1724(2005).
RN   [16]
RP   CHROMOSOMAL TRANSLOCATION WITH JAK2.
RX   PubMed=16091753; DOI=10.1038/sj.onc.1208850;
RA   Bousquet M., Quelen C., De Mas V., Duchayne E., Roquefeuil B.,
RA   Delsol G., Laurent G., Dastugue N., Brousset P.;
RT   "The t(8;9)(p22;p24) translocation in atypical chronic myeloid
RT   leukaemia yields a new PCM1-JAK2 fusion gene.";
RL   Oncogene 24:7248-7252(2005).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-110 AND
RP   SER-1730, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [18]
RP   CHROMOSOMAL TRANSLOCATION WITH JAK2.
RX   PubMed=16769584;
RA   Bacher U., Reiter A., Haferlach T., Mueller L., Schnittger S.,
RA   Kern W., Schoch C.;
RT   "A combination of cytomorphology, cytogenetic analysis, fluorescence
RT   in situ hybridization and reverse transcriptase polymerase chain
RT   reaction for establishing clonality in cases of persisting
RT   hypereosinophilia.";
RL   Haematologica 91:817-820(2006).
RN   [19]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16943179; DOI=10.1083/jcb.200606051;
RA   Srsen V., Gnadt N., Dammermann A., Merdes A.;
RT   "Inhibition of centrosome protein assembly leads to p53-dependent exit
RT   from the cell cycle.";
RL   J. Cell Biol. 174:625-630(2006).
RN   [20]
RP   TISSUE SPECIFICITY, AND CHROMOSOMAL TRANSLOCATION WITH JAK2.
RX   PubMed=16424865; DOI=10.1038/sj.leu.2404104;
RA   Adelaide J., Perot C., Gelsi-Boyer V., Pautas C., Murati A.,
RA   Copie-Bergman C., Imbert M., Chaffanet M., Birnbaum D.,
RA   Mozziconacci M.-J.;
RT   "A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell
RT   lymphoma.";
RL   Leukemia 20:536-537(2006).
RN   [21]
RP   INTERACTION WITH NDE1 AND NDEL1, AND SUBCELLULAR LOCATION.
RX   PubMed=16291865; DOI=10.1091/mbc.E05-04-0360;
RA   Guo J., Yang Z., Song W., Chen Q., Wang F., Zhang Q., Zhu X.;
RT   "Nudel contributes to microtubule anchoring at the mother centriole
RT   and is involved in both dynein-dependent and -independent centrosomal
RT   protein assembly.";
RL   Mol. Biol. Cell 17:680-689(2006).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68 AND SER-69,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68; SER-69;
RP   SER-93; SER-960; SER-1231; SER-1257; SER-1260; SER-1263; SER-1730;
RP   SER-1765; SER-1768 AND SER-1776, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68; SER-69;
RP   SER-93; SER-1185; SER-1697; SER-1765; SER-1768; SER-1776 AND SER-1977,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-399, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [27]
RP   FUNCTION.
RX   PubMed=20551181; DOI=10.1242/jcs.065045;
RA   Sedjai F., Acquaviva C., Chevrier V., Chauvin J.P., Coppin E.,
RA   Aouane A., Coulier F., Tolun A., Pierres M., Birnbaum D., Rosnet O.;
RT   "Control of ciliogenesis by FOR20, a novel centrosome and
RT   pericentriolar satellite protein.";
RL   J. Cell Sci. 123:2391-2401(2010).
RN   [28]
RP   INTERACTION WITH PARD6A, AND SUBCELLULAR LOCATION.
RX   PubMed=20719959; DOI=10.1091/mbc.E10-05-0430;
RA   Kodani A., Tonthat V., Wu B., Suetterlin C.;
RT   "Par6 alpha interacts with the dynactin subunit p150 Glued and is a
RT   critical regulator of centrosomal protein recruitment.";
RL   Mol. Biol. Cell 21:3376-3385(2010).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68; SER-69;
RP   SER-93; SER-861; SER-960 AND SER-1730, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68; SER-431;
RP   SER-1730; SER-1765; SER-1768 AND SER-1958, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [33]
RP   FUNCTION IN CILIOGENESIS, UBIQUITINATION BY MIB1, INTERACTION WITH
RP   CEP131, ASSOCIATION WITH MICROTUBULE, AND SUBCELLULAR LOCATION.
RX   PubMed=24121310; DOI=10.1038/emboj.2013.223;
RA   Villumsen B.H., Danielsen J.R., Povlsen L., Sylvestersen K.B.,
RA   Merdes A., Beli P., Yang Y.G., Choudhary C., Nielsen M.L., Mailand N.,
RA   Bekker-Jensen S.;
RT   "A new cellular stress response that triggers centriolar satellite
RT   reorganization and ciliogenesis.";
RL   EMBO J. 32:3029-3040(2013).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-68; SER-69;
RP   SER-93; SER-110; SER-116; SER-119; SER-159; SER-370; SER-372; SER-384;
RP   SER-588; THR-859; SER-861; SER-960; SER-977; SER-988; SER-991;
RP   SER-1229; SER-1231; SER-1257; SER-1697; SER-1730 AND SER-1977, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [35]
RP   INTERACTION WITH MAP1LC3B; GABARAPAL2 AND GABARAP.
RX   PubMed=24089205; DOI=10.1038/nature12606;
RA   Tang Z., Lin M.G., Stowe T.R., Chen S., Zhu M., Stearns T., Franco B.,
RA   Zhong Q.;
RT   "Autophagy promotes primary ciliogenesis by removing OFD1 from
RT   centriolar satellites.";
RL   Nature 502:254-257(2013).
RN   [36]
RP   INTERACTION WITH CCDC13.
RX   PubMed=24816561; DOI=10.1242/jcs.147785;
RA   Staples C.J., Myers K.N., Beveridge R.D., Patil A.A., Howard A.E.,
RA   Barone G., Lee A.J., Swanton C., Howell M., Maslen S., Skehel J.M.,
RA   Boulton S.J., Collis S.J.;
RT   "Ccdc13 is a novel human centriolar satellite protein required for
RT   ciliogenesis and genome stability.";
RL   J. Cell Sci. 127:2910-2919(2014).
RN   [37]
RP   INTERACTION WITH CCDC113.
RX   PubMed=25074808; DOI=10.1242/jcs.157008;
RA   Firat-Karalar E.N., Sante J., Elliott S., Stearns T.;
RT   "Proteomic analysis of mammalian sperm cells identifies new components
RT   of the centrosome.";
RL   J. Cell Sci. 127:4128-4133(2014).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1468, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [40]
RP   INTERACTION WITH KIAA0753; FOPNL AND OFD1.
RX   PubMed=26643951; DOI=10.1093/hmg/ddv488;
RA   Chevrier V., Bruel A.L., Van Dam T.J., Franco B., Lo Scalzo M.,
RA   Lembo F., Audebert S., Baudelet E., Isnardon D., Bole A., Borg J.P.,
RA   Kuentz P., Thevenon J., Burglen L., Faivre L., Riviere J.B.,
RA   Huynen M.A., Birnbaum D., Rosnet O., Thauvin-Robinet C.;
RT   "OFIP/KIAA0753 forms a complex with OFD1 and FOR20 at pericentriolar
RT   satellites and centrosomes and is mutated in one individual with oral-
RT   facial-digital syndrome.";
RL   Hum. Mol. Genet. 25:497-513(2016).
CC   -!- FUNCTION: Required for centrosome assembly and function. Essential
CC       for the correct localization of several centrosomal proteins
CC       including CEP250, CETN3, PCNT and NEK2. Required to anchor
CC       microtubules to the centrosome. Involved in the biogenesis of
CC       cilia. {ECO:0000269|PubMed:12403812, ECO:0000269|PubMed:15659651,
CC       ECO:0000269|PubMed:16943179, ECO:0000269|PubMed:20551181,
CC       ECO:0000269|PubMed:24121310}.
CC   -!- SUBUNIT: Self-associates. Interacts with C2CD3 (By similarity).
CC       Interacts with BBS4, BBS8, CETN3, HAP1, NDE1, NDEL1, MAP1LC3B,
CC       GABARAPAL2, and GABARAP. Interacts with CEP131; the interaction
CC       increases in response to ultraviolet light (UV) radiation.
CC       Associates with microtubule; association to microtubule is reduced
CC       in response to cellular stress, such as ultraviolet light (UV)
CC       radiation or heat shock, in a process that requires p38 MAP kinase
CC       signaling. Interacts with CCDC113. Interacts with SSX2IP (By
CC       similarity). Interacts with CCDC13 (PubMed:24816561). Interacts
CC       with CEP290 (By similarity). Interacts with PARD6A
CC       (PubMed:20719959). Interacts with KIAA0753/OFIP, FOPNL/FOR20 and
CC       OFD1; the interaction with FOPNL/FOR20 and OFD1 may be mediated by
CC       KIAA0753/OFIP (PubMed:26643951). {ECO:0000250|UniProtKB:Q9R0L6,
CC       ECO:0000269|PubMed:12403812, ECO:0000269|PubMed:14520415,
CC       ECO:0000269|PubMed:15107855, ECO:0000269|PubMed:16291865,
CC       ECO:0000269|PubMed:20719959, ECO:0000269|PubMed:24089205,
CC       ECO:0000269|PubMed:24121310, ECO:0000269|PubMed:24816561,
CC       ECO:0000269|PubMed:25074808, ECO:0000269|PubMed:26643951,
CC       ECO:0000269|PubMed:9361024}.
CC   -!- INTERACTION:
CC       Q8NFJ9:BBS1; NbExp=2; IntAct=EBI-741421, EBI-1805484;
CC       Q96RK4:BBS4; NbExp=16; IntAct=EBI-741421, EBI-1805814;
CC       Q49A88:CCDC14; NbExp=6; IntAct=EBI-741421, EBI-751035;
CC       Q8TD31-3:CCHCR1; NbExp=4; IntAct=EBI-11742977, EBI-10175300;
CC       Q9UPN4:CEP131; NbExp=5; IntAct=EBI-741421, EBI-2558372;
CC       Q9P209:CEP72; NbExp=6; IntAct=EBI-741421, EBI-739498;
CC       Q9UIA0:CYTH4; NbExp=4; IntAct=EBI-11742977, EBI-11521003;
CC       O95166:GABARAP; NbExp=8; IntAct=EBI-741421, EBI-712001;
CC       P60520:GABARAPL2; NbExp=2; IntAct=EBI-741421, EBI-720116;
CC       P54256:Hap1 (xeno); NbExp=3; IntAct=EBI-741421, EBI-994539;
CC       Q2KHM9:KIAA0753; NbExp=7; IntAct=EBI-741421, EBI-2805604;
CC       O75665:OFD1; NbExp=8; IntAct=EBI-741421, EBI-716327;
CC       O95613:PCNT; NbExp=7; IntAct=EBI-741421, EBI-530012;
CC       Q8WXW3:PIBF1; NbExp=7; IntAct=EBI-741421, EBI-2558770;
CC       Q96R06:SPAG5; NbExp=2; IntAct=EBI-741421, EBI-413317;
CC       Q9Y2D8:SSX2IP; NbExp=10; IntAct=EBI-741421, EBI-2212028;
CC       Q9Y3C0:WASHC3; NbExp=4; IntAct=EBI-741421, EBI-712969;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:20719959}. Cytoplasmic granule
CC       {ECO:0000269|PubMed:15107855}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome, centriolar satellite
CC       {ECO:0000269|PubMed:15107855, ECO:0000269|PubMed:20719959}.
CC       Cytoplasm, cytoskeleton, cilium basal body
CC       {ECO:0000269|PubMed:24121310}. Note=Recruitment to the centrosome
CC       requires microtubules and dynein. The majority of the protein
CC       dissociates from the centrosome during metaphase and subsequently
CC       localizes to the cleavage site in telophase. Displaced from
CC       centriolar satellites and centrosome in response to cellular
CC       stress, such as ultraviolet light (UV) radiation or heat shock, in
CC       a process that requires p38 MAP kinase signaling.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q15154-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15154-2; Sequence=VSP_022611;
CC       Name=3;
CC         IsoId=Q15154-3; Sequence=VSP_022609, VSP_022610;
CC   -!- TISSUE SPECIFICITY: Expressed in blood, bone marrow, breast, lymph
CC       node, ovary and thyroid. {ECO:0000269|PubMed:10980597,
CC       ECO:0000269|PubMed:15184884, ECO:0000269|PubMed:16270321,
CC       ECO:0000269|PubMed:16424865}.
CC   -!- INDUCTION: Expression is reduced in breast and ovarian cancer.
CC       {ECO:0000269|PubMed:15184884, ECO:0000269|PubMed:16270321}.
CC   -!- PTM: Ubiquitinated. Undergoes monoubiquitination catalyzed by the
CC       E3 ubiquitin-protein ligase MIB1 in proliferating cells,
CC       preventing cilia formation. Monoubiquitination by MIB1 is
CC       inhibited in response to cellular stress, such as ultraviolet
CC       light (UV) radiation or heat shock, resulting in cilia formation
CC       initiation. {ECO:0000269|PubMed:24121310}.
CC   -!- DISEASE: Note=A chromosomal aberration involving PCM1 is found in
CC       papillary thyroid carcinomas (PTCs). Translocation
CC       t(8;10)(p21.3;q11.2) with RET links the protein kinase domain of
CC       RET to the major portion of PCM1. {ECO:0000269|PubMed:10980597}.
CC   -!- DISEASE: Note=A chromosomal aberration involving PCM1 is found in
CC       a variety of hematological malignancies including atypical chronic
CC       myeloid leukemia (atypical CML) and T-cell lymphoma. Translocation
CC       t(8;9)(p22;p24) with JAK2 links the protein kinase domain of JAK2
CC       to the major portion of PCM1.
CC   -!- SIMILARITY: Belongs to the PCM1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH27477.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH65022.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAC03656.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAC14882.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L27841; AAA60120.1; -; mRNA.
DR   EMBL; AC087273; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087625; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000453; AAH00453.1; -; mRNA.
DR   EMBL; BC027477; AAH27477.1; ALT_SEQ; mRNA.
DR   EMBL; BC065022; AAH65022.1; ALT_SEQ; mRNA.
DR   EMBL; AK091406; BAC03656.1; ALT_INIT; mRNA.
DR   EMBL; AJ297349; CAC14882.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS47812.1; -. [Q15154-1]
DR   PIR; A54103; A54103.
DR   RefSeq; NP_001302437.1; NM_001315508.1.
DR   RefSeq; NP_006188.3; NM_006197.3. [Q15154-1]
DR   UniGene; Hs.491148; -.
DR   ProteinModelPortal; Q15154; -.
DR   SMR; Q15154; -.
DR   BioGrid; 111139; 277.
DR   CORUM; Q15154; -.
DR   DIP; DIP-42189N; -.
DR   IntAct; Q15154; 273.
DR   MINT; Q15154; -.
DR   STRING; 9606.ENSP00000327077; -.
DR   CarbonylDB; Q15154; -.
DR   iPTMnet; Q15154; -.
DR   PhosphoSitePlus; Q15154; -.
DR   BioMuta; PCM1; -.
DR   DMDM; 296439495; -.
DR   EPD; Q15154; -.
DR   MaxQB; Q15154; -.
DR   PaxDb; Q15154; -.
DR   PeptideAtlas; Q15154; -.
DR   PRIDE; Q15154; -.
DR   DNASU; 5108; -.
DR   Ensembl; ENST00000325083; ENSP00000327077; ENSG00000078674.
DR   GeneID; 5108; -.
DR   KEGG; hsa:5108; -.
DR   UCSC; uc003wyi.5; human. [Q15154-1]
DR   CTD; 5108; -.
DR   DisGeNET; 5108; -.
DR   EuPathDB; HostDB:ENSG00000078674.17; -.
DR   GeneCards; PCM1; -.
DR   H-InvDB; HIX0007341; -.
DR   HGNC; HGNC:8727; PCM1.
DR   HPA; CAB058695; -.
DR   HPA; HPA023370; -.
DR   HPA; HPA023374; -.
DR   MalaCards; PCM1; -.
DR   MIM; 600299; gene.
DR   neXtProt; NX_Q15154; -.
DR   Orphanet; 146; Papillary or follicular thyroid carcinoma.
DR   PharmGKB; PA33073; -.
DR   eggNOG; ENOG410IEGR; Eukaryota.
DR   eggNOG; ENOG410YNFX; LUCA.
DR   HOGENOM; HOG000115473; -.
DR   HOVERGEN; HBG053890; -.
DR   InParanoid; Q15154; -.
DR   KO; K16537; -.
DR   OrthoDB; EOG091G00C3; -.
DR   PhylomeDB; Q15154; -.
DR   TreeFam; TF328740; -.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; Q15154; -.
DR   ChiTaRS; PCM1; human.
DR   GeneWiki; PCM1; -.
DR   GenomeRNAi; 5108; -.
DR   PRO; PR:Q15154; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000078674; -.
DR   CleanEx; HS_PCM1; -.
DR   ExpressionAtlas; Q15154; baseline and differential.
DR   Genevisible; Q15154; HS.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0034451; C:centriolar satellite; IDA:UniProtKB.
DR   GO; GO:0005814; C:centriole; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; IEA:Ensembl.
DR   GO; GO:0035869; C:ciliary transition zone; IDA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; ISS:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0000242; C:pericentriolar material; ISS:BHF-UCL.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISS:BHF-UCL.
DR   GO; GO:0007098; P:centrosome cycle; IMP:BHF-UCL.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0031122; P:cytoplasmic microtubule organization; IMP:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0022027; P:interkinetic nuclear migration; ISS:BHF-UCL.
DR   GO; GO:0035735; P:intraciliary transport involved in cilium assembly; IMP:UniProtKB.
DR   GO; GO:0034453; P:microtubule anchoring; ISS:BHF-UCL.
DR   GO; GO:0034454; P:microtubule anchoring at centrosome; IBA:GO_Central.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; ISS:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:1905515; P:non-motile cilium assembly; IMP:GO_Central.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; IMP:UniProtKB.
DR   GO; GO:0071539; P:protein localization to centrosome; IMP:SYSCILIA_CCNET.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0035176; P:social behavior; IEA:Ensembl.
DR   InterPro; IPR031446; PCM1_C.
DR   InterPro; IPR024138; Pericentriolar_Pcm1.
DR   PANTHER; PTHR14164; PTHR14164; 1.
DR   Pfam; PF15717; PCM1_C; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell projection;
KW   Chromosomal rearrangement; Cilium biogenesis/degradation; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895}.
FT   CHAIN         2   2024       Pericentriolar material 1 protein.
FT                                /FTId=PRO_0000274037.
FT   REGION     1279   1799       Interaction with HAP1.
FT                                {ECO:0000269|PubMed:9361024}.
FT   REGION     1913   2024       Interaction with BBS4.
FT                                {ECO:0000269|PubMed:15107855}.
FT   COILED      218    301       {ECO:0000255}.
FT   COILED      400    424       {ECO:0000255}.
FT   COILED      487    543       {ECO:0000255}.
FT   COILED      651    682       {ECO:0000255}.
FT   COILED      726    769       {ECO:0000255}.
FT   COILED      824    858       {ECO:0000255}.
FT   COILED     1063   1089       {ECO:0000255}.
FT   COILED     1515   1539       {ECO:0000255}.
FT   SITE       1314   1315       Breakpoint for translocation to form
FT                                PCM1-JAK2 fusion protein.
FT   SITE       1369   1370       Breakpoint for translocation to form
FT                                PCM1-JAK2 fusion protein.
FT   SITE       1470   1471       Breakpoint for translocation to form
FT                                PCM1-JAK2 fusion protein.
FT   SITE       1609   1610       Breakpoint for translocation to form
FT                                PCM1-RET fusion protein.
FT   SITE       1947   1948       Breakpoint for translocation to form
FT                                PCM1-JAK2 fusion protein.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   MOD_RES      65     65       Phosphoserine.
FT                                {ECO:0000244|PubMed:15144186,
FT                                ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      68     68       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      69     69       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      93     93       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     110    110       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     116    116       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     119    119       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     370    370       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     372    372       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     384    384       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     399    399       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     431    431       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     588    588       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     643    643       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0L6}.
FT   MOD_RES     859    859       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     861    861       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     866    866       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0L6}.
FT   MOD_RES     869    869       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0L6}.
FT   MOD_RES     872    872       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0L6}.
FT   MOD_RES     877    877       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9R0L6}.
FT   MOD_RES     960    960       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     977    977       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     988    988       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     991    991       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1185   1185       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1188   1188       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0L6}.
FT   MOD_RES    1229   1229       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1231   1231       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1257   1257       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1260   1260       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1262   1262       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0L6}.
FT   MOD_RES    1263   1263       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1318   1318       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0L6}.
FT   MOD_RES    1320   1320       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0L6}.
FT   MOD_RES    1468   1468       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1573   1573       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0L6}.
FT   MOD_RES    1697   1697       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1730   1730       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1765   1765       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1768   1768       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1776   1776       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1782   1782       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0L6}.
FT   MOD_RES    1958   1958       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1977   1977       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     263    263       R -> RENEEEDVRTIDSAVGSGSVAESTSLNIDVQSEASD
FT                                TTAR (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_022609.
FT   VAR_SEQ     492   2024       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_022610.
FT   VAR_SEQ    1315   1370       RYESASMSSTCEPCKSRNRHSAQTEEPVQAKVFSRKNHEQL
FT                                EKIIKCNRSTEISSE -> K (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_022611.
FT   VARIANT     159    159       S -> N (in dbSNP:rs412750).
FT                                /FTId=VAR_030164.
FT   VARIANT     159    159       S -> R (in dbSNP:rs412750).
FT                                /FTId=VAR_062172.
FT   VARIANT     176    176       A -> D (in dbSNP:rs2285302).
FT                                /FTId=VAR_030165.
FT   VARIANT     597    597       M -> V (in dbSNP:rs208753).
FT                                {ECO:0000269|PubMed:16421571,
FT                                ECO:0000269|PubMed:8120099}.
FT                                /FTId=VAR_030166.
FT   VARIANT     600    600       S -> P (in dbSNP:rs34325017).
FT                                /FTId=VAR_047381.
FT   VARIANT     691    691       A -> S (in dbSNP:rs17635381).
FT                                /FTId=VAR_030167.
FT   VARIANT     871    871       G -> V (in dbSNP:rs7009117).
FT                                /FTId=VAR_030168.
FT   VARIANT    1251   1251       R -> H (in dbSNP:rs17514547).
FT                                /FTId=VAR_030169.
FT   VARIANT    1326   1326       E -> D (in dbSNP:rs34932823).
FT                                /FTId=VAR_047382.
FT   VARIANT    1543   1543       T -> I (in dbSNP:rs370429).
FT                                /FTId=VAR_030170.
FT   VARIANT    1701   1701       K -> N (in dbSNP:rs36113670).
FT                                /FTId=VAR_047383.
FT   VARIANT    1865   1865       N -> D (in dbSNP:rs35789133).
FT                                /FTId=VAR_047384.
FT   CONFLICT    294    294       R -> RG (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT    311    312       EQ -> DE (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT    405    405       E -> K (in Ref. 3; AAH27477).
FT                                {ECO:0000305}.
FT   CONFLICT    408    408       Q -> K (in Ref. 3; AAH27477/AAH65022).
FT                                {ECO:0000305}.
FT   CONFLICT    447    448       SV -> CL (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT    760    760       Q -> H (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT    946    946       G -> R (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT    952    952       R -> T (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT   1004   1004       Missing (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT   1086   1086       Q -> R (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT   1168   1168       Q -> R (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT   1169   1169       N -> I (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT   1170   1170       S -> L (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT   1342   1342       V -> L (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT   1382   1382       R -> Q (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT   1532   1532       T -> A (in Ref. 4; BAC03656).
FT                                {ECO:0000305}.
FT   CONFLICT   1849   1849       S -> G (in Ref. 4; BAC03656).
FT                                {ECO:0000305}.
FT   CONFLICT   1853   1864       PLEREATSKNDQ -> HWNEKPLVKMTK (in Ref. 1;
FT                                AAA60120). {ECO:0000305}.
FT   CONFLICT   1872   1872       C -> S (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
FT   CONFLICT   1988   1988       E -> V (in Ref. 4; BAC03656).
FT                                {ECO:0000305}.
FT   CONFLICT   1998   1998       I -> M (in Ref. 1; AAA60120).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2024 AA;  228533 MW;  04ACFD7438F773EB CRC64;
     MATGGGPFED GMNDQDLPNW SNENVDDRLN NMDWGAQQKK ANRSSEKNKK KFGVESDKRV
     TNDISPESSP GVGRRRTKTP HTFPHSRYMS QMSVPEQAEL EKLKQRINFS DLDQRSIGSD
     SQGRATAANN KRQLSENRKP FNFLPMQINT NKSKDASTSP PNRETIGSAQ CKELFASALS
     NDLLQNCQVS EEDGRGEPAM ESSQIVSRLV QIRDYITKAS SMREDLVEKN ERSANVERLT
     HLIDHLKEQE KSYMKFLKKI LARDPQQEPM EEIENLKKQH DLLKRMLQQQ EQLRALQGRQ
     AALLALQHKA EQAIAVMDDS VVAETAGSLS GVSITSELNE ELNDLIQRFH NQLRDSQPPA
     VPDNRRQAES LSLTREVSQS RKPSASERLP DEKVELFSKM RVLQEKKQKM DKLLGELHTL
     RDQHLNNSSS SPQRSVDQRS TSAPSASVGL APVVNGESNS LTSSVPYPTA SLVSQNESEN
     EGHLNPSEKL QKLNEVRKRL NELRELVHYY EQTSDMMTDA VNENRKDEET EESEYDSEHE
     NSEPVTNIRN PQVASTWNEV NSHSNAQCVS NNRDGRTVNS NCEINNRSAA NIRALNMPPS
     LDCRYNREGE QEIHVAQGED DEEEEEEAEE EGVSGASLSS HRSSLVDEHP EDAEFEQKIN
     RLMAAKQKLR QLQDLVAMVQ DDDAAQGVIS ASASNLDDFY PAEEDTKQNS NNTRGNANKT
     QKDTGVNEKA REKFYEAKLQ QQQRELKQLQ EERKKLIDIQ EKIQALQTAC PDLQLSAASV
     GNCPTKKYMP AVTSTPTVNQ HETSTSKSVF EPEDSSIVDN ELWSEMRRHE MLREELRQRR
     KQLEALMAEH QRRQGLAETA SPVAVSLRSD GSENLCTPQQ SRTEKTMATW GGSTQCALDE
     EGDEDGYLSE GIVRTDEEEE EEQDASSNDN FSVCPSNSVN HNSYNGKETK NRWKNNCPFS
     ADENYRPLAK TRQQNISMQR QENLRWVSEL SYVEEKEQWQ EQINQLKKQL DFSVSICQTL
     MQDQQTLSCL LQTLLTGPYS VMPSNVASPQ VHFIMHQLNQ CYTQLTWQQN NVQRLKQMLN
     ELMRQQNQHP EKPGGKERGS SASHPPSPSL FCPFSFPTQP VNLFNIPGFT NFSSFAPGMN
     FSPLFPSNFG DFSQNISTPS EQQQPLAQNS SGKTEYMAFP KPFESSSSIG AEKPRNKKLP
     EEEVESSRTP WLYEQEGEVE KPFIKTGFSV SVEKSTSSNR KNQLDTNGRR RQFDEESLES
     FSSMPDPVDP TTVTKTFKTR KASAQASLAS KDKTPKSKSK KRNSTQLKSR VKNIRYESAS
     MSSTCEPCKS RNRHSAQTEE PVQAKVFSRK NHEQLEKIIK CNRSTEISSE TGSDFSMFEA
     LRDTIYSEVA TLISQNESRP HFLIELFHEL QLLNTDYLRQ RALYALQDIV SRHISESHEK
     GENVKSVNSG TWIASNSELT PSESLATTDD ETFEKNFERE THKISEQNDA DNASVLSVSS
     NFEPFATDDL GNTVIHLDQA LARMREYERM KTEAESNSNM RCTCRIIEDG DGAGAGTTVN
     NLEETPVIEN RSSQQPVSEV STIPCPRIDT QQLDRQIKAI MKEVIPFLKE HMDEVCSSQL
     LTSVRRMVLT LTQQNDESKE FVKFFHKQLG SILQDSLAKF AGRKLKDCGE DLLVEISEVL
     FNELAFFKLM QDLDNNSITV KQRCKRKIEA TGVIQSCAKE AKRILEDHGS PAGEIDDEDK
     DKDETETVKQ TQTSEVYDGP KNVRSDISDQ EEDEESEGCP VSINLSKAET QALTNYGSGE
     DENEDEEMEE FEEGPVDVQT SLQANTEATE ENEHDEQVLQ RDFKKTAESK NVPLEREATS
     KNDQNNCPVK PCYLNILEDE QPLNSAAHKE SPPTVDSTQQ PNPLPLRLPE MEPLVPRVKE
     VKSAQETPES SLAGSPDTES PVLVNDYEAE SGNISQKSDE EDFVKVEDLP LKLTIYSEAD
     LRKKMVEEEQ KNHLSGEICE MQTEELAGNS ETLKEPETVG AQSI
//
ID   A0A075B749_HUMAN        Unreviewed;      2482 AA.
AC   A0A075B749;
DT   01-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 2.
DT   28-FEB-2018, entry version 29.
DE   SubName: Full=Myomegalin {ECO:0000313|Ensembl:ENSP00000462316};
GN   Name=PDE4DIP {ECO:0000313|Ensembl:ENSP00000462316};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000462316, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000462316}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000313|Ensembl:ENSP00000462316}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000462316}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC239802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245389; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_011508477.1; XM_011510175.1.
DR   UniGene; Hs.584841; -.
DR   UniGene; Hs.657490; -.
DR   UniGene; Hs.721759; -.
DR   UniGene; Hs.731111; -.
DR   ProteinModelPortal; A0A075B749; -.
DR   EPD; A0A075B749; -.
DR   PeptideAtlas; A0A075B749; -.
DR   Ensembl; ENST00000585156; ENSP00000462316; ENSG00000178104.
DR   GeneID; 9659; -.
DR   UCSC; uc057kif.1; human.
DR   CTD; 9659; -.
DR   EuPathDB; HostDB:ENSG00000178104.19; -.
DR   HGNC; HGNC:15580; PDE4DIP.
DR   OpenTargets; ENSG00000178104; -.
DR   eggNOG; ENOG410J2NR; Eukaryota.
DR   eggNOG; ENOG411281S; LUCA.
DR   GeneTree; ENSGT00530000063845; -.
DR   OrthoDB; EOG091G0VAF; -.
DR   ChiTaRS; PDE4DIP; human.
DR   GenomeRNAi; 9659; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000178104; -.
DR   ExpressionAtlas; A0A075B749; baseline and differential.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:InterPro.
DR   InterPro; IPR012943; Cnn_1N.
DR   InterPro; IPR010630; NBPF_dom.
DR   Pfam; PF07989; Cnn_1N; 1.
DR   Pfam; PF06758; DUF1220; 1.
DR   SMART; SM01148; DUF1220; 1.
DR   PROSITE; PS51316; NBPF; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A075B749,
KW   ECO:0000213|MaxQB:A0A075B749, ECO:0000213|PeptideAtlas:A0A075B749};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN     1687   1778       NBPF. {ECO:0000259|PROSITE:PS51316}.
FT   COILED      142    162       {ECO:0000256|SAM:Coils}.
FT   COILED      178    209       {ECO:0000256|SAM:Coils}.
FT   COILED      225    259       {ECO:0000256|SAM:Coils}.
FT   COILED      305    342       {ECO:0000256|SAM:Coils}.
FT   COILED      378    412       {ECO:0000256|SAM:Coils}.
FT   COILED      420    440       {ECO:0000256|SAM:Coils}.
FT   COILED      492    519       {ECO:0000256|SAM:Coils}.
FT   COILED      534    561       {ECO:0000256|SAM:Coils}.
FT   COILED      611    656       {ECO:0000256|SAM:Coils}.
FT   COILED      685    705       {ECO:0000256|SAM:Coils}.
FT   COILED      717    737       {ECO:0000256|SAM:Coils}.
FT   COILED      750    770       {ECO:0000256|SAM:Coils}.
FT   COILED      797    817       {ECO:0000256|SAM:Coils}.
FT   COILED      885    912       {ECO:0000256|SAM:Coils}.
FT   COILED      920    954       {ECO:0000256|SAM:Coils}.
FT   COILED      964    984       {ECO:0000256|SAM:Coils}.
FT   COILED     1000   1020       {ECO:0000256|SAM:Coils}.
FT   COILED     1143   1177       {ECO:0000256|SAM:Coils}.
FT   COILED     1239   1259       {ECO:0000256|SAM:Coils}.
FT   COILED     1350   1377       {ECO:0000256|SAM:Coils}.
FT   COILED     1487   1521       {ECO:0000256|SAM:Coils}.
FT   COILED     1567   1587       {ECO:0000256|SAM:Coils}.
FT   COILED     1702   1722       {ECO:0000256|SAM:Coils}.
FT   COILED     1875   1895       {ECO:0000256|SAM:Coils}.
FT   COILED     1977   2007       {ECO:0000256|SAM:Coils}.
FT   COILED     2033   2060       {ECO:0000256|SAM:Coils}.
FT   COILED     2065   2120       {ECO:0000256|SAM:Coils}.
FT   COILED     2128   2155       {ECO:0000256|SAM:Coils}.
FT   COILED     2422   2442       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   2482 AA;  280468 MW;  881C3928A36A0E1C CRC64;
     MKGTDSGSCC RRRCDFGCCC RASRRAHYTP YRSGDATRTP QSPRQTPSRE RRRPEPAGSW
     AAAAEEEEAA AAATPWMRDY FAEDDGEMVP RTSHTAAFLS DTKDRGPPVQ SQIWRSGEKV
     PFVQTYSLRA FEKPPQVQTQ ALRDFEKHLN DLKKENFSLK LRIYFLEERM QQKYEASRED
     IYKRNIELKV EVESLKRELQ DKKQHLDKTW ADVENLNSQN EAELRRQFEE RQQETEHVYE
     LLENKIQLLQ EESRLAKNEA ARMAALVEAE KECNLELSEK LKGVTKNWED VPGDQVKPDQ
     YTEALAQRDK RIEELNQSLA AQERLVEQLS REKQQLLHLL EEPTSMEVQP MTEELLKQQK
     LNSHETTITQ QSVSDSHLAE LQEKIQQTEA TNKILQEKLN EMSYELKCAQ ESSQKQDGTI
     QNLKETLKSR ERETEELYQV IEGQNDTMAK LREMLHQSQL GQLHSSEGTS PAQQQVALLD
     LQSALFCSQL EIQKLQRVVR QKERQLADAK QCVQFVEAAA HESEQQKEAS WKHNQELRKA
     LQQLQEELQN KSQQLRAWEA EKYNEIRTQE QNIQHLNHSL SHKEQLLQEF RELLQYRDNS
     DKTLEANEML LEKLRQRIHD KAVALERAID EKFSALEEKE KELRQLRLAV RERDHDLERL
     RDVLSSNEAT MQSMESLLRA KGLEVEQLST TCQNLQWLKE EMETKFSRWQ KEQESIIQQL
     QTSLHDRNKE VEDLSATLLC KLGPGQSEIA EELCQRLQRK ERMLQDLLSD RNKQVLEHEM
     EIQGLLQSVS TREQESQAAA EKLVQALMER NSELQALRQY LGGRDSLMSQ APISNQQAEV
     TPTGRLGKQT DQGSMQIPSR DDSTSLTAKE DVSIPRSTLG DLDTVAGLEK ELSNAKEELE
     LMAKKERESQ MELSALQSMM AVQEEELQVQ AADMESLTRN IQIKEDLIKD LQMQLVDPED
     IPAMERLTQE VLLLREKVAS VESQGQEISG NRRQQLLLML EGLVDERSRL NEALQAERQL
     YSSLVKFHAH PESSERDRTL QVELEGAQVL RSRLEEVLGR SLERLNRLET LAAIGGAAAG
     DDTEDTSTEF TDSIEEEAAH HSHQQLVKVA LEKSLATVET QNPSFSPPSP MGGDSNRCLQ
     EEMLHLRAEF HQHLEEKRKA EEELKELKAQ IEEAGFSSVS HIRNTMLSLC LENAELKEQM
     GEAMSDGWEI EEDKEKGEVM VETVVTKEGL SESSLQAEFR KLQGKLKNAH NIINLLKEQL
     VLSSKEGNSK LTPELLVHLT STIERINTEL VGSPGKHQHQ EEGNVTVRPF PRPQSLDLGA
     TFTVDAHQLD NQSQPRDPGP QSAFSLPGST QHLRSQLSQC KQRYQDLQEK LLLSEATVFA
     QANELEKYRV MLSESLVKQD SKQIQVDLQD LGYETCGRSE NEAEREETTS PECEEHNSLK
     EMVLMEGLCS EQGRRGSTLA SSSERKPLEN QLGKQEEFRV YGKSENILVL RKDIKDLKAQ
     LQNANKVIQN LKSRVRSLSV TSDYSSSLER PRKLRAVGTL EGSSPHSVPD EDEGWLSDGT
     GAFYSPGLQA KKDLESLIQR VSQLEAQLPK NGLEEKLAEE LRSASWPGKY DSLIQDQARE
     LSYLRQKIRE GRGICYLITR HAKDTVKSFE DLLRSNDIDY YLGQSFREQL AQGSQLTERL
     TSKLSTKDHK SEKDQAGLEP LALRLSRELQ EKEKVIEVLQ AKLDARSLTP SSSHALSDSH
     RSPSSTSFLS DELEACSDMD IVSEYTHYEE KKASPSHSDS IHHSSHSAVL SSKPSSTSAS
     QGAKAESNSN PISLPTPQNT PKEANQAHSG FHFHSIPKLA SLPQAPLPSA PSSFLPFSPT
     GPLLLGCCET PVVSLAEAQQ ELQMLQKQLG ESASTVPPAS TATLLSNDLE ADSSYYLNSA
     QPHSPPRGTI ELGRILEPGY LGSSGKWDVM RPQKGSVSGD LSSGSSVYQL NSKPTGADLL
     EEHLGEIRNL RQRLEESICI NDRLREQLEH RLTSTARGRG STSNFYSQGL ESIPQLCNEN
     RVLREDNRRL QAQLSHVSRE HSQETESLRE ALLSSRSHLQ ELEKELEHQK VERQQLLEDL
     REKQQEVLHF REERLSLQEN DSRLQHKLVL LQQQCEEKQQ LFESLQSELQ IYEALYGNSK
     KGLKAYSLDA CHQIPLSSDL SHLVAEVRAL RGQLEQSIQG NNCLRLQLQQ QLESGAGKAS
     LSPSSINQNF PASTDPGNKQ LLLQDSAVSP PVRDVGMNSP ALVFPSSASS TPGSETPIIN
     RANGLGLDTS PVMKTPPKLE GDATDGSFAN KHGRHVIGHI DDYSALRQQI AEGKLLVKKI
     VSLVRSACSF PGLEAQGTEV LGSKGIHELR SSTSALHHAL EESASLLTMF WRAALPSTHI
     PVLPGKVGES TERELLELRT KVSKQERLLQ STTEHLKNAN QQKESMEQFI VSQLTRTHDV
     LKKARTNLEV KSLRALPCTP AL
//
ID   A0A087WVF8_HUMAN        Unreviewed;      2240 AA.
AC   A0A087WVF8;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   28-FEB-2018, entry version 29.
DE   SubName: Full=Myomegalin {ECO:0000313|Ensembl:ENSP00000479409};
GN   Name=PDE4DIP {ECO:0000313|Ensembl:ENSP00000479409};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000479409, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000479409}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000313|Ensembl:ENSP00000479409}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000479409}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC239802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245389; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001185761.2; NM_001198832.2.
DR   UniGene; Hs.584841; -.
DR   UniGene; Hs.657490; -.
DR   UniGene; Hs.721759; -.
DR   UniGene; Hs.731111; -.
DR   ProteinModelPortal; A0A087WVF8; -.
DR   PeptideAtlas; A0A087WVF8; -.
DR   PRIDE; A0A087WVF8; -.
DR   Ensembl; ENST00000618462; ENSP00000479409; ENSG00000178104.
DR   GeneID; 9659; -.
DR   UCSC; uc031uvp.2; human.
DR   CTD; 9659; -.
DR   EuPathDB; HostDB:ENSG00000178104.19; -.
DR   HGNC; HGNC:15580; PDE4DIP.
DR   OpenTargets; ENSG00000178104; -.
DR   eggNOG; ENOG410J2NR; Eukaryota.
DR   eggNOG; ENOG411281S; LUCA.
DR   GeneTree; ENSGT00530000063845; -.
DR   ChiTaRS; PDE4DIP; human.
DR   GenomeRNAi; 9659; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000178104; -.
DR   ExpressionAtlas; A0A087WVF8; baseline and differential.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:InterPro.
DR   InterPro; IPR012943; Cnn_1N.
DR   InterPro; IPR010630; NBPF_dom.
DR   Pfam; PF07989; Cnn_1N; 1.
DR   Pfam; PF06758; DUF1220; 1.
DR   SMART; SM01148; DUF1220; 1.
DR   PROSITE; PS51316; NBPF; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WVF8,
KW   ECO:0000213|MaxQB:A0A087WVF8, ECO:0000213|PeptideAtlas:A0A087WVF8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN     1507   1598       NBPF. {ECO:0000259|PROSITE:PS51316}.
FT   COILED       71     91       {ECO:0000256|SAM:Coils}.
FT   COILED      107    138       {ECO:0000256|SAM:Coils}.
FT   COILED      154    188       {ECO:0000256|SAM:Coils}.
FT   COILED      234    271       {ECO:0000256|SAM:Coils}.
FT   COILED      307    341       {ECO:0000256|SAM:Coils}.
FT   COILED      349    369       {ECO:0000256|SAM:Coils}.
FT   COILED      421    448       {ECO:0000256|SAM:Coils}.
FT   COILED      463    490       {ECO:0000256|SAM:Coils}.
FT   COILED      540    585       {ECO:0000256|SAM:Coils}.
FT   COILED      614    634       {ECO:0000256|SAM:Coils}.
FT   COILED      646    666       {ECO:0000256|SAM:Coils}.
FT   COILED      679    699       {ECO:0000256|SAM:Coils}.
FT   COILED      726    746       {ECO:0000256|SAM:Coils}.
FT   COILED      814    841       {ECO:0000256|SAM:Coils}.
FT   COILED      849    883       {ECO:0000256|SAM:Coils}.
FT   COILED      893    913       {ECO:0000256|SAM:Coils}.
FT   COILED      929    949       {ECO:0000256|SAM:Coils}.
FT   COILED     1072   1106       {ECO:0000256|SAM:Coils}.
FT   COILED     1169   1196       {ECO:0000256|SAM:Coils}.
FT   COILED     1307   1341       {ECO:0000256|SAM:Coils}.
FT   COILED     1387   1407       {ECO:0000256|SAM:Coils}.
FT   COILED     1522   1542       {ECO:0000256|SAM:Coils}.
FT   COILED     1735   1765       {ECO:0000256|SAM:Coils}.
FT   COILED     1791   1818       {ECO:0000256|SAM:Coils}.
FT   COILED     1823   1878       {ECO:0000256|SAM:Coils}.
FT   COILED     1886   1913       {ECO:0000256|SAM:Coils}.
FT   COILED     2180   2200       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   2240 AA;  254069 MW;  91F0BA4B645E89DD CRC64;
     MEQTWTRDYF AEDDGEMVPR TSHTAAFLSD TKDRGPPVQS QIWRSGEKVP FVQTYSLRAF
     EKPPQVQTQA LRDFEKHLND LKKENFSLKL RIYFLEERMQ QKYEASREDI YKRNIELKVE
     VESLKRELQD KKQHLDKTWA DVENLNSQNE AELRRQFEER QQETEHVYEL LENKIQLLQE
     ESRLAKNEAA RMAALVEAEK ECNLELSEKL KGVTKNWEDV PGDQVKPDQY TEALAQRDKR
     IEELNQSLAA QERLVEQLSR EKQQLLHLLE EPTSMEVQPM TEELLKQQKL NSHETTITQQ
     SVSDSHLAEL QEKIQQTEAT NKILQEKLNE MSYELKCAQE SSQKQDGTIQ NLKETLKSRE
     RETEELYQVI EGQNDTMAKL REMLHQSQLG QLHSSEGTSP AQQQVALLDL QSALFCSQLE
     IQKLQRVVRQ KERQLADAKQ CVQFVEAAAH ESEQQKEASW KHNQELRKAL QQLQEELQNK
     SQQLRAWEAE KYNEIRTQEQ NIQHLNHSLS HKEQLLQEFR ELLQYRDNSD KTLEANEMLL
     EKLRQRIHDK AVALERAIDE KFSALEEKEK ELRQLRLAVR ERDHDLERLR DVLSSNEATM
     QSMESLLRAK GLEVEQLSTT CQNLQWLKEE METKFSRWQK EQESIIQQLQ TSLHDRNKEV
     EDLSATLLCK LGPGQSEIAE ELCQRLQRKE RMLQDLLSDR NKQVLEHEME IQGLLQSVST
     REQESQAAAE KLVQALMERN SELQALRQYL GGRDSLMSQA PISNQQAEVT PTGRLGKQTD
     QGSMQIPSRD DSTSLTAKED VSIPRSTLGD LDTVAGLEKE LSNAKEELEL MAKKERESQM
     ELSALQSMMA VQEEELQVQA ADMESLTRNI QIKEDLIKDL QMQLVDPEDI PAMERLTQEV
     LLLREKVASV ESQGQEISGN RRQQLLLMLE GLVDERSRLN EALQAERQLY SSLVKFHAHP
     ESSERDRTLQ VELEGAQVLR SRLEEVLGRS LERLNRLETL AAIGGAAAGD DTEDTSTEFT
     DSIEEEAAHH SHQQLVKVAL EKSLATVETQ NPSFSPPSPM GGDSNRCLQE EMLHLRAEFH
     QHLEEKRKAE EELKELKAQI EEAGFSSVSH IRNTMLSLCL ENAELKEQMG EAMSDGWEIE
     EDKEKGELDN QSQPRDPGPQ SAFSLPGSTQ HLRSQLSQCK QRYQDLQEKL LLSEATVFAQ
     ANELEKYRVM LTGESLVKQD SKQIQVDLQD LGYETCGRSE NEAEREETTS PECEEHNSLK
     EMVLMEGLCS EQGRRGSTLA SSSERKPLEN QLGKQEEFRV YGKSENILVL RKDIKDLKAQ
     LQNANKVIQN LKSRVRSLSV TSDYSSSLER PRKLRAVGTL EGSSPHSVPD EDEGWLSDGT
     GAFYSPGLQA KKDLESLIQR VSQLEAQLPK NGLEEKLAEE LRSASWPGKY DSLIQDQARE
     LSYLRQKIRE GRGICYLITR HAKDTVKSFE DLLRSNDIDY YLGQSFREQL AQGSQLTERL
     TSKLSTKDHK SEKDQAGLEP LALRLSRELQ EKEKVIEVLQ AKLDARSLTP SSSHALSDSH
     RSPSSTSFLS DELEACSDMD IVSEYTHYEE KKASPSHSDS IHHSSHSAVL SSKPSSTSAS
     QGAKAESNSN PISLPTPQNT PKEANQAHSG ASTVPPASTA TLLSNDLEAD SSYYLNSAQP
     HSPPRGTIEL GRILEPGYLG SSGKWDVMRP QKGSVSGDLS SGSSVYQLNS KPTGADLLEE
     HLGEIRNLRQ RLEESICIND RLREQLEHRL TSTARGRGST SNFYSQGLES IPQLCNENRV
     LREDNRRLQA QLSHVSREHS QETESLREAL LSSRSHLQEL EKELEHQKVE RQQLLEDLRE
     KQQEVLHFRE ERLSLQENDS RLQHKLVLLQ QQCEEKQQLF ESLQSELQIY EALYGNSKKG
     LKAYSLDACH QIPLSSDLSH LVAEVRALRG QLEQSIQGNN CLRLQLQQQL ESGAGKASLS
     PSSINQNFPA STDPGNKQLL LQDSAVSPPV RDVGMNSPAL VFPSSASSTP GSETPIINRA
     NGLGLDTSPV MKTPPKLEGD ATDGSFANKH GRHVIGHIDD YSALRQQIAE GKLLVKKIVS
     LVRSACSFPG LEAQGTEVLG SKGIHELRSS TSALHHALEE SASLLTMFWR AALPSTHIPV
     LPGKVGESTE RELLELRTKV SKQERLLQST TEHLKNANQQ KESMEQFIVS QLTRTHDVLK
     KARTNLEVKS LRALPCTPAL
//
ID   A0A087WYE4_HUMAN        Unreviewed;       176 AA.
AC   A0A087WYE4;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   28-FEB-2018, entry version 25.
DE   SubName: Full=Myomegalin {ECO:0000313|Ensembl:ENSP00000481731};
GN   Name=PDE4DIP {ECO:0000313|Ensembl:ENSP00000481731};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000481731, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000481731}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000313|Ensembl:ENSP00000481731}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000481731}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC239802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245389; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001182190.1; NM_001195261.1.
DR   UniGene; Hs.584841; -.
DR   UniGene; Hs.657490; -.
DR   UniGene; Hs.721759; -.
DR   UniGene; Hs.731111; -.
DR   ProteinModelPortal; A0A087WYE4; -.
DR   PeptideAtlas; A0A087WYE4; -.
DR   PRIDE; A0A087WYE4; -.
DR   Ensembl; ENST00000464103; ENSP00000481731; ENSG00000178104.
DR   GeneID; 9659; -.
DR   UCSC; uc021oui.1; human.
DR   CTD; 9659; -.
DR   EuPathDB; HostDB:ENSG00000178104.19; -.
DR   HGNC; HGNC:15580; PDE4DIP.
DR   OpenTargets; ENSG00000178104; -.
DR   eggNOG; ENOG410J2NR; Eukaryota.
DR   eggNOG; ENOG411281S; LUCA.
DR   GeneTree; ENSGT00530000063845; -.
DR   ChiTaRS; PDE4DIP; human.
DR   GenomeRNAi; 9659; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000178104; -.
DR   ExpressionAtlas; A0A087WYE4; baseline and differential.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:InterPro.
DR   InterPro; IPR012943; Cnn_1N.
DR   Pfam; PF07989; Cnn_1N; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WYE4,
KW   ECO:0000213|MaxQB:A0A087WYE4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       13     77       Cnn_1N. {ECO:0000259|Pfam:PF07989}.
FT   COILED       44     75       {ECO:0000256|SAM:Coils}.
FT   COILED       91    125       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   176 AA;  21161 MW;  0FEFE198622F04F0 CRC64;
     MFLCQGFRKY LPEHLNDLKK ENFSLKLRIY FLEERMQQKY EASREDIYKR NIELKVEVES
     LKRELQDKKQ HLDKTWADVE NLNSQNEAEL RRQFEERQQE TEHVYELLEN KIQLLQEESR
     LAKNEAARMA ALVEAEKECN LELSEKLKGV TKNWEDVPGD QVKPDQYTEA LAQRDK
//
ID   A0A0A0MRL8_HUMAN        Unreviewed;       969 AA.
AC   A0A0A0MRL8;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   28-FEB-2018, entry version 26.
DE   SubName: Full=Myomegalin {ECO:0000313|Ensembl:ENSP00000358355};
GN   Name=PDE4DIP {ECO:0000313|Ensembl:ENSP00000358355};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000358355, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000358355}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000313|Ensembl:ENSP00000358355}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000358355}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC239802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245389; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001002812.2; NM_001002812.2.
DR   UniGene; Hs.584841; -.
DR   UniGene; Hs.657490; -.
DR   UniGene; Hs.721759; -.
DR   UniGene; Hs.731111; -.
DR   ProteinModelPortal; A0A0A0MRL8; -.
DR   PeptideAtlas; A0A0A0MRL8; -.
DR   PRIDE; A0A0A0MRL8; -.
DR   Ensembl; ENST00000369349; ENSP00000358355; ENSG00000178104.
DR   GeneID; 9659; -.
DR   UCSC; uc001emc.3; human.
DR   CTD; 9659; -.
DR   EuPathDB; HostDB:ENSG00000178104.19; -.
DR   HGNC; HGNC:15580; PDE4DIP.
DR   OpenTargets; ENSG00000178104; -.
DR   eggNOG; ENOG410J2NR; Eukaryota.
DR   eggNOG; ENOG411281S; LUCA.
DR   GeneTree; ENSGT00530000063845; -.
DR   ChiTaRS; PDE4DIP; human.
DR   GenomeRNAi; 9659; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000178104; -.
DR   ExpressionAtlas; A0A0A0MRL8; baseline and differential.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:InterPro.
DR   InterPro; IPR012943; Cnn_1N.
DR   Pfam; PF07989; Cnn_1N; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MRL8,
KW   ECO:0000213|MaxQB:A0A0A0MRL8, ECO:0000213|PeptideAtlas:A0A0A0MRL8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        6     74       Cnn_1N. {ECO:0000259|Pfam:PF07989}.
FT   COILED       41     72       {ECO:0000256|SAM:Coils}.
FT   COILED       88    122       {ECO:0000256|SAM:Coils}.
FT   COILED      168    205       {ECO:0000256|SAM:Coils}.
FT   COILED      241    275       {ECO:0000256|SAM:Coils}.
FT   COILED      283    303       {ECO:0000256|SAM:Coils}.
FT   COILED      355    382       {ECO:0000256|SAM:Coils}.
FT   COILED      397    424       {ECO:0000256|SAM:Coils}.
FT   COILED      474    519       {ECO:0000256|SAM:Coils}.
FT   COILED      548    568       {ECO:0000256|SAM:Coils}.
FT   COILED      580    600       {ECO:0000256|SAM:Coils}.
FT   COILED      613    633       {ECO:0000256|SAM:Coils}.
FT   COILED      660    680       {ECO:0000256|SAM:Coils}.
FT   COILED      748    775       {ECO:0000256|SAM:Coils}.
FT   COILED      783    817       {ECO:0000256|SAM:Coils}.
FT   COILED      827    847       {ECO:0000256|SAM:Coils}.
FT   COILED      863    883       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   969 AA;  112285 MW;  FCFA6AC1FF598B7A CRC64;
     MSNGYRTLSQ HLNDLKKENF SLKLRIYFLE ERMQQKYEAS REDIYKRNIE LKVEVESLKR
     ELQDKKQHLD KTWADVENLN SQNEAELRRQ FEERQQETEH VYELLENKIQ LLQEESRLAK
     NEAARMAALV EAEKECNLEL SEKLKGVTKN WEDVPGDQVK PDQYTEALAQ RDKRIEELNQ
     SLAAQERLVE QLSREKQQLL HLLEEPTSME VQPMTEELLK QQKLNSHETT ITQQSVSDSH
     LAELQEKIQQ TEATNKILQE KLNEMSYELK CAQESSQKQD GTIQNLKETL KSRERETEEL
     YQVIEGQNDT MAKLREMLHQ SQLGQLHSSE GTSPAQQQVA LLDLQSALFC SQLEIQKLQR
     VVRQKERQLA DAKQCVQFVE AAAHESEQQK EASWKHNQEL RKALQQLQEE LQNKSQQLRA
     WEAEKYNEIR TQEQNIQHLN HSLSHKEQLL QEFRELLQYR DNSDKTLEAN EMLLEKLRQR
     IHDKAVALER AIDEKFSALE EKEKELRQLR LAVRERDHDL ERLRDVLSSN EATMQSMESL
     LRAKGLEVEQ LSTTCQNLQW LKEEMETKFS RWQKEQESII QQLQTSLHDR NKEVEDLSAT
     LLCKLGPGQS EIAEELCQRL QRKERMLQDL LSDRNKQVLE HEMEIQGLLQ SVSTREQESQ
     AAAEKLVQAL MERNSELQAL RQYLGGRDSL MSQAPISNQQ AEVTPTGRLG KQTDQGSMQI
     PSRDDSTSLT AKEDVSIPRS TLGDLDTVAG LEKELSNAKE ELELMAKKER ESQMELSALQ
     SMMAVQEEEL QVQAADMESL TRNIQIKEDL IKDLQMQLVD PEDIPAMERL TQEVLLLREK
     VASVESQGQE ISGNRRQQLL LMLEGLVDER SRLNEALQAE RQLYSSLVKF HAHPESSERD
     RTLQVELEGA QVLRSRLEEV LGRSLERLNR LETLAAIGGA AAGDDTEDTS TEFTDSIEEE
     AAHHSHQQL
//
ID   A0A0A0MRM0_HUMAN        Unreviewed;      2346 AA.
AC   A0A0A0MRM0;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   28-FEB-2018, entry version 28.
DE   SubName: Full=Myomegalin {ECO:0000313|Ensembl:ENSP00000358360};
GN   Name=PDE4DIP {ECO:0000313|Ensembl:ENSP00000358360};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000358360, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000358360}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000313|Ensembl:ENSP00000358360}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000358360}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC239802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245389; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_055459.5; NM_014644.5.
DR   UniGene; Hs.584841; -.
DR   UniGene; Hs.657490; -.
DR   UniGene; Hs.721759; -.
DR   UniGene; Hs.731111; -.
DR   ProteinModelPortal; A0A0A0MRM0; -.
DR   PeptideAtlas; A0A0A0MRM0; -.
DR   PRIDE; A0A0A0MRM0; -.
DR   Ensembl; ENST00000369354; ENSP00000358360; ENSG00000178104.
DR   GeneID; 9659; -.
DR   KEGG; hsa:9659; -.
DR   UCSC; uc031uvr.2; human.
DR   CTD; 9659; -.
DR   EuPathDB; HostDB:ENSG00000178104.19; -.
DR   HGNC; HGNC:15580; PDE4DIP.
DR   OpenTargets; ENSG00000178104; -.
DR   eggNOG; ENOG410J2NR; Eukaryota.
DR   eggNOG; ENOG411281S; LUCA.
DR   GeneTree; ENSGT00530000063845; -.
DR   KO; K16549; -.
DR   ChiTaRS; PDE4DIP; human.
DR   GenomeRNAi; 9659; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000178104; -.
DR   ExpressionAtlas; A0A0A0MRM0; baseline and differential.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:InterPro.
DR   InterPro; IPR012943; Cnn_1N.
DR   InterPro; IPR010630; NBPF_dom.
DR   Pfam; PF07989; Cnn_1N; 1.
DR   Pfam; PF06758; DUF1220; 1.
DR   SMART; SM01148; DUF1220; 1.
DR   PROSITE; PS51316; NBPF; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MRM0,
KW   ECO:0000213|MaxQB:A0A0A0MRM0, ECO:0000213|PeptideAtlas:A0A0A0MRM0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN     1551   1642       NBPF. {ECO:0000259|PROSITE:PS51316}.
FT   COILED       41     72       {ECO:0000256|SAM:Coils}.
FT   COILED       88    122       {ECO:0000256|SAM:Coils}.
FT   COILED      168    205       {ECO:0000256|SAM:Coils}.
FT   COILED      241    275       {ECO:0000256|SAM:Coils}.
FT   COILED      283    303       {ECO:0000256|SAM:Coils}.
FT   COILED      355    382       {ECO:0000256|SAM:Coils}.
FT   COILED      397    424       {ECO:0000256|SAM:Coils}.
FT   COILED      474    519       {ECO:0000256|SAM:Coils}.
FT   COILED      548    568       {ECO:0000256|SAM:Coils}.
FT   COILED      580    600       {ECO:0000256|SAM:Coils}.
FT   COILED      613    633       {ECO:0000256|SAM:Coils}.
FT   COILED      660    680       {ECO:0000256|SAM:Coils}.
FT   COILED      748    775       {ECO:0000256|SAM:Coils}.
FT   COILED      783    817       {ECO:0000256|SAM:Coils}.
FT   COILED      827    847       {ECO:0000256|SAM:Coils}.
FT   COILED      863    883       {ECO:0000256|SAM:Coils}.
FT   COILED     1006   1040       {ECO:0000256|SAM:Coils}.
FT   COILED     1102   1122       {ECO:0000256|SAM:Coils}.
FT   COILED     1213   1240       {ECO:0000256|SAM:Coils}.
FT   COILED     1351   1385       {ECO:0000256|SAM:Coils}.
FT   COILED     1431   1451       {ECO:0000256|SAM:Coils}.
FT   COILED     1566   1586       {ECO:0000256|SAM:Coils}.
FT   COILED     1739   1759       {ECO:0000256|SAM:Coils}.
FT   COILED     1841   1871       {ECO:0000256|SAM:Coils}.
FT   COILED     1897   1924       {ECO:0000256|SAM:Coils}.
FT   COILED     1929   1984       {ECO:0000256|SAM:Coils}.
FT   COILED     1992   2019       {ECO:0000256|SAM:Coils}.
FT   COILED     2286   2306       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   2346 AA;  265103 MW;  8A29AA1514759B0C CRC64;
     MSNGYRTLSQ HLNDLKKENF SLKLRIYFLE ERMQQKYEAS REDIYKRNIE LKVEVESLKR
     ELQDKKQHLD KTWADVENLN SQNEAELRRQ FEERQQETEH VYELLENKIQ LLQEESRLAK
     NEAARMAALV EAEKECNLEL SEKLKGVTKN WEDVPGDQVK PDQYTEALAQ RDKRIEELNQ
     SLAAQERLVE QLSREKQQLL HLLEEPTSME VQPMTEELLK QQKLNSHETT ITQQSVSDSH
     LAELQEKIQQ TEATNKILQE KLNEMSYELK CAQESSQKQD GTIQNLKETL KSRERETEEL
     YQVIEGQNDT MAKLREMLHQ SQLGQLHSSE GTSPAQQQVA LLDLQSALFC SQLEIQKLQR
     VVRQKERQLA DAKQCVQFVE AAAHESEQQK EASWKHNQEL RKALQQLQEE LQNKSQQLRA
     WEAEKYNEIR TQEQNIQHLN HSLSHKEQLL QEFRELLQYR DNSDKTLEAN EMLLEKLRQR
     IHDKAVALER AIDEKFSALE EKEKELRQLR LAVRERDHDL ERLRDVLSSN EATMQSMESL
     LRAKGLEVEQ LSTTCQNLQW LKEEMETKFS RWQKEQESII QQLQTSLHDR NKEVEDLSAT
     LLCKLGPGQS EIAEELCQRL QRKERMLQDL LSDRNKQVLE HEMEIQGLLQ SVSTREQESQ
     AAAEKLVQAL MERNSELQAL RQYLGGRDSL MSQAPISNQQ AEVTPTGRLG KQTDQGSMQI
     PSRDDSTSLT AKEDVSIPRS TLGDLDTVAG LEKELSNAKE ELELMAKKER ESQMELSALQ
     SMMAVQEEEL QVQAADMESL TRNIQIKEDL IKDLQMQLVD PEDIPAMERL TQEVLLLREK
     VASVESQGQE ISGNRRQQLL LMLEGLVDER SRLNEALQAE RQLYSSLVKF HAHPESSERD
     RTLQVELEGA QVLRSRLEEV LGRSLERLNR LETLAAIGGA AAGDDTEDTS TEFTDSIEEE
     AAHHSHQQLV KVALEKSLAT VETQNPSFSP PSPMGGDSNR CLQEEMLHLR AEFHQHLEEK
     RKAEEELKEL KAQIEEAGFS SVSHIRNTML SLCLENAELK EQMGEAMSDG WEIEEDKEKG
     EVMVETVVTK EGLSESSLQA EFRKLQGKLK NAHNIINLLK EQLVLSSKEG NSKLTPELLV
     HLTSTIERIN TELVGSPGKH QHQEEGNVTV RPFPRPQSLD LGATFTVDAH QLDNQSQPRD
     PGPQSAFSLP GSTQHLRSQL SQCKQRYQDL QEKLLLSEAT VFAQANELEK YRVMLTGESL
     VKQDSKQIQV DLQDLGYETC GRSENEAERE ETTSPECEEH NSLKEMVLME GLCSEQGRRG
     STLASSSERK PLENQLGKQE EFRVYGKSEN ILVLRKDIKD LKAQLQNANK VIQNLKSRVR
     SLSVTSDYSS SLERPRKLRA VGTLEGSSPH SVPDEDEGWL SDGTGAFYSP GLQAKKDLES
     LIQRVSQLEA QLPKNGLEEK LAEELRSASW PGKYDSLIQD QARELSYLRQ KIREGRGICY
     LITRHAKDTV KSFEDLLRSN DIDYYLGQSF REQLAQGSQL TERLTSKLST KDHKSEKDQA
     GLEPLALRLS RELQEKEKVI EVLQAKLDAR SLTPSSSHAL SDSHRSPSST SFLSDELEAC
     SDMDIVSEYT HYEEKKASPS HSDSIHHSSH SAVLSSKPSS TSASQGAKAE SNSNPISLPT
     PQNTPKEANQ AHSGFHFHSI PKLASLPQAP LPSAPSSFLP FSPTGPLLLG CCETPVVSLA
     EAQQELQMLQ KQLGESASTV PPASTATLLS NDLEADSSYY LNSAQPHSPP RGTIELGRIL
     EPGYLGSSGK WDVMRPQKGS VSGDLSSGSS VYQLNSKPTG ADLLEEHLGE IRNLRQRLEE
     SICINDRLRE QLEHRLTSTA RGRGSTSNFY SQGLESIPQL CNENRVLRED NRRLQAQLSH
     VSREHSQETE SLREALLSSR SHLQELEKEL EHQKVERQQL LEDLREKQQE VLHFREERLS
     LQENDSRLQH KLVLLQQQCE EKQQLFESLQ SELQIYEALY GNSKKGLKAY SLDACHQIPL
     SSDLSHLVAE VRALRGQLEQ SIQGNNCLRL QLQQQLESGA GKASLSPSSI NQNFPASTDP
     GNKQLLLQDS AVSPPVRDVG MNSPALVFPS SASSTPGSET PIINRANGLG LDTSPVMKTP
     PKLEGDATDG SFANKHGRHV IGHIDDYSAL RQQIAEGKLL VKKIVSLVRS ACSFPGLEAQ
     GTEVLGSKGI HELRSSTSAL HHALEESASL LTMFWRAALP STHIPVLPGK VGESTERELL
     ELRTKVSKQE RLLQSTTEHL KNANQQKESM EQFIVSQLTR THDVLKKART NLEVKSLRAL
     PCTPAL
//
ID   A0A0A0MRM1_HUMAN        Unreviewed;      2362 AA.
AC   A0A0A0MRM1;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   28-FEB-2018, entry version 27.
DE   SubName: Full=Myomegalin {ECO:0000313|Ensembl:ENSP00000358363};
GN   Name=PDE4DIP {ECO:0000313|Ensembl:ENSP00000358363};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000358363, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000358363}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000313|Ensembl:ENSP00000358363}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000358363}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC239802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245389; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001185763.3; NM_001198834.3.
DR   UniGene; Hs.584841; -.
DR   UniGene; Hs.657490; -.
DR   UniGene; Hs.721759; -.
DR   UniGene; Hs.731111; -.
DR   ProteinModelPortal; A0A0A0MRM1; -.
DR   PeptideAtlas; A0A0A0MRM1; -.
DR   PRIDE; A0A0A0MRM1; -.
DR   Ensembl; ENST00000369356; ENSP00000358363; ENSG00000178104.
DR   GeneID; 9659; -.
DR   UCSC; uc031uvq.2; human.
DR   CTD; 9659; -.
DR   EuPathDB; HostDB:ENSG00000178104.19; -.
DR   HGNC; HGNC:15580; PDE4DIP.
DR   OpenTargets; ENSG00000178104; -.
DR   eggNOG; ENOG410J2NR; Eukaryota.
DR   eggNOG; ENOG411281S; LUCA.
DR   GeneTree; ENSGT00530000063845; -.
DR   ChiTaRS; PDE4DIP; human.
DR   GenomeRNAi; 9659; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000178104; -.
DR   ExpressionAtlas; A0A0A0MRM1; baseline and differential.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:InterPro.
DR   InterPro; IPR012943; Cnn_1N.
DR   InterPro; IPR010630; NBPF_dom.
DR   Pfam; PF07989; Cnn_1N; 1.
DR   Pfam; PF06758; DUF1220; 1.
DR   SMART; SM01148; DUF1220; 1.
DR   PROSITE; PS51316; NBPF; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MRM1,
KW   ECO:0000213|MaxQB:A0A0A0MRM1, ECO:0000213|PeptideAtlas:A0A0A0MRM1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN     1551   1642       NBPF. {ECO:0000259|PROSITE:PS51316}.
FT   COILED       41     72       {ECO:0000256|SAM:Coils}.
FT   COILED       88    122       {ECO:0000256|SAM:Coils}.
FT   COILED      168    205       {ECO:0000256|SAM:Coils}.
FT   COILED      241    275       {ECO:0000256|SAM:Coils}.
FT   COILED      283    303       {ECO:0000256|SAM:Coils}.
FT   COILED      355    382       {ECO:0000256|SAM:Coils}.
FT   COILED      397    424       {ECO:0000256|SAM:Coils}.
FT   COILED      474    519       {ECO:0000256|SAM:Coils}.
FT   COILED      548    568       {ECO:0000256|SAM:Coils}.
FT   COILED      580    600       {ECO:0000256|SAM:Coils}.
FT   COILED      613    633       {ECO:0000256|SAM:Coils}.
FT   COILED      660    680       {ECO:0000256|SAM:Coils}.
FT   COILED      748    775       {ECO:0000256|SAM:Coils}.
FT   COILED      783    817       {ECO:0000256|SAM:Coils}.
FT   COILED      827    847       {ECO:0000256|SAM:Coils}.
FT   COILED      863    883       {ECO:0000256|SAM:Coils}.
FT   COILED     1006   1040       {ECO:0000256|SAM:Coils}.
FT   COILED     1102   1122       {ECO:0000256|SAM:Coils}.
FT   COILED     1213   1240       {ECO:0000256|SAM:Coils}.
FT   COILED     1351   1385       {ECO:0000256|SAM:Coils}.
FT   COILED     1431   1451       {ECO:0000256|SAM:Coils}.
FT   COILED     1566   1586       {ECO:0000256|SAM:Coils}.
FT   COILED     1739   1759       {ECO:0000256|SAM:Coils}.
FT   COILED     1841   1871       {ECO:0000256|SAM:Coils}.
FT   COILED     1897   1924       {ECO:0000256|SAM:Coils}.
FT   COILED     1929   1984       {ECO:0000256|SAM:Coils}.
FT   COILED     1992   2019       {ECO:0000256|SAM:Coils}.
FT   COILED     2286   2306       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   2362 AA;  267200 MW;  C47E0094FB787B0D CRC64;
     MSNGYRTLSQ HLNDLKKENF SLKLRIYFLE ERMQQKYEAS REDIYKRNIE LKVEVESLKR
     ELQDKKQHLD KTWADVENLN SQNEAELRRQ FEERQQETEH VYELLENKIQ LLQEESRLAK
     NEAARMAALV EAEKECNLEL SEKLKGVTKN WEDVPGDQVK PDQYTEALAQ RDKRIEELNQ
     SLAAQERLVE QLSREKQQLL HLLEEPTSME VQPMTEELLK QQKLNSHETT ITQQSVSDSH
     LAELQEKIQQ TEATNKILQE KLNEMSYELK CAQESSQKQD GTIQNLKETL KSRERETEEL
     YQVIEGQNDT MAKLREMLHQ SQLGQLHSSE GTSPAQQQVA LLDLQSALFC SQLEIQKLQR
     VVRQKERQLA DAKQCVQFVE AAAHESEQQK EASWKHNQEL RKALQQLQEE LQNKSQQLRA
     WEAEKYNEIR TQEQNIQHLN HSLSHKEQLL QEFRELLQYR DNSDKTLEAN EMLLEKLRQR
     IHDKAVALER AIDEKFSALE EKEKELRQLR LAVRERDHDL ERLRDVLSSN EATMQSMESL
     LRAKGLEVEQ LSTTCQNLQW LKEEMETKFS RWQKEQESII QQLQTSLHDR NKEVEDLSAT
     LLCKLGPGQS EIAEELCQRL QRKERMLQDL LSDRNKQVLE HEMEIQGLLQ SVSTREQESQ
     AAAEKLVQAL MERNSELQAL RQYLGGRDSL MSQAPISNQQ AEVTPTGRLG KQTDQGSMQI
     PSRDDSTSLT AKEDVSIPRS TLGDLDTVAG LEKELSNAKE ELELMAKKER ESQMELSALQ
     SMMAVQEEEL QVQAADMESL TRNIQIKEDL IKDLQMQLVD PEDIPAMERL TQEVLLLREK
     VASVESQGQE ISGNRRQQLL LMLEGLVDER SRLNEALQAE RQLYSSLVKF HAHPESSERD
     RTLQVELEGA QVLRSRLEEV LGRSLERLNR LETLAAIGGA AAGDDTEDTS TEFTDSIEEE
     AAHHSHQQLV KVALEKSLAT VETQNPSFSP PSPMGGDSNR CLQEEMLHLR AEFHQHLEEK
     RKAEEELKEL KAQIEEAGFS SVSHIRNTML SLCLENAELK EQMGEAMSDG WEIEEDKEKG
     EVMVETVVTK EGLSESSLQA EFRKLQGKLK NAHNIINLLK EQLVLSSKEG NSKLTPELLV
     HLTSTIERIN TELVGSPGKH QHQEEGNVTV RPFPRPQSLD LGATFTVDAH QLDNQSQPRD
     PGPQSAFSLP GSTQHLRSQL SQCKQRYQDL QEKLLLSEAT VFAQANELEK YRVMLTGESL
     VKQDSKQIQV DLQDLGYETC GRSENEAERE ETTSPECEEH NSLKEMVLME GLCSEQGRRG
     STLASSSERK PLENQLGKQE EFRVYGKSEN ILVLRKDIKD LKAQLQNANK VIQNLKSRVR
     SLSVTSDYSS SLERPRKLRA VGTLEGSSPH SVPDEDEGWL SDGTGAFYSP GLQAKKDLES
     LIQRVSQLEA QLPKNGLEEK LAEELRSASW PGKYDSLIQD QARELSYLRQ KIREGRGICY
     LITRHAKDTV KSFEDLLRSN DIDYYLGQSF REQLAQGSQL TERLTSKLST KDHKSEKDQA
     GLEPLALRLS RELQEKEKVI EVLQAKLDAR SLTPSSSHAL SDSHRSPSST SFLSDELEAC
     SDMDIVSEYT HYEEKKASPS HSDSIHHSSH SAVLSSKPSS TSASQGAKAE SNSNPISLPT
     PQNTPKEANQ AHSGFHFHSI PKLASLPQAP LPSAPSSFLP FSPTGPLLLG CCETPVVSLA
     EAQQELQMLQ KQLGESASTV PPASTATLLS NDLEADSSYY LNSAQPHSPP RGTIELGRIL
     EPGYLGSSGK WDVMRPQKGS VSGDLSSGSS VYQLNSKPTG ADLLEEHLGE IRNLRQRLEE
     SICINDRLRE QLEHRLTSTA RGRGSTSNFY SQGLESIPQL CNENRVLRED NRRLQAQLSH
     VSREHSQETE SLREALLSSR SHLQELEKEL EHQKVERQQL LEDLREKQQE VLHFREERLS
     LQENDSRLQH KLVLLQQQCE EKQQLFESLQ SELQIYEALY GNSKKGLKAY SLDACHQIPL
     SSDLSHLVAE VRALRGQLEQ SIQGNNCLRL QLQQQLESGA GKASLSPSSI NQNFPASTDP
     GNKQLLLQDS AVSPPVRDVG MNSPALVFPS SASSTPGSET PIINRANGLG LDTSPVMKTP
     PKLEGDATDG SFANKHGRHV IGHIDDYSAL RQQIAEGKLL VKKIVSLVRS ACSFPGLEAQ
     GTEVLGSKGI HELRSSTSAL HHALEESASL LTMFWRAALP STHIPVLPGK VGESTERELL
     ELRTKVSKQE RLLQSTTEHL KNANQQKESM EQFIVSQLTR THDVLKKART NLEEPCKKRS
     HQKSLKQQER WACPPFVQLP IC
//
ID   MYOME_HUMAN             Reviewed;        2346 AA.
AC   Q5VU43; A0A0C4DFQ0; A2RU15; E9PL24; O75042; O75065; Q2YDC1; Q5VU42;
AC   Q5VU44; Q5VU45; Q5VU46; Q5VU47; Q5VU48; Q5VU49; Q68DU2; Q6AZ93;
AC   Q6PK88; Q86T40; Q86TB2; Q8N3W0; Q8TAY9; Q9HCP2; Q9HCP3; Q9HCP4;
AC   Q9HCP5;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   28-FEB-2018, sequence version 2.
DT   28-FEB-2018, entry version 129.
DE   RecName: Full=Myomegalin;
DE   AltName: Full=Cardiomyopathy-associated protein 2;
DE   AltName: Full=Phosphodiesterase 4D-interacting protein;
GN   Name=PDE4DIP; Synonyms=CMYA2, KIAA0454, KIAA0477, MMGL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 10; 11 AND 12), TISSUE
RP   SPECIFICITY, AND VARIANT THR-49.
RC   TISSUE=Myocardium;
RX   PubMed=11374908; DOI=10.1006/geno.2001.6527;
RA   Soejima H., Kawamoto S., Akai J., Miyoshi O., Arai Y., Morohka T.,
RA   Matsuo S., Niikawa N., Kimura A., Okubo K., Mukai T.;
RT   "Isolation of novel heart-specific genes using the BodyMap database.";
RL   Genomics 74:115-120(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 13), FUNCTION (ISOFORM 13),
RP   INTERACTION WITH AKAP9; GAMMA-TUBULIN RING COMPLEX; MAPRE1 AND MAPRE3
RP   (ISOFORM 13), SUBCELLULAR LOCATION (ISOFORM 13), AND MUTAGENESIS
RP   (ISOFORM 13).
RX   PubMed=25217626; DOI=10.1242/jcs.155408;
RA   Wang Z., Zhang C., Qi R.Z.;
RT   "A newly identified myomegalin isoform functions in Golgi microtubule
RT   organization and ER-Golgi transport.";
RL   J. Cell Sci. 127:4904-4917(2014).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RT   "Characterization of cDNA clones in size-fractionated cDNA libraries
RT   from human brain.";
RL   DNA Res. 4:345-349(1997).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 6 AND 7), AND
RP   VARIANTS CYS-708; ILE-1013; THR-1066; GLU-1359; GLU-1736 AND SER-1742.
RC   TISSUE=Amygdala, and Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT CYS-708.
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 8 AND 9), AND
RP   VARIANT THR-49.
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2261-2346 (ISOFORM 4).
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   CHROMOSOMAL TRANSLOCATION WITH PDGFRB.
RX   PubMed=12907457; DOI=10.1182/blood-2003-04-1150;
RA   Wilkinson K., Velloso E.R.P., Lopes L.F., Lee C., Aster J.C.,
RA   Shipp M.A., Aguiar R.C.T.;
RT   "Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder
RT   associated with eosinophilia: involvement of PDGFRB and response to
RT   imatinib.";
RL   Blood 102:4187-4190(2003).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-704, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   FUNCTION (ISOFORM 13), SUBCELLULAR LOCATION (ISOFORM 13), AND
RP   INTERACTION WITH AKAP9 AND CAMSAP2 (ISOFORM 13).
RX   PubMed=27666745; DOI=10.1016/j.devcel.2016.08.009;
RA   Wu J., de Heus C., Liu Q., Bouchet B.P., Noordstra I., Jiang K.,
RA   Hua S., Martin M., Yang C., Grigoriev I., Katrukha E.A.,
RA   Altelaar A.F., Hoogenraad C.C., Qi R.Z., Klumperman J., Akhmanova A.;
RT   "Molecular pathway of microtubule organization at the Golgi
RT   apparatus.";
RL   Dev. Cell 39:44-60(2016).
RN   [15]
RP   FUNCTION (ISOFORM 13), INTERACTION WITH AKAP9; CAMSAP2; MAPRE1 AND
RP   MAPRE3 (ISOFORM 13), AND MUTAGENESIS (ISOFORM 13).
RX   PubMed=28814570; DOI=10.1083/jcb.201701024;
RA   Yang C., Wu J., de Heus C., Grigoriev I., Liv N., Yao Y., Smal I.,
RA   Meijering E., Klumperman J., Qi R.Z., Akhmanova A.;
RT   "EB1 and EB3 regulate microtubule minus end organization and Golgi
RT   morphology.";
RL   J. Cell Biol. 216:3179-3198(2017).
RN   [16]
RP   INTERACTION WITH AKAP9; CDK5RAP2; LGALS3BP AND MAPRE1 (ISOFORM 13),
RP   SUBCELLULAR LOCATION (ISOFORM 13), IDENTIFICATION BY MASS SPECTROMETRY
RP   (ISOFORM 13), MUTAGENESIS (ISOFORM 13), AND DOMAIN.
RX   PubMed=29162697; DOI=10.1073/pnas.1705682114;
RA   Bouguenina H., Salaun D., Mangon A., Muller L., Baudelet E.,
RA   Camoin L., Tachibana T., Cianferani S., Audebert S.,
RA   Verdier-Pinard P., Badache A.;
RT   "EB1-binding-myomegalin protein complex promotes centrosomal
RT   microtubules functions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:E10687-E10696(2017).
CC   -!- FUNCTION: Functions as an anchor sequestering components of the
CC       cAMP-dependent pathway to Golgi and/or centrosomes (By
CC       similarity). {ECO:0000250|UniProtKB:Q9WUJ3}.
CC   -!- FUNCTION: Isoform 13: Participates in microtubule dynamics,
CC       promoting microtubule assembly. Depending upon the cell context,
CC       may act at the level of the Golgi apparatus or that of the
CC       centrosome (PubMed:25217626, PubMed:27666745, PubMed:28814570,
CC       PubMed:29162697). In complex with AKAP9, recruits CAMSAP2 to the
CC       Golgi apparatus and tethers non-centrosomal minus-end microtubules
CC       to the Golgi, an important step for polarized cell movement
CC       (PubMed:27666745, PubMed:28814570). In complex with AKAP9,
CC       EB1/MAPRE1 and CDK5RAP2, contributes to microtubules nucleation
CC       and extension from the centrosome to the cell periphery, a crucial
CC       process for directed cell migration, mitotic spindle orientation
CC       and cell-cycle progression (PubMed:29162697).
CC       {ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:27666745,
CC       ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:29162697}.
CC   -!- SUBUNIT: Interacts with PDE4D (By similarity). Isoform 13
CC       interacts with MAPRE1 and MAPRE3 (PubMed:25217626,
CC       PubMed:28814570, PubMed:29162697). Isoform 13 forms a
CC       pericentrosomal complex with AKAP9, CDK5RAP2 and EB1/MAPRE1;
CC       within this complex, may mediate MAPRE1-binding to CDK5RAP2
CC       (PubMed:29162697). Interaction of isoform 13 with AKAP9 stabilizes
CC       both proteins (PubMed:25217626, PubMed:27666745). Isoform 13
CC       interacts (via N-terminus) with CAMSAP2; this interaction is much
CC       stronger in the presence of AKAP9 (PubMed:27666745). In complex
CC       with AKAP9, Isoform 13 recruits CAMSAP2 to the Golgi apparatus
CC       (PubMed:27666745, PubMed:28814570). Isoform 13 interacts with
CC       unglycosylated LGALS3BP; this interaction may connect the
CC       pericentrosomal complex to the gamma-tubulin ring complex (gamma-
CC       TuRC) to promote microtubule assembly and acetylation
CC       (PubMed:25217626, PubMed:29162697). {ECO:0000250|UniProtKB:Q9WUJ3,
CC       ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:27666745,
CC       ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:29162697}.
CC   -!- INTERACTION:
CC       Q9H6F0:-; NbExp=3; IntAct=EBI-1105124, EBI-10307481;
CC       Q8WTP8:AEN; NbExp=3; IntAct=EBI-1105124, EBI-8637627;
CC       Q8R560:Ankrd1 (xeno); NbExp=2; IntAct=EBI-10769071, EBI-10817505;
CC       Q13895:BYSL; NbExp=5; IntAct=EBI-1105124, EBI-358049;
CC       Q9NX04:C1orf109; NbExp=3; IntAct=EBI-1105124, EBI-8643161;
CC       Q9NVL8:CCDC198; NbExp=3; IntAct=EBI-1105124, EBI-10238351;
CC       Q9NX63:CHCHD3; NbExp=3; IntAct=EBI-1105124, EBI-743375;
CC       Q9H0A8:COMMD4; NbExp=4; IntAct=EBI-10769071, EBI-1550064;
CC       A0A0S2Z3U4:EGR2; NbExp=3; IntAct=EBI-9640281, EBI-16431598;
CC       P04764:Eno1 (xeno); NbExp=2; IntAct=EBI-10769071, EBI-915852;
CC       P15429:Eno3 (xeno); NbExp=2; IntAct=EBI-10769071, EBI-10817548;
CC       Q3B820:FAM161A; NbExp=3; IntAct=EBI-1105124, EBI-719941;
CC       Q5TZK3:FAM74A6; NbExp=3; IntAct=EBI-1105124, EBI-10247271;
CC       Q0D2H9:GOLGA8DP; NbExp=3; IntAct=EBI-1105124, EBI-10181276;
CC       Q08AF8:GOLGA8G; NbExp=3; IntAct=EBI-1105124, EBI-10181260;
CC       Q96CS2:HAUS1; NbExp=3; IntAct=EBI-1105124, EBI-2514791;
CC       Q6P597:KLC3; NbExp=3; IntAct=EBI-1105124, EBI-1643885;
CC       Q96BZ8:LENG1; NbExp=3; IntAct=EBI-1105124, EBI-726510;
CC       P61968:LMO4; NbExp=3; IntAct=EBI-1105124, EBI-2798728;
CC       Q15691:MAPRE1; NbExp=3; IntAct=EBI-1105124, EBI-1004115;
CC       A9UHW6:MIF4GD; NbExp=3; IntAct=EBI-1105124, EBI-373498;
CC       Q5JR59:MTUS2; NbExp=3; IntAct=EBI-1105124, EBI-742948;
CC       Q14896:MYBPC3; NbExp=5; IntAct=EBI-10769071, EBI-704176;
CC       P41227:NAA10; NbExp=3; IntAct=EBI-1105124, EBI-747693;
CC       Q6NYC8:PPP1R18; NbExp=3; IntAct=EBI-1105124, EBI-2557469;
CC       P09456:Prkar1a (xeno); NbExp=2; IntAct=EBI-10769071, EBI-916215;
CC       P12368:Prkar2a (xeno); NbExp=2; IntAct=EBI-10769071, EBI-919521;
CC       Q8WWY3:PRPF31; NbExp=3; IntAct=EBI-1105124, EBI-1567797;
CC       Q14D33:RTP5; NbExp=3; IntAct=EBI-1105124, EBI-10217913;
CC       Q9NUL5:RYDEN; NbExp=3; IntAct=EBI-1105124, EBI-10313866;
CC       Q9BWG6:SCNM1; NbExp=3; IntAct=EBI-1105124, EBI-748391;
CC       O00560:SDCBP; NbExp=3; IntAct=EBI-1105124, EBI-727004;
CC       Q9H788:SH2D4A; NbExp=3; IntAct=EBI-1105124, EBI-747035;
CC       Q9H788-2:SH2D4A; NbExp=3; IntAct=EBI-1105124, EBI-10308083;
CC       P19429:TNNI3; NbExp=4; IntAct=EBI-10769071, EBI-704146;
CC       P23693:Tnni3 (xeno); NbExp=2; IntAct=EBI-10769071, EBI-10817583;
CC       Q08E77:UTP14C; NbExp=3; IntAct=EBI-1105124, EBI-10225961;
CC       Q9BQ24:ZFYVE21; NbExp=3; IntAct=EBI-1105124, EBI-2849569;
CC       Q9H9D4:ZNF408; NbExp=3; IntAct=EBI-1105124, EBI-347633;
CC       Q96IQ9:ZNF414; NbExp=4; IntAct=EBI-9640281, EBI-744257;
CC       Q9P0T4:ZNF581; NbExp=4; IntAct=EBI-9640281, EBI-745520;
CC       Q16670:ZSCAN26; NbExp=3; IntAct=EBI-1105124, EBI-3920053;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus
CC       {ECO:0000269|PubMed:27666745}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome
CC       {ECO:0000250|UniProtKB:Q9WUJ3}.
CC   -!- SUBCELLULAR LOCATION: Isoform 13: Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:29162697}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:29162697}. Golgi apparatus
CC       {ECO:0000269|PubMed:25217626}. Note=Associated with the
CC       microtubule network at the growing distal tip of microtubules
CC       (PubMed:29162697). Targeting to the Golgi apparatus requires AKAP9
CC       (PubMed:25217626). {ECO:0000269|PubMed:25217626,
CC       ECO:0000269|PubMed:29162697}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=12;
CC       Name=1;
CC         IsoId=Q5VU43-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5VU43-2; Sequence=VSP_028772, VSP_028779;
CC         Note=Contains a phosphoserine at position 252.
CC         {ECO:0000244|PubMed:24275569};
CC       Name=3;
CC         IsoId=Q5VU43-3; Sequence=VSP_028773, VSP_028781, VSP_028782;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q5VU43-4; Sequence=VSP_028783;
CC       Name=6;
CC         IsoId=Q5VU43-6; Sequence=VSP_028779;
CC       Name=7;
CC         IsoId=Q5VU43-7; Sequence=VSP_028778, VSP_028780;
CC       Name=8;
CC         IsoId=Q5VU43-8; Sequence=VSP_028774, VSP_028775;
CC       Name=9;
CC         IsoId=Q5VU43-9; Sequence=VSP_028774, VSP_028776, VSP_028777;
CC       Name=10;
CC         IsoId=Q5VU43-10; Sequence=VSP_028776, VSP_028777;
CC       Name=11;
CC         IsoId=Q5VU43-11; Sequence=VSP_028775;
CC       Name=12;
CC         IsoId=Q5VU43-12; Sequence=VSP_028773, VSP_028776, VSP_028777;
CC       Name=13; Synonyms=Myomegalin variant 8
CC       {ECO:0000303|PubMed:25217626}, MMG {ECO:0000303|PubMed:27666745,
CC       ECO:0000303|PubMed:28814570}, MMG8 {ECO:0000303|PubMed:25217626},
CC       Short myomegalin-like EB1 binding protein
CC       {ECO:0000303|PubMed:29162697}, SMYLE
CC       {ECO:0000303|PubMed:29162697};
CC         IsoId=Q5VU43-13; Sequence=VSP_028772, VSP_059333, VSP_059334;
CC         Note=Mutagenesis at position 311-312:LP->AA (loss of MAPRE1- and
CC         MAPRE3-binding and loss of association with microtubule ends, no
CC         effect on AKAP9- and CDK5RAP2-binding, relocalizes from
CC         EB1/MAPRE1 microtubule ends to centrosomal area).
CC         {ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:28814570,
CC         ECO:0000269|PubMed:29162697};
CC   -!- TISSUE SPECIFICITY: Highly expressed in adult and fetal heart, in
CC       skeletal muscle and, to a lower extent, in brain and placenta.
CC       {ECO:0000269|PubMed:11374908}.
CC   -!- DOMAIN: Isoform 13: residues 1-150 are involved in AKAP9-binding.
CC       {ECO:0000269|PubMed:29162697}.
CC   -!- DISEASE: Note=A chromosomal aberration involving PDE4DIP may be
CC       the cause of a myeloproliferative disorder (MBD) associated with
CC       eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP-
CC       PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.
CC   -!- CAUTION: Was intially reported to localize in the cytoplasm and
CC       nucleus (PubMed:11374908). However, many reports in different
CC       species have shown that it is associated with the Golgi apparatus
CC       and the centrosome. {ECO:0000269|PubMed:11374908,
CC       ECO:0000269|PubMed:27666745}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH04860.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA32299.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAA32322.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAD91152.1; Type=Frameshift; Positions=1507; Evidence={ECO:0000305};
CC       Sequence=CAH18128.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PDE4DIP01q22ID180.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB042555; BAB17759.1; -; mRNA.
DR   EMBL; AB042556; BAB17760.1; -; mRNA.
DR   EMBL; AB042557; BAB17761.1; -; mRNA.
DR   EMBL; AB042558; BAB17762.1; -; mRNA.
DR   EMBL; AB007923; BAA32299.2; ALT_INIT; mRNA.
DR   EMBL; AB007946; BAA32322.2; ALT_INIT; mRNA.
DR   EMBL; HQ333476; ADO32613.1; -; mRNA.
DR   EMBL; AL831815; CAD38529.1; -; mRNA.
DR   EMBL; AL832024; CAD89923.1; -; mRNA.
DR   EMBL; AL833273; CAD91152.1; ALT_FRAME; mRNA.
DR   EMBL; CR749273; CAH18128.1; ALT_SEQ; mRNA.
DR   EMBL; AL590452; CAH72521.1; -; Genomic_DNA.
DR   EMBL; AL138791; CAH72521.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72522.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72522.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72523.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72523.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72524.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72524.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72525.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAH72526.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72526.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72527.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72527.1; JOINED; Genomic_DNA.
DR   EMBL; AL590452; CAH72528.1; -; Genomic_DNA.
DR   EMBL; AL138796; CAH72528.1; JOINED; Genomic_DNA.
DR   EMBL; AL138791; CAI22527.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22527.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22822.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22822.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22823.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22823.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22824.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22824.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22825.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22825.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22826.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22826.1; JOINED; Genomic_DNA.
DR   EMBL; AL138796; CAI22827.1; -; Genomic_DNA.
DR   EMBL; AL590452; CAI22827.1; JOINED; Genomic_DNA.
DR   EMBL; AC239802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245389; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004860; AAH04860.1; ALT_SEQ; mRNA.
DR   EMBL; BC025406; AAH25406.1; -; mRNA.
DR   EMBL; BC078660; AAH78660.1; -; mRNA.
DR   EMBL; BC110294; AAI10295.1; -; mRNA.
DR   EMBL; BC132717; AAI32718.1; -; mRNA.
DR   EMBL; BC152439; AAI52440.1; -; mRNA.
DR   EMBL; DA900724; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS72887.1; -. [Q5VU43-8]
DR   CCDS; CCDS72888.1; -. [Q5VU43-3]
DR   CCDS; CCDS72890.1; -. [Q5VU43-6]
DR   CCDS; CCDS72891.1; -. [Q5VU43-1]
DR   CCDS; CCDS72892.1; -. [Q5VU43-4]
DR   CCDS; CCDS72893.1; -. [Q5VU43-11]
DR   CCDS; CCDS72894.1; -. [Q5VU43-2]
DR   PIR; T00069; T00069.
DR   PIR; T00259; T00259.
DR   RefSeq; NP_001002810.1; NM_001002810.3. [Q5VU43-11]
DR   RefSeq; NP_001002811.2; NM_001002811.2.
DR   RefSeq; NP_001002812.2; NM_001002812.2.
DR   RefSeq; NP_001182189.1; NM_001195260.1.
DR   RefSeq; NP_001182190.1; NM_001195261.1.
DR   RefSeq; NP_001185761.2; NM_001198832.2.
DR   RefSeq; NP_001185763.3; NM_001198834.3.
DR   RefSeq; NP_055459.5; NM_014644.5.
DR   RefSeq; NP_071754.3; NM_022359.5. [Q5VU43-8]
DR   RefSeq; XP_016855361.1; XM_016999872.1.
DR   RefSeq; XP_016855362.1; XM_016999873.1.
DR   RefSeq; XP_016858514.1; XM_017003025.1.
DR   RefSeq; XP_016858515.1; XM_017003026.1.
DR   UniGene; Hs.584841; -.
DR   UniGene; Hs.632434; -.
DR   UniGene; Hs.657490; -.
DR   UniGene; Hs.682380; -.
DR   UniGene; Hs.721759; -.
DR   UniGene; Hs.731111; -.
DR   ProteinModelPortal; Q5VU43; -.
DR   SMR; Q5VU43; -.
DR   BioGrid; 115017; 141.
DR   DIP; DIP-51263N; -.
DR   IntAct; Q5VU43; 105.
DR   MINT; Q5VU43; -.
DR   STRING; 9606.ENSP00000358363; -.
DR   iPTMnet; Q5VU43; -.
DR   PhosphoSitePlus; Q5VU43; -.
DR   BioMuta; PDE4DIP; -.
DR   DMDM; 74747041; -.
DR   EPD; Q5VU43; -.
DR   MaxQB; Q5VU43; -.
DR   PaxDb; Q5VU43; -.
DR   PeptideAtlas; Q5VU43; -.
DR   PRIDE; Q5VU43; -.
DR   DNASU; 9659; -.
DR   Ensembl; ENST00000369347; ENSP00000358353; ENSG00000178104. [Q5VU43-11]
DR   Ensembl; ENST00000530472; ENSP00000482121; ENSG00000178104. [Q5VU43-8]
DR   GeneID; 653513; -.
DR   GeneID; 9659; -.
DR   KEGG; hsa:653513; -.
DR   KEGG; hsa:9659; -.
DR   UCSC; uc001emb.3; human. [Q5VU43-1]
DR   CTD; 9659; -.
DR   DisGeNET; 653513; -.
DR   DisGeNET; 9659; -.
DR   EuPathDB; HostDB:ENSG00000178104.19; -.
DR   GeneCards; PDE4DIP; -.
DR   H-InvDB; HIX0178151; -.
DR   HGNC; HGNC:15580; PDE4DIP.
DR   HPA; HPA008162; -.
DR   HPA; HPA012678; -.
DR   MIM; 608117; gene.
DR   neXtProt; NX_Q5VU43; -.
DR   OpenTargets; ENSG00000178104; -.
DR   PharmGKB; PA33131; -.
DR   eggNOG; ENOG410J2NR; Eukaryota.
DR   eggNOG; ENOG411281S; LUCA.
DR   GeneTree; ENSGT00530000063845; -.
DR   HOVERGEN; HBG108166; -.
DR   InParanoid; Q5VU43; -.
DR   KO; K16549; -.
DR   OMA; YECWSER; -.
DR   PhylomeDB; Q5VU43; -.
DR   TreeFam; TF329233; -.
DR   SIGNOR; Q5VU43; -.
DR   ChiTaRS; PDE4DIP; human.
DR   GeneWiki; Myomegalin; -.
DR   GenomeRNAi; 9659; -.
DR   PRO; PR:Q5VU43; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000178104; -.
DR   ExpressionAtlas; Q5VU43; baseline and differential.
DR   Genevisible; Q5VU43; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0030016; C:myofibril; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; ISS:UniProtKB.
DR   GO; GO:0032947; F:protein complex scaffold activity; IDA:UniProtKB.
DR   GO; GO:0043623; P:cellular protein complex assembly; ISS:UniProtKB.
DR   GO; GO:1903358; P:regulation of Golgi organization; IDA:UniProtKB.
DR   InterPro; IPR012943; Cnn_1N.
DR   InterPro; IPR010630; NBPF_dom.
DR   Pfam; PF07989; Cnn_1N; 1.
DR   Pfam; PF06758; DUF1220; 1.
DR   SMART; SM01148; DUF1220; 1.
DR   PROSITE; PS51316; NBPF; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Golgi apparatus;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1   2346       Myomegalin.
FT                                /FTId=PRO_0000307690.
FT   DOMAIN     1551   1642       NBPF. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00647}.
FT   COILED       41    132       {ECO:0000255}.
FT   COILED      162    205       {ECO:0000255}.
FT   COILED      238    318       {ECO:0000255}.
FT   COILED      350    684       {ECO:0000255}.
FT   COILED      743    936       {ECO:0000255}.
FT   COILED     1002   1043       {ECO:0000255}.
FT   COILED     1096   1124       {ECO:0000255}.
FT   COILED     1212   1240       {ECO:0000255}.
FT   COILED     1346   1385       {ECO:0000255}.
FT   COILED     1431   1455       {ECO:0000255}.
FT   COILED     1736   1760       {ECO:0000255}.
FT   COILED     1840   2077       {ECO:0000255}.
FT   COILED     2273   2312       {ECO:0000255}.
FT   SITE        742    743       Breakpoint for insertion to form PDE4DIP-
FT                                PDGFRB fusion protein.
FT   MOD_RES     704    704       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ       1    210       MSNGYRTLSQHLNDLKKENFSLKLRIYFLEERMQQKYEASR
FT                                EDIYKRNIELKVEVESLKRELQDKKQHLDKTWADVENLNSQ
FT                                NEAELRRQFEERQQETEHVYELLENKIQLLQEESRLAKNEA
FT                                ARMAALVEAEKECNLELSEKLKGVTKNWEDVPGDQVKPDQY
FT                                TEALAQRDKRIEELNQSLAAQERLVEQLSREKQQLLHLLEE
FT                                PTSME -> MKEICRICARELCGNQRRWIFHTASKLNLQVL
FT                                LSHVLGKDVPRDGKAEFACSKCAFMLDRIYRFDTVIARIEA
FT                                LSIERLQKLLLEKDRLKFCIASMYRKNNDDSGAEIKAGNGT
FT                                VDMSVLPDARYSALLQEDFAYSGFECWVENEDQIQEPHSCH
FT                                GSEGPGNRPRRCRGCAALRVADSDYEAICKVPRKVARSISC
FT                                GPSSRWSTSICTEEPALSEVGPPDLASTKVPPDGESMEEET
FT                                PGSSVESLDASVQASPPQQKDEETERSAKELGKCDCCSDDQ
FT                                APQHGCNHKLELALSMIKGLDYKPIQSPRGSRLPIPVKSSL
FT                                PGAKPGPSMTDGVSSGFLNRSLKPLYKTPVSYPLELSDLQE
FT                                LWDDLCEDYLPLR (in isoform 2 and isoform
FT                                13). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9455484}.
FT                                /FTId=VSP_028772.
FT   VAR_SEQ       1     10       MSNGYRTLSQ -> MEQTWTRDYFAEDDGEMVPRTSHTAAF
FT                                LSDTKDRGPPVQSQIWRSGEKVPFVQTYSLRAFEKPPQVQT
FT                                QALRDFEK (in isoform 3 and isoform 12).
FT                                {ECO:0000303|PubMed:11374908,
FT                                ECO:0000303|PubMed:9455484}.
FT                                /FTId=VSP_028773.
FT   VAR_SEQ       1     10       MSNGYRTLSQ -> MKGTDSGSCCRRRCDFGCCCRASRRAH
FT                                YTPYRSGDATRTPQSPRQTPSRERRRPEPAGSWAAAAEEEE
FT                                AAAAATPWMRDYFAEDDGEMVPRTSHTAAFLSDTKDRGPPV
FT                                QSQIWRSGEKVPFVQTYSLRAFEKPPQVQTQALRDFEK
FT                                (in isoform 8 and isoform 9).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_028774.
FT   VAR_SEQ     174   2346       Missing (in isoform 8 and isoform 11).
FT                                {ECO:0000303|PubMed:11374908,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_028775.
FT   VAR_SEQ     174    174       R -> I (in isoform 9, isoform 10 and
FT                                isoform 12).
FT                                {ECO:0000303|PubMed:11374908,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_028776.
FT   VAR_SEQ     175   2346       Missing (in isoform 9, isoform 10 and
FT                                isoform 12).
FT                                {ECO:0000303|PubMed:11374908,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_028777.
FT   VAR_SEQ     940    953       AAAGDDTEDTSTEF -> GELESVRIHHKHAY (in
FT                                isoform 13).
FT                                /FTId=VSP_059333.
FT   VAR_SEQ     954   2346       Missing (in isoform 13).
FT                                /FTId=VSP_059334.
FT   VAR_SEQ     968    988       QLVKVALEKSLATVETQNPSF -> QVSQCQGLGLPGWTAH
FT                                SPSEV (in isoform 7).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_028778.
FT   VAR_SEQ     970   2346       Missing (in isoform 2 and isoform 6).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:9455484}.
FT                                /FTId=VSP_028779.
FT   VAR_SEQ     989   2346       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_028780.
FT   VAR_SEQ    1082   1191       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9455484}.
FT                                /FTId=VSP_028781.
FT   VAR_SEQ    1695   1756       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9455484}.
FT                                /FTId=VSP_028782.
FT   VAR_SEQ    2334   2346       VKSLRALPCTPAL -> EPCKKRSHQKSLKQQERWACPPFV
FT                                QLPIC (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_028783.
FT   VARIANT      13     13       N -> S (in dbSNP:rs3010980).
FT                                /FTId=VAR_036627.
FT   VARIANT      25     25       R -> L (in dbSNP:rs1664022).
FT                                /FTId=VAR_036628.
FT   VARIANT      49     49       I -> T (in dbSNP:rs573724).
FT                                {ECO:0000269|PubMed:11374908,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_036629.
FT   VARIANT     143    143       K -> E (in dbSNP:rs1747958).
FT                                /FTId=VAR_056951.
FT   VARIANT     150    150       N -> S (in dbSNP:rs3010980).
FT                                /FTId=VAR_056952.
FT   VARIANT     167    167       A -> T (in dbSNP:rs2590120).
FT                                /FTId=VAR_036630.
FT   VARIANT     171    171       R -> K (in dbSNP:rs3121544).
FT                                /FTId=VAR_051204.
FT   VARIANT     391    391       E -> A (in dbSNP:rs1324366).
FT                                /FTId=VAR_051205.
FT   VARIANT     410    410       E -> V (in dbSNP:rs1061308).
FT                                /FTId=VAR_051206.
FT   VARIANT     482    482       H -> R (in dbSNP:rs1698681).
FT                                /FTId=VAR_051207.
FT   VARIANT     681    681       R -> H (in dbSNP:rs1629011).
FT                                /FTId=VAR_051208.
FT   VARIANT     708    708       R -> C (in dbSNP:rs1628172).
FT                                {ECO:0000269|PubMed:16710414,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_051209.
FT   VARIANT    1013   1013       F -> I (in dbSNP:rs1698624).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_051210.
FT   VARIANT    1066   1066       A -> T (in dbSNP:rs1698647).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_051211.
FT   VARIANT    1359   1359       K -> E (in dbSNP:rs1747958).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_051212.
FT   VARIANT    1736   1736       V -> E (in dbSNP:rs1778159).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_051213.
FT   VARIANT    1742   1742       A -> S (in dbSNP:rs1698605).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_051214.
FT   CONFLICT     33     33       M -> T (in Ref. 5; CAD89923).
FT                                {ECO:0000305}.
FT   CONFLICT     98     98       T -> M (in Ref. 1; BAB17761/BAB17762).
FT                                {ECO:0000305}.
FT   CONFLICT    109    109       I -> M (in Ref. 1; BAB17759/BAB17760/
FT                                BAB17761/BAB17762 and 7; AAH25406/
FT                                AAI10295). {ECO:0000305}.
FT   CONFLICT    401    401       R -> Q (in Ref. 5; CAD91152).
FT                                {ECO:0000305}.
FT   CONFLICT    643    643       M -> V (in Ref. 5; CAD91152).
FT                                {ECO:0000305}.
FT   CONFLICT    776    776       L -> P (in Ref. 5; CAD91152).
FT                                {ECO:0000305}.
FT   CONFLICT    783    783       M -> I (in Ref. 5; CAD38529 and 7;
FT                                AAI32718). {ECO:0000305}.
FT   CONFLICT    830    830       L -> P (in Ref. 5; CAD91152).
FT                                {ECO:0000305}.
FT   CONFLICT    863    863       L -> P (in Ref. 5; CAD38529).
FT                                {ECO:0000305}.
FT   CONFLICT   1266   1266       K -> E (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   1286   1286       E -> G (in Ref. 5; CAD91152).
FT                                {ECO:0000305}.
FT   CONFLICT   1356   1356       K -> R (in Ref. 5; CAD91152).
FT                                {ECO:0000305}.
FT   CONFLICT   1396   1396       W -> R (in Ref. 3; BAA32299 and 5;
FT                                CAD91152/CAH18128). {ECO:0000305}.
FT   CONFLICT   1397   1397       K -> E (in Ref. 5; CAD91152).
FT                                {ECO:0000305}.
FT   CONFLICT   1454   1454       K -> E (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   1504   1504       R -> Q (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   1598   1598       H -> R (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   1610   1610       T -> P (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   1727   1727       L -> P (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   1757   1757       A -> T (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   1867   1867       R -> C (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   1910   1910       D -> E (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   2001   2001       E -> G (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   2088   2088       Missing (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   2291   2291       R -> Q (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
FT   CONFLICT   2317   2317       Q -> R (in Ref. 5; CAH18128).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2346 AA;  265133 MW;  BFE35202ACFFFEB7 CRC64;
     MSNGYRTLSQ HLNDLKKENF SLKLRIYFLE ERMQQKYEAS REDIYKRNIE LKVEVESLKR
     ELQDKKQHLD KTWADVENLN SQNEAELRRQ FEERQQETEH VYELLENKIQ LLQEESRLAK
     NEAARMAALV EAEKECNLEL SEKLKGVTKN WEDVPGDQVK PDQYTEALAQ RDKRIEELNQ
     SLAAQERLVE QLSREKQQLL HLLEEPTSME VQPMTEELLK QQKLNSHETT ITQQSVSDSH
     LAELQEKIQQ TEATNKILQE KLNEMSYELK CAQESSQKQD GTIQNLKETL KSRERETEEL
     YQVIEGQNDT MAKLREMLHQ SQLGQLHSSE GTSPAQQQVA LLDLQSALFC SQLEIQKLQR
     VVRQKERQLA DAKQCVQFVE AAAHESEQQK EASWKHNQEL RKALQQLQEE LQNKSQQLRA
     WEAEKYNEIR TQEQNIQHLN HSLSHKEQLL QEFRELLQYR DNSDKTLEAN EMLLEKLRQR
     IHDKAVALER AIDEKFSALE EKEKELRQLR LAVRERDHDL ERLRDVLSSN EATMQSMESL
     LRAKGLEVEQ LSTTCQNLQW LKEEMETKFS RWQKEQESII QQLQTSLHDR NKEVEDLSAT
     LLCKLGPGQS EIAEELCQRL QRKERMLQDL LSDRNKQVLE HEMEIQGLLQ SVSTREQESQ
     AAAEKLVQAL MERNSELQAL RQYLGGRDSL MSQAPISNQQ AEVTPTGRLG KQTDQGSMQI
     PSRDDSTSLT AKEDVSIPRS TLGDLDTVAG LEKELSNAKE ELELMAKKER ESQMELSALQ
     SMMAVQEEEL QVQAADMESL TRNIQIKEDL IKDLQMQLVD PEDIPAMERL TQEVLLLREK
     VASVESQGQE ISGNRRQQLL LMLEGLVDER SRLNEALQAE RQLYSSLVKF HAHPESSERD
     RTLQVELEGA QVLRSRLEEV LGRSLERLNR LETLAAIGGA AAGDDTEDTS TEFTDSIEEE
     AAHHSHQQLV KVALEKSLAT VETQNPSFSP PSPMGGDSNR CLQEEMLHLR AEFHQHLEEK
     RKAEEELKEL KAQIEEAGFS SVSHIRNTML SLCLENAELK EQMGEAMSDG WEIEEDKEKG
     EVMVETVVTK EGLSESSLQA EFRKLQGKLK NAHNIINLLK EQLVLSSKEG NSKLTPELLV
     HLTSTIERIN TELVGSPGKH QHQEEGNVTV RPFPRPQSLD LGATFTVDAH QLDNQSQPRD
     PGPQSAFSLP GSTQHLRSQL SQCKQRYQDL QEKLLLSEAT VFAQANELEK YRVMLTGESL
     VKQDSKQIQV DLQDLGYETC GRSENEAERE ETTSPECEEH NSLKEMVLME GLCSEQGRRG
     STLASSSERK PLENQLGKQE EFRVYGKSEN ILVLRKDIKD LKAQLQNANK VIQNLKSRVR
     SLSVTSDYSS SLERPWKLRA VGTLEGSSPH SVPDEDEGWL SDGTGAFYSP GLQAKKDLES
     LIQRVSQLEA QLPKNGLEEK LAEELRSASW PGKYDSLIQD QARELSYLRQ KIREGRGICY
     LITRHAKDTV KSFEDLLRSN DIDYYLGQSF REQLAQGSQL TERLTSKLST KDHKSEKDQA
     GLEPLALRLS RELQEKEKVI EVLQAKLDAR SLTPSSSHAL SDSHRSPSST SFLSDELEAC
     SDMDIVSEYT HYEEKKASPS HSDSIHHSSH SAVLSSKPSS TSASQGAKAE SNSNPISLPT
     PQNTPKEANQ AHSGFHFHSI PKLASLPQAP LPSAPSSFLP FSPTGPLLLG CCETPVVSLA
     EAQQELQMLQ KQLGESASTV PPASTATLLS NDLEADSSYY LNSAQPHSPP RGTIELGRIL
     EPGYLGSSGK WDVMRPQKGS VSGDLSSGSS VYQLNSKPTG ADLLEEHLGE IRNLRQRLEE
     SICINDRLRE QLEHRLTSTA RGRGSTSNFY SQGLESIPQL CNENRVLRED NRRLQAQLSH
     VSREHSQETE SLREALLSSR SHLQELEKEL EHQKVERQQL LEDLREKQQE VLHFREERLS
     LQENDSRLQH KLVLLQQQCE EKQQLFESLQ SELQIYEALY GNSKKGLKAY SLDACHQIPL
     SSDLSHLVAE VRALRGQLEQ SIQGNNCLRL QLQQQLESGA GKASLSPSSI NQNFPASTDP
     GNKQLLLQDS AVSPPVRDVG MNSPALVFPS SASSTPGSET PIINRANGLG LDTSPVMKTP
     PKLEGDATDG SFANKHGRHV IGHIDDYSAL RQQIAEGKLL VKKIVSLVRS ACSFPGLEAQ
     GTEVLGSKGI HELRSSTSAL HHALEESASL LTMFWRAALP STHIPVLPGK VGESTERELL
     ELRTKVSKQE RLLQSTTEHL KNANQQKESM EQFIVSQLTR THDVLKKART NLEVKSLRAL
     PCTPAL
//
ID   A0A024R5L7_HUMAN        Unreviewed;       610 AA.
AC   A0A024R5L7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 25.
DE   SubName: Full=Phosphatidylinositol binding clathrin assembly protein, isoform CRA_c {ECO:0000313|EMBL:EAW75122.1};
GN   Name=PICALM {ECO:0000313|EMBL:EAW75122.1};
GN   ORFNames=hCG_1730090 {ECO:0000313|EMBL:EAW75122.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW75122.1};
RN   [1] {ECO:0000313|EMBL:EAW75122.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW75122.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471076; EAW75122.1; -; Genomic_DNA.
DR   RefSeq; NP_001008660.1; NM_001008660.2.
DR   UniGene; Hs.163893; -.
DR   ProteinModelPortal; A0A024R5L7; -.
DR   SMR; A0A024R5L7; -.
DR   PRIDE; A0A024R5L7; -.
DR   GeneID; 8301; -.
DR   CTD; 8301; -.
DR   EuPathDB; HostDB:ENSG00000073921.17; -.
DR   ChiTaRS; PICALM; human.
DR   GenomeRNAi; 8301; -.
DR   Bgee; ENSG00000073921; -.
DR   ExpressionAtlas; A0A024R5L7; baseline and differential.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IEA:InterPro.
DR   GO; GO:0005545; F:1-phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0030276; F:clathrin binding; IEA:InterPro.
DR   GO; GO:0048268; P:clathrin coat assembly; IEA:InterPro.
DR   GO; GO:0006897; P:endocytosis; IEA:InterPro.
DR   Gene3D; 1.20.58.150; -; 1.
DR   Gene3D; 1.25.40.90; -; 1.
DR   InterPro; IPR011417; ANTH_dom.
DR   InterPro; IPR014712; Clathrin_AP_dom2.
DR   InterPro; IPR013809; ENTH.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR030412; PICALM.
DR   PANTHER; PTHR22951:SF16; PTHR22951:SF16; 2.
DR   Pfam; PF07651; ANTH; 1.
DR   SMART; SM00273; ENTH; 1.
DR   SUPFAM; SSF48464; SSF48464; 1.
DR   PROSITE; PS50942; ENTH; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       14    145       ENTH. {ECO:0000259|PROSITE:PS50942}.
FT   COILED      321    348       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   610 AA;  66393 MW;  3B0D0AEB901CF85D CRC64;
     MSGQSLTDRI TAAQHSVTGS AVSKTVCKAT THEIMGPKKK HLDYLIQCTN EMNVNIPQLA
     DSLFERTTNS SWVVVFKSLI TTHHLMVYGN ERFIQYLASR NTLFNLSNFL DKSGLQGYDM
     STFIRRYSRY LNEKAVSYRQ VAFDFTKVKR GADGVMRTMN TEKLLKTVPI IQNQMDALLD
     FNVNSNELTN GVINAAFMLL FKDAIRLFAA YNEGIINLLE KYFDMKKNQC KEGLDIYKKF
     LTRMTRISEF LKVAEQVGID RGDIPDLSQA PSSLLDALEQ HLASLEGKKI KDSTAASRAT
     TLSNAVSSLA STGLSLTKVD EREKQAALEE EQARLKALKE QRLKELAKKP HTSLTTAASP
     VSTSAGGIMT APAIDIFSTP SSSNSTSKLP NDLLDLQQPT FHPSVHPMST ASQVASTWGG
     FTPSPVAQPH PSAGLNVDFE SVFGNKSTNV IVDSGGFDEL GGLLKPTVAS QNQNLPVAKL
     PPSKLVSDDL DSSLANLVGN LGIGNGTTKN DVNWSQPGEK KLTGGSNWQP KVAPTTAWNA
     ATMNGMHFPQ YAPPVMAYPA TTPTGMIGYG IPPQMGSVPV MTQPTLIYSQ PVMRPPNPFG
     PVSGAQIQFM
//
ID   A0A024R5P1_HUMAN        Unreviewed;       652 AA.
AC   A0A024R5P1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 34.
DE   SubName: Full=Phosphatidylinositol binding clathrin assembly protein, isoform CRA_i {ECO:0000313|EMBL:EAW75128.1};
GN   Name=PICALM {ECO:0000313|EMBL:EAW75128.1};
GN   ORFNames=hCG_1730090 {ECO:0000313|EMBL:EAW75128.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW75128.1};
RN   [1] {ECO:0000313|EMBL:EAW75128.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW75128.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471076; EAW75127.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW75128.1; -; Genomic_DNA.
DR   RefSeq; NP_009097.2; NM_007166.3.
DR   UniGene; Hs.163893; -.
DR   SMR; A0A024R5P1; -.
DR   GeneID; 8301; -.
DR   KEGG; hsa:8301; -.
DR   CTD; 8301; -.
DR   EuPathDB; HostDB:ENSG00000073921.17; -.
DR   eggNOG; KOG0251; Eukaryota.
DR   eggNOG; ENOG410XQ90; LUCA.
DR   KO; K20044; -.
DR   OMA; PTGMMAY; -.
DR   OrthoDB; EOG091G0810; -.
DR   ChiTaRS; PICALM; human.
DR   GenomeRNAi; 8301; -.
DR   Bgee; ENSG00000073921; -.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:Ensembl.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IEA:InterPro.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005545; F:1-phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0030276; F:clathrin binding; IEA:InterPro.
DR   GO; GO:0007409; P:axonogenesis; IEA:Ensembl.
DR   GO; GO:0035459; P:cargo loading into vesicle; IEA:Ensembl.
DR   GO; GO:0048268; P:clathrin coat assembly; IEA:InterPro.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; IEA:Ensembl.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0030097; P:hemopoiesis; IEA:Ensembl.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0090647; P:modulation of age-related behavioral decline; IEA:Ensembl.
DR   GO; GO:1902963; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; IEA:Ensembl.
DR   GO; GO:1900223; P:positive regulation of amyloid-beta clearance; IEA:Ensembl.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; IEA:Ensembl.
DR   GO; GO:1902961; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; IEA:Ensembl.
DR   GO; GO:0016188; P:synaptic vesicle maturation; IEA:Ensembl.
DR   Gene3D; 1.20.58.150; -; 1.
DR   Gene3D; 1.25.40.90; -; 1.
DR   InterPro; IPR011417; ANTH_dom.
DR   InterPro; IPR014712; Clathrin_AP_dom2.
DR   InterPro; IPR013809; ENTH.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR030412; PICALM.
DR   PANTHER; PTHR22951:SF16; PTHR22951:SF16; 1.
DR   Pfam; PF07651; ANTH; 1.
DR   SMART; SM00273; ENTH; 1.
DR   SUPFAM; SSF48464; SSF48464; 1.
DR   PROSITE; PS50942; ENTH; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       14    145       ENTH. {ECO:0000259|PROSITE:PS50942}.
FT   COILED      321    348       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   652 AA;  70755 MW;  AC3227E9D32AFEDA CRC64;
     MSGQSLTDRI TAAQHSVTGS AVSKTVCKAT THEIMGPKKK HLDYLIQCTN EMNVNIPQLA
     DSLFERTTNS SWVVVFKSLI TTHHLMVYGN ERFIQYLASR NTLFNLSNFL DKSGLQGYDM
     STFIRRYSRY LNEKAVSYRQ VAFDFTKVKR GADGVMRTMN TEKLLKTVPI IQNQMDALLD
     FNVNSNELTN GVINAAFMLL FKDAIRLFAA YNEGIINLLE KYFDMKKNQC KEGLDIYKKF
     LTRMTRISEF LKVAEQVGID RGDIPDLSQA PSSLLDALEQ HLASLEGKKI KDSTAASRAT
     TLSNAVSSLA STGLSLTKVD EREKQAALEE EQARLKALKE QRLKELAKKP HTSLTTAASP
     VSTSAGGIMT APAIDIFSTP SSSNSTSKLP NDLLDLQQPT FHPSVHPMST ASQVASTWGD
     PFSATVDAVD DAIPSLNPFL TKSSGDVHLS ISSDVSTFTT RTPTHEMFVG FTPSPVAQPH
     PSAGLNVDFE SVFGNKSTNV IVDSGGFDEL GGLLKPTVAS QNQNLPVAKL PPSKLVSDDL
     DSSLANLVGN LGIGNGTTKN DVNWSQPGEK KLTGGSNWQP KVAPTTAWNA ATMAPPVMAY
     PATTPTGMIG YGIPPQMGSV PVMTQPTLIY SQPVMRPPNP FGPVSGAQIQ FM
//
ID   PICAL_HUMAN             Reviewed;         652 AA.
AC   Q13492; B4DTM3; E9PN05; F8VPG7; O60700; Q4LE54; Q6GMQ6; Q86XZ9;
DT   15-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   28-FEB-2018, entry version 170.
DE   RecName: Full=Phosphatidylinositol-binding clathrin assembly protein;
DE   AltName: Full=Clathrin assembly lymphoid myeloid leukemia protein;
GN   Name=PICALM; Synonyms=CALM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION,
RP   TISSUE SPECIFICITY, AND VARIANTS CYS-578 AND GLU-579.
RX   PubMed=8643484; DOI=10.1073/pnas.93.10.4804;
RA   Dreyling M.H., Martinez-Climent J.A., Zheng M., Mao J., Rowley J.D.,
RA   Bohlander S.K.;
RT   "The t(10;11)(p13;q14) in the U937 cell line results in the fusion of
RT   the AF10 gene and CALM, encoding a new member of the AP-3 clathrin
RT   assembly protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:4804-4809(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M.,
RA   Ohara R., Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long
RT   cDNAs encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 575-652 (ISOFORMS 1 AND 2), AND VARIANTS
RP   CYS-578 AND GLU-579.
RC   TISSUE=Bone marrow;
RX   PubMed=9737689; DOI=10.1038/sj.leu.2401109;
RA   Silliman C.C., McGavran L., Wei Q., Miller L.A., Li S., Hunger S.P.;
RT   "Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-
RT   CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-
RT   q21) suggests a potential role for truncated AF10 polypeptides.";
RL   Leukemia 12:1404-1410(1998).
RN   [8]
RP   FUNCTION, INTERACTION WITH CLATHRIN, AND SUBCELLULAR LOCATION.
RX   PubMed=10436022; DOI=10.1091/mbc.10.8.2687;
RA   Tebar F., Bohlander S.K., Sorkin A.;
RT   "Clathrin assembly lymphoid myeloid leukemia (CALM) protein:
RT   localization in endocytic-coated pits, interactions with clathrin, and
RT   the impact of overexpression on clathrin-mediated traffic.";
RL   Mol. Biol. Cell 10:2687-2702(1999).
RN   [9]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PIMREG.
RX   PubMed=16491119; DOI=10.1038/sj.onc.1209438;
RA   Archangelo L.F., Glaesner J., Krause A., Bohlander S.K.;
RT   "The novel CALM interactor CATS influences the subcellular
RT   localization of the leukemogenic fusion protein CALM/AF10.";
RL   Oncogene 25:4099-4109(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-20; SER-303 AND
RP   SER-315, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-238, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Assembly protein recruiting clathrin and adapter protein
CC       complex 2 (AP2) to cell membranes at sites of coated-pit formation
CC       and clathrin-vesicle assembly. May be required to determine the
CC       amount of membrane to be recycled, possibly by regulating the size
CC       of the clathrin cage. Involved in AP2-dependent clathrin-mediated
CC       endocytosis at the neuromuscular junction.
CC       {ECO:0000269|PubMed:10436022}.
CC   -!- SUBUNIT: Binds clathrin; involves primarily the C-terminal
CC       sequences, but the full-length protein is required for full
CC       binding capacity. Binds phosphatidylinositol 4,5- bisphosphate.
CC       Interacts with PIMREG; this interaction may change the subcellular
CC       location into the nucleus. {ECO:0000269|PubMed:10436022,
CC       ECO:0000269|PubMed:16491119}.
CC   -!- SUBCELLULAR LOCATION: Membrane, clathrin-coated pit
CC       {ECO:0000269|PubMed:10436022}. Golgi apparatus
CC       {ECO:0000269|PubMed:10436022}. Cytoplasmic vesicle, clathrin-
CC       coated vesicle {ECO:0000269|PubMed:10436022}. Nucleus
CC       {ECO:0000269|PubMed:16491119}. Note=Colocalized with clathrin in
CC       the Golgi area (PubMed:10436022). Interaction with PIMREG may
CC       target PICALM to the nucleus in some cells (PubMed:16491119).
CC       {ECO:0000269|PubMed:10436022, ECO:0000269|PubMed:16491119}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Type I;
CC         IsoId=Q13492-1; Sequence=Displayed;
CC       Name=2; Synonyms=Type II;
CC         IsoId=Q13492-2; Sequence=VSP_004067;
CC       Name=3;
CC         IsoId=Q13492-3; Sequence=VSP_009607, VSP_009608;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q13492-4; Sequence=VSP_044567, VSP_009607;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q13492-5; Sequence=VSP_044568;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined.
CC       {ECO:0000269|PubMed:8643484}.
CC   -!- DISEASE: Note=A chromosomal aberration involving PICALM is found
CC       in diffuse histiocytic lymphomas. Translocation t(10;11)(p13;q14)
CC       with MLLT10. {ECO:0000269|PubMed:8643484}.
CC   -!- SIMILARITY: Belongs to the PICALM/SNAP91 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE06099.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CALMID64.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U45976; AAB07762.1; -; mRNA.
DR   EMBL; AK300275; BAG62035.1; -; mRNA.
DR   EMBL; AB210017; BAE06099.1; ALT_INIT; mRNA.
DR   EMBL; AP000767; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW75120.1; -; Genomic_DNA.
DR   EMBL; BC048259; AAH48259.2; -; mRNA.
DR   EMBL; BC064357; AAH64357.1; -; mRNA.
DR   EMBL; BC073961; AAH73961.1; -; mRNA.
DR   EMBL; AF060939; AAC16711.1; -; mRNA.
DR   EMBL; AF060940; AAC16712.1; -; mRNA.
DR   CCDS; CCDS31653.1; -. [Q13492-3]
DR   CCDS; CCDS55783.1; -. [Q13492-4]
DR   CCDS; CCDS55784.1; -. [Q13492-5]
DR   CCDS; CCDS8272.1; -. [Q13492-1]
DR   RefSeq; NP_001008660.1; NM_001008660.2. [Q13492-3]
DR   RefSeq; NP_001193875.1; NM_001206946.1. [Q13492-5]
DR   RefSeq; NP_001193876.1; NM_001206947.1. [Q13492-4]
DR   RefSeq; NP_009097.2; NM_007166.3. [Q13492-1]
DR   RefSeq; XP_005274388.1; XM_005274331.2. [Q13492-2]
DR   UniGene; Hs.163893; -.
DR   ProteinModelPortal; Q13492; -.
DR   SMR; Q13492; -.
DR   BioGrid; 113902; 103.
DR   ELM; Q13492; -.
DR   IntAct; Q13492; 55.
DR   MINT; Q13492; -.
DR   STRING; 9606.ENSP00000377015; -.
DR   iPTMnet; Q13492; -.
DR   PhosphoSitePlus; Q13492; -.
DR   SwissPalm; Q13492; -.
DR   BioMuta; PICALM; -.
DR   DMDM; 116242714; -.
DR   EPD; Q13492; -.
DR   MaxQB; Q13492; -.
DR   PaxDb; Q13492; -.
DR   PeptideAtlas; Q13492; -.
DR   PRIDE; Q13492; -.
DR   Ensembl; ENST00000356360; ENSP00000348718; ENSG00000073921. [Q13492-2]
DR   Ensembl; ENST00000393346; ENSP00000377015; ENSG00000073921. [Q13492-1]
DR   Ensembl; ENST00000526033; ENSP00000433846; ENSG00000073921. [Q13492-5]
DR   Ensembl; ENST00000528398; ENSP00000434884; ENSG00000073921. [Q13492-4]
DR   Ensembl; ENST00000532317; ENSP00000436958; ENSG00000073921. [Q13492-3]
DR   GeneID; 8301; -.
DR   KEGG; hsa:8301; -.
DR   UCSC; uc001pbl.4; human. [Q13492-1]
DR   CTD; 8301; -.
DR   DisGeNET; 8301; -.
DR   EuPathDB; HostDB:ENSG00000073921.17; -.
DR   GeneCards; PICALM; -.
DR   HGNC; HGNC:15514; PICALM.
DR   HPA; HPA019053; -.
DR   HPA; HPA019061; -.
DR   MalaCards; PICALM; -.
DR   MIM; 603025; gene.
DR   neXtProt; NX_Q13492; -.
DR   OpenTargets; ENSG00000073921; -.
DR   Orphanet; 99861; Precursor T-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA33287; -.
DR   eggNOG; KOG0251; Eukaryota.
DR   eggNOG; ENOG410XQ90; LUCA.
DR   GeneTree; ENSGT00390000008805; -.
DR   HOGENOM; HOG000015764; -.
DR   HOVERGEN; HBG049391; -.
DR   InParanoid; Q13492; -.
DR   KO; K20044; -.
DR   OMA; PTGMMAY; -.
DR   OrthoDB; EOG091G0810; -.
DR   PhylomeDB; Q13492; -.
DR   TreeFam; TF314861; -.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   SIGNOR; Q13492; -.
DR   ChiTaRS; PICALM; human.
DR   GeneWiki; PICALM; -.
DR   GenomeRNAi; 8301; -.
DR   PMAP-CutDB; Q13492; -.
DR   PRO; PR:Q13492; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000073921; -.
DR   CleanEx; HS_PICALM; -.
DR   ExpressionAtlas; Q13492; baseline and differential.
DR   Genevisible; Q13492; HS.
DR   GO; GO:0009986; C:cell surface; IDA:ARUK-UCL.
DR   GO; GO:0045334; C:clathrin-coated endocytic vesicle; NAS:ARUK-UCL.
DR   GO; GO:0005905; C:clathrin-coated pit; IDA:UniProtKB.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IMP:ARUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005769; C:early endosome; IDA:ARUK-UCL.
DR   GO; GO:0070381; C:endosome to plasma membrane transport vesicle; IDA:ARUK-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031224; C:intrinsic component of membrane; ISS:ARUK-UCL.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0097418; C:neurofibrillary tangle; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0043025; C:neuronal cell body; IDA:Alzheimers_University_of_Toronto.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0045211; C:postsynaptic membrane; ISS:BHF-UCL.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:BHF-UCL.
DR   GO; GO:0031982; C:vesicle; ISS:Alzheimers_University_of_Toronto.
DR   GO; GO:0005545; F:1-phosphatidylinositol binding; ISS:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0035615; F:clathrin adaptor activity; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0030276; F:clathrin binding; IDA:UniProtKB.
DR   GO; GO:0032050; F:clathrin heavy chain binding; IDA:BHF-UCL.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:ARUK-UCL.
DR   GO; GO:0017137; F:Rab GTPase binding; IPI:ARUK-UCL.
DR   GO; GO:0007409; P:axonogenesis; IEA:Ensembl.
DR   GO; GO:0035459; P:cargo loading into vesicle; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0008283; P:cell proliferation; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0048268; P:clathrin coat assembly; IMP:BHF-UCL.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0016197; P:endosomal transport; IMP:BHF-UCL.
DR   GO; GO:0030097; P:hemopoiesis; IEA:Ensembl.
DR   GO; GO:0055072; P:iron ion homeostasis; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0098711; P:iron ion import across plasma membrane; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0007611; P:learning or memory; ISS:ARUK-UCL.
DR   GO; GO:0097753; P:membrane bending; IMP:ARUK-UCL.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0090647; P:modulation of age-related behavioral decline; ISS:ARUK-UCL.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:1902963; P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process; ISS:Alzheimers_University_of_Toronto.
DR   GO; GO:2000009; P:negative regulation of protein localization to cell surface; IMP:ARUK-UCL.
DR   GO; GO:1903077; P:negative regulation of protein localization to plasma membrane; IMP:ARUK-UCL.
DR   GO; GO:0048261; P:negative regulation of receptor-mediated endocytosis; IDA:BHF-UCL.
DR   GO; GO:1900223; P:positive regulation of amyloid-beta clearance; ISS:ARUK-UCL.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:1902961; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; ISS:Alzheimers_University_of_Toronto.
DR   GO; GO:2000370; P:positive regulation of clathrin-dependent endocytosis; NAS:ARUK-UCL.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IMP:ARUK-UCL.
DR   GO; GO:1901216; P:positive regulation of neuron death; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0006461; P:protein complex assembly; TAS:ProtInc.
DR   GO; GO:0031623; P:receptor internalization; IMP:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IDA:UniProtKB.
DR   GO; GO:1902959; P:regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; IMP:Alzheimers_University_of_Toronto.
DR   GO; GO:0030100; P:regulation of endocytosis; IMP:BHF-UCL.
DR   GO; GO:0032880; P:regulation of protein localization; IDA:BHF-UCL.
DR   GO; GO:0097494; P:regulation of vesicle size; IMP:ARUK-UCL.
DR   GO; GO:0016188; P:synaptic vesicle maturation; ISS:Alzheimers_University_of_Toronto.
DR   GO; GO:0045056; P:transcytosis; IMP:ARUK-UCL.
DR   GO; GO:0016050; P:vesicle organization; IMP:ARUK-UCL.
DR   GO; GO:0016192; P:vesicle-mediated transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.150; -; 1.
DR   Gene3D; 1.25.40.90; -; 1.
DR   InterPro; IPR011417; ANTH_dom.
DR   InterPro; IPR014712; Clathrin_AP_dom2.
DR   InterPro; IPR013809; ENTH.
DR   InterPro; IPR008942; ENTH_VHS.
DR   InterPro; IPR030412; PICALM.
DR   PANTHER; PTHR22951:SF16; PTHR22951:SF16; 1.
DR   Pfam; PF07651; ANTH; 1.
DR   SMART; SM00273; ENTH; 1.
DR   SUPFAM; SSF48464; SSF48464; 1.
DR   PROSITE; PS50942; ENTH; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Coated pit; Complete proteome; Cytoplasmic vesicle; Endocytosis;
KW   Golgi apparatus; Isopeptide bond; Membrane; Nucleus; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    652       Phosphatidylinositol-binding clathrin
FT                                assembly protein.
FT                                /FTId=PRO_0000187062.
FT   DOMAIN       14    145       ENTH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00243}.
FT   REGION      221    294       Interaction with PIMREG.
FT                                {ECO:0000269|PubMed:16491119}.
FT   SITE        648    649       Breakpoint for translocation to form
FT                                CALM/MLLT10 fusion protein.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      16     16       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      20     20       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     303    303       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     315    315       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    238    238       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   VAR_SEQ       1     51       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044567.
FT   VAR_SEQ     420    469       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009607.
FT   VAR_SEQ     420    426       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_044568.
FT   VAR_SEQ     593    593       M -> MNGMHFPQY (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009608.
FT   VAR_SEQ     594    613       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9737689}.
FT                                /FTId=VSP_004067.
FT   VARIANT     158    158       T -> P (in dbSNP:rs12800974).
FT                                /FTId=VAR_028191.
FT   VARIANT     383    383       S -> F (in dbSNP:rs12222608).
FT                                /FTId=VAR_028192.
FT   VARIANT     578    578       W -> C (in dbSNP:rs1043858).
FT                                {ECO:0000269|PubMed:8643484,
FT                                ECO:0000269|PubMed:9737689}.
FT                                /FTId=VAR_028193.
FT   VARIANT     579    579       Q -> E (in dbSNP:rs1043859).
FT                                {ECO:0000269|PubMed:8643484,
FT                                ECO:0000269|PubMed:9737689}.
FT                                /FTId=VAR_028194.
FT   VARIANT     641    641       F -> L (in dbSNP:rs556337).
FT                                /FTId=VAR_028195.
FT   CONFLICT    132    132       N -> D (in Ref. 2; BAG62035).
FT                                {ECO:0000305}.
FT   CONFLICT    212    212       N -> H (in Ref. 1; AAB07762).
FT                                {ECO:0000305}.
FT   CONFLICT    331    331       E -> G (in Ref. 2; BAG62035).
FT                                {ECO:0000305}.
SQ   SEQUENCE   652 AA;  70755 MW;  AC3227E9D32AFEDA CRC64;
     MSGQSLTDRI TAAQHSVTGS AVSKTVCKAT THEIMGPKKK HLDYLIQCTN EMNVNIPQLA
     DSLFERTTNS SWVVVFKSLI TTHHLMVYGN ERFIQYLASR NTLFNLSNFL DKSGLQGYDM
     STFIRRYSRY LNEKAVSYRQ VAFDFTKVKR GADGVMRTMN TEKLLKTVPI IQNQMDALLD
     FNVNSNELTN GVINAAFMLL FKDAIRLFAA YNEGIINLLE KYFDMKKNQC KEGLDIYKKF
     LTRMTRISEF LKVAEQVGID RGDIPDLSQA PSSLLDALEQ HLASLEGKKI KDSTAASRAT
     TLSNAVSSLA STGLSLTKVD EREKQAALEE EQARLKALKE QRLKELAKKP HTSLTTAASP
     VSTSAGGIMT APAIDIFSTP SSSNSTSKLP NDLLDLQQPT FHPSVHPMST ASQVASTWGD
     PFSATVDAVD DAIPSLNPFL TKSSGDVHLS ISSDVSTFTT RTPTHEMFVG FTPSPVAQPH
     PSAGLNVDFE SVFGNKSTNV IVDSGGFDEL GGLLKPTVAS QNQNLPVAKL PPSKLVSDDL
     DSSLANLVGN LGIGNGTTKN DVNWSQPGEK KLTGGSNWQP KVAPTTAWNA ATMAPPVMAY
     PATTPTGMIG YGIPPQMGSV PVMTQPTLIY SQPVMRPPNP FGPVSGAQIQ FM
//
ID   A0A024RB02_HUMAN        Unreviewed;       858 AA.
AC   A0A024RB02;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 34.
DE   SubName: Full=PTPRF interacting protein, binding protein 1 (Liprin beta 1), isoform CRA_a {ECO:0000313|EMBL:EAW96559.1};
GN   Name=PPFIBP1 {ECO:0000313|EMBL:EAW96559.1};
GN   ORFNames=hCG_38765 {ECO:0000313|EMBL:EAW96559.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW96559.1};
RN   [1] {ECO:0000313|EMBL:EAW96559.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW96559.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471094; EAW96558.1; -; Genomic_DNA.
DR   EMBL; CH471094; EAW96559.1; -; Genomic_DNA.
DR   RefSeq; NP_001185844.1; NM_001198915.1.
DR   UniGene; Hs.172445; -.
DR   SMR; A0A024RB02; -.
DR   GeneID; 8496; -.
DR   CTD; 8496; -.
DR   EuPathDB; HostDB:ENSG00000110841.13; -.
DR   eggNOG; KOG1899; Eukaryota.
DR   eggNOG; ENOG410XSFF; LUCA.
DR   ChiTaRS; PPFIBP1; human.
DR   GenomeRNAi; 8496; -.
DR   Bgee; ENSG00000110841; -.
DR   CDD; cd09563; SAM_liprin-beta1_2_repeat1; 1.
DR   CDD; cd09566; SAM_liprin-beta1_2_repeat2; 1.
DR   CDD; cd09569; SAM_liprin-beta1_2_repeat3; 1.
DR   InterPro; IPR029515; Liprin.
DR   InterPro; IPR037617; Liprin-beta_SAM_rpt_1.
DR   InterPro; IPR037618; Liprin-beta_SAM_rpt_2.
DR   InterPro; IPR037619; Liprin-beta_SAM_rpt_3.
DR   InterPro; IPR030437; PPFIBP1.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   PANTHER; PTHR12587; PTHR12587; 1.
DR   PANTHER; PTHR12587:SF16; PTHR12587:SF16; 1.
DR   Pfam; PF00536; SAM_1; 2.
DR   Pfam; PF07647; SAM_2; 1.
DR   SMART; SM00454; SAM; 3.
DR   SUPFAM; SSF47769; SSF47769; 3.
DR   PROSITE; PS50105; SAM_DOMAIN; 2.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN      494    558       SAM. {ECO:0000259|PROSITE:PS50105}.
FT   DOMAIN      566    629       SAM. {ECO:0000259|PROSITE:PS50105}.
FT   COILED        9     43       {ECO:0000256|SAM:Coils}.
FT   COILED       54     74       {ECO:0000256|SAM:Coils}.
FT   COILED       99    140       {ECO:0000256|SAM:Coils}.
FT   COILED      152    186       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   858 AA;  96965 MW;  D5BE6B7D1D47C76A CRC64;
     MLQQELLSRT SLETQKLDLM AEISNLKLKL TAVEKDRLDY EDKFRDTEGL IQEINDLRLK
     VSEMDSERLQ YEKKLKSTKS LMAKLSSMKI KVGQMQYEKQ RMEQKWESLK DELASLKEQL
     EEKESEVKRL QEKLVCKMKG EGVEIVDRDI EVQKMKKAVE SLMAANEEKD RKIEDLRQCL
     NRYKKMQDTV VLAQGKDGEY EELLNSSSIS SLLDAQGFSD LEKSPSPTPV MGSPSCDPFN
     TSVPEEFHTT ILQVSIPSLL PATVSMETSE KSKLTPKPET SFEENDGNII LGATVDTQLC
     DKLLTSSLQK SSSLGNLKKE TSDGEKETIQ KTSEDRAPAE SRPFGTLPPR PPGQDTSMDD
     NPFGTRKVRS SFGRGFFKIK SNKRTASAPN LAETEKETAE HLDLAGASSR PKDSQRNSPF
     QIPPPSPDSK KKSRGIMKLF GKLRRSQSTT FNPDDMSEPE FKRGGTRATA GPRLGWSRDL
     GQSNSDLDMP FAKWTKEQVC NWLMEQGLGS YLNSGKHWIA SGQTLLQASQ QDLEKELGIK
     HSLHRKKLQL ALQALGSEEE TNHGKLDFNW VTRWLDDIGL PQYKTQFDEG RVDGRMLHYM
     TVDDLLSLKV VSVLHHLSIK RAIQVLRINN FEPNCLRRRP SDENTIAPSE VQKWTNHRVM
     EWLRSVDLAE YAPNLRGSGV HGGLMVLEPR FNVETMAQLL NIPPNKTLLR RHLATHFNLL
     IGAEAQHQKR DAMELPDYVL LTATAKVKPK KLAFSNFGNL RKKKQEDGEE YVCPMELGQA
     SGSASKKGFK PGLDMRLYEE DDLDRLEQME DSEGTVRQIG AFSEGINNLT HMLKEDDMFK
     DFAARSPSAS ITDEDSNV
//
ID   LIPB1_HUMAN             Reviewed;        1011 AA.
AC   Q86W92; O75336; Q86X70; Q9NY03; Q9ULJ0;
DT   16-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   28-FEB-2018, entry version 144.
DE   RecName: Full=Liprin-beta-1;
DE   AltName: Full=Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1;
DE            Short=PTPRF-interacting protein-binding protein 1;
DE   AltName: Full=hSGT2;
GN   Name=PPFIBP1; Synonyms=KIAA1230;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANT LEU-148, TISSUE
RP   SPECIFICITY, AND FUNCTION.
RX   PubMed=9624153; DOI=10.1074/jbc.273.25.15611;
RA   Serra-Pages C., Medley Q.G., Tang M., Hart A., Streuli M.;
RT   "Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-
RT   interacting proteins.";
RL   J. Biol. Chem. 273:15611-15620(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   LEU-148.
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND VARIANT LEU-148.
RA   Junjian L., Cheng J., Rouli Z., Jie Z.;
RT   "L2, a different isoform of Liprin beta 1, is expressed in high level
RT   in liver tissue.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND VARIANT LEU-148.
RC   TISSUE=Brain;
RA   Sato T., Jigami Y., Uemura H.;
RT   "hSGT2, a liprin related human gene, restores the glycolytic gene
RT   expression of the gcr2 mutant of Saccharomyces cerevisiae.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), AND VARIANT
RP   LEU-148.
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH S100A4.
RX   PubMed=11836260; DOI=10.1074/jbc.M110976200;
RA   Kriajevska M., Fischer-Larsen M., Moertz E., Vorm O., Tulchinsky E.,
RA   Grigorian M., Ambartsumian N., Lukanidin E.;
RT   "Liprin beta 1, a member of the family of LAR transmembrane tyrosine
RT   phosphatase-interacting proteins, is a new target for the metastasis-
RT   associated protein S100A4 (Mts1).";
RL   J. Biol. Chem. 277:5229-5235(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; THR-39; SER-40;
RP   SER-466; SER-579; SER-601; SER-999; SER-1001; SER-1003 AND THR-1005,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-322, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; SER-40; SER-999 AND
RP   SER-1001, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-999, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-540; SER-601 AND
RP   SER-794, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466; SER-540 AND
RP   SER-794, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-471, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May regulate the disassembly of focal adhesions. Did not
CC       bind receptor-like tyrosine phosphatases type 2A.
CC       {ECO:0000269|PubMed:9624153}.
CC   -!- SUBUNIT: Forms homodimers and heterodimers. Interacts with S100A4
CC       in a calcium-dependent mode. {ECO:0000269|PubMed:11836260}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q86W92-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=2;
CC         IsoId=Q86W92-2; Sequence=VSP_009397, VSP_009398, VSP_009399,
CC                                  VSP_009400;
CC         Note=No experimental confirmation available. Contains a
CC         phosphoserine at position 523. {ECO:0000244|PubMed:18669648};
CC       Name=3;
CC         IsoId=Q86W92-3; Sequence=VSP_009394;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q86W92-4; Sequence=VSP_009397;
CC         Note=No experimental confirmation available.;
CC       Name=5; Synonyms=L2;
CC         IsoId=Q86W92-5; Sequence=VSP_009395, VSP_009396;
CC         Note=Due to intron retention.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Absent in liver.
CC       {ECO:0000269|PubMed:9624153}.
CC   -!- DOMAIN: The N-terminal coiled coil regions mediate
CC       homodimerization preferentially and heterodimerization type
CC       beta/beta. The C-terminal, non-coiled coil regions mediate
CC       heterodimerization type beta/alpha and interaction with S100A4.
CC   -!- SIMILARITY: Belongs to the liprin family. Liprin-beta subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH46159.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA86544.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF034802; AAC26103.1; -; mRNA.
DR   EMBL; AB033056; BAA86544.2; ALT_INIT; mRNA.
DR   EMBL; AJ276680; CAB77544.1; -; mRNA.
DR   EMBL; AB049149; BAB39690.1; -; mRNA.
DR   EMBL; BC046159; AAH46159.1; ALT_INIT; mRNA.
DR   EMBL; BC050281; AAH50281.1; -; mRNA.
DR   CCDS; CCDS55812.1; -. [Q86W92-1]
DR   CCDS; CCDS55813.1; -. [Q86W92-4]
DR   CCDS; CCDS55814.1; -. [Q86W92-3]
DR   CCDS; CCDS8713.1; -. [Q86W92-2]
DR   RefSeq; NP_001185844.1; NM_001198915.1. [Q86W92-3]
DR   RefSeq; NP_001185845.1; NM_001198916.1.
DR   RefSeq; NP_003613.3; NM_003622.3.
DR   RefSeq; NP_803193.2; NM_177444.2.
DR   UniGene; Hs.172445; -.
DR   ProteinModelPortal; Q86W92; -.
DR   SMR; Q86W92; -.
DR   BioGrid; 114068; 38.
DR   DIP; DIP-42195N; -.
DR   IntAct; Q86W92; 16.
DR   MINT; Q86W92; -.
DR   STRING; 9606.ENSP00000314724; -.
DR   iPTMnet; Q86W92; -.
DR   PhosphoSitePlus; Q86W92; -.
DR   BioMuta; PPFIBP1; -.
DR   DMDM; 90185247; -.
DR   EPD; Q86W92; -.
DR   MaxQB; Q86W92; -.
DR   PaxDb; Q86W92; -.
DR   PeptideAtlas; Q86W92; -.
DR   PRIDE; Q86W92; -.
DR   Ensembl; ENST00000228425; ENSP00000228425; ENSG00000110841. [Q86W92-2]
DR   Ensembl; ENST00000318304; ENSP00000314724; ENSG00000110841. [Q86W92-1]
DR   Ensembl; ENST00000535047; ENSP00000444046; ENSG00000110841. [Q86W92-5]
DR   Ensembl; ENST00000537927; ENSP00000445425; ENSG00000110841. [Q86W92-3]
DR   Ensembl; ENST00000542629; ENSP00000443442; ENSG00000110841. [Q86W92-4]
DR   GeneID; 8496; -.
DR   KEGG; hsa:8496; -.
DR   UCSC; uc001rhz.3; human. [Q86W92-1]
DR   CTD; 8496; -.
DR   DisGeNET; 8496; -.
DR   EuPathDB; HostDB:ENSG00000110841.13; -.
DR   GeneCards; PPFIBP1; -.
DR   HGNC; HGNC:9249; PPFIBP1.
DR   HPA; HPA001924; -.
DR   MIM; 603141; gene.
DR   neXtProt; NX_Q86W92; -.
DR   OpenTargets; ENSG00000110841; -.
DR   PharmGKB; PA33570; -.
DR   eggNOG; KOG1899; Eukaryota.
DR   eggNOG; ENOG410XSFF; LUCA.
DR   GeneTree; ENSGT00760000119138; -.
DR   HOGENOM; HOG000082535; -.
DR   HOVERGEN; HBG052331; -.
DR   InParanoid; Q86W92; -.
DR   OMA; VPEEFHT; -.
DR   OrthoDB; EOG091G01OJ; -.
DR   PhylomeDB; Q86W92; -.
DR   TreeFam; TF314207; -.
DR   Reactome; R-HSA-388844; Receptor-type tyrosine-protein phosphatases.
DR   ChiTaRS; PPFIBP1; human.
DR   GeneWiki; PPFIBP1; -.
DR   GenomeRNAi; 8496; -.
DR   PRO; PR:Q86W92; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000110841; -.
DR   CleanEx; HS_PPFIBP1; -.
DR   ExpressionAtlas; Q86W92; baseline and differential.
DR   Genevisible; Q86W92; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; NAS:ProtInc.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   CDD; cd09563; SAM_liprin-beta1_2_repeat1; 1.
DR   CDD; cd09566; SAM_liprin-beta1_2_repeat2; 1.
DR   CDD; cd09569; SAM_liprin-beta1_2_repeat3; 1.
DR   InterPro; IPR029515; Liprin.
DR   InterPro; IPR037617; Liprin-beta_SAM_rpt_1.
DR   InterPro; IPR037618; Liprin-beta_SAM_rpt_2.
DR   InterPro; IPR037619; Liprin-beta_SAM_rpt_3.
DR   InterPro; IPR030437; PPFIBP1.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   PANTHER; PTHR12587; PTHR12587; 1.
DR   PANTHER; PTHR12587:SF16; PTHR12587:SF16; 1.
DR   Pfam; PF00536; SAM_1; 2.
DR   Pfam; PF07647; SAM_2; 1.
DR   SMART; SM00454; SAM; 3.
DR   SUPFAM; SSF47769; SSF47769; 3.
DR   PROSITE; PS50105; SAM_DOMAIN; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Coiled coil; Complete proteome;
KW   Isopeptide bond; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Ubl conjugation.
FT   CHAIN         1   1011       Liprin-beta-1.
FT                                /FTId=PRO_0000191034.
FT   DOMAIN      647    711       SAM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   DOMAIN      719    782       SAM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   DOMAIN      804    876       SAM 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   COILED      156    405       {ECO:0000255}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES      39     39       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      40     40       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     322    322       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     434    434       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C8U0}.
FT   MOD_RES     466    466       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     540    540       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     579    579       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     601    601       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     636    636       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C8U0}.
FT   MOD_RES     794    794       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     999    999       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1001   1001       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1003   1003       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1005   1005       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CROSSLNK    471    471       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1    153       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10574462}.
FT                                /FTId=VSP_009394.
FT   VAR_SEQ     158    170       ELLSRTSLETQKL -> VCAEARTKMGFPC (in
FT                                isoform 5). {ECO:0000303|Ref.4,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_009395.
FT   VAR_SEQ     171   1011       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.4, ECO:0000303|Ref.5}.
FT                                /FTId=VSP_009396.
FT   VAR_SEQ     233    263       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9624153}.
FT                                /FTId=VSP_009397.
FT   VAR_SEQ     302    302       D -> DENFKKKLKEKN (in isoform 2).
FT                                {ECO:0000303|PubMed:9624153}.
FT                                /FTId=VSP_009398.
FT   VAR_SEQ     349    349       K -> KKGK (in isoform 2).
FT                                {ECO:0000303|PubMed:9624153}.
FT                                /FTId=VSP_009399.
FT   VAR_SEQ     544    544       L -> LDRKRSASAPTL (in isoform 2).
FT                                {ECO:0000303|PubMed:9624153}.
FT                                /FTId=VSP_009400.
FT   VARIANT     148    148       V -> L (in dbSNP:rs2194816).
FT                                {ECO:0000269|PubMed:10574462,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9624153,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.5}.
FT                                /FTId=VAR_017758.
FT   CONFLICT    308    308       M -> K (in Ref. 6; AAH46159).
FT                                {ECO:0000305}.
FT   CONFLICT    453    453       C -> R (in Ref. 1; AAC26103).
FT                                {ECO:0000305}.
FT   CONFLICT    553    553       E -> A (in Ref. 1; AAC26103).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1011 AA;  114024 MW;  20E30DD99ACD5A92 CRC64;
     MMSDASDMLA AALEQMDGII AGSKALEYSN GIFDCQSPTS PFMGSLRALH LVEDLRGLLE
     MMETDEKEGL RCQIPDSTAE TLVEWLQSQM TNGHLPGNGD VYQERLARLE NDKESLVLQV
     SVLTDQVEAQ GEKIRDLEFC LEEHREKVNA TEEMLQQELL SRTSLETQKL DLMAEISNLK
     LKLTAVEKDR LDYEDKFRDT EGLIQEINDL RLKVSEMDSE RLQYEKKLKS TKSLMAKLSS
     MKIKVGQMQY EKQRMEQKWE SLKDELASLK EQLEEKESEV KRLQEKLVCK MKGEGVEIVD
     RDIEVQKMKK AVESLMAANE EKDRKIEDLR QCLNRYKKMQ DTVVLAQGKD GEYEELLNSS
     SISSLLDAQG FSDLEKSPSP TPVMGSPSCD PFNTSVPEEF HTTILQVSIP SLLPATVSME
     TSEKSKLTPK PETSFEENDG NIILGATVDT QLCDKLLTSS LQKSSSLGNL KKETSDGEKE
     TIQKTSEDRA PAESRPFGTL PPRPPGQDTS MDDNPFGTRK VRSSFGRGFF KIKSNKRTAS
     APNLAETEKE TAEHLDLAGA SSRPKDSQRN SPFQIPPPSP DSKKKSRGIM KLFGKLRRSQ
     STTFNPDDMS EPEFKRGGTR ATAGPRLGWS RDLGQSNSDL DMPFAKWTKE QVCNWLMEQG
     LGSYLNSGKH WIASGQTLLQ ASQQDLEKEL GIKHSLHRKK LQLALQALGS EEETNHGKLD
     FNWVTRWLDD IGLPQYKTQF DEGRVDGRML HYMTVDDLLS LKVVSVLHHL SIKRAIQVLR
     INNFEPNCLR RRPSDENTIA PSEVQKWTNH RVMEWLRSVD LAEYAPNLRG SGVHGGLMVL
     EPRFNVETMA QLLNIPPNKT LLRRHLATHF NLLIGAEAQH QKRDAMELPD YVLLTATAKV
     KPKKLAFSNF GNLRKKKQED GEEYVCPMEL GQASGSASKK GFKPGLDMRL YEEDDLDRLE
     QMEDSEGTVR QIGAFSEGIN NLTHMLKEDD MFKDFAARSP SASITDEDSN V
//
ID   A0A0S2Z456_HUMAN        Unreviewed;       491 AA.
AC   A0A0S2Z456;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 12.
DE   SubName: Full=Papillary renal cell carcinoma isoform 1 {ECO:0000313|EMBL:ALQ33731.1};
DE   Flags: Fragment;
GN   Name=PRCC {ECO:0000313|EMBL:ALQ33731.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33731.1};
RN   [1] {ECO:0000313|EMBL:ALQ33731.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178273; ALQ33731.1; -; mRNA.
DR   RefSeq; NP_005964.3; NM_005973.4.
DR   UniGene; Hs.516948; -.
DR   ProteinModelPortal; A0A0S2Z456; -.
DR   GeneID; 5546; -.
DR   KEGG; hsa:5546; -.
DR   CTD; 5546; -.
DR   KO; K13105; -.
DR   OMA; GAPWVPK; -.
DR   PhylomeDB; A0A0S2Z456; -.
DR   ChiTaRS; PRCC; human.
DR   ExpressionAtlas; A0A0S2Z456; baseline and differential.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   InterPro; IPR018800; PRCC.
DR   PANTHER; PTHR13621; PTHR13621; 1.
DR   Pfam; PF10253; PRCC; 1.
PE   2: Evidence at transcript level;
FT   NON_TER     491    491       {ECO:0000313|EMBL:ALQ33731.1}.
SQ   SEQUENCE   491 AA;  52418 MW;  F99CFD9D42725D57 CRC64;
     MSLVAYASSD ESEPDEAEPE PEEEEAVAPT SGPALGGLFA SLPAPKGPAL LPPPPQMLAP
     AFPPPLLLPP PTGDPRLQPP PPLPFGLGGF PPPPGVSPAE AAGVGEGLGL GLPSPRGPGL
     NLPPPIGGAG PPLGLPKPKK RKEPVKIAAP ELHKGDSDSE EDEPTKKKTI LQGSSEGTGL
     SALLPQPKNL TVKETNRLLL PHAFSRKPSD GSPDTKPSRL ASKTKTSSLA PVVGTTTTTP
     SPSAIKAAAK SAALQVTKQI TQEEDDSDEE VAPENFFSLP EKAEPPGVEP YPYPIPTVPE
     ELPPGTEPEP AFQDDAANAP LEFKMAAGSS GAPWMPKPGD DYSYNQFSTY GDANAAGAYY
     QDYYSGGYYP AQDPALVPPQ EIAPDASFID DEAFKRLQGK RNRGREEINF VEIKGDDQLS
     GAQQWMTKSL TEEKTMKSFS KKKGEQPTGQ QRRKHQITYL IHQAKERELE LKNTWSENKL
     SRRQTQAKYG F
//
ID   A0A0S2Z470_HUMAN        Unreviewed;       459 AA.
AC   A0A0S2Z470;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 11.
DE   SubName: Full=Papillary renal cell carcinoma isoform 3 {ECO:0000313|EMBL:ALQ33733.1};
DE   Flags: Fragment;
GN   Name=PRCC {ECO:0000313|EMBL:ALQ33733.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33733.1};
RN   [1] {ECO:0000313|EMBL:ALQ33733.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- INTERACTION:
CC       Q9NSC5:HOMER3; NbExp=3; IntAct=EBI-16438356, EBI-748420;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178275; ALQ33733.1; -; mRNA.
DR   RefSeq; XP_005245371.1; XM_005245314.1.
DR   UniGene; Hs.516948; -.
DR   IntAct; A0A0S2Z470; 1.
DR   PeptideAtlas; A0A0S2Z470; -.
DR   GeneID; 5546; -.
DR   CTD; 5546; -.
DR   ChiTaRS; PRCC; human.
DR   InterPro; IPR018800; PRCC.
DR   PANTHER; PTHR13621; PTHR13621; 1.
DR   Pfam; PF10253; PRCC; 1.
PE   1: Evidence at protein level;
FT   NON_TER     459    459       {ECO:0000313|EMBL:ALQ33733.1}.
SQ   SEQUENCE   459 AA;  48960 MW;  421D6056F31FA7A1 CRC64;
     MSLVAYASSD ESEPDEAEPE PEEEEAVAPT SGPALGGLFA SLPAPKGPAL LPPPPQMLAP
     AFPPPLLLPP PTGDPRLQPP PPLPFGLGGF PPPPGVSPAE AAGVGEGLGL GLPSPRGPGL
     NLPPPIGGAG PPLGLPKPKK RKEPVKIAAP ELHKGDSDSE EDEPTKKKTI LQGSSEGTGL
     SALLPQPKNL TVKETNRLLL PHAFSRKPSD GSPDTKPSRL ASKTKTSSLA PVVGTTTTTP
     SPSAIKAAAK SAALQVTKQI TQEEDDSDEE VAPENFFSLP EKAEPPGVEP YPYPIPTVPE
     ELPPGTEPEP AFQDDAANAP LEFKMAAGSS GAPWMPKPGD DYSYNQFSTY GDANAAGAYY
     QFKRLQGKRN RGREEINFVE IKGDDQLSGA QQWMTKSLTE EKTMKSFSKK KGEQPTGQQR
     RKHQITYLIH QAKERELELK NTWSENKLSR RQTQAKYGF
//
ID   PRCC_HUMAN              Reviewed;         491 AA.
AC   Q92733; A8K1F7; O00665; O00724; Q5SZ06;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   28-FEB-2018, entry version 155.
DE   RecName: Full=Proline-rich protein PRCC;
DE   AltName: Full=Papillary renal cell carcinoma translocation-associated gene protein;
GN   Name=PRCC; Synonyms=TPRC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH TFE3.
RC   TISSUE=Monocyte;
RX   PubMed=8872474; DOI=10.1093/hmg/5.9.1333;
RA   Sidhar S.K., Clark J., Gill S., Hamoudi R., Crew A.J., Gwilliam R.,
RA   Ross M., Linehan W.M., Birdsall S., Shipley J., Cooper C.S.;
RT   "The t(X;1)(p11.2;q21.2) translocation in papillary renal cell
RT   carcinoma fuses a novel gene PRCC to the TFE3 transcription factor
RT   gene.";
RL   Hum. Mol. Genet. 5:1333-1338(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHROMOSOMAL TRANSLOCATION WITH
RP   TFE3.
RX   PubMed=8986805; DOI=10.1073/pnas.93.26.15294;
RA   Weterman M.A.J., Wilbrink M., Geurts van Kessel A.;
RT   "Fusion of the transcription factor TFE3 gene to a novel gene, PRCC,
RT   in t(X;1)(p11;q21)-positive papillary renal cell carcinomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:15294-15298(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-136.
RC   TISSUE=Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, INTERACTION WITH MAD2L2, AND SUBCELLULAR LOCATION.
RX   PubMed=11717438; DOI=10.1073/pnas.241304198;
RA   Weterman M.A., van Groningen J.J., Tertoolen L., van Kessel A.G.;
RT   "Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective
RT   t(X;1)-positive renal cell carcinomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:13808-13813(2001).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-159 AND
RP   SER-267, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97; SER-114; SER-157;
RP   SER-159; SER-212; THR-239 AND SER-241, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157 AND SER-159, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-159 AND
RP   SER-241, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-157 AND
RP   SER-159, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May regulate cell cycle progression through interaction
CC       with MAD2L2. {ECO:0000269|PubMed:11717438}.
CC   -!- SUBUNIT: Interacts with MAD2L2; the interaction is direct.
CC       {ECO:0000269|PubMed:11717438}.
CC   -!- INTERACTION:
CC       Q9NSC5:HOMER3; NbExp=3; IntAct=EBI-4397741, EBI-748420;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11717438}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous in fetal and adult tissues.
CC   -!- DISEASE: Note=A chromosomal aberration involving PRCC is found in
CC       patients with papillary renal cell carcinoma. Translocation
CC       t(X;1)(p11.2;q21.2) with TFE3. {ECO:0000269|PubMed:8872474,
CC       ECO:0000269|PubMed:8986805}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PRCCID69.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X97124; CAA65791.1; -; mRNA.
DR   EMBL; X99720; CAA68060.1; -; Genomic_DNA.
DR   EMBL; AK289872; BAF82561.1; -; mRNA.
DR   EMBL; AL590666; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW52909.1; -; Genomic_DNA.
DR   EMBL; BC004913; AAH04913.1; -; mRNA.
DR   CCDS; CCDS1157.1; -.
DR   RefSeq; NP_005964.3; NM_005973.4.
DR   UniGene; Hs.516948; -.
DR   ProteinModelPortal; Q92733; -.
DR   BioGrid; 111537; 48.
DR   IntAct; Q92733; 23.
DR   MINT; Q92733; -.
DR   STRING; 9606.ENSP00000271526; -.
DR   iPTMnet; Q92733; -.
DR   PhosphoSitePlus; Q92733; -.
DR   BioMuta; PRCC; -.
DR   DMDM; 2498802; -.
DR   EPD; Q92733; -.
DR   MaxQB; Q92733; -.
DR   PaxDb; Q92733; -.
DR   PeptideAtlas; Q92733; -.
DR   PRIDE; Q92733; -.
DR   Ensembl; ENST00000271526; ENSP00000271526; ENSG00000143294.
DR   GeneID; 5546; -.
DR   KEGG; hsa:5546; -.
DR   UCSC; uc001fqa.4; human.
DR   CTD; 5546; -.
DR   DisGeNET; 5546; -.
DR   EuPathDB; HostDB:ENSG00000143294.14; -.
DR   GeneCards; PRCC; -.
DR   HGNC; HGNC:9343; PRCC.
DR   HPA; CAB017151; -.
DR   HPA; HPA019463; -.
DR   HPA; HPA019481; -.
DR   MalaCards; PRCC; -.
DR   MIM; 179755; gene.
DR   neXtProt; NX_Q92733; -.
DR   OpenTargets; ENSG00000143294; -.
DR   Orphanet; 319308; Translocation renal cell carcinoma.
DR   PharmGKB; PA33704; -.
DR   eggNOG; KOG3903; Eukaryota.
DR   eggNOG; ENOG4111HM1; LUCA.
DR   GeneTree; ENSGT00390000009042; -.
DR   HOGENOM; HOG000247067; -.
DR   HOVERGEN; HBG002845; -.
DR   InParanoid; Q92733; -.
DR   KO; K13105; -.
DR   OMA; GAPWVPK; -.
DR   OrthoDB; EOG091G0P65; -.
DR   PhylomeDB; Q92733; -.
DR   TreeFam; TF318780; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   SIGNOR; Q92733; -.
DR   ChiTaRS; PRCC; human.
DR   GeneWiki; PRCC_(gene); -.
DR   GenomeRNAi; 5546; -.
DR   PRO; PR:Q92733; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143294; -.
DR   CleanEx; HS_PRCC; -.
DR   ExpressionAtlas; Q92733; baseline and differential.
DR   Genevisible; Q92733; HS.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0007093; P:mitotic cell cycle checkpoint; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   InterPro; IPR018800; PRCC.
DR   PANTHER; PTHR13621; PTHR13621; 1.
DR   Pfam; PF10253; PRCC; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Chromosomal rearrangement; Complete proteome; Nucleus;
KW   Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome.
FT   CHAIN         1    491       Proline-rich protein PRCC.
FT                                /FTId=PRO_0000058568.
FT   REGION        1    100       Mediates interaction with MAD2L2.
FT                                {ECO:0000269|PubMed:11717438}.
FT   COMPBIAS     18     25       Poly-Glu.
FT   COMPBIAS     52     55       Poly-Pro.
FT   COMPBIAS     79     84       Poly-Pro.
FT   COMPBIAS     91     94       Poly-Pro.
FT   COMPBIAS    235    239       Poly-Thr.
FT   MOD_RES      97     97       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     114    114       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     157    157       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     212    212       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     218    218       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983}.
FT   MOD_RES     239    239       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     241    241       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     267    267       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VARIANT     136    136       P -> S (in dbSNP:rs11264542).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_024341.
SQ   SEQUENCE   491 AA;  52418 MW;  F99CFD9D42725D57 CRC64;
     MSLVAYASSD ESEPDEAEPE PEEEEAVAPT SGPALGGLFA SLPAPKGPAL LPPPPQMLAP
     AFPPPLLLPP PTGDPRLQPP PPLPFGLGGF PPPPGVSPAE AAGVGEGLGL GLPSPRGPGL
     NLPPPIGGAG PPLGLPKPKK RKEPVKIAAP ELHKGDSDSE EDEPTKKKTI LQGSSEGTGL
     SALLPQPKNL TVKETNRLLL PHAFSRKPSD GSPDTKPSRL ASKTKTSSLA PVVGTTTTTP
     SPSAIKAAAK SAALQVTKQI TQEEDDSDEE VAPENFFSLP EKAEPPGVEP YPYPIPTVPE
     ELPPGTEPEP AFQDDAANAP LEFKMAAGSS GAPWMPKPGD DYSYNQFSTY GDANAAGAYY
     QDYYSGGYYP AQDPALVPPQ EIAPDASFID DEAFKRLQGK RNRGREEINF VEIKGDDQLS
     GAQQWMTKSL TEEKTMKSFS KKKGEQPTGQ QRRKHQITYL IHQAKERELE LKNTWSENKL
     SRRQTQAKYG F
//
ID   Q96FT4_HUMAN            Unreviewed;       491 AA.
AC   Q96FT4;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   31-JAN-2018, entry version 74.
DE   SubName: Full=Papillary renal cell carcinoma (Translocation-associated) {ECO:0000313|EMBL:AAH10450.1};
GN   Name=PRCC {ECO:0000313|EMBL:AAH10450.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH10450.1};
RN   [1] {ECO:0000313|EMBL:AAH10450.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH10450.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC010450; AAH10450.1; -; mRNA.
DR   RefSeq; NP_005964.3; NM_005973.4.
DR   UniGene; Hs.516948; -.
DR   PeptideAtlas; Q96FT4; -.
DR   GeneID; 5546; -.
DR   KEGG; hsa:5546; -.
DR   CTD; 5546; -.
DR   PharmGKB; PA33704; -.
DR   eggNOG; KOG3903; Eukaryota.
DR   eggNOG; ENOG4111HM1; LUCA.
DR   HOVERGEN; HBG002845; -.
DR   KO; K13105; -.
DR   ChiTaRS; PRCC; human.
DR   GenomeRNAi; 5546; -.
DR   Genevisible; Q96FT4; HS.
DR   InterPro; IPR018800; PRCC.
DR   PANTHER; PTHR13621; PTHR13621; 1.
DR   Pfam; PF10253; PRCC; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   491 AA;  52422 MW;  4A808B462FC48126 CRC64;
     MSLVAYASSD ESEPDEAEPE PEEEEAVAPT SGPALGGLFA SLPAPKGPAL LPPPPQMLAP
     AFPPPLLLPP PTGDPRLQPP PPLPFGLGGF PPPPGVSPAE AAGVGEGLGL GLPSPRGPGL
     NLPPPIGGAG PPLGLPKPKK RKEPVKIAAP ELHKGDSDSE EDEPTKKKTI LQGSSEGTGL
     SALLPQPKNL TVKETNRLLL PHAFSRKPSD GSPDTKPSRL ASKTKTSSLA PVVGTTTTTP
     SPSAIKAAAK SAALQVTKQI TQEEDDSDEE VAPENFFSLP EKAEPPGVEP YPYPIPTVPE
     ELPPGTEPEP AFQDDAANAP LEFKMAAGSS GAPWMPKPGD DYSYNQFSTY GDANAAGAYY
     QDYYSGGYYP AQDPALVPTQ EIAPDASFID DEAFKRLQGK RNRGREEINF VEIKGDDQLS
     GAQQWMTKSL TEEKTMKSFS KKKGEQPTGQ QRRKHQITYL IHQAKERELE LKNTWSENKL
     SRRQTQAKYG F
//
ID   PRRX1_HUMAN             Reviewed;         245 AA.
AC   P54821; B5BUM7; O60807;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   28-FEB-2018, entry version 159.
DE   RecName: Full=Paired mesoderm homeobox protein 1;
DE   AltName: Full=Homeobox protein PHOX1;
DE   AltName: Full=Paired-related homeobox protein 1;
DE            Short=PRX-1;
GN   Name=PRRX1; Synonyms=PMX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-197 (ISOFORM 2).
RX   PubMed=1509260; DOI=10.1126/science.257.5073.1089;
RA   Grueneberg D.A., Natesan S., Alexandre C., Gilman M.Z.;
RT   "Human and Drosophila homeodomain proteins that enhance the DNA-
RT   binding activity of serum response factor.";
RL   Science 257:1089-1095(1992).
RN   [5]
RP   VARIANT AGOTC SER-113.
RX   PubMed=21294718; DOI=10.1111/j.1399-0004.2010.01531.x;
RA   Sergi C., Kamnasaran D.;
RT   "PRRX1 is mutated in a fetus with agnathia-otocephaly.";
RL   Clin. Genet. 79:293-295(2011).
CC   -!- FUNCTION: Acts as a transcriptional regulator of muscle creatine
CC       kinase (MCK) and so has a role in the establishment of diverse
CC       mesodermal muscle types. The protein binds to an A/T-rich element
CC       in the muscle creatine enhancer (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PMX1-B;
CC         IsoId=P54821-1; Sequence=Displayed;
CC       Name=2; Synonyms=PMX1-A;
CC         IsoId=P54821-2; Sequence=VSP_002278;
CC   -!- DISEASE: Agnathia-otocephaly complex (AGOTC) [MIM:202650]: A rare
CC       condition characterized by mandibular hypoplasia or agnathia,
CC       ventromedial auricular malposition (melotia) and/or auricular
CC       fusion (synotia), and microstomia with oroglossal hypoplasia or
CC       aglossia. Holoprosencephaly is the most commonly identified
CC       association, but skeletal, genitourinary, and cardiovascular
CC       anomalies, and situs inversus have been reported. The disorder is
CC       almost always lethal. {ECO:0000269|PubMed:21294718}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB451463; BAG70277.1; -; mRNA.
DR   EMBL; Z97200; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC074993; AAH74993.1; -; mRNA.
DR   EMBL; M95929; AAA60085.1; -; mRNA.
DR   CCDS; CCDS1290.1; -. [P54821-1]
DR   CCDS; CCDS1291.1; -. [P54821-2]
DR   RefSeq; NP_008833.1; NM_006902.4. [P54821-2]
DR   RefSeq; NP_073207.1; NM_022716.3. [P54821-1]
DR   UniGene; Hs.283416; -.
DR   ProteinModelPortal; P54821; -.
DR   SMR; P54821; -.
DR   BioGrid; 111405; 1.
DR   IntAct; P54821; 2.
DR   STRING; 9606.ENSP00000239461; -.
DR   iPTMnet; P54821; -.
DR   PhosphoSitePlus; P54821; -.
DR   BioMuta; PRRX1; -.
DR   DMDM; 6174916; -.
DR   PaxDb; P54821; -.
DR   PeptideAtlas; P54821; -.
DR   PRIDE; P54821; -.
DR   DNASU; 5396; -.
DR   Ensembl; ENST00000239461; ENSP00000239461; ENSG00000116132. [P54821-1]
DR   Ensembl; ENST00000367760; ENSP00000356734; ENSG00000116132. [P54821-2]
DR   GeneID; 5396; -.
DR   KEGG; hsa:5396; -.
DR   UCSC; uc001ghe.4; human. [P54821-1]
DR   CTD; 5396; -.
DR   DisGeNET; 5396; -.
DR   EuPathDB; HostDB:ENSG00000116132.11; -.
DR   GeneCards; PRRX1; -.
DR   HGNC; HGNC:9142; PRRX1.
DR   HPA; HPA051084; -.
DR   MalaCards; PRRX1; -.
DR   MIM; 167420; gene.
DR   MIM; 202650; phenotype.
DR   neXtProt; NX_P54821; -.
DR   OpenTargets; ENSG00000116132; -.
DR   Orphanet; 990; Agnathia - holoprosencephaly - situs inversus.
DR   PharmGKB; PA33466; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000231518; -.
DR   HOVERGEN; HBG021349; -.
DR   InParanoid; P54821; -.
DR   KO; K09329; -.
DR   OMA; MATYPPT; -.
DR   OrthoDB; EOG091G0B1L; -.
DR   PhylomeDB; P54821; -.
DR   TreeFam; TF351612; -.
DR   SIGNOR; P54821; -.
DR   ChiTaRS; PRRX1; human.
DR   GeneWiki; PRRX1; -.
DR   GenomeRNAi; 5396; -.
DR   PRO; PR:P54821; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116132; -.
DR   CleanEx; HS_PRRX1; -.
DR   ExpressionAtlas; P54821; baseline and differential.
DR   Genevisible; P54821; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001105; F:RNA polymerase II transcription coactivator activity; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0048844; P:artery morphogenesis; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0042474; P:middle ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0048664; P:neuron fate determination; IEA:Ensembl.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0060021; P:palate development; IEA:Ensembl.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0070570; P:regulation of neuron projection regeneration; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03826; OAR; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Developmental protein; Disease mutation; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Reference proteome.
FT   CHAIN         1    245       Paired mesoderm homeobox protein 1.
FT                                /FTId=PRO_0000049251.
FT   DNA_BIND     94    153       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       222    235       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   MOD_RES      21     21       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63014}.
FT   MOD_RES     160    160       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63013}.
FT   MOD_RES     197    197       Phosphoserine. {ECO:0000255}.
FT   VAR_SEQ     200    245       SAMATYSATCANNSPAQGINMANSIANLRLKAKEYSLQRNQ
FT                                VPTVN -> RSSSLPRCCLHEGLHNGF (in isoform
FT                                2). {ECO:0000303|PubMed:1509260}.
FT                                /FTId=VSP_002278.
FT   VARIANT     113    113       F -> S (in AGOTC; dbSNP:rs387906667).
FT                                {ECO:0000269|PubMed:21294718}.
FT                                /FTId=VAR_066414.
SQ   SEQUENCE   245 AA;  27296 MW;  7CA4B7FD9492FC19 CRC64;
     MTSSYGHVLE RQPALGGRLD SPGNLDTLQA KKNFSVSHLL DLEEAGDMVA AQADENVGEA
     GRSLLESPGL TSGSDTPQQD NDQLNSEEKK KRKQRRNRTT FNSSQLQALE RVFERTHYPD
     AFVREDLARR VNLTEARVQV WFQNRRAKFR RNERAMLANK NASLLKSYSG DVTAVEQPIV
     PRPAPRPTDY LSWGTASPYS AMATYSATCA NNSPAQGINM ANSIANLRLK AKEYSLQRNQ
     VPTVN
//
ID   B4DMM4_HUMAN            Unreviewed;       819 AA.
AC   B4DMM4;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   20-DEC-2017, entry version 51.
DE   SubName: Full=cDNA FLJ60304, highly similar to Rab GTPase-binding effector protein 1 {ECO:0000313|EMBL:BAG59936.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59936.1};
RN   [1] {ECO:0000313|EMBL:BAG59936.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG59936.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK297535; BAG59936.1; -; mRNA.
DR   RefSeq; NP_001278510.1; NM_001291581.1.
DR   UniGene; Hs.584784; -.
DR   UniGene; Hs.592121; -.
DR   UniGene; Hs.732542; -.
DR   PeptideAtlas; B4DMM4; -.
DR   PRIDE; B4DMM4; -.
DR   GeneID; 9135; -.
DR   CTD; 9135; -.
DR   HOVERGEN; HBG055335; -.
DR   GenomeRNAi; 9135; -.
DR   GO; GO:0005768; C:endosome; IEA:InterPro.
DR   GO; GO:0008083; F:growth factor activity; IEA:InterPro.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:InterPro.
DR   GO; GO:0006897; P:endocytosis; IEA:InterPro.
DR   InterPro; IPR003914; Rabaptin.
DR   InterPro; IPR029880; Rabaptin-5.
DR   InterPro; IPR018514; Rabaptin_coiled-coil.
DR   InterPro; IPR015390; Rabaptin_Rab5-bd_dom.
DR   PANTHER; PTHR31179:SF5; PTHR31179:SF5; 1.
DR   Pfam; PF09311; Rab5-bind; 1.
DR   Pfam; PF03528; Rabaptin; 1.
DR   PRINTS; PR01432; RABAPTIN.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       11    452       Rabaptin. {ECO:0000259|Pfam:PF03528}.
FT   DOMAIN      490    796       Rab5-bind. {ECO:0000259|Pfam:PF09311}.
FT   COILED       21     41       {ECO:0000256|SAM:Coils}.
FT   COILED       64     84       {ECO:0000256|SAM:Coils}.
FT   COILED       97    179       {ECO:0000256|SAM:Coils}.
FT   COILED      195    243       {ECO:0000256|SAM:Coils}.
FT   COILED      507    541       {ECO:0000256|SAM:Coils}.
FT   COILED      560    612       {ECO:0000256|SAM:Coils}.
FT   COILED      656    746       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   819 AA;  94109 MW;  A72A1B3B5D8F492C CRC64;
     MAQPGPASQP DEDLKRQNAV LQAAQDDLGH LRTQLWEAQA EMENIKAVAT VSENTKQEAI
     DEVKRQWREE VASLQAVMKE TVRDYEHQFH LRLEQERTQW AQYRESAERE IADLRRRLSE
     GQEEENLENE MKKAQEDAEK LRSVVMPMEK EIAALKDKLT EAEDKIKELE ASKVKELNHY
     LEAEKSCRTD LEMYVAVLNT QKSVLQEDAE KLRKELHEVC HLLKQERQQH NQLKHTWQKA
     NDQFLESQRL LMRDMQRMEI VLTSEQLRQV EELKKKDQED DEQQRLNKRK DHKKADVEEE
     IKIPVVCALT QEESSAQLSN EEEHLDSTRG SVHSLDAGLL LPSGDPFSKS DNDMFKDGLR
     RAQSTDSLGT SGSLQSKALG YNYKAKSAGN LDESDFGPLV GADSVSENFD TASLGSLQMP
     SGFMLTKDQE RAIKAMTPEQ EETASLLSSV TQGMESAYVS PSGYRLVSET EWNLLQKEVH
     NAGNKLGRRC DMCSNYEKQL QGIQIQEAET RDQVKKLQLM LRQANDQLEK TMKDKQELED
     FIKQSSEDSS HQISALVLRA QASEILLEEL QQGLSQAKRD VQEQMAVLMQ SREQVSEELV
     RLQKDNDSLQ GKHSLHVSLQ QAEDFILPDT TEALRELVLK YREDIINVRT AADHVEEKLK
     AEILFLKEQI QAEQCLKENL EETLQLEIEN CKEEIASISS LKAELERIKV EKGQLESTLR
     EKSQQLESLQ EIKISLEEQL KKETAAKATV EQLMFEEKNK AHRLQTELDV SEQVQRDFVK
     LSQTLQVQLE RIRQADSLER IRAILNDTKL TDINQLPET
//
ID   RABE1_HUMAN             Reviewed;         862 AA.
AC   Q15276; B2RAG7; O95369; Q8IVX3;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   28-FEB-2018, entry version 169.
DE   RecName: Full=Rab GTPase-binding effector protein 1;
DE   AltName: Full=Rabaptin-4;
DE   AltName: Full=Rabaptin-5;
DE   AltName: Full=Rabaptin-5alpha;
DE   AltName: Full=Renal carcinoma antigen NY-REN-17;
GN   Name=RABEP1; Synonyms=RAB5EP, RABPT5, RABPT5A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH RAB5A.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=8521472; DOI=10.1016/0092-8674(95)90120-5;
RA   Stenmark H., Vitale G., Ulrich O., Zerial M.;
RT   "Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic
RT   membrane fusion.";
RL   Cell 83:423-432(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH RAB4A AND RAB5A.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10698684; DOI=10.1042/bj3460593;
RA   Nagelkerken B., van Anken E., van Raak M., Gerez L., Mohrmann K.,
RA   van Uden N., Holthuizen J., Pelkmans L., van der Sluijs P.;
RT   "Rabaptin4, a novel effector of the small GTPase rab4a, is recruited
RT   to perinuclear recycling vesicles.";
RL   Biochem. J. 346:593-601(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 807-819, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [6]
RP   INTERACTION WITH RABGEF1.
RX   PubMed=9323142; DOI=10.1016/S0092-8674(00)80380-3;
RA   Horiuchi H., Lippe R., McBride H.M., Rubino M., Woodman P.,
RA   Stenmark H., Rybin V., Wilm M., Ashman K., Mann M., Zerial M.;
RT   "A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links
RT   nucleotide exchange to effector recruitment and function.";
RL   Cell 90:1149-1159(1997).
RN   [7]
RP   PROTEOLYTIC CLEAVAGE BY CASPASES IN APOPTOTIC CELLS.
RX   PubMed=9321397; DOI=10.1093/emboj/16.20.6182;
RA   Cosulich S.C., Horiuchi H., Zerial M., Clarke P.R., Woodman P.G.;
RT   "Cleavage of rabaptin-5 blocks endosome fusion during apoptosis.";
RL   EMBO J. 16:6182-6191(1997).
RN   [8]
RP   INTERACTION WITH TSC2.
RX   PubMed=9045618; DOI=10.1074/jbc.272.10.6097;
RA   Xiao G.-H., Shoarinejad F., Jin F., Golemis E.A., Yeung R.S.;
RT   "The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5
RT   GTPase activating protein (GAP) in modulating endocytosis.";
RL   J. Biol. Chem. 272:6097-6100(1997).
RN   [9]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH RABGEF1.
RX   PubMed=11452015; DOI=10.1091/mbc.12.7.2219;
RA   Lippe R., Miaczynska M., Rybin V., Runge A., Zerial M.;
RT   "Functional synergy between Rab5 effector Rabaptin-5 and exchange
RT   factor Rabex-5 when physically associated in a complex.";
RL   Mol. Biol. Cell 12:2219-2228(2001).
RN   [11]
RP   INTERACTION WITH GGA1; GGA2; GGA3; AP1G1 AND AP1G2, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12505986; DOI=10.1093/emboj/cdg015;
RA   Mattera R., Arighi C.N., Lodge R., Zerial M., Bonifacino J.S.;
RT   "Divalent interaction of the GGAs with the Rabaptin-5-Rabex-5
RT   complex.";
RL   EMBO J. 22:78-88(2003).
RN   [12]
RP   FUNCTION, INTERACTION WITH RAB4A AND AP1G1, AND SUBCELLULAR LOCATION.
RX   PubMed=12773381; DOI=10.1093/emboj/cdg257;
RA   Deneka M., Neeft M., Popa I., van Oort M., Sprong H., Oorschot V.,
RA   Klumperman J., Schu P., van der Sluijs P.;
RT   "Rabaptin-5alpha/rabaptin-4 serves as a linker between rab4 and
RT   gamma(1)-adaptin in membrane recycling from endosomes.";
RL   EMBO J. 22:2645-2657(2003).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407 AND SER-410, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-282, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH ECM29.
RX   PubMed=20682791; DOI=10.1074/jbc.M110.154120;
RA   Gorbea C., Pratt G., Ustrell V., Bell R., Sahasrabudhe S.,
RA   Hughes R.E., Rechsteiner M.;
RT   "A protein interaction network for Ecm29 links the 26 S proteasome to
RT   molecular motors and endosomal components.";
RL   J. Biol. Chem. 285:31616-31633(2010).
RN   [20]
RP   INTERACTION WITH RAB4A.
RX   PubMed=20098723; DOI=10.1371/journal.pbio.1000283;
RA   Hoogenraad C.C., Popa I., Futai K., Martinez-Sanchez E.,
RA   Sanchez-Martinez E., Wulf P.S., van Vlijmen T., Dortland B.R.,
RA   Oorschot V., Govers R., Monti M., Heck A.J., Sheng M., Klumperman J.,
RA   Rehmann H., Jaarsma D., Kapitein L.C., van der Sluijs P.;
RT   "Neuron specific Rab4 effector GRASP-1 coordinates membrane
RT   specialization and maturation of recycling endosomes.";
RL   PLoS Biol. 8:E1000283-E1000283(2010).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407 AND SER-410, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407 AND SER-410, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [24]
RP   FUNCTION.
RX   PubMed=22841712; DOI=10.1016/j.febslet.2012.07.055;
RA   Ninkovic M., Mitkovski M., Kohl T., Stuhmer W., Pardo L.A.;
RT   "Physical and functional interaction of KV10.1 with Rabaptin-5 impacts
RT   ion channel trafficking.";
RL   FEBS Lett. 586:3077-3084(2012).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377; SER-407 AND
RP   SER-410, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-374; SER-407; THR-408
RP   AND SER-410, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.31 ANGSTROMS) OF 789-862 IN COMPLEX WITH
RP   RAB5A, SUBUNIT, AND MUTAGENESIS OF ASP-812; GLU-815; GLN-818; ASP-820;
RP   PHE-821; VAL-822; GLN-826 AND GLN-829.
RX   PubMed=15378032; DOI=10.1038/nsmb832;
RA   Zhu G., Zhai P., Liu J., Terzyan S., Li G., Zhang X.C.;
RT   "Structural basis of Rab5-Rabaptin5 interaction in endocytosis.";
RL   Nat. Struct. Mol. Biol. 11:975-983(2004).
CC   -!- FUNCTION: Rab effector protein acting as linker between gamma-
CC       adaptin, RAB4A and RAB5A. Involved in endocytic membrane fusion
CC       and membrane trafficking of recycling endosomes. Involved in KCNH1
CC       channels trafficking to and from the cell membrane
CC       (PubMed:22841712). Stimulates RABGEF1 mediated nucleotide exchange
CC       on RAB5A. {ECO:0000269|PubMed:10698684,
CC       ECO:0000269|PubMed:11452015, ECO:0000269|PubMed:12773381,
CC       ECO:0000269|PubMed:22841712, ECO:0000269|PubMed:8521472}.
CC   -!- SUBUNIT: Homodimer when bound to RAB5A (PubMed:15378032).
CC       Heterodimer with RABGEF1 (PubMed:11452015, PubMed:9323142). The
CC       heterodimer binds RAB4A and RAB5A that have been activated by GTP-
CC       binding (PubMed:10698684, PubMed:8521472, PubMed:20098723). Binds
CC       TSC2, GGA1, GGA2, GGA3, AP1G1 and AP1G2 (PubMed:12505986,
CC       PubMed:12773381, PubMed:9045618). Interacts with ECM29
CC       (PubMed:20682791). Interacts with KCNH1 (By similarity).
CC       {ECO:0000250|UniProtKB:O35550, ECO:0000269|PubMed:10698684,
CC       ECO:0000269|PubMed:11452015, ECO:0000269|PubMed:12505986,
CC       ECO:0000269|PubMed:12773381, ECO:0000269|PubMed:15378032,
CC       ECO:0000269|PubMed:20098723, ECO:0000269|PubMed:20682791,
CC       ECO:0000269|PubMed:8521472, ECO:0000269|PubMed:9045618,
CC       ECO:0000269|PubMed:9323142}.
CC   -!- INTERACTION:
CC       O43747:AP1G1; NbExp=2; IntAct=EBI-447043, EBI-447609;
CC       O75843:AP1G2; NbExp=2; IntAct=EBI-447043, EBI-373637;
CC       Q86YD7:FAM90A1; NbExp=4; IntAct=EBI-447043, EBI-6658203;
CC       Q9UJY5:GGA1; NbExp=8; IntAct=EBI-447043, EBI-447141;
CC       Q9UJY4:GGA2; NbExp=6; IntAct=EBI-447043, EBI-447646;
CC       Q9NZ52:GGA3; NbExp=4; IntAct=EBI-447043, EBI-447404;
CC       Q96EZ8:MCRS1; NbExp=4; IntAct=EBI-447043, EBI-348259;
CC       Q9HAT8:PELI2; NbExp=4; IntAct=EBI-447043, EBI-448407;
CC       Q5TAP6:UTP14C; NbExp=4; IntAct=EBI-447043, EBI-11737646;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Early endosome. Recycling
CC       endosome. Cytoplasmic vesicle.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Rabaptin-5;
CC         IsoId=Q15276-1; Sequence=Displayed;
CC       Name=2; Synonyms=Rabaptin-4;
CC         IsoId=Q15276-2; Sequence=VSP_010451;
CC   -!- PTM: Proteolytic cleavage by caspases in apoptotic cells causes
CC       loss of endosome fusion activity. {ECO:0000269|PubMed:9321397}.
CC   -!- SIMILARITY: Belongs to the rabaptin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X91141; CAA62580.1; -; mRNA.
DR   EMBL; AF098638; AAC70781.1; -; mRNA.
DR   EMBL; AK314183; BAG36864.1; -; mRNA.
DR   EMBL; BC041700; AAH41700.1; -; mRNA.
DR   CCDS; CCDS42243.1; -. [Q15276-2]
DR   CCDS; CCDS45592.1; -. [Q15276-1]
DR   RefSeq; NP_001077054.1; NM_001083585.2. [Q15276-2]
DR   RefSeq; NP_001278510.1; NM_001291581.1.
DR   RefSeq; NP_004694.2; NM_004703.5. [Q15276-1]
DR   UniGene; Hs.584784; -.
DR   UniGene; Hs.592121; -.
DR   UniGene; Hs.732542; -.
DR   PDB; 1P4U; X-ray; 2.20 A; B=435-447.
DR   PDB; 1TU3; X-ray; 2.31 A; F/G/H/I/J=789-862.
DR   PDB; 1X79; X-ray; 2.41 A; B/C=551-661.
DR   PDB; 4N3Y; X-ray; 2.20 A; B/C=552-642.
DR   PDB; 4N3Z; X-ray; 3.10 A; B/C=552-642.
DR   PDB; 4Q9U; X-ray; 4.62 A; C/D/G/H=552-642.
DR   PDBsum; 1P4U; -.
DR   PDBsum; 1TU3; -.
DR   PDBsum; 1X79; -.
DR   PDBsum; 4N3Y; -.
DR   PDBsum; 4N3Z; -.
DR   PDBsum; 4Q9U; -.
DR   ProteinModelPortal; Q15276; -.
DR   SMR; Q15276; -.
DR   BioGrid; 114583; 76.
DR   CORUM; Q15276; -.
DR   DIP; DIP-29350N; -.
DR   IntAct; Q15276; 59.
DR   MINT; Q15276; -.
DR   STRING; 9606.ENSP00000262477; -.
DR   iPTMnet; Q15276; -.
DR   PhosphoSitePlus; Q15276; -.
DR   BioMuta; RABEP1; -.
DR   DMDM; 116242743; -.
DR   EPD; Q15276; -.
DR   MaxQB; Q15276; -.
DR   PaxDb; Q15276; -.
DR   PeptideAtlas; Q15276; -.
DR   PRIDE; Q15276; -.
DR   Ensembl; ENST00000341923; ENSP00000339569; ENSG00000029725. [Q15276-2]
DR   Ensembl; ENST00000537505; ENSP00000445408; ENSG00000029725. [Q15276-1]
DR   GeneID; 9135; -.
DR   KEGG; hsa:9135; -.
DR   UCSC; uc032ery.2; human. [Q15276-1]
DR   CTD; 9135; -.
DR   DisGeNET; 9135; -.
DR   EuPathDB; HostDB:ENSG00000029725.16; -.
DR   GeneCards; RABEP1; -.
DR   HGNC; HGNC:17677; RABEP1.
DR   HPA; CAB004549; -.
DR   HPA; HPA019669; -.
DR   HPA; HPA024235; -.
DR   HPA; HPA024691; -.
DR   MIM; 603616; gene.
DR   neXtProt; NX_Q15276; -.
DR   OpenTargets; ENSG00000029725; -.
DR   PharmGKB; PA134884097; -.
DR   eggNOG; KOG0993; Eukaryota.
DR   eggNOG; ENOG410XSZ1; LUCA.
DR   GeneTree; ENSGT00530000063743; -.
DR   HOGENOM; HOG000234329; -.
DR   HOVERGEN; HBG055335; -.
DR   InParanoid; Q15276; -.
DR   KO; K12480; -.
DR   OMA; QKEVHNA; -.
DR   OrthoDB; EOG091G0H2C; -.
DR   PhylomeDB; Q15276; -.
DR   TreeFam; TF329365; -.
DR   Reactome; R-HSA-8854214; TBC/RABGAPs.
DR   SIGNOR; Q15276; -.
DR   ChiTaRS; RABEP1; human.
DR   EvolutionaryTrace; Q15276; -.
DR   GeneWiki; RABEP1; -.
DR   GenomeRNAi; 9135; -.
DR   PMAP-CutDB; Q15276; -.
DR   PRO; PR:Q15276; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000029725; -.
DR   CleanEx; HS_RABEP1; -.
DR   ExpressionAtlas; Q15276; baseline and differential.
DR   Genevisible; Q15276; HS.
DR   GO; GO:0005769; C:early endosome; TAS:ProtInc.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:UniProtKB.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0043234; C:protein complex; IMP:CAFA.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0008083; F:growth factor activity; IEA:InterPro.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:InterPro.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006897; P:endocytosis; TAS:ProtInc.
DR   GO; GO:0061025; P:membrane fusion; TAS:ProtInc.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0016192; P:vesicle-mediated transport; IMP:UniProtKB.
DR   InterPro; IPR003914; Rabaptin.
DR   InterPro; IPR029880; Rabaptin-5.
DR   InterPro; IPR018514; Rabaptin_coiled-coil.
DR   InterPro; IPR015390; Rabaptin_Rab5-bd_dom.
DR   PANTHER; PTHR31179:SF5; PTHR31179:SF5; 1.
DR   Pfam; PF09311; Rab5-bind; 1.
DR   Pfam; PF03528; Rabaptin; 1.
DR   PRINTS; PR01432; RABAPTIN.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis;
KW   Coiled coil; Complete proteome; Cytoplasm; Cytoplasmic vesicle;
KW   Direct protein sequencing; Endocytosis; Endosome; Phosphoprotein;
KW   Polymorphism; Protein transport; Reference proteome; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    862       Rab GTPase-binding effector protein 1.
FT                                /FTId=PRO_0000187556.
FT   COILED       11    345       {ECO:0000255}.
FT   COILED      534    816       {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     282    282       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     374    374       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     377    377       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     407    407       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     408    408       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     410    410       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     758    790       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10698684}.
FT                                /FTId=VSP_010451.
FT   VARIANT     640    640       E -> G (in dbSNP:rs3026099).
FT                                /FTId=VAR_028106.
FT   MUTAGEN     812    812       D->K: No effect on RAB5A binding
FT                                affinity. {ECO:0000269|PubMed:15378032}.
FT   MUTAGEN     815    815       E->K: No effect on RAB5A binding
FT                                affinity. {ECO:0000269|PubMed:15378032}.
FT   MUTAGEN     818    818       Q->W: Strongly decreases RAB5A binding
FT                                affinity. {ECO:0000269|PubMed:15378032}.
FT   MUTAGEN     820    820       D->K: Strongly decreases RAB5A binding
FT                                affinity. {ECO:0000269|PubMed:15378032}.
FT   MUTAGEN     821    821       F->R: Strongly decreases RAB5A binding
FT                                affinity. {ECO:0000269|PubMed:15378032}.
FT   MUTAGEN     822    822       V->D: Strongly decreases RAB5A binding
FT                                affinity. {ECO:0000269|PubMed:15378032}.
FT   MUTAGEN     826    826       Q->A: Strongly decreases RAB5A binding
FT                                affinity. {ECO:0000269|PubMed:15378032}.
FT   MUTAGEN     829    829       Q->A: Strongly decreases RAB5A binding
FT                                affinity. {ECO:0000269|PubMed:15378032}.
FT   CONFLICT    149    149       S -> Y (in Ref. 1; CAA62580 and 2;
FT                                AAC70781). {ECO:0000305}.
FT   CONFLICT    628    628       M -> I (in Ref. 3; BAG36864).
FT                                {ECO:0000305}.
FT   HELIX       553    633       {ECO:0000244|PDB:4N3Y}.
FT   HELIX       805    836       {ECO:0000244|PDB:1TU3}.
FT   HELIX       841    847       {ECO:0000244|PDB:1TU3}.
SQ   SEQUENCE   862 AA;  99290 MW;  CAAF91638B8ED516 CRC64;
     MAQPGPASQP DVSLQQRVAE LEKINAEFLR AQQQLEQEFN QKRAKFKELY LAKEEDLKRQ
     NAVLQAAQDD LGHLRTQLWE AQAEMENIKA IATVSENTKQ EAIDEVKRQW REEVASLQAV
     MKETVRDYEH QFHLRLEQER TQWAQYRESA EREIADLRRR LSEGQEEENL ENEMKKAQED
     AEKLRSVVMP MEKEIAALKD KLTEAEDKIK ELEASKVKEL NHYLEAEKSC RTDLEMYVAV
     LNTQKSVLQE DAEKLRKELH EVCHLLEQER QQHNQLKHTW QKANDQFLES QRLLMRDMQR
     MEIVLTSEQL RQVEELKKKD QEDDEQQRLN KRKDHKKADV EEEIKIPVVC ALTQEESSAQ
     LSNEEEHLDS TRGSVHSLDA GLLLPSGDPF SKSDNDMFKD GLRRAQSTDS LGTSGSLQSK
     ALGYNYKAKS AGNLDESDFG PLVGADSVSE NFDTASLGSL QMPSGFMLTK DQERAIKAMT
     PEQEETASLL SSVTQGMESA YVSPSGYRLV SETEWNLLQK EVHNAGNKLG RRCDMCSNYE
     KQLQGIQIQE AETRDQVKKL QLMLRQANDQ LEKTMKDKQE LEDFIKQSSE DSSHQISALV
     LRAQASEILL EELQQGLSQA KRDVQEQMAV LMQSREQVSE ELVRLQKDND SLQGKHSLHV
     SLQQAEDFIL PDTTEALREL VLKYREDIIN VRTAADHVEE KLKAEILFLK EQIQAEQCLK
     ENLEETLQLE IENCKEEIAS ISSLKAELER IKVEKGQLES TLREKSQQLE SLQEIKISLE
     EQLKKETAAK ATVEQLMFEE KNKAQRLQTE LDVSEQVQRD FVKLSQTLQV QLERIRQADS
     LERIRAILND TKLTDINQLP ET
//
ID   RBM15_HUMAN             Reviewed;         977 AA.
AC   Q96T37; A1A693; Q3ZB86; Q4V760; Q5D058; Q5T613; Q86VW9; Q96PE4;
AC   Q96SC5; Q96SC6; Q96SC9; Q96SD0; Q96T38; Q9BRA5; Q9H6R8; Q9H9Y0;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2003, sequence version 2.
DT   28-FEB-2018, entry version 171.
DE   RecName: Full=Putative RNA-binding protein 15;
DE   AltName: Full=One-twenty two protein 1;
DE   AltName: Full=RNA-binding motif protein 15;
GN   Name=RBM15; Synonyms=OTT, OTT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND CHROMOSOMAL
RP   TRANSLOCATION WITH MKL1.
RX   PubMed=11431691; DOI=10.1038/90054;
RA   Ma Z., Morris S.W., Valentine V., Li M., Herbrick J.-A., Cui X.,
RA   Bouman D., Li Y., Mehta P.K., Nizetic D., Kaneko Y., Chan G.C.F.,
RA   Chan L.C., Squire J., Scherer S.W., Hitzler J.K.;
RT   "Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of
RT   acute megakaryoblastic leukemia.";
RL   Nat. Genet. 28:220-221(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND CHROMOSOMAL
RP   TRANSLOCATION WITH MKL1.
RX   PubMed=11344311; DOI=10.1073/pnas.101001498;
RA   Mercher T., Coniat M.B.-L., Monni R., Mauchauffe M., Khac F.N.,
RA   Gressin L., Mugneret F., Leblanc T., Dastugue N., Berger R.,
RA   Bernard O.A.;
RT   "Involvement of a human gene related to the Drosophila spen gene in
RT   the recurrent t(1;22) translocation of acute megakaryocytic
RT   leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:5776-5779(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Hepatoma, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 21-977 (ISOFORM 1).
RC   TISSUE=Melanoma, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH EBV BSFL2/BMLF1.
RX   PubMed=16129689; DOI=10.1074/jbc.M501725200;
RA   Hiriart E., Gruffat H., Buisson M., Mikaelian I., Keppler S.,
RA   Meresse P., Mercher T., Bernard O.A., Sergeant A., Manet E.;
RT   "Interaction of the Epstein-Barr virus mRNA export factor EB2 with
RT   human Spen proteins SHARP, OTT1, and a novel member of the family,
RT   OTT3, links Spen proteins with splicing regulation and mRNA export.";
RL   J. Biol. Chem. 280:36935-36945(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-568; SER-622 AND
RP   SER-700, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, ALTERNATIVE INITIATION (ISOFORM 4),
RP   RNA-BINDING, AND INTERACTION WITH NXF1.
RX   PubMed=17001072; DOI=10.1074/jbc.M608745200;
RA   Lindtner S., Zolotukhin A.S., Uranishi H., Bear J., Kulkarni V.,
RA   Smulevitch S., Samiotaki M., Panayotou G., Felber B.K., Pavlakis G.N.;
RT   "RNA-binding motif protein 15 binds to the RNA transport element RTE
RT   and provides a direct link to the NXF1 export pathway.";
RL   J. Biol. Chem. 281:36915-36928(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-568; SER-670 AND
RP   SER-674, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-257; SER-259; SER-292;
RP   SER-294; THR-568; SER-670; SER-674; SER-741 AND SER-935, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH DBP5.
RX   PubMed=19786495; DOI=10.1093/nar/gkp782;
RA   Zolotukhin A.S., Uranishi H., Lindtner S., Bear J., Pavlakis G.N.,
RA   Felber B.K.;
RT   "Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA.";
RL   Nucleic Acids Res. 37:7151-7162(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-670 AND SER-674, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-450, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-210; SER-257;
RP   SER-259; SER-294; SER-365; THR-568; SER-622; SER-670; SER-765 AND
RP   SER-935, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-294; THR-568;
RP   SER-741 AND SER-765, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   INTERACTION WITH SETD1B, AND MUTAGENESIS OF LYS-795; LYS-898 AND
RP   PHE-923.
RX   PubMed=22927943; DOI=10.1371/journal.pone.0042965;
RA   Lee J.H., Skalnik D.G.;
RT   "Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4
RT   methyltransferase via a SPOC domain that is required for cytokine-
RT   independent proliferation.";
RL   PLoS ONE 7:E42965-E42965(2012).
RN   [23]
RP   IDENTIFICATION IN THE WTAP COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=24100041; DOI=10.1074/jbc.M113.500397;
RA   Horiuchi K., Kawamura T., Iwanari H., Ohashi R., Naito M., Kodama T.,
RA   Hamakubo T.;
RT   "Identification of Wilms' tumor 1-associating protein complex and its
RT   role in alternative splicing and the cell cycle.";
RL   J. Biol. Chem. 288:33292-33302(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179; SER-208; SER-253;
RP   SER-257; SER-259; SER-292; SER-294; THR-568; SER-622; SER-656;
RP   SER-670; SER-674; SER-700; SER-741; SER-765; SER-767; SER-781 AND
RP   SER-935, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-257; SER-259;
RP   TYR-266; SER-292; SER-294; THR-568; SER-670; SER-674; SER-700 AND
RP   SER-741, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-246; LYS-406; LYS-420;
RP   LYS-445 AND LYS-744, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May function as an mRNA export factor, stimulating
CC       export and expression of RTE-containing mRNAs which are present in
CC       many retrotransposons that require to be exported prior to
CC       splicing. High affinity binding of pre-mRNA to RBM15 may allow
CC       targeting of the mRNP to the export helicase DBP5 in a manner that
CC       is independent of splicing-mediated NXF1 deposition, resulting in
CC       export prior to splicing. May be implicated in HOX gene
CC       regulation. {ECO:0000269|PubMed:17001072,
CC       ECO:0000269|PubMed:19786495}.
CC   -!- SUBUNIT: Interacts with Epstein-Barr virus BSFL2/BMLF1. Interacts
CC       (via SPOC domain) with SETD1B. Interacts with NXF1, the
CC       interaction is required to promote mRNA export. Component of the
CC       WTAP complex composed of WTAP, ZC3H13, CBLL1, VIRMA, RBM15, BCLAF1
CC       and THRAP3 (PubMed:24100041). {ECO:0000269|PubMed:16129689,
CC       ECO:0000269|PubMed:17001072, ECO:0000269|PubMed:19786495,
CC       ECO:0000269|PubMed:22927943, ECO:0000269|PubMed:24100041}.
CC   -!- INTERACTION:
CC       Q13137:CALCOCO2; NbExp=3; IntAct=EBI-2514922, EBI-739580;
CC       Q9C0F1:CEP44; NbExp=3; IntAct=EBI-2514922, EBI-744115;
CC       Q92841:DDX17; NbExp=5; IntAct=EBI-2514922, EBI-746012;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-2514922, EBI-741037;
CC       Q8IVL1:NAV2; NbExp=3; IntAct=EBI-2514922, EBI-741200;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus membrane; Peripheral
CC       membrane protein. Nucleus speckle {ECO:0000269|PubMed:24100041}.
CC       Nucleus, nucleoplasm {ECO:0000269|PubMed:24100041}.
CC       Note=Colocalizes at the nuclear pore with DBP5 and NXF1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=4;
CC       Name=1; Synonyms=RBM15s+ae;
CC         IsoId=Q96T37-1; Sequence=Displayed;
CC       Name=2; Synonyms=RBM15L;
CC         IsoId=Q96T37-2; Sequence=VSP_005811;
CC       Name=3; Synonyms=RBM15S;
CC         IsoId=Q96T37-3; Sequence=VSP_005812;
CC       Name=4;
CC         IsoId=Q96T37-4; Sequence=VSP_053877, VSP_005811;
CC         Note=Produced by alternative initiation of isoform 2.;
CC   -!- DISEASE: Note=A chromosomal aberration involving RBM15 may be a
CC       cause of acute megakaryoblastic leukemia. Translocation
CC       t(1;22)(p13;q13) with MKL1. Although both reciprocal fusion
CC       transcripts are detected in acute megakaryoblastic leukemia (AMKL,
CC       FAB-M7), the RBM15-MKL1 chimeric protein has all the putative
CC       functional domains encoded by each gene and is the candidate
CC       oncogene. {ECO:0000269|PubMed:11344311,
CC       ECO:0000269|PubMed:11431691}.
CC   -!- SIMILARITY: Belongs to the RRM Spen family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14088.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB15185.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/OTTID175.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF368062; AAK54722.1; -; mRNA.
DR   EMBL; AF368063; AAK54723.1; -; mRNA.
DR   EMBL; AF368064; AAK54724.1; -; mRNA.
DR   EMBL; AF364035; AAK56920.1; ALT_TERM; mRNA.
DR   EMBL; AJ303089; CAC38828.1; ALT_TERM; mRNA.
DR   EMBL; AJ303090; CAC38829.1; ALT_TERM; mRNA.
DR   EMBL; AJ297259; CAC38861.1; -; Genomic_DNA.
DR   EMBL; AJ297259; CAC38862.1; -; Genomic_DNA.
DR   EMBL; AK022541; BAB14088.1; ALT_INIT; mRNA.
DR   EMBL; AK025596; BAB15185.1; ALT_INIT; mRNA.
DR   EMBL; AL355488; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56439.1; -; Genomic_DNA.
DR   EMBL; BC006397; AAH06397.2; -; mRNA.
DR   EMBL; BC047479; AAH47479.1; -; mRNA.
DR   EMBL; BC062316; AAH62316.1; -; mRNA.
DR   EMBL; BC098140; AAH98140.1; -; mRNA.
DR   EMBL; BC103493; AAI03494.1; -; mRNA.
DR   EMBL; BC103507; AAI03508.1; -; mRNA.
DR   EMBL; BK005915; DAA05818.1; -; mRNA.
DR   CCDS; CCDS59198.1; -. [Q96T37-3]
DR   CCDS; CCDS822.1; -. [Q96T37-1]
DR   RefSeq; NP_001188474.1; NM_001201545.1. [Q96T37-3]
DR   RefSeq; NP_073605.4; NM_022768.4. [Q96T37-1]
DR   UniGene; Hs.435947; -.
DR   UniGene; Hs.708172; -.
DR   UniGene; Hs.732334; -.
DR   ProteinModelPortal; Q96T37; -.
DR   SMR; Q96T37; -.
DR   BioGrid; 122293; 49.
DR   CORUM; Q96T37; -.
DR   IntAct; Q96T37; 21.
DR   MINT; Q96T37; -.
DR   STRING; 9606.ENSP00000358799; -.
DR   iPTMnet; Q96T37; -.
DR   PhosphoSitePlus; Q96T37; -.
DR   SwissPalm; Q96T37; -.
DR   BioMuta; RBM15; -.
DR   DMDM; 32363506; -.
DR   EPD; Q96T37; -.
DR   MaxQB; Q96T37; -.
DR   PaxDb; Q96T37; -.
DR   PeptideAtlas; Q96T37; -.
DR   PRIDE; Q96T37; -.
DR   DNASU; 64783; -.
DR   Ensembl; ENST00000369784; ENSP00000358799; ENSG00000162775. [Q96T37-1]
DR   Ensembl; ENST00000487146; ENSP00000473552; ENSG00000162775. [Q96T37-3]
DR   Ensembl; ENST00000602849; ENSP00000473638; ENSG00000162775. [Q96T37-2]
DR   Ensembl; ENST00000618772; ENSP00000483133; ENSG00000162775. [Q96T37-1]
DR   GeneID; 64783; -.
DR   KEGG; hsa:64783; -.
DR   UCSC; uc001dzl.1; human. [Q96T37-1]
DR   CTD; 64783; -.
DR   DisGeNET; 64783; -.
DR   EuPathDB; HostDB:ENSG00000162775.14; -.
DR   GeneCards; RBM15; -.
DR   HGNC; HGNC:14959; RBM15.
DR   HPA; CAB015201; -.
DR   HPA; HPA019824; -.
DR   HPA; HPA049642; -.
DR   MalaCards; RBM15; -.
DR   MIM; 606077; gene.
DR   neXtProt; NX_Q96T37; -.
DR   OpenTargets; ENSG00000162775; -.
DR   Orphanet; 402023; 'Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)'.
DR   PharmGKB; PA34264; -.
DR   eggNOG; KOG0112; Eukaryota.
DR   eggNOG; ENOG410XSAC; LUCA.
DR   GeneTree; ENSGT00530000063730; -.
DR   HOVERGEN; HBG058366; -.
DR   InParanoid; Q96T37; -.
DR   KO; K13190; -.
DR   OMA; YVCFRTP; -.
DR   OrthoDB; EOG091G0615; -.
DR   PhylomeDB; Q96T37; -.
DR   TreeFam; TF315637; -.
DR   SIGNOR; Q96T37; -.
DR   ChiTaRS; RBM15; human.
DR   GeneWiki; RBM15; -.
DR   GenomeRNAi; 64783; -.
DR   PRO; PR:Q96T37; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162775; -.
DR   ExpressionAtlas; Q96T37; baseline and differential.
DR   Genevisible; Q96T37; HS.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0003676; F:nucleic acid binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IEA:Ensembl.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0060674; P:placenta blood vessel development; IEA:Ensembl.
DR   GO; GO:0007221; P:positive regulation of transcription of Notch receptor target; IEA:Ensembl.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd12553; RRM1_RBM15; 1.
DR   CDD; cd12555; RRM2_RBM15; 1.
DR   CDD; cd12557; RRM3_RBM15; 1.
DR   Gene3D; 2.40.290.10; -; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR034470; RBM15_RRM1.
DR   InterPro; IPR034472; RBM15_RRM2.
DR   InterPro; IPR034473; RBM15_RRM3.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR016194; SPOC-like_C_dom_sf.
DR   InterPro; IPR012921; SPOC_C.
DR   InterPro; IPR010912; SPOC_met.
DR   Pfam; PF00076; RRM_1; 2.
DR   Pfam; PF07744; SPOC; 1.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF100939; SSF100939; 1.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   PROSITE; PS50102; RRM; 3.
DR   PROSITE; PS50917; SPOC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative initiation; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome; Host-virus interaction;
KW   Isopeptide bond; Membrane; Nucleus; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; Repeat; RNA-binding; Ubl conjugation.
FT   CHAIN         1    977       Putative RNA-binding protein 15.
FT                                /FTId=PRO_0000081777.
FT   DOMAIN      170    252       RRM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      374    451       RRM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      455    529       RRM 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      777    956       SPOC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00249}.
FT   COMPBIAS     60    166       Gly/Ser-rich.
FT   COMPBIAS    616    732       Arg-rich.
FT   SITE        954    955       Breakpoint for translocation to form
FT                                RBM15-MKL1.
FT   MOD_RES     109    109       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     179    179       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     208    208       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     210    210       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     253    253       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     257    257       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     259    259       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     266    266       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     292    292       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     294    294       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     365    365       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     450    450       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     568    568       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     622    622       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     656    656       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     670    670       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     674    674       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     700    700       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     741    741       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     765    765       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     767    767       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     781    781       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     935    935       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    246    246       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    406    406       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    420    420       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    445    445       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    744    744       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1     44       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_053877.
FT   VAR_SEQ     955    977       GFGFQIGVRYENKKRENLALTLL -> AKLVEQRMKIWNSK
FT                                L (in isoform 3).
FT                                {ECO:0000303|PubMed:11431691,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_005812.
FT   VAR_SEQ     956    977       FGFQIGVRYENKKRENLALTLL -> AS (in isoform
FT                                2 and isoform 4).
FT                                {ECO:0000303|PubMed:11431691}.
FT                                /FTId=VSP_005811.
FT   MUTAGEN     795    795       K->A: Disrupts interaction with SETD1B.
FT                                {ECO:0000269|PubMed:22927943}.
FT   MUTAGEN     898    898       K->A: Disrupts interaction with SETD1B.
FT                                {ECO:0000269|PubMed:22927943}.
FT   MUTAGEN     923    923       F->A: Disrupts interaction with SETD1B.
FT                                {ECO:0000269|PubMed:22927943}.
FT   CONFLICT     99     99       H -> L (in Ref. 1; AAK54722/AAK54723/
FT                                AAK54724 and 3; BAB14088). {ECO:0000305}.
FT   CONFLICT    227    227       D -> N (in Ref. 6; AAI03494).
FT                                {ECO:0000305}.
FT   CONFLICT    705    705       R -> G (in Ref. 1; AAK54722/AAK54723/
FT                                AAK54724 and 3; BAB14088). {ECO:0000305}.
SQ   SEQUENCE   977 AA;  107189 MW;  FB26AFE246E40282 CRC64;
     MRTAGRDPVP RRSPRWRRAV PLCETSAGRR VTQLRGDDLR RPATMKGKER SPVKAKRSRG
     GEDSTSRGER SKKLGGSGGS NGSSSGKTDS GGGSRRSLHL DKSSSRGGSR EYDTGGGSSS
     SRLHSYSSPS TKNSSGGGES RSSSRGGGGE SRSSGAASSA PGGGDGAEYK TLKISELGSQ
     LSDEAVEDGL FHEFKRFGDV SVKISHLSGS GSGDERVAFV NFRRPEDARA AKHARGRLVL
     YDRPLKIEAV YVSRRRSRSP LDKDTYPPSA SVVGASVGGH RHPPGGGGGQ RSLSPGGAAL
     GYRDYRLQQL ALGRLPPPPP PPLPRDLERE RDYPFYERVR PAYSLEPRVG AGAGAAPFRE
     VDEISPEDDQ RANRTLFLGN LDITVTESDL RRAFDRFGVI TEVDIKRPSR GQTSTYGFLK
     FENLDMSHRA KLAMSGKIII RNPIKIGYGK ATPTTRLWVG GLGPWVPLAA LAREFDRFGT
     IRTIDYRKGD SWAYIQYESL DAAHAAWTHM RGFPLGGPDR RLRVDFADTE HRYQQQYLQP
     LPLTHYELVT DAFGHRAPDP LRGARDRTPP LLYRDRDRDL YPDSDWVPPP PPVRERSTRT
     AATSVPAYEP LDSLDRRRDG WSLDRDRGDR DLPSSRDQPR KRRLPEESGG RHLDRSPESD
     RPRKRHCAPS PDRSPELSSS RDRYNSDNDR SSRLLLERPS PIRDRRGSLE KSQGDKRDRK
     NSASAERDRK HRTTAPTEGK SPLKKEDRSD GSAPSTSTAS SKLKSPSQKQ DGGTAPVASA
     SPKLCLAWQG MLLLKNSNFP SNMHLLQGDL QVASSLLVEG STGGKVAQLK ITQRLRLDQP
     KLDEVTRRIK VAGPNGYAIL LAVPGSSDSR SSSSSAASDT ATSTQRPLRN LVSYLKQKQA
     AGVISLPVGG NKDKENTGVL HAFPPCEFSQ QFLDSPAKAL AKSEEDYLVM IIVRGFGFQI
     GVRYENKKRE NLALTLL
//
ID   A0A0A0MTC1_HUMAN        Unreviewed;      5256 AA.
AC   A0A0A0MTC1;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   28-FEB-2018, entry version 32.
DE   SubName: Full=E3 ubiquitin-protein ligase RNF213 {ECO:0000313|Ensembl:ENSP00000425956};
GN   Name=RNF213 {ECO:0000313|Ensembl:ENSP00000425956};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000425956, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000425956, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:18318008}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [5] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [6] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12] {ECO:0000213|PubMed:25218447}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [13] {ECO:0000313|Ensembl:ENSP00000425956}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000425956}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC123764; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124319; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877677; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF510430; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005257602.2; XM_005257545.4.
DR   RefSeq; XP_005257603.2; XM_005257546.4.
DR   RefSeq; XP_006722058.1; XM_006721995.3.
DR   UniGene; Hs.195642; -.
DR   UniGene; Hs.740662; -.
DR   UniGene; Hs.745415; -.
DR   ProteinModelPortal; A0A0A0MTC1; -.
DR   PeptideAtlas; A0A0A0MTC1; -.
DR   PRIDE; A0A0A0MTC1; -.
DR   Ensembl; ENST00000508628; ENSP00000425956; ENSG00000173821.
DR   GeneID; 57674; -.
DR   UCSC; uc060ldc.1; human.
DR   CTD; 57674; -.
DR   EuPathDB; HostDB:ENSG00000173821.19; -.
DR   HGNC; HGNC:14539; RNF213.
DR   OpenTargets; ENSG00000173821; -.
DR   GeneTree; ENSGT00630000089884; -.
DR   OMA; SAGNMLF; -.
DR   OrthoDB; EOG091G002Z; -.
DR   ChiTaRS; RNF213; human.
DR   GenomeRNAi; 57674; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000173821; -.
DR   ExpressionAtlas; A0A0A0MTC1; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0016887; F:ATPase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IEA:InterPro.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR031248; RNF213.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR22605; PTHR22605; 1.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF52540; SSF52540; 3.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MTC1,
KW   ECO:0000213|MaxQB:A0A0A0MTC1, ECO:0000213|PeptideAtlas:A0A0A0MTC1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536}.
FT   DOMAIN     4046   4084       RING-type. {ECO:0000259|PROSITE:PS50089}.
FT   COILED      398    418       {ECO:0000256|SAM:Coils}.
FT   COILED      863    883       {ECO:0000256|SAM:Coils}.
FT   COILED     1442   1462       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   5256 AA;  596487 MW;  AC42E9F881CADA18 CRC64;
     MECPSCQHVS KEETPKFCSQ CGERLPPAAP IADSENNNST MASASEGEME CGQELKEEGG
     PCLFPGSDSW QENPEEPCSK ASWTVQEGAT SEVLVDAAVD LISDEWEAAN AIPSKRRKQD
     AAPLEAASVP SADCEQSKKK KRKKKKKGNK SASSELASLP LSPASPCHLT LLSNPWPQDT
     ALPHSQAQQS GPTGQPSQPP GTATTPLEGD GLSAPTEVGD SPLQAQALGE AGVATGSEAQ
     SSPQFQDHTE GEDQDASIPS GGRGLSQEGT GPPTSAGEGH SRTEDAAQEL LLPESKGGSS
     EPGTELQTTE QQAGASASMA VDAVAEPANA VKGAGKEMKE KTQRMKQPPA TTPPFKTHCQ
     EAETKTKDEM AAAEEKVGKN EQGEPEDLKK PEGKNRSAAA VKNEKEQKNQ EADVQEVKAS
     TLSPGGGVTV FFHAIISLHF PFNPDLHKVF IRGGEEFGES KWDSNICELH YTRDLGHDRV
     LVEGIVCISK KHLDKYIPYK YVIYNGESFE YEFIYKHQQK KGEYVNRCLF IKSSLLGSGD
     WHQYYDIVYM KPHGRLQKVM NHITDGPRKD LVKGKQIAAA LMLDSTFSIL QTWDTINLNS
     FFTQFEQFCF VLQQPMIYEG QAQLWTDLQY REKEVKRYLW QHLKKHVVPL PDGKSTDFLP
     VDCPVRSKLK TGLIVLFVVE KIELLLEGSL DWLCHLLTSD ASSPDEFHRD LSHILGIPQS
     WRLYLVNLCQ RCMDTRTYTW LGALPVLHCC MELAPRHKDA WRQPEDTWAA LEGLSFSPFR
     EQMLDTSSLL QFMREKQHLL SIDEPLFRSW FSLLPLSHLV MYMENFIEHL GRFPAHILDC
     LSGIYYRLPG LEQVLNTQDV QDVQNVQNIL EMLLRLLDTY RDKIPEEALS PSYLTVCLKL
     HEAICSSTKL LKFYELPALS AEIVCRMIRL LSLVDSAGQR DETGNNSVQT VFQGTLAATK
     RWLREVFTKN MLTSSGASFT YVKEIEVWRR LVEIQFPAEH GWKESLLGDM EWRLTKEEPL
     SQITAYCNSC WDTKGLEDSV AKTFEKCIIE AVSSACQSQT SILQGFSYSD LRKFGIVLSA
     VITKSWPRTA DNFDDILKHL LTLADVKHVF RLCGTDEKIL ANVTEDAKRL IAVADSVLTK
     VVGDLLSGTI LVGQLELIIK HKNQFLDIWQ LREKSLSPQD EQCAVEEALD WRREELLLLK
     KEKRCVDSLL KMCGNVKHLI QVDFGVLAVR HSQDLSSKRL NDTVTVRLST SSNSQRATHY
     HLSSQVQEMA GKIDLLRDSH IFQLFWREAA EPLSEPKEDQ EAAELLSEPE EESERHILEL
     EEVYDYLYQP SYRKFIKLHQ DLKSGEVTLA EIDVIFKDFV NKYTDLDSEL KIMCTVDHQD
     QRDWIKDRVE QIKEYHHLHQ AVHAAKVILQ VKESLGLNGD FSVLNTLLNF TDNFDDFRRE
     TLDQINQELI QAKKLLQDIS EARCKGLQAL SLRKEFICWV REALGGINEL KVFVDLASIS
     AGENDIDVDR VACFHDAVQG YASLLFKLDP SVDFSAFMKH LKKLWKALDK DQYLPRKLCD
     SARNLEWLKT VNESHGSVER SSLTLATAIN QRGIYVIQAP KGGQKISPDT VLHLILPESP
     GSHEESREYS LEEVKELLNK LMLMSGKKDR NNTEVERFSE VFCSVQRLSQ AFIDLHSAGN
     MLFRTWIAMA YCSPKQGVSL QMDFGLDLVT ELKEGGDVTE LLAALCRQME HFLDSWKRFV
     TQKRMEHFYL NFYTAEQLVY LSTELRKQPP SDAALTMLSF IKSNCTLRDV LRASVGCGSE
     AARYRMRRVM EELPLMLLSE FSLVDKLRII MEQSMRCLPA FLPDCLDLET LGHCLAHLAG
     MGGSPVERCL PRGLQVGQPN LVVCGHSEVL PAALAVYMQT PSQPLPTYDE VLLCTPATTF
     EEVALLLRRC LTLGSLGHKV YSLLFADQLS YEVARQAEEL FHNLCTQQHR EDYQLVMVCD
     GDWEHCYLPS AFSQHKVFVT PQAPLEAIQA YLAGHYRVPK QTLSAAAVFN DRLCVGIVAS
     ERAGVGKSLY VKRLHDKMKM QLNVKNVPLK TIRLIDPQVD ESRVLGALLP FLDAQYQKVP
     VLFHLDVTSS VQTGIWVFLF KLLILQYLMD INGKMWLRNP CHLYIVEILE RRTSVPSRSS
     SALRTRVPQF SFLDIFPKVT CRPPKEVIDM ELSALRSDTE PGMDLWEFCS ETFQRPYQYL
     RRFNQNQDLD TFQYQEGSVE GTPEECLQHF LFHCGVINPS WSELRNFARF LNYQLRDCEA
     SLFCNPSFIG DTLRGFKKFV VTFMIFMARD FATPSLHTSD QSPGKHMVTM DGVREEDLAP
     FSLRKRWESE PHPYVFFNDD HTTMTFIGFH LQPNINGSVD AISHLTGKVI KRDVMTRDLY
     QGLLLQRVPF NVDFDKLPRH KKLERLCLTL GIPQATDPDK TYELTTDNML KILAIEMRFR
     CGIPVIIMGE TGCGKTRLIK FLSDLRRGGT NADTIKLVKV HGGTTADMIY SRVREAENVA
     FANKDQHQLD TILFFDEANT TEAISCIKEV LCDHMVDGQP LAEDSGLHII AACNPYRKHS
     EEMICRLESA GLGYRVSMEE TADRLGSIPL RQLVYRVHAL PPSLIPLVWD FGQLSDVAEK
     LYIQQIVQRL VESISLDENG TRVITEVLCA SQGFMRKTED ECSFVSLRDV ERCVKVFRWF
     HEHSAMLLAQ LNAFLSKSSV SKNHTERDPV LWSLMLAIGV CYHASLEKKD SYRKAIARFF
     PKPYDDSRLL LDEITRAQDL FLDGVPLRKT IAKNLALKEN VFMMVVCIEL KIPLFLVGKP
     GSSKSLAKTI VADAMQGPAA YSDLFRSLKQ VHLVSFQCSP HSTPQGIIST FRQCARFQQG
     KDLQQYVSVV VLDEVGLAED SPKMPLKTLH PLLEDGCIED DPAPHKKVGF VGISNWALDP
     AKMNRGIFVS RGSPNETELI ESAKGICSSD ILVQDRVQGY FASFAKAYET VCKRQDKEFF
     GLRDYYSLIK MVFAAAKASN RKPSPQDIAQ AVLRNFSGKD DIQALDIFLA NLPEAKCSEE
     VSPMQLIKQN IFGPSQKVPG GEQEDAESRY LLVLTKNYVA LQILQQTFFE GDQQPEIIFG
     SGFPKDQEYT QLCRNINRVK ICMETGKMVL LLNLQNLYES LYDALNQYYV HLGGQKYVDL
     GLGTHRVKCR VHPNFRLIVI EEKDVVYKHF PIPLINRLEK HYLDINTVLE KWQKSIVEEL
     CAWVEKFINV KAHHFQKRHK YSPSDVFIGY HSDACASVVL QVIERQGPRA LTEELHQKVS
     EEAKSILLNC ATPDAVVRLS AYSLGGFAAE WLSQEYFHRQ RHNSFADFLQ AHLHTADLER
     HAIFTEITTF SRLLTSHDCE ILESEVTGRA PKPTLLWLQQ FDTEYSFLKE VRNCLTNTAK
     CKILIFQTDF EDGIRSAQLI ASAKYSVINE INKIRENEDR IFVYFITKLS RVGRGTAYVG
     FHGGLWQSVH IDDLRRSTLM VSDVTRLQHV TISQLFAPGD LPELGLEHRA EDGHEEAMET
     EASTSGEVAE VAEEAMETES SEKVGKETSE LGGSDVSILD TTRLLRSCVQ SAVGMLRDQN
     ESCTRNMRRV VLLLGLLNED DACHASFLRV SKMRLSVFLK KQEESQFHPL EWLAREACNQ
     DALQEAGTFR HTLWKRVQGA VTPLLASMIS FIDRDGNLEL LTRPDTPPWA RDLWMFIFSD
     TMLLNIPLVM NNERHKGEMA YIVVQNHMNL SENASNNVPF SWKIKDYLEE LWVQAQYITD
     AEGLPKKFVD IFQQTPLGRF LAQLHGEPQQ ELLQCYLKDF ILLTMRVSTE EELKFLQMAL
     WSCTRKLKAA SEAPEEEVSL PWVHLAYQRF RSRLQNFSRI LTIYPQVLHS LMEARWNHEL
     AGCEMTLDAF AAMACTEMLT RNTLKPSPQA WLQLVKNLSM PLELICSDEH MQGSGSLAQA
     VIREVRAQWS RIFSTALFVE HVLLGTESRV PELQGLVTEH VFLLDKCLRE NSDVKTHGPF
     EAVMRTLCEC KETASKTLSR FGIQPCSICL GDAKDPVCLP CDHVHCLRCL RAWFASEQMI
     CPYCLTALPD EFSPAVSQAH REAIEKHARF RQMCNSFFVD LVSTICFKDN APPEKEVIES
     LLSLLFVQKG RLRDAAQRHC EHTKSLSPFN DVVDKTPVIR SVILKLLLKY SFHDVKDYIQ
     EYLTLLKKKA FITEDKTELY MLFINCLEDS ILEKTSAYSR NDELNHLEEE GRFLKAYSPA
     SRGREPANEA SVEYLQEVAR IRLCLDRAAD FLSEPEGGPE MAKEKQCYLQ QVKQFCIRVE
     NDWHRVYLVR KLSSQRGMEF VQGLSKPGRP HQWVFPKDVV KQQGLRQDHP GQMDRYLVYG
     DEYKALRDAV AKAVLECKPL GIKTALKACK TPQSQQSAYF LLTLFREVAI LYRSHNASLH
     PTPEQCEAVS KFIGECKILS PPDISRFATS LVDNSVPLLR AGPSDSNLDG TVTEMAIHAA
     AVLLCGQNEL LEPLKNLAFS PATMAHAFLP TMPEDLLAQA RRWKGLERVH WYTCPNGHPC
     SVGECGRPME QSICIDCHAP IGGIDHKPRD GFHLVKDKAD RTQTGHVLGN PQRRDVVTCD
     RGLPPVVFLL IRLLTHLALL LGASQSSQAL INIIKPPVRD PKGFLQQHIL KDLEQLAKML
     GHSADETIGV VHLVLRRLLQ EQHQLSSRRL LNFDTELSTK EMRNNWEKEI AAVISPELEH
     LDKTLPTMNN LISQDKRISS NPVAKIIYGD PVTFLPHLPR KSVVHCSKIW SCRKRITVEY
     LQHIVEQKNG KERVPILWHF LQKEAELRLV KFLPEILALQ RDLVKQFQNV QQVEYSSIRG
     FLSKHSSDGL RQLLHNRITV FLSTWNKLRR SLETNGEINL PKDYCSTDLD LDTEFEILLP
     RRRGLGLCAT ALVSYLIRLH NEIVYAVEKL SKENNSYSVD AAEVTELHVI SYEVERDLTP
     LILSNCQYQV EEGRETVQEF DLEKIQRQIV SRFLQGKPRL SLKGIPTLVY RHDWNYEHLF
     MDIKNKMAQD SLPSSVISAI SGQLQSYSDA CEVLSVVEVT LGFLSTAGGD PNMQLNVYTQ
     DILQMGDQTI HVLKALNRCQ LKHTIALWQF LSAHKSEQLL RLHKEPFGEI SSRYKADLSP
     ENAKLLSTFL NQTGLDAFLL ELHEMIILKL KNPQTQTEER FRPQWSLRDT LVSYMQTKES
     EILPEMASQF PEEILLASCV SVWKTAAVLK WNREMR
//
ID   A0A0A0MTR7_HUMAN        Unreviewed;      5207 AA.
AC   A0A0A0MTR7;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   28-FEB-2018, entry version 33.
DE   SubName: Full=E3 ubiquitin-protein ligase RNF213 {ECO:0000313|Ensembl:ENSP00000464087};
GN   Name=RNF213 {ECO:0000313|Ensembl:ENSP00000464087};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000464087, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000464087, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:18318008}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [5] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [6] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12] {ECO:0000213|PubMed:25218447}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [13] {ECO:0000313|Ensembl:ENSP00000464087}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000464087}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC123764; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124319; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877677; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF510430; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001243000.2; NM_001256071.2.
DR   UniGene; Hs.195642; -.
DR   UniGene; Hs.740662; -.
DR   UniGene; Hs.745415; -.
DR   ProteinModelPortal; A0A0A0MTR7; -.
DR   EPD; A0A0A0MTR7; -.
DR   PeptideAtlas; A0A0A0MTR7; -.
DR   PRIDE; A0A0A0MTR7; -.
DR   Ensembl; ENST00000582970; ENSP00000464087; ENSG00000173821.
DR   GeneID; 57674; -.
DR   KEGG; hsa:57674; -.
DR   UCSC; uc021uen.3; human.
DR   CTD; 57674; -.
DR   EuPathDB; HostDB:ENSG00000173821.19; -.
DR   HGNC; HGNC:14539; RNF213.
DR   OpenTargets; ENSG00000173821; -.
DR   eggNOG; ENOG410IE7S; Eukaryota.
DR   eggNOG; ENOG410Z1EV; LUCA.
DR   GeneTree; ENSGT00630000089884; -.
DR   ChiTaRS; RNF213; human.
DR   GenomeRNAi; 57674; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000173821; -.
DR   ExpressionAtlas; A0A0A0MTR7; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0016887; F:ATPase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IEA:InterPro.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR031248; RNF213.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR22605; PTHR22605; 1.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF52540; SSF52540; 3.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MTR7,
KW   ECO:0000213|MaxQB:A0A0A0MTR7, ECO:0000213|PeptideAtlas:A0A0A0MTR7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536}.
FT   DOMAIN     3997   4035       RING-type. {ECO:0000259|PROSITE:PS50089}.
FT   COILED      349    369       {ECO:0000256|SAM:Coils}.
FT   COILED      814    834       {ECO:0000256|SAM:Coils}.
FT   COILED     1393   1413       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   5207 AA;  591408 MW;  A66146709A630E03 CRC64;
     MECPSCQHVS KEETPKFCSQ CGERLPPAAP IADSENNNST MASASEGEME CGQELKEEGG
     PCLFPGSDSW QENPEEPCSK ASWTVQESKK KKRKKKKKGN KSASSELASL PLSPASPCHL
     TLLSNPWPQD TALPHSQAQQ SGPTGQPSQP PGTATTPLEG DGLSAPTEVG DSPLQAQALG
     EAGVATGSEA QSSPQFQDHT EGEDQDASIP SGGRGLSQEG TGPPTSAGEG HSRTEDAAQE
     LLLPESKGGS SEPGTELQTT EQQAGASASM AVDAVAEPAN AVKGAGKEMK EKTQRMKQPP
     ATTPPFKTHC QEAETKTKDE MAAAEEKVGK NEQGEPEDLK KPEGKNRSAA AVKNEKEQKN
     QEADVQEVKA STLSPGGGVT VFFHAIISLH FPFNPDLHKV FIRGGEEFGE SKWDSNICEL
     HYTRDLGHDR VLVEGIVCIS KKHLDKYIPY KYVIYNGESF EYEFIYKHQQ KKGEYVNRCL
     FIKSSLLGSG DWHQYYDIVY MKPHGRLQKV MNHITDGPRK DLVKGKQIAA ALMLDSTFSI
     LQTWDTINLN SFFTQFEQFC FVLQQPMIYE GQAQLWTDLQ YREKEVKRYL WQHLKKHVVP
     LPDGKSTDFL PVDCPVRSKL KTGLIVLFVV EKIELLLEGS LDWLCHLLTS DASSPDEFHR
     DLSHILGIPQ SWRLYLVNLC QRCMDTRTYT WLGALPVLHC CMELAPRHKD AWRQPEDTWA
     ALEGLSFSPF REQMLDTSSL LQFMREKQHL LSIDEPLFRS WFSLLPLSHL VMYMENFIEH
     LGRFPAHILD CLSGIYYRLP GLEQVLNTQD VQDVQNVQNI LEMLLRLLDT YRDKIPEEAL
     SPSYLTVCLK LHEAICSSTK LLKFYELPAL SAEIVCRMIR LLSLVDSAGQ RDETGNNSVQ
     TVFQGTLAAT KRWLREVFTK NMLTSSGASF TYVKEIEVWR RLVEIQFPAE HGWKESLLGD
     MEWRLTKEEP LSQITAYCNS CWDTKGLEDS VAKTFEKCII EAVSSACQSQ TSILQGFSYS
     DLRKFGIVLS AVITKSWPRT ADNFDDILKH LLTLADVKHV FRLCGTDEKI LANVTEDAKR
     LIAVADSVLT KVVGDLLSGT ILVGQLELII KHKNQFLDIW QLREKSLSPQ DEQCAVEEAL
     DWRREELLLL KKEKRCVDSL LKMCGNVKHL IQVDFGVLAV RHSQDLSSKR LNDTVTVRLS
     TSSNSQRATH YHLSSQVQEM AGKIDLLRDS HIFQLFWREA AEPLSEPKED QEAAELLSEP
     EEESERHILE LEEVYDYLYQ PSYRKFIKLH QDLKSGEVTL AEIDVIFKDF VNKYTDLDSE
     LKIMCTVDHQ DQRDWIKDRV EQIKEYHHLH QAVHAAKVIL QVKESLGLNG DFSVLNTLLN
     FTDNFDDFRR ETLDQINQEL IQAKKLLQDI SEARCKGLQA LSLRKEFICW VREALGGINE
     LKVFVDLASI SAGENDIDVD RVACFHDAVQ GYASLLFKLD PSVDFSAFMK HLKKLWKALD
     KDQYLPRKLC DSARNLEWLK TVNESHGSVE RSSLTLATAI NQRGIYVIQA PKGGQKISPD
     TVLHLILPES PGSHEESREY SLEEVKELLN KLMLMSGKKD RNNTEVERFS EVFCSVQRLS
     QAFIDLHSAG NMLFRTWIAM AYCSPKQGVS LQMDFGLDLV TELKEGGDVT ELLAALCRQM
     EHFLDSWKRF VTQKRMEHFY LNFYTAEQLV YLSTELRKQP PSDAALTMLS FIKSNCTLRD
     VLRASVGCGS EAARYRMRRV MEELPLMLLS EFSLVDKLRI IMEQSMRCLP AFLPDCLDLE
     TLGHCLAHLA GMGGSPVERC LPRGLQVGQP NLVVCGHSEV LPAALAVYMQ TPSQPLPTYD
     EVLLCTPATT FEEVALLLRR CLTLGSLGHK VYSLLFADQL SYEVARQAEE LFHNLCTQQH
     REDYQLVMVC DGDWEHCYLP SAFSQHKVFV TPQAPLEAIQ AYLAGHYRVP KQTLSAAAVF
     NDRLCVGIVA SERAGVGKSL YVKRLHDKMK MQLNVKNVPL KTIRLIDPQV DESRVLGALL
     PFLDAQYQKV PVLFHLDVTS SVQTGIWVFL FKLLILQYLM DINGKMWLRN PCHLYIVEIL
     ERRTSVPSRS SSALRTRVPQ FSFLDIFPKV TCRPPKEVID MELSALRSDT EPGMDLWEFC
     SETFQRPYQY LRRFNQNQDL DTFQYQEGSV EGTPEECLQH FLFHCGVINP SWSELRNFAR
     FLNYQLRDCE ASLFCNPSFI GDTLRGFKKF VVTFMIFMAR DFATPSLHTS DQSPGKHMVT
     MDGVREEDLA PFSLRKRWES EPHPYVFFND DHTTMTFIGF HLQPNINGSV DAISHLTGKV
     IKRDVMTRDL YQGLLLQRVP FNVDFDKLPR HKKLERLCLT LGIPQATDPD KTYELTTDNM
     LKILAIEMRF RCGIPVIIMG ETGCGKTRLI KFLSDLRRGG TNADTIKLVK VHGGTTADMI
     YSRVREAENV AFANKDQHQL DTILFFDEAN TTEAISCIKE VLCDHMVDGQ PLAEDSGLHI
     IAACNPYRKH SEEMICRLES AGLGYRVSME ETADRLGSIP LRQLVYRVHA LPPSLIPLVW
     DFGQLSDVAE KLYIQQIVQR LVESISLDEN GTRVITEVLC ASQGFMRKTE DECSFVSLRD
     VERCVKVFRW FHEHSAMLLA QLNAFLSKSS VSKNHTERDP VLWSLMLAIG VCYHASLEKK
     DSYRKAIARF FPKPYDDSRL LLDEITRAQD LFLDGVPLRK TIAKNLALKE NVFMMVVCIE
     LKIPLFLVGK PGSSKSLAKT IVADAMQGPA AYSDLFRSLK QVHLVSFQCS PHSTPQGIIS
     TFRQCARFQQ GKDLQQYVSV VVLDEVGLAE DSPKMPLKTL HPLLEDGCIE DDPAPHKKVG
     FVGISNWALD PAKMNRGIFV SRGSPNETEL IESAKGICSS DILVQDRVQG YFASFAKAYE
     TVCKRQDKEF FGLRDYYSLI KMVFAAAKAS NRKPSPQDIA QAVLRNFSGK DDIQALDIFL
     ANLPEAKCSE EVSPMQLIKQ NIFGPSQKVP GGEQEDAESR YLLVLTKNYV ALQILQQTFF
     EGDQQPEIIF GSGFPKDQEY TQLCRNINRV KICMETGKMV LLLNLQNLYE SLYDALNQYY
     VHLGGQKYVD LGLGTHRVKC RVHPNFRLIV IEEKDVVYKH FPIPLINRLE KHYLDINTVL
     EKWQKSIVEE LCAWVEKFIN VKAHHFQKRH KYSPSDVFIG YHSDACASVV LQVIERQGPR
     ALTEELHQKV SEEAKSILLN CATPDAVVRL SAYSLGGFAA EWLSQEYFHR QRHNSFADFL
     QAHLHTADLE RHAIFTEITT FSRLLTSHDC EILESEVTGR APKPTLLWLQ QFDTEYSFLK
     EVRNCLTNTA KCKILIFQTD FEDGIRSAQL IASAKYSVIN EINKIRENED RIFVYFITKL
     SRVGRGTAYV GFHGGLWQSV HIDDLRRSTL MVSDVTRLQH VTISQLFAPG DLPELGLEHR
     AEDGHEEAME TEASTSGEVA EVAEEAMETE SSEKVGKETS ELGGSDVSIL DTTRLLRSCV
     QSAVGMLRDQ NESCTRNMRR VVLLLGLLNE DDACHASFLR VSKMRLSVFL KKQEESQFHP
     LEWLAREACN QDALQEAGTF RHTLWKRVQG AVTPLLASMI SFIDRDGNLE LLTRPDTPPW
     ARDLWMFIFS DTMLLNIPLV MNNERHKGEM AYIVVQNHMN LSENASNNVP FSWKIKDYLE
     ELWVQAQYIT DAEGLPKKFV DIFQQTPLGR FLAQLHGEPQ QELLQCYLKD FILLTMRVST
     EEELKFLQMA LWSCTRKLKA ASEAPEEEVS LPWVHLAYQR FRSRLQNFSR ILTIYPQVLH
     SLMEARWNHE LAGCEMTLDA FAAMACTEML TRNTLKPSPQ AWLQLVKNLS MPLELICSDE
     HMQGSGSLAQ AVIREVRAQW SRIFSTALFV EHVLLGTESR VPELQGLVTE HVFLLDKCLR
     ENSDVKTHGP FEAVMRTLCE CKETASKTLS RFGIQPCSIC LGDAKDPVCL PCDHVHCLRC
     LRAWFASEQM ICPYCLTALP DEFSPAVSQA HREAIEKHAR FRQMCNSFFV DLVSTICFKD
     NAPPEKEVIE SLLSLLFVQK GRLRDAAQRH CEHTKSLSPF NDVVDKTPVI RSVILKLLLK
     YSFHDVKDYI QEYLTLLKKK AFITEDKTEL YMLFINCLED SILEKTSAYS RNDELNHLEE
     EGRFLKAYSP ASRGREPANE ASVEYLQEVA RIRLCLDRAA DFLSEPEGGP EMAKEKQCYL
     QQVKQFCIRV ENDWHRVYLV RKLSSQRGME FVQGLSKPGR PHQWVFPKDV VKQQGLRQDH
     PGQMDRYLVY GDEYKALRDA VAKAVLECKP LGIKTALKAC KTPQSQQSAY FLLTLFREVA
     ILYRSHNASL HPTPEQCEAV SKFIGECKIL SPPDISRFAT SLVDNSVPLL RAGPSDSNLD
     GTVTEMAIHA AAVLLCGQNE LLEPLKNLAF SPATMAHAFL PTMPEDLLAQ ARRWKGLERV
     HWYTCPNGHP CSVGECGRPM EQSICIDCHA PIGGIDHKPR DGFHLVKDKA DRTQTGHVLG
     NPQRRDVVTC DRGLPPVVFL LIRLLTHLAL LLGASQSSQA LINIIKPPVR DPKGFLQQHI
     LKDLEQLAKM LGHSADETIG VVHLVLRRLL QEQHQLSSRR LLNFDTELST KEMRNNWEKE
     IAAVISPELE HLDKTLPTMN NLISQDKRIS SNPVAKIIYG DPVTFLPHLP RKSVVHCSKI
     WSCRKRITVE YLQHIVEQKN GKERVPILWH FLQKEAELRL VKFLPEILAL QRDLVKQFQN
     VQQVEYSSIR GFLSKHSSDG LRQLLHNRIT VFLSTWNKLR RSLETNGEIN LPKDYCSTDL
     DLDTEFEILL PRRRGLGLCA TALVSYLIRL HNEIVYAVEK LSKENNSYSV DAAEVTELHV
     ISYEVERDLT PLILSNCQYQ VEEGRETVQE FDLEKIQRQI VSRFLQGKPR LSLKGIPTLV
     YRHDWNYEHL FMDIKNKMAQ DSLPSSVISA ISGQLQSYSD ACEVLSVVEV TLGFLSTAGG
     DPNMQLNVYT QDILQMGDQT IHVLKALNRC QLKHTIALWQ FLSAHKSEQL LRLHKEPFGE
     ISSRYKADLS PENAKLLSTF LNQTGLDAFL LELHEMIILK LKNPQTQTEE RFRPQWSLRD
     TLVSYMQTKE SEILPEMASQ FPEEILLASC VSVWKTAAVL KWNREMR
//
ID   RN213_HUMAN             Reviewed;        5207 AA.
AC   Q63HN8; C9JCP4; D6RI12; F8WKS1; Q658P6; Q69YK7; Q6MZR1; Q8IWF4;
AC   Q8IZX1; Q8IZX2; Q8N406; Q8TEU0; Q9H6C9; Q9H6H9; Q9H6P3; Q9H8A9;
AC   Q9HCF4; Q9HCL8;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2012, sequence version 3.
DT   28-FEB-2018, entry version 134.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF213 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:21799892};
DE            EC=3.6.4.- {ECO:0000269|PubMed:21799892};
DE   AltName: Full=ALK lymphoma oligomerization partner on chromosome 17 {ECO:0000303|PubMed:12112524};
DE   AltName: Full=Mysterin {ECO:0000303|PubMed:26126547};
DE   AltName: Full=RING finger protein 213 {ECO:0000305};
DE   AltName: Full=RING-type E3 ubiquitin transferase RNF213 {ECO:0000305};
GN   Name=RNF213 {ECO:0000312|HGNC:HGNC:14539};
GN   Synonyms=ALO17 {ECO:0000303|PubMed:12112524},
GN   C17orf27 {ECO:0000312|HGNC:HGNC:14539},
GN   KIAA1554 {ECO:0000303|PubMed:10997877},
GN   KIAA1618 {ECO:0000303|PubMed:10997877},
GN   MYSTR {ECO:0000303|PubMed:26126547};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   AUTOUBIQUITINATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, VARIANTS
RP   ASP-3962; GLN-4062; SER-4608; ASN-4863; ASP-4950; VAL-5021; GLU-5160
RP   AND GLY-5176, AND VARIANTS MYMY2 ASN-4013 AND LYS-4810.
RX   PubMed=21799892; DOI=10.1371/journal.pone.0022542;
RA   Liu W., Morito D., Takashima S., Mineharu Y., Kobayashi H., Hitomi T.,
RA   Hashikata H., Matsuura N., Yamazaki S., Toyoda A., Kikuta K.,
RA   Takagi Y., Harada K.H., Fujiyama A., Herzig R., Krischek B., Zou L.,
RA   Kim J.E., Kitakaze M., Miyamoto S., Nagata K., Hashimoto N.,
RA   Koizumi A.;
RT   "Identification of RNF213 as a susceptibility gene for moyamoya
RT   disease and its possible role in vascular development.";
RL   PLoS ONE 6:E22542-E22542(2011).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 3021-5207 (ISOFORMS 1/2).
RC   TISSUE=Endometrium, Lymph node, Melanoma, and Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-163 (ISOFORMS 1 AND 2/3), AND
RP   CHROMOSOMAL TRANSLOCATION WITH ALK.
RX   PubMed=12112524; DOI=10.1002/gcc.10033;
RA   Cools J., Wlodarska I., Somers R., Mentens N., Pedeutour F., Maes B.,
RA   De Wolf-Peeters C., Pauwels P., Hagemeijer A., Marynen P.;
RT   "Identification of novel fusion partners of ALK, the anaplastic
RT   lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory
RT   myofibroblastic tumor.";
RL   Genes Chromosomes Cancer 34:354-362(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 136-1509 AND 3888-5207
RP   (ISOFORMS 1/2).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3770-5207 (ISOFORMS 1/2).
RC   TISSUE=Spleen, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   INTERACTION WITH M.TUBERCULOSIS RV3655C (MICROBIAL INFECTION), AND
RP   INDUCTION (MICROBIAL INFECTION).
RX   PubMed=20454556; DOI=10.1371/journal.pone.0010474;
RA   Danelishvili L., Yamazaki Y., Selker J., Bermudez L.E.;
RT   "Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins
RT   participate in the suppression of macrophage apoptosis.";
RL   PLoS ONE 5:E10474-E10474(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-217 AND SER-1258, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-217; SER-1258 AND
RP   SER-2273, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-208; SER-217 AND
RP   SER-1258, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1151, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [20]
RP   FUNCTION, SUBUNIT, AND MUTAGENESIS OF LYS-2426; GLU-2488; LYS-2775 AND
RP   GLU-2845.
RX   PubMed=24658080; DOI=10.1038/srep04442;
RA   Morito D., Nishikawa K., Hoseki J., Kitamura A., Kotani Y., Kiso K.,
RA   Kinjo M., Fujiyoshi Y., Nagata K.;
RT   "Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+
RT   ATPase, which dynamically changes its oligomeric state.";
RL   Sci. Rep. 4:4442-4442(2014).
RN   [21]
RP   INDUCTION.
RX   PubMed=26070522; DOI=10.1016/j.jstrokecerebrovasdis.2015.01.041;
RA   Zhao S., Gong Z., Zhang J., Xu X., Liu P., Guan W., Jing L., Peng T.,
RA   Teng J., Jia Y.;
RT   "Elevated serum microRNA Let-7c in Moyamoya disease.";
RL   J. Stroke Cerebrovasc. Dis. 24:1709-1714(2015).
RN   [22]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=26278786; DOI=10.1038/srep13191;
RA   Ohkubo K., Sakai Y., Inoue H., Akamine S., Ishizaki Y., Matsushita Y.,
RA   Sanefuji M., Torisu H., Ihara K., Sardiello M., Hara T.;
RT   "Moyamoya disease susceptibility gene RNF213 links inflammatory and
RT   angiogenic signals in endothelial cells.";
RL   Sci. Rep. 5:13191-13191(2015).
RN   [23]
RP   FUNCTION.
RX   PubMed=26766444; DOI=10.1016/j.devcel.2015.12.015;
RA   Scholz B., Korn C., Wojtarowicz J., Mogler C., Augustin I.,
RA   Boutros M., Niehrs C., Augustin H.G.;
RT   "Endothelial RSPO3 controls vascular stability and pruning through
RT   non-canonical WNT/Ca(2+)/NFAT signaling.";
RL   Dev. Cell 36:79-93(2016).
RN   [24]
RP   VARIANTS GLU-2554; VAL-3891; GLY-3915; MET-4567 AND MET-4765, AND
RP   VARIANTS MYMY2 THR-4399 AND LYS-4810.
RX   PubMed=21048783; DOI=10.1038/jhg.2010.132;
RA   Kamada F., Aoki Y., Narisawa A., Abe Y., Komatsuzaki S., Kikuchi A.,
RA   Kanno J., Niihori T., Ono M., Ishii N., Owada Y., Fujimura M.,
RA   Mashimo Y., Suzuki Y., Hata A., Tsuchiya S., Tominaga T.,
RA   Matsubara Y., Kure S.;
RT   "A genome-wide association study identifies RNF213 as the first
RT   Moyamoya disease gene.";
RL   J. Hum. Genet. 56:34-40(2011).
RN   [25]
RP   VARIANTS MYMY2 THR-4399 AND LYS-4810, AND VARIANTS ARG-4007; LEU-4367;
RP   PRO-4586; VAL-4631; ASP-4950; VAL-5021 AND ILE-5136.
RX   PubMed=23110205; DOI=10.1371/journal.pone.0048179;
RA   Wu Z., Jiang H., Zhang L., Xu X., Zhang X., Kang Z., Song D.,
RA   Zhang J., Guan M., Gu Y.;
RT   "Molecular analysis of RNF213 gene for moyamoya disease in the Chinese
RT   Han population.";
RL   PLoS ONE 7:E48179-E48179(2012).
RN   [26]
RP   CHARACTERIZATION OF VARIANT MYMY2 LYS-4810.
RX   PubMed=23994138; DOI=10.1016/j.bbrc.2013.08.067;
RA   Hitomi T., Habu T., Kobayashi H., Okuda H., Harada K.H., Osafune K.,
RA   Taura D., Sone M., Asaka I., Ameku T., Watanabe A., Kasahara T.,
RA   Sudo T., Shiota F., Hashikata H., Takagi Y., Morito D., Miyamoto S.,
RA   Nakao K., Koizumi A.;
RT   "The moyamoya disease susceptibility variant RNF213 R4810K
RT   (rs112735431) induces genomic instability by mitotic abnormality.";
RL   Biochem. Biophys. Res. Commun. 439:419-426(2013).
RN   [27]
RP   VARIANT THR-4185.
RX   PubMed=25043520; DOI=10.1111/ijs.12306;
RA   Smith K.R., Leventer R.J., Mackay M.T., Pope K., Gillies G.,
RA   Delatycki M.B., Amor D.J., Bahlo M., Lockhart P.J.;
RT   "Identification of a novel RNF213 variant in a family with
RT   heterogeneous intracerebral vasculopathy.";
RL   Int. J. Stroke 9:E26-E27(2014).
RN   [28]
RP   VARIANTS MYMY2 ASN-4013 AND LYS-4810, AND VARIANTS ALA-529 DEL;
RP   GLN-3922; TYR-3997; CYS-4019; VAL-4076; LYS-4115 DEL; GLU-4237;
RP   THR-4732 AND ILE-5163.
RX   PubMed=25278557; DOI=10.1161/STROKEAHA.114.006244;
RG   University of Washington Center for Mendelian Genomics;
RA   Cecchi A.C., Guo D., Ren Z., Flynn K., Santos-Cortez R.L., Leal S.M.,
RA   Wang G.T., Regalado E.S., Steinberg G.K., Shendure J., Bamshad M.J.,
RA   Grotta J.C., Nickerson D.A., Pannu H., Milewicz D.M.;
RT   "RNF213 rare variants in an ethnically diverse population with
RT   Moyamoya disease.";
RL   Stroke 45:3200-3207(2014).
RN   [29]
RP   VARIANT PHE-4118, AND INVOLVEMENT IN MYMY2.
RX   PubMed=26198278; DOI=10.1002/ajmg.a.37230;
RA   Harel T., Posey J.E., Graham B.H., Walkiewicz M., Yang Y.,
RA   Lalani S.R., Belmont J.W.;
RT   "Atypical presentation of moyamoya disease in an infant with a de novo
RT   RNF213 variant.";
RL   Am. J. Med. Genet. A 167A:2742-2747(2015).
RN   [30]
RP   CHARACTERIZATION OF VARIANT MYMY2 LYS-4810, FUNCTION, SUBUNIT, AND
RP   MUTAGENESIS OF GLU-2488.
RX   PubMed=26126547; DOI=10.1161/JAHA.115.002146;
RA   Kobayashi H., Matsuda Y., Hitomi T., Okuda H., Shioi H., Matsuda T.,
RA   Imai H., Sone M., Taura D., Harada K.H., Habu T., Takagi Y.,
RA   Miyamoto S., Koizumi A.;
RT   "Biochemical and functional characterization of RNF213 (Mysterin)
RT   R4810K, a susceptibility mutation of Moyamoya disease, in angiogenesis
RT   in vitro and in vivo.";
RL   J. Am. Heart. Assoc. 4:0-0(2015).
RN   [31]
RP   VARIANTS VAL-1622; MET-3933 AND CYS-4131, AND VARIANT MYMY2 LYS-4810.
RX   PubMed=25956231; DOI=10.1016/j.jns.2015.04.019;
RA   Lee M.J., Chen Y.F., Fan P.C., Wang K.C., Wang K., Wang J., Kuo M.F.;
RT   "Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan.";
RL   J. Neurol. Sci. 353:161-165(2015).
RN   [32]
RP   VARIANTS CYS-4019; LYS-4042; ALA-4146 AND LEU-4677, CHARACTERIZATION
RP   OF VARIANT MYMY2 ASN-4013, AND CHARACTERIZATION OF VARIANTS CYS-4019
RP   AND ALA-4146.
RX   PubMed=27736983; DOI=10.1371/journal.pone.0164759;
RA   Kobayashi H., Brozman M., Kyselova K., Viszlayova D., Morimoto T.,
RA   Roubec M., Skoloudik D., Petrovicova A., Juskanic D., Strauss J.,
RA   Halaj M., Kurray P., Hranai M., Harada K.H., Inoue S., Yoshida Y.,
RA   Habu T., Herzig R., Youssefian S., Koizumi A.;
RT   "RNF213 rare variants in Slovakian and Czech moyamoya disease
RT   patients.";
RL   PLoS ONE 11:E0164759-E0164759(2016).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase involved in angiogenesis
CC       (PubMed:21799892, PubMed:26278786, PubMed:26766444,
CC       PubMed:26126547). Involved in the non-canonical Wnt signaling
CC       pathway in vascular development: acts by mediating ubiquitination
CC       and degradation of FLNA and NFATC2 downstream of RSPO3, leading to
CC       inhibit the non-canonical Wnt signaling pathway and promoting
CC       vessel regression (PubMed:26766444). Also has ATPase activity
CC       (PubMed:24658080, PubMed:26126547). {ECO:0000269|PubMed:21799892,
CC       ECO:0000269|PubMed:24658080, ECO:0000269|PubMed:26126547,
CC       ECO:0000269|PubMed:26278786, ECO:0000269|PubMed:26766444}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:21799892}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000305|PubMed:21799892}.
CC   -!- SUBUNIT: Homooligomer; probably forms homohexamers.
CC       {ECO:0000269|PubMed:24658080, ECO:0000269|PubMed:26126547}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with M.tuberculosis
CC       protein Rv3655c, which impairs caspase-8 activation and suppresses
CC       macrophage apoptosis by blocking the extrinsic pathway.
CC       {ECO:0000269|PubMed:20454556}.
CC   -!- INTERACTION:
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-10248548, EBI-618309;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-10248548, EBI-10171697;
CC       Q04864:REL; NbExp=3; IntAct=EBI-10248548, EBI-307352;
CC       P36406:TRIM23; NbExp=3; IntAct=EBI-10248548, EBI-740098;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-10248548, EBI-719493;
CC       Q15654:TRIP6; NbExp=3; IntAct=EBI-10248548, EBI-742327;
CC       Q5T124:UBXN11; NbExp=3; IntAct=EBI-10248548, EBI-746004;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:21799892}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q63HN8-3; Sequence=Displayed;
CC         Note=Major isoform detected in all tissues examined.;
CC       Name=2;
CC         IsoId=Q63HN8-4; Sequence=VSP_042417;
CC         Note=Minor isoform with restricted expression. Gene prediction
CC         based on partial EST data.;
CC       Name=3;
CC         IsoId=Q63HN8-5; Sequence=VSP_042418, VSP_042419;
CC       Name=4;
CC         IsoId=Q63HN8-6; Sequence=VSP_042416, VSP_042420;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed (at protein level).
CC       {ECO:0000269|PubMed:21799892}.
CC   -!- INDUCTION: Down-regulated by let-7c miRNA, which binds to the 3'-
CC       UTR transcript of RNF213 (PubMed:26070522). Induced by pro-
CC       inflammatory cytokines (PubMed:26278786).
CC       {ECO:0000269|PubMed:26070522, ECO:0000269|PubMed:26278786}.
CC   -!- INDUCTION: (Microbial infection) Is up-regulated in macrophages
CC       infected by M.tuberculosis. {ECO:0000269|PubMed:20454556}.
CC   -!- DOMAIN: The RING-type zinc finger domain is required for the
CC       ubiquitin-protein ligase activity. {ECO:0000269|PubMed:21799892}.
CC   -!- PTM: Autoubiquitinated. {ECO:0000269|PubMed:21799892}.
CC   -!- DISEASE: Moyamoya disease 2 (MYMY2) [MIM:607151]: A progressive
CC       cerebral angiopathy characterized by bilateral intracranial
CC       carotid artery stenosis and telangiectatic vessels in the region
CC       of the basal ganglia. The abnormal vessels resemble a 'puff of
CC       smoke' (moyamoya) on cerebral angiogram. Affected individuals can
CC       develop transient ischemic attacks and/or cerebral infarction, and
CC       rupture of the collateral vessels can cause intracranial
CC       hemorrhage. Hemiplegia of sudden onset and epileptic seizures
CC       constitute the prevailing presentation in childhood, while
CC       subarachnoid bleeding occurs more frequently in adults.
CC       {ECO:0000269|PubMed:21048783, ECO:0000269|PubMed:21799892,
CC       ECO:0000269|PubMed:23110205, ECO:0000269|PubMed:23994138,
CC       ECO:0000269|PubMed:25278557, ECO:0000269|PubMed:25956231,
CC       ECO:0000269|PubMed:26126547, ECO:0000269|PubMed:26198278,
CC       ECO:0000269|PubMed:27736983}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving RNF213 is
CC       associated with anaplastic large-cell lymphoma (ALCL).
CC       Translocation t(2;17)(p23;q25) with ALK.
CC       {ECO:0000269|PubMed:12112524}.
CC   -!- SIMILARITY: Belongs to the AAA ATPase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH32220.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB13444.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAB14708.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB15212.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB15280.1; Type=Erroneous termination; Positions=4257; Note=Translated as Gln.; Evidence={ECO:0000305};
CC       Sequence=BAB15330.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAH10615.1; Type=Frameshift; Positions=211, 213, 221, 266; Evidence={ECO:0000305};
CC       Sequence=CAH56189.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ALO17ID480.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB537889; BAK53191.1; -; mRNA.
DR   EMBL; AL832920; CAH10615.1; ALT_FRAME; mRNA.
DR   EMBL; AL833201; CAH56308.1; -; mRNA.
DR   EMBL; BX640932; CAE45967.1; -; mRNA.
DR   EMBL; BX647946; CAH56189.1; ALT_INIT; mRNA.
DR   EMBL; AC123764; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124319; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032220; AAH32220.1; ALT_INIT; mRNA.
DR   EMBL; BC036891; AAH36891.1; -; mRNA.
DR   EMBL; BC040341; AAH40341.1; -; mRNA.
DR   EMBL; AF397204; AAN63520.1; -; mRNA.
DR   EMBL; AF397205; AAN63521.1; -; mRNA.
DR   EMBL; AB046774; BAB13380.1; -; mRNA.
DR   EMBL; AB046838; BAB13444.1; ALT_SEQ; mRNA.
DR   EMBL; AK023871; BAB14708.1; ALT_INIT; mRNA.
DR   EMBL; AK025676; BAB15212.1; ALT_INIT; mRNA.
DR   EMBL; AK025914; BAB15280.1; ALT_SEQ; mRNA.
DR   EMBL; AK026038; BAB15330.1; ALT_INIT; mRNA.
DR   EMBL; AK074030; BAB84856.1; -; mRNA.
DR   CCDS; CCDS11772.1; -. [Q63HN8-5]
DR   CCDS; CCDS58606.1; -. [Q63HN8-3]
DR   RefSeq; NP_001243000.2; NM_001256071.2.
DR   RefSeq; NP_066005.2; NM_020954.3. [Q63HN8-5]
DR   UniGene; Hs.195642; -.
DR   UniGene; Hs.740662; -.
DR   UniGene; Hs.745415; -.
DR   ProteinModelPortal; Q63HN8; -.
DR   BioGrid; 121705; 37.
DR   IntAct; Q63HN8; 16.
DR   STRING; 9606.ENSP00000324392; -.
DR   iPTMnet; Q63HN8; -.
DR   PhosphoSitePlus; Q63HN8; -.
DR   BioMuta; RNF213; -.
DR   DMDM; 380865458; -.
DR   EPD; Q63HN8; -.
DR   MaxQB; Q63HN8; -.
DR   PaxDb; Q63HN8; -.
DR   PeptideAtlas; Q63HN8; -.
DR   PRIDE; Q63HN8; -.
DR   DNASU; 57674; -.
DR   Ensembl; ENST00000319921; ENSP00000324392; ENSG00000173821. [Q63HN8-5]
DR   GeneID; 57674; -.
DR   KEGG; hsa:57674; -.
DR   UCSC; uc002jyf.5; human. [Q63HN8-3]
DR   CTD; 57674; -.
DR   DisGeNET; 57674; -.
DR   EuPathDB; HostDB:ENSG00000173821.19; -.
DR   GeneCards; RNF213; -.
DR   H-InvDB; HIX0014240; -.
DR   HGNC; HGNC:14539; RNF213.
DR   HPA; HPA003347; -.
DR   HPA; HPA026790; -.
DR   MalaCards; RNF213; -.
DR   MIM; 607151; phenotype.
DR   MIM; 613768; gene.
DR   neXtProt; NX_Q63HN8; -.
DR   OpenTargets; ENSG00000173821; -.
DR   Orphanet; 2573; Moyamoya disease.
DR   PharmGKB; PA134898812; -.
DR   PharmGKB; PA162401681; -.
DR   eggNOG; ENOG410IE7S; Eukaryota.
DR   eggNOG; ENOG410Z1EV; LUCA.
DR   GeneTree; ENSGT00630000089884; -.
DR   HOGENOM; HOG000185147; -.
DR   HOVERGEN; HBG073493; -.
DR   InParanoid; Q63HN8; -.
DR   TreeFam; TF343131; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF213; human.
DR   GeneWiki; RNF213; -.
DR   GenomeRNAi; 57674; -.
DR   PMAP-CutDB; Q9HCF4; -.
DR   PRO; PR:Q63HN8; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000173821; -.
DR   CleanEx; HS_KIAA1618; -.
DR   ExpressionAtlas; Q63HN8; baseline and differential.
DR   Genevisible; Q63HN8; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IMP:UniProtKB.
DR   GO; GO:2000051; P:negative regulation of non-canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0002040; P:sprouting angiogenesis; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR031248; RNF213.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR22605; PTHR22605; 1.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF52540; SSF52540; 3.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Angiogenesis; Chromosomal rearrangement;
KW   Coiled coil; Complete proteome; Cytoplasm; Disease mutation;
KW   Hydrolase; Isopeptide bond; Metal-binding; Phosphoprotein;
KW   Proto-oncogene; Reference proteome; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   5207       E3 ubiquitin-protein ligase RNF213.
FT                                /FTId=PRO_0000415917.
FT   ZN_FING    3997   4036       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   COILED      343    374       {ECO:0000255}.
FT   MOD_RES     208    208       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     217    217       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1258   1258       Phosphoserine.
FT                                {ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2273   2273       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK   1151   1151       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   VAR_SEQ       1   4650       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042416.
FT   VAR_SEQ      87     87       E -> EGATSEVLVDAAVDLISDEWEAANAIPSKRRKQDAA
FT                                PLEAASVPSADCEQ (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_042417.
FT   VAR_SEQ    1009   1063       SQTSILQGFSYSDLRKFGIVLSAVITKSWPRTADNFNDILK
FT                                HLLTLADVKHVFRL -> VNNLSSWETDSGSQLCSAMTQLR
FT                                AMKHPLGLSSSANSEIGKWAPSSLAKGNGAEI (in
FT                                isoform 3). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_042418.
FT   VAR_SEQ    1064   5207       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_042419.
FT   VAR_SEQ    4651   4660       QEQHQLSSRR -> MTRKSAPTSG (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042420.
FT   VARIANT     529    529       Missing (rare variant detected in a
FT                                sporadic case of Moyamoya disease in
FT                                Caucasian population).
FT                                {ECO:0000269|PubMed:25278557}.
FT                                /FTId=VAR_075635.
FT   VARIANT    1622   1622       A -> V (rare variant detected in a
FT                                sporadic case of Moyamoya disease in East
FT                                Asian population).
FT                                {ECO:0000269|PubMed:25956231}.
FT                                /FTId=VAR_075636.
FT   VARIANT    2554   2554       D -> E (in dbSNP:rs138516230).
FT                                {ECO:0000269|PubMed:21048783}.
FT                                /FTId=VAR_067020.
FT   VARIANT    3891   3891       M -> V (rare variant detected in a
FT                                sporadic case of Moyamoya disease).
FT                                {ECO:0000269|PubMed:21048783}.
FT                                /FTId=VAR_067021.
FT   VARIANT    3915   3915       E -> G (in dbSNP:rs61740658).
FT                                {ECO:0000269|PubMed:21048783}.
FT                                /FTId=VAR_067022.
FT   VARIANT    3922   3922       R -> Q (rare variant detected in a
FT                                sporadic case of Moyamoya disease in
FT                                Caucasian population).
FT                                {ECO:0000269|PubMed:25278557}.
FT                                /FTId=VAR_075637.
FT   VARIANT    3933   3933       V -> M (rare variant detected in a
FT                                sporadic case of Moyamoya disease in East
FT                                Asian population).
FT                                {ECO:0000269|PubMed:25956231}.
FT                                /FTId=VAR_075638.
FT   VARIANT    3962   3962       N -> D (variant detected in cases of
FT                                Moyamoya disease in Caucasian
FT                                populations).
FT                                {ECO:0000269|PubMed:21799892}.
FT                                /FTId=VAR_067023.
FT   VARIANT    3997   3997       C -> Y (rare variant detected in a
FT                                sporadic case of Moyamoya disease in
FT                                Caucasian population).
FT                                {ECO:0000269|PubMed:25278557}.
FT                                /FTId=VAR_075639.
FT   VARIANT    4007   4007       P -> R (rare variant detected in a
FT                                sporadic case of Moyamoya disease in East
FT                                Asian population).
FT                                {ECO:0000269|PubMed:23110205}.
FT                                /FTId=VAR_075640.
FT   VARIANT    4013   4013       D -> N (in MYMY2; variant detected in
FT                                cases of Moyamoya disease in Caucasian
FT                                and Asian populations; inhibitory effect
FT                                on angiogenic activity of vascular
FT                                endothelial cells).
FT                                {ECO:0000269|PubMed:21799892,
FT                                ECO:0000269|PubMed:25278557,
FT                                ECO:0000269|PubMed:27736983}.
FT                                /FTId=VAR_067024.
FT   VARIANT    4019   4019       R -> C (rare variant detected in a
FT                                sporadic case of Moyamoya disease in
FT                                Caucasian population; associated with K-
FT                                4042 in cases of Moyamoya disease in
FT                                Slovakian and Czech populations;
FT                                inhibitory effect on angiogenic activity
FT                                of vascular endothelial cells).
FT                                {ECO:0000269|PubMed:25278557,
FT                                ECO:0000269|PubMed:27736983}.
FT                                /FTId=VAR_075641.
FT   VARIANT    4042   4042       E -> K (rare variant associated with C-
FT                                4019 in cases of Moyamoya disease in
FT                                Slovakian and Czech populations).
FT                                {ECO:0000269|PubMed:27736983}.
FT                                /FTId=VAR_079573.
FT   VARIANT    4062   4062       R -> Q (variant detected in cases of
FT                                Moyamoya disease in Caucasian
FT                                populations).
FT                                {ECO:0000269|PubMed:21799892}.
FT                                /FTId=VAR_067025.
FT   VARIANT    4076   4076       I -> V (rare variant detected in a
FT                                sporadic case of Moyamoya disease in
FT                                Asian population).
FT                                {ECO:0000269|PubMed:25278557}.
FT                                /FTId=VAR_075642.
FT   VARIANT    4115   4115       Missing (rare variant detected in a
FT                                sporadic case of Moyamoya disease in
FT                                Caucasian population).
FT                                {ECO:0000269|PubMed:25278557}.
FT                                /FTId=VAR_075643.
FT   VARIANT    4118   4118       S -> F (rare variant detected in a
FT                                sporadic case of Moyamoya disease in
FT                                Caucasian population).
FT                                {ECO:0000269|PubMed:26198278}.
FT                                /FTId=VAR_075644.
FT   VARIANT    4131   4131       R -> C (rare variant detected in a
FT                                sporadic case of Moyamoya disease in East
FT                                Asian population).
FT                                {ECO:0000269|PubMed:25956231}.
FT                                /FTId=VAR_075645.
FT   VARIANT    4146   4146       V -> A (rare variant detected in cases of
FT                                Moyamoya disease in Slovakian and Czech
FT                                populations; inhibitory effect on
FT                                angiogenic activity of vascular
FT                                endothelial cells).
FT                                {ECO:0000269|PubMed:27736983}.
FT                                /FTId=VAR_079574.
FT   VARIANT    4185   4185       K -> T (found in a heterozygous family
FT                                with heterogeneous intracerebral
FT                                vasculopathy).
FT                                {ECO:0000269|PubMed:25043520}.
FT                                /FTId=VAR_075646.
FT   VARIANT    4237   4237       D -> E (rare variant detected in a
FT                                sporadic case of Moyamoya disease in
FT                                Caucasian population).
FT                                {ECO:0000269|PubMed:25278557}.
FT                                /FTId=VAR_075647.
FT   VARIANT    4367   4367       Q -> L (rare variant detected in a
FT                                sporadic case of Moyamoya disease in East
FT                                Asian population).
FT                                {ECO:0000269|PubMed:23110205}.
FT                                /FTId=VAR_075648.
FT   VARIANT    4399   4399       A -> T (in MYMY2; dbSNP:rs148731719).
FT                                {ECO:0000269|PubMed:21048783,
FT                                ECO:0000269|PubMed:23110205}.
FT                                /FTId=VAR_067026.
FT   VARIANT    4567   4567       V -> M (rare variant detected in a
FT                                sporadic case of Moyamoya disease;
FT                                dbSNP:rs145282452).
FT                                {ECO:0000269|PubMed:21048783}.
FT                                /FTId=VAR_067027.
FT   VARIANT    4586   4586       T -> P (rare variant detected in a
FT                                sporadic case of Moyamoya disease in East
FT                                Asian population).
FT                                {ECO:0000269|PubMed:23110205}.
FT                                /FTId=VAR_075649.
FT   VARIANT    4608   4608       P -> S (variant detected in cases of
FT                                Moyamoya disease in Caucasian
FT                                populations).
FT                                {ECO:0000269|PubMed:21799892}.
FT                                /FTId=VAR_067028.
FT   VARIANT    4631   4631       L -> V (rare variant detected in a
FT                                sporadic case of Moyamoya disease in East
FT                                Asian population).
FT                                {ECO:0000269|PubMed:23110205}.
FT                                /FTId=VAR_075650.
FT   VARIANT    4677   4677       W -> L (rare polymorphism).
FT                                {ECO:0000269|PubMed:27736983}.
FT                                /FTId=VAR_079575.
FT   VARIANT    4732   4732       K -> T (rare variant detected in a
FT                                sporadic case of Moyamoya disease in
FT                                Caucasian population).
FT                                {ECO:0000269|PubMed:25278557}.
FT                                /FTId=VAR_075651.
FT   VARIANT    4765   4765       V -> M (rare variant detected in a
FT                                sporadic case of Moyamoya disease).
FT                                {ECO:0000269|PubMed:21048783}.
FT                                /FTId=VAR_067029.
FT   VARIANT    4810   4810       R -> K (in MYMY2; very frequent in
FT                                individuals affected by Moyamoya disease;
FT                                strongly increases the risk of Moyamoya
FT                                disease; induces genomic instability;
FT                                shows decreased ATPase activity, possibly
FT                                caused by stabilization of the oligomeric
FT                                state). {ECO:0000269|PubMed:21048783,
FT                                ECO:0000269|PubMed:21799892,
FT                                ECO:0000269|PubMed:23110205,
FT                                ECO:0000269|PubMed:23994138,
FT                                ECO:0000269|PubMed:25278557,
FT                                ECO:0000269|PubMed:25956231,
FT                                ECO:0000269|PubMed:26126547}.
FT                                /FTId=VAR_067030.
FT   VARIANT    4863   4863       D -> N (variant detected in cases of
FT                                Moyamoya disease in East Asian
FT                                populations).
FT                                {ECO:0000269|PubMed:21799892}.
FT                                /FTId=VAR_067031.
FT   VARIANT    4950   4950       E -> D (variant detected in cases of
FT                                Moyamoya disease in East Asian
FT                                populations and rare variant detected in
FT                                a sporadic case of Moyamoya disease).
FT                                {ECO:0000269|PubMed:21799892,
FT                                ECO:0000269|PubMed:23110205}.
FT                                /FTId=VAR_067032.
FT   VARIANT    5021   5021       A -> V (variant detected in cases of
FT                                Moyamoya disease in East Asian
FT                                populations and rare variant detected in
FT                                a sporadic case of Moyamoya disease;
FT                                dbSNP:rs138130613).
FT                                {ECO:0000269|PubMed:21799892,
FT                                ECO:0000269|PubMed:23110205}.
FT                                /FTId=VAR_067033.
FT   VARIANT    5136   5136       M -> I (rare variant detected in a
FT                                sporadic case of Moyamoya disease in East
FT                                Asian population).
FT                                {ECO:0000269|PubMed:23110205}.
FT                                /FTId=VAR_075652.
FT   VARIANT    5160   5160       D -> E (variant detected in cases of
FT                                Moyamoya disease in East Asian
FT                                populations).
FT                                {ECO:0000269|PubMed:21799892}.
FT                                /FTId=VAR_067034.
FT   VARIANT    5163   5163       V -> I (rare variant detected in a
FT                                sporadic case of Moyamoya disease in
FT                                Caucasian population).
FT                                {ECO:0000269|PubMed:25278557}.
FT                                /FTId=VAR_075653.
FT   VARIANT    5176   5176       E -> G (variant detected in cases of
FT                                Moyamoya disease in East Asian
FT                                populations).
FT                                {ECO:0000269|PubMed:21799892}.
FT                                /FTId=VAR_067035.
FT   MUTAGEN    2426   2426       K->A: Decreased ATPase activity.
FT                                {ECO:0000269|PubMed:24658080}.
FT   MUTAGEN    2488   2488       E->A: Decreased ATPase activity.
FT                                {ECO:0000269|PubMed:24658080}.
FT   MUTAGEN    2488   2488       E->Q: Loss of ATPase hydrolysis.
FT                                Stabilization of the oligomeric state.
FT                                Inhibited angiogenesis.
FT                                {ECO:0000269|PubMed:26126547}.
FT   MUTAGEN    2775   2775       K->A: Decreased ATPase activity.
FT                                {ECO:0000269|PubMed:24658080}.
FT   MUTAGEN    2845   2845       E->A: Decreased ATPase activity.
FT                                {ECO:0000269|PubMed:24658080}.
FT   CONFLICT    270    270       M -> T (in Ref. 4; AAH36891/AAH40341).
FT                                {ECO:0000305}.
FT   CONFLICT    321    321       M -> T (in Ref. 4; AAH36891/AAH40341).
FT                                {ECO:0000305}.
FT   CONFLICT    369    369       K -> N (in Ref. 4; AAH36891).
FT                                {ECO:0000305}.
FT   CONFLICT   1045   1045       N -> D (in Ref. 1; BAK53191 and 6;
FT                                BAB13444). {ECO:0000305}.
FT   CONFLICT   1133   1133       Q -> K (in Ref. 6; BAB13444).
FT                                {ECO:0000305}.
FT   CONFLICT   1195   1195       V -> M (in Ref. 6; BAB13444).
FT                                {ECO:0000305}.
FT   CONFLICT   1272   1272       E -> Q (in Ref. 6; BAB13444).
FT                                {ECO:0000305}.
FT   CONFLICT   1331   1331       D -> G (in Ref. 6; BAB13444).
FT                                {ECO:0000305}.
FT   CONFLICT   3323   3323       R -> G (in Ref. 2; CAH56189).
FT                                {ECO:0000305}.
FT   CONFLICT   4220   4220       E -> G (in Ref. 7; BAB15212).
FT                                {ECO:0000305}.
FT   CONFLICT   4571   4571       D -> G (in Ref. 7; BAB15280).
FT                                {ECO:0000305}.
FT   CONFLICT   4853   4853       K -> R (in Ref. 7; BAB15212).
FT                                {ECO:0000305}.
FT   CONFLICT   4892   4892       N -> S (in Ref. 7; BAB15212).
FT                                {ECO:0000305}.
FT   CONFLICT   5139   5139       L -> S (in Ref. 7; BAB15280).
FT                                {ECO:0000305}.
FT   CONFLICT   5187   5187       L -> P (in Ref. 7; BAB15330).
FT                                {ECO:0000305}.
SQ   SEQUENCE   5207 AA;  591407 MW;  9BA6847099EE6E08 CRC64;
     MECPSCQHVS KEETPKFCSQ CGERLPPAAP IADSENNNST MASASEGEME CGQELKEEGG
     PCLFPGSDSW QENPEEPCSK ASWTVQESKK KKRKKKKKGN KSASSELASL PLSPASPCHL
     TLLSNPWPQD TALPHSQAQQ SGPTGQPSQP PGTATTPLEG DGLSAPTEVG DSPLQAQALG
     EAGVATGSEA QSSPQFQDHT EGEDQDASIP SGGRGLSQEG TGPPTSAGEG HSRTEDAAQE
     LLLPESKGGS SEPGTELQTT EQQAGASASM AVDAVAEPAN AVKGAGKEMK EKTQRMKQPP
     ATTPPFKTHC QEAETKTKDE MAAAEEKVGK NEQGEPEDLK KPEGKNRSAA AVKNEKEQKN
     QEADVQEVKA STLSPGGGVT VFFHAIISLH FPFNPDLHKV FIRGGEEFGE SKWDSNICEL
     HYTRDLGHDR VLVEGIVCIS KKHLDKYIPY KYVIYNGESF EYEFIYKHQQ KKGEYVNRCL
     FIKSSLLGSG DWHQYYDIVY MKPHGRLQKV MNHITDGPRK DLVKGKQIAA ALMLDSTFSI
     LQTWDTINLN SFFTQFEQFC FVLQQPMIYE GQAQLWTDLQ YREKEVKRYL WQHLKKHVVP
     LPDGKSTDFL PVDCPVRSKL KTGLIVLFVV EKIELLLEGS LDWLCHLLTS DASSPDEFHR
     DLSHILGIPQ SWRLYLVNLC QRCMDTRTYT WLGALPVLHC CMELAPRHKD AWRQPEDTWA
     ALEGLSFSPF REQMLDTSSL LQFMREKQHL LSIDEPLFRS WFSLLPLSHL VMYMENFIEH
     LGRFPAHILD CLSGIYYRLP GLEQVLNTQD VQDVQNVQNI LEMLLRLLDT YRDKIPEEAL
     SPSYLTVCLK LHEAICSSTK LLKFYELPAL SAEIVCRMIR LLSLVDSAGQ RDETGNNSVQ
     TVFQGTLAAT KRWLREVFTK NMLTSSGASF TYVKEIEVWR RLVEIQFPAE HGWKESLLGD
     MEWRLTKEEP LSQITAYCNS CWDTKGLEDS VAKTFEKCII EAVSSACQSQ TSILQGFSYS
     DLRKFGIVLS AVITKSWPRT ADNFNDILKH LLTLADVKHV FRLCGTDEKI LANVTEDAKR
     LIAVADSVLT KVVGDLLSGT ILVGQLELII KHKNQFLDIW QLREKSLSPQ DEQCAVEEAL
     DWRREELLLL KKEKRCVDSL LKMCGNVKHL IQVDFGVLAV RHSQDLSSKR LNDTVTVRLS
     TSSNSQRATH YHLSSQVQEM AGKIDLLRDS HIFQLFWREA AEPLSEPKED QEAAELLSEP
     EEESERHILE LEEVYDYLYQ PSYRKFIKLH QDLKSGEVTL AEIDVIFKDF VNKYTDLDSE
     LKIMCTVDHQ DQRDWIKDRV EQIKEYHHLH QAVHAAKVIL QVKESLGLNG DFSVLNTLLN
     FTDNFDDFRR ETLDQINQEL IQAKKLLQDI SEARCKGLQA LSLRKEFICW VREALGGINE
     LKVFVDLASI SAGENDIDVD RVACFHDAVQ GYASLLFKLD PSVDFSAFMK HLKKLWKALD
     KDQYLPRKLC DSARNLEWLK TVNESHGSVE RSSLTLATAI NQRGIYVIQA PKGGQKISPD
     TVLHLILPES PGSHEESREY SLEEVKELLN KLMLMSGKKD RNNTEVERFS EVFCSVQRLS
     QAFIDLHSAG NMLFRTWIAM AYCSPKQGVS LQMDFGLDLV TELKEGGDVT ELLAALCRQM
     EHFLDSWKRF VTQKRMEHFY LNFYTAEQLV YLSTELRKQP PSDAALTMLS FIKSNCTLRD
     VLRASVGCGS EAARYRMRRV MEELPLMLLS EFSLVDKLRI IMEQSMRCLP AFLPDCLDLE
     TLGHCLAHLA GMGGSPVERC LPRGLQVGQP NLVVCGHSEV LPAALAVYMQ TPSQPLPTYD
     EVLLCTPATT FEEVALLLRR CLTLGSLGHK VYSLLFADQL SYEVARQAEE LFHNLCTQQH
     REDYQLVMVC DGDWEHCYLP SAFSQHKVFV TPQAPLEAIQ AYLAGHYRVP KQTLSAAAVF
     NDRLCVGIVA SERAGVGKSL YVKRLHDKMK MQLNVKNVPL KTIRLIDPQV DESRVLGALL
     PFLDAQYQKV PVLFHLDVTS SVQTGIWVFL FKLLILQYLM DINGKMWLRN PCHLYIVEIL
     ERRTSVPSRS SSALRTRVPQ FSFLDIFPKV TCRPPKEVID MELSALRSDT EPGMDLWEFC
     SETFQRPYQY LRRFNQNQDL DTFQYQEGSV EGTPEECLQH FLFHCGVINP SWSELRNFAR
     FLNYQLRDCE ASLFCNPSFI GDTLRGFKKF VVTFMIFMAR DFATPSLHTS DQSPGKHMVT
     MDGVREEDLA PFSLRKRWES EPHPYVFFND DHTTMTFIGF HLQPNINGSV DAISHLTGKV
     IKRDVMTRDL YQGLLLQRVP FNVDFDKLPR HKKLERLCLT LGIPQATDPD KTYELTTDNM
     LKILAIEMRF RCGIPVIIMG ETGCGKTRLI KFLSDLRRGG TNADTIKLVK VHGGTTADMI
     YSRVREAENV AFANKDQHQL DTILFFDEAN TTEAISCIKE VLCDHMVDGQ PLAEDSGLHI
     IAACNPYRKH SEEMICRLES AGLGYRVSME ETADRLGSIP LRQLVYRVHA LPPSLIPLVW
     DFGQLSDVAE KLYIQQIVQR LVESISLDEN GTRVITEVLC ASQGFMRKTE DECSFVSLRD
     VERCVKVFRW FHEHSAMLLA QLNAFLSKSS VSKNHTERDP VLWSLMLAIG VCYHASLEKK
     DSYRKAIARF FPKPYDDSRL LLDEITRAQD LFLDGVPLRK TIAKNLALKE NVFMMVVCIE
     LKIPLFLVGK PGSSKSLAKT IVADAMQGPA AYSDLFRSLK QVHLVSFQCS PHSTPQGIIS
     TFRQCARFQQ GKDLQQYVSV VVLDEVGLAE DSPKMPLKTL HPLLEDGCIE DDPAPHKKVG
     FVGISNWALD PAKMNRGIFV SRGSPNETEL IESAKGICSS DILVQDRVQG YFASFAKAYE
     TVCKRQDKEF FGLRDYYSLI KMVFAAAKAS NRKPSPQDIA QAVLRNFSGK DDIQALDIFL
     ANLPEAKCSE EVSPMQLIKQ NIFGPSQKVP GGEQEDAESR YLLVLTKNYV ALQILQQTFF
     EGDQQPEIIF GSGFPKDQEY TQLCRNINRV KICMETGKMV LLLNLQNLYE SLYDALNQYY
     VHLGGQKYVD LGLGTHRVKC RVHPNFRLIV IEEKDVVYKH FPIPLINRLE KHYLDINTVL
     EKWQKSIVEE LCAWVEKFIN VKAHHFQKRH KYSPSDVFIG YHSDACASVV LQVIERQGPR
     ALTEELHQKV SEEAKSILLN CATPDAVVRL SAYSLGGFAA EWLSQEYFHR QRHNSFADFL
     QAHLHTADLE RHAIFTEITT FSRLLTSHDC EILESEVTGR APKPTLLWLQ QFDTEYSFLK
     EVRNCLTNTA KCKILIFQTD FEDGIRSAQL IASAKYSVIN EINKIRENED RIFVYFITKL
     SRVGRGTAYV GFHGGLWQSV HIDDLRRSTL MVSDVTRLQH VTISQLFAPG DLPELGLEHR
     AEDGHEEAME TEASTSGEVA EVAEEAMETE SSEKVGKETS ELGGSDVSIL DTTRLLRSCV
     QSAVGMLRDQ NESCTRNMRR VVLLLGLLNE DDACHASFLR VSKMRLSVFL KKQEESQFHP
     LEWLAREACN QDALQEAGTF RHTLWKRVQG AVTPLLASMI SFIDRDGNLE LLTRPDTPPW
     ARDLWMFIFS DTMLLNIPLV MNNERHKGEM AYIVVQNHMN LSENASNNVP FSWKIKDYLE
     ELWVQAQYIT DAEGLPKKFV DIFQQTPLGR FLAQLHGEPQ QELLQCYLKD FILLTMRVST
     EEELKFLQMA LWSCTRKLKA ASEAPEEEVS LPWVHLAYQR FRSRLQNFSR ILTIYPQVLH
     SLMEARWNHE LAGCEMTLDA FAAMACTEML TRNTLKPSPQ AWLQLVKNLS MPLELICSDE
     HMQGSGSLAQ AVIREVRAQW SRIFSTALFV EHVLLGTESR VPELQGLVTE HVFLLDKCLR
     ENSDVKTHGP FEAVMRTLCE CKETASKTLS RFGIQPCSIC LGDAKDPVCL PCDHVHCLRC
     LRAWFASEQM ICPYCLTALP DEFSPAVSQA HREAIEKHAR FRQMCNSFFV DLVSTICFKD
     NAPPEKEVIE SLLSLLFVQK GRLRDAAQRH CEHTKSLSPF NDVVDKTPVI RSVILKLLLK
     YSFHDVKDYI QEYLTLLKKK AFITEDKTEL YMLFINCLED SILEKTSAYS RNDELNHLEE
     EGRFLKAYSP ASRGREPANE ASVEYLQEVA RIRLCLDRAA DFLSEPEGGP EMAKEKQCYL
     QQVKQFCIRV ENDWHRVYLV RKLSSQRGME FVQGLSKPGR PHQWVFPKDV VKQQGLRQDH
     PGQMDRYLVY GDEYKALRDA VAKAVLECKP LGIKTALKAC KTPQSQQSAY FLLTLFREVA
     ILYRSHNASL HPTPEQCEAV SKFIGECKIL SPPDISRFAT SLVDNSVPLL RAGPSDSNLD
     GTVTEMAIHA AAVLLCGQNE LLEPLKNLAF SPATMAHAFL PTMPEDLLAQ ARRWKGLERV
     HWYTCPNGHP CSVGECGRPM EQSICIDCHA PIGGIDHKPR DGFHLVKDKA DRTQTGHVLG
     NPQRRDVVTC DRGLPPVVFL LIRLLTHLAL LLGASQSSQA LINIIKPPVR DPKGFLQQHI
     LKDLEQLAKM LGHSADETIG VVHLVLRRLL QEQHQLSSRR LLNFDTELST KEMRNNWEKE
     IAAVISPELE HLDKTLPTMN NLISQDKRIS SNPVAKIIYG DPVTFLPHLP RKSVVHCSKI
     WSCRKRITVE YLQHIVEQKN GKERVPILWH FLQKEAELRL VKFLPEILAL QRDLVKQFQN
     VQQVEYSSIR GFLSKHSSDG LRQLLHNRIT VFLSTWNKLR RSLETNGEIN LPKDYCSTDL
     DLDTEFEILL PRRRGLGLCA TALVSYLIRL HNEIVYAVEK LSKENNSYSV DAAEVTELHV
     ISYEVERDLT PLILSNCQYQ VEEGRETVQE FDLEKIQRQI VSRFLQGKPR LSLKGIPTLV
     YRHDWNYEHL FMDIKNKMAQ DSLPSSVISA ISGQLQSYSD ACEVLSVVEV TLGFLSTAGG
     DPNMQLNVYT QDILQMGDQT IHVLKALNRC QLKHTIALWQ FLSAHKSEQL LRLHKEPFGE
     ISSRYKADLS PENAKLLSTF LNQTGLDAFL LELHEMIILK LKNPQTQTEE RFRPQWSLRD
     TLVSYMQTKE SEILPEMASQ FPEEILLASC VSVWKTAAVL KWNREMR
//
ID   RPN1_HUMAN              Reviewed;         607 AA.
AC   P04843; B2R5Z0; D3DNB6; Q68DT1;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   28-FEB-2018, entry version 175.
DE   RecName: Full=Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1;
DE   AltName: Full=Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit;
DE   AltName: Full=Ribophorin I;
DE            Short=RPN-I;
DE   AltName: Full=Ribophorin-1;
DE   Flags: Precursor;
GN   Name=RPN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3034581;
RA   Crimaudo C., Hortsch M., Gausepohl H., Meyer D.I.;
RT   "Human ribophorins I and II: the primary structure and membrane
RT   topology of two highly conserved rough endoplasmic reticulum-specific
RT   glycoproteins.";
RL   EMBO J. 6:75-82(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterine endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K.,
RA   Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J.,
RA   Hearing V.J., Hunt D.F., Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=12887896; DOI=10.1016/S1097-2765(03)00243-0;
RA   Kelleher D.J., Karaoglu D., Mandon E.C., Gilmore R.;
RT   "Oligosaccharyltransferase isoforms that contain different catalytic
RT   STT3 subunits have distinct enzymatic properties.";
RL   Mol. Cell 12:101-111(2003).
RN   [8]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-299.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-187, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=25135935; DOI=10.1083/jcb.201404083;
RA   Cherepanova N.A., Shrimal S., Gilmore R.;
RT   "Oxidoreductase activity is necessary for N-glycosylation of cysteine-
RT   proximal acceptor sites in glycoproteins.";
RL   J. Cell Biol. 206:525-539(2014).
RN   [13]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=23606741; DOI=10.1242/jcs.115410;
RA   Dumax-Vorzet A., Roboti P., High S.;
RT   "OST4 is a subunit of the mammalian oligosaccharyltransferase required
RT   for efficient N-glycosylation.";
RL   J. Cell Sci. 126:2595-2606(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-538, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Essential subunit of the N-oligosaccharyl transferase
CC       (OST) complex which catalyzes the transfer of a high mannose
CC       oligosaccharide from a lipid-linked oligosaccharide donor to an
CC       asparagine residue within an Asn-X-Ser/Thr consensus motif in
CC       nascent polypeptide chains. {ECO:0000250|UniProtKB:E2RQ08,
CC       ECO:0000250|UniProtKB:Q9GMB0, ECO:0000305}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Component of the oligosaccharyltransferase (OST) complex.
CC       OST exists in two different complex forms which contain common
CC       core subunits RPN1, RPN2, OST48, OST4, DAD1 and TMEM258, either
CC       STT3A or STT3B as catalytic subunits, and form-specific accessory
CC       subunits. OST can form stable complexes with the Sec61 complex or
CC       with both the Sec61 and TRAP complexes (By similarity).
CC       {ECO:0000250|UniProtKB:E2RQ08, ECO:0000269|PubMed:23606741,
CC       ECO:0000269|PubMed:25135935, ECO:0000305}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=5; IntAct=EBI-355963, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-355963, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-355963, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:E2RQ08, ECO:0000250|UniProtKB:Q9GMB0}.
CC       Endoplasmic reticulum membrane; Single-pass type I membrane
CC       protein {ECO:0000305}. Melanosome. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested.
CC       {ECO:0000269|PubMed:12887896}.
CC   -!- SIMILARITY: Belongs to the OST1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00281; CAA68392.1; -; mRNA.
DR   EMBL; AK312369; BAG35287.1; -; mRNA.
DR   EMBL; CR749284; CAH18139.1; -; mRNA.
DR   EMBL; CH471052; EAW79306.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79307.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79308.1; -; Genomic_DNA.
DR   EMBL; BC010839; AAH10839.1; -; mRNA.
DR   CCDS; CCDS3051.1; -.
DR   PIR; A26168; A26168.
DR   RefSeq; NP_002941.1; NM_002950.3.
DR   UniGene; Hs.518244; -.
DR   UniGene; Hs.603636; -.
DR   ProteinModelPortal; P04843; -.
DR   SMR; P04843; -.
DR   BioGrid; 112099; 157.
DR   CORUM; P04843; -.
DR   DIP; DIP-38152N; -.
DR   IntAct; P04843; 47.
DR   MINT; P04843; -.
DR   STRING; 9606.ENSP00000296255; -.
DR   iPTMnet; P04843; -.
DR   PhosphoSitePlus; P04843; -.
DR   SwissPalm; P04843; -.
DR   BioMuta; RPN1; -.
DR   DMDM; 132559; -.
DR   EPD; P04843; -.
DR   MaxQB; P04843; -.
DR   PaxDb; P04843; -.
DR   PeptideAtlas; P04843; -.
DR   PRIDE; P04843; -.
DR   TopDownProteomics; P04843; -.
DR   DNASU; 6184; -.
DR   Ensembl; ENST00000296255; ENSP00000296255; ENSG00000163902.
DR   GeneID; 6184; -.
DR   KEGG; hsa:6184; -.
DR   UCSC; uc003ekr.2; human.
DR   CTD; 6184; -.
DR   DisGeNET; 6184; -.
DR   EuPathDB; HostDB:ENSG00000163902.11; -.
DR   GeneCards; RPN1; -.
DR   HGNC; HGNC:10381; RPN1.
DR   HPA; CAB009748; -.
DR   HPA; HPA026828; -.
DR   HPA; HPA051520; -.
DR   MalaCards; RPN1; -.
DR   MIM; 180470; gene.
DR   neXtProt; NX_P04843; -.
DR   OpenTargets; ENSG00000163902; -.
DR   Orphanet; 402020; 'Acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)'.
DR   PharmGKB; PA34777; -.
DR   eggNOG; KOG2291; Eukaryota.
DR   eggNOG; ENOG410XQVZ; LUCA.
DR   GeneTree; ENSGT00390000009630; -.
DR   HOGENOM; HOG000247000; -.
DR   HOVERGEN; HBG012864; -.
DR   InParanoid; P04843; -.
DR   KO; K12666; -.
DR   OMA; MKVASIT; -.
DR   OrthoDB; EOG091G05K5; -.
DR   PhylomeDB; P04843; -.
DR   TreeFam; TF312988; -.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-446203; Asparagine N-linked glycosylation.
DR   SIGNOR; P04843; -.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; RPN1; human.
DR   GeneWiki; RPN1; -.
DR   GenomeRNAi; 6184; -.
DR   PRO; PR:P04843; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163902; -.
DR   CleanEx; HS_RPN1; -.
DR   ExpressionAtlas; P04843; baseline and differential.
DR   Genevisible; P04843; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0008250; C:oligosaccharyltransferase complex; TAS:HGNC.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0004579; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB.
DR   InterPro; IPR007676; Ribophorin_I.
DR   PANTHER; PTHR21049; PTHR21049; 1.
DR   Pfam; PF04597; Ribophorin_I; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Endoplasmic reticulum; Glycoprotein;
KW   Isopeptide bond; Membrane; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     23
FT   CHAIN        24    607       Dolichyl-diphosphooligosaccharide--
FT                                protein glycosyltransferase subunit 1.
FT                                /FTId=PRO_0000022241.
FT   TOPO_DOM     24    438       Lumenal. {ECO:0000255}.
FT   TRANSMEM    439    457       Helical. {ECO:0000255}.
FT   TOPO_DOM    458    607       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     187    187       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     538    538       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q91YQ5}.
FT   CARBOHYD    299    299       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CROSSLNK    538    538       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
SQ   SEQUENCE   607 AA;  68569 MW;  A2351A9CFABAEB6C CRC64;
     MEAPAAGLFL LLLLGTWAPA PGSASSEAPP LINEDVKRTV DLSSHLAKVT AEVVLAHLGG
     GSTSRATSFL LALEPELEAR LAHLGVQVKG EDEEENNLEV RETKIKGKSG RFFTVKLPVA
     LDPGAKISVI VETVYTHVLH PYPTQITQSE KQFVVFEGNH YFYSPYPTKT QTMRVKLASR
     NVESYTKLGN PTRSEDLLDY GPFRDVPAYS QDTFKVHYEN NSPFLTITSM TRVIEVSHWG
     NIAVEENVDL KHTGAVLKGP FSRYDYQRQP DSGISSIRSF KTILPAAAQD VYYRDEIGNV
     STSHLLILDD SVEMEIRPRF PLFGGWKTHY IVGYNLPSYE YLYNLGDQYA LKMRFVDHVF
     DEQVIDSLTV KIILPEGAKN IEIDSPYEIS RAPDELHYTY LDTFGRPVIV AYKKNLVEQH
     IQDIVVHYTF NKVLMLQEPL LVVAAFYILF FTVIIYVRLD FSITKDPAAE ARMKVACITE
     QVLTLVNKRI GLYRHFDETV NRYKQSRDIS TLNSGKKSLE TEHKALTSEI ALLQSRLKTE
     GSDLCDRVSE MQKLDAQVKE LVLKSAVEAE RLVAGKLKKD TYIENEKLIS GKRQELVTKI
     DHILDAL
//
ID   B4E1S6_HUMAN            Unreviewed;       126 AA.
AC   B4E1S6;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 75.
DE   RecName: Full=Syndecan {ECO:0000256|RuleBase:RU000649};
GN   Name=SDC4 {ECO:0000313|EMBL:EAW75860.1};
GN   ORFNames=hCG_38363 {ECO:0000313|EMBL:EAW75860.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64888.1};
RN   [1] {ECO:0000313|EMBL:EAW75860.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW75860.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAG64888.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG64888.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Cell surface proteoglycan.
CC       {ECO:0000256|RuleBase:RU000649}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU000649};
CC       Single-pass type I membrane protein
CC       {ECO:0000256|RuleBase:RU000649}.
CC   -!- SIMILARITY: Belongs to the syndecan proteoglycan family.
CC       {ECO:0000256|RuleBase:RU000649}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK303964; BAG64888.1; -; mRNA.
DR   EMBL; CH471077; EAW75860.1; -; Genomic_DNA.
DR   RefSeq; XP_011527279.1; XM_011528977.2.
DR   UniGene; Hs.632267; -.
DR   MaxQB; B4E1S6; -.
DR   PeptideAtlas; B4E1S6; -.
DR   GeneID; 6385; -.
DR   CTD; 6385; -.
DR   eggNOG; ENOG410IXIG; Eukaryota.
DR   eggNOG; ENOG4111QSA; LUCA.
DR   HOVERGEN; HBG004501; -.
DR   ChiTaRS; SDC4; human.
DR   GenomeRNAi; 6385; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR003585; Neurexin-like.
DR   InterPro; IPR001050; Syndecan.
DR   InterPro; IPR027789; Syndecan/Neurexin_dom.
DR   InterPro; IPR030479; Syndecan_CS.
DR   PANTHER; PTHR10915; PTHR10915; 1.
DR   Pfam; PF01034; Syndecan; 1.
DR   SMART; SM00294; 4.1m; 1.
DR   PROSITE; PS00964; SYNDECAN; 1.
PE   2: Evidence at transcript level;
KW   Glycoprotein {ECO:0000256|RuleBase:RU000649};
KW   Heparan sulfate {ECO:0000256|RuleBase:RU000649};
KW   Membrane {ECO:0000256|SAAS:SAAS00416869, ECO:0000256|SAM:Phobius};
KW   Proteoglycan {ECO:0000256|RuleBase:RU000649};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00416869,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00416869,
KW   ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     74     98       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       97    115       4.1m. {ECO:0000259|SMART:SM00294}.
SQ   SEQUENCE   126 AA;  13910 MW;  FFFFA5D3D4B914A4 CRC64;
     MIGPEVVHPL VPLDNHIPER AGSGSQVPTE PKKLEENEVI PKRISPVEES EDVSNKVSMS
     STVQGSNIFE RTEVLAALIV GGIVGILFAV FLILLLMYRM KKKDEGSYDL GKKPIYKKAP
     TNEFYA
//
ID   SDC4_HUMAN              Reviewed;         198 AA.
AC   P31431; O00773; Q16833; Q53FN9; Q6FGN3;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   28-FEB-2018, entry version 185.
DE   RecName: Full=Syndecan-4;
DE            Short=SYND4;
DE   AltName: Full=Amphiglycan;
DE   AltName: Full=Ryudocan core protein;
DE   Flags: Precursor;
GN   Name=SDC4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANT LEU-12.
RC   TISSUE=Lung fibroblast;
RX   PubMed=1500433; DOI=10.1083/jcb.118.4.961;
RA   David G., van der Schueren B., Marynen P., Cassiman J.-J.,
RA   van den Berghe H.;
RT   "Molecular cloning of amphiglycan, a novel integral membrane heparan
RT   sulfate proteoglycan expressed by epithelial and fibroblastic cells.";
RL   J. Cell Biol. 118:961-969(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7916598; DOI=10.1006/bbrc.1993.1122;
RA   Kojima T., Inazawa J., Takamatsu J., Rosenberg R.D., Saito H.;
RT   "Human ryudocan core protein: molecular cloning and characterization
RT   of the cDNA, and chromosomal localization of the gene.";
RL   Biochem. Biophys. Res. Commun. 190:814-822(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8797100; DOI=10.1093/oxfordjournals.jbchem.a021338;
RA   Takagi A., Kojima T., Tsuzuki S., Katsumi A., Yamazaki T., Sugiura I.,
RA   Hamaguchi M., Saito H.;
RT   "Structural organization and promoter activity of the human ryudocan
RT   gene.";
RL   J. Biochem. 119:979-984(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LEU-12.
RC   TISSUE=Stomach;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 75-153 (ISOFORM 2).
RA   Hillier L., Clark N., Dubuque T., Elliston K., Hawkins M., Holman M.,
RA   Hultman M., Kucaba T., Le M., Lennon G., Marra M., Parsons J.,
RA   Rifkin L., Rohlfing T., Soares M., Tan F., Trevaskis E., Waterston R.,
RA   Williamson A., Wohldmann P., Wilson R.;
RT   "The WashU-Merck EST project.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 125-153 (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=8889549; DOI=10.1101/gr.6.9.807;
RA   Hillier L.D., Lennon G., Becker M., Bonaldo M.F., Chiapelli B.,
RA   Chissoe S., Dietrich N., DuBuque T., Favello A., Gish W., Hawkins M.,
RA   Hultman M., Kucaba T., Lacy M., Le M., Le N., Mardis E., Moore B.,
RA   Morris M., Parsons J., Prange C., Rifkin L., Rohlfing T.,
RA   Schellenberg K., Bento Soares M., Tan F., Thierry-Meg J.,
RA   Trevaskis E., Underwood K., Wohldman P., Waterston R., Wilson R.,
RA   Marra M.;
RT   "Generation and analysis of 280,000 human expressed sequence tags.";
RL   Genome Res. 6:807-828(1996).
RN   [12]
RP   SHEDDING, AND SUBCELLULAR LOCATION.
RX   PubMed=9169435; DOI=10.1074/jbc.272.23.14713;
RA   Subramanian S.V., Fitzgerald M.L., Bernfield M.;
RT   "Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and
RT   growth factor receptor activation.";
RL   J. Biol. Chem. 272:14713-14720(1997).
RN   [13]
RP   ALTERNATIVE SPLICING (ISOFORM 2), AND SUBCELLULAR LOCATION.
RX   PubMed=14675776; DOI=10.1016/S0014-5793(03)01354-1;
RA   Xing Y., Xu Q., Lee C.;
RT   "Widespread production of novel soluble protein isoforms by
RT   alternative splicing removal of transmembrane anchoring domains.";
RL   FEBS Lett. 555:572-578(2003).
RN   [14]
RP   INTERACTION WITH CDCP1.
RX   PubMed=16007225; DOI=10.1038/sj.onc.1208582;
RA   Bhatt A.S., Erdjument-Bromage H., Tempst P., Craik C.S., Moasser M.M.;
RT   "Adhesion signaling by a novel mitotic substrate of src kinases.";
RL   Oncogene 24:5333-5343(2005).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   FUNCTION.
RX   PubMed=22660413; DOI=10.1038/ncb2502;
RA   Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G.,
RA   Geeraerts A., Ivarsson Y., Depoortere F., Coomans C., Vermeiren E.,
RA   Zimmermann P., David G.;
RT   "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.";
RL   Nat. Cell Biol. 14:677-685(2012).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   STRUCTURE BY NMR OF 171-198.
RX   PubMed=11456484; DOI=10.1021/bi002750r;
RA   Shin J., Lee W., Lee D., Koo B.-K., Han I., Lim Y., Woods A.,
RA   Couchman J.R., Oh E.-S.;
RT   "Solution structure of the dimeric cytoplasmic domain of syndecan-4.";
RL   Biochemistry 40:8471-8478(2001).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 193-198 IN COMPLEX WITH
RP   SDCBP.
RX   PubMed=12842047; DOI=10.1016/S0969-2126(03)00125-4;
RA   Kang B.S., Cooper D.R., Devedjiev Y., Derewenda U., Derewenda Z.S.;
RT   "Molecular roots of degenerate specificity in syntenin's PDZ2 domain:
RT   reassessment of the PDZ recognition paradigm.";
RL   Structure 11:845-853(2003).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 182-198 IN COMPLEX WITH
RP   SDCBP.
RX   PubMed=16533050; DOI=10.1021/bi052225y;
RA   Grembecka J., Cierpicki T., Devedjiev Y., Derewenda U., Kang B.S.,
RA   Bushweller J.H., Derewenda Z.S.;
RT   "The binding of the PDZ tandem of syntenin to target proteins.";
RL   Biochemistry 45:3674-3683(2006).
CC   -!- FUNCTION: Cell surface proteoglycan that bears heparan sulfate.
CC       Regulates exosome biogenesis in concert with SDCBP and PDCD6IP
CC       (PubMed:22660413). {ECO:0000269|PubMed:22660413}.
CC   -!- SUBUNIT: Homodimer. Interacts (via its cytoplasmic domain) with
CC       GIPC (via its PDZ domain). Interacts (via its cytoplasmic domain)
CC       with NUDT16L1 (By similarity). Interacts with CDCP1 and SDCBP.
CC       {ECO:0000250|UniProtKB:O35988, ECO:0000269|PubMed:12842047,
CC       ECO:0000269|PubMed:16007225, ECO:0000269|PubMed:16533050}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-3913237, EBI-3913237;
CC       P17252:PRKCA; NbExp=2; IntAct=EBI-3913237, EBI-1383528;
CC       P34741:SDC2; NbExp=2; IntAct=EBI-3913237, EBI-1172957;
CC       O75056:SDC3; NbExp=2; IntAct=EBI-3913237, EBI-1642090;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-3913237, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Membrane {ECO:0000255}; Single-
CC       pass type I membrane protein {ECO:0000255}. Secreted
CC       {ECO:0000269|PubMed:9169435}. Note=Shedding of the ectodomain
CC       produces a soluble form. {ECO:0000269|PubMed:9169435}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P31431-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P31431-2; Sequence=VSP_044449;
CC         Note=Soluble form, lacks the transmembrane domain.;
CC   -!- TISSUE SPECIFICITY: Expressed in epithelial and fibroblastic
CC       cells. {ECO:0000269|PubMed:1500433}.
CC   -!- PTM: Shedding is enhanced by a number of factors such as
CC       heparanase, thrombin or EGF. Also by stress and wound healing.
CC       PMA-mediated shedding is inhibited by TIMP3.
CC       {ECO:0000269|PubMed:9169435}.
CC   -!- SIMILARITY: Belongs to the syndecan proteoglycan family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X67016; CAA47406.1; -; mRNA.
DR   EMBL; D13292; BAA02550.1; -; mRNA.
DR   EMBL; D79206; BAA19613.1; -; Genomic_DNA.
DR   EMBL; AK312507; BAG35408.1; -; mRNA.
DR   EMBL; CR542045; CAG46842.1; -; mRNA.
DR   EMBL; CR542074; CAG46871.1; -; mRNA.
DR   EMBL; AK222695; BAD96415.1; -; mRNA.
DR   EMBL; AK223243; BAD96963.1; -; mRNA.
DR   EMBL; AL021578; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75861.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75862.1; -; Genomic_DNA.
DR   EMBL; BC030805; AAH30805.1; -; mRNA.
DR   EMBL; AA151028; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AA258502; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS13350.1; -. [P31431-1]
DR   PIR; JC1457; JC1457.
DR   RefSeq; NP_002990.2; NM_002999.3. [P31431-1]
DR   UniGene; Hs.632267; -.
DR   PDB; 1EJP; NMR; -; A/B=171-198.
DR   PDB; 1EJQ; NMR; -; A/B=171-198.
DR   PDB; 1OBY; X-ray; 1.85 A; P/Q=193-198.
DR   PDB; 1YBO; X-ray; 2.30 A; C/D=182-198.
DR   PDBsum; 1EJP; -.
DR   PDBsum; 1EJQ; -.
DR   PDBsum; 1OBY; -.
DR   PDBsum; 1YBO; -.
DR   ProteinModelPortal; P31431; -.
DR   SMR; P31431; -.
DR   BioGrid; 112286; 19.
DR   DIP; DIP-29945N; -.
DR   ELM; P31431; -.
DR   IntAct; P31431; 17.
DR   MINT; P31431; -.
DR   STRING; 9606.ENSP00000361818; -.
DR   TCDB; 9.A.35.1.1; the peptide translocating syndecan (syndecan) family.
DR   iPTMnet; P31431; -.
DR   PhosphoSitePlus; P31431; -.
DR   BioMuta; SDC4; -.
DR   DMDM; 2851418; -.
DR   EPD; P31431; -.
DR   PaxDb; P31431; -.
DR   PeptideAtlas; P31431; -.
DR   PRIDE; P31431; -.
DR   TopDownProteomics; P31431-1; -. [P31431-1]
DR   DNASU; 6385; -.
DR   Ensembl; ENST00000372733; ENSP00000361818; ENSG00000124145. [P31431-1]
DR   GeneID; 6385; -.
DR   KEGG; hsa:6385; -.
DR   UCSC; uc002xnu.4; human. [P31431-1]
DR   CTD; 6385; -.
DR   DisGeNET; 6385; -.
DR   EuPathDB; HostDB:ENSG00000124145.6; -.
DR   GeneCards; SDC4; -.
DR   HGNC; HGNC:10661; SDC4.
DR   HPA; CAB013240; -.
DR   HPA; HPA005716; -.
DR   MIM; 600017; gene.
DR   neXtProt; NX_P31431; -.
DR   OpenTargets; ENSG00000124145; -.
DR   PharmGKB; PA35591; -.
DR   eggNOG; ENOG410IXIG; Eukaryota.
DR   eggNOG; ENOG4111QSA; LUCA.
DR   GeneTree; ENSGT00530000063116; -.
DR   HOGENOM; HOG000263414; -.
DR   HOVERGEN; HBG004501; -.
DR   InParanoid; P31431; -.
DR   KO; K16338; -.
DR   OMA; QEPDDFE; -.
DR   OrthoDB; EOG091G0OOE; -.
DR   PhylomeDB; P31431; -.
DR   TreeFam; TF320463; -.
DR   Reactome; R-HSA-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-HSA-2022928; HS-GAG biosynthesis.
DR   Reactome; R-HSA-2024096; HS-GAG degradation.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3560783; Defective B4GALT7 causes EDS, progeroid type.
DR   Reactome; R-HSA-3560801; Defective B3GAT3 causes JDSSDHD.
DR   Reactome; R-HSA-3656237; Defective EXT2 causes exostoses 2.
DR   Reactome; R-HSA-3656253; Defective EXT1 causes exostoses 1, TRPS2 and CHDS.
DR   Reactome; R-HSA-4420332; Defective B3GALT6 causes EDSP2 and SEMDJL1.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   SIGNOR; P31431; -.
DR   ChiTaRS; SDC4; human.
DR   EvolutionaryTrace; P31431; -.
DR   GeneWiki; SDC4; -.
DR   GenomeRNAi; 6385; -.
DR   PMAP-CutDB; P31431; -.
DR   PRO; PR:P31431; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000124145; -.
DR   CleanEx; HS_SDC4; -.
DR   Genevisible; P31431; HS.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0043034; C:costamere; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IEA:Ensembl.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0001968; F:fibronectin binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005080; F:protein kinase C binding; IEA:Ensembl.
DR   GO; GO:0070053; F:thrombospondin receptor activity; IMP:BHF-UCL.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome.
DR   GO; GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome.
DR   GO; GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome.
DR   GO; GO:0060122; P:inner ear receptor cell stereocilium organization; IEA:Ensembl.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:1903543; P:positive regulation of exosomal secretion; IMP:UniProtKB.
DR   GO; GO:1903553; P:positive regulation of extracellular exosome assembly; IMP:UniProtKB.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; IEA:Ensembl.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl.
DR   GO; GO:0010762; P:regulation of fibroblast migration; IEA:Ensembl.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0001657; P:ureteric bud development; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   InterPro; IPR003585; Neurexin-like.
DR   InterPro; IPR001050; Syndecan.
DR   InterPro; IPR027789; Syndecan/Neurexin_dom.
DR   InterPro; IPR030479; Syndecan_CS.
DR   PANTHER; PTHR10915; PTHR10915; 1.
DR   Pfam; PF01034; Syndecan; 1.
DR   SMART; SM00294; 4.1m; 1.
DR   PROSITE; PS00964; SYNDECAN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Glycoprotein;
KW   Heparan sulfate; Membrane; Polymorphism; Proteoglycan;
KW   Reference proteome; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    198       Syndecan-4.
FT                                /FTId=PRO_0000033511.
FT   TOPO_DOM     19    145       Extracellular. {ECO:0000255}.
FT   TRANSMEM    146    170       Helical. {ECO:0000255}.
FT   TOPO_DOM    171    198       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     39     39       O-linked (Xyl...) (heparan sulfate)
FT                                serine. {ECO:0000250}.
FT   CARBOHYD     61     61       O-linked (Xyl...) (heparan sulfate)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD     63     63       O-linked (Xyl...) (heparan sulfate)
FT                                serine. {ECO:0000255}.
FT   VAR_SEQ     149    198       ALIVGGIVGILFAVFLILLLMYRMKKKDEGSYDLGKKPIYK
FT                                KAPTNEFYA -> GCPEH (in isoform 2).
FT                                {ECO:0000303|PubMed:8889549,
FT                                ECO:0000303|Ref.10}.
FT                                /FTId=VSP_044449.
FT   VARIANT      12     12       F -> L (in dbSNP:rs2228384).
FT                                {ECO:0000269|PubMed:1500433,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_021851.
FT   STRAND      192    194       {ECO:0000244|PDB:1EJQ}.
FT   STRAND      196    198       {ECO:0000244|PDB:1OBY}.
SQ   SEQUENCE   198 AA;  21642 MW;  8229AA2733F77A10 CRC64;
     MAPARLFALL LFFVGGVAES IRETEVIDPQ DLLEGRYFSG ALPDDEDVVG PGQESDDFEL
     SGSGDLDDLE DSMIGPEVVH PLVPLDNHIP ERAGSGSQVP TEPKKLEENE VIPKRISPVE
     ESEDVSNKVS MSSTVQGSNI FERTEVLAAL IVGGIVGILF AVFLILLLMY RMKKKDEGSY
     DLGKKPIYKK APTNEFYA
//
ID   S45A3_HUMAN             Reviewed;         553 AA.
AC   Q96JT2; A8K2U9;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   31-JAN-2018, entry version 113.
DE   RecName: Full=Solute carrier family 45 member 3;
DE   AltName: Full=Prostate cancer-associated protein 6;
DE   AltName: Full=Prostein;
GN   Name=SLC45A3; Synonyms=PCANAP6, PRST;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INDUCTION.
RC   TISSUE=Prostate;
RX   PubMed=11245466;
RA   Xu J., Kalos M., Stolk J.A., Zasloff E.J., Zhang X., Houghton R.L.,
RA   Filho A.M., Nolasco M., Badaro R., Reed S.G.;
RT   "Identification and characterization of prostein, a novel prostate-
RT   specific protein.";
RL   Cancer Res. 61:1563-1568(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thalamus, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=14997204; DOI=10.1038/sj.bjc.6601642;
RA   Kiessling A., Stevanovic S., Fuessel S., Weigle B., Rieger M.A.,
RA   Temme A., Rieber E.P., Schmitz M.;
RT   "Identification of an HLA-A(*)0201-restricted T-cell epitope derived
RT   from the prostate cancer-associated protein prostein.";
RL   Br. J. Cancer 90:1034-1040(2004).
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Prostate specific. Expressed in all prostatic
CC       glandular cells. Expressed both in normal and cancerous prostates.
CC       {ECO:0000269|PubMed:11245466, ECO:0000269|PubMed:14997204}.
CC   -!- INDUCTION: Up-regulated by androgens.
CC       {ECO:0000269|PubMed:11245466}.
CC   -!- MISCELLANEOUS: Marker for prostate cells. May be used, in case of
CC       prostate cancers, as a target antigen for prostate carcinomas-
CC       directed cytotoxic T-cell lymphocytes.
CC   -!- SIMILARITY: Belongs to the glycoside-pentoside-hexuronide (GPH)
CC       cation symporter transporter (TC 2.A.2) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY033593; AAK54386.1; -; mRNA.
DR   EMBL; AK290364; BAF83053.1; -; mRNA.
DR   EMBL; AK313479; BAG36263.1; -; mRNA.
DR   EMBL; CH471067; EAW91575.1; -; Genomic_DNA.
DR   EMBL; BC050416; AAH50416.1; -; mRNA.
DR   CCDS; CCDS1458.1; -.
DR   RefSeq; NP_149093.1; NM_033102.2.
DR   RefSeq; XP_005245613.1; XM_005245556.3.
DR   RefSeq; XP_005245614.1; XM_005245557.4.
DR   RefSeq; XP_016858127.1; XM_017002638.1.
DR   UniGene; Hs.278695; -.
DR   ProteinModelPortal; Q96JT2; -.
DR   STRING; 9606.ENSP00000356113; -.
DR   TCDB; 2.A.2.4.8; the glycoside-pentoside-hexuronide (gph):cation symporter family.
DR   iPTMnet; Q96JT2; -.
DR   PhosphoSitePlus; Q96JT2; -.
DR   BioMuta; SLC45A3; -.
DR   DMDM; 46396996; -.
DR   MaxQB; Q96JT2; -.
DR   PaxDb; Q96JT2; -.
DR   PeptideAtlas; Q96JT2; -.
DR   PRIDE; Q96JT2; -.
DR   Ensembl; ENST00000367145; ENSP00000356113; ENSG00000158715.
DR   GeneID; 85414; -.
DR   KEGG; hsa:85414; -.
DR   UCSC; uc001hda.2; human.
DR   CTD; 85414; -.
DR   DisGeNET; 85414; -.
DR   EuPathDB; HostDB:ENSG00000158715.5; -.
DR   GeneCards; SLC45A3; -.
DR   HGNC; HGNC:8642; SLC45A3.
DR   HPA; HPA019073; -.
DR   HPA; HPA019075; -.
DR   MIM; 605097; gene.
DR   neXtProt; NX_Q96JT2; -.
DR   OpenTargets; ENSG00000158715; -.
DR   PharmGKB; PA32981; -.
DR   eggNOG; KOG0637; Eukaryota.
DR   eggNOG; ENOG410XPTR; LUCA.
DR   GeneTree; ENSGT00390000018882; -.
DR   HOGENOM; HOG000013046; -.
DR   HOVERGEN; HBG053519; -.
DR   InParanoid; Q96JT2; -.
DR   KO; K15379; -.
DR   OMA; LCGASAC; -.
DR   OrthoDB; EOG091G0DTJ; -.
DR   PhylomeDB; Q96JT2; -.
DR   TreeFam; TF325412; -.
DR   Reactome; R-HSA-189200; Cellular hexose transport.
DR   ChiTaRS; SLC45A3; human.
DR   GeneWiki; SLC45A3; -.
DR   GenomeRNAi; 85414; -.
DR   PRO; PR:Q96JT2; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000158715; -.
DR   CleanEx; HS_SLC45A3; -.
DR   Genevisible; Q96JT2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008506; F:sucrose:proton symporter activity; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0051119; F:sugar transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0008645; P:hexose transport; TAS:Reactome.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0010907; P:positive regulation of glucose metabolic process; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048713; P:regulation of oligodendrocyte differentiation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0015770; P:sucrose transport; ISS:ParkinsonsUK-UCL.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   Pfam; PF07690; MFS_1; 1.
DR   SUPFAM; SSF103473; SSF103473; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    553       Solute carrier family 45 member 3.
FT                                /FTId=PRO_0000122519.
FT   TRANSMEM     19     39       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM     52     72       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM     88    108       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    120    140       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    161    181       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    198    218       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    275    295       Helical; Name=7. {ECO:0000255}.
FT   TRANSMEM    323    343       Helical; Name=8. {ECO:0000255}.
FT   TRANSMEM    353    373       Helical; Name=9. {ECO:0000255}.
FT   TRANSMEM    382    402       Helical; Name=10. {ECO:0000255}.
FT   TRANSMEM    522    542       Helical; Name=11. {ECO:0000255}.
FT   COMPBIAS    455    458       Poly-Pro.
SQ   SEQUENCE   553 AA;  59323 MW;  0AFA23FBC742A667 CRC64;
     MVQRLWVSRL LRHRKAQLLL VNLLTFGLEV CLAAGITYVP PLLLEVGVEE KFMTMVLGIG
     PVLGLVCVPL LGSASDHWRG RYGRRRPFIW ALSLGILLSL FLIPRAGWLA GLLCPDPRPL
     ELALLILGVG LLDFCGQVCF TPLEALLSDL FRDPDHCRQA YSVYAFMISL GGCLGYLLPA
     IDWDTSALAP YLGTQEECLF GLLTLIFLTC VAATLLVAEE AALGPTEPAE GLSAPSLSPH
     CCPCRARLAF RNLGALLPRL HQLCCRMPRT LRRLFVAELC SWMALMTFTL FYTDFVGEGL
     YQGVPRAEPG TEARRHYDEG VRMGSLGLFL QCAISLVFSL VMDRLVQRFG TRAVYLASVA
     AFPVAAGATC LSHSVAVVTA SAALTGFTFS ALQILPYTLA SLYHREKQVF LPKYRGDTGG
     ASSEDSLMTS FLPGPKPGAP FPNGHVGAGG SGLLPPPPAL CGASACDVSV RVVVGEPTEA
     RVVPGRGICL DLAILDSAFL LSQVAPSLFM GSIVQLSQSV TAYMVSAAGL GLVAIYFATQ
     VVFDKSDLAK YSA
//
ID   A0A024RC40_HUMAN        Unreviewed;       418 AA.
AC   A0A024RC40;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 26.
DE   SubName: Full=Synovial sarcoma translocation, chromosome 18, isoform CRA_b {ECO:0000313|EMBL:EAX01211.1};
GN   Name=SS18 {ECO:0000313|EMBL:EAX01211.1};
GN   ORFNames=hCG_37175 {ECO:0000313|EMBL:EAX01211.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX01211.1};
RN   [1] {ECO:0000313|EMBL:EAX01211.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX01211.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471088; EAX01211.1; -; Genomic_DNA.
DR   RefSeq; NP_001007560.1; NM_001007559.2.
DR   UniGene; Hs.129261; -.
DR   PRIDE; A0A024RC40; -.
DR   GeneID; 6760; -.
DR   KEGG; hsa:6760; -.
DR   CTD; 6760; -.
DR   EuPathDB; HostDB:ENSG00000141380.13; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   KO; K15623; -.
DR   OMA; AFAPHRQ; -.
DR   OrthoDB; EOG091G0O10; -.
DR   PhylomeDB; A0A024RC40; -.
DR   ChiTaRS; SS18; human.
DR   GenomeRNAi; 6760; -.
DR   Bgee; ENSG00000141380; -.
DR   ExpressionAtlas; A0A024RC40; baseline and differential.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IEA:Ensembl.
DR   GO; GO:0071564; C:npBAF complex; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   4: Predicted;
SQ   SEQUENCE   418 AA;  45929 MW;  7E089D557538252F CRC64;
     MSVAFAAPRQ RGKGEITPAA IQKMLDDNNH LIQCIMDSQN KGKTSECSQY QQMLHTNLVY
     LATIADSNQN MQSLLPAPPT QNMPMGPGGM NQSGPPPPPR SHNMPSDGMV GGGPPAPHMQ
     NQMNGQMPGP NHMPMQGPGP NQLNMTNSSM NMPSSSHGSM GGYNHSVPSS QSMPVQNQMT
     MSQGQPMGNY GPRPNMSMQP NQGPMMHQQP PSQQYNMPQG GGQHYQGQQP PMGMMGQVNQ
     GNHMMGQRQI PPYRPPQQGP PQQYSGQEDY YGDQYSHGGQ GPPEGMNQQY YPDGHNDYGY
     QQPSYPEQGY DRPYEDSSQH YYEGGNSQYG QQQDAYQGPP PQQGYPPQQQ QYPGQQGYPG
     QQQGYGPSQG GPGPQYPNYP QGQGQQYGGY RPTQPGPPQP PQQRPYGYDQ GQYGNYQQ
//
ID   B4DLD3_HUMAN            Unreviewed;       395 AA.
AC   B4DLD3;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 69.
DE   SubName: Full=Protein SSXT {ECO:0000313|Ensembl:ENSP00000438066};
DE   SubName: Full=cDNA FLJ58120, highly similar to SSXT protein {ECO:0000313|EMBL:BAG59495.1};
GN   Name=SS18 {ECO:0000313|Ensembl:ENSP00000438066};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59495.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000438066, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., O'Neill K., Piqani B., Smith C.L., Talamas J.A.,
RA   Topham K., Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q.,
RA   Zimmer A.R., Fujiyama A., Hattori M., Birren B.W., Sakaki Y.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [2] {ECO:0000313|EMBL:BAG59495.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Tongue {ECO:0000313|EMBL:BAG59495.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000438066}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC091021; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK296949; BAG59495.1; -; mRNA.
DR   RefSeq; NP_001295130.1; NM_001308201.1.
DR   RefSeq; XP_011524447.1; XM_011526145.1.
DR   UniGene; Hs.129261; -.
DR   EPD; B4DLD3; -.
DR   MaxQB; B4DLD3; -.
DR   PeptideAtlas; B4DLD3; -.
DR   Ensembl; ENST00000542420; ENSP00000438066; ENSG00000141380.
DR   GeneID; 6760; -.
DR   UCSC; uc010xbi.3; human.
DR   CTD; 6760; -.
DR   EuPathDB; HostDB:ENSG00000141380.13; -.
DR   HGNC; HGNC:11340; SS18.
DR   OpenTargets; ENSG00000141380; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   GeneTree; ENSGT00500000044808; -.
DR   HOVERGEN; HBG003892; -.
DR   ChiTaRS; SS18; human.
DR   GenomeRNAi; 6760; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000141380; -.
DR   ExpressionAtlas; B4DLD3; baseline and differential.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:B4DLD3,
KW   ECO:0000213|MaxQB:B4DLD3, ECO:0000213|PeptideAtlas:B4DLD3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   395 AA;  43519 MW;  791BCA279022C064 CRC64;
     MLDDNNHLIQ CIMDSQNKGK TSECSQYQQM LHTNLVYLAT IADSNQNMQS LLPAPPTQNM
     PMGPGGMNQS GPPPPPRSHN MPSDGMVGGG PPAPHMQNQM NGQMPGPNHM PMQGPGPNQL
     NMTNSSMNMP SSSHGSMGGY NHSVPSSQSM PVQNQMTMSQ GQPMGNYGPR PNMSMQPNQG
     PMMHQQPPSQ QYNMPQGGGQ HYQGQQPPMG MMGQVNQGNH MMGQRQIPPY RPPQQGPPQQ
     YSGQEDYYGD QYSHGGQGPP EGMNQQYYPD GHNDYGYQQP SYPEQGYDRP YEDSSQHYYE
     GGNSQYGQQQ DAYQGPPPQQ GYPPQQQQYP GQQGYPGQQQ GYGPSQGGPG PQYPNYPQGQ
     GQQYGGYRPT QPGPPQPPQQ RPYGYDQGQY GNYQQ
//
ID   B4DR34_HUMAN            Unreviewed;       336 AA.
AC   B4DR34;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 62.
DE   SubName: Full=cDNA FLJ59390, highly similar to SSXT protein {ECO:0000313|EMBL:BAG61146.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG61146.1};
RN   [1] {ECO:0000313|EMBL:BAG61146.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK299082; BAG61146.1; -; mRNA.
DR   RefSeq; XP_006722590.1; XM_006722527.2.
DR   UniGene; Hs.129261; -.
DR   ProteinModelPortal; B4DR34; -.
DR   MaxQB; B4DR34; -.
DR   PeptideAtlas; B4DR34; -.
DR   PRIDE; B4DR34; -.
DR   GeneID; 6760; -.
DR   CTD; 6760; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   HOVERGEN; HBG003892; -.
DR   GenomeRNAi; 6760; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   336 AA;  36886 MW;  75B1F14CB4B956A3 CRC64;
     MPMGPGGMNQ SGPPPPPRSH NMPSDGMVGG GPPAPHMQNQ MNGQMPGPNH MPMQGPGPNQ
     LNMTNSSMNM PSSSHGSMGG YNHSVPSSQS MPVQNQMTMS QGQPMGNYGP RPNMSMQPNQ
     GPMMHQQPPS QQYNMPQGGG QHYQGQQPPM GMMGQVNQGN HMMGQRQIPP YRPPQQGPPQ
     QYSGQEDYYG DQYSHGGQGP PEGMNQQYYP DGHNDYGYQQ PSYPEQGYDR PYEDSSQHYY
     EGGNSQYGQQ QDAYQGPPPQ QGYPPQQQQY PGQQGYPGQQ QGYGPSQGGP GPQYPNYPQG
     QGQQYGGYRP TQPGPPQPPQ QRPYGYDQGQ YGNYQQ
//
ID   B4E2J6_HUMAN            Unreviewed;       335 AA.
AC   B4E2J6;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 56.
DE   SubName: Full=cDNA FLJ58566, highly similar to SSXT protein {ECO:0000313|EMBL:BAG65158.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65158.1};
RN   [1] {ECO:0000313|EMBL:BAG65158.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG65158.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK304305; BAG65158.1; -; mRNA.
DR   RefSeq; XP_011524454.1; XM_011526152.2.
DR   UniGene; Hs.129261; -.
DR   ProteinModelPortal; B4E2J6; -.
DR   MaxQB; B4E2J6; -.
DR   PeptideAtlas; B4E2J6; -.
DR   GeneID; 6760; -.
DR   CTD; 6760; -.
DR   HOVERGEN; HBG003892; -.
DR   GenomeRNAi; 6760; -.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   335 AA;  36452 MW;  A26BA61269370C44 CRC64;
     MLHTNLVYLA TIADSNQNMQ SLLPAPPTQN MPMGPGGMNQ SGPPPPPRSH NMPSDGMVGG
     GPPAPHMQNQ MNGQMPGPNH MPMQGPGPNQ LNMTNSSMNM PSSSHGSMGG YNHSVPSSQS
     MPVQNQMTMS QGQPMGNYGP RPNMSMQPNQ GPMMHQQPPS QQYNMPQGGG QHYQGQQPPM
     GMMGQVNQGN HMMGQRQIPP YRPPQQGPPQ QYSGQEDYYG DQYSHGGQGP PEGMNQQYYP
     DGNSQYGQQQ DAYQGPPPQQ GYPPQQQQYP GQQGYPGQQQ GYGPSQGGPG PQYPNYPQGQ
     GQQYGGYRPT QPGPPQPPQQ RPYGYDQGQY GNYQQ
//
ID   SSXT_HUMAN              Reviewed;         418 AA.
AC   Q15532; B0YJ95; Q16404; Q4VAX1; Q9BXC6;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   31-JAN-2002, sequence version 3.
DT   27-SEP-2017, entry version 147.
DE   RecName: Full=Protein SSXT;
DE   AltName: Full=Protein SYT;
DE   AltName: Full=Synovial sarcoma translocated to X chromosome protein;
GN   Name=SS18; Synonyms=SSXT, SYT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND SSXT-SSX2 FUSION PROTEIN.
RC   TISSUE=Synovial sarcoma;
RX   PubMed=7951320; DOI=10.1038/ng0894-502;
RA   Clark J., Rocques P.J., Crew A.J., Gill S., Shipley J., Chan A.M.-L.,
RA   Gusterson B.A., Cooper C.S.;
RT   "Identification of novel genes, SYT and SSX, involved in the
RT   t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma.";
RL   Nat. Genet. 7:502-508(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11368913; DOI=10.1016/S0378-1119(01)00412-7;
RA   Brodin B., Haslam K., Yang K., Bartolazzi A., Xie Y., Starborg M.,
RA   Lundeberg J., Larsson O.;
RT   "Cloning and characterization of spliced fusion transcript variants of
RT   synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible
RT   regulatory role of the fusion gene product in wild type SYT
RT   expression.";
RL   Gene 268:173-182(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 405-410 (SSXT-SSX2 FUSION PROTEIN), AND
RP   CHROMOSOMAL TRANSLOCATION WITH SSX2.
RX   PubMed=7495284;
RA   Fligman I., Lonardo F., Jhanwar S.C., Gerald W.L., Woodruff J.,
RA   Ladanyi M.;
RT   "Molecular diagnosis of synovial sarcoma and characterization of a
RT   variant SYT-SSX2 fusion transcript.";
RL   Am. J. Pathol. 147:1592-1599(1995).
RN   [7]
RP   CHROMOSOMAL TRANSLOCATION WITH SSX1, AND CHROMOSOMAL TRANSLOCATION
RP   WITH SSX2.
RX   PubMed=7539744;
RA   Crew A.J., Clark J., Fisher C., Gill S., Grimer R., Chand A.,
RA   Shipley J., Gusterson B.A., Cooper C.S.;
RT   "Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with
RT   homology to the Kruppel-associated box in human synovial sarcoma.";
RL   EMBO J. 14:2333-2340(1995).
RN   [8]
RP   INTERACTION WITH MLLT10.
RX   PubMed=11423977; DOI=10.1038/sj.onc.1204419;
RA   de Bruijn D.R., dos Santos N.R., Thijssen J., Balemans M.,
RA   Debernardi S., Linder B., Young B.D., Geurts van Kessel A.;
RT   "The synovial sarcoma associated protein SYT interacts with the acute
RT   leukemia associated protein AF10.";
RL   Oncogene 20:3281-3289(2001).
RN   [9]
RP   FUNCTION, ALTERNATIVE SPLICING, AND INTERACTION WITH RBM14.
RX   PubMed=15919756; DOI=10.1210/en.2004-1513;
RA   Iwasaki T., Koibuchi N., Chin W.W.;
RT   "Synovial sarcoma translocation (SYT) encodes a nuclear receptor
RT   coactivator.";
RL   Endocrinology 146:3892-3899(2005).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Appears to function synergistically with RBM14 as a
CC       transcriptional coactivator. Isoform 1 and isoform 2 function in
CC       nuclear receptor coactivation. Isoform 1 and isoform 2 function in
CC       general transcriptional coactivation.
CC       {ECO:0000269|PubMed:15919756}.
CC   -!- SUBUNIT: Interacts with MLLT10. Isoform 1 interacts with RBM14
CC       isoform 1. Isoform 2 interacts with RBM14 isoform 1.
CC       {ECO:0000269|PubMed:11423977, ECO:0000269|PubMed:15919756}.
CC   -!- INTERACTION:
CC       P15336:ATF2; NbExp=2; IntAct=EBI-2560599, EBI-1170906;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=SYTins, SYT-L;
CC         IsoId=Q15532-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15532-2; Sequence=VSP_006258;
CC   -!- TISSUE SPECIFICITY: Fairly ubiquitously expressed. Expressed in
CC       synovial sarcomas and in other human cell lines. The fusion genes
CC       SSXT-SSX1 and SSXT-SSX2 are expressed only in synovial sarcomas.
CC   -!- DISEASE: Note=A chromosomal aberration involving SS18 may be a
CC       cause of synovial sarcoma. Translocation t(X;18)(p11.2;q11.2). The
CC       translocation is specifically found in more than 80% of synovial
CC       sarcoma. The fusion products SSXT-SSX1 or SSXT-SSX2 are probably
CC       responsible for transforming activity. Heterogeneity in the
CC       position of the breakpoint can occur (low frequency).
CC       {ECO:0000269|PubMed:7495284, ECO:0000269|PubMed:7539744}.
CC   -!- SIMILARITY: Belongs to the SS18 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK21314.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA55792.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SS18ID84ch18q11.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X79201; CAA55792.1; ALT_INIT; mRNA.
DR   EMBL; X79200; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF343880; AAK21314.1; ALT_INIT; mRNA.
DR   EMBL; EF445031; ACA06073.1; -; Genomic_DNA.
DR   EMBL; CH471088; EAX01210.1; -; Genomic_DNA.
DR   EMBL; BC096223; AAH96223.1; -; mRNA.
DR   EMBL; S79894; AAB35674.1; ALT_TERM; mRNA.
DR   CCDS; CCDS32807.1; -. [Q15532-1]
DR   CCDS; CCDS54183.1; -. [Q15532-2]
DR   PIR; S46269; S46269.
DR   RefSeq; NP_001007560.1; NM_001007559.2. [Q15532-1]
DR   RefSeq; NP_001295130.1; NM_001308201.1.
DR   RefSeq; NP_005628.2; NM_005637.3. [Q15532-2]
DR   UniGene; Hs.129261; -.
DR   BioGrid; 112638; 48.
DR   IntAct; Q15532; 21.
DR   STRING; 9606.ENSP00000414516; -.
DR   iPTMnet; Q15532; -.
DR   PhosphoSitePlus; Q15532; -.
DR   BioMuta; SS18; -.
DR   EPD; Q15532; -.
DR   MaxQB; Q15532; -.
DR   PaxDb; Q15532; -.
DR   PeptideAtlas; Q15532; -.
DR   PRIDE; Q15532; -.
DR   DNASU; 6760; -.
DR   Ensembl; ENST00000269137; ENSP00000269137; ENSG00000141380. [Q15532-2]
DR   Ensembl; ENST00000415083; ENSP00000414516; ENSG00000141380. [Q15532-1]
DR   GeneID; 6760; -.
DR   KEGG; hsa:6760; -.
DR   UCSC; uc002kvm.4; human. [Q15532-1]
DR   CTD; 6760; -.
DR   DisGeNET; 6760; -.
DR   EuPathDB; HostDB:ENSG00000141380.13; -.
DR   GeneCards; SS18; -.
DR   HGNC; HGNC:11340; SS18.
DR   HPA; HPA055741; -.
DR   HPA; HPA059539; -.
DR   MalaCards; SS18; -.
DR   MIM; 600192; gene.
DR   neXtProt; NX_Q15532; -.
DR   OpenTargets; ENSG00000141380; -.
DR   Orphanet; 3273; Synovial sarcoma.
DR   PharmGKB; PA36164; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   GeneTree; ENSGT00500000044808; -.
DR   HOVERGEN; HBG003892; -.
DR   InParanoid; Q15532; -.
DR   KO; K15623; -.
DR   OMA; AFAPHRQ; -.
DR   OrthoDB; EOG091G0O10; -.
DR   PhylomeDB; Q15532; -.
DR   TreeFam; TF330999; -.
DR   SIGNOR; Q15532; -.
DR   ChiTaRS; SS18; human.
DR   GeneWiki; SS18; -.
DR   GenomeRNAi; 6760; -.
DR   PRO; PR:Q15532; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000141380; -.
DR   CleanEx; HS_SS18; -.
DR   ExpressionAtlas; Q15532; baseline and differential.
DR   Genevisible; Q15532; HS.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IEA:Ensembl.
DR   GO; GO:0071564; C:npBAF complex; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome; Nucleus; Proto-oncogene;
KW   Reference proteome; Repeat; Transcription; Transcription regulation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    418       Protein SSXT.
FT                                /FTId=PRO_0000181823.
FT   REPEAT      344    356       1.
FT   REPEAT      357    369       2.
FT   REGION        2    186       Transcriptional activation.
FT   REGION      344    369       2 X 13 AA imperfect tandem repeats.
FT   MOTIF        50     53       SH2-binding. {ECO:0000255}.
FT   MOTIF       374    377       SH2-binding. {ECO:0000255}.
FT   MOTIF       392    401       SH3-binding. {ECO:0000255}.
FT   MOTIF       413    416       SH2-binding. {ECO:0000255}.
FT   COMPBIAS     95     99       Poly-Pro.
FT   COMPBIAS    175    418       Gln-rich.
FT   SITE        366    367       Breakpoint for translocation to form the
FT                                SSXT-SSX1 fusion protein (rare).
FT                                {ECO:0000269|PubMed:7539744}.
FT   SITE        410    411       Breakpoint for translocation to form the
FT                                SSXT-SSX1 or SSXT-SSX2 fusion proteins.
FT                                {ECO:0000269|PubMed:7539744}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   VAR_SEQ     295    325       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7951320}.
FT                                /FTId=VSP_006258.
SQ   SEQUENCE   418 AA;  45929 MW;  7E089D557538252F CRC64;
     MSVAFAAPRQ RGKGEITPAA IQKMLDDNNH LIQCIMDSQN KGKTSECSQY QQMLHTNLVY
     LATIADSNQN MQSLLPAPPT QNMPMGPGGM NQSGPPPPPR SHNMPSDGMV GGGPPAPHMQ
     NQMNGQMPGP NHMPMQGPGP NQLNMTNSSM NMPSSSHGSM GGYNHSVPSS QSMPVQNQMT
     MSQGQPMGNY GPRPNMSMQP NQGPMMHQQP PSQQYNMPQG GGQHYQGQQP PMGMMGQVNQ
     GNHMMGQRQI PPYRPPQQGP PQQYSGQEDY YGDQYSHGGQ GPPEGMNQQY YPDGHNDYGY
     QQPSYPEQGY DRPYEDSSQH YYEGGNSQYG QQQDAYQGPP PQQGYPPQQQ QYPGQQGYPG
     QQQGYGPSQG GPGPQYPNYP QGQGQQYGGY RPTQPGPPQP PQQRPYGYDQ GQYGNYQQ
//
ID   Q4VAX0_HUMAN            Unreviewed;       387 AA.
AC   Q4VAX0;
DT   05-JUL-2005, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2005, sequence version 1.
DT   28-FEB-2018, entry version 105.
DE   SubName: Full=Synovial sarcoma translocation, chromosome 18 {ECO:0000313|EMBL:AAH96224.1};
DE   SubName: Full=Synovial sarcoma translocation, chromosome 18, isoform CRA_a {ECO:0000313|EMBL:EAX01209.1};
DE   SubName: Full=cDNA FLJ57021, highly similar to SSXT protein {ECO:0000313|EMBL:BAG63015.1};
DE   SubName: Full=cDNA, FLJ79201, highly similar to SSXT protein {ECO:0000313|EMBL:BAH14673.1};
GN   Name=SS18 {ECO:0000313|EMBL:AAH96224.1};
GN   ORFNames=hCG_37175 {ECO:0000313|EMBL:EAX01209.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH96224.1};
RN   [1] {ECO:0000313|EMBL:EAX01209.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAH96224.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000313|EMBL:EAX01209.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG63015.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Synovial membrane tissue {ECO:0000313|EMBL:BAG63015.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BAH14673.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAH14673.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC096221; AAH96221.1; -; mRNA.
DR   EMBL; BC096224; AAH96224.1; -; mRNA.
DR   EMBL; AK301504; BAG63015.1; -; mRNA.
DR   EMBL; AK316302; BAH14673.1; -; mRNA.
DR   EMBL; CH471088; EAX01209.1; -; Genomic_DNA.
DR   EMBL; CH471088; EAX01213.1; -; Genomic_DNA.
DR   RefSeq; NP_005628.2; NM_005637.3.
DR   UniGene; Hs.129261; -.
DR   MaxQB; Q4VAX0; -.
DR   DNASU; 6760; -.
DR   GeneID; 6760; -.
DR   UCSC; uc002kvn.4; human.
DR   CTD; 6760; -.
DR   EuPathDB; HostDB:ENSG00000141380.13; -.
DR   PharmGKB; PA36164; -.
DR   HOVERGEN; HBG003892; -.
DR   ChiTaRS; SS18; human.
DR   GenomeRNAi; 6760; -.
DR   Bgee; ENSG00000141380; -.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   387 AA;  42216 MW;  A1D64C2C588C532A CRC64;
     MSVAFAAPRQ RGKGEITPAA IQKMLDDNNH LIQCIMDSQN KGKTSECSQY QQMLHTNLVY
     LATIADSNQN MQSLLPAPPT QNMPMGPGGM NQSGPPPPPR SHNMPSDGMV GGGPPAPHMQ
     NQMNGQMPGP NHMPMQGPGP NQLNMTNSSM NMPSSSHGSM GGYNHSVPSS QSMPVQNQMT
     MSQGQPMGNY GPRPNMSMQP NQGPMMHQQP PSQQYNMPQG GGQHYQGQQP PMGMMGQVNQ
     GNHMMGQRQI PPYRPPQQGP PQQYSGQEDY YGDQYSHGGQ GPPEGMNQQY YPDGNSQYGQ
     QQDAYQGPPP QQGYPPQQQQ YPGQQGYPGQ QQGYGPSQGG PGPQYPNYPQ GQGQQYGGYR
     PTQPGPPQPP QQRPYGYDQG QYGNYQQ
//
ID   B4DSR7_HUMAN            Unreviewed;       416 AA.
AC   B4DSR7;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 43.
DE   SubName: Full=cDNA FLJ58470, highly similar to SS18-like protein 1 {ECO:0000313|EMBL:BAG61729.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG61729.1};
RN   [1] {ECO:0000313|EMBL:BAG61729.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG61729.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK299881; BAG61729.1; -; mRNA.
DR   RefSeq; XP_005260446.1; XM_005260389.3.
DR   UniGene; Hs.154429; -.
DR   MaxQB; B4DSR7; -.
DR   PeptideAtlas; B4DSR7; -.
DR   GeneID; 26039; -.
DR   CTD; 26039; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   HOGENOM; HOG000048717; -.
DR   HOVERGEN; HBG003892; -.
DR   GenomeRNAi; 26039; -.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   416 AA;  45291 MW;  79D8B103A767CB92 CRC64;
     MSVAFASARP RGKGEVTQQT IQKMLDENHH LIQCILEYQS KGKTAECTQY QQILHRNLVY
     LATIADSNQN MQSLLPAPPT QNMNLGPGAL TQSGSSQGLH SQGSLSDAIS TGLPPSSLLQ
     GQIGNGPSHV SMQQTAPNTL PTTSMSISGP GYSHAGPASQ GVPMQGQGTI GNYVSRTNIN
     MQSNPVSMMQ QQAATSHYSS AQGGSQHYQG QSSIAMMGQG SQGSSMMGQR PMAPYRPSQQ
     GSSQQYLGQE EYYGEQYSHS QGAAEPMGQQ YYPDGHGDYA YQQSSYTEQS YDRSFEESTQ
     HYYEGGNSQY SQQQAGYQQG AAQQQTYSQQ QYPSQQSYPG QQQGYGSAQG APSQYPGYQQ
     GQGQQYGSYR APQTAPSAQQ QRPYGYEQAS FLDVSRCAHP PRLSRHNEDF SYGHEE
//
ID   CREST_HUMAN             Reviewed;         396 AA.
AC   O75177; A6NNE3; A8K620; B3KWR8; E1P5H7; Q5JXJ3; Q6MZV9; Q6NTH3;
AC   Q6XYD9; Q8NE69; Q9BR55; Q9H4K6;
DT   31-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   31-JAN-2002, sequence version 2.
DT   28-FEB-2018, entry version 138.
DE   RecName: Full=Calcium-responsive transactivator;
DE   AltName: Full=SS18-like protein 1;
DE   AltName: Full=SYT homolog 1;
GN   Name=SS18L1; Synonyms=CREST, KIAA0693;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Small intestine;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Wan D.F., Qin W.X., Zhou X.M., Zhang P.P., Jiang H.Q., Gu J.R.;
RT   "Novel Homo sapiens cDNA clones with function of promoting mice
RT   NIH/3T3 cells' growth.";
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Brain, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5), AND VARIANT
RP   ILE-189.
RC   TISSUE=Lymph, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18331714; DOI=10.1016/j.devcel.2007.12.007;
RA   Wang X., Yang Y., Duan Q., Jiang N., Huang Y., Darzynkiewicz Z.,
RA   Dai W.;
RT   "sSgo1, a major splice variant of Sgo1, functions in centriole
RT   cohesion where it is regulated by Plk1.";
RL   Dev. Cell 14:331-341(2008).
CC   -!- FUNCTION: Transcriptional activator which is required for calcium-
CC       dependent dendritic growth and branching in cortical neurons.
CC       Recruits CREB-binding protein (CREBBP) to nuclear bodies.
CC       Component of the CREST-BRG1 complex, a multiprotein complex that
CC       regulates promoter activation by orchestrating a calcium-dependent
CC       release of a repressor complex and a recruitment of an activator
CC       complex. In resting neurons, transcription of the c-FOS promoter
CC       is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1
CC       repressor complex. Upon calcium influx, RB1 is dephosphorylated by
CC       calcineurin, which leads to release of the repressor complex. At
CC       the same time, there is increased recruitment of CREBBP to the
CC       promoter by a CREST-dependent mechanism, which leads to
CC       transcriptional activation. The CREST-BRG1 complex also binds to
CC       the NR2B promoter, and activity-dependent induction of NR2B
CC       expression involves a release of HDAC1 and recruitment of CREBBP
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Dimerization may be necessary for its function
CC       in neuronal dendritic development. Interacts (via C-terminus) with
CC       CREBBP (via N-terminus), EP300 and SMARCA4/BRG1. Interacts with
CC       the nBAF complex. Association with CREBBP facilitates
CC       transcription while the association with SMARCA4/BRG1 suppresses
CC       CREST-mediated transcription in resting neurons (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q6AI39:BICRAL; NbExp=4; IntAct=EBI-12035119, EBI-1012434;
CC       P33240:CSTF2; NbExp=3; IntAct=EBI-744674, EBI-711360;
CC       O15320:CTAGE5; NbExp=3; IntAct=EBI-744674, EBI-1050253;
CC       Q92567:FAM168A; NbExp=4; IntAct=EBI-744674, EBI-7957930;
CC       A0A0S2Z4Q4:HGS; NbExp=3; IntAct=EBI-12035119, EBI-16429135;
CC       O14964:HGS; NbExp=3; IntAct=EBI-12035119, EBI-740220;
CC       P17931:LGALS3; NbExp=3; IntAct=EBI-744674, EBI-1170392;
CC       Q6NVH9:LGALS3; NbExp=3; IntAct=EBI-744674, EBI-10187804;
CC       Q8NDC0:MAPK1IP1L; NbExp=3; IntAct=EBI-744674, EBI-741424;
CC       Q15427:SF3B4; NbExp=4; IntAct=EBI-744674, EBI-348469;
CC       P14678-2:SNRPB; NbExp=3; IntAct=EBI-744674, EBI-372475;
CC       Q5TAL4:SNRPC; NbExp=3; IntAct=EBI-744674, EBI-10246938;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome,
CC       centromere, kinetochore {ECO:0000250}. Note=Localizes to nuclear
CC       bodies. Colocalizes with SGO1 at kinetochore (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O75177-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75177-2; Sequence=VSP_038700;
CC       Name=3;
CC         IsoId=O75177-3; Sequence=VSP_038698;
CC       Name=4;
CC         IsoId=O75177-4; Sequence=VSP_038697;
CC       Name=5;
CC         IsoId=O75177-5; Sequence=VSP_038699;
CC   -!- TISSUE SPECIFICITY: Ubiquitous; with lowest levels in spleen.
CC   -!- DOMAIN: The MFD (multi-functional domain) domain is involved in
CC       transcription transactivation, nuclear body targeting and
CC       dimerization. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SS18 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA31668.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SS18L1ID474ch20q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB014593; BAA31668.1; ALT_INIT; mRNA.
DR   EMBL; BX640848; CAE45918.1; -; mRNA.
DR   EMBL; AY203931; AAP34454.1; -; mRNA.
DR   EMBL; AK125656; BAG54230.1; -; mRNA.
DR   EMBL; AK291485; BAF84174.1; -; mRNA.
DR   EMBL; AL078633; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75393.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75392.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75395.1; -; Genomic_DNA.
DR   EMBL; BC034494; AAH34494.1; -; mRNA.
DR   EMBL; BC068993; AAH68993.1; -; mRNA.
DR   CCDS; CCDS13491.1; -. [O75177-1]
DR   RefSeq; NP_001288707.1; NM_001301778.1. [O75177-4]
DR   RefSeq; NP_945173.1; NM_198935.2. [O75177-1]
DR   RefSeq; XP_005260448.1; XM_005260391.1. [O75177-2]
DR   RefSeq; XP_011527066.1; XM_011528764.2. [O75177-2]
DR   RefSeq; XP_011527069.1; XM_011528767.1. [O75177-5]
DR   UniGene; Hs.154429; -.
DR   ProteinModelPortal; O75177; -.
DR   BioGrid; 117505; 42.
DR   IntAct; O75177; 27.
DR   MINT; O75177; -.
DR   STRING; 9606.ENSP00000333012; -.
DR   iPTMnet; O75177; -.
DR   PhosphoSitePlus; O75177; -.
DR   BioMuta; SS18L1; -.
DR   EPD; O75177; -.
DR   MaxQB; O75177; -.
DR   PaxDb; O75177; -.
DR   PeptideAtlas; O75177; -.
DR   PRIDE; O75177; -.
DR   DNASU; 26039; -.
DR   Ensembl; ENST00000331758; ENSP00000333012; ENSG00000184402. [O75177-1]
DR   Ensembl; ENST00000370848; ENSP00000359885; ENSG00000184402. [O75177-3]
DR   GeneID; 26039; -.
DR   KEGG; hsa:26039; -.
DR   UCSC; uc002ycb.4; human. [O75177-1]
DR   CTD; 26039; -.
DR   DisGeNET; 26039; -.
DR   EuPathDB; HostDB:ENSG00000184402.14; -.
DR   GeneCards; SS18L1; -.
DR   HGNC; HGNC:15592; SS18L1.
DR   HPA; CAB011827; -.
DR   HPA; HPA059046; -.
DR   MIM; 606472; gene.
DR   neXtProt; NX_O75177; -.
DR   OpenTargets; ENSG00000184402; -.
DR   PharmGKB; PA37989; -.
DR   eggNOG; KOG3227; Eukaryota.
DR   eggNOG; ENOG41128HA; LUCA.
DR   GeneTree; ENSGT00500000044808; -.
DR   HOVERGEN; HBG003892; -.
DR   InParanoid; O75177; -.
DR   OMA; HYNSAQG; -.
DR   OrthoDB; EOG091G0O10; -.
DR   PhylomeDB; O75177; -.
DR   TreeFam; TF330999; -.
DR   SIGNOR; O75177; -.
DR   ChiTaRS; SS18L1; human.
DR   GeneWiki; SS18L1; -.
DR   GenomeRNAi; 26039; -.
DR   PRO; PR:O75177; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000184402; -.
DR   CleanEx; HS_SS18L1; -.
DR   ExpressionAtlas; O75177; baseline and differential.
DR   Genevisible; O75177; HS.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0000780; C:condensed nuclear chromosome, centromeric region; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000776; C:kinetochore; IDA:MGI.
DR   GO; GO:0071565; C:nBAF complex; IEA:Ensembl.
DR   GO; GO:0016604; C:nuclear body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   GO; GO:0016569; P:covalent chromatin modification; IEA:UniProtKB-KW.
DR   GO; GO:0016358; P:dendrite development; IEA:Ensembl.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR007726; SS18_fam.
DR   Pfam; PF05030; SSXT; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Calcium; Centromere;
KW   Chromatin regulator; Chromosome; Complete proteome; Kinetochore;
KW   Nucleus; Polymorphism; Reference proteome; Repeat; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    396       Calcium-responsive transactivator.
FT                                /FTId=PRO_0000181825.
FT   REGION        1    148       N-terminal auto-inhibitory domain;
FT                                necessary for interaction with
FT                                SMARCA4/BRG1. {ECO:0000250}.
FT   REGION      149    232       Methionine-rich intra-molecular domain.
FT                                {ECO:0000250}.
FT   REGION      246    317       MFD domain. {ECO:0000250}.
FT   REGION      334    396       Necessary for nuclear localization.
FT                                {ECO:0000250}.
FT   REGION      387    396       Necessary for interaction with CREBBP and
FT                                for the recruitment of CREBBP to the
FT                                nuclear bodies. {ECO:0000250}.
FT   MOTIF        50     53       SH2-binding. {ECO:0000255}.
FT   MOTIF       353    356       SH2-binding. {ECO:0000255}.
FT   MOTIF       371    379       SH3-binding. {ECO:0000255}.
FT   MOTIF       391    394       SH2-binding. {ECO:0000255}.
FT   COMPBIAS    190    396       Gln-rich.
FT   VAR_SEQ       1    131       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038697.
FT   VAR_SEQ       1     82       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_038698.
FT   VAR_SEQ       1     49       MSVAFASARPRGKGEVTQQTIQKMLDENHHLIQCILEYQSK
FT                                GKTAECTQ -> MQSLSTEARYVPRVPQHRDQISPRSPQHG
FT                                GQICPRSPLHRGQICPRSPPARR (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_038699.
FT   VAR_SEQ       1     23       MSVAFASARPRGKGEVTQQTIQK -> M (in isoform
FT                                2). {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_038700.
FT   VARIANT     189    189       M -> I (in dbSNP:rs17853304).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_062534.
FT   VARIANT     321    321       A -> T (in dbSNP:rs36106901).
FT                                /FTId=VAR_053691.
FT   CONFLICT    128    128       S -> G (in Ref. 2; CAE45918).
FT                                {ECO:0000305}.
FT   CONFLICT    139    139       T -> S (in Ref. 4; BAF84174).
FT                                {ECO:0000305}.
FT   CONFLICT    143    143       T -> A (in Ref. 4; BAG54230).
FT                                {ECO:0000305}.
SQ   SEQUENCE   396 AA;  42990 MW;  B76B7D61C7DF5592 CRC64;
     MSVAFASARP RGKGEVTQQT IQKMLDENHH LIQCILEYQS KGKTAECTQY QQILHRNLVY
     LATIADSNQN MQSLLPAPPT QNMNLGPGAL TQSGSSQGLH SQGSLSDAIS TGLPPSSLLQ
     GQIGNGPSHV SMQQTAPNTL PTTSMSISGP GYSHAGPASQ GVPMQGQGTI GNYVSRTNIN
     MQSNPVSMMQ QQAATSHYSS AQGGSQHYQG QSSIAMMGQG SQGSSMMGQR PMAPYRPSQQ
     GSSQQYLGQE EYYGEQYSHS QGAAEPMGQQ YYPDGHGDYA YQQSSYTEQS YDRSFEESTQ
     HYYEGGNSQY SQQQAGYQQG AAQQQTYSQQ QYPSQQSYPG QQQGYGSAQG APSQYPGYQQ
     GQGQQYGSYR APQTAPSAQQ QRPYGYEQGQ YGNYQQ
//
ID   STRN_HUMAN              Reviewed;         780 AA.
AC   O43815; Q3KP65; Q53TQ8; Q9NP38;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 4.
DT   28-FEB-2018, entry version 167.
DE   RecName: Full=Striatin;
GN   Name=STRN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=9693043; DOI=10.1006/geno.1998.5342;
RA   Moqrich A., Mattei M.-G., Bartoli M., Rakitina T., Baillat G.,
RA   Monneron A., Castets F.;
RT   "Cloning of human striatin cDNA (STRN), gene mapping to 2p22-p21, and
RT   preferential expression in brain.";
RL   Genomics 51:136-139(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227; SER-229; SER-245
RP   AND SER-259, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Calmodulin-binding protein which may function as
CC       scaffolding or signaling protein and may play a role in dendritic
CC       Ca(2+) signaling.
CC   -!- SUBUNIT: Interacts with protein phosphatase 2A (PP2A) (Potential).
CC       Interacts with CTTNBP2; this interaction may regulate dendritic
CC       spine distribution of STRN. Activation of glutamate receptors
CC       weakens the interaction with CTTNBP2 (By similarity).
CC       {ECO:0000250, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q9P2B4:CTTNBP2NL; NbExp=6; IntAct=EBI-1046642, EBI-1774273;
CC       Q9Y3A3:MOB4; NbExp=5; IntAct=EBI-1046642, EBI-713935;
CC       Q9BUL8:PDCD10; NbExp=4; IntAct=EBI-1046642, EBI-740195;
CC       P67775:PPP2CA; NbExp=5; IntAct=EBI-1046642, EBI-712311;
CC       P30153:PPP2R1A; NbExp=8; IntAct=EBI-1046642, EBI-302388;
CC       Q6NUQ1:RINT1; NbExp=3; IntAct=EBI-1046642, EBI-726876;
CC       Q9Y6E0:STK24; NbExp=3; IntAct=EBI-1046642, EBI-740175;
CC       O00506:STK25; NbExp=3; IntAct=EBI-1046642, EBI-618295;
CC       Q13033:STRN3; NbExp=9; IntAct=EBI-1046642, EBI-1053857;
CC       Q9UBB9:TFIP11; NbExp=3; IntAct=EBI-1046642, EBI-1105213;
CC       Q9H2K2:TNKS2; NbExp=2; IntAct=EBI-1046642, EBI-4398527;
CC       Q9Y228:TRAF3IP3; NbExp=2; IntAct=EBI-1046642, EBI-765817;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cell
CC       projection, dendritic spine {ECO:0000250}. Note=CTTNBP2-binding
CC       may regulate dendritic spine distribution. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43815-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43815-2; Sequence=VSP_023495, VSP_023496;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Preferentially expressed in brain.
CC       {ECO:0000269|PubMed:9693043}.
CC   -!- SIMILARITY: Belongs to the WD repeat striatin family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/STRNID44243ch2p22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ223814; CAA11560.1; -; mRNA.
DR   EMBL; AC007404; AAY24273.1; -; Genomic_DNA.
DR   EMBL; AC007382; AAF66162.1; -; Genomic_DNA.
DR   EMBL; BC106879; AAI06880.1; -; mRNA.
DR   CCDS; CCDS1784.1; -. [O43815-1]
DR   RefSeq; NP_003153.2; NM_003162.3. [O43815-1]
DR   UniGene; Hs.127486; -.
DR   ProteinModelPortal; O43815; -.
DR   BioGrid; 112674; 91.
DR   CORUM; O43815; -.
DR   ELM; O43815; -.
DR   IntAct; O43815; 55.
DR   STRING; 9606.ENSP00000263918; -.
DR   iPTMnet; O43815; -.
DR   PhosphoSitePlus; O43815; -.
DR   BioMuta; STRN; -.
DR   EPD; O43815; -.
DR   MaxQB; O43815; -.
DR   PaxDb; O43815; -.
DR   PeptideAtlas; O43815; -.
DR   PRIDE; O43815; -.
DR   Ensembl; ENST00000263918; ENSP00000263918; ENSG00000115808. [O43815-1]
DR   Ensembl; ENST00000379213; ENSP00000368513; ENSG00000115808. [O43815-2]
DR   GeneID; 6801; -.
DR   KEGG; hsa:6801; -.
DR   UCSC; uc002rpn.4; human. [O43815-1]
DR   CTD; 6801; -.
DR   DisGeNET; 6801; -.
DR   EuPathDB; HostDB:ENSG00000115808.11; -.
DR   GeneCards; STRN; -.
DR   HGNC; HGNC:11424; STRN.
DR   HPA; HPA017286; -.
DR   MIM; 614765; gene.
DR   neXtProt; NX_O43815; -.
DR   OpenTargets; ENSG00000115808; -.
DR   PharmGKB; PA36224; -.
DR   eggNOG; KOG0642; Eukaryota.
DR   eggNOG; ENOG410XR31; LUCA.
DR   GeneTree; ENSGT00520000055597; -.
DR   HOGENOM; HOG000236343; -.
DR   HOVERGEN; HBG007117; -.
DR   InParanoid; O43815; -.
DR   KO; K17608; -.
DR   OMA; FNMETRQ; -.
DR   OrthoDB; EOG091G0509; -.
DR   PhylomeDB; O43815; -.
DR   TreeFam; TF313387; -.
DR   SignaLink; O43815; -.
DR   ChiTaRS; STRN; human.
DR   GeneWiki; STRN; -.
DR   GenomeRNAi; 6801; -.
DR   PMAP-CutDB; O43815; -.
DR   PRO; PR:O43815; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115808; -.
DR   CleanEx; HS_STRN; -.
DR   Genevisible; O43815; HS.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0043197; C:dendritic spine; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0070016; F:armadillo repeat domain binding; IPI:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0030331; F:estrogen receptor binding; IPI:UniProtKB.
DR   GO; GO:0032403; F:protein complex binding; IDA:UniProtKB.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IDA:UniProtKB.
DR   GO; GO:0070830; P:bicellular tight junction assembly; NAS:UniProtKB.
DR   GO; GO:0016358; P:dendrite development; ISS:UniProtKB.
DR   GO; GO:0007626; P:locomotory behavior; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IMP:UniProtKB.
DR   Gene3D; 2.130.10.10; -; 2.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR013258; Striatin_N.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF08232; Striatin; 1.
DR   Pfam; PF00400; WD40; 5.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 4.
DR   PROSITE; PS50082; WD_REPEATS_2; 4.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calmodulin-binding; Cell projection;
KW   Coiled coil; Complete proteome; Cytoplasm; Membrane; Phosphoprotein;
KW   Reference proteome; Repeat; WD repeat.
FT   CHAIN         1    780       Striatin.
FT                                /FTId=PRO_0000051232.
FT   REPEAT      461    500       WD 1.
FT   REPEAT      514    553       WD 2.
FT   REPEAT      567    606       WD 3.
FT   REPEAT      662    701       WD 4.
FT   REPEAT      704    743       WD 5.
FT   REPEAT      750    779       WD 6.
FT   REGION       55     63       Caveolin-binding. {ECO:0000255}.
FT   REGION      149    166       Calmodulin-binding. {ECO:0000255}.
FT   COILED       53    120       {ECO:0000255}.
FT   MOD_RES     137    137       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O55106}.
FT   MOD_RES     225    225       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O55106}.
FT   MOD_RES     227    227       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     229    229       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     245    245       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     259    259       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      29     40       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023495.
FT   VAR_SEQ     311    348       EKEDQCLMPEAWNVDQGVITKLKEQYKKERKGKKGVKR ->
FT                                G (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023496.
FT   CONFLICT    191    191       S -> I (in Ref. 1; CAA11560).
FT                                {ECO:0000305}.
FT   CONFLICT    423    423       L -> P (in Ref. 1; CAA11560).
FT                                {ECO:0000305}.
FT   CONFLICT    611    611       T -> I (in Ref. 1; CAA11560).
FT                                {ECO:0000305}.
FT   CONFLICT    677    677       P -> S (in Ref. 1; CAA11560).
FT                                {ECO:0000305}.
SQ   SEQUENCE   780 AA;  86132 MW;  DDB18A11102BEA35 CRC64;
     MDEQAGPGVF FSNNHPGAGG AKGLGPLAEA AAAGDGAAAA GAARAQYSLP GILHFLQHEW
     ARFEVERAQW EVERAELQAQ IAFLQGERKG QENLKKDLVR RIKMLEYALK QERAKYHKLK
     YGTELNQGDM KPPSYDSDEG NETEVQPQQN SQLMWKQGRQ LLRQYLQEVG YTDTILDVKS
     KRVRALLGFS SDVTDREDDK NQDSVVNGTE AEVKETAMIA KSELTDSASV LDNFKFLESA
     AADFSDEDED DDVDGREKSV IDTSTIVRKK ALPDSGEDRD TKEALKEFDF LVTSEEGDNE
     SRSAGDGTDW EKEDQCLMPE AWNVDQGVIT KLKEQYKKER KGKKGVKRPN RSKLQDMLAN
     LRDVDELPSL QPSVGSPSRP SSSRLPEHEI NRADEVEALT FPPSSGKSFI MGADEALESE
     LGLGELAGLT VANEADSLTY DIANNKDALR KTWNPKFTLR SHFDGIRALA FHPIEPVLIT
     ASEDHTLKMW NLQKTAPAKK STSLDVEPIY TFRAHKGPVL CVVMSSNGEQ CYSGGTDGLI
     QGWNTTNPNI DPYDSYDPSV LRGPLLGHTD AVWGLAYSAA HQRLLSCSAD GTLRLWNTTE
     VAPALSVFND TKELGIPASV DLVSSDPSHM VASFSKGYTS IFNMETQQRI LTLESNVDTT
     ANSSCQINRV ISHPTLPISI TAHEDRHIKF YDNNTGKLIH SMVAHLEAVT SLAVDPNGLY
     LMSGSHDCSI RLWNLESKTC IQEFTAHRKK FEESIHDVAF HPSKCYIASA GADALAKVFV
//
ID   B7Z4W0_HUMAN            Unreviewed;       280 AA.
AC   B7Z4W0;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   20-DEC-2017, entry version 57.
DE   SubName: Full=cDNA FLJ51911, highly similar to Transcription elongation factor A protein 1 {ECO:0000313|EMBL:BAH12696.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH12696.1};
RN   [1] {ECO:0000313|EMBL:BAH12696.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00649}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK297957; BAH12696.1; -; mRNA.
DR   RefSeq; NP_958845.1; NM_201437.2.
DR   UniGene; Hs.491745; -.
DR   PeptideAtlas; B7Z4W0; -.
DR   PRIDE; B7Z4W0; -.
DR   GeneID; 6917; -.
DR   CTD; 6917; -.
DR   HOGENOM; HOG000195015; -.
DR   HOVERGEN; HBG055022; -.
DR   GenomeRNAi; 6917; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 1.10.472.30; -; 1.
DR   Gene3D; 1.20.930.10; -; 1.
DR   InterPro; IPR035100; TF_IIS-typ.
DR   InterPro; IPR003617; TFIIS/CRSP70_N_sub.
DR   InterPro; IPR035441; TFIIS/LEDGF_dom_sf.
DR   InterPro; IPR003618; TFIIS_cen_dom.
DR   InterPro; IPR036575; TFIIS_cen_dom_sf.
DR   InterPro; IPR017923; TFIIS_N.
DR   InterPro; IPR006289; TFSII.
DR   InterPro; IPR001222; Znf_TFIIS.
DR   Pfam; PF08711; Med26; 1.
DR   Pfam; PF01096; TFIIS_C; 1.
DR   Pfam; PF07500; TFIIS_M; 1.
DR   PIRSF; PIRSF006704; TF_IIS; 1.
DR   SMART; SM00510; TFS2M; 1.
DR   SMART; SM00509; TFS2N; 1.
DR   SMART; SM00440; ZnF_C2C2; 1.
DR   SUPFAM; SSF46942; SSF46942; 1.
DR   SUPFAM; SSF47676; SSF47676; 1.
DR   TIGRFAMs; TIGR01385; TFSII; 1.
DR   PROSITE; PS51321; TFIIS_CENTRAL; 1.
DR   PROSITE; PS51319; TFIIS_N; 1.
DR   PROSITE; PS00466; ZF_TFIIS_1; 1.
DR   PROSITE; PS51133; ZF_TFIIS_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Elongation factor {ECO:0000313|EMBL:BAH12696.1};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00472};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00649};
KW   Protein biosynthesis {ECO:0000313|EMBL:BAH12696.1};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00472};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00472}.
FT   DOMAIN        1     59       TFIIS N-terminal.
FT                                {ECO:0000259|PROSITE:PS51319}.
FT   DOMAIN      119    235       TFIIS central.
FT                                {ECO:0000259|PROSITE:PS51321}.
FT   DOMAIN      238    278       TFIIS-type.
FT                                {ECO:0000259|PROSITE:PS51133}.
FT   ZN_FING     238    278       TFIIS-type. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00472}.
FT   COILED      202    222       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   280 AA;  31674 MW;  318336FC090137F0 CRC64;
     MEDEVVRFAK KMDKMVQKKN APTRIGMSVN AIRKQSTDEE VTSLAKSLIK SWKKLLDGPS
     TEKDLDEKKK EPAITSQNSP EAREESTSSG NVSNRKDETN ARDTYVSSFP RAPSTSDSVR
     LKCREMLAAA LRTGDDYIAI GADEEELGSQ IEEAIYQEIR NTDMKYKNRV RSRISNLKDA
     KNPNLRKNVL CGNIPPDLFA RMTAEEMASD ELKEMRKNLT KEAIREHQMA KTGGTQTDLF
     TCGKCKKKNC TYTQVQTRSA DEPMTTFVVC NECGNRWKFC
//
ID   TCEA1_HUMAN             Reviewed;         301 AA.
AC   P23193; A6NF25; A8K339; Q15563; Q6FG87;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   28-FEB-2018, entry version 191.
DE   RecName: Full=Transcription elongation factor A protein 1;
DE   AltName: Full=Transcription elongation factor S-II protein 1;
DE   AltName: Full=Transcription elongation factor TFIIS.o;
GN   Name=TCEA1; Synonyms=GTF2S, TFIIS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Kidney;
RX   PubMed=1708494; DOI=10.1093/nar/19.5.1073;
RA   Yoo O., Yoon H., Baek K., Jeon C., Miyamoto K., Ueno A., Agarwal K.;
RT   "Cloning, expression and characterization of the human transcription
RT   elongation factor, TFIIS.";
RL   Nucleic Acids Res. 19:1073-1079(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1378807; DOI=10.1016/0378-1119(92)90522-Q;
RA   Chen H.C., England L., Kane C.M.;
RT   "Characterization of a HeLa cDNA clone encoding the human SII protein,
RT   an elongation factor for RNA polymerase II.";
RL   Gene 116:253-258(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8112616; DOI=10.1016/0378-1119(94)90767-6;
RA   Park H.R., Baek K.H., Jeon C.J., Agarwal K., Yoo O.;
RT   "Characterization of the gene encoding the human transcriptional
RT   elongation factor TFIIS.";
RL   Gene 139:263-267(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 1-9 AND 32-44, ACETYLATION AT MET-1, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=T-cell;
RA   Bienvenut W.V., Kanor S., Tissot J.-D., Quadroni M.;
RL   Submitted (MAY-2006) to UniProtKB.
RN   [10]
RP   CHROMOSOMAL TRANSLOCATION WITH PLAG1.
RX   PubMed=10029085;
RA   Astroem A.-K., Voz M.L., Kas K., Roeijer E., Wedell B., Mandahl N.,
RA   Van de Ven W., Mark J., Stenman G.;
RT   "Conserved mechanism of PLAG1 activation in salivary gland tumors with
RT   and without chromosome 8q12 abnormalities: identification of SII as a
RT   new fusion partner gene.";
RL   Cancer Res. 59:918-923(1999).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-100, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   INTERACTION WITH UBR5 AND CDK9.
RX   PubMed=21127351; DOI=10.1074/jbc.M110.176628;
RA   Cojocaru M., Bouchard A., Cloutier P., Cooper J.J., Varzavand K.,
RA   Price D.H., Coulombe B.;
RT   "Transcription factor IIS cooperates with the E3 ligase UBR5 to
RT   ubiquitinate the CDK9 subunit of the positive transcription elongation
RT   factor B.";
RL   J. Biol. Chem. 286:5012-5022(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-100, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; SER-81 AND SER-100,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   STRUCTURE BY NMR OF 256-301.
RX   PubMed=7626141; DOI=10.1038/365277a0;
RA   Qian X., Jeon C., Yoon H., Agarwal K., Weiss M.A.;
RT   "Structure of a new nucleic-acid-binding motif in eukaryotic
RT   transcriptional elongation factor TFIIS.";
RL   Nature 365:277-279(1993).
CC   -!- FUNCTION: Necessary for efficient RNA polymerase II transcription
CC       elongation past template-encoded arresting sites. The arresting
CC       sites in DNA have the property of trapping a certain fraction of
CC       elongating RNA polymerases that pass through, resulting in locked
CC       ternary complexes. Cleavage of the nascent transcript by S-II
CC       allows the resumption of elongation from the new 3'-terminus.
CC   -!- SUBUNIT: Interacts with EAF2 (By similarity). Associates with UBR5
CC       and forms a transcription regulatory complex made of CDK9, RNAP
CC       II, UBR5 and TFIIS/TCEA1 that can stimulate target gene
CC       transcription (e.g. gamma fibrinogen/FGG) by recruiting their
CC       promoters. {ECO:0000250, ECO:0000269|PubMed:21127351}.
CC   -!- INTERACTION:
CC       Q8WVC0:LEO1; NbExp=4; IntAct=EBI-2608271, EBI-932432;
CC       Q8N7H5:PAF1; NbExp=4; IntAct=EBI-2608271, EBI-2607770;
CC       P24928:POLR2A; NbExp=5; IntAct=EBI-2608271, EBI-295301;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P23193-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P23193-2; Sequence=VSP_006409;
CC   -!- DISEASE: Note=A chromosomal aberration involving TCEA1 may be a
CC       cause of salivary gland pleiomorphic adenomas (PA) [181030].
CC       Pleiomorphic adenomas are the most common benign epithelial tumors
CC       of the salivary gland. Translocation t(3;8)(p21;q12) with PLAG1.
CC       {ECO:0000269|PubMed:10029085}.
CC   -!- MISCELLANEOUS: S-II binds to RNA-polymerase II in the absence of
CC       transcription.
CC   -!- SIMILARITY: Belongs to the TFS-II family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X62585; CAA44470.1; -; mRNA.
DR   EMBL; X57198; CAA40484.1; -; mRNA.
DR   EMBL; M81601; AAA61138.1; -; mRNA.
DR   EMBL; X73534; CAA51940.1; -; Genomic_DNA.
DR   EMBL; AK290454; BAF83143.1; -; mRNA.
DR   EMBL; CR542221; CAG47017.1; -; mRNA.
DR   EMBL; BT019995; AAV38798.1; -; mRNA.
DR   EMBL; AC100821; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC072460; AAH72460.1; -; mRNA.
DR   CCDS; CCDS47857.1; -. [P23193-2]
DR   CCDS; CCDS47858.1; -. [P23193-1]
DR   PIR; S17361; S17361.
DR   PIR; S26831; S26831.
DR   PIR; S34159; S34159.
DR   RefSeq; NP_006747.1; NM_006756.3. [P23193-1]
DR   RefSeq; NP_958845.1; NM_201437.2. [P23193-2]
DR   UniGene; Hs.491745; -.
DR   PDB; 1TFI; NMR; -; A=252-301.
DR   PDB; 3NDQ; X-ray; 1.93 A; A=131-232.
DR   PDB; 5IY6; EM; 7.20 A; U=1-301.
DR   PDB; 5IY7; EM; 8.60 A; U=1-301.
DR   PDB; 5IY8; EM; 7.90 A; U=1-301.
DR   PDB; 5IYA; EM; 5.40 A; U=1-301.
DR   PDB; 5IYB; EM; 3.90 A; U=1-301.
DR   PDB; 5IYC; EM; 3.90 A; U=1-301.
DR   PDBsum; 1TFI; -.
DR   PDBsum; 3NDQ; -.
DR   PDBsum; 5IY6; -.
DR   PDBsum; 5IY7; -.
DR   PDBsum; 5IY8; -.
DR   PDBsum; 5IYA; -.
DR   PDBsum; 5IYB; -.
DR   PDBsum; 5IYC; -.
DR   ProteinModelPortal; P23193; -.
DR   SMR; P23193; -.
DR   BioGrid; 112779; 73.
DR   DIP; DIP-48480N; -.
DR   IntAct; P23193; 23.
DR   STRING; 9606.ENSP00000428426; -.
DR   iPTMnet; P23193; -.
DR   PhosphoSitePlus; P23193; -.
DR   DMDM; 1174652; -.
DR   EPD; P23193; -.
DR   MaxQB; P23193; -.
DR   PaxDb; P23193; -.
DR   PeptideAtlas; P23193; -.
DR   PRIDE; P23193; -.
DR   DNASU; 6917; -.
DR   Ensembl; ENST00000396401; ENSP00000395483; ENSG00000187735. [P23193-2]
DR   Ensembl; ENST00000521604; ENSP00000428426; ENSG00000187735. [P23193-1]
DR   GeneID; 6917; -.
DR   KEGG; hsa:6917; -.
DR   UCSC; uc003xru.5; human. [P23193-1]
DR   CTD; 6917; -.
DR   DisGeNET; 6917; -.
DR   EuPathDB; HostDB:ENSG00000187735.12; -.
DR   GeneCards; TCEA1; -.
DR   H-InvDB; HIX0057264; -.
DR   HGNC; HGNC:11612; TCEA1.
DR   HPA; HPA043786; -.
DR   MIM; 601425; gene.
DR   neXtProt; NX_P23193; -.
DR   OpenTargets; ENSG00000187735; -.
DR   PharmGKB; PA36371; -.
DR   eggNOG; KOG1105; Eukaryota.
DR   eggNOG; COG1594; LUCA.
DR   GeneTree; ENSGT00390000017794; -.
DR   HOGENOM; HOG000195015; -.
DR   HOVERGEN; HBG055022; -.
DR   InParanoid; P23193; -.
DR   KO; K03145; -.
DR   OMA; KKAQVPM; -.
DR   OrthoDB; EOG091G10EJ; -.
DR   PhylomeDB; P23193; -.
DR   TreeFam; TF314970; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-167152; Formation of HIV elongation complex in the absence of HIV Tat.
DR   Reactome; R-HSA-167200; Formation of HIV-1 elongation complex containing HIV-1 Tat.
DR   Reactome; R-HSA-167238; Pausing and recovery of Tat-mediated HIV elongation.
DR   Reactome; R-HSA-167243; Tat-mediated HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167246; Tat-mediated elongation of the HIV-1 transcript.
DR   Reactome; R-HSA-167287; HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167290; Pausing and recovery of HIV elongation.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6796648; TP53 Regulates Transcription of DNA Repair Genes.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   SIGNOR; P23193; -.
DR   ChiTaRS; TCEA1; human.
DR   EvolutionaryTrace; P23193; -.
DR   GeneWiki; TCEA1; -.
DR   GenomeRNAi; 6917; -.
DR   PMAP-CutDB; P23193; -.
DR   PRO; PR:P23193; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000187735; -.
DR   CleanEx; HS_TCEA1; -.
DR   ExpressionAtlas; P23193; baseline and differential.
DR   Genevisible; P23193; HS.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005669; C:transcription factor TFIID complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:1901919; P:positive regulation of exoribonuclease activity; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   Gene3D; 1.10.472.30; -; 1.
DR   Gene3D; 1.20.930.10; -; 1.
DR   InterPro; IPR035100; TF_IIS-typ.
DR   InterPro; IPR003617; TFIIS/CRSP70_N_sub.
DR   InterPro; IPR035441; TFIIS/LEDGF_dom_sf.
DR   InterPro; IPR003618; TFIIS_cen_dom.
DR   InterPro; IPR036575; TFIIS_cen_dom_sf.
DR   InterPro; IPR017923; TFIIS_N.
DR   InterPro; IPR006289; TFSII.
DR   InterPro; IPR001222; Znf_TFIIS.
DR   Pfam; PF08711; Med26; 1.
DR   Pfam; PF01096; TFIIS_C; 1.
DR   Pfam; PF07500; TFIIS_M; 1.
DR   PIRSF; PIRSF006704; TF_IIS; 1.
DR   SMART; SM00510; TFS2M; 1.
DR   SMART; SM00509; TFS2N; 1.
DR   SMART; SM00440; ZnF_C2C2; 1.
DR   SUPFAM; SSF46942; SSF46942; 1.
DR   SUPFAM; SSF47676; SSF47676; 1.
DR   TIGRFAMs; TIGR01385; TFSII; 1.
DR   PROSITE; PS51321; TFIIS_CENTRAL; 1.
DR   PROSITE; PS51319; TFIIS_N; 1.
DR   PROSITE; PS00466; ZF_TFIIS_1; 1.
DR   PROSITE; PS51133; ZF_TFIIS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome;
KW   Direct protein sequencing; DNA-binding; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    301       Transcription elongation factor A protein
FT                                1.
FT                                /FTId=PRO_0000121446.
FT   DOMAIN        3     80       TFIIS N-terminal. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00649}.
FT   DOMAIN      140    256       TFIIS central. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00651}.
FT   ZN_FING     259    299       TFIIS-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00472}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.9}.
FT   MOD_RES      57     57       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      81     81       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      97     97       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     100    100       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   CROSSLNK     55     55       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:Q15560}.
FT   VAR_SEQ      22     42       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1708494}.
FT                                /FTId=VSP_006409.
FT   CONFLICT    127    127       V -> L (in Ref. 2; AAA61138).
FT                                {ECO:0000305}.
FT   CONFLICT    141    141       R -> Q (in Ref. 3; CAA51940).
FT                                {ECO:0000305}.
FT   CONFLICT    205    205       N -> Y (in Ref. 3; CAA51940).
FT                                {ECO:0000305}.
FT   CONFLICT    237    237       R -> W (in Ref. 3; CAA51940).
FT                                {ECO:0000305}.
FT   CONFLICT    285    285       M -> V (in Ref. 3; CAA51940).
FT                                {ECO:0000305}.
FT   CONFLICT    300    300       F -> I (in Ref. 6; AC100821).
FT                                {ECO:0000305}.
FT   HELIX       139    151       {ECO:0000244|PDB:3NDQ}.
FT   HELIX       152    156       {ECO:0000244|PDB:3NDQ}.
FT   HELIX       157    161       {ECO:0000244|PDB:3NDQ}.
FT   HELIX       165    180       {ECO:0000244|PDB:3NDQ}.
FT   STRAND      182    184       {ECO:0000244|PDB:3NDQ}.
FT   HELIX       185    198       {ECO:0000244|PDB:3NDQ}.
FT   HELIX       204    211       {ECO:0000244|PDB:3NDQ}.
FT   HELIX       217    222       {ECO:0000244|PDB:3NDQ}.
FT   TURN        225    227       {ECO:0000244|PDB:3NDQ}.
FT   STRAND      264    266       {ECO:0000244|PDB:1TFI}.
FT   STRAND      271    276       {ECO:0000244|PDB:1TFI}.
FT   STRAND      278    283       {ECO:0000244|PDB:1TFI}.
FT   STRAND      286    294       {ECO:0000244|PDB:1TFI}.
FT   STRAND      297    299       {ECO:0000244|PDB:1TFI}.
SQ   SEQUENCE   301 AA;  33970 MW;  8A685107A56D2DA1 CRC64;
     MEDEVVRFAK KMDKMVQKKN AAGALDLLKE LKNIPMTLEL LQSTRIGMSV NAIRKQSTDE
     EVTSLAKSLI KSWKKLLDGP STEKDLDEKK KEPAITSQNS PEAREESTSS GNVSNRKDET
     NARDTYVSSF PRAPSTSDSV RLKCREMLAA ALRTGDDYIA IGADEEELGS QIEEAIYQEI
     RNTDMKYKNR VRSRISNLKD AKNPNLRKNV LCGNIPPDLF ARMTAEEMAS DELKEMRKNL
     TKEAIREHQM AKTGGTQTDL FTCGKCKKKN CTYTQVQTRS ADEPMTTFVV CNECGNRWKF
     C
//
ID   A0A024R5T1_HUMAN        Unreviewed;       682 AA.
AC   A0A024R5T1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 34.
DE   SubName: Full=Transcription factor 12 (HTF4, helix-loop-helix transcription factors 4), isoform CRA_c {ECO:0000313|EMBL:EAW77517.1};
GN   Name=TCF12 {ECO:0000313|EMBL:EAW77517.1};
GN   ORFNames=hCG_40686 {ECO:0000313|EMBL:EAW77517.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW77517.1};
RN   [1] {ECO:0000313|EMBL:EAW77517.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW77517.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471082; EAW77513.1; -; Genomic_DNA.
DR   EMBL; CH471082; EAW77516.1; -; Genomic_DNA.
DR   EMBL; CH471082; EAW77517.1; -; Genomic_DNA.
DR   RefSeq; NP_001309086.1; NM_001322157.1.
DR   RefSeq; NP_001309094.1; NM_001322165.1.
DR   RefSeq; NP_003196.1; NM_003205.3.
DR   RefSeq; NP_996921.1; NM_207038.1.
DR   UniGene; Hs.511504; -.
DR   SMR; A0A024R5T1; -.
DR   GeneID; 6938; -.
DR   KEGG; hsa:6938; -.
DR   CTD; 6938; -.
DR   EuPathDB; HostDB:ENSG00000140262.17; -.
DR   eggNOG; KOG3910; Eukaryota.
DR   eggNOG; ENOG410XYUA; LUCA.
DR   KO; K15603; -.
DR   ChiTaRS; TCF12; human.
DR   GenomeRNAi; 6938; -.
DR   Bgee; ENSG00000140262; -.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   4: Predicted;
FT   DOMAIN      577    630       BHLH. {ECO:0000259|PROSITE:PS50888}.
SQ   SEQUENCE   682 AA;  72965 MW;  9736113D9361D3F5 CRC64;
     MNPQQQRMAA IGTDKELSDL LDFSAMFSPP VNSGKTRPTT LGSSQFSGSG IDERGGTTSW
     GTSGQPSPSY DSSRGFTDSP HYSDHLNDSR LGAHEGLSPT PFMNSNLMGK TSERGSFSLY
     SRDTGLPGCQ SSLLRQDLGL GSPAQLSSSG KPGTAYYSFS ATSSRRRPLH DSAALDPLQA
     KKVRKVPPGL PSSVYAPSPN SDDFNRESPS YPSPKPPTSM FASTFFMQDG THNSSDLWSS
     SNGMSQPGFG GILGTSTSHM SQSSSYGNLH SHDRLSYPPH SVSPTDINTS LPPMSSFHRG
     STSSSPYVAA SHTPPINGSD SILGTRGNAA GSSQTGDALG KALASIYSPD HTSSSFPSNP
     STPVGSPSPL TGTSQWPRPG GQAPSSPSYE NSLHSLQSRM EDRLDRLDDA IHVLRNHAVG
     PSTSLPAGHS DIHSLLGPSH NAPIGSLNSN YGGSSLVASS RSASMVGTHR EDSVSLNGNH
     SVLSSTVTTS STDLNHKTQE NYRGGLQSQS GTVVTTEIKT ENKEKDENLH EPPSSDDMKS
     DDESSQKDIK VSSRGRTSST NEDEDLNPEQ KIEREKERRM ANNARERLRV RDINEAFKEL
     GRMCQLHLKS EKPQTKLLIL HQAVAVILSL EQQVRERNLN PKAACLKRRE EEKVSAVSAE
     PPTTLPGTHP GLSETTNPMG HM
//
ID   A0A024R5Z0_HUMAN        Unreviewed;       706 AA.
AC   A0A024R5Z0;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 30.
DE   SubName: Full=Transcription factor 12 (HTF4, helix-loop-helix transcription factors 4), isoform CRA_b {ECO:0000313|EMBL:EAW77514.1};
GN   Name=TCF12 {ECO:0000313|EMBL:EAW77514.1};
GN   ORFNames=hCG_40686 {ECO:0000313|EMBL:EAW77514.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW77514.1};
RN   [1] {ECO:0000313|EMBL:EAW77514.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW77514.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471082; EAW77514.1; -; Genomic_DNA.
DR   RefSeq; NP_001309080.1; NM_001322151.1.
DR   RefSeq; NP_001309088.1; NM_001322159.1.
DR   RefSeq; NP_001309091.1; NM_001322162.1.
DR   RefSeq; NP_996919.1; NM_207036.1.
DR   RefSeq; NP_996920.1; NM_207037.1.
DR   UniGene; Hs.511504; -.
DR   ProteinModelPortal; A0A024R5Z0; -.
DR   SMR; A0A024R5Z0; -.
DR   PRIDE; A0A024R5Z0; -.
DR   GeneID; 6938; -.
DR   CTD; 6938; -.
DR   EuPathDB; HostDB:ENSG00000140262.17; -.
DR   eggNOG; KOG3910; Eukaryota.
DR   eggNOG; ENOG410XYUA; LUCA.
DR   OMA; YYSFSAT; -.
DR   OrthoDB; EOG091G07E2; -.
DR   PhylomeDB; A0A024R5Z0; -.
DR   ChiTaRS; TCF12; human.
DR   GenomeRNAi; 6938; -.
DR   Bgee; ENSG00000140262; -.
DR   ExpressionAtlas; A0A024R5Z0; baseline and differential.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0035497; F:cAMP response element binding; IEA:Ensembl.
DR   GO; GO:0070888; F:E-box binding; IEA:Ensembl.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   4: Predicted;
FT   DOMAIN      601    654       BHLH. {ECO:0000259|PROSITE:PS50888}.
SQ   SEQUENCE   706 AA;  75845 MW;  75B7B4173C9B660D CRC64;
     MNPQQQRMAA IGTDKELSDL LDFSAMFSPP VNSGKTRPTT LGSSQFSGSG IDERGGTTSW
     GTSGQPSPSY DSSRGFTDSP HYSDHLNDSR LGAHEGLSPT PFMNSNLMGK TSERGSFSLY
     SRDTGLPGCQ SSLLRQDLGL GSPAQLSSSG KPGTAYYSFS ATSSRRRPLH DSAALDPLQA
     KKVRKVPPGL PSSVYAPSPN SDDFNRESPS YPSPKPPTSM FASTFFMQDG THNSSDLWSS
     SNGMSQPGFG GILGTSTSHM SQSSSYGNLH SHDRLSYPPH SVSPTDINTS LPPMSSFHRG
     STSSSPYVAA SHTPPINGSD SILGTRGNAA GSSQTGDALG KALASIYSPD HTSSSFPSNP
     STPVGSPSPL TGTSQWPRPG GQAPSSPSYE NSLHSLKNRV EQQLHEHLQD AMSFLKDVCE
     QSRMEDRLDR LDDAIHVLRN HAVGPSTSLP AGHSDIHSLL GPSHNAPIGS LNSNYGGSSL
     VASSRSASMV GTHREDSVSL NGNHSVLSST VTTSSTDLNH KTQENYRGGL QSQSGTVVTT
     EIKTENKEKD ENLHEPPSSD DMKSDDESSQ KDIKVSSRGR TSSTNEDEDL NPEQKIEREK
     ERRMANNARE RLRVRDINEA FKELGRMCQL HLKSEKPQTK LLILHQAVAV ILSLEQQVRE
     RNLNPKAACL KRREEEKVSA VSAEPPTTLP GTHPGLSETT NPMGHM
//
ID   F5GY10_HUMAN            Unreviewed;       536 AA.
AC   F5GY10;
DT   28-JUN-2011, integrated into UniProtKB/TrEMBL.
DT   28-JUN-2011, sequence version 1.
DT   28-FEB-2018, entry version 60.
DE   SubName: Full=Transcription factor 12 {ECO:0000313|Ensembl:ENSP00000440017};
GN   Name=TCF12 {ECO:0000313|Ensembl:ENSP00000440017};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000440017, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000440017, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [3] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y.,
RA   Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [4] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [7] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [8] {ECO:0000313|Ensembl:ENSP00000440017}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [9] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11] {ECO:0000213|PubMed:25218447}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [12] {ECO:0000213|PubMed:25755297}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurethsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide Analysis of SUMOylation Dynamics in Response to
RT   Replication Stress Reveals Novel Small Ubiquitin-like Modified Target
RT   Proteins and Acceptor Lysines Relevant for Genome Stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [13] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000440017}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC010999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016525; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090511; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090532; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001293148.1; NM_001306219.2.
DR   UniGene; Hs.511504; -.
DR   ProteinModelPortal; F5GY10; -.
DR   EPD; F5GY10; -.
DR   MaxQB; F5GY10; -.
DR   PeptideAtlas; F5GY10; -.
DR   PRIDE; F5GY10; -.
DR   Ensembl; ENST00000543579; ENSP00000440017; ENSG00000140262.
DR   GeneID; 6938; -.
DR   UCSC; uc010bft.4; human.
DR   CTD; 6938; -.
DR   EuPathDB; HostDB:ENSG00000140262.17; -.
DR   HGNC; HGNC:11623; TCF12.
DR   OpenTargets; ENSG00000140262; -.
DR   eggNOG; KOG3910; Eukaryota.
DR   eggNOG; ENOG410XYUA; LUCA.
DR   GeneTree; ENSGT00510000046438; -.
DR   ChiTaRS; TCF12; human.
DR   GenomeRNAi; 6938; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140262; -.
DR   ExpressionAtlas; F5GY10; baseline and differential.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:F5GY10,
KW   ECO:0000213|MaxQB:F5GY10, ECO:0000213|PeptideAtlas:F5GY10};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      431    484       BHLH. {ECO:0000259|PROSITE:PS50888}.
SQ   SEQUENCE   536 AA;  58023 MW;  F3822C94BCA627F4 CRC64;
     MYCAYPVPGM GSNSLMYYYN GKTVYAPSPN SDDFNRESPS YPSPKPPTSM FASTFFMQDG
     THNSSDLWSS SNGMSQPGFG GILGTSTSHM SQSSSYGNLH SHDRLSYPPH SVSPTDINTS
     LPPMSSFHRG STSSSPYVAA SHTPPINGSD SILGTRGNAA GSSQTGDALG KALASIYSPD
     HTSSSFPSNP STPVGSPSPL TGTSQWPRPG GQAPSSPSYE NSLHSLKNRV EQQLHEHLQD
     AMSFLKDVCE QSRMEDRLDR LDDAIHVLRN HAVGPSTSLP AGHSDIHSLL GPSHNAPIGS
     LNSNYGGSSL VASSRSASMV GTHREDSVSL NGNHSVLSST VTTSSTDLNH KTQENYRGGL
     QSQSGTVVTT EIKTENKEKD ENLHEPPSSD DMKSDDESSQ KDIKVSSRGR TSSTNEDEDL
     NPEQKIEREK ERRMANNARE RLRVRDINEA FKELGRMCQL HLKSEKPQTK LLILHQAVAV
     ILSLEQQVRE RNLNPKAACL KRREEEKVSA VSAEPPTTLP GTHPGLSETT NPMGHM
//
ID   HTF4_HUMAN              Reviewed;         682 AA.
AC   Q99081; B4E1W1; Q7Z3D9; Q86TC1; Q86VM2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   28-FEB-2018, entry version 169.
DE   RecName: Full=Transcription factor 12;
DE            Short=TCF-12;
DE   AltName: Full=Class B basic helix-loop-helix protein 20;
DE            Short=bHLHb20;
DE   AltName: Full=DNA-binding protein HTF4;
DE   AltName: Full=E-box-binding protein;
DE   AltName: Full=Transcription factor HTF-4;
GN   Name=TCF12; Synonyms=BHLHB20, HEB, HTF4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1446075; DOI=10.3109/10425179209020819;
RA   Zhang Y., Bina M.;
RT   "The nucleotide sequence of the human transcription factor HTF4a
RT   cDNA.";
RL   DNA Seq. 2:397-403(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=1312219; DOI=10.1128/MCB.12.3.1031;
RA   Hu J.S., Olson E.N., Kingston R.E.;
RT   "HEB, a helix-loop-helix protein related to E2A and ITF2 that can
RT   modulate the DNA-binding ability of myogenic regulatory factors.";
RL   Mol. Cell. Biol. 12:1031-1042(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Endometrium, and Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 352-682.
RX   PubMed=1886779; DOI=10.1093/nar/19.16.4555;
RA   Zhang Y., Babin J., Feldhaus A.L., Singh H., Sharp P.A., Bina M.;
RT   "HTF4: a new human helix-loop-helix protein.";
RL   Nucleic Acids Res. 19:4555-4555(1991).
RN   [9]
RP   GENE ORGANIZATION, AND ALTERNATIVE SPLICING.
RX   PubMed=12826747; DOI=10.1159/000071042;
RA   Gan T.I., Rowen L., Nesbitt R., Roe B.A., Wu H., Hu P., Yao Z.,
RA   Kim U.J., O'Sickey T., Bina M.;
RT   "Genomic organization of human TCF12 gene and spliced mRNA variants
RT   producing isoforms of transcription factor HTF4.";
RL   Cytogenet. Genome Res. 98:245-248(2002).
RN   [10]
RP   INTERACTION WITH RUNX1T1.
RX   PubMed=16616331; DOI=10.1016/j.ccr.2006.03.012;
RA   Liu Y., Cheney M.D., Gaudet J.J., Chruszcz M., Lukasik S.M.,
RA   Sugiyama D., Lary J., Cole J., Dauter Z., Minor W., Speck N.A.,
RA   Bushweller J.H.;
RT   "The tetramer structure of the Nervy homology two domain, NHR2, is
RT   critical for AML1/ETO's activity.";
RL   Cancer Cell 9:249-260(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   DOMAIN.
RX   PubMed=17467953; DOI=10.1016/j.ygeno.2007.02.003;
RA   Piskacek S., Gregor M., Nemethova M., Grabner M., Kovarik P.,
RA   Piskacek M.;
RT   "Nine-amino-acid transactivation domain: establishment and prediction
RT   utilities.";
RL   Genomics 89:756-768(2007).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-313, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; SER-333 AND THR-557,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-559, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-67; SER-79;
RP   SER-98; SER-116; THR-313; SER-333; SER-540; SER-558 AND SER-559, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-519 AND LYS-550, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-519, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-110; LYS-181; LYS-519;
RP   LYS-609 AND LYS-653, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.91 ANGSTROMS) OF 177-200 IN COMPLEX WITH
RP   RUNX1T1, INTERACTION WITH AML1-MTG8/ETO, AND MUTAGENESIS OF PRO-187;
RP   PRO-191 AND SER-192.
RX   PubMed=23812588; DOI=10.1038/nature12287;
RA   Sun X.J., Wang Z., Wang L., Jiang Y., Kost N., Soong T.D., Chen W.Y.,
RA   Tang Z., Nakadai T., Elemento O., Fischle W., Melnick A., Patel D.J.,
RA   Nimer S.D., Roeder R.G.;
RT   "A stable transcription factor complex nucleated by oligomeric AML1-
RT   ETO controls leukaemogenesis.";
RL   Nature 500:93-97(2013).
RN   [25]
RP   INTERACTION WITH BHLHA9.
RX   PubMed=25466284; DOI=10.1016/j.ajhg.2014.10.012;
RA   Malik S., Percin F.E., Bornholdt D., Albrecht B., Percesepe A.,
RA   Koch M.C., Landi A., Fritz B., Khan R., Mumtaz S., Akarsu N.A.,
RA   Grzeschik K.H.;
RT   "Mutations affecting the BHLHA9 DNA-binding domain cause MSSD,
RT   mesoaxial synostotic syndactyly with phalangeal reduction, Malik-
RT   Percin type.";
RL   Am. J. Hum. Genet. 95:649-659(2014).
RN   [26]
RP   STRUCTURE BY NMR OF 11-28 IN COMPLEX WITH RUNX1T1, AND SUBUNIT.
RX   PubMed=19204326; DOI=10.1182/blood-2008-06-161307;
RA   Park S., Chen W., Cierpicki T., Tonelli M., Cai X., Speck N.A.,
RA   Bushweller J.H.;
RT   "Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its
RT   contribution to AML1-ETO activity.";
RL   Blood 113:3558-3567(2009).
RN   [27]
RP   VARIANTS CRS3 PRO-600 AND GLU-614.
RX   PubMed=23354436; DOI=10.1038/ng.2531;
RG   500 Whole-Genome Sequences (WGS500) Consortium;
RA   Sharma V.P., Fenwick A.L., Brockop M.S., McGowan S.J., Goos J.A.,
RA   Hoogeboom A.J., Brady A.F., Jeelani N.O., Lynch S.A., Mulliken J.B.,
RA   Murray D.J., Phipps J.M., Sweeney E., Tomkins S.E., Wilson L.C.,
RA   Bennett S., Cornall R.J., Broxholme J., Kanapin A., Johnson D.,
RA   Wall S.A., van der Spek P.J., Mathijssen I.M., Maxson R.E.,
RA   Twigg S.R., Wilkie A.O.;
RT   "Mutations in TCF12, encoding a basic helix-loop-helix partner of
RT   TWIST1, are a frequent cause of coronal craniosynostosis.";
RL   Nat. Genet. 45:304-307(2013).
RN   [28]
RP   VARIANT CRS3 ARG-483.
RX   PubMed=25271085; DOI=10.1038/ejhg.2014.205;
RA   Paumard-Hernandez B., Berges-Soria J., Barroso E.,
RA   Rivera-Pedroza C.I., Perez-Carrizosa V., Benito-Sanz S.,
RA   Lopez-Messa E., Santos F., Garcia-Recuero I.I., Romance A.,
RA   Ballesta-Martinez J.M., Lopez-Gonzalez V., Campos-Barros A., Cruz J.,
RA   Guillen-Navarro E., Sanchez Del Pozo J., Lapunzina P.,
RA   Garcia-Minaur S., Heath K.E.;
RT   "Expanding the mutation spectrum in 182 Spanish probands with
RT   craniosynostosis: identification and characterization of novel TCF12
RT   variants.";
RL   Eur. J. Hum. Genet. 23:907-914(2015).
CC   -!- FUNCTION: Transcriptional regulator. Involved in the initiation of
CC       neuronal differentiation. Activates transcription by binding to
CC       the E box (5'-CANNTG-3').
CC   -!- SUBUNIT: Efficient DNA binding requires dimerization with another
CC       bHLH protein. Forms homo- or heterooligomers with myogenin, E12
CC       and ITF2 proteins. Interacts with PTF1A. Interacts with NEUROD2
CC       (By similarity). Interacts with RUNX1T1. Interacts with AML1-
CC       MTG8/ETO (via nervy homology region 2 in oligomerized form)
CC       (PubMed:23812588). Interacts with BHLHA9 (PubMed:25466284).
CC       {ECO:0000250|UniProtKB:Q61286, ECO:0000269|PubMed:16616331,
CC       ECO:0000269|PubMed:19204326, ECO:0000269|PubMed:23812588,
CC       ECO:0000269|PubMed:25466284}.
CC   -!- INTERACTION:
CC       Q8IUR7:ARMC8; NbExp=3; IntAct=EBI-722877, EBI-1049469;
CC       Q6XD76:ASCL4; NbExp=3; IntAct=EBI-722877, EBI-10254793;
CC       Q96MC5:C16orf45; NbExp=3; IntAct=EBI-722877, EBI-718468;
CC       Q9NX04:C1orf109; NbExp=3; IntAct=EBI-722877, EBI-8643161;
CC       P42773:CDKN2C; NbExp=5; IntAct=EBI-11952764, EBI-711290;
CC       Q8IYR0:CFAP206; NbExp=3; IntAct=EBI-722877, EBI-749051;
CC       O75575:CRCP; NbExp=3; IntAct=EBI-722877, EBI-2654687;
CC       Q3B7T1-5:EDRF1; NbExp=3; IntAct=EBI-722877, EBI-10240074;
CC       O75593:FOXH1; NbExp=2; IntAct=EBI-722877, EBI-1759806;
CC       Q96MH2:HEXIM2; NbExp=4; IntAct=EBI-722877, EBI-5460660;
CC       Q9BPY8:HOPX; NbExp=3; IntAct=EBI-722877, EBI-10295883;
CC       Q02363:ID2; NbExp=2; IntAct=EBI-722877, EBI-713450;
CC       Q02535:ID3; NbExp=3; IntAct=EBI-722877, EBI-1387094;
CC       Q96S90:LYSMD1; NbExp=3; IntAct=EBI-722877, EBI-10293291;
CC       O60336:MAPKBP1; NbExp=3; IntAct=EBI-722877, EBI-947402;
CC       Q6P2C6:MLLT6; NbExp=3; IntAct=EBI-722877, EBI-5773143;
CC       Q8NDC4:MORN4; NbExp=3; IntAct=EBI-722877, EBI-10269566;
CC       Q8WVZ3:MORN4; NbExp=3; IntAct=EBI-722877, EBI-10277137;
CC       Q9UJ70:NAGK; NbExp=3; IntAct=EBI-722877, EBI-372578;
CC       Q9Y4Z2:NEUROG3; NbExp=5; IntAct=EBI-11952764, EBI-10328570;
CC       Q9UJX0:OSGIN1; NbExp=3; IntAct=EBI-722877, EBI-9057006;
CC       P25786:PSMA1; NbExp=3; IntAct=EBI-722877, EBI-359352;
CC       P47897:QARS; NbExp=3; IntAct=EBI-722877, EBI-347462;
CC       P47897-2:QARS; NbExp=3; IntAct=EBI-722877, EBI-10209725;
CC       Q9Y5S9:RBM8A; NbExp=4; IntAct=EBI-11952764, EBI-447231;
CC       Q1RLL8:RNASEL; NbExp=3; IntAct=EBI-722877, EBI-10239181;
CC       Q06455-4:RUNX1T1; NbExp=2; IntAct=EBI-11952764, EBI-10224192;
CC       Q9NZD8:SPG21; NbExp=3; IntAct=EBI-722877, EBI-742688;
CC       P30626:SRI; NbExp=3; IntAct=EBI-722877, EBI-750459;
CC       P42229:STAT5A; NbExp=3; IntAct=EBI-722877, EBI-749537;
CC       O75716:STK16; NbExp=3; IntAct=EBI-722877, EBI-749295;
CC       P17542:TAL1; NbExp=4; IntAct=EBI-722877, EBI-1753878;
CC       Q6ZMU5:TRIM72; NbExp=3; IntAct=EBI-722877, EBI-2341648;
CC       Q99598:TSNAX; NbExp=3; IntAct=EBI-722877, EBI-742638;
CC       Q8WVJ9:TWIST2; NbExp=3; IntAct=EBI-722877, EBI-1797313;
CC       Q548N1:VPS28; NbExp=3; IntAct=EBI-722877, EBI-10243107;
CC       Q9UK41:VPS28; NbExp=3; IntAct=EBI-11952764, EBI-727424;
CC       A0A0S2Z6P0:ZNF688; NbExp=3; IntAct=EBI-11952764, EBI-16429989;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=a;
CC         IsoId=Q99081-1; Sequence=Displayed;
CC       Name=2; Synonyms=b;
CC         IsoId=Q99081-2; Sequence=VSP_039109, VSP_039110;
CC       Name=3; Synonyms=c;
CC         IsoId=Q99081-3; Sequence=VSP_040024;
CC       Name=4;
CC         IsoId=Q99081-4; Sequence=VSP_057419, VSP_057420;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in several tissues and cell types
CC       including skeletal muscle, thymus, and a B-cell line.
CC   -!- DOMAIN: the 9aaTAD motif is a transactivation domain present in a
CC       large number of yeast and animal transcription factors.
CC       {ECO:0000269|PubMed:17467953}.
CC   -!- DISEASE: Craniosynostosis 3 (CRS3) [MIM:615314]: A primary
CC       abnormality of skull growth involving premature fusion of one or
CC       more cranial sutures. The growth velocity of the skull often
CC       cannot match that of the developing brain resulting in an abnormal
CC       head shape and, in some cases, increased intracranial pressure,
CC       which must be treated promptly to avoid permanent
CC       neurodevelopmental disability. {ECO:0000269|PubMed:23354436,
CC       ECO:0000269|PubMed:25271085}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TCF12ID406.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M83233; AAB62389.1; -; mRNA.
DR   EMBL; M80627; AAA58632.1; -; mRNA.
DR   EMBL; AL831981; CAD89914.1; -; mRNA.
DR   EMBL; AK304007; BAG64923.1; -; mRNA.
DR   EMBL; BX537967; CAD97931.1; -; mRNA.
DR   EMBL; AC010999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016525; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090511; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090532; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77512.1; -; Genomic_DNA.
DR   EMBL; BC050556; AAH50556.1; -; mRNA.
DR   EMBL; M65209; AAC37571.1; -; mRNA.
DR   EMBL; BK001049; DAA01129.1; -; mRNA.
DR   CCDS; CCDS10159.1; -. [Q99081-1]
DR   CCDS; CCDS10160.1; -. [Q99081-3]
DR   CCDS; CCDS42042.1; -. [Q99081-2]
DR   CCDS; CCDS76761.1; -. [Q99081-4]
DR   PIR; A42121; A42121.
DR   RefSeq; NP_001293149.1; NM_001306220.2. [Q99081-4]
DR   RefSeq; NP_001309080.1; NM_001322151.1. [Q99081-3]
DR   RefSeq; NP_001309086.1; NM_001322157.1. [Q99081-1]
DR   RefSeq; NP_001309088.1; NM_001322159.1. [Q99081-3]
DR   RefSeq; NP_001309091.1; NM_001322162.1. [Q99081-3]
DR   RefSeq; NP_001309094.1; NM_001322165.1. [Q99081-1]
DR   RefSeq; NP_003196.1; NM_003205.3. [Q99081-1]
DR   RefSeq; NP_996919.1; NM_207036.1. [Q99081-3]
DR   RefSeq; NP_996920.1; NM_207037.1. [Q99081-3]
DR   RefSeq; NP_996921.1; NM_207038.1. [Q99081-1]
DR   RefSeq; NP_996923.1; NM_207040.1. [Q99081-2]
DR   UniGene; Hs.511504; -.
DR   PDB; 2KNH; NMR; -; B=11-28.
DR   PDB; 4JOL; X-ray; 2.91 A; E/F/G/H=177-200.
DR   PDBsum; 2KNH; -.
DR   PDBsum; 4JOL; -.
DR   ProteinModelPortal; Q99081; -.
DR   SMR; Q99081; -.
DR   BioGrid; 112798; 78.
DR   CORUM; Q99081; -.
DR   DIP; DIP-29403N; -.
DR   IntAct; Q99081; 88.
DR   MINT; Q99081; -.
DR   STRING; 9606.ENSP00000331057; -.
DR   iPTMnet; Q99081; -.
DR   PhosphoSitePlus; Q99081; -.
DR   BioMuta; TCF12; -.
DR   DMDM; 1708332; -.
DR   EPD; Q99081; -.
DR   MaxQB; Q99081; -.
DR   PaxDb; Q99081; -.
DR   PeptideAtlas; Q99081; -.
DR   PRIDE; Q99081; -.
DR   DNASU; 6938; -.
DR   Ensembl; ENST00000267811; ENSP00000267811; ENSG00000140262. [Q99081-1]
DR   Ensembl; ENST00000333725; ENSP00000331057; ENSG00000140262. [Q99081-3]
DR   Ensembl; ENST00000343827; ENSP00000342459; ENSG00000140262. [Q99081-2]
DR   Ensembl; ENST00000438423; ENSP00000388940; ENSG00000140262. [Q99081-3]
DR   Ensembl; ENST00000537840; ENSP00000444696; ENSG00000140262. [Q99081-4]
DR   Ensembl; ENST00000557843; ENSP00000453737; ENSG00000140262. [Q99081-1]
DR   GeneID; 6938; -.
DR   KEGG; hsa:6938; -.
DR   UCSC; uc002aea.4; human. [Q99081-1]
DR   UCSC; uc010ugo.3; human.
DR   CTD; 6938; -.
DR   DisGeNET; 6938; -.
DR   EuPathDB; HostDB:ENSG00000140262.17; -.
DR   GeneCards; TCF12; -.
DR   HGNC; HGNC:11623; TCF12.
DR   HPA; CAB004432; -.
DR   HPA; HPA065827; -.
DR   MalaCards; TCF12; -.
DR   MIM; 600480; gene.
DR   MIM; 615314; phenotype.
DR   neXtProt; NX_Q99081; -.
DR   OpenTargets; ENSG00000140262; -.
DR   Orphanet; 209916; Extraskeletal myxoid chondrosarcoma.
DR   Orphanet; 35099; Isolated brachycephaly.
DR   Orphanet; 35098; Isolated plagiocephaly.
DR   PharmGKB; PA36381; -.
DR   eggNOG; KOG3910; Eukaryota.
DR   eggNOG; ENOG410XYUA; LUCA.
DR   GeneTree; ENSGT00510000046438; -.
DR   HOGENOM; HOG000234180; -.
DR   HOVERGEN; HBG003854; -.
DR   InParanoid; Q99081; -.
DR   KO; K15603; -.
DR   OMA; YYSFSAT; -.
DR   PhylomeDB; Q99081; -.
DR   TreeFam; TF321672; -.
DR   Reactome; R-HSA-375170; CDO in myogenesis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   SIGNOR; Q99081; -.
DR   ChiTaRS; TCF12; human.
DR   EvolutionaryTrace; Q99081; -.
DR   GeneWiki; TCF12; -.
DR   GenomeRNAi; 6938; -.
DR   PRO; PR:Q99081; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140262; -.
DR   CleanEx; HS_TCF12; -.
DR   ExpressionAtlas; Q99081; baseline and differential.
DR   Genevisible; Q99081; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:LIFEdb.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IDA:BHF-UCL.
DR   GO; GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0035497; F:cAMP response element binding; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0070888; F:E-box binding; IEA:Ensembl.
DR   GO; GO:0035326; F:enhancer binding; IC:BHF-UCL.
DR   GO; GO:0071837; F:HMG box domain binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0046332; F:SMAD binding; IPI:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0007517; P:muscle organ development; TAS:ProtInc.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:1902036; P:regulation of hematopoietic stem cell differentiation; TAS:Reactome.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Craniosynostosis; Developmental protein; Differentiation;
KW   Disease mutation; DNA-binding; Isopeptide bond; Neurogenesis; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1    682       Transcription factor 12.
FT                                /FTId=PRO_0000127228.
FT   DOMAIN      577    630       bHLH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00981}.
FT   REGION      119    140       Leucine-zipper.
FT   REGION      182    196       Interaction with RUNX1T1.
FT                                {ECO:0000269|PubMed:23812588}.
FT   REGION      632    655       Class A specific domain.
FT   MOTIF        19     27       9aaTAD.
FT   MOD_RES      47     47       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      67     67       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      79     79       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      98     98       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     116    116       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     313    313       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     333    333       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     540    540       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     557    557       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     558    558       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     559    559       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    110    110       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    181    181       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    519    519       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    550    550       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   CROSSLNK    609    609       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    653    653       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1    170       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_039109.
FT   VAR_SEQ       1     39       MNPQQQRMAAIGTDKELSDLLDFSAMFSPPVNSGKTRPT
FT                                -> MGKRYMHHPQIQMISTVNLLVIHLLSHQPVCSLALSLC
FT                                K (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057419.
FT   VAR_SEQ      40    275       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057420.
FT   VAR_SEQ     171    193       DSAALDPLQAKKVRKVPPGLPSS -> MYCAYPVPGMGSNS
FT                                LMYYYNGKT (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_039110.
FT   VAR_SEQ     396    396       L -> LKNRVEQQLHEHLQDAMSFLKDVCE (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040024.
FT   VARIANT     300    300       G -> S (in dbSNP:rs12442879).
FT                                /FTId=VAR_049543.
FT   VARIANT     483    483       L -> R (in CRS3; dbSNP:rs36060670).
FT                                {ECO:0000269|PubMed:25271085}.
FT                                /FTId=VAR_072271.
FT   VARIANT     600    600       L -> P (in CRS3).
FT                                {ECO:0000269|PubMed:23354436}.
FT                                /FTId=VAR_070096.
FT   VARIANT     614    614       Q -> E (in CRS3; dbSNP:rs886037641).
FT                                {ECO:0000269|PubMed:23354436}.
FT                                /FTId=VAR_070097.
FT   MUTAGEN     187    187       P->A: Decreases interaction with RUNX1T1.
FT                                {ECO:0000269|PubMed:23812588}.
FT   MUTAGEN     191    191       P->A: Decreases interaction with RUNX1T1.
FT                                {ECO:0000269|PubMed:23812588}.
FT   MUTAGEN     192    192       S->A: Decreases interaction with RUNX1T1.
FT                                {ECO:0000269|PubMed:23812588}.
FT   CONFLICT    523    523       K -> E (in Ref. 4; CAD89914).
FT                                {ECO:0000305}.
FT   HELIX        15     18       {ECO:0000244|PDB:2KNH}.
FT   TURN         24     26       {ECO:0000244|PDB:2KNH}.
SQ   SEQUENCE   682 AA;  72965 MW;  9736113D9361D3F5 CRC64;
     MNPQQQRMAA IGTDKELSDL LDFSAMFSPP VNSGKTRPTT LGSSQFSGSG IDERGGTTSW
     GTSGQPSPSY DSSRGFTDSP HYSDHLNDSR LGAHEGLSPT PFMNSNLMGK TSERGSFSLY
     SRDTGLPGCQ SSLLRQDLGL GSPAQLSSSG KPGTAYYSFS ATSSRRRPLH DSAALDPLQA
     KKVRKVPPGL PSSVYAPSPN SDDFNRESPS YPSPKPPTSM FASTFFMQDG THNSSDLWSS
     SNGMSQPGFG GILGTSTSHM SQSSSYGNLH SHDRLSYPPH SVSPTDINTS LPPMSSFHRG
     STSSSPYVAA SHTPPINGSD SILGTRGNAA GSSQTGDALG KALASIYSPD HTSSSFPSNP
     STPVGSPSPL TGTSQWPRPG GQAPSSPSYE NSLHSLQSRM EDRLDRLDDA IHVLRNHAVG
     PSTSLPAGHS DIHSLLGPSH NAPIGSLNSN YGGSSLVASS RSASMVGTHR EDSVSLNGNH
     SVLSSTVTTS STDLNHKTQE NYRGGLQSQS GTVVTTEIKT ENKEKDENLH EPPSSDDMKS
     DDESSQKDIK VSSRGRTSST NEDEDLNPEQ KIEREKERRM ANNARERLRV RDINEAFKEL
     GRMCQLHLKS EKPQTKLLIL HQAVAVILSL EQQVRERNLN PKAACLKRRE EEKVSAVSAE
     PPTTLPGTHP GLSETTNPMG HM
//
ID   Q05BK6_HUMAN            Unreviewed;       366 AA.
AC   Q05BK6;
DT   14-NOV-2006, integrated into UniProtKB/TrEMBL.
DT   14-NOV-2006, sequence version 1.
DT   28-FEB-2018, entry version 74.
DE   SubName: Full=TFG protein {ECO:0000313|EMBL:AAH41600.1};
GN   Name=TFG {ECO:0000313|EMBL:AAH41600.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH41600.1};
RN   [1] {ECO:0000313|EMBL:AAH41600.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH41600.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large scale characterization of plant versus mammal
RT   proteins reveals similar and idiosyncratic N-alpha-acetylation
RT   features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [7] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- INTERACTION:
CC       Q5VV41:ARHGEF16; NbExp=3; IntAct=EBI-10246902, EBI-1057448;
CC       Q5TAB7:RIPPLY2; NbExp=3; IntAct=EBI-10246902, EBI-10246897;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC041600; AAH41600.1; -; mRNA.
DR   RefSeq; NP_001182408.1; NM_001195479.1.
DR   UniGene; Hs.518123; -.
DR   ProteinModelPortal; Q05BK6; -.
DR   IntAct; Q05BK6; 2.
DR   MaxQB; Q05BK6; -.
DR   PeptideAtlas; Q05BK6; -.
DR   DNASU; 10342; -.
DR   GeneID; 10342; -.
DR   UCSC; uc062lzu.1; human.
DR   CTD; 10342; -.
DR   EuPathDB; HostDB:ENSG00000114354.12; -.
DR   eggNOG; ENOG410IH8P; Eukaryota.
DR   eggNOG; ENOG410Z8FQ; LUCA.
DR   HOVERGEN; HBG009087; -.
DR   ChiTaRS; TFG; human.
DR   GenomeRNAi; 10342; -.
DR   Bgee; ENSG00000114354; -.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0042802; F:identical protein binding; IEA:InterPro.
DR   GO; GO:0048208; P:COPII vesicle coating; IEA:InterPro.
DR   CDD; cd06401; PB1_TFG; 1.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR034857; PB1_TFG.
DR   InterPro; IPR033512; TFG.
DR   PANTHER; PTHR15335; PTHR15335; 1.
DR   Pfam; PF00564; PB1; 1.
DR   SMART; SM00666; PB1; 1.
DR   PROSITE; PS51745; PB1; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       10     91       PB1. {ECO:0000259|PROSITE:PS51745}.
FT   COILED      102    122       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   366 AA;  40691 MW;  AC0BD52B2DAD48F3 CRC64;
     MNGQLDLSGK LIIKAQLGED IRRIPIHNED ITYDELVLMM QRVFRGKLLS NDEVTIKYKD
     EDGDLITIFD SSDLSFAIQC SRILKLTLFV NGQPRPLESS QVKYLRRELI ELRNKVNRLL
     DSLEPPGEPG PSTNIPENDT VDGREEKSAS DSSGKQSTQV MAASMSAFDP LKNQDEINKN
     VMSAFGLTDD QVSGPPSAPA EDRSGTPDSI ASSSSAAHPP GVQPQQPPYT GAQTQAGQMY
     QQYSNRPAMV HSSRRLHLSS LNSMVFSIQQ AIVSRLDLNN LSSSRDMASN QLPRHQLLPF
     LVSLNNCLLS RHSSTRRAII LHKLTLPKLL SLLIILWLLP LNLEWLQANL GPINQDQVLL
     HFLEVP
//
ID   TFG_HUMAN               Reviewed;         400 AA.
AC   Q92734; D3DN49; G5E9V1; K0J5S8; K0J6K2; Q15656; Q969I2;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 2.
DT   28-FEB-2018, entry version 161.
DE   RecName: Full=Protein TFG;
DE   AltName: Full=TRK-fused gene protein;
GN   Name=TFG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=9169129; DOI=10.1006/geno.1997.4625;
RA   Mencinger M., Panagopoluos I., Andreasson P., Lassen C., Mitelman F.,
RA   Aman P.;
RT   "Characterization and chromosomal mapping of the human TFG gene
RT   involved in thyroid carcinoma.";
RL   Genomics 41:327-331(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4), VARIANT HMSNO LEU-285,
RP   AND ALTERNATIVE SPLICING.
RX   PubMed=22883144; DOI=10.1016/j.ajhg.2012.07.014;
RA   Ishiura H., Sako W., Yoshida M., Kawarai T., Tanabe O., Goto J.,
RA   Takahashi Y., Date H., Mitsui J., Ahsan B., Ichikawa Y., Iwata A.,
RA   Yoshino H., Izumi Y., Fujita K., Maeda K., Goto S., Koizumi H.,
RA   Morigaki R., Ikemura M., Yamauchi N., Murayama S., Nicholson G.A.,
RA   Ito H., Sobue G., Nakagawa M., Kaji R., Tsuji S.;
RT   "The TRK-fused gene is mutated in hereditary motor and sensory
RT   neuropathy with proximal dominant involvement.";
RL   Am. J. Hum. Genet. 91:320-329(2012).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-193, AND CHROMOSOMAL TRANSLOCATION
RP   WITH NTRK1.
RX   PubMed=7565764; DOI=10.1128/MCB.15.11.6118;
RA   Greco A., Mariani C., Miranda C., Lupas A., Pagliardini S., Pomati M.,
RA   Pierotti M.A.;
RT   "The DNA rearrangement that generates the TRK-T3 oncogene involves a
RT   novel gene on chromosome 3 whose product has a potential coiled-coil
RT   domain.";
RL   Mol. Cell. Biol. 15:6118-6127(1995).
RN   [10]
RP   PROTEIN SEQUENCE OF 1-10; 15-22; 24-42 AND 48-57, ACETYLATION AT
RP   MET-1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Calvo F., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50 AND SER-197, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   FUNCTION, SUBUNIT, VARIANT SPG57 CYS-106, AND CHARACTERIZATION OF
RP   VARIANT SPG57 CYS-106.
RX   PubMed=23479643; DOI=10.1073/pnas.1217197110;
RA   Beetz C., Johnson A., Schuh A.L., Thakur S., Varga R.E.,
RA   Fothergill T., Hertel N., Bomba-Warczak E., Thiele H., Nurnberg G.,
RA   Altmuller J., Saxena R., Chapman E.R., Dent E.W., Nurnberg P.,
RA   Audhya A.;
RT   "Inhibition of TFG function causes hereditary axon degeneration by
RT   impairing endoplasmic reticulum structure.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:5091-5096(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-385 AND ARG-400, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [20]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-149.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [21]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PDCD6,
RP   CHARACTERIZATION OF VARIANT SPG57 CYS-106, AND CHARACTERIZATION OF
RP   VARIANT HMSNO LEU-285.
RX   PubMed=27813252; DOI=10.1111/febs.13949;
RA   Kanadome T., Shibata H., Kuwata K., Takahara T., Maki M.;
RT   "The calcium-binding protein ALG-2 promotes endoplasmic reticulum exit
RT   site localization and polymerization of Trk-fused gene (TFG)
RT   protein.";
RL   FEBS J. 284:56-76(2017).
RN   [22]
RP   VARIANTS SPG57 CYS-106 AND HIS-106, AND CHARACTERIZATION OF VARIANTS
RP   SPG57 CYS-106 AND HIS-106.
RX   PubMed=27492651; DOI=10.1002/humu.23060;
RA   Harlalka G.V., McEntagart M.E., Gupta N., Skrzypiec A.E., Mucha M.W.,
RA   Chioza B.A., Simpson M.A., Sreekantan-Nair A., Pereira A.,
RA   Guenther S., Jahic A., Modarres H., Moore-Barton H., Trembath R.C.,
RA   Kabra M., Baple E.L., Thakur S., Patton M.A., Beetz C., Pawlak R.,
RA   Crosby A.H.;
RT   "Novel genetic, clinical, and pathomechanistic insights into TFG-
RT   associated hereditary spastic paraplegia.";
RL   Hum. Mutat. 37:1157-1161(2016).
CC   -!- FUNCTION: Plays a role in the normal dynamic function of the
CC       endoplasmic reticulum (ER) and its associated microtubules
CC       (PubMed:23479643, PubMed:27813252). {ECO:0000269|PubMed:23479643,
CC       ECO:0000269|PubMed:27813252}.
CC   -!- SUBUNIT: Self-associates to form an oligomeric complex
CC       (PubMed:23479643). Interacts with PDCD6; promoting localization
CC       and polymerization of TFG at endoplasmic reticulum exit site.
CC       {ECO:0000269|PubMed:23479643, ECO:0000269|PubMed:27813252}.
CC   -!- INTERACTION:
CC       Self; NbExp=6; IntAct=EBI-357061, EBI-357061;
CC       P50995:ANXA11; NbExp=3; IntAct=EBI-357061, EBI-715243;
CC       Q5T0G8:ANXA11; NbExp=3; IntAct=EBI-357061, EBI-10245225;
CC       Q5VV41:ARHGEF16; NbExp=3; IntAct=EBI-357061, EBI-1057448;
CC       Q8N9W6:BOLL; NbExp=4; IntAct=EBI-357061, EBI-998198;
CC       Q9NP55:BPIFA1; NbExp=4; IntAct=EBI-357061, EBI-953896;
CC       Q53EZ4:CEP55; NbExp=5; IntAct=EBI-357061, EBI-747776;
CC       P33240:CSTF2; NbExp=5; IntAct=EBI-357061, EBI-711360;
CC       Q15038:DAZAP2; NbExp=4; IntAct=EBI-357061, EBI-724310;
CC       Q01844:EWSR1; NbExp=3; IntAct=EBI-357061, EBI-739737;
CC       Q92567-2:FAM168A; NbExp=4; IntAct=EBI-357061, EBI-11978259;
CC       A0A0S2Z4Q4:HGS; NbExp=3; IntAct=EBI-357061, EBI-16429135;
CC       P52597:HNRNPF; NbExp=3; IntAct=EBI-357061, EBI-352986;
CC       Q9Y5V3:MAGED1; NbExp=7; IntAct=EBI-357061, EBI-716006;
CC       Q8NDC0:MAPK1IP1L; NbExp=7; IntAct=EBI-357061, EBI-741424;
CC       Q9UBV8:PEF1; NbExp=5; IntAct=EBI-357061, EBI-724639;
CC       O15162:PLSCR1; NbExp=2; IntAct=EBI-357061, EBI-740019;
CC       P86480:PRR20D; NbExp=4; IntAct=EBI-357061, EBI-12754095;
CC       Q93062:RBPMS; NbExp=3; IntAct=EBI-357061, EBI-740322;
CC       O95486:SEC24A; NbExp=3; IntAct=EBI-357061, EBI-749911;
CC       Q9NZD8:SPG21; NbExp=5; IntAct=EBI-357061, EBI-742688;
CC       O60806:TBX19; NbExp=4; IntAct=EBI-357061, EBI-12096770;
CC       A5D8V6:VPS37C; NbExp=5; IntAct=EBI-357061, EBI-2559305;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:27813252}. Note=Localizes to endoplasmic
CC       reticulum exit site (ERES) (PubMed:27813252).
CC       {ECO:0000269|PubMed:27813252}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q92734-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92734-2; Sequence=VSP_047131;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q92734-3; Sequence=VSP_057414, VSP_057415;
CC       Name=4;
CC         IsoId=Q92734-4; Sequence=VSP_047131, VSP_057414, VSP_057415;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Note=A chromosomal aberration involving TFG is found in
CC       papillary thyroid carcinomas (PTCs). Translocation t(1;3)(q21;q11)
CC       with NTRK1. The TFG sequence is fused to the 3'-end of NTRK1
CC       generating the TRKT3 (TRK-T3) fusion transcript.
CC       {ECO:0000269|PubMed:7565764}.
CC   -!- DISEASE: Neuropathy, hereditary motor and sensory, Okinawa type
CC       (HMSNO) [MIM:604484]: A neurodegenerative disorder characterized
CC       by young adult onset of proximal muscle weakness and atrophy,
CC       muscle cramps, and fasciculations, with later onset of distal
CC       sensory impairment. The disorder is slowly progressive and
CC       clinically resembles amyotrophic lateral sclerosis.
CC       {ECO:0000269|PubMed:22883144, ECO:0000269|PubMed:27813252}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Spastic paraplegia 57, autosomal recessive (SPG57)
CC       [MIM:615658]: A complicated form of spastic paraplegia, a
CC       neurodegenerative disorder characterized by a slow, gradual,
CC       progressive weakness and spasticity of the lower limbs. Rate of
CC       progression and the severity of symptoms are quite variable.
CC       Initial symptoms may include difficulty with balance, weakness and
CC       stiffness in the legs, muscle spasms, and dragging the toes when
CC       walking. Complicated forms are recognized by additional variable
CC       features including spastic quadriparesis, seizures, dementia,
CC       amyotrophy, extrapyramidal disturbance, cerebral or cerebellar
CC       atrophy, optic atrophy, and peripheral neuropathy, as well as by
CC       extra neurological manifestations. {ECO:0000269|PubMed:23479643,
CC       ECO:0000269|PubMed:27492651, ECO:0000269|PubMed:27813252}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TFGID281.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y07968; CAA69264.1; -; mRNA.
DR   EMBL; AB731569; BAM48926.1; -; mRNA.
DR   EMBL; AB731570; BAM48927.1; -; mRNA.
DR   EMBL; AK093456; BAG52721.1; -; mRNA.
DR   EMBL; BT007428; AAP36096.1; -; mRNA.
DR   EMBL; CR456781; CAG33062.1; -; mRNA.
DR   EMBL; AC068763; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457659; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457666; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79813.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79814.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79815.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79816.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79817.1; -; Genomic_DNA.
DR   EMBL; BC001483; AAH01483.1; -; mRNA.
DR   EMBL; BC009241; AAH09241.1; -; mRNA.
DR   EMBL; BC023599; AAH23599.1; -; mRNA.
DR   EMBL; X85960; CAA59936.1; ALT_TERM; mRNA.
DR   CCDS; CCDS2939.1; -. [Q92734-1]
DR   CCDS; CCDS56266.1; -. [Q92734-2]
DR   RefSeq; NP_001007566.1; NM_001007565.2. [Q92734-1]
DR   RefSeq; NP_001182407.1; NM_001195478.1. [Q92734-1]
DR   RefSeq; NP_001182408.1; NM_001195479.1. [Q92734-2]
DR   RefSeq; NP_006061.2; NM_006070.5. [Q92734-1]
DR   RefSeq; XP_005247123.1; XM_005247066.1. [Q92734-2]
DR   RefSeq; XP_006713535.1; XM_006713472.1. [Q92734-1]
DR   RefSeq; XP_006713536.1; XM_006713473.1. [Q92734-1]
DR   RefSeq; XP_011510636.1; XM_011512334.1. [Q92734-1]
DR   RefSeq; XP_016861016.1; XM_017005527.1. [Q92734-2]
DR   RefSeq; XP_016861017.1; XM_017005528.1. [Q92734-2]
DR   RefSeq; XP_016861018.1; XM_017005529.1. [Q92734-2]
DR   RefSeq; XP_016861019.1; XM_017005530.1. [Q92734-2]
DR   UniGene; Hs.518123; -.
DR   ProteinModelPortal; Q92734; -.
DR   SMR; Q92734; -.
DR   BioGrid; 115624; 121.
DR   IntAct; Q92734; 123.
DR   MINT; Q92734; -.
DR   STRING; 9606.ENSP00000240851; -.
DR   iPTMnet; Q92734; -.
DR   PhosphoSitePlus; Q92734; -.
DR   SwissPalm; Q92734; -.
DR   BioMuta; TFG; -.
DR   DMDM; 223634676; -.
DR   EPD; Q92734; -.
DR   MaxQB; Q92734; -.
DR   PaxDb; Q92734; -.
DR   PeptideAtlas; Q92734; -.
DR   PRIDE; Q92734; -.
DR   DNASU; 10342; -.
DR   Ensembl; ENST00000240851; ENSP00000240851; ENSG00000114354. [Q92734-1]
DR   Ensembl; ENST00000418917; ENSP00000397182; ENSG00000114354. [Q92734-2]
DR   Ensembl; ENST00000476228; ENSP00000417952; ENSG00000114354. [Q92734-2]
DR   Ensembl; ENST00000490574; ENSP00000419960; ENSG00000114354. [Q92734-1]
DR   Ensembl; ENST00000615993; ENSP00000479269; ENSG00000114354. [Q92734-3]
DR   Ensembl; ENST00000620299; ENSP00000479981; ENSG00000114354. [Q92734-3]
DR   GeneID; 10342; -.
DR   KEGG; hsa:10342; -.
DR   UCSC; uc003due.4; human. [Q92734-1]
DR   UCSC; uc031sau.2; human.
DR   CTD; 10342; -.
DR   DisGeNET; 10342; -.
DR   EuPathDB; HostDB:ENSG00000114354.12; -.
DR   GeneCards; TFG; -.
DR   H-InvDB; HIX0003505; -.
DR   HGNC; HGNC:11758; TFG.
DR   HPA; HPA019473; -.
DR   HPA; HPA052206; -.
DR   MalaCards; TFG; -.
DR   MIM; 602498; gene.
DR   MIM; 604484; phenotype.
DR   MIM; 615658; phenotype.
DR   neXtProt; NX_Q92734; -.
DR   OpenTargets; ENSG00000114354; -.
DR   Orphanet; 209916; Extraskeletal myxoid chondrosarcoma.
DR   Orphanet; 90117; Hereditary motor and sensory neuropathy, Okinawa type.
DR   Orphanet; 146; Papillary or follicular thyroid carcinoma.
DR   Orphanet; 320406; Spastic paraplegia-optic atrophy-neuropathy syndrome.
DR   PharmGKB; PA36473; -.
DR   eggNOG; ENOG410IH8P; Eukaryota.
DR   eggNOG; ENOG410Z8FQ; LUCA.
DR   GeneTree; ENSGT00510000047809; -.
DR   HOGENOM; HOG000132915; -.
DR   HOVERGEN; HBG009087; -.
DR   InParanoid; Q92734; -.
DR   KO; K09292; -.
DR   OMA; DCLEPPA; -.
DR   OrthoDB; EOG091G0O5G; -.
DR   PhylomeDB; Q92734; -.
DR   TreeFam; TF318743; -.
DR   Reactome; R-HSA-204005; COPII (Coat Protein 2) Mediated Vesicle Transport.
DR   SignaLink; Q92734; -.
DR   SIGNOR; Q92734; -.
DR   ChiTaRS; TFG; human.
DR   GeneWiki; TFG_(gene); -.
DR   GenomeRNAi; 10342; -.
DR   PRO; PR:Q92734; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114354; -.
DR   CleanEx; HS_TFG; -.
DR   ExpressionAtlas; Q92734; baseline and differential.
DR   Genevisible; Q92734; HS.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070971; C:endoplasmic reticulum exit site; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004871; F:signal transducer activity; HMP:UniProtKB.
DR   GO; GO:0048208; P:COPII vesicle coating; TAS:Reactome.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IMP:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; HMP:UniProtKB.
DR   CDD; cd06401; PB1_TFG; 1.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR034857; PB1_TFG.
DR   InterPro; IPR033512; TFG.
DR   PANTHER; PTHR15335; PTHR15335; 1.
DR   Pfam; PF00564; PB1; 1.
DR   SMART; SM00666; PB1; 1.
DR   PROSITE; PS51745; PB1; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Coiled coil; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Endoplasmic reticulum;
KW   Hereditary spastic paraplegia; Methylation; Neurodegeneration;
KW   Neuropathy; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome.
FT   CHAIN         1    400       Protein TFG.
FT                                /FTId=PRO_0000072500.
FT   DOMAIN       10     91       PB1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01081}.
FT   COILED       97    124       {ECO:0000255}.
FT   SITE        193    194       Breakpoint for translocation to form TRK-
FT                                T3.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.10}.
FT   MOD_RES      50     50       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     197    197       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     385    385       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     400    400       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   VAR_SEQ     237    240       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_047131.
FT   VAR_SEQ     274    284       ASYSQQTGPQQ -> GFQSMERFHCK (in isoform 3
FT                                and isoform 4).
FT                                {ECO:0000303|PubMed:22883144}.
FT                                /FTId=VSP_057414.
FT   VAR_SEQ     285    400       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:22883144}.
FT                                /FTId=VSP_057415.
FT   VARIANT     106    106       R -> C (in SPG57; defective self-assembly
FT                                into an oligomeric complex; impaired
FT                                interaction with PDCD6; causes
FT                                mitochondrial fragmentation;
FT                                dbSNP:rs587777175).
FT                                {ECO:0000269|PubMed:23479643,
FT                                ECO:0000269|PubMed:27492651,
FT                                ECO:0000269|PubMed:27813252}.
FT                                /FTId=VAR_070986.
FT   VARIANT     106    106       R -> H (in SPG57; causes mitochondrial
FT                                fragmentation; dbSNP:rs376971794).
FT                                {ECO:0000269|PubMed:27492651}.
FT                                /FTId=VAR_078075.
FT   VARIANT     149    149       A -> S (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035668.
FT   VARIANT     211    211       A -> V (in dbSNP:rs430945).
FT                                /FTId=VAR_054322.
FT   VARIANT     285    285       P -> L (in HMSNO; does not affect
FT                                interaction with PDCD6;
FT                                dbSNP:rs207482230).
FT                                {ECO:0000269|PubMed:22883144,
FT                                ECO:0000269|PubMed:27813252}.
FT                                /FTId=VAR_068917.
FT   VARIANT     364    364       T -> P (in dbSNP:rs6772054).
FT                                /FTId=VAR_054323.
FT   CONFLICT     13     13       I -> V (in Ref. 1; CAA69264 and 9;
FT                                CAA59936). {ECO:0000305}.
SQ   SEQUENCE   400 AA;  43448 MW;  D8A559D0F7314D1F CRC64;
     MNGQLDLSGK LIIKAQLGED IRRIPIHNED ITYDELVLMM QRVFRGKLLS NDEVTIKYKD
     EDGDLITIFD SSDLSFAIQC SRILKLTLFV NGQPRPLESS QVKYLRRELI ELRNKVNRLL
     DSLEPPGEPG PSTNIPENDT VDGREEKSAS DSSGKQSTQV MAASMSAFDP LKNQDEINKN
     VMSAFGLTDD QVSGPPSAPA EDRSGTPDSI ASSSSAAHPP GVQPQQPPYT GAQTQAGQIE
     GQMYQQYQQQ AGYGAQQPQA PPQQPQQYGI QYSASYSQQT GPQQPQQFQG YGQQPTSQAP
     APAFSGQPQQ LPAQPPQQYQ ASNYPAQTYT AQTSQPTNYT VAPASQPGMA PSQPGAYQPR
     PGFTSLPGST MTPPPSGPNP YARNRPPFGQ GYTQPGPGYR
//
ID   TMPS2_HUMAN             Reviewed;         492 AA.
AC   O15393; A8K6Z8; B2R8E5; B7Z459; D3DSJ2; F8WES1; Q6GTK7; Q9BXX1;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 3.
DT   28-FEB-2018, entry version 173.
DE   RecName: Full=Transmembrane protease serine 2;
DE            EC=3.4.21.-;
DE   AltName: Full=Serine protease 10;
DE   Contains:
DE     RecName: Full=Transmembrane protease serine 2 non-catalytic chain;
DE   Contains:
DE     RecName: Full=Transmembrane protease serine 2 catalytic chain;
DE   Flags: Precursor;
GN   Name=TMPRSS2; Synonyms=PRSS10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS MET-160 AND
RP   GLN-329.
RX   PubMed=9325052; DOI=10.1006/geno.1997.4845;
RA   Paoloni-Giacobino A., Chen H., Peitsch M.C., Rossier C.,
RA   Antonarakis S.E.;
RT   "Cloning of the TMPRSS2 gene, which encodes a novel serine protease
RT   with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3.";
RL   Genomics 44:309-320(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-160.
RX   PubMed=11414763; DOI=10.1006/geno.2001.6551;
RA   Teng D.-H., Chen Y., Lian L., Ha P.C., Tavtigian S.V., Wong A.K.C.;
RT   "Mutation analyses of 268 candidate genes in human tumor cell lines.";
RL   Genomics 74:352-364(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS.
RX   PubMed=11245484;
RA   Afar D.E.H., Vivanco I., Hubert R.S., Kuo J., Chen E., Saffran D.C.,
RA   Raitano A.B., Jakobovits A.;
RT   "Catalytic cleavage of the androgen-regulated TMPRSS2 protease results
RT   in its secretion by prostate and prostate cancer epithelia.";
RL   Cancer Res. 61:1686-1692(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Prostate, Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=11169526;
RX   DOI=10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T;
RA   Vaarala M.H., Porvari K.S., Kellokumpu S., Kyllonen A.P., Vihko P.T.;
RT   "Expression of transmembrane serine protease TMPRSS2 in mouse and
RT   human tissues.";
RL   J. Pathol. 193:134-140(2001).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND GLYCOSYLATION.
RX   PubMed=20382709; DOI=10.2353/ajpath.2010.090665;
RA   Chen Y.W., Lee M.S., Lucht A., Chou F.P., Huang W., Havighurst T.C.,
RA   Kim K., Wang J.K., Antalis T.M., Johnson M.D., Lin C.Y.;
RT   "TMPRSS2, a serine protease expressed in the prostate on the apical
RT   surface of luminal epithelial cells and released into semen in
RT   prostasomes, is misregulated in prostate cancer cells.";
RL   Am. J. Pathol. 176:2986-2996(2010).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AUTOCATALYTIC CLEAVAGE, AND
RP   INTERACTION WITH ACE2.
RX   PubMed=21068237; DOI=10.1128/JVI.02062-10;
RA   Shulla A., Heald-Sargent T., Subramanya G., Zhao J., Perlman S.,
RA   Gallagher T.;
RT   "A transmembrane serine protease is linked to the severe acute
RT   respiratory syndrome coronavirus receptor and activates virus entry.";
RL   J. Virol. 85:873-882(2011).
RN   [12]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=21325420; DOI=10.1128/JVI.02232-10;
RA   Glowacka I., Bertram S., Muller M.A., Allen P., Soilleux E.,
RA   Pfefferle S., Steffen I., Tsegaye T.S., He Y., Gnirss K., Niemeyer D.,
RA   Schneider H., Drosten C., Pohlmann S.;
RT   "Evidence that TMPRSS2 activates the severe acute respiratory syndrome
RT   coronavirus spike protein for membrane fusion and reduces viral
RT   control by the humoral immune response.";
RL   J. Virol. 85:4122-4134(2011).
RN   [13]
RP   FUNCTION.
RX   PubMed=23536651; DOI=10.1128/JVI.03372-12;
RA   Bertram S., Dijkman R., Habjan M., Heurich A., Gierer S., Glowacka I.,
RA   Welsch K., Winkler M., Schneider H., Hofmann-Winkler H., Thiel V.,
RA   Pohlmann S.;
RT   "TMPRSS2 activates the human coronavirus 229E for cathepsin-
RT   independent host cell entry and is expressed in viral target cells in
RT   the respiratory epithelium.";
RL   J. Virol. 87:6150-6160(2013).
RN   [14]
RP   FUNCTION.
RX   PubMed=23966399; DOI=10.1128/JVI.01490-13;
RA   Abe M., Tahara M., Sakai K., Yamaguchi H., Kanou K., Shirato K.,
RA   Kawase M., Noda M., Kimura H., Matsuyama S., Fukuhara H., Mizuta K.,
RA   Maenaka K., Ami Y., Esumi M., Kato A., Takeda M.;
RT   "TMPRSS2 is an activating protease for respiratory parainfluenza
RT   viruses.";
RL   J. Virol. 87:11930-11935(2013).
RN   [15]
RP   FUNCTION.
RX   PubMed=24027332; DOI=10.1128/JVI.01890-13;
RA   Shirato K., Kawase M., Matsuyama S.;
RT   "Middle East respiratory syndrome coronavirus infection mediated by
RT   the transmembrane serine protease TMPRSS2.";
RL   J. Virol. 87:12552-12561(2013).
RN   [16]
RP   FUNCTION.
RX   PubMed=24227843; DOI=10.1128/JVI.02202-13;
RA   Heurich A., Hofmann-Winkler H., Gierer S., Liepold T., Jahn O.,
RA   Poehlmann S.;
RT   "TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by
RT   TMPRSS2 augments entry driven by the severe acute respiratory syndrome
RT   coronavirus spike protein.";
RL   J. Virol. 88:1293-1307(2014).
RN   [17]
RP   VARIANTS MET-160; CYS-254; GLN-329 AND ASN-491.
RX   PubMed=17918732; DOI=10.1002/humu.20617;
RA   Guipponi M., Toh M.-Y., Tan J., Park D., Hanson K., Ballana E.,
RA   Kwong D., Cannon P.Z.F., Wu Q., Gout A., Delorenzi M., Speed T.P.,
RA   Smith R.J.H., Dahl H.-H.M., Petersen M., Teasdale R.D., Estivill X.,
RA   Park W.J., Scott H.S.;
RT   "An integrated genetic and functional analysis of the role of type II
RT   transmembrane serine proteases (TMPRSSs) in hearing loss.";
RL   Hum. Mutat. 29:130-141(2008).
CC   -!- FUNCTION: Serine protease that proteolytically cleaves and
CC       activates the viral spike glycoproteins which facilitate virus-
CC       cell membrane fusions; spike proteins are synthesized and
CC       maintained in precursor intermediate folding states and
CC       proteolysis permits the refolding and energy release required to
CC       create stable virus-cell linkages and membrane coalescence.
CC       Facilitates human SARS coronavirus (SARS-CoV) infection via two
CC       independent mechanisms, proteolytic cleavage of ACE2, which might
CC       promote viral uptake, and cleavage of coronavirus spike
CC       glycoprotein which activates the glycoprotein for cathepsin L-
CC       independent host cell entry. Proteolytically cleaves and activates
CC       the spike glycoproteins of human coronavirus 229E (HCoV-229E) and
CC       human coronavirus EMC (HCoV-EMC) and the fusion glycoproteins F0
CC       of Sendai virus (SeV), human metapneumovirus (HMPV), human
CC       parainfluenza 1, 2, 3, 4a and 4b viruses (HPIV). Essential for
CC       spread and pathogenesis of influenza A virus (strains H1N1, H3N2
CC       and H7N9); involved in proteolytic cleavage and activation of
CC       hemagglutinin (HA) protein which is essential for viral
CC       infectivity. {ECO:0000269|PubMed:21068237,
CC       ECO:0000269|PubMed:21325420, ECO:0000269|PubMed:23536651,
CC       ECO:0000269|PubMed:23966399, ECO:0000269|PubMed:24027332,
CC       ECO:0000269|PubMed:24227843}.
CC   -!- SUBUNIT: The catalytically active form interacts with ACE2.
CC       {ECO:0000269|PubMed:21068237}.
CC   -!- INTERACTION:
CC       Q5BJH2-2:TMEM128; NbExp=4; IntAct=EBI-12345267, EBI-10694905;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20382709,
CC       ECO:0000269|PubMed:21068237}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:20382709, ECO:0000269|PubMed:21068237}.
CC   -!- SUBCELLULAR LOCATION: Transmembrane protease serine 2 catalytic
CC       chain: Secreted {ECO:0000269|PubMed:20382709}. Note=Activated by
CC       cleavage and secreted. {ECO:0000269|PubMed:20382709}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O15393-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15393-2; Sequence=VSP_045083;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in prostate epithelial cells
CC       and in prostate cancers. Expressed in type II pneumocytes in the
CC       lung (at protein level). Expressed strongly in small intestine.
CC       Also expressed in colon, stomach and salivary gland.
CC       {ECO:0000269|PubMed:11169526, ECO:0000269|PubMed:20382709,
CC       ECO:0000269|PubMed:21325420}.
CC   -!- PTM: Proteolytically processed; by an autocatalytic mechanism.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00274}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TMPRSS2ID42592ch21q22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U75329; AAC51784.1; -; mRNA.
DR   EMBL; AF123453; AAD37117.1; -; mRNA.
DR   EMBL; AF270487; AAK29280.1; -; mRNA.
DR   EMBL; AK291813; BAF84502.1; -; mRNA.
DR   EMBL; AK296860; BAH12445.1; -; mRNA.
DR   EMBL; AK313338; BAG36142.1; -; mRNA.
DR   EMBL; AK222784; BAD96504.1; -; mRNA.
DR   EMBL; AP001610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471079; EAX09597.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09598.1; -; Genomic_DNA.
DR   EMBL; BC051839; AAH51839.1; -; mRNA.
DR   CCDS; CCDS33564.1; -. [O15393-1]
DR   CCDS; CCDS54486.1; -. [O15393-2]
DR   RefSeq; NP_001128571.1; NM_001135099.1. [O15393-2]
DR   RefSeq; NP_005647.3; NM_005656.3. [O15393-1]
DR   RefSeq; XP_011528033.1; XM_011529731.2. [O15393-1]
DR   UniGene; Hs.439309; -.
DR   ProteinModelPortal; O15393; -.
DR   SMR; O15393; -.
DR   BioGrid; 112968; 1.
DR   IntAct; O15393; 57.
DR   STRING; 9606.ENSP00000381588; -.
DR   BindingDB; O15393; -.
DR   ChEMBL; CHEMBL1795140; -.
DR   GuidetoPHARMACOLOGY; 2421; -.
DR   MEROPS; S01.247; -.
DR   iPTMnet; O15393; -.
DR   PhosphoSitePlus; O15393; -.
DR   BioMuta; TMPRSS2; -.
DR   MaxQB; O15393; -.
DR   PaxDb; O15393; -.
DR   PeptideAtlas; O15393; -.
DR   PRIDE; O15393; -.
DR   DNASU; 7113; -.
DR   Ensembl; ENST00000332149; ENSP00000330330; ENSG00000184012. [O15393-1]
DR   Ensembl; ENST00000398585; ENSP00000381588; ENSG00000184012. [O15393-2]
DR   Ensembl; ENST00000458356; ENSP00000391216; ENSG00000184012. [O15393-1]
DR   GeneID; 7113; -.
DR   KEGG; hsa:7113; -.
DR   UCSC; uc002yzj.4; human. [O15393-1]
DR   CTD; 7113; -.
DR   DisGeNET; 7113; -.
DR   EuPathDB; HostDB:ENSG00000184012.11; -.
DR   GeneCards; TMPRSS2; -.
DR   HGNC; HGNC:11876; TMPRSS2.
DR   HPA; HPA034493; -.
DR   HPA; HPA035787; -.
DR   MIM; 602060; gene.
DR   neXtProt; NX_O15393; -.
DR   OpenTargets; ENSG00000184012; -.
DR   PharmGKB; PA36577; -.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   GeneTree; ENSGT00760000118962; -.
DR   HOGENOM; HOG000251822; -.
DR   HOVERGEN; HBG013304; -.
DR   InParanoid; O15393; -.
DR   KO; K09633; -.
DR   OMA; QVYSSQR; -.
DR   OrthoDB; EOG091G0DF7; -.
DR   PhylomeDB; O15393; -.
DR   TreeFam; TF351678; -.
DR   SIGNOR; O15393; -.
DR   ChiTaRS; TMPRSS2; human.
DR   GeneWiki; TMPRSS2; -.
DR   GenomeRNAi; 7113; -.
DR   PRO; PR:O15393; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000184012; -.
DR   CleanEx; HS_TMPRSS2; -.
DR   ExpressionAtlas; O15393; baseline and differential.
DR   Genevisible; O15393; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0008236; F:serine-type peptidase activity; TAS:ProtInc.
DR   GO; GO:0046598; P:positive regulation of viral entry into host cell; IDA:UniProtKB.
DR   GO; GO:0016540; P:protein autoprocessing; IMP:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   CDD; cd00112; LDLa; 1.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   Gene3D; 3.10.250.10; -; 1.
DR   InterPro; IPR036055; LDL_receptor-like_sf.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001190; SRCR.
DR   InterPro; IPR017448; SRCR-like_dom.
DR   InterPro; IPR036772; SRCR-like_dom_sf.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF15494; SRCR_2; 1.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00192; LDLa; 1.
DR   SMART; SM00202; SR; 1.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF56487; SSF56487; 1.
DR   SUPFAM; SSF57424; SSF57424; 1.
DR   PROSITE; PS01209; LDLRA_1; 1.
DR   PROSITE; PS50068; LDLRA_2; 1.
DR   PROSITE; PS50287; SRCR_2; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Autocatalytic cleavage; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Hydrolase; Membrane;
KW   Polymorphism; Protease; Reference proteome; Secreted; Serine protease;
KW   Signal-anchor; Transmembrane; Transmembrane helix; Zymogen.
FT   CHAIN         1    255       Transmembrane protease serine 2 non-
FT                                catalytic chain.
FT                                /FTId=PRO_0000027855.
FT   CHAIN       256    492       Transmembrane protease serine 2 catalytic
FT                                chain.
FT                                /FTId=PRO_0000027856.
FT   TOPO_DOM      1     84       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     85    105       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM    106    492       Extracellular. {ECO:0000255}.
FT   DOMAIN      112    149       LDL-receptor class A.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN      150    242       SRCR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      256    489       Peptidase S1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00274}.
FT   ACT_SITE    296    296       Charge relay system. {ECO:0000250}.
FT   ACT_SITE    345    345       Charge relay system. {ECO:0000250}.
FT   ACT_SITE    441    441       Charge relay system.
FT   SITE        255    256       Cleavage. {ECO:0000255}.
FT   CARBOHYD    213    213       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    249    249       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    113    126       {ECO:0000250}.
FT   DISULFID    120    139       {ECO:0000250}.
FT   DISULFID    133    148       {ECO:0000250}.
FT   DISULFID    172    231       {ECO:0000250}.
FT   DISULFID    185    241       {ECO:0000250}.
FT   DISULFID    244    365       Interchain (between non-catalytic and
FT                                catalytic chains). {ECO:0000255|PROSITE-
FT                                ProRule:PRU00124, ECO:0000255|PROSITE-
FT                                ProRule:PRU00196, ECO:0000255|PROSITE-
FT                                ProRule:PRU00274}.
FT   DISULFID    281    297       {ECO:0000250}.
FT   DISULFID    410    426       {ECO:0000250}.
FT   DISULFID    437    465       {ECO:0000250}.
FT   VAR_SEQ       1      1       M -> MPPAPPGGESGCEERGAAGHIEHSRYLSLLDAVDNS
FT                                KM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045083.
FT   VARIANT     160    160       V -> M (in dbSNP:rs12329760).
FT                                {ECO:0000269|PubMed:11414763,
FT                                ECO:0000269|PubMed:17918732,
FT                                ECO:0000269|PubMed:9325052}.
FT                                /FTId=VAR_027674.
FT   VARIANT     254    254       S -> C. {ECO:0000269|PubMed:17918732}.
FT                                /FTId=VAR_038002.
FT   VARIANT     329    329       E -> Q (in dbSNP:rs775137340).
FT                                {ECO:0000269|PubMed:17918732,
FT                                ECO:0000269|PubMed:9325052}.
FT                                /FTId=VAR_038003.
FT   VARIANT     449    449       K -> N (in dbSNP:rs1056602).
FT                                /FTId=VAR_011692.
FT   VARIANT     491    491       D -> N (in dbSNP:rs779875214).
FT                                {ECO:0000269|PubMed:17918732}.
FT                                /FTId=VAR_038004.
FT   MUTAGEN     255    255       R->Q: Loss of cleavage.
FT                                {ECO:0000269|PubMed:11245484}.
FT   MUTAGEN     441    441       S->A: Loss of activity.
FT                                {ECO:0000269|PubMed:11245484}.
FT   CONFLICT     26     26       Y -> H (in Ref. 4; BAF84502).
FT                                {ECO:0000305}.
FT   CONFLICT     62     62       N -> S (in Ref. 4; BAH12445).
FT                                {ECO:0000305}.
FT   CONFLICT    163    163       S -> P (in Ref. 4; BAF84502).
FT                                {ECO:0000305}.
FT   CONFLICT    242    242       I -> L (in Ref. 1; AAC51784).
FT                                {ECO:0000305}.
FT   CONFLICT    489    491       RAD -> KAN (in Ref. 1; AAC51784).
FT                                {ECO:0000305}.
SQ   SEQUENCE   492 AA;  53859 MW;  C05B5531C8A311C7 CRC64;
     MALNSGSPPA IGPYYENHGY QPENPYPAQP TVVPTVYEVH PAQYYPSPVP QYAPRVLTQA
     SNPVVCTQPK SPSGTVCTSK TKKALCITLT LGTFLVGAAL AAGLLWKFMG SKCSNSGIEC
     DSSGTCINPS NWCDGVSHCP GGEDENRCVR LYGPNFILQV YSSQRKSWHP VCQDDWNENY
     GRAACRDMGY KNNFYSSQGI VDDSGSTSFM KLNTSAGNVD IYKKLYHSDA CSSKAVVSLR
     CIACGVNLNS SRQSRIVGGE SALPGAWPWQ VSLHVQNVHV CGGSIITPEW IVTAAHCVEK
     PLNNPWHWTA FAGILRQSFM FYGAGYQVEK VISHPNYDSK TKNNDIALMK LQKPLTFNDL
     VKPVCLPNPG MMLQPEQLCW ISGWGATEEK GKTSEVLNAA KVLLIETQRC NSRYVYDNLI
     TPAMICAGFL QGNVDSCQGD SGGPLVTSKN NIWWLIGDTS WGSGCAKAYR PGVYGNVMVF
     TDWIYRQMRA DG
//
ID   TOP1_HUMAN              Reviewed;         765 AA.
AC   P11387; A8KA78; E1P5W3; O43256; Q12855; Q12856; Q15610; Q5TFY3;
AC   Q9UJN0;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   28-FEB-2018, entry version 205.
DE   RecName: Full=DNA topoisomerase 1;
DE            EC=5.99.1.2;
DE   AltName: Full=DNA topoisomerase I;
GN   Name=TOP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=2833744; DOI=10.1073/pnas.85.8.2543;
RA   D'Arpa P., Machlin P.S., Ratrie H. III, Rothfield N.F.,
RA   Cleveland D.W., Earnshaw W.C.;
RT   "cDNA cloning of human DNA topoisomerase I: catalytic activity of a
RT   67.7-kDa carboxyl-terminal fragment.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:2543-2547(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1851751;
RA   Kunze N., Yang G., Dolberg M., Sundarp R., Knippers R., Richter A.;
RT   "Structure of the human type I DNA topoisomerase gene.";
RL   J. Biol. Chem. 266:9610-9616(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-14.
RX   PubMed=2176592; DOI=10.1111/j.1432-1033.1990.tb15620.x;
RA   Kunze N., Klein M., Richter A., Knippers R.;
RT   "Structural characterisation of the human DNA topoisomerase I gene
RT   promoter.";
RL   Eur. J. Biochem. 194:323-330(1990).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-17; 107-117; 224-239; 253-262; 292-299; 355-362;
RP   426-434; 476-484; 509-532; 550-587; 591-615; 625-634; 656-663;
RP   694-712; 721-734 AND 736-742, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-765, AND VARIANTS CPT-RESISTANT
RP   LEUKEMIA THR-370 AND SER-722.
RC   TISSUE=Peripheral blood;
RX   PubMed=7882333;
RA   Fujimori A., Harker W.G., Kohlhagen G., Hoki Y., Pommier Y.;
RT   "Mutation at the catalytic site of topoisomerase I in CEM/C2, a human
RT   leukemia cell line resistant to camptothecin.";
RL   Cancer Res. 55:1339-1346(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 344-765.
RX   PubMed=2461859; DOI=10.1111/j.1432-1033.1988.tb14404.x;
RA   Oddou P., Schmidt U., Knippers R., Richter A.;
RT   "Monoclonal antibodies neutralizing mammalian DNA topoisomerase I
RT   activity.";
RL   Eur. J. Biochem. 177:523-529(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 541-765.
RX   PubMed=2544263;
RA   Zhou B.S., Bastow K.F., Cheng Y.C.;
RT   "Characterization of the 3' region of the human DNA topoisomerase I
RT   gene.";
RL   Cancer Res. 49:3922-3927(1989).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 657-765.
RX   PubMed=2479024; DOI=10.1073/pnas.86.21.8492;
RA   Maul G.G., Jimenez S.A., Riggs E., Ziemnicka-Kotula D.;
RT   "Determination of an epitope of the diffuse systemic sclerosis marker
RT   antigen DNA topoisomerase I: sequence similarity with retroviral
RT   p30gag protein suggests a possible cause for autoimmunity in systemic
RT   sclerosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8492-8496(1989).
RN   [12]
RP   CHROMOSOMAL TRANSLOCATION WITH NUP98.
RX   PubMed=10556215;
RA   Ahuja H.G., Felix C.A., Aplan P.D.;
RT   "The t(11;20)(p15;q11) chromosomal translocation associated with
RT   therapy-related myelodysplastic syndrome results in an NUP98-TOP1
RT   fusion.";
RL   Blood 94:3258-3261(1999).
RN   [13]
RP   SUMOYLATION AT LYS-117, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   LYS-103; LYS-117; LYS-153 AND TYR-723.
RX   PubMed=12149243; DOI=10.1074/jbc.M200388200;
RA   Rallabhandi P., Hashimoto K., Mo Y.-Y., Beck W.T., Moitra P.K.,
RA   D'Arpa P.;
RT   "Sumoylation of topoisomerase I is involved in its partitioning
RT   between nucleoli and nucleoplasm and its clearing from nucleoli in
RT   response to camptothecin.";
RL   J. Biol. Chem. 277:40020-40026(2002).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   INTERACTION WITH SV40 LARGE T ANTIGEN.
RX   PubMed=18003733; DOI=10.1128/JVI.01314-07;
RA   Khopde S., Simmons D.T.;
RT   "Simian virus 40 DNA replication is dependent on an interaction
RT   between topoisomerase I and the C-terminal end of T antigen.";
RL   J. Virol. 82:1136-1145(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=19168442; DOI=10.1161/CIRCRESAHA.108.183905;
RA   Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S.,
RA   Poller W., Schultheiss H.P., Rauch U.;
RT   "Cdc2-like kinases and DNA topoisomerase I regulate alternative
RT   splicing of tissue factor in human endothelial cells.";
RL   Circ. Res. 104:589-599(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-280, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-10; SER-57 AND SER-112, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-10, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   FUNCTION.
RX   PubMed=22904072; DOI=10.1093/nar/gks779;
RA   Onishi Y., Kawano Y.;
RT   "Rhythmic binding of Topoisomerase I impacts on the transcription of
RT   Bmal1 and circadian period.";
RL   Nucleic Acids Res. 40:9482-9492(2012).
RN   [24]
RP   PHOSPHORYLATION AT SER-506.
RX   PubMed=23185622; DOI=10.1371/journal.pone.0050427;
RA   Bandyopadhyay K., Li P., Gjerset R.A.;
RT   "CK2-mediated hyperphosphorylation of topoisomerase I targets serine
RT   506, enhances topoisomerase I-DNA Binding, and increases cellular
RT   camptothecin sensitivity.";
RL   PLoS ONE 7:E50427-E50427(2012).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND SER-10, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117; LYS-134; LYS-153;
RP   LYS-158 AND LYS-164, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [29]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117; LYS-148; LYS-153 AND
RP   LYS-164, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-148; LYS-153; LYS-164 AND
RP   LYS-336, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [31]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-101; LYS-103; LYS-117;
RP   LYS-134; LYS-148; LYS-153; LYS-158; LYS-164; LYS-172; LYS-204;
RP   LYS-336; LYS-549; LYS-642; LYS-700 AND LYS-712, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 175-765 IN COMPLEX WITH DNA,
RP   AND ACTIVE SITE.
RX   PubMed=9488644; DOI=10.1126/science.279.5356.1504;
RA   Redinbo M.R., Stewart L., Kuhn P., Champoux J.J., Hol W.G.J.;
RT   "Crystal structures of human topoisomerase I in covalent and
RT   noncovalent complexes with DNA.";
RL   Science 279:1504-1513(1998).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 215-765 OF MUTANT PHE-723 IN
RP   COMPLEX WITH DNA.
RX   PubMed=9488652; DOI=10.1126/science.279.5356.1534;
RA   Stewart L., Redinbo M.R., Qiu X., Hol W.G.J., Champoux J.J.;
RT   "A model for the mechanism of human topoisomerase I.";
RL   Science 279:1534-1541(1998).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 203-765 IN COMPLEX WITH DNA,
RP   AND ACTIVE SITE.
RX   PubMed=10841763; DOI=10.1021/bi992690t;
RA   Redinbo M.R., Champoux J.J., Hol W.G.J.;
RT   "Novel insights into catalytic mechanism from a crystal structure of
RT   human topoisomerase I in complex with DNA.";
RL   Biochemistry 39:6832-6840(2000).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (3.14 ANGSTROMS) OF 202-765 IN COMPLEX WITH DNA.
RX   PubMed=12209008; DOI=10.1073/pnas.192282699;
RA   Lesher D.T., Pommier Y., Stewart L., Redinbo M.R.;
RT   "8-Oxoguanine rearranges the active site of human topoisomerase I.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:12102-12107(2002).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 174-765 IN COMPLEXES WITH
RP   DNA AND TOPOTECAN, AND ACTIVE SITE.
RX   PubMed=12426403; DOI=10.1073/pnas.242259599;
RA   Staker B.L., Hjerrild K., Feese M.D., Behnke C.A., Burgin A.B. Jr.,
RA   Stewart L.;
RT   "The mechanism of topoisomerase I poisoning by a camptothecin
RT   analog.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:15387-15392(2002).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 203-764 IN COMPLEX WITH DNA,
RP   AND ACTIVE SITE.
RX   PubMed=12533542; DOI=10.1074/jbc.M212930200;
RA   Chrencik J.E., Burgin A.B., Pommier Y., Stewart L., Redinbo M.R.;
RT   "Structural impact of the leukemia drug 1-beta-D-
RT   arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase
RT   I-DNA complex.";
RL   J. Biol. Chem. 278:12461-12466(2003).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (3.13 ANGSTROMS) OF 174-765, MUTAGENESIS OF
RP   LYS-532, CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=14594810; DOI=10.1074/jbc.M309959200;
RA   Interthal H., Quigley P.M., Hol W.G., Champoux J.J.;
RT   "The role of lysine 532 in the catalytic mechanism of human
RT   topoisomerase I.";
RL   J. Biol. Chem. 279:2984-2992(2004).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 201-765 IN COMPLEX WITH DNA
RP   AND TOPOTECAN, AND ACTIVE SITE.
RX   PubMed=15165849; DOI=10.1016/j.jmb.2004.03.077;
RA   Chrencik J.E., Staker B.L., Burgin A.B., Pourquier P., Pommier Y.,
RA   Stewart L., Redinbo M.R.;
RT   "Mechanisms of camptothecin resistance by human topoisomerase I
RT   mutations.";
RL   J. Mol. Biol. 339:773-784(2004).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 174-765 IN COMPLEXES WITH
RP   DNA AND SYNTHETIC INHIBITORS, AND ACTIVE SITE.
RX   PubMed=15801827; DOI=10.1021/jm049146p;
RA   Staker B.L., Feese M.D., Cushman M., Pommier Y., Zembower D.,
RA   Stewart L., Burgin A.B.;
RT   "Structures of three classes of anticancer agents bound to the human
RT   topoisomerase I-DNA covalent complex.";
RL   J. Med. Chem. 48:2336-2345(2005).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 174-765 IN COMPLEX WITH DNA
RP   AND SYNTHETIC INHIBITORS, CATALYTIC ACTIVITY, FUNCTION, AND ACTIVE
RP   SITE.
RX   PubMed=16033260; DOI=10.1021/jm050076b;
RA   Ioanoviciu A., Antony S., Pommier Y., Staker B.L., Stewart L.,
RA   Cushman M.;
RT   "Synthesis and mechanism of action studies of a series of
RT   norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with
RT   a flipped orientation in the ternary DNA-enzyme-inhibitor complex as
RT   determined by X-ray crystallographic analysis.";
RL   J. Med. Chem. 48:4803-4814(2005).
RN   [42]
RP   VARIANT CPT-RESISTANT LEUKEMIA GLY-533.
RX   PubMed=1849260; DOI=10.1093/nar/19.1.69;
RA   Tamura H., Kohchi C., Yamada R., Ikeda T., Koiwai O., Patterson E.,
RA   Keene J.D., Okada K., Kjeldsen E., Nishikawa K.;
RT   "Molecular cloning of a cDNA of a camptothecin-resistant human DNA
RT   topoisomerase I and identification of mutation sites.";
RL   Nucleic Acids Res. 19:69-75(1991).
RN   [43]
RP   VARIANT CPT-RESISTANT LUNG CANCER ALA-729.
RX   PubMed=1332703; DOI=10.1016/0006-291X(92)91094-7;
RA   Kubota N., Kanzawa F., Nishio K., Takeda Y., Ohmori T., Fujiwara Y.,
RA   Terashima Y., Saijo N.;
RT   "Detection of topoisomerase I gene point mutation in CPT-11 resistant
RT   lung cancer cell line.";
RL   Biochem. Biophys. Res. Commun. 188:571-577(1992).
RN   [44]
RP   VARIANT [LARGE SCALE ANALYSIS] BREAST CANCER ARG-326.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Releases the supercoiling and torsional tension of DNA
CC       introduced during the DNA replication and transcription by
CC       transiently cleaving and rejoining one strand of the DNA duplex.
CC       Introduces a single-strand break via transesterification at a
CC       target site in duplex DNA. The scissile phosphodiester is attacked
CC       by the catalytic tyrosine of the enzyme, resulting in the
CC       formation of a DNA-(3'-phosphotyrosyl)-enzyme intermediate and the
CC       expulsion of a 5'-OH DNA strand. The free DNA strand then rotates
CC       around the intact phosphodiester bond on the opposing strand, thus
CC       removing DNA supercoils. Finally, in the religation step, the DNA
CC       5'-OH attacks the covalent intermediate to expel the active-site
CC       tyrosine and restore the DNA phosphodiester backbone (By
CC       similarity). Regulates the alternative splicing of tissue factor
CC       (F3) pre-mRNA in endothelial cells. Involved in the circadian
CC       transcription of the core circadian clock component ARNTL/BMAL1 by
CC       altering the chromatin structure around the ROR response elements
CC       (ROREs) on the ARNTL/BMAL1 promoter.
CC       {ECO:0000250|UniProtKB:Q13472, ECO:0000269|PubMed:14594810,
CC       ECO:0000269|PubMed:16033260, ECO:0000269|PubMed:19168442,
CC       ECO:0000269|PubMed:22904072, ECO:0000269|PubMed:2833744}.
CC   -!- CATALYTIC ACTIVITY: ATP-independent breakage of single-stranded
CC       DNA, followed by passage and rejoining. {ECO:0000255|PROSITE-
CC       ProRule:PRU10130, ECO:0000269|PubMed:14594810,
CC       ECO:0000269|PubMed:16033260, ECO:0000269|PubMed:2833744}.
CC   -!- ENZYME REGULATION: Specifically inhibited by camptothecin (CPT), a
CC       plant alkaloid with antitumor activity.
CC   -!- SUBUNIT: Monomer. Interacts with SV40 Large T antigen; this
CC       interactions allows viral DNA replication.
CC       {ECO:0000269|PubMed:10841763, ECO:0000269|PubMed:12209008,
CC       ECO:0000269|PubMed:12533542, ECO:0000269|PubMed:15165849,
CC       ECO:0000269|PubMed:16033260, ECO:0000269|PubMed:18003733,
CC       ECO:0000269|PubMed:9488644, ECO:0000269|PubMed:9488652}.
CC   -!- INTERACTION:
CC       P00519:ABL1; NbExp=7; IntAct=EBI-876302, EBI-375543;
CC       P01106:MYC; NbExp=2; IntAct=EBI-876302, EBI-447544;
CC       Q99801:NKX3-1; NbExp=6; IntAct=EBI-876302, EBI-1385894;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus
CC       {ECO:0000269|PubMed:12149243}. Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:12149243}. Note=Diffuse nuclear localization
CC       with some enrichment in nucleoli. On CPT treatment, cleared from
CC       nucleoli into nucleoplasm. Sumoylated forms found in both
CC       nucleoplasm and nucleoli.
CC   -!- TISSUE SPECIFICITY: Endothelial cells.
CC       {ECO:0000269|PubMed:19168442}.
CC   -!- PTM: Sumoylated. Lys-117 is the main site of sumoylation.
CC       Sumoylation plays a role in partitioning TOP1 between nucleoli and
CC       nucleoplasm. Levels are dramatically increased on camptothecin
CC       (CPT) treatment. {ECO:0000269|PubMed:12149243}.
CC   -!- PTM: Phosphorylation at Ser-506 by CK2 increases binding to
CC       supercoiled DNA and sensitivity to camptothecin.
CC       {ECO:0000269|PubMed:23185622}.
CC   -!- DISEASE: Note=A chromosomal aberration involving TOP1 is found in
CC       a form of therapy-related myelodysplastic syndrome. Translocation
CC       t(11;20)(p15;q11) with NUP98. {ECO:0000269|PubMed:10556215}.
CC   -!- MISCELLANEOUS: Eukaryotic topoisomerase I and II can relax both
CC       negative and positive supercoils, whereas prokaryotic enzymes
CC       relax only negative supercoils.
CC   -!- SIMILARITY: Belongs to the type IB topoisomerase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA36834.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TOP1ID320ch20q11.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03250; AAA61207.1; -; mRNA.
DR   EMBL; M60706; AAA61206.1; -; Genomic_DNA.
DR   EMBL; M60688; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60689; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60690; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60691; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60692; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60693; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60694; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60695; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60696; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60697; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60698; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60699; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60700; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60701; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60702; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60703; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60704; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; M60705; AAA61206.1; JOINED; Genomic_DNA.
DR   EMBL; AK292943; BAF85632.1; -; mRNA.
DR   EMBL; AL035652; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL022394; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75994.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75995.1; -; Genomic_DNA.
DR   EMBL; X52601; CAA36834.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; U07804; AAB60379.1; -; mRNA.
DR   EMBL; U07806; AAB60380.1; -; mRNA.
DR   EMBL; X16479; CAA34500.2; -; mRNA.
DR   EMBL; M27913; AAA61208.1; -; mRNA.
DR   CCDS; CCDS13312.1; -.
DR   PIR; A30887; ISHUT1.
DR   RefSeq; NP_003277.1; NM_003286.3.
DR   UniGene; Hs.472737; -.
DR   PDB; 1A31; X-ray; 2.10 A; A=175-765.
DR   PDB; 1A35; X-ray; 2.50 A; A=175-765.
DR   PDB; 1A36; X-ray; 2.80 A; A=175-765.
DR   PDB; 1EJ9; X-ray; 2.60 A; A=203-765.
DR   PDB; 1K4S; X-ray; 3.20 A; A=174-765.
DR   PDB; 1K4T; X-ray; 2.10 A; A=174-765.
DR   PDB; 1LPQ; X-ray; 3.14 A; A=202-765.
DR   PDB; 1NH3; X-ray; 3.10 A; A=203-765.
DR   PDB; 1R49; X-ray; 3.13 A; A=174-765.
DR   PDB; 1RR8; X-ray; 2.60 A; C=203-765.
DR   PDB; 1RRJ; X-ray; 2.30 A; A=201-765.
DR   PDB; 1SC7; X-ray; 3.00 A; A=174-765.
DR   PDB; 1SEU; X-ray; 3.00 A; A=174-765.
DR   PDB; 1T8I; X-ray; 3.00 A; A=174-765.
DR   PDB; 1TL8; X-ray; 3.10 A; A=174-765.
DR   PDBsum; 1A31; -.
DR   PDBsum; 1A35; -.
DR   PDBsum; 1A36; -.
DR   PDBsum; 1EJ9; -.
DR   PDBsum; 1K4S; -.
DR   PDBsum; 1K4T; -.
DR   PDBsum; 1LPQ; -.
DR   PDBsum; 1NH3; -.
DR   PDBsum; 1R49; -.
DR   PDBsum; 1RR8; -.
DR   PDBsum; 1RRJ; -.
DR   PDBsum; 1SC7; -.
DR   PDBsum; 1SEU; -.
DR   PDBsum; 1T8I; -.
DR   PDBsum; 1TL8; -.
DR   DisProt; DP00075; -.
DR   ProteinModelPortal; P11387; -.
DR   SMR; P11387; -.
DR   BioGrid; 113003; 182.
DR   CORUM; P11387; -.
DR   DIP; DIP-36356N; -.
DR   ELM; P11387; -.
DR   IntAct; P11387; 65.
DR   MINT; P11387; -.
DR   STRING; 9606.ENSP00000354522; -.
DR   BindingDB; P11387; -.
DR   ChEMBL; CHEMBL1781; -.
DR   DrugBank; DB05806; BNP 1350.
DR   DrugBank; DB04690; Camptothecin.
DR   DrugBank; DB04882; Edotecarin.
DR   DrugBank; DB05129; Elsamitrucin.
DR   DrugBank; DB00762; Irinotecan.
DR   DrugBank; DB05482; LE-SN38.
DR   DrugBank; DB04967; Lucanthone.
DR   DrugBank; DB05630; Sodium stibogluconate.
DR   DrugBank; DB01030; Topotecan.
DR   DrugBank; DB06069; XMT-1001.
DR   iPTMnet; P11387; -.
DR   PhosphoSitePlus; P11387; -.
DR   SwissPalm; P11387; -.
DR   BioMuta; TOP1; -.
DR   DMDM; 12644118; -.
DR   SWISS-2DPAGE; P11387; -.
DR   EPD; P11387; -.
DR   MaxQB; P11387; -.
DR   PaxDb; P11387; -.
DR   PeptideAtlas; P11387; -.
DR   PRIDE; P11387; -.
DR   Ensembl; ENST00000361337; ENSP00000354522; ENSG00000198900.
DR   GeneID; 7150; -.
DR   KEGG; hsa:7150; -.
DR   UCSC; uc002xjl.4; human.
DR   CTD; 7150; -.
DR   DisGeNET; 7150; -.
DR   EuPathDB; HostDB:ENSG00000198900.5; -.
DR   GeneCards; TOP1; -.
DR   H-InvDB; HIX0015818; -.
DR   H-InvDB; HIX0040702; -.
DR   HGNC; HGNC:11986; TOP1.
DR   HPA; CAB009058; -.
DR   HPA; HPA019039; -.
DR   MIM; 126420; gene.
DR   neXtProt; NX_P11387; -.
DR   OpenTargets; ENSG00000198900; -.
DR   PharmGKB; PA353; -.
DR   eggNOG; KOG0981; Eukaryota.
DR   eggNOG; COG3569; LUCA.
DR   GeneTree; ENSGT00390000016347; -.
DR   HOVERGEN; HBG007988; -.
DR   InParanoid; P11387; -.
DR   KO; K03163; -.
DR   OMA; ATWLAMW; -.
DR   OrthoDB; EOG091G02KT; -.
DR   PhylomeDB; P11387; -.
DR   TreeFam; TF105281; -.
DR   BRENDA; 5.99.1.2; 2681.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   SIGNOR; P11387; -.
DR   ChiTaRS; TOP1; human.
DR   EvolutionaryTrace; P11387; -.
DR   GeneWiki; TOP1; -.
DR   GenomeRNAi; 7150; -.
DR   PMAP-CutDB; P11387; -.
DR   PRO; PR:P11387; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000198900; -.
DR   CleanEx; HS_TOP1; -.
DR   Genevisible; P11387; HS.
DR   GO; GO:0009330; C:DNA topoisomerase complex (ATP-hydrolyzing); IMP:CAFA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000932; C:P-body; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0032993; C:protein-DNA complex; IMP:CAFA.
DR   GO; GO:0031298; C:replication fork protection complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IMP:CAFA.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003917; F:DNA topoisomerase type I activity; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IMP:CAFA.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IMP:CAFA.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003697; F:single-stranded DNA binding; IMP:CAFA.
DR   GO; GO:0097100; F:supercoiled DNA binding; IMP:CAFA.
DR   GO; GO:0006338; P:chromatin remodeling; IMP:UniProtKB.
DR   GO; GO:0007059; P:chromosome segregation; IBA:GO_Central.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IEP:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; IBA:GO_Central.
DR   GO; GO:0006265; P:DNA topological change; IDA:UniProtKB.
DR   GO; GO:0040016; P:embryonic cleavage; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IMP:CAFA.
DR   GO; GO:0016310; P:phosphorylation; NAS:UniProtKB.
DR   GO; GO:0012501; P:programmed cell death; NAS:UniProtKB.
DR   GO; GO:0016925; P:protein sumoylation; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; IEP:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd00659; Topo_IB_C; 1.
DR   Gene3D; 1.10.10.41; -; 1.
DR   Gene3D; 1.10.132.10; -; 1.
DR   Gene3D; 2.170.11.10; -; 2.
DR   Gene3D; 3.90.15.10; -; 1.
DR   InterPro; IPR011010; DNA_brk_join_enz.
DR   InterPro; IPR013034; DNA_topo_DNA_db_N_dom1.
DR   InterPro; IPR013030; DNA_topo_DNA_db_N_dom2.
DR   InterPro; IPR001631; TopoI.
DR   InterPro; IPR018521; TopoI_AS.
DR   InterPro; IPR025834; TopoI_C_dom.
DR   InterPro; IPR014711; TopoI_cat_a-hlx-sub_euk.
DR   InterPro; IPR014727; TopoI_cat_a/b-sub_euk.
DR   InterPro; IPR013500; TopoI_cat_euk.
DR   InterPro; IPR008336; TopoI_DNA-bd_euk.
DR   InterPro; IPR036202; TopoI_DNA-bd_euk_N_sf.
DR   InterPro; IPR013499; TopoI_euk.
DR   PANTHER; PTHR10290; PTHR10290; 1.
DR   Pfam; PF14370; Topo_C_assoc; 1.
DR   Pfam; PF01028; Topoisom_I; 1.
DR   Pfam; PF02919; Topoisom_I_N; 1.
DR   PRINTS; PR00416; EUTPISMRASEI.
DR   SMART; SM00435; TOPEUc; 1.
DR   SUPFAM; SSF56349; SSF56349; 2.
DR   SUPFAM; SSF56741; SSF56741; 1.
DR   PROSITE; PS00176; TOPOISOMERASE_I_EUK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Biological rhythms;
KW   Chromosomal rearrangement; Complete proteome;
KW   Direct protein sequencing; DNA-binding; Host-virus interaction;
KW   Isomerase; Isopeptide bond; Nucleus; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; Reference proteome; Topoisomerase; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|Ref.7}.
FT   CHAIN         2    765       DNA topoisomerase 1.
FT                                /FTId=PRO_0000145201.
FT   REGION      425    426       Interaction with DNA.
FT   REGION      488    493       Interaction with DNA.
FT   REGION      585    587       Interaction with DNA.
FT   COMPBIAS     23    204       Lys-rich.
FT   ACT_SITE    723    723       O-(3'-phospho-DNA)-tyrosine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10130,
FT                                ECO:0000269|PubMed:10841763,
FT                                ECO:0000269|PubMed:12426403,
FT                                ECO:0000269|PubMed:12533542,
FT                                ECO:0000269|PubMed:15165849,
FT                                ECO:0000269|PubMed:15801827,
FT                                ECO:0000269|PubMed:16033260,
FT                                ECO:0000269|PubMed:9488644}.
FT   SITE        316    316       Interaction with DNA.
FT   SITE        364    364       Interaction with DNA.
FT   SITE        412    412       Interaction with DNA.
FT   SITE        443    443       Interaction with DNA.
FT   SITE        501    501       Interaction with DNA.
FT   SITE        532    532       Interaction with DNA.
FT   SITE        574    574       Interaction with DNA.
FT   SITE        632    632       Interaction with DNA.
FT   SITE        650    650       Interaction with DNA.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      57     57       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     112    112       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     172    172       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q04750}.
FT   MOD_RES     280    280       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     506    506       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:23185622}.
FT   CROSSLNK    101    101       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    103    103       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate. {ECO:0000305}.
FT   CROSSLNK    103    103       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    117    117       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    117    117       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    117    117       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    134    134       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    148    148       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    153    153       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate. {ECO:0000305}.
FT   CROSSLNK    153    153       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    158    158       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    164    164       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    172    172       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    204    204       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    336    336       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    549    549       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    642    642       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    700    700       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    712    712       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VARIANT     214    214       G -> S (in dbSNP:rs6029542).
FT                                /FTId=VAR_052592.
FT   VARIANT     326    326       K -> R (in breast cancer; somatic
FT                                mutation). {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036555.
FT   VARIANT     370    370       M -> T (in CPT-resistant leukemia).
FT                                {ECO:0000269|PubMed:7882333}.
FT                                /FTId=VAR_010666.
FT   VARIANT     533    533       D -> G (in CPT-resistant leukemia;
FT                                dbSNP:rs267607131).
FT                                {ECO:0000269|PubMed:1849260}.
FT                                /FTId=VAR_007530.
FT   VARIANT     722    722       N -> S (in CPT-resistant leukemia).
FT                                {ECO:0000269|PubMed:7882333}.
FT                                /FTId=VAR_010667.
FT   VARIANT     729    729       T -> A (in CPT-resistant lung cancer).
FT                                {ECO:0000269|PubMed:1332703}.
FT                                /FTId=VAR_007531.
FT   MUTAGEN     103    103       K->R: Localizes in both nucleoplasm and
FT                                nucleoli; when associated with R-117 or
FT                                R-153. Almost complete loss of
FT                                sumoylation, concentrates in nucleoli and
FT                                no clearing from nucleoli on CPT
FT                                treatment; when associated with R-117 and
FT                                R-153. {ECO:0000269|PubMed:12149243}.
FT   MUTAGEN     117    117       K->R: 5-fold decrease in sumoylation.
FT                                Localizes in both nucleoplasm and
FT                                nucleoli; when associated with or without
FT                                R-103 or R-153. Almost complete loss of
FT                                sumoylation, concentrates in nucleoli and
FT                                no clearing from nucleoli on CPT
FT                                treatment; when associated with R-103 and
FT                                R-153. {ECO:0000269|PubMed:12149243}.
FT   MUTAGEN     153    153       K->R: Localizes in both nucleoplasm and
FT                                nucleoli; when associated with R-103 or
FT                                R-117. Almost complete loss of
FT                                sumoylation, concentrates in nucleoli and
FT                                no clearing from nucleoli on CPT
FT                                treatment; when associated with R-103 and
FT                                R-117. {ECO:0000269|PubMed:12149243}.
FT   MUTAGEN     532    532       K->A: Almost abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:14594810}.
FT   MUTAGEN     532    532       K->R: Strongly reduced enzyme activity.
FT                                {ECO:0000269|PubMed:14594810}.
FT   MUTAGEN     723    723       Y->F: No change in CPT-induced clearing
FT                                from nuclei.
FT                                {ECO:0000269|PubMed:12149243}.
FT   CONFLICT    145    145       A -> V (in Ref. 1; AAA61207).
FT                                {ECO:0000305}.
FT   HELIX       205    207       {ECO:0000244|PDB:1K4T}.
FT   STRAND      220    222       {ECO:0000244|PDB:1A35}.
FT   STRAND      236    238       {ECO:0000244|PDB:1A35}.
FT   STRAND      240    242       {ECO:0000244|PDB:1A36}.
FT   STRAND      245    247       {ECO:0000244|PDB:1A36}.
FT   HELIX       251    261       {ECO:0000244|PDB:1A31}.
FT   TURN        262    265       {ECO:0000244|PDB:1A31}.
FT   HELIX       267    270       {ECO:0000244|PDB:1A31}.
FT   HELIX       272    285       {ECO:0000244|PDB:1A31}.
FT   HELIX       288    293       {ECO:0000244|PDB:1A31}.
FT   HELIX       297    299       {ECO:0000244|PDB:1A31}.
FT   HELIX       303    317       {ECO:0000244|PDB:1A31}.
FT   HELIX       321    338       {ECO:0000244|PDB:1A31}.
FT   STRAND      339    343       {ECO:0000244|PDB:1A31}.
FT   STRAND      346    351       {ECO:0000244|PDB:1A31}.
FT   STRAND      358    360       {ECO:0000244|PDB:1A31}.
FT   STRAND      364    366       {ECO:0000244|PDB:1A31}.
FT   TURN        368    371       {ECO:0000244|PDB:1A31}.
FT   HELIX       379    381       {ECO:0000244|PDB:1A31}.
FT   STRAND      383    385       {ECO:0000244|PDB:1A31}.
FT   STRAND      396    398       {ECO:0000244|PDB:1SEU}.
FT   STRAND      402    405       {ECO:0000244|PDB:1A31}.
FT   STRAND      413    417       {ECO:0000244|PDB:1A31}.
FT   TURN        419    421       {ECO:0000244|PDB:1A31}.
FT   STRAND      424    427       {ECO:0000244|PDB:1A31}.
FT   STRAND      431    433       {ECO:0000244|PDB:1K4S}.
FT   HELIX       434    464       {ECO:0000244|PDB:1A31}.
FT   HELIX       470    485       {ECO:0000244|PDB:1A31}.
FT   TURN        495    497       {ECO:0000244|PDB:1A31}.
FT   HELIX       504    506       {ECO:0000244|PDB:1A31}.
FT   HELIX       509    511       {ECO:0000244|PDB:1A31}.
FT   STRAND      514    518       {ECO:0000244|PDB:1A31}.
FT   STRAND      521    530       {ECO:0000244|PDB:1A31}.
FT   HELIX       532    534       {ECO:0000244|PDB:1A31}.
FT   STRAND      536    542       {ECO:0000244|PDB:1A31}.
FT   HELIX       545    553       {ECO:0000244|PDB:1A31}.
FT   TURN        554    557       {ECO:0000244|PDB:1A31}.
FT   TURN        564    567       {ECO:0000244|PDB:1A31}.
FT   HELIX       570    580       {ECO:0000244|PDB:1A31}.
FT   STRAND      581    583       {ECO:0000244|PDB:1NH3}.
FT   HELIX       586    605       {ECO:0000244|PDB:1A31}.
FT   STRAND      608    610       {ECO:0000244|PDB:1T8I}.
FT   HELIX       612    625       {ECO:0000244|PDB:1A31}.
FT   TURN        626    631       {ECO:0000244|PDB:1SC7}.
FT   HELIX       640    643       {ECO:0000244|PDB:1K4T}.
FT   HELIX       644    673       {ECO:0000244|PDB:1K4T}.
FT   HELIX       678    710       {ECO:0000244|PDB:1K4T}.
FT   STRAND      712    714       {ECO:0000244|PDB:1K4T}.
FT   TURN        721    723       {ECO:0000244|PDB:1A31}.
FT   HELIX       726    735       {ECO:0000244|PDB:1A31}.
FT   HELIX       740    742       {ECO:0000244|PDB:1A31}.
FT   HELIX       746    751       {ECO:0000244|PDB:1A31}.
FT   HELIX       753    758       {ECO:0000244|PDB:1A31}.
SQ   SEQUENCE   765 AA;  90726 MW;  6FBED540BCF7BE28 CRC64;
     MSGDHLHNDS QIEADFRLND SHKHKDKHKD REHRHKEHKK EKDREKSKHS NSEHKDSEKK
     HKEKEKTKHK DGSSEKHKDK HKDRDKEKRK EEKVRASGDA KIKKEKENGF SSPPQIKDEP
     EDDGYFVPPK EDIKPLKRPR DEDDADYKPK KIKTEDTKKE KKRKLEEEED GKLKKPKNKD
     KDKKVPEPDN KKKKPKKEEE QKWKWWEEER YPEGIKWKFL EHKGPVFAPP YEPLPENVKF
     YYDGKVMKLS PKAEEVATFF AKMLDHEYTT KEIFRKNFFK DWRKEMTNEE KNIITNLSKC
     DFTQMSQYFK AQTEARKQMS KEEKLKIKEE NEKLLKEYGF CIMDNHKERI ANFKIEPPGL
     FRGRGNHPKM GMLKRRIMPE DIIINCSKDA KVPSPPPGHK WKEVRHDNKV TWLVSWTENI
     QGSIKYIMLN PSSRIKGEKD WQKYETARRL KKCVDKIRNQ YREDWKSKEM KVRQRAVALY
     FIDKLALRAG NEKEEGETAD TVGCCSLRVE HINLHPELDG QEYVVEFDFL GKDSIRYYNK
     VPVEKRVFKN LQLFMENKQP EDDLFDRLNT GILNKHLQDL MEGLTAKVFR TYNASITLQQ
     QLKELTAPDE NIPAKILSYN RANRAVAILC NHQRAPPKTF EKSMMNLQTK IDAKKEQLAD
     ARRDLKSAKA DAKVMKDAKT KKVVESKKKA VQRLEEQLMK LEVQATDREE NKQIALGTSK
     LNYLDPRITV AWCKKWGVPI EKIYNKTQRE KFAWAIDMAD EDYEF
//
ID   Q9BVT2_HUMAN            Unreviewed;       176 AA.
AC   Q9BVT2;
DT   01-JUN-2001, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2001, sequence version 1.
DT   31-JAN-2018, entry version 88.
DE   SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:AAH00943.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH00943.1};
RN   [1] {ECO:0000313|EMBL:AAH00943.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:AAH00943.1};
RA   Strausberg R.;
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC000943; AAH00943.1; -; mRNA.
DR   RefSeq; NP_003277.1; NM_003286.3.
DR   UniGene; Hs.472737; -.
DR   PeptideAtlas; Q9BVT2; -.
DR   GeneID; 7150; -.
DR   KEGG; hsa:7150; -.
DR   CTD; 7150; -.
DR   eggNOG; KOG0981; Eukaryota.
DR   eggNOG; COG3569; LUCA.
DR   HOVERGEN; HBG076631; -.
DR   KO; K03163; -.
DR   GO; GO:0005694; C:chromosome; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003917; F:DNA topoisomerase type I activity; IEA:InterPro.
DR   GO; GO:0006265; P:DNA topological change; IEA:InterPro.
DR   Gene3D; 1.10.132.10; -; 1.
DR   InterPro; IPR011010; DNA_brk_join_enz.
DR   InterPro; IPR001631; TopoI.
DR   InterPro; IPR018521; TopoI_AS.
DR   InterPro; IPR025834; TopoI_C_dom.
DR   InterPro; IPR014727; TopoI_cat_a/b-sub_euk.
DR   InterPro; IPR013500; TopoI_cat_euk.
DR   InterPro; IPR013499; TopoI_euk.
DR   PANTHER; PTHR10290; PTHR10290; 1.
DR   Pfam; PF14370; Topo_C_assoc; 1.
DR   Pfam; PF01028; Topoisom_I; 1.
DR   SMART; SM00435; TOPEUc; 1.
DR   SUPFAM; SSF56349; SSF56349; 2.
DR   PROSITE; PS00176; TOPOISOMERASE_I_EUK; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN        1    148       TOPEUc. {ECO:0000259|SMART:SM00435}.
FT   COILED       55     89       {ECO:0000256|SAM:Coils}.
FT   COILED       95    122       {ECO:0000256|SAM:Coils}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH00943.1}.
SQ   SEQUENCE   176 AA;  20342 MW;  2D922F02D032E4CD CRC64;
     RTYNASITLQ QQLKELTAPD ENIPAKILSY NRANRAVAIL CNHQRAPPKT FEKSMMNLQT
     KIDAKKEQLA DARRDLKSAK ADAKVMKDAK TKKVVESKKK AVQRLEEQLM KLEVQATDRE
     ENKQIALGTS KLNYLDPRIT VAWCKKWGVP IEKIYNKTQR EKFAWAIDMA DEDYEF
//
ID   TPM4_HUMAN              Reviewed;         248 AA.
AC   P67936; P07226; Q15659; Q5U0D9; Q9BU85; Q9H8Q3; Q9UCS1; Q9UCS2;
AC   Q9UCS3; Q9UCS4;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-FEB-2018, entry version 140.
DE   RecName: Full=Tropomyosin alpha-4 chain;
DE   AltName: Full=TM30p1;
DE   AltName: Full=Tropomyosin-4;
GN   Name=TPM4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fibroblast;
RX   PubMed=3612796; DOI=10.1016/0022-2836(87)90710-8;
RA   McLeod A.R., Talbot K., Smillie L.B., Houlker C.;
RT   "Characterization of a cDNA defining a gene family encoding TM30p1, a
RT   human fibroblast tropomyosin.";
RL   J. Mol. Biol. 194:1-10(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Ovarian carcinoma, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-12.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-11; 45-54; 56-69; 77-89; 133-146 AND 216-223,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (NOV-2005) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 9-31; 44-61; 89-95; 205-214 AND 231-243 (ISOFORM
RP   1), FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Platelet;
RX   PubMed=1836432; DOI=10.1111/j.1365-2362.1991.tb01397.x;
RA   Crabos M., Yamakado T., Heizmann C.W., Cerletti N., Buehler F.R.,
RA   Erne P.;
RT   "The calcium binding protein tropomyosin in human platelets and
RT   cardiac tissue: elevation in hypertensive cardiac hypertrophy.";
RL   Eur. J. Clin. Invest. 21:472-478(1991).
RN   [9]
RP   PROTEIN SEQUENCE OF 13-27; 45-82; 132-142; 154-169 AND 216-228, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 118-248.
RC   TISSUE=Fibroblast;
RX   PubMed=3865200; DOI=10.1073/pnas.82.23.7835;
RA   MacLeod A.R., Houlker C., Reinach F.C., Smillie L.B., Talbot K.,
RA   Modi G., Walsh F.S.;
RT   "A muscle-type tropomyosin in human fibroblasts: evidence for
RT   expression by an alternative RNA splicing mechanism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:7835-7839(1985).
RN   [11]
RP   PROTEIN SEQUENCE OF 177-189 AND 228-247.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-177 AND LYS-215, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-216, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-204.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Binds to actin filaments in muscle and non-muscle cells.
CC       Plays a central role, in association with the troponin complex, in
CC       the calcium dependent regulation of vertebrate striated muscle
CC       contraction. Smooth muscle contraction is regulated by interaction
CC       with caldesmon. In non-muscle cells is implicated in stabilizing
CC       cytoskeleton actin filaments (By similarity). Binds calcium
CC       (PubMed:1836432). {ECO:0000250|UniProtKB:P09495,
CC       ECO:0000269|PubMed:1836432}.
CC   -!- SUBUNIT: Homodimer. Heterodimer of an alpha (TPM1, TPM3 or TPM4)
CC       and a beta (TPM2) chain. {ECO:0000250|UniProtKB:P04692}.
CC   -!- INTERACTION:
CC       O75365-2:PTP4A3; NbExp=2; IntAct=EBI-1642100, EBI-14013960;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P09495}. Note=Associates with F-actin
CC       stress fibers. {ECO:0000250|UniProtKB:P09495}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P67936-1, P07226-1;
CC         Sequence=Displayed;
CC       Name=2;
CC         IsoId=P67936-2, P07226-2;
CC         Sequence=VSP_006611;
CC   -!- TISSUE SPECIFICITY: Detected in cardiac tissue and platelets, the
CC       form found in cardiac tissue is a higher molecular weight than the
CC       form found in platelets. Expressed at higher levels in the
CC       platelets of hypertensive patients with cardiac hypertrophy than
CC       in the platelets of hypertensive patients without cardiac
CC       hypertrophy (at protein level). {ECO:0000269|PubMed:1836432}.
CC   -!- DOMAIN: The molecule is in a coiled coil structure that is formed
CC       by 2 polypeptide chains. The sequence exhibits a prominent seven-
CC       residues periodicity.
CC   -!- SIMILARITY: Belongs to the tropomyosin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TPM4ID359.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X05276; CAA28888.1; -; mRNA.
DR   EMBL; AK023385; BAB14554.1; -; mRNA.
DR   EMBL; AK315076; BAG37545.1; -; mRNA.
DR   EMBL; BT019634; AAV38440.1; -; mRNA.
DR   EMBL; CH471106; EAW84521.1; -; Genomic_DNA.
DR   EMBL; BC002827; AAH02827.1; -; mRNA.
DR   EMBL; BC037576; AAH37576.1; -; mRNA.
DR   EMBL; BC067225; AAH67225.1; -; mRNA.
DR   EMBL; M12127; AAA36774.1; -; mRNA.
DR   CCDS; CCDS12338.1; -.
DR   CCDS; CCDS46007.1; -. [P67936-2]
DR   PIR; S07282; S07282.
DR   RefSeq; NP_001138632.1; NM_001145160.1. [P67936-2]
DR   RefSeq; NP_003281.1; NM_003290.2. [P67936-1]
DR   UniGene; Hs.631618; -.
DR   UniGene; Hs.665133; -.
DR   ProteinModelPortal; P67936; -.
DR   SMR; P67936; -.
DR   BioGrid; 113024; 93.
DR   IntAct; P67936; 55.
DR   iPTMnet; P67936; -.
DR   PhosphoSitePlus; P67936; -.
DR   SwissPalm; P67936; -.
DR   BioMuta; TPM4; -.
DR   DMDM; 54039751; -.
DR   DOSAC-COBS-2DPAGE; P67936; -.
DR   OGP; P07226; -.
DR   EPD; P67936; -.
DR   PeptideAtlas; P67936; -.
DR   PRIDE; P67936; -.
DR   DNASU; 7171; -.
DR   Ensembl; ENST00000300933; ENSP00000300933; ENSG00000167460. [P67936-1]
DR   Ensembl; ENST00000344824; ENSP00000345230; ENSG00000167460. [P67936-2]
DR   GeneID; 7171; -.
DR   KEGG; hsa:7171; -.
DR   UCSC; uc002ndi.3; human.
DR   CTD; 7171; -.
DR   DisGeNET; 7171; -.
DR   EuPathDB; HostDB:ENSG00000167460.14; -.
DR   GeneCards; TPM4; -.
DR   H-InvDB; HIX0022609; -.
DR   HGNC; HGNC:12013; TPM4.
DR   HPA; CAB004685; -.
DR   HPA; HPA047089; -.
DR   HPA; HPA053624; -.
DR   MalaCards; TPM4; -.
DR   MIM; 600317; gene.
DR   neXtProt; NX_P67936; -.
DR   OpenTargets; ENSG00000167460; -.
DR   Orphanet; 178342; Inflammatory myofibroblastic tumor.
DR   PharmGKB; PA36693; -.
DR   GeneTree; ENSGT00550000074494; -.
DR   HOVERGEN; HBG107404; -.
DR   InParanoid; P67936; -.
DR   KO; K10375; -.
DR   OMA; LQHELIT; -.
DR   OrthoDB; EOG091G0UO7; -.
DR   PhylomeDB; P67936; -.
DR   TreeFam; TF351519; -.
DR   Reactome; R-HSA-390522; Striated Muscle Contraction.
DR   Reactome; R-HSA-445355; Smooth Muscle Contraction.
DR   ChiTaRS; TPM4; human.
DR   GeneWiki; TPM4; -.
DR   GenomeRNAi; 7171; -.
DR   PRO; PR:P67936; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000167460; -.
DR   CleanEx; HS_TPM4; -.
DR   ExpressionAtlas; P67936; baseline and differential.
DR   Genevisible; P67936; HS.
DR   GO; GO:0005884; C:actin filament; IBA:GO_Central.
DR   GO; GO:0030863; C:cortical cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005856; C:cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031941; C:filamentous actin; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005862; C:muscle thin filament tropomyosin; TAS:ProtInc.
DR   GO; GO:0002102; C:podosome; IEA:Ensembl.
DR   GO; GO:0001725; C:stress fiber; IDA:MGI.
DR   GO; GO:0051015; F:actin filament binding; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; NAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0008307; F:structural constituent of muscle; TAS:ProtInc.
DR   GO; GO:0007015; P:actin filament organization; IBA:GO_Central.
DR   GO; GO:0006928; P:movement of cell or subcellular component; TAS:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; IBA:GO_Central.
DR   GO; GO:0030049; P:muscle filament sliding; TAS:Reactome.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Alternative splicing; Calcium;
KW   Coiled coil; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Metal-binding; Muscle protein;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|Ref.7}.
FT   CHAIN         2    248       Tropomyosin alpha-4 chain.
FT                                /FTId=PRO_0000205635.
FT   COILED        2    248       {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P09495}.
FT   MOD_RES     177    177       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     215    215       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     216    216       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     44       MAGLNSLEAVKRKIQALQQQADEAEDRAQGLQRELDGERER
FT                                REK -> MEAIKKKMQMLKLDKENAIDRAEQAEADKKAAED
FT                                KCKQVEEELTHLQKKLKGTEDELDKYSEDLKDAQEKLELTE
FT                                KKASD (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_006611.
FT   VARIANT     204    204       E -> Q (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036535.
FT   CONFLICT     59     59       V -> F (in Ref. 5; AAH02827).
FT                                {ECO:0000305}.
FT   CONFLICT    152    152       L -> S (in Ref. 10; AAA36774).
FT                                {ECO:0000305}.
FT   CONFLICT    162    163       KN -> RT (in Ref. 10; AAA36774).
FT                                {ECO:0000305}.
SQ   SEQUENCE   248 AA;  28522 MW;  5D5CDF6BF76552A8 CRC64;
     MAGLNSLEAV KRKIQALQQQ ADEAEDRAQG LQRELDGERE RREKAEGDVA ALNRRIQLVE
     EELDRAQERL ATALQKLEEA EKAADESERG MKVIENRAMK DEEKMEIQEM QLKEAKHIAE
     EADRKYEEVA RKLVILEGEL ERAEERAEVS ELKCGDLEEE LKNVTNNLKS LEAASEKYSE
     KEDKYEEEIK LLSDKLKEAE TRAEFAERTV AKLEKTIDDL EEKLAQAKEE NVGLHQTLDQ
     TLNELNCI
//
ID   V9HW56_HUMAN            Unreviewed;       248 AA.
AC   V9HW56;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   31-JAN-2018, entry version 36.
DE   SubName: Full=Epididymis secretory protein Li 108 {ECO:0000313|EMBL:ACI45997.1};
DE   SubName: Full=Tropomyosin 4, isoform CRA_a {ECO:0000313|EMBL:EAW84523.1};
GN   Name=HEL-S-108 {ECO:0000313|EMBL:ACI45997.1};
GN   Synonyms=TPM4 {ECO:0000313|EMBL:EAW84523.1};
GN   ORFNames=hCG_1999582 {ECO:0000313|EMBL:EAW84523.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI45997.1};
RN   [1] {ECO:0000313|EMBL:EAW84523.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW84523.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACI45997.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J., Wang H., Liu J., Liu F.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the tropomyosin family.
CC       {ECO:0000256|RuleBase:RU004515}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ224305; ACI45997.1; -; mRNA.
DR   EMBL; CH471106; EAW84523.1; -; Genomic_DNA.
DR   RefSeq; NP_003281.1; NM_003290.2.
DR   UniGene; Hs.631618; -.
DR   UniGene; Hs.665133; -.
DR   IntAct; V9HW56; 2.
DR   GeneID; 7171; -.
DR   KEGG; hsa:7171; -.
DR   UCSC; uc002ndj.3; human.
DR   CTD; 7171; -.
DR   EuPathDB; HostDB:ENSG00000167460.14; -.
DR   KO; K10375; -.
DR   ChiTaRS; TPM4; human.
DR   GenomeRNAi; 7171; -.
DR   Bgee; ENSG00000167460; -.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00486935, ECO:0000256|SAM:Coils}.
FT   COILED        7     97       {ECO:0000256|SAM:Coils}.
FT   COILED      105    244       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   248 AA;  28522 MW;  5D5CDF6BF76552A8 CRC64;
     MAGLNSLEAV KRKIQALQQQ ADEAEDRAQG LQRELDGERE RREKAEGDVA ALNRRIQLVE
     EELDRAQERL ATALQKLEEA EKAADESERG MKVIENRAMK DEEKMEIQEM QLKEAKHIAE
     EADRKYEEVA RKLVILEGEL ERAEERAEVS ELKCGDLEEE LKNVTNNLKS LEAASEKYSE
     KEDKYEEEIK LLSDKLKEAE TRAEFAERTV AKLEKTIDDL EEKLAQAKEE NVGLHQTLDQ
     TLNELNCI
//
ID   TPR_HUMAN               Reviewed;        2363 AA.
AC   P12270; Q15624; Q15655; Q5SWY0; Q99968;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   28-FEB-2018, entry version 184.
DE   RecName: Full=Nucleoprotein TPR;
DE   AltName: Full=Megator;
DE   AltName: Full=NPC-associated intranuclear protein;
DE   AltName: Full=Translocated promoter region protein;
GN   Name=TPR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=1549355;
RA   Mitchell P.J., Cooper C.S.;
RT   "Nucleotide sequence analysis of human tpr cDNA clones.";
RL   Oncogene 7:383-388(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1437155;
RA   Mitchell P.J., Cooper C.S.;
RT   "The human tpr gene encodes a protein of 2094 amino acids that has
RT   extensive coiled-coil regions and an acidic C-terminal domain.";
RL   Oncogene 7:2329-2333(1992).
RN   [3]
RP   SEQUENCE REVISION, CHARACTERIZATION, AND SUBCELLULAR LOCATION.
RX   PubMed=7798308; DOI=10.1083/jcb.127.6.1515;
RA   Byrd D.A., Sweet D.J., Pante N., Konstantinov K.N., Guan T.,
RA   Saphire A.C.S., Mitchell P.J., Cooper C.S., Aebi U., Gerace L.;
RT   "Tpr, a large coiled coil protein whose amino terminus is involved in
RT   activation of oncogenic kinases, is localized to the cytoplasmic
RT   surface of the nuclear pore complex.";
RL   J. Cell Biol. 127:1515-1526(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Embryonic brain;
RX   PubMed=9024684; DOI=10.1083/jcb.136.3.515;
RA   Cordes V.C., Reidenbach S., Rackwitz H.R., Franke W.W.;
RT   "Identification of protein p270/Tpr as a constitutive component of the
RT   nuclear pore complex-attached intranuclear filaments.";
RL   J. Cell Biol. 136:515-529(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-191 (ISOFORM 1/2), AND CHROMOSOMAL
RP   REARRANGEMENT WITH NTRK1.
RX   PubMed=1532241;
RA   Greco A., Pierotti M.A., Bongarzone I., Pagliardini S., Lanzi C.,
RA   Della Porta G.;
RT   "TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes
RT   in human papillary thyroid carcinomas.";
RL   Oncogene 7:237-242(1992).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-142 (ISOFORM 1/2).
RX   PubMed=3387099;
RA   King H.W.S., Tempest P.R., Merrifield K.R., Rance A.J.;
RT   "tpr homologues activate met and raf.";
RL   Oncogene 2:617-619(1988).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-11; 502-511; 1192-1201 AND 1421-1427, CLEAVAGE
RP   OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Hepatoma, and Osteosarcoma;
RA   Bienvenut W.V., Glen H., Brunton V.G., Frame M.C., Boldt K.,
RA   von Kriegsheim A.F., Kolch W.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [10]
RP   CHROMOSOMAL REARRANGEMENT WITH MET.
RX   PubMed=2300559; DOI=10.1073/pnas.87.2.738;
RA   Soman N.R., Wogan G.N., Rhim J.S.;
RT   "TPR-MET oncogenic rearrangement: detection by polymerase chain
RT   reaction amplification of the transcript and expression in human tumor
RT   cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:738-742(1990).
RN   [11]
RP   SUBCELLULAR LOCATION, AND NPC-BINDING DOMAIN AND NUCLEAR IMPORT
RP   DOMAIN.
RX   PubMed=9828100; DOI=10.1006/excr.1998.4246;
RA   Cordes V.C., Hase M.E., Muller L.;
RT   "Molecular segments of protein Tpr that confer nuclear targeting and
RT   association with the nuclear pore complex.";
RL   Exp. Cell Res. 245:43-56(1998).
RN   [12]
RP   FUNCTION, NPC-BINDING DOMAIN AND NUCLEAR IMPORT DOMAIN, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=9864356; DOI=10.1083/jcb.143.7.1801;
RA   Bangs P., Burke B., Powers C., Craig R., Purohit A., Doxsey S.;
RT   "Functional analysis of Tpr: identification of nuclear pore complex
RT   association and nuclear localization domains and a role in mRNA
RT   export.";
RL   J. Cell Biol. 143:1801-1812(1998).
RN   [13]
RP   HOMODIMERIZATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LEU-458 AND
RP   MET-489.
RX   PubMed=11514627; DOI=10.1091/mbc.12.8.2433;
RA   Hase M.E., Kuznetsov N.V., Cordes V.C.;
RT   "Amino acid substitutions of coiled-coil protein Tpr abrogate
RT   anchorage to the nuclear pore complex but not parallel, in-register
RT   homodimerization.";
RL   Mol. Biol. Cell 12:2433-2452(2001).
RN   [14]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12424524; DOI=10.1007/s00412-002-0208-2;
RA   Kuznetsov N.V., Sandblad L., Hase M.E., Hunziker A., Hergt M.,
RA   Cordes V.C.;
RT   "The evolutionarily conserved single-copy gene for murine Tpr encodes
RT   one prevalent isoform in somatic cells and lacks paralogs in higher
RT   eukaryotes.";
RL   Chromosoma 111:236-255(2002).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11952838; DOI=10.1046/j.1365-2443.2002.00525.x;
RA   Shibata S., Matsuoka Y., Yoneda Y.;
RT   "Nucleocytoplasmic transport of proteins and poly(A)+ RNA in
RT   reconstituted Tpr-less nuclei in living mammalian cells.";
RL   Genes Cells 7:421-434(2002).
RN   [16]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11839768; DOI=10.1083/jcb.200106046;
RA   Frosst P., Guan T., Subauste C., Hahn K., Gerace L.;
RT   "Tpr is localized within the nuclear basket of the pore complex and
RT   has a role in nuclear protein export.";
RL   J. Cell Biol. 156:617-630(2002).
RN   [17]
RP   ABSENCE OF FUNCTION IN ANCHORING NUCLEOPORINS, INTERACTION WITH
RP   NUP153, HOMODIMERIZATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   LEU-458 AND MET-489.
RX   PubMed=12802065; DOI=10.1091/mbc.E02-09-0620;
RA   Hase M.E., Cordes V.C.;
RT   "Direct interaction with nup153 mediates binding of Tpr to the
RT   periphery of the nuclear pore complex.";
RL   Mol. Biol. Cell 14:1923-1940(2003).
RN   [18]
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE NUCLEAR PORE COMPLEX.
RX   PubMed=15229283; DOI=10.1091/mbc.E04-03-0165;
RA   Krull S., Thyberg J., Bjorkroth B., Rackwitz H.R., Cordes V.C.;
RT   "Nucleoporins as components of the nuclear pore complex core structure
RT   and Tpr as the architectural element of the nuclear basket.";
RL   Mol. Biol. Cell 15:4261-4277(2004).
RN   [19]
RP   FUNCTION IN NUCLEAR PROTEIN EXPORT, AND INTERACTION WITH HTT.
RX   PubMed=15654337; DOI=10.1038/ng1503;
RA   Cornett J., Cao F., Wang C.E., Ross C.A., Bates G.P., Li S.H.,
RA   Li X.J.;
RT   "Polyglutamine expansion of huntingtin impairs its nuclear export.";
RL   Nat. Genet. 37:198-204(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2073, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1185, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [22]
RP   FUNCTION IN STRESS-INDUCED NUCLEAR MRNA EXPORT, AND INTERACTION WITH
RP   HSF1.
RX   PubMed=17897941; DOI=10.1074/jbc.M704054200;
RA   Skaggs H.S., Xing H., Wilkerson D.C., Murphy L.A., Hong Y.,
RA   Mayhew C.N., Sarge K.D.;
RT   "HSF1-TPR interaction facilitates export of stress-induced HSP70
RT   mRNA.";
RL   J. Biol. Chem. 282:33902-33907(2007).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2155, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2050, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [25]
RP   INTERACTION WITH MAD2L1 AND MAD1L1, FUNCTION, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=18981471; DOI=10.1101/gad.1677208;
RA   Lee S.H., Sterling H., Burlingame A., McCormick F.;
RT   "Tpr directly binds to Mad1 and Mad2 and is important for the Mad1-
RT   Mad2-mediated mitotic spindle checkpoint.";
RL   Genes Dev. 22:2926-2931(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2155, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [27]
RP   FUNCTION IN PROTEIN IMPORT, INTERACTION WITH MAPK1, PHOSPHORYLATION BY
RP   MAPK1, AND SUBCELLULAR LOCATION.
RX   PubMed=18794356; DOI=10.1128/MCB.00925-08;
RA   Vomastek T., Iwanicki M.P., Burack W.R., Tiwari D., Kumar D.,
RA   Parsons J.T., Weber M.J., Nandicoori V.K.;
RT   "Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites
RT   and docking domain on the nuclear pore complex protein Tpr
RT   cooperatively regulate ERK2-Tpr interaction.";
RL   Mol. Cell. Biol. 28:6954-6966(2008).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379; SER-1185; SER-2048
RP   AND SER-2155, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [29]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [30]
RP   ASSOCIATION WITH XPO1/CRM1 AND IMPORTIN ALPHA/IMPORTIN BETA RECEPTOR,
RP   AND INTERACTION WITH KPNB1.
RX   PubMed=19835572; DOI=10.1186/1471-2121-10-74;
RA   Ben-Efraim I., Frosst P.D., Gerace L.;
RT   "Karyopherin binding interactions and nuclear import mechanism of
RT   nuclear pore complex protein Tpr.";
RL   BMC Cell Biol. 10:74-74(2009).
RN   [31]
RP   FUNCTION, INTERACTION WITH MAD1L1; MAD2L1 AND TTK, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=19273613; DOI=10.1083/jcb.200811012;
RA   Lince-Faria M., Maffini S., Orr B., Ding Y., Florindo C., Sunkel C.E.,
RA   Tavares A., Johansen J., Johansen K.M., Maiato H.;
RT   "Spatiotemporal control of mitosis by the conserved spindle matrix
RT   protein Megator.";
RL   J. Cell Biol. 184:647-657(2009).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1185; SER-2050 AND
RP   SER-2155, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [33]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-252; LYS-312; LYS-345;
RP   LYS-428; LYS-457; LYS-713; LYS-723; LYS-748 AND LYS-755, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [34]
RP   FUNCTION, ORGANIZATION OF PERINUCLEAR CHROMATIN, SUBCELLULAR LOCATION,
RP   AND PROTEOLYTIC PROCESSING.
RX   PubMed=20407419; DOI=10.1038/emboj.2010.54;
RA   Krull S., Dorries J., Boysen B., Reidenbach S., Magnius L., Norder H.,
RA   Thyberg J., Cordes V.C.;
RT   "Protein Tpr is required for establishing nuclear pore-associated
RT   zones of heterochromatin exclusion.";
RL   EMBO J. 29:1659-1673(2010).
RN   [35]
RP   FUNCTION, INTERACTION WITH DCTN1; DYNEIN; DYNLL1; MAD2L1; NUP153 AND
RP   TUBULIN, AND SUBCELLULAR LOCATION.
RX   PubMed=20133940; DOI=10.1074/jbc.M110.105890;
RA   Nakano H., Funasaka T., Hashizume C., Wong R.W.;
RT   "Nucleoporin translocated promoter region (Tpr) associates with dynein
RT   complex, preventing chromosome lagging formation during mitosis.";
RL   J. Biol. Chem. 285:10841-10849(2010).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379; SER-1185; THR-1692
RP   AND SER-2155, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [37]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [38]
RP   FUNCTION IN UNSPLICED RNA EXPORT.
RX   PubMed=21613532; DOI=10.1261/rna.2616111;
RA   Coyle J.H., Bor Y.C., Rekosh D., Hammarskjold M.L.;
RT   "The Tpr protein regulates export of mRNAs with retained introns that
RT   traffic through the Nxf1 pathway.";
RL   RNA 17:1344-1356(2011).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1185 AND SER-2073, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [40]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [41]
RP   FUNCTION IN UNSPLICED RNA EXPORT, INTERACTION WITH MAPK1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=22253824; DOI=10.1371/journal.pone.0029921;
RA   Rajanala K., Nandicoori V.K.;
RT   "Localization of nucleoporin Tpr to the nuclear pore complex is
RT   essential for Tpr mediated regulation of the export of unspliced
RT   RNA.";
RL   PLoS ONE 7:E29921-E29921(2012).
RN   [42]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379; SER-1185; THR-1692;
RP   SER-2034; SER-2037; SER-2048; SER-2050; THR-2137 AND SER-2155, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [44]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379; SER-522; SER-523;
RP   SER-632; SER-1893 AND SER-2155, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [45]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-2111, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [46]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH MTA1.
RX   PubMed=24970816;
RA   Liu J., Xu D., Wang H., Zhang Y., Chang Y., Zhang J., Wang J., Li C.,
RA   Liu H., Zhao M., Lin C., Zhan Q., Huang C., Qian H.;
RT   "The subcellular distribution and function of MTA1 in cancer
RT   differentiation.";
RL   Oncotarget 5:5153-5164(2014).
CC   -!- FUNCTION: Component of the nuclear pore complex (NPC), a complex
CC       required for the trafficking across the nuclear envelope.
CC       Functions as a scaffolding element in the nuclear phase of the NPC
CC       essential for normal nucleocytoplasmic transport of proteins and
CC       mRNAs, plays a role in the establishment of nuclear-peripheral
CC       chromatin compartmentalization in interphase, and in the mitotic
CC       spindle checkpoint signaling during mitosis. Involved in the
CC       quality control and retention of unspliced mRNAs in the nucleus;
CC       in association with NUP153, regulates the nuclear export of
CC       unspliced mRNA species bearing constitutive transport element
CC       (CTE) in a NXF1- and KHDRBS1-independent manner. Negatively
CC       regulates both the association of CTE-containing mRNA with large
CC       polyribosomes and translation initiation. Does not play any role
CC       in Rev response element (RRE)-mediated export of unspliced mRNAs.
CC       Implicated in nuclear export of mRNAs transcribed from heat shock
CC       gene promoters; associates both with chromatin in the HSP70
CC       promoter and with mRNAs transcribed from this promoter under
CC       stress-induced conditions. Modulates the nucleocytoplasmic
CC       transport of activated MAPK1/ERK2 and huntingtin/HTT and may serve
CC       as a docking site for the XPO1/CRM1-mediated nuclear export
CC       complex. According to some authors, plays a limited role in the
CC       regulation of nuclear protein export (PubMed:22253824 and
CC       PubMed:11952838). Plays also a role as a structural and functional
CC       element of the perinuclear chromatin distribution; involved in the
CC       formation and/or maintenance of NPC-associated perinuclear
CC       heterochromatin exclusion zones (HEZs). Finally, acts as a spatial
CC       regulator of the spindle-assembly checkpoint (SAC) response
CC       ensuring a timely and effective recruitment of spindle checkpoint
CC       proteins like MAD1L1 and MAD2L1 to unattached kinetochore during
CC       the metaphase-anaphase transition before chromosome congression.
CC       Its N-terminus is involved in activation of oncogenic kinases.
CC       {ECO:0000269|PubMed:11952838, ECO:0000269|PubMed:15654337,
CC       ECO:0000269|PubMed:17897941, ECO:0000269|PubMed:18794356,
CC       ECO:0000269|PubMed:18981471, ECO:0000269|PubMed:19273613,
CC       ECO:0000269|PubMed:20133940, ECO:0000269|PubMed:20407419,
CC       ECO:0000269|PubMed:21613532, ECO:0000269|PubMed:22253824,
CC       ECO:0000269|PubMed:9864356}.
CC   -!- SUBUNIT: Interacts with IFI204 (via C-terminal region). Interacts
CC       with IFI203 (By similarity). Homodimer. Part of the nuclear pore
CC       complex (NPC). Associates with the XPO1/CRM1-mediated nuclear
CC       export complex, the Importin alpha/Importin beta receptor and the
CC       dynein 1 complex. Interacts (via C-terminal domain) with the
CC       KPNB1; the interaction occurs in a RanGTP-dependent manner.
CC       Interacts (via C-terminal regionand phosphorylated form) with
CC       MAPK1/ERK2 (via phosphorylated form); the interaction requires
CC       dimerization of MAPK1/ERK2 and increases following EGF
CC       stimulation. Interacts with MAPK3/ERK1; the interaction increases
CC       following EGF stimulation. Interacts (via coiled coil region) with
CC       NUP153; the interaction is direct. Interacts with HSF1; the
CC       interaction increases in a stress-responsive manner and stimulates
CC       export of stress-induced HSP70 mRNA. Interacts with
CC       huntingtin/HTT; the interaction is inhibited by aggregated
CC       huntingtin/HTT forms with expanded polyglutamine stretch.
CC       Interacts with MAD1L1 (via N-terminal region), MAD2L1, and TTK;
CC       the interactions occurs in a microtubule-independent manner.
CC       Interacts (via middle region) with DYNLL1. Interacts with DCTN1,
CC       dynein, NUP153 and tubulin. Interacts with MTA1. {ECO:0000250,
CC       ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283,
CC       ECO:0000269|PubMed:15654337, ECO:0000269|PubMed:17897941,
CC       ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:18981471,
CC       ECO:0000269|PubMed:19273613, ECO:0000269|PubMed:19835572,
CC       ECO:0000269|PubMed:20133940, ECO:0000269|PubMed:22253824,
CC       ECO:0000269|PubMed:24970816}.
CC   -!- INTERACTION:
CC       Q9Y6D9:MAD1L1; NbExp=2; IntAct=EBI-1048528, EBI-742610;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12802065}.
CC       Nucleus membrane {ECO:0000269|PubMed:11514627,
CC       ECO:0000269|PubMed:11952838, ECO:0000269|PubMed:18794356,
CC       ECO:0000269|PubMed:9024684, ECO:0000269|PubMed:9828100,
CC       ECO:0000269|PubMed:9864356}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:11514627, ECO:0000269|PubMed:9024684,
CC       ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356};
CC       Nucleoplasmic side {ECO:0000269|PubMed:11514627,
CC       ECO:0000269|PubMed:9024684, ECO:0000269|PubMed:9828100,
CC       ECO:0000269|PubMed:9864356}. Nucleus envelope
CC       {ECO:0000269|PubMed:12424524, ECO:0000269|PubMed:7798308}.
CC       Nucleus, nuclear pore complex {ECO:0000269|PubMed:11514627,
CC       ECO:0000269|PubMed:11839768, ECO:0000269|PubMed:12802065,
CC       ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:18981471,
CC       ECO:0000269|PubMed:7798308, ECO:0000269|PubMed:9024684,
CC       ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}. Cytoplasm
CC       {ECO:0000269|PubMed:11952838, ECO:0000269|PubMed:12802065}.
CC       Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:19273613}.
CC       Chromosome, centromere, kinetochore {ECO:0000269|PubMed:18981471}.
CC       Nucleus membrane {ECO:0000269|PubMed:12802065,
CC       ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:7798308};
CC       Peripheral membrane protein {ECO:0000269|PubMed:12802065,
CC       ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:7798308};
CC       Cytoplasmic side {ECO:0000269|PubMed:12802065,
CC       ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:7798308}.
CC       Note=Detected as discrete intranuclear foci with IFI204 (By
CC       similarity). In interphase, localizes to the nucleoplasmic side of
CC       the nuclear pore complex (NPC) core structure, forming a fibrous
CC       structure called the nuclear basket. Detected exclusively to the
CC       cytoplasmic margin of NPC (PubMed:7798308). Docking to the inner
CC       nucleoplasmic side of the NPC is mediated through binding to
CC       nucleoporins. Anchored by NUP153 to the NPC. The assembly of the
CC       NPC is a stepwise process in which Trp-containing peripheral
CC       structures assemble after other components, including p62.
CC       Detected as filaments that emanate from the nuclear basket of the
CC       NPC and extend to the nucleolus to delineate a chromatin-free
CC       network extending from the nuclear envelope to the perinucleolar
CC       region. Detected in diffuse and discrete spheroidal intranuclear
CC       foci. Nucleocytoplasmic shuttling protein imported into the
CC       nucleus in a XPO1/CRM1- and Importin alpha/Importin beta receptor-
CC       dependent manner. Remains localized to the nuclear membrane after
CC       poliovirus (PV) infection. During mitosis, remains associated with
CC       the nuclear envelope until prometaphase. Associated with the
CC       mitotic spindle from late prometaphase until anaphase. Reorganized
CC       during mitosis in a viscous and dynamic nuclear-derived spindle
CC       matrix that embeds the microtubule spindle apparatus from pole to
CC       pole in a microtubule-independent manner. Recruited to the
CC       reforming nuclear envelope during telophase and cytokinesis.
CC       Detected at kinetochores during prometaphase (PubMed:18981471).
CC       Colocalizes with MAD2L1 in the spindle matrix but not at
CC       kinetochore (PubMed:19273613). Colocalizes with dynein, dynactin,
CC       tubulin at kinetochore during the metaphase-anaphase transition.
CC       Colocalizes with DYNLL1 at the mitotic spindle. {ECO:0000250,
CC       ECO:0000269|PubMed:18981471, ECO:0000269|PubMed:19273613,
CC       ECO:0000269|PubMed:7798308}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P12270-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P12270-2; Sequence=VSP_057406, VSP_057407;
CC   -!- TISSUE SPECIFICITY: Expressed in esophagus, ovary, liver, skin,
CC       smooth muscles, cerebrum and fetal cerebellum (at protein level).
CC       Highest in testis, lung, thymus, spleen and brain, lower levels in
CC       heart, liver and kidney. {ECO:0000269|PubMed:12424524,
CC       ECO:0000269|PubMed:9024684}.
CC   -!- DOMAIN: The N-terminal domain mediates intranuclear attachment to
CC       the nuclear pore complex. The C-terminal domain mediates its
CC       nuclear import.
CC   -!- PTM: Phosphorylated. Phosphorylation occurs on serine and
CC       threonine residues (comprised in the C-terminal region) by
CC       MAPK1/ERK2 and stabilizes the interaction between these two
CC       proteins. {ECO:0000269|PubMed:18794356}.
CC   -!- PTM: Proteolytically degraded after poliovirus (PV) infection;
CC       degradation is restricted to its unfolded C-terminal tail domain
CC       whereas its coiled-coil domain containing NCP- and NUP153-binding
CC       domains withstand degradation.
CC   -!- DISEASE: Note=A chromosomal aberration involving TPR has been
CC       found in papillary thyroid carcinomas (PTCs). Intrachromosomal
CC       rearrangement that links the 5'-end of the TPR gene to the protein
CC       kinase domain of NTRK1 forms the fusion protein TRK-T1. TRK-T1 is
CC       a 55 kDa protein reacting with antibodies against the carboxy
CC       terminus of the NTRK1 protein. {ECO:0000269|PubMed:1532241}.
CC   -!- DISEASE: Note=Involved in tumorigenic rearrangements with the MET.
CC       {ECO:0000269|PubMed:2300559}.
CC   -!- SIMILARITY: Belongs to the TPR family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TPRID282.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X63105; CAA44819.1; -; mRNA.
DR   EMBL; X66397; CAA47021.1; -; mRNA.
DR   EMBL; U69668; AAB48030.1; -; mRNA.
DR   EMBL; AL596220; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133553; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW91205.1; -; Genomic_DNA.
DR   EMBL; X62947; CAA44719.1; ALT_TERM; mRNA.
DR   EMBL; Y00672; CAA68681.1; -; mRNA.
DR   CCDS; CCDS41446.1; -. [P12270-1]
DR   PIR; S23741; S23741.
DR   RefSeq; NP_003283.2; NM_003292.2. [P12270-1]
DR   UniGene; Hs.279640; -.
DR   PDB; 5TO5; X-ray; 2.50 A; A/B=2-142.
DR   PDB; 5TO6; X-ray; 2.70 A; A/B/C/D=2-142.
DR   PDB; 5TO7; X-ray; 2.60 A; A/B/C/D=2-142.
DR   PDB; 5TVB; X-ray; 2.75 A; A/B=2-142.
DR   PDBsum; 5TO5; -.
DR   PDBsum; 5TO6; -.
DR   PDBsum; 5TO7; -.
DR   PDBsum; 5TVB; -.
DR   ProteinModelPortal; P12270; -.
DR   SMR; P12270; -.
DR   BioGrid; 113028; 89.
DR   CORUM; P12270; -.
DR   DIP; DIP-50405N; -.
DR   IntAct; P12270; 29.
DR   MINT; P12270; -.
DR   STRING; 9606.ENSP00000356448; -.
DR   TCDB; 1.I.1.1.3; the eukaryotic nuclear pore complex (e-npc) family.
DR   iPTMnet; P12270; -.
DR   PhosphoSitePlus; P12270; -.
DR   BioMuta; TPR; -.
DR   DMDM; 215274208; -.
DR   EPD; P12270; -.
DR   MaxQB; P12270; -.
DR   PaxDb; P12270; -.
DR   PeptideAtlas; P12270; -.
DR   PRIDE; P12270; -.
DR   Ensembl; ENST00000367478; ENSP00000356448; ENSG00000047410. [P12270-1]
DR   Ensembl; ENST00000613151; ENSP00000483425; ENSG00000047410. [P12270-2]
DR   GeneID; 7175; -.
DR   KEGG; hsa:7175; -.
DR   UCSC; uc001grv.4; human. [P12270-1]
DR   UCSC; uc057nyz.1; human.
DR   CTD; 7175; -.
DR   DisGeNET; 7175; -.
DR   EuPathDB; HostDB:ENSG00000047410.13; -.
DR   GeneCards; TPR; -.
DR   HGNC; HGNC:12017; TPR.
DR   HPA; HPA019661; -.
DR   HPA; HPA019663; -.
DR   HPA; HPA024336; -.
DR   MalaCards; TPR; -.
DR   MIM; 189940; gene.
DR   neXtProt; NX_P12270; -.
DR   OpenTargets; ENSG00000047410; -.
DR   Orphanet; 146; Papillary or follicular thyroid carcinoma.
DR   PharmGKB; PA36696; -.
DR   eggNOG; KOG4674; Eukaryota.
DR   eggNOG; ENOG410XSA1; LUCA.
DR   GeneTree; ENSGT00730000111014; -.
DR   HOGENOM; HOG000139431; -.
DR   HOVERGEN; HBG009158; -.
DR   InParanoid; P12270; -.
DR   KO; K09291; -.
DR   OMA; RWKARTQ; -.
DR   OrthoDB; EOG091G006U; -.
DR   PhylomeDB; P12270; -.
DR   TreeFam; TF350364; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-159227; Transport of the SLBP independent Mature mRNA.
DR   Reactome; R-HSA-159230; Transport of the SLBP Dependant Mature mRNA.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-HSA-165054; Rev-mediated nuclear export of HIV RNA.
DR   Reactome; R-HSA-168271; Transport of Ribonucleoproteins into the Host Nucleus.
DR   Reactome; R-HSA-168276; NS1 Mediated Effects on Host Pathways.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-168333; NEP/NS2 Interacts with the Cellular Export Machinery.
DR   Reactome; R-HSA-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-HSA-180746; Nuclear import of Rev protein.
DR   Reactome; R-HSA-180910; Vpr-mediated nuclear import of PICs.
DR   Reactome; R-HSA-191859; snRNP Assembly.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5619107; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC).
DR   Reactome; R-HSA-6784531; tRNA processing in the nucleus.
DR   SIGNOR; P12270; -.
DR   ChiTaRS; TPR; human.
DR   GenomeRNAi; 7175; -.
DR   PMAP-CutDB; P12270; -.
DR   PRO; PR:P12270; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000047410; -.
DR   CleanEx; HS_TPR; -.
DR   ExpressionAtlas; P12270; baseline and differential.
DR   Genevisible; P12270; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005868; C:cytoplasmic dynein complex; IDA:UniProtKB.
DR   GO; GO:0019898; C:extrinsic component of membrane; IDA:UniProtKB.
DR   GO; GO:0043657; C:host cell; IEA:GOC.
DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0042405; C:nuclear inclusion body; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0034399; C:nuclear periphery; IDA:UniProtKB.
DR   GO; GO:0005643; C:nuclear pore; IDA:UniProtKB.
DR   GO; GO:0044615; C:nuclear pore nuclear basket; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0070840; F:dynein complex binding; IDA:UniProtKB.
DR   GO; GO:0031072; F:heat shock protein binding; IDA:UniProtKB.
DR   GO; GO:0051019; F:mitogen-activated protein kinase binding; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IDA:UniProtKB.
DR   GO; GO:0005487; F:nucleocytoplasmic transporter activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0015631; F:tubulin binding; IDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0034605; P:cellular response to heat; IDA:UniProtKB.
DR   GO; GO:0035457; P:cellular response to interferon-alpha; ISS:UniProtKB.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0000189; P:MAPK import into nucleus; IMP:UniProtKB.
DR   GO; GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome.
DR   GO; GO:0007094; P:mitotic spindle assembly checkpoint; IMP:UniProtKB.
DR   GO; GO:0006406; P:mRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0031990; P:mRNA export from nucleus in response to heat stress; IDA:UniProtKB.
DR   GO; GO:0046832; P:negative regulation of RNA export from nucleus; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0045947; P:negative regulation of translational initiation; IMP:UniProtKB.
DR   GO; GO:0006999; P:nuclear pore organization; IMP:UniProtKB.
DR   GO; GO:0031453; P:positive regulation of heterochromatin assembly; IMP:UniProtKB.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; IMP:UniProtKB.
DR   GO; GO:0090267; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; ISS:UniProtKB.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; IMP:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; TAS:ProtInc.
DR   GO; GO:0016925; P:protein sumoylation; TAS:Reactome.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0006110; P:regulation of glycolytic process; TAS:Reactome.
DR   GO; GO:0010965; P:regulation of mitotic sister chromatid separation; IMP:UniProtKB.
DR   GO; GO:1901673; P:regulation of mitotic spindle assembly; IMP:UniProtKB.
DR   GO; GO:0070849; P:response to epidermal growth factor; IDA:UniProtKB.
DR   GO; GO:0006405; P:RNA export from nucleus; IMP:UniProtKB.
DR   GO; GO:0006404; P:RNA import into nucleus; IDA:UniProtKB.
DR   GO; GO:0006409; P:tRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; TAS:Reactome.
DR   GO; GO:0019083; P:viral transcription; TAS:Reactome.
DR   InterPro; IPR012929; TPR/MLP1.
DR   Pfam; PF07926; TPR_MLP1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell cycle;
KW   Cell division; Centromere; Chromosomal rearrangement; Chromosome;
KW   Coiled coil; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Kinetochore; Membrane; Methylation;
KW   Mitosis; mRNA transport; Nuclear pore complex; Nucleus;
KW   Phosphoprotein; Polymorphism; Protein transport; Proto-oncogene;
KW   Reference proteome; Translocation; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.9}.
FT   CHAIN         2   2363       Nucleoprotein TPR.
FT                                /FTId=PRO_0000204920.
FT   REGION        3     13       Sufficient for interaction with TPR.
FT   REGION       14    117       Necessary for interaction with HSF1.
FT                                {ECO:0000269|PubMed:17897941}.
FT   REGION      437    513       Necessary for association to the NPC.
FT   REGION     1218   1320       Necessary for interaction with HSF1.
FT                                {ECO:0000269|PubMed:17897941}.
FT   REGION     1812   1867       Sufficient and essential for mediating
FT                                its nuclear import.
FT   COILED       29    370       {ECO:0000255}.
FT   COILED      423    602       {ECO:0000255}.
FT   COILED      661   1173       {ECO:0000255}.
FT   COILED     1215   1630       {ECO:0000255}.
FT   COMPBIAS    527    530       Poly-Ser.
FT   COMPBIAS   1833   1836       Poly-Glu.
FT   COMPBIAS   1971   1978       Poly-Asp.
FT   COMPBIAS   2309   2312       Poly-Ser.
FT   SITE        191    191       Breakpoint for translocation to form TRK-
FT                                T1.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.9}.
FT   MOD_RES     252    252       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     312    312       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     345    345       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     379    379       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     428    428       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     457    457       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     477    477       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:F6ZDS4}.
FT   MOD_RES     522    522       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     523    523       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     632    632       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     713    713       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     723    723       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     748    748       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     755    755       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1185   1185       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1690   1690       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:F6ZDS4}.
FT   MOD_RES    1692   1692       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1893   1893       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2034   2034       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2037   2037       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2048   2048       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2050   2050       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2073   2073       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES    2106   2106       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:F6ZDS4}.
FT   MOD_RES    2111   2111       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES    2116   2116       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:F6ZDS4}.
FT   MOD_RES    2137   2137       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2155   2155       Phosphoserine.
FT                                {ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2163   2163       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:F6ZDS4}.
FT   MOD_RES    2343   2343       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:F6ZDS4}.
FT   MOD_RES    2345   2345       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:F6ZDS4}.
FT   MOD_RES    2354   2354       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:F6ZDS4}.
FT   VAR_SEQ     726    726       E -> L (in isoform 2).
FT                                {ECO:0000303|PubMed:1549355}.
FT                                /FTId=VSP_057406.
FT   VAR_SEQ     727   2363       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1549355}.
FT                                /FTId=VSP_057407.
FT   VARIANT     960    960       S -> N (in dbSNP:rs3753565).
FT                                /FTId=VAR_020429.
FT   VARIANT    1428   1428       V -> G (in dbSNP:rs35550453).
FT                                /FTId=VAR_047289.
FT   VARIANT    1707   1707       T -> A (in dbSNP:rs35766045).
FT                                /FTId=VAR_047290.
FT   MUTAGEN     458    458       L->P: Diminishes association to NPC but
FT                                not homodimerization. Inhibits
FT                                association to NPC, interaction with
FT                                NUP153 and nuclear membrane localization
FT                                but not homodimerization; when associated
FT                                with P-489. {ECO:0000269|PubMed:11514627,
FT                                ECO:0000269|PubMed:12802065}.
FT   MUTAGEN     489    489       M->P: Diminishes association to NPC but
FT                                not homodimerization. Inhibits
FT                                association to NPC, interaction with
FT                                NUP153 and nuclear membrane localization
FT                                but not homodimerization; when associated
FT                                with P-458. {ECO:0000269|PubMed:11514627,
FT                                ECO:0000269|PubMed:12802065}.
FT   CONFLICT     32     32       Q -> R (in Ref. 5; CAA44719 and 6;
FT                                CAA68681). {ECO:0000305}.
FT   CONFLICT    779    779       V -> I (in Ref. 4; AAB48030).
FT                                {ECO:0000305}.
FT   CONFLICT    906    906       Q -> R (in Ref. 4; AAB48030).
FT                                {ECO:0000305}.
FT   CONFLICT   1239   1239       Q -> E (in Ref. 3; CAA47021).
FT                                {ECO:0000305}.
FT   CONFLICT   1952   1965       Missing (in Ref. 3; CAA47021).
FT                                {ECO:0000305}.
FT   HELIX         5      8       {ECO:0000244|PDB:5TO5}.
FT   HELIX        11     14       {ECO:0000244|PDB:5TO5}.
FT   HELIX        19    140       {ECO:0000244|PDB:5TO5}.
SQ   SEQUENCE   2363 AA;  267293 MW;  01E669CBDC496772 CRC64;
     MAAVLQQVLE RTELNKLPKS VQNKLEKFLA DQQSEIDGLK GRHEKFKVES EQQYFEIEKR
     LSHSQERLVN ETRECQSLRL ELEKLNNQLK ALTEKNKELE IAQDRNIAIQ SQFTRTKEEL
     EAEKRDLIRT NERLSQELEY LTEDVKRLNE KLKESNTTKG ELQLKLDELQ ASDVSVKYRE
     KRLEQEKELL HSQNTWLNTE LKTKTDELLA LGREKGNEIL ELKCNLENKK EEVSRLEEQM
     NGLKTSNEHL QKHVEDLLTK LKEAKEQQAS MEEKFHNELN AHIKLSNLYK SAADDSEAKS
     NELTRAVEEL HKLLKEAGEA NKAIQDHLLE VEQSKDQMEK EMLEKIGRLE KELENANDLL
     SATKRKGAIL SEEELAAMSP TAAAVAKIVK PGMKLTELYN AYVETQDQLL LEKLENKRIN
     KYLDEIVKEV EAKAPILKRQ REEYERAQKA VASLSVKLEQ AMKEIQRLQE DTDKANKQSS
     VLERDNRRME IQVKDLSQQI RVLLMELEEA RGNHVIRDEE VSSADISSSS EVISQHLVSY
     RNIEELQQQN QRLLVALREL GETREREEQE TTSSKITELQ LKLESALTEL EQLRKSRQHQ
     MQLVDSIVRQ RDMYRILLSQ TTGVAIPLHA SSLDDVSLAS TPKRPSTSQT VSTPAPVPVI
     ESTEAIEAKA ALKQLQEIFE NYKKEKAENE KIQNEQLEKL QEQVTDLRSQ NTKISTQLDF
     ASKRYEMLQD NVEGYRREIT SLHERNQKLT ATTQKQEQII NTMTQDLRGA NEKLAVAEVR
     AENLKKEKEM LKLSEVRLSQ QRESLLAEQR GQNLLLTNLQ TIQGILERSE TETKQRLSSQ
     IEKLEHEISH LKKKLENEVE QRHTLTRNLD VQLLDTKRQL DTETNLHLNT KELLKNAQKE
     IATLKQHLSN MEVQVASQSS QRTGKGQPSN KEDVDDLVSQ LRQTEEQVND LKERLKTSTS
     NVEQYQAMVT SLEESLNKEK QVTEEVRKNI EVRLKESAEF QTQLEKKLME VEKEKQELQD
     DKRRAIESME QQLSELKKTL SSVQNEVQEA LQRASTALSN EQQARRDCQE QAKIAVEAQN
     KYERELMLHA ADVEALQAAK EQVSKMASVR QHLEETTQKA ESQLLECKAS WEERERMLKD
     EVSKCVCRCE DLEKQNRLLH DQIEKLSDKV VASVKEGVQG PLNVSLSEEG KSQEQILEIL
     RFIRREKEIA ETRFEVAQVE SLRYRQRVEL LERELQELQD SLNAEREKVQ VTAKTMAQHE
     ELMKKTETMN VVMETNKMLR EEKERLEQDL QQMQAKVRKL ELDILPLQEA NAELSEKSGM
     LQAEKKLLEE DVKRWKARNQ HLVSQQKDPD TEEYRKLLSE KEVHTKRIQQ LTEEIGRLKA
     EIARSNASLT NNQNLIQSLK EDLNKVRTEK ETIQKDLDAK IIDIQEKVKT ITQVKKIGRR
     YKTQYEELKA QQDKVMETSA QSSGDHQEQH VSVQEMQELK ETLNQAETKS KSLESQVENL
     QKTLSEKETE ARNLQEQTVQ LQSELSRLRQ DLQDRTTQEE QLRQQITEKE EKTRKAIVAA
     KSKIAHLAGV KDQLTKENEE LKQRNGALDQ QKDELDVRIT ALKSQYEGRI SRLERELREH
     QERHLEQRDE PQEPSNKVPE QQRQITLKTT PASGERGIAS TSDPPTANIK PTPVVSTPSK
     VTAAAMAGNK STPRASIRPM VTPATVTNPT TTPTATVMPT TQVESQEAMQ SEGPVEHVPV
     FGSTSGSVRS TSPNVQPSIS QPILTVQQQT QATAFVQPTQ QSHPQIEPAN QELSSNIVEV
     VQSSPVERPS TSTAVFGTVS ATPSSSLPKR TREEEEDSTI EASDQVSDDT VEMPLPKKLK
     SVTPVGTEEE VMAEESTDGE VETQVYNQDS QDSIGEGVTQ GDYTPMEDSE ETSQSLQIDL
     GPLQSDQQTT TSSQDGQGKG DDVIVIDSDD EEEDDDENDG EHEDYEEDEE DDDDDEDDTG
     MGDEGEDSNE GTGSADGNDG YEADDAEGGD GTDPGTETEE SMGGGEGNHR AADSQNSGEG
     NTGAAESSFS QEVSREQQPS SASERQAPRA PQSPRRPPHP LPPRLTIHAP PQELGPPVQR
     IQMTRRQSVG RGLQLTPGIG GMQQHFFDDE DRTVPSTPTL VVPHRTDGFA EAIHSPQVAG
     VPRFRFGPPE DMPQTSSSHS DLGQLASQGG LGMYETPLFL AHEEESGGRS VPTTPLQVAA
     PVTVFTESTT SDASEHASQS VPMVTTSTGT LSTTNETATG DDGDEVFVEA ESEGISSEAG
     LEIDSQQEEE PVQASDESDL PSTSQDPPSS SSVDTSSSQP KPFRRVRLQT TLRQGVRGRQ
     FNRQRGVSHA MGGRGGINRG NIN
//
ID   TRIPB_HUMAN             Reviewed;        1979 AA.
AC   Q15643; B2RUT2; O14689; O15154; O95949;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 3.
DT   28-FEB-2018, entry version 162.
DE   RecName: Full=Thyroid receptor-interacting protein 11;
DE            Short=TR-interacting protein 11;
DE            Short=TRIP-11;
DE   AltName: Full=Clonal evolution-related gene on chromosome 14 protein;
DE   AltName: Full=Golgi-associated microtubule-binding protein 210;
DE            Short=GMAP-210;
DE   AltName: Full=Trip230;
GN   Name=TRIP11; Synonyms=CEV14;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH RB1 AND
RP   THRB.
RC   TISSUE=Fibroblast;
RX   PubMed=9256431; DOI=10.1073/pnas.94.17.9040;
RA   Chang K.-H., Chen Y., Chen T.-T., Chou W.-H., Chen P.-L., Ma Y.-T.,
RA   Yang-Feng T.L., Leng L., Tsai M.-J., O'Malley B.W., Lee W.-H.;
RT   "A thyroid hormone receptor coactivator negatively regulated by the
RT   retinoblastoma protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:9040-9045(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, INTERACTION WITH MICROTUBULES, AND VARIANT SER-1827.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10189370; DOI=10.1083/jcb.145.1.83;
RA   Infante C., Ramos-Morales F., Fedriani F., Bornens M., Rios R.M.;
RT   "GMAP-210, a cis-Golgi network-associated protein, is a minus end
RT   microtubule-binding protein.";
RL   J. Cell Biol. 145:83-98(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LEU-39 AND
RP   SER-1827.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1188-1979, CHROMOSOMAL TRANSLOCATION
RP   WITH PDGFRB, TISSUE SPECIFICITY, AND VARIANT SER-1827.
RC   TISSUE=Leukemia;
RX   PubMed=9373237;
RA   Abe A., Emi N., Tanimoto M., Terasaki H., Marunouchi T., Saito H.;
RT   "Fusion of the platelet-derived growth factor receptor beta to a novel
RT   gene CEV14 in acute myelogenous leukemia after clonal evolution.";
RL   Blood 90:4271-4277(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1757-1944, INTERACTION WITH THRB, AND
RP   VARIANT SER-1827.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=7776974; DOI=10.1210/mend.9.2.7776974;
RA   Lee J.W., Choi H.-S., Gyuris J., Brent R., Moore D.D.;
RT   "Two classes of proteins dependent on either the presence or absence
RT   of thyroid hormone for interaction with the thyroid hormone
RT   receptor.";
RL   Mol. Endocrinol. 9:243-254(1995).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1891, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464; SER-1842 AND
RP   THR-1846, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1842 AND THR-1846, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   INVOLVEMENT IN ACG1A.
RX   PubMed=20089971; DOI=10.1056/NEJMoa0900158;
RA   Smits P., Bolton A.D., Funari V., Hong M., Boyden E.D., Lu L.,
RA   Manning D.K., Dwyer N.D., Moran J.L., Prysak M., Merriman B.,
RA   Nelson S.F., Bonafe L., Superti-Furga A., Ikegawa S., Krakow D.,
RA   Cohn D.H., Kirchhausen T., Warman M.L., Beier D.R.;
RT   "Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-
RT   210.";
RL   N. Engl. J. Med. 362:206-216(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464 AND SER-1842, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464 AND SER-1891, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-1846.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J.,
RA   Heath S., Shannon W.D., Nagarajan R., Walter M.J., Link D.C.,
RA   Graubert T.A., DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
RN   [17]
RP   VARIANT ALA-559.
RX   PubMed=27717682; DOI=10.1016/j.jstrokecerebrovasdis.2016.09.003;
RA   Mukawa M., Nariai T., Onda H., Yoneyama T., Aihara Y., Hirota K.,
RA   Kudo T., Sumita K., Maehara T., Kawamata T., Kasuya H., Akagawa H.;
RT   "Exome sequencing identified CCER2 as a novel candidate gene for
RT   Moyamoya disease.";
RL   J. Stroke Cerebrovasc. Dis. 26:150-161(2017).
CC   -!- FUNCTION: Binds the ligand binding domain of the thyroid receptor
CC       (THRB) in the presence of triiodothyronine and enhances THRB-
CC       modulated transcription. Golgi auto-antigen; probably involved in
CC       maintaining cis-Golgi structure. {ECO:0000269|PubMed:10189370,
CC       ECO:0000269|PubMed:9256431}.
CC   -!- SUBUNIT: Binds RB1.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network membrane
CC       {ECO:0000269|PubMed:10189370}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:10189370}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:10189370}. Note=Associates with the ends of
CC       centrosome-nucleated microtubules.
CC   -!- TISSUE SPECIFICITY: Highly expressed in pancreas, muscle, heart,
CC       testis, peripheral blood leukocytes, and in several leukemia cell
CC       lines. Detected at intermediate levels in placenta and kidney, and
CC       at low levels in brain and lung. {ECO:0000269|PubMed:10189370,
CC       ECO:0000269|PubMed:9373237}.
CC   -!- DOMAIN: Extended rod-like protein with coiled-coil domains.
CC   -!- DISEASE: Note=A chromosomal aberration involving TRIP11 may be a
CC       cause of acute myelogenous leukemia. Translocation
CC       t(5;14)(q33;q32) with PDGFRB. The fusion protein may be involved
CC       in clonal evolution of leukemia and eosinophilia.
CC       {ECO:0000269|PubMed:9373237}.
CC   -!- DISEASE: Achondrogenesis 1A (ACG1A) [MIM:200600]: A form of
CC       achondrogenesis type 1, a lethal form of chondrodysplasia
CC       characterized by deficient ossification in the lumbar vertebrae
CC       and absent ossification in the sacral, pubic and ischial bones and
CC       clinically by stillbirth or early death. In addition to severe
CC       micromelia, there is a disproportionately large cranium due to
CC       marked edema of soft tissues. {ECO:0000269|PubMed:20089971}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB84386.1; Type=Frameshift; Positions=1932, 1955; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CEV14ID96.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF007217; AAD09135.1; -; mRNA.
DR   EMBL; Y12490; CAA73095.1; -; mRNA.
DR   EMBL; AL049872; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC146845; AAI46846.1; -; mRNA.
DR   EMBL; AF011368; AAB84386.1; ALT_FRAME; mRNA.
DR   EMBL; L40380; AAC41730.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS9899.1; -.
DR   PIR; T03719; T03719.
DR   RefSeq; NP_004230.2; NM_004239.4.
DR   UniGene; Hs.632339; -.
DR   UniGene; Hs.741740; -.
DR   ProteinModelPortal; Q15643; -.
DR   SMR; Q15643; -.
DR   BioGrid; 114732; 25.
DR   DIP; DIP-40357N; -.
DR   IntAct; Q15643; 20.
DR   MINT; Q15643; -.
DR   STRING; 9606.ENSP00000267622; -.
DR   iPTMnet; Q15643; -.
DR   PhosphoSitePlus; Q15643; -.
DR   BioMuta; TRIP11; -.
DR   DMDM; 292495059; -.
DR   EPD; Q15643; -.
DR   MaxQB; Q15643; -.
DR   PaxDb; Q15643; -.
DR   PeptideAtlas; Q15643; -.
DR   PRIDE; Q15643; -.
DR   Ensembl; ENST00000267622; ENSP00000267622; ENSG00000100815.
DR   GeneID; 9321; -.
DR   KEGG; hsa:9321; -.
DR   UCSC; uc001xzy.4; human.
DR   CTD; 9321; -.
DR   DisGeNET; 9321; -.
DR   EuPathDB; HostDB:ENSG00000100815.12; -.
DR   GeneCards; TRIP11; -.
DR   H-InvDB; HIX0202079; -.
DR   HGNC; HGNC:12305; TRIP11.
DR   HPA; HPA002570; -.
DR   HPA; HPA070684; -.
DR   MalaCards; TRIP11; -.
DR   MIM; 200600; phenotype.
DR   MIM; 604505; gene.
DR   neXtProt; NX_Q15643; -.
DR   OpenTargets; ENSG00000100815; -.
DR   Orphanet; 93299; Achondrogenesis type 1A.
DR   PharmGKB; PA36984; -.
DR   eggNOG; ENOG410IF24; Eukaryota.
DR   eggNOG; ENOG410XT0E; LUCA.
DR   GeneTree; ENSGT00710000106769; -.
DR   HOGENOM; HOG000168282; -.
DR   HOVERGEN; HBG079281; -.
DR   InParanoid; Q15643; -.
DR   OMA; YHKMMDI; -.
DR   OrthoDB; EOG091G00A6; -.
DR   PhylomeDB; Q15643; -.
DR   TreeFam; TF351148; -.
DR   Reactome; R-HSA-5620924; Intraflagellar transport.
DR   Reactome; R-HSA-6811438; Intra-Golgi traffic.
DR   SIGNOR; Q15643; -.
DR   GeneWiki; TRIP11; -.
DR   GenomeRNAi; 9321; -.
DR   PRO; PR:Q15643; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100815; -.
DR   CleanEx; HS_TRIP11; -.
DR   ExpressionAtlas; Q15643; baseline and differential.
DR   Genevisible; Q15643; HS.
DR   GO; GO:0005929; C:cilium; IEA:GOC.
DR   GO; GO:0005801; C:cis-Golgi network; IEA:Ensembl.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0002079; C:inner acrosomal membrane; IEA:Ensembl.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0002081; C:outer acrosomal membrane; IEA:Ensembl.
DR   GO; GO:0030133; C:transport vesicle; TAS:Reactome.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0003413; P:chondrocyte differentiation involved in endochondral bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0007030; P:Golgi organization; IEA:Ensembl.
DR   GO; GO:0060122; P:inner ear receptor cell stereocilium organization; IEA:Ensembl.
DR   GO; GO:0035735; P:intraciliary transport involved in cilium assembly; TAS:Reactome.
DR   GO; GO:0006486; P:protein glycosylation; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0003281; P:ventricular septum development; IEA:Ensembl.
DR   InterPro; IPR000237; GRIP_dom.
DR   PROSITE; PS50913; GRIP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosomal rearrangement; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Dwarfism; Golgi apparatus;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:25944712}.
FT   CHAIN         2   1979       Thyroid receptor-interacting protein 11.
FT                                /FTId=PRO_0000190076.
FT   DOMAIN     1774   1823       GRIP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00250}.
FT   COILED       52   1773       {ECO:0000255}.
FT   SITE       1754   1755       Breakpoint for translocation to form
FT                                TRIP11-PDGFRB.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:25944712}.
FT   MOD_RES     464    464       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1842   1842       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1846   1846       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1891   1891       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT      39     39       M -> L (in dbSNP:rs17127898).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_055861.
FT   VARIANT     506    506       E -> A (in dbSNP:rs2273186).
FT                                /FTId=VAR_055862.
FT   VARIANT     559    559       V -> A. {ECO:0000269|PubMed:27717682}.
FT                                /FTId=VAR_079175.
FT   VARIANT     795    795       V -> L (in dbSNP:rs34699762).
FT                                /FTId=VAR_055863.
FT   VARIANT     884    884       D -> G (in dbSNP:rs34967261).
FT                                /FTId=VAR_055864.
FT   VARIANT    1040   1040       I -> V (in dbSNP:rs34805848).
FT                                /FTId=VAR_055865.
FT   VARIANT    1107   1107       E -> D (in dbSNP:rs4619320).
FT                                /FTId=VAR_060344.
FT   VARIANT    1413   1413       D -> A (in dbSNP:rs12884523).
FT                                /FTId=VAR_060345.
FT   VARIANT    1503   1503       M -> V (in dbSNP:rs34839498).
FT                                /FTId=VAR_055866.
FT   VARIANT    1576   1576       R -> H (in dbSNP:rs35007347).
FT                                /FTId=VAR_055867.
FT   VARIANT    1749   1749       E -> A (in dbSNP:rs2273183).
FT                                /FTId=VAR_055868.
FT   VARIANT    1752   1752       R -> K (in dbSNP:rs11851376).
FT                                /FTId=VAR_055869.
FT   VARIANT    1827   1827       G -> S (in dbSNP:rs1051340).
FT                                {ECO:0000269|PubMed:10189370,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7776974,
FT                                ECO:0000269|PubMed:9373237}.
FT                                /FTId=VAR_060346.
FT   VARIANT    1846   1846       T -> I (in dbSNP:rs141259390).
FT                                {ECO:0000269|PubMed:18987736}.
FT                                /FTId=VAR_054151.
FT   CONFLICT    121    121       L -> F (in Ref. 1; AAD09135).
FT                                {ECO:0000305}.
FT   CONFLICT    382    382       A -> G (in Ref. 1; AAD09135).
FT                                {ECO:0000305}.
FT   CONFLICT    391    391       Q -> R (in Ref. 1; AAD09135).
FT                                {ECO:0000305}.
FT   CONFLICT    516    516       D -> A (in Ref. 1; AAD09135).
FT                                {ECO:0000305}.
FT   CONFLICT    561    563       KEK -> FVL (in Ref. 1; AAD09135).
FT                                {ECO:0000305}.
FT   CONFLICT   1202   1202       N -> H (in Ref. 2). {ECO:0000305}.
FT   CONFLICT   1237   1237       H -> R (in Ref. 5; AAB84386).
FT                                {ECO:0000305}.
FT   CONFLICT   1346   1347       QQ -> HE (in Ref. 5; AAB84386).
FT                                {ECO:0000305}.
FT   CONFLICT   1658   1665       QLSVSQEQ -> RFCLSGT (in Ref. 1;
FT                                AAD09135). {ECO:0000305}.
FT   CONFLICT   1670   1670       A -> R (in Ref. 1; AAD09135).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1979 AA;  227586 MW;  437EB5F5966BB1AE CRC64;
     MSSWLGGLGS GLGQSLGQVG GSLASLTGQI SNFTKDMLME GTEEVEAELP DSRTKEIEAI
     HAILRSENER LKKLCTDLEE KHEASEIQIK QQSTSYRNQL QQKEVEISHL KARQIALQDQ
     LLKLQSAAQS VPSGAGVPAT TASSSFAYGI SHHPSAFHDD DMDFGDIISS QQEINRLSNE
     VSRLESEVGH WRHIAQTSKA QGTDNSDQSE ICKLQNIIKE LKQNRSQEID DHQHEMSVLQ
     NAHQQKLTEI SRRHREELSD YEERIEELEN LLQQGGSGVI ETDLSKIYEM QKTIQVLQIE
     KVESTKKMEQ LEDKIKDINK KLSSAENDRD ILRREQEQLN VEKRQIMEEC ENLKLECSKL
     QPSAVKQSDT MTEKERILAQ SASVEEVFRL QQALSDAENE IMRLSSLNQD NSLAEDNLKL
     KMRIEVLEKE KSLLSQEKEE LQMSLLKLNN EYEVIKSTAT RDISLDSELH DLRLNLEAKE
     QELNQSISEK ETLIAEIEEL DRQNQEATKH MILIKDQLSK QQNEGDSIIS KLKQDLNDEK
     KRVHQLEDDK MDITKELDVQ KEKLIQSEVA LNDLHLTKQK LEDKVENLVD QLNKSQESNV
     SIQKENLELK EHIRQNEEEL SRIRNELMQS LNQDSNSNFK DTLLKEREAE VRNLKQNLSE
     LEQLNENLKK VAFDVKMENE KLVLACEDVR HQLEECLAGN NQLSLEKNTI VETLKMEKGE
     IEAELCWAKK RLLEEANKYE KTIEELSNAR NLNTSALQLE HEHLIKLNQK KDMEIAELKK
     NIEQMDTDHK ETKDVLSSSL EEQKQLTQLI NKKEIFIEKL KERSSKLQEE LDKYSQALRK
     NEILRQTIEE KDRSLGSMKE ENNHLQEELE RLREEQSRTA PVADPKTLDS VTELASEVSQ
     LNTIKEHLEE EIKHHQKIIE DQNQSKMQLL QSLQEQKKEM DEFRYQHEQM NATHTQLFLE
     KDEEIKSLQK TIEQIKTQLH EERQDIQTDN SDIFQETKVQ SLNIENGSEK HDLSKAETER
     LVKGIKEREL EIKLLNEKNI SLTKQIDQLS KDEVGKLTQI IQQKDLEIQA LHARISSTSH
     TQDVVYLQQQ LQAYAMEREK VFAVLNEKTR ENSHLKTEYH KMMDIVAAKE AALIKLQDEN
     KKLSTRFESS GQDMFRETIQ NLSRIIREKD IEIDALSQKC QTLLAVLQTS STGNEAGGVN
     SNQFEELLQE RDKLKQQVKK MEEWKQQVMT TVQNMQHESA QLQEELHQLQ AQVLVDSDNN
     SKLQVDYTGL IQSYEQNETK LKNFGQELAQ VQHSIGQLCN TKDLLLGKLD IISPQLSSAS
     LLTPQSAECL RASKSEVLSE SSELLQQELE ELRKSLQEKD ATIRTLQENN HRLSDSIAAT
     SELERKEHEQ TDSEIKQLKE KQDVLQKLLK EKDLLIKAKS DQLLSSNENF TNKVNENELL
     RQAVTNLKER ILILEMDIGK LKGENEKIVE TYRGKETEYQ ALQETNMKFS MMLREKEFEC
     HSMKEKALAF EQLLKEKEQG KTGELNQLLN AVKSMQEKTV VFQQERDQVM LALKQKQMEN
     TALQNEVQRL RDKEFRSNQE LERLRNHLLE SEDSYTREAL AAEDREAKLR KKVTVLEEKL
     VSSSNAMENA SHQASVQVES LQEQLNVVSK QRDETALQLS VSQEQVKQYA LSLANLQMVL
     EHFQQEEKAM YSAELEKQKQ LIAEWKKNAE NLEGKVISLQ ECLDEANAAL DSASRLTEQL
     DVKEEQIEEL KRQNELRQEM LDDVQKKLMS LANSSEGKVD KVLMRNLFIG HFHTPKNQRH
     EVLRLMGSIL GVRREEMEQL FHDDQGGVTR WMTGWLGGGS KSVPNTPLRP NQQSVVNSSF
     SELFVKFLET ESHPSIPPPK LSVHDMKPLD SPGRRKRDTN APESFKDTAE SRSGRRTDVN
     PFLAPRSAAV PLINPAGLGP GGPGHLLLKP ISDVLPTFTP LPALPDNSAG VVLKDLLKQ
//
ID   A0A024RDS3_HUMAN        Unreviewed;      1377 AA.
AC   A0A024RDS3;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 32.
DE   SubName: Full=Zinc finger protein 198, isoform CRA_b {ECO:0000313|EMBL:EAX08245.1};
GN   Name=ZNF198 {ECO:0000313|EMBL:EAX08245.1};
GN   ORFNames=hCG_20496 {ECO:0000313|EMBL:EAX08245.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX08245.1};
RN   [1] {ECO:0000313|EMBL:EAX08245.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX08245.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471075; EAX08245.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08246.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08248.1; -; Genomic_DNA.
DR   RefSeq; NP_001177893.1; NM_001190964.2.
DR   RefSeq; NP_001177894.1; NM_001190965.2.
DR   RefSeq; NP_003444.1; NM_003453.4.
DR   RefSeq; NP_932072.1; NM_197968.3.
DR   RefSeq; XP_005266577.1; XM_005266520.3.
DR   RefSeq; XP_016876218.1; XM_017020729.1.
DR   UniGene; Hs.507433; -.
DR   SMR; A0A024RDS3; -.
DR   GeneID; 7750; -.
DR   KEGG; hsa:7750; -.
DR   CTD; 7750; -.
DR   EuPathDB; HostDB:ENSG00000121741.16; -.
DR   eggNOG; ENOG410IE8I; Eukaryota.
DR   eggNOG; ENOG410XQR6; LUCA.
DR   OMA; CKPHMQS; -.
DR   OrthoDB; EOG091G00KQ; -.
DR   ChiTaRS; ZMYM2; human.
DR   GenomeRNAi; 7750; -.
DR   Bgee; ENSG00000121741; -.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   InterPro; IPR021893; DUF3504.
DR   InterPro; IPR011017; TRASH_dom.
DR   InterPro; IPR010507; Znf_MYM.
DR   Pfam; PF12012; DUF3504; 1.
DR   Pfam; PF06467; zf-FCS; 8.
DR   SMART; SM00746; TRASH; 9.
PE   4: Predicted;
FT   DOMAIN      331    367       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      373    413       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      425    460       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      467    506       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      584    620       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      639    675       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      681    716       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      727    762       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      768    803       TRASH. {ECO:0000259|SMART:SM00746}.
SQ   SEQUENCE   1377 AA;  154911 MW;  2652D4C766492FF9 CRC64;
     MDTSSVGGLE LTDQTPVLLG STAMATSLTN VGNSFSGPAN PLVSRSNKFQ NSSVEDDDDV
     VFIEPVQPPP PSVPVVADQR TITFTSSKNE ELQGNDSKIT PSSKELASQK GSVSETIVID
     DEEDMETNQG QEKNSSNFIE RRPPETKNRT NDVDFSTSSF SRSKVNAGMG NSGITTEPDS
     EIQIANVTTL ETGVSSVNDG QLENTDGRDM NLMITHVTSL QNTNLGDVSN GLQSSNFGVN
     IQTYTPSLTS QTKTGVGPFN PGRMNVAGDV FQNGESATHH NPDSWISQSA SFPRNQKQPG
     VDSLSPVASL PKQIFQPSVQ QQPTKPVKVT CANCKKPLQK GQTAYQRKGS AHLFCSTTCL
     SSFSHKPAPK KLCVMCKKDI TTMKGTIVAQ VDSSESFQEF CSTSCLSLYE DKQNPTKGAL
     NKSRCTICGK LTEIRHEVSF KNMTHKLCSD HCFNRYRMAN GLIMNCCEQC GEYLPSKGAG
     NNVLVIDGQQ KRFCCQSCVS EYKQVGSHPS FLKEVRDHMQ DSFLMQPEKY GKLTTCTGCR
     TQCRFFDMTQ CIGPNGYMEP YCSTACMNSH KTKYAKSQSL GIICHFCKRN SLPQYQATMP
     DGKLYNFCNS SCVAKFQALS MQSSPNGQFV APSDIQLKCN YCKNSFCSKP EILEWENKVH
     QFCSKTCSDD YKKLHCIVTY CEYCQEEKTL HETVNFSGVK RPFCSEGCKL LYKQDFARRL
     GLRCVTCNYC SQLCKKGATK ELDGVVRDFC SEDCCKKFQD WYYKAARCDC CKSQGTLKER
     VQWRGEMKHF CDQHCLLRFY CQQNEPNMTT QKGPENLHYD QGCQTSRTKM TGSAPPPSPT
     PNKEMKNKAV LCKPLTMTKA TYCKPHMQTK SCQTDDTWRT EYVPVPIPVP VYIPVPMHMY
     SQNIPVPTTV PVPVPVPVFL PAPLDSSEKI PAAIEELKSK VSSDALDTEL LTMTDMMSED
     EGKTETTNIN SVIIETDIIG SDLLKNSDPE TQSSMPDVPY EPDLDIEIDF PRAAEELDME
     NEFLLPPVFG EEYEEQPRPR SKKKGAKRKA VSGYQSHDDS SDNSECSFPF KYTYGVNAWK
     HWVKTRQLDE DLLVLDELKS SKSVKLKEDL LSHTTAELNY GLAHFVNEIR RPNGENYAPD
     SIYYLCLGIQ EYLCGSNRKD NIFIDPGYQT FEQELNKILR SWQPSILPDG SIFSRVEEDY
     LWRIKQLGSH SPVALLNTLF YFNTKYFGLK TVEQHLRLSF GTVFRHWKKN PLTMENKACL
     RYQVSSLCGT DNEDKITTGK RKHEDDEPVF EQIENTANPS RCPVKMFECY LSKSPQNLNQ
     RMDVFYLQPE CSSSTDSPVW YTSTSLDRNT LENMLVRVLL VKDIYDKDNY ELDEDTD
//
ID   A8K126_HUMAN            Unreviewed;      1247 AA.
AC   A8K126;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   31-JAN-2018, entry version 45.
DE   SubName: Full=cDNA FLJ76647, highly similar to Homo sapiens zinc finger protein 198 (ZNF198), mRNA {ECO:0000313|EMBL:BAF82430.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF82430.1};
RN   [1] {ECO:0000313|EMBL:BAF82430.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAF82430.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK289741; BAF82430.1; -; mRNA.
DR   RefSeq; NP_932072.1; NM_197968.3.
DR   UniGene; Hs.507433; -.
DR   ProteinModelPortal; A8K126; -.
DR   IntAct; A8K126; 1.
DR   PeptideAtlas; A8K126; -.
DR   PRIDE; A8K126; -.
DR   GeneID; 7750; -.
DR   CTD; 7750; -.
DR   eggNOG; ENOG410IE8I; Eukaryota.
DR   eggNOG; ENOG410XQR6; LUCA.
DR   HOVERGEN; HBG057545; -.
DR   GenomeRNAi; 7750; -.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   InterPro; IPR021893; DUF3504.
DR   InterPro; IPR011017; TRASH_dom.
DR   InterPro; IPR010507; Znf_MYM.
DR   Pfam; PF12012; DUF3504; 1.
DR   Pfam; PF06467; zf-FCS; 8.
DR   SMART; SM00746; TRASH; 9.
PE   2: Evidence at transcript level;
FT   DOMAIN      331    367       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      373    413       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      425    460       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      467    506       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      584    620       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      639    675       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      681    716       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      727    762       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      768    803       TRASH. {ECO:0000259|SMART:SM00746}.
FT   NON_TER    1247   1247       {ECO:0000313|EMBL:BAF82430.1}.
SQ   SEQUENCE   1247 AA;  139732 MW;  E7F36D42D7477F45 CRC64;
     MDTSSVGGLE LTDQTPVLLG STAMATSLTN VGNSLSGPAN PLVSRSNKFQ NSSVEDDDDV
     VFIEPVQPPP PSVPVVADQR TITFTSSKNE ELQGNDSKIT PSSKELASQK GSVSETIVID
     DEEDMETNQG QEKNSSNFIE RRPPETKNRT NDVDFSTSSF SRSKVNAGMG NSGITTEPDS
     EIQIANVTTL ETGVSSVNDG QLENTDGRDM NLMITHVTSL QNTNLGDVSN GLQSSNFGVN
     IQTYTPSLTS QTKTGVGPFN PGRMNVAGDV FQNGESATHH NPDSWISQSA SFPRNQKQPG
     VDSLSPVASL PKQIFQPSVQ QQPTKPVKVT CANCKKPLQK GQTAYQRKGS AHLFCSTTCL
     SSFSHKPAPK KLCVMCKKDI TTMKGTIVAQ VDSSESFQEF CSTSCLSLYE DKQNPTKGAL
     NKSRCTICGK LTEIRHEVSF KNMTHKLCSD HCFNRYRMAN GLIMNCCEQC GEYLPSKGAG
     NNVLVIDGQQ KRFCCQSCVS EYKQVGSHPS FLKEVRDHMQ DSFLMQPDKY GKLTTCTGCR
     TQCRFFDMTQ CIGPNGYMEP YCSTACMNSH KTKYAKSQSL GIICHFCKRN SLPQYQATMP
     DGKLYNFCNS SCVAKFQALS MQSSPNGQFV APSDIQLKCN YCKNSFCSKP EILEWENKVH
     QFCSKTCSDD YKKLHCIVTY CEYCQEEKTL HETVNFSGVK RPFCSEGCKL LYKQDFARRL
     GLRCVTCNYC SQLCKKGATK ELDGVVRDFC SEDCCKKFQD WYYKAARCDC CKSQGTLKER
     VQWRGEMKHF CDQHCLLRLY CQQNEPNMTT QKGPENLHYD QGCQTSRTKM TGSAPPPSPT
     PNKEMKNKAV LCKPLTMTKA TYCKPHMQTK SCQTDDTWRT EYVPVPIPVP VYIPVPMHMY
     SQNIPVPTTV PVPVPVPVFL PAPLDSSEKI PAAIEELKSK VSSDALDTEL LTMTDMMSED
     EGKTETTNIN SVIIETDIIG SDLLKNSDPE TQSSMPDVPY EPDLDIEIDF PRAAEELDME
     NEFLLPPVFG EEYEEQPRPR SKKKGAKRKA VSGYQSHDDS SDNSECSFPF KYTYGVNAWK
     HWVKTRQLDE DLLVLDELKS SKSVKLKEDL LSHTTAELNY GLAHFVNEIR RPNGENYAPD
     SIYYLCLGIQ EYLCGSNRKD NIFIDPGYQT FEQELNKILR SWQPSILPDG SIFSRVEEDY
     LWRIKQLGSH SPVALLNTLF YFNTKYFGLK TVEQHLRLSF GTVFRHW
//
ID   ZMYM2_HUMAN             Reviewed;        1377 AA.
AC   Q9UBW7; A6NDG0; A6NI02; O43212; O43434; O60898; Q5W0Q4; Q5W0T3;
AC   Q63HP0; Q8NE39; Q9H0V5; Q9H538; Q9UEU2;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   28-FEB-2018, entry version 163.
DE   RecName: Full=Zinc finger MYM-type protein 2;
DE   AltName: Full=Fused in myeloproliferative disorders protein;
DE   AltName: Full=Rearranged in atypical myeloproliferative disorder protein;
DE   AltName: Full=Zinc finger protein 198;
GN   Name=ZMYM2; Synonyms=FIM, RAMP, ZNF198;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION.
RX   PubMed=9576949; DOI=10.1073/pnas.95.10.5712;
RA   Popovici C., Adelaide J., Ollendorff V., Chaffanet M., Guasch G.,
RA   Jacrot M., Leroux D., Birnbaum D., Pebusque M.-J.;
RT   "Fibroblast growth factor receptor 1 is fused to FIM in stem-cell
RT   myeloproliferative disorder with t(8;13)(p12;q12).";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:5712-5717(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9716603;
RA   Reiter A., Sohal J., Kulkarni S., Chase A., Macdonald D.H.C.,
RA   Aguiar R.C.T., Goncalves C., Hernandez J.M., Jennings B.A.,
RA   Goldman J.M., Cross N.C.P.;
RT   "Consistent fusion of ZNF198 to the fibroblast growth factor receptor-
RT   1 in the t(8;13)(p11;q12) myeloproliferative syndrome.";
RL   Blood 92:1735-1742(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9889006; DOI=10.1006/geno.1998.5634;
RA   Kulkarni S., Reiter A.J., Smedley D., Goldman J.M., Cross N.C.P.;
RT   "The genomic structure of ZNF198 and location of breakpoints in the
RT   t(8;13) myeloproliferative syndrome.";
RL   Genomics 55:118-121(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Endometrial tumor;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 152-1377 (ISOFORM 1).
RX   PubMed=9694738;
RA   Still I.H., Cowell J.K.;
RT   "The t(8;13) atypical myeloproliferative disorder: further analysis of
RT   the ZNF198 gene and lack of evidence for multiple genes disrupted on
RT   chromosome 13.";
RL   Blood 92:1456-1458(1998).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 170-1020 (ISOFORM 1).
RX   PubMed=9499416; DOI=10.1093/hmg/7.4.637;
RA   Smedley D., Hamoudi R., Clark J., Warren W., Abdul-Rauf M., Somers G.,
RA   Venter D., Fagan K., Cooper C., Shipley J.;
RT   "The t(8;13)(p11;q11-12) rearrangement associated with an atypical
RT   myeloproliferative disorder fuses the fibroblast growth factor
RT   receptor 1 gene to a novel gene RAMP.";
RL   Hum. Mol. Genet. 7:637-642(1998).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 621-1377 (ISOFORM 1).
RX   PubMed=9425908; DOI=10.1038/ng0198-84;
RA   Xiao S., Nalabolu S.R., Aster J.C., Ma J., Abruzzo L., Jaffe E.S.,
RA   Stone R., Weissman S.M., Hudson T.J., Fletcher J.A.;
RT   "FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13)
RT   leukaemia/lymphoma syndrome.";
RL   Nat. Genet. 18:84-87(1998).
RN   [12]
RP   IDENTIFICATION IN THE BHC COMPLEX WITH GSE1; GTF2I; HDAC1; HDAC2;
RP   HMG20B; KDM1A; RCOR1; PHF21A; ZNF217 AND ZMYM3.
RX   PubMed=12493763; DOI=10.1074/jbc.M208992200;
RA   Hakimi M.-A., Dong Y., Lane W.S., Speicher D.W., Shiekhattar R.;
RT   "A candidate X-linked mental retardation gene is a component of a new
RT   family of histone deacetylase-containing complexes.";
RL   J. Biol. Chem. 278:7234-7239(2003).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-838 AND THR-1376, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-305 AND THR-1376, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-305; SER-838 AND
RP   SER-958, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159; SER-305 AND
RP   SER-838, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-88; LYS-98; LYS-104;
RP   LYS-253; LYS-297; LYS-441; LYS-529; LYS-532 AND LYS-649, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-88; LYS-297; LYS-325;
RP   LYS-529 AND LYS-576, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-88; LYS-98; LYS-441;
RP   LYS-513; LYS-529; LYS-532 AND LYS-700, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-48; LYS-88; LYS-98; LYS-104;
RP   LYS-147; LYS-253; LYS-297; LYS-312; LYS-325; LYS-348; LYS-366;
RP   LYS-417; LYS-441; LYS-491; LYS-503; LYS-513; LYS-529; LYS-532;
RP   LYS-576; LYS-603; LYS-649; LYS-658; LYS-688; LYS-700; LYS-709;
RP   LYS-764; LYS-788; LYS-812 AND LYS-829, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May function as a transcription factor.
CC   -!- SUBUNIT: May be a component of a BHC histone deacetylase complex
CC       that contains HDAC1, HDAC2, HMG20B/BRAF35, KDM1A, RCOR1/CoREST,
CC       PHF21A/BHC80, ZMYM2, ZNF217, ZMYM3, GSE1 and GTF2I.
CC       {ECO:0000269|PubMed:12493763}.
CC   -!- INTERACTION:
CC       Q9UHL9:GTF2IRD1; NbExp=5; IntAct=EBI-2797576, EBI-372530;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UBW7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UBW7-2; Sequence=VSP_039065, VSP_039066, VSP_039067;
CC   -!- DISEASE: Note=A chromosomal aberration involving ZMYM2 may be a
CC       cause of stem cell leukemia lymphoma syndrome (SCLL).
CC       Translocation t(8;13)(p11;q12) with FGFR1. SCLL usually presents
CC       as lymphoblastic lymphoma in association with a myeloproliferative
CC       disorder, often accompanied by pronounced peripheral eosinophilia
CC       and/or prominent eosinophilic infiltrates in the affected bone
CC       marrow. {ECO:0000269|PubMed:9716603}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB88464.1; Type=Frameshift; Positions=330, 966, 1009, 1017; Evidence={ECO:0000305};
CC       Sequence=AAC23591.1; Type=Frameshift; Positions=330; Evidence={ECO:0000305};
CC       Sequence=CAA73875.1; Type=Frameshift; Positions=388, 403, 406, 409, 418; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ZNF198ID114.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y13472; CAA73875.1; ALT_FRAME; mRNA.
DR   EMBL; AJ224901; CAA12204.1; -; mRNA.
DR   EMBL; AJ007676; CAA07604.1; -; Genomic_DNA.
DR   EMBL; AJ007677; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007678; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007679; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007680; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007681; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007682; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007683; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007684; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007685; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007686; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007687; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007688; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007689; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007690; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007691; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007692; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007693; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007694; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007695; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ007696; CAA07604.1; JOINED; Genomic_DNA.
DR   EMBL; AL136621; CAB66556.2; -; mRNA.
DR   EMBL; BX647944; CAH56193.1; -; mRNA.
DR   EMBL; AL137119; CAH70133.1; -; Genomic_DNA.
DR   EMBL; AL138688; CAH70133.1; JOINED; Genomic_DNA.
DR   EMBL; AL137119; CAH70134.1; -; Genomic_DNA.
DR   EMBL; AL138688; CAH71822.1; -; Genomic_DNA.
DR   EMBL; AL137119; CAH71822.1; JOINED; Genomic_DNA.
DR   EMBL; CH471075; EAX08244.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08247.1; -; Genomic_DNA.
DR   EMBL; BC036372; AAH36372.1; -; mRNA.
DR   EMBL; AF060181; AAC23591.1; ALT_FRAME; mRNA.
DR   EMBL; AF035374; AAB88464.1; ALT_FRAME; mRNA.
DR   EMBL; AF012126; AAC01561.1; -; mRNA.
DR   CCDS; CCDS45016.1; -. [Q9UBW7-1]
DR   PIR; T45119; T45119.
DR   RefSeq; NP_001177893.1; NM_001190964.2. [Q9UBW7-1]
DR   RefSeq; NP_001177894.1; NM_001190965.2. [Q9UBW7-1]
DR   RefSeq; NP_003444.1; NM_003453.4. [Q9UBW7-1]
DR   RefSeq; NP_932072.1; NM_197968.3. [Q9UBW7-1]
DR   RefSeq; XP_005266577.1; XM_005266520.3. [Q9UBW7-1]
DR   RefSeq; XP_011533526.1; XM_011535224.2.
DR   RefSeq; XP_016876218.1; XM_017020729.1.
DR   UniGene; Hs.507433; -.
DR   ProteinModelPortal; Q9UBW7; -.
DR   SMR; Q9UBW7; -.
DR   BioGrid; 113534; 71.
DR   CORUM; Q9UBW7; -.
DR   IntAct; Q9UBW7; 45.
DR   MINT; Q9UBW7; -.
DR   STRING; 9606.ENSP00000372322; -.
DR   iPTMnet; Q9UBW7; -.
DR   PhosphoSitePlus; Q9UBW7; -.
DR   BioMuta; ZMYM2; -.
DR   DMDM; 17369677; -.
DR   EPD; Q9UBW7; -.
DR   PaxDb; Q9UBW7; -.
DR   PeptideAtlas; Q9UBW7; -.
DR   PRIDE; Q9UBW7; -.
DR   DNASU; 7750; -.
DR   Ensembl; ENST00000382871; ENSP00000372324; ENSG00000121741. [Q9UBW7-1]
DR   Ensembl; ENST00000382874; ENSP00000372327; ENSG00000121741. [Q9UBW7-1]
DR   Ensembl; ENST00000610343; ENSP00000479904; ENSG00000121741. [Q9UBW7-1]
DR   GeneID; 7750; -.
DR   KEGG; hsa:7750; -.
DR   UCSC; uc031zxt.2; human. [Q9UBW7-1]
DR   CTD; 7750; -.
DR   DisGeNET; 7750; -.
DR   EuPathDB; HostDB:ENSG00000121741.16; -.
DR   GeneCards; ZMYM2; -.
DR   HGNC; HGNC:12989; ZMYM2.
DR   HPA; HPA031765; -.
DR   MIM; 602221; gene.
DR   neXtProt; NX_Q9UBW7; -.
DR   OpenTargets; ENSG00000121741; -.
DR   PharmGKB; PA37569; -.
DR   eggNOG; ENOG410IE8I; Eukaryota.
DR   eggNOG; ENOG410XQR6; LUCA.
DR   GeneTree; ENSGT00550000074408; -.
DR   HOVERGEN; HBG058385; -.
DR   InParanoid; Q9UBW7; -.
DR   OMA; CKPHMQS; -.
DR   OrthoDB; EOG091G00KQ; -.
DR   PhylomeDB; Q9UBW7; -.
DR   TreeFam; TF336988; -.
DR   Reactome; R-HSA-1839117; Signaling by cytosolic FGFR1 fusion mutants.
DR   Reactome; R-HSA-5655302; Signaling by FGFR1 in disease.
DR   ChiTaRS; ZMYM2; human.
DR   GeneWiki; ZMYM2; -.
DR   GenomeRNAi; 7750; -.
DR   PRO; PR:Q9UBW7; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000121741; -.
DR   ExpressionAtlas; Q9UBW7; baseline and differential.
DR   Genevisible; Q9UBW7; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; NAS:UniProtKB.
DR   GO; GO:0007010; P:cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   GO; GO:0022604; P:regulation of cell morphogenesis; IBA:GO_Central.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR021893; DUF3504.
DR   InterPro; IPR011017; TRASH_dom.
DR   InterPro; IPR010507; Znf_MYM.
DR   Pfam; PF12012; DUF3504; 1.
DR   Pfam; PF06467; zf-FCS; 8.
DR   SMART; SM00746; TRASH; 9.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Complete proteome;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1   1377       Zinc finger MYM-type protein 2.
FT                                /FTId=PRO_0000191382.
FT   ZN_FING     352    386       MYM-type 1.
FT   ZN_FING     398    436       MYM-type 2.
FT   ZN_FING     445    480       MYM-type 3.
FT   ZN_FING     491    549       MYM-type 4.
FT   ZN_FING     559    597       MYM-type 5.
FT   ZN_FING     605    652       MYM-type 6.
FT   ZN_FING     660    694       MYM-type 7.
FT   ZN_FING     701    740       MYM-type 8.
FT   ZN_FING     747    781       MYM-type 9.
FT   SITE        913    914       Breakpoint for translocation to form
FT                                ZMYM2-FGFR1.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     305    305       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     838    838       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     958    958       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1064   1064       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9CU65}.
FT   MOD_RES    1376   1376       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   CROSSLNK     48     48       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     88     88       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     98     98       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    104    104       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    147    147       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    253    253       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    297    297       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    312    312       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    325    325       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    348    348       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    366    366       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    417    417       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    441    441       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    491    491       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    503    503       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    513    513       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    529    529       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    532    532       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    576    576       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    603    603       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    649    649       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    658    658       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    688    688       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    700    700       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    709    709       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    764    764       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    788    788       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    812    812       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    829    829       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     165    251       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_039065.
FT   VAR_SEQ     529    549       KYGKLTTCTGCRTQCRFFDMT -> VSRNVNGVQGLNIFEH
FT                                CYYCH (in isoform 2).
FT                                {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_039066.
FT   VAR_SEQ     550   1377       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_039067.
FT   CONFLICT    102    102       S -> P (in Ref. 4; CAH56193).
FT                                {ECO:0000305}.
FT   CONFLICT    110    110       K -> E (in Ref. 7; AAH36372).
FT                                {ECO:0000305}.
FT   CONFLICT    304    304       L -> V (in Ref. 4; CAB66556).
FT                                {ECO:0000305}.
FT   CONFLICT    330    330       T -> S (in Ref. 4; CAB66556).
FT                                {ECO:0000305}.
FT   CONFLICT    411    412       DK -> EQ (in Ref. 1; CAA73875).
FT                                {ECO:0000305}.
FT   CONFLICT    424    424       R -> G (in Ref. 4; CAB66556).
FT                                {ECO:0000305}.
FT   CONFLICT    657    659       NKV -> ASL (in Ref. 5; CAH70133/
FT                                CAH71822). {ECO:0000305}.
FT   CONFLICT    736    736       K -> G (in Ref. 1; CAA73875).
FT                                {ECO:0000305}.
FT   CONFLICT    766    767       Missing (in Ref. 5; CAH70133/CAH71822).
FT                                {ECO:0000305}.
FT   CONFLICT    856    856       T -> I (in Ref. 7; AAH36372).
FT                                {ECO:0000305}.
FT   CONFLICT    967    967       Missing (in Ref. 9; AAB88464).
FT                                {ECO:0000305}.
FT   CONFLICT   1009   1010       DF -> IS (in Ref. 9; AAB88464).
FT                                {ECO:0000305}.
FT   CONFLICT   1016   1016       Missing (in Ref. 9; AAB88464).
FT                                {ECO:0000305}.
FT   CONFLICT   1259   1259       C -> R (in Ref. 7; AAH36372).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1377 AA;  154911 MW;  2652D4C766492FF9 CRC64;
     MDTSSVGGLE LTDQTPVLLG STAMATSLTN VGNSFSGPAN PLVSRSNKFQ NSSVEDDDDV
     VFIEPVQPPP PSVPVVADQR TITFTSSKNE ELQGNDSKIT PSSKELASQK GSVSETIVID
     DEEDMETNQG QEKNSSNFIE RRPPETKNRT NDVDFSTSSF SRSKVNAGMG NSGITTEPDS
     EIQIANVTTL ETGVSSVNDG QLENTDGRDM NLMITHVTSL QNTNLGDVSN GLQSSNFGVN
     IQTYTPSLTS QTKTGVGPFN PGRMNVAGDV FQNGESATHH NPDSWISQSA SFPRNQKQPG
     VDSLSPVASL PKQIFQPSVQ QQPTKPVKVT CANCKKPLQK GQTAYQRKGS AHLFCSTTCL
     SSFSHKPAPK KLCVMCKKDI TTMKGTIVAQ VDSSESFQEF CSTSCLSLYE DKQNPTKGAL
     NKSRCTICGK LTEIRHEVSF KNMTHKLCSD HCFNRYRMAN GLIMNCCEQC GEYLPSKGAG
     NNVLVIDGQQ KRFCCQSCVS EYKQVGSHPS FLKEVRDHMQ DSFLMQPEKY GKLTTCTGCR
     TQCRFFDMTQ CIGPNGYMEP YCSTACMNSH KTKYAKSQSL GIICHFCKRN SLPQYQATMP
     DGKLYNFCNS SCVAKFQALS MQSSPNGQFV APSDIQLKCN YCKNSFCSKP EILEWENKVH
     QFCSKTCSDD YKKLHCIVTY CEYCQEEKTL HETVNFSGVK RPFCSEGCKL LYKQDFARRL
     GLRCVTCNYC SQLCKKGATK ELDGVVRDFC SEDCCKKFQD WYYKAARCDC CKSQGTLKER
     VQWRGEMKHF CDQHCLLRFY CQQNEPNMTT QKGPENLHYD QGCQTSRTKM TGSAPPPSPT
     PNKEMKNKAV LCKPLTMTKA TYCKPHMQTK SCQTDDTWRT EYVPVPIPVP VYIPVPMHMY
     SQNIPVPTTV PVPVPVPVFL PAPLDSSEKI PAAIEELKSK VSSDALDTEL LTMTDMMSED
     EGKTETTNIN SVIIETDIIG SDLLKNSDPE TQSSMPDVPY EPDLDIEIDF PRAAEELDME
     NEFLLPPVFG EEYEEQPRPR SKKKGAKRKA VSGYQSHDDS SDNSECSFPF KYTYGVNAWK
     HWVKTRQLDE DLLVLDELKS SKSVKLKEDL LSHTTAELNY GLAHFVNEIR RPNGENYAPD
     SIYYLCLGIQ EYLCGSNRKD NIFIDPGYQT FEQELNKILR SWQPSILPDG SIFSRVEEDY
     LWRIKQLGSH SPVALLNTLF YFNTKYFGLK TVEQHLRLSF GTVFRHWKKN PLTMENKACL
     RYQVSSLCGT DNEDKITTGK RKHEDDEPVF EQIENTANPS RCPVKMFECY LSKSPQNLNQ
     RMDVFYLQPE CSSSTDSPVW YTSTSLDRNT LENMLVRVLL VKDIYDKDNY ELDEDTD
//
ID   ZN384_HUMAN             Reviewed;         577 AA.
AC   Q8TF68; O15407; Q7Z722; Q8N938;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   28-FEB-2018, entry version 146.
DE   RecName: Full=Zinc finger protein 384;
DE   AltName: Full=CAG repeat protein 1;
DE   AltName: Full=CAS-interacting zinc finger protein;
DE   AltName: Full=Nuclear matrix transcription factor 4;
DE            Short=Nuclear matrix protein 4;
DE   AltName: Full=Trinucleotide repeat-containing gene 1 protein;
GN   Name=ZNF384; Synonyms=CAGH1, CIZ, NMP4, TNRC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RA   Matsuo M.Y.;
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 395-577 (ISOFORMS 1/2/3).
RC   TISSUE=Brain cortex;
RX   PubMed=9225980; DOI=10.1007/s004390050476;
RA   Margolis R.L., Abraham M.R., Gatchell S.B., Li S.-H., Kidwai A.S.,
RA   Breschel T.S., Stine O.C., Callahan C., McInnis M.G., Ross C.A.;
RT   "cDNAs with long CAG trinucleotide repeats from human brain.";
RL   Hum. Genet. 100:114-122(1997).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
CC   -!- FUNCTION: Transcription factor that binds the consensus DNA
CC       sequence [GC]AAAAA. Seems to bind and regulate the promoters of
CC       MMP1, MMP3, MMP7 and COL1A1 (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with BCAR1. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q8TF68-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TF68-2; Sequence=VSP_006920;
CC       Name=3;
CC         IsoId=Q8TF68-3; Sequence=VSP_040314, VSP_040315;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ZNF384ID42881ch12p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB070238; BAB85125.1; -; Genomic_DNA.
DR   EMBL; AK095734; BAC04618.1; -; mRNA.
DR   EMBL; AC125494; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471116; EAW88756.1; -; Genomic_DNA.
DR   EMBL; BC053361; AAH53361.1; -; mRNA.
DR   EMBL; U80738; AAB91437.1; -; mRNA.
DR   CCDS; CCDS31732.1; -. [Q8TF68-3]
DR   CCDS; CCDS44817.1; -. [Q8TF68-1]
DR   CCDS; CCDS8557.1; -. [Q8TF68-2]
DR   RefSeq; NP_001035009.1; NM_001039920.2. [Q8TF68-3]
DR   RefSeq; NP_001129206.1; NM_001135734.2. [Q8TF68-1]
DR   RefSeq; NP_597733.2; NM_133476.4. [Q8TF68-2]
DR   RefSeq; XP_016874430.1; XM_017018941.1. [Q8TF68-1]
DR   RefSeq; XP_016874431.1; XM_017018942.1. [Q8TF68-1]
DR   RefSeq; XP_016874432.1; XM_017018943.1. [Q8TF68-1]
DR   RefSeq; XP_016874438.1; XM_017018949.1. [Q8TF68-2]
DR   RefSeq; XP_016874439.1; XM_017018950.1. [Q8TF68-2]
DR   UniGene; Hs.103315; -.
DR   ProteinModelPortal; Q8TF68; -.
DR   SMR; Q8TF68; -.
DR   BioGrid; 128100; 8.
DR   IntAct; Q8TF68; 3.
DR   STRING; 9606.ENSP00000354592; -.
DR   iPTMnet; Q8TF68; -.
DR   PhosphoSitePlus; Q8TF68; -.
DR   BioMuta; ZNF384; -.
DR   DMDM; 296453052; -.
DR   EPD; Q8TF68; -.
DR   MaxQB; Q8TF68; -.
DR   PaxDb; Q8TF68; -.
DR   PeptideAtlas; Q8TF68; -.
DR   PRIDE; Q8TF68; -.
DR   Ensembl; ENST00000319770; ENSP00000321650; ENSG00000126746. [Q8TF68-2]
DR   Ensembl; ENST00000355772; ENSP00000348018; ENSG00000126746. [Q8TF68-3]
DR   Ensembl; ENST00000361959; ENSP00000354592; ENSG00000126746. [Q8TF68-1]
DR   Ensembl; ENST00000396801; ENSP00000380019; ENSG00000126746. [Q8TF68-1]
DR   GeneID; 171017; -.
DR   KEGG; hsa:171017; -.
DR   UCSC; uc001qqa.4; human. [Q8TF68-1]
DR   CTD; 171017; -.
DR   DisGeNET; 171017; -.
DR   EuPathDB; HostDB:ENSG00000126746.17; -.
DR   GeneCards; ZNF384; -.
DR   HGNC; HGNC:11955; ZNF384.
DR   HPA; HPA004051; -.
DR   MIM; 609951; gene.
DR   neXtProt; NX_Q8TF68; -.
DR   OpenTargets; ENSG00000126746; -.
DR   PharmGKB; PA36644; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00900000140926; -.
DR   HOGENOM; HOG000233753; -.
DR   HOVERGEN; HBG058173; -.
DR   InParanoid; Q8TF68; -.
DR   OMA; IHAKSHT; -.
DR   OrthoDB; EOG091G05IN; -.
DR   PhylomeDB; Q8TF68; -.
DR   TreeFam; TF336115; -.
DR   ChiTaRS; ZNF384; human.
DR   GeneWiki; ZNF384; -.
DR   GenomeRNAi; 171017; -.
DR   PRO; PR:Q8TF68; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000126746; -.
DR   CleanEx; HS_ZNF384; -.
DR   ExpressionAtlas; Q8TF68; baseline and differential.
DR   Genevisible; Q8TF68; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF57667; SSF57667; 5.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 8.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 8.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; DNA-binding; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN         1    577       Zinc finger protein 384.
FT                                /FTId=PRO_0000047552.
FT   ZN_FING     228    250       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     256    278       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     284    306       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     317    339       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     345    367       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     373    397       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     403    425       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     433    455       C2H2-type 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   COMPBIAS    461    521       Gln-rich.
FT   COMPBIAS    466    499       Ala-rich.
FT   MOD_RES     214    214       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ     102    156       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040314.
FT   VAR_SEQ     293    353       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040315.
FT   VAR_SEQ     300    360       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_006920.
FT   CONFLICT    501    501       Missing (in Ref. 1; BAB85125, 2;
FT                                BAC04618, 4; EAW88756, 5; AAH53361 and 6;
FT                                AAB91437). {ECO:0000305}.
SQ   SEQUENCE   577 AA;  63219 MW;  5899CAB02DBBE0CB CRC64;
     MEESHFNSNP YFWPSIPTVS GQIENTMFIN KMKDQLLPEK GCGLAPPHYP TLLTVPASVS
     LPSGISMDTE SKSDQLTPHS QASVTQNITV VPVPSTGLMT AGVSCSQRWR REGSQSRGPG
     LVITSPSGSL VTTASSAQTF PISAPMIVSA LPPGSQALQV VPDLSKKVAS TLTEEGGGGG
     GGGGSVAPKP PRGRKKKRML ESGLPEMNDP YVLSPEDDDD HQKDGKTYRC RMCSLTFYSK
     SEMQIHSKSH TETKPHKCPH CSKTFANSSY LAQHIRIHSG AKPYSCNFCE KSFRQLSHLQ
     QHTRIHSKMH TETIKPHKCP HCSKTFANTS YLAQHLRIHS GAKPYNCSYC QKAFRQLSHL
     QQHTRIHTGD RPYKCAHPGC EKAFTQLSNL QSHRRQHNKD KPFKCHNCHR AYTDAASLEV
     HLSTHTVKHA KVYTCTICSR AYTSETYLMK HMRKHNPPDL QQQVQAAAAA AAVAQAQAQA
     QAQAQAQAQA QAQAQASQAS QQQQQQQQQQ QQQQQQPPPH FQSPGAAPQG GGGGDSNPNP
     PPQCSFDLTP YKTAEHHKDI CLTVTTSTIQ VEHLASS
//
